<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34916049</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>128</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Mar</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Goal-directed haemodynamic therapy during general anaesthesia for noncardiac surgery: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>416</StartPage><EndPage>433</EndPage><MedlinePgn>416-433</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2021.10.046</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(21)00733-9</ELocationID><Abstract><AbstractText Label="BACKGROUND">During general anaesthesia for noncardiac surgery, there remain knowledge gaps regarding the effect of goal-directed haemodynamic therapy on patient-centred outcomes.</AbstractText><AbstractText Label="METHODS">Included clinical trials investigated goal-directed haemodynamic therapy during general anaesthesia in adults undergoing noncardiac surgery and reported at least one patient-centred postoperative outcome. PubMed and Embase were searched for relevant articles on March 8, 2021. Two investigators performed abstract screening, full-text review, data extraction, and bias assessment. The primary outcomes were mortality and hospital length of stay, whereas 15 postoperative complications were included based on availability. From a main pool of comparable trials, meta-analyses were performed on trials with homogenous outcome definitions. Certainty of evidence was evaluated using Grading of Recommendations, Assessment, Development, and Evaluations (GRADE).</AbstractText><AbstractText Label="RESULTS">The main pool consisted of 76 trials with intermediate risk of bias for most outcomes. Overall, goal-directed haemodynamic therapy might reduce mortality (odds ratio=0.84; 95% confidence interval [CI], 0.64 to 1.09) and shorten length of stay (mean difference=-0.72 days; 95% CI, -1.10 to -0.35) but with low certainty in the evidence. For both outcomes, larger effects favouring goal-directed haemodynamic therapy were seen in abdominal surgery, very high-risk surgery, and using targets based on preload variation by the respiratory cycle. However, formal tests for subgroup differences were not statistically significant. Goal-directed haemodynamic therapy decreased risk of several postoperative outcomes, but only infectious outcomes and anastomotic leakage reached moderate certainty of evidence.</AbstractText><AbstractText Label="CONCLUSIONS">Goal-directed haemodynamic therapy during general anaesthesia might decrease mortality, hospital length of stay, and several postoperative complications. Only infectious postoperative complications and anastomotic leakage reached moderate certainty in the evidence.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jessen</LastName><ForeName>Marie K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Research Center for Emergency Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vallentin</LastName><ForeName>Mikael F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Prehospital Emergency Medical Services, Central Denmark Region, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holmberg</LastName><ForeName>Mathias J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Research Center for Emergency Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Department of Cardiology, Viborg Regional Hospital, Viborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bolther</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hansen</LastName><ForeName>Frederik B</ForeName><Initials>FB</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holst</LastName><ForeName>Johanne M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magnussen</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hansen</LastName><ForeName>Niklas S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johannsen</LastName><ForeName>Cecilie M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Enevoldsen</LastName><ForeName>Johannes</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jensen</LastName><ForeName>Thomas H</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University Hospital of North Norway, Narvik, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roessler</LastName><ForeName>Lara L</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lind</LastName><ForeName>Peter C</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Department of Surgical Gastroenterology, Aalborg University Hospital, Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klitholm</LastName><ForeName>Maibritt P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eggertsen</LastName><ForeName>Mark A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caap</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boye</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dabrowski</LastName><ForeName>Karol M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vormfenne</LastName><ForeName>Lasse</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>H&#xf8;ybye</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Research Center for Emergency Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henriksen</LastName><ForeName>Jeppe</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karlsson</LastName><ForeName>Carl M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Aalborg University Hospital, Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balleby</LastName><ForeName>Ida R</ForeName><Initials>IR</Initials><AffiliationInfo><Affiliation>National Hospital of the Faroe Islands, Torshavn, Faroe Islands, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasmussen</LastName><ForeName>Marie S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Aalborg University Hospital, Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe6;lestik</LastName><ForeName>Kim</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Viborg Regional Hospital, Viborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Granfeldt</LastName><ForeName>Asger</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Department of Anesthesiology and Intensive Care, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andersen</LastName><ForeName>Lars W</ForeName><Initials>LW</Initials><AffiliationInfo><Affiliation>Research Center for Emergency Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Prehospital Emergency Medical Services, Central Denmark Region, Aarhus, Denmark; Department of Anesthesiology and Intensive Care, Aarhus University Hospital, Aarhus, Denmark. Electronic address: lwandersen@clin.au.dk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Br J Anaesth. 2022 Apr;128(4):e286-e288. doi: 10.1016/j.bja.2022.01.011.</RefSource><PMID Version="1">35131095</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Br J Anaesth. 2023 Apr;130(4):390-393. doi: 10.1016/j.bja.2022.12.022.</RefSource><PMID Version="1">36732140</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013502" MajorTopicYN="N">General Surgery</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">fluid</Keyword><Keyword MajorTopicYN="N">general anaesthesia</Keyword><Keyword MajorTopicYN="N">goal-directed haemodynamic therapy</Keyword><Keyword MajorTopicYN="N">haemodynamics</Keyword><Keyword MajorTopicYN="N">perioperative care</Keyword><Keyword MajorTopicYN="N">postoperative complications</Keyword><Keyword MajorTopicYN="N">stroke volume</Keyword></KeywordList><CoiStatement>None of the authors have any conflicts of interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>17</Day><Hour>5</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>12</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34916049</ArticleId><ArticleId IdType="pmc">PMC8900265</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2021.10.046</ArticleId><ArticleId IdType="pii">S0007-0912(21)00733-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Weiser T.G., Haynes A.B., Molina G., et al. Size and distribution of the global volume of surgery in 2012. Bull World Health Organ. 2016;94:201&#x2013;209F.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4773932</ArticleId><ArticleId IdType="pubmed">26966331</ArticleId></ArticleIdList></Reference><Reference><Citation>Global patient outcomes after elective surgery: prospective cohort study in 27 low-, middle- and high-income countries. Br J Anaesth. 2016;117:601&#x2013;609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5091334</ArticleId><ArticleId IdType="pubmed">27799174</ArticleId></ArticleIdList></Reference><Reference><Citation>Biccard B.M., Madiba T.E., Kluyts H.L., et al. Perioperative patient outcomes in the African Surgical Outcomes Study: a 7-day prospective observational cohort study. Lancet. 2018;391:1589&#x2013;1598.</Citation><ArticleIdList><ArticleId IdType="pubmed">29306587</ArticleId></ArticleIdList></Reference><Reference><Citation>Gleason L.J., Schmitt E.M., Kosar C.M., et al. Effect of delirium and other major complications on outcomes after elective surgery in older adults. JAMA Surg. 2015;150:1134&#x2013;1140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4684425</ArticleId><ArticleId IdType="pubmed">26352694</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitt E.M., Saczynski J.S., Kosar C.M., et al. The Successful Aging after Elective Surgery (SAGES) study: cohort description and data quality procedures. J&#xa0;Am Geriatr Soc. 2015;63:2463&#x2013;2471.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4688907</ArticleId><ArticleId IdType="pubmed">26662213</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufmann T., Clement R.P., Scheeren T.W.L., Saugel B., Keus F., van der Horst I.C.C. Perioperative goal-directed therapy: a systematic review without meta-analysis. Acta Anaesthesiol Scand. 2018;62:1340&#x2013;1355.</Citation><ArticleIdList><ArticleId IdType="pubmed">29978454</ArticleId></ArticleIdList></Reference><Reference><Citation>Ripoll&#xe9;s J., Espinosa A., Mart&#xed;nez-Hurtado E., et al. Intraoperative goal directed hemodynamic therapy in noncardiac surgery: a systematic review and meta-analysis. Braz J Anesthesiol. 2016;66:513&#x2013;528.</Citation><ArticleIdList><ArticleId IdType="pubmed">27591466</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao G., Peng P., Zhou Y., Li J., Jiang H., Shao J. The accuracy and effectiveness of goal directed fluid therapy in plateau-elderly gastrointestinal cancer patients: a prospective randomized controlled trial. Int J Clin Exp Med. 2018;11:8516&#x2013;8522.</Citation></Reference><Reference><Citation>Yuan J., Sun Y., Pan C., Li T. Goal-directed fluid therapy for reducing risk of surgical site infections following abdominal surgery &#x2014; a systematic review and meta-analysis of randomized controlled trials. Int J Surg. 2017;39:74&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">28126672</ArticleId></ArticleIdList></Reference><Reference><Citation>Rollins K., Mathias N., Lobo D. Meta-analysis of goal-directed fluid therapy using transoesophageal Doppler monitoring in patients undergoing elective colorectal surgery. BJS Open. 2019;3:606&#x2013;616.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6773648</ArticleId><ArticleId IdType="pubmed">31592512</ArticleId></ArticleIdList></Reference><Reference><Citation>Cronhjort M., Wall O., Nyberg E., et al. Impact of hemodynamic goal-directed resuscitation on mortality in adult critically ill patients: a systematic review and meta-analysis. J&#xa0;Clin Monit Comput. 2018;32:403&#x2013;414.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5943381</ArticleId><ArticleId IdType="pubmed">28593456</ArticleId></ArticleIdList></Reference><Reference><Citation>Grocott M.P., Dushianthan A., Hamilton M.A., Mythen M.G., Harrison D., Rowan K. Perioperative increase in global blood flow to explicit defined goals and outcomes following surgery. Cochrane Database Syst Rev. 2012;11:CD004082.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6477700</ArticleId><ArticleId IdType="pubmed">23152223</ArticleId></ArticleIdList></Reference><Reference><Citation>Som A., Maitra S., Bhattacharjee S., Baidya D.K. Goal directed fluid therapy decreases postoperative morbidity but not mortality in major non-cardiac surgery: a meta-analysis and trial sequential analysis of randomized controlled trials. J&#xa0;Anesth. 2017;31:66&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">27738801</ArticleId></ArticleIdList></Reference><Reference><Citation>Benes J., Giglio M., Brienza N., Michard F. The effects of goal-directed fluid therapy based on dynamic parameters on post-surgical outcome: a meta-analysis of randomized controlled trials. Crit Care. 2014;18:584.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4234857</ArticleId><ArticleId IdType="pubmed">25348900</ArticleId></ArticleIdList></Reference><Reference><Citation>Michard F., Giglio M.T., Brienza N. Perioperative goal-directed therapy with uncalibrated pulse contour methods: impact on fluid management and postoperative outcome. Br J Anaesth. 2017;119:22&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">28605442</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng S., Yang S., Xiao W., Wang X., Yang K., Wang T. Effects of perioperative goal-directed fluid therapy combined with the application of alpha-1 adrenergic agonists on postoperative outcomes: a systematic review and meta-analysis. BMC Anesthesiol. 2018;18:113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6098606</ArticleId><ArticleId IdType="pubmed">30119644</ArticleId></ArticleIdList></Reference><Reference><Citation>Odor P.M., Bampoe S., Gilhooly D., Creagh-Brown B., Moonesinghe S.R. Perioperative interventions for prevention of postoperative pulmonary complications: systematic review and meta-analysis. BMJ. 2020;368:m540.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7190038</ArticleId><ArticleId IdType="pubmed">32161042</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton M.A., Cecconi M., Rhodes A. A&#xa0;systematic review and meta-analysis on the use of preemptive hemodynamic intervention to improve postoperative outcomes in moderate and high-risk surgical patients. Anesth Analg. 2011;112:1392&#x2013;1402.</Citation><ArticleIdList><ArticleId IdType="pubmed">20966436</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger M.M., Gradwohl-Matis I., Brunauer A., Ulmer H., D&#xfc;nser M.W. Targets of perioperative fluid therapy and their effects on postoperative outcome: a systematic review and meta-analysis. Minerva Anestesiol. 2015;81:794&#x2013;808.</Citation><ArticleIdList><ArticleId IdType="pubmed">25220553</ArticleId></ArticleIdList></Reference><Reference><Citation>Ripoll&#xe9;s-Melchor J., Espinosa &#xc1;., Mart&#xed;nez-Hurtado E., et al. Perioperative goal-directed hemodynamic therapy in noncardiac surgery: a systematic review and meta-analysis. J&#xa0;Clin Anesth. 2016;28:105&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pubmed">26440438</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurgel S.T., do Nascimento P., Jr. Maintaining tissue perfusion in high-risk surgical patients: a systematic review of randomized clinical trials. Anesth Analg. 2011;112:1384&#x2013;1391.</Citation><ArticleIdList><ArticleId IdType="pubmed">21156979</ArticleId></ArticleIdList></Reference><Reference><Citation>Messina A., Robba C., Calabr&#xf2; L., et al. Association between perioperative fluid administration and postoperative outcomes: a 20-year systematic review and a meta-analysis of randomized goal-directed trials in major visceral/noncardiac surgery. Crit Care. 2021;25:43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7849093</ArticleId><ArticleId IdType="pubmed">33522953</ArticleId></ArticleIdList></Reference><Reference><Citation>Giglio M., Dalfino L., Puntillo F., Brienza N. Hemodynamic goal-directed therapy and postoperative kidney injury: an updated meta-analysis with trial sequential analysis. Crit Care. 2019;23:232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6593609</ArticleId><ArticleId IdType="pubmed">31242941</ArticleId></ArticleIdList></Reference><Reference><Citation>Dushianthan A., Knight M., Russell P., Grocott M.P. Goal-directed haemodynamic therapy (GDHT) in surgical patients: systematic review and meta-analysis of the impact of GDHT on post-operative pulmonary complications. Perioper Med (Lond) 2020;9:30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7560066</ArticleId><ArticleId IdType="pubmed">33072306</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalfino L., Giglio M.T., Puntillo F., Marucci M., Brienza N. Haemodynamic goal-directed therapy and postoperative infections: earlier is better. A systematic review and meta-analysis. Crit Care. 2011;15:R154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3219028</ArticleId><ArticleId IdType="pubmed">21702945</ArticleId></ArticleIdList></Reference><Reference><Citation>Arulkumaran N., Corredor C., Hamilton M.A., et al. Cardiac complications associated with goal-directed therapy in high-risk surgical patients: a meta-analysis. Br J Anaesth. 2014;112:648&#x2013;659.</Citation><ArticleIdList><ArticleId IdType="pubmed">24413429</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M.J., McKenzie J.E., Bossuyt P.M., et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J., Thomas J., Chandler J., et al.   2020. Cochrane handbook for systematic reviews of interventions.www.training.cochrane.org/handbook Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J., Sterne J., Savovi&#x107; J., et al. A&#xa0;revised tool for assessing risk of bias in randomized trials. Cochrane Database Syst Rev. 2016;10 doi: 10.1002/14651858.CD201601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD201601</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Jammer I., Wickboldt N., Sander M., et al. Standards for definitions and use of outcome measures for clinical effectiveness research in perioperative medicine: European Perioperative Clinical Outcome (EPCO) definitions: a statement from the ESA-ESICM joint taskforce on perioperative outcome measures. Eur J Anaesthesiol. 2015;32:88&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pubmed">25058504</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharp S.J., Thompson S.G., Altman D.G. The relation between treatment benefit and underlying risk in meta-analysis. BMJ. 1996;313:735&#x2013;738.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2352108</ArticleId><ArticleId IdType="pubmed">8819447</ArticleId></ArticleIdList></Reference><Reference><Citation>Reade M.C., Delaney A., Bailey M.J., Angus D.C. Bench-to-bedside review: avoiding pitfalls in critical care meta-analysis&#x2014;funnel plots, risk estimates, types of heterogeneity, baseline risk and the ecologic fallacy. Crit Care. 2008;12:220.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2575558</ArticleId><ArticleId IdType="pubmed">18671838</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeting M.J., Sutton A.J., Lambert P.C. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med. 2004;23:1351&#x2013;1375.</Citation><ArticleIdList><ArticleId IdType="pubmed">15116347</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradburn M.J., Deeks J.J., Berlin J.A., Russell Localio A. Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. Stat Med. 2007;26:53&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">16596572</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J., Luo D., Weng H., et al. Optimally estimating the sample standard deviation from the five-number summary. Res Synth Methods. 2020;11:641&#x2013;654.</Citation><ArticleIdList><ArticleId IdType="pubmed">32562361</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J., Green S. 2011. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [Updated March 2011]</Citation></Reference><Reference><Citation>Guyatt G.H., Oxman A.D., Vist G.E., et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924&#x2013;926.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoemaker W.C., Appel P.L., Kram H.B., Waxman K., Lee T.S. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest. 1988;94:1176&#x2013;1186.</Citation><ArticleIdList><ArticleId IdType="pubmed">3191758</ArticleId></ArticleIdList></Reference><Reference><Citation>Bender J.S., Smith-Meek M.A., Jones C.E. Routine pulmonary artery catheterization does not reduce morbidity and mortality of elective vascular surgery: results of a prospective, randomized trial. Ann Surg. 1997;226:229&#x2013;236. discussion 36&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1191013</ArticleId><ArticleId IdType="pubmed">9339929</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinclair S., James S., Singer M. Intraoperative intravascular volume optimisation and length of hospital stay after repair of proximal femoral fracture: randomised controlled trial. BMJ. 1997;315:909&#x2013;912.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2127619</ArticleId><ArticleId IdType="pubmed">9361539</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway D.H., Mayall R., Abdul-Latif M.S., Gilligan S., Tackaberry C. Randomised controlled trial investigating the influence of intravenous fluid titration using oesophageal Doppler monitoring during bowel surgery. Anaesthesia. 2002;57:845&#x2013;849.</Citation><ArticleIdList><ArticleId IdType="pubmed">12190747</ArticleId></ArticleIdList></Reference><Reference><Citation>Gan T.J., Soppitt A., Maroof M., et al. Goal-directed intraoperative fluid administration reduces length of hospital stay after major surgery. Anesthesiology. 2002;97:820&#x2013;826.</Citation><ArticleIdList><ArticleId IdType="pubmed">12357146</ArticleId></ArticleIdList></Reference><Reference><Citation>Venn R., Steele A., Richardson P., Poloniecki J., Grounds M., Newman P. Randomized controlled trial to investigate influence of the fluid challenge on duration of hospital stay and perioperative morbidity in patients with hip fractures. Br J Anaesth. 2002;88:65&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">11881887</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakeling H.G., McFall M.R., Jenkins C.S., et al. Intraoperative oesophageal Doppler guided fluid management shortens postoperative hospital stay after major bowel surgery. Br J Anaesth. 2005;95:634&#x2013;642.</Citation><ArticleIdList><ArticleId IdType="pubmed">16155038</ArticleId></ArticleIdList></Reference><Reference><Citation>Noblett S.E., Snowden C.P., Shenton B.K., Horgan A.F. Randomized clinical trial assessing the effect of Doppler-optimized fluid management on outcome after elective colorectal resection. Br J Surg. 2006;93:1069&#x2013;1076.</Citation><ArticleIdList><ArticleId IdType="pubmed">16888706</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes M.R., Oliveira M.A., Pereira V.O., Lemos I.P., Auler J.O., Jr., Michard F. Goal-directed fluid management based on pulse pressure variation monitoring during high-risk surgery: a pilot randomized controlled trial. Crit Care. 2007;11:R100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2556743</ArticleId><ArticleId IdType="pubmed">17822565</ArticleId></ArticleIdList></Reference><Reference><Citation>Buettner M., Schummer W., Huettemann E., Schenke S., van Hout N., Sakka S.G. Influence of systolic-pressure-variation-guided intraoperative fluid management on organ function and oxygen transport. Br J Anaesth. 2008;101:194&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pubmed">18511439</ArticleId></ArticleIdList></Reference><Reference><Citation>Harten J., Crozier J.E., McCreath B., et al. Effect of intraoperative fluid optimisation on renal function in patients undergoing emergency abdominal surgery: a randomised controlled pilot study (ISRCTN 11799696) Int J Surg. 2008;6:197&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pubmed">18424200</ArticleId></ArticleIdList></Reference><Reference><Citation>Senagore A.J., Emery T., Luchtefeld M., Kim D., Dujovny N., Hoedema R. Fluid management for laparoscopic colectomy: a prospective, randomized assessment of goal-directed administration of balanced salt solution or hetastarch coupled with an enhanced recovery program. Dis Colon Rectum. 2009;52:1935&#x2013;1940.</Citation><ArticleIdList><ArticleId IdType="pubmed">19934912</ArticleId></ArticleIdList></Reference><Reference><Citation>Benes J., Chytra I., Altmann P., et al. Intraoperative fluid optimization using stroke volume variation in high risk surgical patients: results of prospective randomized study. Crit Care. 2010;14:R118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2911766</ArticleId><ArticleId IdType="pubmed">20553586</ArticleId></ArticleIdList></Reference><Reference><Citation>Forget P., Lois F., de Kock M. Goal-directed fluid management based on the pulse oximeter-derived pleth variability index reduces lactate levels and improves fluid management. Anesth Analg. 2010;111:910&#x2013;914.</Citation><ArticleIdList><ArticleId IdType="pubmed">20705785</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer J., Boldt J., Mengistu A.M., R&#xf6;hm K.D., Suttner S. Goal-directed intraoperative therapy based on autocalibrated arterial pressure waveform analysis reduces hospital stay in high-risk surgical patients: a randomized, controlled trial. Crit Care. 2010;14:R18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2875533</ArticleId><ArticleId IdType="pubmed">20156348</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Linden P.J., Dierick A., Wilmin S., Bellens B., De Hert S.G. A&#xa0;randomized controlled trial comparing an intraoperative goal-directed strategy with routine clinical practice in patients undergoing peripheral arterial surgery. Eur J Anaesthesiol. 2010;27:788&#x2013;793.</Citation><ArticleIdList><ArticleId IdType="pubmed">20613538</ArticleId></ArticleIdList></Reference><Reference><Citation>Challand C., Struthers R., Sneyd J.R., et al. Randomized controlled trial of intraoperative goal-directed fluid therapy in aerobically fit and unfit patients having major colorectal surgery. Br J Anaesth. 2012;108:53&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">21873370</ArticleId></ArticleIdList></Reference><Reference><Citation>Pillai P., McEleavy I., Gaughan M., et al. A&#xa0;double-blind randomized controlled clinical trial to assess the effect of Doppler optimized intraoperative fluid management on outcome following radical cystectomy. J&#xa0;Urol. 2011;186:2201&#x2013;2206.</Citation><ArticleIdList><ArticleId IdType="pubmed">22014804</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandstrup B., Svendsen P.E., Rasmussen M., et al. Which goal for fluid therapy during colorectal surgery is followed by the best outcome: near-maximal stroke volume or zero fluid balance? Br J Anaesth. 2012;109:191&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pubmed">22710266</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Qiao H., He Z., Wang Y., Che X., Liang W. Intraoperative fluid management in open gastrointestinal surgery: goal-directed versus restrictive. Clinics (Sao Paulo) 2012;67:1149&#x2013;1155.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3460017</ArticleId><ArticleId IdType="pubmed">23070341</ArticleId></ArticleIdList></Reference><Reference><Citation>Bisgaard J., Gilsaa T., R&#xf8;nholm E., Toft P. Optimising stroke volume and oxygen delivery in abdominal aortic surgery: a randomised controlled trial. Acta Anaesthesiol Scand. 2013;57:178&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">22897633</ArticleId></ArticleIdList></Reference><Reference><Citation>Bundgaard-Nielsen M., Jans &#xd8;., M&#xfc;ller R.G., et al. Does goal-directed fluid therapy affect postoperative orthostatic intolerance?: a randomized trial. Anesthesiology. 2013;119:813&#x2013;823.</Citation><ArticleIdList><ArticleId IdType="pubmed">23756453</ArticleId></ArticleIdList></Reference><Reference><Citation>El Sharkawy O.A., Refaat E.K., Ibraheem A.E., et al. Transoesophageal Doppler compared to central venous pressure for perioperative hemodynamic monitoring and fluid guidance in liver resection. Saudi J Anaesth. 2013;7:378&#x2013;386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3858686</ArticleId><ArticleId IdType="pubmed">24348287</ArticleId></ArticleIdList></Reference><Reference><Citation>McKenny M., Conroy P., Wong A., et al. A&#xa0;randomised prospective trial of intra-operative oesophageal Doppler-guided fluid administration in major gynaecological surgery. Anaesthesia. 2013;68:1224&#x2013;1231.</Citation><ArticleIdList><ArticleId IdType="pubmed">24116747</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramsingh D.S., Sanghvi C., Gamboa J., Cannesson M., Applegate R.L., 2nd Outcome impact of goal directed fluid therapy during high risk abdominal surgery in low to moderate risk patients: a randomized controlled trial. J&#xa0;Clin Monit Comput. 2013;27:249&#x2013;257.</Citation><ArticleIdList><ArticleId IdType="pubmed">23264068</ArticleId></ArticleIdList></Reference><Reference><Citation>Salzwedel C., Puig J., Carstens A., et al. Perioperative goal-directed hemodynamic therapy based on radial arterial pulse pressure variation and continuous cardiac index trending reduces postoperative complications after major abdominal surgery: a multi-center, prospective, randomized study. Crit Care. 2013;17:R191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4057030</ArticleId><ArticleId IdType="pubmed">24010849</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheeren T.W., Wiesenack C., Gerlach H., Marx G. Goal-directed intraoperative fluid therapy guided by stroke volume and its variation in high-risk surgical patients: a prospective randomized multicentre study. J&#xa0;Clin Monit Comput. 2013;27:225&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pubmed">23558909</ArticleId></ArticleIdList></Reference><Reference><Citation>Srinivasa S., Taylor M.H., Singh P.P., Yu T.C., Soop M., Hill A.G. Randomized clinical trial of goal-directed fluid therapy within an enhanced recovery protocol for elective colectomy. Br J Surg. 2013;100:66&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">23132508</ArticleId></ArticleIdList></Reference><Reference><Citation>Zakhaleva J., Tam J., Denoya P.I., Bishawi M., Bergamaschi R. The impact of intravenous fluid administration on complication rates in bowel surgery within an enhanced recovery protocol: a randomized controlled trial. Colorectal Dis. 2013;15:892&#x2013;899.</Citation><ArticleIdList><ArticleId IdType="pubmed">23905554</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng H., Guo H., Ye J.R., Chen L., Ma H.P. Goal-directed fluid therapy in gastrointestinal surgery in older coronary heart disease patients: randomized trial. World J Surg. 2013;37:2820&#x2013;2829.</Citation><ArticleIdList><ArticleId IdType="pubmed">24048581</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearse R.M., Harrison D.A., MacDonald N., et al. Effect of a perioperative, cardiac output-guided hemodynamic therapy algorithm on outcomes following major gastrointestinal surgery: a randomized clinical trial and systematic review. JAMA. 2014;311:2181&#x2013;2190.</Citation><ArticleIdList><ArticleId IdType="pubmed">24842135</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng K., Li J., Cheng H., Ji F.H. Goal-directed fluid therapy based on stroke volume variations improves fluid management and gastrointestinal perfusion in patients undergoing major orthopedic surgery. Med Princ Pract. 2014;23:413&#x2013;420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5586912</ArticleId><ArticleId IdType="pubmed">24994571</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesta&#xf1;a D., Espinosa E., Eden A., et al. Perioperative goal-directed hemodynamic optimization using noninvasive cardiac output monitoring in major abdominal surgery: a prospective, randomized, multicenter, pragmatic trial: POEMAS Study (PeriOperative goal-directed thErapy in Major Abdominal Surgery) Anesth Analg. 2014;119:579&#x2013;587.</Citation><ArticleIdList><ArticleId IdType="pubmed">25010820</ArticleId></ArticleIdList></Reference><Reference><Citation>Phan T.D., D'Souza B., Rattray M.J., Johnston M.J., Cowie B.S. A&#xa0;randomised controlled trial of fluid restriction compared to oesophageal Doppler-guided goal-directed fluid therapy in elective major colorectal surgery within an Enhanced Recovery after Surgery program. Anaesth Intensive Care. 2014;42:752&#x2013;760.</Citation><ArticleIdList><ArticleId IdType="pubmed">25342408</ArticleId></ArticleIdList></Reference><Reference><Citation>Shillcutt S.K., Montzingo C.R., Agrawal A., et al. Echocardiography-based hemodynamic management of left ventricular diastolic dysfunction: a feasibility and safety study. Echocardiography. 2014;31:1189&#x2013;1198.</Citation><ArticleIdList><ArticleId IdType="pubmed">24660834</ArticleId></ArticleIdList></Reference><Reference><Citation>Benes J., Haidingerova L., Pouska J., et al. Fluid management guided by a continuous non-invasive arterial pressure device is associated with decreased postoperative morbidity after total knee and hip replacement. BMC Anesthesiol. 2015;15:148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4608292</ArticleId><ArticleId IdType="pubmed">26471495</ArticleId></ArticleIdList></Reference><Reference><Citation>Colantonio L., Claroni C., Fabrizi L., et al. A&#xa0;randomized trial of goal directed vs. standard fluid therapy in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. J&#xa0;Gastrointest Surg. 2015;19:722&#x2013;729.</Citation><ArticleIdList><ArticleId IdType="pubmed">25595308</ArticleId></ArticleIdList></Reference><Reference><Citation>Correa-Gallego C., Tan K.S., Arslan-Carlon V., et al. Goal-directed fluid therapy using stroke volume variation for resuscitation after low central venous pressure-assisted liver resection: a randomized clinical trial. J&#xa0;Am Coll Surg. 2015;221:591&#x2013;601.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4926263</ArticleId><ArticleId IdType="pubmed">26206652</ArticleId></ArticleIdList></Reference><Reference><Citation>Funk D.J., HayGlass K.T., Koulack J., Harding G., Boyd A., Brinkman R. A&#xa0;randomized controlled trial on the effects of goal-directed therapy on the inflammatory response open abdominal aortic aneurysm repair. Crit Care. 2015;19:247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4479246</ArticleId><ArticleId IdType="pubmed">26062689</ArticleId></ArticleIdList></Reference><Reference><Citation>Jammer I., Tuovila M., Ulvik A. Stroke volume variation to guide fluid therapy: is it suitable for high-risk surgical patients? A terminated randomized controlled trial. Perioper Med (Lond) 2015;4:6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4511544</ArticleId><ArticleId IdType="pubmed">26203353</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar L., Kanneganti Y.S., Rajan S. Outcomes of implementation of enhanced goal directed therapy in high-risk patients undergoing abdominal surgery. Indian J Anaesth. 2015;59:228&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4408651</ArticleId><ArticleId IdType="pubmed">25937649</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai C.W., Starkie T., Creanor S., et al. Randomized controlled trial of stroke volume optimization during elective major abdominal surgery in patients stratified by aerobic fitness. Br J Anaesth. 2015;115:578&#x2013;589.</Citation><ArticleIdList><ArticleId IdType="pubmed">26385666</ArticleId></ArticleIdList></Reference><Reference><Citation>Broch O., Carstens A., Gruenewald M., et al. Non-invasive hemodynamic optimization in major abdominal surgery: a feasibility study. Minerva Anestesiol. 2016;82:1158&#x2013;1169.</Citation><ArticleIdList><ArticleId IdType="pubmed">27352070</ArticleId></ArticleIdList></Reference><Reference><Citation>Hand W.R., Stoll W.D., McEvoy M.D., et al. Intraoperative goal-directed hemodynamic management in free tissue transfer for head and neck cancer. Head Neck. 2016;38:E1974&#x2013;E1980.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7179726</ArticleId><ArticleId IdType="pubmed">26829494</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar L., Rajan S., Baalachandran R. Outcomes associated with stroke volume variation versus central venous pressure guided fluid replacements during major abdominal surgery. J&#xa0;Anaesthesiol Clin Pharmacol. 2016;32:182&#x2013;186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4874071</ArticleId><ArticleId IdType="pubmed">27275046</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmid S., Kapfer B., Heim M., et al. Algorithm-guided goal-directed haemodynamic therapy does not improve renal function after major abdominal surgery compared to good standard clinical care: a prospective randomised trial. Crit Care. 2016;20:50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4782303</ArticleId><ArticleId IdType="pubmed">26951105</ArticleId></ArticleIdList></Reference><Reference><Citation>Elgendy M.A., Esmat I.M., Kassim D.Y. Outcome of intraoperative goal-directed therapy using Vigileo/FloTrac in high-risk patients scheduled for major abdominal surgeries: a prospective randomized trial. Egypt J Anaesth. 2017;33:263&#x2013;269.</Citation></Reference><Reference><Citation>G&#xf3;mez-Izquierdo J.C., Trainito A., Mirzakandov D., et al. Goal-directed fluid therapy does not reduce primary postoperative ileus after elective laparoscopic colorectal surgery: a randomized controlled trial. Anesthesiology. 2017;127:36&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">28459732</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang M., Li Y., Lin L., et al. Effect of goal-directed fluid therapy on the prognosis of elderly patients with hypertension receiving plasmakinetic energy transurethral resection of prostate. Int J Clin Exp Med. 2017;10:1290&#x2013;1296.</Citation></Reference><Reference><Citation>Luo J., Xue J., Liu J., Liu B., Liu L., Chen G. Goal-directed fluid restriction during brain surgery: a prospective randomized controlled trial. Ann Intensive Care. 2017;7:16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5313491</ArticleId><ArticleId IdType="pubmed">28211020</ArticleId></ArticleIdList></Reference><Reference><Citation>Reisinger K.W., Willigers H.M., Jansen J., et al. Doppler-guided goal-directed fluid therapy does not affect intestinal cell damage but increases global gastrointestinal perfusion in colorectal surgery: a randomized controlled trial. Colorectal Dis. 2017;19:1081&#x2013;1091.</Citation><ArticleIdList><ArticleId IdType="pubmed">29028286</ArticleId></ArticleIdList></Reference><Reference><Citation>Stens J., Hering J.P., van der Hoeven C.W.P., et al. The added value of cardiac index and pulse pressure variation monitoring to mean arterial pressure-guided volume therapy in moderate-risk abdominal surgery (COGUIDE): a pragmatic multicentre randomised controlled trial. Anaesthesia. 2017;72:1078&#x2013;1087.</Citation><ArticleIdList><ArticleId IdType="pubmed">28543041</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinberg L., Ianno D., Churilov L., et al. Restrictive intraoperative fluid optimisation algorithm improves outcomes in patients undergoing pancreaticoduodenectomy: a prospective multicentre randomized controlled trial. PLoS One. 2017;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5589093</ArticleId><ArticleId IdType="pubmed">28880931</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J., Ma Y., Wang T., Xu G., Fan L., Zhang Y. Goal-directed fluid management based on the auto-calibrated arterial pressure-derived stroke volume variation in patients undergoing supratentorial neoplasms surgery. Int J Clin Exp Med. 2017;10:3106&#x2013;3114.</Citation></Reference><Reference><Citation>Calvo-Vecino J.M., Ripoll&#xe9;s-Melchor J., Mythen M.G., et al. Effect of goal-directed haemodynamic therapy on postoperative complications in low-moderate risk surgical patients: a multicentre randomised controlled trial (FEDORA trial) Br J Anaesth. 2018;120:734&#x2013;744.</Citation><ArticleIdList><ArticleId IdType="pubmed">29576114</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufmann K.B., Baar W., Rexer J., et al. Evaluation of hemodynamic goal-directed therapy to reduce the incidence of bone cement implantation syndrome in patients undergoing cemented hip arthroplasty &#x2014; a randomized parallel-arm trial. BMC Anesthesiol. 2018;18:63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5991443</ArticleId><ArticleId IdType="pubmed">29875024</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.J., Kim E.J., Lee H.J., et al. Effect of goal-directed haemodynamic therapy in free flap reconstruction for head and neck cancer. Acta Anaesthesiol Scand. 2018;62:903&#x2013;914.</Citation><ArticleIdList><ArticleId IdType="pubmed">29574681</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin K., Ding J., Wu Y., Peng M. Goal-directed fluid therapy based on noninvasive cardiac output monitor reduces postoperative complications in elderly patients after gastrointestinal surgery: a randomized controlled trial. Pak J Med Sci. 2018;34:1320&#x2013;1325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6290223</ArticleId><ArticleId IdType="pubmed">30559778</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang N., Liang M., Zhang D.D., et al. Effect of goal-directed fluid therapy on early cognitive function in elderly patients with spinal stenosis: a case-control study. Int J Surg. 2018;54:201&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pubmed">29678619</ArticleId></ArticleIdList></Reference><Reference><Citation>Cesur S., &#xc7;ardak&#xf6;z&#xfc; T., Ku&#x15f; A., T&#xfc;rky&#x131;lmaz N., Yavuz &#xd6;. Comparison of conventional fluid management with PVI-based goal-directed fluid management in elective colorectal surgery. J&#xa0;Clin Monit Comput. 2019;33:249&#x2013;257.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6420438</ArticleId><ArticleId IdType="pubmed">29948666</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies S.J., Yates D.R., Wilson R.J.T., et al. A&#xa0;randomised trial of non-invasive cardiac output monitoring to guide haemodynamic optimisation in high risk patients undergoing urgent surgical repair of proximal femoral fractures (ClearNOF trial NCT02382185) Perioper Med (Lond) 2019;8:8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6686254</ArticleId><ArticleId IdType="pubmed">31406569</ArticleId></ArticleIdList></Reference><Reference><Citation>Godai K., Matsunaga A., Kanmura Y. The effects of hemodynamic management using the trend of the perfusion index and pulse pressure variation on tissue perfusion: a randomized pilot study. JA Clin Rep. 2019;5:72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6966939</ArticleId><ArticleId IdType="pubmed">32026142</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasanin A., Zanata T., Osman S., et al. Pulse pressure variation-guided fluid therapy during supratentorial brain tumour excision: a randomized controlled trial. Open Access Maced J Med Sci. 2019;7:2474&#x2013;2479.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6814473</ArticleId><ArticleId IdType="pubmed">31666850</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F., Lv J., Zhang W., Liu Z., Dong L., Wang Y. Randomized controlled trial of regional tissue oxygenation following goal-directed fluid therapy during laparoscopic colorectal surgery. Int J Clin Exp Pathol. 2019;12:4390&#x2013;4399.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6949884</ArticleId><ArticleId IdType="pubmed">31933842</ArticleId></ArticleIdList></Reference><Reference><Citation>Sujatha P.P., Nileshwar A., Krishna H.M., Prasad S.S., Prabhu M., Kamath S.U. Goal-directed vs traditional approach to intraoperative fluid therapy during open major bowel surgery: is there a difference? Anesthesiol Res Pract. 2019;2019:3408940.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6907038</ArticleId><ArticleId IdType="pubmed">31871449</ArticleId></ArticleIdList></Reference><Reference><Citation>Szturz P., Folwarczny P., Kula R., Neiser J., &#x160;ev&#x10d;&#xed;k P., Benes J. Multi-parametric functional hemodynamic optimization improves postsurgical outcome after intermediate risk open gastrointestinal surgery: a randomized controlled trial. Minerva Anestesiol. 2019;85:244&#x2013;254.</Citation><ArticleIdList><ArticleId IdType="pubmed">29756693</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinberg L., Ianno D., Churilov L., et al. Goal directed fluid therapy for major liver resection: a multicentre randomized controlled trial. Ann Med Surg (Lond) 2019;45:45&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6642079</ArticleId><ArticleId IdType="pubmed">31360460</ArticleId></ArticleIdList></Reference><Reference><Citation>Arslan-Carlon V., Tan K.S., Dalbagni G., et al. Goal-directed versus standard fluid therapy to decrease ileus after open radical cystectomy: a prospective randomized controlled trial. Anesthesiology. 2020;133:293&#x2013;303.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8320377</ArticleId><ArticleId IdType="pubmed">32472804</ArticleId></ArticleIdList></Reference><Reference><Citation>De Cassai A., Bond O., Marini S., et al. [Pulse pressure variation guided fluid therapy during kidney transplantation: a randomized controlled trial] Braz J Anesthesiol. 2020;70:194&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9373208</ArticleId><ArticleId IdType="pubmed">32534731</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer M.O., Lemoine S., Tavernier B., et al. Individualized fluid management using the pleth variability index: a randomized clinical trial. Anesthesiology. 2020;133:31&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">32205547</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki Y., Ono Y., Inokuchi R., Ishida T., Kumada Y., Shinohara K. Intraoperative fluid management in hepato-biliary-pancreatic operation using stroke volume variation monitoring: a single-center, open-label, randomized pilot study. Medicine (Baltimore) 2020;99</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7738119</ArticleId><ArticleId IdType="pubmed">33327334</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicklas J.Y., Diener O., Leistenschneider M., et al. Personalised haemodynamic management targeting baseline cardiac index in high-risk patients undergoing major abdominal surgery: a randomised single-centre clinical trial. Br J Anaesth. 2020;125:122&#x2013;132.</Citation><ArticleIdList><ArticleId IdType="pubmed">32711724</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneck E., Schulte D., Habig L., et al. Hypotension Prediction Index based protocolized haemodynamic management reduces the incidence and duration of intraoperative hypotension in primary total hip arthroplasty: a single centre feasibility randomised blinded prospective interventional trial. J&#xa0;Clin Monit Comput. 2020;34:1149&#x2013;1158.</Citation><ArticleIdList><ArticleId IdType="pubmed">31784852</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaper J., Schiffer E., Barcelos G.K., et al. Goal-directed hemodynamic therapy versus restrictive normovolemic therapy in major open abdominal surgery: a randomized controlled trial. Surgery. 2021;169:1164&#x2013;1174.</Citation><ArticleIdList><ArticleId IdType="pubmed">33143931</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards M.  FLO-ELA Protocol v2.0. 2020. pp. 1&#x2013;65.http://floela.org/downloads/Protocol%20v2.0.pdf</Citation></Reference><Reference><Citation>Edwards M.R., Forbes G., MacDonald N., et al. Optimisation of Perioperative Cardiovascular Management to Improve Surgical Outcome II (OPTIMISE II) trial: study protocol for a multicentre international trial of cardiac output-guided fluid therapy with low-dose inotrope infusion compared with usual care in patients undergoing major elective gastrointestinal surgery. BMJ Open. 2019;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6341180</ArticleId><ArticleId IdType="pubmed">30647034</ArticleId></ArticleIdList></Reference><Reference><Citation>Molliex S., Passot S., Futier E., et al. Stepped wedge cluster randomised controlled trial to assess the effectiveness of an optimisation strategy for general anaesthesia on postoperative morbidity and mortality in elderly patients (the OPTI-AGED study): a study protocol. BMJ Open. 2018;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6009551</ArticleId><ArticleId IdType="pubmed">29921685</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">30914063</PMID><DateCompleted><Year>2019</Year><Month>11</Month><Day>13</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1741-7015</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Mar</Month><Day>26</Day></PubDate></JournalIssue><Title>BMC medicine</Title><ISOAbbreviation>BMC Med</ISOAbbreviation></Journal><ArticleTitle>Comparison of statins for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis.</ArticleTitle><Pagination><StartPage>67</StartPage><MedlinePgn>67</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">67</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12916-019-1298-5</ELocationID><Abstract><AbstractText Label="BACKGROUND">Statins may prevent recurrent ischemic events after ischemic stroke. Determining which statin to use remains controversial. We aimed to summarize the evidence for the use of statins in secondary prevention for patients with ischemic stroke by comparing benefits and harms of various statins.</AbstractText><AbstractText Label="METHODS">We searched for randomized controlled trials (RCTs) assessing statins in patients with ischemic stroke or transient ischemic attack (TIA) in MEDLINE, EMBASE, and CENTRAL up to July 2017. Two authors extracted data and appraised risks of bias. We performed pairwise meta-analyses and trial sequential analyses (TSA) to compare statins versus placebo/no statin, and network meta-analyses using frequentist random-effects models to compare statins through indirect evidence. We used GRADE to rate the overall certainty of evidence. Primary outcomes were all-cause mortality and all strokes. Secondary outcomes were different types of strokes, cardiovascular events, and adverse events.</AbstractText><AbstractText Label="RESULTS">We identified nine trials (10,741 patients). No head-to-head RCTs were found. The median follow-up period was 2.5&#x2009;years. Statins did not seem to modify all stroke and all-cause mortality outcomes; they were associated with a decreased risk of ischemic stroke (odds ratio, OR, 0.81 [95% CI, 0.70 to 0.93]; absolute risk difference, ARD, -&#x2009;1.6% [95% CI, -&#x2009;2.6 to -&#x2009;0.6%]), ischemic stroke or TIA (OR, 0.75 [95% CI, 0.64 to 0.87]; ARD, -&#x2009;4.2% [95% CI, -&#x2009;6.2 to -&#x2009;2.1%]), and cardiovascular event (OR, 0.75 [95% CI, 0.69 to 0.83]; ARD, -&#x2009;5.4% [95% CI, -&#x2009;6.8 to -&#x2009;3.6%]), and did not seem to modify rhabdomyolysis, myalgia, or rise in creatine kinase. In the comparison of different statins, moderate- to high-quality evidence indicated that differences between pharmaceutical products seemed modest, with high doses (e.g., atorvastatin 80&#x2009;mg/day and simvastatin 40&#x2009;mg/day) associated with the greatest benefits. TSA excluded random error as a cause of the findings for ischemic stroke and cardiovascular event outcomes. Evidence for increased risk of hemorrhagic stroke was sensitive to the exclusion of the SPARCL trial.</AbstractText><AbstractText Label="CONCLUSIONS">Evidence strongly suggests that statins are associated with a reduction in the absolute risk of ischemic strokes and cardiovascular events. Differences in effects among statins were modest, signaling potential therapeutic equivalence.</AbstractText><AbstractText Label="TRIAL REGISTRATION">PROSPERO CRD42018079112.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tramacere</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Research and Clinical Development, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133, Milan, Italy. irene.tramacere@istituto-besta.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boncoraglio</LastName><ForeName>Giorgio B</ForeName><Initials>GB</Initials><AffiliationInfo><Affiliation>Department of Cerebrovascular Disease, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banzi</LastName><ForeName>Rita</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center for Drug Regulatory Policies, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Giovane</LastName><ForeName>Cinzia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwag</LastName><ForeName>Koren H</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Medical School for International Health, Ben Gurion University, Beersheba, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Squizzato</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Insubria, Varese, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moja</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit of Clinical Epidemiology, IRCCS Galeazzi Orthopedic Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000099094">Network Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>03</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med</MedlineTA><NlmUniqueID>101190723</NlmUniqueID><ISSNLinking>1741-7015</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019161">Hydroxymethylglutaryl-CoA Reductase Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Evid Based Nurs. 2021 Jan;24(1):24. doi: 10.1136/ebnurs-2019-103136.</RefSource><PMID Version="1">31874941</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019161" MajorTopicYN="Y">Hydroxymethylglutaryl-CoA Reductase Inhibitors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="Y">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055502" MajorTopicYN="N">Secondary Prevention</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Network meta-analysis</Keyword><Keyword MajorTopicYN="N">RCT</Keyword><Keyword MajorTopicYN="N">Secondary prevention</Keyword><Keyword MajorTopicYN="N">Statins</Keyword><Keyword MajorTopicYN="N">Stroke</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword></KeywordList><CoiStatement>ETHICS APPROVAL AND CONSENT TO PARTICIPATE: Not applicable. CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER&#x2019;S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>3</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>3</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30914063</ArticleId><ArticleId IdType="pmc">PMC6436237</ArticleId><ArticleId IdType="doi">10.1186/s12916-019-1298-5</ArticleId><ArticleId IdType="pii">10.1186/s12916-019-1298-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Meschia JF, Bushnell C, Boden-Albala B, Braun LT, Bravata DM, Chaturvedi S, et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(12):3754&#x2013;3832. doi: 10.1161/STR.0000000000000046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STR.0000000000000046</ArticleId><ArticleId IdType="pmc">PMC5020564</ArticleId><ArticleId IdType="pubmed">25355838</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . The top 10 causes of death. 2018.</Citation></Reference><Reference><Citation>Giles MF, Rothwell PM. Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol. 2007;6(12):1063&#x2013;1072. doi: 10.1016/S1474-4422(07)70274-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(07)70274-0</ArticleId><ArticleId IdType="pubmed">17993293</ArticleId></ArticleIdList></Reference><Reference><Citation>Amarenco P, Lavall&#xe9;e PC, Labreuche J, Albers GW, Bornstein NM, Canh&#xe3;o P, et al. One-year risk of stroke after transient ischemic attack or minor stroke. N Engl J Med. 2016;374(16):1533&#x2013;1542. doi: 10.1056/NEJMoa1412981.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1412981</ArticleId><ArticleId IdType="pubmed">27096581</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis SM, Donnan GA. Clinical practice. Secondary prevention after ischemic stroke or transient ischemic attack. N Engl J Med. 2012;366(20):1914&#x2013;1922. doi: 10.1056/NEJMcp1107281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcp1107281</ArticleId><ArticleId IdType="pubmed">22591297</ArticleId></ArticleIdList></Reference><Reference><Citation>Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke. 2014;45(7):2160&#x2013;2236. doi: 10.1161/STR.0000000000000024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STR.0000000000000024</ArticleId><ArticleId IdType="pubmed">24788967</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothwell PM, Giles MF, Chandratheva A, Marquardt L, Geraghty O, Redgrave JN, et al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet. 2007;370(9596):1432&#x2013;1442. doi: 10.1016/S0140-6736(07)61448-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)61448-2</ArticleId><ArticleId IdType="pubmed">17928046</ArticleId></ArticleIdList></Reference><Reference><Citation>Hackam DG, Spence JD. Combining multiple approaches for the secondary prevention of vascular events after stroke: a quantitative modeling study. Stroke. 2007;38(6):1881&#x2013;1885. doi: 10.1161/STROKEAHA.106.475525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.106.475525</ArticleId><ArticleId IdType="pubmed">17431209</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, et al. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet. 2016;388(10059):2532&#x2013;2561. doi: 10.1016/S0140-6736(16)31357-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)31357-5</ArticleId><ArticleId IdType="pubmed">27616593</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1. doi: 10.1186/2046-4053-4-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-4-1</ArticleId><ArticleId IdType="pmc">PMC4320440</ArticleId><ArticleId IdType="pubmed">25554246</ArticleId></ArticleIdList></Reference><Reference><Citation>Giorgio Boncoraglio, Cinzia Del Giovane, Alessandro Squizzato, Lorenzo Moja, Irene Tramacere. Statins for secondary prevention in patients with ischemic stroke or transient ischemic attack: a network meta-analysis. PROSPERO 2018 CRD42018079112 Available from: http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42018079112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6436237</ArticleId><ArticleId IdType="pubmed">30914063</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777&#x2013;784. doi: 10.7326/M14-2385.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M14-2385</ArticleId><ArticleId IdType="pubmed">26030634</ArticleId></ArticleIdList></Reference><Reference><Citation>Manktelow BN, Potter JF. Interventions in the management of serum lipids for preventing stroke recurrence. Cochrane Database Syst Rev. 2009;3:CD002091.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6664829</ArticleId><ArticleId IdType="pubmed">19588332</ArticleId></ArticleIdList></Reference><Reference><Citation>Squizzato A, Romualdi E, Dentali F, Ageno W. Statins for acute ischemic stroke. Cochrane Database Syst Rev. 2011;8:CD007551.</Citation><ArticleIdList><ArticleId IdType="pubmed">21833959</ArticleId></ArticleIdList></Reference><Reference><Citation>Salanti G. Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool. Res Synth Methods. 2012;3(2):80&#x2013;97. doi: 10.1002/jrsm.1037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.1037</ArticleId><ArticleId IdType="pubmed">26062083</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemphill JC, 3rd, Greenberg SM, Anderson CS, Becker K, Bendok BR, Cushman M, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46(7):2032&#x2013;2060. doi: 10.1161/STR.0000000000000069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STR.0000000000000069</ArticleId><ArticleId IdType="pubmed">26022637</ArticleId></ArticleIdList></Reference><Reference><Citation>Salanti G, Kavvoura FK, Ioannidis JP. Exploring the geometry of treatment networks. Ann Intern Med. 2008;148(7):544&#x2013;553. doi: 10.7326/0003-4819-148-7-200804010-00011.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-148-7-200804010-00011</ArticleId><ArticleId IdType="pubmed">18378949</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Altman DG, Sterne JAC, eds. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org.</Citation></Reference><Reference><Citation>Sch&#xfc;nemann H, Bro&#x17c;ek J, Guyatt G, Oxman A, editors. GRADE handbook for grading quality of evidence and strength of recommendations. Updated October 2013: The GRADE Working Group; 2013. Available from guidelinedevelopment.org/handbook</Citation></Reference><Reference><Citation>Salanti G, Del Giovane C, Chaimani A, Caldwell DM, Higgins JP. Evaluating the quality of evidence from a network meta-analysis. PLoS One. 2014;9(7):e99682. doi: 10.1371/journal.pone.0099682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0099682</ArticleId><ArticleId IdType="pmc">PMC4084629</ArticleId><ArticleId IdType="pubmed">24992266</ArticleId></ArticleIdList></Reference><Reference><Citation>Salanti G, Ades AE, Ioannidis JP. Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol. 2011;64(2):163&#x2013;171. doi: 10.1016/j.jclinepi.2010.03.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2010.03.016</ArticleId><ArticleId IdType="pubmed">20688472</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557&#x2013;560. doi: 10.1136/bmj.327.7414.557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner RM, Davey J, Clarke MJ, Thompson SG, Higgins JP. Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane database of systematic reviews. Int J Epidemiol. 2012;41(3):818&#x2013;827. doi: 10.1093/ije/dys041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dys041</ArticleId><ArticleId IdType="pmc">PMC3396310</ArticleId><ArticleId IdType="pubmed">22461129</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014;129(25 Suppl 2):S1&#x2013;S45. doi: 10.1161/01.cir.0000437738.63853.7a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.cir.0000437738.63853.7a</ArticleId><ArticleId IdType="pubmed">24222016</ArticleId></ArticleIdList></Reference><Reference><Citation>Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. J Clin Epidemiol. 2008;61(8):763&#x2013;769. doi: 10.1016/j.jclinepi.2007.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2007.10.007</ArticleId><ArticleId IdType="pubmed">18411040</ArticleId></ArticleIdList></Reference><Reference><Citation>Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol. 2008;61(1):64&#x2013;75. doi: 10.1016/j.jclinepi.2007.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2007.03.013</ArticleId><ArticleId IdType="pubmed">18083463</ArticleId></ArticleIdList></Reference><Reference><Citation>Brok J, Thorlund K, Wetterslev J, Gluud C. Apparently conclusive meta-analyses may be inconclusive--trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. Int J Epidemiol. 2009;38(1):287&#x2013;298. doi: 10.1093/ije/dyn188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyn188</ArticleId><ArticleId IdType="pubmed">18824466</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorlund K, Devereaux PJ, Wetterslev J, Guyatt G, Ioannidis JP, Thabane L, et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? Int J Epidemiol. 2009;38(1):276&#x2013;286. doi: 10.1093/ije/dyn179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyn179</ArticleId><ArticleId IdType="pubmed">18824467</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobias A. Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull. 1999;8(47):1&#x2013;48.</Citation></Reference><Reference><Citation>Plehn JF, Davis BR, Sacks FM, Rouleau JL, Pfeffer MA, Bernstein V, et al. Reduction of stroke incidence after myocardial infarction with pravastatin: the cholesterol and recurrent events (CARE) study. The Care Investigators. Circulation. 1999;99(2):216&#x2013;223. doi: 10.1161/01.CIR.99.2.216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.99.2.216</ArticleId><ArticleId IdType="pubmed">9892586</ArticleId></ArticleIdList></Reference><Reference><Citation>White HD, Simes RJ, Anderson NE, Hankey GJ, Watson JD, Hunt D, et al. Pravastatin therapy and the risk of stroke. N Engl J Med. 2000;343(5):317&#x2013;326. doi: 10.1056/NEJM200008033430502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200008033430502</ArticleId><ArticleId IdType="pubmed">10922421</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins R, Armitage J, Parish S, Sleight P, Peto R. Heart protection study collaborative group. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet. 2004;363(9411):757&#x2013;767. doi: 10.1016/S0140-6736(04)15690-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(04)15690-0</ArticleId><ArticleId IdType="pubmed">15016485</ArticleId></ArticleIdList></Reference><Reference><Citation>Amarenco P, Bogousslavsky J, Callahan A, 3rd, Goldstein LB, Hennerici M, Rudolph AE, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355(6):549&#x2013;559. doi: 10.1056/NEJMoa061894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa061894</ArticleId><ArticleId IdType="pubmed">16899775</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuk AM, Buchan AM, Investigators FASTER. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol. 2007;6(11):961&#x2013;969. doi: 10.1016/S1474-4422(07)70250-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(07)70250-8</ArticleId><ArticleId IdType="pubmed">17931979</ArticleId></ArticleIdList></Reference><Reference><Citation>Yakusevich VV, Malygin AY, Lychenko SV, Petrochenko AS, Kabanov AV. The efficacy of high-dose simvastatin in acute period of ischemic stroke. Ration Pharmacother Cardiol. 2012;8(1):4&#x2013;16. doi: 10.20996/1819-6446-2012-8-1-4-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.20996/1819-6446-2012-8-1-4-16</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosomi N, Nagai Y, Kohriyama T, Ohtsuki T, Aoki S, Nezu T, et al. The Japan statin treatment against recurrent stroke (J-STARS): a multicenter, randomized, open-label, parallel-group study. EBioMedicine. 2015;2(9):1071&#x2013;1078. doi: 10.1016/j.ebiom.2015.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2015.08.006</ArticleId><ArticleId IdType="pmc">PMC4588424</ArticleId><ArticleId IdType="pubmed">26501105</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueno Y, Yamashiro K, Tanaka Y, Watanabe M, Miyamoto N, Shimada Y, et al. Rosuvastatin may stabilize atherosclerotic aortic plaque: transesophageal echocardiographic study in the EPISTEME trial. Atherosclerosis. 2015;239(2):476&#x2013;482. doi: 10.1016/j.atherosclerosis.2015.02.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2015.02.021</ArticleId><ArticleId IdType="pubmed">25702618</ArticleId></ArticleIdList></Reference><Reference><Citation>Heo JH, Song D, Nam HS, Kim EY, Kim YD, Lee KY, et al. Effect and safety of rosuvastatin in acute ischemic stroke. J Stroke. 2016;18(1):87&#x2013;95. doi: 10.5853/jos.2015.01578.</Citation><ArticleIdList><ArticleId IdType="doi">10.5853/jos.2015.01578</ArticleId><ArticleId IdType="pmc">PMC4747071</ArticleId><ArticleId IdType="pubmed">26846760</ArticleId></ArticleIdList></Reference><Reference><Citation>Montaner J, Bustamante A, Garc&#xed;a-Matas S, Mart&#xed;nez-Zabaleta M, Jim&#xe9;nez C, de la Torre J, et al. Combination of thrombolysis and statins in acute stroke is safe: results of the STARS randomized trial (stroke treatment with acute reperfusion and simvastatin) Stroke. 2016;47(11):2870&#x2013;2873. doi: 10.1161/STROKEAHA.116.014600.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.116.014600</ArticleId><ArticleId IdType="pubmed">27758944</ArticleId></ArticleIdList></Reference><Reference><Citation>Amarenco P, Goldstein LB, Szarek M, Sillesen H, Rudolph AE, Callahan A, 3rd, et al. Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial. Stroke. 2007;38(12):3198&#x2013;3204. doi: 10.1161/STROKEAHA.107.493106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.107.493106</ArticleId><ArticleId IdType="pubmed">17962589</ArticleId></ArticleIdList></Reference><Reference><Citation>Bero L, Oostvogel F, Bacchetti P, Lee K. Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others. PLoS Med. 2007;4(6):e184. doi: 10.1371/journal.pmed.0040184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0040184</ArticleId><ArticleId IdType="pmc">PMC1885451</ArticleId><ArticleId IdType="pubmed">17550302</ArticleId></ArticleIdList></Reference><Reference><Citation>Bero L. Bias related to funding source in statin trials. BMJ. 2014;349:g5949. doi: 10.1136/bmj.g5949.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.g5949</ArticleId><ArticleId IdType="pubmed">25281682</ArticleId></ArticleIdList></Reference><Reference><Citation>Moja L, Pecoraro V, Ciccolallo L, Dall'Olmo L, Virgili G, Garattini S. Flaws in animal studies exploring statins and impact on meta-analysis. Eur J Clin Investig. 2014;44(6):597&#x2013;612. doi: 10.1111/eci.12264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.12264</ArticleId><ArticleId IdType="pubmed">24665945</ArticleId></ArticleIdList></Reference><Reference><Citation>Pecoraro V, Moja L, Dall'Olmo L, Cappellini G, Garattini S. Most appropriate animal models to study the efficacy of statins: a systematic review. Eur J Clin Investig. 2014;44(9):848&#x2013;871. doi: 10.1111/eci.12304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.12304</ArticleId><ArticleId IdType="pubmed">25066257</ArticleId></ArticleIdList></Reference><Reference><Citation>Schachter M. Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update. Fundam Clin Pharmacol. 2005;19(1):117&#x2013;125. doi: 10.1111/j.1472-8206.2004.00299.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1472-8206.2004.00299.x</ArticleId><ArticleId IdType="pubmed">15660968</ArticleId></ArticleIdList></Reference><Reference><Citation>Dreier JP, Endres M. Statin-associated rhabdomyolysis triggered by grapefruit consumption. Neurology. 2004;62(4):670. doi: 10.1212/WNL.62.4.670.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.62.4.670</ArticleId><ArticleId IdType="pubmed">14981197</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuvonen PJ. Drug interactions with HMG-CoA reductase inhibitors (statins): the importance of CYP enzymes, transporters and pharmacogenetics. Curr Opin Investig Drugs. 2010;11(3):323&#x2013;332.</Citation><ArticleIdList><ArticleId IdType="pubmed">20178046</ArticleId></ArticleIdList></Reference><Reference><Citation>Amarenco P, Labreuche J. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol. 2009;8(5):453&#x2013;463. doi: 10.1016/S1474-4422(09)70058-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(09)70058-4</ArticleId><ArticleId IdType="pubmed">19375663</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang JX, Wang EQ, Wang W, Liu Y, Cheng G. The efficacy and safety of high-dose statins in acute phase of ischemic stroke and transient ischemic attack: a systematic review. Intern Emerg Med. 2017;12(5):679&#x2013;687. doi: 10.1007/s11739-017-1650-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-017-1650-8</ArticleId><ArticleId IdType="pubmed">28303440</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29381513</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>127</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>A Systematic Review of Outcomes Associated With Withholding or Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Before Noncardiac Surgery.</ArticleTitle><Pagination><StartPage>678</StartPage><EndPage>687</EndPage><MedlinePgn>678-687</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000002837</ELocationID><Abstract><AbstractText Label="BACKGROUND">The global rate of major noncardiac surgical procedures is increasing annually, and of those patients presenting for surgery, increasing numbers are taking either an angiotensin-converting enzyme inhibitor (ACE-I) or an angiotensin receptor blocker (ARB). The current recommendations of whether to continue or withhold ACE-I and ARB in the perioperative period are conflicting. Previous meta-analyses have linked preoperative ACE-I/ARB therapy to the increased incidence of postinduction hypotension; however, they have failed to correlate this with adverse patient outcomes. The aim of this meta-analysis was to determine whether continuation or withholding ACE-I or ARB therapy in the perioperative period is associated with mortality and major morbidity.</AbstractText><AbstractText Label="METHODS">This meta-analysis was prospectively registered on PROSPERO (CRD42017055291). A comprehensive search of MEDLINE (PubMed), CINAHL (EBSCO host), ProQuest, Cochrane database, Scopus, and Web of Science was conducted on December 6, 2016. We included adult patients &gt;18 years of age on chronic ACE-I or ARB therapy who underwent noncardiac surgery in which ACE-I or ARB was either withheld or continued on the morning of surgery. Primary outcomes included all-cause mortality and major cardiac events (MACE). Secondary outcomes included the risk of congestive heart failure, acute kidney injury, stroke, intraoperative/postoperative hypotension, and the length of hospital stay.</AbstractText><AbstractText Label="RESULTS">After abstract review, the full text of 25 studies was retrieved, of which 9 fulfilled the inclusion criteria: 5 were randomized control trials, and 4 were cohort studies. These studies included a total of 6022 patients on chronic ACE-I/ARB therapy before noncardiac surgery. A total of 1816 patients withheld treatment the morning of surgery and 4206 continued their ACE-I/ARB. Preoperative demographics were similar between the 2 groups. Withholding ACE-I/ARB therapy was not associated with a difference in mortality (odds ratio [OR], 0.97; 95% confidence interval [CI], 0.62-1.52; I = 0%) or MACE (OR, 1.12; 95% CI, 0.82-1.52; I = 0%). However, withholding therapy was associated with significantly less intraoperative hypotension (OR, 0.63; 95% CI, 0.47-0.85; I = 71%). No effect estimate could be pooled concerning length of hospital stay and congestive heart failure.</AbstractText><AbstractText Label="CONCLUSIONS">This meta-analysis did not demonstrate an association between perioperative administration of ACE-I/ARB and mortality or MACE. It did, however, confirm the current observation that perioperative continuation of ACE-I/ARBs is associated with an increased incidence of intraoperative hypotension. A large randomized control trial is necessary to determine the appropriate perioperative management of ACE-I and ARBs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hollmann</LastName><ForeName>Caryl</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>From the Department of Anaesthesia and Perioperative Medicine, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernandes</LastName><ForeName>Nicole L</ForeName><Initials>NL</Initials></Author><Author ValidYN="Y"><LastName>Biccard</LastName><ForeName>Bruce M</ForeName><Initials>BM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047228">Angiotensin II Type 1 Receptor Blockers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000806">Angiotensin-Converting Enzyme Inhibitors</NameOfSubstance></Chemical></ChemicalList><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Anesth Analg. 2018 Sep;127(3):598-600. doi: 10.1213/ANE.0000000000003516.</RefSource><PMID Version="1">30113975</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D047228" MajorTopicYN="N">Angiotensin II Type 1 Receptor Blockers</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000806" MajorTopicYN="N">Angiotensin-Converting Enzyme Inhibitors</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011300" MajorTopicYN="N">Preoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29381513</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000002837</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35612866</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2380-6591</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>7</Issue><PubDate><Year>2022</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA cardiology</Title><ISOAbbreviation>JAMA Cardiol</ISOAbbreviation></Journal><ArticleTitle>Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior Stroke: A Post Hoc Analysis From the AUGUSTUS Trial.</ArticleTitle><Pagination><StartPage>682</StartPage><EndPage>689</EndPage><MedlinePgn>682-689</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamacardio.2022.1166</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Data are limited regarding the risk of cerebrovascular ischemic events and major bleeding in patients with atrial fibrillation (AF) and recent acute coronary syndrome (ACS) and/or percutaneous coronary intervention (PCI).</AbstractText><AbstractText Label="OBJECTIVE">Determine the efficacy and safety of apixaban or vitamin K antagonists (VKA) and aspirin or placebo according to prior stroke, transient ischemic attack (TIA), or thromboembolism (TE).</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">In this prospective, multicenter, 2-by-2 factorial, randomized clinical trial, post hoc parallel analyses were performed to compare randomized treatment regimens according to presence or absence of prior stroke/TIA/TE using Cox proportional hazards models. Patients with AF, recent ACS or PCI, and planned use of P2Y12 inhibitors for 6 months or longer were included; 33 patients with missing data about prior stroke/TIA/TE were excluded.</AbstractText><AbstractText Label="INTERVENTIONS">Apixaban (5 mg or 2.5 mg twice daily) or VKA and aspirin or placebo.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">Major or clinically relevant nonmajor (CRNM) bleeding.</AbstractText><AbstractText Label="RESULTS">Of 4581 patients included, 633 (13.8%) had prior stroke/TIA/TE. Patients with vs without prior stroke/TIA/TE were older; had higher CHA2DS2-VASC and HAS-BLED scores; and more frequently had prior bleeding, heart failure, diabetes, and prior oral anticoagulant use. Apixaban was associated with lower rates of major or CRNM bleeding and death or hospitalization than VKA in patients with (hazard ratio [HR], 0.69; 95% CI, 0.46-1.03) and without (HR, 0.68; 95% CI, 0.57-0.82) prior stroke/TIA/TE. Patients without prior stroke/TIA/TE receiving aspirin vs placebo had higher rates of bleeding; this difference appeared less substantial among patients with prior stroke/TIA/TE (P&#x2009;=&#x2009;.01 for interaction). Aspirin was associated with numerically lower rates of death or ischemic events than placebo in patients with (HR, 0.71; 95% CI, 0.42-1.20) and without (HR, 0.93; 95% CI, 0.72-1.21) prior stroke/TIA/TE (not statistically significant).</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">The safety and efficacy of apixaban compared with VKA was consistent with the AUGUSTUS findings, irrespective of prior stroke/TIA/TE. Aspirin increased major or CRNM bleeding, particularly in patients without prior stroke/TIA/TE. Although aspirin may have some benefit in patients with prior stroke, our findings support the use of apixaban and a P2Y12 inhibitor without aspirin for the majority of patients with AF and ACS and/or PCI, regardless of prior stroke/TIA/TE status.</AbstractText><AbstractText Label="TRIAL REGISTRATION">ClinicalTrials.gov Identifier: NCT02415400.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bahit</LastName><ForeName>M Cecilia</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>INECO Neurociencias Oro&#xf1;o, Fundaci&#xf3;n INECO, Rosario, Santa Fe, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vora</LastName><ForeName>Amit N</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>UPMC Heart and Vascular Institute, Harrisburg, Pennsylvania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zhuokai</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wojdyla</LastName><ForeName>Daniel M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Laine</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goodman</LastName><ForeName>Shaun G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Terrence Donnelly Heart Center, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aronson</LastName><ForeName>Ronald</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Bristol Myers Squibb, Lawrenceville, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jordan</LastName><ForeName>J Dedrick</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Neurology, Duke University School of Medicine, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kolls</LastName><ForeName>Brad J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Duke University School of Medicine, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dombrowski</LastName><ForeName>Keith E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery and Brain Repair, University of South Florida, Tampa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vinereanu</LastName><ForeName>Dragos</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Carol Davila University of Medicine and Pharmacy, University and Emergency Hospital, Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halvorsen</LastName><ForeName>Sigrun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berwanger</LastName><ForeName>Otavio</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Hospital Israelita Albert Einstein, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Windecker</LastName><ForeName>Stephan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Swiss Cardiovascular Center, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehran</LastName><ForeName>Roxana</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Research Foundation, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Granger</LastName><ForeName>Christopher B</ForeName><Initials>CB</Initials><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alexander</LastName><ForeName>John H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopes</LastName><ForeName>Renato D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02415400</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Cardiol</MedlineTA><NlmUniqueID>101676033</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005343">Fibrinolytic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011720">Pyrazoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011728">Pyridones</NameOfSubstance></Chemical><Chemical><RegistryNumber>3Z9Y7UWC1J</RegistryNumber><NameOfSubstance UI="C522181">apixaban</NameOfSubstance></Chemical><Chemical><RegistryNumber>5Q7ZVV76EI</RegistryNumber><NameOfSubstance UI="D014859">Warfarin</NameOfSubstance></Chemical><Chemical><RegistryNumber>R16CO5Y76E</RegistryNumber><NameOfSubstance UI="D001241">Aspirin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D054058" MajorTopicYN="Y">Acute Coronary Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001241" MajorTopicYN="N">Aspirin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="Y">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005343" MajorTopicYN="N">Fibrinolytic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="Y">Ischemic Attack, Transient</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062645" MajorTopicYN="Y">Percutaneous Coronary Intervention</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011720" MajorTopicYN="N">Pyrazoles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011728" MajorTopicYN="N">Pyridones</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013923" MajorTopicYN="Y">Thromboembolism</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014859" MajorTopicYN="N">Warfarin</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Bahit reported other fees from Bristol Myers Squibb and Pfizer during the conduct of the study and other from Merck Sharp &amp; Dohme, CSL Behring, Vifor, and Boehringer Ingelheim outside the submitted work. Dr Vora reported grants from Medtronic outside the submitted work. Dr Thomas reported grants from Akili Interactive Labs, Amgen, Gilead, and Novartis. Dr Goodman reported grants and other fees from Amgen, Bristol Myers Squibb/Pfizer, Bayer, Boehringer Ingelheim, Anthos Therapeutics, AstraZeneca, CSL Behring, Daiichi-Sankyo, Eli Lilly, Esperion, Fenix Group International, Ferring Pharmaceuticals, GlaxoSmithKline, HLS Therapeutics, Janssen/Johnson &amp; Johnson, Luitpold Pharmaceuticals, Matrizyme, Merck, Novartis, Novo Nordisk, Pendopharm, Regeneron, Sanofi, Servier, Tenax Therapeutics, and Valeo Pharma outside the submitted work and salary support and honoraria from the Heart and Stroke Foundation of Ontario/University of Toronto, Canadian Heart Research Centre, MD Primer, Canadian VIGOUR Centre, Cleveland Clinic Coordinating Center for Clinical Research, Duke Clinical Research Institute, New York University Clinical Coordinating Centre, PERFUSE Research Institute, and TIMI Study Group (Brigham Health). Dr Aronson reported being a salaried employee of Bristol Myers Squibb during the conduct of the study and owning stock in Bristol Myers Squibb outside the submitted work. Dr Kolls reported grants from Pfizer and Bristol Myers Squibb during the conduct of the study. Dr Vinereanu reported grants from Bristol Myers Squibb and Pfizer during the conduct of the study and grants and/or personal fees from Bayer, Boehringer Ingelheim, Pfizer, Novartis, and Daiichi Sankyo outside the submitted work. Dr Halvorsen reported personal fees from Bayer, Amgen, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Pfizer, Sanofi, and Merck outside the submitted work. Dr Berwanger reported grants and consulting fees from AstraZeneca, Bayer, Pfizer, Servier, Amgen, Novartis, and Boehringer Ingelheim and consulting fees from Sanofi and Novo Nordisk outside the submitted work. Dr Windecker reported institutional research and educational grants from Abbott, Amgen, AstraZeneca, Bristol Myers Squibb, Bayer, Biotronik, Boston Scientific, Cardinal Health, Cardiovalve, CSL Behring, Daiichi Sankyo, Edwards Lifesciences, Guerbet, InfraRedx, Johnson &amp; Johnson, Medicure, Medtronic, Novartis, Polares, OrPha Suisse, Pfizer, Regeneron, Sanofi-Aventis, Sinomed, Terumo, and V-Wave outside the submitted work; reported serving as unpaid advisory board member and/or unpaid member of the steering/executive group of trials funded by Abbott, Abiomed, Amgen, AstraZeneca, Bayer, Bristol Myers Squibb, Boston Scientific, Biotronik, Cardiovalve, Edwards Lifesciences, Janssen, MedAlliance, Medtronic, Novartis, Polares, Recardio, Sinomed, Terumo, V-Wave and Xeltis; and reported being a member of the steering/executive committee group of several investigator-initiated trials that receive funding by industry without impact on his personal remuneration. Dr Mehran reported grants from Abbott, Abiomed, Alleviant, AM Pharma, Applied Therapeutics, Arena, AstraZeneca, Bayer, Beth Israel Deaconess, Biosensors, Biotronik, Boston Scientific, Bristol Myers Squibb/Sanofi, CardiaWave, CellAegis, CeloNova, CERC, Chiesi, Concept Medical, CSL Behring, DSI, Duke University, Eli Lilly/Daiichi Sankyo, Humacyte, Insel Gruppe, Janssen, Medtronic, Novartis, OrbusNeich, Philips, Vivasure, and Zoll; and personal and other fees from Abbott Vascular, Boston Scientific, CIRM, Cine-Med Research, Janssen, WebMD, Idorsia Pharmaceuticals, Medscape, Medtronic, Novartis, Philips, Siemens Medical Solutions, Roivant Sciences, Sanofi, Spectranetics/Philips/Volcano Corporation, Bristol Myers Squibb, Novartis, Watermark Research, American Medical Association Scientific Advisory Board, SCAI Women in Innovations, and Biosensors Scientific Advisory Board (spouse); equity of less than 1% from Applied Therapeutics, Claret Medical, Elixir Medical, STEL, ControlRad (spouse); and being an executive committee member for Janssen Pharmaceuticals and Bristol Myers Squibb outside the submitted work. Dr Granger reported research grants from Akros, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Daiichi Sankyo, Janssen, Pfizer, Armetheon, US Food and Drug Administration, GlaxoSmithKline, The Medicines Company, Medtronic Foundation, Medtronic, and Novartis and consulting fees from Abiomed, Alnylam Pharma, Anthos, Bayer, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, Cardionomic, Celecor Therapeutics, Correvio, Daiichi Sankyo, Espero, Janssen, Pfizer, Philips, AbbVie, Armetheon, AstraZeneca, Eli Lilly, Gilead, GlaxoSmithKline, HengRui, Hoffmann-La Roche, The Medicines Company, National Institutes of Health, Novartis, Sirtex, Reata, Verseon, Apple, Medscape, Medtronic, Merck, Novo Nordisk, Roche Diagnostics, Rho Pharmaceuticals, and Tenac.io. Dr Alexander reported grants from Bristol Myers Squibb during the conduct of the study and grants and/or personal fees from AbbVie, Akros, AtriCure, Bayer, Bristol Myers Squibb, CryoLife, CSL Behring, Ferring, Humacyte, Janssen, Pfizer, and Portola outside the submitted work. Dr Lopes reported grants from Bristol Myers Squibb, GlaxoSmithKline, Medtronic, Pfizer, and Sanofi and personal consulting fees from Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Daiichi Sankyo, GlaxoSmithKline, Medtronic, Pfizer, Portolz, and Sanofi outside the submitted work. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>25</Day><Hour>11</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35612866</ArticleId><ArticleId IdType="pmc">PMC9134037</ArticleId><ArticleId IdType="doi">10.1001/jamacardio.2022.1166</ArticleId><ArticleId IdType="pii">2792587</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lopes RD, Hong H, Harskamp RE, et al. . Optimal antithrombotic regimens for patients with atrial fibrillation undergoing percutaneous coronary intervention: an updated network meta-analysis. JAMA Cardiol. 2020;5(5):582-589. doi:10.1001/jamacardio.2019.6175</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2019.6175</ArticleId><ArticleId IdType="pmc">PMC7240352</ArticleId><ArticleId IdType="pubmed">32101251</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes RD, Heizer G, Aronson R, et al. ; AUGUSTUS Investigators . Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation. N Engl J Med. 2019;380(16):1509-1524. doi:10.1056/NEJMoa1817083</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1817083</ArticleId><ArticleId IdType="pubmed">30883055</ArticleId></ArticleIdList></Reference><Reference><Citation>Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation. Chest. 2010;137(2):263-272. doi:10.1378/chest.09-1584</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.09-1584</ArticleId><ArticleId IdType="pubmed">19762550</ArticleId></ArticleIdList></Reference><Reference><Citation>Easton JD, Lopes RD, Bahit MC, et al. ; ARISTOTLE Committees and Investigators . Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial. Lancet Neurol. 2012;11(6):503-511. doi:10.1016/S1474-4422(12)70092-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(12)70092-3</ArticleId><ArticleId IdType="pubmed">22572202</ArticleId></ArticleIdList></Reference><Reference><Citation>Myint PK, Kwok CS, Roffe C, et al. ; British Cardiovascular Intervention Society and the National Institute for Cardiovascular Outcomes Research . Determinants and outcomes of stroke following percutaneous coronary intervention by indication. Stroke. 2016;47(6):1500-1507. doi:10.1161/STROKEAHA.116.012700</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.116.012700</ArticleId><ArticleId IdType="pubmed">27165953</ArticleId></ArticleIdList></Reference><Reference><Citation>Natsuaki M, Morimoto T, Watanabe H, et al. ; CREDO&#x2010;Kyoto PCI/CABG registry cohort&#x2010;2, RESET and NEXT trial investigators . Ischemic and bleeding risk after percutaneous coronary intervention in patients with prior ischemic and hemorrhagic stroke. J Am Heart Assoc. 2019;8(22):e013356. doi:10.1161/JAHA.119.013356</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.119.013356</ArticleId><ArticleId IdType="pmc">PMC6915281</ArticleId><ArticleId IdType="pubmed">31701821</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallentin L, Becker RC, Budaj A, et al. ; PLATO Investigators . Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361(11):1045-1057. doi:10.1056/NEJMoa0904327</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0904327</ArticleId><ArticleId IdType="pubmed">19717846</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes RD, Vora AN, Liaw D, et al. . An open-label, 2 &#xd7; 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: rationale and design of the AUGUSTUS trial. Am Heart J. 2018;200:17-23. doi:10.1016/j.ahj.2018.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2018.03.001</ArticleId><ArticleId IdType="pubmed">29898844</ArticleId></ArticleIdList></Reference><Reference><Citation>Harskamp RE, Fanaroff AC, Lopes RD, et al. . Antithrombotic therapy in patients with atrial fibrillation after acute coronary syndromes or percutaneous intervention. J Am Coll Cardiol. 2022;79(5):417-427. doi:10.1016/j.jacc.2021.11.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2021.11.035</ArticleId><ArticleId IdType="pubmed">35115097</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulman S, Kearon C; Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis . Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3(4):692-694. doi:10.1111/j.1538-7836.2005.01204.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2005.01204.x</ArticleId><ArticleId IdType="pubmed">15842354</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson CM, Mehran R, Bode C, et al. . Prevention of bleeding in patients with atrial fibrillation undergoing PCI. N Engl J Med. 2016;375(25):2423-2434. doi:10.1056/NEJMoa1611594</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1611594</ArticleId><ArticleId IdType="pubmed">27959713</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannon CP, Bhatt DL, Oldgren J, et al. ; RE-DUAL PCI Steering Committee and Investigators . Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. N Engl J Med. 2017;377(16):1513-1524. doi:10.1056/NEJMoa1708454</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1708454</ArticleId><ArticleId IdType="pubmed">28844193</ArticleId></ArticleIdList></Reference><Reference><Citation>Vranckx P, Valgimigli M, Eckardt L, et al. . Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial. Lancet. 2019;394(10206):1335-1343. doi:10.1016/S0140-6736(19)31872-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)31872-0</ArticleId><ArticleId IdType="pubmed">31492505</ArticleId></ArticleIdList></Reference><Reference><Citation>Hankey GJ, Patel MR, Stevens SR, et al. ; ROCKET AF Steering Committee Investigators . Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF. Lancet Neurol. 2012;11(4):315-322. doi:10.1016/S1474-4422(12)70042-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(12)70042-X</ArticleId><ArticleId IdType="pubmed">22402056</ArticleId></ArticleIdList></Reference><Reference><Citation>Diener HC, Connolly SJ, Ezekowitz MD, et al. ; RE-LY study group . Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial. Lancet Neurol. 2010;9(12):1157-1163. doi:10.1016/S1474-4422(10)70274-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70274-X</ArticleId><ArticleId IdType="pubmed">21059484</ArticleId></ArticleIdList></Reference><Reference><Citation>Rost NS, Giugliano RP, Ruff CT, et al. ; ENGAGE AF-TIMI 48 Investigators . Outcomes with edoxaban versus warfarin in patients with previous cerebrovascular events: findings from ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48). Stroke. 2016;47(8):2075-2082. doi:10.1161/STROKEAHA.116.013540</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.116.013540</ArticleId><ArticleId IdType="pubmed">27387994</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">34785609</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>25</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-632X</ISSN><JournalIssue CitedMedium="Internet"><Volume>97</Volume><Issue>20 Suppl 2</Issue><PubDate><Year>2021</Year><Month>Nov</Month><Day>16</Day></PubDate></JournalIssue><Title>Neurology</Title><ISOAbbreviation>Neurology</ISOAbbreviation></Journal><ArticleTitle>Periprocedural Management During Stroke Thrombectomy.</ArticleTitle><Pagination><StartPage>S105</StartPage><EndPage>S114</EndPage><MedlinePgn>S105-S114</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1212/WNL.0000000000012798</ELocationID><Abstract><AbstractText Label="PURPOSE OF REVIEW">Endovascular therapy (EVT) for acute ischemic stroke caused by large vessel occlusion is a powerful and evidence-based tool to achieve reperfusion and results in improved neurologic outcome. Focus has now shifted toward optimizing the procedure. We reviewed the relevant current literature on periprocedural stroke care such as pretreatment with IV tissue plasminogen activator (tPA), choice of anesthesia, ventilation strategy, and blood pressure management.</AbstractText><AbstractText Label="RECENT FINDINGS">IV tPA should not be withheld in a patients with stroke eligible for EVT. A meta-analysis of randomized trials on general anesthesia (GA) vs procedural sedation has shown better neurologic outcomes with protocol-based GA in centers with dedicated neuroanesthesia teams. There are no data from randomized trials on blood pressure control, but according to available evidence, systolic blood pressure should probably be held at &gt;140 mm Hg during the procedure and &lt;160 mm Hg after reperfusion. In ventilated patients, extreme deviations from normoxemia and normocapnia should be avoided.</AbstractText><AbstractText Label="SUMMARY">Periprocedural care influences the outcome after EVT for large vessel ischemic stroke. More evidence from prospective ongoing and future studies is urgently needed to identify its optimization.</AbstractText><CopyrightInformation>&#xa9; 2021 American Academy of Neurology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Simonsen</LastName><ForeName>Claus Z</ForeName><Initials>CZ</Initials><Identifier Source="ORCID">0000-0003-1363-0266</Identifier><AffiliationInfo><Affiliation>From the Department of Neurology (C.Z.S.) and Department of Anesthesia (M.R.), Section of Neuroanesthesia, Aarhus University Hospital, Aarhus, Denmark; and Department of Neurology (J.B.), Klinikum Kassel, Germany. clasim@rm.dk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xf6;sel</LastName><ForeName>Julian</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-2326-0473</Identifier><AffiliationInfo><Affiliation>From the Department of Neurology (C.Z.S.) and Department of Anesthesia (M.R.), Section of Neuroanesthesia, Aarhus University Hospital, Aarhus, Denmark; and Department of Neurology (J.B.), Klinikum Kassel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasmussen</LastName><ForeName>Mads</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0416-6767</Identifier><AffiliationInfo><Affiliation>From the Department of Neurology (C.Z.S.) and Department of Anesthesia (M.R.), Section of Neuroanesthesia, Aarhus University Hospital, Aarhus, Denmark; and Department of Neurology (J.B.), Klinikum Kassel, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurology</MedlineTA><NlmUniqueID>0401060</NlmUniqueID><ISSNLinking>0028-3878</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.21.68</RegistryNumber><NameOfSubstance UI="D010959">Tissue Plasminogen Activator</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D061605" MajorTopicYN="N">Administration, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="Y">Perioperative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017131" MajorTopicYN="Y">Thrombectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010959" MajorTopicYN="N">Tissue Plasminogen Activator</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>17</Day><Hour>6</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34785609</ArticleId><ArticleId IdType="doi">10.1212/WNL.0000000000012798</ArticleId><ArticleId IdType="pii">97/20_Supplement_2/S105</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32585201</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>12</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-6259</ISSN><JournalIssue CitedMedium="Internet"><Volume>111</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Feb</Month></PubDate></JournalIssue><Title>The Annals of thoracic surgery</Title><ISOAbbreviation>Ann Thorac Surg</ISOAbbreviation></Journal><ArticleTitle>Platelet Transfusion in Cardiac Surgery: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>607</StartPage><EndPage>614</EndPage><MedlinePgn>607-614</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.athoracsur.2020.04.139</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0003-4975(20)30960-7</ELocationID><Abstract><AbstractText Label="BACKGROUND">Blood transfusion is a well-established independent risk factor for mortality in patients undergoing cardiac surgery but the impact of platelet transfusion is less clear. We performed a systematic review and meta-analysis of observational studies comparing outcomes of patients who received platelet transfusion after cardiac surgery.</AbstractText><AbstractText Label="METHODS">We searched MEDLINE and EMBASE databases to January 2019 for studies comparing perioperative outcomes in patients undergoing cardiac surgery with and without platelet transfusion.</AbstractText><AbstractText Label="RESULTS">There were nine observational studies reporting 101,511 patients: 12% with and 88% without platelet transfusion. In unmatched/unadjusted studies, patients who received platelet transfusion were older, with greater incidence of renal, peripheral, and cerebrovascular disease, myocardial infarction, left ventricular dysfunction, and anemia. They were more likely to have nonelective, combined surgery; preoperative hemodynamic instability and endocarditis; and more likely to be receiving clopidogrel preoperatively. Perioperative complications were significantly increased without adjusting for these baseline differences. After pooling only matched/adjusted data, differences were not found between patients who did receive platelets and patients who did not in operative mortality (risk ratio [RR] 1.26; 95% confidence interval [CI], 0.69 to 2.32, P&#xa0;= .46, five studies), stroke (RR 0.94; 95% CI, 0.62 to 1.45; P&#xa0;= .79; five studies), myocardial infarction (RR 1.29; 95% CI, 0.95 to 1.77; P&#xa0;= .11; three studies), reoperation for bleeding (RR 1.20; 95% CI, 0.46 to 3.18; P&#xa0;= .71; three studies), infection (RR 1.02; 95% CI, 0.86 to 1.20; P&#xa0;= .85; six studies); and perioperative dialysis (RR 0.91; 95% CI, 0.63 to 1.32; P&#xa0;= .62; three studies).</AbstractText><AbstractText Label="CONCLUSIONS">After accounting for baseline differences, platelet transfusion was not linked with perioperative complications in cardiac surgery patients. Given the small number of observational studies, these findings should be considered hypothesis generating.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yanagawa</LastName><ForeName>Bobby</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada. Electronic address: yanagawab@smh.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ribeiro</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazer</LastName><ForeName>C David</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada; Department of Critical Care and Medicine, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Davy</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Medicine, MEDICI Center, University of Western Ontario, London, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Janet</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Medicine, MEDICI Center, University of Western Ontario, London, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verma</LastName><ForeName>Subodh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Friedrich</LastName><ForeName>Jan O</ForeName><Initials>JO</Initials><AffiliationInfo><Affiliation>Department of Critical Care and Medicine, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Canadian Cardiovascular Surgery Meta-Analysis Working Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Ann Thorac Surg</MedlineTA><NlmUniqueID>15030100R</NlmUniqueID><ISSNLinking>0003-4975</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Ann Thorac Surg. 2021 Feb;111(2):614. doi: 10.1016/j.athoracsur.2020.05.046.</RefSource><PMID Version="1">32599043</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017713" MajorTopicYN="N">Platelet Transfusion</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32585201</ArticleId><ArticleId IdType="doi">10.1016/j.athoracsur.2020.04.139</ArticleId><ArticleId IdType="pii">S0003-4975(20)30960-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28431770</PMID><DateCompleted><Year>2018</Year><Month>04</Month><Day>03</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1874-1754</ISSN><JournalIssue CitedMedium="Internet"><Volume>240</Volume><PubDate><Year>2017</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>International journal of cardiology</Title><ISOAbbreviation>Int J Cardiol</ISOAbbreviation></Journal><ArticleTitle>Aortic stenosis and non-cardiac surgery: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>145</StartPage><EndPage>153</EndPage><MedlinePgn>145-153</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijcard.2017.04.037</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0167-5273(16)34897-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Aortic stenosis (AS) poses a perioperative management dilemma to physicians looking after patients who require non-cardiac surgery. The objective of this review is to investigate mortality and adverse cardiovascular events in patients with and without AS who underwent non-cardiac surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched MEDLINE and EMBASE for studies that evaluated mortality and adverse cardiovascular events in patients with and without AS who underwent non-cardiac surgery. Pooled risk ratios for mortality and adverse outcomes (myocardial infarction, stroke, heart failure, death) were calculated using the dichotomous analysis method and subgroup analysis was performed considering the effect of severity of AS and symptoms.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 9 relevant studies with 29,327 participants. Among studies of severe AS, there was no significant difference in mortality (RR: 1.49, 95%CI:0.85-2.61; P=0.16) associated with non-cardiac surgery, but there was a significant increase in the composite adverse outcome (RR: 2.30, 95%CI:1.33-3.97; P=0.003). When the analysis involved any other degree of AS, eight studies were included and the pooled results showed a significant increase in composite adverse outcome (RR: 1.64, 95%CI:1.23-2.19; P&lt;0.001) and myocardial infarction (RR: 1.90, 95%CI:1.54-2.34; P&lt;0.001). When patients with asymptomatic AS were considered, the pooled results of four studies suggested an increased risk of composite adverse outcomes (RR: 1.59, 95%CI:1.19-2.12; P=0.002) but not mortality, myocardial infarction, heart failure or stroke.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Patients with AS undergoing non-cardiac surgery have not been shown to be at increased risk of mortality, but have significantly higher rates of adverse cardiovascular events compared to patients without AS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kwok</LastName><ForeName>Chun Shing</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Cardiovascular Research Group, Keele University, Stoke-on-Trent, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bagur</LastName><ForeName>Rodrigo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cardiovascular Research Group, Keele University, Stoke-on-Trent, UK; Division of Cardiology, London Health Sciences Centre, Department of Medicine, Western University, London, Ontario, Canada; Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada. Electronic address: rodrigobagur@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rashid</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiovascular Research Group, Keele University, Stoke-on-Trent, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lavi</LastName><ForeName>Ronit</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Medicine, London Health Sciences Centre, Western University, London, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cibelli</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Royal Brompton Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Belder</LastName><ForeName>Mark A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>The James Cook University Hospital, Middlesbrough, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moat</LastName><ForeName>Neil</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Royal Brompton Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hildick-Smith</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Sussex Cardiac Centre, Brighton &amp; Sussex University Hospitals, Brighton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ludman</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Queen Elizabeth Hospital, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mamas</LastName><ForeName>Mamas A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Cardiovascular Research Group, Keele University, Stoke-on-Trent, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>04</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int J Cardiol</MedlineTA><NlmUniqueID>8200291</NlmUniqueID><ISSNLinking>0167-5273</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001024" MajorTopicYN="N">Aortic Valve Stenosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="N">Heart Failure</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adverse cardiovascular outcomes</Keyword><Keyword MajorTopicYN="N">Aortic stenosis</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Non-cardiac surgery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>4</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28431770</ArticleId><ArticleId IdType="doi">10.1016/j.ijcard.2017.04.037</ArticleId><ArticleId IdType="pii">S0167-5273(16)34897-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30300177</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>03</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>127</Volume><Issue>6</Issue><PubDate><Year>2018</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>Fluid Challenge During Anesthesia: A Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>1353</StartPage><EndPage>1364</EndPage><MedlinePgn>1353-1364</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000003834</ELocationID><Abstract><AbstractText Label="BACKGROUND">Assessing the volemic status of patients undergoing surgery is part of the routine management for the anesthesiologist. This assessment is commonly performed by means of dynamic indexes based on the cardiopulmonary interaction during mechanical ventilation (if available) or by administering a fluid challenge (FC). The FC is used during surgery to optimize predefined hemodynamic targets, the so-called Goal-Directed Therapy (GDT), or to correct hemodynamic instability (non-GDT).</AbstractText><AbstractText Label="METHODS">In this systematic review, we considered the FC components in studies adopting either GDT or non-GDT, to assess whether differences exist between the 2 approaches. In addition, we performed a meta-analysis to ascertain the effectiveness of dynamic indexes pulse pressure variation (PPV) and stroke volume (SV) variation (SVV), in predicting fluid responsiveness.</AbstractText><AbstractText Label="RESULTS">Thirty-five non-GDT and 33 GDT studies met inclusion criteria, including 5017 patients. In the vast majority of non-GDT and GDT studies, the FC consisted in the administration of colloids (85.7% and 90.9%, respectively). In 29 non-GDT studies, the colloid infused was the 6% hydroxyethyl starch (6% HES; 96.6% of this subgroup). In 20 GDT studies, the colloid infused was the 6% HES (66.7% of this subgroup), while in 5 studies was a gelatin (16.7% of this subgroup), in 3 studies an unspecified colloid (10.0% of this subgroup), and in 1 study albumin (3.3%) or, in another study, both HES 6% and gelatin (3.3%). In non-GDT studies, the median volume infused was 500 mL; the time of infusion and hemodynamic target to assess fluid responsiveness lacked standardization. In GDT studies, FC usually consisted in the administration of 250 mL of colloids (48.8%) in 10 minutes (45.4%) targeting an SV increase &gt;10% (57.5%). Only in 60.6% of GDT studies, a safety limit was adopted. PPV pooled area under the curve (95% confidence interval [CI]) was 0.86 (0.80-0.92). The mean (standard deviation) PPV threshold predicting fluid responsiveness was 10.5% (3.2) (range, 8%-15%), while the pooled (95% CI) sensitivity and specificity were 0.80 (0.74-0.85) and 0.83 (0.73-0.91), respectively. SVV pooled area under the curve (95% CI) was 0.87 (0.81-0.93). The mean (standard deviation) SVV threshold predicting fluid responsiveness was 11.3% (3.1) (range, 7.5%-15.5%), while the pooled (95% CI) sensitivity and specificity were 0.82 (0.75-0.89) and 0.77 (0.71-0.82), respectively.</AbstractText><AbstractText Label="CONCLUSIONS">The key components of FC including type of fluid (colloids, often 6% HES), volume (500 and 250 mL in non-GDT studies and GDT studies, respectively), and time of infusion (10 minutes) are quite standardized in operating room. However, pooled sensitivity and specificity of both PPV and SVV are limited.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Messina</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the IRCCS Humanitas, Humanitas University, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pelaia</LastName><ForeName>Corrado</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruni</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garofalo</LastName><ForeName>Eugenio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonicolini</LastName><ForeName>Eleonora</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Critical Care, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Longhini</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dellara</LastName><ForeName>Erica</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care Medicine, Sant'Andrea Hospital, Vercelli, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saderi</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Clinical Epidemiology and Medical Statistics Unit, Department of Biomedical Sciences, University of Sassari, Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romagnoli</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Critical Care, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sotgiu</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Clinical Epidemiology and Medical Statistics Unit, Department of Biomedical Sciences, University of Sassari, Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cecconi</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the IRCCS Humanitas, Humanitas University, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navalesi</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003102">Colloids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006895">Hydroxyethyl Starch Derivatives</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="N">Anesthesia</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000776" MajorTopicYN="N">Anesthesiology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001794" MajorTopicYN="N">Blood Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002319" MajorTopicYN="N">Cardiovascular System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003102" MajorTopicYN="N">Colloids</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="N">Fluid Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006895" MajorTopicYN="N">Hydroxyethyl Starch Derivatives</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016343" MajorTopicYN="N">Monitoring, Intraoperative</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009873" MajorTopicYN="N">Operating Rooms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30300177</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000003834</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29533470</PMID><DateCompleted><Year>2018</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-493X</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month><Day>13</Day></PubDate></JournalIssue><Title>The Cochrane database of systematic reviews</Title><ISOAbbreviation>Cochrane Database Syst Rev</ISOAbbreviation></Journal><ArticleTitle>Perioperative beta-blockers for preventing surgery-related mortality and morbidity.</ArticleTitle><Pagination><StartPage>CD004476</StartPage><MedlinePgn>CD004476</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">CD004476</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/14651858.CD004476.pub3</ELocationID><Abstract><AbstractText Label="BACKGROUND">Randomized controlled trials have yielded conflicting results regarding the ability of beta-blockers to influence perioperative cardiovascular morbidity and mortality. Thus routine prescription of these drugs in unselected patients remains a controversial issue.</AbstractText><AbstractText Label="OBJECTIVES">The objective of this review was to systematically analyse the effects of perioperatively administered beta-blockers for prevention of surgery-related mortality and morbidity in patients undergoing any type of surgery while under general anaesthesia.</AbstractText><AbstractText Label="SEARCH METHODS">We identified trials by searching the following databases from the date of their inception until June 2013: MEDLINE, Embase , the Cochrane Central Register of Controlled Trials (CENTRAL), Biosis Previews, CAB Abstracts, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Derwent Drug File, Science Citation Index Expanded, Life Sciences Collection, Global Health and PASCAL. In addition, we searched online resources to identify grey literature.</AbstractText><AbstractText Label="SELECTION CRITERIA">We included randomized controlled trials if participants were randomly assigned to a beta-blocker group or a control group (standard care or placebo). Surgery (any type) had to be performed with all or at least a significant proportion of participants under general anaesthesia.</AbstractText><AbstractText Label="DATA COLLECTION AND ANALYSIS">Two review authors independently extracted data from all studies. In cases of disagreement, we reassessed the respective studies to reach consensus. We computed summary estimates in the absence of significant clinical heterogeneity. Risk ratios (RRs) were used for dichotomous outcomes, and mean differences (MDs) were used for continuous outcomes. We performed subgroup analyses for various potential effect modifiers.</AbstractText><AbstractText Label="MAIN RESULTS">We included 88 randomized controlled trials with 19,161 participants. Six studies (7%) met the highest methodological quality criteria (studies with overall low risk of bias: adequate sequence generation, adequate allocation concealment, double/triple-blinded design with a placebo group, intention-to-treat analysis), whereas in the remaining trials, some form of bias was present or could not be definitively excluded (studies with overall unclear or high risk of bias). Outcomes were evaluated separately for cardiac and non-cardiac surgery.CARDIAC SURGERY (53 trials)We found no clear evidence of an effect of beta-blockers on the following outcomes.&#x2022; All-cause mortality: RR 0.73, 95% CI 0.35 to 1.52, 3783 participants, moderate quality evidence.&#x2022; Acute myocardial infarction (AMI): RR 1.04, 95% CI 0.71 to 1.51, 3553 participants, moderate quality evidence.&#x2022; Myocardial ischaemia: RR 0.51, 95% CI 0.25 to 1.05, 166 participants, low quality evidence.&#x2022; Cerebrovascular events: RR 1.52, 95% CI 0.58 to 4.02, 1400 participants, low quality evidence.&#x2022; Hypotension: RR 1.54, 95% CI 0.67 to 3.51, 558 participants, low quality evidence.&#x2022; Bradycardia: RR 1.61, 95% CI 0.97 to 2.66, 660 participants, low quality evidence.&#x2022; Congestive heart failure: RR 0.22, 95% CI 0.04 to 1.34, 311 participants, low quality evidence.Beta-blockers significantly reduced the occurrence of the following endpoints.&#x2022; Ventricular arrhythmias: RR 0.37, 95% CI 0.24 to 0.58, number needed to treat for an additional beneficial outcome (NNTB) 29, 2292 participants, moderate quality evidence.&#x2022; Supraventricular arrhythmias: RR 0.44, 95% CI 0.36 to 0.53, NNTB five, 6420 participants, high quality evidence.&#x2022; On average, beta-blockers reduced length of hospital stay by 0.54 days (95% CI -0.90 to -0.19, 2450 participants, low quality evidence).NON-CARDIAC SURGERY (35 trials)Beta-blockers significantly increased the occurrence of the following adverse events.&#x2022; All-cause mortality: RR 1.25, 95% CI 1.00 to 1.57, 11,413 participants, low quality of evidence, number needed to treat for an additional harmful outcome (NNTH) 167.&#x2022; Hypotension: RR 1.50, 95% CI 1.38 to 1.64, NNTH 16, 10,947 participants, high quality evidence.&#x2022; Bradycardia: RR 2.23, 95% CI 1.48 to 3.36, NNTH 21, 11,033 participants, moderate quality evidence.We found a potential increase in the occurrence of the following outcomes with the use of beta-blockers.&#x2022; Cerebrovascular events: RR 1.59, 95% CI 0.93 to 2.71, 9150 participants, low quality evidence.Whereas no clear evidence of an effect was found when all studies were analysed, restricting the meta-analysis to low risk of bias studies revealed a significant increase in cerebrovascular events with the use of beta-blockers: RR 2.09, 95% CI 1.14 to 3.82, NNTH 265, 8648 participants.Beta-blockers significantly reduced the occurrence of the following endpoints.&#x2022; AMI: RR 0.73, 95% CI 0.61 to 0.87, NNTB 76, 10,958 participants, high quality evidence.&#x2022; Myocardial ischaemia: RR 0.51, 95% CI 0.34 to 0.77, NNTB nine, 978 participants, moderate quality evidence.&#x2022; Supraventricular arrhythmias: RR 0.73, 95% CI 0.57 to 0.94, NNTB 112, 8744 participants, high quality evidence.We found no clear evidence of an effect of beta-blockers on the following outcomes.&#x2022; Ventricular arrhythmias: RR 0.68, 95% CI 0.31 to 1.49, 476 participants, moderate quality evidence.&#x2022; Congestive heart failure: RR 1.18, 95% CI 0.94 to 1.48, 9173 participants, moderate quality evidence.&#x2022; Length of hospital stay: mean difference -0.45 days, 95% CI -1.75 to 0.84, 551 participants, low quality evidence.</AbstractText><AbstractText Label="AUTHORS' CONCLUSIONS">According to our findings, perioperative application of beta-blockers still plays a pivotal role in cardiac surgery, as they can substantially reduce the high burden of supraventricular and ventricular arrhythmias in the aftermath of surgery. Their influence on mortality, AMI, stroke, congestive heart failure, hypotension and bradycardia in this setting remains unclear.In non-cardiac surgery, evidence shows an association of beta-blockers with increased all-cause mortality. Data from low risk of bias trials further suggests an increase in stroke rate with the use of beta-blockers. As the quality of evidence is still low to moderate, more evidence is needed before a definitive conclusion can be drawn. The substantial reduction in supraventricular arrhythmias and AMI in this setting seems to be offset by the potential increase in mortality and stroke.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Blessberger</LastName><ForeName>Hermann</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Med Campus III, Kepler University Hospital, Medical Faculty of the Johannes Kepler University Linz, Krankenhausstra&#xdf;e 9, Linz, Austria, 4020.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kammler</LastName><ForeName>Juergen</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Domanovits</LastName><ForeName>Hans</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Schlager</LastName><ForeName>Oliver</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Wildner</LastName><ForeName>Brigitte</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Azar</LastName><ForeName>Danyel</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Schillinger</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Wiesbauer</LastName><ForeName>Franz</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Steinwender</LastName><ForeName>Clemens</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cochrane Database Syst Rev</MedlineTA><NlmUniqueID>100909747</NlmUniqueID><ISSNLinking>1361-6137</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000319">Adrenergic beta-Antagonists</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>Cochrane Database Syst Rev. 2014 Sep 18;(9):CD004476. doi: 10.1002/14651858.CD004476.pub2.</RefSource><PMID Version="1">25233038</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000319" MajorTopicYN="N">Adrenergic beta-Antagonists</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="N">Arrhythmias, Cardiac</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001919" MajorTopicYN="N">Bradycardia</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013504" MajorTopicYN="N">Cardiovascular Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002423" MajorTopicYN="N">Cause of Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002561" MajorTopicYN="N">Cerebrovascular Disorders</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017202" MajorTopicYN="N">Myocardial Ischemia</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>H. Blessberger: received consultancy honoraria from Ever Neuro Pharma in 2012. J. Kammler: none known. H. Domanovits: received honoraria from MSD, Sanofi&#x2010;Aventis, Boehringer&#x2010;Ingelheim and Amomed Pharma for giving lectures and consulting. O. Schlager: none known. B. Wildner: none known. D. Azar: none known. M. Schillinger: none known. F. Wiesbauer: received payments from Medtronic for lectures on cardiac resynchronization therapy and received travel grants to attend the EuroEcho meeting from GE and Medtronic. Dr. Wiesbauer was part&#x2010;time employee of Ever Neuro Pharma between September 2010 and September 2011 and is currently managing director of Medmastery &#x2010; a company producing online training materials for doctors. All these activities were unrelated to this review. C. Steinwender: received honoraria from MSD, Sanofi&#x2010;Aventis, Boehringer&#x2010;Ingelheim, Bayer Austria, Medtronic, Biotronik, Abbott Vascular, St.Jude Medical and Boston Scientific for giving lectures. Ever Neuro Pharma, Medmastery, Sanofi&#x2010;Aventis, Boehringer&#x2010;Ingelheim Europe, Medtronic, Biotronik, GE, Bayer Austria, Abbott Vascular, St. Jude Medical and Boston Scientific do not produce, market or distribute any of the studied drug entities. MSD (timolol) and Amomed Pharma (esmolol) both have a beta&#x2010;blocker in their portfolio.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>3</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29533470</ArticleId><ArticleId IdType="pmc">PMC6494407</ArticleId><ArticleId IdType="doi">10.1002/14651858.CD004476.pub3</ArticleId></ArticleIdList><ReferenceList><Title>References to studies included in this review</Title><ReferenceList><Title>Abel 1983 {published data only}</Title><Reference><Citation>Abel RM, Gelder HM, Pores IH, Liguori J. Continued propranolol administration following coronary bypass surgery. Archives of Surgery 1983;118:727&#x2010;31. [PUBMED: 6601941]</Citation><ArticleIdList><ArticleId IdType="pubmed">6601941</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ali 1997 {published data only}</Title><Reference><Citation>Ali IM, Sanalla AA, Clark V. Beta&#x2010;blocker effects on postoperative atrial fibrillation. European Journal of Cardio&#x2010;Thoracic Surgery 1997;11:1154&#x2010;7. [PUBMED: 9237602]</Citation><ArticleIdList><ArticleId IdType="pubmed">9237602</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Apipan 2010 {published data only}</Title><Reference><Citation>Apipan B, Rummasak D. Efficacy and safety of oral propranolol premedication to reduce reflex tachycardia during hypotensive anesthesia with sodium nitroprusside in orthognathic surgery: a double&#x2010;blind randomized clinical trial. American Association of Oral and Maxillofacial Surgeons 2010;68:120&#x2010;4. [PUBMED: 20006165]</Citation><ArticleIdList><ArticleId IdType="pubmed">20006165</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Auer 2004 {published data only}</Title><Reference><Citation>Auer J, Weber T, Berent R, Puschmann R, Hartl P, Ng C, et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SSPAF), a randomized, placebo&#x2010;controlled trial. American Heart Journal 2004;147(4):636&#x2010;43. [PUBMED: 15077078]</Citation><ArticleIdList><ArticleId IdType="pubmed">15077078</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Babin&#x2010;Ebell 1996 {published data only}</Title><Reference><Citation>Babin&#x2010;Ebell J, Keith PR, Elert O. Efficacy and safety of low&#x2010;dose propranolol versus diltiazem in the prophylaxis of supraventricular tachyarrhythmia after coronary artery bypass grafting. European Journal of Cardio&#x2010;Thoracic Surgery 1996;10:412&#x2010;6. [PUBMED: 8817135]</Citation><ArticleIdList><ArticleId IdType="pubmed">8817135</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bayliff 1999 {published data only}</Title><Reference><Citation>Bayliff CD, Massel DR, Inculet RI, Malthaner RA, Quinton SD, Powell FS, et al. Propranolol for the prevention of postoperative arrhythmias in general thoracic surgery. Annals of Thoracic Surgery 1999;67:182&#x2010;6. [PUBMED: 10086546 ]</Citation><ArticleIdList><ArticleId IdType="pubmed">10086546</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bert 2001 {published data only}</Title><Reference><Citation>Bert A, Reinert SE, Singh AK. A beta&#x2010;blocker, not magnesium, is effective prophylaxis for atrial tachyarrhythmias after coronary artery bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia 2001;15:204&#x2010;9. [PUBMED: 11312480]</Citation><ArticleIdList><ArticleId IdType="pubmed">11312480</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Booth 2004 {published data only}</Title><Reference><Citation>Booth JV, Ward EE, Colgan KC, Funk BL, El&#x2010;Moalem H, Smith MP, et al. Metoprolol and coronary artery bypass grafting surgery: does intraoperative metoprolol attenuate acute &#x3b2;&#x2010;adrenergic receptor desensitization during cardiac surgery?. Anaesthesia and Analgesia 2004;98:1224&#x2010;31. [PUBMED: 15105192]</Citation><ArticleIdList><ArticleId IdType="pubmed">15105192</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Burns 1988 {published data only}</Title><Reference><Citation>Burns JMA, Hart DM, Hughes RL, Kelman AW, Hillis WS. Effects of nadolol on arrhythmias during laparoscopy performed under general anaesthesia. British Journal of Anaesthesiology 1988;61:345&#x2010;6. [PUBMED: 2972306]</Citation><ArticleIdList><ArticleId IdType="pubmed">2972306</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>But 2006 {published data only}</Title><Reference><Citation>But AK, Yapici E, Erdil F, &#xd6;zt&#xfc;rk E, Gedik E, Durmus M, et al. The effects of esmolol and magnesium on blood glucose regulation in the patients with type II diabetes mellitus undergoing CABG surgery [Koroner arter cerrahisi planlanan tip II diyabetes mellitus olgularinda esmolol ve magnezyumun kan sekeri reg&#xfc;lasyonuna etkisi]. Gogus&#x2010;Kalp&#x2010;Damar Anestezi ve Yogun Bakim Dernegi Dergesi 2006;124(4):143&#x2010;8. [PUBMED: not available]</Citation></Reference></ReferenceList><ReferenceList><Title>Coleman 1980 {published data only}</Title><Reference><Citation>Coleman AJ, Jordan C. Cardiovascular response to anaesthesia. Influence of beta&#x2010;adrenergic blockade with metoprolol. Anaesthesia 1980;35:972&#x2010;8. [PUBMED: 7004251]</Citation><ArticleIdList><ArticleId IdType="pubmed">7004251</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Connolly 2003 {published data only}</Title><Reference><Citation>Connolly SJ, Cybulsky I, Lamy A, Roberts RS, Tech M, O'Brien B, et al. Double&#x2010;blind, placebo&#x2010;controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta&#x2010;blocker length of stay (BLOS) study. American Heart Journal 2003;145:226&#x2010;32. [PUBMED: 12595838]</Citation><ArticleIdList><ArticleId IdType="pubmed">12595838</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cork 1995 {published data only}</Title><Reference><Citation>Cork RC, Kramer TH, Dreischmeier B, Behr S, Nardo JA. The effect of esmolol given during cardiopulmonary bypass. Cardiovascular Anesthesia 1995;80:28&#x2010;40. [PUBMED: 7802296]</Citation><ArticleIdList><ArticleId IdType="pubmed">7802296</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cucchiara 1986 {published data only}</Title><Reference><Citation>Cicchiara RF, Benefiel DJ, Matteo RS, DeWood M, Albin MS. Evaluation of esmolol in controlling increases in heart rate and blood pressure during endotracheal intubation in patients undergoing carotid endarterectomy. Anesthesiology 1986;65:528&#x2010;31. [PUBMED: 2877599 ]</Citation><ArticleIdList><ArticleId IdType="pubmed">2877599</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Daudon 1986 {published data only}</Title><Reference><Citation>Daudon P, Corcos T, Gandjabakhch I, Levasseur JP, Cabrol A, Cabrol C. Prevention of atrial fibrillation or flutter by acebutolol after coronary bypass grafting. American Journal of Cardiology 1986;58:933&#x2010;6. [PUBMED: 3535474]</Citation><ArticleIdList><ArticleId IdType="pubmed">3535474</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>De Azevedo L&#xfa;cio 2003 {published data only}</Title><Reference><Citation>Azevedo L&#xfa;cio E, Flores A, Blacher C, Leaes PE, Lucchese FA, Pinto Ribeiro J. Effectiveness of metoprolol in preventing atrial fibrillation and flutter in the postoperative period of coronary artery bypass graft surgery [Efetividade do metoprolol na prevencao de fibrilacao e flutter atrial no pos&#x2010;operatorio de cirurgia de revascularizacao miocardica]. Arquivos Brasileiros de Cardiologia 2003;82(1):37&#x2010;41. [PUBMED: 14978593]</Citation><ArticleIdList><ArticleId IdType="pubmed">14978593</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>DIPOM &#x2010; Juul 2006 {published and unpublished data}</Title><Reference><Citation>Juul AB, Wetterslev J, Gluud C, Kofoed&#x2010;Enevoldsen A, Gorm J, Callesen T, et al. Effect of perioperative &#x3b2; blockade in patients with diabetes undergoing major non&#x2010;cardiac surgery: randomised placebo controlled, blinded multicentre trial. BMJ 2006;332(7556):1482. [PUBMED: 16793810]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1482337</ArticleId><ArticleId IdType="pubmed">16793810</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Dy 1998 {published data only}</Title><Reference><Citation>Dy J, Jayasundera T, Kapadala D, Cuperman C, Whitman G, DiSesa V, et al. Post&#x2010;operative atrial fibrillation&#x2014;a randomized trial of metoprolol, flecainide, and placebo. Journal of the American College of Cardiology. 1998; Vol. 31, issue SuplA:324A.</Citation></Reference></ReferenceList><ReferenceList><Title>Evrard 2000 {published data only}</Title><Reference><Citation>Evrard P, Gonzalez M, Jamart J, Malhomme B, Blommaert D, Eucher P, et al. Prophylaxis of supraventricular and ventricular arrhythmias after coronary artery bypass grafting with low&#x2010;dose sotalol. Annals of Thoracic Surgery 2000;70:151&#x2010;6. [PUBMED: 10921700]</Citation><ArticleIdList><ArticleId IdType="pubmed">10921700</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Forlani 2002 {published data only}</Title><Reference><Citation>Forlani S, Paulis R, Notaris S, Nardi P, Tomai F, Proietti I, et al. Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting. Annals of Thoracic Surgery 2002;74:720&#x2010;6. [PUBMED: 12238830]</Citation><ArticleIdList><ArticleId IdType="pubmed">12238830</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Gibson 1988 {published data only}</Title><Reference><Citation>Gibson BE, Black S, Maass L, Cucchiara RF. Esmolol for the control of hypertension after neurologic surgery. Clinical Pharmacologic Therapy 1988;44:650&#x2010;3. [PUBMED: 2904310]</Citation><ArticleIdList><ArticleId IdType="pubmed">2904310</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Gomes 1999 {published data only}</Title><Reference><Citation>Gomes JA, Ip J, Santoni&#x2010;Rugiu F, Mehta D, Ergin A, Lansman S, et al. Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patient: a randomized, double&#x2010;blind, placebo&#x2010;controlled study. Journal of the American College of Cardiology 1999;34(2):334&#x2010;9. [PUBMED: 10440141]</Citation><ArticleIdList><ArticleId IdType="pubmed">10440141</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Graham 1996 {published data only}</Title><Reference><Citation>Graham SP, Hasnain S, Celano J. Low dose but not medium dose beta blockers reduce post&#x2010;operative atrial fibrillation. Circulation 1996;94(8 Suppl 1):190&#x2010;1.</Citation></Reference></ReferenceList><ReferenceList><Title>Gupta 2011 {published data only}</Title><Reference><Citation>Gupta D, Srivastava S, Dubey RK, Prakash PS, Singh PK, Singh U. Comparative evaluation of atenolol and clonidine premedication on cardiovascular response to nasal speculum insertion during trans&#x2010;sphenoid surgery for resection of pituitary adenoma: a prospective, randomised, double&#x2010;blind, controlled study. Indian Journal of Anaesthesia 2011;55(2):135&#x2010;40. [PUBMED: 21712869]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3106385</ArticleId><ArticleId IdType="pubmed">21712869</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Hammon 1984 {published data only}</Title><Reference><Citation>Hammon JW, Wood AJJ, Prager RL, Wood M, Muirhead J, Bender HW Jr. Perioperative beta blockade with propranolol: reduction in myocardial oxygen demands and incidence of atrial and ventricular arrhythmias. Annals of Thoracic Surgery 1984;38:363&#x2010;7. [PUBMED: 6385890]</Citation><ArticleIdList><ArticleId IdType="pubmed">6385890</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Harrison 1987 {published data only}</Title><Reference><Citation>Harrison L, Ralley FE, Wynands E, Robbins GR, Sami M, Ripley R, et al. The role of an ultra short&#x2010;acting adrenergic blocker (esmolol) in patients undergoing coronary artery bypass surgery. Anesthesiology 1987;66:413&#x2010;8. [PUBMED: 2881505]</Citation><ArticleIdList><ArticleId IdType="pubmed">2881505</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Inada 1989 {published data only}</Title><Reference><Citation>Inada E, Cullen DJ, Nemeskal AR, Teplick R. Effect of labetalol or lidocaine on the hemodynamic response to intubation: a controlled randomized double&#x2010;blind study. Journal of Clinical Anesthesiology 1998;1(3):207&#x2010;13. [PUBMED: 2697239]</Citation><ArticleIdList><ArticleId IdType="pubmed">2697239</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ivey 1983 {published data only}</Title><Reference><Citation>Ivey MF, Ivey TD, Bailey WW, Williams DB, Hessel EA, Miller DW. Influence of propranolol on supraventricular tachycardia early after coronary artery revascularization. Journal of Cardiovascular Surgery 1983;85:214&#x2010;8. [PUBMED: 6337306]</Citation><ArticleIdList><ArticleId IdType="pubmed">6337306</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Jacquet 1994 {published data only}</Title><Reference><Citation>Jacquet L, Evenepoel M, Marenne F, Evrard P, Verhelst R, Dion R, et al. Hemodynamic effects and safety of sotalol in the prevention of supraventricular arrhythmias after coronary artery bypass surgery. Journal of Cardiothoracic and Vascular Anesthesia 1994;8:431&#x2010;6. [PUBMED: 7948800]</Citation><ArticleIdList><ArticleId IdType="pubmed">7948800</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Jakobsen 1992 {published data only}</Title><Reference><Citation>Jakobsen CJ, Blom L. Effect of pre&#x2010;operative metoprolol on cardiovascular and catecholamine response and bleeding during hysterectomy. European Journal of Anaesthesiology 1992;9:209&#x2010;15. [PUBMED: 1600972]</Citation><ArticleIdList><ArticleId IdType="pubmed">1600972</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Jakobsen 1997 {published data only}</Title><Reference><Citation>Jakobsen CJ, Bille S, Ahlburg P, Rybro L, Pedersen KD, Rasmussen B. Preoperative metoprolol improves cardiovascular stability and reduces oxygen consumption after thoracotomy. Acta Anaesthesiologica Scandinavica 1997;41:1324&#x2010;30. [PUBMED: 9422300]</Citation><ArticleIdList><ArticleId IdType="pubmed">9422300</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Janssen 1986 {published data only}</Title><Reference><Citation>Janssen J, Loomans L, Harink J, Taams M, Brunninkhuis L, Starre P, et al. Prevention and treatment of supraventricular tachycardia shortly after coronary artery bypass grafting: a randomized open trial. Angiology 1986;60:601&#x2010;9. [PUBMED: 2874755]</Citation><ArticleIdList><ArticleId IdType="pubmed">2874755</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kawaguchi 2010 {published data only}</Title><Reference><Citation>Kawaguchi M, Utada K, Yoshitani K, Uchino H, Takeda Y, Masui K, et al. Effects of a short&#x2010;acting &#x3b2;1 receptor antagonist landiolol on hemodynamics and tissue injury markers in patients with subarachnoid hemorrhage undergoing intracranial aneurysm surgery. Journal of Neurosurgical Anesthesiology 2010;22(3):230&#x2010;9. [PUBMED: 20118792]</Citation><ArticleIdList><ArticleId IdType="pubmed">20118792</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Khuri 1987 {published data only}</Title><Reference><Citation>Khuri SF, Okike N, Josa M, Salm TJV, Assoussa S, Leone L, et al. Efficacy of nadolol in preventing supraventricular tachycardia after coronary artery bypass grafting. American Journal of Cardiology 1987;60:51&#x2010;8D. [PUBMED: 3498356]</Citation><ArticleIdList><ArticleId IdType="pubmed">3498356</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kurian 2001 {published data only}</Title><Reference><Citation>Kurian SM, Evans R, Fernandes NO, Sherry KM. The effect of an infusion of esmolol on the incidence of myocardial ischaemia during tracheal extubation following coronary artery surgery. Anaesthesia 2001;56:1163&#x2010;8. [PUBMED: 11736772]</Citation><ArticleIdList><ArticleId IdType="pubmed">11736772</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lai 2006 {published data only}</Title><Reference><Citation>Lai R, Xu M, Huang W, Wang X, Zeng W, Lin W. Beneficial effects of metoprolol on perioperative cardiac function of elderly esophageal cancer patients. Chinese Journal of Cancer 2006;25(5):609&#x2010;13. [PUBMED: 16687084]</Citation><ArticleIdList><ArticleId IdType="pubmed">16687084</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lamb 1988 {published data only}</Title><Reference><Citation>Lamb RK, Prabhakar G, Thorpe JAC, Smith S, Norton R, Dyde JA. The use of atenolol in the prevention of supraventricular arrhythmias following coronary artery surgery. European Heart Journal 1988;9:32&#x2010;6. [PUBMED: 3257915]</Citation><ArticleIdList><ArticleId IdType="pubmed">3257915</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lee 2010 {published data only}</Title><Reference><Citation>Lee SJ, Lee JN. The effect of perioperative esmolol infusion on the post&#x2010;operative nausea, vomiting and pain after laparoscopic appendectomy. Korean Journal of Anesthesiology 2010;59(3):179&#x2010;84. [PUBMED: 20877702]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2946035</ArticleId><ArticleId IdType="pubmed">20877702</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Liu 1986 {published data only}</Title><Reference><Citation>Liu PL, Gatt S, Gugino LD, Mallampati SR, Covino BG. Esmolol for control of increases in heart rate and blood pressure during tracheal intubation after thiopentone and succinylcholine. Canadian Anaesthetists' Society Journal 1986;33:556&#x2010;62. [PUBMED: 3768764]</Citation><ArticleIdList><ArticleId IdType="pubmed">3768764</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Liu 2006 {published data only}</Title><Reference><Citation>Liu Y, Huang C, He M, Zhang L, Cai H, Guo Q. Influences of perioperative metoprolol on haemodynamics and myocardial ischaemia in elderly patients undergoing noncardiac surgery. Journal of Central South University &#x2010; Medical Sciences (Zhong Nan Da Xue Xue Bao Yi Xue Ban) 2006;31(2):249&#x2010;53. [PUBMED: 16706126]</Citation><ArticleIdList><ArticleId IdType="pubmed">16706126</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Magnusson 1986 {published data only}</Title><Reference><Citation>Magnusson J, Thulin T, Werner O, J&#xe4;rhult J, Thomson D. Haemodynamic effects of pretreatment with metoprolol in hypertensive patients undergoing surgery. British Journal of Anaesthesiology 1986;58:251&#x2010;60. [PUBMED: 3511930]</Citation><ArticleIdList><ArticleId IdType="pubmed">3511930</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mangano 1996 {published data only}</Title><Reference><Citation>Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. New England Journal of Medicine 1996;335(23):1713&#x2010;20. [PUBMED: 8929262]</Citation><ArticleIdList><ArticleId IdType="pubmed">8929262</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Martinussen 1988 {published data only}</Title><Reference><Citation>Martinussen HJ, Lolk A, Szczepanski C, Alstrup P. Supraventricular tachyarrhythmias after coronary bypass surgery &#x2010; a double blind randomized trial of prophylactic low dose propranolol. Thoracic Cardiovascular Surgeon 1988;36:206&#x2010;7. [PUBMED: 2903581]</Citation><ArticleIdList><ArticleId IdType="pubmed">2903581</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Marwick 2009 {published data only}</Title><Reference><Citation>Marwick TH, Branagan H, Venkatesh B, Stewart S. Use of a nurse&#x2010;led intervention to optimize beta&#x2010;blockade for reducing cardiac events after major noncardiac surgery. American Heart Journal 2009;157(4):784&#x2010;90. [PUBMED: 19332211]</Citation><ArticleIdList><ArticleId IdType="pubmed">19332211</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Matangi 1985 {published data only}</Title><Reference><Citation>Matangi MF, Neutze JM, Graham KJ, Hill DG, Kerr AR, Barratt&#x2010;Boyes BG. Arrhythmia prophylaxis after aorta&#x2010;coronary bypass. The effect of minidose propranolol. Journal of Thoracic and Cardiovascular Surgery 1985;89:439&#x2010;43. [PUBMED: 3871883]</Citation><ArticleIdList><ArticleId IdType="pubmed">3871883</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Matangi 1989 {published data only}</Title><Reference><Citation>Matangi MF, Strickland J, Garbe GJ, Habib N, Basu A, Burgess JJ, et al. Atenolol for the prevention of arrhythmias following coronary artery bypass grafting. Canadian Journal of Cardiology 1989;5(4):229&#x2010;34. [PUBMED: 2659151]</Citation><ArticleIdList><ArticleId IdType="pubmed">2659151</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Materne 1985 {published data only}</Title><Reference><Citation>Materne P, Larbuisson R, Collignon P, Limet R, Kulbertus H. Prevention by acebutolol of rhythm disorders following coronary bypass surgery. International Journal of Cardiology 1985;8:275&#x2010;83. [PUBMED: 3894250]</Citation><ArticleIdList><ArticleId IdType="pubmed">3894250</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Matsuura 2001 {published data only}</Title><Reference><Citation>Matsuura K, Takahara Y, Sudo Y, Ishida K. Effect of sotalol in the prevention of atrial fibrillation following coronary artery bypass grafting. Japanese Journal of Thoracic and Cardiovascular Surgery 2001;49:614&#x2010;7. [PUBMED: 11692587]</Citation><ArticleIdList><ArticleId IdType="pubmed">11692587</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Miller 1990 {published data only}</Title><Reference><Citation>Miller DR, Martineau RJ, Hull KA, Hill J. Bolus administration of esmolol for controlling the hemodynamic response to laryngoscopy and intubation: efficacy and effects on myocardial performance. Journal of Cardiothoracic Anesthesia 1990;4(5 Suppl 2):31&#x2010;6.</Citation></Reference></ReferenceList><ReferenceList><Title>Miller 1991 {published data only}</Title><Reference><Citation>Miller DR, Martineau RJ, Wynands JE, Hill J. Bolus administration of esmolol for controlling the haemodynamic response to tracheal intubation: the Canadian multicentre trial. Canadian Journal of Anesthesia 1991;38(7):849&#x2010;58. [PUBMED: 1683818 ]</Citation><ArticleIdList><ArticleId IdType="pubmed">1683818</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mohr 1981 {published data only}</Title><Reference><Citation>Mohr R, Smolinsky A, Goor DA. Prevention of supraventricular tachyarrhythmia with low&#x2010;dose propranolol after coronary bypass. Journal of Thoracic and Cardiovascular Surgery 1981;81:840&#x2010;5. [PUBMED: 7015021]</Citation><ArticleIdList><ArticleId IdType="pubmed">7015021</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Moon 2011 {published data only}</Title><Reference><Citation>Moon YE, Hwang WJ, Koh HJ, Min JY, Lee J. The sparing effect of low&#x2010;dose esmolol on sevoflurane during laparoscopic gynaecological surgery. Journal of International Medical Research 2011;39:1861&#x2010;9. [PUBMED: 22117987 ]</Citation><ArticleIdList><ArticleId IdType="pubmed">22117987</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Myhre 1984 {published data only}</Title><Reference><Citation>Myhre ESP, Sorlie D, AArbakke J, Hals PA, Straume B. Effects of low dose propranolol after coronary bypass surgery. Journal of Cardiovascular Surgery 1984;25:348&#x2010;51. [PUBMED: 6148345]</Citation><ArticleIdList><ArticleId IdType="pubmed">6148345</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Neary 2006 {published data only}</Title><Reference><Citation>Neary WD, McCrirrick A, Foy C, Heather BP, Earnshaw JJ. Lessons learned from a randomised controlled study of perioperative beta blockade in high risk patients undergoing emergency surgery. Surgeon 2006;4(3):139&#x2010;43. [PUBMED: 16764198]</Citation><ArticleIdList><ArticleId IdType="pubmed">16764198</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Neustein 1994 {published data only}</Title><Reference><Citation>Neustein SM, Bronheim DS, Lasker S, Reich DL, Thys DM. Esmolol and intraoperative myocardial ischemia: a double&#x2010;blind study. Journal of Cardiothoracic and Vascular Anesthesia 1994;8(3):273&#x2010;7. [PUBMED: 7914754]</Citation><ArticleIdList><ArticleId IdType="pubmed">7914754</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Nystr&#xf6;m 1993 {published data only}</Title><Reference><Citation>Nystr&#xf6;m U, Edvardsson N, Berggren H, Pizzarelli GP, Radergran K. Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery. Thoracic and Cardiovascular Surgeon 1993;41:34&#x2010;7. [PUBMED: 8103611]</Citation><ArticleIdList><ArticleId IdType="pubmed">8103611</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ogawa 2013 {published data only}</Title><Reference><Citation>Ogawa S, Okawa Y, Goto Y, Aoki M, Baba H. Perioperative use of beta blocker in coronary artery bypass grafting. Asian Cardiovascular and Thoracic Annals 2013;21(3):265&#x2010;9. [DOI: 10.1177/0218492312451166]</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0218492312451166</ArticleId><ArticleId IdType="pubmed">24570490</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Oka 1980 {published data only}</Title><Reference><Citation>Oka Y, Frishman W, Becker RM, Kadish A, Strom J, Matsumoto M, et al. Clinical pharmacology of the new beta&#x2010;adrenergic blocking drugs. Part 10. Beta&#x2010;adrenoceptor blockade and coronary artery surgery. American Heart Journal 1980;99(2):255&#x2010;69. [PUBMED: 6101516]</Citation><ArticleIdList><ArticleId IdType="pubmed">6101516</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ormerod 1984 {published data only}</Title><Reference><Citation>Ormerod OJM, McGregor CGA, Stone DL, Wisbey C, Petch MC. Arrhythmias after coronary bypass surgery. British Heart Journal 1984;51:618&#x2010;21. [PUBMED: 6610435]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC481561</ArticleId><ArticleId IdType="pubmed">6610435</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Osada 2012 {published data only}</Title><Reference><Citation>Osada H, Nakajima H, Masuyama S, Morishima M, Su T. Landiolol hydrochloride: prevention of atrial fibrillation after open&#x2010;heart surgery. European Heart Journal 2012;33(Suppl 1):65. [DOI: 10.1093/eurheartj/ehs281]</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehs281</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Oxorn 1990 {published data only}</Title><Reference><Citation>Oxorn D, Know JWD, Hill J. Bolus doses of esmolol for the prevention of perioperative hypertension and tachycardia. Canadian Journal of Anaesthesiology 1990;37(2):206&#x2010;9. [PUBMED: 1968784]</Citation><ArticleIdList><ArticleId IdType="pubmed">1968784</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Paull 1997 {published data only}</Title><Reference><Citation>Paull DL, Tidwell SL, Guyton SW, Harvey E, Woolf RA, Holmes JR, et al. Beta&#x2010;blockade to prevent atrial dysrhythmias following coronary bypass surgery. American Journal of Surgery 1997;173:419&#x2010;21. [PUBMED: 9168080]</Citation><ArticleIdList><ArticleId IdType="pubmed">9168080</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Pfisterer 1997 {published data only}</Title><Reference><Citation>Pfister ME, Kl&#xf6;ter&#x2010;Weber UC, Huber M, Osswald S, Buser PT, Skarvan K, et al. Prevention of supraventricular tachyarrhythmias after open heart operation by low&#x2010;dose sotalol: a prospective, double&#x2010;blind, randomized, placebo&#x2010;controlled study. Annals of Thoracic Surgery 1997;64:1113&#x2010;9. [PUBMED: 9354537]</Citation><ArticleIdList><ArticleId IdType="pubmed">9354537</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>POBBLE 2005 {published data only}</Title><Reference><Citation>Brady AR, Gibbs JS, Greenhalgh RM, Powell JT, Sydes MR, POBBLE trial investigators. Perioperative beta&#x2010;blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double&#x2010;blind controlled trial. Journal of Vascular Surgery 2005;41(4):602&#x2010;9. [PUBMED: 15874923]</Citation><ArticleIdList><ArticleId IdType="pubmed">15874923</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>POISE 2008 {published data only}</Title><Reference><Citation>Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, et al. Effects of extended&#x2010;release metoprolol succinate in patients undergoing non&#x2010;cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008;371:1839&#x2010;47. [PUBMED: 18479744]</Citation><ArticleIdList><ArticleId IdType="pubmed">18479744</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Raby 1999 {published data only}</Title><Reference><Citation>Raby KE, Brull SJ, Timimi F, Akhtar S, Rosenbaum S, Naimi C, et al. The effect of heart rate control on myocardial ischemia among high&#x2010;risk patients after vascular surgery. Anesthesia and Analgesia 1999;88:477&#x2010;82. [PUBMED: 10071990]</Citation><ArticleIdList><ArticleId IdType="pubmed">10071990</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Reves 1990 {published data only}</Title><Reference><Citation>Reves JG, Croughwell ND, Hawkins E, Smith LR, Jacobs JR, Rankin S, et al. Esmolol for treatment of intraoperative tachycardia and/or hypertension in patients having cardiac operations. Bolus loading technique. Journal of Thoracic and Cardiovascular Surgery 1990;100:221&#x2010;7. [PUBMED: 1974664]</Citation><ArticleIdList><ArticleId IdType="pubmed">1974664</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rubin 1987 {published data only}</Title><Reference><Citation>Rubin DA, Nieminski KE, Reed GE, Herman MV. Predictors, prevention, and long&#x2010;term prognosis of atrial fibrillation after coronary artery bypass graft operation. Journal of Thoracic and Cardiovascular Surgery 1987;94:331&#x2010;5. [PUBMED: 3306163]</Citation><ArticleIdList><ArticleId IdType="pubmed">3306163</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sakaguchi 2012 {published data only}</Title><Reference><Citation>Sakaguchi M, Sasaki Y, Hidekazu H, Hosono M, Nakahira A, Seo H, et al. Efficacy of landiolol hydrochloride for prevention of atrial fibrillation after heart valve surgery. International Heart Journal 2012;53(6):359&#x2010;63. [PUBMED: 23258136]</Citation><ArticleIdList><ArticleId IdType="pubmed">23258136</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Salazar 1979 {published data only}</Title><Reference><Citation>Salazar C, Frishman W, Friedman S, Patel J, Lin YT, Oka Y, et al. Beta&#x2010;blockade therapy for supraventricular tachyarrhythmias after coronary surgery: a propranolol withdrawal syndrome?. Angiology 1979;30(12):816&#x2010;9. [PUBMED: 316976]</Citation><ArticleIdList><ArticleId IdType="pubmed">316976</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sandler 1990 {published data only}</Title><Reference><Citation>Sandler AN, Leitch LF, Badner NH, Colmenares M, Kimball B. Esmolol compared with placebo in preventing increases in heart rate and blood pressure during rigid bronchoscopy. Journal of Cardiothoracic Anesthesia 1990;4(5 Suppl 2):44&#x2010;50.</Citation></Reference></ReferenceList><ReferenceList><Title>Sezai 2011 {published data only}</Title><Reference><Citation>Sezai A, Minami K, Nakai T, Hata M, Yoshitake I, Wakui S, et al. Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial. Journal of Thoracic and Cardiovascular Surgery 2011;141(6):1478&#x2010;87. [PUBMED: 21269646]</Citation><ArticleIdList><ArticleId IdType="pubmed">21269646</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sezai 2012 {published data only}</Title><Reference><Citation>Sezai A, Nakai T, Hata M, Yoshitake I, Shiono M, Kunimoto S, et al. Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study. Journal of Thoracic and Cardiovascular Surgery 2012;144(5):1241&#x2010;8. [PUBMED: 22858430]</Citation><ArticleIdList><ArticleId IdType="pubmed">22858430</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Shukla 2010 {published data only}</Title><Reference><Citation>Shukla S, Gupta K, Gurha P, Sharma M, Sanjay RR, Shukla R, et al. Role of &#x3b2; blockade in anaesthesia and postoperative pain management after major lower abdominal surgery. Internet Journal of Anesthesiology 2010;25(1):pagination not available. [DOI: 10.5580/170f]</Citation><ArticleIdList><ArticleId IdType="doi">10.5580/170f</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Silverman 1982 {published data only}</Title><Reference><Citation>Silverman NA, Wright R, Levitsky S. Efficacy of low&#x2010;dose propranolol in preventing postoperative supraventricular tachyarrhythmias: a prospective, randomized study. Annals of Surgery 1982;196(2):194&#x2010;7. [PUBMED: 6979982]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1352475</ArticleId><ArticleId IdType="pubmed">6979982</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Stephenson 1980 {published data only}</Title><Reference><Citation>Stephenson LW, MacVaugh H, Tomasello DN, Josephson ME. Propranolol for prevention of postoperative cardiac arrhythmias: a randomized study. Annals of Thoracic Surgery 1980;29(2):113&#x2010;6. [PUBMED: 6965579]</Citation><ArticleIdList><ArticleId IdType="pubmed">6965579</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Stone 1988 {published data only}</Title><Reference><Citation>Stone JG, Foex P, Sear JW, Johnson LL, Khambatta HJ, Triner L. Myocardial ischemia in untreated hypertensive patients: effect of a single small oral dose of a beta&#x2010;adrenergic blocking agent. Anesthesiology 1988;68:495&#x2010;500. [PUBMED: 2895596]</Citation><ArticleIdList><ArticleId IdType="pubmed">2895596</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sun 2011 {published data only}</Title><Reference><Citation>Sun J, Ding Z, Qian Y. Effect of short&#x2010;acting beta blocker on the cardiac recovery after cardiopulmonary bypass. Journal of Cardiothoracic Surgery 2011;6(99):pagination not available. [DOI: 10.1186/1749-8090-6-99; PUBMED: 21854625]</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1749-8090-6-99</ArticleId><ArticleId IdType="pmc">PMC3179708</ArticleId><ArticleId IdType="pubmed">21854625</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Suttorp 1991 {published data only}</Title><Reference><Citation>Suttorp MJ, Kingma JH, Peels HO, Koomen EM, Tijssen JG, Hemel NM, et al. Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting. American Journal of Cardiology 1991;68:1163&#x2010;9. [PUBMED: 1951075]</Citation><ArticleIdList><ArticleId IdType="pubmed">1951075</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Vecht 1986 {published data only}</Title><Reference><Citation>Vecht RJ, Nicolaides EP, Ikeuke JK, Liassides C, Cleary J, Cooper WB. Incidence and prevention of supraventricular tachyarrhythmias after coronary bypass surgery. International Journal of Cardiology 1986;13:125&#x2010;34. [PUBMED: 3539826]</Citation><ArticleIdList><ArticleId IdType="pubmed">3539826</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Wallace 1998 {published data only}</Title><Reference><Citation>Wallace A, Layug B, Tateo I, Li J, Hollenberg M, Browner W, et al. Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group. Anesthesiology 1998;88(1):7&#x2010;17. [PUBMED: 9447850]</Citation><ArticleIdList><ArticleId IdType="pubmed">9447850</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Wenke 1999 {published data only}</Title><Reference><Citation>Wenke K, Parsa MHA, Imhof M, Kemkes BM. Efficacy of metoprolol in prevention of supraventricular arrhythmias after coronary artery bypass grafting [Wirksamkeit der Metoprolol&#x2010;Therapie in der Pr&#xe4;vention supraventrikul&#xe4;rer Arrhythmien nach koronarer Bypass&#x2010;Operation]. Zeitschrift f&#xfc;r Kardiologie 1999;88:647&#x2010;52. [PUBMED: 10525926]</Citation><ArticleIdList><ArticleId IdType="pubmed">10525926</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>White 1984 {published data only}</Title><Reference><Citation>White HD, Antman EM, Glynn MA, Collins JJ, Cohn LH, Shemin RJ, et al. Efficacy and safety of timolol for prevention of supraventricular tachyarrhythmias after coronary artery bypass surgery. Circulation 1984;70:479&#x2010;84. [PUBMED: 6378423]</Citation><ArticleIdList><ArticleId IdType="pubmed">6378423</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Whitehead 1980 {published data only}</Title><Reference><Citation>Whitehead MH, Whitmarsh VB, Horton JN. Metoprolol in anaesthesia for oral surgery. Anaesthesia 1980;35:779&#x2010;82. [PUBMED: 7004258]</Citation><ArticleIdList><ArticleId IdType="pubmed">7004258</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Williams 1982 {published data only}</Title><Reference><Citation>Williams JB, Stephenson LW, Holford FD, Langer T, Dunkman WB, Josephson ME. Arrhythmia prophylaxis using propranolol after coronary artery surgery. Annals of Throacic Surgery 1982;34(4):435&#x2010;8. [PUBMED: 6982689 ]</Citation><ArticleIdList><ArticleId IdType="pubmed">6982689</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Yang 2006 {published data only}</Title><Reference><Citation>Yang H, Raymer K, Butler R, Parlow J, Roberts R, Tech M. The effects of perioperative beta&#x2010;blockade: results of the metoprolol after vascular surgery (MaVS) study, a randomized controlled trial. American Heart Journal 2006;152:983&#x2010;90. [PUBMED: 17070177]</Citation><ArticleIdList><ArticleId IdType="pubmed">17070177</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Yang 2008 {published data only}</Title><Reference><Citation>Yang X, Wu X, Wang S, Wang Q. Effects of metoprolol on perioperative cardiovascular events in patients with risk or at high risk for coronary artery disease undergoing non&#x2010;cardiac surgery. Chinese Medical Journal (Zhonghua Yi Xue Za Zhi) 2008;88(21):1476&#x2010;80. [PUBMED: 18953854]</Citation><ArticleIdList><ArticleId IdType="pubmed">18953854</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zaugg 1999 {published data only}</Title><Reference><Citation>Zaugg M, Tagliente T, Lucchinetti E, Jacobs E, Drol M, Bodian C, et al. Beneficial effects from beta&#x2010;adrenergic blockade in elderly patients undergoing noncardiac surgery. Anesthesiology 1999;91:1674&#x2010;86. [PUBMED: 10598610]</Citation><ArticleIdList><ArticleId IdType="pubmed">10598610</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to studies excluded from this review</Title><ReferenceList><Title>DECREASE&#x2010;IV 2009 {published data only}</Title><Reference><Citation>Dunkelgrun M, Boersma E, Schouten O, Koopman&#x2010;van Gemert AWMM, Poorten F, Bax JJ, et al. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate&#x2010;risk patients undergoing noncardiovascular surgery&#x2014;A randomized controlled trial (DECREASE&#x2010;IV). Annals of Surgery 2009;249:921&#x2010;6. [PUBMED: 19474688]</Citation><ArticleIdList><ArticleId IdType="pubmed">19474688</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kl&#xf6;ter&#x2010;Weber 1998 {published data only}</Title><Reference><Citation>Kl&#xf6;ter&#x2010;Weber U, Osswald S, Buser P, Huber M, Skarvan K, Stulz P, et al. Significance of supraventricular tachyarrhythmias after coronary artery bypass graft surgery and their prevention by low&#x2010;dose sotalol: a prospective double&#x2010;blind randomized placebo&#x2010;controlled study. Journal of Cardiovascular Pharmacology and Therapeutics 1998;3(3):209&#x2010;16. [PUBMED: 10684499]</Citation><ArticleIdList><ArticleId IdType="pubmed">10684499</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Poldermans 1999 {published data only}</Title><Reference><Citation>Poldermans D, Boersma E, Bax JJ, Thomson IR, Ven LL, Blankensteijn JD, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high&#x2010;risk patients undergoing vascular surgery. New England Journal of Medicine 1999;341(24):1789&#x2010;94. [PUBMED: 10588963]</Citation><ArticleIdList><ArticleId IdType="pubmed">10588963</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Suttner 2009 {published data only}</Title><Reference><Citation>Suttner S, Boldt J, Mengistu A, Lang K, Mayer J. Influence of continuous perioperative beta&#x2010;blockade in combination with phosphodiesterase inhibition on haemodynamics and myocardial ischaemia in high&#x2010;risk vascular surgery patients. British Journal of Anaesthesia 2009;102(5):597&#x2010;607. [PUBMED: 19336536]</Citation><ArticleIdList><ArticleId IdType="pubmed">19336536</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>Additional references</Title><ReferenceList><Title>Bangalore 2008</Title><Reference><Citation>Bangalore S, Wetterslev J, Pranesh S, Sawhney S, Gluud C, Messerli FH. Perioperative &#x3b2; blockers in patients having non&#x2010;cardiac surgery: a meta&#x2010;analysis. Lancet 2008;372:1962&#x2010;76. [PUBMED: 19012955]</Citation><ArticleIdList><ArticleId IdType="pubmed">19012955</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bouri 2013</Title><Reference><Citation>Bouri S, Shun&#x2010;Shin MJ, Cole GD, Mayet J, Francis DP. Meta&#x2010;analysis of secure randomised controlled trials of &#x3b2;&#x2010;blockade to prevent perioperative death in non&#x2010;cardiac surgery. Heart 2014;100(6):456&#x2010;64. [DOI: 10.1136/heartjnl-2013-304262; PUBMED: 23904357]</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2013-304262</ArticleId><ArticleId IdType="pmc">PMC3932762</ArticleId><ArticleId IdType="pubmed">23904357</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Chopra 2012</Title><Reference><Citation>Chopra V, Eagle KA. Perioperative mischief: the price of academic misconduct. American Journal of Medicine 2012;125(10):953&#x2010;5. [PUBMED: 22884175]</Citation><ArticleIdList><ArticleId IdType="pubmed">22884175</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Crystal 2002</Title><Reference><Citation>Crystal E, Connolly SJ, Sleik K, Ginger TJ, Yusuf S. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta&#x2010;analysis. Circulation 2002;106:75&#x2010;80. [PUBMED: 12093773]</Citation><ArticleIdList><ArticleId IdType="pubmed">12093773</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>DerSimonian 1986</Title><Reference><Citation>DerSimonian R, Laird N. Meta&#x2010;analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177&#x2010;88. [PUBMED: 3802833]</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Devereaux 2004</Title><Reference><Citation>Devereaux PJ, Yusuf S, Yang H, Choi PTL, Guyatt GH. Are the recommendations to use perioperative beta&#x2010;blocker therapy in patients undergoing noncardiac surgery based on reliable evidence?. Canadian Medical Association Journal 2004;171(3):245&#x2010;7. [PUBMED: 15289423]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC490075</ArticleId><ArticleId IdType="pubmed">15289423</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Duval 2000</Title><Reference><Citation>Duval S, Tweedie R. Trim and fill: a simple funnel&#x2010;plot&#x2010;based method of testing and adjusting for publication bias in meta&#x2010;analysis. Biometrics 2000;56(2):455&#x2010;63. [PUBMED: 10877304]</Citation><ArticleIdList><ArticleId IdType="pubmed">10877304</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Egger 1997</Title><Reference><Citation>Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta&#x2010;analysis detected by a simple, graphical test. BMJ 1997;315(7109):629&#x2010;34. [PUBMED: 9310563]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Fihn 2012</Title><Reference><Citation>Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2012;126(25):3097&#x2010;137. [PUBMED: 23166210]</Citation><ArticleIdList><ArticleId IdType="pubmed">23166210</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Fleisher 2001</Title><Reference><Citation>Fleisher LA, Eagle KA. Lowering cardiac risk in noncardiac surgery. New England Journal of Medicine 2001;345:1677&#x2010;82. [PUBMED: 11759647]</Citation><ArticleIdList><ArticleId IdType="pubmed">11759647</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Fleisher 2007</Title><Reference><Citation>Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Fleischmann KE, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular care and care for noncardiac surgery: a report of the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 2007;116(17):1971&#x2010;96. [PUBMED: 17950159]</Citation><ArticleIdList><ArticleId IdType="pubmed">17901356</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Fleisher 2014</Title><Reference><Citation>Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Journal of the American College of Cardiology 2014;64(22):e77&#x2010;137. [PUBMED: 25091544]</Citation><ArticleIdList><ArticleId IdType="pubmed">25091544</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Guyatt 2008</Title><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck&#x2010;Ytter Y, Alonso&#x2010;Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336(7650):924&#x2010;6. [PUBMED: 18436948]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Hammermeister 1990</Title><Reference><Citation>Hammermeister KE, Burchfield C, Johnstin R. Identification of patients at greatest risk for developing major complications at cardiac surgery. Circulation 1990;82:IV&#x2010;380&#x2010;9. [PUBMED: 2225429]</Citation><ArticleIdList><ArticleId IdType="pubmed">2225429</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Higgins 2002</Title><Reference><Citation>Higgins JP, Thompson SG. Quantifying heterogeneity in a meta&#x2010;analysis. Statistics in Medicine 2002;21(11):1539&#x2010;58. [PUBMED: 12111919]</Citation><ArticleIdList><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Higgins 2003</Title><Reference><Citation>Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta&#x2010;analyses. BMJ 2003;327:557&#x2010;60. [PUBMED: 12958120]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Higgins 2011</Title><Reference><Citation>Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.</Citation></Reference></ReferenceList><ReferenceList><Title>Hillis 2011</Title><Reference><Citation>Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG, et al. 2011 ACCF/AHA guidelines for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011;124(23):e652&#x2010;e735. [PUBMED: 22064599]</Citation><ArticleIdList><ArticleId IdType="pubmed">22064599</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Juni 1999</Title><Reference><Citation>Juni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta&#x2010;analysis. JAMA 1999;282(11):1054&#x2010;60. [PUBMED: 10493204]</Citation><ArticleIdList><ArticleId IdType="pubmed">10493204</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kaplan 1993</Title><Reference><Citation>Kaplan JA. Cardiac Anesthesia. Philadelphia: WB Saunders, 1993.</Citation></Reference></ReferenceList><ReferenceList><Title>Kjekshus 1987</Title><Reference><Citation>Kjekshus J. Heart rate reduction&#x2014;a mechanism of benefit?. European Heart Journal 1987;8(Suppl L):115&#x2010;22. [PUBMED: 2897914]</Citation><ArticleIdList><ArticleId IdType="pubmed">2897914</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kjekshus 1991</Title><Reference><Citation>Kjekshus J, Gullestad L. Heart rate as a therapeutic target in heart failure. European Heart Journal 1991;1(Suppl H):H64&#x2010;9.</Citation></Reference></ReferenceList><ReferenceList><Title>Kristensen 2014</Title><Reference><Citation>Kristensen SD, Knuuti J, Saraste A, Anker S, Botker HE, DeHert S, et al. 2014 ESC/ESA Guidelines on non&#x2010;cardiac surgery: cardiovascular assessment and management. European Heart Journal 2014;35:2383&#x2010;431. [PUBMED: 25086026]</Citation><ArticleIdList><ArticleId IdType="pubmed">25086026</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lancet 1986</Title><Reference><Citation>No authors listed. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS&#x2010;1. First International Study of Infarct Survival Collaborative Group. Lancet 1986;2(8498):57&#x2010;66. [PUBMED: 2873379]</Citation><ArticleIdList><ArticleId IdType="pubmed">2873379</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lancet 1999</Title><Reference><Citation>No authors listed. The Cardiac Insufficiency Bisoprolol Study II (CIBIS&#x2010;II): a randomised trial. Lancet 1999;353(9146):9&#x2010;13. [PUBMED: 10023943]</Citation><ArticleIdList><ArticleId IdType="pubmed">10023943</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lauer 1989</Title><Reference><Citation>Lauer MS, Eagle KA, Buckley MJ, DeSanctis RW. Atrial fibrillation following coronary artery bypass surgery. Progress in Cardiovascular Disease 1989;31:367&#x2010;78. [PUBMED: 2646657 ]</Citation><ArticleIdList><ArticleId IdType="pubmed">2646657</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mangano 1990a</Title><Reference><Citation>Mangano DT, Browner WS, Hollenberg M, London MJ, Tubau JF, Tateo IM. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. New England Journal of Medicine 1990;323(26):1781&#x2010;8. [PUBMED: 2247116]</Citation><ArticleIdList><ArticleId IdType="pubmed">2247116</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mangano 1990b</Title><Reference><Citation>Mangano DT. Perioperative cardiac morbidity. Anesthesiology 1990;72(1):153&#x2010;84. [PUBMED: 2404426]</Citation><ArticleIdList><ArticleId IdType="pubmed">2404426</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mangano 1995</Title><Reference><Citation>Mangano DT, Goldman L. Preoperative assessment of patients with known or suspected coronary disease. New England Journal of Medicine 1995;333(26):1750&#x2010;6. [PUBMED: 7491140]</Citation><ArticleIdList><ArticleId IdType="pubmed">7491140</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Moher 2001</Title><Reference><Citation>Moher D, Schulz KF, Altman DG, for the CONSORT group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel&#x2010;group randomised trials. Lancet 2001;357(9263):1191&#x2010;4. [PUBMED: 11323066]</Citation><ArticleIdList><ArticleId IdType="pubmed">11323066</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Montalescot 2013</Title><Reference><Citation>Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, et al. 2013 ESC guidelines in the management of stable coronary artery disease. European Heart Journal 2013;34(38):2949&#x2010;3003. [PUBMED: 23996286]</Citation><ArticleIdList><ArticleId IdType="pubmed">23996286</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Pepine 1994</Title><Reference><Citation>Pepine CJ, Cohn PF, Deedwania PC, Gibson RS, Handberg E, Hill JA, et al. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST). Circulation 1994;90(2):762&#x2010;68. [PUBMED: 8044945]</Citation><ArticleIdList><ArticleId IdType="pubmed">8044945</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Poldermans 2009</Title><Reference><Citation>Poldermans D, Bax JJ, Boersma E, Hert S, Eeckhout E, Fowkes G, et al. Guidelines for pre&#x2010;operative cardiac risk assessment and perioperative cardiac management in non&#x2010;cardiac surgery. European Heart Journal 2009;30:2769&#x2010;812. [PUBMED: 19713421]</Citation><ArticleIdList><ArticleId IdType="pubmed">19713421</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rahimzadeh 2008</Title><Reference><Citation>Rahimzadeh P, Faiz SHR, Etemadi SH. Evaluation of the metoprolol effects in controlled hypotension and reduction of bleeding during head and neck surgery. University of Medical Sciences Journal 2008;1(4):37&#x2010;43.</Citation></Reference></ReferenceList><ReferenceList><Title>RevMan 5.3 [Computer program]</Title><Reference><Citation>The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.</Citation></Reference></ReferenceList><ReferenceList><Title>Ryden 1983</Title><Reference><Citation>Ryden L, Ariniego R, Arnman K, Herlitz J, Hjalmarson A, Holmberg S, et al. A double&#x2010;blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias. New England Journal of Medicine 1983;308(11):614&#x2010;8. [PUBMED: 6828092]</Citation><ArticleIdList><ArticleId IdType="pubmed">6828092</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Stevens 2003</Title><Reference><Citation>Stevens RD, Burri H, Tramer M. Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review. Anesthesia and Analgesia 2003;97(3):623&#x2010;33. [PUBMED: 12933373]</Citation><ArticleIdList><ArticleId IdType="pubmed">12933373</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Thorlund 2011</Title><Reference><Citation>Thorlund K, Engstr&#xf6;m J, Wetterslev J, Brok J, Imberger G, Gluud C. User Manual for Trial Sequential Analysis (TSA). Copenhagen, Denmark: Copenhagen Trial Unit, Centre for Clincal Intervention Research, 2011. [www.ctu.dk/tsa]</Citation></Reference></ReferenceList><ReferenceList><Title>Wetterslev 2008</Title><Reference><Citation>Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta&#x2010;analysis. Journal of Clinical Epidemiology 2008;61(1):64&#x2010;75. [PUBMED: 18083463]</Citation><ArticleIdList><ArticleId IdType="pubmed">18083463</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Wheatley 2003</Title><Reference><Citation>Wheatley KW, Clayton D. Be skeptical about unexpected large apparent treatment effects: the case of an MRC AML 12 randomization. Controlled Clinical Trials 2003;24(1):66&#x2010;70. [DOI: 10.1016/S0197-2456(02)00273-8]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0197-2456(02)00273-8</ArticleId><ArticleId IdType="pubmed">12559643</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to other published versions of this review</Title><ReferenceList><Title>Blessberger 2014</Title><Reference><Citation>Blessberger H, Kammler J, Domanovits H, Schlager O, Wildner B, Azar D, Schillinger M, Wiesbauer F, Steinwender C. Perioperative beta&#x2010;blockers for preventing surgery&#x2010;related mortality and morbidity. Cochrane Database of Systematic Reviews 2014, Issue 9. [DOI: 10.1002/14651858.CD004476.pub2]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD004476.pub2</ArticleId><ArticleId IdType="pubmed">25233038</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Wiesbauer 2007</Title><Reference><Citation>Wiesbauer F, Schlager O, Domanovits H, Wildner B, Maurer G, Muellner M, et al. Perioperative &#x3b2;&#x2010;blockers for preventing surgery&#x2010;related mortality and morbidity: a systematic review and meta&#x2010;analysis. Anesthesia and Analgesia 2007;104(1):27&#x2010;41. [PUBMED: 17179240]</Citation><ArticleIdList><ArticleId IdType="pubmed">17179240</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39177060</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>23</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1747-4949</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>2</Issue><PubDate><Year>2025</Year><Month>Feb</Month></PubDate></JournalIssue><Title>International journal of stroke : official journal of the International Stroke Society</Title><ISOAbbreviation>Int J Stroke</ISOAbbreviation></Journal><ArticleTitle>Recurrent ischemic stroke/transient ischemic attack after patent foramen ovale closure: A cohort study.</ArticleTitle><Pagination><StartPage>196</StartPage><EndPage>204</EndPage><MedlinePgn>196-204</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/17474930241281120</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Patent foramen ovale (PFO) has been associated with ischemic stroke and transient ischemic attack (TIA). Guidelines recommend PFO closure for stroke prevention in selected patients, but the risk of recurrent stroke remains high compared to the background population. We aimed to evaluate the causes of recurrent stroke/TIA and post-interventional complications in patients after PFO closure.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Patients from the Central Denmark Region who underwent PFO closure at Aarhus University Hospital between November 5, 2018, and May 12, 2023, following an ischemic stroke, TIA, amaurosis fugax, or retinal emboli were included. Data on patient demographics, risk factors, procedural details, post-interventional complications, and recurrent stroke/TIA were collected from electronic medical records.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">PFO closure was performed in 310 patients (median age: 49&#x2009;years). During a median follow-up of 2.6&#x2009;years (interquartile range: 1.5-3.6, 814 total patient-years), recurrent stroke/TIA was observed in 8 patients (2.6%), or 0.98 recurrent strokes per 100 patient-years. Recurrent stroke/TIA was more frequent in patients with hypertension (50.0% vs. 16.9%, p&#x2009;=&#x2009;0.039). Recurrent stroke/TIA was related to thrombophilia or hematologic conditions entailing hypercoagulability in 62.5% of patients. New-onset atrial fibrillation was observed in 9.4% of patients within 45&#x2009;days after the procedure. None of these patients subsequently developed an ischemic event. Other adverse outcomes were uncommon.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Rates of recurrent ischemic stroke/TIA after PFO closure were comparable to findings in previous trials. Pre-existing vascular risk factors (hypertension), and a hypercoagulable state were associated with recurrent ischemic stroke/TIA.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>S&#xf8;rensen</LastName><ForeName>Henrik</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grove</LastName><ForeName>Erik L</ForeName><Initials>EL</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hojbjerg</LastName><ForeName>Johanne Andersen</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andersen</LastName><ForeName>Asger</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nielsen-Kudsk</LastName><ForeName>Jens Erik</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simonsen</LastName><ForeName>Claus Z</ForeName><Initials>CZ</Initials><Identifier Source="ORCID">0000-0003-1363-0266</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Stroke</MedlineTA><NlmUniqueID>101274068</NlmUniqueID><ISSNLinking>1747-4930</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054092" MajorTopicYN="Y">Foramen Ovale, Patent</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="Y">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000083242" MajorTopicYN="Y">Ischemic Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003718" MajorTopicYN="N" Type="Geographic">Denmark</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute stroke</Keyword><Keyword MajorTopicYN="N">patent foramen ovale</Keyword><Keyword MajorTopicYN="N">prevention</Keyword><Keyword MajorTopicYN="N">prognosis</Keyword><Keyword MajorTopicYN="N">thrombophilia</Keyword></KeywordList><CoiStatement>Declaration of conflicting interestThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article:CZS receives speaker fee from Pfizer. ELG has received speaker honoraria or consultancy fees from AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Pfizer, Novo Nordisk, Lundbeck Pharma, and Organon. He is an investigator in clinical studies sponsored by AstraZeneca, Idorsia, and Bayer and has received unrestricted research grants from Boehringer Ingelheim. JEN-K receives research grants from Novo Nordic Foundation, Abbott, and Boston Scientific. AA has received funding from the Karen Elise Jensen Foundation, speaker honoraria, or consultancy fees from ABBOTT, Gore Medical, Angiodynamics, EPS Vascular Jannsen, Inari Medical, and Magneto Thrombectomy Solutions. HS and JAH have no conflicts to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>1</Month><Day>31</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>23</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39177060</ArticleId><ArticleId IdType="doi">10.1177/17474930241281120</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27894896</PMID><DateCompleted><Year>2018</Year><Month>01</Month><Day>10</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2165</ISSN><JournalIssue CitedMedium="Internet"><Volume>53</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Jan</Month></PubDate></JournalIssue><Title>European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery</Title><ISOAbbreviation>Eur J Vasc Endovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Systematic Review and Meta-analysis of Dual Versus Single Antiplatelet Therapy in Carotid Interventions.</ArticleTitle><Pagination><StartPage>53</StartPage><EndPage>67</EndPage><MedlinePgn>53-67</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejvs.2016.10.011</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1078-5884(16)30543-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The importance of antiplatelet therapy for the management and prevention of ischaemic stroke cannot be overstated. Despite the established guidelines, there is no clear consensus on how to manage antiplatelet therapy during and after carotid interventions.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The objective was to undertake a systematic literature review and perform a meta-analysis to assess the effects of dual antiplatelet therapy in carotid endarterectomy (CEA) and stenting (CAS).</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">Electronic information sources (MEDLINE, EMBASE, CINAHL, CENTRAL) and bibliographic reference lists were searched to identify randomised controlled trials (RCTs) and observational studies reporting comparative outcomes of dual versus single antiplatelet therapy in CEA and CAS.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Primary outcomes were mortality and stroke within 30 days of intervention. Secondary outcomes were transient ischaemic attack (TIA), major bleeding, groin or neck haematoma, and myocardial infarction (MI). Dichotomous outcome measures were reported using the risk difference (RD) and 95% confidence interval (CI). Combined overall treatment effects were calculated using fixed-effect or random-effects models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Three RCTs and seven observational studies were identified reporting a total of 36,881 CEAs and 150 CAS procedures. In CEA, there were no differences in stroke/TIA/death between single and dual antiplatelet therapy, but there was a significant risk of major bleeding (RD, 0.00; 95% CI, 0.00-0.01; p&#xa0;=&#xa0;.0003) and neck haematoma with dual therapy (RD, 0.04; 95% CI, 0.01-0.06; p&#xa0;=&#xa0;.001). In addition, the rate of MI was higher in the dual therapy group than the single therapy group (RD, 0.00; 95% CI, 0.00-0.01; p&#xa0;=&#xa0;.003). In CAS, there was no difference in major bleeding or haematoma formation, but a significant difference in TIA in favour of dual therapy was identified (RD -0.13, 95% CI,&#xa0;-0.22 to&#xa0;-0.05; p&#xa0;=&#xa0;.003).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Dual antiplatelet therapy demonstrates advantages over single therapy only in CAS, as indicated by a reduced risk of TIA. Dual antiplatelet therapy was associated with an increased risk of bleeding complications in patients undergoing CEA.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barkat</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Liverpool Vascular and Endovascular Service, Royal Liverpool University Hospital, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hajibandeh</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Blackpool Victoria Hospital, Blackpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hajibandeh</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Queen's Medical Centre, Nottingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torella</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Liverpool Vascular and Endovascular Service, Royal Liverpool University Hospital, Liverpool, UK; School of Physical Sciences, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antoniou</LastName><ForeName>G A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Department of Vascular and Endovascular Surgery, The Royal Oldham Hospital, Pennine Acute Hospitals NHS Trust, Manchester, UK. Electronic address: antoniou.ga@hotmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>11</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Vasc Endovasc Surg</MedlineTA><NlmUniqueID>9512728</NlmUniqueID><ISSNLinking>1078-5884</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010975">Platelet Aggregation Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016894" MajorTopicYN="N">Endarterectomy, Carotid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006406" MajorTopicYN="N">Hematoma</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="N">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010975" MajorTopicYN="N">Platelet Aggregation Inhibitors</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015607" MajorTopicYN="N">Stents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antiplatelet therapy</Keyword><Keyword MajorTopicYN="N">Carotid disease</Keyword><Keyword MajorTopicYN="N">Carotid endarterectomy</Keyword><Keyword MajorTopicYN="N">Carotid stenting</Keyword><Keyword MajorTopicYN="N">Stroke</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27894896</ArticleId><ArticleId IdType="doi">10.1016/j.ejvs.2016.10.011</ArticleId><ArticleId IdType="pii">S1078-5884(16)30543-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30797928</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>20</Day></DateCompleted><DateRevised><Year>2020</Year><Month>01</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-8769</ISSN><JournalIssue CitedMedium="Internet"><Volume>126</Volume><PubDate><Year>2019</Year><Month>Jun</Month></PubDate></JournalIssue><Title>World neurosurgery</Title><ISOAbbreviation>World Neurosurg</ISOAbbreviation></Journal><ArticleTitle>Carotid Revascularization in Older Adults: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>656</StartPage><EndPage>663.e1</EndPage><MedlinePgn>656-663.e1</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2019.02.030</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1878-8750(19)30441-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Results from studies comparing carotid artery endarterectomy (CEA) with carotid artery stenting (CAS) in the elderly population are variable in the literature. The objective of this study was to investigate whether CEA or CAS is associated with a better safety profile in older adults (&gt;80 years of age) for treatment of symptomatic and asymptomatic stenosis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A random-effects meta-analysis was performed, and the I<sup>2</sup> statistic was used to assess heterogeneity according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Subgroup analyses were performed as needed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Nine studies comprising 5955 patients were included in this meta-analysis. No differences were identified in terms of 30-day stroke (CEA: 5.8% [n&#xa0;= 257/4415]; CAS: 10.5% [n&#xa0;= 81/767]; odds ratio [OR], 0.57; 95% confidence interval [CI], 0.30-1.08; I<sup>2</sup>&#xa0;= 26.1%), myocardial infarction (MI) (CEA: 1.1% [n&#xa0;= 4/357]; CAS: 0.5% [n&#xa0;= 2/355]; OR, 1.67; 95% CI, 0.37-7.46; I<sup>2</sup>&#xa0;= 0%), transient ischemic attack (TIA) (CEA: 0% [n&#xa0;= 0/98]; CAS: 4.2% [n&#xa0;= 7/166]; OR, 0.28; 95% CI, 0.03-2.52; I<sup>2</sup>&#xa0;= 0%), death (CEA: 1.5% [n&#xa0;= 8/523]; CAS: 0.9% [n&#xa0;= 4/431]; OR, 1.41; 95% CI, 0.43-4.58; I<sup>2</sup>&#xa0;= 0%), and cranial nerve injury (CEA: 5.8% [n&#xa0;= 3/51]; CAS: 0% [n&#xa0;= 0/51]; OR, 4.74; 95% CI, 0.5-44.98; I<sup>2</sup>&#xa0;=0%). A subgroup comparing CEA with transfemoral protected CAS showed that patients in the CEA group had a statistically significant lower risk of 30-day stroke (OR, 0.31; 95% CI, 0.17-0.57; I<sup>2</sup>&#xa0;= 30.8%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study shows that CEA is associated with a statistically significant lower risk of 30-day stroke in the elderly population compared with transfemoral CAS with distal or proximal protection. No differences were noted in the rates of periprocedural TIA, MI, death, and cranial nerve injury between CEA and CAS in the original pooled analysis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Texakalidis</LastName><ForeName>Pavlos</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, School of Medicine, Emory University, Atlanta, Georgia, USA. Electronic address: pavlostex.med@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaitidis</LastName><ForeName>Nikolaos</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>401 General Military Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giannopoulos</LastName><ForeName>Stefanos</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, 251 HAF and VA Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giannopoulos</LastName><ForeName>Spyridon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Medical School, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Machinis</LastName><ForeName>Theofilos</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Virginia Commonwealth University, Richmond, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jabbour</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivet</LastName><ForeName>Dennis</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Virginia Commonwealth University, Richmond, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reavey-Cantwell</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Virginia Commonwealth University, Richmond, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rangel-Castilla</LastName><ForeName>Leonardo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>02</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>World Neurosurg</MedlineTA><NlmUniqueID>101528275</NlmUniqueID><ISSNLinking>1878-8750</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016893" MajorTopicYN="N">Carotid Stenosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002548" MajorTopicYN="N">Cerebral Revascularization</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020209" MajorTopicYN="N">Cranial Nerve Injuries</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016894" MajorTopicYN="Y">Endarterectomy, Carotid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015607" MajorTopicYN="Y">Stents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Carotid</Keyword><Keyword MajorTopicYN="N">Embolic protection</Keyword><Keyword MajorTopicYN="N">Endarterectomy</Keyword><Keyword MajorTopicYN="N">Octogenarians</Keyword><Keyword MajorTopicYN="N">Older adults</Keyword><Keyword MajorTopicYN="N">Stenting</Keyword><Keyword MajorTopicYN="N">Stroke</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>12</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30797928</ArticleId><ArticleId IdType="doi">10.1016/j.wneu.2019.02.030</ArticleId><ArticleId IdType="pii">S1878-8750(19)30441-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31653356</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>01</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-1913</ISSN><JournalIssue CitedMedium="Internet"><Volume>124</Volume><Issue>12</Issue><PubDate><Year>2019</Year><Month>Dec</Month><Day>15</Day></PubDate></JournalIssue><Title>The American journal of cardiology</Title><ISOAbbreviation>Am J Cardiol</ISOAbbreviation></Journal><ArticleTitle>Meta-analysis Evaluating the Safety and Efficacy of Transcarotid Transcatheter Aortic Valve Implantation.</ArticleTitle><Pagination><StartPage>1940</StartPage><EndPage>1946</EndPage><MedlinePgn>1940-1946</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.amjcard.2019.09.015</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0002-9149(19)31053-7</ELocationID><Abstract><AbstractText>We performed a systemic review and meta-analysis of studies evaluating transcarotid vascular access for transcatheter aortic valve implantation (TAVI). Published studies evaluating transcarotid vascular access for TAVI were included in this analysis. Outcomes of interest included 30-day mortality, stroke/transient ischemic attack (TIA), new pacemaker implantation, acute kidney injury (AKI), major vascular complication, major bleeding, and myocardial infarction. Pooled estimate for 30-day mortality was 5.3% (95% confidence interval [CI] 4.0% to 6.8%; I<sup>2</sup>&#x202f;=&#x202f;4%), stroke/TIA was 3.4% (95% CI 2.4% to 4.6%; I<sup>2</sup>&#x202f;=&#x202f;0%), new pacemaker implantation was 15.3% (95% CI 10.8% to 19.7%; I<sup>2</sup>&#x202f;=&#x202f;72%), AKI was 3.4% (95% CI 1.3% to 6.5%; I<sup>2</sup>&#x202f;=&#x202f;58%), major vascular complication was 2.4% (95% CI 1.1% to 3.7%; I<sup>2</sup>&#x202f;=&#x202f;46%), major bleeding was 4.3% (95% CI 2.8% to 6.1%; I<sup>2</sup>&#x202f;=&#x202f;11%), and myocardial infarction was 1.1% (95% CI 0.4% to 2.0%; I<sup>2</sup>&#x202f;=&#x202f;0%). Metaregression was carried out to study the association of effect size with the continuous study-level covariates that included average age, proportion of males, and mean STS score. In this regard, mean STS score showed association with major vascular complications (coefficient: 0.008; p&#x202f;=&#x202f;0.049). Cumulative meta-analysis carried out showed that there was temporal trend of decreasing incidence of stroke/TIA, major vascular complications, and AKI for transcarotid TAVI. In conclusion, transcarotid access for TAVI is a reasonable choice in patients requiring alternate access to transfemoral route.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Usman</LastName><ForeName>Muhammad Shariq</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Dow University of Health Sciences, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rawasia</LastName><ForeName>Wasiq Faraz</ForeName><Initials>WF</Initials><AffiliationInfo><Affiliation>River Region Cardiology Associates, Montgomery, Alabama.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siddiqi</LastName><ForeName>Tariq Jamal</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Dow University of Health Sciences, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mujeeb</LastName><ForeName>Firzah Abdul</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Dow University of Health Sciences, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nadeem</LastName><ForeName>Shahrukh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Dow University of Health Sciences, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alkhouli</LastName><ForeName>Mohamad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Mayo Clinic School of Medicine - Mayo Clinic, Rochester, Minnesota. Electronic address: Alkhouli.Mohamad@mayo.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Cardiol</MedlineTA><NlmUniqueID>0207277</NlmUniqueID><ISSNLinking>0002-9149</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001024" MajorTopicYN="N">Aortic Valve Stenosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006328" MajorTopicYN="N">Cardiac Catheterization</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002339" MajorTopicYN="Y">Carotid Arteries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006350" MajorTopicYN="N">Heart Valve Prosthesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019918" MajorTopicYN="N">Heart Valve Prosthesis Implantation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061214" MajorTopicYN="N">Patient Safety</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062666" MajorTopicYN="Y">Vascular Access Devices</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31653356</ArticleId><ArticleId IdType="doi">10.1016/j.amjcard.2019.09.015</ArticleId><ArticleId IdType="pii">S0002-9149(19)31053-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28904228</PMID><DateCompleted><Year>2017</Year><Month>10</Month><Day>09</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1524-4628</ISSN><JournalIssue CitedMedium="Internet"><Volume>48</Volume><Issue>10</Issue><PubDate><Year>2017</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Stroke</Title><ISOAbbreviation>Stroke</ISOAbbreviation></Journal><ArticleTitle>Anesthesia-Related Outcomes for Endovascular Stroke Revascularization: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>2784</StartPage><EndPage>2791</EndPage><MedlinePgn>2784-2791</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1161/STROKEAHA.117.017786</ELocationID><Abstract><AbstractText Label="BACKGROUND AND PURPOSE">There is currently controversy on the ideal anesthesia strategy during mechanical thrombectomy for acute ischemic stroke. We performed a systematic review and meta-analysis of studies comparing clinical and angiographic outcomes of patients undergoing general anesthesia (GA group) and those receiving either local anesthesia or conscious sedation (non-GA group).</AbstractText><AbstractText Label="METHODS">A literature search on anesthesia and endovascular treatment of acute ischemic stroke was performed. Using random-effects meta-analysis, we evaluated the following outcomes: recanalization rate, good functional outcome at 90 days (modified Rankin Score&#x2264;2), symptomatic intracranial hemorrhage, death, vascular complications, respiratory complications, procedure time, and time to groin puncture.</AbstractText><AbstractText Label="RESULTS">Twenty-two studies (3 randomized controlled trials and 19 observational studies), including 4716 patients (1819 GA and 2897 non-GA) were included. In the nonadjusted analysis, patients in the GA group had higher odds of death (odds ratio [OR], 2.02; 95% confidence interval [CI], 1.66-2.45) and respiratory complications (OR, 1.70; 95% CI, 1.22-2.37) and lower odds of good functional outcome (OR, 0.58; 95% CI, 0.48-0.64) compared with the non-GA group. There was no difference in procedure time between the 2 primary comparison groups. When adjusting for baseline National Institutes of Health Stroke Scale, GA was still associated with lower odds of good functional outcome (OR, 0.59; 95% CI, 0.29-0.94). When considering studies performed in the stent-retriever/aspiration era, there was no significant difference in good neurological outcome rates (OR, 0.84; 95% CI, 0.67-1.06).</AbstractText><AbstractText Label="CONCLUSIONS">Acute ischemic stroke patients undergoing intra-arterial therapy may have worse outcomes when treated with GA as compared with conscious sedation/local anesthesia. However, major limitations of current evidence (ie, retrospective studies and selection bias) indicate a need for adequately powered, multicenter randomized controlled trials to answer this question.</AbstractText><CopyrightInformation>&#xa9; 2017 American Heart Association, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brinjikji</LastName><ForeName>Waleed</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>From the Department of Radiology (W.B., H.J.C., D.F.K.), Department of Neurosurgery (W.B., D.F.K.), Department of Anesthesia (J.P., T.L.W.), Division of Preventive Medicine (M.H.M.), Knowledge and Evaluation Research Unit (M.H.M.), and Department of Neurology (A.A.R.), Mayo Clinic, Rochester, MN. brinjikji.waleed@mayo.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasternak</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>From the Department of Radiology (W.B., H.J.C., D.F.K.), Department of Neurosurgery (W.B., D.F.K.), Department of Anesthesia (J.P., T.L.W.), Division of Preventive Medicine (M.H.M.), Knowledge and Evaluation Research Unit (M.H.M.), and Department of Neurology (A.A.R.), Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murad</LastName><ForeName>Mohammad H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>From the Department of Radiology (W.B., H.J.C., D.F.K.), Department of Neurosurgery (W.B., D.F.K.), Department of Anesthesia (J.P., T.L.W.), Division of Preventive Medicine (M.H.M.), Knowledge and Evaluation Research Unit (M.H.M.), and Department of Neurology (A.A.R.), Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cloft</LastName><ForeName>Harry J</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>From the Department of Radiology (W.B., H.J.C., D.F.K.), Department of Neurosurgery (W.B., D.F.K.), Department of Anesthesia (J.P., T.L.W.), Division of Preventive Medicine (M.H.M.), Knowledge and Evaluation Research Unit (M.H.M.), and Department of Neurology (A.A.R.), Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Welch</LastName><ForeName>Tasha L</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>From the Department of Radiology (W.B., H.J.C., D.F.K.), Department of Neurosurgery (W.B., D.F.K.), Department of Anesthesia (J.P., T.L.W.), Division of Preventive Medicine (M.H.M.), Knowledge and Evaluation Research Unit (M.H.M.), and Department of Neurology (A.A.R.), Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kallmes</LastName><ForeName>David F</ForeName><Initials>DF</Initials><AffiliationInfo><Affiliation>From the Department of Radiology (W.B., H.J.C., D.F.K.), Department of Neurosurgery (W.B., D.F.K.), Department of Anesthesia (J.P., T.L.W.), Division of Preventive Medicine (M.H.M.), Knowledge and Evaluation Research Unit (M.H.M.), and Department of Neurology (A.A.R.), Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rabinstein</LastName><ForeName>Alejandro A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>From the Department of Radiology (W.B., H.J.C., D.F.K.), Department of Neurosurgery (W.B., D.F.K.), Department of Anesthesia (J.P., T.L.W.), Division of Preventive Medicine (M.H.M.), Knowledge and Evaluation Research Unit (M.H.M.), and Department of Neurology (A.A.R.), Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Stroke</MedlineTA><NlmUniqueID>0235266</NlmUniqueID><ISSNLinking>0039-2499</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Stroke. 2018 Jan;49(1):e20. doi: 10.1161/STROKEAHA.117.019573.</RefSource><PMID Version="1">29222225</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Stroke. 2018 Jan;49(1):e21. doi: 10.1161/STROKEAHA.117.019656.</RefSource><PMID Version="1">29222228</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000772" MajorTopicYN="N">Anesthesia, Local</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002545" MajorTopicYN="N">Brain Ischemia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002548" MajorTopicYN="N">Cerebral Revascularization</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="N">Endovascular Procedures</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anesthesia, local</Keyword><Keyword MajorTopicYN="N">confidence intervals</Keyword><Keyword MajorTopicYN="N">humans</Keyword><Keyword MajorTopicYN="N">retrospective studies</Keyword><Keyword MajorTopicYN="N">stroke</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28904228</ArticleId><ArticleId IdType="doi">10.1161/STROKEAHA.117.017786</ArticleId><ArticleId IdType="pii">STROKEAHA.117.017786</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27919293</PMID><DateCompleted><Year>2018</Year><Month>01</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Dec</Month><Day>05</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Perioperative statin therapy in cardiac surgery: a meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>395</StartPage><MedlinePgn>395</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">395</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Several studies suggest beneficial effects of perioperative statin therapy on postoperative outcome after cardiac surgery. However, recent randomized controlled trials (RCTs) show potential detrimental effects. The objective of this systematic review is to examine the association between perioperative statin therapy and clinical outcomes in cardiac surgery patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Electronic databases were searched up to 1 November 2016 for RCTs of preoperative statin therapy versus placebo or no treatment in adult cardiac surgery. Postoperative outcomes were acute kidney injury, atrial fibrillation, myocardial infarction, stroke, infections, and mortality. We calculated odds ratios (ORs) and 95% confidence intervals (CIs) using fixed-effects meta-analyses. Primary analysis was restricted to trials with low risk of bias according to Cochrane methodology, and sensitivity analyses examined whether the risk of bias of included studies was associated with different results. We performed trial sequential analysis (TSA) to test the strength of the results.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We included data from 23 RCTs involving 5102 patients. Meta-analysis of trials with low risk of bias showed that statin therapy was associated with an increase in acute kidney injury (314 of 1318 (23.82%) with statins versus 262 of 1319 (19.86%) with placebo; OR 1.26 (95%CI 1.05 to 1.52); p&#x2009;=&#x2009;0.01); these results were supported by TSA. No difference in postoperative atrial fibrillation, myocardial infarction, stroke, infections, or mortality was present. On sensitivity analysis, statin therapy was associated with a slight increase in hospital mortality. Meta-analysis&#xa0;including also trials with high or unclear risk of bias showed no beneficial effects of statin therapy on any postoperative outcomes.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">There is no evidence that statin therapy in the days prior to cardiac surgery is beneficial for patients' outcomes. Particularly, statins are not protective against postoperative atrial fibrillation, myocardial infarction, stroke, or infections. Statins are associated with a possible increased risk of acute kidney injury and a detrimental effect on hospital survival could not be excluded. Future RCTs should further evaluate the safety profile of this therapy in relation to patients' outcomes and assess the more appropriate time point for discontinuation of statins before cardiac surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Putzu</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Anesthesia and Intensive Care, Cardiocentro Ticino, Via Tesserete 48, Lugano, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Capelli</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Anesthesia and Intensive Care, Cardiocentro Ticino, Via Tesserete 48, Lugano, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belletti</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cassina</LastName><ForeName>Tiziano</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Anesthesia and Intensive Care, Cardiocentro Ticino, Via Tesserete 48, Lugano, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrari</LastName><ForeName>Enrico</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Cardiocentro Ticino, Via Tesserete 48, Lugano, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallo</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Cardiocentro Ticino, Via Tesserete 48, Lugano, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casso</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Anesthesia and Intensive Care, Cardiocentro Ticino, Via Tesserete 48, Lugano, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, Milano, Italy. landoni.giovanni@hsr.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vita-Salute San Raffaele University, Via Olgettina 58, Milano, Italy. landoni.giovanni@hsr.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR001860</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>12</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019161">Hydroxymethylglutaryl-CoA Reductase Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019161" MajorTopicYN="N">Hydroxymethylglutaryl-CoA Reductase Inhibitors</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Atrial fibrillation</Keyword><Keyword MajorTopicYN="N">Cardiac anesthesia</Keyword><Keyword MajorTopicYN="N">Cardiac surgery</Keyword><Keyword MajorTopicYN="N">Intensive care</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Myocardial infarction</Keyword><Keyword MajorTopicYN="N">Statins</Keyword><Keyword MajorTopicYN="N">Stroke</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>12</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27919293</ArticleId><ArticleId IdType="mid">NIHMS1054800</ArticleId><ArticleId IdType="pmc">PMC5139027</ArticleId><ArticleId IdType="doi">10.1186/s13054-016-1560-6</ArticleId><ArticleId IdType="pii">10.1186/s13054-016-1560-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>LaPar DJ, Crosby IK, Rich JB, Fonner E, Kron IL, Ailawadi G, et al. A contemporary cost analysis of postoperative morbidity after coronary artery bypass grafting with and without concomitant aortic valve replacement to improve patient quality and cost-effective care. Ann Thorac Surg. 2013;96:1621&#x2013;7. doi: 10.1016/j.athoracsur.2013.05.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2013.05.050</ArticleId><ArticleId IdType="pubmed">23972932</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim LK, Looser P, Swaminathan RV, Minutello RM, Wong SC, Girardi L, et al. Outcomes in patients undergoing coronary artery bypass graft surgery in the United States based on hospital volume, 2007 to 2011. J Thorac Cardiovasc Surg. 2016;151:1686&#x2013;92. doi: 10.1016/j.jtcvs.2016.01.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2016.01.050</ArticleId><ArticleId IdType="pubmed">26964912</ArticleId></ArticleIdList></Reference><Reference><Citation>Beckmann A, Funkat A-K, Lewandowski J, Frie M, Ernst M, Hekmat K, et al. Cardiac surgery in Germany during 2014: a report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg. 2015;63:258&#x2013;69. doi: 10.1055/s-0035-1544425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0035-1544425</ArticleId><ArticleId IdType="pubmed">26011675</ArticleId></ArticleIdList></Reference><Reference><Citation>Karkouti K, Wijeysundera DN, Yau TM, Callum JL, Cheng DC, Crowther M, et al. Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation. 2009;119:495&#x2013;502. doi: 10.1161/CIRCULATIONAHA.108.786913.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.108.786913</ArticleId><ArticleId IdType="pubmed">19153273</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol. 2006;1:19&#x2013;32. doi: 10.2215/CJN.00240605.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.00240605</ArticleId><ArticleId IdType="pubmed">17699187</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillinov AM, Bagiella E, Moskowitz AJ, Raiten JM, Groh MA, Bowdish ME, et al. Rate control versus rhythm control for atrial fibrillation after cardiac surgery. N Engl J Med. 2016;374:1911&#x2013;21. doi: 10.1056/NEJMoa1602002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1602002</ArticleId><ArticleId IdType="pmc">PMC4908812</ArticleId><ArticleId IdType="pubmed">27043047</ArticleId></ArticleIdList></Reference><Reference><Citation>Helgadottir S, Sigurdsson MI, Ingvarsdottir IL, Arnar DO, Gudbjartsson T, Almassi G, et al. Atrial fibrillation following cardiac surgery: risk analysis and long-term survival. J Cardiothorac Surg. 2012;7:87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3515503</ArticleId><ArticleId IdType="pubmed">22992266</ArticleId></ArticleIdList></Reference><Reference><Citation>Svircevic V, Nierich AP, Moons KGM, Brandon Bravo Bruinsma GJ, Kalkman CJ, van Dijk D. Fast-track anesthesia and cardiac surgery: a retrospective cohort study of 7989 patients. Anesth Analg. 2009;108:727&#x2013;33. doi: 10.1213/ane.0b013e318193c423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0b013e318193c423</ArticleId><ArticleId IdType="pubmed">19224776</ArticleId></ArticleIdList></Reference><Reference><Citation>Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg. 2012;143:4&#x2013;34. doi: 10.1016/j.jtcvs.2011.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2011.10.015</ArticleId><ArticleId IdType="pubmed">22172748</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulik A, Levin R, Ruel M, Mesana TG, Solomon DH, Choudhry NK. Patterns and predictors of statin use after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg. 2007;134:932&#x2013;8. doi: 10.1016/j.jtcvs.2007.05.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2007.05.039</ArticleId><ArticleId IdType="pubmed">17903510</ArticleId></ArticleIdList></Reference><Reference><Citation>Mihos CG, Salas MJ, Santana O. The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in cardiovascular disease: a comprehensive review. Cardiol Rev. 18:298&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pubmed">20926939</ArticleId></ArticleIdList></Reference><Reference><Citation>Sodha NR, Sellke FW. The effect of statins on perioperative inflammation in cardiac and thoracic surgery. J Thorac Cardiovasc Surg. 2015;149:1495&#x2013;501. doi: 10.1016/j.jtcvs.2015.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2015.02.005</ArticleId><ArticleId IdType="pubmed">25791954</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotani MI, Morise AP, Haque R, Jain AC, Gupta N, Gibson CM. Association between short-term simvastatin therapy before coronary artery bypass grafting and postoperative myocardial blood flow as assessed by positron emission tomography. Am J Cardiol. 2003;91:1107&#x2013;9. doi: 10.1016/S0002-9149(03)00158-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9149(03)00158-9</ArticleId><ArticleId IdType="pubmed">12714156</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan W, Pintar T, Anton J, Lee V-V, Vaughn WK, Collard CD. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation. 2004;110:II45&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15364837</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascual DA, Arribas JM, Tornel PL, Mar&#xed;n F, Oliver C, Ahumada M, et al. Preoperative statin therapy and troponin T predict early complications of coronary artery surgery. Ann Thorac Surg. 2006;81:78&#x2013;83. doi: 10.1016/j.athoracsur.2005.07.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2005.07.038</ArticleId><ArticleId IdType="pubmed">16368340</ArticleId></ArticleIdList></Reference><Reference><Citation>Liakopoulos OJ, Choi Y-H, Haldenwang PL, Strauch J, Wittwer T, D&#xf6;rge H, et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30,000 patients. Eur Heart J. 2008;29:1548&#x2013;59. doi: 10.1093/eurheartj/ehn198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehn198</ArticleId><ArticleId IdType="pubmed">18506053</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn EW, Liakopoulos OJ, Stange S, Deppe A-C, Slottosch I, Choi Y-H, et al. Preoperative statin therapy in cardiac surgery: a meta-analysis of 90,000 patients. Eur J Cardiothorac Surg. 2014;45:17&#x2013;26. doi: 10.1093/ejcts/ezt181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezt181</ArticleId><ArticleId IdType="pubmed">23562936</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar&#xed;n F, Pascual DA, Rold&#xe1;n V, Arribas JM, Ahumada M, Tornel PL, et al. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting. Am J Cardiol. 2006;97:55&#x2013;60. doi: 10.1016/j.amjcard.2005.07.124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2005.07.124</ArticleId><ArticleId IdType="pubmed">16377284</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabata M, Khalpey Z, Pirundini PA, Byrne ML, Cohn LH, Rawn JD. Renoprotective effect of preoperative statins in coronary artery bypass grafting. Am J Cardiol. 2007;100:442&#x2013;4. doi: 10.1016/j.amjcard.2007.03.071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2007.03.071</ArticleId><ArticleId IdType="pubmed">17659925</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman CI, Lucek DM, Hammond J, White CM. Preoperative statins and infectious complications following cardiac surgery. Curr Med Res Opin. 2007;23:1783&#x2013;90. doi: 10.1185/030079907X210570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1185/030079907X210570</ArticleId><ArticleId IdType="pubmed">17597556</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings FT, Hendricks PA, Schildcrout JS, Shi Y, Petracek MR, Byrne JG, et al. High-dose perioperative Atorvastatin and acute kidney injury following cardiac surgery: a randomized clinical trial. JAMA. 2016;315:877&#x2013;88. doi: 10.1001/jama.2016.0548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0548</ArticleId><ArticleId IdType="pmc">PMC4843765</ArticleId><ArticleId IdType="pubmed">26906014</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z, Jayaram R, Jiang L, Emberson J, Zhao Y, Li Q, et al. Perioperative Rosuvastatin in cardiac surgery. N Engl J Med. 2016;374:1744&#x2013;53. doi: 10.1056/NEJMoa1507750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1507750</ArticleId><ArticleId IdType="pubmed">27144849</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Green S (editors).&#xa0;Cochrane Handbook for Systematic Reviews of Interventions&#xa0;Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org.</Citation></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, Mulrow C, G&#xf8;tzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700. doi: 10.1136/bmj.b2700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2700</ArticleId><ArticleId IdType="pmc">PMC2714672</ArticleId><ArticleId IdType="pubmed">19622552</ArticleId></ArticleIdList></Reference><Reference><Citation>Landoni G, Putzu A, Capelli B, Belletti A. Perioperative statin therapy in cardiac surgery: a meta-analysis of randomized controlled trials [Internet]. Available from: http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42016039509. Accessed 23 Nov 2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5139027</ArticleId><ArticleId IdType="pubmed">27919293</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Altman DG, G&#xf8;tzsche PC, J&#xfc;ni P, Moher D, Oxman AD, et al. The Cochrane Collaboration&#x2019;s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi: 10.1136/bmj.d5928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924&#x2013;6. doi: 10.1136/bmj.39489.470347.AD.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.AD</ArticleId><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol. 2008;61:64&#x2013;75. doi: 10.1016/j.jclinepi.2007.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2007.03.013</ArticleId><ArticleId IdType="pubmed">18083463</ArticleId></ArticleIdList></Reference><Reference><Citation>Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. J Clin Epidemiol. 2008;61:763&#x2013;9. doi: 10.1016/j.jclinepi.2007.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2007.10.007</ArticleId><ArticleId IdType="pubmed">18411040</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorlund K, Devereaux PJ, Wetterslev J, Guyatt G, Ioannidis JPA, Thabane L, et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? Int J Epidemiol. 2009;38:276&#x2013;86. doi: 10.1093/ije/dyn179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyn179</ArticleId><ArticleId IdType="pubmed">18824467</ArticleId></ArticleIdList></Reference><Reference><Citation>Almansob MAS, Xu B, Zhou L, Hu X-X, Chen W, Chang F-J, et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: a randomized controlled trial. Arterioscler Thromb Vasc Biol. 2012;32:2304&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">22796581</ArticleId></ArticleIdList></Reference><Reference><Citation>Baran &#xc7;, Durdu S, Dalva K, Zaim &#xc7;, Dogan A, Ocakoglu G, et al. Effects of preoperative short term use of atorvastatin on endothelial progenitor cells after coronary surgery: a randomized, controlled trial. Stem Cell Rev. 2012;8:963&#x2013;71. doi: 10.1007/s12015-011-9321-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-011-9321-z</ArticleId><ArticleId IdType="pubmed">22076751</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkan O, Katrancioglu N, Ozker E, Ozerdem G, Bakici Z, Yilmaz MB. Reduced P-selectin in hearts pretreated with fluvastatin: a novel benefit for patients undergoing open heart surgery. Thorac Cardiovasc Surg. 2009;57:91&#x2013;5. doi: 10.1055/s-2008-1039107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2008-1039107</ArticleId><ArticleId IdType="pubmed">19241310</ArticleId></ArticleIdList></Reference><Reference><Citation>Caorsi C, Pineda F, Munoz C. Pravastatin immunomodulates IL-6 and C-reactive protein, but not IL-1 and TNF-alpha, in cardio-pulmonary bypass. Eur Cytokine Netw. 2008;19:99&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pubmed">18632424</ArticleId></ArticleIdList></Reference><Reference><Citation>Casta&#xf1;o M, Gonz&#xe1;lez-Santos JM, L&#xf3;pez J, Garc&#xed;a B, Centeno JE, Aparicio B, et al. Effect of preoperative oral pravastatin reload in systemic inflammatory response and myocardial damage after coronary artery bypass grafting. A pilot double-blind placebo-controlled study. J Cardiovasc Surg (Torino) 2015;56:617&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">25968407</ArticleId></ArticleIdList></Reference><Reference><Citation>Chello M, Patti G, Candura D, Mastrobuoni S, Di Sciascio G, Agr&#xf2; F, et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Crit Care Med. 2006;34:660&#x2013;7. doi: 10.1097/01.CCM.0000201407.89977.EA.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000201407.89977.EA</ArticleId><ArticleId IdType="pubmed">16505650</ArticleId></ArticleIdList></Reference><Reference><Citation>Christenson JT. Preoperative lipid-control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. Eur J Cardiothorac Surg. 1999;15:394&#x2013;9. doi: 10.1016/S1010-7940(99)00034-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1010-7940(99)00034-2</ArticleId><ArticleId IdType="pubmed">10371111</ArticleId></ArticleIdList></Reference><Reference><Citation>Dehghani MR, Kasianzadeh M, Rezaei Y, Sepehrvand N. Atorvastatin reduces the incidence of postoperative atrial fibrillation in statin-naive patients undergoing isolated heart valve surgery: a double-blind, placebo-controlled randomized trial. J Cardiovasc Pharmacol Ther. 2015;20:465&#x2013;72. doi: 10.1177/1074248414564869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1074248414564869</ArticleId><ArticleId IdType="pubmed">25540059</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji Q, Mei Y, Wang X, Sun Y, Feng J, Cai J, et al. Effect of preoperative atorvastatin therapy on atrial fibrillation following off-pump coronary artery bypass grafting. Circ J. 2009;73:2244&#x2013;9. doi: 10.1253/circj.CJ-09-0352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-09-0352</ArticleId><ArticleId IdType="pubmed">19822977</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannacio VA, Iorio D, De Amicis V, Di Lello F, Musumeci F. Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. J Thorac Cardiovasc Surg. 2008;136:1541&#x2013;8. doi: 10.1016/j.jtcvs.2008.06.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2008.06.038</ArticleId><ArticleId IdType="pubmed">19114204</ArticleId></ArticleIdList></Reference><Reference><Citation>Melina G, Angeloni E, Di Nucci G, Benedetto U, Fiorani B, Sclafani G, et al. Preoperative HMG-CoA reductase inhibitors and atrial fibrillation in patients undergoing CABG: a prospective randomised trial. Eur Hear J. 2009;30:32.</Citation></Reference><Reference><Citation>Park JH, Shim J-K, Song J-W, Soh S, Kwak Y-L. Effect of atorvastatin on the incidence of acute kidney injury following valvular heart surgery: a randomized, placebo-controlled trial. Intensive Care Med. 2016;42:1398&#x2013;407. doi: 10.1007/s00134-016-4358-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4358-8</ArticleId><ArticleId IdType="pubmed">27120082</ArticleId></ArticleIdList></Reference><Reference><Citation>Patti G, Chello M, Candura D, Pasceri V, D&#x2019;Ambrosio A, Covino E, et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation. 2006;114:1455&#x2013;61. doi: 10.1161/CIRCULATIONAHA.106.621763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.621763</ArticleId><ArticleId IdType="pubmed">17000910</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR, Calzavacca P, Licari E, Ligabo EV, Echeverri JE, Haase M, et al. Pilot double-blind, randomized controlled trial of short-term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology (Carlton) 2012;17:215&#x2013;24. doi: 10.1111/j.1440-1797.2011.01546.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1797.2011.01546.x</ArticleId><ArticleId IdType="pubmed">22117606</ArticleId></ArticleIdList></Reference><Reference><Citation>Bin SY, On YK, Kim JH, Shin D-H, Kim JS, Sung J, et al. The effects of atorvastatin on the occurrence of postoperative atrial fibrillation after off-pump coronary artery bypass grafting surgery. Am Heart J. 2008;156:373.</Citation><ArticleIdList><ArticleId IdType="pubmed">18657672</ArticleId></ArticleIdList></Reference><Reference><Citation>Spadaccio C, Pollari F, Casacalenda A, Alfano G, Genovese J, Covino E, et al. Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. J Cardiovasc Pharmacol. 2010;55:30&#x2013;8. doi: 10.1097/FJC.0b013e3181c37d4d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/FJC.0b013e3181c37d4d</ArticleId><ArticleId IdType="pubmed">19834333</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Ji Q, Mei Y, Wang X, Feng J, Cai J, et al. Role of preoperative atorvastatin administration in protection against postoperative atrial fibrillation following conventional coronary artery bypass grafting. Int Heart J. 2011;52:7&#x2013;11. doi: 10.1536/ihj.52.7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1536/ihj.52.7</ArticleId><ArticleId IdType="pubmed">21321461</ArticleId></ArticleIdList></Reference><Reference><Citation>Vukovic PM, Maravic-Stojkovic VR, Peric MS, Jovic MD, Cirkovic MV, Gradinac SD, et al. Steroids and statins: an old and a new anti-inflammatory strategy compared. Perfusion. 2011;26:31&#x2013;7. doi: 10.1177/0267659110385607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0267659110385607</ArticleId><ArticleId IdType="pubmed">20921085</ArticleId></ArticleIdList></Reference><Reference><Citation>Youn Y-N, Park S-Y, Hwang Y, Joo H-C, Yoo K-J. Impact of high-dose statin pretreatment in patients with stable angina during off-pump coronary artery bypass. Korean J Thorac Cardiovasc Surg. 2011;44:208&#x2013;14. doi: 10.5090/kjtcs.2011.44.3.208.</Citation><ArticleIdList><ArticleId IdType="doi">10.5090/kjtcs.2011.44.3.208</ArticleId><ArticleId IdType="pmc">PMC3249304</ArticleId><ArticleId IdType="pubmed">22263153</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamayo E, Alvarez FJ, Alonso O, Bustamante R, Castrodeza J, Soria S, et al. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass. J Cardiovasc Surg (Torino) 2009;50:687&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">19741581</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrascal Y, Arnold RJ, De la Fuente L, Revilla A, Sevilla T, Arce N, et al. Efficacy of atorvastatin in prevention of atrial fibrillation after heart valve surgery in the PROFACE trial (PROphylaxis of postoperative atrial Fibrillation After Cardiac surgEry). J Arrhythm Elsevier. 2016;32:191&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4913150</ArticleId><ArticleId IdType="pubmed">27354864</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, et al. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet. 2016;0:2152&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">27616593</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulik A, Ruel M, Jneid H, Ferguson TB, Hiratzka LF, Ikonomidis JS, et al. Secondary prevention after coronary artery bypass graft surgery. Circulation. 2015;131:927-964.</Citation><ArticleIdList><ArticleId IdType="pubmed">25679302</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R. Perioperative statins in cardiac surgery and acute kidney injury. JAMA. 2016;315:873&#x2013;4. doi: 10.1001/jama.2016.0245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0245</ArticleId><ArticleId IdType="pubmed">26905755</ArticleId></ArticleIdList></Reference><Reference><Citation>Layton JB, Hansen MK, Jakobsen C-J, Kshirsagar AV, Andreasen JJ, Hjortdal VE, et al. Statin initiation and acute kidney injury following elective cardiovascular surgery: a population cohort study in Denmark&#x2020;. Eur J Cardiothorac Surg. 2016;49:995&#x2013;1000. doi: 10.1093/ejcts/ezv246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezv246</ArticleId><ArticleId IdType="pubmed">26188012</ArticleId></ArticleIdList></Reference><Reference><Citation>Layton JB, Kshirsagar AV, Simpson RJ, Pate V, Jonsson Funk M, St&#xfc;rmer T, et al. Effect of statin use on acute kidney injury risk following coronary artery bypass grafting. Am J Cardiol. 2013;111:823&#x2013;8. doi: 10.1016/j.amjcard.2012.11.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2012.11.047</ArticleId><ArticleId IdType="pmc">PMC3637989</ArticleId><ArticleId IdType="pubmed">23273532</ArticleId></ArticleIdList></Reference><Reference><Citation>Molnar AO, Parikh CR, Coca SG, Thiessen-Philbrook H, Koyner JL, Shlipak MG, et al. Association between preoperative statin use and acute kidney injury biomarkers in cardiac surgical procedures. Ann Thorac Surg. 2014;97:2081&#x2013;7. doi: 10.1016/j.athoracsur.2014.02.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2014.02.033</ArticleId><ArticleId IdType="pmc">PMC4068122</ArticleId><ArticleId IdType="pubmed">24725831</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Gu C, Gao M, Yu W, Yu Y. Preoperative statin therapy and renal outcomes after cardiac surgery: a meta-analysis and meta-regression of 59,771 patients. Can J Cardiol. 2015;31:1051&#x2013;60. doi: 10.1016/j.cjca.2015.02.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2015.02.034</ArticleId><ArticleId IdType="pubmed">26081692</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunelli SM, Waikar SS, Bateman BT, Chang TI, Lii J, Garg AX, et al. Preoperative statin use and postoperative acute kidney injury. Am J Med. 2012;125:1195&#x2013;204. doi: 10.1016/j.amjmed.2012.06.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2012.06.021</ArticleId><ArticleId IdType="pmc">PMC3597342</ArticleId><ArticleId IdType="pubmed">23062398</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn EW, Slottosch I, Wahlers T, Liakopoulos OJ. Preoperative statin therapy for patients undergoing cardiac surgery. Cochrane Database Syst Rev. 2015;13:CD008493.</Citation><ArticleIdList><ArticleId IdType="pubmed">26270008</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewicki M, Ng I, Schneider AG. HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass. Cochrane Database Syst Rev. 2015;11:CD010480.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10788137</ArticleId><ArticleId IdType="pubmed">25758322</ArticleId></ArticleIdList></Reference><Reference><Citation>Golomb BA, Evans MA. Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism. Am J Cardiovasc Drugs. 2008;8:373&#x2013;418. doi: 10.2165/0129784-200808060-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/0129784-200808060-00004</ArticleId><ArticleId IdType="pmc">PMC2849981</ArticleId><ArticleId IdType="pubmed">19159124</ArticleId></ArticleIdList></Reference><Reference><Citation>Kain V, Kapadia B, Misra P, Saxena U, Mol MJ, Erkelens DW, et al. Simvastatin may induce insulin resistance through a novel fatty acid mediated cholesterol independent mechanism. Sci Rep. 2015;5:13823. doi: 10.1038/srep13823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep13823</ArticleId><ArticleId IdType="pmc">PMC4561915</ArticleId><ArticleId IdType="pubmed">26345110</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniades C, Bakogiannis C, Tousoulis D, Reilly S, Zhang M-H, Paschalis A, et al. Preoperative atorvastatin treatment in CABG patients rapidly improves vein graft redox state by inhibition of Rac1 and NADPH-oxidase activity. Circulation. 2010;122:S66&#x2013;73. doi: 10.1161/CIRCULATIONAHA.109.927376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.109.927376</ArticleId><ArticleId IdType="pubmed">20837928</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezaei Y, Gholami-Fesharaki M, Dehghani MR, Arya A, Haghjoo M, Arjmand N. Statin antiarrhythmic effect on atrial fibrillation in statin-naive patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials. J Cardiovasc Pharmacol Ther. 2016;21:167&#x2013;76. doi: 10.1177/1074248415602557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1074248415602557</ArticleId><ArticleId IdType="pubmed">26333596</ArticleId></ArticleIdList></Reference><Reference><Citation>Trezzi M, Blackstone EH, Sun Z, Li L, Sabik JF, Lytle BW, et al. Statin therapy is associated with fewer infections after cardiac operations. Ann Thorac Surg. 2013;95:892&#x2013;900.</Citation><ArticleIdList><ArticleId IdType="pubmed">23380476</ArticleId></ArticleIdList></Reference><Reference><Citation>National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Truwit JD, Bernard GR, Steingrub J, Matthay MA, Liu KD, et al. Rosuvastatin for sepsis-associated acute respiratory distress syndrome. N Engl J Med. 2014;370:2191&#x2013;200. doi: 10.1056/NEJMoa1401520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1401520</ArticleId><ArticleId IdType="pmc">PMC4241052</ArticleId><ArticleId IdType="pubmed">24835849</ArticleId></ArticleIdList></Reference><Reference><Citation>Papazian L, Roch A, Charles P-E, Penot-Ragon C, Perrin G, Roulier P, et al. Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: a randomized clinical trial. JAMA. 2013;310:1692&#x2013;700. doi: 10.1001/jama.2013.280031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2013.280031</ArticleId><ArticleId IdType="pubmed">24108510</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark LL, Ikonomidis JS, Crawford FA, Crumbley A, Kratz JM, Stroud MR, et al. Preoperative statin treatment is associated with reduced postoperative mortality and morbidity in patients undergoing cardiac surgery: an 8-year retrospective cohort study. J Thorac Cardiovasc Surg. 2006;131:679&#x2013;85. doi: 10.1016/j.jtcvs.2005.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2005.11.006</ArticleId><ArticleId IdType="pubmed">16515923</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Xu X, Ni H. Small studies may overestimate the effect sizes in critical care meta-analyses: a meta-epidemiological study. Crit Care. 2013;17:R2. doi: 10.1186/cc11919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11919</ArticleId><ArticleId IdType="pmc">PMC4056100</ArticleId><ArticleId IdType="pubmed">23302257</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopewell S, Loudon K, Clarke MJ, Oxman AD, Dickersin K. Publication bias in clinical trials due to statistical significance or direction of trial results. Cochrane Database Syst Rev. 2009;(1):MR000006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8276556</ArticleId><ArticleId IdType="pubmed">19160345</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormuth CR, Hemmelgarn BR, Paterson JM, James MT, Teare GF, Raymond CB, et al. Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases. BMJ. 2013;346:f880. doi: 10.1136/bmj.f880.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.f880</ArticleId><ArticleId IdType="pubmed">23511950</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30821845</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-493X</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>The Cochrane database of systematic reviews</Title><ISOAbbreviation>Cochrane Database Syst Rev</ISOAbbreviation></Journal><ArticleTitle>Epidural analgesia for adults undergoing cardiac surgery with or without cardiopulmonary bypass.</ArticleTitle><Pagination><StartPage>CD006715</StartPage><MedlinePgn>CD006715</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">CD006715</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/14651858.CD006715.pub3</ELocationID><Abstract><AbstractText Label="BACKGROUND">General anaesthesia combined with epidural analgesia may have a beneficial effect on clinical outcomes. However, use of epidural analgesia for cardiac surgery is controversial due to a theoretical increased risk of epidural haematoma associated with systemic heparinization. This review was published in 2013, and it was updated in 2019.</AbstractText><AbstractText Label="OBJECTIVES">To determine the impact of perioperative epidural analgesia in adults undergoing cardiac surgery, with or without cardiopulmonary bypass, on perioperative mortality and cardiac, pulmonary, or neurological morbidity.</AbstractText><AbstractText Label="SEARCH METHODS">We searched CENTRAL, MEDLINE, and Embase in November 2018, and two trial registers up to February 2019, together with references and relevant conference abstracts.</AbstractText><AbstractText Label="SELECTION CRITERIA">We included all randomized controlled trials (RCTs) including adults undergoing any type of cardiac surgery under general anaesthesia and comparing epidural analgesia versus another modality of postoperative pain treatment. The primary outcome was mortality.</AbstractText><AbstractText Label="DATA COLLECTION AND ANALYSIS">We used standard methodological procedures as expected by Cochrane.</AbstractText><AbstractText Label="MAIN RESULTS">We included 69 trials with 4860 participants: 2404 given epidural analgesia and 2456 receiving comparators (systemic analgesia, peripheral nerve block, intrapleural analgesia, or wound infiltration). The mean (or median) age of participants varied between 43.5 years and 74.6 years. Surgeries performed were coronary artery bypass grafting or valvular procedures and surgeries for congenital heart disease. We judged that no trials were at low risk of bias for all domains, and that all trials were at unclear/high risk of bias for blinding of participants and personnel taking care of study participants.Epidural analgesia versus systemic analgesiaTrials show there may be no difference in mortality at 0 to 30 days (risk difference (RD) 0.00, 95% confidence interval (CI) -0.01 to 0.01; 38 trials with 3418 participants; low-quality evidence), and there may be a reduction in myocardial infarction at 0 to 30 days (RD -0.01, 95% CI -0.02 to 0.00; 26 trials with 2713 participants; low-quality evidence). Epidural analgesia may reduce the risk of 0 to 30 days respiratory depression (RD -0.03, 95% CI -0.05 to -0.01; 21 trials with 1736 participants; low-quality evidence). There is probably little or no difference in risk of pneumonia at 0 to 30 days (RD -0.03, 95% CI -0.07 to 0.01; 10 trials with 1107 participants; moderate-quality evidence), and epidural analgesia probably reduces the risk of atrial fibrillation or atrial flutter at 0 to 2 weeks (RD -0.06, 95% CI -0.10 to -0.01; 18 trials with 2431 participants; moderate-quality evidence). There may be no difference in cerebrovascular accidents at 0 to 30 days (RD -0.00, 95% CI -0.01 to 0.01; 18 trials with 2232 participants; very low-quality evidence), and none of the included trials reported any epidural haematoma events at 0 to 30 days (53 trials with 3982 participants; low-quality evidence). Epidural analgesia probably reduces the duration of tracheal intubation by the equivalent of 2.4 hours (standardized mean difference (SMD) -0.78, 95% CI -1.01 to -0.55; 40 trials with 3353 participants; moderate-quality evidence). Epidural analgesia reduces pain at rest and on movement up to 72 hours after surgery. At six to eight hours, researchers noted a reduction in pain, equivalent to a reduction of 1 point on a 0 to 10 pain scale (SMD -1.35, 95% CI -1.98 to -0.72; 10 trials with 502 participants; moderate-quality evidence). Epidural analgesia may increase risk of hypotension (RD 0.21, 95% CI 0.09 to 0.33; 17 trials with 870 participants; low-quality evidence) but may make little or no difference in the need for infusion of inotropics or vasopressors (RD 0.00, 95% CI -0.06 to 0.07; 23 trials with 1821 participants; low-quality evidence).Epidural analgesia versus other comparatorsFewer studies compared epidural analgesia versus peripheral nerve blocks (four studies), intrapleural analgesia (one study), and wound infiltration (one study). Investigators provided no data for pulmonary complications, atrial fibrillation or flutter, or for any of the comparisons. When reported, other outcomes for these comparisons (mortality, myocardial infarction, neurological complications, duration of tracheal intubation, pain, and haemodynamic support) were uncertain due to the small numbers of trials and participants.</AbstractText><AbstractText Label="AUTHORS' CONCLUSIONS">Compared with systemic analgesia, epidural analgesia may reduce the risk of myocardial infarction, respiratory depression, and atrial fibrillation/atrial flutter, as well as the duration of tracheal intubation and pain, in adults undergoing cardiac surgery. There may be little or no difference in mortality, pneumonia, and epidural haematoma, and effects on cerebrovascular accident are uncertain. Evidence is insufficient to show the effects of epidural analgesia compared with peripheral nerve blocks, intrapleural analgesia, or wound infiltration.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guay</LastName><ForeName>Joanne</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Faculty of Medicine, University of Sherbrooke, Sherbrooke, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kopp</LastName><ForeName>Sandra</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>03</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cochrane Database Syst Rev</MedlineTA><NlmUniqueID>100909747</NlmUniqueID><ISSNLinking>1361-6137</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>Cochrane Database Syst Rev. 2013 Jun 06;(6):CD006715. doi: 10.1002/14651858.CD006715.pub2.</RefSource><PMID Version="1">23740694</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015360" MajorTopicYN="N">Analgesia, Epidural</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="N">Arrhythmias, Cardiac</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001026" MajorTopicYN="N">Coronary Artery Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012120" MajorTopicYN="N">Respiration Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Joanne Guay: none known. Sandra Kopp: none known</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>3</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30821845</ArticleId><ArticleId IdType="pmc">PMC6396869</ArticleId><ArticleId IdType="doi">10.1002/14651858.CD006715.pub3</ArticleId></ArticleIdList><ReferenceList><Title>References to studies included in this review</Title><ReferenceList><Title>Aguero&#x2010;Martinez 2012 {unpublished data only}</Title><Reference><Citation>Aguero Martinez MO. Copy of our manuscript. Email to: J Guay, 4 December 2017.</Citation></Reference><Reference><Citation>Aguero&#x2010;Martinez MO. Anesthetic multimodal methods for coronary artery surgery without extracorporeal circulation. http://apps.who.int/trialsearch/Trial2.aspx?TrialID=RPCEC00000131 2012.</Citation></Reference><Reference><Citation>Aguerro Martinez MO. Information on our trial. Email to: J Guay, 21 March 2018.</Citation></Reference><Reference><Citation>Ag&#xfc;ero Mart&#xed;nez MO, Jim&#xe9;nez Paneque RE. Multimodal analgesia for off&#x2010;pump CABG: a randomized clinical trial [M&#xe9;todos anest&#xe9;sicos multimodales en el procedimiento quir&#xfa;rgico de revascularizaci&#xf3;n mioc&#xe1;rdica sin circulaci&#xf3;n extracorp&#xf3;rea:ensayo cl&#xed;nico aleatorizado]. CORE: https://core.ac.uk/display/11816611. Accessed 5 December 2017. [oai:generic.eprints.org:500/core394 ]</Citation></Reference></ReferenceList><ReferenceList><Title>Bach 2002 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Bach F, Grundmann U, Bauer M, Buchinger H, Solt&#xe9;sz S, Graeter T, et al. Modulation of the inflammatory response to cardiopulmonary bypass by dopexamine and epidural anesthesia. Acta Anaesthesiologica Scandinavica 2002;46(10):1227&#x2010;35. [PUBMED: 12421195]</Citation><ArticleIdList><ArticleId IdType="pubmed">12421195</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bakhtiary 2007 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Bakhtiary F, Therapidis P, Dzemali O, Ak K, Ackermann H, Meininger D, et al. Impact of high thoracic epidural anesthesia on incidence of perioperative atrial fibrillation in off&#x2010;pump coronary bypass grafting: a prospective randomized study. Journal of Thoracic and Cardiovascular Surgery 2007;134(2):460&#x2010;4. [DOI: 10.1016/j.jtcvs.2007.03.043; PUBMED: 17662790]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2007.03.043</ArticleId><ArticleId IdType="pubmed">17662790</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Barrington 2005 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Barrington MJ, Kluger R, Watson R, Scott DA, Harris KJ. Epidural anesthesia for coronary artery bypass surgery compared with general anesthesia alone does not reduce biochemical markers of myocardial damage. Anesthesia and Analgesia 2005;100(4):921&#x2010;8. [DOI: 10.1213/01.ANE.0000146437.88485.47; PUBMED: 15781499]</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ANE.0000146437.88485.47</ArticleId><ArticleId IdType="pubmed">15781499</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bektas 2015 {published and unpublished data}</Title><Reference><Citation>Bektas S. Information on our trial. Email to: J Guay, 11 April 2018.</Citation></Reference><Reference><Citation>Bektas S. Information on our trial. Email to: J Guay, 11 April 2018.</Citation></Reference><Reference><Citation>Bektas S. Information on our trial. Email to: J Guay, 21 March 2018.</Citation></Reference><Reference><Citation>Bektas SG, Turan S, Karadeniz U, Ozturk B, Yavas S, Biricik D, et al. Does high thoracic epidural analgesia with levobupivacaine preserve myocardium? A prospective randomized study. BioMed Research International 2015;2015:658678. [DOI: 10.1155/2015/658678; PUBMED: 25918718]</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/658678</ArticleId><ArticleId IdType="pmc">PMC4395980</ArticleId><ArticleId IdType="pubmed">25918718</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Berendes 2003 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Berendes E, Schmidt C, Aken H, Hartlage MG, Wirtz S, Reinecke H, et al. Reversible cardiac sympathectomy by high thoracic epidural anesthesia improves regional left ventricular function in patients undergoing coronary artery bypass grafting: a randomized trial. Archives of Surgery 2003;138(12):1283&#x2010;90. [DOI: 10.1001/archsurg.138.12.1283; PUBMED: 14662525]</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.138.12.1283</ArticleId><ArticleId IdType="pubmed">14662525</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Brix&#x2010;Christensen 1998 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Brix&#x2010;Christensen V, Tonnesen E, Sanchez RG, Bilfinger TV, Stefano GB. Endogenous morphine levels increase following cardiac surgery as part of the antiinflammatory response?. International Journal of Cardiology 1997;62(3):191&#x2010;7. [PUBMED: 9476677]</Citation><ArticleIdList><ArticleId IdType="pubmed">9476677</ArticleId></ArticleIdList></Reference><Reference><Citation>Brix&#x2010;Christensen V, Tonnesen E, Sorensen IJ, Bilfinger TV, Sanchez RG, Stefano GB. Effects of anaesthesia based on high versus low doses of opioids on the cytokine and acute&#x2010;phase protein responses in patients undergoing cardiac surgery. Acta Anaesthesiologica Scandinavica 1998;42(1):63&#x2013;70. [PUBMED: 9527747]</Citation><ArticleIdList><ArticleId IdType="pubmed">9527747</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Caputo 2011 {published and unpublished data}</Title><Reference><Citation>Angelini G. Information on our trial. Email to: J Guay, 16 March 2018.</Citation></Reference><Reference><Citation>Caputo M, Alwair H, Rogers CA, Ginty M, Monk C, Tomkins S, et al. Myocardial, inflammatory, and stress responses in off&#x2010;pump coronary artery bypass graft surgery with thoracic epidural anesthesia. Annals of Thoracic Surgery 2009;87(4):119&#x2010;26. [CRSREF: 2991383; PUBMED: 19324137]</Citation><ArticleIdList><ArticleId IdType="pubmed">19324137</ArticleId></ArticleIdList></Reference><Reference><Citation>Caputo M, Alwair H, Rogers CA, Pike K, Cohen A, Monk C, et al. Thoracic epidural anesthesia improves early outcomes in patients undergoing off&#x2010;pump coronary artery bypass surgery: a prospective, randomized, controlled trial. Anesthesiology 2011;114(2):380&#x2010;90. [PUBMED: 21245735]</Citation><ArticleIdList><ArticleId IdType="pubmed">21245735</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajakaruna C, Rogers C, Pike K, Alwair H, Cohen A, Tomkins S, et al. Superior haemodynamic stability during off&#x2010;pump coronary surgery with thoracic epidural anaesthesia: results from a prospective randomized controlled trial. Interactive Cardiovascular and Thoracic Surgery 2013;16(5):602&#x2010;7. [DOI: 10.1093/icvts/ivt001; PUBMED: 23357523]</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivt001</ArticleId><ArticleId IdType="pmc">PMC3630420</ArticleId><ArticleId IdType="pubmed">23357523</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Celik 2015 {published and unpublished data}</Title><Reference><Citation>Kudsioglu T. Information on our trial. Email to: J Guay, 11 April 2018.</Citation></Reference><Reference><Citation>&#xc7;elik BB, Kudsio&#x11f;lu T, Al&#x131;c&#x131;ku&#x15f; Z, Yap&#x131;c&#x131; N, Orhan G, Tando&#x11f;ar N, et al. The effects of thoracic epidural analgesia on postoperative pain and myocardial protection in coronary artery bypass surgery [Koroner arter cerrahisinde torakal epidural analjezinin postoperatif a&#x11f;r&#x131; ve miyokard korunmas&#x131; &#x171;zerine etkileri]. Haseki Tip Bulteni 2015;53(1):72&#x2010;6. [DOI: 10.4274/haseki.2163]</Citation><ArticleIdList><ArticleId IdType="doi">10.4274/haseki.2163</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cheng&#x2010;Wei 2017 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Cheng&#x2010;Wei L, Tzu&#x2010;Yu L. Comparison of thoracic epidural bupivacaine with fentanyl and local infusion of bupivacaine combined with intravenous patient&#x2010;controlled analgesia for pain relief in patients undergoing minimally invasive cardiac surgery. http://www.asaabstracts.com/strands/asaabstracts/searchresults.htm?base=1&amp;index=1&amp;display=50&amp;highlight=true&amp;highlightcolor=0&amp;bold=true&amp;italic=false. Boston, MA; 21&#x2010;25 October 2017: American Society of Anesthesiologists Annual Meeting, 2017:A1161.</Citation></Reference></ReferenceList><ReferenceList><Title>de Vries 2002 {published and unpublished data}</Title><Reference><Citation>Vries AJ. Information on our trial. Email to: J Guay, 12 April 2018.</Citation></Reference><Reference><Citation>Vries AJ, Mariani MA, Maaten JM, Loef BG, Lip H. To ventilate or not after minimally invasive direct coronary artery bypass surgery: the role of epidural anesthesia. Journal of Cardiothoracic and Vascular Anesthesia 2002;16(1):21&#x2010;6. [DOI: 10.1053/jcan.2002.29645; PUBMED: 11854873]</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/jcan.2002.29645</ArticleId><ArticleId IdType="pubmed">11854873</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Dohle 2001 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Dhole S, Mehta Y, Saxena H, Juneja R, Trehan N. Comparison of continuous thoracic epidural and paravertebral blocks for postoperative analgesia after minimally invasive direct coronary artery bypass surgery. Journal of Cardiothoracic and Vascular Anesthesia 2001;15(3):288&#x2010;92. [DOI: 10.1053/jcan.2001.23271; PUBMED: 11426357]</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/jcan.2001.23271</ArticleId><ArticleId IdType="pubmed">11426357</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>El&#x2010;Baz 1987 {published data only (unpublished sought but not used)}</Title><Reference><Citation>El&#x2010;Baz N, Goldin M. Continuous epidural infusion of morphine for pain relief after cardiac operations. Journal of Thoracic and Cardiovascular Surgery 1987;93(6):878&#x2013;83. [PUBMED: 2952842]</Citation><ArticleIdList><ArticleId IdType="pubmed">2952842</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>El&#x2010;Morsy 2012 {published data only (unpublished sought but not used)}</Title><Reference><Citation>El&#x2010;Morsy GZ, El&#x2010;Deeb A. The outcome of thoracic epidural anesthesia in elderly patients undergoing coronary artery bypass graft surgery. Saudi Journal of Anaesthesia 2012;6(1):16&#x2010;21. [DOI: 10.4103/1658-354X.93048; PUBMED: 22412771]</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1658-354X.93048</ArticleId><ArticleId IdType="pmc">PMC3299108</ArticleId><ArticleId IdType="pubmed">22412771</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>El&#x2010;Shora 2018 {published and unpublished data}</Title><Reference><Citation>Arafat A. Information on our trial. Email to: J Guay 20 Novembre 2018.</Citation></Reference><Reference><Citation>El&#x2010;Shora HA, Beleehy AA, Abdelwahab AA, Ali GA, Omran TE, Hassan EA, et al. Bilateral paravertebral block versus thoracic epidural analgesia for pain control post&#x2010;cardiac surgery: a randomized controlled trial. Thoracic and Cardiovascular Surgeon 2018 August 16 [Epub ahead of print]. [DOI: 10.1055/s-0038-1668496; MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0038-1668496</ArticleId><ArticleId IdType="pubmed">30114712</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Fawcett 1997 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Edwards RE, Quin AC, Fawcett WJ, MacDonald IA, Hall GM. Effect of thoracic extradural anaesthesia started after cardiopulmonary bypass on catecholamine values. British Journal of Anaesthesia. London, 1&#x2010;5 June: European Society of Anaesthesiologists Annual Congress Abstracts, 1996; Vol. 76, issue Suppl 2:54.</Citation></Reference><Reference><Citation>Fawcett WJ, Edwards RE, Quinn AC, MacDonald IA, Hall GM. Thoracic epidural analgesia started after cardiopulmonary bypass: adrenergic, cardiovascular and respiratory sequelae. Anaesthesia 1997;52(4):294&#x2010;9. [PUBMED: 9135178]</Citation><ArticleIdList><ArticleId IdType="pubmed">9135178</ArticleId></ArticleIdList></Reference><Reference><Citation>Fawcett WJ, Quinn AC, Edwards RE, Hall GM. Thoracic extradural anaesthesia improves respiratory function after cardiac surgery. British Journal of Anaesthesia. London. 1&#x2010;5 June: European Society of Anaesthesiologists Annual Congress Abstracts, 1996; Vol. 76 (Suppl 2):71.</Citation></Reference></ReferenceList><ReferenceList><Title>Fillinger 2002 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Fillinger MP, Yeager MP, Dodds TM, Fillinger MF, Whalen PK, Glass DD. Epidural anesthesia and analgesia: effects on recovery from cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia 2002;16(1):15&#x2010;20. [DOI: 10.1053/jcan.2002.29639; PUBMED: 11854872]</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/jcan.2002.29639</ArticleId><ArticleId IdType="pubmed">11854872</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Greisen 2012 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Greisen J, Nielsen DV, Sloth E, Jakobsen CJ. High thoracic epidural analgesia decreases stress hyperglycemia and insulin need in cardiac surgery patients. Acta Anaesthesiologica Scandinavica 2013;57(2):171&#x2010;7. [DOI: 10.1111/j.1399-6576.2012.02731.x; EudraCT 2005&#x2010;000617&#x2010;35; PUBMED: 22762307 ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-6576.2012.02731.x</ArticleId><ArticleId IdType="pubmed">22762307</ArticleId></ArticleIdList></Reference><Reference><Citation>Greisen J, Nielsen DV, Sloth E, Jakobsen CJ. High thoracic epidural analgesia reduces the need for insulin, preserves glucose metabolism and attenuates stress hyperglycaemia in cardiac surgery patients. Applied Cardiopulmonary Pathophysiology. 2012; Vol. 16:193&#x2010;4.</Citation></Reference></ReferenceList><ReferenceList><Title>Gurses 2013 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Gurses E, Berk D, Sungurtekin H, Mete A, Serin S. Effects of high thoracic epidural anesthesia on mixed venous oxygen saturation in coronary artery bypass grafting surgery. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 2013;19:222&#x2010;9. [DOI: 10.12659/MSM.883861; DOI: 10.12659/MSM.883861; PUBMED: 23531633]</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.883861</ArticleId><ArticleId IdType="doi">10.12659/MSM.883861</ArticleId><ArticleId IdType="pmc">PMC3628587</ArticleId><ArticleId IdType="pubmed">23531633</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Hansdottir 2006 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Hansdottir V, Philip J, Olsen MF, Eduard C, Houltz E, Ricksten SE. Thoracic epidural versus intravenous patient&#x2010;controlled analgesia after cardiac surgery: a randomized controlled trial on length of hospital stay and patient&#x2010;perceived quality of recovery. Anesthesiology 2006;104(1):142&#x2010;51. [PUBMED: 16394700 ]</Citation><ArticleIdList><ArticleId IdType="pubmed">16394700</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Heijmans 2007 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Heijmans J, Fransen E, Buurman W, Maessen J, Roekaerts P. Comparison of the modulatory effects of four different fast&#x2010;track anesthetic techniques on the inflammatory response to cardiac surgery with cardiopulmonary bypass. Journal of Cardiothoracic and Vascular Anesthesia 2007;21(4):512&#x2010;8. [DOI: 10.1053/j.jvca.2007.02.008; PUBMED: 17678776]</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2007.02.008</ArticleId><ArticleId IdType="pubmed">17678776</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Huh 2004 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Huh IY, Sim JY, Lim YJ, Choi IC. The effects of high thoracic epidural patient controlled analgesia after open heart surgery. Korean Journal of Anesthesiology 2004;47:521&#x2010;6. [DOI: 10.4097/kjae.2004.47.4.521]</Citation><ArticleIdList><ArticleId IdType="doi">10.4097/kjae.2004.47.4.521</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Hutchenson 2006 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Hutchenson J, Sonntag H, Hill E, et al. High thoracic epidural anesthesia&#x2019;s effect on myocardial blood flow, oxygen consumption, myocardial work and markers of ischemia during coronary artery bypass grafting:a randomised controlled trial. Anesthesia and Analgesia. San Diego, 2006; Vol. 102:SCA&#x2010;13.</Citation></Reference><Reference><Citation>Rieke H, Abernathy JH, Kazmaier S, Mielck F, Hutchenson K, Hanekop G. High thoracic epidural anaesthesia in patients undergoing CABG reduces sympathetic effects on myocardial blood flow and myocardial oxygen uptake and its effect on myocardial ischemia. Anestezjologia i Ratownictwo 2011;5:150&#x2010;60.</Citation></Reference></ReferenceList><ReferenceList><Title>Jakobsen 2012 {published and unpublished data}</Title><Reference><Citation>Greisen J, Nielsen DV, Ryhammer PK, Sloth E, Jacobsen CJ. High thoracic epidural analgesia supplement seems to protect renal function, evaluated by serum creatinine changes, in cardiac surgery patients: a randomized study. Cardiovascular System 2013, (1):11. [DOI: 10.7243/2052-4358-1-11]</Citation><ArticleIdList><ArticleId IdType="doi">10.7243/2052-4358-1-11</ArticleId></ArticleIdList></Reference><Reference><Citation>Greisen J, Ryhammer PK, Nielsen DV, Sloth E, Jakobsen CJ. High thoracic epidural analgesia supplement may protect renal function in cardiac surgery patients. Applied Cardiopulmonary Pathophysiology. 2013; Vol. 17 Issue 2:179&#x2010;80.</Citation></Reference><Reference><Citation>Jakobsen CJ. Information on our trial. Email to: J Guay, 16 March 2018.</Citation></Reference><Reference><Citation>Jakobsen CJ, Bhavsar R, Nielsen DV, Ryhammer PK, Sloth E, Greisen J. High thoracic epidural analgesia in cardiac surgery: part 1 &#x2010; high thoracic epidural analgesia improves cardiac performance in cardiac surgery patients. Journal of Cardiothoracic and Vascular Anesthesia 2012;26(6):1039&#x2010;47. [DOI: 10.1053/j.jvca.2012.05.007; PUBMED: 22770758]</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2012.05.007</ArticleId><ArticleId IdType="pubmed">22770758</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakobsen CJ, Kirkegaard H, Christiansen CL, Lorentzen AG, Severinsen IK, Sloth E. Epidural anaesthesia reduces NT&#x2010;proBNP after cardiac surgery. European Journal of Anaesthesiology. 2007; Vol. 24, issue Suppl 41:1&#x2010;18.</Citation></Reference><Reference><Citation>Nielsen DV, Bhavsar R, Greisen J, Ryhammer PK, Sloth E, Jakobsen CJ. High thoracic epidural analgesia in cardiac surgery: part 2 &#x2010; high thoracic epidural analgesia does not reduce time in or improve quality of recovery in the intensive care unit. Journal of Cardiothoracic and Vascular Anesthesia 2012;26(6):1048&#x2010;54. [DOI: 10.1053/j.jvca.2012.05.008; PUBMED: 22770692]</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2012.05.008</ArticleId><ArticleId IdType="pubmed">22770692</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kendall 2004 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Kendall JB, Russell GN, Scawn ND, Akrofi M, Cowan CM, Fox MA. A prospective, randomised, single&#x2010;blind pilot study to determine the effect of anaesthetic technique on troponin T release after off&#x2010;pump coronary artery surgery. Anaesthesia 2004;59(6):545&#x2010;9. [DOI: 10.1111/j.1365-2044.2004.03713.x; PUBMED: 15144293]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.2004.03713.x</ArticleId><ArticleId IdType="pubmed">15144293</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kilickan 2006 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Gonca S, Kilickan L, Dalcik C, Dalcik H, Bayindir O. The cardioprotective effects of thoracal epidural anesthesia are induced by the expression of vascular endothelial growth factor and inducible nitric oxide synthase in cardiopulmonary bypass surgery. Journal of Cardiovascular Surgery 2007;48(1):93&#x2010;102. [PUBMED: 17308528]</Citation><ArticleIdList><ArticleId IdType="pubmed">17308528</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilickan L, Solak M, Bayindir O. Thoracic epidural anesthesia preserves myocardial function during intraoperative and postoperative period in coronary artery bypass grafting operation. Journal of Cardiovascular Surgery 2005;46(6):559&#x2010;67. [PUBMED: 16424844]</Citation><ArticleIdList><ArticleId IdType="pubmed">16424844</ArticleId></ArticleIdList></Reference><Reference><Citation>Kili&#xe7;kan L, Gonca S, Dal&#xe7;ik C, Dal&#xe7;ik H, Solak M, Bayindir O, et al. General anesthesia with thoracic epidural anesthesia in the cardiopulmonary bypass surgery reduces apoptosis by upregulating antiapoptotic protein Bcl&#x2010;2. Journal of Cardiovascular Surgery 2006;47(3):315&#x2010;22. [PUBMED: 16760868]</Citation><ArticleIdList><ArticleId IdType="pubmed">16760868</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kilickan 2008 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Kilickan L, Yumuk Z, Bayindir O. The effect of combined preinduction thoracic epidural anaesthesia and glucocorticoid administration on perioperative interleukin&#x2010;10 levels and hyperglycemia: a randomized controlled trial. Journal of Cardiovascular Surgery 2008;49(1):87&#x2010;93. [PUBMED: 18212693]</Citation><ArticleIdList><ArticleId IdType="pubmed">18212693</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kirno 1994 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Kirn&#xf6; K, Friberg P, Grzegorczyk A, Milocco I, Ricksten SE, Lundin S. Thoracic epidural anesthesia during coronary artery bypass surgery: effects on cardiac sympathetic activity, myocardial blood flow and metabolism, and central hemodynamics. Anesthesia and Analgesia 1994;79(6):1075&#x2010;81. [PUBMED: 7978429]</Citation><ArticleIdList><ArticleId IdType="pubmed">7978429</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kirov 2011 {published and unpublished data}</Title><Reference><Citation>Kirov M. Information on our trial. Email to: J Guay, 16 March 2018.</Citation></Reference><Reference><Citation>Kirov MY, Eremeev AV, Smetkin AA, Bjertnaes LJ. Epidural anesthesia and postoperative analgesia with ropivacaine and fentanyl in off&#x2010;pump coronary artery bypass grafting: a randomized, controlled study. BMC Anesthesiology 2011;11:17. [DOI: 10.1186/1471-2253-11-17; PUBMED: 21923942]</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2253-11-17</ArticleId><ArticleId IdType="pmc">PMC3182129</ArticleId><ArticleId IdType="pubmed">21923942</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Konishi 1995 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Konishi A, Kikuchi K. Postoperative management following open heart surgery by thoracic epidural anesthesia. Japanese Journal of Anesthesiology 1995;44(8):1113&#x2010;7. [PUBMED: 7474310]</Citation><ArticleIdList><ArticleId IdType="pubmed">7474310</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kundu 2007 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Kundu RK, Beg AK, Hossain S, Haque N, Mahafuddoza, Chowdury A. Comparative study of haemodynamic status and arrhythmia between combined epidural with general anaesthesia and general anaesthesia alone in off&#x2010;pump coronary artery bypass (OPCAB) surgery. Journal of Bangladesh College of Physicians and Surgeons 2008;26:116&#x2010;20.</Citation></Reference></ReferenceList><ReferenceList><Title>Kunstyr 2001 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Kunst&#xfd;&#x159; J, St&#x159;&#xed;tesk&#xfd; M, Kri&#x161;tof J, &#x160;krovina B, Kotul&#xe1;k T. Postoperative analgesia in cardiac surgery [Poopera&#x10d;n&#xed; analgezie v kardiochirurgii]. Anesteziologie a Neodkladna Pece 2001;12(4):191&#x2010;4.</Citation></Reference></ReferenceList><ReferenceList><Title>Lenkutis 2009 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Lenkutis T, Benetis R, Sirvinskas E, Raliene L, Judickaite L. Effects of epidural anesthesia on intrathoracic blood volume and extravascular lung water during on&#x2010;pump cardiac surgery. Perfusion 2009;24(4):243&#x2010;8. [DOI: 10.1177/0267659109348724; PUBMED: 19808745]</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0267659109348724</ArticleId><ArticleId IdType="pubmed">19808745</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Liem 1992 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Liem TH, Booij LH, Gielen MJ, Hasenbos MA, Egmond J. Coronary artery bypass grafting using two different anesthetic techniques: part 3 &#x2010; adrenergic responses. Journal of Cardiothoracic and Vascular Anesthesia 1992;6(2):162&#x2010;7. [PUBMED: 1533167]</Citation><ArticleIdList><ArticleId IdType="pubmed">1533167</ArticleId></ArticleIdList></Reference><Reference><Citation>Liem TH, Booij LH, Hasenbos MA, Gielen MJ. Coronary artery bypass grafting using two different anesthetic techniques: part 1 &#x2010; hemodynamic results. Journal of Cardiothoracic &amp; Vascular Anesthesia 1992;6(2):148&#x2010;55. [PUBMED: 1533165]</Citation><ArticleIdList><ArticleId IdType="pubmed">1533165</ArticleId></ArticleIdList></Reference><Reference><Citation>Liem TH, Hasenbos MA, Booij LH, Gielen MJ. Coronary artery bypass grafting using two different anesthetic techniques: part 2 &#x2010; postoperative outcome. Journal of Cardiothoracic and Vascular Anesthesia 1992;6(2):156&#x2010;61. [PUBMED: 1533166]</Citation><ArticleIdList><ArticleId IdType="pubmed">1533166</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Loick 1999 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Loick HM, Mollhoff T, Erren M, Berendes E, Rolf N, Aken H. Thoracic epidural anesthesia lowers catecholamine and YNF alpha release after CABG in humans. Anesthesia and Analgesia. Orlando, FL; March 7&#x2010;11, 1998: International Anesthesia Research Society; 72nd Clinical and Scientific Congress: Cardiovascular Anesthesia, 1998; Vol. 86, issue 2S:81S. [DOI: 10.1097/00000539-199802001-00081]</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000539-199802001-00081</ArticleId></ArticleIdList></Reference><Reference><Citation>Loick HM, Schmidt C, Aken H, Junker R, Erren M, Berendes E, et al. High thoracic epidural anesthesia, but not clonidine, attenuates the perioperative stress response via sympatholysis and reduces the release of troponin T in patients undergoing coronary artery bypass grafting. Anesthesia and Analgesia 1999;88(4):701&#x2010;9. [PUBMED: 10195508]</Citation><ArticleIdList><ArticleId IdType="pubmed">10195508</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lundstrom 2005 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Lundstrom LH, Nygard E, Hviid LB, Pedersen FM, Ravn J, Aldershvile J, et al. The effects of thoracic epidural analgesia on the occurence of late postoperative hypoxemia in patients undergoing elective coronary bypass surgery: a randomized controlled trial. Chest 2005;128(3):1564&#x2010;70. [PUBMED: 16162759]</Citation><ArticleIdList><ArticleId IdType="pubmed">16162759</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lyons 1998 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Lyons FM, Riedel BJ, Haw M, Royston D. Myocardial protection during coronary artery bypass graft surgery with thoracic epidural analgesia. British Journal of Anaesthesia. 1980; Vol. 80, issue Suppl 1:55&#x2010;56.</Citation></Reference></ReferenceList><ReferenceList><Title>Mehta 1998 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Mehta Y, Swaminathan M, Mishra Y, Trehan N. A comparative evaluation of intrapleural pain relief after minimally invasive direct coronary artery bypass surgery. Journal of Cardiothoracic and Vascular Anesthesia 1998;12(2):162&#x2010;5. [PUBMED: 9583546 ; PUBMED: 9583546]</Citation><ArticleIdList><ArticleId IdType="pubmed">9583546</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mehta 2008 {published and unpublished data}</Title><Reference><Citation>Mehta Y. Information on our trial. Email to: J Guay, 2 April 2018.</Citation></Reference><Reference><Citation>Mehta Y, Arora D, Sharma KK, Mishra Y, Wasir H, Trehan N. Comparison of continuous thoracic epidural and paravertebral block for postoperative analgesia after robotic&#x2010;assisted coronary artery bypass surgery. Annals of Cardiac Anaesthesia 2008;11(2):91&#x2010;6. [DOI: 10.4103/0971-9784.41576; PUBMED: 18603748]</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0971-9784.41576</ArticleId><ArticleId IdType="pubmed">18603748</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mehta 2010 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Mehta Y, Vats M, Sharma M, Arora R, Trehan N. Thoracic epidural analgesia for off&#x2010;pump coronary artery bypass surgery in patients with chronic obstructive pulmonary disease. Annals of Cardiac Anaesthesia 2010;13(3):224&#x2010;30. [PUBMED: 20826963]</Citation><ArticleIdList><ArticleId IdType="pubmed">20826963</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mishra 2004 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Mishra S Chauhan S, Kiran U, Bhan A, Eisai AK. Does addition of epidural analgesia enhance "Fast tracking" in routine CABG patients?. Indian Journal of Thoracic and Cardiovascular Surgery. 2004; Vol. 20, issue Jan&#x2010;Mar:6, Abstract 14.</Citation></Reference></ReferenceList><ReferenceList><Title>Moore 1995 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Moore CM, Cross MH, Desborough JP, Burrin JM, Macdonald IA, Hall GM. Hormonal effects of thoracic extradural analgesia for cardiac surgery. British Journal of Anesthesia 1995;75(4):387&#x2010;93. [PUBMED: 7488474]</Citation><ArticleIdList><ArticleId IdType="pubmed">7488474</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Nagaraja 2018 {published data only}</Title><Reference><Citation>Nagaraja PS, Ragavendran S, Singh NG, Asai O, Bhavya G, Manjunath N, et al. Comparison of continuous thoracic epidural analgesia with bilateral erector spinae plane block for perioperative pain management in cardiac surgery. Annals of Cardiac Anaesthesia 2018;21(3):323&#x2010;7. [CENTRAL: 01629440; DOI: 10.4103/aca.ACA_16_18; EMBASE: 623313977; MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/aca.ACA_16_18</ArticleId><ArticleId IdType="pmc">PMC6078032</ArticleId><ArticleId IdType="pubmed">30052229</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Neskovic 2013 {published and unpublished data}</Title><Reference><Citation>Neskovic V. Information on our trial. Email to: J Guay, 20 March 2018.</Citation></Reference><Reference><Citation>Neskovic V. Information on our trial. Email to: J Guay, 24 March 2018.</Citation></Reference><Reference><Citation>Neskovic V, Milojevic P, Unic&#x2010;Stojanovic D, Slavkovic Z. Blood transfusion in cardiac surgery &#x2010; does the choice of anesthesia or type of surgery matter?. Vojnosanitetski Pregled 2013;70(5):439&#x2010;44. [DOI: 10.2298/VSP1305439N; PUBMED: 23789281]</Citation><ArticleIdList><ArticleId IdType="doi">10.2298/VSP1305439N</ArticleId><ArticleId IdType="pubmed">23789281</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Nygard 2004 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Nyg&#xe5;rd E, S&#xf8;rensen LH, Hviid LB, Pedersen FM, Ravn J, Thomassen L, et al. Effects of amiodarone and thoracic epidural analgesia on atrial fibrillation after coronary artery bypass grafting. Journal of Cardiothoracic Vascular Anesthesia 2004;18(6):709&#x2010;14. [DOI: 10.1053/j.jvca.2004.08.006; PUBMED: 15650978]</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2004.08.006</ArticleId><ArticleId IdType="pubmed">15650978</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Obersztyn 2018 {published data only}</Title><Reference><Citation>Obersztyn M, Trejnowska E, Nadziakiewicz P, Knapik P. Evaluation of thoracic epidural analgesia in patients undergoing coronary artery bypass surgery &#x2010; a prospective randomized trial. Kardiochirurgia I Torakochirurgia Polska 2018;15(2):72&#x2010;8. [DOI: 10.5114/kitp.2018.76471; MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/kitp.2018.76471</ArticleId><ArticleId IdType="pmc">PMC6066681</ArticleId><ArticleId IdType="pubmed">30069186</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Onan 2011 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Onan IS, Onan B, Korkmaz AA, Oklu L, Kilickan L, Gonca S, et al. Effects of thoracic epidural anesthesia on flow and endothelium of internal thoracic artery in coronary artery bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia 2011;25(6):1063&#x2010;70. [DOI: 10.1053/j.jvca.2011.06.004; PUBMED: 21835638]</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2011.06.004</ArticleId><ArticleId IdType="pubmed">21835638</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Onan 2013 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Onan B, Onan IS, Kilickan L, Sanisoglu I. Effects of epidural anesthesia on acute and chronic pain after coronary artery bypass grafting. Journal of Cardiac Surgery 2013;28(3):248&#x2010;53. [DOI: 10.1111/jocs.12086; PUBMED: 23461638]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocs.12086</ArticleId><ArticleId IdType="pubmed">23461638</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Palomero 2008 {published and unpublished data}</Title><Reference><Citation>Palomero MA. Information on our trial. Email to: J Guay, 3 April 2018.</Citation></Reference><Reference><Citation>Palomero Rodriguez MA. Information on our trial. Email to: J Guay, 21 March 2018.</Citation></Reference><Reference><Citation>Palomero Rodriguez MA, Suarez Gonzalo L, Villar Alvarez F, Varela Crespo C, Moreno Gomez Limon I, Criado Jimenez A. Thoracic epidural anesthesia decreases C&#x2010;reactive protein levels in patients undergoing elective coronary artery bypass graft surgery with cardiopulmonary bypass. Minerva Anestesiologica 2008;74(11):619&#x2010;26. [PUBMED: 18971890]</Citation><ArticleIdList><ArticleId IdType="pubmed">18971890</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Petrovski 2006 {published data only}</Title><Reference><Citation>Petrovski V, Slavevski D, Stoicovski E, Belostotskii V, Hristov N, Mitrev Z. The advantages of combined epidural and general anesthesia vs. conventional general anesthesia in off pump coronary artery bypass surgery. Anesthesia and Analgesia. May 1, 2006: Society of Cardiovascular Anesthesiologists 28th AnnualMeeting and Workshops, 2006:SCA68.</Citation></Reference></ReferenceList><ReferenceList><Title>Priestley 2002 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Priestley MC, Cope L, Halliwell R, Gibson P, Chard RB, Skinner M, et al. Thoracic epidural anesthesia for cardiac surgery: the effects on tracheal intubation time and length of hospital stay. Anesthesia and Analgesia 2002;94(2):275&#x2013;82. [PUBMED: 11812684]</Citation><ArticleIdList><ArticleId IdType="pubmed">11812684</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rein 1989 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Rein KA, Stenseth R, Myhre HO, Levang OW, Krogstad A. The influence of thoracic epidural analgesia on transcapillary fluid balance in subcutaneous tissue. A study in patients undergoing aortocoronary bypass surgery. Acta Anaesthesiologica Scandinavica 1989;33(1):79&#x2010;83. [PUBMED: 2644753]</Citation><ArticleIdList><ArticleId IdType="pubmed">2644753</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Royse 2003 {published and unpublished data}</Title><Reference><Citation>Royse C. Information on our trial. Email to: J Guay, 16 March 2018.</Citation></Reference><Reference><Citation>Royse C, Remedios C, Royse A. High thoracic epidural analgesia reduces the risk of long&#x2010;term depression in patients undergoing coronary artery bypass surgery. Annals of Thoracic and Cardiovascular Surgery 2007;13(1):32&#x2010;5. [PUBMED: 17392668 ]</Citation><ArticleIdList><ArticleId IdType="pubmed">17392668</ArticleId></ArticleIdList></Reference><Reference><Citation>Royse C, Royse A, Soeding P, Blake D, Pang J. Prospective randomized trial of high thoracic epidural analgesia for coronary artery bypass surgery. Annals of Thoracic Surgery 2003;75(1):93&#x2010;100. [PUBMED: 12537199]</Citation><ArticleIdList><ArticleId IdType="pubmed">12537199</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Scott 2001 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Scott NB, Turfrey DJ, Ray DAA, Nzewi O, Sutcliffe NP, Lal AB, et al. A prospective randomized study of the potential benefits of thoracic epidural anesthesia and analgesia in patients undergoing coronary artery bypass grafting. Anesthesia and Analgesia 2001;93(3):528&#x2010;35. [PUBMED: 11524314]</Citation><ArticleIdList><ArticleId IdType="pubmed">11524314</ArticleId></ArticleIdList></Reference><Reference><Citation>Turfrey D, Ray D. The effect of thoracic epidural analgesia on postoperative complications after cardiac surgery &#x2010; a prospective study. British Journal of Anaesthesia. 1998; Vol. 80, issue Suppl 2:17.</Citation></Reference></ReferenceList><ReferenceList><Title>Sen 2017 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Sen AC, Rajan S, Balachandran R, Kumar L, Nair SG. Comparison of perioperative thoracic epidural fentanyl with bupivacaine and intravenous fentanyl for analgesia in patients undergoing coronary artery bypass grafting surgery. Anesthesia, Essays and Researches 2017;11(1):105&#x2010;9. [DOI: 10.4103/0259-1162.186613; PUBMED: 28298766]</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0259-1162.186613</ArticleId><ArticleId IdType="pmc">PMC5341684</ArticleId><ArticleId IdType="pubmed">28298766</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sharma 2010 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Sharma M, Mehta Y, Sawhney R, Vats M, Trehan N. Thoracic epidural analgesia in obese patients with body mass index of more than 30 kg/m&#xb2; for off pump coronary artery bypass surgery. Annals Cardiac Anaesthesia 2010;13(1):28&#x2010;33. [DOI: 10.4103/0971-9784.58831; PUBMED: 20075532 ]</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0971-9784.58831</ArticleId><ArticleId IdType="pubmed">20075532</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Stenseth 1994 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Stenseth R. Information on our trial. Email to: J Guay, 28 May 2018.</Citation></Reference><Reference><Citation>Stenseth R, Berg EM, Bjella L, Christensen O, Levang OW, Gisvold SE. Effects of thoracic epidural analgesia on coronary hemodynamics and myocardial metabolism in coronary artery bypass surgery. Journal of Cardlothoracic and Vascular Anesthesta 1995;9(5):503&#x2010;9. [PUBMED: 8547549]</Citation><ArticleIdList><ArticleId IdType="pubmed">8547549</ArticleId></ArticleIdList></Reference><Reference><Citation>Stenseth R, Bjella L, Berg EM, Christensen O, Levang OW, Gisvold SE. Thoracic epidural analgesia in aortocoronary bypass surgery. I: haemodynamic effects. Acta Anaesthesiologica Scandinavica 1994;38(8):826&#x2010;33. [PUBMED: 7887106]</Citation><ArticleIdList><ArticleId IdType="pubmed">7887106</ArticleId></ArticleIdList></Reference><Reference><Citation>Stenseth R, Bjella L, Berg EM, Christensen O, Levang OW, Gisvold SE. Thoracic epidural analgesia in aortocoronary bypass surgery. II: effects on the endocrine metabolic response. Acta Anaesthesiologica Scandinavica 1994;38(8):834&#x2010;9. [PUBMED: 7887107 ]</Citation><ArticleIdList><ArticleId IdType="pubmed">7887107</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Stenseth 1996 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Stenseth R. Information on our trial. Email to: J Guay, 28 May 2018.</Citation></Reference><Reference><Citation>Stenseth R, Bjella L, Berg EM, Christensen O, Levang OW, Gisvold SE. Effects of thoracic epidural analgesia on pulmonary function after coronary artery bypass surgery. European Journal of Cardiothoracic Surgery 1996;10(10):859&#x2010;65. [PUBMED: 8911839]</Citation><ArticleIdList><ArticleId IdType="pubmed">8911839</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Stritesky 2006 {published data only}</Title><Reference><Citation>Stritesky M, Rubes D, Semrad M, Lips M. A comparison of haemodynamic changes using thoracic epidural anesthesia versus standard balanced anaesthesia during on&#x2010;pump coronary artery bypass grafting. Anesteziologie a Intenzivni Medicina 2006;17:138&#x2010;44.</Citation></Reference></ReferenceList><ReferenceList><Title>Svircevic 2011 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Svircevic V, Nierich AP, Moons KG, Diephuis JC, Ennema JJ, Brandon Bravo Bruinsma GJ, et al. Thoracic epidural anesthesia for cardiac surgery: a randomized trial. Anesthesiology 2011;114(2):262&#x2010;70. [DOI: 10.1097/ALN.0b013e318201d2de; PUBMED: 21239976 ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e318201d2de</ArticleId><ArticleId IdType="pubmed">21239976</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Tenenbein 2008 {published and unpublished data}</Title><Reference><Citation>Kowalski S. Information on our trial. Email to: J Guay, 27 March 2018.</Citation></Reference><Reference><Citation>Tenenbein PK, Debrouwere R, Maguire D, Duke PC, Muirhead B, Enns J, et al. Thoracic epidural analgesia improves pulmonary function in patients undergoing cardiac surgery. Canadian Journal of Anaesthesia 2008;55(6):344&#x2010;50. [DOI: 10.1007/BF03021489; PUBMED: 18566197]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03021489</ArticleId><ArticleId IdType="pubmed">18566197</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Tenling 1999 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Tenling A, Joachimsson P&#x2010;O, Tyden H, Hedenstierna G. Thoracic epidural analgesia as an adjunct to general anaesthesia for cardiac surgery. Effects on pulmonary mechanics. Acta Anaesthesiologica Scandinavica 2000;44(9):1071&#x2010;6. [PUBMED: 11028725]</Citation><ArticleIdList><ArticleId IdType="pubmed">11028725</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenling A, Joachimsson PO, Tyd&#xe9;n H, Wegenius G, Hedenstierna G. Thoracic epidural anesthesia as an adjunct to general anesthesia for cardiac surgery: effects on ventilation&#x2010;perfusion relationships. Journal of Cardiothoracic and Vascular Anesthesia 1999;13(3):258&#x2010;64. [PUBMED: 10392674]</Citation><ArticleIdList><ArticleId IdType="pubmed">10392674</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Usui 1990 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Usui K, Yasuda A, Tadokoro M, Kon&#x2010;nai T, Shoji Y, Yoshida S. Epidural morphine as a sedative after open heart surgery: in cases of coronary artery bypass graft. Kyobu Geka &#x2010; Japanese Journal of Thoracic Surgery 1990;43(1):19&#x2010;23. [PUBMED: 2304293]</Citation><ArticleIdList><ArticleId IdType="pubmed">2304293</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Volk 2003 {published data only}</Title><Reference><Citation>Volk T, Dopfmer UR, Schmutzler M, Rimpau S, Schnitzler H, Konertz W, et al. Stress induced IL&#x2010;10 does not seem to be essential for early monocyte deactivation following cardiac surgery. Cytokine 2003;24(6):237&#x2010;43. [DOI: 10.1016/S1043-4666(03)00090-5; PUBMED: 14609565]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1043-4666(03)00090-5</ArticleId><ArticleId IdType="pubmed">14609565</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Yang 1996 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Yang C, Deng S. Effects of epidural block combined with general anesthesia on stress response during cardiopulmonary bypass. Chinese Journal of Anesthesiology 1996;16:492.</Citation></Reference></ReferenceList><ReferenceList><Title>Yilmaz 2007 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Yilmaz C, &#xc7;oruh T, Yap&#x131;c&#x131; N, Y&#x131;lmaz &#xd6;, Ma&#xe7;ika H, Ayka&#xe7; Z. The effects of preemptive analgesia with thoracic epidural on respiratory function tests, pain scores and hemodynamics in coronary artery bypass graft surgery. Anestezi Dergisi 2007;15:20&#x2010;7.</Citation></Reference></ReferenceList><ReferenceList><Title>Yung 1997 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Yung MC, Chang Y, Lai ST, Tsou MY, Chan KH. Improved postoperative pain relief via preemptive analgesia in relation to heart rate variability for coronary artery bypass grafting: a preliminary report. Zhonghua Yi Xue Za Zhi 1997;60(1):28&#x2010;35. [PUBMED: 9316325]</Citation><ArticleIdList><ArticleId IdType="pubmed">9316325</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zawar 2015 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Zawar BP, Mehta Y, Juneja R, Arora D, Raizada A, Trehan N. Nonanalgesic benefits of combined thoracic epidural analgesia with general anesthesia in high risk elderly off pump coronary artery bypass patients. Annals of Cardiac Anaesthesia 2015;18(3):385&#x2010;91. [DOI: 10.4103/0971-9784.159810; PUBMED: 26139745]</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0971-9784.159810</ArticleId><ArticleId IdType="pmc">PMC4881722</ArticleId><ArticleId IdType="pubmed">26139745</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zhou 2010 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Zhou X, Hong C. Clinical study of postoperative thoracic epidural block in cardiac thoracic surgery [&#x80f8;&#x90e8;&#x786c;&#x819c;&#x5916;&#x963b;&#x6ede;&#x5728;&#x5fc3;&#x810f;&#x5f00;&#x80f8;&#x624b;&#x672f;&#x672f;&#x540e;&#x9547;&#x75db;&#x7684;&#x4e34;&#x5e8a;&#x7814;&#x7a76;.]. Sichan Medical Journal 2010;31(3):344&#x2010;6. [10.16252/j .cnki .issn1004&#x2010;0501&#x2010;2010.03.021]</Citation></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to studies excluded from this review</Title><ReferenceList><Title>Amat&#x2010;Santos 2012 {published data only}</Title><Reference><Citation>Amat&#x2010;Santos IJ, Dumont E, Villeneuve J, Doyle D, Rheault M, Lavigne D, et al. Effect of thoracic epidural analgesia on clinical outcomes following transapical transcatheter aortic valve implantation. Heart (British Cardiac Society) 2012;98(21):1583&#x2010;90. [DOI: 10.1136/heartjnl-2012-302185; PUBMED: 22791654]</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2012-302185</ArticleId><ArticleId IdType="pubmed">22791654</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Anderson 2005 {published data only}</Title><Reference><Citation>Anderson RE, Ehrenberg J, Barr G, Brismar K, Owall A, Alserius T, et al. Effects of thoracic epidural analgesia on glucose homeostasis after cardiac surgery in patients with and without diabetes mellitus. European Journal of Anaesthesiology 2005;22(7):524&#x2010;9. [PUBMED: 16045142]</Citation><ArticleIdList><ArticleId IdType="pubmed">16045142</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Casalino 2006 {published data only}</Title><Reference><Citation>Casalino S, Mangia F, Stelian E, Novelli E, Diena M, Tesler UF. High thoracic epidural anesthesia in cardiac surgery: risk factors for arterial hypotension. Texas Heart Institute Journal 2006;33(2):148&#x2010;53. [PUBMED: 16878616]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1524708</ArticleId><ArticleId IdType="pubmed">16878616</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Chae 1998 {published data only}</Title><Reference><Citation>Chae BK, Lee HW, Sun K, Choi YH, Kim HM. The effect of combined epidural and light general anesthesia on stress hormones in open heart surgery patients. Surgery Today 1998;28(7):727&#x2010;31. [PUBMED: 9697266]</Citation><ArticleIdList><ArticleId IdType="pubmed">9697266</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Chakravarthy 2005 {published data only}</Title><Reference><Citation>Chakravarthy M, Thimmangowda P, Krishnamurthy J, Nadiminti S, Jawali V. Thoracic epidural anesthesia in cardiac surgical patients: a prospective audit of 2113 cases. Journal of Cardiothoracic and Vascular Anesthesia 2005;19(1):44&#x2010;8. [PUBMED: 15747268]</Citation><ArticleIdList><ArticleId IdType="pubmed">15747268</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Crescenzi 2009 {published data only}</Title><Reference><Citation>Crescenzi G, Landoni G, Monaco F, Bignami E, Luca M, Frau G, et al. Epidural anesthesia in elderly patients undergoing coronary artery bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia 2009;23(6):807&#x2010;12. [PUBMED: 19376734]</Citation><ArticleIdList><ArticleId IdType="pubmed">19376734</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Djaiani 2000 {published data only}</Title><Reference><Citation>Djaiani G. Thoracic epidural anesthesia as an adjunct to general anesthesia for cardiac surgery: effects on ventilation&#x2010;perfusion relationships. Journal of Cardiothoracic and Vascular Anesthesia 2000;14(3):359&#x2010;60. [DOI: 10.1053/cr.2000.5816; PUBMED: 10890498]</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/cr.2000.5816</ArticleId><ArticleId IdType="pubmed">10890498</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>El&#x2010;Morsy 2012a {published data only}</Title><Reference><Citation>El&#x2010;Morsy GZ, El&#x2010;Deeb A, El&#x2010;Desouky T, Elsharkawy AA, Elgamal MA. Can thoracic paravertebral block replace thoracic epidural block in pediatric cardiac surgery? A randomized blinded study. Annals of Cardiac Anaesthesia 2012;15(4):259&#x2010;63. [DOI: 10.4103/0971-9784.101848; PUBMED: 23041682]</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0971-9784.101848</ArticleId><ArticleId IdType="pubmed">23041682</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Jideus 2001 {published data only}</Title><Reference><Citation>Jideus L, Joachimsson PE, Stridsberg M, Ericson M, Tyden H, Nilsson L, et al. Thoracic epidural anesthesia does not influence the occurrence of postoperative sustained atrial fibrillation. Annals of Thoracic Surgery 2001;72(1):65&#x2010;71. [PUBMED: 11465233]</Citation><ArticleIdList><ArticleId IdType="pubmed">11465233</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Joachimsson 1989 {published data only}</Title><Reference><Citation>Joachimsson PO, Nystrom SO, Tyden H. Early extubation after coronary artery surgery in efficiently rewarmed patients: a postoperative comparison of opioid anesthesia versus inhalational anesthesia and thoracic epidural analgesia. Journal of Cardiothoracic Anesthesia 1989;3(4):444&#x2010;54. [PUBMED: 2520917]</Citation><ArticleIdList><ArticleId IdType="pubmed">2520917</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kaunien&#x117; 2016 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Kaunien&#x117; A, Urbonait&#x117; A, Lenkutis T, &#x160;irvinskas E, &#x160;vag&#x17e;dien&#x117; M. Effects of combined anesthesia on kidney function after coronary artery bypass graft surgery with cardiopulmonary bypass [Kombinuotos anestezijos poveikis inkstu funkcijaipo vainkinu arteriju suntavimo, naudojant dirtinekraujo apytaka]. Biomedicine 2016;26(4):31&#x2010;4. [DOI: 10.5200/sm-hs.2016.054]</Citation><ArticleIdList><ArticleId IdType="doi">10.5200/sm-hs.2016.054</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kessler 2002 {published data only}</Title><Reference><Citation>Kessler P, Neidhart G, Lischke V, Bremerich DH, Aybek T, Dogan S, et al. Coronary bypass operation with complete median sternotomy in awake patients with high thoracic peridural anesthesia [Koronare bypassoperation mit kompletter medianer sternotomie am wachen patienten in hoher thorakaler periduralanasthesie]. Der Anaesthesist 2002;51(7):533&#x2010;8. [PUBMED: 12243038]</Citation><ArticleIdList><ArticleId IdType="pubmed">12243038</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kessler 2005 {published data only}</Title><Reference><Citation>Kessler P, Aybek T, Neidhart G, Dogan S, Lischke V, Bremerich DH, et al. Comparison of three anesthetic techniques for off&#x2010;pump coronary artery bypass grafting: general anesthesia, combined general and high thoracic epidural anesthesia, or high thoracic epidural anesthesia alone. Journal of Cardiothoracic and Vascular Anesthesia 2005;19(1):32&#x2010;9. [PUBMED: 15747266]</Citation><ArticleIdList><ArticleId IdType="pubmed">15747266</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kunstyr 2008 {published data only}</Title><Reference><Citation>Kunstyr J, Klein A, Lindner J, Rubes D, Blaha J, Jansa P, et al. Use of high&#x2010;thoracic epidural analgesia in pulmonary endarterectomy: a randomized feasibility study. Heart Surgery Forum 2008;11(4):E202&#x2010;8. [DOI: 10.1532/HSF98.2008i036; PUBMED: 18782697]</Citation><ArticleIdList><ArticleId IdType="doi">10.1532/HSF98.2008i036</ArticleId><ArticleId IdType="pubmed">18782697</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kurtoglu 2009 {published data only}</Title><Reference><Citation>Kurtoglu M, Ates S, Bakkaloglu B, Besbas S, Duvan I, Akdas H, et al. Epidural anesthesia versus general anesthesia in patients undergoing minimally invasive direct coronary artery bypass surgery. Anadolu Kardiyoloji Dergisi 2009;9(1):54&#x2010;8. [PUBMED: 19196575]</Citation><ArticleIdList><ArticleId IdType="pubmed">19196575</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lagunilla 2006 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Lagunilla J, Garcia&#x2010;Bengochea JB, Fernandez AL, Alvarez J, Rubio J, Rodriguez J, et al. High thoracic epidural blockade increases myocardial oxygen availability in coronary surgery patients. Acta Anaesthesiologica Scandinavica 2006;50(7):780&#x2010;6. [PUBMED: 16879458]</Citation><ArticleIdList><ArticleId IdType="pubmed">16879458</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Liang 2012 {published data only}</Title><Reference><Citation>Liang Y, Chu H, Zhen H, Wang S, Gu M. A prospective randomized study of intraoperative thoracic epidural analgesia in off&#x2010;pump coronary artery bypass surgery. Journal of Anesthesia 2012;26(3):393&#x2010;9. [DOI: 10.1007/s00540-012-1325-6; PUBMED: 22274169]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-012-1325-6</ArticleId><ArticleId IdType="pubmed">22274169</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Liem 1998 {published data only}</Title><Reference><Citation>Liem TH, Williams JP, Hensens AG, Singh SK. Minimally invasive direct coronary artery bypass procedure using a high thoracic epidural plus general anesthetic technique. Journal of Cardiothoracic and Vascular Anesthesia 1998;12(6):668&#x2010;72. [PUBMED: 9854665]</Citation><ArticleIdList><ArticleId IdType="pubmed">9854665</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Martinez 2012 {published data only}</Title><Reference><Citation>Martinez A, Oslaida M, Jimenez Paneque R, Cordero Escobar I, Cruz Bouza R, Cabrera Pratts A. Neuroaxial anesthesia methods combined with general anesthesia for beating heart surgery. British Journal of Anaesthesia. 2012; Vol. 108 (S2):ii215&#x2010;ii277. [DOI: 10.1093/bja/aer485]</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aer485</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Novikov 2011 {published data only}</Title><Reference><Citation>Novikov OV, Guleshov VA, Morozov UA, Komarov RN, Iavorovskij AG. Metabolic disorders as a result of intestine ischemia and its defensive factors due to aorta prosthetics and cross&#x2010;clamping of descending aorta before celiac trunk [&#x41c;&#x435;&#x442;&#x430;&#x431;&#x43e;&#x43b;&#x438;&#x447;&#x435;&#x441;&#x43a;&#x438;&#x435; &#x43d;&#x430;&#x440;&#x443;&#x448;&#x435;&#x43d;&#x438;&#x44f; &#x43a;&#x430;&#x43a; &#x440;&#x435;&#x437;&#x443;&#x43b;&#x44c;&#x442;&#x430;&#x442; &#x43f;&#x43e;&#x432;&#x440;&#x435;&#x436;&#x434;&#x435;&#x43d;&#x438;&#x44f; &#x43a;&#x438;&#x448;&#x435;&#x447;&#x43d;&#x438;&#x43a;&#x430; &#x438; &#x444;&#x430;&#x442;&#x43e;&#x440;&#x44b; &#x435;&#x433;&#x43e; &#x437;&#x430;&#x449;&#x438;&#x442;&#x44b; &#x43f;&#x440;&#x438; &#x43e;&#x43f;&#x435;&#x440;&#x430;&#x446;&#x438;&#x44f;&#x445; &#x43f;&#x440;&#x43e;&#x442;&#x435;&#x437;&#x438;&#x440;&#x43e;&#x44c;&#x430;&#x43d;&#x438;&#x44f; &#x430;&#x43e;&#x440;&#x442;&#x44b; &#x441; &#x443;&#x440;&#x43e;&#x432;&#x43d;&#x435;&#x43c; &#x43f;&#x435;&#x440;&#x435;&#x436;&#x430;&#x442;&#x438;&#x44f; &#x432;&#x44b;&#x448;&#x435; &#x447;&#x440;&#x435;&#x432;&#x43d;&#x43e;&#x433;&#x43e; &#x441;&#x442;&#x432;&#x43e;&#x43b;&#x430;]. Anesteziologiia i Reanimatologiia 2011;56(6):4&#x2010;7. [PUBMED: 22379904]</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Olivier 2005 {published data only}</Title><Reference><Citation>Olivier JF, Le N, Choini&#xe8;re JL, Prieto I, Basile F, Hemmerling T. Comparison of three different epidural solutions in off&#x2010;pump cardiac surgery: pilot study. British Journal of Anaesthesia 2005;95(5):685&#x2010;91. [PUBMED: 16183682]</Citation><ArticleIdList><ArticleId IdType="pubmed">16183682</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Orsolya 2015 {published data only}</Title><Reference><Citation>Orsolya M, Attila&#x2010;Zoltan M, Gherman V, Zaharie F, Bolboaca S, Chira C, et al. The effect of anaesthetic management on neutrophil gelatinase associated lipocalin (NGAL) levels after robotic surgical oncology. Journal of B.U.ON. 2015;20(1):317&#x2010;24. [PUBMED: 25778333]</Citation><ArticleIdList><ArticleId IdType="pubmed">25778333</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ortega 2011 {published data only}</Title><Reference><Citation>Ortega RH, Alfonso OG, Men&#xe9;ndez PA, Font IM, Rodr&#xed;guez JM, Mart&#xed;nez JM, et al. Postoperative analgesic efficacy of epidural morphine in myocardial bypass surgery [Efficacia analgesica postoperatoria de la morfina epidural en la cirurgia de revascularizacion miocardica]. Corsalud 2011;3(1):15&#x2010;25.</Citation></Reference></ReferenceList><ReferenceList><Title>Ovezov 2011 {published data only}</Title><Reference><Citation>Obezov &#x410;&#x41c;, &#x41a;im SU, Danilin &#x410;&#x41c;, Prokoshev &#x420;V, Charenco DV. Combined inhalation and epidural anaesthesia, during aortocoronary bypass surgery on beating heart [&#x421;&#x43e;&#x447;&#x435;&#x442;&#x430;&#x43d;&#x43d;&#x430;&#x44f; &#x438;&#x43d;&#x433;&#x430;&#x43b;&#x44f;&#x446;&#x438;&#x43e;&#x43d;&#x43d;&#x43e;&#x2010;&#x44d;&#x43f;&#x438;&#x434;&#x443;&#x440;&#x430;&#x43b;&#x44c;&#x43d;&#x430;&#x44f; &#x430;&#x43d;&#x441;&#x442;&#x435;&#x437;&#x438;&#x44f; &#x43f;&#x440;&#x438; &#x43f;&#x440;&#x44f;&#x43c;&#x43e;&#x439; &#x440;&#x435;&#x432;&#x430;&#x441;&#x43a;&#x43b;&#x44f;&#x440;&#x438;&#x437;&#x446;&#x438;&#x438; &#x43c;&#x438;&#x43e;&#x43a;&#x430;&#x440;&#x434;&#x430; &#x43d;&#x430; &#x440;&#x430;&#x431;&#x43e;&#x442;&#x430;&#x44e;&#x449;&#x435;&#x43c; &#x441;&#x435;&#x440;&#x434;&#x446;&#x435;]. Anesteziologiia i Reanimatologiia 2011;54(6):8&#x2010;12. [PUBMED: 22379905]</Citation><ArticleIdList><ArticleId IdType="pubmed">22379905</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rao 2016 {published data only}</Title><Reference><Citation>Rao TR, Dal A, Dronumraju A, Kumar KK, J Ibrahim J. Coronary artery bypass surgery in "awake" patient: a prospective study. International Journal of Scientific Study 2016;3(10):18&#x2010;22. [DOI: 10.17354/ijss/2016/04]</Citation><ArticleIdList><ArticleId IdType="doi">10.17354/ijss/2016/04</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Salman 2012 {published data only}</Title><Reference><Citation>Salman N, Serter FT, U&#xe7;ar HI, G&#xfc;naydin S, Yorgancio&#x11f;lu AC. Comparison between intravenous and thoracic epidural analgesia in single coronary artery bypass graft surgery. Turkish Journal of Medical Sciences 2012;42(4):581&#x2010;9. [DOI: 10.3906/sag-1107-9]</Citation><ArticleIdList><ArticleId IdType="doi">10.3906/sag-1107-9</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Salvi 2004 {published data only}</Title><Reference><Citation>Salvi L, Sisillo E, Brambillasca C, Juliano G, Salis S, Marino MR. High thoracic epidural anesthesia for off&#x2010;pump coronary artery bypass surgery. Journal of Cardiothoracic and Vascular Anesthesia 2004;18(3):256&#x2010;62. [PUBMED: 15232802]</Citation><ArticleIdList><ArticleId IdType="pubmed">15232802</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Schmidt 2005 {published data only}</Title><Reference><Citation>Schmidt C, Hinder F, Aken H, Theilmeier G, Bruch C, Wirtz SP, et al. The effect of high thoracic epidural anesthesia on systolic and diastolic left ventricular function in patients with coronary artery disease. Anesthesia and Analgesia 2005;100(6):1561&#x2010;9. [DOI: 10.1213/01.ANE.0000154963.29271.36; PUBMED: 15920175]</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ANE.0000154963.29271.36</ArticleId><ArticleId IdType="pubmed">15920175</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Stenger 2013 {published data only}</Title><Reference><Citation>Stenger M, Fabrin A, Schmidt H, Greisen J, Erik Mortensen P, Jakobsen CJ. High thoracic epidural analgesia as an adjunct to general anesthesia is associated with better outcome in low&#x2010;to&#x2010;moderate risk cardiac surgery patients. Journal of Cardiothoracic and Vascular Anesthesia 2013;27(6):1301&#x2010;9. [DOI: 10.1053/j.jvca.2012.12.001; PUBMED: 23906858]</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2012.12.001</ArticleId><ArticleId IdType="pubmed">23906858</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Stenseth 1993 {published data only}</Title><Reference><Citation>Stenseth R, Berg EM, Bjella L, Christensen O, Levang OW, Gisvold SE. The influence of thoracic epidural analgesia alone and in combination with general anesthesia on cardiovascular function and myocardial metabolism in patients receiving beta&#x2010;adrenergic blockers. Anesthesia and Analgesia 1993;77(3):463&#x2010;8. [PUBMED: 8103648]</Citation><ArticleIdList><ArticleId IdType="pubmed">8103648</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Thorelius 1996 {published data only}</Title><Reference><Citation>Thorelius J, Ekroth R, Hallhagen S, et al. Thoracolumbar epidural blockade as adjunct to high dose fentanyl/midazolam anesthesia in coronary surgery: effects of sternotomy. European Journal of Cardiothoracic Surgery 1996;10:754&#x2010;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">8905278</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Thorelius 1997 {published data only}</Title><Reference><Citation>Thorelius J. Neuroendocrine blockade in coronary surgery. A clinical study with reference to myocardial metabolism and performance. Scandinavian Cardiovascular Journal 1997;31(3):185. [DOI: 10.3109/14017439709058093; PUBMED: 9264171]</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/14017439709058093</ArticleId><ArticleId IdType="pubmed">9264171</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Toda 2013 {published data only}</Title><Reference><Citation>Toda A, Watanabe G, Matsumoto I, Tomita S, Yamaguchi S, Ohtake H. Monitoring brain oxygen saturation during awake off&#x2010;pump coronary artery bypass. Asian Cardiovascular and Thoracic Annals 2013;21(1):14&#x2010;21. [DOI: 10.1177/0218492312444908; PUBMED: 23430415]</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0218492312444908</ArticleId><ArticleId IdType="pubmed">23430415</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Turfrey 1997 {published data only}</Title><Reference><Citation>Turfrey DJ, Ray DA, Sutcliffe NP, Ramayya P, Kenny GN, Scott NB. Thoracic epidural anaesthesia for coronary artery bypass graft surgery. Effects on postoperative complications. Anaesthesia 1997;52(11):1090&#x2010;5. [PUBMED: 9404174]</Citation><ArticleIdList><ArticleId IdType="pubmed">9404174</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Yashiki 2005 {published data only}</Title><Reference><Citation>Yashiki N, Watanabe G, Tomita S, Nishida S, Yasuda T, Arai S. Thoracic epidural anesthesia for coronary bypass surgery affects autonomic neural function and arrhythmias. Innovations (Philadelphia, Pa.) 2005;1(2):83&#x2010;7. [DOI: 10.1097/01.gim.0000198517.54063.74; PUBMED: 22436549]</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.gim.0000198517.54063.74</ArticleId><ArticleId IdType="pubmed">22436549</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to ongoing studies</Title><ReferenceList><Title>CTRI/2012/04/002608 {published data only}</Title><Reference><Citation>Prakash B. Non&#x2010;analgesic benefits of combined thoracic epidural analgesia in elderly off&#x2010;pump coronary artery bypass grafting patients. World Health Organization Clinical Trials Registry Platform. date first received 27 April 2012. [CTRI/2012/04/002608]</Citation></Reference></ReferenceList><ReferenceList><Title>CTRI/2018/05/013902 {published data only}</Title><Reference><Citation>Sen C. A study of central and mixed venous oxygen saturation with outcomes in open heart surgery patients between two groups: conventional general anaesthesia and combined with perioperative thoracic epidural or intravenous analgesia. World Health Organization Clinical Trials Registry Platform. date first received 15 May 2018. [CTRI/2018/05/013902]</Citation></Reference></ReferenceList><ReferenceList><Title>NCT03719248 {published data only}</Title><Reference><Citation>Elgebaly AS. Thoracic epidural reduces risks of increased left ventricular mass index during coronary artery bypass graft surgery. World Health Organization Clinical Trials Registry Platform. Accessed 25 October 2018. [NCT03719248]</Citation></Reference></ReferenceList></ReferenceList><ReferenceList><Title>Additional references</Title><ReferenceList><Title>Barbosa 2016</Title><Reference><Citation>Barbosa FT, Cunha RM, Silva Ramos FW, Lima FJ, Rodrigues AK, do Nascimento Galvao AM, et al. Effectiveness of combined regional&#x2010;general anesthesia for reducing mortality in coronary artery bypass: meta&#x2010;analysis. Brazilian Journal of Anesthesiology 2016;66(2):183&#x2010;93. [PUBMED: 26952228]</Citation><ArticleIdList><ArticleId IdType="pubmed">26952228</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Borenstein 2009</Title><Reference><Citation>Borenstein M, Hedges LV, Higgins JP, Rothstein HR. Publication bias. In: Borenstein M, Hedges LV, Higgins JPT, Rothstein HR editor(s). Introduction to Meta&#x2010;Analysis. 1st Edition. Chichester, UK: Wiley, 2009:277&#x2010;92.</Citation></Reference></ReferenceList><ReferenceList><Title>Bos 2018</Title><Reference><Citation>Bos EM, Haumann J, Quelerij M, Vandertop WP, Kalkman CJ, Hollmann MW, et al. Haematoma and abscess after neuraxial anaesthesia: a review of 647 cases. British Journal of Anaesthesia 2018;120(4):693&#x2010;704. [PUBMED: 29576110]</Citation><ArticleIdList><ArticleId IdType="pubmed">29576110</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Brant 2017</Title><Reference><Citation>Brant R. Sample size calculator. www.stat.ubc.ca/&#x2dc;rollin/stats/ssize/index.html. Accessed March 2018.</Citation></Reference></ReferenceList><ReferenceList><Title>Cates 2016</Title><Reference><Citation>Cates C. Visual Rx Version 4. www.nntonline.net/visualrx. Accessed March 2018.</Citation></Reference></ReferenceList><ReferenceList><Title>Chaney 1997</Title><Reference><Citation>Chaney MA. Intrathecal and epidural anesthesia and analgesia for cardiac surgery. Anesthesia and Analgesia 1997;84(6):1211&#x2010;21. [PUBMED: 9174295]</Citation><ArticleIdList><ArticleId IdType="pubmed">9174295</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Choi 2009</Title><Reference><Citation>Choi PT, Beattie WS, Bryson GL, Paul JE, Yang H. Effects of neuraxial blockade may be difficult to study using large randomized controlled trials: the PeriOperative Epidural Trial (POET) Pilot Study. Plos One 2009;4(2):e4644. [PUBMED: 19247497]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2645707</ArticleId><ArticleId IdType="pubmed">19247497</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Comprehensive Meta&#x2010;Analysis 2007 [Computer program]</Title><Reference><Citation>Meta&#x2010;Analysis.com. Comprehensive Meta&#x2010;Analysis. Version 2.2.044 for Windows.. 2007.</Citation></Reference></ReferenceList><ReferenceList><Title>De Oliveira 2012</Title><Reference><Citation>Oliveira GS Jr, Knautz JS, Sherwani S, McCarthy RJ. Systemic magnesium to reduce postoperative arrhythmias after coronary artery bypass graft surgery: a meta&#x2010;analysis of randomized controlled trials. Journal of Cardiothoracic and Vascular Anesthesia 2012;26(4):643&#x2010;50. [PUBMED: 22560953]</Citation><ArticleIdList><ArticleId IdType="pubmed">22560953</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Deeks 2002</Title><Reference><Citation>Deeks JJ. Issues in the selection of a summary statistic for meta&#x2010;analysis of clinical trials with binary outcomes. Statistics in Medicine 2002;21(11):1575&#x2010;600. [PUBMED: 12111921]</Citation><ArticleIdList><ArticleId IdType="pubmed">12111921</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Duval 2000a</Title><Reference><Citation>Duval S, Tweedie R. Trim and fill: a simple funnel&#x2010;plot&#x2010;based method of testing and adjusting for publication bias in meta&#x2010;analysis. Biometrics 2000;56(2):455&#x2010;63. [PUBMED: 10877304]</Citation><ArticleIdList><ArticleId IdType="pubmed">10877304</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Duval 2000b</Title><Reference><Citation>Duval S, Tweedie R. A non parametric &#x2019;trim and fill&#x2019; method accounting for publication bias in meta&#x2010;analysis. Journal of the American Statistical Association 2000;95:89&#x2010;98.</Citation></Reference></ReferenceList><ReferenceList><Title>El&#x2010;Baz 1984</Title><Reference><Citation>El&#x2010;Baz NM, Faber LP, Jensik RJ. Continuous epidural infusion of morphine for treatment of pain after thoracic surgery: a new technique. Anesthesia and Analgesia 1984;63(8):757&#x2010;64. [PUBMED: 6465562]</Citation><ArticleIdList><ArticleId IdType="pubmed">6465562</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>GRADEpro GDT [Computer program]</Title><Reference><Citation>McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed August 2017. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015.</Citation></Reference></ReferenceList><ReferenceList><Title>Guay 2006</Title><Reference><Citation>Guay J. The benefits of adding epidural analgesia to general anesthesia: a metaanalysis. Journal of Anesthesia 2006;20(4):335&#x2010;40. [PUBMED: 17072704]</Citation><ArticleIdList><ArticleId IdType="pubmed">17072704</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Guay 2014</Title><Reference><Citation>Guay J, Choi P, Suresh S, Albert N, Kopp S, Pace NL. Neuraxial blockade for the prevention of postoperative mortality and major morbidity: an overview of Cochrane systematic reviews. Cochrane Database of Systematic Reviews 2014, Issue 1. [DOI: 10.1002/14651858.CD010108.pub2; PUBMED: 24464831]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD010108.pub2</ArticleId><ArticleId IdType="pmc">PMC7087466</ArticleId><ArticleId IdType="pubmed">24464831</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Guay 2016a</Title><Reference><Citation>Guay J, Nishimori M, Kopp S. Epidural local anaesthetics versus opioid&#x2010;based analgesic regimens for postoperative gastrointestinal paralysis, vomiting and pain after abdominal surgery. Cochrane Database of Systematic Reviews 2016, Issue 7. [DOI: 10.1002/14651858.CD001893.pub2; PUBMED: 27419911]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD001893.pub2</ArticleId><ArticleId IdType="pmc">PMC6457860</ArticleId><ArticleId IdType="pubmed">27419911</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Guay 2016b</Title><Reference><Citation>Guay J, Kopp S. Epidural pain relief versus systemic opioid&#x2010;based pain relief for abdominal aortic surgery. Cochrane Database of Systematic Reviews 2016, Issue 1. [DOI: 10.1002/14651858.CD005059.pub4; PUBMED: 26731032]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD005059.pub4</ArticleId><ArticleId IdType="pmc">PMC6464571</ArticleId><ArticleId IdType="pubmed">26731032</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Healthcare Improvement Scotland Committee 2018</Title><Reference><Citation>Healthcare Improvement Scotland Committee. Cardiac arrhythmias in coronary heart disease: a national guideline. Available at https://www.sign.ac.uk/assets/sign152.pdf. 2018 September: 1&#x2010;69.</Citation></Reference></ReferenceList><ReferenceList><Title>Higgins 2003</Title><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta&#x2010;analyses. BMJ (Clinical research ed.) 2003;327(7414):557&#x2010;60. [PUBMED: 12958120]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Higgins 2011a</Title><Reference><Citation>Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.</Citation></Reference></ReferenceList><ReferenceList><Title>Higgins 2011b</Title><Reference><Citation>Sch&#xfc;nemann HJ, Oxman AD, Vist GE, Higgins JP, Deeks JJ, Glaziou P, et al. Chapter 12. Interpreting results and drawing conclusions. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.</Citation></Reference></ReferenceList><ReferenceList><Title>Horlocker 2018</Title><Reference><Citation>Horlocker TT, Vandermeuelen E, Kopp SL, Gogarten W, Leffert LR, Benzon HT. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence&#x2010;Based Guidelines (Fourth Edition). Regional Anesthesia and Pain Medicine 2018;43(3):263&#x2010;309. [PUBMED: 29561531]</Citation><ArticleIdList><ArticleId IdType="pubmed">29561531</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kowalewski 2016</Title><Reference><Citation>Kowalewski M, Pawliszak W, Malvindi PG, Bokszanski MP, Perlinski D, Raffa GM, et al. Off&#x2010;pump coronary artery bypass grafting improves short&#x2010;term outcomes in high&#x2010;risk patients compared with on&#x2010;pump coronary artery bypass grafting: meta&#x2010;analysis. Journal of Thoracic and Cardiovascular Surgery 2016;151(1):60&#x2010;77.e1&#x2010;58. [PUBMED: 26433633]</Citation><ArticleIdList><ArticleId IdType="pubmed">26433633</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Landoni 2015</Title><Reference><Citation>Landoni G, Isella F, Greco M, Zangrillo A, Royse CF. Benefits and risks of epidural analgesia in cardiac surgery. British Journal of Anaesthesia 2015;115(1):25&#x2010;32. [PUBMED: 26089444]</Citation><ArticleIdList><ArticleId IdType="pubmed">26089444</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>McColl 1998</Title><Reference><Citation>McColl A, Smith H, White P, Field J. General practitioner's perceptions of the route to evidence based medicine: a questionnaire survey. BMJ 1998;316(7128):361&#x2010;5. [PUBMED: 9487174]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2665572</ArticleId><ArticleId IdType="pubmed">9487174</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Moen 2004</Title><Reference><Citation>Moen V, Dahlgren N, Irestedt L. Severe neurological complications after central neuraxial blockades in Sweden 1990&#x2010;1999. Anesthesiology 2004;101(4):950&#x2010;9. [PUBMED: 15448529]</Citation><ArticleIdList><ArticleId IdType="pubmed">15448529</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Moher 2009</Title><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta&#x2010;analyses: the PRISMA statement. BMJ (Clinical research ed.) 2009;339:b2535. [PUBMED: 19622551]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2714657</ArticleId><ArticleId IdType="pubmed">19622551</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Pace 2011</Title><Reference><Citation>Pace NL. Research methods for meta&#x2010;analyses. Best Practice and Research. Clinical Anaesthesiology 2011;25(4):523&#x2010;33. [PUBMED: 22099918]</Citation><ArticleIdList><ArticleId IdType="pubmed">22099918</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Pogue 1998</Title><Reference><Citation>Pogue J, Yusuf S. Overcoming the limitations of current meta&#x2010;analysis of randomised controlled trials. Lancet (London, England) 1998;351(9095):47&#x2010;52. [PUBMED: 9433436]</Citation><ArticleIdList><ArticleId IdType="pubmed">9433436</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Review Manager 2014 [Computer program]</Title><Reference><Citation>Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.</Citation></Reference></ReferenceList><ReferenceList><Title>Salicath 2018</Title><Reference><Citation>Salicath JH, Yeoh EC, Bennett MH. Epidural analgesia versus patient&#x2010;controlled intravenous analgesia for pain following intra&#x2010;abdominal surgery in adults. Cochrane Database of Systematic Reviews 2018, Issue 8. [DOI: 10.1002/14651858.CD010434.pub2; PUBMED: 30161292]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD010434.pub2</ArticleId><ArticleId IdType="pmc">PMC6513588</ArticleId><ArticleId IdType="pubmed">30161292</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sch&#xfc;nemann 2013</Title><Reference><Citation>Sch&#xfc;nemann H, Bro&#x17c;ek J, Guyatt G, Oxman A. Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. Grading of Recommendations, Assessment, Development and Evaluation (GRADE) Working Group 2013. https://gdt.gradepro.org/app/handbook/handbook.html#h.svwngs6pm0f2, 2013.</Citation></Reference></ReferenceList><ReferenceList><Title>Thomas 1999</Title><Reference><Citation>Thomas PW, Sanders DJ, Berrisford RG. Pulmonary haemorrhage after percutaneous paravertebral block. British Journal of Anaesthesia 1999;83(4):668&#x2010;9. [PUBMED: 10673891]</Citation><ArticleIdList><ArticleId IdType="pubmed">10673891</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Tsui 2018</Title><Reference><Citation>Tsui BCH, Navaratnam M, Boltz G, Maeda K, Caruso TJ. Bilateral automatized intermittent bolus erector spinae plane analgesic blocks for sternotomy in a cardiac patient who underwent cardiopulmonary bypass: a new era of cardiac regional anesthesia. Journal of Clinical Anesthesia 2018; Vol. 48:9&#x2010;10. [PUBMED: 29684728]</Citation><ArticleIdList><ArticleId IdType="pubmed">29684728</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ueshima 2018</Title><Reference><Citation>Ueshima H. Pneumothorax after the erector spinae plane block. Journal of Clinical Anesthesia 2018; Vol. 48:12. [PUBMED: 29684727]</Citation><ArticleIdList><ArticleId IdType="pubmed">29684727</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zhang 2015</Title><Reference><Citation>Zhang S, Wu X, Guo H, Ma L. Thoracic epidural anesthesia improves outcomes in patients undergoing cardiac surgery: meta&#x2010;analysis of randomized controlled trials. European Journal of Medical Research 2015;20:25. [PUBMED: 25888937]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4375848</ArticleId><ArticleId IdType="pubmed">25888937</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to other published versions of this review</Title><ReferenceList><Title>Svircevic 2007</Title><Reference><Citation>Svircevic V, Passier M, Nierich AP, Kalkman CJ, Dijk D, Heijden G, et al. Epidural analgesia for cardiac surgery. Cochrane Database of Systematic Reviews 2007, Issue 3. [DOI: 10.1002/14651858.CD006715]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD006715</ArticleId><ArticleId IdType="pubmed">23740694</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Svircevic 2013</Title><Reference><Citation>Svircevic V, Passier MM, Nierich AP, Dijk D, Kalkman CJ, Heijden GJ. Epidural analgesia for cardiac surgery. Cochrane Database of Systematic Reviews 2013, Issue 6. [DOI: 10.1002/14651858.CD006715.pub2]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD006715.pub2</ArticleId><ArticleId IdType="pubmed">23740694</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25233038</PMID><DateCompleted><Year>2015</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-493X</ISSN><JournalIssue CitedMedium="Internet"><Issue>9</Issue><PubDate><Year>2014</Year><Month>Sep</Month><Day>18</Day></PubDate></JournalIssue><Title>The Cochrane database of systematic reviews</Title><ISOAbbreviation>Cochrane Database Syst Rev</ISOAbbreviation></Journal><ArticleTitle>Perioperative beta-blockers for preventing surgery-related mortality and morbidity.</ArticleTitle><Pagination><StartPage>CD004476</StartPage><MedlinePgn>CD004476</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/14651858.CD004476.pub2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Randomized controlled trials have yielded conflicting results regarding the ability of beta-blockers to influence perioperative cardiovascular morbidity and mortality. Thus routine prescription of these drugs in unselected patients remains a controversial issue.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The objective of this review was to systematically analyse the effects of perioperatively administered beta-blockers for prevention of surgery-related mortality and morbidity in patients undergoing any type of surgery while under general anaesthesia.</AbstractText><AbstractText Label="SEARCH METHODS" NlmCategory="METHODS">We identified trials by searching the following databases from the date of their inception until June 2013: MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials (CENTRAL), Biosis Previews, CAB Abstracts, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Derwent Drug File, Science Citation Index Expanded, Life Sciences Collection, Global Health and PASCAL. In addition, we searched online resources to identify grey literature.</AbstractText><AbstractText Label="SELECTION CRITERIA" NlmCategory="METHODS">We included randomized controlled trials if participants were randomly assigned to a beta-blocker group or a control group (standard care or placebo). Surgery (any type) had to be performed with all or at least a significant proportion of participants under general anaesthesia.</AbstractText><AbstractText Label="DATA COLLECTION AND ANALYSIS" NlmCategory="METHODS">Two review authors independently extracted data from all studies. In cases of disagreement, we reassessed the respective studies to reach consensus. We computed summary estimates in the absence of significant clinical heterogeneity. Risk ratios (RRs) were used for dichotomous outcomes, and mean differences (MDs) were used for continuous outcomes. We performed subgroup analyses for various potential effect modifiers.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">We included 89 randomized controlled trials with 19,211 participants. Six studies (7%) met the highest methodological quality criteria (studies with overall low risk of bias: adequate sequence generation, adequate allocation concealment, double/triple-blinded design with a placebo group, intention-to-treat analysis), whereas in the remaining trials, some form of bias was present or could not be definitively excluded (studies with overall unclear or high risk of bias). Outcomes were evaluated separately for cardiac and non-cardiac surgery. CARDIAC SURGERY (53 trials)We found no clear evidence of an effect of beta-blockers on the following outcomes.&#x2022; All-cause mortality: RR 0.73, 95% CI 0.35 to 1.52, 3783 participants, moderate quality of evidence.&#x2022; Acute myocardial infarction (AMI): RR 1.04, 95% CI 0.71 to 1.51, 3553 participants, moderate quality of evidence.&#x2022; Myocardial ischaemia: RR 0.51, 95% CI 0.25 to 1.05, 166 participants, low quality of evidence.&#x2022; Cerebrovascular events: RR 1.52, 95% CI 0.58 to 4.02, 1400 participants, low quality of evidence.&#x2022; Hypotension: RR 1.54, 95% CI 0.67 to 3.51, 558 participants, low quality of evidence.&#x2022; Bradycardia: RR 1.61, 95% CI 0.97 to 2.66, 660 participants, low quality of evidence.&#x2022; Congestive heart failure: RR 0.22, 95% CI 0.04 to 1.34, 311 participants, low quality of evidence.Beta-blockers significantly reduced the occurrence of the following endpoints.&#x2022; Ventricular arrhythmias: RR 0.37, 95% CI 0.24 to 0.58, number needed to treat for an additional beneficial outcome (NNTB) 29, 2292 participants, moderate quality of evidence.&#x2022; Supraventricular arrhythmias: RR 0.44, 95% CI 0.36 to 0.53, NNTB six, 6420 participants, high quality of evidence.&#x2022; On average, beta-blockers reduced length of hospital stay by 0.54 days (95% CI -0.90 to -0.19, 2450 participants, low quality of evidence). NON-CARDIAC SURGERY (36 trials)We found a potential increase in the occurrence of the following outcomes with the use of beta-blockers.&#x2022; All-cause mortality: RR 1.24, 95% CI 0.99 to 1.54, 11,463 participants, low quality of evidence.Whereas no clear evidence of an effect was noted when all studies were analysed, restricting the meta-analysis to low risk of bias studies revealed a significant increase in all-cause mortality with the use of beta-blockers: RR 1.27, 95% CI 1.01 to 1.59, number needed to treat for an additional harmful outcome (NNTH) 189, 10,845 participants.&#x2022; Cerebrovascular events: RR 1.59, 95% CI 0.93 to 2.71, 9150 participants, low quality of evidence.Whereas no clear evidence of an effect was found when all studies were analysed, restricting the meta-analysis to low risk of bias studies revealed a significant increase in cerebrovascular events with the use of beta-blockers: RR 2.09, 95% CI 1.14 to 3.82, NNTH 255, 8648 participants.Beta-blockers significantly reduced the occurrence of the following endpoints.&#x2022; AMI: RR 0.73, 95% CI 0.61 to 0.87, NNTB 72, 10,958 participants, high quality of evidence.&#x2022; Myocardial ischaemia: RR 0.43, 95% CI 0.27 to 0.70, NNTB seven, 1028 participants, moderate quality of evidence.&#x2022; Supraventricular arrhythmias: RR 0.72, 95% CI 0.56 to 0.92, NNTB 111, 8794 participants, high quality of evidence.Beta-blockers significantly increased the occurrence of the following adverse events.&#x2022; Hypotension: RR 1.50, 95% CI 1.38 to 1.64, NNTH 15, 10,947 participants, high quality of evidence.&#x2022; Bradycardia: RR 2.24, 95% CI 1.49 to 3.35, NNTH 18, 11,083 participants, moderate quality of evidence.We found no clear evidence of an effect of beta-blockers on the following outcomes.&#x2022; Ventricular arrhythmias: RR 0.64, 95% CI 0.30 to 1.33, 526 participants, moderate quality of evidence.&#x2022; Congestive heart failure: RR 1.17, 95% CI 0.93 to 1.47, 9223 participants, moderate quality of evidence.&#x2022; Length of hospital stay: mean difference -0.27 days, 95% CI -1.29 to 0.75, 601 participants, low quality of evidence.</AbstractText><AbstractText Label="AUTHORS' CONCLUSIONS" NlmCategory="CONCLUSIONS">According to our findings, perioperative application of beta-blockers still plays a pivotal role in cardiac surgery , as they can substantially reduce the high burden of supraventricular and ventricular arrhythmias in the aftermath of surgery. Their influence on mortality, AMI, stroke, congestive heart failure, hypotension and bradycardia in this setting remains unclear.In non-cardiac surgery, evidence from low risk of bias trials shows an increase in all-cause mortality and stroke with the use of beta-blockers. As the quality of evidence is still low to moderate, more evidence is needed before a definitive conclusion can be drawn. The substantial reduction in supraventricular arrhythmias and AMI in this setting seems to be offset by the potential increase in mortality and stroke.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Blessberger</LastName><ForeName>Hermann</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine I - Cardiology, Linz General Hospital (Allgemeines Krankenhaus Linz) Johannes Kepler University School of Medicine, Krankenhausstra&#xdf;e 9, Linz, Austria, 4020.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kammler</LastName><ForeName>Juergen</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Domanovits</LastName><ForeName>Hans</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Schlager</LastName><ForeName>Oliver</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Wildner</LastName><ForeName>Brigitte</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Azar</LastName><ForeName>Danyel</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Schillinger</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Wiesbauer</LastName><ForeName>Franz</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Steinwender</LastName><ForeName>Clemens</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>09</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cochrane Database Syst Rev</MedlineTA><NlmUniqueID>100909747</NlmUniqueID><ISSNLinking>1361-6137</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000319">Adrenergic beta-Antagonists</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Dtsch Med Wochenschr. 2015 Jan;140(2):85. doi: 10.1055/s-0040-100501.</RefSource><PMID Version="1">25612277</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2015 May 26;313(20):2070-1. doi: 10.1001/jama.2015.1883.</RefSource><PMID Version="1">26010637</PMID></CommentsCorrections><CommentsCorrections RefType="UpdateIn"><RefSource>Cochrane Database Syst Rev. 2018 Mar 13;3:CD004476. doi: 10.1002/14651858.CD004476.pub3.</RefSource><PMID Version="1">29533470</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000319" MajorTopicYN="N">Adrenergic beta-Antagonists</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="N">Arrhythmias, Cardiac</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013504" MajorTopicYN="N">Cardiovascular Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002423" MajorTopicYN="N">Cause of Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002561" MajorTopicYN="N">Cerebrovascular Disorders</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017202" MajorTopicYN="N">Myocardial Ischemia</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>10</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25233038</ArticleId><ArticleId IdType="doi">10.1002/14651858.CD004476.pub2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30062736</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>09</Day></DateCompleted><DateRevised><Year>2019</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2044</ISSN><JournalIssue CitedMedium="Internet"><Volume>73</Volume><Issue>10</Issue><PubDate><Year>2018</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Anaesthesia</Title><ISOAbbreviation>Anaesthesia</ISOAbbreviation></Journal><ArticleTitle>Meta-analysis and trial sequential analysis of local vs. general anaesthesia for carotid endarterectomy.</ArticleTitle><Pagination><StartPage>1280</StartPage><EndPage>1289</EndPage><MedlinePgn>1280-1289</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/anae.14320</ELocationID><Abstract><AbstractText>Controversy exists regarding the best choice of anaesthesia for carotid endarterectomy. We aimed to evaluate the peri-operative outcomes of local vs. general anaesthesia for carotid endarterectomy. We conducted a systematic search of electronic information sources and applied a combination of free text and controlled vocabulary searches adapted to thesaurus headings, search operators and limits in each of the electronic databases. We defined peri-operative stroke, transient ischaemic attack, mortality and myocardial infarction as the primary outcome measures. We identified 12 randomised controlled trials and 21 observational studies reporting a total of 58,212 patients undergoing carotid endarterectomy under local or general anaesthesia. Analysis of observational studies demonstrated that local anaesthesia was associated with a significantly lower incidence of stroke (odds ratio (OR (95% CI) 0.66 (0.55-0.80), p&#xa0;&lt;&#xa0;0.0001), transient ischaemic attack (0.52 (0.38-0.70), p&#xa0;&lt;&#xa0;0.0001), myocardial infarction (0.55 (0.41-0.75), p&#xa0;=&#xa0;0.0002) and mortality (0.72 (0.56-0.94), p&#xa0;=&#xa0;0.01) compared with general anaesthesia. Analysis of randomised controlled trials did not find a significant difference in the risk of stroke (0.92 (0.67-1.28), p&#xa0;=&#xa0;0.63), transient ischaemic attack (2.20 (0.48-10.03), p&#xa0;=&#xa0;0.31), myocardial infarction (1.25 (0.57-2.72), p&#xa0;=&#xa0;0.58) or mortality (0.61 (0.35-1.05), p&#xa0;=&#xa0;0.07) between local and general anaesthesia. On trial sequential analysis of the randomised trials, the Z-curve did not cross the &#x3b1;-spending boundaries or futility boundaries for stroke, mortality and transient ischaemic attack, suggesting that more trials are needed to reach conclusive results. Our meta-analysis of observational studies suggests that local anaesthesia for carotid endarterectomy may be associated with lower peri-operative morbidity and mortality compared with general anaesthesia. Although randomised studies have not confirmed any advantage for local anaesthesia, this may be due to a lack of pooled statistical power in these trials.</AbstractText><CopyrightInformation>&#xa9; 2018 Association of Anaesthetists.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hajibandeh</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Stepping Hill Hospital, Stockport, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hajibandeh</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Royal Bolton Hospital, Bolton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antoniou</LastName><ForeName>S A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of General Surgery, University Hospital of Heraklion, University of Crete, Heraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torella</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Liverpool Vascular and Endovascular Service, Royal Liverpool University Hospital, Liverpool, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Physical Sciences, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antoniou</LastName><ForeName>G A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Department of Vascular and Endovascular Surgery, The Royal Oldham Hospital, Pennine Acute Hospitals NHS Trust, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Honorary Senior Lecturer, Division of Cardiovascular Sciences, School of Medical Sciences, University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>07</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Anaesthesia</MedlineTA><NlmUniqueID>0370524</NlmUniqueID><ISSNLinking>0003-2409</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000772" MajorTopicYN="N">Anesthesia, Local</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016893" MajorTopicYN="N">Carotid Stenosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016894" MajorTopicYN="N">Endarterectomy, Carotid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="N">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">carotid endarterectomy</Keyword><Keyword MajorTopicYN="N">general anaesthesia</Keyword><Keyword MajorTopicYN="N">local anaesthesia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30062736</ArticleId><ArticleId IdType="doi">10.1111/anae.14320</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30458156</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>17</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-6259</ISSN><JournalIssue CitedMedium="Internet"><Volume>107</Volume><Issue>4</Issue><PubDate><Year>2019</Year><Month>Apr</Month></PubDate></JournalIssue><Title>The Annals of thoracic surgery</Title><ISOAbbreviation>Ann Thorac Surg</ISOAbbreviation></Journal><ArticleTitle>Prothrombin Complex Concentrate in Cardiac Surgery: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>1275</StartPage><EndPage>1283</EndPage><MedlinePgn>1275-1283</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.athoracsur.2018.10.013</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0003-4975(18)31661-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">Prothrombin complex concentrate (PCC) has recently emerged as an effective alternative to fresh frozen plasma (FFP) in treating excessive perioperative bleeding. This systematic review and meta-analysis evaluated the safety and efficacy of PCC administration as first-line treatment for coagulopathy after adult cardiac surgery.</AbstractText><AbstractText Label="METHODS">PubMed/MEDLINE, EMBASE, and the Cochrane Library were searched from inception to the end of March 2018 to identify eligible articles. Adult patients undergoing cardiac surgery and receiving perioperative PCC were compared with patients receiving FFP.</AbstractText><AbstractText Label="RESULTS">A total of 861 adult patients from four studies were retrieved. No randomized studies were identified. Pooled odds ratios (ORs) showed that the PCC cohort was associated with a significant reduction in the risk of RBC transfusion (OR, 2.22; 95% confidence interval [CI], 1.45 to 3.40) and units of RBC received (OR, 1.34; 95% CI, 0.78 to 1.90). No differences were observed between the groups for reexploration for bleeding (OR, 1.09; 95% CI, 0.66 to 1.82), chest drain output at 24 hours (OR, 66.36; 95% CI,&#xa0;-82.40 to 216.11), hospital mortality (OR, 0.94; 95% CI, 0.59 to 1.49), stroke (OR, 0.80; 95% CI, 0.41 to 1.56), and occurrence of acute kidney injury (OR, 0.80; 95% CI, 0.58 to 1.12). A trend toward increased risk of renal replacement therapy was observed in the PCC group (OR, 0.41; 95% CI, 0.16 to 1.02).</AbstractText><AbstractText Label="CONCLUSIONS">In patients with significant bleeding after cardiac surgery, PCC administration seems to be more effective than FFP in reducing perioperative blood transfusions. No additional risks of thromboembolic events or other adverse reactions were observed. Randomized controlled trials are needed to establish the safety of PCC in cardiac surgery definitively.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Roman</LastName><ForeName>Marius</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, University of Leicester, Glenfield Hospital, Leicester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biancari</LastName><ForeName>Fausto</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Heart Center, Turku University Hospital and University of Turku, Turku, Finland; Department of Surgery, University of Oulu, Oulu, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Aamer B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Critical Care, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agarwal</LastName><ForeName>Seema</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Liverpool Heart and Chest Hospital, Liverpool, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hadjinikolaou</LastName><ForeName>Leon</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cardiac Surgery Unit, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Sarraf</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiac Surgery Unit, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsang</LastName><ForeName>Geoff</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Cardiac Surgery Unit, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oo</LastName><ForeName>Aung Y</ForeName><Initials>AY</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Barts Heart Centre, St. Bartholomew's Hospital, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Field</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Liverpool Heart and Chest Hospital, Liverpool, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santini</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Integrated Surgical and Diagnostic Sciences, Division of Cardiac Surgery, University of Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mariscalco</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, University of Leicester, Glenfield Hospital, Leicester, United Kingdom; Cardiac Surgery Unit, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom. Electronic address: giovannimariscalco@yahoo.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Ann Thorac Surg</MedlineTA><NlmUniqueID>15030100R</NlmUniqueID><ISSNLinking>0003-4975</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001779">Blood Coagulation Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>37224-63-8</RegistryNumber><NameOfSubstance UI="C025667">prothrombin complex concentrates</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001779" MajorTopicYN="N">Blood Coagulation Factors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010949" MajorTopicYN="Y">Plasma</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019106" MajorTopicYN="N">Postoperative Hemorrhage</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>5</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30458156</ArticleId><ArticleId IdType="doi">10.1016/j.athoracsur.2018.10.013</ArticleId><ArticleId IdType="pii">S0003-4975(18)31661-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">21239975</PMID><DateCompleted><Year>2011</Year><Month>03</Month><Day>03</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1175</ISSN><JournalIssue CitedMedium="Internet"><Volume>114</Volume><Issue>2</Issue><PubDate><Year>2011</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Anesthesiology</Title><ISOAbbreviation>Anesthesiology</ISOAbbreviation></Journal><ArticleTitle>Meta-analysis of thoracic epidural anesthesia versus general anesthesia for cardiac surgery.</ArticleTitle><Pagination><StartPage>271</StartPage><EndPage>282</EndPage><MedlinePgn>271-82</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ALN.0b013e318201d300</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">A combination of general anesthesia (GA) with thoracic epidural anesthesia (TEA) may have a beneficial effect on clinical outcomes after cardiac surgery. We have performed a meta-analysis to compare mortality and cardiac, respiratory, and neurologic complications in patients undergoing cardiac surgery with GA alone or a combination of GA with TEA.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Randomized studies comparing outcomes in patients undergoing cardiac surgery with either GA alone or GA in combination with TEA were retrieved from PubMed, Science Citation index, EMBASE, CINHAL, and Central Cochrane Controlled Trial Register databases.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The search strategy yielded 1,390 studies; 28 studies that included 2,731 patients met the selection criteria. Compared with GA alone, the combined risk ratio for patients receiving GA with TEA was 0.81 (95% CI: 0.40-1.64) for mortality, 0.80 (95% CI: 0.52-1.24) for myocardial infarction, and 0.59 (95% CI: 0.24-1.46) for stroke. The risk ratios for the respiratory complications and supraventricular arrhythmias were 0.53 (95% CI: 0.40-0.69) and 0.68 (95% CI: 0.50-0.93), respectively.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This meta-analysis showed that the use of TEA in patients undergoing cardiac surgery reduces the risk of postoperative supraventricular arrhythmias and respiratory complications. The sparsity of events precludes conclusions about mortality, myocardial infarction, and stroke, but the estimates suggest a reduced risk after TEA. The risk of side effects of TEA, including epidural hematoma, could not be assessed with the current dataset, and therefore TEA should be used with caution until its benefit-harm profile is further elucidated.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Svircevic</LastName><ForeName>Vesna</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Anesthesiology Resident, Department of Anesthesiology, University Medical Center Utrecht, Utrecht, The Netherlands. v.svircevic@umcutrecht.nl</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Dijk</LastName><ForeName>Diederik</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Nierich</LastName><ForeName>Arno P</ForeName><Initials>AP</Initials></Author><Author ValidYN="Y"><LastName>Passier</LastName><ForeName>Martijn P</ForeName><Initials>MP</Initials></Author><Author ValidYN="Y"><LastName>Kalkman</LastName><ForeName>Cor J</ForeName><Initials>CJ</Initials></Author><Author ValidYN="Y"><LastName>van der Heijden</LastName><ForeName>Geert J M G</ForeName><Initials>GJ</Initials></Author><Author ValidYN="Y"><LastName>Bax</LastName><ForeName>Leon</ForeName><Initials>L</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesthesiology</MedlineTA><NlmUniqueID>1300217</NlmUniqueID><ISSNLinking>0003-3022</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000767" MajorTopicYN="Y">Anesthesia, Epidural</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013904" MajorTopicYN="N">Thoracic Vertebrae</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21239975</ArticleId><ArticleId IdType="doi">10.1097/ALN.0b013e318201d300</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28127789</PMID><DateCompleted><Year>2017</Year><Month>10</Month><Day>04</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1550-9613</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>3</Issue><PubDate><Year>2017</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine</Title><ISOAbbreviation>J Ultrasound Med</ISOAbbreviation></Journal><ArticleTitle>Transcranial Doppler Monitoring in Carotid Endarterectomy: A Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>621</StartPage><EndPage>630</EndPage><MedlinePgn>621-630</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.7863/ultra.16.02077</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To evaluate the efficacy of intraoperative transcranial Doppler monitoring in predicting perioperative strokes after carotid endarterectomy (CEA).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">An electronic search of PubMed, Embase, and Web of Science databases was conducted for studies on transcranial Doppler monitoring in CEA published from January 1970 through September 2015. All titles and abstracts were independently screened on the basis of predetermined inclusion criteria, which included randomized clinical trials and prospective or retrospective cohort reviews, patients who underwent CEA with intraoperative transcranial Doppler monitoring (either middle cerebral artery velocity [MCAV] or cerebral microembolic signals [MES]) and postoperative neurologic assessments up to 30 days after the surgery, and studies including an abstract, published in English on adult humans 18 years and older with a sample size of 50 or greater.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 25articles with a sample population of 4705 patients were analyzed. Among the study patients, 189 developed perioperative strokes. Transcranial Doppler monitoring (either MCAV or MES) showed specificity of 72.7% (95% confidence interval [CI], 61.2%-81.8%) and sensitivity of 56.1% (95% CI, 46.8%-65.0%) for predicting perioperative strokes. Intraoperative MCAV changes during CEA showed strong specificity of 84.1% (95% CI, 74.4%-90.6) and sensitivity of 49.7% (95% CI, 40.6%-58.8) for predicting perioperative strokes.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Patients with perioperative strokes are 4 times more likely to have had transcranial Doppler changes (either MCAV or MES) during CEA compared to patients without strokes. Simultaneous MCAV and MES monitoring by transcranial Doppler sonography and combined intraoperative monitoring of transcranial Doppler sonography with somatosensory evoked potentials and electroencephalography during CEA to predict perioperative stroke could not be evaluated because of a lack of clinical studies combining these measures.</AbstractText><CopyrightInformation>&#xa9; 2017 by the American Institute of Ultrasound in Medicine.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Udesh</LastName><ForeName>Reshmi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurologic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natarajan</LastName><ForeName>Piruthiviraj</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurologic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thiagarajan</LastName><ForeName>Karthy</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurologic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wechsler</LastName><ForeName>Lawrence R</ForeName><Initials>LR</Initials><AffiliationInfo><Affiliation>Department of Neurologic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crammond</LastName><ForeName>Donald J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Neurologic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balzer</LastName><ForeName>Jeffrey R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Neurologic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thirumala</LastName><ForeName>Parthasarathy D</ForeName><Initials>PD</Initials><AffiliationInfo><Affiliation>Department of Neurologic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>01</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Ultrasound Med</MedlineTA><NlmUniqueID>8211547</NlmUniqueID><ISSNLinking>0278-4297</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002339" MajorTopicYN="N">Carotid Arteries</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016894" MajorTopicYN="N">Endarterectomy, Carotid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007430" MajorTopicYN="N">Intraoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017585" MajorTopicYN="N">Ultrasonography, Doppler, Transcranial</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">carotid endarterectomy</Keyword><Keyword MajorTopicYN="N">intraoperative neuromonitoring</Keyword><Keyword MajorTopicYN="N">perioperative stroke</Keyword><Keyword MajorTopicYN="N">transcranial Doppler sonography</Keyword><Keyword MajorTopicYN="N">transient ischemic attack</Keyword><Keyword MajorTopicYN="N">vascular ultrasound</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>2</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28127789</ArticleId><ArticleId IdType="doi">10.7863/ultra.16.02077</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40185666</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>23</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>134</Volume><Issue>5</Issue><PubDate><Year>2025</Year><Month>May</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Remote ischaemic preconditioning and survival in noncardiac surgery: a meta-analysis of randomised trials.</ArticleTitle><Pagination><StartPage>1373</StartPage><EndPage>1384</EndPage><MedlinePgn>1373-1384</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2025.02.023</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(25)00144-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Remote ischaemic preconditioning (RIPC) is an intervention involving brief periods of limb ischaemia to protect remote organs from subsequent ischaemic injury. Although evidence exists on the beneficial effects of RIPC on biomarkers, its effect on survival is unknown. We performed a meta-analysis of randomised controlled trials (RCTs) to evaluate whether RIPC improves survival in noncardiac surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched several electronic databases for randomised trials comparing RIPC vs a control group in adult noncardiac surgical settings. The primary outcome was mortality at the longest follow-up available. We conducted a random-effects meta-analysis to calculate the risk ratio (RR) and 95% confidence intervals (CIs). Bayesian statistics were used to estimate the probability of mortality benefit (RR &lt;1).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 72 RCTs, which included 7457 subjects. Mortality was reported in 28 RCTs and was lower in the RIPC group compared with the control group (88/2122 [4.1%] vs 102/1767 [5.8%]; RR 0.74, 95% CI 0.57-0.98, P=0.03; I<sup>2</sup>=0%; moderate certainty; number needed to treat&#xa0;= 67), corresponding to a 97.0% probability of any reduction in mortality. RIPC was also associated with a reduced incidence of postoperative stroke (moderate certainty) and with a shorter duration of hospital stay (low certainty).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Remote ischaemic preconditioning was associated with improved survival and reduced postoperative stroke and hospital stay in noncardiac surgery. These findings warrant careful considerations of the benefits of RIPC and support the need for a large, multicentre RCT to confirm these promising results.</AbstractText><AbstractText Label="SYSTEMATIC REVIEW PROTOCOL" NlmCategory="UNASSIGNED">CRD42024588358 (PROSPERO).</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fresilli</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Labanca</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turi</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casuale</LastName><ForeName>Valeria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vietri</LastName><ForeName>Simone</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lombardi</LastName><ForeName>Gaetano</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Covello</LastName><ForeName>Remo Daniel</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care Unit, Emergency Department, Busto Arsizio Hospital, ASST Valle Olona, Busto Arsizio, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Todd Campbell</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy; School of Medicine, Vita-Salute San Raffaele University, Milan, Italy. Electronic address: landoni.giovanni@hsr.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greco</LastName><ForeName>Massimiliano</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy; Department of Anesthesiology and Intensive Care, IRCCS Humanitas Research Hospital, Rozzano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>RIPC group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019194" MajorTopicYN="Y">Ischemic Preconditioning</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="Y">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">anaesthesia</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">noncardiac surgery</Keyword><Keyword MajorTopicYN="N">organ protection</Keyword><Keyword MajorTopicYN="N">remote ischaemic preconditioning (RIPC)</Keyword></KeywordList><CoiStatement>Declaration of interest The authors declare that they have no conflict of interest.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Lembo</LastName><ForeName>Rosalba</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Giardina</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Nakhnoukh</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Oliva</LastName><ForeName>Federico Mattia</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pontillo</LastName><ForeName>Domenico</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Brusasco</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Anaesthesia and Intensive Care Unit, E.O. Ospedali Galliera, Genoa, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Roasio</LastName><ForeName>Agostino</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Anaesthesia and Intensive Care Unit, Cardinal Massaia Hospital, Asti, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Konkayev</LastName><ForeName>Aidos</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Astana Medical University, Astana, Kazakhstan; National Scientific Center of Traumatology and Orthopedia named acad NBatpenov, Astana Medical University, Astana, Kazakhstan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lei</LastName><ForeName>Chong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Perioperative Medicine, Xijing Hospital, Xi'an, China.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Yavorovskiy</LastName><ForeName>Andrey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care, I.M. Sechenov First Moscow State Medical University of the Russian Ministry of Health, Moscow, Russia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Likhvantsev</LastName><ForeName>Valery</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>V. Negovsky Reanimatology Research Institute, Moscow, Russia.</Affiliation></AffiliationInfo></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>1</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>5</Day><Hour>15</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>4</Day><Hour>21</Hour><Minute>59</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40185666</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2025.02.023</ArticleId><ArticleId IdType="pii">S0007-0912(25)00144-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">28823937</PMID><DateCompleted><Year>2018</Year><Month>06</Month><Day>18</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-1632</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>12</Issue><PubDate><Year>2017</Year><Month>Dec</Month></PubDate></JournalIssue><Title>The spine journal : official journal of the North American Spine Society</Title><ISOAbbreviation>Spine J</ISOAbbreviation></Journal><ArticleTitle>Risk of aspirin continuation in spinal surgery: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1939</StartPage><EndPage>1946</EndPage><MedlinePgn>1939-1946</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.spinee.2017.08.238</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1529-9430(17)30912-9</ELocationID><Abstract><AbstractText Label="BACKGROUND CONTEXT">Aspirin is typically discontinued in spinal surgery because of increased risk of hemorrhagic complications. The risk of perioperative continuation of aspirin in neurosurgery needed to be evaluated.</AbstractText><AbstractText Label="PURPOSE">This study aimed to evaluate all available evidence about continuation of aspirin and to compare peri- and postoperative blood loss and complication rates between patients that continued aspirin and those who discontinued aspirin perioperatively in spinal surgery.</AbstractText><AbstractText Label="STUDY SETTING">Systematic review and meta-analysis were carried out.</AbstractText><AbstractText Label="METHOD">A meta-analysis was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Studies comparing aspirin continuation with discontinuation were included. Studies using a combination of anticlotting agents or non-spinal procedures were excluded. Operative outcomes (blood loss and operative length) and different complications (surgical site infection [SSI]), stroke, myocardial infarction within 30 days postoperatively) were extracted. Overall prevalence and means were calculated for the reported outcomes in fixed-effects models with heterogeneity (I-squared [I<sup>2</sup>]) and effect modification (P-interaction) assessment.</AbstractText><AbstractText Label="RESULTS">Out of 1,339 studies, three case series were included in the meta-analysis. No significant differences in mean operating time were seen between the aspirin-continuing group (mean=201.8 minutes, 95% confidence interval [CI]=193.3; 210.3; I<sup>2</sup>=95.4%; 170 patients) and the aspirin-discontinuing group (mean=178.4 minutes, 95% CI=119.1; 237.6; I<sup>2</sup>=93.5%; 200 patients); (P-interaction=0.78). No significant differences in mean perioperative blood loss were seen between the aspirin-continuing group (mean=553.9 milliliters, 95% CI=468.0; 639.9; I<sup>2</sup>=83.4%; 170 patients) and the aspirin-discontinuing group (mean=538.7 milliliters, 95% CI=427.6; 649.8; I<sup>2</sup>=985.5%; 200 patients); (P-interaction=0.96). Similar non-significant differences between the two groups were found for cardiac events, stroke, and surgical site infections.</AbstractText><AbstractText Label="CONCLUSIONS">This meta-analysis showed an absence of significant differences in perioperative complications between aspirin continuation and discontinuation. Because of the paucity of included studies, further well-designed prospective trials are imperative to demonstrate potential benefit and safety.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Goes</LastName><ForeName>Rik</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Haaglanden Medical Center, Lijnbaan 32, 2512VA, The Hague, The Netherlands. Electronic address: rikgoes@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muskens</LastName><ForeName>Ivo S</ForeName><Initials>IS</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Brain Center Rudolf Magnus, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands; Cushing Neurosurgery Outcomes Center (CNOC), Department of Neurosurgery, Brigham and Woman's Hospital, 60 Fenwood Road, 1st Floor, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Timothy R</ForeName><Initials>TR</Initials><AffiliationInfo><Affiliation>Cushing Neurosurgery Outcomes Center (CNOC), Department of Neurosurgery, Brigham and Woman's Hospital, 60 Fenwood Road, 1st Floor, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mekary</LastName><ForeName>Rania A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Cushing Neurosurgery Outcomes Center (CNOC), Department of Neurosurgery, Brigham and Woman's Hospital, 60 Fenwood Road, 1st Floor, Boston, MA, USA; Department of Pharmaceutical Business and Administrative Sciences, MCPHS University, 179 Longwood Ave, Boston, MA, 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Broekman</LastName><ForeName>Marike L D</ForeName><Initials>MLD</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Brain Center Rudolf Magnus, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands; Cushing Neurosurgery Outcomes Center (CNOC), Department of Neurosurgery, Brigham and Woman's Hospital, 60 Fenwood Road, 1st Floor, Boston, MA, USA; Department of Neurology, Massachusetts General Hospital, 15 Parkman Street 835, Boston, MA, 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moojen</LastName><ForeName>Wouter A</ForeName><Initials>WA</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Haaglanden Medical Center, Lijnbaan 32, 2512VA, The Hague, The Netherlands; Department of Neurosurgery, Haga Teaching Hospital, Els Borst-Eilersplein 275, 2545AA, The Hague, The Netherlands; Department of Neurosurgery, Leiden University Medical Center, Albinusdreef 2, 2333ZA, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>08</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Spine J</MedlineTA><NlmUniqueID>101130732</NlmUniqueID><ISSNLinking>1529-9430</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000894">Anti-Inflammatory Agents, Non-Steroidal</NameOfSubstance></Chemical><Chemical><RegistryNumber>R16CO5Y76E</RegistryNumber><NameOfSubstance UI="D001241">Aspirin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000894" MajorTopicYN="N">Anti-Inflammatory Agents, Non-Steroidal</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001241" MajorTopicYN="N">Aspirin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019635" MajorTopicYN="N">Neurosurgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019106" MajorTopicYN="N">Postoperative Hemorrhage</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013122" MajorTopicYN="N">Spinal Diseases</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Continuation</Keyword><Keyword MajorTopicYN="N">Low-dose aspirin</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Neurosurgery</Keyword><Keyword MajorTopicYN="N">Perioperative complications</Keyword><Keyword MajorTopicYN="N">Spinal surgery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>8</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>8</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28823937</ArticleId><ArticleId IdType="doi">10.1016/j.spinee.2017.08.238</ArticleId><ArticleId IdType="pii">S1529-9430(17)30912-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33905851</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1615-5947</ISSN><JournalIssue CitedMedium="Internet"><Volume>76</Volume><PubDate><Year>2021</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Annals of vascular surgery</Title><ISOAbbreviation>Ann Vasc Surg</ISOAbbreviation></Journal><ArticleTitle>Risk Factors for Delirium after Vascular Surgery: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>500</StartPage><EndPage>513</EndPage><MedlinePgn>500-513</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.avsg.2021.03.034</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0890-5096(21)00338-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Vascular surgery is considered a risk factor for the development of postoperative delirium (POD). In this systematic review we provide a report on the incidence and risk-factors of POD after vascular surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic literature search was conducted using Pubmed with the MeSH terms and key words "delirium" or "confusion", "vascular surgery procedures" and "risk factors or "risk assessment". Studies were selected for review after meeting the following inclusion criteria: vascular surgery, POD diagnosed using validated screening tools, and DSM-derived criteria to assess delirium. A meta-analysis was performed for each endpoint if at least two studies could be combined.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Sixteen articles met the abovementioned criteria. The incidence of delirium ranged from 5% to 39%. Various preoperative risk factors were identified that is, age (Random MD 3.96, CI 2.57-5.35), hypertension (Fixed OR 1.30, CI 1.05-1.59), diabetes mellitus (Random OR 2.15, CI 1.30-3.56), hearing impairment (Fixed OR 1.89, CI 1.28-2.81), history of cerebrovascular incident or transient ischemic attack (Fixed OR 2.20, CI 1.68-2.88), renal failure (Fixed OR 1.61, CI 1.19-2.17), and pre-operative low haemoglobin level (fixed MD -0.76, CI -1.04 to -0.47). Intra-operative risk factors were duration of surgery (Random MD 15.68; CI 2.79-28.57), open aneurysm repair (Fixed OR 4.99, CI 3.10-8.03), aortic cross clamping time (fixed MD 7.99, CI 2.56-13.42), amputation surgery (random OR 3.77, CI 2.13-6.67), emergency surgery (Fixed OR 4.84, CI 2.81-8.32) and total blood loss (Random MD 496.5, CI 84.51-908.44) and need for blood transfusion (Random OR 3.72, CI 1.57-8.80). Regional anesthesia on the other hand, had a protective effect. Delirium was associated with longer ICU and hospital length of stay, and more frequent discharge to a care facility.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">POD after vascular surgery is a frequent complication and effect-size pooling supports the concept that delirium is a heterogeneous disorder. The risk factors identified can be used to either design a validated risk factor model or individual preventive strategies for high-risk patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Visser</LastName><ForeName>Linda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Vascular Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Electronic address: l.visser2@dz.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prent</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Vascular Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banning</LastName><ForeName>Louise B D</ForeName><Initials>LBD</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Vascular Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Leeuwen</LastName><ForeName>Barbara L</ForeName><Initials>BL</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Surgical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeebregts</LastName><ForeName>Clark J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Vascular Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pol</LastName><ForeName>Robert A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Transplantation Surgery, University Medical Center Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Ann Vasc Surg</MedlineTA><NlmUniqueID>8703941</NlmUniqueID><ISSNLinking>0890-5096</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003693" MajorTopicYN="N">Delirium</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014656" MajorTopicYN="N">Vascular Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>3</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>27</Day><Hour>20</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33905851</ArticleId><ArticleId IdType="doi">10.1016/j.avsg.2021.03.034</ArticleId><ArticleId IdType="pii">S0890-5096(21)00338-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30103970</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>27</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-5883</ISSN><JournalIssue CitedMedium="Internet"><Volume>391</Volume><PubDate><Year>2018</Year><Month>Aug</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of the neurological sciences</Title><ISOAbbreviation>J Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>Endovascular treatment of symptomatic vertebral artery stenosis: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>48</StartPage><EndPage>53</EndPage><MedlinePgn>48-53</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jns.2018.05.024</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-510X(18)30248-X</ELocationID><Abstract><AbstractText Label="BACKGROUND">The study aim was to evaluate the safety and efficacy of endovascular treatment (EVT) versus medical treatment (MT) in patients with symptomatic vertebral artery (VA) stenosis.</AbstractText><AbstractText Label="METHODS">Randomized controlled trials with active and control groups receiving EVT plus MT and MT alone in patients with vertebro-basilar transient ischemic attack (TIA) or stroke and VA stenosis were identified. Primary endpoints included the occurrence of any stroke, any vertebro-basilar stroke, vertebro-basilar ischemic stroke, and vertebro-basilar TIA. Secondary endpoints were myocardial infarction, vascular death, and composite vascular outcome. All endpoints were assessed at short and long-term. Risk ratios (RRs) with 95% confidence intervals (CIs) have been estimated.</AbstractText><AbstractText Label="RESULTS">Four trials were included involving 370 participants, 194 and 176 for EVT and MT arms, respectively. There was no overall effect of EVT on the occurrence of any stroke [short-term: RR 3.05 (95% CI 0.33-28.49); long-term: RR 0.75 (95% CI 0.40-1.40)], any vertebro-basilar stroke [short-term RR 3.05 (95% CI 0.33-28.49); long-term RR 0.91 (95% CI 0.42-1.99)], vertebro-basilar ischemic stroke [short-term: RR 1.02 (95% CI 0.07-15.88); long-term RR 1.27 (95% CI 0.36-4.50)], vertebro-basilar TIA [short-term: RR 5.00 (95% CI 0.28-90.18); long-term: RR 0.85 (95% CI 0.39-1.81)]. There were no differences across the treatments in any secondary outcome.</AbstractText><AbstractText Label="CONCLUSIONS">There were no clear-cut benefits or harms for EVT versus MT alone in patients with symptomatic VA stenosis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lattanzi</LastName><ForeName>Simona</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neurological Clinic, Department of Experimental and Clinical Medicine, Marche Polytechnic University, Via Conca 71, 60020 Ancona, Italy. Electronic address: alfierelattanzisimona@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brigo</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Biomedicine and Movement Science, University of Verona, Italy; Division of Neurology, "Franz Tappeiner" Hospital, Merano, BZ, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Napoli</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neurological Service, San Camillo de' Lellis General Hospital, Rieti, Italy; Neurological Section, Neuro-epidemiology Unit, SMDN, Centre for Cardiovascular Medicine and Cerebrovascular Disease Prevention, Sulmona, L'Aquila, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cagnetti</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Neurological Clinic, Department of Experimental and Clinical Medicine, Marche Polytechnic University, Via Conca 71, 60020 Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corradetti</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Neurological Clinic, Department of Experimental and Clinical Medicine, Marche Polytechnic University, Via Conca 71, 60020 Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silvestrini</LastName><ForeName>Mauro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neurological Clinic, Department of Experimental and Clinical Medicine, Marche Polytechnic University, Via Conca 71, 60020 Ancona, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>05</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Neurol Sci</MedlineTA><NlmUniqueID>0375403</NlmUniqueID><ISSNLinking>0022-510X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="Y">Endovascular Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="N">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014715" MajorTopicYN="N">Vertebrobasilar Insufficiency</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Endovascular treatment</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword><Keyword MajorTopicYN="N">Vertebral artery stenosis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>3</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30103970</ArticleId><ArticleId IdType="doi">10.1016/j.jns.2018.05.024</ArticleId><ArticleId IdType="pii">S0022-510X(18)30248-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26642777</PMID><DateCompleted><Year>2016</Year><Month>12</Month><Day>22</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1873-4286</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>13</Issue><PubDate><Year>2016</Year></PubDate></JournalIssue><Title>Current pharmaceutical design</Title><ISOAbbreviation>Curr Pharm Des</ISOAbbreviation></Journal><ArticleTitle>General or Local Anesthesia for TAVI? A Systematic Review of the Literature and Meta-Analysis.</ArticleTitle><Pagination><StartPage>1868</StartPage><EndPage>1878</EndPage><MedlinePgn>1868-78</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Transcatheter aortic valve implantation (TAVI) is becoming a valuable alternative to surgical aortic valve replacement in patients with severe aortic stenosis that are at high surgical risk or deemed inoperable. The optimal anesthesia technique for TAVI is still undecided. We performed a systematic review and metaanalysis to compare the safety of locoregional anesthesia (LRA) with or without conscious sedation and general anesthesia (GA) for the TAVI-procedure.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched PUBMED, MEDLINE, EMBASE and the Cochrane central register of controlled trials from January 1st 2002 to February 15th 2015. The primary outcome parameters searched were 30-days mortality, hospital length of stay, procedure time, use of adrenergic support, stroke rate, incidence of myocardial infarction, incidence of acute kidney injury, rate of procedural succes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Ten studies, including 5919 patients, fulfilled the inclusion criteria. None of these studies was randomized resulting in a considerable risk of bias. The choice for a specific anesthesia technique did neither affect the average 30-day mortality rate [RR 0.91 (95% CI: 0.53 to 1.56), p=0.72] nor a wide variety of safety endpoints. LRA for TAVI was associated with a significantly shorter procedure time when compared to GA, and a reduction in hospital length of stay. However, LRA significantly increased the risk for implantation of a permanent pacemaker (RR 1.23, p=0.02) and for paravalvular leakage (RR 1.31, p=0.006.).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Neither mortality nor the incidence of major adverse cardiac and cerebrovascular events after TAVI is affected by the choice for either LRA or GA.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maas</LastName><ForeName>E H A</ForeName><Initials>EH</Initials></Author><Author ValidYN="Y"><LastName>Pieters</LastName><ForeName>B M A</ForeName><Initials>BM</Initials></Author><Author ValidYN="Y"><LastName>Van de Velde</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Rex</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, UZ Leuven, Herestraat 9, 3000 Leuven, Belgium. steffen.rex@uzleuven.be.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United Arab Emirates</Country><MedlineTA>Curr Pharm Des</MedlineTA><NlmUniqueID>9602487</NlmUniqueID><ISSNLinking>1381-6128</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000772" MajorTopicYN="Y">Anesthesia, Local</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001024" MajorTopicYN="N">Aortic Valve Stenosis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065467" MajorTopicYN="Y">Transcatheter Aortic Valve Replacement</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>12</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>12</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26642777</ArticleId><ArticleId IdType="doi">10.2174/1381612822666151208121825</ArticleId><ArticleId IdType="pii">CPD-EPUB-72334</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39584914</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>25</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2076-3271</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>11</Day></PubDate></JournalIssue><Title>Medical sciences (Basel, Switzerland)</Title><ISOAbbreviation>Med Sci (Basel)</ISOAbbreviation></Journal><ArticleTitle>Beta-Blocker Use in Patients Undergoing Non-Cardiac Surgery: A Systematic Review and Meta-Analysis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">64</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/medsci12040064</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The use of beta-blockers in the perioperative period has been widely investigated due to their potential to reduce the risk of major adverse cardiovascular and cerebrovascular events (MACCE) and mortality; yet their overall impact on various postoperative outcomes remains debated. This study constitutes a systematic review and meta-analysis of the impact of beta-blockers on mortality, MI, stroke, and other adverse effects such as hypotension and bradycardia in patients undergoing non-cardiac surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A comprehensive systematic review and meta-analysis were conducted according to PRISMA 2020 guidelines. Searches were performed across PubMed, Cochrane, Web of Science, Scopus, EMBASE, and CINAHL databases; we included randomized controlled trials and cohort and case-control studies published from 1999 to 2024.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">This meta-analysis included data from 28 studies encompassing 1,342,430 patients. Perioperative beta-blockers were associated with a significant increase in stroke risk (RR 1.42, 95% CI: 1.03 to 1.97, <i>p</i> = 0.03, I<sup>2</sup> = 62%). However, no statistically significant association was found between beta-blocker use and mortality (RR 0.62, 95% CI: 0.38 to 1.01, <i>p</i> = 0.05, I<sup>2</sup> = 100%). Subgroup analyses revealed a protective effect on mortality for patients with high risks, such as patients with a history of atrial fibrillation, chronic heart failure, and other arrhythmias. For myocardial infarction (RR 0.82, 95% CI: 0.53 to 1.28, <i>p</i> = 0.36, I<sup>2</sup> = 86%), a reduction in events was observed in the subgroup of randomized controlled trials. Beta-blockers significantly increased the risk of hypotension (RR 1.46, 95% CI: 1.26 to 1.70, <i>p</i> &lt; 0.01, I<sup>2</sup> = 25%) and bradycardia (RR 2.26, 95% CI: 1.37 to 3.74, <i>p</i> &lt; 0.01, I<sup>2</sup> = 64%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Perioperative beta-blockers show increasing rates of stroke events following non-cardiac surgery but do not significantly impact the incidence of MI or mortality. The increased risks of hypotension and bradycardia necessitate careful patient selection and monitoring. Future research should aim to refine patient selection criteria and optimize perioperative management to balance the benefits and risks of beta-blocker use in surgical settings.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Herrera Hern&#xe1;ndez</LastName><ForeName>Dom&#xe9;nica</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Facultad de Medicina, Pontificia Universidad Cat&#xf3;lica del Ecuador, Quito 170525, Ecuador.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abreu</LastName><ForeName>B&#xe1;rbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Facultad de Medicina, Universidad de Carabobo, Valencia 2005, Venezuela.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Tania Siu</ForeName><Initials>TS</Initials><Identifier Source="ORCID">0000-0002-3867-3601</Identifier><AffiliationInfo><Affiliation>Radiology Department, Thomas Jefferson University, Philadelphia, PA 19107, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rojas</LastName><ForeName>Andreina</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Facultad de Medicina, Universidad de Oriente, N&#xfa;cleo Anzo&#xe1;tegui, Barcelona 6001, Venezuela.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romero</LastName><ForeName>Kevin L&#xf3;pez</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Facultad de Medicina, Universidad del Salvador, San Salvador 1101, El Salvador.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Contreras</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nogueyra</LastName><ForeName>Sol Villa</ForeName><Initials>SV</Initials><Identifier Source="ORCID">0009-0005-7944-6834</Identifier><AffiliationInfo><Affiliation>Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires C1053ABK, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sosa</LastName><ForeName>Zulma</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Facultad de medicina, Universidad Evang&#xe9;lica de El Salvador, San Salvador 1101, El Salvador.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alvarez</LastName><ForeName>Samantha M</ForeName><Initials>SM</Initials><Identifier Source="ORCID">0009-0006-4354-1706</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, Saint George's University, True Blue FZ818, Grenada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;nchez Cruz</LastName><ForeName>Camila</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Facultad de Medicina, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico, Ciudad de M&#xe9;xico 04510, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calder&#xf3;n Martinez</LastName><ForeName>Ernesto</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-2237-9536</Identifier><AffiliationInfo><Affiliation>Facultad de Medicina, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico, Ciudad de M&#xe9;xico 04510, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, The University of Texas Health Science Medical Center, Houston, TX 77030, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Med Sci (Basel)</MedlineTA><NlmUniqueID>101629322</NlmUniqueID><ISSNLinking>2076-3271</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000319">Adrenergic beta-Antagonists</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000319" MajorTopicYN="Y">Adrenergic beta-Antagonists</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001919" MajorTopicYN="N">Bradycardia</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">bradycardia</Keyword><Keyword MajorTopicYN="N">cardiovascular outcomes</Keyword><Keyword MajorTopicYN="N">hypotension</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">myocardial infarction</Keyword><Keyword MajorTopicYN="N">non-cardiac surgery</Keyword><Keyword MajorTopicYN="N">perioperative beta-blockers</Keyword><Keyword MajorTopicYN="N">stroke</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>25</Day><Hour>12</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>25</Day><Hour>12</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>25</Day><Hour>9</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39584914</ArticleId><ArticleId IdType="pmc">PMC11587062</ArticleId><ArticleId IdType="doi">10.3390/medsci12040064</ArticleId><ArticleId IdType="pii">medsci12040064</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Steiner C.A., Karaca Z., Moore B.J., Imshaug M.C., Pickens G. Surgeries in Hospital-Based Ambulatory Surgery and Hospital Inpatient Settings, 2014. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. 20 July 2020.  [(accessed on 10 May 2024)]; Available online:  https://www.ncbi.nlm.nih.gov/books/NBK442035/</Citation></Reference><Reference><Citation>Smilowitz N.R., Berger J.S. Perioperative Cardiovascular Risk Assessment and Management for Noncardiac Surgery: A Review. JAMA. 2020;324:279&#x2013;290. doi: 10.1001/jama.2020.7840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.7840</ArticleId><ArticleId IdType="pubmed">32692391</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiser T.G., Haynes A.B., Molina G., Lipsitz S.R., Esquivel M.M., Uribe-Leitz T., Fu R., Azad T., Chao T.E., Berry W.R., et al. Estimate of the global volume of surgery in 2012: An assessment supporting improved health outcomes. Lancet. 2015;385:S11. doi: 10.1016/S0140-6736(15)60806-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)60806-6</ArticleId><ArticleId IdType="pubmed">26313057</ArticleId></ArticleIdList></Reference><Reference><Citation>Devereaux P.J., Goldman L., Cook D.J., Gilbert K., Leslie K., Guyatt G.H. Perioperative cardiac events in patients undergoing noncardiac surgery: A review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ Can. Med. Assoc. J. 2005;173:627. doi: 10.1503/cmaj.050011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.050011</ArticleId><ArticleId IdType="pmc">PMC1197163</ArticleId><ArticleId IdType="pubmed">16157727</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahendran S., Thiagalingam A., Hillis G., Halliwell R., Pleass H.C.C., Chow C.K. Cardiovascular Risk Management in the Peri-operative Setting. Med. J. Aust. 2023;219:30&#x2013;39. doi: 10.5694/mja2.51988.</Citation><ArticleIdList><ArticleId IdType="doi">10.5694/mja2.51988</ArticleId><ArticleId IdType="pubmed">37302136</ArticleId></ArticleIdList></Reference><Reference><Citation>Smilowitz N.R., Berger J.S. Perioperative Management to Reduce Cardiovascular Events. Circulation. 2016;133:1125. doi: 10.1161/CIRCULATIONAHA.115.017787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.115.017787</ArticleId><ArticleId IdType="pmc">PMC4800678</ArticleId><ArticleId IdType="pubmed">26976917</ArticleId></ArticleIdList></Reference><Reference><Citation>Mrkobrada M., Chan M.T.V., Cowan D., Campbell D., Wang C.Y., Torres D., Malaga G., Sanders R.D., Sharma M., Brown C., et al. Perioperative covert stroke in patients undergoing non-cardiac surgery (NeuroVISION): A prospective cohort study. Lancet. 2019;394:1022&#x2013;1029. doi: 10.1016/S0140-6736(19)31795-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)31795-7</ArticleId><ArticleId IdType="pubmed">31422895</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganesh R., Kebede E., Mueller M., Gilman E., Mauck K.F. Perioperative Cardiac Risk Reduction in Noncardiac Surgery. Mayo Clin. Proc. 2021;96:2260&#x2013;2276. doi: 10.1016/j.mayocp.2021.03.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.03.014</ArticleId><ArticleId IdType="pubmed">34226028</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleisher L.A., Fleischmann K.E., Auerbach A.D., Barnason S.A., Beckman J.A., Bozkurt B., Davila-Roman V.G., Gerhard-Herman M.D., Holly T.A., Kane G.C., et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130:2215&#x2013;2245. doi: 10.1161/CIR.0000000000000105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000105</ArticleId><ArticleId IdType="pubmed">25085962</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijeysundera D.N., Duncan D., Nkonde-Price C., Virani S.S., Washam J.B., Fleischmann K.E., Fleisher L.A. Perioperative beta blockade in noncardiac surgery: A systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014;130:2246&#x2013;2264.</Citation><ArticleIdList><ArticleId IdType="pubmed">25085964</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xfc;scher T.F., Gersh B., Landmesser U., Ruschitzka F. Is the panic about beta-blockers in perioperative care justified? Eur. Heart J. 2014;35:2442&#x2013;2444. doi: 10.1093/eurheartj/ehu056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehu056</ArticleId><ArticleId IdType="pubmed">24510635</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajibandeh S., Hajibandeh S., Antoniou S.A., Torella F., Antoniou G.A. Effect of beta-blockers on perioperative outcomes in vascular and endovascular surgery: A systematic review and meta-analysis. BJA Br. J. Anaesth. 2017;118:11&#x2013;21. doi: 10.1093/bja/aew380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aew380</ArticleId><ArticleId IdType="pubmed">28039238</ArticleId></ArticleIdList></Reference><Reference><Citation>Blessberger H., Lewis S.R., Pritchard M.W., Fawcett L.J., Domanovits H., Schlager O., Wildner B., Kammler J., Steinwender C. Perioperative beta-blockers for preventing surgery-related mortality and morbidity in adults undergoing non-cardiac surgery. Cochrane Database Syst. Rev. 2019;9:CD013438. doi: 10.1002/14651858.CD013438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD013438</ArticleId><ArticleId IdType="pmc">PMC6761481</ArticleId><ArticleId IdType="pubmed">31556094</ArticleId></ArticleIdList></Reference><Reference><Citation>Calderon Martinez E., Flores Vald&#xe9;s J.R., Castillo J.L., Castillo J.V., Blanco Montecino R.M., Morin Jimenez J.E., Escamilla D.A., Diarte E. Ten Steps to Conduct a Systematic Review. Cureus. 2023;15:e51422.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10828625</ArticleId><ArticleId IdType="pubmed">38299136</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., Shamseer L., Tetzlaff J.M., Akl E.A., Brennan S.E., et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouzzani M., Hammady H., Fedorowicz Z., Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst. Rev. 2016;5:210. doi: 10.1186/s13643-016-0384-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-016-0384-4</ArticleId><ArticleId IdType="pmc">PMC5139140</ArticleId><ArticleId IdType="pubmed">27919275</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Handbook for Systematic Reviews of Interventions|Cochrane Training [Internet]  [(accessed on 13 April 2024)].  Available online:  https://training.cochrane.org/handbook/current.</Citation></Reference><Reference><Citation>Sterne J.A.C., Savovi&#x107; J., Page M.J., Elbers R.G., Blencowe N.S., Boutron I., Cates C.J., Cheng H.-Y., Corbett M.S., Eldridge S.M., et al. RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. doi: 10.1136/bmj.l4898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l4898</ArticleId><ArticleId IdType="pubmed">31462531</ArticleId></ArticleIdList></Reference><Reference><Citation>Ka-Lok Lo C., Mertz D., Loeb M. Newcastle-Ottawa Scale: Comparing Reviewers&#x2019; to Authors&#x2019; Assessments. 2014.  [(accessed on 14 June 2024)].  Available online:  http://www.biomedcentral.com/1471-2288/14/45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4021422</ArticleId><ArticleId IdType="pubmed">24690082</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarzer G., Carpenter J.R., R&#xfc;cker G. Meta-Analysis with R. 2015.  [(accessed on 14 June 2024)].  Available online:  https://link.springer.com/10.1007/978-3-319-21416-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-21416-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson D., White I.R., Thompson S.G. Extending DerSimonian and Laird&#x2019;s methodology to perform multivariate random effects meta-analyses. Stat. Med. 2010;29:1282&#x2013;1297. doi: 10.1002/sim.3602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.3602</ArticleId><ArticleId IdType="pubmed">19408255</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J.P.T., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 2002;21:1539&#x2013;1558. doi: 10.1002/sim.1186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1186</ArticleId><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Viechtbauer W., Cheung M.W.L. Outlier and influence diagnostics for meta-analysis. Res. Synth. Methods. 2010;1:112&#x2013;125. doi: 10.1002/jrsm.11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.11</ArticleId><ArticleId IdType="pubmed">26061377</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M., Smith G.D., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629&#x2013;634. doi: 10.1136/bmj.315.7109.629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.315.7109.629</ArticleId><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>London M.J., Hur K., Schwartz G.G., Henderson W.G. Association of Perioperative-Blockade with Mortality and Cardiovascular Morbidity Following Major Noncardiac Surgery. JAMA. 2013;309:1704&#x2013;1713. doi: 10.1001/jama.2013.4135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2013.4135</ArticleId><ArticleId IdType="pubmed">23613075</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindenauer P.K., Pekow P., Wang K., Mamidi D.K., Gutierrez B., Benjamin E.M. Perioperative Beta-Blocker Therapy and Mortality after Major Noncardiac Surgery. N. Engl. J. Med. 2005;353:349&#x2013;361. doi: 10.1056/NEJMoa041895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa041895</ArticleId><ArticleId IdType="pubmed">16049209</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahl R., Matthiessen P., Sj&#xf6;lin G., Cao Y., Wallin G., Ljungqvist O., Mohseni S. Effects of beta-blocker therapy on mortality after elective colon cancer surgery: A Swedish nationwide cohort study. BMJ Open. 2020;10:e036164. doi: 10.1136/bmjopen-2019-036164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2019-036164</ArticleId><ArticleId IdType="pmc">PMC7342478</ArticleId><ArticleId IdType="pubmed">32641361</ArticleId></ArticleIdList></Reference><Reference><Citation>McKenzie N.L., Ward R.P., Nagele P., Rubin D.S. Preoperative &#x3b2;-Blocker Therapy and Stroke or Major Adverse Cardiac Events in Major Abdominal Surgery: A Retrospective Cohort Study. Anesthesiology. 2023;138:42&#x2013;54. doi: 10.1097/ALN.0000000000004404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000004404</ArticleId><ArticleId IdType="pmc">PMC9771981</ArticleId><ArticleId IdType="pubmed">36227278</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahl R., Matthiessen P., Fang X., Cao Y., Sjolin G., Lindgren R., Ljungqvist O., Mohseni S. &#x3b2;-Blockade in Rectal Cancer Surgery: A Simple Measure of Improving Outcomes. Ann. Surg. 2018;271:140&#x2013;146. doi: 10.1097/SLA.0000000000002970.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000002970</ArticleId><ArticleId IdType="pubmed">30048321</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahl R., Matthiessen P., Cao Y., Sjolin G., Ljungqvist O., Mohseni S. The Relationship Between Severe Complications, Beta-Blocker Therapy and Long-Term Survival Following Emergency Surgery for Colon Cancer. World J Surg. 2019;43:2527&#x2013;2535. doi: 10.1007/s00268-019-05058-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-019-05058-z</ArticleId><ArticleId IdType="pubmed">31214833</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammad Ismail A., Ahl R., Forssten M.P., Cao Y., Wretenberg P., Borg T., Mohseni S. Beta-Blocker Therapy Is Associated with Increased 1-Year Survival after Hip Fracture Surgery: A Retrospective Cohort Study. Anesth. Analg. 2021;133:1225&#x2013;1234. doi: 10.1213/ANE.0000000000005659.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005659</ArticleId><ArticleId IdType="pmc">PMC8505142</ArticleId><ArticleId IdType="pubmed">34260428</ArticleId></ArticleIdList></Reference><Reference><Citation>Juul A.B., Wetterslev J., Gluud C., Kofoed-Enevoldsen A., Jensen G., Callesen T., N&#xf8;rgaard P., Fruergaard K., Bestle M., Vedelsdal R., et al. Effect of perioperative blockade in patients with diabetes undergoing major non-cardiac surgery: Randomised placebo controlled, blinded multicentre trial. BMJ. 2006;332:1482. doi: 10.1136/bmj.332.7556.1482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.332.7556.1482</ArticleId><ArticleId IdType="pmc">PMC1482337</ArticleId><ArticleId IdType="pubmed">16793810</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunkelgrun M., Boersma E., Schouten O., Koopman-van Gemert A.W., Van Poorten F., Bax J.J., Thomson I.R., Poldermans D., Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: A randomized controlled trial (DECREASE-IV) Ann. Surg. 2009;249:921&#x2013;926. doi: 10.1097/SLA.0b013e3181a77d00.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e3181a77d00</ArticleId><ArticleId IdType="pubmed">19474688</ArticleId></ArticleIdList></Reference><Reference><Citation>Devereaux P.J., Yang H., Yusuf S., Guyatt G., Leslie K., Villar J.C. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): A randomised controlled trial POISE Study Group. Lancet. 2008;371:1839&#x2013;1847.</Citation><ArticleIdList><ArticleId IdType="pubmed">18479744</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakobsen C.J., Bille S., Ahlburg P., Rybro L., Hjortholm K., Andresen E.B. Perioperative Metoprolol Reduces the Frequency of Atrial Fibrillation After Thoracotomy for Lung Resection. J. Cardiothorac. Vasc. Anesth. 1997;11:746&#x2013;751. doi: 10.1016/S1053-0770(97)90169-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1053-0770(97)90169-5</ArticleId><ArticleId IdType="pubmed">9327317</ArticleId></ArticleIdList></Reference><Reference><Citation>Karapandzic V.M., Vujisic-Tesic B.D., Pesko P.M., Nenadic B.M., Babic D.D. The effect of metoprolol on perioperative outcome in coronary patients undergoing nonvascular abdominal surgery. J. Clin. Anesth. 2008;20:284&#x2013;289. doi: 10.1016/j.jclinane.2007.12.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2007.12.014</ArticleId><ArticleId IdType="pubmed">18617127</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangano D., Layug E., Wallace A., Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery abstract. N. Engl. J. Med. 1996;335:1713&#x2013;1721. doi: 10.1056/NEJM199612053352301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199612053352301</ArticleId><ArticleId IdType="pubmed">8929262</ArticleId></ArticleIdList></Reference><Reference><Citation>Neary W.D., McCrirrick A., Foy C., Heather B.P., Earnshaw J.J. Lessons learned from a randomised controlled study of perioperative beta blockade in high risk patients undergoing emergency surgery. Surgeon. 2006;4:139&#x2013;143. doi: 10.1016/S1479-666X(06)80083-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1479-666X(06)80083-1</ArticleId><ArticleId IdType="pubmed">16764198</ArticleId></ArticleIdList></Reference><Reference><Citation>Noordzij P.G., Poldermans D., Schouten O., Schreiner F., Feringa H.H., Dunkelgrun M., Kertai M.D., Boersma E. Beta-blockers and statins are individually associated with reduced mortality in patients undergoing noncardiac, nonvascular surgery. Coron Artery Dis. 2007;18:67&#x2013;72. doi: 10.1097/MCA.0b013e328010a461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCA.0b013e328010a461</ArticleId><ArticleId IdType="pubmed">17172933</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J., Kim J., Kwon J.H., Park S.J., Min J.J., Lee S.M., Gwon H.-C., Lee Y.T., Park M., Lee S.H. Association between perioperative &#x3b2;-blocker use and clinical outcome of non-cardiac surgery in coronary revascularized patients without severe ventricular dysfunction or heart failure. PLoS ONE. 2018;13:e0201311. doi: 10.1371/journal.pone.0201311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0201311</ArticleId><ArticleId IdType="pmc">PMC6070245</ArticleId><ArticleId IdType="pubmed">30067841</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns J.M.A., Hart D.M., Hughes R.L., Kelman A.W., Hillis W.S. Effects of nadolol on arrhythmias during laparoscopy performed under general anaesthesia. Br. J. Anaesth. 1988;61:345&#x2013;346. doi: 10.1093/bja/61.3.345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/61.3.345</ArticleId><ArticleId IdType="pubmed">2972306</ArticleId></ArticleIdList></Reference><Reference><Citation>Brady A.R., Gibbs J.S.R., Greenhalgh R.M., Powell J.T., Sydes M.R. Perioperative &#x3b2;-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: Results of a randomized double-blind controlled trial. J. Vasc. Surg. 2005;41:602&#x2013;609.</Citation><ArticleIdList><ArticleId IdType="pubmed">15874923</ArticleId></ArticleIdList></Reference><Reference><Citation>Poldermans D., Boersma E., Bax J.J., Thompson I., Van De Ven L.L.M., Blankensteijn J.D., Baars H.F., Yo T.I., Trocino G., Vigna C., et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N. Engl. J. Med. 1999;341:1789&#x2013;1794. doi: 10.1056/NEJM199912093412402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199912093412402</ArticleId><ArticleId IdType="pubmed">10588963</ArticleId></ArticleIdList></Reference><Reference><Citation>Richman J.S., Graham L.A., DeRussy A., Maddox T.M., Itani K.M.F., Hawn M.T. Perioperative beta blockers and statins for noncardiac surgery patients with coronary stents. Am. J. Surg. 2017;214:180&#x2013;185. doi: 10.1016/j.amjsurg.2017.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2017.05.001</ArticleId><ArticleId IdType="pubmed">28641862</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoyama H., Otsuka Y., Aoyama Y. Landiolol infusion during general anesthesia does not prevent postoperative atrial fibrillation in patients undergoing lung resection. Gen. Thorac. Cardiovasc. Surg. 2016;64:735&#x2013;741. doi: 10.1007/s11748-016-0707-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11748-016-0707-3</ArticleId><ArticleId IdType="pubmed">27553581</ArticleId></ArticleIdList></Reference><Reference><Citation>Raby K.E., Brull S.J., Timimi F., Akhtar S., Rosenbaum S., Naimi C., Whittemore A.D. The Effect of Heart Rate Control on Myocardial Ischemia Among High-Risk Patients After Vascular Surgery. Anesth. Analg. 1999;88:477&#x2013;482.</Citation><ArticleIdList><ArticleId IdType="pubmed">10071990</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammad Ismail A., Borg T., Sjolin G., Pourlotfi A., Holm S., Cao Y., Wretenberg P., Ahl R., Mohseni S. &#x3b2;-adrenergic blockade is associated with a reduced risk of 90-day mortality after surgery for hip fractures. Trauma Surg. Acute Care Open. 2020;5:e000533. doi: 10.1136/tsaco-2020-000533.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/tsaco-2020-000533</ArticleId><ArticleId IdType="pmc">PMC7394016</ArticleId><ArticleId IdType="pubmed">32789190</ArticleId></ArticleIdList></Reference><Reference><Citation>Urban M.K., Markowitz S.M., Gordon M.A., Urquhart B.L., Kligfield P. Postoperative Prophylactic Administration of-Adrenergic Blockers in Patients at Risk for Myocardial Ischemia. Anesth. Analg. 2000;90:1257&#x2013;1261. doi: 10.1097/00000539-200006000-00001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000539-200006000-00001</ArticleId><ArticleId IdType="pubmed">10825304</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H., Raymer K., Butler R., Parlow J., Roberts R. The effects of perioperative &#x3b2;-blockade: Results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am. Heart J. 2006;152:983&#x2013;990. doi: 10.1016/j.ahj.2006.07.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2006.07.024</ArticleId><ArticleId IdType="pubmed">17070177</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaugg M., Tagliente T., Lucchinetti E., Jacobs E., Krol M., Bodian C., Reich D.L., Silverstein J.H. Beneficial Effects from-Adrenergic Blockade in Elderly Patients Undergoing Noncardiac Surgery. Anesthesiology. 1999;91:1674&#x2013;1686. doi: 10.1097/00000542-199912000-00020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199912000-00020</ArticleId><ArticleId IdType="pubmed">10598610</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaugg M., Bestmann L., Wacker J., Lucchinetti E., Boltres A., Schulz C., Hersberger M., K&#xe4;lin G., Furrer L., Hofer C., et al. Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: The Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: A double-blinded, placebo-controlled, multicenter trial with 1-year follow-up. Anesthesiology. 2007;107:33&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">17585213</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayliff C.D., Massel D.R., Inculet R.I., Malthaner R.A., Quinton S.D., Powell F.S., Kennedy R.S. Propranolol for the prevention of postoperative arrhythmias in general thoracic surgery. Ann Thorac Surg. 1999;67:182&#x2013;186. doi: 10.1016/S0003-4975(98)01226-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0003-4975(98)01226-0</ArticleId><ArticleId IdType="pubmed">10086546</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciccarelli M., Sorriento D., Coscioni E., Iaccarino G., Santulli G. Chapter 11&#x2014;Adrenergic Receptors, Endocrinology of the Heart in Health and Disease. Academic Press; Cambridge, MA, USA: 2017. pp. 285&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-803111-7.00011-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziff O.J., Samra M., Howard J.P., Bromage D.I., Ruschitzka F., Francis D.P., Kotecha D. Beta-blocker efficacy across different cardiovascular indications: An umbrella review and meta-analytic assessment. BMC Med. 2020;18:103. doi: 10.1186/s12916-020-01564-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-020-01564-3</ArticleId><ArticleId IdType="pmc">PMC7199339</ArticleId><ArticleId IdType="pubmed">32366251</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakamoto A., Yagi K., Okamura T., Harada T., Usuda J. Perioperative Administration of an Intravenous Beta-Blocker Landiolol Hydrochloride in Patients with Lung Cancer: A Japanese Retrospective Exploratory Clinical Study. Sci. Rep. 2019;9:5217. doi: 10.1038/s41598-019-41520-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-41520-7</ArticleId><ArticleId IdType="pmc">PMC6435747</ArticleId><ArticleId IdType="pubmed">30914694</ArticleId></ArticleIdList></Reference><Reference><Citation>Alegria S., Costa J., Vaz-Carneiro A., Caldeira D. Cochrane Corner: Perioperative beta-blockers for preventing surgery-related mortality and morbidity. Rev. Port. Cardiol. 2019;38:691&#x2013;694. doi: 10.1016/j.repc.2018.10.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.repc.2018.10.014</ArticleId><ArticleId IdType="pubmed">31928792</ArticleId></ArticleIdList></Reference><Reference><Citation>Farzam K., Jan A.  [(accessed on 10 October 2024)];Beta Blockers. Encyclopedia of Toxicology.  (4th ed.). 2023 Volume 2:V2-33&#x2013;V2-37. Volume 1&#x2013;9 [Internet] Available online:  https://www.ncbi.nlm.nih.gov/books/NBK532906/</Citation></Reference><Reference><Citation>Tiemuerniyazi X., Nan Y., Song Y., Yang Z., Zhao W., Xu F., Feng W. Effect of &#x3b2;-blocker on patients with moderate functional mitral regurgitation undergoing surgical aortic valve replacement. ESC Heart Fail. 2022;9:3317&#x2013;3326. doi: 10.1002/ehf2.14053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.14053</ArticleId><ArticleId IdType="pmc">PMC9715846</ArticleId><ArticleId IdType="pubmed">35822509</ArticleId></ArticleIdList></Reference><Reference><Citation>Windle S., Stannard D. Perioperative Beta-Blockers for Preventing Surgery-Related Mortality and Morbidity in Adults Undergoing Non-Cardiac Surgery. J. Perianesth. Nurs. 2021;36:730&#x2013;731. doi: 10.1016/j.jopan.2021.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jopan.2021.08.006</ArticleId><ArticleId IdType="pubmed">34886953</ArticleId></ArticleIdList></Reference><Reference><Citation>Halvorsen S., Mehilli J., Cassese S., Hall T.S., Abdelhamid M., Barbato E., De Hert S., de Laval I., Geisler T., Hinterbuchner L., et al. 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. Eur. Heart J. 2022;43:3826&#x2013;3924. doi: 10.1093/eurheartj/ehac270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac270</ArticleId><ArticleId IdType="pubmed">36017553</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37572568</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-1913</ISSN><JournalIssue CitedMedium="Internet"><Volume>204</Volume><PubDate><Year>2023</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>The American journal of cardiology</Title><ISOAbbreviation>Am J Cardiol</ISOAbbreviation></Journal><ArticleTitle>Meta-Analysis of the Outcomes of Peri-Device Leak After Left Atrial Appendage Closure.</ArticleTitle><Pagination><StartPage>325</StartPage><EndPage>332</EndPage><MedlinePgn>325-332</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.amjcard.2023.07.102</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0002-9149(23)00635-5</ELocationID><Abstract><AbstractText>Left atrial appendage closure (LAAC) reduces the risk of thromboembolic stroke in atrial fibrillation. Peri-device leak (PDL) after LAAC may affect the subsequent risk of thromboembolism. We conducted a systematic review and meta-analysis to evaluate the effect of PDL after LAAC. We searched PubMed/Medline, Embase, and Google Scholar for studies reporting outcomes of PDL after LAAC from inception through October 2022. The primary outcome was the composite of stroke, transient ischemic attack (TIA), or systemic embolism (SE). Secondary outcomes included all-cause and cardiovascular mortality, ischemic stroke, TIA, and device-related thrombus. Outcomes were pooled using random-effects models. We used I<sup>2</sup> statistics to assess statistical heterogeneity; I<sup>2</sup> &gt;50% considered significant heterogeneity. This study included 54,279 patients from 11 studies (6 observational, 2 nonrandomized controlled trials [non-RCTs] primary results, 2 RCT post hoc analyses, and 1 analysis combining 2 RCTs data). PDL was associated with a significant increase in the composite outcome of stroke, TIA, or SE (odds ratio 1.63, 95% confidence interval 1.06 to 2.52, p&#xa0;=&#xa0;0.03, I<sup>2</sup>&#xa0;=&#xa0;43%) as compared with cases with no PDL. There were no significant differences in all-cause or cardiovascular mortality, ischemic stroke, TIA, or device-related thrombus. In conclusion, PDL after LAAC is associated with an increased risk of thromboembolism (composite stroke, TIA, or SE) without impacting mortality.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mostafa</LastName><ForeName>Mostafa Reda</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Medicine, Rochester Regional Health, Unity Hospital, Rochester, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eid</LastName><ForeName>Mohamed Magdi</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Medicine, Rochester Regional Health, Unity Hospital, Rochester, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abuelazm</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Abdouh</LastName><ForeName>Ahmad</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Kentucky, Lexington, Kentucky.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Najim</LastName><ForeName>Mostafa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Rochester Regional Health, Unity Hospital, Rochester, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hassan</LastName><ForeName>Abdul Rhman</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Sakka</LastName><ForeName>Amro A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Renjithal</LastName><ForeName>Sarath Lal Mannumbeth</ForeName><Initials>SLM</Initials><AffiliationInfo><Affiliation>Department of Medicine, Rochester Regional Health, Unity Hospital, Rochester, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malik</LastName><ForeName>Muhammad Ahmed</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Medicine, Rochester Regional Health, Unity Hospital, Rochester, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohamed</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, Cairo University School of Medicine, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balmer-Swain</LastName><ForeName>Mallory</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department Cardiology, Rochester Regional Health, Unity Hospital, Rochester, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paul</LastName><ForeName>Timir K</ForeName><Initials>TK</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, University of Tennessee at Nashville, Ascension St. Thomas Hospital, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldsweig</LastName><ForeName>Andrew M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Baystate Medical Center and University of Massachusetts-Baystate, Springfield, Massachusetts. Electronic address: goldsa04@nyu.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Cardiol</MedlineTA><NlmUniqueID>0207277</NlmUniqueID><ISSNLinking>0002-9149</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020517" MajorTopicYN="Y">Atrial Appendage</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="Y">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004617" MajorTopicYN="Y">Embolism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="Y">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000083242" MajorTopicYN="Y">Ischemic Stroke</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013923" MajorTopicYN="Y">Thromboembolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="Y">Thrombosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">LARIAT</Keyword><Keyword MajorTopicYN="N">Watchman device</Keyword><Keyword MajorTopicYN="N">amulet device</Keyword><Keyword MajorTopicYN="N">atrial fibrillation</Keyword><Keyword MajorTopicYN="N">left atrial appendage closure</Keyword><Keyword MajorTopicYN="N">left atrial appendage occlusion</Keyword><Keyword MajorTopicYN="N">peri-device leak</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest Dr Goldsweig is a consultant at Inari Medical and receives speaking fees from Philips, Edwards. The remaining authors have no competing interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>13</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>12</Day><Hour>18</Hour><Minute>8</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37572568</ArticleId><ArticleId IdType="doi">10.1016/j.amjcard.2023.07.102</ArticleId><ArticleId IdType="pii">S0002-9149(23)00635-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33264235</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1529-7535</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies</Title><ISOAbbreviation>Pediatr Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Echocardiographic Parameters and Mortality in Pediatric Sepsis: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>251</StartPage><EndPage>261</EndPage><MedlinePgn>251-261</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/PCC.0000000000002622</ELocationID><Abstract><AbstractText Label="OBJECTIVE">We conducted a systematic review and meta-analysis to investigate the prognostic value of echocardiographic parameters in pediatric septic patients.</AbstractText><AbstractText Label="DATA SOURCES">MEDLINE, PubMed, and EMBASE (last update April 5, 2020).</AbstractText><AbstractText Label="STUDY SELECTION">Observational studies of pediatric sepsis providing echocardiographic parameters in relation to mortality.</AbstractText><AbstractText Label="DATA EXTRACTION">Echocardiography data were categorized as those describing left ventricular systolic or diastolic function, right ventricular function, and strain echocardiography parameters. Data from neonates and children were considered separately. Analysis is reported as standardized mean difference and 95% CI.</AbstractText><AbstractText Label="DATA SYNTHESIS">We included data from 14 articles (n = 5 neonates, n = 9 children). The fractional shortening was the most commonly reported variable (11 studies, n = 555 patients) and we did not identify an association with mortality (standardized mean difference 0.22, 95% CI [-0.02 to 0.47]; p = 0.07, I2 = 28%). In addition, we did not find any association with mortality also for left ventricular ejection fraction (nine studies, n = 417; standardized mean difference 0.06, 95% CI [-0.27 to 0.40]; p = 0.72, I2 = 51%), peak velocity of systolic mitral annular motion determined by tissue Doppler imaging wave (four studies, n = 178; standardized mean difference -0.01, 95% CI [-0.34 to 0.33]; p = 0.97, I2 = 0%), and myocardial performance index (five studies, n = 219; standardized mean difference -0.51, 95% CI [-1.10 to 0.08]; p = 0.09, I2 = 63%). However, in regard to left ventricular diastolic function, there was an association with mortality for higher early wave of transmitral flow/peak velocity of early diastolic mitral annular motion determined by tissue Doppler imaging ratio (four studies, n = 189, standardized mean difference -0.45, 95% CI [-0.80 to -0.10]; p = 0.01, I2 = 0%) or lower peak velocity of early diastolic mitral annular motion determined by tissue Doppler imaging wave (three studies, n = 159; standardized mean difference 0.49, 95% CI [0.13-0.85]; p = 0.008, I2 = 0%). We did not find any association with mortality for early wave of transmitral flow/late (atrial) wave of trans-mitral flow ratio (six studies, n = 273; standardized mean difference 0.28, 95% CI [-0.42 to 0.99]; p = 0.43, I2 = 81%) and peak velocity of systolic mitral annular motion determined by tissue Doppler imaging wave measured at the tricuspid annulus (three studies, n = 148; standardized mean difference -0.18, 95% CI [-0.53 to 0.17]; p = 0.32, I2 = 0%). Only a few studies were conducted with strain echocardiography.</AbstractText><AbstractText Label="CONCLUSIONS">This meta-analysis of echocardiography parameters in pediatric sepsis failed to find any association between the measures of left ventricular systolic or right ventricular function and mortality. However, mortality was associated with higher early wave of transmitral flow/peak velocity of early diastolic mitral annular motion determined by tissue Doppler imaging or lower peak velocity of early diastolic mitral annular motion determined by tissue Doppler imaging, indicating possible importance of left ventricular diastolic dysfunction. These are preliminary findings because of high clinical heterogeneity in the studies to date.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sanfilippo</LastName><ForeName>Filippo</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, A.O.U. "Policlinico-Vittorio Emanuele," Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>La Rosa</LastName><ForeName>Valeria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>School of Anaesthesia and Intensive Care, University Hospital "G. Rodolico," University of Catania, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grasso</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Anaesthesia and Intensive Care, University Hospital "G. Rodolico," University of Catania, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santonocito</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, A.O.U. "Policlinico-Vittorio Emanuele," Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minardi</LastName><ForeName>Carmelo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, A.O.U. "Policlinico-Vittorio Emanuele," Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveri</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, A.O.U. "Policlinico-Vittorio Emanuele," Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iacobelli</LastName><ForeName>Roberta</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pediatric Cardiology and Cardiac Surgery, Pediatric Cardiology Unit, Bambino Gesu' Hospital, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Astuto</LastName><ForeName>Marinella</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, A.O.U. "Policlinico-Vittorio Emanuele," Catania, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Anaesthesia and Intensive Care, University Hospital "G. Rodolico," University of Catania, Catania, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of General Surgery and Medical-Surgical Specialties, Section of Anesthesia and Intensive Care, University of Catania, Catania, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pediatr Crit Care Med</MedlineTA><NlmUniqueID>100954653</NlmUniqueID><ISSNLinking>1529-7535</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Pediatr Crit Care Med. 2021 Mar 1;22(3):329-332. doi: 10.1097/PCC.0000000000002671.</RefSource><PMID Version="1">33657615</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001783" MajorTopicYN="N">Blood Flow Velocity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="N">Echocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018619" MajorTopicYN="N">Echocardiography, Doppler, Pulsed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016277" MajorTopicYN="Y">Ventricular Function, Left</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have disclosed that they do not have any potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>2</Day><Hour>17</Hour><Minute>11</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33264235</ArticleId><ArticleId IdType="doi">10.1097/PCC.0000000000002622</ArticleId><ArticleId IdType="pii">00130478-202103000-00004</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, et al.: The global burden of paediatric and neonatal sepsis: A systematic review. Lancet Respir Med. 2018; 6:223&#x2013;230</Citation></Reference><Reference><Citation>Liu L, Oza S, Hogan D, et al.: Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: An updated systematic analysis. Lancet. 2015; 385:430&#x2013;440</Citation></Reference><Reference><Citation>Weiss SL, Fitzgerald JC, Pappachan J, et al.; Sepsis Prevalence, Outcomes, and Therapies (SPROUT) Study Investigators and Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Global epidemiology of pediatric severe sepsis: The sepsis prevalence, outcomes, and therapies study. Am J Respir Crit Care Med. 2015; 191:1147&#x2013;1157</Citation></Reference><Reference><Citation>Kaur G, Vinayak N, Mittal K, et al.: Clinical outcome and predictors of mortality in children with sepsis, severe sepsis, and septic shock from Rohtak, Haryana: A prospective observational study. Indian J Crit Care Med. 2014; 18:437&#x2013;441</Citation></Reference><Reference><Citation>Goldstein B, Giroir B, Randolph A; International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005; 6:2&#x2013;8</Citation></Reference><Reference><Citation>Raj S, Killinger JS, Gonzalez JA, et al.: Myocardial dysfunction in pediatric septic shock. J Pediatr. 2014; 164:72&#x2013;77.e2</Citation></Reference><Reference><Citation>Sanfilippo F, Orde S, Oliveri F, et al.: The challenging diagnosis of septic cardiomyopathy. Chest. 2019; 156:635&#x2013;636</Citation></Reference><Reference><Citation>Weiss SL, Balamuth F, Hensley J, et al.: The epidemiology of hospital death following pediatric severe sepsis: When, why, and how children with sepsis die. Pediatr Crit Care Med. 2017; 18:823&#x2013;830</Citation></Reference><Reference><Citation>Weiss SL, Peters MJ, Alhazzani W, et al.: Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Pediatr Crit Care Med. 2020; 21:e52&#x2013;e106</Citation></Reference><Reference><Citation>Davis AL, Carcillo JA, Aneja RK, et al.: American College of Critical Care Medicine clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock. Crit Care Med. 2017; 45:1061&#x2013;1093</Citation></Reference><Reference><Citation>Expert Round Table on Echocardiography in ICU. International consensus statement on training standards for advanced critical care echocardiography. Intensive Care Med. 2014; 40:654&#x2013;666</Citation></Reference><Reference><Citation>Vieillard-Baron A, Millington SJ, Sanfilippo F, et al.: A decade of progress in critical care echocardiography: A narrative review. Intensive Care Med. 2019; 45:770&#x2013;788</Citation></Reference><Reference><Citation>Sanfilippo F, Corredor C, Arcadipane A, et al.: Tissue Doppler assessment of diastolic function and relationship with mortality in critically ill septic patients: A systematic review and meta-analysis. Br J Anaesth. 2017; 119:583&#x2013;594</Citation></Reference><Reference><Citation>Sanfilippo F, Corredor C, Fletcher N, et al.: Diastolic dysfunction and mortality in septic patients: A systematic review and meta-analysis. Intensive Care Med. 2015; 41:1004&#x2013;1013</Citation></Reference><Reference><Citation>Sanfilippo F, Corredor C, Fletcher N, et al.: Erratum to: Diastolic dysfunction and mortality in septic patients: A systematic review and meta-analysis. Intensive Care Med. 2015; 41:1178&#x2013;1179</Citation></Reference><Reference><Citation>Sanfilippo F, Corredor C, Fletcher N, et al.: Left ventricular systolic function evaluated by strain echocardiography and relationship with mortality in patients with severe sepsis or septic shock: A systematic review and meta-analysis. Crit Care. 2018; 22:183</Citation></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, et al.: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. J Clin Epidemiol. 2009; 62:e1&#x2013;34</Citation></Reference><Reference><Citation>Luo D, Wan X, Liu J, et al.: Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018; 27:1785&#x2013;1805</Citation></Reference><Reference><Citation>Wan X, Wang W, Liu J, et al.: Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014; 14:135</Citation></Reference><Reference><Citation>Wells G, Shea B, O&#x2019;Connell D, et al.: The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-Analyses. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm . Accessed July 10, 2020</Citation></Reference><Reference><Citation>Jain A, Sankar J, Anubhuti A, et al.: Prevalence and outcome of sepsis-induced myocardial dysfunction in children with &#x2018;sepsis&#x2019; &#x2018;with&#x2019; and &#x2018;without shock&#x2019;-a prospective observational study. J Trop Pediatr. 2018; 64:501&#x2013;509</Citation></Reference><Reference><Citation>Sankar J, Das RR, Jain A, et al.: Prevalence and outcome of diastolic dysfunction in children with fluid refractory septic shock&#x2013;a prospective observational study. Pediatr Crit Care Med. 2014; 15:e370&#x2013;e378</Citation></Reference><Reference><Citation>Abdel-Hady HE, Matter MK, El-Arman MM: Myocardial dysfunction in neonatal sepsis: A tissue Doppler imaging study. Pediatr Crit Care Med. 2012; 13:318&#x2013;323</Citation></Reference><Reference><Citation>Baranwal AK, Deepthi G, Rohit MK, et al.: Longitudinal study of CPK-MB and echocardiographic measures of myocardial dysfunction in pediatric sepsis: Are patients with shock different from those without? Indian J Crit Care Med. 2020; 24:109&#x2013;115</Citation></Reference><Reference><Citation>Domico M, Liao P, Anas N, et al.: Elevation of brain natriuretic peptide levels in children with septic shock. Pediatr Crit Care Med. 2008; 9:478&#x2013;483</Citation></Reference><Reference><Citation>El-Zayat RS, Shalaby AG: Mitral annular plane systolic excursion as a predictor of mortality in children with septic shock. Pediatr Crit Care Med. 2018; 19:e486&#x2013;e494</Citation></Reference><Reference><Citation>Fahmey SS, Hodeib M, Refaat K, et al.: Evaluation of myocardial function in neonatal sepsis using tissue Doppler imaging. Journal Matern Fetal Neonatal Med. 2019; 33:3752&#x2013;3756</Citation></Reference><Reference><Citation>Li J, Ning B, Wang Y, et al.: The prognostic value of left ventricular systolic function and cardiac biomarkers in pediatric severe sepsis. Medicine (Baltimore). 2019; 98:e15070</Citation></Reference><Reference><Citation>Tomerak RH, El-Badawy AA, Hussein G, et al.: Echocardiogram done early in neonatal sepsis: What does it add? J Invest Med. 2012; 60:680&#x2013;684</Citation></Reference><Reference><Citation>Williams FZ, Sachdeva R, Travers CD, et al.: Characterization of myocardial dysfunction in fluid- and catecholamine-refractory pediatric septic shock and its clinical significance. J Intensive Care Med. 2019; 34:17&#x2013;25</Citation></Reference><Reference><Citation>Wu JR, Chen IC, Dai ZK, et al.: Early elevated b-type natriuretic peptide levels are associated with cardiac dysfunction and poor clinical outcome in pediatric septic patients. Acta Cardiol Sin. 2015; 31:485&#x2013;493</Citation></Reference><Reference><Citation>Carmona F, Manso PH, Silveira VS, et al.: Inflammation, myocardial dysfunction, and mortality in children with septic shock: An observational study. Pediatr Cardiol. 2014; 35:463&#x2013;470</Citation></Reference><Reference><Citation>Patel MD, Mariano K, Dunbar T, et al.: Cardiac dysfunction identified by strain echocardiography is associated with illness severity in pediatric sepsis. Pediatr Crit Care Med. 2020; 21:e192&#x2013;e199</Citation></Reference><Reference><Citation>Saini SS, Kumar P, Kumar RM: Hemodynamic changes in preterm neonates with septic shock: A prospective observational study*. Pediatr Crit Care Med. 2014; 15:443&#x2013;450</Citation></Reference><Reference><Citation>Haileselassie B, Su E, Pozios I, et al.: Strain echocardiography parameters correlate with disease severity in children and infants with sepsis. Pediatr Crit Care Med. 2016; 17:383&#x2013;390</Citation></Reference><Reference><Citation>Basu S, Frank LH, Fenton KE, et al.: Two-dimensional speckle tracking imaging detects impaired myocardial performance in children with septic shock, not recognized by conventional echocardiography. Pediatr Crit Care Med. 2012; 13:259&#x2013;264</Citation></Reference><Reference><Citation>Huang S, Sanfilippo F, Herpain A, et al.: Systematic review and literature appraisal on methodology of conducting and reporting critical-care echocardiography studies: A report from the European Society of Intensive Care Medicine PRICES expert panel. Ann Intensive Care. 2020; 10:49</Citation></Reference><Reference><Citation>Sanfilippo F, Scolletta S, Morelli A, et al.: Practical approach to diastolic dysfunction in light of the new guidelines and clinical applications in the operating room and in the intensive care. Ann Intensive Care. 2018; 8:100</Citation></Reference><Reference><Citation>Dallaire F, Slorach C, Hui W, et al.: Reference values for pulse wave Doppler and tissue Doppler imaging in pediatric echocardiography. Circ Cardiovasc Imaging. 2015; 8:e002167</Citation></Reference><Reference><Citation>Nagueh SF, Smiseth OA, Appleton CP, et al.; Houston, Texas; Oslo, Norway; Phoenix, Arizona; Nashville, Tennessee; Hamilton, Ontario, Canada; Uppsala, Sweden; Ghent and Li&#xe8;ge, Belgium; Cleveland, Ohio; Novara, Italy; Rochester, Minnesota; Bucharest, Romania; and St. Louis, Missouri. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016; 17:1321&#x2013;1360</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30870677</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>13</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4529</ISSN><JournalIssue CitedMedium="Internet"><Volume>57</Volume><PubDate><Year>2019</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of clinical anesthesia</Title><ISOAbbreviation>J Clin Anesth</ISOAbbreviation></Journal><ArticleTitle>High-dose versus low-dose opioid anesthesia in adult cardiac surgery: A meta-analysis.</ArticleTitle><Pagination><StartPage>57</StartPage><EndPage>62</EndPage><MedlinePgn>57-62</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinane.2019.03.009</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0952-8180(19)30046-7</ELocationID><Abstract><AbstractText Label="STUDY OBJECTIVE" NlmCategory="OBJECTIVE">We performed a systematic comparison of high-dose and low-dose opioid anesthesia in cardiac surgery.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Systematic review and meta-analysis of randomized controlled trials (RCTs).</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Operating room.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">1400 adult patients undergoing cardiac surgery using general anesthesia.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">All RCTs comparing the effects of various doses of intravenous opioids (morphine, fentanyl, sufentanil, and remifentanil) during adult cardiac surgery using general anesthesia published until May 2018 (full-text English articles reporting data from human subjects) were included.</AbstractText><AbstractText Label="MEASUREMENTS" NlmCategory="METHODS">Primary outcome was intensive care unit (ICU) length of stay (LOS). Secondary outcomes were ventilation time, use of vasopressors, perioperative myocardial infarction, perioperative stroke, and hospital LOS.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">Eighteen articles were included (1400 patients). There was no difference in ICU LOS between studies using high or low dose of opioids (both short-acting and long-acting) (standard mean difference [SMD]-0.02, 95%CI: -0.15-0.11, P&#x202f;=&#x202f;0.74). Similarly, there was no difference in secondary outcomes of ventilation time (SMD-0.27, 95%CI: -0.63-0.09, P&#x202f;=&#x202f;0.14), use of vasopressors (OR 0.61, 95%CI: 0.29-1.30, P&#x202f;=&#x202f;0.20), myocardial infarction (risk difference 0.00, 95% CI: -0.02-0.03, P&#x202f;=&#x202f;0.70), stroke (RD 0.00, 95% CI: -0.01-0.01, P&#x202f;=&#x202f;0.92) and hospital LOS (SMD 0.03, 95% CI: -0.26-0.33, P&#x202f;=&#x202f;0.84). At meta-regression, there was no effect of age, gender, or type of opioid on the difference between groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our data suggest that low-dose opioids, both short acting and long acting, are safe and effective to use in adult cardiac surgery patients, independent of the clinical characteristics of the patients and the type of opioid used. In view of the current opioid epidemic, low-dose opioid anesthesia should be considered for cardiac surgery patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rong</LastName><ForeName>Lisa Q</ForeName><Initials>LQ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Weill Cornell Medicine/New York Presbyterian, NY, NY, USA. Electronic address: lir9065@med.cornell.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamel</LastName><ForeName>Mohamed K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Weill Cornell Medicine/New York Presbyterian, NY, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahouma</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Weill Cornell Medicine/New York Presbyterian, NY, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naik</LastName><ForeName>Ajita</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Weill Cornell Medicine/New York Presbyterian, NY, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>Kritika</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Weill Cornell Medicine/New York Presbyterian, NY, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abouarab</LastName><ForeName>Ahmed A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Weill Cornell Medicine/New York Presbyterian, NY, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Franco</LastName><ForeName>Antonino</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Weill Cornell Medicine/New York Presbyterian, NY, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Demetres</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Samuel J. Wood Library &amp; C.V. Starr Biomedical Information Center, Weill Cornell Medicine, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mustapich</LastName><ForeName>Taylor L</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Weill Cornell Medicine/New York Presbyterian, NY, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fitzgerald</LastName><ForeName>Meghann M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Weill Cornell Medicine/New York Presbyterian, NY, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pryor</LastName><ForeName>Kane O</ForeName><Initials>KO</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Weill Cornell Medicine/New York Presbyterian, NY, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaudino</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Weill Cornell Medicine/New York Presbyterian, NY, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Anesth</MedlineTA><NlmUniqueID>8812166</NlmUniqueID><ISSNLinking>0952-8180</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000701">Analgesics, Opioid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000701" MajorTopicYN="N">Analgesics, Opioid</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiac anesthesia</Keyword><Keyword MajorTopicYN="N">Cardiac surgery</Keyword><Keyword MajorTopicYN="N">Fast-track anesthesia</Keyword><Keyword MajorTopicYN="N">Opioids</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30870677</ArticleId><ArticleId IdType="doi">10.1016/j.jclinane.2019.03.009</ArticleId><ArticleId IdType="pii">S0952-8180(19)30046-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31882332</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-0938</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>7</Issue><PubDate><Year>2020</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Cardiovascular revascularization medicine : including molecular interventions</Title><ISOAbbreviation>Cardiovasc Revasc Med</ISOAbbreviation></Journal><ArticleTitle>Efficacy and Safety of Transcarotid Transcatheter Aortic Valve Replacement: A Systematic Review.</ArticleTitle><Pagination><StartPage>917</StartPage><EndPage>926</EndPage><MedlinePgn>917-926</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.carrev.2019.12.012</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1553-8389(19)30808-5</ELocationID><Abstract><AbstractText Label="BACKGROUND">In patients who are not suitable for traditional access routes for transcatheter aortic valve replacement (TAVR) due to severe peripheral vascular disease (PVD) or prohibitive surgical risk, carotid artery (CA) access is an emerging route for TAVR. This study represents the most up to date on outcomes of carotid access TAVR.</AbstractText><AbstractText Label="METHODS">A systematic review was conducted as per the Preferred Reporting Instructions for Systematic Reviews and Meta-analysis (PRISMA). We performed a thorough electronic search through Pubmed, SCOPUS and Embase databases. Statistical analyses were performed using SPSS version 24 (IBM Corporation, Armonk, New York, USA).</AbstractText><AbstractText Label="RESULTS">A total of 15 non-randomized studies were included in this systematic review comprising of patients that received TAVR via 4 vascular access sites, transcarotid (TC) (N&#x202f;=&#x202f;1035), transfemoral (TF) (N&#x202f;=&#x202f;1116), transapical (TAP) (N&#x202f;=&#x202f;307), transaortic (TAO) (N&#x202f;=&#x202f;176) and transaxillary (TAX) (N&#x202f;=&#x202f;90). In the Transcarotid cases, device success was achieved in 95.6% of patients (n&#x202f;=&#x202f;748). The 30-day and 1-yr mortality was 4.2% and 10.5% respectively. 15.3% of patients required new pacemaker implantation. In-hospital stroke or TIA occurred in 4% of cases. 30-day stroke or TIA occurred in 5% of cases. There were no hemorrhagic strokes. 30-day Mortality was significantly higher in the Transaortic group (12.1%) compared to the Transcarotid group (2.6%) [RR&#x202f;=&#x202f;2.93 95% CI&#x202f;=&#x202f;1.15-7.58; p&#x202f;=&#x202f;0.027]. There were no differences in outcomes between the Transcarotid group and the Transapical or Transaxillary groups.</AbstractText><AbstractText Label="CONCLUSION">The most contemporary data on Carotid access TAVR shows impressive device success, low rates of stroke and pacemaker implantation and an acceptable 30-day and 1-year mortality. 30-day mortality was significantly lower in TC compared to TAO patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bob-Manuel</LastName><ForeName>Tamunoinemi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>John Ochsner Heart and Vascular Center, New Orleans, LA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almusawi</LastName><ForeName>Hussein</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Hospital Medicine, Leonard J Charbert Medical Center, Houma, LA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rezan</LastName><ForeName>Tameem</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>John Ochsner Heart and Vascular Center, New Orleans, LA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khaira</LastName><ForeName>Harmanjot</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>John Ochsner Heart and Vascular Center, New Orleans, LA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akingbola</LastName><ForeName>Akinbolaji</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>John Ochsner Heart and Vascular Center, New Orleans, LA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nasir</LastName><ForeName>Ayman</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>John Ochsner Heart and Vascular Center, New Orleans, LA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soto</LastName><ForeName>Jose Tafur</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>John Ochsner Heart and Vascular Center, New Orleans, LA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jenkins</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>John Ochsner Heart and Vascular Center, New Orleans, LA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ibebuogu</LastName><ForeName>Uzoma N</ForeName><Initials>UN</Initials><AffiliationInfo><Affiliation>Division of Cardiology, University of Tennessee Health Science Center, Memphis, TN, USA. Electronic address: uibebuog@uthsc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cardiovasc Revasc Med</MedlineTA><NlmUniqueID>101238551</NlmUniqueID><ISSNLinking>1878-0938</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001024" MajorTopicYN="N">Aortic Valve Stenosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="N">Arrhythmias, Cardiac</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002304" MajorTopicYN="N">Cardiac Pacing, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002339" MajorTopicYN="Y">Carotid Arteries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002406" MajorTopicYN="Y">Catheterization, Peripheral</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="N">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011677" MajorTopicYN="N">Punctures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065467" MajorTopicYN="Y">Transcatheter Aortic Valve Replacement</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Carotid access</Keyword><Keyword MajorTopicYN="N">Safety</Keyword><Keyword MajorTopicYN="N">Severe aortic stenosis</Keyword><Keyword MajorTopicYN="N">TAVR</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31882332</ArticleId><ArticleId IdType="doi">10.1016/j.carrev.2019.12.012</ArticleId><ArticleId IdType="pii">S1553-8389(19)30808-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28901120</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1827-1596</ISSN><JournalIssue CitedMedium="Internet"><Volume>83</Volume><Issue>11</Issue><PubDate><Year>2017</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Minerva anestesiologica</Title><ISOAbbreviation>Minerva Anestesiol</ISOAbbreviation></Journal><ArticleTitle>Perioperative stroke: incidence, etiologic factors, and prevention.</ArticleTitle><Pagination><StartPage>1178</StartPage><EndPage>1189</EndPage><MedlinePgn>1178-1189</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.23736/S0375-9393.17.11976-0</ELocationID><Abstract><AbstractText>Stroke is a devastating complication that is difficult to diagnose in the perioperative setting because of the effects of anesthetic and analgesic agents. Lingering anesthesia effects hinder clinicians in identifying stroke symptoms, frequently resulting in a delay in diagnosis and treatment and in unfavorable outcomes. The authors performed a systematic search in PubMed and the Cochrane Central Register. The search aimed to identify studies published between January 1990 and December 2015 related to the common etiologic factors, incidence, risk factors, risk modifiers, and early management of perioperative stroke. Additional articles were identified after review of the references of selected articles. Although perioperative stroke is uncommon, the mortality rate is high. Patients have higher risk of perioperative stroke when undergoing cardiac and vascular operations than uncomplicated orthopedic and general procedures. Preoperative optimization for preexisting risk factors may reduce the rate of perioperative stroke. Prompt, early management can improve patient outcomes. Recognition of the incidence, risk factors, and causes of perioperative stroke may lead to prevention and proper management.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pai</LastName><ForeName>Sher-Lu</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Jacksonville, FL, USA - pai.sherlu@mayo.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>R Doris</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aniskevich</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Minerva Anestesiol</MedlineTA><NlmUniqueID>0375272</NlmUniqueID><ISSNLinking>0375-9393</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="Y">Intraoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28901120</ArticleId><ArticleId IdType="doi">10.23736/S0375-9393.17.11976-0</ArticleId><ArticleId IdType="pii">S0375-9393.17.11976-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39493352</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2292-5503</ISSN><JournalIssue CitedMedium="Print"><Volume>32</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Plastic surgery (Oakville, Ont.)</Title><ISOAbbreviation>Plast Surg (Oakv)</ISOAbbreviation></Journal><ArticleTitle>Local/Regional Anesthesia Versus General Anesthesia in Phalanx Fractures/Dislocations.</ArticleTitle><Pagination><StartPage>646</StartPage><EndPage>652</EndPage><MedlinePgn>646-652</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/22925503231180886</ELocationID><Abstract><AbstractText><b>Background:</b> Traditionally, surgical repair of phalanx fractures was performed under general anesthesia. However, the emergence of regional and local anesthesia, otherwise known as Wide-awake Local Anesthesia No Tourniquet, provides an alternative approach where general anesthesia is undesirable. The choice of anesthetic approach resides with clinicians, though it is important to factor in the evidence that regional/local provides not only an alternative anesthesia approach but also potentially avoids comorbidities associated with general anesthesia. This study hypothesizes that the use of local/regional anesthesia for phalanx fracture/dislocation has comparable outcomes to general anesthesia and provides for fewer adverse events. <b>Methods:</b> To answer the research purpose, the investigators designed and implemented a retrospective cohort study of consecutive cases reported to the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database between January 1, 2015, and December 31, 2019. The study population included patients in the NSQIP database who underwent operative fixation of a phalanx fracture or dislocation in 2 cohorts, those with local/regional anesthesia or general anesthesia. The predictor variables were preoperative patient demographic data, including age, gender, surgical specialty, elective surgery, diabetes, smoking, hypertension, and open wound. <b>Results:</b> A total of 2831 patients were identified in the NSQIP database between January 1, 2015, and December 31, 2019. Local/regional anesthesia was performed in 13% of patients with the remaining 87% receiving general anesthesia. Surgical site occurrences were not clinically significant between the 2 groups. Overall, 30-day post-operative complications in the local/regional cohort included one patient with a deep vein thrombosis (0.03%) and pulmonary embolus (0.02%). Overall, 30-day post-operative complications in the general anesthesia cohort included pneumonia (0.12%) and stroke (0.08%). <b>Conclusions:</b> Surgery using the regional/local anesthesia techniques for patients with phalanx fractures or dislocations is safe and can be used in situations where general anesthesia is undesirable as post-operative 30-day complications are similar to those with general anesthesia.</AbstractText><CopyrightInformation>&#xa9; 2023 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rich</LastName><ForeName>Matthew D</ForeName><Initials>MD</Initials><Identifier Source="ORCID">0000-0002-6183-5883</Identifier><AffiliationInfo><Affiliation>Division of Plastic Surgery, Department of Surgery, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rauzi</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Plastic Surgery, Department of Surgery, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sorenson</LastName><ForeName>Thomas J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Department of Plastic Surgery, NYU Langone, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hillard</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Plastic Surgery, Department of Surgery, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Plastic and Hand Surgery, Regions Hospital, Saint Paul, MN, USA.</Affiliation><Identifier Source="RINGGOLD">7031</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahajan</LastName><ForeName>Ashish Y</ForeName><Initials>AY</Initials><AffiliationInfo><Affiliation>Division of Plastic Surgery, Department of Surgery, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Plastic and Hand Surgery, Regions Hospital, Saint Paul, MN, USA.</Affiliation><Identifier Source="RINGGOLD">7031</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Plast Surg (Oakv)</MedlineTA><NlmUniqueID>101623618</NlmUniqueID><ISSNLinking>2292-5503</ISSNLinking></MedlineJournalInfo><OtherAbstract Type="Publisher" Language="fre"><AbstractText><b>Contexte:</b> La r&#xe9;paration chirurgicale des fractures de phalanges se faisait traditionnellement sous anesth&#xe9;sie g&#xe9;n&#xe9;rale. Cependant, l&#x2019;&#xe9;mergence de l&#x2019;anesth&#xe9;sie r&#xe9;gionale et locale, &#xe9;galement appel&#xe9;e anesth&#xe9;sie locale sur patient &#xe9;veill&#xe9; sans garrot (WALANT) offre une alternative lorsqu&#x2019;une anesth&#xe9;sie g&#xe9;n&#xe9;rale n&#x2019;est pas souhaitable. Le choix de l&#x2019;approche anesth&#xe9;sique d&#xe9;pend des cliniciens bien qu&#x2019;il soit important de prendre en compte le fait que l&#x2019;anesth&#xe9;sie r&#xe9;gionale/locale offre non seulement une autre approche, mais qu&#x2019;elle peut aussi &#xe9;viter les comorbidit&#xe9;s associ&#xe9;es &#xe0; l&#x2019;anesth&#xe9;sie g&#xe9;n&#xe9;rale. Cette &#xe9;tude a pos&#xe9; comme hypoth&#xe8;se que le recours &#xe0; l&#x2019;anesth&#xe9;sie locale/r&#xe9;gionale pour les fractures/dislocations de phalanges obtenait des r&#xe9;sultats comparables &#xe0; l&#x2019;anesth&#xe9;sie g&#xe9;n&#xe9;rale et &#xe9;tait associ&#xe9;e &#xe0; moins d&#x2019;&#xe9;v&#xe9;nements ind&#xe9;sirables. <b>M&#xe9;thodes:</b> Pour r&#xe9;pondre &#xe0; l&#x2019;objectif de la recherche, les chercheurs ont con&#xe7;u et mis en place une &#xe9;tude r&#xe9;trospective de cohorte de cas cons&#xe9;cutifs d&#xe9;clar&#xe9;s dans la base de donn&#xe9;es du Programme national d&#x2019;am&#xe9;lioration de la qualit&#xe9; chirurgicale (NSQIP) de l&#x2019;American College of Surgeons entre le 1er janvier 2015 et le 31 d&#xe9;cembre 2019. La population de l&#x2019;&#xe9;tude a inclus les patients de la base de donn&#xe9;es NSQIP ayant subi la r&#xe9;paration chirurgicale d&#x2019;une fracture ou d&#x2019;une dislocation de phalange dans deux cohortes : une cohorte de patients op&#xe9;r&#xe9;s sous anesth&#xe9;sie locale/r&#xe9;gionale et une cohorte de patients op&#xe9;r&#xe9;s sous anesth&#xe9;sie g&#xe9;n&#xe9;rale. Les variables pr&#xe9;dictives &#xe9;taient les donn&#xe9;es d&#xe9;mographiques pr&#xe9;op&#xe9;ratoires des patients incluant leur &#xe2;ge, sexe, la sp&#xe9;cialit&#xe9; chirurgicale, la chirurgie programm&#xe9;e, l&#x2019;existence d&#x2019;un diab&#xe8;te, de tabagisme, d&#x2019;hypertension et d&#x2019;une plaie ouverte. <b>R&#xe9;sultats:</b> Au total, 2831 patients ont &#xe9;t&#xe9; identifi&#xe9;s dans la base de donn&#xe9;es NSQIP entre le 1er janvier 2015 et le 31 d&#xe9;cembre 2019. Une anesth&#xe9;sie locale/r&#xe9;gionale a &#xe9;t&#xe9; r&#xe9;alis&#xe9;e chez 13 % des patients; une anesth&#xe9;sie g&#xe9;n&#xe9;rale a &#xe9;t&#xe9; utilis&#xe9;e pour les autres 87 % des patients. L&#x2019;emplacement du site chirurgical n&#x2019;a pas eu une signification clinique entre les deux groupes. Globalement, les complications postop&#xe9;ratoires &#xe0; 30 jours dans la cohorte d&#x2019;anesth&#xe9;sie locale/r&#xe9;gionale ont inclus un patient ayant une TVP (0,03 %) et une embolie pulmonaire (0,02 %). Globalement, les complications postop&#xe9;ratoires dans la cohorte d&#x2019;anesth&#xe9;sie g&#xe9;n&#xe9;rale ont inclus des pneumonies (0,12 %) et un AVC (0,08 %). <b>Conclusion:</b> La chirurgie faisant appel aux techniques d&#x2019;anesth&#xe9;sie locale/r&#xe9;gionale pour les patients atteints de fractures ou de luxations de phalanges est s&#xe9;curitaire et peut &#xea;tre utilis&#xe9;e dans les cas o&#xf9; l&#x2019;anesth&#xe9;sie g&#xe9;n&#xe9;rale n&#x2019;est pas souhaitable puisque les complications postop&#xe9;ratoires &#xe0; 30 jours sont comparables &#xe0; celles de l&#x2019;anesth&#xe9;sie g&#xe9;n&#xe9;rale.</AbstractText><CopyrightInformation>&#xa9; 2023 The Author(s).</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">WALANT</Keyword><Keyword MajorTopicYN="N">local anesthesia</Keyword><Keyword MajorTopicYN="N">local/regional anesthesia</Keyword><Keyword MajorTopicYN="N">phalanx dislocation</Keyword><Keyword MajorTopicYN="N">phalanx fracture</Keyword><Keyword MajorTopicYN="N">upper extremity</Keyword></KeywordList><CoiStatement>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>4</Day><Hour>5</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39493352</ArticleId><ArticleId IdType="pmc">PMC11528577</ArticleId><ArticleId IdType="doi">10.1177/22925503231180886</ArticleId><ArticleId IdType="pii">10.1177_22925503231180886</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chan VW, Peng, PW, Kaszas Z, Middleton WJ, Muni R, Anastakis DG. et al. A comparative study of general anesthesia, intravenous regional anesthesia, and axillary block for outpatient hand surgery: clinical outcome and cost analysis. Anesth Analg. 2001;93(5):1181-1184.</Citation><ArticleIdList><ArticleId IdType="pubmed">11682392</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadzic A, Arliss J, Kerimoglu B, Karaca P, Yufa M, Claudio R, et al. A comparison of infraclavicular nerve block versus general anesthesia for hand and wrist day-case surgeries. Anesthesiology. 2004;101(1):127-132.</Citation><ArticleIdList><ArticleId IdType="pubmed">15220781</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds M, Srinivasan RC, Person DW. Complications after clinic-based wide awake local anesthesia No tourniquet hand surgery at a single private practice. Hand (N Y). 2022. Sep;17(5):865-868:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9465789</ArticleId><ArticleId IdType="pubmed">33307838</ArticleId></ArticleIdList></Reference><Reference><Citation>Maliha SG, Cohen O, Jacoby A, Sharma S. et al. A cost and efficiency analysis of the WALANT technique for the management of trigger finger in a procedure room of a Major City Hospital. Plast Reconstr Surg Glob Open. 2019;7(11):e2509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6908359</ArticleId><ArticleId IdType="pubmed">31942301</ArticleId></ArticleIdList></Reference><Reference><Citation>https://www.facs.org/media/fcvlu3t0/nsqip_puf_user_guide_2015.pdf User Guide for the 2015 ACS NSQIP Participant Use Data File (PUF). 2016 [cited 2019 August]; User Manual].</Citation></Reference><Reference><Citation>Burke FD, Dias J, Heras Palou C, Bradley M, Wildin C, et al. Providing care for hand disorders a re-appraisal of need. J Hand Surg Br. 2004;29(6):575-579.</Citation><ArticleIdList><ArticleId IdType="pubmed">15542219</ArticleId></ArticleIdList></Reference><Reference><Citation>Connors KM, Guerra SM, Koehler SM. Current evidence involving WALANT surgery. J Hand Surg Glob Online. 2022 1;4(6):452-455.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9678641</ArticleId><ArticleId IdType="pubmed">36420465</ArticleId></ArticleIdList></Reference><Reference><Citation>Turrentine FE, Wang H, Simpson V, Jones S,et al. Surgical risk factors, morbidity, and mortality in elderly patients. J Am Coll Surg. 2006;203(6):865-877.</Citation><ArticleIdList><ArticleId IdType="pubmed">17116555</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurtzman JS Etcheson JI, Koehler SM. Wide-awake local anesthesia with No tourniquet: an updated review. Plast Reconstr Surg Glob Open. 2021;9(3):e3507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7997095</ArticleId><ArticleId IdType="pubmed">33786267</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Neill N, Abdall-Razak A, Norton E, Kumar A, Shah H, Khatkar H, et al. Use of Wide-Awake Local Anaesthetic No Tourniquet (WALANT) in upper limb and hand surgery: a systematic review protocol. Int J Surg Protoc. 2020;20:8-12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7125343</ArticleId><ArticleId IdType="pubmed">32258835</ArticleId></ArticleIdList></Reference><Reference><Citation>Pina M, Cusano A, LeVasseur M, Olivieri-Ortiz R, Ferreira J, Parrino A . et al. Wide awake local anesthesia no tourniquet technique in hand surgery: the patient experience. Hand (N Y). 2021;18(4):655&#x2013;661.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10233642</ArticleId><ArticleId IdType="pubmed">34872360</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris M, Chung F. Complications of general anesthesia. Clin Plast Surg. 2013;40(4):503-513.</Citation><ArticleIdList><ArticleId IdType="pubmed">24093647</ArticleId></ArticleIdList></Reference><Reference><Citation>Ad&#x131;yeke E, Ad&#x131;yeke L. Factors affecting general or regional anesthesia preference in patients with elective surgery: factors of general or regional anesthesia preference. Med Sci Discov. 2020;7(7):570-574.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39488717</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>03</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1475-2840</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>02</Day></PubDate></JournalIssue><Title>Cardiovascular diabetology</Title><ISOAbbreviation>Cardiovasc Diabetol</ISOAbbreviation></Journal><ArticleTitle>Association between stress hyperglycemia ratio and postoperative major adverse cardiovascular and cerebrovascular events in noncardiac surgeries: a large perioperative cohort study.</ArticleTitle><Pagination><StartPage>392</StartPage><MedlinePgn>392</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">392</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12933-024-02467-w</ELocationID><Abstract><AbstractText Label="BACKGROUND">There has been a concerning rise in the incidence of major adverse cardiovascular and cerebrovascular events (MACCE) following noncardiac surgeries (NCS), significantly impacting surgical outcomes and patient prognosis. Glucose metabolism abnormalities induced by stress response under acute medical conditions may be a risk factor for postoperative MACCE. This study aims to explore the association between stress hyperglycemia ratio (SHR) and postoperative MACCE in patients undergoing general anesthesia for NCS.</AbstractText><AbstractText Label="METHODS">There were 12,899 patients in this perioperative cohort study. The primary outcome was MACCE within 30 days postoperatively, defined as angina, acute myocardial infarction, cardiac arrest, arrhythmia, heart failure, stroke, or in-hospital all-cause mortality. Kaplan-Meier curves visualized the cumulative incidence of MACCE. Cox proportional hazard models were utilized to assess the association between the risk of MACCE and different SHR groups. Restricted cubic spline analyses were conducted to explore potential nonlinear relationships. Additionally, exploratory subgroup analyses and sensitivity analyses were performed.</AbstractText><AbstractText Label="RESULTS">A total of 592 (4.59%) participants experienced MACCE within 30 days after surgery, and 1,045 (8.10%) within 90 days. After adjusting for confounding factors, compared to the SHR T2 group, the risk of MACCE within 30 days after surgery increased by 1.34 times (95% CI 1.08-1.66) in the T3 group and by 1.35 times (95% CI 1.08-1.68) in the T1 group respectively. In the non-diabetes group, the risk of MACCE within 30 days after surgery increased by 1.60 times (95% CI 1.21-2.12) in the T3 group and by 1.61 times (95% CI 1.21-2.14) in the T1 group respectively, while no statistically significant increase in risk was observed in the diabetes group. Similar results were observed within 90 days after surgery in the non-diabetes group. Additionally, a statistically significant U-shaped nonlinear relationship was observed in the non-diabetes group (30 days: P for nonlinear&#x2009;=&#x2009;0.010; 90 days: P for nonlinear&#x2009;=&#x2009;0.008).</AbstractText><AbstractText Label="CONCLUSION">In this large perioperative cohort study, we observed that both higher and lower SHR were associated with an increased risk of MACCE within 30 and 90 days after NCS, especially in patients without diabetes. These findings suggest that SHR potentially plays a key role in stratifying cardiovascular and cerebrovascular risk after NCS.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Lyu</LastName><ForeName>Zhihan</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, No. 639 Zhizaoju Road, Shanghai, 200011, China. lvzhihan@sjtu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Ji</LastName><ForeName>Yunxi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Yuhang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Big Data and Artificial Intelligence, Chizhou University, Chizhou, Anhui, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cardiovasc Diabetol</MedlineTA><NlmUniqueID>101147637</NlmUniqueID><ISSNLinking>1475-2840</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="Y">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="Y">Blood Glucose</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="Y">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002561" MajorTopicYN="Y">Cerebrovascular Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006943" MajorTopicYN="Y">Hyperglycemia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="Y">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cohort study</Keyword><Keyword MajorTopicYN="N">Complications</Keyword><Keyword MajorTopicYN="N">Diabetes mellitus</Keyword><Keyword MajorTopicYN="N">Major adverse cardiovascular and cerebrovascular events</Keyword><Keyword MajorTopicYN="N">Noncardiac surgery</Keyword><Keyword MajorTopicYN="N">Perioperative medicine</Keyword><Keyword MajorTopicYN="N">Stress hyperglycemia ratio</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>3</Day><Hour>0</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39488717</ArticleId><ArticleId IdType="pmc">PMC11531114</ArticleId><ArticleId IdType="doi">10.1186/s12933-024-02467-w</ArticleId><ArticleId IdType="pii">10.1186/s12933-024-02467-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Weiser TG, Haynes AB, Molina G, Lipsitz SR, Esquivel MM, Uribe-Leitz T, et al. Estimate of the global volume of surgery in 2012: an assessment supporting improved health outcomes. Lancet Lond Engl. 2015;385(Suppl 2):S11.</Citation><ArticleIdList><ArticleId IdType="pubmed">26313057</ArticleId></ArticleIdList></Reference><Reference><Citation>Smilowitz NR, Gupta N, Ramakrishna H, Guo Y, Berger JS, Bangalore S. Perioperative major adverse cardiovascular and cerebrovascular events associated with noncardiac surgery. JAMA Cardiol. 2017;2:181&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5563847</ArticleId><ArticleId IdType="pubmed">28030663</ArticleId></ArticleIdList></Reference><Reference><Citation>Haynes AB, Weiser TG, Berry WR, Lipsitz SR, Breizat A-HS, Dellinger EP, et al. A surgical safety checklist to reduce morbidity and mortality in a global population. N Engl J Med. 2009;360:491&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">19144931</ArticleId></ArticleIdList></Reference><Reference><Citation>Vascular Events In Noncardiac Surgery Patients Cohort Evaluation (VISION), Study Investigators, Devereaux PJ, Chan MTV, Alonso-Coello P, Walsh M, Berwanger O, et al. Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA. 2012;307:2295&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pubmed">22706835</ArticleId></ArticleIdList></Reference><Reference><Citation>Sessler DI, Meyhoff CS, Zimmerman NM, Mao G, Leslie K, V&#xe1;squez SM, et al. Period-dependent associations between Hypotension during and for four days after noncardiac surgery and a composite of myocardial infarction and death: a Substudy of the POISE-2 trial. Anesthesiology. 2018;128:317&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">29189290</ArticleId></ArticleIdList></Reference><Reference><Citation>Semel ME, Lipsitz SR, Funk LM, Bader AM, Weiser TG, Gawande AA. Rates and patterns of death after surgery in the United States, 1996 and 2006. Surgery. 2012;151:171&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">21975292</ArticleId></ArticleIdList></Reference><Reference><Citation>Devereaux PJ, Sessler DI. Cardiac complications in patients undergoing major noncardiac surgery. N Engl J Med. 2015;373:2258&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">26630144</ArticleId></ArticleIdList></Reference><Reference><Citation>Frisch A, Chandra P, Smiley D, Peng L, Rizzo M, Gatcliffe C, et al. Prevalence and clinical outcome of hyperglycemia in the Perioperative period in noncardiac surgery. Diabetes Care. 2010;33:1783&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2909062</ArticleId><ArticleId IdType="pubmed">20435798</ArticleId></ArticleIdList></Reference><Reference><Citation>Sazgary L, Puelacher C, Lurati Buse G, Glarner N, Lampart A, Bolliger D, et al. Incidence of major adverse cardiac events following non-cardiac surgery. Eur Heart J Acute Cardiovasc Care. 2021;10:550&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8245139</ArticleId><ArticleId IdType="pubmed">33620378</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang AW, Yoon JA, Mirsaidi N, Schulman-Rosenbaum RC. Perioperative management of blood glucose in adults with diabetes mellitus. In: Schulman-Rosenbaum RC, editor. Diabetes Manag Hosp Patients Compr Clin Guide. Cham: Springer International Publishing; 2023. pp. 267&#x2013;86. 10.1007/978-3-031-44648-1_19</Citation></Reference><Reference><Citation>Hatzakorzian R, Bui H, Carvalho G, Shan WLP, Sidhu S, Schricker T. Fasting blood glucose levels in patients presenting for elective surgery. Nutr Burbank Los Angel Cty Calif. 2011;27:298&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="pubmed">20541364</ArticleId></ArticleIdList></Reference><Reference><Citation>Piironen K, Putaala J, Rosso C, Samson Y. Glucose and acute stroke: evidence for an interlude. Stroke. 2012;43:898&#x2013;902.</Citation><ArticleIdList><ArticleId IdType="pubmed">22343652</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Zhang Q, Gu H, Zhou Q, Li Z, Zhao X. Comparison of stress hyperglycemia ratio and glycemic gap on acute ICH in-hospital outcomes. Ann Clin Transl Neurol. 2024;11:1492&#x2013;501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11187964</ArticleId><ArticleId IdType="pubmed">38590111</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Z, Liang X, Zhang Y, Dai Y, Zeng L, Chen W, et al. Positive association between stress hyperglycemia ratio and pulmonary infection in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention. Cardiovasc Diabetol. 2023;22:76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10067314</ArticleId><ArticleId IdType="pubmed">37004002</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao S, Liu Q, Ding X, Chen H, Zhao X, Li H. Predictive value of the Acute-to-chronic glycemic ratio for In-Hospital outcomes in patients with ST-Segment Elevation myocardial infarction undergoing percutaneous coronary intervention. Angiology. 2020;71:38&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6886151</ArticleId><ArticleId IdType="pubmed">31554413</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Liu L, Huang H, Li N, He J, Yao H, et al. Stress hyperglycemia ratio and in-hospital prognosis in non-surgical patients with heart failure and type 2 diabetes. Cardiovasc Diabetol. 2022;21:290.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9791974</ArticleId><ArticleId IdType="pubmed">36572923</ArticleId></ArticleIdList></Reference><Reference><Citation>Glumac S, Kardum G, Sodic L, Bulat C, Covic I, Carev M, et al. Longitudinal assessment of preoperative dexamethasone administration on cognitive function after cardiac surgery: a 4-year follow-up of a randomized controlled trial. BMC Anesthesiol. 2021;21:129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8063389</ArticleId><ArticleId IdType="pubmed">33892653</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah AD, Langenberg C, Rapsomaniki E, Denaxas S, Pujades-Rodriguez M, Gale CP, et al. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1&#xb7;9 million people. Lancet Diabetes Endocrinol. 2015;3:105&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4303913</ArticleId><ArticleId IdType="pubmed">25466521</ArticleId></ArticleIdList></Reference><Reference><Citation>Dal Canto E, Ceriello A, Ryd&#xe9;n L, Ferrini M, Hansen TB, Schnell O, et al. Diabetes as a cardiovascular risk factor: an overview of global trends of macro and micro vascular complications. Eur J Prev Cardiol. 2019;26:25&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">31722562</ArticleId></ArticleIdList></Reference><Reference><Citation>Dungan KM, Braithwaite SS, Preiser J-C. Stress hyperglycaemia. Lancet Lond Engl. 2009;373:1798&#x2013;807.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3144755</ArticleId><ArticleId IdType="pubmed">19465235</ArticleId></ArticleIdList></Reference><Reference><Citation>Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87:978&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">11889147</ArticleId></ArticleIdList></Reference><Reference><Citation>Long MT, Anderson AL, Curry TB. What is new in perioperative dysglycemia? Intensive Care Med. 2022;48:1230&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">35916913</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Boom W, Schroeder RA, Manning MW, Setji TL, Fiestan G-O, Dunson DB. Effect of A1C and glucose on postoperative mortality in Noncardiac and Cardiac surgeries. Diabetes Care. 2018;41:782&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">29440113</ArticleId></ArticleIdList></Reference><Reference><Citation>Krinsley JS, Rule PR, Roberts GW, Brownlee M, Preiser J-C, Chaudry S, et al. Relative hypoglycemia and lower hemoglobin A1c-Adjusted time in Band are strongly Associated with increased mortality in critically ill patients. Crit Care Med. 2022;50:e664&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">35132022</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts GW, Quinn SJ, Valentine N, Alhawassi T, O&#x2019;Dea H, Stranks SN, et al. Relative hyperglycemia, a marker of critical illness: introducing the stress hyperglycemia ratio. J Clin Endocrinol Metab. 2015;100:4490&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">26485219</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Zheng Y, Li C, Gao J, Meng X, Zhang K, et al. The impact of the stress hyperglycemia ratio on short-term and long-term poor prognosis in patients with Acute Coronary Syndrome: insight from a large cohort study in Asia. Diabetes Care. 2022;45:947&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">35045167</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdu FA, Galip J, Qi P, Zhang W, Mohammed A-Q, Liu L, et al. Association of stress hyperglycemia ratio and poor long-term prognosis in patients with myocardial infarction with non-obstructive coronary arteries. Cardiovasc Diabetol. 2023;22:11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9843969</ArticleId><ArticleId IdType="pubmed">36647062</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui K, Fu R, Yang J, Xu H, Yin D, Song W, et al. Stress hyperglycemia ratio and long-term mortality after acute myocardial infarction in patients with and without diabetes: a prospective, nationwide, and multicentre registry. Diabetes Metab Res Rev. 2022;38:e3562.</Citation><ArticleIdList><ArticleId IdType="pubmed">35772392</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo J, Li Z, Qin X, Zhang X, Liu X, Zhang W, et al. Association of stress hyperglycemia ratio with in-hospital new-onset atrial fibrillation and long-term outcomes in patients with acute myocardial infarction. Diabetes Metab Res Rev. 2024;40:e3726.</Citation><ArticleIdList><ArticleId IdType="pubmed">37712510</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie E, Ye Z, Wu Y, Zhao X, Li Y, Shen N, et al. Predictive value of the stress hyperglycemia ratio in dialysis patients with acute coronary syndrome: insights from a multi-center observational study. Cardiovasc Diabetol. 2023;22:288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10612265</ArticleId><ArticleId IdType="pubmed">37891639</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim L, Lee H, Jung C-W, Sim D, Borrat X, Pollard TJ, et al. INSPIRE, a publicly available research dataset for perioperative medicine. Sci Data. 2024;11:655.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11192876</ArticleId><ArticleId IdType="pubmed">38906912</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew MS, Puelacher C, Patel A, Hammarskj&#xf6;ld F, Lyckner S, Kollind M, et al. Identification of myocardial injury using perioperative troponin surveillance in major noncardiac surgery and net benefit over the revised Cardiac Risk Index. Br J Anaesth. 2022;128:26&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">34857357</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabat&#xe9; S, Mases A, Guilera N, Canet J, Castillo J, Orrego C, et al. Incidence and predictors of major perioperative adverse cardiac and cerebrovascular events in non-cardiac surgery. Br J Anaesth. 2011;107:879&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">21890661</ArticleId></ArticleIdList></Reference><Reference><Citation>Saugel B, Sessler DI. Perioperative blood pressure management. Anesthesiology. 2021;134:250&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">33206118</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrenfeld JM, Funk LM, Van Schalkwyk J, Merry AF, Sandberg WS, Gawande A. The incidence of hypoxemia during surgery: evidence from two institutions. Can J Anaesth J Can Anesth. 2010;57:888&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2991088</ArticleId><ArticleId IdType="pubmed">20680710</ArticleId></ArticleIdList></Reference><Reference><Citation>van Buuren S, Groothuis-Oudshoorn K. Mice: multivariate imputation by chained equations in R. J Stat Softw. 2011;45:1&#x2013;67.</Citation></Reference><Reference><Citation>Behnoush AH, Maleki S, Arzhangzadeh A, Khalaji A, Pezeshki PS, Vaziri Z, et al. Prediabetes and major adverse cardiac events after acute coronary syndrome: an overestimated concept. Clin Cardiol. 2024;47:e24262.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10983809</ArticleId><ArticleId IdType="pubmed">38558072</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J, Oh AR, Lee S-H, Lee J-H, Min JJ, Kwon J-H, et al. Associations between preoperative glucose and hemoglobin A1c level and myocardial Injury after noncardiac surgery. J Am Heart Assoc. 2021;10:e019216.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8174354</ArticleId><ArticleId IdType="pubmed">33728934</ArticleId></ArticleIdList></Reference><Reference><Citation>Paolisso P, Bergamaschi L, Rambaldi P, Gatta G, Fo&#xe0; A, Angeli F, et al. Impact of admission hyperglycemia on heart failure events and mortality in patients with Takotsubo Syndrome at Long-Term Follow-up: data from HIGH-GLUCOTAKO investigators. Diabetes Care. 2021;44:2158&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">34187841</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon JA, Kim DY, Sohn MK, Lee J, Lee S-G, Lee Y-S, et al. Effect of stress hyperglycemia and intensive rehabilitation therapy in non-diabetic hemorrhagic stroke: Korean stroke cohort for Functioning and Rehabilitation. Eur J Neurol. 2016;23:1658&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">27444813</ArticleId></ArticleIdList></Reference><Reference><Citation>Desilles J-P, Meseguer E, Labreuche J, Lapergue B, Sirimarco G, Gonzalez-Valcarcel J, et al. Diabetes mellitus, admission glucose, and outcomes after stroke thrombolysis: a registry and systematic review. Stroke. 2013;44:1915&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">23704108</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation. 2005;111:3078&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">15939812</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Qian J, Yan W, Liu X, Zhao Y, Che L. Relationship between hyperglycaemia at admission and prognosis in patients with acute myocardial infarction: a retrospective cohort study. Postgrad Med J. 2022;pmj-2021-141454.</Citation><ArticleIdList><ArticleId IdType="pubmed">37130824</ArticleId></ArticleIdList></Reference><Reference><Citation>Demarchi A, Cornara S, Somaschini A, Fortuni F, Mandurino-Mirizzi A, Crimi G, et al. Has hyperglycemia a different prognostic role in STEMI patients with or without diabetes? Nutr Metab Cardiovasc Dis NMCD. 2021;31:528&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">33223396</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W, Yang Y-M, Zhu J, Wu S, Wang J, Zhang H, et al. Predictive value of the stress hyperglycemia ratio in patients with acute ST-segment elevation myocardial infarction: insights from a multi-center observational study. Cardiovasc Diabetol. 2022;21:48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8962934</ArticleId><ArticleId IdType="pubmed">35351149</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Zhou Y, Huang H, Liu R, Kang Y, Zhu T, et al. Impact of stress hyperglycemia ratio on mortality in patients with critical acute myocardial infarction: insight from American MIMIC-IV and the Chinese CIN-II study. Cardiovasc Diabetol. 2023;22:281.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10589959</ArticleId><ArticleId IdType="pubmed">37865764</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Kim T-H, Yoon K-H, Chung WS, Ahn Y, Jeong M-H, et al. The stress hyperglycemia ratio, an index of relative hyperglycemia, as a predictor of clinical outcomes after percutaneous coronary intervention. Int J Cardiol. 2017;241:57&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">28256326</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R, et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes. 2008;57:1349&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">18299315</ArticleId></ArticleIdList></Reference><Reference><Citation>Punthakee Z, Iglesias PP, Alonso-Coello P, Gich I, India I, Malaga G, et al. Association of preoperative glucose concentration with myocardial injury and death after non-cardiac surgery (GlucoVISION): a prospective cohort study. Lancet Diabetes Endocrinol. 2018;6:790&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7028328</ArticleId><ArticleId IdType="pubmed">30057170</ArticleId></ArticleIdList></Reference><Reference><Citation>Marik PE, Zaloga GP. Adrenal insufficiency in the critically ill: a new look at an old problem. Chest. 2002;122:1784&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">12426284</ArticleId></ArticleIdList></Reference><Reference><Citation>Mifsud S, Schembri EL, Gruppetta M. Stress-induced hyperglycaemia. Br J Hosp Med Lond Engl 2005. 2018;79:634&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">30418830</ArticleId></ArticleIdList></Reference><Reference><Citation>Jh V, Jc B. Neuroendocrine and behavioral consequences of hyperglycemia in cancer. Endocrinology. 2020;161. https://pubmed.ncbi.nlm.nih.gov/32193527/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7174055</ArticleId><ArticleId IdType="pubmed">32193527</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C-J, Liao W-I, Wang J-C, Tsai C-L, Lee J-T, Peng G-S, et al. Usefulness of glycated hemoglobin A1c-based adjusted glycemic variables in diabetic patients presenting with acute ischemic stroke. Am J Emerg Med. 2017;35:1240&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">28363620</ArticleId></ArticleIdList></Reference><Reference><Citation>Preiser J-C, Provenzano B, Mongkolpun W, Halenarova K, Cnop M. Perioperative management of oral glucose-lowering drugs in the patient with type 2 diabetes. Anesthesiology. 2020;133:430&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">32667156</ArticleId></ArticleIdList></Reference><Reference><Citation>Mongkolpun W, Provenzano B, Preiser J-C. Updates in Glycemic Management in the hospital. Curr Diabetes Rep. 2019;19:133.</Citation><ArticleIdList><ArticleId IdType="pubmed">31748830</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieuwdorp M, van Haeften TW, Gouverneur MCLG, Mooij HL, van Lieshout MHP, Levi M, et al. Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes. 2006;55:480&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">16443784</ArticleId></ArticleIdList></Reference><Reference><Citation>Stegenga ME, van der Crabben SN, Bl&#xfc;mer RME, Levi M, Meijers JCM, Serlie MJ, et al. Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia. Blood. 2008;112:82&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2435690</ArticleId><ArticleId IdType="pubmed">18316629</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu J, Tang J, Lai Y, Gao Y, Ye Z, Guan C, et al. Association of stress hyperglycemia ratio with intracoronary thrombus burden in diabetic patients with ST-segment elevation myocardial infarction. J Thorac Dis. 2020;12:6598&#x2013;608.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7711417</ArticleId><ArticleId IdType="pubmed">33282361</ArticleId></ArticleIdList></Reference><Reference><Citation>Stalikas N, Papazoglou AS, Karagiannidis E, Panteris E, Moysidis D, Daios S, et al. Association of stress induced hyperglycemia with angiographic findings and clinical outcomes in patients with ST-elevation myocardial infarction. Cardiovasc Diabetol. 2022;21:140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9327277</ArticleId><ArticleId IdType="pubmed">35883091</ArticleId></ArticleIdList></Reference><Reference><Citation>McNamara JJ, Mills D, Aaby GV. Effect of hypertonic glucose on hemorrhagic shock in rabbits. Ann Thorac Surg. 1970;9:116&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">5410974</ArticleId></ArticleIdList></Reference><Reference><Citation>Malfitano C, Alba Loureiro TC, Rodrigues B, Sirvente R, Salemi VMC, Rabechi NB, et al. Hyperglycaemia protects the heart after myocardial infarction: aspects of programmed cell survival and cell death. Eur J Heart Fail. 2010;12:659&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">20406798</ArticleId></ArticleIdList></Reference><Reference><Citation>Losser M-R, Damoisel C, Payen D. Bench-to-bedside review: glucose and stress conditions in the intensive care unit. Crit Care Lond Engl. 2010;14:231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2945096</ArticleId><ArticleId IdType="pubmed">20727232</ArticleId></ArticleIdList></Reference><Reference><Citation>Ausk KJ, Boyko EJ, Ioannou GN. Insulin resistance predicts mortality in nondiabetic individuals in the U.S. Diabetes Care. 2010;33:1179&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2875420</ArticleId><ArticleId IdType="pubmed">20200308</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedblad B, Nilsson P, Engstr&#xf6;m G, Berglund G, Janzon L. Insulin resistance in non-diabetic subjects is associated with increased incidence of myocardial infarction and death. Diabet Med J Br Diabet Assoc. 2002;19:470&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">12060058</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv Z, Ji Y, Xu S, Li C, Cai W. Chinese visceral adiposity index and its transition patterns: impact on cardiovascular and cerebrovascular diseases in a national cohort study. Lipids Health Dis. 2024;23:124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11057120</ArticleId><ArticleId IdType="pubmed">38685072</ArticleId></ArticleIdList></Reference><Reference><Citation>Haneuse S, VanderWeele TJ, Arterburn D. Using the E-Value to assess the potential effect of unmeasured confounding in observational studies. JAMA. 2019;321:602&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">30676631</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39586050</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1526-632X</ISSN><JournalIssue CitedMedium="Internet"><Volume>103</Volume><Issue>12</Issue><PubDate><Year>2024</Year><Month>Dec</Month><Day>24</Day></PubDate></JournalIssue><Title>Neurology</Title><ISOAbbreviation>Neurology</ISOAbbreviation></Journal><ArticleTitle>Incident Stroke After First-Time TIA According to ABCD<sup>2</sup> Score: A Nationwide Cohort Study.</ArticleTitle><Pagination><StartPage>e210053</StartPage><MedlinePgn>e210053</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1212/WNL.0000000000210053</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES" NlmCategory="OBJECTIVE">Transient ischemic attack (TIA) is associated with a higher short-term incidence of stroke. However, long-term data on this association are lacking. Therefore, this study aimed to determine the long-term incidence of ischemic stroke after TIA according to ABCD<sup>2</sup> score and to identify factors associated with stroke after TIA.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">All Danish patients &#x2265;18 years with first-time TIA were included from the Danish Stroke Registry (2014-2020). The study population was stratified into a high-risk (&#x2265;4 points) and low-risk (&lt;4 points) group according to the modified ABCD<sup>2</sup> score (age &#x2265;60 years, hypertension, clinical features, and diabetes). The 3-year cumulative incidence of stroke and all-cause mortality was assessed using the Aalen-Johansen and Kaplan-Meier estimators, respectively. Factors associated with 3-year stroke rate were identified using multivariable Cox regression models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 21,433 patients with first-time TIA were included: 1,280 (6.0%) in the high-risk group and 20,153 (94.0%) in the low-risk group. Patients with high-risk ABCD<sup>2</sup> scores were older (median 77.5 [P25-P75 70.8-84.1] vs 70.3 [P25-P75 60.1-78.2]), more often female (53.1%), had more comorbidities (e.g., ischemic heart disease, heart failure, and atrial fibrillation), and received more medication (e.g., any antiplatelet therapy or oral anticoagulants and cholesterol-lowering drugs) at baseline. The 3-year cumulative incidence of stroke after TIA was 6.0% (95% CI 4.6-7.5) in the high-risk group and 4.2% (95% CI 3.9-4.5) in the low-risk group (<i>p</i> = 0.004) with an unadjusted hazard ratio (HR) 1.56 (95% CI 1.21-2.00). Factors associated with 3-year stroke rate included age &#x2265;60 years (HR 2.21, 95% CI 1.76-2.78), current smoking (HR 1.37, 95% CI 1.13-1.65), unilateral weakness (HR 1.25, 95% CI 1.04-1.51), peripheral artery disease (HR 1.53, 95% CI 1.09-2.14), and chronic kidney disease (HR 1.39, 95% CI 1.01-1.90). The 3-year cumulative incidence of all-cause mortality was 28.9% (95% CI 26.1-31.7) in the high-risk group and 10.3% (95% CI 9.9-10.8) in the low-risk group.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Patients with high-risk ABCD<sup>2</sup> score had an almost 60% higher associated long-term rate of ischemic stroke compared with those with low-risk ABCD<sup>2</sup> score. Future trials focusing on preventive strategies, including evidence-based antithrombotic strategies, especially for the high-risk group are warranted.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Al-Chaer</LastName><ForeName>Katia</ForeName><Initials>K</Initials><Identifier Source="ORCID">0009-0004-1046-6928</Identifier><AffiliationInfo><Affiliation>From the Department of Cardiology (K.A.C., A.A., N.E.V., J.H.B., M.N.K., L.K., E.F.), Rigshospitalet, Copenhagen University Hospital; Danish Center for Health Services Research (S.P.J.), Department of Clinical Medicine, Aalborg University; Department of Brain and Spinal Cord Injury (C.K.), Neuroscience Center, Rigshospitalet, Copenhagen University Hospital; Department of Cardiology (M.S.), Copenhagen University Hospital, Herlev and Gentofte; and Department of Cardiology and Clinical Investigation (C.T.-P.), Nordsj&#xe6;llands Hospital, Hiller&#xf8;d, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alhakak</LastName><ForeName>Amna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Department of Cardiology (K.A.C., A.A., N.E.V., J.H.B., M.N.K., L.K., E.F.), Rigshospitalet, Copenhagen University Hospital; Danish Center for Health Services Research (S.P.J.), Department of Clinical Medicine, Aalborg University; Department of Brain and Spinal Cord Injury (C.K.), Neuroscience Center, Rigshospitalet, Copenhagen University Hospital; Department of Cardiology (M.S.), Copenhagen University Hospital, Herlev and Gentofte; and Department of Cardiology and Clinical Investigation (C.T.-P.), Nordsj&#xe6;llands Hospital, Hiller&#xf8;d, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vinding</LastName><ForeName>Naja Emborg</ForeName><Initials>NE</Initials><AffiliationInfo><Affiliation>From the Department of Cardiology (K.A.C., A.A., N.E.V., J.H.B., M.N.K., L.K., E.F.), Rigshospitalet, Copenhagen University Hospital; Danish Center for Health Services Research (S.P.J.), Department of Clinical Medicine, Aalborg University; Department of Brain and Spinal Cord Injury (C.K.), Neuroscience Center, Rigshospitalet, Copenhagen University Hospital; Department of Cardiology (M.S.), Copenhagen University Hospital, Herlev and Gentofte; and Department of Cardiology and Clinical Investigation (C.T.-P.), Nordsj&#xe6;llands Hospital, Hiller&#xf8;d, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butt</LastName><ForeName>Jawad H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>From the Department of Cardiology (K.A.C., A.A., N.E.V., J.H.B., M.N.K., L.K., E.F.), Rigshospitalet, Copenhagen University Hospital; Danish Center for Health Services Research (S.P.J.), Department of Clinical Medicine, Aalborg University; Department of Brain and Spinal Cord Injury (C.K.), Neuroscience Center, Rigshospitalet, Copenhagen University Hospital; Department of Cardiology (M.S.), Copenhagen University Hospital, Herlev and Gentofte; and Department of Cardiology and Clinical Investigation (C.T.-P.), Nordsj&#xe6;llands Hospital, Hiller&#xf8;d, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karacan</LastName><ForeName>Munise N</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>From the Department of Cardiology (K.A.C., A.A., N.E.V., J.H.B., M.N.K., L.K., E.F.), Rigshospitalet, Copenhagen University Hospital; Danish Center for Health Services Research (S.P.J.), Department of Clinical Medicine, Aalborg University; Department of Brain and Spinal Cord Injury (C.K.), Neuroscience Center, Rigshospitalet, Copenhagen University Hospital; Department of Cardiology (M.S.), Copenhagen University Hospital, Herlev and Gentofte; and Department of Cardiology and Clinical Investigation (C.T.-P.), Nordsj&#xe6;llands Hospital, Hiller&#xf8;d, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnsen</LastName><ForeName>S&#xf8;ren Paaske</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>From the Department of Cardiology (K.A.C., A.A., N.E.V., J.H.B., M.N.K., L.K., E.F.), Rigshospitalet, Copenhagen University Hospital; Danish Center for Health Services Research (S.P.J.), Department of Clinical Medicine, Aalborg University; Department of Brain and Spinal Cord Injury (C.K.), Neuroscience Center, Rigshospitalet, Copenhagen University Hospital; Department of Cardiology (M.S.), Copenhagen University Hospital, Herlev and Gentofte; and Department of Cardiology and Clinical Investigation (C.T.-P.), Nordsj&#xe6;llands Hospital, Hiller&#xf8;d, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kruuse</LastName><ForeName>Christina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-4210-0523</Identifier><AffiliationInfo><Affiliation>From the Department of Cardiology (K.A.C., A.A., N.E.V., J.H.B., M.N.K., L.K., E.F.), Rigshospitalet, Copenhagen University Hospital; Danish Center for Health Services Research (S.P.J.), Department of Clinical Medicine, Aalborg University; Department of Brain and Spinal Cord Injury (C.K.), Neuroscience Center, Rigshospitalet, Copenhagen University Hospital; Department of Cardiology (M.S.), Copenhagen University Hospital, Herlev and Gentofte; and Department of Cardiology and Clinical Investigation (C.T.-P.), Nordsj&#xe6;llands Hospital, Hiller&#xf8;d, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schou</LastName><ForeName>Morten</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Department of Cardiology (K.A.C., A.A., N.E.V., J.H.B., M.N.K., L.K., E.F.), Rigshospitalet, Copenhagen University Hospital; Danish Center for Health Services Research (S.P.J.), Department of Clinical Medicine, Aalborg University; Department of Brain and Spinal Cord Injury (C.K.), Neuroscience Center, Rigshospitalet, Copenhagen University Hospital; Department of Cardiology (M.S.), Copenhagen University Hospital, Herlev and Gentofte; and Department of Cardiology and Clinical Investigation (C.T.-P.), Nordsj&#xe6;llands Hospital, Hiller&#xf8;d, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torp-Pedersen</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>From the Department of Cardiology (K.A.C., A.A., N.E.V., J.H.B., M.N.K., L.K., E.F.), Rigshospitalet, Copenhagen University Hospital; Danish Center for Health Services Research (S.P.J.), Department of Clinical Medicine, Aalborg University; Department of Brain and Spinal Cord Injury (C.K.), Neuroscience Center, Rigshospitalet, Copenhagen University Hospital; Department of Cardiology (M.S.), Copenhagen University Hospital, Herlev and Gentofte; and Department of Cardiology and Clinical Investigation (C.T.-P.), Nordsj&#xe6;llands Hospital, Hiller&#xf8;d, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#xf8;ber</LastName><ForeName>Lars</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-6635-1466</Identifier><AffiliationInfo><Affiliation>From the Department of Cardiology (K.A.C., A.A., N.E.V., J.H.B., M.N.K., L.K., E.F.), Rigshospitalet, Copenhagen University Hospital; Danish Center for Health Services Research (S.P.J.), Department of Clinical Medicine, Aalborg University; Department of Brain and Spinal Cord Injury (C.K.), Neuroscience Center, Rigshospitalet, Copenhagen University Hospital; Department of Cardiology (M.S.), Copenhagen University Hospital, Herlev and Gentofte; and Department of Cardiology and Clinical Investigation (C.T.-P.), Nordsj&#xe6;llands Hospital, Hiller&#xf8;d, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fosb&#xf8;l</LastName><ForeName>Emil</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>From the Department of Cardiology (K.A.C., A.A., N.E.V., J.H.B., M.N.K., L.K., E.F.), Rigshospitalet, Copenhagen University Hospital; Danish Center for Health Services Research (S.P.J.), Department of Clinical Medicine, Aalborg University; Department of Brain and Spinal Cord Injury (C.K.), Neuroscience Center, Rigshospitalet, Copenhagen University Hospital; Department of Cardiology (M.S.), Copenhagen University Hospital, Herlev and Gentofte; and Department of Cardiology and Clinical Investigation (C.T.-P.), Nordsj&#xe6;llands Hospital, Hiller&#xf8;d, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurology</MedlineTA><NlmUniqueID>0401060</NlmUniqueID><ISSNLinking>0028-3878</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="Y">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003718" MajorTopicYN="N" Type="Geographic">Denmark</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="Y">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000083242" MajorTopicYN="N">Ischemic Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>25</Day><Hour>18</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>25</Day><Hour>18</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>25</Day><Hour>16</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39586050</ArticleId><ArticleId IdType="doi">10.1212/WNL.0000000000210053</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38471194</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4529</ISSN><JournalIssue CitedMedium="Internet"><Volume>95</Volume><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of clinical anesthesia</Title><ISOAbbreviation>J Clin Anesth</ISOAbbreviation></Journal><ArticleTitle>Postoperative haemoglobin and anaemia-associated ischaemic events after major noncardiac surgery: A sex-stratified cohort study.</ArticleTitle><Pagination><StartPage>111439</StartPage><MedlinePgn>111439</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinane.2024.111439</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0952-8180(24)00068-0</ELocationID><Abstract><AbstractText Label="STUDY OBJECTIVE">To determine the sex-specific associations between postoperative haemoglobin and mortality or complications reflecting ischaemia or inadequate oxygen supply after major noncardiac surgery.</AbstractText><AbstractText Label="DESIGN">A retrospective cohort study with prospective validation.</AbstractText><AbstractText Label="SETTING">A large university hospital health system in China.</AbstractText><AbstractText Label="PATIENTS">Men and women undergoing elective major noncardiac surgery.</AbstractText><AbstractText Label="INTERVENTIONS AND MEASUREMENTS">The primary exposure was nadir haemoglobin within 48&#xa0;h after surgery. The outcome of interest was a composite of postoperative mortality or ischaemic events including myocardial injury, acute kidney injury and stroke within hospitalisation.</AbstractText><AbstractText Label="MAIN RESULTS">The study included 26,049 patients (15,757 men and 10,292 women). Low postoperative haemoglobin was a strong predictor of the composite outcome in both sexes, with the risk progressively increasing as the nadir haemoglobin concentration dropped below 130&#xa0;g&#xa0;l<sup>-1</sup> in men and 120&#xa0;g&#xa0;l<sup>-1</sup> in women (adjusted odds ratio [OR] 1.43, 95% CI 1.37-1.50 in men, and OR 1.45, 95% CI 1.35-1.55 in women, per 10&#xa0;g&#xa0;l<sup>-1</sup> decrease in postoperative nadir haemoglobin). Above these sex-specific thresholds, the change of nadir haemoglobin was no longer associated with odds of the composite outcome in either men or women. There was no significant interaction between patient sex and the association between postoperative haemoglobin and the composite outcome (Pinteraction&#xa0;=&#xa0;0.673). Validation in an external prospective cohort (n&#xa0;=&#xa0;2120) with systematic postoperative troponin and creatinine measurement confirmed our findings.</AbstractText><AbstractText Label="CONCLUSIONS">Postoperative haemoglobin levels following major noncardiac surgery were nonlinearly associated with ischaemic complications or mortality, without any clinically important interaction with patient sex.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Bing-Cheng</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Yi-Shan</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Wen-Chi</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>Shao-Hui</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jia-Ming</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Ye-Hong</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Wei-Feng</ForeName><Initials>WF</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China. Electronic address: sglwfeng01@21cn.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ke-Xuan</ForeName><Initials>KX</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China. Electronic address: liukexuan705@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Anesth</MedlineTA><NlmUniqueID>8812166</NlmUniqueID><ISSNLinking>0952-8180</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006454">Hemoglobins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006454" MajorTopicYN="Y">Hemoglobins</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000740" MajorTopicYN="Y">Anemia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007511" MajorTopicYN="N">Ischemia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anaemia</Keyword><Keyword MajorTopicYN="N">Haemoglobin</Keyword><Keyword MajorTopicYN="N">Noncardiac surgery</Keyword><Keyword MajorTopicYN="N">Patient blood management</Keyword><Keyword MajorTopicYN="N">Sex</Keyword></KeywordList><CoiStatement>Declaration of competing interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>28</Day><Hour>7</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>13</Day><Hour>0</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>12</Day><Hour>19</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38471194</ArticleId><ArticleId IdType="doi">10.1016/j.jclinane.2024.111439</ArticleId><ArticleId IdType="pii">S0952-8180(24)00068-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33039657</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-5568</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Anaesthesia, critical care &amp; pain medicine</Title><ISOAbbreviation>Anaesth Crit Care Pain Med</ISOAbbreviation></Journal><ArticleTitle>Anaesthesia and haemodynamic management of acute ischaemic stroke patients before, during and after endovascular therapy.</ArticleTitle><Pagination><StartPage>859</StartPage><EndPage>870</EndPage><MedlinePgn>859-870</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.accpm.2020.05.020</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2352-5568(20)30220-4</ELocationID><Abstract><AbstractText>Endovascular therapy (EVT) is now standard of care for eligible patients with acute ischaemic stroke caused by large vessel occlusion in the anterior circulation. EVT can be performed with general anaesthesia (GA) or with monitored anaesthesia care, involving local anaesthesia with or without conscious sedation (LA/CS). Controversies remain regarding the optimal choice of anaesthetic strategy and observational studies suggested poorer functional outcome and higher mortality in patients treated under GA, essentially because of its haemodynamic consequences and the delay to put patients under GA. However, these studies are limited by selection bias, the most severe patients being more likely to receive GA and recent randomised trials and meta-analysis showed that protocol-based GA compared with LA/CS is significantly associated with less disability at 3 months. Unlike for intravenous thrombolysis, few data exist to guide management of blood pressure (BP) before and during EVT, but arterial hypotension should be avoided as long as the occlusion persists. BP targets following EVT should probably be adapted to the degree of recanalisation and the extent of ischaemia. Lower BP levels may be warranted to prevent reperfusion injuries even if prospective haemodynamic management evaluations after EVT are lacking.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020. Published by Elsevier Masson SAS.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Valent</LastName><ForeName>Arnaud</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Critical Care, Lariboisi&#xe8;re Hospital, DMU Parabol, AP-HP Nord &amp; University of Paris, Paris, France; UMR-S 942 MASCOT, Inserm, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma&#xef;er</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Interventional Neuroradiology, Fondation Ophtalmologique Adolphe de Rothschild, 75019 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chabanne</LastName><ForeName>Russell</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Perioperative Medicine, University Hospital of Clermont-Ferrand, Clermont-Ferrand Cedex, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Degos</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Critical Care, Piti&#xe9; Salp&#xea;tri&#xe8;re Hospital, AP-HP-SU, Paris, France, Groupe recherche clinique BIOSFAST, Sorbonne University, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lapergue</LastName><ForeName>Bertrand</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Stroke Centre Neurology Division, H&#xf4;pital Foch, 92150, Suresnes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lukaszewicz</LastName><ForeName>Anne-Claire</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Service d'Anesth&#xe9;sie R&#xe9;animation, H&#xf4;pital Neurologique, Hospices Civils de Lyon, Bron, France; EA 7426 PI3 (Pathophysiology of Injury-induced Immunosuppression), Hospices Civils de Lyon/Universit&#xe9; de Lyon/bioM&#xe9;rieux, H&#xf4;pital E. Herriot, Lyon cedex 03, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazighi</LastName><ForeName>Mikael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology and Stroke Centre, Lariboisi&#xe8;re Hospital, AP-HP, Paris University, Sorbonne Paris Cit&#xe9;, Paris, France; D&#xe9;partement Hospitalo-Universistaire Neurovasc, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gayat</LastName><ForeName>Etienne</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Critical Care, Lariboisi&#xe8;re Hospital, DMU Parabol, AP-HP Nord &amp; University of Paris, Paris, France; UMR-S 942 MASCOT, Inserm, France. Electronic address: etienne.gayat@aphp.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Anaesth Crit Care Pain Med</MedlineTA><NlmUniqueID>101652401</NlmUniqueID><ISSNLinking>2352-5568</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001794" MajorTopicYN="N">Blood Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002545" MajorTopicYN="Y">Brain Ischemia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="Y">Endovascular Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000083242" MajorTopicYN="Y">Ischemic Stroke</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute ischaemic stroke</Keyword><Keyword MajorTopicYN="N">Blood pressure</Keyword><Keyword MajorTopicYN="N">Endovascular therapy</Keyword><Keyword MajorTopicYN="N">General anaesthesia</Keyword><Keyword MajorTopicYN="N">Haemodynamics</Keyword><Keyword MajorTopicYN="N">Monitored anaesthesia care</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>11</Day><Hour>20</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33039657</ArticleId><ArticleId IdType="doi">10.1016/j.accpm.2020.05.020</ArticleId><ArticleId IdType="pii">S2352-5568(20)30220-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">28647732</PMID><DateCompleted><Year>2018</Year><Month>04</Month><Day>12</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1421-9913</ISSN><JournalIssue CitedMedium="Internet"><Volume>78</Volume><Issue>1-2</Issue><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>European neurology</Title><ISOAbbreviation>Eur Neurol</ISOAbbreviation></Journal><ArticleTitle>Perioperative Strokes Following Surgical Correction of Mitral Valves: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>63</StartPage><EndPage>70</EndPage><MedlinePgn>63-70</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1159/000477164</ELocationID><Abstract><AbstractText Label="OBJECTIVE">The primary aim of this meta-analysis was to quantify the impact of perioperative strokes on stroke-related mortality after open mitral valve (MV) procedures were performed.</AbstractText><AbstractText Label="METHODS">An electronic search of the PubMed, Embase, and the Web of Science databases was performed to retrieve articles published up to December 2015, relevant to patients undergoing MV procedures. Data were extracted from the final list of 25 studies to calculate a summary OR for 30-day stroke-related mortality.</AbstractText><AbstractText Label="RESULTS">The stroke rate in the total sample population was 1.62% (73/4,498). The 30-day all-cause mortality rate was 3.51% (158/4,498). The percentage of total deaths caused by stroke was 6.87%. The summary OR of stroke-related mortality following MV procedures was estimated to be 7.22 (95% CI 4.13-12.63, p &lt; 0.0001). A subgroup analysis was done for studies involving concomitant MV surgery and coronary artery bypass grafting. The summary estimate of the subgroup showed an OR of 8.508 (95% CI 1.552-46.622, p = 0.0136).</AbstractText><AbstractText Label="CONCLUSION">Perioperative strokes following open MV procedures may be associated with more than 7 times greater odds of 30-day stroke-related mortality. They appear to be more commonly occurring than what is reported by current literature, making further studies investigating possible mechanisms and preventive measures a priority.</AbstractText><CopyrightInformation>&#xa9; 2017 S. Karger AG, Basel.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Udesh</LastName><ForeName>Reshmi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natarajan</LastName><ForeName>Piruthiviraj</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Jeevanantham</LastName><ForeName>Vinodh</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Gleason</LastName><ForeName>Thomas G</ForeName><Initials>TG</Initials></Author><Author ValidYN="Y"><LastName>Badhwar</LastName><ForeName>Vinay</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Thirumala</LastName><ForeName>Parthasarathy D</ForeName><Initials>PD</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>06</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Eur Neurol</MedlineTA><NlmUniqueID>0150760</NlmUniqueID><ISSNLinking>0014-3022</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D013504" MajorTopicYN="N">Cardiovascular Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008943" MajorTopicYN="N">Mitral Valve</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">In-hospital mortality</Keyword><Keyword MajorTopicYN="N">Mitral valve surgery</Keyword><Keyword MajorTopicYN="N">Morbidity</Keyword><Keyword MajorTopicYN="N">Perioperative stroke</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28647732</ArticleId><ArticleId IdType="doi">10.1159/000477164</ArticleId><ArticleId IdType="pii">000477164</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26952228</PMID><DateCompleted><Year>2017</Year><Month>01</Month><Day>17</Day></DateCompleted><DateRevised><Year>2017</Year><Month>01</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-2291</ISSN><JournalIssue CitedMedium="Internet"><Volume>66</Volume><Issue>2</Issue><PubDate><Year>2016</Year><Season>Mar-Apr</Season></PubDate></JournalIssue><Title>Brazilian journal of anesthesiology (Elsevier)</Title><ISOAbbreviation>Braz J Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Effectiveness of combined regional-general anesthesia for reducing mortality in coronary artery bypass: meta-analysis.</ArticleTitle><Pagination><StartPage>183</StartPage><EndPage>193</EndPage><MedlinePgn>183-93</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bjane.2014.05.012</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0104-0014(14)00221-8</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES" NlmCategory="OBJECTIVE">Neuraxial anesthesia (NA) has been used in association with general anesthesia (GA) for coronary artery bypass; however, anticoagulation during surgery makes us question the viability of benefits by the risk of epidural hematoma. The aim of this study was to perform a meta-analyzes examining the efficacy of NA associated with GA compared to GA alone for coronary artery bypass on mortality reduction.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Mortality, arrhythmias, cerebrovascular accident (CVA), myocardial infarction (MI), length of hospital stay (LHS), length of ICU stay (ICUS), reoperations, blood transfusion (BT), quality of life, satisfaction degree, and postoperative cognitive dysfunction were analyzed. The weighted mean difference (MD) was estimated for continuous variables, and relative risk (RR) and risk difference (RD) for categorical variables.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">17 original articles analyzed. Meta-analysis of mortality (RD=-0.01, 95% CI=-0.03 to 0.01), CVA (RR=0.79, 95% CI=0.32-1.95), MI (RR=0.96, 95% CI=0.52-1.79) and LHS (MD=-1.94, 95% CI=-3.99 to 0.12) were not statistically significant. Arrhythmia was less frequent with NA (RR=0.68, 95% CI=0.50-0.93). ICUS was lower in NA (MD=-2.09, 95% CI=-2.92 to -1.26).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">There was no significant difference in mortality. Combined NA and GA showed lower incidence of arrhythmias and lower ICUS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2014 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barbosa</LastName><ForeName>Fabiano Timb&#xf3;</ForeName><Initials>FT</Initials><AffiliationInfo><Affiliation>Universidade Federal de Alagoas, Macei&#xf3;, AL, Brazil. Electronic address: fabianotimbo@yahoo.com.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Cunha</LastName><ForeName>Rafael Martins</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Hospital Unimed, Macei&#xf3;, AL, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Silva Ramos</LastName><ForeName>Fernando Wagner</ForeName><Initials>FW</Initials><AffiliationInfo><Affiliation>Universidade Federal de Alagoas, Macei&#xf3;, AL, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Lima</LastName><ForeName>Fernando Jos&#xe9; Camello</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Universidade Federal de Alagoas, Macei&#xf3;, AL, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodrigues</LastName><ForeName>Amanda Karine Barros</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Universidade Federal de Alagoas, Macei&#xf3;, AL, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>do Nascimento Galv&#xe3;o</LastName><ForeName>Ailton Mota</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Universidade Federal de Alagoas, Macei&#xf3;, AL, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Sousa-Rodrigues</LastName><ForeName>C&#xe9;lio Fernando</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>Universidade Federal de Alagoas, Macei&#xf3;, AL, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lima</LastName><ForeName>Paula Monique Barbosa</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Universidade Federal de Alagoas, Macei&#xf3;, AL, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>01</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Braz J Anesthesiol</MedlineTA><NlmUniqueID>101624623</NlmUniqueID><ISSNLinking>0104-0014</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000765" MajorTopicYN="N">Anesthesia, Conduction</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001026" MajorTopicYN="N">Coronary Artery Bypass</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006406" MajorTopicYN="N">Hematoma</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anestesia geral</Keyword><Keyword MajorTopicYN="N">Anestesia neuroaxial</Keyword><Keyword MajorTopicYN="N">Coronary artery bypass</Keyword><Keyword MajorTopicYN="N">General anesthesia</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Metan&#xe1;lise</Keyword><Keyword MajorTopicYN="N">Mortalidade</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Neuraxial anesthesia</Keyword><Keyword MajorTopicYN="N">Revasculariza&#xe7;&#xe3;o mioc&#xe1;rdica</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26952228</ArticleId><ArticleId IdType="doi">10.1016/j.bjane.2014.05.012</ArticleId><ArticleId IdType="pii">S0104-0014(14)00221-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36419366</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>22</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-5415</ISSN><JournalIssue CitedMedium="Internet"><Volume>71</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of the American Geriatrics Society</Title><ISOAbbreviation>J Am Geriatr Soc</ISOAbbreviation></Journal><ArticleTitle>Postoperative delirium after transcatheter aortic valve replacement: An updated systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>646</StartPage><EndPage>660</EndPage><MedlinePgn>646-660</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jgs.18104</ELocationID><Abstract><AbstractText Label="AIMS">To perform an updated systematic review and meta-analysis of postoperative delirium (POD) after transcatheter aortic valve replacement (TAVR).</AbstractText><AbstractText Label="METHODS">We conducted a systematic literature search of PubMed, Embase, and Cochrane Library databases from the time of the first human TAVR procedure in 2002 until December 24, 2021, which was supplemented by manual searches of bibliographies. Data were collected on incidence rates, risk factors, and/or associated mortality of POD after TAVR. Pooled analyses were conducted using random effects models to yield mean differences, odds ratios, hazard ratios, and risk ratios, with 95% confidence intervals.</AbstractText><AbstractText Label="RESULTS">A total of 70 articles (69 studies) comprising 413,389 patients were included. The study heterogeneity was substantial. The pooled mean incidence of POD after TAVR in all included studies was 9.8% (95% CI: 8.7%-11.0%), whereas that in studies using validated tools to assess for delirium at least once a day for at least 2 consecutive days after TAVR was 20.7% (95% CI: 17.8%-23.7%). According to the level of evidence and results of meta-analysis, independent preoperative risk factors with a high level of evidence included increased age, male sex, prior stroke or transient ischemic attack, atrial fibrillation/flutter, weight loss, electrolyte abnormality, and impaired Instrumental Activities of Daily Living; intraoperative risk factors included non-transfemoral access and general anesthesia; and acute kidney injury was a postoperative risk factor. POD after TAVR was associated with significantly increased mortality (pooled unadjusted RR: 2.20, 95% CI: 1.79-2.71; pooled adjusted RR: 1.62, 95% CI: 1.25-2.10), particularly long-term mortality (pooled unadjusted HR: 2.84, 95% CI: 1.91-4.23; pooled adjusted HR: 1.88, 95% CI: 1.30-2.73).</AbstractText><AbstractText Label="CONCLUSIONS">POD after TAVR is common and is associated with an increased risk of mortality. Accurate identification of risk factors for POD after TAVR and implementation of preventive measures are critical to improve prognosis.</AbstractText><CopyrightInformation>&#xa9; 2022 The American Geriatrics Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Xiaoteng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Huijun</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Qingdao Women and Children's Hospital, Qingdao University, Qingdao, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Kangning</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shao</LastName><ForeName>Qiaoyu</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Shuo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Dunliang</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Qingdao Women and Children's Hospital, Qingdao University, Qingdao, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhijian</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yujie</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Geriatr Soc</MedlineTA><NlmUniqueID>7503062</NlmUniqueID><ISSNLinking>0002-8614</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065467" MajorTopicYN="Y">Transcatheter Aortic Valve Replacement</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071257" MajorTopicYN="Y">Emergence Delirium</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001024" MajorTopicYN="Y">Aortic Valve Stenosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000203" MajorTopicYN="N">Activities of Daily Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001021" MajorTopicYN="N">Aortic Valve</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">incidence</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">postoperative delirium</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword><Keyword MajorTopicYN="N">transcatheter aortic valve replacement</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>24</Day><Hour>1</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36419366</ArticleId><ArticleId IdType="doi">10.1111/jgs.18104</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Kotekar N, Shenkar A, Nagaraj R. Postoperative cognitive dysfunction - current preventive strategies. Clin Interv Aging. 2018;13:2267-2273.</Citation></Reference><Reference><Citation>Mattison MLP. Delirium. Ann Intern Med. 2020;173(7):Itc49-itc64.</Citation></Reference><Reference><Citation>van der Wulp K, van Wely MH, Rooijakkers MJP, et al. Delirium after TAVR: Crosspassing the limit of resilience. JACC Cardiovasc Interv. 2020;13(21):2453-2466.</Citation></Reference><Reference><Citation>Swarbrick CJ, Partridge JSL. Evidence-based strategies to reduce the incidence of postoperative delirium: a narrative review. Anaesthesia. 2022;77(Suppl 1):92-101.</Citation></Reference><Reference><Citation>G&#xe9;n&#xe9;reux P, Piazza N, Alu MC, et al. Valve academic research consortium 3: updated endpoint definitions for aortic valve clinical research. J Am Coll Cardiol. 2021;77(21):2717-2746.</Citation></Reference><Reference><Citation>Abawi M, Pagnesi M, Agostoni P, et al. Postoperative delirium in individuals undergoing Transcatheter aortic valve replacement: a systematic review and meta-analysis. J Am Geriatr Soc. 2018;66(12):2417-2424.</Citation></Reference><Reference><Citation>Tilley E, Psaltis PJ, Loetscher T, et al. Meta-analysis of prevalence and risk factors for delirium after Transcatheter aortic valve implantation. Am J Cardiol. 2018;122(11):1917-1923.</Citation></Reference><Reference><Citation>Prasitlumkum N, Mekritthikrai R, Kewcharoen J, Kanitsoraphan C, Mao MA, Cheungpasitporn W. Delirium is associated with higher mortality in transcatheter aortic valve replacement: systemic review and meta-analysis. Cardiovasc Interv Ther. 2020;35(2):168-176.</Citation></Reference><Reference><Citation>Kuipers S, Klein Klouwenberg PM, Cremer OL. Incidence, risk factors and outcomes of new-onset atrial fibrillation in patients with sepsis: a systematic review. Crit Care. 2014;18(6):688.</Citation></Reference><Reference><Citation>The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Accessed January 1, 2022. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp</Citation></Reference><Reference><Citation>Higgins JP, Altman DG, G&#xf8;tzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.</Citation></Reference><Reference><Citation>Thiele H, Kurz T, Feistritzer HJ, et al. Comparison of newer generation self-expandable vs. balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial. Eur Heart J. 2020;41(20):1890-1899.</Citation></Reference><Reference><Citation>Thiele H, Kurz T, Feistritzer HJ, et al. General versus local anesthesia with conscious sedation in Transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial. Circulation. 2020;142(15):1437-1447.</Citation></Reference><Reference><Citation>Vendrik J, Vlastra W, van Mourik MS, et al. Early mobilisation after transfemoral transcatheter aortic valve implantation: results of the MobiTAVI trial. Neth Hear J. 2020;28(5):240-248.</Citation></Reference><Reference><Citation>van der Wulp K, van Wely MH, Schoon Y, et al. Geriatric assessment in the prediction of delirium and long-term survival after transcatheter aortic valve implantation. J Thorac Cardiovasc Surg. 2021;161(6):2095-2102.e2093.</Citation></Reference><Reference><Citation>van der Wulp K, van Wely M, van Heijningen L, et al. Delirium after Transcatheter aortic valve implantation under general anesthesia: incidence, predictors, and relation to long-term survival. J Am Geriatr Soc. 2019;67(11):2325-2330.</Citation></Reference><Reference><Citation>Shi SM, Sung M, Afilalo J, et al. Delirium incidence and functional outcomes after Transcatheter and surgical aortic valve replacement. J Am Geriatr Soc. 2019;67(7):1393-1401.</Citation></Reference><Reference><Citation>Sharma V, Katznelson R, Horlick E, et al. Delirium after transcatheter aortic valve implantation via the femoral or apical route. Anaesthesia. 2016;71(8):901-907.</Citation></Reference><Reference><Citation>Seppelt PC, Mas-Peiro S, De Rosa R, et al. Dynamics of cerebral oxygenation during rapid ventricular pacing and its impact on outcome in transfemoral transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2021;97(1):E146-e153.</Citation></Reference><Reference><Citation>Schoenenberger AW, Zuber C, Moser A, et al. Evolution of cognitive function after Transcatheter aortic valve implantation. Circ Cardiovasc Interv. 2016;9(10):e003590.</Citation></Reference><Reference><Citation>Michels B, Holzamer A, Graf BM, et al. Butyrylcholinesterase as a perioperative complication marker in patients after transcatheter aortic valve implantation: a prospective observational study. BMJ Open. 2021;11(7):e042857.</Citation></Reference><Reference><Citation>Mauri V, Reuter K, K&#xf6;rber MI, et al. Incidence, risk factors and impact on long-term outcome of postoperative delirium after Transcatheter aortic valve replacement. Front Cardiovasc Med. 2021;8:645724.</Citation></Reference><Reference><Citation>Luque T, Noriega FJ, McInerney A, et al. Impact of delirium in acute cardiac care unit after transcatheter aortic valve replacement. Int J Cardiol. 2021;330:164-170.</Citation></Reference><Reference><Citation>Lauck SB, Sathananthan J, Park J, et al. Post-procedure protocol to facilitate next-day discharge: results of the multidisciplinary, multimodality but minimalist TAVR study. Catheter Cardiovasc Interv. 2020;96(2):450-458.</Citation></Reference><Reference><Citation>Khan MM, Lanct&#xf4;t KL, Fremes SE, et al. The value of screening for cognition, depression, and frailty in patients referred for TAVI. Clin Interv Aging. 2019;14:841-848.</Citation></Reference><Reference><Citation>Jagielak D, Bramlage P, Pawlaczyk R, et al. Transaortic transcatheter aortic valve implantation: results of the polish arm of the ROUTE registry. Cardiol J. 2015;22(6):651-656.</Citation></Reference><Reference><Citation>Humbert M, B&#xfc;la CJ, Muller O, Krief H, Monney P. Delirium in older patients undergoing aortic valve replacement: incidence, predictors, and cognitive prognosis. BMC Geriatr. 2021;21(1):153.</Citation></Reference><Reference><Citation>Hoogma DF, Venmans E, Al Tmimi L, et al. Postoperative delirium and quality of life after transcatheter and surgical aortic valve replacement: a prospective observational study. J Thorac Cardiovasc Surg. 2021;S0022-5223(21)01626-3.</Citation></Reference><Reference><Citation>Goudzwaard JA, de Ronde-Tillmans MJAG, El Faquir N, et al. The Erasmus frailty score is associated with delirium and 1-year mortality after Transcatheter aortic valve implantation in older patients. The TAVI Care &amp; Cure program. Int J Cardiol. 2019;276:48-52.</Citation></Reference><Reference><Citation>Fanning JP, Wesley AJ, Walters DL, et al. Neurological injury in intermediate-risk Transcatheter aortic valve implantation. J Am Heart Assoc. 2016;5(11):e004203.</Citation></Reference><Reference><Citation>Erdoes G, Basciani R, Huber C, et al. Transcranial Doppler-detected cerebral embolic load during transcatheter aortic valve implantation. Eur J Cardiothorac Surg. 2012;41(4):778-783.</Citation></Reference><Reference><Citation>Eide LS, Ranhoff AH, Lauck S, et al. Indwelling urinary catheters, aortic valve treatment and delirium: a prospective cohort study. BMJ Open. 2018;8(11):e021708.</Citation></Reference><Reference><Citation>Drudi LM, Ades M, Asgar A, et al. Interaction between frailty and access site in older adults undergoing Transcatheter aortic valve replacement. J Am Coll Cardiol Intv. 2018;11(21):2185-2192.</Citation></Reference><Reference><Citation>Boureau AS, Trochu JN, Rouaud A, et al. Predictors of health-related quality of life decline after transcatheter aortic valve replacement in older patients with severe aortic stenosis. J Nutr Health Aging. 2017;21(1):105-111.</Citation></Reference><Reference><Citation>Blumenstein J, M&#xf6;llmann H, Bleiziffer S, et al. Transcatheter aortic valve implantation in nonagenarians: insights from the German aortic valve registry (GARY). Clin Res Cardiol. 2020;109(9):1099-1106.</Citation></Reference><Reference><Citation>Bestehorn K, Bestehorn M, Fleck E. Influence of different approaches of aortic valve replacement on the incidence of post-operative delirium in intermediate risk patients - a matched pair analysis. Curr Med Res Opin. 2015;31(12):2157-2163.</Citation></Reference><Reference><Citation>Beishuizen SJ, Festen S, Loonstra YE, van der Werf HW, de Rooij SE, van Munster BC. Delirium, functional decline and quality of life after transcatheter aortic valve implantation: an explorative study. Geriatr Gerontol Int. 2020;20(12):1202-1207.</Citation></Reference><Reference><Citation>Adrie C, Parlato M, Salmi L, et al. Bacterial translocation and plasma cytokines during transcatheter and open-heart aortic valve implantation. Shock. 2015;43(1):62-67.</Citation></Reference><Reference><Citation>Uhle F, Castrup C, Necaev AM, et al. Inflammation and its consequences after surgical versus Transcatheter aortic valve replacement. Artif Organs. 2018;42(2):E1-e12.</Citation></Reference><Reference><Citation>Sherif MA, Zahn R, Gerckens U, et al. Effect of gender differences on 1-year mortality after transcatheter aortic valve implantation for severe aortic stenosis: results from a multicenter real-world registry. Clin Res Cardiol. 2014;103(8):613-620.</Citation></Reference><Reference><Citation>Nijenhuis VJ, Huitema MP, Vorselaars VM, et al. Echocardiographic pulmonary hypertension probability is associated with clinical outcomes after transcatheter aortic valve implantation. Int J Cardiol. 2016;225:218-225.</Citation></Reference><Reference><Citation>Kundi H, Popma JJ, Reynolds MR, et al. Frailty and related outcomes in patients undergoing transcatheter valve therapies in a nationwide cohort. Eur Heart J. 2019;40(27):2231-2239.</Citation></Reference><Reference><Citation>Fanning JP, Walters DL, Wesley AJ, et al. Intraoperative cerebral perfusion disturbances during Transcatheter aortic valve replacement. Ann Thorac Surg. 2017;104(5):1564-1568.</Citation></Reference><Reference><Citation>Eggebrecht H, Bestehorn M, Haude M, et al. Outcomes of transfemoral transcatheter aortic valve implantation at hospitals with and without on-site cardiac surgery department: insights from the prospective German aortic valve replacement quality assurance registry (AQUA) in 17 919 patients. Eur Heart J. 2016;37(28):2240-2248.</Citation></Reference><Reference><Citation>Egerod I, Nielsen S, Lisby KH, Darmer MR, Pedersen PU. Immediate post-operative responses to transcatheter aortic valve implantation: an observational study. Eur J Cardiovasc Nurs. 2015;14(3):232-239.</Citation></Reference><Reference><Citation>Chu MW, Bagur R, Losenno KL, et al. Early clinical outcomes of a novel self-expanding transapical transcatheter aortic valve bioprosthesis. J Thorac Cardiovasc Surg. 2017;153(4):810-818.</Citation></Reference><Reference><Citation>Yamashita A, Suzuki S, Otsuka T, et al. Six-minute walk test predicts postoperative delirium after Transcatheter aortic valve replacement. J Cardiothorac Vasc Anesth. 2021;35(9):2613-2617.</Citation></Reference><Reference><Citation>Wesselink EM, Abawi M, Kooistra NHM, et al. Intraoperative hypotension and delirium among older adults undergoing transcatheter aortic valve replacement. J Am Geriatr Soc. 2021;69(11):3177-3185.</Citation></Reference><Reference><Citation>Tse L, Bowering JB, Schwarz SKW, Moore RL, Burns KD, Barr AM. Postoperative delirium following transcatheter aortic valve implantation: a historical cohort study. Can J Anesth. 2015;62(1):22-30.</Citation></Reference><Reference><Citation>Stachon P, Kaier K, Zirlik A, et al. Risk factors and outcome of postoperative delirium after transcatheter aortic valve replacement. Clin Res Cardiol. 2018;107(9):756-762.</Citation></Reference><Reference><Citation>Stachon P, Kaier K, Heidt T, et al. Nationwide outcomes of aortic valve replacement for pure aortic regurgitation in Germany 2008-2015. Catheter Cardiovasc Interv. 2020;95(4):810-816.</Citation></Reference><Reference><Citation>Stachon P, Kaier K, Heidt T, et al. The use and outcomes of cerebral protection devices for patients undergoing Transfemoral Transcatheter aortic valve replacement in clinical practice. J Am Coll Cardiol Intv. 2021;14(2):161-168.</Citation></Reference><Reference><Citation>Stachon P, Hehn P, Wolf D, et al. In-hospital outcomes of self-expanding and balloon-expandable transcatheter heart valves in Germany. Clin Res Cardiol. 2021;110(12):1977-1982.</Citation></Reference><Reference><Citation>Soundhar A, Udesh R, Mehta A, et al. Delirium following Transcatheter aortic valve replacement: National Inpatient Sample Analysis. J Cardiothorac Vasc Anesth. 2017;31(6):1977-1984.</Citation></Reference><Reference><Citation>Santarpino G, Pfeiffer S, Jessl J, et al. Clinical outcome and cost analysis of Sutureless versus Transcatheter aortic valve implantation with propensity score matching analysis. Am J Cardiol. 2015;116(11):1737-1743.</Citation></Reference><Reference><Citation>Potter BJ, Thompson C, Green P, Clancy S. Incremental cost and length of stay associated with postprocedure delirium in transcatheter and surgical aortic valve replacement patients in the United States. Catheter Cardiovasc Interv. 2019;93(6):1132-1136.</Citation></Reference><Reference><Citation>Martinez C, Cicenia M, Sprynger M, et al. Myocardial function in patients with radiation-associated aortic stenosis undergoing Transcatheter aortic valve replacement: a layer-specific strain analysis study. JACC Cardiovasc Imaging. 2020;13(6):1450-1452.</Citation></Reference><Reference><Citation>Maniar HS, Lindman BR, Escallier K, et al. Delirium after surgical and transcatheter aortic valve replacement is associated with increased mortality. J Thorac Cardiovasc Surg. 2016;151(3):815-823.e812.</Citation></Reference><Reference><Citation>Maier A, Hammerich B, Humburger F, et al. A logistic regression analysis comparing minimalistic approach and intubation anaesthesia in patients undergoing transfemoral transcatheter aortic valve replacement. PLoS One. 2020;15(2):e0227345.</Citation></Reference><Reference><Citation>Lee SW, Lee S, Hahm KD. Postoperative pulmonary complications after Transcatheter aortic valve implantation under monitored anesthesia care versus general anesthesia: retrospective analysis at a single large volume center. J Clin Med. 2021;10(22):5365.</Citation></Reference><Reference><Citation>Kwak MJ, Rasu R, Morgan RO, et al. The Association of Economic Outcome and Geriatric Syndromes among older adults with Transcatheter aortic valve replacement (TAVR). J Health Econ Outcomes Res. 2020;7(2):175-181.</Citation></Reference><Reference><Citation>Kalyoncuo&#x11f;lu M, Biter H&#x130;, Durmu&#x15f; G, Ba&#x15f;tan B, Can MM. C-reactive protein to albumin ratio as a novel inflammatory biomarker for postoperative delirium in patients undergoing transcatheter aortic valve replacement. Haseki Tip Bulteni. 2020;58(2):183-192.</Citation></Reference><Reference><Citation>Jain V, Kalra A, Panhwar MS, et al. Outcomes of transcatheter aortic valve replacement in patients with cognitive dysfunction. J Am Geriatr Soc. 2021;69(5):1363-1369.</Citation></Reference><Reference><Citation>Huded CP, Huded JM, Sweis RN, et al. The impact of delirium on healthcare utilization and survival after transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2017;89(7):1286-1291.</Citation></Reference><Reference><Citation>Goldfuss S, Wittmann S, W&#xfc;rschinger F, et al. Anaesthesia-related complications and side-effects in TAVI: a retrospective study in Germany. BMJ Open. 2019;9(4):e025825.</Citation></Reference><Reference><Citation>Goins AE, Smeltz A, Ramm C, et al. General anesthesia for Transcatheter aortic valve replacement: Total intravenous anesthesia is associated with less delirium as compared to volatile agent technique. J Cardiothorac Vasc Anesth. 2018;32(4):1570-1577.</Citation></Reference><Reference><Citation>Giuseffi JL, Borges NE, Boehm LM, et al. Delirium after Transcatheter aortic valve replacement. Am J Crit Care. 2017;26(4):e58-e64.</Citation></Reference><Reference><Citation>Gauthier C, Astarci P, Baele P, et al. Mid-term survival after transcatheter aortic valve implantation: results with respect to the anesthetic management and to the access route (transfemoral versus transapical). Ann Card Anaesth. 2015;18(3):343-351.</Citation></Reference><Reference><Citation>Chen EY, Sukumar N, Dai F, Akhtar S, Schonberger RB. A pilot analysis of the association between types of monitored anesthesia care drugs and outcomes in Transfemoral aortic valve replacement performed without general anesthesia. J Cardiothorac Vasc Anesth. 2018;32(2):666-671.</Citation></Reference><Reference><Citation>Bansal A, Saad A, Jain V, et al. Delirium predicts worse outcomes in both Transcatheter and surgical aortic valve replacement. JACC Cardiovasc Interv. 2021;14(15):1738-1740.</Citation></Reference><Reference><Citation>Bagienski M, Kleczynski P, Dziewierz A, et al. Incidence of postoperative delirium and its impact on outcomes after Transcatheter aortic valve implantation. Am J Cardiol. 2017;120(7):1187-1192.</Citation></Reference><Reference><Citation>Abawi M, Nijhoff F, Agostoni P, et al. Incidence, predictive factors, and effect of delirium after Transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2016;9(2):160-168.</Citation></Reference><Reference><Citation>van Mourik MS, Geenen LME, Delewi R, et al. Predicting hospitalisation duration after transcatheter aortic valve implantation. Open Heart. 2017;4(1):e000549.</Citation></Reference><Reference><Citation>Kwak MJ, Bhise V, Warner MT, et al. National trend of utilization, clinical and economic outcomes of transcatheter aortic valve replacement among patients with chronic obstructive pulmonary disease. Curr Med Res Opin. 2019;35(8):1321-1329.</Citation></Reference><Reference><Citation>Wilbring M, Tugtekin SM, Alexiou K, Simonis G, Matschke K, Kappert U. Transapical transcatheter aortic valve implantation vs. conventional aortic valve replacement in high-risk patients with previous cardiac surgery: a propensity-score analysis. Eur J Cardiothorac Surg. 2013;44(1):42-47.</Citation></Reference><Reference><Citation>Vukadinovikj A, Baumg&#xe1;rtner E, Bohmann K, H&#xe4;rter D, Wimmer-Greinecker G, Burgdorf C. Transcatheter valve-in-valve implantation versus surgical redo aortic root replacement in patients with degenerated freestyle aortic bioprosthesis. Catheter Cardiovasc Interv. 2021;97(7):1472-1478.</Citation></Reference><Reference><Citation>Ooms JF, Van Wiechen MP, Hokken TW, et al. Simplified trans-axillary aortic valve replacement under local anesthesia - a single-center early experience. Cardiovasc Revasc Med. 2021;23:7-13.</Citation></Reference><Reference><Citation>Grubitzsch H, Zobel S, Christ T, et al. Redo procedures for degenerated stentless aortic xenografts and the role of valve-in-valve transcatheter techniques. Eur J Cardiothorac Surg. 2017;51(4):653-659.</Citation></Reference><Reference><Citation>Strike E, Arklina B, Stradins P, et al. Postoperative pain management strategies and delirium after Transapical aortic valve replacement: a randomized controlled trial. J Cardiothorac Vasc Anesth. 2019;33(6):1668-1672.</Citation></Reference><Reference><Citation>Bruno RR, Lin Y, Wolff G, et al. Virtual reality-assisted conscious sedation during transcatheter aortic valve implantation: a randomised pilot study. EuroIntervention. 2020;16(12):E1014-E1020.</Citation></Reference><Reference><Citation>Van Mieghem NM, van Gils L, Ahmad H, et al. Filter-based cerebral embolic protection with transcatheter aortic valve implantation: the randomised MISTRAL-C trial. EuroIntervention. 2016;12(4):499-507.</Citation></Reference><Reference><Citation>Hosker C, Ward D. Hypoactive delirium. BMJ. 2017;357:j2047.</Citation></Reference><Reference><Citation>De J, Wand AP. Delirium screening: a systematic review of delirium screening tools in hospitalized patients. Gerontologist. 2015;55(6):1079-1099.</Citation></Reference><Reference><Citation>Shi Q, Warren L, Saposnik G, Macdermid JC. Confusion assessment method: a systematic review and meta-analysis of diagnostic accuracy. Neuropsychiatr Dis Treat. 2013;9:1359-1370.</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence. Delirium: prevention, diagnosis and management. Clinical guideline CG103. Updated 14 March 2019. Accessed at https://www.nice.org.uk/guidance/cg103/chapter/Introduction.</Citation></Reference><Reference><Citation>Postoperative delirium in older adults. Best practice statement from the American Geriatrics Society. J Am Coll Surg. 2015;220(2):136-148.e131.</Citation></Reference><Reference><Citation>Sato K, Jones PM. Sedation versus general anesthesia for transcatheter aortic valve replacement. J Thorac Dis. 2018;10(Suppl 30):S3588-s3594.</Citation></Reference><Reference><Citation>Wood DA, Lauck SB, Cairns JA, et al. The Vancouver 3M (multidisciplinary, multimodality, but minimalist) clinical pathway facilitates safe next-day discharge home at low-, medium-, and high-volume Transfemoral Transcatheter aortic valve replacement centers: the 3M TAVR study. JACC Cardiovasc Interv. 2019;12(5):459-469.</Citation></Reference><Reference><Citation>Wood DA. Could a "simplified" Transcatheter aortic valve replacement procedure eliminate post-operative delirium? JACC Cardiovasc Interv. 2016;9(2):169-170.</Citation></Reference><Reference><Citation>Mayr NP, Hapfelmeier A, Martin K, et al. Comparison of sedation and general anaesthesia for transcatheter aortic valve implantation on cerebral oxygen saturation and neurocognitive outcome&#x2020;. Br J Anaesth. 2016;116(1):90-99.</Citation></Reference><Reference><Citation>Hughes CG, Boncyk CS, Culley DJ, et al. American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on postoperative delirium prevention. Anesth Analg. 2020;130(6):1572-1590.</Citation></Reference><Reference><Citation>Morcos M, Burgdorf C, Vukadinivikj A, et al. Kidney injury as post-interventional complication of TAVI. Clin Res Cardiol. 2021;110(3):313-322.</Citation></Reference><Reference><Citation>L&#xfc;sebrink E, Massberg S, Orban M. Ten things ICU specialists need to know about new valvular procedures in interventional cardiology. Intensive Care Med. 2020;46(1):102-106.</Citation></Reference><Reference><Citation>Kornowski R, Tang GHL. Reducing acute kidney injury after Transcatheter aortic valve replacement: consider a multiprong strategy. Circ Cardiovasc Interv. 2021;14(4):e010718.</Citation></Reference><Reference><Citation>Barbanti M, Gulino S, Capranzano P, et al. Acute kidney injury with the RenalGuard system in patients undergoing Transcatheter aortic valve replacement: the PROTECT-TAVI trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter aortic valve implantation). JACC Cardiovasc Interv. 2015;8(12):1595-1604.</Citation></Reference><Reference><Citation>Arbel Y, Ben-Assa E, Puzhevsky D, et al. Forced diuresis with matched hydration during transcatheter aortic valve implantation for reducing acute kidney injury: a randomized, sham-controlled study (REDUCE-AKI). Eur Heart J. 2019;40(38):3169-3178.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">31072705</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>General Anesthesia Versus Local Anesthesia in Carotid Endarterectomy: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>219</StartPage><EndPage>234</EndPage><MedlinePgn>219-234</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2019.03.029</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(19)30289-7</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The choice of anesthetic technique in carotid endarterectomy (CEA) has been controversial. This study compared the outcomes of general anesthesia (GA) and local anesthesia (LA) in CEA.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Systematic review and meta-analysis of comparative studies.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Hospitals.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Adult patients undergoing CEA with either LA or GA.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">The effects of GA and LA on CEA outcomes were compared.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">PubMed, OVID, Scopus, and Embase were searched to June 2018. Thirty-one studies with 152,376 patients were analyzed. A random effect model was used, and heterogeneity was assessed with the I<sup>2</sup> and chi-square tests. LA was associated with shorter surgical time (weighted mean difference -9.15 min [-15.55 to -2.75]; p&#x202f;=&#x202f;0.005) and less stroke (odds ratio [OR] 0.76 [0.62-0.92]; p&#x202f;=&#x202f;0.006), cardiac complications (OR 0.59 [0.47-0.73]; p &lt; 0.00001), and in-hospital mortality (OR 0.72 [0.59-0.90]; p&#x202f;=&#x202f;0.003). Transient neurologic deficit rates were similar (OR 0.69 [0.46-1.04]; p&#x202f;=&#x202f;0.07). Heterogeneity was significant for surgical time (I<sup>2</sup>&#x202f;=&#x202f;0.99, chi-square&#x202f;=&#x202f;1,336.04; p &lt; 0.00001), transient neurologic deficit (I<sup>2</sup>&#x202f;=&#x202f;0.41, chi-square&#x202f;=&#x202f;28.81; p&#x202f;=&#x202f;0.04), and cardiac complications (I<sup>2</sup>&#x202f;=&#x202f;0.42, chi-square&#x202f;=&#x202f;43.32; p&#x202f;=&#x202f;0.01) but not for stroke (I<sup>2</sup>&#x202f;=&#x202f;0.22, chi-square&#x202f;=&#x202f;30.72; p&#x202f;=&#x202f;0.16) and mortality (I<sup>2</sup>&#x202f;=&#x202f;0.00, chi-square&#x202f;=&#x202f;21.69; p&#x202f;=&#x202f;0.65). Randomized controlled trial subgroup analysis was performed, and all the aforementioned variables were not significantly different or heterogenous.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The results from this study showed no inferiority of using LA to GA in patients undergoing CEA. Future investigations should be reported more systematically, preferably with randomization or propensity-matched analysis, and thus registries will facilitate investigation of this subject. Anesthetic choice in CEA should be individualized and encouraged where applicable.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Harky</LastName><ForeName>Amer</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Countess of Chester, Chester, United Kingdom. Electronic address: aaharky@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Jeffrey Shi Kai</ForeName><Initials>JSK</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kot</LastName><ForeName>Thompson Ka Ming</ForeName><Initials>TKM</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanli</LastName><ForeName>Dilan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Gundogmus State Hospital, Antalya, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahimli</LastName><ForeName>Rashad</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Bulent Ecevit University, Zonguldak, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belamaric</LastName><ForeName>Zlatka</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Perioperative Medicine, Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Marcus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwan</LastName><ForeName>Ian Yu Young</ForeName><Initials>IYY</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bithas</LastName><ForeName>Christiana</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Liverpool, Liverpool, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Makar</LastName><ForeName>Ragai</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Countess of Chester, Chester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chandrasekar</LastName><ForeName>Ramasubramanyan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Countess of Chester, Chester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dimitri</LastName><ForeName>Sameh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Countess of Chester, Chester, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>03</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000772" MajorTopicYN="N">Anesthesia, Local</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016893" MajorTopicYN="Y">Carotid Stenosis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016894" MajorTopicYN="Y">Endarterectomy, Carotid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anesthetic technique</Keyword><Keyword MajorTopicYN="N">carotid endarterectomy</Keyword><Keyword MajorTopicYN="N">general anesthesia</Keyword><Keyword MajorTopicYN="N">local anesthesia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31072705</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2019.03.029</ArticleId><ArticleId IdType="pii">S1053-0770(19)30289-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32422272</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>11</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6809</ISSN><JournalIssue CitedMedium="Internet"><Volume>72</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of vascular surgery</Title><ISOAbbreviation>J Vasc Surg</ISOAbbreviation></Journal><ArticleTitle>An updated systematic review and meta-analysis of results of transcervical carotid artery stenting with flow reversal.</ArticleTitle><Pagination><StartPage>1489</StartPage><EndPage>1498.e1</EndPage><MedlinePgn>1489-1498.e1</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jvs.2020.04.501</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0741-5214(20)31159-9</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Transcervical carotid artery stenting (CAS) has emerged as an alternative to transfemoral CAS. An earlier systematic review from our group (n&#xa0;= 12 studies; 739 transcervical CAS procedures [489/739 with flow reversal]) demonstrated that transcervical CAS is a safe procedure associated with a low incidence of stroke and complications. Since then, new studies have been published adding nearly 1600 patients to the literature. We aimed to update our early systematic review and also to perform a meta-analysis to investigate outcomes specifically after transcervical CAS with flow reversal.</AbstractText><AbstractText Label="METHODS">An electronic search of PubMed/MEDLINE, Embase, and the Cochrane databases was carried out to identify studies reporting outcomes after transcervical CAS with flow reversal. Crude event rates for outcomes of interest were estimated by simple pooling of data. A proportion meta-analysis was also performed to estimate pooled outcome rates.</AbstractText><AbstractText Label="RESULTS">A total of 18 studies (n&#xa0;= 2110 transcervical CAS procedures with flow reversal) were identified. A high technical success (98.25%) and a low mortality rate (0.48%) were recorded. The crude rates of major stroke, minor stroke, transient ischemic attack, and myocardial infarction (MI) were 0.71%, 0.90%, 0.57%, and 0.57%, respectively; a cranial nerve injury occurred in 0.28% of the procedures. A neck hematoma was reported in 1.04% of the procedures, and a carotid artery dissection occurred in 0.76% of the interventions; in 1.09% of the cases, conversion to carotid endarterectomy was required. After a meta-analysis was undertaken, the pooled technical success rate was 98.69% (95% confidence interval [CI], 97.19-99.70). A pooled mortality rate of 0.04% (95% CI, 0.00-0.29) was recorded. The pooled rate of any type of neurologic complications was 1.88 (95% CI, 1.24-2.61), whereas the pooled rates of major stroke, minor stroke, and transient ischemic attack were 0.12% (95% CI, 0.00-0.46), 0.15% (95% CI, 0.00-0.50), and 0.01% (95% CI, 0.00-0.22), respectively. The pooled rate of bradycardia/hypotension was 10.21% (95% CI, 3.99-18.51), whereas the pooled rate of MI was 0.08% (95% CI, 0.00-0.39). A neck hematoma after transcervical CAS was recorded in 1.51% (95% CI, 0.22-3.54) of the procedures; in 0.74% (95% CI, 0.05-1.95) of the interventions, conversion to CEA was required. Finally, a carotid artery dissection during transcervical CAS occurred in 0.47% (95% CI, 0.00-1.38) of the procedures.</AbstractText><AbstractText Label="CONCLUSIONS">This updated systematic review and meta-analysis demonstrated that transcervical CAS with flow reversal is associated with high technical success, almost zero mortality, and low rates of major stroke, minor stroke, MI, and complications.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Paraskevas</LastName><ForeName>Kosmas I</ForeName><Initials>KI</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, "Attikon" University Hospital, National and Kapodistrian University of Athens, Athens, Greece. Electronic address: paraskevask@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antonopoulos</LastName><ForeName>Constantine N</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, "Attikon" University Hospital, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kakisis</LastName><ForeName>John D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, "Attikon" University Hospital, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geroulakos</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, "Attikon" University Hospital, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vasc Surg</MedlineTA><NlmUniqueID>8407742</NlmUniqueID><ISSNLinking>0741-5214</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Vasc Surg. 2020 Oct;72(4):1499. doi: 10.1016/j.jvs.2020.05.017.</RefSource><PMID Version="1">32972593</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Vasc Surg. 2021 Mar;73(3):1110. doi: 10.1016/j.jvs.2020.08.153.</RefSource><PMID Version="1">33632496</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Vasc Surg. 2021 Mar;73(3):1110-1111. doi: 10.1016/j.jvs.2020.10.015.</RefSource><PMID Version="1">33632497</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Vasc Surg. 2021 May;73(5):1835-1838. doi: 10.1016/j.jvs.2020.11.051.</RefSource><PMID Version="1">33894898</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Vasc Surg. 2021 May;73(5):1838-1839. doi: 10.1016/j.jvs.2020.12.077.</RefSource><PMID Version="1">33894899</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001166" MajorTopicYN="N">Arteriovenous Shunt, Surgical</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017536" MajorTopicYN="N">Carotid Artery, Common</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016893" MajorTopicYN="N">Carotid Stenosis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005268" MajorTopicYN="N">Femoral Vein</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="N">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007601" MajorTopicYN="N">Jugular Veins</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015607" MajorTopicYN="N">Stents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Carotid artery stenosis</Keyword><Keyword MajorTopicYN="N">Carotid artery stenting</Keyword><Keyword MajorTopicYN="N">Flow reversal</Keyword><Keyword MajorTopicYN="N">Stroke</Keyword><Keyword MajorTopicYN="N">Transcervical access</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>12</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32422272</ArticleId><ArticleId IdType="doi">10.1016/j.jvs.2020.04.501</ArticleId><ArticleId IdType="pii">S0741-5214(20)31159-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">30506982</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>02</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2162-3279</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Brain and behavior</Title><ISOAbbreviation>Brain Behav</ISOAbbreviation></Journal><ArticleTitle>Anesthesia for endovascular treatment in anterior circulation stroke: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>e01178</StartPage><MedlinePgn>e01178</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e01178</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/brb3.1178</ELocationID><Abstract><AbstractText Label="BACKGROUND">Endovascular treatment in patients with acute anterior circulation stroke could be performed under either conscious sedation (CS) or general anesthesia (GA). Although several studies have investigated the association between the clinical outcomes and the two anesthesia methods, consensus is lacking.</AbstractText><AbstractText Label="METHODS">PubMed and EMBASE searches were used to select full-text articles comparing the effects of GA and CS on functional outcome and complications in patients with anterior circulation ischemic stroke. Enrolled patients were assigned to receive endovascular treatment with CS or GA, with a primary outcome of functional independency within 90&#xa0;days. Secondary outcomes included intracranial hemorrhage, all-cause mortality at 90&#xa0;days, pneumonia, and intraprocedural complications.</AbstractText><AbstractText Label="RESULTS">Thirteen studies (3 RCTs and 10 observational studies), which included 3,857 patients (CS&#xa0;=&#xa0;2,129, GA&#xa0;=&#xa0;1,728), were eligible for the analysis. The overall analysis including the RCTs and observational studies demonstrated that the functional independence within 90&#xa0;days occurred more frequently among patients with CS compared with GA (OR, 1.42; 95% CI, 1.05-1.92, p&#xa0;=&#xa0;0.02); and the risk of mortality was higher with GA compared with CS; furthermore, CS was associated with lower rate of intracranial hemorrhage. In RCTs, GA was associated with increased functional independence (OR, 0.55; 95% CI, 0.34-0.89, p&#xa0;=&#xa0;0.01) and successful reperfusion (OR, 0.51; 95% CI, 0.30-0.89, p&#xa0;=&#xa0;0.02).</AbstractText><AbstractText Label="CONCLUSIONS">In the overall analysis and observational studies, CS was associated with improved functional outcomes and relatively safe for anterior ischemic stroke compared with GA. While the pooled data from RCTs suggested that GA was associated with improved outcomes. The inconsistency indicated that more large-scale RCTs are required to evaluate what factors influenced the effect of the anesthesia methods on clinical outcomes.</AbstractText><CopyrightInformation>&#xa9; 2018 The Authors. Brain and Behavior published by Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xuefei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Zheng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, The first Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Shenzhen Shekou People's Hospital, Shenzhen, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Yinping</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Shabei</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Key Clinical Department and Key Discipline of Neurology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0001-9233-5788</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>12</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Brain Behav</MedlineTA><NlmUniqueID>101570837</NlmUniqueID></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020520" MajorTopicYN="N">Brain Infarction</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016292" MajorTopicYN="Y">Conscious Sedation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="N">Endovascular Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017131" MajorTopicYN="N">Thrombectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute ischemic stroke</Keyword><Keyword MajorTopicYN="N">anterior circulation</Keyword><Keyword MajorTopicYN="N">conscious sedation</Keyword><Keyword MajorTopicYN="N">endovascular treatment</Keyword><Keyword MajorTopicYN="N">general anesthesia</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>11</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>12</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30506982</ArticleId><ArticleId IdType="pmc">PMC6346417</ArticleId><ArticleId IdType="doi">10.1002/brb3.1178</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abou&#x2010;Chebl, A. , Lin, R. , Hussain, M. S. , Jovin, T. G. , Levy, E. I. , Liebeskind, D. S. , &#x2026; Gupta, R. (2010). Conscious sedation versus general anesthesia during endovascular therapy for acute anterior circulation stroke: Preliminary results from a retrospective, multicenter study. Stroke, 41(6), 1175&#x2013;1179. 10.1161/STROKEAHA.109.574129</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.109.574129</ArticleId><ArticleId IdType="pubmed">20395617</ArticleId></ArticleIdList></Reference><Reference><Citation>Abou&#x2010;Chebl, A. , Yeatts, S. D. , Yan, B. , Cockroft, K. , Goyal, M. , Jovin, T. , ... Hill, M. D. (2015). Impact of general anesthesia on safety and outcomes in the endovascular arm of interventional management of stroke (IMS) III trial. Stroke, 46(8), 2142&#x2013;2148. 10.1161/strokeaha.115.008761</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/strokeaha.115.008761</ArticleId><ArticleId IdType="pmc">PMC4519363</ArticleId><ArticleId IdType="pubmed">26138125</ArticleId></ArticleIdList></Reference><Reference><Citation>Abou&#x2010;Chebl, A. , Zaidat, O. O. , Castonguay, A. C. , Gupta, R. , Sun, C. H. , Martin, C. O. , &#x2026; Nogueira R. G. (2014). North American SOLITAIRE Stent&#x2010;Retriever Acute Stroke Registry: Choice of anesthesia and outcomes. Stroke, 45(5), 1396&#x2013;1401. 10.1161/STROKEAHA.113.003698</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.113.003698</ArticleId><ArticleId IdType="pubmed">24668201</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams, H. P. Jr , del Zoppo, G. , Alberts, M. J. , Bhatt, D. L. , Brass, L. , &amp; Furlan, A. , &#x2026;Quality of Care Outcomes in Research Interdisciplinary Working Group . (2007). Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation, 115(20), e478&#x2013;e534. 10.1161/STROKEAHA.107.181486</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.107.181486</ArticleId><ArticleId IdType="pubmed">17515473</ArticleId></ArticleIdList></Reference><Reference><Citation>Badhiwala, J. H. , Nassiri, F. , Alhazzani, W. , Selim, M. H. , Farrokhyar, F. , Spears, J. , &#x2026; Almenawer, S. A. (2015). Endovascular Thrombectomy for Acute Ischemic Stroke: A Meta&#x2010;analysis. JAMA, 314(17), 1832&#x2013;1843. 10.1001/jama.2015.13767</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.13767</ArticleId><ArticleId IdType="pubmed">26529161</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkhemer, O. A. , van den Berg, L. A. , Fransen, P. S. , Beumer, D. , &amp; Yoo, A. J. , Lingsma&#x2026; MR CLEAN investigators . (2016). The effect of anesthetic management during intra&#x2010;arterial therapy for acute stroke in MR CLEAN. Neurology, 87(7), 656&#x2013;664. 10.1212/WNL.0000000000002976</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002976</ArticleId><ArticleId IdType="pubmed">27421546</ArticleId></ArticleIdList></Reference><Reference><Citation>Bracard, S. , Ducrocq, X. , Mas, J. L. , Soudant, M. , Oppenheim, C. , Moulin, T. , &amp; &#x2026; THRACE investigators . (2016). Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): A randomised controlled trial. The Lancet Neurology, 15(11), 1138&#x2013;1147. 10.1016/S1474-4422(16)30177-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(16)30177-6</ArticleId><ArticleId IdType="pubmed">27567239</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinjikji, W. , Murad, M. H. , Rabinstein, A. A. , Cloft, H. J. , Lanzino, G. , &amp; Kallmes, D. F. (2015). Conscious sedation versus general anesthesia during endovascular acute ischemic stroke treatment: A systematic review and meta&#x2010;analysis. AJNR American Journal of Neuroradiology., 36(3), 525&#x2013;529. 10.3174/ajnr.A4159</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A4159</ArticleId><ArticleId IdType="pmc">PMC8013063</ArticleId><ArticleId IdType="pubmed">25395655</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinjikji, W. , Pasternak, J. , Murad, M. H. , Cloft, H. J. , Welch, T. L. , Kallmes, D. F. , &amp; Rabinstein, A. A. (2017). Anesthesia&#x2010;related outcomes for endovascular stroke revascularization: A systematic review and meta&#x2010;analysis. Stroke, 48(10), 2784&#x2013;2791. 10.1161/STROKEAHA.117.017786</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.117.017786</ArticleId><ArticleId IdType="pubmed">28904228</ArticleId></ArticleIdList></Reference><Reference><Citation>Britton, A. , McKee, M. , Black, N. , McPherson, K. , &amp; Sanderson, C. (1998). Bain C. Choosing between randomised and non&#x2010;randomised studies: A systematic review. Health technology assessment . (Winchester, England), 2(13), pp. i&#x2013;iv, 1&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pubmed">9793791</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell, B. C. , Hill, M. D. , Rubiera, M. , Menon, B. K. , Demchuk, A. , Donnan, G. A. , &#x2026; Goyal, M. (2016). Safety and efficacy of solitaire stent thrombectomy: Individual patient data meta&#x2010;analysis of randomized trials. Stroke, 47(3), 798&#x2013;806. 10.1161/STROKEAHA.115.012360</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.115.012360</ArticleId><ArticleId IdType="pmc">PMC4760381</ArticleId><ArticleId IdType="pubmed">26888532</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell, B. C. V. , vanZwam, W. H. , Goyal, M. , Menon, B. K. , Dippel, D. W. J. , &amp; Demchuk, A. M. ,. &#x2026; HERMES collaborators . (2018). Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: A meta&#x2010;analysis of individual patient data. The Lancet Neurology., 17(1), 47&#x2013;53. 10.1016/S1474-4422(17)30407-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30407-6</ArticleId><ArticleId IdType="pubmed">29263006</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian, R. , &amp; Laird, N. (2015). Meta&#x2010;analysis in clinical trials revisited. Contemporary Clinical Trials., 45(Pt A), 139&#x2013;145. 10.1016/j.cct.2015.09.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cct.2015.09.002</ArticleId><ArticleId IdType="pmc">PMC4639420</ArticleId><ArticleId IdType="pubmed">26343745</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger, M. , Davey Smith, G. , Schneider, M. , &amp; Minder, C. (1997). Bias in meta&#x2010;analysis detected by a simple, graphical test. BMJ (Clinical Research ed)., 315(7109), 629&#x2013;634. 10.1136/bmj.315.7109.629</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.315.7109.629</ArticleId><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Elgendy, I. Y. , Kumbhani, D. J. , Mahmoud, A. , Bhatt, D. L. , &amp; Bavry, A. A. (2015). Mechanical thrombectomy for acute ischemic stroke: A meta&#x2010;analysis of randomized trials. Journal of the American College of Cardiology., 66(22), 2498&#x2013;2505.</Citation><ArticleIdList><ArticleId IdType="pubmed">26653623</ArticleId></ArticleIdList></Reference><Reference><Citation>Erickson, K. M., &amp; Cole, D. J. (2005). Review of developments in anesthesia for carotid endarterectomy. [Miscellaneous]. Current Opinion in Anaesthesiology., 18(5), 466&#x2013;470.</Citation><ArticleIdList><ArticleId IdType="pubmed">16534277</ArticleId></ArticleIdList></Reference><Reference><Citation>Gravel, G. , Boulouis, G. , Benhassen, W. , Rodriguez&#x2010;Regent, C. , Trystram, D. , Edjlali&#x2010;Goujon, M. , &#x2026; Naggara, O. N. (2018). Anaesthetic management during intracranial mechanical thrombectomy: Systematic review and meta&#x2010;analysis of current data. Journal of Neurology, Neurosurgery, and Psychiatry. 10.1136/jnnp-2018-318549</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-318549</ArticleId><ArticleId IdType="pubmed">30257967</ArticleId></ArticleIdList></Reference><Reference><Citation>HERMES, ISC . (2017). HERMES: Hightly effective reperfusion evaluated in multiple endovascular stroke trials. ISC: International stroke conference.</Citation></Reference><Reference><Citation>Higgins, J. P. , Altman, D. G. , G&#xf8;tzsche, P. C. , J&#xfc;ni, P. , Moher, D. , Oxman, A. D. , &#x2026; Cochrane Statistical Methods Group . (2011) The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (Clinical research ed). 343:d5928 10.1136/bmj.d5928</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins, J. P. , Thompson, S. G. , Deeks, J. J. , &amp; Altman, D. G. (2003). Measuring inconsistency in meta&#x2010;analyses. BMJ (Clinical Research ed)., 327(7414), 557&#x2013;560. 10.1136/bmj.327.7414.557</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Hozo, S. P. , Djulbegovic, B. , &amp; Hozo, I. (2005). Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Research Methodology., 5, 13 10.1186/1471-2288-5-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-5-13</ArticleId><ArticleId IdType="pmc">PMC1097734</ArticleId><ArticleId IdType="pubmed">15840177</ArticleId></ArticleIdList></Reference><Reference><Citation>Hungerford, J. P. , Hyer, M. , Turk, A. S. , Turner, R. D. , Chaudry, M. I. , Fargen, K. M. , &amp; Spiotta, A. M. (2016). Impact of ASPECT scores and infarct distribution on outcomes among patients undergoing thrombectomy for acute ischemic stroke with the ADAPT technique. J Neurointerv Surg., 9(9), 823&#x2013;829. 10.1136/neurintsurg-2016-012528</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/neurintsurg-2016-012528</ArticleId><ArticleId IdType="pubmed">27550306</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilyas, A. , Chen, C. J. , Ding, D. , Foreman, P. M. , Buell, T. J. , Ironside, N. , &#x2026; Worrall, B. B. (2018). Endovascular mechanical thrombectomy for acute ischemic stroke under general anesthesia versus conscious sedation: A systematic review and meta&#x2010;analysis. World Neurosurgery., 112, e355&#x2013;e367. 10.1016/j.wneu.2018.01.049</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2018.01.049</ArticleId><ArticleId IdType="pubmed">29355808</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagani, M. , Brinjikji, W. , Rabinstein, A. A. , Pasternak, J. J. , &amp; Kallmes, D. F. (2016). Hemodynamics during anesthesia for intra&#x2010;arterial therapy of acute ischemic stroke. Journal of NeuroInterventional Surgery., 8(9), 883&#x2013;888. 10.1136/neurintsurg-2015-011867</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/neurintsurg-2015-011867</ArticleId><ArticleId IdType="pubmed">26371294</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin, Z. C. , Zhou, X. H. , &amp; He, J. (2015). Statistical methods for dealing with publication bias in meta&#x2010;analysis. Statistics in Medicine., 34(2), 343&#x2013;360. 10.1002/sim.6342</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.6342</ArticleId><ArticleId IdType="pubmed">25363575</ArticleId></ArticleIdList></Reference><Reference><Citation>John, N. , Mitchell, P. , Dowling, R. , &amp; Yan, B. (2013). Is general anaesthesia preferable to conscious sedation in the treatment of acute ischaemic stroke with intra&#x2010;arterial mechanical thrombectomy? A review of the literature. Neuroradiology, 55(1), 93&#x2013;100. 10.1007/s00234-012-1084-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00234-012-1084-y</ArticleId><ArticleId IdType="pubmed">22922866</ArticleId></ArticleIdList></Reference><Reference><Citation>John, S. , Thebo, U. , Gomes, J. , Saqqur, M. , Farag, E. , Xu, J. , &#x2026; Hussain, M. S. (2014). Intra&#x2010;arterial therapy for acute ischemic stroke under general anesthesia versus monitored anesthesia care. Cerebrovascular Diseases (Basel, Switzerland), 38(4), 262&#x2013;267. 10.1159/000368216</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000368216</ArticleId><ArticleId IdType="pubmed">25401730</ArticleId></ArticleIdList></Reference><Reference><Citation>Jumaa, M. A. , Zhang, F. , Ruiz&#x2010;Ares, G. , Gelzinis, T. , Malik, A. M. , Aleu, A. , &#x2026; Jovin, T. G. (2010). Comparison of safety and clinical and radiographic outcomes in endovascular acute stroke therapy for proximal middle cerebral artery occlusion with intubation and general anesthesia versus the nonintubated state. Stroke, 41(6), 1180&#x2013;1184. 10.1161/STROKEAHA.109.574194</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.109.574194</ArticleId><ArticleId IdType="pubmed">20431082</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, C. H. , Jeon, J. P. , Kim, S. E. , Choi, H. J. , &amp; Cho, Y. J. (2018). Endovascular treatment with intravenous thrombolysis versus endovascular treatment alone for acute anterior circulation stroke: A meta&#x2010;analysis of observational studies. Journal of Korean Neurosurgical Society. 61(4), 467&#x2013;473. 10.3340/jkns.2017.0505.006</Citation><ArticleIdList><ArticleId IdType="doi">10.3340/jkns.2017.0505.006</ArticleId><ArticleId IdType="pmc">PMC6046573</ArticleId><ArticleId IdType="pubmed">29631383</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, Y. W. , Son, S. , Kang, D. H. , Hwang, Y. H. , &amp; Kim, Y. S. (2017). Endovascular thrombectomy for M2 occlusions: Comparison between forced arterial suction thrombectomy and stent retriever thrombectomy. J Neurointerv Surg., 9(7), 626&#x2013;630. 10.1136/neurintsurg-2016-012466</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/neurintsurg-2016-012466</ArticleId><ArticleId IdType="pubmed">27382124</ArticleId></ArticleIdList></Reference><Reference><Citation>Lapergue, B. , Blanc, R. , Guedin, P. , Decroix, J. P. , Labreuche, J. , Preda, C. , &#x2026; Piotin, M. (2016). A direct aspiration, first pass technique (ADAPT) versus stent retrievers for acute stroke therapy: An observational comparative study. AJNR American Journal of Neuroradiology., 37(10), 1860&#x2013;1865. 10.3174/ajnr.A4840</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A4840</ArticleId><ArticleId IdType="pmc">PMC7960455</ArticleId><ArticleId IdType="pubmed">27256852</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, F. , Deshaies, E. M. , Singla, A. , Villwock, M. R. , Melnyk, V. , Gorji, R. , &amp; Yang, Z. J. (2014). Impact of anesthesia on mortality during endovascular clot removal for acute ischemic stroke. Journal of Neurosurgical Anesthesiology, 26(4), 286&#x2013;290. 10.1097/ANA.0000000000000031</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ANA.0000000000000031</ArticleId><ArticleId IdType="pubmed">24296538</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;whagen Hend&#xe9;n, P. , Rentzos, A. , Karlsson, J. E. , Rosengren, L. , Leiram, B. , Sundeman, H. , &#x2026; Ricksten, S. E. (2017). General anesthesia versus conscious sedation for endovascular treatment of acute ischemic stroke: The AnStroke trial (anesthesia during stroke). Stroke, 48(6), 1601&#x2013;1607. 10.1161/STROKEAHA.117.016554</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.117.016554</ArticleId><ArticleId IdType="pubmed">28522637</ArticleId></ArticleIdList></Reference><Reference><Citation>Marmagkiolis, K. , Hakeem, A. , Cilingiroglu, M. , Gundogdu, B. , Iliescu, C. , Tsitlakidou, D. , &amp; Katramados, A. (2015). Safety and efficacy of stent retrievers for the management of acute ischemic stroke: Comprehensive review and meta&#x2010;analysis. JACC Cardiovascular Interventions, 8(13), 1758&#x2013;1765. 10.1016/j.jcin.2015.07.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2015.07.021</ArticleId><ArticleId IdType="pubmed">26476611</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher, D. , Liberati, A. , Tetzlaff, J. , &amp; Altman, D. G. (2009). Preferred reporting items for systematic reviews and meta&#x2010;analyses: The PRISMA statement. BMJ (Clinical Research ed)., 339, b2535 10.1371/journal.pmed.1000097</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1000097</ArticleId><ArticleId IdType="pmc">PMC2714657</ArticleId><ArticleId IdType="pubmed">19622551</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichols, C. , Carrozzella, J. , Yeatts, S. , Tomsick, T. , Broderick, J. , &amp; Khatri, P. (2010). Is periprocedural sedation during acute stroke therapy associated with poorer functional outcomes? J Neurointerv Surg., 2(1), 67&#x2013;70. 10.1136/jnis.2009.001768</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnis.2009.001768</ArticleId><ArticleId IdType="pmc">PMC2860799</ArticleId><ArticleId IdType="pubmed">20431708</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff, J. A. R. , Sch&#xf6;nenberger, S. , Nagel, S. , Ringleb, P. A. , Hacke, W. , Bendszus, M. , &#x2026; M&#xf6;hlenbruch, M. A. (2018). Effect of General anesthesia versus conscious sedation for stroke thrombectomy on angiographic workflow in a randomized trial: A post hoc analysis of the SIESTA trial. Radiology, 286(3), 1016&#x2013;1021. 10.1148/radiol.2017171002</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2017171002</ArticleId><ArticleId IdType="pubmed">29083986</ArticleId></ArticleIdList></Reference><Reference><Citation>Saber, H. , Rajah, G. B. , Kherallah, R. Y. , Jadhav, A. P. , &amp; Narayanan, S. (2018). Comparison of the efficacy and safety of thrombectomy devices in acute stroke : A network meta&#x2010;analysis of randomized trials. J Neurointerv Surg., 10(8), 729&#x2013;734. 10.1136/neurintsurg-2017-013544</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/neurintsurg-2017-013544</ArticleId><ArticleId IdType="pubmed">29246906</ArticleId></ArticleIdList></Reference><Reference><Citation>Saver, J. L. , Goyal, M. , van der Lugt, A. , Menon, B. K. , Majoie, C. B. , Dippel, D. W. , &#x2026; HERMES Collaborators . (2016). Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: A meta&#x2010;analysis. JAMA, 316(12), 1279&#x2013;1288. 10.1001/jama.2016.13647</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.13647</ArticleId><ArticleId IdType="pubmed">27673305</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xf6;nenberger, S. , Uhlmann, L. , Hacke, W. , Schieber, S. , Mundiyanapurath, S. , Purrucker, J. C. , &#x2026; B&#xf6;sel, J. (2016). Effect of conscious sedation vs general anesthesia on early neurological improvement among patients with ischemic stroke undergoing endovascular thrombectomy: A randomized clinical trial. JAMA, 316(19), 1986&#x2013;1996. 10.1001/jama.2016.16623</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.16623</ArticleId><ArticleId IdType="pubmed">27785516</ArticleId></ArticleIdList></Reference><Reference><Citation>Sedgwick, P. (2015). What is publication bias in a meta&#x2010;analysis? BMJ (Clinical Research ed)., 351, h4419 10.1136/bmj.h4419</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.h4419</ArticleId><ArticleId IdType="pubmed">26276792</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan, W. , Yang, D. , Wang, H. , Xu, L. , Zhang, M. , Liu, W. , &#x2026; Liu, X. (2018). General anesthesia may have similar outcomes with conscious sedation in thrombectomy patients with acute ischemic stroke: A real&#x2010;world registry in China. European Neurology., 80(1&#x2013;2), 1&#x2013;7. 10.1159/000490901</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000490901</ArticleId><ArticleId IdType="pubmed">30048983</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonsen, C. Z. , Yoo, A. J. , S&#xf8;rensen, L. H. , Juul, N. , Johnsen, S. P. , Andersen, G. , &amp; Rasmussen, M. (2018). Effect of general anesthesia and conscious sedation during endovascular therapy on infarct growth and clinical outcomes in acute ischemic stroke: A randomized clinical trial. JAMA Neurol., 75(4), 470&#x2013;477. 10.1001/jamaneurol.2017.4474</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.4474</ArticleId><ArticleId IdType="pmc">PMC5885172</ArticleId><ArticleId IdType="pubmed">29340574</ArticleId></ArticleIdList></Reference><Reference><Citation>Slezak, A. , Kurmann, R. , Oppliger, L. , Broeg&#x2010;Morvay, A. , Gralla, J. , Schroth, G. , &#x2026; Mono, M. L. (2017). Impact of anesthesia on the outcome of acute ischemic stroke after endovascular treatment with the solitaire stent retriever. AJNR American Journal of Neuroradiology., 38(7), 1362&#x2013;1367. 10.3174/ajnr.A5183</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A5183</ArticleId><ArticleId IdType="pmc">PMC7959912</ArticleId><ArticleId IdType="pubmed">28473340</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang, A. (2010). Critical evaluation of the Newcastle&#x2010;Ottawa scale for the assessment of the quality of nonrandomized studies in meta&#x2010;analyses. European Journal of Epidemiology., 25(9), 603&#x2013;605. 10.1007/s10654-010-9491-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-010-9491-z</ArticleId><ArticleId IdType="pubmed">20652370</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Berg, L. A. , Koelman, D. L. , Berkhemer, O. A. , Rozeman, A. D. , Fransen, P. S. , &amp; Beumer, D. , &#x2026; Participating centers . (2015). Type of anesthesia and differences in clinical outcome after intra&#x2010;arterial treatment for ischemic stroke. Stroke, 46(5), 1257&#x2013;1262. 10.1161/STROKEAHA.115.008699</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.115.008699</ArticleId><ArticleId IdType="pubmed">25851766</ArticleId></ArticleIdList></Reference><Reference><Citation>Whalin, M. K. , Lopian, S. , Wyatt, K. , Sun, C. H. , Nogueira, R. G. , Glenn, B. A. , &#x2026; Gupta, R. (2014). Dexmedetomidine: A safe alternative to general anesthesia for endovascular stroke treatment. J Neurointerv Surg., 6(4), 270&#x2013;275. 10.1136/neurintsurg-2013-010773</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/neurintsurg-2013-010773</ArticleId><ArticleId IdType="pubmed">23761479</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39582698</PMID><DateRevised><Year>2024</Year><Month>11</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2589-790X</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>CJC open</Title><ISOAbbreviation>CJC Open</ISOAbbreviation></Journal><ArticleTitle>Cardiac Papillary Fibroelastoma and Cerebrovascular Events: A Systematic Review.</ArticleTitle><Pagination><StartPage>1259</StartPage><EndPage>1273</EndPage><MedlinePgn>1259-1273</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cjco.2024.07.008</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Cardiac papillary fibroelastomas (CPFs) are benign endocardial tumours with embolic potential. This article is a systematic review to identify the clinical profile, diagnosis, tumour characteristics, and treatment modalities in patients with CPF presenting with stroke or transient ischemic attack (TIA).</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This systematic review was conducted using the PubMed and Embase databases, including case reports and/or series and observational studies (for a search period of up until April 2022). A descriptive summary of case reports and/or series, and a narrative summary of observational studies, were completed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 161 cases were identified from 133 case reports and 11 case series. The mean age of patients was 54.8 years, and 46.6% were male. TIA and stroke were reported in 32.3% and 67.8%, respectively. The most common stroke territory was multiple brain sites (36.6%). The mean tumour size was 11.8 mm. Most of the tumours were left-sided (98.7%). The mitral valve was the most involved valve (38.9%), with the anterior leaflet being the commonest site (61.3%). A total of 91.4% of tumours were independently mobile; 10.6% of tumours missed by transthoracic echocardiography were identified on transesophageal echocardiography. Antiplatelet and anticoagulation treatment were used in 87.9% and 12.1% of cases, respectively. Simple excision, valve repair, and valve replacement were performed in 66.7%, 16.7%, and 16.7%, respectively. The logistic regression model revealed that age was the only significant predictor; an increase in the log-odds of recurrent cerebrovascular events occurred with increasing age.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">CPFs are a differential diagnosis of cryptogenic stroke, especially if the initial workup for stroke is negative. Transesophageal echocardiography serves as a better imaging tool, compared to transthoracic echocardiography, in identifying CPF. Although the consensus for CPF management remains controversial, surgical excision is the primary approach for left-sided CPF presenting as stroke or TIA.</AbstractText><CopyrightInformation>&#xa9; 2024 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Neupane</LastName><ForeName>Gagan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Mercy Hospital, Springfield, Missouri, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Raksha</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Florida Atlantic University, Boca Raton, Florida, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parajuli</LastName><ForeName>Rabindra</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Odum School of Ecology, University of Georgia, Athens, Georgia, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Geosciences, Florida Atlantic University, Boca Raton, Florida, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathews</LastName><ForeName>Adithya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Tampa General Hospital, Florida, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khalili</LastName><ForeName>Houman</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Memorial Healthcare System, Florida, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>CJC Open</MedlineTA><NlmUniqueID>101763635</NlmUniqueID><ISSNLinking>2589-790X</ISSNLinking></MedlineJournalInfo><OtherAbstract Type="Publisher" Language="fre"><AbstractText Label="CONTEXTE" NlmCategory="UNASSIGNED">Les fibro&#xe9;lastomes papillaires cardiaques (FPC) sont des tumeurs endocardiques b&#xe9;nignes pouvant provoquer une embolie. Cet article est une revue syst&#xe9;matique visant &#xe0; d&#xe9;finir le profil clinique, le diagnostic, les caract&#xe9;ristiques tumorales et les modalit&#xe9;s de traitement chez les patients atteints de FPC qui subissent un accident vasculaire c&#xe9;r&#xe9;bral (AVC) ou un accident isch&#xe9;mique transitoire (AIT).</AbstractText><AbstractText Label="M&#xc9;THODOLOGIE" NlmCategory="UNASSIGNED">Cette revue syst&#xe9;matique a &#xe9;t&#xe9; men&#xe9;e &#xe0; partir des bases de donn&#xe9;es PubMed et Embase, comprenant des rapports et/ou s&#xe9;ries de cas et des &#xe9;tudes observationnelles (la p&#xe9;riode couverte allait jusqu&#x2019;&#xe0; avril 2022). Un r&#xe9;sum&#xe9; descriptif des rapports et/ou s&#xe9;ries de cas et un r&#xe9;sum&#xe9; narratif des &#xe9;tudes observationnelles ont &#xe9;t&#xe9; r&#xe9;dig&#xe9;s.</AbstractText><AbstractText Label="R&#xc9;SULTATS" NlmCategory="UNASSIGNED">Au total, 161 cas ont &#xe9;t&#xe9; retenus sur 133 rapports de cas et 11 s&#xe9;ries de cas. L&#x2019;&#xe2;ge moyen des patients &#xe9;tait de 54,8 ans, et 46,6 % &#xe9;taient des hommes. Des AIT et des AVC ont &#xe9;t&#xe9; signal&#xe9;s chez respectivement 32,3 % et 67,8 % des patients. Le territoire infarci regroupait le plus souvent de multiples si&#xe8;ges c&#xe9;r&#xe9;braux (36,6 %). La taille moyenne des tumeurs &#xe9;tait de 11,8 mm. La plupart des tumeurs (98,7 %) se trouvaient du c&#xf4;t&#xe9; gauche. La valve mitrale &#xe9;tait la valve la plus atteinte (38,9 %), le feuillet ant&#xe9;rieur &#xe9;tant le foyer le plus fr&#xe9;quent (61,3 %). Au total, 91,4 % des tumeurs &#xe9;taient mobiles de mani&#xe8;re ind&#xe9;pendante; 10,6 % des tumeurs non d&#xe9;cel&#xe9;es par &#xe9;chocardiographie transthoracique ont &#xe9;t&#xe9; d&#xe9;tect&#xe9;es par &#xe9;chocardiographie trans&#x153;sophagienne. Des traitements antiplaquettaires et anticoagulants ont &#xe9;t&#xe9; utilis&#xe9;s chez respectivement 87,9 % et 12,1 % des cas. Une excision simple, une r&#xe9;paration de la valve et un remplacement de la valve ont &#xe9;t&#xe9; r&#xe9;alis&#xe9;s chez respectivement 66,7 %, 16,7 % et 16,7 % des cas. Le mod&#xe8;le de r&#xe9;gression logistique a r&#xe9;v&#xe9;l&#xe9; que l&#x2019;&#xe2;ge &#xe9;tait le seul facteur pr&#xe9;dictif important; le ratio &#xab; log-odds &#xbb; des &#xe9;v&#xe9;nements c&#xe9;r&#xe9;brovasculaires r&#xe9;currents a augment&#xe9; avec l&#x2019;&#xe2;ge.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Les FPC constituent un diagnostic diff&#xe9;rentiel de l&#x2019;AVC cryptog&#xe9;nique, particuli&#xe8;rement si l&#x2019;examen initial pour l&#x2019;AVC a donn&#xe9; un r&#xe9;sultat n&#xe9;gatif. L&#x2019;&#xe9;chocardiographie trans&#x153;sophagienne est un meilleur outil d&#x2019;imagerie que l&#x2019;&#xe9;chographie transthoracique pour d&#xe9;celer les FPC. Bien que le consensus pour le traitement des FPC demeure controvers&#xe9;, l&#x2019;excision chirurgicale est la principale technique pour les FPC du c&#xf4;t&#xe9; gauche qui se manifestent sous la forme d&#x2019;un AVC ou d&#x2019;un AIT.</AbstractText><CopyrightInformation>&#xa9; 2024 The Authors.</CopyrightInformation></OtherAbstract></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>25</Day><Hour>11</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>25</Day><Hour>11</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>25</Day><Hour>4</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39582698</ArticleId><ArticleId IdType="pmc">PMC11583865</ArticleId><ArticleId IdType="doi">10.1016/j.cjco.2024.07.008</ArticleId><ArticleId IdType="pii">S2589-790X(24)00287-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tyebally S., Chen D., Bhattacharyya S., et al. Cardiac tumors: JACC CardioOncology state-of-the-art review. JACC CardioOncol. 2020;2:293&#x2013;311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352246</ArticleId><ArticleId IdType="pubmed">34396236</ArticleId></ArticleIdList></Reference><Reference><Citation>Habertheuer A., Laufer G., Wiedemann D., et al. Primary cardiac tumors on the verge of oblivion: a European experience over 15 years. J&#xa0;Cardiothorac Surg. 2015;10:56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4423145</ArticleId><ArticleId IdType="pubmed">25928192</ArticleId></ArticleIdList></Reference><Reference><Citation>Gowda R.M., Khan I.A., Nair C.K., et al. Cardiac papillary fibroelastoma: a comprehensive analysis of 725 cases. Am Heart J. 2003;146:404&#x2013;410.</Citation><ArticleIdList><ArticleId IdType="pubmed">12947356</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoltowska D.M., Sadic E., Becoats K., et al. Cardiac papillary fibroelastoma. J&#xa0;Geriatr Cardiol. 2021;18:346&#x2013;351.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8185441</ArticleId><ArticleId IdType="pubmed">34149823</ArticleId></ArticleIdList></Reference><Reference><Citation>Capotosto L., Elena G., Massoni F., et al. Cardiac tumors: echocardiographic diagnosis and forensic correlations. Am J Forensic Med Pathol. 2016;37:306&#x2013;316.</Citation><ArticleIdList><ArticleId IdType="pubmed">27617419</ArticleId></ArticleIdList></Reference><Reference><Citation>Cianciulli T.F., Soumoulou J.B., Lax J.A., et al. Papillary fibroelastoma: clinical and echocardiographic features and initial approach in 54 cases. Echocardiography. 2016;33:1811&#x2013;1817.</Citation><ArticleIdList><ArticleId IdType="pubmed">27566126</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J.P., Asher C.R., Yang X.S., et al. Clinical and echocardiographic characteristics of papillary fibroelastomas: a retrospective and prospective study in 162 patients. Circulation. 2001;103:2687&#x2013;2693.</Citation><ArticleIdList><ArticleId IdType="pubmed">11390338</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M.J., McKenzie J.E., Bossuyt P.M., et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Neupane G., Sharma R. Cardiac papillary fibroelastoma and stroke: a systematic review. https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022324810 Available at:</Citation></Reference><Reference><Citation>RStudio Team  RStudio: Integrated Development for R. RStudio, PBC, Boston, MA. 2020. http://www.rstudio.com/ Available at:</Citation></Reference><Reference><Citation>R Core Team  The R Project for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2021. http://www.R-project.org Available at:</Citation></Reference><Reference><Citation>Wickham H. ggplot2: Elegant Graphics for Data Analysis. Springer-Verlag New York. https://ggplot2.tidyverse.org Available at:</Citation></Reference><Reference><Citation>Joanna Briggs Institute (JBI)  Critical appraisal tools for use in JBI systematic reviews: checklist for qualitative research. https://jbi.global/critical-appraisal-tools Available at:</Citation></Reference><Reference><Citation>Nuffield Department of Primary Care Health Sciences Medical Sciences Division. et&#xa0;al. Oxford Centre for Evidence-Based Medicine (OCEBM) levels of evidence. https://www.cebm.ox.ac.uk/resources/levels-of-evidence/ocebm-levels-of-evidence Available at:</Citation></Reference><Reference><Citation>Rodrigues J.D., Ferreira J., Almeida J., et al. Cardiac papillary fibroelastoma: report of a surgical series. Rev Port Cardiol. 2018;37:981&#x2013;986.</Citation><ArticleIdList><ArticleId IdType="pubmed">30528564</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolek M., Dvorackova J., Motyka O., Brat R. Cardiac papillary fibroelastomas: a 10-year single-center surgical experience and long-term echocardiographic follow-up study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020;164:84&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">31748759</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurmann R., El-Am E., Bois M., et al. Clincal and echocardiographic characteristics in patients with pathology proven cardiac papillary fibroelastomas. Eur Heart J. 2019;40:278.</Citation><ArticleIdList><ArticleId IdType="pubmed">34871621</ArticleId></ArticleIdList></Reference><Reference><Citation>Yee H.C., Nwosu J.E., Lii A.D., Velasco M., Millman A. Echocardographic features of papillary fibroelastoma and their consequences and management. Am J Cardiol. 1997;80:811&#x2013;814.</Citation><ArticleIdList><ArticleId IdType="pubmed">9315601</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamin S.S., Maleszewski J.J., Scott C.G., et al. Prognostic and bioepidemiologic implications of papillary fibroelastomas. J&#xa0;Am Coll Cardiol. 2015;65:2420&#x2013;2429.</Citation><ArticleIdList><ArticleId IdType="pubmed">26046736</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorour A.A., Kurmann R.D., El-Am E.A., et al. Recurrence of pathologically proven papillary fibroelastoma. Ann Thorac Surg. 2022;113:1208&#x2013;1214.</Citation><ArticleIdList><ArticleId IdType="pubmed">34022212</ArticleId></ArticleIdList></Reference><Reference><Citation>Mkalaluh S., Szczechowicz M., Torabi S., et al. Surgery for cardiac papillary fibroelastoma: a 12-year single institution experience. Med Sci Monit Basic Res. 2017;23:258&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5523956</ArticleId><ArticleId IdType="pubmed">28706178</ArticleId></ArticleIdList></Reference><Reference><Citation>Alozie A., Zimpfer A., Erbersdobler A., et al. Surgery for valvular and nonvalvular papillary fibroelastomas. Semin Thorac Cardiovasc Surg. 2022;34:560&#x2013;568.</Citation><ArticleIdList><ArticleId IdType="pubmed">34022368</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu Saleh W.K., Al Jabbari O., Ramlawi B., Reardon M.J. Cardiac papillary fibroelastoma: single-institution experience with 14 surgical patients. Tex Heart Inst J. 2016;43:148&#x2013;151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4845562</ArticleId><ArticleId IdType="pubmed">27127431</ArticleId></ArticleIdList></Reference><Reference><Citation>Anastacio M.M., Moon M.R., Damiano R.J.J., et al. Surgical experience with cardiac papillary fibroelastoma over a 15-year period. Ann Thorac Surg. 2012;94:537&#x2013;541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4329773</ArticleId><ArticleId IdType="pubmed">22626753</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngaage D.L., Mullany C.J., Daly R.C., et al. Surgical treatment of cardiac papillary fibroelastoma: a single center experience with eighty-eight patients. Ann Thorac Surg. 2005;80:1712&#x2013;1718.</Citation><ArticleIdList><ArticleId IdType="pubmed">16242444</ArticleId></ArticleIdList></Reference><Reference><Citation>Klarich K.W., Enriquez-Sarano M., Gura G.M., et al. Papillary fibroelastoma: echocardiographic characteristics for diagnosis and pathologic correlation. J&#xa0;Am Coll Cardiol. 1997;30:784&#x2013;790.</Citation><ArticleIdList><ArticleId IdType="pubmed">9283541</ArticleId></ArticleIdList></Reference><Reference><Citation>Steger C.M., Hager T., Ruttmann E. Primary cardiac tumours: a single-center 41-year experience. ISRN Cardiol. 2012;2012</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3391967</ArticleId><ArticleId IdType="pubmed">22792486</ArticleId></ArticleIdList></Reference><Reference><Citation>Dell&#x2019;amore A., Albertini A., Lamarra M. Twenty years experience in oncologic surgery for primary cardiac tumors. G&#xa0;Chir. 2013;34:106&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3915578</ArticleId><ArticleId IdType="pubmed">23660160</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards F.H., Hale D., Cohen A., et al. Primary cardiac valve tumors. Ann Thorac Surg. 1991;52:1127&#x2013;1131.</Citation><ArticleIdList><ArticleId IdType="pubmed">1953134</ArticleId></ArticleIdList></Reference><Reference><Citation>Val-Bernal J.F., Mayorga M., Garijo M.F., Val D., Nistal J.F. Cardiac papillary fibroelastoma: retrospective clinicopathologic study of 17 tumors with resection at a single institution and literature review. Pathol Res Pract. 2013;209:208&#x2013;214.</Citation><ArticleIdList><ArticleId IdType="pubmed">23455367</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopaldas R.R., Atluri P.V., Blaustein A.S., et al. Papillary fibroelastoma of the aortic valve: operative approaches upon incidental discovery. Tex Heart Inst J. 2009;36:160&#x2013;163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2676606</ArticleId><ArticleId IdType="pubmed">19436815</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagot C.N., Arya R. Virchow and his triad: a question of attribution. Br J Haematol. 2008;143:180&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pubmed">18783400</ArticleId></ArticleIdList></Reference><Reference><Citation>Semerano A., Saliou G., Sanvito F., et al. Fishing an anemone in the brain: embolized cardiac fibroelastoma revealed after stroke thrombectomy. Eur Heart J. 2021;42:4094&#x2013;4095.</Citation><ArticleIdList><ArticleId IdType="pubmed">33517423</ArticleId></ArticleIdList></Reference><Reference><Citation>Leekoff M.L., Masur J.E., Burke A.P., et al. Clinical reasoning: an unusual cause of adult cryptogenic ischemic stroke. Neurology. 2018;90:386&#x2013;391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5818164</ArticleId><ArticleId IdType="pubmed">29459447</ArticleId></ArticleIdList></Reference><Reference><Citation>Biraschi F., Diana F., Alesini F., Guidetti G., Peschillo S. Effective ADAPT thrombectomy in a patient with acute stroke due to cardiac papillary elastofibroma: histological thrombus confirmation. J&#xa0;Stroke Cerebrovasc Dis. 2016;25:e185&#x2013;e187.</Citation><ArticleIdList><ArticleId IdType="pubmed">27539711</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke A., Virmani R. Amer Registry of Pathology; Washington, DC: 1996. Tumors of the Heart and Great Vessels (Atlas of Tumor Pathology&#x2014;3rd Series.</Citation></Reference><Reference><Citation>Wintersperger B.J., Becker C.R., Gulbins H., et al. Tumors of the cardiac valves: imaging findings in magnetic resonance imaging, electron beam computed tomography, and echocardiography. Eur Radiol. 2000;10:443&#x2013;449.</Citation><ArticleIdList><ArticleId IdType="pubmed">10756993</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33092804</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>28</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>126</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jan</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Systematic review and consensus definitions for the Standardized Endpoints in Perioperative Medicine (StEP) initiative: cardiovascular outcomes.</ArticleTitle><Pagination><StartPage>56</StartPage><EndPage>66</EndPage><MedlinePgn>56-66</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2020.09.023</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(20)30780-7</ELocationID><Abstract><AbstractText Label="BACKGROUND">Adverse cardiovascular events are a leading cause of perioperative morbidity and mortality. The definitions of perioperative cardiovascular adverse events are heterogeneous. As part of the international Standardized Endpoints in Perioperative Medicine initiative, this study aimed to find consensus amongst clinical trialists on a set of standardised and valid cardiovascular outcomes for use in future perioperative clinical trials.</AbstractText><AbstractText Label="METHODS">We identified currently used perioperative cardiovascular outcomes by a systematic review of the anaesthesia and perioperative medicine literature (PubMed/Ovid, Embase, and Cochrane Library). We performed a three-stage Delphi consensus-gaining process that involved 55 clinician researchers worldwide. Cardiovascular outcomes were first shortlisted and the most suitable definitions determined. These cardiovascular outcomes were then assessed for validity, reliability, feasibility, and clarity.</AbstractText><AbstractText Label="RESULTS">We identified 18 cardiovascular outcomes. Participation in the three Delphi rounds was 100% (n=19), 71% (n=55), and 89% (n=17), respectively. A final list of nine cardiovascular outcomes was elicited from the consensus: myocardial infarction, myocardial injury, cardiovascular death, non-fatal cardiac arrest, coronary revascularisation, major adverse cardiac events, pulmonary embolism, deep vein thrombosis, and atrial fibrillation. These nine cardiovascular outcomes were rated by the majority of experts as valid, reliable, feasible, and clearly defined.</AbstractText><AbstractText Label="CONCLUSIONS">These nine consensus cardiovascular outcomes can be confidently used as endpoints in clinical trials designed to evaluate perioperative interventions with the goal of improving perioperative outcomes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Beattie</LastName><ForeName>W Scott</ForeName><Initials>WS</Initials><AffiliationInfo><Affiliation>Cardiovascular Anesthesia, University Health Network, University of Toronto, Toronto, ON, Canada. Electronic address: scott.beattie@uhn.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lalu</LastName><ForeName>Manoj</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bocock</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wijeysundera</LastName><ForeName>Duminda N</ForeName><Initials>DN</Initials><AffiliationInfo><Affiliation>Li Ka Shing Knowledge Institute, St Michaels Hospital, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagele</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Critical Care, University of Chicago, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fleisher</LastName><ForeName>Lee A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, University of Pennsylvania Health System, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurz</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Outcomes Research, Cleveland Clinic, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biccard</LastName><ForeName>Bruce</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Medicine, University of Cape Town, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leslie</LastName><ForeName>Kate</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Melbourne, Vic., Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Howell</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Leeds School of Medicine, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovani</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Center for Intensive Care and Anesthesiology, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grocott</LastName><ForeName>Hilary</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Medicine, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lamy</LastName><ForeName>Andre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richards</LastName><ForeName>Toby</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University of Western Australia, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Myles</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Alfred Health and Monash University Department of Anaesthesia and Perioperative Medicine, Melbourne, Vic., Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>StEP COMPAC Group</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Patient Comfort</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Clinical Indicators</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Delirium Postoperative Cognitive Dysfunction Stroke</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Cardiovascular</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Data Extractors</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Respiratory</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Inflammation Sepsis</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Acute Kidney Injury</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Bleeding Complications Patient Blood Management</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Healthcare Resource Utilisation</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Patient-Centred Outcomes</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Organ Failure and Survival</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Cancer Surgery</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>10/104/06</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D032921" MajorTopicYN="N">Consensus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003697" MajorTopicYN="N">Delphi Technique</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023381" MajorTopicYN="N">Endpoint Determination</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000079645" MajorTopicYN="N">Perioperative Medicine</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">MACE</Keyword><Keyword MajorTopicYN="N">cardiovascular events</Keyword><Keyword MajorTopicYN="N">clinical trials</Keyword><Keyword MajorTopicYN="N">myocardial infarction</Keyword><Keyword MajorTopicYN="N">outcome measures</Keyword><Keyword MajorTopicYN="N">perioperative medicine</Keyword><Keyword MajorTopicYN="N">standardised endpoint</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Cooper</LastName><ForeName>D Jamie</ForeName><Initials>DJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Myles</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gan</LastName><ForeName>T J</ForeName><Initials>TJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kurz</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Peyton</LastName><ForeName>Phil</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sessler</LastName><ForeName>Dan</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tram&#xe8;r</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cyna</LastName><ForeName>Alan</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Oliveira</LastName><ForeName>Gildasio S</ForeName><Initials>GS</Initials><Suffix>Jr</Suffix></Investigator><Investigator ValidYN="Y"><LastName>Wu</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jensen</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kehlet</LastName><ForeName>Henrik</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Botti</LastName><ForeName>Mari</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Boney</LastName><ForeName>Oliver</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haller</LastName><ForeName>Guy</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grocott</LastName><ForeName>Mike</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cook</LastName><ForeName>Tim</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fleisher</LastName><ForeName>Lee</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Neuman</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Story</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gruen</LastName><ForeName>Russell</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bampoe</LastName><ForeName>Sam</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Evered</LastName><ForeName>Lis</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scott</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Silbert</LastName><ForeName>Brendan</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Dijk</LastName><ForeName>Diederik</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kalkman</LastName><ForeName>Cor</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chan</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grocott</LastName><ForeName>Hilary</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haller</LastName><ForeName>Guy</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eckenhoff</LastName><ForeName>Rod</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rasmussen</LastName><ForeName>Lars</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eriksson</LastName><ForeName>Lars</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beattie</LastName><ForeName>Scott</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wijeysundera</LastName><ForeName>Duminda</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fleisher</LastName><ForeName>Lee</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leslie</LastName><ForeName>Kate</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Biccard</LastName><ForeName>Bruce</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Howell</LastName><ForeName>Simon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grocott</LastName><ForeName>Hilary</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nagele</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Richards</LastName><ForeName>Toby</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lamy</LastName><ForeName>Andre</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lalu</LastName><ForeName>Manoj</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bartlett</LastName><ForeName>Richard J</ForeName><Initials>RJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>McMonnies</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gerstl</LastName><ForeName>Jakob V.E.</ForeName><Initials>JV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jay</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kishlyansky</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Machina</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bobcock</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Feng</LastName><ForeName>Simon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pearse</LastName><ForeName>Rupert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mythen</LastName><ForeName>Monty</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Canet</LastName><ForeName>Jaume</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moller</LastName><ForeName>Ann</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gin</LastName><ForeName>Tony</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schultz</LastName><ForeName>Marcus</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pelosi</LastName><ForeName>Paolo</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gabreu</LastName><ForeName>Marcelo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Futier</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Creagh-Brown</LastName><ForeName>Ben</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abbott</LastName><ForeName>Tom</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mythen</LastName><ForeName>Monty</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kalkman</LastName><ForeName>Cor</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Klein</LastName><ForeName>Andy</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Corcoran</LastName><ForeName>Tomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cooper</LastName><ForeName>D Jamie</ForeName><Initials>DJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dieleman</LastName><ForeName>Stefan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Diouf</LastName><ForeName>Elisabeth</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>McIlroy</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bellomo</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shaw</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Prowle</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Karkouti</LastName><ForeName>Keyvan</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Billings</LastName><ForeName>Josh</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wijeysundera</LastName><ForeName>Duminda</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Klein</LastName><ForeName>Andy</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Richards</LastName><ForeName>Toby</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mazer</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Myles</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jayarajah</LastName><ForeName>Mohindas</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Karkouti</LastName><ForeName>Keyvan</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Murphy</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lamy</LastName><ForeName>Andre</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bartoszko</LastName><ForeName>Justyna</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sneyd</LastName><ForeName>Rob</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beattie</LastName><ForeName>Scott</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fleisher</LastName><ForeName>Lee</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grocott</LastName><ForeName>Mike</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sessler</LastName><ForeName>Dan</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morris</LastName><ForeName>Steve</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>George</LastName><ForeName>Ron</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moonesinghe</LastName><ForeName>Ramani</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chan</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cook</LastName><ForeName>Tim</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Myles</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shulman</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Neuman</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kalkman</LastName><ForeName>Cor</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lane-Fall</LastName><ForeName>Meghan</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nilsson</LastName><ForeName>Ulrica</ForeName><Initials>U</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stevenson</LastName><ForeName>Nathalie</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grocott</LastName><ForeName>Mike</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Myles</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pearse</LastName><ForeName>Rupert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kurz</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moonesinghe</LastName><ForeName>Ramani</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cooper</LastName><ForeName>Jamie Dj</ForeName><Initials>JD</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Klei</LastName><ForeName>Wilton</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cabrini</LastName><ForeName>Luca</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miller</LastName><ForeName>Tim</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pace</LastName><ForeName>Nathan</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jackson</LastName><ForeName>Sandy</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Buggy</LastName><ForeName>Donal</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sessler</LastName><ForeName>Dan</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leslie</LastName><ForeName>Kate</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Short</LastName><ForeName>Tim</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kurz</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Riedel</LastName><ForeName>Bernhard</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gottumukkala</LastName><ForeName>Vijay</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pace</LastName><ForeName>Nathan</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alkhaffaf</LastName><ForeName>Bilal</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Johnson</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>23</Day><Hour>5</Hour><Minute>36</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33092804</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2020.09.023</ArticleId><ArticleId IdType="pii">S0007-0912(20)30780-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">34642940</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-493X</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>10</Issue><PubDate><Year>2021</Year><Month>Oct</Month><Day>13</Day></PubDate></JournalIssue><Title>The Cochrane database of systematic reviews</Title><ISOAbbreviation>Cochrane Database Syst Rev</ISOAbbreviation></Journal><ArticleTitle>Local versus general anaesthesia for carotid endarterectomy.</ArticleTitle><Pagination><StartPage>CD000126</StartPage><MedlinePgn>CD000126</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">CD000126</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/14651858.CD000126.pub5</ELocationID><Abstract><AbstractText Label="BACKGROUND">Carotid endarterectomy may significantly reduce the risk of stroke in people with recently symptomatic, severe carotid artery stenosis. However, there are significant perioperative risks that may be minimised by performing the operation under local rather than general anaesthetics. This is an update of a Cochrane Review first published in 1996, and previously updated in 2004, 2008, and 2013.</AbstractText><AbstractText Label="OBJECTIVES">To determine whether carotid endarterectomy under local anaesthetic: 1) reduces the risk of perioperative stroke and death compared with general anaesthetic; 2) reduces the complication rate (other than stroke) following carotid endarterectomy; and 3) is acceptable to individuals and surgeons.</AbstractText><AbstractText Label="SEARCH METHODS">We searched CENTRAL, MEDLINE, Embase, and two trials registers (to February 2021). We also reviewed reference lists of articles identified.</AbstractText><AbstractText Label="SELECTION CRITERIA">Randomised controlled trials (RCTs) comparing the use of local anaesthetics to general anaesthetics for people having carotid endarterectomy were eligible.</AbstractText><AbstractText Label="DATA COLLECTION AND ANALYSIS">Three review authors independently extracted data, assessed risk of bias, and evaluated quality of evidence using the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) tool. We calculated a pooled Peto odds ratio (OR) and corresponding 95% confidence interval (CI) for the following outcomes that occurred within 30 days of surgery: stroke, death, ipsilateral stroke, stroke or death, myocardial infarction, local haemorrhage, and arteries shunted.</AbstractText><AbstractText Label="MAIN RESULTS">We included 16 RCTs involving 4839 participants, of which 3526 were obtained from the single largest trial (GALA). The main findings from our meta-analysis showed that, within 30 days of operation, neither incidence of stroke nor death were significantly different between local and general anaesthesia. Of these, the incidence of stroke in the local and general anaesthesia groups was 3.2% and 3.5%, respectively (Peto odds ratio (OR) 0.91, 95% confidence interval (CI) 0.66 to 1.26; P = 0.58; 13 studies, 4663 participants; low-quality evidence). The rate of ipsilateral stroke under both types of anaesthesia was 3.1% (Peto OR 1.03, 95% CI 0.71 to 1.48; P = 0.89; 2 studies, 3733 participants; low-quality evidence). The incidence of stroke or death in the local anaesthesia group was 3.5%, while stroke or death incidence was 4.1% in the general anaesthesia group (Peto OR 0.85, 95% CI 0.62 to 1.16; P = 0.31; 11 studies, 4391 participants; low-quality evidence). A lower rate of death was observed in the local anaesthetic group but evidence was of low quality (Peto OR 0.61, 95% CI 0.35 to 1.06; P = 0.08; 12 studies, 4421 participants).</AbstractText><AbstractText Label="AUTHORS' CONCLUSIONS">The incidence of stroke and death were not convincingly different between local and general anaesthesia for people undergoing carotid endarterectomy. The current evidence supports the choice of either approach. Further high-quality studies are still needed as the evidence is of limited reliability.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rerkasem</LastName><ForeName>Amaraporn</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Environmental - Occupational Health Sciences and Non Communicable Diseases Center of Excellence, Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orrapin</LastName><ForeName>Saritphat</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, Department of Surgery, Faculty of Medicine, Thammasat University (Rangsit Campus), Pathum Thani, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Howard</LastName><ForeName>Dominic Pj</ForeName><Initials>DP</Initials><AffiliationInfo><Affiliation>Centre for Prevention of Stroke and Dementia, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nantakool</LastName><ForeName>Sothida</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Environmental - Occupational Health Sciences and Non Communicable Diseases Center of Excellence, Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rerkasem</LastName><ForeName>Kittipan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Environmental - Occupational Health Sciences and Non Communicable Diseases Center of Excellence, Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cochrane Database Syst Rev</MedlineTA><NlmUniqueID>100909747</NlmUniqueID><ISSNLinking>1361-6137</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>Cochrane Database Syst Rev. 2013 Dec 19;(12):CD000126. doi: 10.1002/14651858.CD000126.pub4.</RefSource><PMID Version="1">24353155</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000772" MajorTopicYN="N">Anesthesia, Local</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016893" MajorTopicYN="Y">Carotid Stenosis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016894" MajorTopicYN="Y">Endarterectomy, Carotid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>AR: none known.&#x2028;SO: none known.&#x2028;DPJH: none known.&#x2028;SN: none known.&#x2028;KR: none known.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>13</Day><Hour>7</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34642940</ArticleId><ArticleId IdType="pmc">PMC8511439</ArticleId><ArticleId IdType="doi">10.1002/14651858.CD000126.pub5</ArticleId></ArticleIdList><ReferenceList><Title>References to studies included in this review</Title><ReferenceList><Title>Binder 1999 {published and unpublished data}</Title><Reference><Citation>Binder M, Fitzgerald R, Fried H, Schwarz S. Carotid endarterectomy surgery in cervical block: an economic alternative to general anaesthesia? [Karotisdesobliteration in cervicalisblockade: eine okonomische alternative zur vollnarkose?]. Gesundheits&#xf6;konomie und Qualit&#xe4;tsmanagement 1999;4:19-24.</Citation></Reference></ReferenceList><ReferenceList><Title>Forssell 1989 {published data only}</Title><Reference><Citation>Forssell C, Takolander R, Bergqvist D, Johansson A, Persson NH. Local versus general anaesthesia in carotid surgery. A prospective, randomised study. European Journal of Vascular Surgery 1989;3:503-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">2696648</ArticleId></ArticleIdList></Reference><Reference><Citation>Forssell C. Studies on Risks and Results in Carotid Artery Surgery [Dissertation]. Malmo (Sweden): Lund University, 1991.</Citation></Reference><Reference><Citation>Takolander R, Bergqvist D, Hulthen L, Johansson A, Katzman PL. Carotid artery surgery. Local versus general anaesthetic as related to sympathetic activity and cardiovascular effects. European Journal of Vascular Surgery 1990;4:265-70.</Citation><ArticleIdList><ArticleId IdType="pubmed">2191876</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>GALA 2008 {published and unpublished data}</Title><Reference><Citation>GALA Trial Collaborative Group. General anaesthesia versus local anaesthesia for carotid surgery (GALA): a multicentre, randomised controlled trial. Lancet 2008;372:2132-42.</Citation><ArticleIdList><ArticleId IdType="pubmed">19041130</ArticleId></ArticleIdList></Reference><Reference><Citation>Girn HR, Dellagrammaticas D, Laughlan K, Gough MJ, GALA Trial Collaborators. Carotid endarterectomy: technical practices of surgeons participating in the GALA trial. European Journal of Vascular and Endovascular Surgery 2008;36:385-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">18639475</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes M, Soares MO, Dumville JC, Lewis SC, Torgerson DJ, Bodenham AR, GALA Collaborative Group. Cost-effectiveness analysis of general anaesthesia versus local anaesthesia for carotid surgery (GALA Trial). British Journal of Surgery 2010;97:1218-25.</Citation><ArticleIdList><ArticleId IdType="pubmed">20602498</ArticleId></ArticleIdList></Reference><Reference><Citation>Gough MJ, Bodenham A, Horrocks M, Colam B, Lewis SC, Rothwell PM, et al. GALA: an international multicentre randomised trial comparing general anaesthesia versus local anaesthesia for carotid surgery. Trials 2008;9:doi: 10.1186/1745-6215-9-28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2413207</ArticleId><ArticleId IdType="pubmed">18495004</ArticleId></ArticleIdList></Reference><Reference><Citation>Gough MJ, GALA trial Collaborators. The GALA trial - a summary of the findings. European Journal of Vascular and Endovascular Surgery 2008;36:505-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">18815058</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber CF, Friedl H, Hueppe M, Hintereder G, Schmitz-Rixen T, Zwissler B, et al. Impact of general versus local anesthesia on early postoperative cognitive dysfunction following carotid endarterectomy: GALA study subgroup analysis. World Journal of Surgery 2009;33:1526-32.</Citation><ArticleIdList><ArticleId IdType="pubmed">19424750</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijeyaratne SM, Collins MA, Barth JH, Gough MJ. Jugular venous neurone specific enolase (NSE) increases following carotid endarterectomy under general, but not local, anaesthesia. European Journal of Vascular and Endovascular Surgery 2009;38:262-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">19540138</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Gimenez 2004 {published data only}</Title><Reference><Citation>Gimenez A, Gonzales E, Lloret MD, Hospedales J, Bellmunt S, Vallespin J, et al. A comparison of general anaesthesia and loco-regional anaesthesia in surgery of the internal carotid artery and its repercussion on haemodynamic control. Cardiovascular Surgery 2003;11(Suppl 2):97.</Citation></Reference></ReferenceList><ReferenceList><Title>Hussien 2017 {published and unpublished data}</Title><Reference><Citation>Hussien GZ, Elbadawy AM, Elshamaa HA. Lactate/pyruvate monitoring during carotid endarterectomy under general anaesthesia versus cervical plexus block: a randomised controlled study. Indian Journal of Anaesthesia 2017;61(5):424-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5444222</ArticleId><ArticleId IdType="pubmed">28584353</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kasprzak 2006 {published and unpublished data}</Title><Reference><Citation>Kasprzak P, Altmeppen J, Rosin L, Metz CH, Horn M, Jauch KW. Local versus general anaesthesia in carotid surgery - results of a prospective randomised study. Cardiovascular Surgery 1999;7(Suppl 1):16.</Citation></Reference><Reference><Citation>Kasprzak PM, Altmeppen J, Angerer M, Mann S, Mackh J, Topel J. General versus locoregional anesthesia in carotid surgery: a prospective randomised trial. VASA 2006;35:232-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">17109365</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Luchetti 2008 {published data only}</Title><Reference><Citation>Luchetti M, Canella M, Zoppi M, Massei R. Comparison of regional anesthesia versus combined regional and general anesthesia for elective carotid endarterectomy: a small exploratory study. Regional Anesthesia and Pain Medicine 2008;33:340-5.</Citation><ArticleIdList><ArticleId IdType="pubmed">18675745</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mazul&#x2010;Sunko 2010 {published and unpublished data}</Title><Reference><Citation>Mazul-Sunko B, Hromatko I, Tadinac M, Sekulic A, Ivanec Z, Gvozdenovic A, et al. Subclinical neurocognitive dysfunction after carotid endarterectomy - the impact of shunting. Journal of Neurosurgical Anesthesiology 2010;22:195-201.</Citation><ArticleIdList><ArticleId IdType="pubmed">20479673</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>McCarthy 2004 {published data only}</Title><Reference><Citation>McCarthy RJ, Nasr MK, McAteer P, Horrocks M. Physiological advantages of cerebral blood flow during carotid endarterectomy under local anaesthesia. European Journal of Vascular and Endovascular Surgery 2002;24:215-21.</Citation><ArticleIdList><ArticleId IdType="pubmed">12217282</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy RJ, Trigg R, John C, Gough MJ, Horrocks M. Patient satisfaction for carotid endarterectomy performed under local anaesthesia. European Journal of Vascular and Endovascular Surgery 2004;27:654-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15121119</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Moritz 2010 {published data only}</Title><Reference><Citation>Moritz S, Schmidt C, Bucher M, Wiesenack C, Zimmermann M, Schebesch KM, et al. Neuromonitoring in carotid surgery: are the results obtained in awake patients transferable to patients under sevoflurane/fentanyl anesthesia? Journal of Neurosurgical Anesthesiology 2010;22:288-95.</Citation><ArticleIdList><ArticleId IdType="pubmed">20479662</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mrozek 2007 {published data only}</Title><Reference><Citation>Mrozek Z, Koutna J, Marek O. Anesthesia options in carotid endarterectomy. Anesteziologie a Intenzivni Medicina 2007;18:202-9.</Citation></Reference></ReferenceList><ReferenceList><Title>Orlick&#xfd; 2019 {published and unpublished data}</Title><Reference><Citation>Orlick&#xfd; M, Hrb&#xe1;&#x10d; T, Same&#x161; M, Vachata P, Hej&#x10d;l A, Ot&#xe1;hal D, et al. Anesthesia type determines risk of cerebral infarction after carotid endarterectomy. Journal of Vascular Surgery 2019;70(1):138-47.</Citation><ArticleIdList><ArticleId IdType="pubmed">30792052</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Pluskwa 1989 {published data only}</Title><Reference><Citation>Pluskwa F, Bonnet F, Abhay K, Touboul C, Rey B, Marcandoro J, et al. Blood pressure profiles during carotid endarterectomy. Comparing flunitrazepam/fentanyl/nitrous oxide with epidural anaesthesia (author's translation). Annales Fran&#xe7;aises d'Anesth&#xe8;sie et de R&#xe8;animation 1989;8:26-32.</Citation><ArticleIdList><ArticleId IdType="pubmed">2653119</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Prough 1989 {published data only}</Title><Reference><Citation>Prough DS, Scuderi PE, McWhorter JM, Balestrieri FJ, Davis CH, Stullken EH. Hemodynamic status following regional and general anesthesia for carotid endarterectomy. Journal of Neurosurgical Anesthesiology 1989;1:35-40.</Citation><ArticleIdList><ArticleId IdType="pubmed">15815237</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sbarigia 1999 {published and unpublished data}</Title><Reference><Citation>Sbarigia E, DarioVizza C, Antonini M, Speziale F, Maritti M, Fiorani B, et al. Locoregional versus general anesthesia in carotid surgery: is there an impact on perioperative myocardial ischemia? Results of a prospective monocentric randomized trial. Journal of Vascular Surgery 1999;30:131-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">10394163</ArticleId></ArticleIdList></Reference><Reference><Citation>Vizza C, Sbarigia E, Antonini M, Speziale F, Maritti M, Fiorani B, et al. Perioperative myocardial ischemia in patients treated with carotid surgery. Impact of the type of anesthesia (locoregional vs general). Minerva Cardioangiologica 1999;47(12):626-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">10670233</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sindelic 2004 {published data only}</Title><Reference><Citation>Sindelic R, Viajkovic G, Davidovic L, Vujanac B, Vjestica M. Comparison of the influence of general and regional anesthesia on basic haemodynamic parameters during carotid endarterectomy. Acta Chirurgica Iugoslavica 2004;51:37-43.</Citation><ArticleIdList><ArticleId IdType="pubmed">16018364</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to studies excluded from this review</Title><ReferenceList><Title>Krajnic 2011 {published data only}</Title><Reference><Citation>Krajnic VM, Kozlov SP, Deshko UV, Kuklin AV, Kravchenko AA. General anesthesia vs combined anesthesia during internal carotid artery surgery. Anesteziologiya i Reanimatologiya 2011;6:20-4.</Citation><ArticleIdList><ArticleId IdType="pubmed">22379908</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Martynov 2018 {published data only}</Title><Reference><Citation>Martynov D, Tomaschuk D. Comparison between combined (deep and superficial) cervical plexus block with low-concentrated levobupivacaine and ropivacaine for carotid endarterecomy. Regional Anesthesia and Pain Medicine 2018;43(Suppl 1):e125-6. [Abst.ESRA8-0253]</Citation></Reference></ReferenceList><ReferenceList><Title>Ozturk 2018 {published data only}</Title><Reference><Citation>Kavrut Ozturk N, Kavakli AS, Sagdic K, Inanoglu K, Umot Ayoglu R. A randomized controlled trial examining the effect of the addition of the mandibular block to cervical plexus block for carotid endarterectomy. Journal of Cardiothoracic and Vascular Anesthesia 2018;32(2):877-82.</Citation><ArticleIdList><ArticleId IdType="pubmed">29397291</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ramachandran 2011 {published data only}</Title><Reference><Citation>Ramachandran SK, Picton P, Shanks A, Dorje P, Pandit JJ. Comparison of intermediate vs subcutaneous cervical plexus block for carotid endarterectomy. British Journal of Anaesthesia 2011;107(2):157-63.</Citation><ArticleIdList><ArticleId IdType="pubmed">21613278</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sindjelic 2010 {published data only}</Title><Reference><Citation>Sindjelic RP, Vlajkovic GP, Davidovic LB, Markovic DZ, Markovic MD. The addition of fentanyl to local anesthetics affects the quality and duration of cervical plexus block: a randomized, controlled trial. Anesthesia and Analgesia 2010;111(1):234-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">20519423</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>Additional references</Title><ReferenceList><Title>APT 1994</Title><Reference><Citation>Antiplatelet Trialists Collaboration. Collaborative overview of trials of antiplatelet therapy - I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:81-106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2539220</ArticleId><ArticleId IdType="pubmed">8298418</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bass 1989</Title><Reference><Citation>Bass A, Krupski WC, Schneider PA, Otis SM, Dilley RB, Bernstein EF. Intraoperative transcranial doppler: limitations of the method. Journal of Vascular Surgery 1989;10:549-53.</Citation><ArticleIdList><ArticleId IdType="pubmed">2681842</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Becquemin 1991</Title><Reference><Citation>Becquemin JP, Paris E, Valverde A, Pluskwa F, Melliere D. Carotid surgery. Is regional anesthesia always appropriate? Journal of Cardiovascular Surgery 1991;32:592-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">1939322</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Benjamin 1993</Title><Reference><Citation>Benjamin ME, Silva MB, Watt C, McCaffrey MT, Burford-Foggs A, Flinn WR. Awake patient monitoring to determine the need for shunting during carotid endarterectomy. Surgery 1993;114:673-81.</Citation><ArticleIdList><ArticleId IdType="pubmed">8211681</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Buche 1988</Title><Reference><Citation>Buche M, Grenier Y, Schoevaerdts JC, Jaumin P, Ponlot R, Chalant CH. Comparative results after endarterectomy of internal carotid artery performed with or without a shunt. Journal of Cardiovascular Surgery 1988;29:428-31.</Citation><ArticleIdList><ArticleId IdType="pubmed">3417742</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Collins 2001</Title><Reference><Citation>Collins R, MacMahon S. Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials. Lancet 2001;357:373-80.</Citation><ArticleIdList><ArticleId IdType="pubmed">11211013</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Corson 1987</Title><Reference><Citation>Corson JD, Chang BB, Shah DM, Leather RP, DeLeo BM, Karmody AM. The influence of anesthetic choice on carotid endarterectomy outcome. Archives of Surgery 1987;122:807-12.</Citation><ArticleIdList><ArticleId IdType="pubmed">3592971</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>ECST 1991</Title><Reference><Citation>European Carotid Surgery Trialists Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet 1991;337:1235-43.</Citation><ArticleIdList><ArticleId IdType="pubmed">1674060</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Gnanadev 1989</Title><Reference><Citation>Gnanadev DA, Wang N, Communale FL, Reile DA. Carotid artery stump pressure: how reliable is it in predicting the need for a shunt? Annals of Vascular Surgery 1989;3:313-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">2597616</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Godin 1989</Title><Reference><Citation>Godin MS, Bell WH, Schwedler M, Kerstein MD. Cost effectiveness of regional anesthesia in carotid endarterectomy. American Surgeon 1989;55:656-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">2510569</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Gomes 2010</Title><Reference><Citation>Gomes M, Soares MO, Dumvile JC, Lewis SC, Torgerson DJ, Bodenham AR, et al. Cost-effectiveness analysis of general anaesthesia versus local anaesthesia for carotid surgery (GALA Trial). British Journal of Surgery 2010;97:1218-25.</Citation><ArticleIdList><ArticleId IdType="pubmed">20602498</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Gumerlock 1988</Title><Reference><Citation>Gumerlock MK, Neuwelt EA. Carotid endarterectomy: to shunt or not to shunt. Stroke 1988;19:1485-90.</Citation><ArticleIdList><ArticleId IdType="pubmed">3201506</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Gurer 2003</Title><Reference><Citation>Gurer O, Yapici F, Enc Y, Cinar B, Ketenci B, Ozler A. Local versus general anaesthesia for carotid endarterectomy: report of 329 cases. Vascular and Endovascular Surgery 2003;37:171-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">12799725</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Hajibandeh 2018</Title><Reference><Citation>Hajibandeh S, Hajibandeh S, Antoniou SA, Torella F, Antoniou GA. Meta-analysis and trial sequential analysis of local vs. general anaesthesia for carotid endarterectomy. Anaesthesia 2018;73(10):1280-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">30062736</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Higgins 2003</Title><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Higgins 2011</Title><Reference><Citation>Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org.</Citation></Reference></ReferenceList><ReferenceList><Title>Javid 1979</Title><Reference><Citation>Javid H, Julian OC, Dye WS, Hunter JA, Najafi H, Goldin MD, et al. Seventeen-year experience with routine shunting in carotid surgery. World Journal of Surgery 1979;3:167-77.</Citation><ArticleIdList><ArticleId IdType="pubmed">483843</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kearse 1992</Title><Reference><Citation>Kearse LA, Brown EN, McPeck K. Somatosensory evoked potential sensitivity relative to electroencephalography for cerebral ischemia during carotid endarterectomy. Stroke 1992;23:498-505.</Citation><ArticleIdList><ArticleId IdType="pubmed">1561679</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kresowik 1991</Title><Reference><Citation>Kresowik TF, Worsey MJ, Khoury MD, Krain LS, Shamma AR, Sharp WJ, et al. Limitations of electroencephalographic monitoring in the detection of cerebral ischemia accompanying carotid endarterectomy. Journal of Vascular Surgery 1991;13:439-43.</Citation><ArticleIdList><ArticleId IdType="pubmed">1999866</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Markowitz 1984</Title><Reference><Citation>Markowitz TP, Adinolfi MF, Kerstein MD. Barbiturate therapy in the postoperative endarterectomy patient with a neurologic deficit. American Journal of Surgery 1984;148:221-3.</Citation><ArticleIdList><ArticleId IdType="pubmed">6465429</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>McCarthy 2001</Title><Reference><Citation>McCarthy RJ, Walker R, McAteer P, Budd JS, Horrocks M. Patient and hospital benefits of local anaesthesia for carotid endarterectomy. European Journal of Vascular and Endovascular Surgery 2001;22:13-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">11461096</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Michenfelder 1975</Title><Reference><Citation>Michenfelder JD, Milde JH. Cerebral protection by anesthetics during ischemia (a review). Resuscitation 1975;4:219-33.</Citation><ArticleIdList><ArticleId IdType="pubmed">822486</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>NASCET 1991</Title><Reference><Citation>North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. New England Journal of Medicine 1991;325:445-53.</Citation><ArticleIdList><ArticleId IdType="pubmed">1852179</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ott 1980</Title><Reference><Citation>Ott DA, Cooley DA, Chapa L, Coelho A. Carotid endarterectomy without temporary intraluminal shunt. Study of 309 consecutive operations. Annals of Surgery 1980;191:708-14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1344778</ArticleId><ArticleId IdType="pubmed">7387232</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Page 2021</Title><Reference><Citation>Page MJ, Higgins JP, Sterne JA. Chapter 13: Assessing risk of bias due to missing results in a synthesis. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021. Available from www.training.cochrane.org/handbook.</Citation></Reference></ReferenceList><ReferenceList><Title>Prioleau 1977</Title><Reference><Citation>Prioleau WH, Aiken AF, Hairston P. Carotid endarterectomy: neurologic complications as related to surgical techniques. Annals of Surgery 1977;185:678-83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1396228</ArticleId><ArticleId IdType="pubmed">860880</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Reddy 1987</Title><Reference><Citation>Reddy K, West M, Anderson B. Carotid endarterectomy without indwelling shunts and intraoperative electrophysiologic monitoring. Canadian Journal of Neurological Sciences 1987;14:131-5.</Citation><ArticleIdList><ArticleId IdType="pubmed">3607614</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rerkasem 2010</Title><Reference><Citation>Rerkasem K, Rothwell PM. Routine or selective carotid artery shunting for carotid endarterectomy and different methods of monitoring in selective shunting. Stroke 2010;41:e53-4.</Citation><ArticleIdList><ArticleId IdType="pubmed">12624319</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rerkasem 2011</Title><Reference><Citation>Rerkasem K, Rothwell P. Carotid endarterectomy for symptomatic carotid stenosis. Cochrane Database of Systematic Reviews 2011, Issue 4. Art. No: CD001081. [DOI: 10.1002/14651858.CD001081.pub2]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD001081.pub2</ArticleId><ArticleId IdType="pubmed">21491381</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Review Manager 2014 [Computer program]</Title><Reference><Citation>Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5). Version 5.4. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2020.</Citation></Reference></ReferenceList><ReferenceList><Title>Ricotta 1983</Title><Reference><Citation>Ricotta JJ, Charlton MH, DeWeese JA. Determining criteria for shunt placement during carotid endarterectomy. EEG versus back pressure. Annals of Surgery 1983;198:642-5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1353138</ArticleId><ArticleId IdType="pubmed">6639165</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rothwell 2003</Title><Reference><Citation>Rothwell PM, Eliasziw M, Gutnikov SA, Fox AJ, Taylor DW, Mayberg MR, et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003;361:107-16.</Citation><ArticleIdList><ArticleId IdType="pubmed">12531577</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Schweiger 1988</Title><Reference><Citation>Schweiger H, Kamp HD, Dinkel M. Somatosensory evoked potentials (SEP) during carotid endarterectomy - end of shunt debate? In: Boccalon H, editors(s). Angiology: Strategy for Diagnosis and Therapeutics. Paris (France): John Libbey Eurotext, 1988:353-5.</Citation></Reference></ReferenceList><ReferenceList><Title>Steiger 1989</Title><Reference><Citation>Steiger HJ, Schaffler L, Boll J, Liechti S. Results of microsurgical carotid endarterectomy. A prospective study with transcranial Doppler and EEG monitoring, and elective shunting. Acta Neurochirurgica 1989;100:31-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">2816532</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sundt 1986</Title><Reference><Citation>Sundt TM Jr, Ebersold MJ, Sharbrough FW, Piepgras DG, Marsh WR, Messick JM Jr. The risk-benefit ratio of intraoperative shunting during carotid endarterectomy. Relevancy to operative and postoperative results and complications. Annals of Surgery 1986;203:196-204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1251069</ArticleId><ArticleId IdType="pubmed">3947156</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sweeting 2004</Title><Reference><Citation>Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Statistics in Medicine 2004;23:1351-75.</Citation><ArticleIdList><ArticleId IdType="pubmed">15116347</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Thompson 1979</Title><Reference><Citation>Thompson JE. Complications of carotid endarterectomy and their prevention. World Journal of Surgery 1979;3:155-65.</Citation><ArticleIdList><ArticleId IdType="pubmed">483842</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Weber 2009</Title><Reference><Citation>Weber CF, Friedl H, Hueppe M, Hintereder G, Schmitz-Rixen T, Zwissler B, et al. Impact of general versus local anesthesia on early postoperative cognitive dysfunction following carotid endarterectomy: GALA study subgroup analysis. World Journal of Surgery 2009;33:1526-32.</Citation><ArticleIdList><ArticleId IdType="pubmed">19424750</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Wells 1963</Title><Reference><Citation>Wells BA, Keats AS, Cooly DA. Increased tolerance to cerebral ischemia produced by general anesthesia during temporary carotid occlusion. Surgery 1963;54:216-23.</Citation><ArticleIdList><ArticleId IdType="pubmed">13999872</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to other published versions of this review</Title><ReferenceList><Title>Rerkasem 2004</Title><Reference><Citation>Rerkasem K, Bond R, Rothwell PM. Local versus general anaesthesia for carotid endarterectomy. Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No: CD000126. [DOI: 10.1002/14651858.CD000126]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD000126</ArticleId><ArticleId IdType="pubmed">15106144</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rerkasem 2008</Title><Reference><Citation>Rerkasem K, Rothwell PM. Local versus general anaesthesia for carotid endarterectomy. Cochrane Database of Systematic Reviews 2008, Issue 4. Art. No: CD000126. [DOI: 10.1002/14651858.CD000126]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD000126</ArticleId><ArticleId IdType="pubmed">18843606</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Tangkanakul 1996</Title><Reference><Citation>Tangkanakul C, Counsell C, Warlow C. Carotid endarterectomy performed under local anaesthetic compared to general anaesthetic: a systematic review of the evidence. Cochrane Database of Systematic Reviews 1996, Issue 3. Art. No: CD000126. [DOI: 10.1002/14651858.CD000126]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD000126</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Vaniyapong 2013</Title><Reference><Citation>Vaniyapong T, Chongruksut W, Rerkasem K. Local versus general anaesthesia for carotid endarterectomy. Cochrane Database of Systematic Reviews 2013, Issue 12. Art. No: CD000126. [DOI: 10.1002/14651858.CD000126.pub4]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD000126.pub4</ArticleId><ArticleId IdType="pubmed">24353155</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37257673</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>25</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6809</ISSN><JournalIssue CitedMedium="Internet"><Volume>78</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of vascular surgery</Title><ISOAbbreviation>J Vasc Surg</ISOAbbreviation></Journal><ArticleTitle>Systematic review and meta-analysis of the treatment strategies for coronary artery bypass graft patients with concomitant carotid artery atherosclerotic disease.</ArticleTitle><Pagination><StartPage>1083</StartPage><EndPage>1094.e8</EndPage><MedlinePgn>1083-1094.e8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jvs.2023.04.043</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0741-5214(23)01273-9</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Stroke is one of the devastating complications after coronary artery bypass graft (CABG). Underlying carotid artery atherosclerotic disease is reported to be an independent risk factor. The optimal treatment strategy for these patients remains under debate.</AbstractText><AbstractText Label="METHODS">We aimed to perform a network meta-analysis to evaluate the safety and efficacy of additional carotid interventions for patients with concomitant carotid artery atherosclerotic disease who require CABG by comparing perioperative adverse event rates. All articles through February 2022 were searched using MEDLINE and EMBASE to identify studies that investigated outcomes of CABG only as well as additional staged vs combined carotid interventions by both carotid endarterectomy (CEA) and carotid artery stenting (CAS).</AbstractText><AbstractText Label="RESULTS">Two randomized controlled trials and 23 observational studies were included, yielding a total of 32,473 patients who underwent combined CEA and CABG (n&#xa0;= 20,204), CEA and staged CABG (n&#xa0;= 6882), CABG and staged CEA (n&#xa0;= 340), CAS and CABG regardless of timing and sequences (n&#xa0;= 1224), and CABG only (n&#xa0;= 3823). No strategy showed a significant advantage over CABG only in all perioperative outcomes. CEA and staged CABG was associated with the lowest perioperative stroke/transient ischemic attack (TIA) rate, significantly lower compared with CAS and CABG (odds ratio [OR], 0.52; 95% confidence interval [CI], 0.36-0.76) as well as CABG and staged CEA (OR, 0.41; 95% CI, 0.23-0.74), but was also associated with the highest perioperative mortality (OR, 2.50; 95% CI, 1.67-3.85, vs CAS and CABG) and myocardial infarction rate (OR, 3.70 [95% CI, 1.16-12.5] and OR, 2.50 [95% CI, 1.35-4.55] vs CAS and CABG, vs combined CEA and CABG, respectively).</AbstractText><AbstractText Label="CONCLUSIONS">CEA and staged CABG are associated with low perioperative stroke/transient ischemic attack rates with a tradeoff of higher mortality and myocardial infarction rate. No strategy showed a significant advantage over the CABG-only strategy in all perioperative outcomes, outlining the importance of a tailored approach and determining proper indications for carotid intervention in these patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tsukagoshi</LastName><ForeName>Junji</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Texas Medical Branch, Galveston, TX.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yokoyama</LastName><ForeName>Yujiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Surgery, St. Luke's University Health Network, Bethlehem, PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujisaki</LastName><ForeName>Tomohiro</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Morningside and West, New York, NY; Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takagi</LastName><ForeName>Hisato</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Shizuoka Medical Center, Shizuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shirasu</LastName><ForeName>Takuro</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, Department of Surgery, The University of Tokyo, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuno</LastName><ForeName>Toshiki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY. Electronic address: tkuno@montefiore.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000099094">Network Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vasc Surg</MedlineTA><NlmUniqueID>8407742</NlmUniqueID><ISSNLinking>0741-5214</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Vasc Surg. 2023 Oct;78(4):1095. doi: 10.1016/j.jvs.2023.05.039.</RefSource><PMID Version="1">37739742</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016893" MajorTopicYN="Y">Carotid Stenosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="Y">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015607" MajorTopicYN="N">Stents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001026" MajorTopicYN="N">Coronary Artery Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002340" MajorTopicYN="Y">Carotid Artery Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016894" MajorTopicYN="Y">Endarterectomy, Carotid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="Y">Myocardial Infarction</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002339" MajorTopicYN="N">Carotid Arteries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003324" MajorTopicYN="Y">Coronary Artery Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Carotid artery atherosclerotic disease</Keyword><Keyword MajorTopicYN="N">Carotid artery stenting</Keyword><Keyword MajorTopicYN="N">Carotid endarterectomy</Keyword><Keyword MajorTopicYN="N">Coronary artery bypass graft</Keyword><Keyword MajorTopicYN="N">Stroke</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>1</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>31</Day><Hour>19</Hour><Minute>26</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37257673</ArticleId><ArticleId IdType="doi">10.1016/j.jvs.2023.04.043</ArticleId><ArticleId IdType="pii">S0741-5214(23)01273-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32947294</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>132</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>Retrograde Autologous Priming in Cardiac Surgery: Results From a Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>100</StartPage><EndPage>107</EndPage><MedlinePgn>100-107</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000005151</ELocationID><Abstract><AbstractText Label="BACKGROUND">Retrograde autologous priming (RAP) before cardiopulmonary bypass (CPB) may minimize allogeneic red cell transfusion. We conducted a systematic review of the literature to examine the impact of RAP on perioperative allogeneic red cell transfusions in cardiac surgical patients.</AbstractText><AbstractText Label="METHODS">This study involved a systematic review and meta-analysis of randomized controlled trials (RCTs) and observational studies evaluating the use of RAP in cardiac surgery involving CPB. The primary outcome was intraoperative allogeneic red cell transfusion. Secondary outcomes included whole hospital allogeneic transfusions and adverse events such as acute kidney injury (AKI) and stroke.</AbstractText><AbstractText Label="RESULTS">A total of 11 RCTs (n = 1337 patients) were included, comparing RAP patients (n = 674) to control (n = 663). In addition, 10 observational studies (n = 2327) were included, comparing RAP patients (n = 1257) to control (n = 1070). Overall, RAP was associated with a significantly reduced incidence of intraoperative red cell transfusion (n = 18 studies; odds ratio [OR] = 0.34; 95% confidence interval [CI], 0.22-0.55, P &lt; .001) compared to controls. This effect was seen among RCTs (n = 10 studies; OR = 0.19; 95% CI, 0.08-0.45, P &lt; .001) and observational studies (n = 8 studies; OR = 0.66; 95% CI, 0.50-0.87, P = .004) in isolation. RAP was also associated with a significantly reduced incidence of whole hospital red cell transfusion (n = 5 studies; OR = 0.28; 95% CI, 0.19-0.41, P &lt; .001). Among the studies that reported AKI and stroke outcomes, there was no statistically significant increased odds of AKI or stroke in either RAP or control patients.</AbstractText><AbstractText Label="CONCLUSIONS">Based on the pooled results of the available literature, RAP is associated with a significant reduction in intraoperative and whole hospital allogeneic red cell transfusion. Use of RAP may prevent hemodilution of cardiac surgical patients and thus, lessen transfusions. Additional high-quality prospective studies are necessary to determine the ideal priming volume necessary to confer the greatest benefit without incurring organ injury.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hensley</LastName><ForeName>Nadia B</ForeName><Initials>NB</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology/Critical Care Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gyi</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology/Critical Care Medicine, The Johns Hopkins University, School of Medicine, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zorrilla-Vaca</LastName><ForeName>Andres</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Universidad del Valle School of Medicine, Cali, Columbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Chun W</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lawton</LastName><ForeName>Jennifer S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Charles H</ForeName><Initials>CH</Initials><Suffix>4th</Suffix><AffiliationInfo><Affiliation>Department of Anesthesiology/Critical Care Medicine, The Johns Hopkins University, School of Medicine, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frank</LastName><ForeName>Steve M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology/Critical Care Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grant</LastName><ForeName>Michael C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology/Critical Care Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Brian C</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology/Critical Care Medicine, The Johns Hopkins University, School of Medicine, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Anesth Analg. 2021 Jan;132(1):98-99. doi: 10.1213/ANE.0000000000005286.</RefSource><PMID Version="1">33315607</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001804" MajorTopicYN="N">Blood Transfusion, Autologous</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="N">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>18</Day><Hour>20</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32947294</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000005151</ArticleId><ArticleId IdType="pii">00000539-202101000-00017</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ferraris VA, Brown JR, Despotis GJ, et al.; Society of Thoracic Surgeons Blood Conservation Guideline Task Force. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg. 2011;91:944&#x2013;982.</Citation></Reference><Reference><Citation>Pfuntner A, Wier LM, Stocks C. Most frequent procedures performed in US hospitals, 2010: statistical brief #149. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. 2006.Rockville, MD: Agency for Healthcare Research and Quality (US);</Citation></Reference><Reference><Citation>Panico FG, Neptune WB. A mechanism to eliminate the donor blood prime from the pump-oxygenator. Surg Forum. 1960;10:605&#x2013;609.</Citation></Reference><Reference><Citation>Rosengart TK, DeBois W, O&#x2019;Hara M, et al. Retrograde autologous priming for cardiopulmonary bypass: a safe and effective means of decreasing hemodilution and transfusion requirements. J Thorac Cardiovasc Surg. 1998;115:426&#x2013;438.</Citation></Reference><Reference><Citation>Wahba A, Milojevic M, Boer C, et al. 2019 EACTS/EACTA/EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery. Eur J Cardiothorac Surg. 2020;57:210&#x2013;251.</Citation></Reference><Reference><Citation>Higgins JP, Altman DG, G&#xf8;tzsche PC, et al.; Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration&#x2019;s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.</Citation></Reference><Reference><Citation>Hultcrantz M, Rind D, Akl EA, et al. The GRADE Working Group clarifies the construct of certainty of evidence. J Clin Epidemiol. 2017;87:4&#x2013;13.</Citation></Reference><Reference><Citation>Cheng M, Li JQ, Wu TC, Tian WC. Short-term effects and safety analysis of retrograde autologous blood priming for cardiopulmonary bypass in patients with cardiac valve replacement surgery. Cell Biochem Biophys. 2015;73:441&#x2013;446.</Citation></Reference><Reference><Citation>Hofmann B, Kaufmann C, Stiller M, et al. Positive impact of retrograde autologous priming in adult patients undergoing cardiac surgery: a randomized clinical trial. J Cardiothorac Surg. 2018;13:50.</Citation></Reference><Reference><Citation>Hou X, Yang F, Liu R, et al. Retrograde autologous priming of the cardiopulmonary bypass circuit reduces blood transfusion in small adults: a prospective, randomized trial. Eur J Anaesthesiol. 2009;26:1061&#x2013;1066.</Citation></Reference><Reference><Citation>Reges RV, Vicente WV, Rodrigues AJ, et al. Retrograde autologous priming in cardiopulmonary bypass in adult patients: effects on blood transfusion and hemodilution. Rev Bras Cir Cardiovasc. 2011;26:609&#x2013;616.</Citation></Reference><Reference><Citation>Rousou JA, Engelman RM, Flack JE III, Deaton DW, Garb JL, Owen SG. The &#x2018;primeless pump&#x2019;: a novel technique for intraoperative blood conservation. Cardiovasc Surg. 1999;7:228&#x2013;235.</Citation></Reference><Reference><Citation>Saxena P, Saxena N, Jain A, Sharma VK. Intraoperative autologous blood donation and retrograde autologous priming for cardiopulmonary bypass: a safe and effective technique for blood conservation. Ann Card Anaesth. 2003;6:47&#x2013;51.</Citation></Reference><Reference><Citation>Shapira OM, Aldea GS, Treanor PR, et al. Reduction of allogeneic blood transfusions after open heart operations by lowering cardiopulmonary bypass prime volume. Ann Thorac Surg. 1998;65:724&#x2013;730.</Citation></Reference><Reference><Citation>Sobieski MA 2nd, Slaughter MS, Hart DE, Pappas PS, Tatooles AJ. Prospective study on cardiopulmonary bypass prime reduction and its effect on intraoperative blood product and hemoconcentrator use. Perfusion. 2005;20:31&#x2013;37.</Citation></Reference><Reference><Citation>Ancheri SA, Rao SV. Retrograde autologous priming reduces transfusion requirements during CPB. Indian J Appl Res. 2016;6:20&#x2013;24.</Citation></Reference><Reference><Citation>Kearsey C, Thekkudan J, Robbins S, Ng A, Lakshmanan S, Luckraz H. Assessing the effectiveness of retrograde autologous priming of the cardiopulmonary bypass machine in isolated coronary artery bypass grafts. Ann R Coll Surg Engl. 2013;95:207&#x2013;210.</Citation></Reference><Reference><Citation>Nanjappa A, Gill J, Sadat U, Colah S, Abu-Omar Y, Nair S. The effect of retrograde autologous priming on intraoperative blood product transfusion in coronary artery bypass grafting. Perfusion. 2013;28:530&#x2013;535.</Citation></Reference><Reference><Citation>Severdija EE, Heijmans JH, Theunissen M, Maessen JG, Roekaerts PH, Weerwind PW. Retrograde autologous priming reduces transfusion requirements in coronary artery bypass surgery. Perfusion. 2011;26:315&#x2013;321.</Citation></Reference><Reference><Citation>Teman N, Delavari N, Romano M, Prager R, Yang B, Haft J. Effects of autologous priming on blood conservation after cardiac surgery. Perfusion. 2014;29:333&#x2013;339.</Citation></Reference><Reference><Citation>Vandewiele K, Bov&#xe9; T, De Somer FM, et al. The effect of retrograde autologous priming volume on haemodilution and transfusion requirements during cardiac surgery. Interact Cardiovasc Thorac Surg. 2013;16:778&#x2013;783.</Citation></Reference><Reference><Citation>Williams HC, Schiller W, Mellert F, Fimmers R, Welz A, Probst C. Retrograde autologous priming in surgery of thoracic aortic aneurysm. Interact Cardiovasc Thorac Surg. 2019;28:876&#x2013;883.</Citation></Reference><Reference><Citation>Zelinka ES, Ryan P, McDonald J, Larson J. Retrograde autologous prime with shortened bypass circuits decreases blood transfusion in high-risk coronary artery surgery patients. J Extra Corpor Technol. 2004;36:343&#x2013;347.</Citation></Reference><Reference><Citation>Balachandran S, Cross MH, Karthikeyan S, Mulpur A, Hansbro SD, Hobson P. Retrograde autologous priming of the cardiopulmonary bypass circuit reduces blood transfusion after coronary artery surgery. Ann Thorac Surg. 2002;73:1912&#x2013;1918.</Citation></Reference><Reference><Citation>Hwang J, Huh J, Kim J, et al. The effect of retrograde autologous priming of the cardiopulmonary bypass circuit on cerebral oxygenation. J Cardiothorac Vasc Anesth. 2011;25:995&#x2013;999.</Citation></Reference><Reference><Citation>Trapp C, Schiller W, Mellert F, et al. Retrograde autologous priming as a safe and easy method to reduce hemodilution and transfusion requirements during cardiac surgery. Thorac Cardiovasc Surg. 2015;63:628&#x2013;634.</Citation></Reference><Reference><Citation>Murphy GS, Szokol JW, Nitsun M, et al. The failure of retrograde autologous priming of the cardiopulmonary bypass circuit to reduce blood use after cardiac surgical procedures. Anesth Analg. 2004;98:1201&#x2013;1207.</Citation></Reference><Reference><Citation>Sun P, Ji B, Sun Y, et al. Effects of retrograde autologous priming on blood transfusion and clinical outcomes in adults: a meta-analysis. Perfusion. 2013;28:238&#x2013;243.</Citation></Reference><Reference><Citation>Saczkowski R, Bernier PL, Tchervenkov CI, Arellano R. Retrograde autologous priming and allogeneic blood transfusions: a meta-analysis. Interact Cardiovasc Thorac Surg. 2009;8:373&#x2013;376.</Citation></Reference><Reference><Citation>Walsh M, Devereaux PJ, Garg AX, et al. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology. 2013;119:507&#x2013;515.</Citation></Reference><Reference><Citation>Sun LY, Chung AM, Farkouh ME, et al. Defining an intraoperative hypotension threshold in association with atroke in cardiac surgery. Anesthesiology. 2018;129:440&#x2013;447.</Citation></Reference><Reference><Citation>Joshi B, Ono M, Brown C, et al. Predicting the limits of cerebral autoregulation during cardiopulmonary bypass. Anesth Analg. 2012;114:503&#x2013;510.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24346781</PMID><DateCompleted><Year>2014</Year><Month>07</Month><Day>11</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1806-9460</ISSN><JournalIssue CitedMedium="Internet"><Volume>131</Volume><Issue>6</Issue><PubDate><Year>2013</Year></PubDate></JournalIssue><Title>Sao Paulo medical journal = Revista paulista de medicina</Title><ISOAbbreviation>Sao Paulo Med J</ISOAbbreviation></Journal><ArticleTitle>Neuraxial anesthesia for orthopedic surgery: systematic review and meta-analysis of randomized clinical trials.</ArticleTitle><Pagination><StartPage>411</StartPage><EndPage>421</EndPage><MedlinePgn>411-21</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1590/1516-3180.2013.1316667</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1516-31802013000600411</ELocationID><Abstract><AbstractText Label="CONTEXT AND OBJECTIVE" NlmCategory="OBJECTIVE">Taking the outcome of mortality into consideration, there is controversy about the beneficial effects of neuraxial anesthesia for orthopedic surgery. The aim of this study was to compare the effectiveness and safety of neuraxial anesthesia versus general anesthesia for orthopedic surgery.</AbstractText><AbstractText Label="DESIGN AND SETTING" NlmCategory="METHODS">Systematic review at Universidade Federal de Alagoas.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched the Cochrane Central Register of Controlled Trials (Issue 10, 2012), PubMed (1966 to November 2012), Lilacs (1982 to November 2012), SciELO, EMBASE (1974 to November 2012) and reference lists of the studies included. Only randomized controlled trials were included.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Out of 5,032 titles and abstracts, 17 studies were included. There were no statistically significant differences in mortality (risk difference, RD: -0.01; 95% confidence interval, CI: -0.04 to 0.01; n = 1903), stroke (RD: 0.02; 95% CI: -0.04 to 0.08; n = 259), myocardial infarction (RD: -0.01; 95% CI: -0.04 to 0.02; n = 291), length of hospitalization (mean difference, -0.05; 95% CI: -0.69 to 0.58; n = 870), postoperative cognitive dysfunction (RD: 0.00; 95% CI: -0.04 to 0.05; n = 479) or pneumonia (odds ratio, 0.61; 95% CI: 0.25 to 1.49; n = 167).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">So far, the evidence available from the studies included is insufficient to prove that neuraxial anesthesia is more effective and safer than general anesthesia for orthopedic surgery. However, this systematic review does not rule out clinically important differences with regard to mortality, stroke, myocardial infarction, length of hospitalization, postoperative cognitive dysfunction or pneumonia.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barbosa</LastName><ForeName>Fabiano Timb&#xf3;</ForeName><Initials>FT</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Universidade Federal de Alagoas, Macei&#xf3;Alagoas, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castro</LastName><ForeName>Aldemar Ara&#xfa;jo</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Surgery, Universidade Estadual de Ci&#xea;ncias da Sa&#xfa;de de Alagoas, Macei&#xf3;Alagoas, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sousa-Rodrigues</LastName><ForeName>C&#xe9;lio Fernando de</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Universidade Estadual de Ci&#xea;ncias da Sa&#xfa;de de Alagoas, Macei&#xf3;Alagoas, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Sao Paulo Med J</MedlineTA><NlmUniqueID>100897261</NlmUniqueID><ISSNLinking>1516-3180</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000767" MajorTopicYN="N">Anesthesia, Epidural</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000775" MajorTopicYN="N">Anesthesia, Spinal</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019637" MajorTopicYN="Y">Orthopedic Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="N">Pneumonia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="por"><AbstractText Label="CONTEXTO E OBJETIVO:">Considerando o desfecho de mortalidade, existe controv&#xe9;rsia acerca dos efeitos ben&#xe9;ficos da anestesia neuroaxial (AN) para cirurgias ortop&#xe9;dicas. O objetivo do estudo foi comparar efetividade e seguran&#xe7;a da AN <i>versus</i> anestesia geral (AG) para cirurgias ortop&#xe9;dicas.</AbstractText><AbstractText Label="TIPO DE ESTUDO E LOCAL:">Revis&#xe3;o sistem&#xe1;tica na Universidade Federal de Alagoas.</AbstractText><AbstractText Label="M&#xc9;TODOS:">Buscamos em Cochrane Central Register of Controlled Trials (2012, volume 10), PubMed (1966 at&#xe9; novembro de 2012), Lilacs (1982 at&#xe9; novembro de 2012), SciELO, EMBASE (1974 at&#xe9; novembro de 2012) e listas de refer&#xea;ncias dos estudos inclu&#xed;dos. Apenas ensaios cl&#xed;nicos randomizados foram inclu&#xed;dos. RESULTADOS: Dentre 5.032 t&#xed;tulos e resumos, 17 estudos foram inclu&#xed;dos. N&#xe3;o houve diferen&#xe7;a estat&#xed;stica em mortalidade (diferen&#xe7;a de risco, DR: -0,01; intervalo de confian&#xe7;a de 95%, IC: -0,04 a 0.01; n = 1903), em acidente vascular encef&#xe1;lico (DR: 0,02; IC 95%: -0,04 a 0,08; n = 259, em infarto mioc&#xe1;rdico (DR: -0.01; IC 95%: -0,04 a 0.02; n = 291), tempo de hospitaliza&#xe7;&#xe3;o (diferen&#xe7;a m&#xe9;dia, -0,05; IC 95%: -0,69 a 0,58; n = 870), em disfun&#xe7;&#xe3;o cognitiva p&#xf3;s-operat&#xf3;ria (DR: 0,00; IC 95%: -0,04 a 0,05; n = 479) e pneumonia (raz&#xe3;o de chances, 0,61; IC 95%: 0,25 a 1,49; n = 167).</AbstractText><AbstractText Label="CONCLUS&#xc3;O:">At&#xe9; o momento, as evid&#xea;ncias s&#xe3;o insuficientes nos estudos inclu&#xed;dos para provar que AN &#xe9; mais efetiva e segura do que AG para cirurgias ortop&#xe9;dicas. Esta revis&#xe3;o sistem&#xe1;tica n&#xe3;o descartou diferen&#xe7;as cl&#xed;nicas importantes para mortalidade, acidente vascular encef&#xe1;lico, infarto mioc&#xe1;rdico, tempo de interna&#xe7;&#xe3;o, disfun&#xe7;&#xe3;o cognitiva p&#xf3;s-operat&#xf3;ria e pneumonia.</AbstractText></OtherAbstract><CoiStatement>
<b>Conflict of interest:</b> None</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2013</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24346781</ArticleId><ArticleId IdType="pmc">PMC10871823</ArticleId><ArticleId IdType="doi">10.1590/1516-3180.2013.1316667</ArticleId><ArticleId IdType="pii">S1516-31802013000600411</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Moraca RJ, Sheldon DG, Thirlby RC. The role of epidural anesthesia and analgesia in surgical practice. Ann Surg. 2003;238(5):663&#x2013;663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1356143</ArticleId><ArticleId IdType="pubmed">14578727</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu S, Zhang ZY, Hua YQ, Li J, Cai ZD. A comparison of regional and general anaesthesia for total replacement of the hip or knee: a meta-analysis. J Bone Joint Surg Br. 2009;91(7):935&#x2013;942.</Citation><ArticleIdList><ArticleId IdType="pubmed">19567860</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodgers A, Walker N, Schug S, et al. Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ. 2000;321(7275):1493&#x2013;1493.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC27550</ArticleId><ArticleId IdType="pubmed">11118174</ArticleId></ArticleIdList></Reference><Reference><Citation>Le-Wendling L, Bihorac A, Baslanti TO, et al. Regional anesthesia as compared with general anesthesia for surgery in geriatric patients with hip fracture: does it decrease morbidity, mortality, and health care costs? Results of a single-centered study. Pain Med. 2012;13(7):948&#x2013;956.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3730262</ArticleId><ArticleId IdType="pubmed">22758782</ArticleId></ArticleIdList></Reference><Reference><Citation>Macfarlane AJ, Prasad GA, Chan VW, Brull R. Does regional anaesthesia improve outcome after total hip arthroplasty? A systematic review. Br J Anaesth. 2009;103(3):335&#x2013;345.</Citation><ArticleIdList><ArticleId IdType="pubmed">19628483</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauermann WJ, Shilling AM, Zuo Z. A comparison of neuraxial block versus general anesthesia for elective total hip replacement: a meta-analysis. Anesth Analg. 2006;103(4):1018&#x2013;1025.</Citation><ArticleIdList><ArticleId IdType="pubmed">17000823</ArticleId></ArticleIdList></Reference><Reference><Citation>Guay J. The effect of neuraxial blocks on surgical blood loss and blood transfusion requirements: a meta-analysis. J Clin Anesth. 2006;18(2):124&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pubmed">16563330</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker MJ, Handoll HH, Griffiths R. Anaesthesia for hip fracture surgery in adults. Cochrane Database Syst Rev. 2004;(4):CD000521&#x2013;CD000521.</Citation><ArticleIdList><ArticleId IdType="pubmed">15494999</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins  JPT, Green  S.  Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from: www.cochrane-handbook.org Accessed in 2013 (Jul 23)</Citation></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Shnaider I, Chung F. Outcomes in day surgery. Curr Opin Anaesthesiol. 2006;19(6):622&#x2013;629.</Citation><ArticleIdList><ArticleId IdType="pubmed">17093366</ArticleId></ArticleIdList></Reference><Reference><Citation>Review Manager (RevMan) [Computer program]. Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2011. Available from: http://ims.cochrane.org/revman/ Accessed in 2013 (Jul 23)</Citation></Reference><Reference><Citation>Anwer HM, Swelem SE, el-Sheshai A, Moustafa AA. Postoperative cognitive dysfunction in adult and elderly patients--general anesthesia vs subarachnoid or epidural analgesia. Middle East J Anesthesiol. 2006;18(6):1123&#x2013;1138.</Citation><ArticleIdList><ArticleId IdType="pubmed">17263267</ArticleId></ArticleIdList></Reference><Reference><Citation>Attari MA, Mirhosseini SA, Honarmand A, Safavi MR. Spinal anesthesia versus general anesthesia for elective lumbar spine surgery: A randomized clinical trial. J Res Med Sci. 2011;16(4):524&#x2013;529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3214358</ArticleId><ArticleId IdType="pubmed">22091269</ArticleId></ArticleIdList></Reference><Reference><Citation>Berggren D, Gustafson Y, Eriksson B, et al. Postoperative confusion after anesthesia in elderly patients with femoral neck fractures. Anesth Analg. 1987;66(6):497&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pubmed">3578861</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigler D, Adelh&#xf8;j B, Petring OU, et al. Mental function and morbidity after acute hip surgery during spinal and general anaesthesia. Anaesthesia. 1985;40(7):672&#x2013;676.</Citation><ArticleIdList><ArticleId IdType="pubmed">4025772</ArticleId></ArticleIdList></Reference><Reference><Citation>Borghi B, Laici C, Iuorio S, et al. Anestesia epidurale vs generale [Epidural vs general anaesthesia] Minerva Anestesiol. 2002;68(4):171&#x2013;177.</Citation><ArticleIdList><ArticleId IdType="pubmed">12024077</ArticleId></ArticleIdList></Reference><Reference><Citation>Casati A, Aldegheri G, Vinciguerra E, et al. Randomized comparison between sevoflurane anaesthesia and unilateral spinal anaesthesia in elderly patients undergoing orthopaedic surgery. Eur J Anaesthesiol. 2003;20(8):640&#x2013;646.</Citation><ArticleIdList><ArticleId IdType="pubmed">12932066</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu CP, Yap JC, Chen PP, Hung HH. Postoperative outcome in Chinese patients having primary total knee arthroplasty under general anaesthesia/intravenous patient-controlled analgesia compared to spinal-epidural anaesthesia/analgesia. Hong Kong Med J. 2006;12(6):442&#x2013;447.</Citation><ArticleIdList><ArticleId IdType="pubmed">17148797</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Ambrosio A, Borghi B, Damato A, et al. Reducing perioperative blood loss in patients undergoing total hip arthroplasty. Int J Artif Organs. 1999;22(1):47&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">10098585</ArticleId></ArticleIdList></Reference><Reference><Citation>Dauphin A, Raymer KE, Stanton EB, Fuller HD. Comparison of general anesthesia with and without lumbar epidural for total hip arthroplasty: effects of epidural block on hip arthroplasty. J Clin Anesth. 1997;9(3):200&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pubmed">9172026</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis FM, Laurenson VG. Spinal anaesthesia or general anaesthesia for emergency hip surgery in elderly patients. Anaesth Intensive Care. 1981;9(4):352&#x2013;358.</Citation><ArticleIdList><ArticleId IdType="pubmed">6797318</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis FM, Woolner DF, Frampton C, et al. Prospective, multi-centre trial of mortality following general or spinal anaesthesia for hip fracture surgery in the elderly. Br J Anaesth. 1987;59(9):1080&#x2013;1088.</Citation><ArticleIdList><ArticleId IdType="pubmed">3311100</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorr LD. Regional anesthesia improves perioperative events in patients having total hip or knee replacement. J Bone Joint Surg Am. 2010;92(5):1264&#x2013;1264.</Citation><ArticleIdList><ArticleId IdType="pubmed">20439678</ArticleId></ArticleIdList></Reference><Reference><Citation>Eroglu A, Uzunlar H, Erciyes N. Comparison of hypotensive epidural anesthesia and hypotensive total intravenous anesthesia on intraoperative blood loss during total hip replacement. J Clin Anesth. 2005;17(6):420&#x2013;425.</Citation><ArticleIdList><ArticleId IdType="pubmed">16171661</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonano C, Leitgeb U, Sitzwohl C, et al. Spinal versus general anesthesia for orthopedic surgery: anesthesia drug and supply costs. Anesth Analg. 2006;102(2):524&#x2013;529.</Citation><ArticleIdList><ArticleId IdType="pubmed">16428554</ArticleId></ArticleIdList></Reference><Reference><Citation>Hole A, Terjesen T, Breivik H. Epidural versus general anaesthesia for total hip arthroplasty in elderly patients. Acta Anaesthesiol Scand. 1980;24(4):279&#x2013;287.</Citation><ArticleIdList><ArticleId IdType="pubmed">7468115</ArticleId></ArticleIdList></Reference><Reference><Citation>Jellish WS, Thalji Z, Stevenson K, Shea J. A prospective randomized study comparing short- and intermediate-term perioperative outcome variables after spinal or general anesthesia for lumbar disk and laminectomy surgery. Anesth Analg. 1996;83(3):559&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pubmed">8780281</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones MJ, Piggott SE, Vaughan RS, et al. Cognitive and functional competence after anaesthesia in patients aged over 60: controlled trial of general and regional anaesthesia for elective hip or knee replacement. BMJ. 1990;300(6741):1683&#x2013;1687.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1663336</ArticleId><ArticleId IdType="pubmed">2390547</ArticleId></ArticleIdList></Reference><Reference><Citation>Juelsgaard P, Sand NP, Felsby S, et al. Perioperative myocardial ischaemia in patients undergoing surgery for fractured hip randomized to incremental spinal, single-dose spinal or general anaesthesia. Eur J Anaesthesiol. 1998;15(6):656&#x2013;663.</Citation><ArticleIdList><ArticleId IdType="pubmed">9884850</ArticleId></ArticleIdList></Reference><Reference><Citation>Keith I. Anaesthesia and blood loss in total hip replacement. Anaesthesia. 1977;32(5):444&#x2013;450.</Citation><ArticleIdList><ArticleId IdType="pubmed">869143</ArticleId></ArticleIdList></Reference><Reference><Citation>Luger TJ, Kammerlander C, Gosch M, et al. Neuroaxial versus general anaesthesia in geriatric patients for hip fracture surgery: does it matter? Osteoporos Int. 2010;21(Suppl 4):S555&#x2013;S572.</Citation><ArticleIdList><ArticleId IdType="pubmed">21057995</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann RA, Bisset WI. Anaesthesia for lower limb amputation. A comparison of spinal analgesia and general anaesthesia in the elderly. Anaesthesia. 1983;38(12):1185&#x2013;1191.</Citation><ArticleIdList><ArticleId IdType="pubmed">6419632</ArticleId></ArticleIdList></Reference><Reference><Citation>McKenzie PJ, Wishart HY, Dewar KM, Gray I, Smith G. Comparison of the effects of spinal anaesthesia and general anaesthesia on postoperative oxygenation and perioperative mortality. Br J Anaesth. 1980;52(1):49&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">6769450</ArticleId></ArticleIdList></Reference><Reference><Citation>McLaren AD, Stockwell MC, Reid VT. Anaesthetic techniques for surgical correction of fractured neck of femur. A comparative study of spinal and general anaesthesia in the elderly. Anaesthesia. 1978;33(1):10&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">626331</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell D, Friedman RJ, Baker JD 3rd, et al. Prevention of thromboembolic disease following total knee arthroplasty. Epidural versus general anesthesia. Clin Orthop Relat Res. 1991;a(269):109&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pubmed">1864027</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielson WR, Gelb AW, Casey JE, et al. Long-term cognitive and social sequelae of general versus regional anesthesia during arthroplasty in the elderly. Anesthesiology. 1990;73(6):1103&#x2013;1109.</Citation><ArticleIdList><ArticleId IdType="pubmed">2248389</ArticleId></ArticleIdList></Reference><Reference><Citation>Racle JP, Benkhadra A, Poy JY, Gleizal B, Gaudray A. Etude comparative de l'anesth&#xe9;sie g&#xe9;n&#xe9;rale et de la rachianesth&#xe9;sie chez la femme &#xe2;g&#xe9;e dans la chirurgie de la hanche [Comparative study of general and spinal anesthesia in elderly women in hip surgery] Ann Fr Anesth Reanim. 1986;5(1):24&#x2013;30. (Fre).</Citation><ArticleIdList><ArticleId IdType="pubmed">3706840</ArticleId></ArticleIdList></Reference><Reference><Citation>Riis J, Lomholt B, Haxholdt O, et al. Immediate and long-term mental recovery from general versus epidural anesthesia in elderly patients. Acta Anaesthesiol Scand. 1983;27(1):44&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">6837235</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutcliffe AJ, Parker M. Mortality after spinal and general anaesthesia for surgical fixation of hip fractures. Anaesthesia. 1994;49(3):237&#x2013;240.</Citation><ArticleIdList><ArticleId IdType="pubmed">8147519</ArticleId></ArticleIdList></Reference><Reference><Citation>Valentin N, Lomholt B, Jensen JS, Hejgaard N, Kreiner S. Spinal or general anaesthesia for surgery of the fractured hip? A prospective study of mortality in 578 patients. Br J Anaesth. 1986;58(3):284&#x2013;291.</Citation><ArticleIdList><ArticleId IdType="pubmed">3947489</ArticleId></ArticleIdList></Reference><Reference><Citation>White IW, Chappell WA. Anaesthesia for surgical correction of fractured femoral neck. A comparison of three techniques. Anaesthesia. 1980;35(11):1107&#x2013;1110.</Citation><ArticleIdList><ArticleId IdType="pubmed">7446914</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams-Russo P, Sharrock NE, Haas SB, et al. Randomized trial of epidural versus general anesthesia: outcomes after primary total knee replacement. Clin Orthop Relat Res. 1996;(331):199&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pubmed">8895639</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams-Russo P, Sharrock NE, Mattis S, Szatrowski TP, Charlson ME. Cognitive effects after epidural vs general anesthesia in older adults. A randomized trial. JAMA. 1995;274(1):44&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">7791257</ArticleId></ArticleIdList></Reference><Reference><Citation>Gauss A, Jahn SK, Eberhart LH, et al. Kardioprotektion durch thorakale Periduralan&#xe4;sthesie?: Metaanalyse [Cardioprotection by thoracic epidural anesthesia?: meta-analysis] Anaesthesist. 2011;60(10):950&#x2013;962.</Citation><ArticleIdList><ArticleId IdType="pubmed">21993475</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbosa FT, Cavalcante JC, Juc&#xe1; MJ, Castro AA. Neuraxial anaesthesia for lower-limb revascularization. Cochrane Database Syst Rev. 2010;(1):CD007083&#x2013;CD007083.</Citation><ArticleIdList><ArticleId IdType="pubmed">20091615</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36445384</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1912</ISSN><JournalIssue CitedMedium="Internet"><Volume>396</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Naunyn-Schmiedeberg's archives of pharmacology</Title><ISOAbbreviation>Naunyn Schmiedebergs Arch Pharmacol</ISOAbbreviation></Journal><ArticleTitle>The effect of tamsulosin in postoperative urinary retention: a meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>441</StartPage><EndPage>451</EndPage><MedlinePgn>441-451</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00210-022-02343-y</ELocationID><Abstract><AbstractText>Tamsulosin is a therapeutic drug of alpha-adrenergic antagonists. Previous randomized controlled trials and retrospective analyses have proved the efficacy of tamsulosin on many urinary system diseases. However, there is still a conflict about whether tamsulosin could prevent postoperative urinary retention (POUR). This meta-analysis aims to probe into the efficacy of tamsulosin for preventing POUR versus placebo. We searched MEDLINE, EMBASE, and Cochrane Library from December 31, 1999 to April 30, 2022, for randomized controlled trials (RCTs). Studies that were not RCTs or without negative controls were excluded. Cochrane Collaboration harmonized criteria were used to assess the risk of bias in included studies. Revman (version 5.3) software was invited to synthesize the results. We performed subgroup analyses to explore the factors that could influence tamsulosin's efficacy in POUR prevention. Our meta-analysis pooled 13 RCTs with 2163 patients. We concluded that tamsulosin brought about a significant reduction in the risk of POUR versus placebo (13.54% vs 20.88% for tamsulosin vs placebo, RR&#x2009;=&#x2009;0.63, 95% CI 0.47 to 0.84, P&#x2009;=&#x2009;0.002). Tamsulosin could significantly reduce the risk of POUR in abdominal (11.52% vs 20.25% for tamsulosin vs placebo, RR&#x2009;=&#x2009;0.52, 95% CI 0.31 to 0.88, P&#x2009;=&#x2009;0.02) and female pelvic surgery (15.57% vs 31.50% for tamsulosin vs placebo, RR&#x2009;=&#x2009;0.51, 95% CI 0.31 to 0.82, P&#x2009;=&#x2009;0.006) but not in spinal surgery (13.45% vs 12.75% for tamsulosin vs placebo, RR&#x2009;=&#x2009;1.07, 95% CI 0.72 to 1.60, P&#x2009;=&#x2009;0.73) and lower limb surgery (21.43% vs 33.33% for tamsulosin vs placebo, RR&#x2009;=&#x2009;0.64, 95% CI 0.35 to 1.14, P&#x2009;=&#x2009;0.13). The preventive effect of postoperative (17.70% vs 33.93% for tamsulosin vs placebo, RR&#x2009;=&#x2009;0.53, 95% CI 0.33 to 0.85, P&#x2009;=&#x2009;0.008) and postoperative with preoperative tamsulosin (13.96% vs 23.44% for tamsulosin vs placebo, RR&#x2009;=&#x2009;0.64, 95% CI 0.43 to 0.93, P&#x2009;=&#x2009;0.02) on POUR were significantly better than preoperative management (11.95% vs 14.63% for tamsulosin vs placebo, RR&#x2009;=&#x2009;0.62, 95% CI 0.23 to 1.65, P&#x2009;=&#x2009;0.34). Postoperative catheter placement appears to have a negative impact on the POUR-preventive effect of tamsulosin. (9.37% vs 16.46% for tamsulosin vs placebo, RR&#x2009;=&#x2009;0.51, 95% CI 0.31 to 0.83, P&#x2009;=&#x2009;0.007) Tamsulosin showed significantly effect on POUR prevention in patients during spinal (15.07% vs 26.51% for tamsulosin vs placebo, RR&#x2009;=&#x2009;0.52, 95% CI 0.31 to 0.90, P&#x2009;=&#x2009;0.02) and epidural anesthesia (12.50% vs 29.79% for tamsulosin vs placebo, RR&#x2009;=&#x2009;0.42, 95% CI 0.18 to 1.00, P&#x2009;=&#x2009;0.05) but not in general anesthesia (12.40% vs 18.52% for tamsulosin vs placebo, RR&#x2009;=&#x2009;0.68, 95% CI 0.45 to 1.03, P&#x2009;=&#x2009;0.07). Tamsulosin shows better outcomes for preventing POUR than placebo. Besides, tamsulosin showed a different effect on POUR prevention in the various surgical sites, anesthesia, medication management, and catheter use. However, our conclusions still have some limitations due to the lack of evidence.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Gao</LastName><ForeName>Bixi</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, The First Affiliated Hospital of Soochow University, Jiangsu Province, Suzhou, 215006, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Stroke Research, Soochow University, Suzhou, 215006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Dingding</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, The First Affiliated Hospital of Soochow University, Jiangsu Province, Suzhou, 215006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yunjiang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, The First Affiliated Hospital of Soochow University, Jiangsu Province, Suzhou, 215006, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Stroke Research, Soochow University, Suzhou, 215006, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosurgery, Yancheng Third People's Hospital, Jiangsu Province, Yancheng, 224000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zongqi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, The First Affiliated Hospital of Soochow University, Jiangsu Province, Suzhou, 215006, China. twilighter@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Stroke Research, Soochow University, Suzhou, 215006, China. twilighter@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, The First Affiliated Hospital of Soochow University, Jiangsu Province, Suzhou, 215006, China. wangz19640309@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Stroke Research, Soochow University, Suzhou, 215006, China. wangz19640309@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>82002643</GrantID><Agency>National Natural Science Foundation of China under Grant</Agency><Country/></Grant><Grant><GrantID>2019M651954</GrantID><Agency>China Postdoctoral Science Foundation under Grant</Agency><Country/></Grant><Grant><GrantID>GSWS2019002</GrantID><Agency>Suzhou Health Talents Training Project</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Naunyn Schmiedebergs Arch Pharmacol</MedlineTA><NlmUniqueID>0326264</NlmUniqueID><ISSNLinking>0028-1298</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>G3P28OML5I</RegistryNumber><NameOfSubstance UI="D000077409">Tamsulosin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077409" MajorTopicYN="N">Tamsulosin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016055" MajorTopicYN="Y">Urinary Retention</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="Y">Anesthesia</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Post-operative urinary retention</Keyword><Keyword MajorTopicYN="N">Prevention</Keyword><Keyword MajorTopicYN="N">Subgroup analysis</Keyword><Keyword MajorTopicYN="N">Tamsulosin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>29</Day><Hour>11</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36445384</ArticleId><ArticleId IdType="doi">10.1007/s00210-022-02343-y</ArticleId><ArticleId IdType="pii">10.1007/s00210-022-02343-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Akkoc A, Aydin C, Topaktas R, Kartalmis M, Altin S, Isen K, Metin A (2016) Prophylactic effects of alpha-blockers, tamsulosin and alfuzosin, on postoperative urinary retention in male patients undergoing urologic surgery under spinal anaesthesia. Int Braz J Urol 42:578&#x2013;584</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S1677-5538.IBJU.2015.0256</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldini G, Bagry H, Aprikian A, Carli F (2009) Postoperative urinary retention: anesthetic and perioperative considerations. Anesthesiology 110:1139&#x2013;1157</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e31819f7aea</ArticleId></ArticleIdList></Reference><Reference><Citation>Basheer A, Alsaidi M, Schultz L, Chedid M, Abdulhak M, Seyfried D (2017) Preventive effect of tamsulosin on postoperative urinary retention in neurosurgical patients. Surg Neurol Int 8:75</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/sni.sni_5_17</ArticleId></ArticleIdList></Reference><Reference><Citation>Caparelli ML, Shikhman A, Runyan B, Allamaneni S, Hobler S (2021) The use of tamsulosin to prevent postoperative urinary retention in laparoscopic inguinal hernia repair: a randomized double-blind placebo-controlled study. Surg Endosc 35:5538&#x2013;5545</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-020-08050-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Y, Chi KY, Tai TW, Cheng YS, Lee PH, Huang CC, Lee JS (2021) Risk factors for postoperative urinary retention following elective spine surgery: a meta-analysis. Spine J 21:1802&#x2013;1811</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.spinee.2021.05.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman GC, Sheyn D, Petrikovets A, Mahajan ST, El-Nashar S, Pollard R, Mangel JM (2020) Tamsulosin to prevent postoperative urinary retention after female pelvic reconstructive surgery. Female Pelvic Med Reconstr Surg 26:682&#x2013;687</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SPV.0000000000000650</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman GC, Sheyn D, Slopnick EA, Roberts K, El-Nashar SA, Henderson JW, Mangel J, Hijaz AK, Pollard RR, Mahajan ST (2021) Tamsulosin vs placebo to prevent postoperative urinary retention following female pelvic reconstructive surgery: a multicenter randomized controlled trial. Am J Obstet Gynecol&#xa0;225(3):274&#x2013;e1</Citation></Reference><Reference><Citation>Choi CI, Kim JK, Choo MS, Lee SH, Chang JD, Han JH (2021) Preventive effects of tamsulosin for postoperative urinary retention after lower limb arthroplasty: A randomized controlled study. Investig Clin Urol 62:569&#x2013;576</Citation></Reference><Reference><Citation>Clancy C, Coffey JC, O&#x2019;Riordain MG, Burke JP (2018) A meta-analysis of the efficacy of prophylactic alpha-blockade for the prevention of urinary retention following primary unilateral inguinal hernia repair. Am J Surg 216:337&#x2013;341</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2017.02.017</ArticleId></ArticleIdList></Reference><Reference><Citation>Crain NA, Goharderakhshan RZ, Reddy NC, Apfel AM, Navarro RA (2021) The role of intraoperative urinary catheters on postoperative urinary retention after total joint Arthroplasty: a multi-hospital retrospective study on 9,580 patients. Arch Bone Jt Surg 9:480&#x2013;486</Citation></Reference><Reference><Citation>Cui Y, Chen J, Zeng F, Liu P, Hu J, Li H, Li C, Cheng X, Chen M, Li Y, Li Y, Yang Z, Chen Z, Chand H, Chen H, Zu X (2019) Tamsulosin as a medical expulsive therapy for ureteral stones: a systematic review and meta-analysis of randomized controlled trials. J Urol 201:950&#x2013;955</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JU.0000000000000029</ArticleId></ArticleIdList></Reference><Reference><Citation>Delajara M, Wendelspiess Chavez Juarez F (2013) Birthweight outcomes in Bolivia: the role of maternal height, ethnicity, and behavior. Econ Hum Biol 11:56&#x2013;68</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ehb.2012.03.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher E, Subramonian K, Omar MI (2014) The role of alpha blockers prior to removal of urethral catheter for acute urinary retention in men. Cochrane Database Syst Rev CD006744</Citation></Reference><Reference><Citation>Gandhi SD, Patel SA, Maltenfort M, Anderson DG, Vaccaro AR, Albert TJ, Rihn JA (2014) Patient and surgical factors associated with postoperative urinary retention after lumbar spine surgery. Spine (Phila Pa 1976) 39:1905&#x2013;1909</Citation></Reference><Reference><Citation>Goldman G, Leviav A, Mazor A, Kashtan H, Aladgem D, Greenstein A, Wiznitzer T (1988) Alpha-adrenergic blocker for posthernioplasty urinary retention. Prevention and Treatment Arch Surg 123:35&#x2013;36</Citation></Reference><Reference><Citation>Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, Saint S, Schaeffer AJ, Tambayh PA, Tenke P, Nicolle LE, Infectious Diseases Society of A (2010) Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis 50:625&#x2013;663</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/650482</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Craig SJ, Rowlingson JC, Morton SP, Thomas CJ, Persinger MB, Isbell J, Lau CL, Kozower BD (2014) Early removal of urinary catheter after surgery requiring thoracic epidural: a prospective trial. J Cardiothorac Vasc Anesth 28:1302&#x2013;1306</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2014.05.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong IG, You D, Yoon JH, Hong S, Lim JH, Hong JH, Choo MS, Ahn H, Kim CS (2014) Impact of tamsulosin on urinary retention following early catheter removal after robot-assisted laparoscopic radical prostatectomy: a prospective randomized controlled trial. Int J Urol 21:164&#x2013;168</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/iju.12225</ArticleId></ArticleIdList></Reference><Reference><Citation>Koukoulis GD, Bouliaris K, Perivoliotis K, Tepetes K (2021) Prophylactic administration of alpha blocker for the prevention of urinary retention in males undergoing inguinal hernia repair under spinal anesthesia: interim analysis of a randomized controlled trial. Cureus 13:e19669</Citation></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2700</ArticleId></ArticleIdList></Reference><Reference><Citation>Lingaraj K, Ruben M, Chan YH, Das SD (2007) Identification of risk factors for urinary retention following total knee arthroplasty: a Singapore hospital experience. Singapore Med J 48:213&#x2013;216</Citation></Reference><Reference><Citation>Liu SJ, Deng YJ, Zeng Y, Zhao M, Guo J, Gao QH (2022) Efficacy and safety of guihuang formula in treating type iii prostatitis patients with dampness-heat and blood stasis syndrome: a randomized controlled trial. Chin J Integr Med</Citation></Reference><Reference><Citation>Lo E, Nicolle LE, Coffin SE, Gould C, Maragakis LL, Meddings J, Pegues DA, Pettis AM, Saint S, Yokoe DS (2014) Strategies to prevent catheter-associated urinary tract infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 35:464&#x2013;479</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/675718</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Z, Dong Z, Ding H, Wang H, Ma B, Wang Z (2012) Tamsulosin for ureteral stones: a systematic review and meta-analysis of a randomized controlled trial. Urol Int 89:107&#x2013;115</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000338909</ArticleId></ArticleIdList></Reference><Reference><Citation>Madani AH, Aval HB, Mokhtari G, Nasseh H, Esmaeili S, Shakiba M, Shakiba RS, Seyed Damavand SM (2014) Effectiveness of tamsulosin in prevention of post-operative urinary retention: a randomized double-blind placebo-controlled study. Int Braz J Urol 40:30&#x2013;36</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S1677-5538.IBJU.2014.01.05</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayo BC, Louie PK, Bohl DD, Massel DH, Iantorno SE, Ahn J, Tabaraee E, Modi KD, Long WW, Singh K (2016) Effects of intraoperative anesthetic medications on postoperative urinary retention after single-level lumbar fusion. Spine (Phila Pa 1976) 41:1441&#x2013;1446</Citation></Reference><Reference><Citation>Mohammadi-Fallah M, Hamedanchi S, Tayyebi-Azar A (2012) Preventive effect of tamsulosin on postoperative urinary retention. Korean J Urol 53:419&#x2013;423</Citation><ArticleIdList><ArticleId IdType="doi">10.4111/kju.2012.53.6.419</ArticleId></ArticleIdList></Reference><Reference><Citation>Osman NI, Hillary CJ, Mangera A, Aldamanhoori R, Inman RD, Chapple CR (2018) The midurethral fascial &#x201c;sling on a string&#x201d;: an alternative to midurethral synthetic tapes in the era of mesh complications. Eur Urol 74:191&#x2013;196</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eururo.2018.04.031</ArticleId></ArticleIdList></Reference><Reference><Citation>Papageorge CM, Howington B, Leverson G, Kennedy GD, Carchman EH (2021) Preoperative tamsulosin to prevent postoperative urinary retention: a randomized controlled trial. J Surg Res 262:130&#x2013;139</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2020.12.055</ArticleId></ArticleIdList></Reference><Reference><Citation>Plochocki A, King B (2022) Medical treatment of benign prostatic hyperplasia. Urol Clin North Am 49:231&#x2013;238</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ucl.2021.12.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Rughani A, Cushing D, Lary CW, Cox S, Jumper B, Johnson N, Florman J (2022) Does tamsulosin decrease postoperative urinary retention in spine surgery? A double-blind, randomized controlled trial. J Neurosurg pp 1&#x2013;8</Citation></Reference><Reference><Citation>Sancho-Martinez I, Nivet E, Izpisua Belmonte JC (2011) Purging and isolating pluripotent cells, &#x201c;sweet&#x201d; dreams become true? Cell Res 21:1526&#x2013;1527</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2011.163</ArticleId></ArticleIdList></Reference><Reference><Citation>Schubert MF, Thomas JR, Gagnier JJ, McCarthy CM, Lee JJ, Urquhart AG, Pour AE (2019) The AAHKS Clinical Research Award: Prophylactic tamsulosin does not reduce the risk of urinary retention following lower extremity arthroplasty: a double-blinded randomized controlled trial. J Arthroplasty 34:S17&#x2013;S23</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2019.03.039</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw MK, Pahari H (2014) The role of peri-operative use of alpha-blocker in preventing lower urinary tract symptoms in high risk patients of urinary retention undergoing inguinal hernia repair in males above 50 years. J Indian Med Assoc 112(13&#x2013;14):16</Citation></Reference><Reference><Citation>Shokrpour M, Shakiba E, Sirous A, Kamali A (2019) Evaluation the efficacy of prophylactic tamsulosin in preventing acute urinary retention and other obstructive urinary symptoms following colporrhaphy surgery. J Family Med Prim Care 8:722&#x2013;727</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jfmpc.jfmpc_18_19</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas S, Harris N, Dobransky J, Grammatopoulos G, Gartke K, Liew A, Papp S (2021) Urinary catheter use in patients with hip fracture: are current guidelines appropriate? A retrospective review. Can J Surg 64:E630&#x2013;E635</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cjs.014620</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaucher C, Gonzalez-Martinez E (2015) Telephone and coordination of intensive care in hospital. Rev Infirm pp 38&#x2013;39</Citation></Reference><Reference><Citation>Wang RC, Smith-Bindman R, Whitaker E, Neilson J, Allen IE, Stoller ML, Fahimi J (2017) Effect of tamsulosin on stone passage for ureteral stones: a systematic review and meta-analysis. Ann Emerg Med 69(353&#x2013;361):e353</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2016.06.044</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeif HJ, Subramonian K (2009) Alpha blockers prior to removal of a catheter for acute urinary retention in adult men. Cochrane Database Syst Rev CD006744</Citation></Reference><Reference><Citation>Zhang HL, Huang ZG, Qiu Y, Cheng X, Zou XQ, Liu TT (2017) Tamsulosin for treatment of lower urinary tract symptoms in women: a systematic review and meta-analysis. Int J Impot Res 29:148&#x2013;156</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ijir.2017.12</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z, Cui Y, Wu J, Ding R, Cai T, Gao Z (2019) Meta-analysis of the efficacy and safety of combination of tamsulosin plus dutasteride compared with tamsulosin monotherapy in treating benign prostatic hyperplasia. BMC Urol 19:17</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12894-019-0446-8</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36571785</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>23</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1816-5370</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Asian cardiovascular &amp; thoracic annals</Title><ISOAbbreviation>Asian Cardiovasc Thorac Ann</ISOAbbreviation></Journal><ArticleTitle>Systematic review and network meta-analysis of various nadir temperature strategies for hypothermic circulatory arrest for aortic arch surgery.</ArticleTitle><Pagination><StartPage>102</StartPage><EndPage>114</EndPage><MedlinePgn>102-114</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/02184923221144959</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The optimal nadir temperature for hypothermic circulatory arrest during aortic arch surgery remains unclear. We aimed to assess and compare clinical outcomes of all three temperature strategies (deep, moderate, and mild hypothermia) using a network meta-analysis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">After literature search with MEDLINE and EMBASE through December 2021, studies comparing clinical outcomes with deep (&lt;20&#xb0;C), moderate (20-28&#xb0;C), or mild (&gt;28&#xb0;C) hypothermic circulatory arrest were included. The outcomes of interest were perioperative mortality, stroke, transient ischemia attack (TIA), acute kidney injury (AKI), postoperative bleeding, operative time, and length of hospital stay.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-four comparative studies were identified, including 6018 patients undergoing aortic arch surgery using hypothermic circulatory arrest (deep: 2,978, moderate: 2,525, and mild: 515). Compared to deep hypothermia, mild and moderate hypothermia were associated with lower mortality (mild vs. deep: odds ratio [OR] 0.50; 95% confidence interval (CI) 0.29-0.87, moderate vs. deep: OR 0.68; 95% CI 0.54-0.86). In addition, mild hypothermia was associated with lower stroke (OR 0.50; 95% CI 0.28-0.89), AKI (OR 0.36; 95% CI 0.15-0.88) and postoperative bleeding (OR 0.55; 95% CI 0.31-0.97) compared to deep hypothermia. There was no significant difference between mild and moderate hypothermia in mortality, AKI or bleeding occurrence, while mild hypothermia was associated with shorter operative time and hospital stay. There was no significant difference in TIA rate among three groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Mild hypothermia was associated with overall more favorable clinical outcomes with comparable neurological complications compared to deep hypothermia. Furthermore, considering the shorter operative time and hospital stay compared with moderate hypothermia, mild hypothermia may be warranted when appropriate adjunctive cerebral perfusion is employed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shimamura</LastName><ForeName>Junichi</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-7980-5036</Identifier><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Department of Surgery, 10033London Health Sciences Centre, London, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yokoyama</LastName><ForeName>Yujiro</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-8552-9496</Identifier><AffiliationInfo><Affiliation>Department of Surgery, 14352Easton Hospital, Easton, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuno</LastName><ForeName>Toshiki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Montefiore Medical center, Albert Einstein Medical College, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujisaki</LastName><ForeName>Tomohiro</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai St Luke's and West, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fukuhara</LastName><ForeName>Shinichi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, University of Michigan Cardiovascular Center, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takayama</LastName><ForeName>Hiroo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Cardiothoracic Surgery, Department of Surgery, New York Presbyterian Hospital, Columbia University Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ota</LastName><ForeName>Takeyoshi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Section of Cardiac and Thoracic Surgery, Department of Surgery, 2462The University of Chicago, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Michael Wa</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Department of Surgery, 10033London Health Sciences Centre, London, Ontario, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000099094">Network Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Asian Cardiovasc Thorac Ann</MedlineTA><NlmUniqueID>9503417</NlmUniqueID><ISSNLinking>0218-4923</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001013" MajorTopicYN="N">Aorta, Thoracic</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013696" MajorTopicYN="N">Temperature</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007035" MajorTopicYN="Y">Hypothermia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="Y">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050792" MajorTopicYN="N">Circulatory Arrest, Deep Hypothermia Induced</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010477" MajorTopicYN="N">Perfusion</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002560" MajorTopicYN="N">Cerebrovascular Circulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007036" MajorTopicYN="Y">Hypothermia, Induced</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aortic arch</Keyword><Keyword MajorTopicYN="N">hypothermic circulatory arrest</Keyword><Keyword MajorTopicYN="N">network meta-analysis</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>26</Day><Hour>12</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36571785</ArticleId><ArticleId IdType="doi">10.1177/02184923221144959</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38807326</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>29</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2165</ISSN><JournalIssue CitedMedium="Internet"><Volume>65</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery</Title><ISOAbbreviation>Eur J Vasc Endovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Comparison of Methods for Monitoring Intra-operative Cerebral Perfusion in Patients Undergoing Carotid Endarterectomy with Selective Shunting: A Systematic Review and Network Meta-Analysis of Randomised Controlled Trials and Cohort Studies.</ArticleTitle><Pagination><StartPage>233</StartPage><EndPage>243</EndPage><MedlinePgn>233-243</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejvs.2022.08.025</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1078-5884(22)00531-7</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aimed to analyse the influence of different methods of monitoring cerebral perfusion (MCP) on stroke, death, and use of intraluminal shunt during carotid endarterectomy (CEA).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review and network meta-analysis was conducted and registered in the PROSPERO registry (CRD42021246360). Medline, Embase, CENTRAL, and Web of Science were searched. Randomised controlled trials (RCTs) and cohort studies with &gt; 50 participants that compared clinical outcomes for different MCP in patients undergoing CEA were included. Papers reporting one or a combination of two of the following MCPs were included in the analysis: awake testing (AT), near infrared spectroscopy (NIRS), electroencephalography (EEG), somatosensory evoked potential (SSEP), motor evoked potential (MEP), transcranial Doppler (TCD), and stump pressure (SP). A random effects network meta-analysis was performed using a binomial likelihood function with a specified logit link for peri-operative stroke or death and shunting as outcomes. Near infrared spectroscopy was excluded due to the lack of studies that could be used for statistical analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 1 834 publications, 17 studies (15 cohort studies and two RCTs) including 21 538 participants were incorporated in the quantitative analysis. Electroencephalography was used in the largest number of participants (7 429 participants, six studies), while AT was used in the highest number of studies (10 studies). All monitoring modalities had worse outcomes with respect to stroke or death when compared with AT, with ORs ranging between 1.3 (95% credible interval [CrI] 0.2 - 10.9) for SSEP&#xa0;+ MEP and 3.1 (CrI 0.3 - 35.0) for patients monitored with a combination of EEG and TCD. However, the wide CrI indicated that there is no statistically significant difference between the monitoring methods. Patients monitored with a combination of EEG and TCD had the lowest odds of being shunted, while SP had the highest odds of being shunted, also with no statistically significant difference.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">There is a lack of high quality data on this topic in the literature. The present study showed no significant difference between monitoring methods investigated in the network meta-analysis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jovanovic</LastName><ForeName>Aleksa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Epidemiology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jonsson</LastName><ForeName>Magnus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Department of Vascular Surgery, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roy</LastName><ForeName>Joy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Department of Vascular Surgery, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eriksson</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mutavdzic</LastName><ForeName>Perica</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Belgrade, Belgrade, Serbia; Clinic for Vascular and Endovascular Surgery, Serbian Clinical Centre, Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trailovic</LastName><ForeName>Ranko</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Belgrade, Belgrade, Serbia; Clinic for Vascular and Endovascular Surgery, Serbian Clinical Centre, Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koncar</LastName><ForeName>Igor</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Belgrade, Belgrade, Serbia; Clinic for Vascular and Endovascular Surgery, Serbian Clinical Centre, Belgrade, Serbia. Electronic address: Dr.koncar@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D000099094">Network Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Vasc Endovasc Surg</MedlineTA><NlmUniqueID>9512728</NlmUniqueID><ISSNLinking>1078-5884</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002560" MajorTopicYN="Y">Cerebrovascular Circulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004569" MajorTopicYN="N">Electroencephalography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016894" MajorTopicYN="Y">Endarterectomy, Carotid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005073" MajorTopicYN="N">Evoked Potentials, Somatosensory</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016343" MajorTopicYN="N">Monitoring, Intraoperative</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="Y">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017585" MajorTopicYN="N">Ultrasonography, Doppler, Transcranial</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Carotid endarterectomy</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Monitoring of cerebral perfusion</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>29</Day><Hour>1</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38807326</ArticleId><ArticleId IdType="doi">10.1016/j.ejvs.2022.08.025</ArticleId><ArticleId IdType="pii">S1078-5884(22)00531-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38234158</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>03</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1747-4949</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>International journal of stroke : official journal of the International Stroke Society</Title><ISOAbbreviation>Int J Stroke</ISOAbbreviation></Journal><ArticleTitle>Type of anesthesia for endovascular therapy in acute ischemic stroke: A literature review and meta-analysis.</ArticleTitle><Pagination><StartPage>735</StartPage><EndPage>746</EndPage><MedlinePgn>735-746</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/17474930241228956</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Endovascular thrombectomy (EVT) has been proven as the standard treatment for acute ischemic stroke (AIS) patients due to large vessel occlusion (LVO). However, the ideal anesthetic strategy during EVT still remains unclear. Therefore, this systematic review and meta-analysis aimed to determine the optimal anesthetic modality for patients with AIS undergoing EVT based on current randomized controlled trials (RCTs).</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">The databases Medline (via PubMed), EMBASE, Web of Science, and the Cochrane Library were searched for RCTs comparing general anesthesia (GA) and conscious sedation (CS) in AIS patients undergoing EVT. The primary outcome was a favorable functional outcome at 90&#x2009;days postintervention. Data analysis was conducted using the Review Manager software (RevMan V.5.3).</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Eight RCTs involving 1199 patients were included. There was no significant difference between GA and CS group in the rate of functional independence (risk ratio (RR)&#x2009;=&#x2009;1.10, 95% confidence interval (CI)&#x2009;=&#x2009;0.96 to 1.25; <i>p</i>&#x2009;=&#x2009;0.17; <i>I</i><sup>2</sup>&#x2009;=&#x2009;30%). Compared with the CS group, the GA group attained a higher successful recanalization rate (RR&#x2009;=&#x2009;1.14, 95% CI&#x2009;=&#x2009;1.08 to 1.20; <i>p</i>&#x2009;&lt;&#x2009;0.00001; <i>I</i><sup>2</sup>&#x2009;=&#x2009;17%). In addition, patients in the GA were associated with a higher rate of hypotension (RR&#x2009;=&#x2009;1.87, 95% CI&#x2009;=&#x2009;1.44 to 2.41; <i>p</i>&#x2009;&lt;&#x2009;0.00001; <i>I</i><sup>2</sup>&#x2009;=&#x2009;66%) and a higher incidence of pneumonia (RR&#x2009;=&#x2009;1.38, 95% CI&#x2009;=&#x2009;1.05 to 1.8; <i>p</i>&#x2009;=&#x2009;0.02; <i>I</i><sup>2</sup>&#x2009;=&#x2009;37%).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">For AIS patients receiving EVT, the choice of anesthetic modality did not influence the 3-month neurological outcome while GA is superior to CS in terms of successful reperfusion rate. Moreover, the patients in the GA group were at a higher risk of developing hypotension and pneumonia. Further studies are required to provide more sufficient evidence.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Yitong</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-3872-9038</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Xuanwu Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Yao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Yanhui</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xuanwu Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Guang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xuanwu Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Na</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xuanwu Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Meng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xuanwu Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Miao</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xuanwu Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xuanwu Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Tianlong</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xuanwu Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Stroke</MedlineTA><NlmUniqueID>101274068</NlmUniqueID><ISSNLinking>1747-4930</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="Y">Endovascular Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000083242" MajorTopicYN="Y">Ischemic Stroke</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="N">Anesthesia</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017131" MajorTopicYN="N">Thrombectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016292" MajorTopicYN="N">Conscious Sedation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute ischemic stroke</Keyword><Keyword MajorTopicYN="N">conscious sedation</Keyword><Keyword MajorTopicYN="N">endovascular therapy</Keyword><Keyword MajorTopicYN="N">general anesthesia</Keyword></KeywordList><CoiStatement>Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>4</Day><Hour>13</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>18</Day><Hour>2</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38234158</ArticleId><ArticleId IdType="doi">10.1177/17474930241228956</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23740694</PMID><DateCompleted><Year>2013</Year><Month>11</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-493X</ISSN><JournalIssue CitedMedium="Internet"><Issue>6</Issue><PubDate><Year>2013</Year><Month>Jun</Month><Day>06</Day></PubDate></JournalIssue><Title>The Cochrane database of systematic reviews</Title><ISOAbbreviation>Cochrane Database Syst Rev</ISOAbbreviation></Journal><ArticleTitle>Epidural analgesia for cardiac surgery.</ArticleTitle><Pagination><StartPage>CD006715</StartPage><MedlinePgn>CD006715</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/14651858.CD006715.pub2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">A combination of general anaesthesia (GA) with thoracic epidural analgesia (TEA) may have a beneficial effect on clinical outcomes by reducing the risk of perioperative complications after cardiac surgery.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The objective of this review was to determine the impact of perioperative epidural analgesia in cardiac surgery on perioperative mortality and cardiac, pulmonary or neurological morbidity. We performed a meta-analysis to compare the risk of adverse events and mortality in patients undergoing cardiac surgery under general anaesthesia with and without epidural analgesia.</AbstractText><AbstractText Label="SEARCH METHODS" NlmCategory="METHODS">We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (2012, Issue 12) in The Cochrane Library; MEDLINE (PubMed) (1966 to November 2012); EMBASE (1989 to November 2012); CINHAL (1982 to November 2012) and the Science Citation Index (1988 to November 2012).</AbstractText><AbstractText Label="SELECTION CRITERIA" NlmCategory="METHODS">We included randomized controlled trials comparing outcomes in adult patients undergoing cardiac surgery with either GA alone or GA in combination with TEA.</AbstractText><AbstractText Label="DATA COLLECTION AND ANALYSIS" NlmCategory="METHODS">All publications found during the search were manually and independently reviewed by the two authors. We identified 5035 titles, of which 4990 studies did not satisfy the selection criteria or were duplicate publications, that were retrieved from the five different databases. We performed a full review on 45 studies, of which 31 publications met all inclusion criteria. These 31 publications reported on a total of 3047 patients, 1578 patients with GA and 1469 patients with GA plus TEA.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">Through our search (November 2012) we have identified 5035 titles,&#xa0;of which 31 publications met our inclusion criteria and reported on a total of 3047 patients. Compared with GA alone, the pooled risk ratio (RR) for patients receiving GA with TEA showed an odds ratio (OR) of 0.84 (95% CI 0.33 to 2.13, 31 studies) for mortality; 0.76 (95% CI 0.49 to 1.19, 17 studies) for myocardial infarction; and 0.50 (95% CI 0.21 to 1.18, 10 studies) for stroke. The relative risks (RR) for respiratory complications and supraventricular arrhythmias were 0.68 (95% CI 0.54 to 0.86, 14 studies) and 0.65 (95% CI 0.50 to 0.86, 15 studies) respectively.</AbstractText><AbstractText Label="AUTHORS' CONCLUSIONS" NlmCategory="CONCLUSIONS">This meta-analysis of studies, identified to 2010, showed that the use of TEA in patients undergoing coronary artery bypass graft surgery may reduce the risk of postoperative supraventricular arrhythmias and respiratory complications. There were no effects of TEA with GA on the risk of mortality, myocardial infarction or neurological complications compared with GA alone.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Svircevic</LastName><ForeName>Vesna</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Perioperative Care and Emergency Medicine, University Medical Center Utrecht, Utrecht, Netherlands. vesnasvircevic@hotmail.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Passier</LastName><ForeName>Martijn M</ForeName><Initials>MM</Initials></Author><Author ValidYN="Y"><LastName>Nierich</LastName><ForeName>Arno P</ForeName><Initials>AP</Initials></Author><Author ValidYN="Y"><LastName>van Dijk</LastName><ForeName>Diederik</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Kalkman</LastName><ForeName>Cor J</ForeName><Initials>CJ</Initials></Author><Author ValidYN="Y"><LastName>van der Heijden</LastName><ForeName>Geert J</ForeName><Initials>GJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>06</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cochrane Database Syst Rev</MedlineTA><NlmUniqueID>100909747</NlmUniqueID><ISSNLinking>1361-6137</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateIn"><RefSource>Cochrane Database Syst Rev. 2019 Mar 01;3:CD006715. doi: 10.1002/14651858.CD006715.pub3.</RefSource><PMID Version="1">30821845</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015360" MajorTopicYN="N">Analgesia, Epidural</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="N">Arrhythmias, Cardiac</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001026" MajorTopicYN="N">Coronary Artery Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012120" MajorTopicYN="N">Respiration Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>6</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>6</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23740694</ArticleId><ArticleId IdType="doi">10.1002/14651858.CD006715.pub2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23391083</PMID><DateCompleted><Year>2013</Year><Month>08</Month><Day>05</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1545-1550</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2013</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists</Title><ISOAbbreviation>J Endovasc Ther</ISOAbbreviation></Journal><ArticleTitle>Carotid artery stenting-induced hemodynamic instability.</ArticleTitle><Pagination><StartPage>48</StartPage><EndPage>60</EndPage><MedlinePgn>48-60</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1583/12-4015.1</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To present a systematic review and meta-analysis investigating the incidence of carotid artery stenting (CAS)-induced hemodynamic instability (HI) and to explore differences in periprocedural risk among patients with and without CAS-associated HI.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Multiple electronic health databases were searched for all articles published between January 2000 and December 2011 describing CAS-associated hemodynamic instability. Twenty-seven studies with a total of 4204 patients were analyzed, placing emphasis on the HI incidence and its correlation with postprocedure morbidity and mortality. A meta-regression analysis was conducted to investigate the role of potential meaningful modifiers upon HI.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The meta-analysis for overall HI rate showed a pooled proportion of 39.4%. The pooled estimate for hypotension was 12.1%, 12.2% for bradycardia, and 12.5% for both hypotension and bradycardia. Persistent HI was found to occur in a pooled rate of 19.2%. No statistically significant differences were found between patients with and without HI after CAS with respect to death, stroke, transient ischemic attack (TIA), or major adverse events. The meta-regression analysis revealed statistically significant associations of mean age with HI, of &#x2264;10-mm distance between the carotid bifurcation and the site of minimum lumen diameter with bradycardia, and of prior ipsilateral CEA with persistent HI.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">CAS-induced HI occurs in a considerable percentage of patients without increasing the perioperative risk. However, applying the appropriate prophylactic measures and strictly monitoring blood pressure and heart rate during the procedure and immediately after should be encouraged for early recognition and correction of these hemodynamic disturbances.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mylonas</LastName><ForeName>Spyridon N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Athens University Medical School, Attikon University Hospital, Athens, Greece. spyrosmylonas@gmail.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moulakakis</LastName><ForeName>Konstantinos G</ForeName><Initials>KG</Initials></Author><Author ValidYN="Y"><LastName>Antonopoulos</LastName><ForeName>Constantinos N</ForeName><Initials>CN</Initials></Author><Author ValidYN="Y"><LastName>Kakisis</LastName><ForeName>John D</ForeName><Initials>JD</Initials></Author><Author ValidYN="Y"><LastName>Liapis</LastName><ForeName>Christos D</ForeName><Initials>CD</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Endovasc Ther</MedlineTA><NlmUniqueID>100896915</NlmUniqueID><ISSNLinking>1526-6028</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Endovasc Ther. 2013 Feb;20(1):61-3. doi: 10.1583/12-4015C.1.</RefSource><PMID Version="1">23391084</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001919" MajorTopicYN="N">Bradycardia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016893" MajorTopicYN="N">Carotid Stenosis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="Y">Hemodynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015607" MajorTopicYN="N">Stents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>8</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23391083</ArticleId><ArticleId IdType="doi">10.1583/12-4015.1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">29907575</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>13</Day></DateCompleted><DateRevised><Year>2019</Year><Month>03</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1759-8486</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>2</Issue><PubDate><Year>2019</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of neurointerventional surgery</Title><ISOAbbreviation>J Neurointerv Surg</ISOAbbreviation></Journal><ArticleTitle>Current evidence for anesthesia management during endovascular stroke therapy: updated systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>107</StartPage><EndPage>113</EndPage><MedlinePgn>107-113</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/neurintsurg-2018-013916</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Debate continues about the optimal anesthetic management for patients undergoing endovascular treatment (ET) of acute ischemic stroke due to emergent large vessel occlusion.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To compare, using current evidence, the clinical outcomes and procedural characteristics among patients undergoing general anesthesia (GA) and local or monitored anesthesia (non-GA).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a systematic review and meta-analysis of all available studies that involved the use of stent retrievers for ET (stentriever group). Additionally, we included studies that were published in 2015 and later, and compared the clinical outcomes among the studies using stentrievers or no stentrievers (pre-stentriever group). Outcome variables included functional independence (FI; modified Rankin Scale scores of 0-2), symptomatic hemorrhage, mortality, procedure duration, and vascular and respiratory complications. We calculated pooled odds ratios and 95% CIs using random-effects models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Sixteen studies (three randomized controlled clinical trials (RCTs) and 13 non-randomized studies) were identified comprising 5836 patients. Although non-GA was associated with higher odds of 3-month FI (OR=1.57; 95%&#x2009;CI 1.17 to 2.10; P=0.003) and lower odds of 3-month mortality (OR=0.62; 95%&#x2009;CI 0.47 to 0.82; P=0.0006, substantial heterogeneity was noted across included trials. Sensitivity analyses of RCTs showed that non-GA was inversely associated with FI (OR=0.55; 95%&#x2009;CI 0.34 to 0.89; P=0.01; I<sup>2</sup>=15%), while no association was noted with mortality (OR=1.36; 95%&#x2009;CI 0.79 to 2.34; P=0.27; I<sup>2</sup>=0%).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our updated meta-analysis demonstrates favorable results with non-GA, probably owing to inclusion of non-randomized studies. Recent single-center RCTs indicate that GA is associated with higher odds of FI at 3&#x2009;months, while other outcomes are similar between the two groups.</AbstractText><CopyrightInformation>&#xa9; Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Goyal</LastName><ForeName>Nitin</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Malhotra</LastName><ForeName>Konark</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, West Virginia University-Charleston Division, Charleston, West Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishfaq</LastName><ForeName>Muhammad F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsivgoulis</LastName><ForeName>Georgios</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Second Department of Neurology, "Attikon University Hospital", School of Medicine, National &amp; Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nickele</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University of Tennessee Health Science Center and Semmes-Murphey Clinic, Memphis, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoit</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University of Tennessee Health Science Center and Semmes-Murphey Clinic, Memphis, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arthur</LastName><ForeName>Adam S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University of Tennessee Health Science Center and Semmes-Murphey Clinic, Memphis, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alexandrov</LastName><ForeName>Andrei V</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University of Tennessee Health Science Center and Semmes-Murphey Clinic, Memphis, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elijovich</LastName><ForeName>Lucas</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosurgery, University of Tennessee Health Science Center and Semmes-Murphey Clinic, Memphis, Tennessee, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>06</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Neurointerv Surg</MedlineTA><NlmUniqueID>101517079</NlmUniqueID><ISSNLinking>1759-8478</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002545" MajorTopicYN="N">Brain Ischemia</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="N">Endovascular Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019317" MajorTopicYN="N">Evidence-Based Medicine</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064795" MajorTopicYN="N">Intraoperative Neurophysiological Monitoring</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015607" MajorTopicYN="N">Stents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anesthesia</Keyword><Keyword MajorTopicYN="N">intubation</Keyword><Keyword MajorTopicYN="N">outcomes</Keyword><Keyword MajorTopicYN="N">stroke</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>3</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29907575</ArticleId><ArticleId IdType="doi">10.1136/neurintsurg-2018-013916</ArticleId><ArticleId IdType="pii">neurintsurg-2018-013916</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30101624</PMID><DateCompleted><Year>2019</Year><Month>11</Month><Day>14</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1545-1550</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>5</Issue><PubDate><Year>2018</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists</Title><ISOAbbreviation>J Endovasc Ther</ISOAbbreviation></Journal><ArticleTitle>Preoperative Use of Statins in Carotid Artery Stenting: A Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>624</StartPage><EndPage>631</EndPage><MedlinePgn>624-631</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1526602818794030</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To determine through meta-analysis whether administration of statins before carotid artery stenting (CAS) is associated with fewer periprocedural adverse events.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">All randomized and observational English-language studies of periprocedural statin administration prior to CAS that reported the outcomes of interest (stroke, transient ischemic attack, myocardial infarction, and death at 30 days) were included in a random-effects meta-analysis. The I<sup>2</sup> statistic was used to assess heterogeneity. Meta-regression analysis was performed to determine whether an association of statin treatment with risk of outcome events was influenced by other trial-level baseline characteristics of statin-treated and untreated patients.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eleven studies comprising 4088 patients were included. Patients who received statins prior to CAS had a significantly lower risk of stroke (OR 0.39, 95% CI 0.27 to 0.58, p&lt;0.01; I<sup>2</sup>=0%) and death (OR 0.30, 95% CI 0.10 to 0.96, p=0.042; I<sup>2</sup>=0%). Statin use was not associated with a reduced risk of transient ischemic attack or myocardial infarction. In meta-regression analysis, other trial-level baseline characteristics had no significant influence on the association of statin treatment with death or stroke.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Statin therapy prior to CAS is associated with decreased risk of perioperative stroke and death without any effect on the rates of transient ischemic attack or myocardial infarction.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Texakalidis</LastName><ForeName>Pavlos</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-8715-6651</Identifier><AffiliationInfo><Affiliation>1 Aristotle University of Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giannopoulos</LastName><ForeName>Stefanos</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>2 251 HAF and VA Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jonnalagadda</LastName><ForeName>Anil K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>3 Division of Cardiology, Medstar Washington Hospital Center, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chitale</LastName><ForeName>Rohan V</ForeName><Initials>RV</Initials><AffiliationInfo><Affiliation>4 Department of Neurosurgery, Vanderbilt University Hospital, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jabbour</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>5 Department of Neurosurgery, Thomas Jefferson University, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Armstrong</LastName><ForeName>Ehrin J</ForeName><Initials>EJ</Initials><Identifier Source="ORCID">0000-0002-1381-4754</Identifier><AffiliationInfo><Affiliation>6 Division of Cardiology, Denver VA Medical Center, University of Colorado, Denver, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwartz</LastName><ForeName>Gregory G</ForeName><Initials>GG</Initials><AffiliationInfo><Affiliation>6 Division of Cardiology, Denver VA Medical Center, University of Colorado, Denver, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kokkinidis</LastName><ForeName>Damianos G</ForeName><Initials>DG</Initials><Identifier Source="ORCID">0000-0002-1381-4754</Identifier><AffiliationInfo><Affiliation>7 Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>08</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Endovasc Ther</MedlineTA><NlmUniqueID>100896915</NlmUniqueID><ISSNLinking>1526-6028</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019161">Hydroxymethylglutaryl-CoA Reductase Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002340" MajorTopicYN="N">Carotid Artery Diseases</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="N">Endovascular Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019161" MajorTopicYN="N">Hydroxymethylglutaryl-CoA Reductase Inhibitors</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065840" MajorTopicYN="N">Protective Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015607" MajorTopicYN="Y">Stents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">carotid stent/stenting</Keyword><Keyword MajorTopicYN="N">internal carotid artery</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">myocardial infarction</Keyword><Keyword MajorTopicYN="N">statins</Keyword><Keyword MajorTopicYN="N">stenosis</Keyword><Keyword MajorTopicYN="N">stroke</Keyword><Keyword MajorTopicYN="N">transient ischemic attack</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30101624</ArticleId><ArticleId IdType="doi">10.1177/1526602818794030</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">21596585</PMID><DateCompleted><Year>2012</Year><Month>02</Month><Day>03</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>5</Issue><PubDate><Year>2011</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Recombinant activated factor VII increases stroke in cardiac surgery: a meta-analysis.</ArticleTitle><Pagination><StartPage>804</StartPage><EndPage>810</EndPage><MedlinePgn>804-10</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2011.03.004</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Recombinant activated factor VII (rFVIIa) is used in various surgical procedures to reduce the incidence of major blood loss and the need for re-exploration. Few clinical trials have investigated rFVIIa in cardiac surgery. The authors performed a meta-analysis focusing on the rate of stroke and surgical re-exploration.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Meta-analysis.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Hospitals.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">A total of 470 patients.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">None.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">Four investigators independently searched PubMed and conference proceedings including backward snowballing (ie, scanning of reference of retrieved articles and pertinent reviews) and contacted international experts. A total of 470 patients (254 receiving rFVIIa and 216 controls) from 6 clinical trials (2 randomized, 3 propensity matched, and 1 case matched) were included in the analysis. The use of rFVIIa was associated with an increased rate of stroke (12/254 [4.7%] in the rFVIIa group v 2/216 [0.9%] in the control arm, odds ratio [OR] = 3.69 [1.1-12.38], p = 0.03) with a nonsignificant reduction in rate of surgical re-exploration (13% v 42% [OR = 0.27 (0.04-1.9), p = 0.19]). The authors observed a trend toward an increase of overall perioperative thromboembolic events (19/254 [7.5%] in the rFVIIa group v 10/216 [5.6%] in the control arm [OR = 1.84 (0.82-4.09), p = 0.14]). No difference in the rate of death was observed.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The administration of rFVIIa in cardiac surgery patients could result in a significant increase of stroke with a trend toward a reduction of the need for surgical re-exploration. The authors do not recommend routine use in cardiac surgery patients. rFVIIa may be considered with caution in patients with refractory life-threatening bleeding.</AbstractText><CopyrightInformation>Copyright &#xa9; 2011 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ponschab</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Universit&#xe0; Vita-Salute San Raffaele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Biondi-Zoccai</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Bignami</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Frati</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Nicolotti</LastName><ForeName>Davide</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Monaco</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Pappalardo</LastName><ForeName>Federico</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Zangrillo</LastName><ForeName>Alberto</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>05</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>9001-25-6</RegistryNumber><NameOfSubstance UI="D005167">Factor VII</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005167" MajorTopicYN="N">Factor VII</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061214" MajorTopicYN="N">Patient Safety</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012086" MajorTopicYN="N">Reoperation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065227" MajorTopicYN="N">Transfusion Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014652" MajorTopicYN="N">Vascular Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>1</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21596585</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2011.03.004</ArticleId><ArticleId IdType="pii">S1053-0770(11)00119-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">24612945</PMID><DateCompleted><Year>2015</Year><Month>06</Month><Day>18</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1741-7015</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2014</Year><Month>Mar</Month><Day>10</Day></PubDate></JournalIssue><Title>BMC medicine</Title><ISOAbbreviation>BMC Med</ISOAbbreviation></Journal><ArticleTitle>Local versus general anesthesia for transcatheter aortic valve implantation (TAVR)--systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>41</StartPage><MedlinePgn>41</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/1741-7015-12-41</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The hypothesis of this study was that local anesthesia with monitored anesthesia care (MAC) is not harmful in comparison to general anesthesia (GA) for patients undergoing Transcatheter Aortic Valve Implantation (TAVR).TAVR is a rapidly spreading treatment option for severe aortic valve stenosis. Traditionally, in most centers, this procedure is done under GA, but more recently procedures with MAC have been reported.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a systematic review and meta-analysis comparing MAC versus GA in patients undergoing transfemoral TAVR. Trials were identified through a literature search covering publications from 1 January 2005 through 31 January 2013. The main outcomes of interest of this literature meta-analysis were 30-day overall mortality, cardiac-/procedure-related mortality, stroke, myocardial infarction, sepsis, acute kidney injury, procedure time and duration of hospital stay. A random effects model was used to calculate the pooled relative risks (RR) with 95% confidence intervals.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Seven observational studies and a total of 1,542 patients were included in this analysis. None of the studies were randomized. Compared to GA, MAC was associated with a shorter hospital stay (-3.0 days (-5.0 to -1.0); P = 0.004) and a shorter procedure time (MD -36.3 minutes (-58.0 to -15.0 minutes); P &lt;0.001). Overall 30-day mortality was not significantly different between MAC and GA (RR 0.77 (0.38 to 1.56); P = 0.460), also cardiac- and procedure-related mortality was similar between both groups (RR 0.90 (0.34 to 2.39); P = 0.830).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">These data did not show a significant difference in short-term outcomes for MAC or GA in TAVR. MAC may be associated with reduced procedural time and shorter hospital stay. Now randomized trials are needed for further evaluation of MAC in the setting of TAVR.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fr&#xf6;hlich</LastName><ForeName>Georg M</ForeName><Initials>GM</Initials></Author><Author ValidYN="Y"><LastName>Lansky</LastName><ForeName>Alexandra J</ForeName><Initials>AJ</Initials></Author><Author ValidYN="Y"><LastName>Webb</LastName><ForeName>John</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Roffi</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Toggweiler</LastName><ForeName>Stefan</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Reinthaler</LastName><ForeName>Markus</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Duolao</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Hutchinson</LastName><ForeName>Nevil</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Wendler</LastName><ForeName>Olaf</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Hildick-Smith</LastName><ForeName>David</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Meier</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>The Heart Hospital, University College London Hospitals, London, UK. pascalmeier74@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>03</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med</MedlineTA><NlmUniqueID>101190723</NlmUniqueID><ISSNLinking>1741-7015</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000772" MajorTopicYN="Y">Anesthesia, Local</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001024" MajorTopicYN="N">Aortic Valve Stenosis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065467" MajorTopicYN="N">Transcatheter Aortic Valve Replacement</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>3</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24612945</ArticleId><ArticleId IdType="pmc">PMC4022332</ArticleId><ArticleId IdType="doi">10.1186/1741-7015-12-41</ArticleId><ArticleId IdType="pii">1741-7015-12-41</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S. PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597&#x2013;1607. doi: 10.1056/NEJMoa1008232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1008232</ArticleId><ArticleId IdType="pubmed">20961243</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancellotti P, Rosenhek R, Pibarot P, Iung B, Otto CM, Tornos P, Donal E, Prendergast B, Magne J, La Canna G, Pi&#xe9;rard LA, Maurer G. ESC Working Group on Valvular Heart Disease Position Paper - heart valve clinics: organization, structure, and experiences. Eur Heart J. 2013;34:1597&#x2013;1606. doi: 10.1093/eurheartj/ehs443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehs443</ArticleId><ArticleId IdType="pubmed">23293304</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, Teiger E, Lefevre T, Himbert D, Tchetche D, Carri&#xe9; D, Albat B, Cribier A, Rioufol G, Sudre A, Blanchard D, Collet F, Dos Santos P, Meneveau N, Tirouvanziam A, Caussin C, Guyon P, Boschat J, Le Breton H, Collart F, Houel R. et al.Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med. 2012;366:1705&#x2013;1715. doi: 10.1056/NEJMoa1114705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1114705</ArticleId><ArticleId IdType="pubmed">22551129</ArticleId></ArticleIdList></Reference><Reference><Citation>Stiles S.  TAVR in-Hospital Death, Stroke Rates Stay Low Even as Use Climbs: GARY. Munich: European Society of Cardiology ESC 2012; 2012.   http://www.medscape.com/viewarticle/769866.</Citation></Reference><Reference><Citation>Linke A, Bosmans J, Gerckens U, Wenaweser P, Tamburino C, Brecker S, Bauernschmitt R. Local vs. General Anaesthesia: Impact on the outcomes of transcatheter aortic valve implantation: insights from the multicentre ADVANCE study. Munich: European Society of Cardiology ESC; 2012.</Citation></Reference><Reference><Citation>Motloch LJ, Rottlaender D, Reda S, Larbig R, Bruns M, M&#xfc;ller-Ehmsen J, Strauch J, Madershahian N, Erdmann E, Wahlers T, Hoppe UC. Local versus general anesthesia for transfemoral aortic valve implantation. Clin Res Cardiol. 2012;101:45&#x2013;53. doi: 10.1007/s00392-011-0362-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-011-0362-8</ArticleId><ArticleId IdType="pubmed">21931964</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto M, Meguro K, Mouillet G, Bergoend E, Monin JL, Lim P, Dubois-Rande JL, Teiger E. Effect of local anesthetic management with conscious sedation in patients undergoing transcatheter aortic valve implantation. Am J Cardiol. 2013;111:94&#x2013;99. doi: 10.1016/j.amjcard.2012.08.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2012.08.053</ArticleId><ArticleId IdType="pubmed">23068861</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruppert V, Leurs LJ, Rieger J, Steckmeier B, Buth J, Umscheid T. EUROSTAR Collaborators. Risk-adapted outcome after endovascular aortic aneurysm repair: analysis of anesthesia types based on EUROSTAR data. J Endovasc Ther. 2007;14:12&#x2013;22. doi: 10.1583/06-1957.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1583/06-1957.1</ArticleId><ArticleId IdType="pubmed">17291150</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilpatrick B, Slinger P. Lung protective strategies in anaesthesia. Br J Anaesth. 2010;105:i108&#x2013;i116. doi: 10.1093/bja/aeq299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aeq299</ArticleId><ArticleId IdType="pmc">PMC9149602</ArticleId><ArticleId IdType="pubmed">21148650</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim T, Kim HJ, Lee JM, Kim JH, Hong DM, Jeon Y, Roh YJ, Lim YJ, Bahk JH. The head-down tilt position decreases vasopressor requirement during hypotension following induction of anaesthesia in patients undergoing elective coronary artery bypass graft and valvular heart surgeries. Eur J Anaesthesiol. 2011;28:45&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">21088595</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K. EPIC II Group of Investigators. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302:2323&#x2013;2329. doi: 10.1001/jama.2009.1754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2009.1754</ArticleId><ArticleId IdType="pubmed">19952319</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535. doi: 10.1136/bmj.b2535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2535</ArticleId><ArticleId IdType="pmc">PMC2714657</ArticleId><ArticleId IdType="pubmed">19622551</ArticleId></ArticleIdList></Reference><Reference><Citation>Tricco AC, Straus SE, Moher D. How can we improve the interpretation of systematic reviews? BMC Med. 2011;9:31. doi: 10.1186/1741-7015-9-31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1741-7015-9-31</ArticleId><ArticleId IdType="pmc">PMC3072347</ArticleId><ArticleId IdType="pubmed">21450084</ArticleId></ArticleIdList></Reference><Reference><Citation>tctmd. The Source for Interventional Cardiovascular News and Education.   http://www.tctmd.com.</Citation></Reference><Reference><Citation>The Heart Org. Medscape Cardiology.   http://www.theheart.org.</Citation></Reference><Reference><Citation>EuroPCR:   http://www.europcronline.com.</Citation></Reference><Reference><Citation>American College of Cardiology. CardioSource.   http://www.cardiosource.com.</Citation></Reference><Reference><Citation>CRTonline.   http://www.crtonline.org.</Citation></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177&#x2013;188. doi: 10.1016/0197-2456(86)90046-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-2456(86)90046-2</ArticleId><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc. 2009;172:137&#x2013;159. doi: 10.1111/j.1467-985X.2008.00552.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1467-985X.2008.00552.x</ArticleId><ArticleId IdType="pmc">PMC2667312</ArticleId><ArticleId IdType="pubmed">19381330</ArticleId></ArticleIdList></Reference><Reference><Citation>Sankey SS, Weissfeld LA, Fine MJ, Kapoor W. An assessment of the use of the continuity correction for sparse data in meta-analysis. Commun Stat. 1996;25:1031&#x2013;1056.</Citation></Reference><Reference><Citation>Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539&#x2013;1558. doi: 10.1002/sim.1186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1186</ArticleId><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller JJ. The inverse of the Freeman-Tukey double arcsine transformation. Am Stat. 1978;32:138.</Citation></Reference><Reference><Citation>Behan M, Haworth P, Hutchinson N, Trivedi U, Laborde JC, Hildick-Smith D. Percutaneous aortic valve implants under sedation: our initial experience. Catheter Cardiovasc Interv. 2008;72:1012&#x2013;1015. doi: 10.1002/ccd.21777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.21777</ArticleId><ArticleId IdType="pubmed">19021273</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-Dor I, Looser PM, Maluenda G, Weddington TC, Kambouris NG, Barbash IM, Hauville C, Okubagzi P, Corso PJ, Satler LF, Pichard AD, Waksman R. Transcatheter aortic valve replacement under monitored anesthesia care versus general anesthesia with intubation. Cardiovasc Revasc Med. 2012;13:207&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pubmed">22818531</ArticleId></ArticleIdList></Reference><Reference><Citation>Covello RD, Ruggeri L, Landoni G, Guarracino F, Bignami E, Gonfalini M, Virzo I, Michev I, Colombo A, Zangrillo A. Transcatheter implantation of an aortic valve: anesthesiological management. Minerva Anestesiol. 2010;76:100&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pubmed">20150850</ArticleId></ArticleIdList></Reference><Reference><Citation>Deh&#xe9;din B, Guinot PG, Ibrahim H, Allou N, Provench&#xe8;re S, Dilly MP, Vahanian A, Himbert D, Brochet E, Radu C, Nataf P, Montravers P, Longrois D, Depoix JP. Anesthesia and perioperative management of patients who undergo transfemoral transcatheter aortic valve implantation: an observational study of general versus local/regional anesthesia in 125 consecutive patients. J Cardiothorac Vasc Anesth. 2011;25:1036&#x2013;1043. doi: 10.1053/j.jvca.2011.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2011.05.008</ArticleId><ArticleId IdType="pubmed">21803602</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulur P, Nishimori M, Ballantyne JC. Regional anaesthesia versus general anaesthesia, morbidity and mortality. Best Pract Res Clin Anaesthesiol. 2006;20:249&#x2013;263. doi: 10.1016/j.bpa.2005.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpa.2005.10.002</ArticleId><ArticleId IdType="pubmed">16850776</ArticleId></ArticleIdList></Reference><Reference><Citation>Bainbridge D, Martin J, Arango M, Cheng D. for the Evidence-based Peri-operative Clinical Outcomes Research (EpiCOR) Group. Evidence-based peri-operative clinical outcomes research, perioperative and anaesthetic-related mortality in developed and developing countries: a systematic review and meta-analysis. Lancet. 2012;380:1075&#x2013;1081. doi: 10.1016/S0140-6736(12)60990-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(12)60990-8</ArticleId><ArticleId IdType="pubmed">22998717</ArticleId></ArticleIdList></Reference><Reference><Citation>Cioni M, Taramasso M, Giacomini A, Montorfano M, Latib A, Colombo A, Alfieri O, Maisano F. Transaxillary approach: short- and mid-term results in a single-center experience. Innovations (Phila) 2011;6:361&#x2013;365. doi: 10.1097/IMI.0b013e318248e9ed.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/IMI.0b013e318248e9ed</ArticleId><ArticleId IdType="pubmed">22436770</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips D. Aortic stenosis: a review. AANA J. 2006;74:309&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pubmed">16918123</ArticleId></ArticleIdList></Reference><Reference><Citation>Gripari P, Ewe SH, Fusini L, Muratori M, Ng AC, Cefal&#xf9; C, Delgado V, Schalij MJ, Bax JJ, Marsan NA, Tamborini G, Pepi M. Intraoperative 2D and 3D transoesophageal echocardiographic predictors of aortic regurgitation after transcatheter aortic valve implantation. Heart. 2012;98:1229&#x2013;1236. doi: 10.1136/heartjnl-2012-301998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2012-301998</ArticleId><ArticleId IdType="pubmed">22826560</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold M, Achenbach S, Pfeiffer I, Ensminger S, Marwan M, Einhaus F, Pflederer T, Ropers D, Schuhbaeck A, Anders K, Lell M, Uder M, Ludwig J, Weyand M, Daniel WG, Feyrer R. A method to determine suitable fluoroscopic projections for transcatheter aortic valve implantation by computed tomography. J Cardiovasc Comput Tomogr. 2012;6:422&#x2013;428. doi: 10.1016/j.jcct.2012.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcct.2012.10.008</ArticleId><ArticleId IdType="pubmed">23217463</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S, Ling LH, Halloran K, Morton JB, Spence SJ, Joseph S, Kistler PM, Sparks PB, Kalman JM. Esophageal hematoma after atrial fibrillation ablation: incidence, clinical features, and sequelae of esophageal injury of a different sort. Circ Arrhythm Electrophysiol. 2012;5:701&#x2013;705. doi: 10.1161/CIRCEP.112.970624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.112.970624</ArticleId><ArticleId IdType="pubmed">22544279</ArticleId></ArticleIdList></Reference><Reference><Citation>Association of Anaesthetists of Great Britain and Ireland. Day case and short stay surgery: 2. Anaesthesia. 2011;66:417&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pubmed">21418041</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenzel RP, Edmond MB. The impact of hospital-acquired bloodstream infections. Emerg Infect Dis. 2001;7:174&#x2013;177. doi: 10.3201/eid0702.010203.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid0702.010203</ArticleId><ArticleId IdType="pmc">PMC2631709</ArticleId><ArticleId IdType="pubmed">11294700</ArticleId></ArticleIdList></Reference><Reference><Citation>Duggan M, Kavanagh BP. Perioperative modifications of respiratory function. Best Pract Res Clin Anaesthesiol. 2010;24:145&#x2013;155. doi: 10.1016/j.bpa.2009.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpa.2009.12.001</ArticleId><ArticleId IdType="pubmed">20608553</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Guerrero ML, Verdejo C, Azofra J, de G&#xf3;rgolas M. Hospital-acquired infectious endocarditis not associated with cardiac surgery: an emerging problem. Clin Infect Dis. 1995;20:16&#x2013;23. doi: 10.1093/clinids/20.1.16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinids/20.1.16</ArticleId><ArticleId IdType="pubmed">7727642</ArticleId></ArticleIdList></Reference><Reference><Citation>Neyt M, Van Brabandt H, Devriese S, Van De Sande S. A cost-utility analysis of transcatheter aortic valve implantation in Belgium: focusing on a well-defined and identifiable population. BMJ Open. 2012;2:e001032.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3358616</ArticleId><ArticleId IdType="pubmed">22561354</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasta JF, McLaughlin TP, Mody SH, Piech CT. Daily cost of an intensive care unit day: the contribution of mechanical ventilation. Crit Care Med. 2005;33:1266&#x2013;1271. doi: 10.1097/01.CCM.0000164543.14619.00.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000164543.14619.00</ArticleId><ArticleId IdType="pubmed">15942342</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarantini G, Gasparetto V, Napodano M, Fraccaro C, Gerosa G, Isabella G. Valvular leak after transcatheter aortic valve implantation: a clinician update on epidemiology, pathophysiology and clinical implications. Am J Cardiovasc Dis. 2011;1:312&#x2013;320.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3253519</ArticleId><ArticleId IdType="pubmed">22254207</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">37268801</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1496-8975</ISSN><JournalIssue CitedMedium="Internet"><Volume>70</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Canadian journal of anaesthesia = Journal canadien d'anesthesie</Title><ISOAbbreviation>Can J Anaesth</ISOAbbreviation></Journal><ArticleTitle>General anesthesia or conscious sedation for thrombectomy in stroke patients: an updated systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1167</StartPage><EndPage>1181</EndPage><MedlinePgn>1167-1181</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12630-023-02481-8</ELocationID><Abstract><AbstractText Label="PURPOSE">Endovascular treatment for stroke patients usually requires anesthesia care, with no current consensus on the best anesthetic management strategy. Several randomized controlled trials and meta-analyses have attempted to address this. In 2022, additional evidence from three new trials was published: the GASS trial, the CANVAS II trial, and preliminary results from the AMETIS trial, prompting the execution of this updated systematic review and meta-analysis. The primary objective of this study was to evaluate the effects of general anesthesia and conscious sedation on functional outcomes measured with the modified Rankin scale (mRS) at three months.</AbstractText><AbstractText Label="METHODS">We performed a systematic review and meta-analysis of randomized controlled trials investigating conscious sedation and general anesthesia in endovascular treatment. The following databases were examined: PubMed, Scopus, Embase, and the Cochrane Database of Randomized Controlled Trials and Systematic Reviews. The Risk of Bias 2 tool was used to assess bias. In addition, trial sequence analysis was performed on the primary outcome to estimate if the cumulative effect is significant enough to be unaffected by further studies.</AbstractText><AbstractText Label="RESULTS">Nine randomized controlled trials were identified, including 1,342 patients undergoing endovascular treatment for stroke. No significant differences were detected between general anesthesia and conscious sedation with regards to mRS, functional independence (mRS, 0-2), procedure duration, onset to reperfusion, mortality, hospital length of stay, and intensive care unit length of stay. Patients treated under general anesthesia may have more frequent successful reperfusion, though the time from groin to reperfusion was slightly longer. Trial sequential analysis showed that additional trials are unlikely to show marked differences in mean mRS at three months.</AbstractText><AbstractText Label="CONCLUSIONS">In this updated systematic review and meta-analysis, the choice of anesthetic strategy for endovascular treatment of stroke patients did not significantly impact functional outcome as measured with the mRS at three months. Patients managed with general anesthesia may have more frequent successful reperfusion.</AbstractText><AbstractText Label="TRIAL REGISTRATION">PROSPERO (CRD42022319368); registered 19 April 2022.</AbstractText><CopyrightInformation>&#xa9; 2023. Canadian Anesthesiologists' Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Geraldini</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>UOC Anesthesia and Intensive Care Unit, Institute of Anesthesia and Intensive Care, Padua University Hospital, Via Giustiniani 1, 35127, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diana</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>UOC Anesthesia and Intensive Care Unit, Institute of Anesthesia and Intensive Care, Padua University Hospital, Via Giustiniani 1, 35127, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fregolent</LastName><ForeName>Davide</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Cassai</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9773-1832</Identifier><AffiliationInfo><Affiliation>UOC Anesthesia and Intensive Care Unit, Institute of Anesthesia and Intensive Care, Padua University Hospital, Via Giustiniani 1, 35127, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boscolo</LastName><ForeName>Annalisa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>UOC Anesthesia and Intensive Care Unit, Institute of Anesthesia and Intensive Care, Padua University Hospital, Via Giustiniani 1, 35127, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pettenuzzo</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>UOC Anesthesia and Intensive Care Unit, Institute of Anesthesia and Intensive Care, Padua University Hospital, Via Giustiniani 1, 35127, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sella</LastName><ForeName>Nicol&#xf2;</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>UOC Anesthesia and Intensive Care Unit, Institute of Anesthesia and Intensive Care, Padua University Hospital, Via Giustiniani 1, 35127, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lupelli</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navalesi</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>UOC Anesthesia and Intensive Care Unit, Institute of Anesthesia and Intensive Care, Padua University Hospital, Via Giustiniani 1, 35127, Padua, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munari</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>UOC Anesthesia and Intensive Care Unit, Institute of Anesthesia and Intensive Care, Padua University Hospital, Via Giustiniani 1, 35127, Padua, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurointensive Care Unit, Padua University Hospital, Padua, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Anesth&#xe9;sie g&#xe9;n&#xe9;rale ou s&#xe9;dation consciente pour la thrombectomie chez les personnes victimes d&#x2019;un accident vasculaire c&#xe9;r&#xe9;bral&#xa0;: une mise &#xe0; jour sous forme de revue syst&#xe9;matique avec m&#xe9;ta-analyse.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Can J Anaesth</MedlineTA><NlmUniqueID>8701709</NlmUniqueID><ISSNLinking>0832-610X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017131" MajorTopicYN="Y">Thrombectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016292" MajorTopicYN="Y">Conscious Sedation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="fre"><AbstractText>R&#xe9;SUM&#xe9;: OBJECTIF: Le traitement endovasculaire pour les patient&#xb7;es victimes d&#x2019;un accident vasculaire c&#xe9;r&#xe9;bral (AVC) n&#xe9;cessite g&#xe9;n&#xe9;ralement des soins d&#x2019;anesth&#xe9;sie, mais il n&#x2019;existe actuellement aucun consensus sur la meilleure strat&#xe9;gie de prise en charge anesth&#xe9;sique. Plusieurs &#xe9;tudes randomis&#xe9;es contr&#xf4;l&#xe9;es et m&#xe9;ta-analyses ont tent&#xe9; d&#x2019;aborder cette question. En 2022, des donn&#xe9;es probantes suppl&#xe9;mentaires provenant de trois nouvelles &#xe9;tudes ont &#xe9;t&#xe9; publi&#xe9;es : l&#x2019;&#xe9;tude GASS, l&#x2019;&#xe9;tude CANVAS II et les r&#xe9;sultats pr&#xe9;liminaires de l&#x2019;&#xe9;tude AMETIS, ce qui a motiv&#xe9; la r&#xe9;alisation de cette revue syst&#xe9;matique et m&#xe9;ta-analyse mises &#xe0; jour. L&#x2019;objectif principal de cette &#xe9;tude &#xe9;tait d&#x2019;&#xe9;valuer les effets de l&#x2019;anesth&#xe9;sie g&#xe9;n&#xe9;rale et de la s&#xe9;dation consciente sur les devenirs fonctionnels mesur&#xe9;s avec l&#x2019;&#xe9;chelle de Rankin modifi&#xe9;e (mRS) &#xe0; trois mois. M&#xe9;THODE: Nous avons r&#xe9;alis&#xe9; une revue syst&#xe9;matique avec m&#xe9;ta-analyse d&#x2019;&#xe9;tudes randomis&#xe9;es contr&#xf4;l&#xe9;es portant sur la s&#xe9;dation consciente et l&#x2019;anesth&#xe9;sie g&#xe9;n&#xe9;rale dans le traitement endovasculaire. Les bases de donn&#xe9;es suivantes ont &#xe9;t&#xe9; examin&#xe9;es : PubMed, Scopus, Embase et la base de donn&#xe9;es Cochrane des &#xe9;tudes randomis&#xe9;es contr&#xf4;l&#xe9;es et des revues syst&#xe9;matiques. L&#x2019;outil Risque de biais 2 a &#xe9;t&#xe9; utilis&#xe9; pour &#xe9;valuer le biais. De plus, une analyse s&#xe9;quentielle des &#xe9;tudes a &#xe9;t&#xe9; effectu&#xe9;e sur le crit&#xe8;re d&#x2019;&#xe9;valuation principal afin d&#x2019;estimer si l&#x2019;effet cumulatif &#xe9;tait suffisamment significatif pour ne pas &#xea;tre affect&#xe9; par d&#x2019;autres &#xe9;tudes. R&#xe9;SULTATS: Neuf &#xe9;tudes randomis&#xe9;es contr&#xf4;l&#xe9;es ont &#xe9;t&#xe9; identifi&#xe9;es, incluant 1342 patient&#xb7;es b&#xe9;n&#xe9;ficiant d&#x2019;un traitement endovasculaire pour un AVC. Aucune diff&#xe9;rence significative n&#x2019;a &#xe9;t&#xe9; d&#xe9;tect&#xe9;e entre l&#x2019;anesth&#xe9;sie g&#xe9;n&#xe9;rale et la s&#xe9;dation consciente en ce qui concerne la mRS, l&#x2019;ind&#xe9;pendance fonctionnelle (mRS, 0-2), la dur&#xe9;e de l&#x2019;intervention, le moment d&#x2019;apparition de la reperfusion, la mortalit&#xe9;, la dur&#xe9;e de s&#xe9;jour &#xe0; l&#x2019;h&#xf4;pital et la dur&#xe9;e de s&#xe9;jour en unit&#xe9; de soins intensifs. Les patient&#xb7;es trait&#xe9;&#xb7;es sous anesth&#xe9;sie g&#xe9;n&#xe9;rale pourraient avoir une reperfusion r&#xe9;ussie plus fr&#xe9;quente, bien que le temps entre l&#x2019;aine et la reperfusion &#xe9;tait l&#xe9;g&#xe8;rement plus long. L&#x2019;analyse s&#xe9;quentielle des &#xe9;tudes a montr&#xe9; qu&#x2019;il est peu probable que d&#x2019;autres &#xe9;tudes montrent des diff&#xe9;rences marqu&#xe9;es dans la mRS moyenne &#xe0; trois mois. CONCLUSION: Dans cette revue syst&#xe9;matique et m&#xe9;ta-analyse mises &#xe0; jour, le choix de la strat&#xe9;gie anesth&#xe9;sique pour le traitement endovasculaire des personnes victimes d&#x2019;un AVC n&#x2019;a pas eu d&#x2019;impact significatif sur les devenirs fonctionnels mesur&#xe9;s avec la mRS &#xe0; trois mois. La r&#xe9;ussite de la reperfusion pourrait &#xea;tre plus fr&#xe9;quente chez les patient&#xb7;es pris&#xb7;es en charge par anesth&#xe9;sie g&#xe9;n&#xe9;rale. ENREGISTREMENT DE L&#x2019;&#xe9;TUDE: PROSPERO (CRD42022319368); enregistr&#xe9;e le 19 avril 2022.</AbstractText><CopyrightInformation>&#xa9; 2023. Canadian Anesthesiologists' Society.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anesthesia</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">stroke</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>3</Day><Hour>11</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>2</Day><Hour>23</Hour><Minute>27</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37268801</ArticleId><ArticleId IdType="doi">10.1007/s12630-023-02481-8</ArticleId><ArticleId IdType="pii">10.1007/s12630-023-02481-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. Global health estimates: life expectancy and leading causes of death and disability, 2022. Available from URL: https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates (accessed December 2022).</Citation></Reference><Reference><Citation>Dornbos D 3<sup>rd</sup>, Arthur AS. Current state of the art in endovascular stroke treatment. Neurol Clin 2022; 40: 309&#x2013;19. https://doi.org/10.1016/j.ncl.2021.11.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2021.11.008</ArticleId><ArticleId IdType="pubmed">35465877</ArticleId></ArticleIdList></Reference><Reference><Citation>American Society of Anesthesiologists&#x2019;. Continuum of depth of sedation: definition of general anesthesia and levels of sedation/analgesia, 2019. Available from URL: https://www.asahq.org/standards-and-guidelines/continuum-of-depth-of-sedation-definition-of-general-anesthesia-and-levels-of-sedationanalgesia (accessed December 2022).</Citation></Reference><Reference><Citation>Bai X, Zhang X, Wang T, et al. General anesthesia versus conscious sedation for endovascular therapy in acute ischemic stroke: a systematic review and meta-analysis. J Clin Neurosci 2021; 86: 10&#x2013;7. https://doi.org/10.1016/j.jocn.2021.01.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2021.01.012</ArticleId><ArticleId IdType="pubmed">33775311</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell D, Diprose WK, Deng C, Barber PA. General anesthesia versus conscious sedation in endovascular thrombectomy for stroke: a meta-analysis of 4 randomized controlled trials. J Neurosurg Anesthesiol 2021; 33: 21&#x2013;7. https://doi.org/10.1097/ana.0000000000000646</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ana.0000000000000646</ArticleId><ArticleId IdType="pubmed">31567645</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xf6;nenberger S, Hend&#xe9;n PL, Simonsen CZ, et al. Association of general anesthesia vs procedural sedation with functional outcome among patients with acute ischemic stroke undergoing thrombectomy: a systematic review and meta-analysis. JAMA 2019; 322: 1283&#x2013;93. https://doi.org/10.1001/jama.2019.11455</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.11455</ArticleId><ArticleId IdType="pubmed">31573636</ArticleId><ArticleId IdType="pmc">6777267</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Jia L, Fang F, Ma L, Cai B, Faramand A. General anesthesia versus conscious sedation for intracranial mechanical thrombectomy: a systematic review and meta-analysis of randomized clinical trials. J Am Heart Assoc 2019; 8: e011754. https://doi.org/10.1161/jaha.118.011754</Citation></Reference><Reference><Citation>Lee CW, Chang YP, Huang YT, et al. General anesthesia but not conscious sedation improves functional outcome in patients receiving endovascular thrombectomy for acute ischemic stroke: a meta-analysis of randomized clinical trials and trial sequence analysis. Front Neurol 2022; 13: 1017098. https://doi.org/10.3389/fneur.2022.1017098</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.1017098</ArticleId><ArticleId IdType="pubmed">36188372</ArticleId><ArticleId IdType="pmc">9515609</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell D, Butler E, Barber PA. End the confusion: general anaesthesia improves patient outcomes in endovascular thrombectomy. Br J Anaesth 2022; 129: 461&#x2013;4. https://doi.org/10.1016/j.bja.2022.06.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2022.06.018</ArticleId><ArticleId IdType="pubmed">35868883</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurice A, Eug&#xe8;ne F, Ronzi&#xe8;re T, et al. General anesthesia versus sedation, both with hemodynamic control, during intraarterial treatment for stroke: the GASS randomized trial. Anesthesiology 2022; 136: 567&#x2013;76. https://doi.org/10.1097/aln.0000000000004142</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/aln.0000000000004142</ArticleId><ArticleId IdType="pubmed">35226737</ArticleId></ArticleIdList></Reference><Reference><Citation>Chabanne R, Geeraerts T, Begard M, et al. Procedural sedation versus general anesthesia in anterior circulation large vessel occlusion thrombectomy: the Anesthesia Management in Endovascular Therapy for Ischemic Stroke (AMETIS) randomized controlled trial (conference abstract). Eur Stroke J 2022; 7: 3&#x2013;545. https://doi.org/10.1177/23969873221087559</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/23969873221087559</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang F, Wu Y, Wang X, et al. General anesthesia vs conscious sedation for endovascular treatment in patients with posterior circulation acute ischemic stroke: an exploratory randomized clinical trial. JAMA Neurol 2022; e223018. https://doi.org/10.1001/jamaneurol.2022.3018</Citation></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009; 339: b2700. https://doi.org/10.1136/bmj.b2700</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2700</ArticleId><ArticleId IdType="pubmed">19622552</ArticleId><ArticleId IdType="pmc">2714672</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Savovi&#x107; J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019; 366: l4898. https://doi.org/10.1136/bmj.l4898</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l4898</ArticleId><ArticleId IdType="pubmed">31462531</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924&#x2013;6. https://doi.org/10.1136/bmj.39489.470347.ad</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.ad</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId><ArticleId IdType="pmc">2335261</ArticleId></ArticleIdList></Reference><Reference><Citation>Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005; 5: 13. https://doi.org/10.1186/1471-2288-5-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-5-13</ArticleId><ArticleId IdType="pubmed">15840177</ArticleId><ArticleId IdType="pmc">1097734</ArticleId></ArticleIdList></Reference><Reference><Citation>Cumpston M, Li T, Page MJ, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev 2019; 10: ED000142. https://doi.org/10.1002/14651858.ed000142</Citation></Reference><Reference><Citation>R&#xf6;ver C, Knapp G, Friede T. Hartung-Knapp-Sidik-Jonkman approach and its modification for random-effects meta-analysis with few studies. BMC Med Res Methodol 2015; 15: 99. https://doi.org/10.1186/s12874-015-0091-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-015-0091-1</ArticleId><ArticleId IdType="pubmed">26573817</ArticleId><ArticleId IdType="pmc">4647507</ArticleId></ArticleIdList></Reference><Reference><Citation>IntHout J, Ioannidis JP, Borm GF. The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method. BMC Med Res Methodol 2014; 14: 25. https://doi.org/10.1186/1471-2288-14-25</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-25</ArticleId><ArticleId IdType="pubmed">24548571</ArticleId><ArticleId IdType="pmc">4015721</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarzer G, Carpenter JR, Rucker G. Meta-Analysis with R, 1<sup>st</sup> ed. Cham: Springer International Publishing; 2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-21416-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Veroniki AA, Jackson D, Viechtbauer W, et al. Methods to estimate the between&#x2010;study variance and its uncertainty in meta&#x2010;analysis. Res Synth Methods 2016; 7: 55&#x2013;79. https://doi.org/10.1002/jrsm.1164</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.1164</ArticleId><ArticleId IdType="pubmed">26332144</ArticleId></ArticleIdList></Reference><Reference><Citation>De Cassai A, Pasin L, Boscolo A, Salvago M, Navalesi P. Trial sequential analysis: plain and simple. Korean J Anesthesiol 2021; 74: 363&#x2013;5. https://doi.org/10.4097/kja.20637</Citation><ArticleIdList><ArticleId IdType="doi">10.4097/kja.20637</ArticleId><ArticleId IdType="pubmed">33333708</ArticleId></ArticleIdList></Reference><Reference><Citation>Broderick JP, Adeoye O, Elm J. Evolution of the modified Rankin scale and its use in future stroke trials. Stroke 2017; 48: 2007&#x2013;12. https://doi.org/10.1161/strokeaha.117.017866</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/strokeaha.117.017866</ArticleId><ArticleId IdType="pubmed">28626052</ArticleId><ArticleId IdType="pmc">5552200</ArticleId></ArticleIdList></Reference><Reference><Citation>Bath PM, Lees KR, Schellinger PD, et al. Statistical analysis of the primary outcome in acute stroke trials. Stroke 2012; 43: 1171&#x2013;8. https://doi.org/10.1161/strokeaha.111.641456</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/strokeaha.111.641456</ArticleId><ArticleId IdType="pubmed">22426314</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;whagen Hend&#xe9;n P, Rentzos A, Karlsson JE, et al. General anesthesia versus conscious sedation for endovascular treatment of acute ischemic stroke: the AnStroke trial (anesthesia during stroke). Stroke 2017; 48: 1601&#x2013;7. https://doi.org/10.1161/strokeaha.117.016554</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/strokeaha.117.016554</ArticleId><ArticleId IdType="pubmed">28522637</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xf6;nenberger S, Uhlmann L, Hacke W, et al. Effect of conscious sedation vs general anesthesia on early neurological improvement among patients with ischemic stroke undergoing endovascular thrombectomy: a randomized clinical trial. JAMA 2016; 316: 1986&#x2013;96. https://doi.org/10.1001/jama.2016.16623</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.16623</ArticleId><ArticleId IdType="pubmed">27785516</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonsen CZ, Yoo AJ, S&#xf8;rensen LH, et al. Effect of general anesthesia and conscious sedation during endovascular therapy on infarct growth and clinical outcomes in acute ischemic stroke: a randomized clinical trial. JAMA Neurol 2018; 75: 470&#x2013;7. https://doi.org/10.1001/jamaneurol.2017.4474</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.4474</ArticleId><ArticleId IdType="pubmed">29340574</ArticleId><ArticleId IdType="pmc">5885172</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, Liang F, Wu Y, et al. Choice of Anesthesia for EndoVAScular treatment of acute ischemic stroke (CANVAS): results of the CANVAS pilot randomized controlled trial. J Neurosurg Anesthesiol 2020; 32: 41&#x2013;7. https://doi.org/10.1097/ana.0000000000000567</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ana.0000000000000567</ArticleId><ArticleId IdType="pubmed">30531556</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren C, Xu G, Liu Y, Liu G, Wang J, Gao J. Effect of conscious sedation vs. general anesthesia on outcomes in patients undergoing mechanical thrombectomy for acute ischemic stroke: a prospective randomized clinical trial. Front Neurol 2020; 11: 170. https://doi.org/10.3389/fneur.2020.00170</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00170</ArticleId><ArticleId IdType="pubmed">32265821</ArticleId><ArticleId IdType="pmc">7105779</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu G, Shi Z, Li B, Shao W, Xu B. General anesthesia versus monitored anesthesia care during endovascular therapy for vertebrobasilar stroke. Am J Transl Res 2021; 13: 1558&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">33841679</ArticleId><ArticleId IdType="pmc">8014376</ArticleId></ArticleIdList></Reference><Reference><Citation>Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2019; 50: e344&#x2013;418. https://doi.org/10.1161/str.0000000000000211</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/str.0000000000000211</ArticleId><ArticleId IdType="pubmed">31662037</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosello R, Riera R, Tosello G, et al. Type of anaesthesia for acute ischaemic stroke endovascular treatment. Cochrane Database Syst Rev 2022; 7: CD013690. https://doi.org/10.1002/14651858.cd013690.pub2</Citation></Reference><Reference><Citation>Brinjikji W, Murad MH, Rabinstein AA, Cloft HJ, Lanzino G, Kallmes DF. Conscious sedation versus general anesthesia during endovascular acute ischemic stroke treatment: a systematic review and meta-analysis. AJNR Am J Neuroradiol 2015; 36: 525&#x2013;9. https://doi.org/10.3174/ajnr.a4159</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.a4159</ArticleId><ArticleId IdType="pubmed">25395655</ArticleId><ArticleId IdType="pmc">8013063</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinjikji W, Pasternak J, Murad MH, et al. Anesthesia-related outcomes for endovascular stroke revascularization: a systematic review and meta-analysis. Stroke 2017; 48: 2784&#x2013;91. https://doi.org/10.1161/strokeaha.117.017786</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/strokeaha.117.017786</ArticleId><ArticleId IdType="pubmed">28904228</ArticleId></ArticleIdList></Reference><Reference><Citation>Butt W, Dhillon PS, Podlasek A, et al. Local anesthesia as a distinct comparator versus conscious sedation and general anesthesia in endovascular stroke treatment: a systematic review and meta-analysis. J Neurointerv Surg 2022; 14: 221&#x2013;6. https://doi.org/10.1136/neurintsurg-2021-017360</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/neurintsurg-2021-017360</ArticleId><ArticleId IdType="pubmed">33758063</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilyas A, Chen C-J, Ding D, et al. Endovascular mechanical thrombectomy for acute ischemic stroke under general anesthesia versus conscious sedation: a systematic review and meta-analysis. World Neurosurg 2018; 112: e355&#x2013;67. https://doi.org/10.1016/j.wneu.2018.01.049</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2018.01.049</ArticleId><ArticleId IdType="pubmed">29355808</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing R, Dai HJ, Lin F, Ge WY, Pan LH. Conscious sedation versus general anesthesia for patients with acute ischemic stroke undergoing endovascular therapy: a systematic review and meta-analysis. Biomed Res Int 2018; 2018: 1&#x2013;9. https://doi.org/10.1155/2018/2318489</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/2318489</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan TF, Zhang JR, Liu L. Effect of general anesthesia vs. conscious sedation on the outcomes of acute ischemic stroke patients after endovascular therapy: a meta-analysis of randomized clinical trials. Front Neurol 2019; 10: 1131. https://doi.org/10.3389/fneur.2019.01131</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.01131</ArticleId><ArticleId IdType="pubmed">31736853</ArticleId><ArticleId IdType="pmc">6834687</ArticleId></ArticleIdList></Reference><Reference><Citation>Gravel G, Boulouis G, Benhassen W, et al. Anaesthetic management during intracranial mechanical thrombectomy: systematic review and meta-analysis of current data. J Neurol Neurosurg Psychiatry 2019; 90: 68&#x2013;74. https://doi.org/10.1136/jnnp-2018-318549</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-318549</ArticleId><ArticleId IdType="pubmed">30257967</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim C, Kim SE, Jeon JP. Influence of anesthesia type on outcomes after endovascular treatment in acute ischemic stroke: meta-analysis. Neurointervention 2019; 14: 17&#x2013;26. https://doi.org/10.5469/neuroint.2019.00045</Citation><ArticleIdList><ArticleId IdType="doi">10.5469/neuroint.2019.00045</ArticleId><ArticleId IdType="pubmed">30827063</ArticleId><ArticleId IdType="pmc">6433186</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Hu Z, Li Q, et al. Anesthesia for endovascular treatment in anterior circulation stroke: a systematic review and meta-analysis. Brain Behav 2019; 9: e01178. https://doi.org/10.1002/brb3.1178</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.1178</ArticleId><ArticleId IdType="pubmed">30506982</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen H, Ma X, Wu Z, et al. Conscious sedation compared to general anesthesia for intracranial mechanical thrombectomy: a meta-analysis. Brain Behav 2021; 11: e02161. https://doi.org/10.1002/brb3.2161</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.2161</ArticleId><ArticleId IdType="pubmed">33960706</ArticleId><ArticleId IdType="pmc">8213640</ArticleId></ArticleIdList></Reference><Reference><Citation>Feil K, Herzberg M, Dorn F, et al. General anesthesia versus conscious sedation in mechanical thrombectomy. J Stroke 2021; 23: 103&#x2013;12. https://doi.org/10.5853/jos.2020.02404</Citation><ArticleIdList><ArticleId IdType="doi">10.5853/jos.2020.02404</ArticleId><ArticleId IdType="pubmed">33600707</ArticleId><ArticleId IdType="pmc">7900389</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappellari M, Pracucci G, Forlivesi S, et al. General anesthesia versus conscious sedation and local anesthesia during thrombectomy for acute ischemic stroke. Stroke 2020; 51: 2036&#x2013;44. https://doi.org/10.1161/strokeaha.120.028963</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/strokeaha.120.028963</ArticleId><ArticleId IdType="pubmed">32517584</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhillon PS, Butt W, Podlasek A, et al. Association between anesthesia modality and clinical outcomes following endovascular stroke treatment in the extended time window. J Neurointerv Surg 2022; https://doi.org/10.1136/neurintsurg-2022-018846</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/neurintsurg-2022-018846</ArticleId><ArticleId IdType="pubmed">35450928</ArticleId></ArticleIdList></Reference><Reference><Citation>Han H, Wang Y, Wang H, et al. General anesthesia vs. local anesthesia during endovascular treatment for acute large vessel occlusion: a propensity score-matched analysis. Front Neurol 2022; 12: 801024. https://doi.org/10.3389/fneur.2021.801024</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.801024</ArticleId><ArticleId IdType="pubmed">35237222</ArticleId><ArticleId IdType="pmc">8884159</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonsen CZ, Sch&#xf6;nenberger S, Hend&#xe9;n PL, et al. Patients requiring conversion to general anesthesia during endovascular therapy have worse outcomes: a post hoc analysis of data from the SAGA collaboration. AJNR Am J Neuroradiol 2020; 41: 2298&#x2013;302. https://doi.org/10.3174/ajnr.a6823</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.a6823</ArticleId><ArticleId IdType="pubmed">33093133</ArticleId><ArticleId IdType="pmc">7963249</ArticleId></ArticleIdList></Reference><Reference><Citation>Geraldini F, De Cassai A, Napoli M, et al. Risk factors for general anesthesia conversion in anterior circulation stroke patients undergoing endovascular treatment. Cerebrovasc Dis 2021; 51: 481&#x2013;7. https://doi.org/10.1159/000520929</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000520929</ArticleId><ArticleId IdType="pubmed">34965527</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M, Kronsteiner D, Pfaff JA, et al. Emergency intubation during thrombectomy for acute ischemic stroke in patients under primary procedural sedation. Neurol Res Pract 2021; 3: 27. https://doi.org/10.1186/s42466-021-00125-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42466-021-00125-0</ArticleId><ArticleId IdType="pubmed">34001285</ArticleId><ArticleId IdType="pmc">8130257</ArticleId></ArticleIdList></Reference><Reference><Citation>Manning NW, Warne CD, Meyers PM. Reperfusion and clinical outcomes in acute ischemic stroke: systematic review and meta-analysis of the Stent-retriever-based, early window endovascular stroke trials. Front Neurol 2018; 9: 301. https://doi.org/10.3389/fneur.2018.00301</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00301</ArticleId><ArticleId IdType="pubmed">29867718</ArticleId><ArticleId IdType="pmc">5968377</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SH, Kim BJ, Han MK, et al. Futile reperfusion and predicted therapeutic benefits after successful endovascular treatment according to initial stroke severity. BMC Neurol 2019; 19: 11. https://doi.org/10.1186/s12883-019-1237-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-019-1237-2</ArticleId><ArticleId IdType="pubmed">30646858</ArticleId><ArticleId IdType="pmc">6332890</ArticleId></ArticleIdList></Reference><Reference><Citation>Hindman BJ, Dexter F. Anesthetic management of emergency endovascular thrombectomy for acute ischemic stroke, part 2: integrating and applying observational reports and randomized clinical trials. Anesth Analg 2019; 128: 706&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000004045</ArticleId><ArticleId IdType="pubmed">30883416</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34955053</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1545-1550</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists</Title><ISOAbbreviation>J Endovasc Ther</ISOAbbreviation></Journal><ArticleTitle>Clinical Utility of Intravascular Ultrasound (IVUS) in Carotid Artery Interventions: A Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>678</StartPage><EndPage>691</EndPage><MedlinePgn>678-691</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/15266028211064824</ELocationID><Abstract><AbstractText Label="BACKGROUND">Carotid plaque morphology plays an important role in determining outcome of carotid artery stenting (CAS). Intravascular ultrasound (IVUS) and its extension VH (Virtual Histology)-IVUS evaluate plaque characteristics in real time and guide decision making during stenting. To date, there is no consensus about indications of IVUS and its validated methods. This systematic review and meta-analysis aims to evaluate the clinical utility of IVUS in carotid artery interventions (CAS) and develop a future consensus for research and practice parameters.</AbstractText><AbstractText Label="METHODS">A systematic review and meta-analysis was performed of the English literature articles published till February 2021. Studies reporting on IVUS parameters and findings and also its performance compared with other imaging modalities were included in review. Pooled prevalence with 95% confidence intervals (CI) was calculated. The statistical analysis was conducted in R version 3.6.2.</AbstractText><AbstractText Label="RESULTS">A total of 2015 patients from 29 studies were included. Proportional meta-analysis was performed on 1566 patients from 11 studies. In 9 studies, stroke/transient ischemic attack (TIA) had a pooled prevalence of 4% (95% CI 3%-5%) while asymptomatic stroke had a pooled prevalence of 46% (95% CI 31%-62%) in 4 studies following IVUS. Two studies reported that IVUS detected more plaque protrusion compared with angiography (n=33/396 vs 11/396). IVUS led to stent type or size change in 8 of 48 cases which were missed on angiography in 3 other studies. Concordance between VH-IVUS and true histology was good at 80% to 85% reported in 2 studies.</AbstractText><AbstractText Label="CONCLUSIONS">This systematic review and meta-analysis showed, though IVUS fared better to computed tomography (CT)/magnetic resonance (MR) angiography for better stent selection during CAS, with low to moderate risk of bias in the studies included. However, large scale, preferably randomized controlled studies are needed to predict its role in determining clinical outcome.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mishra</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pandit</LastName><ForeName>A K</ForeName><Initials>AK</Initials><Identifier Source="ORCID">0000-0003-2847-9730</Identifier><AffiliationInfo><Affiliation>Department of Neurology, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miyachi</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, Neuroendovascular Therapy Center, Aichi Medical University, Nagakute, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohshima</LastName><ForeName>T</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-4810-1703</Identifier><AffiliationInfo><Affiliation>Department of Neurological Surgery, Neuroendovascular Therapy Center, Aichi Medical University, Nagakute, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kawaguchi</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, Neuroendovascular Therapy Center, Aichi Medical University, Nagakute, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vishnu</LastName><ForeName>V Y</ForeName><Initials>VY</Initials><AffiliationInfo><Affiliation>Department of Neurology, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Misra</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Srivastava</LastName><ForeName>M V P</ForeName><Initials>MVP</Initials><AffiliationInfo><Affiliation>Department of Neurology, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Srivastava</LastName><ForeName>A K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Department of Neurology, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kale</LastName><ForeName>S S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phalak</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Endovasc Ther</MedlineTA><NlmUniqueID>100896915</NlmUniqueID><ISSNLinking>1526-6028</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002339" MajorTopicYN="N">Carotid Arteries</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016893" MajorTopicYN="Y">Carotid Stenosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018810" MajorTopicYN="N">Magnetic Resonance Angiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058226" MajorTopicYN="Y">Plaque, Atherosclerotic</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015607" MajorTopicYN="N">Stents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018084" MajorTopicYN="N">Ultrasonography, Interventional</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">IVUS</Keyword><Keyword MajorTopicYN="N">carotid stenting</Keyword><Keyword MajorTopicYN="N">clinical utility</Keyword><Keyword MajorTopicYN="N">intravascular ultrasound</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>27</Day><Hour>5</Hour><Minute>29</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34955053</ArticleId><ArticleId IdType="doi">10.1177/15266028211064824</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37085013</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>25</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1615-5947</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Annals of vascular surgery</Title><ISOAbbreviation>Ann Vasc Surg</ISOAbbreviation></Journal><ArticleTitle>Cervical Debranching: Regional versus General Anesthesia for Carotid-Subclavian Bypass. A Single Center Experience.</ArticleTitle><Pagination><StartPage>132</StartPage><EndPage>139</EndPage><MedlinePgn>132-139</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.avsg.2023.04.009</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0890-5096(23)00230-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">We report here the first cohort study comparing regional and general anaesthesia for left subclavian artery (LSA) revascularization.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A single-centre retrospective cohort study was performed, including all consecutive patients who underwent cervical debranching with carotid-subclavian bypass before aortic repair from February 2018 to May 2022. Patients were divided into 2 groups according to the type of anesthesia: Regional anesthesia (RA) versus general anesthesia (GA). Primary endpoints included the following: 1) technical success of RA and 2) neurological complications (NCs) (stroke and peripheral neurological lesions). Secondary endpoints included postoperative bleeding, wound complications, 30-day reintervention rate, and midterm events.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eighty-three patients were included in the study. The mean age was 64&#xa0;years (interquartile range [IQR]:13.5) and 69% were male. Thirty-seven patients (44.5%) were performed under RA. Technical success of RA was 89.2%. Two minor strokes (2.4%) were observed in the GA group (P&#xa0;=&#xa0;0.199). Peripheral neurological disorders occurred in 4 patients (4.8%) (RA group n&#xa0;=&#xa0;1 (2.7%), GA group n&#xa0;=&#xa0;3 (6.5%), P&#xa0;=&#xa0;0.491). 30-day complication rate was 27.7% (n&#xa0;=&#xa0;23, GA: n&#xa0;=&#xa0;15 (32.6%), RA: n&#xa0;=&#xa0;8 (21.6%), P&#xa0;=&#xa0;0.266). 30-day reintervention rate was 14.5% (n&#xa0;=&#xa0;12) ten bleeding complications (12%) (RA group n&#xa0;=&#xa0;3 (8.1%), GA group n&#xa0;=&#xa0;7 (15.2%), P&#xa0;=&#xa0;0.323), and 2 seroma evacuations (2.4%) in the RA group. The incidence of superficial wound infections was n&#xa0;=&#xa0;6 (7.2%) (RA group n&#xa0;=&#xa0;2 (5.4%), GA group n&#xa0;=&#xa0;4 (8.7%), P&#xa0;=&#xa0;0.565). Median follow-up time was 22&#xa0;months (IQR 22&#xa0;min/max 1-44).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In our cohort, RA for carotid subclavian bypass surgery proved to be a feasible and effective anesthetic procedure compared with GA.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mehmedovic</LastName><ForeName>Aldin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Vascular Surgery Department, Ludwig Maximilian University Hospital, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsilimparis</LastName><ForeName>Nikolaos</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Vascular Surgery Department, Ludwig Maximilian University Hospital, Munich, Germany. Electronic address: Nikolaos.Tsilimparis@med.uni-muenchen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stavroulakis</LastName><ForeName>Konstantinos</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Vascular Surgery Department, Ludwig Maximilian University Hospital, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rantner</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Vascular Surgery Department, Ludwig Maximilian University Hospital, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernandez Prendes</LastName><ForeName>Carlota</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Vascular Surgery Department, Ludwig Maximilian University Hospital, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gouveia E Melo</LastName><ForeName>Ryan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Vascular Surgery Department, Ludwig Maximilian University Hospital, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abicht</LastName><ForeName>Jan-Michael</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Anesthesiology Department, Ludwig Maximilian University Hospital, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stana</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Vascular Surgery Department, Ludwig Maximilian University Hospital, Munich, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Ann Vasc Surg</MedlineTA><NlmUniqueID>8703941</NlmUniqueID><ISSNLinking>0890-5096</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019651" MajorTopicYN="Y">Plastic Surgery Procedures</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>22</Day><Hour>10</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>21</Day><Hour>19</Hour><Minute>29</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37085013</ArticleId><ArticleId IdType="doi">10.1016/j.avsg.2023.04.009</ArticleId><ArticleId IdType="pii">S0890-5096(23)00230-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38472159</PMID><DateCompleted><Year>2025</Year><Month>02</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1477-111X</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>2</Issue><PubDate><Year>2025</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Perfusion</Title><ISOAbbreviation>Perfusion</ISOAbbreviation></Journal><ArticleTitle>Meta-analysis of central and peripheral cannulation for type A aortic dissection.</ArticleTitle><Pagination><StartPage>417</StartPage><EndPage>430</EndPage><MedlinePgn>417-430</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/02676591241238865</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute type A aortic dissection necessitates rapid and effective arterial cannulation techniques for optimal outcomes. This meta-analysis compares the safety and effectiveness of direct aortic cannulation (AoC) with peripheral cannulation (PC) via the femoral or axillary arteries in aortic surgery for acute type A aortic dissection.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review following PRISMA guidelines identified 10 retrospective studies encompassing 2518 patients (961 AoC, 1557 PC). Pooled odds ratios (OR) with 95% confidence intervals (CI) were calculated to analyze perioperative characteristics, short-term mortality rates, and postoperative complications including stroke and acute kidney injury.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Short-term mortality did not significantly differ between AoC and PC (OR [95% CI] = 0.78 [0.61-1.01], <i>p</i> = .06). Likewise, postoperative stroke (OR [95% CI] = 0.86 [0.63-1.17], <i>p</i> = .33) nor acute kidney injury (OR [95% CI] = 1.11 [0.89-1.37], <i>p</i> = .35) showed no significant differences. AoC exhibited shorter operation time whereas there were no significant differences in aortic cross clamp time and cardiopulmonary bypass time between both groups. Our meta-regression analysis, considering the distal extent of aortic replacement, indicated that variations in aortic replacement rates did not significantly impact the observed outcomes.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">AoC is a viable alternative to PC for acute type A aortic dissection. While both approaches offer comparable outcomes, AoC's advantage in shorter operation time warrants thoughtful consideration in clinical practice.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Naito</LastName><ForeName>Noritsugu</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-1789-5993</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Shizuoka Medical Center, Shizuoka, Japan.</Affiliation><Identifier Source="RINGGOLD">26357</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takagi</LastName><ForeName>Hisato</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Shizuoka Medical Center, Shizuoka, Japan.</Affiliation><Identifier Source="RINGGOLD">26357</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Perfusion</MedlineTA><NlmUniqueID>8700166</NlmUniqueID><ISSNLinking>0267-6591</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000784" MajorTopicYN="Y">Aortic Dissection</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002406" MajorTopicYN="Y">Catheterization, Peripheral</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002404" MajorTopicYN="Y">Catheterization</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001014" MajorTopicYN="Y">Aortic Aneurysm</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute aortic dissection</Keyword><Keyword MajorTopicYN="N">aortic cannulation</Keyword><Keyword MajorTopicYN="N">peripheral cannulation</Keyword><Keyword MajorTopicYN="N">surgical technique</Keyword></KeywordList><CoiStatement>Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>13</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38472159</ArticleId><ArticleId IdType="doi">10.1177/02676591241238865</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31281922</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2020</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1532-2092</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>10</Issue><PubDate><Year>2019</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology</Title><ISOAbbreviation>Europace</ISOAbbreviation></Journal><ArticleTitle>Sex-related differences in catheter ablation of atrial fibrillation: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1509</StartPage><EndPage>1518</EndPage><MedlinePgn>1509-1518</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/europace/euz179</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">The sex-related differences in the clinical outcomes of rhythm and safety after catheter ablation remain unclear. The purpose of this study was to compare the clinical outcomes of catheter ablation for atrial fibrillation (AF) in women and men.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">The Medline and EMBASE databases were searched for published articles up to December 2018. Studies that met our predefined inclusion criteria were included. The primary endpoints were freedom from AF/atrial tachycardia (AT) recurrence, stroke/transient ischaemic attack (TIA), and all-cause mortality. After literature search and detailed assessment, 19 observational studies (151&#xa0;370 patients; 34% women) were identified. Our analyses showed that the rate of freedom from AF/AT recurrence was lower in women than men at the 2.4-year follow-up [odds ratio (OR): 0.75, 95% confidence interval (CI) 0.69-0.81; P&#x2009;&lt;&#x2009;0.0001]. Moreover, women had an increased risk of stroke/TIA (OR: 1.42, 95% CI 1.21-1.67; P&#x2009;&lt;&#x2009;0.0001) and all-cause mortality (OR: 1.53, 95% CI 1.02-2.28; P&#x2009;=&#x2009;0.04). Nevertheless, for the endpoint of all-cause mortality, there was no significant difference between the two genders in the subgroup of prospective studies (OR: 1.19, 95% CI 0.69-2.05; P&#x2009;=&#x2009;0.53). Additionally, women were more likely to experience major complications compared with men (pericardial effusion/tamponade, major bleeding requiring transfusion, and pacemaker implantation).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Women who underwent catheter ablation of AF might experience lower efficacy and a higher risk of stroke/TIA and major complications than men. The reasons for these sex-related differences need to be further studied.</AbstractText><CopyrightInformation>Published on behalf of the European Society of Cardiology. All rights reserved. &#xa9; The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Xiaocheng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, 1 Youyi Rd, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Qiongwen</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Chongqing General Hospital, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, 1 Youyi Rd, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, 1 Youyi Rd, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Shu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, 1 Youyi Rd, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Dongying</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, 1 Youyi Rd, Chongqing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Europace</MedlineTA><NlmUniqueID>100883649</NlmUniqueID><ISSNLinking>1099-5129</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="N">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Atrial fibrillation</Keyword><Keyword MajorTopicYN="N">Catheter ablation</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Sex</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31281922</ArticleId><ArticleId IdType="doi">10.1093/europace/euz179</ArticleId><ArticleId IdType="pii">5529272</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31154101</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>20</Day></DateCompleted><DateRevised><Year>2020</Year><Month>01</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-8769</ISSN><JournalIssue CitedMedium="Internet"><Volume>129</Volume><PubDate><Year>2019</Year><Month>Sep</Month></PubDate></JournalIssue><Title>World neurosurgery</Title><ISOAbbreviation>World Neurosurg</ISOAbbreviation></Journal><ArticleTitle>Role of Preoperative Embolization in Carotid Body Tumor Surgery: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>503</StartPage><EndPage>513.e2</EndPage><MedlinePgn>503-513.e2</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2019.05.209</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1878-8750(19)31486-X</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Carotid body tumors (CBTs) are highly vascularized tumors which can render tumor resection surgery challenging. There is evidence suggesting that preoperative selective embolization can reduce blood loss during surgery and decrease the risk of perioperative complications; however, recent reports have questioned the benefits that preoperative embolization provides. The objective of this study is to investigate the impact of preoperative embolization on CBT surgical resection.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This study was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Eligible studies were identified through a search of PubMed, Scopus, and Cochrane Central Register of Controlled Trials until March 2019. A random effects model meta-analysis was conducted, and the I<sup>2</sup> statistic was used to assess for heterogeneity.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-five studies comprising 1326 patients were included. Patients who received preoperative embolization had statistically significant lower intraoperative blood loss (weighted mean difference [WMD],&#xa0;-135.32; 95% confidence interval [CI],&#xa0;-224.58 to&#xa0;-46.06; I<sup>2</sup>&#xa0;= 78.6%). Duration of the procedure was statistically significantly shorter in the preembolization group than the nonembolization group (WMD,&#xa0;-38.61; 95% CI,&#xa0;-65.61 to&#xa0;-11.62; I<sup>2</sup>&#xa0;= 71.9%). There were no differences in the rates of cranial nerve (CN) injuries (odds ratio [OR], 1.13; 95% CI, 0.68-1.86; I<sup>2</sup>&#xa0;= 12.9%), stroke (OR, 1.75; 95% CI, 0.70-4.36; I<sup>2</sup>&#xa0;= 0%), transient ischemic attacks (TIAs) (OR, 0.55; 95% CI, 0.11-2.65; I<sup>2</sup>&#xa0;= 0%), or length of stay (WMD, 0.32; 95% CI,&#xa0;-1.35 to 1.98; I<sup>2</sup>&#xa0;= 96.4%) between the 2 groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Patients who received embolization prior to CBT resection had statistically significant lower blood loss and shorter duration of operation. The rates of CN palsy, stroke, TIA, and length of stay were similar between patients who had preoperative embolization and those who did not.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Texakalidis</LastName><ForeName>Pavlos</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia, USA. Electronic address: Pavlos.texakalidis@emory.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Charisis</LastName><ForeName>Nektarios</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Surgery, Stony Brook University, Long Island, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giannopoulos</LastName><ForeName>Stefanos</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, 251 Helenic Airforce Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xenos</LastName><ForeName>Dimitrios</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rangel-Castilla</LastName><ForeName>Leonardo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tassiopoulos</LastName><ForeName>Apostolos K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Department of Surgery, Stony Brook University, Long Island, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jabbour</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grossberg</LastName><ForeName>Jonathan A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Machinis</LastName><ForeName>Theofilos</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Virginia Commonwealth University, Richmond, Virginia, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>05</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>World Neurosurg</MedlineTA><NlmUniqueID>101528275</NlmUniqueID><ISSNLinking>1878-8750</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002345" MajorTopicYN="N">Carotid Body Tumor</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004621" MajorTopicYN="N">Embolization, Therapeutic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011300" MajorTopicYN="N">Preoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Carotid body tumor</Keyword><Keyword MajorTopicYN="N">Embolization</Keyword><Keyword MajorTopicYN="N">Paraganglioma</Keyword><Keyword MajorTopicYN="N">Resection</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31154101</ArticleId><ArticleId IdType="doi">10.1016/j.wneu.2019.05.209</ArticleId><ArticleId IdType="pii">S1878-8750(19)31486-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25888937</PMID><DateCompleted><Year>2016</Year><Month>02</Month><Day>01</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2047-783X</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2015</Year><Month>Mar</Month><Day>15</Day></PubDate></JournalIssue><Title>European journal of medical research</Title><ISOAbbreviation>Eur J Med Res</ISOAbbreviation></Journal><ArticleTitle>Thoracic epidural anesthesia improves outcomes in patients undergoing cardiac surgery: meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>25</StartPage><MedlinePgn>25</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">25</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40001-015-0091-y</ELocationID><Abstract><AbstractText>To assess the efficacy of thoracic epidural anesthesia (TEA) with or without general anesthesia (GA) versus GA in patients who underwent cardiac surgery, PubMed, Embase, the Cochrane online database, and Web of Science were searched with the limit of randomized controlled trials (RCTs) relevant to 'thoracic epidural anesthesia' and 'cardiac surgery'. Studies were identified and data were extracted by two reviewers independently. The quality of included studies was also assessed according to the Cochrane handbook. Outcomes of mortality, cardiac and respiratory functions, and treatment-associated complications were pooled and analyzed. The comprehensive search yielded 2,230 citations, and 25 of them enrolling 3,062 participants were included according to the inclusion criteria. Compared with GA alone, patients received TEA and GA showed reduced risks of death, myocardial infarction, and stroke, though there were no significant differences (P &gt; 0.05). With regard to treatment-related complications, the pooled results for respiratory complications (risk ratio (RR), 0.69; 95% CI: 0.51, 0.91, P &lt; 0.05), supraventricular arrhythmias (RR, 0.61; 95% CI: 0.42, 0.87, P &lt; 0.05), and pain (mean difference (MD), -1.27; 95% CI: -2.20, -0.35, P &lt; 0.05) were 0.69, 0.61, and -1.27, respectively. TEA was also associated with significant reduction of stays in intensive care unit (MD, -2.36; 95% CI: -4.20, -0.52, P &lt; 0.05) and hospital (MD, -1.51; 95% CI: -3.03, 0.02, P &gt; 0.05) and time to tracheal extubation (MD, -2.06; 95% CI:-2.68, -1.45, P &lt; 0.05). TEA could reduce the risk of complications such as supraventricular arrhythmias, stays in hospital or intensive care unit, and time to tracheal extubation in patients who experienced cardiac surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Shengsuo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of anesthesiology, General Hospital of Beijing military region PLA, Beijing, 100010, China. bzmzk@sohu.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xinmin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of anesthesiology, The First Hospital, Peking University, Beijing, 100034, China. zhangshengsuomed@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Hang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of anesthesiology, General Hospital of Beijing military region PLA, Beijing, 100010, China. gh-wyb@126.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of anesthesiology, General Hospital of Beijing military region PLA, Beijing, 100010, China. acellor@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>03</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Med Res</MedlineTA><NlmUniqueID>9517857</NlmUniqueID><ISSNLinking>0949-2321</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000767" MajorTopicYN="N">Anesthesia, Epidural</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="Y">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019616" MajorTopicYN="N">Thoracic Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013904" MajorTopicYN="Y">Thoracic Vertebrae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>1</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>3</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25888937</ArticleId><ArticleId IdType="pmc">PMC4375848</ArticleId><ArticleId IdType="doi">10.1186/s40001-015-0091-y</ArticleId><ArticleId IdType="pii">10.1186/s40001-015-0091-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yegin A, Erdogan A, Kayacan N, Karsli B. Early postoperative pain management after thoracic surgery; pre- and postoperative versus postoperative epidural analgesia: a randomised study. Eur J Cardiothorac Surg. 2003;24:420&#x2013;4. doi: 10.1016/S1010-7940(03)00345-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1010-7940(03)00345-2</ArticleId><ArticleId IdType="pubmed">12965314</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemmerling TM, Romano G, Terrasini N, Noiseux N. Anesthesia for off-pump coronary artery bypass surgery. Ann Card Anaesth. 2013;16:28&#x2013;39. doi: 10.4103/0971-9784.105367.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0971-9784.105367</ArticleId><ArticleId IdType="pubmed">23287083</ArticleId></ArticleIdList></Reference><Reference><Citation>Coriat P, Beaussier M. Fast-tracking after coronary artery bypass graft surgery. Anesth Analg. 2001;92:1081&#x2013;3. doi: 10.1097/00000539-200105000-00001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000539-200105000-00001</ArticleId><ArticleId IdType="pubmed">11323325</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirno K, Friberg P, Grzegorczyk A, Milocco I, Ricksten SE, Lundin S. Thoracic epidural anesthesia during coronary artery bypass surgery: effects on cardiac sympathetic activity, myocardial blood flow and metabolism, and central hemodynamics. Anesth Analg. 1994;79:1075&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">7978429</ArticleId></ArticleIdList></Reference><Reference><Citation>Nygard E, Kofoed KF, Freiberg J, Holm S, Aldershvile J, Eliasen K, et al. Effects of high thoracic epidural analgesia on myocardial blood flow in patients with ischemic heart disease. Circulation. 2005;111:2165&#x2013;70. doi: 10.1161/01.CIR.0000163551.33812.1A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000163551.33812.1A</ArticleId><ArticleId IdType="pubmed">15851604</ArticleId></ArticleIdList></Reference><Reference><Citation>Loick HM, Schmidt C, Van Aken H, Junker R, Erren M, Berendes E, et al. High thoracic epidural anesthesia, but not clonidine, attenuates the perioperative stress response via sympatholysis and reduces the release of troponin T in patients undergoing coronary artery bypass grafting. Anesth Analg. 1999;88:701&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10195508</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballantyne JC, Carr DB, de Ferranti S, Suarez T, Lau J, Chalmers TC, et al. The comparative effects of postoperative analgesic therapies on pulmonary outcome: cumulative meta-analyses of randomized, controlled trials. Anesth Analg. 1998;86:598&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pubmed">9495424</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunt SA. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) J Am Coll Cardiol. 2005;46:e1&#x2013;82. doi: 10.1016/j.jacc.2005.08.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2005.08.022</ArticleId><ArticleId IdType="pubmed">16168273</ArticleId></ArticleIdList></Reference><Reference><Citation>Beattie WS, Badner NH, Choi P. Epidural analgesia reduces postoperative myocardial infarction: a meta-analysis. Anesth Analg. 2001;93:853&#x2013;8. doi: 10.1097/00000539-200110000-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000539-200110000-00010</ArticleId><ArticleId IdType="pubmed">11574345</ArticleId></ArticleIdList></Reference><Reference><Citation>Unic-Stojanovic D, Babic S, Jovic M. Benefits, risks and complications of perioperative use of epidural anesthesia. Med Arh. 2012;66:340&#x2013;3. doi: 10.5455/medarh.2012.66.340-343.</Citation><ArticleIdList><ArticleId IdType="doi">10.5455/medarh.2012.66.340-343</ArticleId><ArticleId IdType="pubmed">23097975</ArticleId></ArticleIdList></Reference><Reference><Citation>Freise H, Van Aken HK. Risks and benefits of thoracic epidural anaesthesia. Br J Anaesth. 2011;107:859&#x2013;68. doi: 10.1093/bja/aer339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aer339</ArticleId><ArticleId IdType="pubmed">22058144</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarci M, Joshi A, Attia R. In patients undergoing thoracic surgery is paravertebral block as effective as epidural analgesia for pain management? Interact Cardiovasc Thorac Surg. 2010;10:92&#x2013;6. doi: 10.1510/icvts.2009.221127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1510/icvts.2009.221127</ArticleId><ArticleId IdType="pubmed">19854794</ArticleId></ArticleIdList></Reference><Reference><Citation>Beattie WS, Badner NH, Choi PT. Meta-analysis demonstrates statistically significant reduction in postoperative myocardial infarction with the use of thoracic epidural analgesia. Anesth Analg. 2003;97:919&#x2013;20. doi: 10.1213/01.ANE.0000074660.05733.10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ANE.0000074660.05733.10</ArticleId><ArticleId IdType="pubmed">12933434</ArticleId></ArticleIdList></Reference><Reference><Citation>Svircevic V, van Dijk D, Nierich AP, Passier MP, Kalkman CJ, van der Heijden GJ, et al. Meta-analysis of thoracic epidural anesthesia versus general anesthesia for cardiac surgery. Anesthesiology. 2011;114:271&#x2013;82. doi: 10.1097/ALN.0b013e318201d300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e318201d300</ArticleId><ArticleId IdType="pubmed">21239975</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowalewski R, Seal D, Tang T, Prusinkiewicz C, Ha D. Neuraxial anesthesia for cardiac surgery: thoracic epidural and high spinal anesthesia - why is it different? HSR Proc Intensive Care Cardiovasc Anesth. 2011;3:25&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3484610</ArticleId><ArticleId IdType="pubmed">23440039</ArticleId></ArticleIdList></Reference><Reference><Citation>Hett DA. Anaesthesia for off-pump coronary artery surgery. Contin Educ Anaesth Crit Care Pain. 2006;6:60&#x2013;2. doi: 10.1093/bjaceaccp/mkl005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bjaceaccp/mkl005</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemmerling TM, Cyr S, Terrasini N. Epidural catheterization in cardiac surgery: the 2012 risk assessment. Ann Card Anaesth. 2013;16:169&#x2013;77. doi: 10.4103/0971-9784.114237.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0971-9784.114237</ArticleId><ArticleId IdType="pubmed">23816670</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho AM, Chung DC, Joynt GM. Neuraxial blockade and hematoma in cardiac surgery: estimating the risk of a rare adverse event that has not (yet) occurred. Chest. 2000;117:551&#x2013;5. doi: 10.1378/chest.117.2.551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.117.2.551</ArticleId><ArticleId IdType="pubmed">10669702</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu SS, Block BM, Wu CL. Effects of perioperative central neuraxial analgesia on outcome after coronary artery bypass surgery: a meta-analysis. Anesthesiology. 2004;101:153&#x2013;61. doi: 10.1097/00000542-200407000-00024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200407000-00024</ArticleId><ArticleId IdType="pubmed">15220785</ArticleId></ArticleIdList></Reference><Reference><Citation>Bignami E, Landoni G, Biondi-Zoccai GG, Boroli F, Messina M, Dedola E, et al. Epidural analgesia improves outcome in cardiac surgery: a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth. 2010;24:586&#x2013;97. doi: 10.1053/j.jvca.2009.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2009.09.015</ArticleId><ArticleId IdType="pubmed">20005129</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1. 0 [updated March 2011]. The Cochrane Collaboration. 2011. www.cochrane-handbook.org, 2014.</Citation></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557&#x2013;60. doi: 10.1136/bmj.327.7414.557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Armitage P, Berry G, Matthews JNS. Statistical methods in medical research. Hoboken, New Jersey: John Wiley &amp; Sons; 2008.</Citation></Reference><Reference><Citation>Bach F, Grundmann U, Bauer M, Buchinger H, Soltesz S, Graeter T, et al. Modulation of the inflammatory response to cardiopulmonary bypass by dopexamine and epidural anesthesia. Acta Anaesthesiol Scand. 2002;46:1227&#x2013;35. doi: 10.1034/j.1399-6576.2002.461010.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1399-6576.2002.461010.x</ArticleId><ArticleId IdType="pubmed">12421195</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakhtiary F, Therapidis P, Dzemali O, Ak K, Ackermann H, Meininger D, et al. Impact of high thoracic epidural anesthesia on incidence of perioperative atrial fibrillation in off-pump coronary bypass grafting: a prospective randomized study. J Thorac Cardiovasc Surg. 2007;134:460&#x2013;4. doi: 10.1016/j.jtcvs.2007.03.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2007.03.043</ArticleId><ArticleId IdType="pubmed">17662790</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrington MJ, Kluger R, Watson R, Scott DA, Harris KJ. Epidural anesthesia for coronary artery bypass surgery compared with general anesthesia alone does not reduce biochemical markers of myocardial damage. Anesth Analg. 2005;100:921&#x2013;8. doi: 10.1213/01.ANE.0000146437.88485.47.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ANE.0000146437.88485.47</ArticleId><ArticleId IdType="pubmed">15781499</ArticleId></ArticleIdList></Reference><Reference><Citation>Berendes E, Schmidt C, Van Aken H, Hartlage MG, Wirtz S, Reinecke H, et al. Reversible cardiac sympathectomy by high thoracic epidural anesthesia improves regional left ventricular function in patients undergoing coronary artery bypass grafting: a randomized trial. Arch Surg. 2003;138:1283&#x2013;90. doi: 10.1001/archsurg.138.12.1283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.138.12.1283</ArticleId><ArticleId IdType="pubmed">14662525</ArticleId></ArticleIdList></Reference><Reference><Citation>Caputo M, Alwair H, Rogers CA, Ginty M, Monk C, Tomkins S, et al. Myocardial, inflammatory, and stress responses in off-pump coronary artery bypass graft surgery with thoracic epidural anesthesia. Ann Thorac Surg. 2009;87:1119&#x2013;26. doi: 10.1016/j.athoracsur.2008.12.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2008.12.047</ArticleId><ArticleId IdType="pubmed">19324137</ArticleId></ArticleIdList></Reference><Reference><Citation>Caputo M, Alwair H, Rogers CA, Pike K, Cohen A, Monk C, et al. Thoracic epidural anesthesia improves early outcomes in patients undergoing off-pump coronary artery bypass surgery: a prospective, randomized, controlled trial. Anesthesiology. 2011;114:380&#x2013;90. doi: 10.1097/ALN.0b013e318201f571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e318201f571</ArticleId><ArticleId IdType="pubmed">21245735</ArticleId></ArticleIdList></Reference><Reference><Citation>de Vries AJ, Mariani MA, van der Maaten JM, Loef BG, Lip H. To ventilate or not after minimally invasive direct coronary artery bypass surgery: the role of epidural anesthesia. J Cardiothorac Vasc Anesth. 2002;16:21&#x2013;6. doi: 10.1053/jcan.2002.29645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/jcan.2002.29645</ArticleId><ArticleId IdType="pubmed">11854873</ArticleId></ArticleIdList></Reference><Reference><Citation>Fillinger MP, Yeager MP, Dodds TM, Fillinger MF, Whalen PK, Glass DD. Epidural anesthesia and analgesia: effects on recovery from cardiac surgery. J Cardiothorac Vasc Anesth. 2002;16:15&#x2013;20. doi: 10.1053/jcan.2002.29639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/jcan.2002.29639</ArticleId><ArticleId IdType="pubmed">11854872</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansdottir V, Philip J, Olsen MF, Eduard C, Houltz E, Ricksten SE. Thoracic epidural versus intravenous patient-controlled analgesia after cardiac surgery: a randomized controlled trial on length of hospital stay and patient-perceived quality of recovery. Anesthesiology. 2006;104:142&#x2013;51. doi: 10.1097/00000542-200601000-00020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200601000-00020</ArticleId><ArticleId IdType="pubmed">16394700</ArticleId></ArticleIdList></Reference><Reference><Citation>Heijmans J, Fransen E, Buurman W, Maessen J, Roekaerts P. Comparison of the modulatory effects of four different fast-track anesthetic techniques on the inflammatory response to cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2007;21:512&#x2013;8. doi: 10.1053/j.jvca.2007.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2007.02.008</ArticleId><ArticleId IdType="pubmed">17678776</ArticleId></ArticleIdList></Reference><Reference><Citation>Kendall JB, Russell GN, Scawn ND, Akrofi M, Cowan CM, Fox MA. A prospective, randomised, single-blind pilot study to determine the effect of anaesthetic technique on troponin T release after off-pump coronary artery surgery. Anaesthesia. 2004;59:545&#x2013;9. doi: 10.1111/j.1365-2044.2004.03713.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.2004.03713.x</ArticleId><ArticleId IdType="pubmed">15144293</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagunilla J, Garcia-Bengochea JB, Fernandez AL, Alvarez J, Rubio J, Rodriguez J, et al. High thoracic epidural blockade increases myocardial oxygen availability in coronary surgery patients. Acta Anaesthesiol Scand. 2006;50:780&#x2013;6. doi: 10.1111/j.1399-6576.2006.01059.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-6576.2006.01059.x</ArticleId><ArticleId IdType="pubmed">16879458</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundstrom LH, Nygard E, Hviid LB, Pedersen FM, Ravn J, Aldershvile J, et al. The effect of thoracic epidural analgesia on the occurrence of late postoperative hypoxemia in patients undergoing elective coronary bypass surgery: a randomized controlled trial. Chest. 2005;128:1564&#x2013;70. doi: 10.1378/chest.128.3.1564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.128.3.1564</ArticleId><ArticleId IdType="pubmed">16162759</ArticleId></ArticleIdList></Reference><Reference><Citation>Nygard E, Sorensen LH, Hviid LB, Pedersen FM, Ravn J, Thomassen L, et al. Effects of amiodarone and thoracic epidural analgesia on atrial fibrillation after coronary artery bypass grafting. J Cardiothorac Vasc Anesth. 2004;18:709&#x2013;14. doi: 10.1053/j.jvca.2004.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2004.08.006</ArticleId><ArticleId IdType="pubmed">15650978</ArticleId></ArticleIdList></Reference><Reference><Citation>Onan IS, Onan B, Korkmaz AA, Oklu L, Kilickan L, Gonca S, et al. Effects of thoracic epidural anesthesia on flow and endothelium of internal thoracic artery in coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2011;25:1063&#x2013;70. doi: 10.1053/j.jvca.2011.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2011.06.004</ArticleId><ArticleId IdType="pubmed">21835638</ArticleId></ArticleIdList></Reference><Reference><Citation>Priestley MC, Cope L, Halliwell R, Gibson P, Chard RB, Skinner M, et al. Thoracic epidural anesthesia for cardiac surgery: the effects on tracheal intubation time and length of hospital stay. Anesth Analg. 2002;94:275&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">11812684</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott NB, Turfrey DJ, Ray DA, Nzewi O, Sutcliffe NP, Lal AB, et al. A prospective randomized study of the potential benefits of thoracic epidural anesthesia and analgesia in patients undergoing coronary artery bypass grafting. Anesth Analg. 2001;93:528&#x2013;35. doi: 10.1097/00000539-200109000-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000539-200109000-00003</ArticleId><ArticleId IdType="pubmed">11524314</ArticleId></ArticleIdList></Reference><Reference><Citation>Svircevic V, Nierich AP, Moons KG, Diephuis JC, Ennema JJ, Brandon Bravo Bruinsma GJ, et al. Thoracic epidural anesthesia for cardiac surgery: a randomized trial. Anesthesiology. 2011;114:262&#x2013;70. doi: 10.1097/ALN.0b013e318201d2de.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e318201d2de</ArticleId><ArticleId IdType="pubmed">21239976</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilickan L, Gonca S, Dalcik C, Dalcik H, Solak M, Bayindir O, et al. General anesthesia with thoracic epidural anesthesia in the cardiopulmonary bypass surgery reduces apoptosis by upregulating antiapoptotic protein Bcl-2. J Cardiovasc Surg (Torino). 2006;47:315&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">16760868</ArticleId></ArticleIdList></Reference><Reference><Citation>Royse C, Royse A, Soeding P, Blake D, Pang J. Prospective randomized trial of high thoracic epidural analgesia for coronary artery bypass surgery. Ann Thorac Surg. 2003;75:93&#x2013;100. doi: 10.1016/S0003-4975(02)04074-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0003-4975(02)04074-2</ArticleId><ArticleId IdType="pubmed">12537199</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma M, Mehta Y, Sawhney R, Vats M, Trehan N. Thoracic epidural analgesia in obese patients with body mass index of more than 30 kg/m2 for off pump coronary artery bypass surgery. Ann Card Anaesth. 2010;13:28&#x2013;33. doi: 10.4103/0971-9784.58831.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0971-9784.58831</ArticleId><ArticleId IdType="pubmed">20075532</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurses E, Berk D, Sungurtekin H, Mete A, Serin S. Effects of high thoracic epidural anesthesia on mixed venous oxygen saturation in coronary artery bypass grafting surgery. Med Sci Monit. 2013;19:222&#x2013;9. doi: 10.12659/MSM.883861.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.883861</ArticleId><ArticleId IdType="pmc">PMC3628587</ArticleId><ArticleId IdType="pubmed">23531633</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajakaruna C, Rogers C, Pike K, Alwair H, Cohen A, Tomkins S, et al. Superior haemodynamic stability during off-pump coronary surgery with thoracic epidural anaesthesia: results from a prospective randomized controlled trial. Interact Cardiovasc Thorac Surg. 2013;16:602&#x2013;7. doi: 10.1093/icvts/ivt001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivt001</ArticleId><ArticleId IdType="pmc">PMC3630420</ArticleId><ArticleId IdType="pubmed">23357523</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakobsen CJ, Bhavsar R, Nielsen DV, Ryhammer PK, Sloth E, Greisen J. High thoracic epidural analgesia in cardiac surgery. Part 1&#x2013;high thoracic epidural analgesia improves cardiac performance in cardiac surgery patients. J Cardiothorac Vasc Anesth. 2012;26:1039&#x2013;47. doi: 10.1053/j.jvca.2012.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2012.05.007</ArticleId><ArticleId IdType="pubmed">22770758</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen DV, Bhavsar R, Greisen J, Ryhammer PK, Sloth E, Jakobsen CJ. High thoracic epidural analgesia in cardiac surgery. Part 2&#x2013;high thoracic epidural analgesia does not reduce time in or improve quality of recovery in the intensive care unit. J Cardiothorac Vasc Anesth. 2012;26:1048&#x2013;54. doi: 10.1053/j.jvca.2012.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2012.05.008</ArticleId><ArticleId IdType="pubmed">22770692</ArticleId></ArticleIdList></Reference><Reference><Citation>Onan B, Onan IS, Kilickan L, Sanisoglu I. Effects of epidural anesthesia on acute and chronic pain after coronary artery bypass grafting. J Card Surg. 2013;28:248&#x2013;53. doi: 10.1111/jocs.12086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocs.12086</ArticleId><ArticleId IdType="pubmed">23461638</ArticleId></ArticleIdList></Reference><Reference><Citation>Barton S. Which clinical studies provide the best evidence? The best RCT still trumps the best observational study. BMJ. 2000;321:255&#x2013;6. doi: 10.1136/bmj.321.7256.255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.321.7256.255</ArticleId><ArticleId IdType="pmc">PMC1118259</ArticleId><ArticleId IdType="pubmed">10915111</ArticleId></ArticleIdList></Reference><Reference><Citation>Nimmo SM. Benefit and outcome after epidural analgesia. Contin Educ Anaesth Crit Care Pain. 2004;4:44&#x2013;7. doi: 10.1093/bjaceaccp/mkh014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bjaceaccp/mkh014</ArticleId></ArticleIdList></Reference><Reference><Citation>DiNardo JA, Zvara DA. Anesthesia for cardiac surgery. Hoboken, New Jersey: Blackwell Pub; 2008.</Citation></Reference><Reference><Citation>Liu S, Carpenter RL, Neal JM. Epidural anesthesia and analgesia. Their role in postoperative outcome. Anesthesiology. 1995;82:1474&#x2013;506. doi: 10.1097/00000542-199506000-00019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199506000-00019</ArticleId><ArticleId IdType="pubmed">7793661</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangano DT. Perioperative cardiac morbidity. Can J Anaesth. 1994;41:R13&#x2013;9. doi: 10.1007/BF03009958.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03009958</ArticleId></ArticleIdList></Reference><Reference><Citation>Guay J. The benefits of adding epidural analgesia to general anesthesia: a metaanalysis. J Anesth. 2006;20:335&#x2013;40. doi: 10.1007/s00540-006-0423-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-006-0423-8</ArticleId><ArticleId IdType="pubmed">17072704</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta Y, Arora D, Vats M. Epidural analgesia in high risk cardiac surgical patients. HSR Proc Intensive Care Cardiovasc Anesth. 2012;4:11&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3484927</ArticleId><ArticleId IdType="pubmed">23440670</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">29019011</PMID><DateCompleted><Year>2019</Year><Month>02</Month><Day>19</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1863-6713</ISSN><JournalIssue CitedMedium="Internet"><Volume>67</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Jan</Month></PubDate></JournalIssue><Title>General thoracic and cardiovascular surgery</Title><ISOAbbreviation>Gen Thorac Cardiovasc Surg</ISOAbbreviation></Journal><ArticleTitle>A systematic review and meta-analysis of mechanical vs biological composite aortic root replacement, early and 1-year results.</ArticleTitle><Pagination><StartPage>70</StartPage><EndPage>76</EndPage><MedlinePgn>70-76</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11748-017-0845-2</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Composite aortic root replacement is a standard procedure for various aortic root pathologies. This systematic review was set to identify the postoperative outcomes for composite mechanical root replacement (mCRR) compared to composite biological root replacement (bCRR).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We systematically reviewed four major databases for all papers assessing outcomes in composite root replacement. Articles selected were chosen by two reviewers. Amongst our inclusion and exclusion criteria, all pediatric populations were excluded as were studies with a cohort less than 50 patients.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified seven studies that conformed to our inclusion criteria and incorporated 2240 patients. In-hospital mortality was higher but non-significant in the mechanical group (6.1 vs 4.2% respectively). There was no significant difference demonstrated in the risk of in-hospital stroke, late stroke and re-operation in either groups. Additionally, there was no significant difference in: endocarditis, 1-year mortality, 5-year mortality, mean cardiopulmonary or aortic cross-clamp time.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Composite mechanical root offers no superiority to composite biological root. There is a significant increase in the perioperative bleeding amongst composite mechanical root cohort. There is a need for further randomized control trail to assess the efficacy of either methods.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bashir</LastName><ForeName>Mohamad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Barts Heart Centre, St. Bartholomew's Hospital, London, EC1A 7BE, UK. Mohamad.bashir@bartshealth.nhs.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harky</LastName><ForeName>Amer</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Barts Heart Centre, St. Bartholomew's Hospital, London, EC1A 7BE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Froghi</LastName><ForeName>Saied</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, Imperial College NHS Trust, Hammersmith Hospital, Du Cane Rd, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adams</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Barts Heart Centre, St. Bartholomew's Hospital, London, EC1A 7BE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garner</LastName><ForeName>Megan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Barts Heart Centre, St. Bartholomew's Hospital, London, EC1A 7BE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Prity</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Barts Heart Centre, St. Bartholomew's Hospital, London, EC1A 7BE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oo</LastName><ForeName>Aung</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Barts Heart Centre, St. Bartholomew's Hospital, London, EC1A 7BE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uppal</LastName><ForeName>Rakesh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Barts Heart Centre, St. Bartholomew's Hospital, London, EC1A 7BE, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>10</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Gen Thorac Cardiovasc Surg</MedlineTA><NlmUniqueID>101303952</NlmUniqueID><ISSNLinking>1863-6705</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001013" MajorTopicYN="N">Aorta, Thoracic</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017545" MajorTopicYN="N">Aortic Aneurysm, Thoracic</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001807" MajorTopicYN="Y">Blood Vessel Prosthesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014656" MajorTopicYN="N">Vascular Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aneurysm</Keyword><Keyword MajorTopicYN="N">Aortic root</Keyword><Keyword MajorTopicYN="N">Composite root</Keyword><Keyword MajorTopicYN="N">Valve</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29019011</ArticleId><ArticleId IdType="doi">10.1007/s11748-017-0845-2</ArticleId><ArticleId IdType="pii">10.1007/s11748-017-0845-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lancet. 1999 Nov 27;354(9193):1896-900</Citation><ArticleIdList><ArticleId IdType="pubmed">10584742</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Surg. 2001 May;71(5):1454-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11383782</ArticleId></ArticleIdList></Reference><Reference><Citation>J Heart Valve Dis. 2001 Jul;10(4):451-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11499589</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Surg Forum. 2002;5(1):52-5; discussion 56</Citation><ArticleIdList><ArticleId IdType="pubmed">11944629</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Surg. 2002 Nov;74(5):S1769-72; discussion S1792-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12440662</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cardiothorac Surg. 2003 Mar;23(3):305-10</Citation><ArticleIdList><ArticleId IdType="pubmed">12614798</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart. 2003 Jul;89(7):715-21</Citation><ArticleIdList><ArticleId IdType="pubmed">12807838</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Surg. 1977 Aug;24(2):140-8</Citation><ArticleIdList><ArticleId IdType="pubmed">141915</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cardiothorac Surg. 2003 Dec;24(6):886-97</Citation><ArticleIdList><ArticleId IdType="pubmed">14643805</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2004 Sep 14;110(11):1364-71</Citation><ArticleIdList><ArticleId IdType="pubmed">15313937</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cardiothorac Surg. 2006 Sep;30(3):485-91</Citation><ArticleIdList><ArticleId IdType="pubmed">16857373</ArticleId></ArticleIdList></Reference><Reference><Citation>Gen Thorac Cardiovasc Surg. 2007 Jan;55(1):6-11</Citation><ArticleIdList><ArticleId IdType="pubmed">17444165</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Cardiovasc Surg. 2007 Jun;133(6):1455-63</Citation><ArticleIdList><ArticleId IdType="pubmed">17532939</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2007 Sep 11;116(11 Suppl):I294-300</Citation><ArticleIdList><ArticleId IdType="pubmed">17846320</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Cardiovasc Surg. 2008 Apr;135(4):878-84; discussion 884</Citation><ArticleIdList><ArticleId IdType="pubmed">18374773</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cardiothorac Surg. 2010 Jun;37(6):1317-21</Citation><ArticleIdList><ArticleId IdType="pubmed">20444618</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Cardiovasc Surg. 2010 Dec;140(6 Suppl):S64-70; discussion S86-91</Citation><ArticleIdList><ArticleId IdType="pubmed">21092800</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Cardiol. 2011 Mar-Apr;27(2):262.e15-20</Citation><ArticleIdList><ArticleId IdType="pubmed">21459276</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Surg. 2012 Sep;94(3):737-43</Citation><ArticleIdList><ArticleId IdType="pubmed">22626762</ArticleId></ArticleIdList></Reference><Reference><Citation>Korean J Thorac Cardiovasc Surg. 2012 Jun;45(3):141-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22708080</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cardiothorac Surg. 2013 Aug;44(2):337-45</Citation><ArticleIdList><ArticleId IdType="pubmed">23295449</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2013 Sep 10;128(11 Suppl 1):S253-62</Citation><ArticleIdList><ArticleId IdType="pubmed">24030416</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cardiothorac Surg. 2014 Oct;46(4):685-92; discussion 692</Citation><ArticleIdList><ArticleId IdType="pubmed">24497393</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Cardiovasc Surg. 2015 Jan;149(1):116-22.e4</Citation><ArticleIdList><ArticleId IdType="pubmed">24934089</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Heart J. 2014 Nov 1;35(41):2873-926</Citation><ArticleIdList><ArticleId IdType="pubmed">25173340</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorax. 1968 Jul;23(4):338-9</Citation><ArticleIdList><ArticleId IdType="pubmed">5664694</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Surg. 1995 Aug;60(2 Suppl):S65-70</Citation><ArticleIdList><ArticleId IdType="pubmed">7646213</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cardiothorac Surg. 1996;10(3):207-13</Citation><ArticleIdList><ArticleId IdType="pubmed">8664022</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34348400</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1938-2480</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>The journal of knee surgery</Title><ISOAbbreviation>J Knee Surg</ISOAbbreviation></Journal><ArticleTitle>Characterizing Intraoperative Vasopressor Use in Total Knee Arthroplasty: A Retrospective Cohort Study.</ArticleTitle><Pagination><StartPage>216</StartPage><EndPage>221</EndPage><MedlinePgn>216-221</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0041-1731721</ELocationID><Abstract><AbstractText>Preoperative optimization and protocols for joint replacement care pathways have led to decreased length of stay (LOS)and narcotic use, and are increasingly important in delivering quality, cost savings, and shifting appropriate cases to an outpatient setting. The intraoperative use of vasopressors is independently associated with increased LOS and risk of adverse postoperative events including death, and in total hip arthroplasty, there is an increased risk for intensive care unit (ICU) admission. Our aim is to characterize the patient characteristics associated with vasopressor use specifically in total knee arthroplasty (TKA). We retrospectively reviewed the electronic medical records of a cohort of patients who underwent inpatient primary TKA at a single academic hospital from January 1, 2017 to December 31, 2018. Demographics, comorbidities, perioperative factors, and intraoperative medication administration were compared with multivariate regression to identify patients who may require intraoperative vasopressors. Out of these, 748 patients underwent TKA, 439 patients required intraoperative vasopressors, while 307 did not. Significant independent predictors of vasopressor use were older age (odds ratio [OR]&#x2009;=&#x2009;1.06, 95% confidence interval [CI]: 1.03-1.08) and history of a prior cerebrovascular accident (CVA; OR&#x2009;=&#x2009;11.80, CI: 1.48-93.81). While not significant, male sex (OR&#x2009;=&#x2009;0.72, CI: 0.50-1.04) and regional anesthesia (OR&#x2009;=&#x2009;0.64, CI: 0.40-1.05) were nearing significance as negative independent predictors of vasopressor use. In a secondary analysis, we did not observe an increase in complications attributable to vasopressor administration intraoperatively. In conclusion, nearly 59% of patients undergoing TKA received intraoperative vasopressor support. History of stroke and older age were significantly associated with increased intraoperative vasopressor use. As the first study to examine vasopressor usage in a TKA patient population, we believe that understanding the association between patient characteristics and intraoperative vasopressor support will help orthopaedic surgeons select the appropriate surgical setting during preoperative optimization.</AbstractText><CopyrightInformation>Thieme. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lentine</LastName><ForeName>Brandon</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Boston Medical Center, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaickus</LastName><ForeName>Max</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Boston University School of Medicine, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shewmaker</LastName><ForeName>Grant</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Boston University School of Medicine, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niu</LastName><ForeName>Ruijia</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Boston Medical Center, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Son</LastName><ForeName>Sung Jun</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Boston University School of Medicine, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mustafa</LastName><ForeName>Wissam</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Boston University School of Medicine, Boston Medical Center, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reist</LastName><ForeName>Hailee</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, University of Vermont Medical Center, Burlington, Vermont.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Eric L</ForeName><Initials>EL</Initials><Identifier Source="ORCID">0000-0003-1609-7639</Identifier><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, New England Baptist Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Knee Surg</MedlineTA><NlmUniqueID>101137599</NlmUniqueID><ISSNLinking>1538-8506</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019645" MajorTopicYN="Y">Arthroplasty, Replacement, Knee</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019644" MajorTopicYN="Y">Arthroplasty, Replacement, Hip</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>4</Day><Hour>20</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34348400</ArticleId><ArticleId IdType="doi">10.1055/s-0041-1731721</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25167086</PMID><DateCompleted><Year>2015</Year><Month>01</Month><Day>23</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1530-0293</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>12</Issue><PubDate><Year>2014</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Critical care medicine</Title><ISOAbbreviation>Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Transfusion triggers for guiding RBC transfusion for cardiovascular surgery: a systematic review and meta-analysis*.</ArticleTitle><Pagination><StartPage>2611</StartPage><EndPage>2624</EndPage><MedlinePgn>2611-24</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/CCM.0000000000000548</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Restrictive red cell transfusion is recommended to minimize risk associated with exposure to allogeneic blood. However, perioperative anemia is an independent risk factor for adverse outcomes after cardiovascular surgery. The purpose of this systematic review and meta-analysis is to determine whether perioperative restrictive transfusion thresholds are associated with inferior clinical outcomes in randomized trials of cardiovascular surgery patients.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">The Cochrane Central Register of Controlled Trials, MEDLINE, and EMBASE from inception to October 2013; reference lists of published guidelines, reviews, and associated articles, as well as conference proceedings. No language restrictions were applied.</AbstractText><AbstractText Label="STUDY SELECTION" NlmCategory="METHODS">We included controlled trials in which adult patients undergoing cardiac or vascular surgery were randomized to different transfusion thresholds, described as a hemoglobin or hematocrit level below which RBCs were transfused.</AbstractText><AbstractText Label="DATA EXTRACTION" NlmCategory="METHODS">Two authors independently extracted data from included trials. We pooled risk ratios of dichotomous outcomes and mean differences of continuous outcomes across trials using random-effects models.</AbstractText><AbstractText Label="DATA SYNTHESIS" NlmCategory="RESULTS">Seven studies (enrolling 1,262 participants) met inclusion criteria with restrictive and liberal transfusion thresholds most commonly differing by a hemoglobin of 1 g/dL or hematocrit of 6-7%, resulting in decreased transfusions by 0.71 units of RBCs (95% CI, 0.31-1.09, p = 0.0002) without an associated change in adverse events: mortality (risk ratio, 1.12; 95% CI, 0.65-1.95; p = 0.60), myocardial infarction (risk ratio, 0.94; 95% CI, 0.30-2.99; p = 0.92), stroke (risk ratio, 1.15; 95% CI, 0.57-2.32; p = 0.70), acute renal failure (risk ratio, 0.98; 95% CI, 0.64-1.49; p = 0.91), infections (risk ratio, 1.23; 95% CI, 0.85-1.78; p = 0.27), or length of stay. There was no between-trial heterogeneity for any pooled analysis. Including four pediatric trials (456 participants) and 10 trials utilizing only intraoperative acute normovolemic hemodilution (872 participants) did not substantially change the results except that unlike the transfusion threshold trials, the hemodilution trials did not reduce the proportion of patients transfused (interaction p = 0.01).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Further randomized controlled trials are necessary to determine the optimal transfusion strategy for patients undergoing cardiovascular surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Curley</LastName><ForeName>Gerard F</ForeName><Initials>GF</Initials><AffiliationInfo><Affiliation>1Departments of Anesthesia and Critical Care, Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada. 2Departments of Medicine and Laboratory Medicine and Pathobiology (Mount Sinai Hospital), Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada. 3Department of Anesthesia, Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada. 4Departments of Critical Care and Medicine, Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shehata</LastName><ForeName>Nadine</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Mazer</LastName><ForeName>C David</ForeName><Initials>CD</Initials></Author><Author ValidYN="Y"><LastName>Hare</LastName><ForeName>Gregory M T</ForeName><Initials>GM</Initials></Author><Author ValidYN="Y"><LastName>Friedrich</LastName><ForeName>Jan O</ForeName><Initials>JO</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Canadian Institutes of Health Research</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Crit Care Med</MedlineTA><NlmUniqueID>0355501</NlmUniqueID><ISSNLinking>0090-3493</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006454">Hemoglobins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care Med. 2014 Dec;42(12):2647-8. doi: 10.1097/CCM.0000000000000588.</RefSource><PMID Version="1">25402293</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D013504" MajorTopicYN="N">Cardiovascular Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017707" MajorTopicYN="N">Erythrocyte Transfusion</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006400" MajorTopicYN="N">Hematocrit</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006438" MajorTopicYN="N">Hemodilution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006454" MajorTopicYN="N">Hemoglobins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25167086</ArticleId><ArticleId IdType="doi">10.1097/CCM.0000000000000548</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23903267</PMID><DateCompleted><Year>2013</Year><Month>12</Month><Day>23</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1806-9460</ISSN><JournalIssue CitedMedium="Internet"><Volume>131</Volume><Issue>3</Issue><PubDate><Year>2013</Year></PubDate></JournalIssue><Title>Sao Paulo medical journal = Revista paulista de medicina</Title><ISOAbbreviation>Sao Paulo Med J</ISOAbbreviation></Journal><ArticleTitle>Neuraxial anesthesia versus general anesthesia for urological surgery: systematic review.</ArticleTitle><Pagination><StartPage>179</StartPage><EndPage>186</EndPage><MedlinePgn>179-86</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1516-31802013000300179</ELocationID><Abstract><AbstractText>CONTEXT AND OBJECTIVE Choosing the best anesthetic technique for urological surgery with the aim of mortality reduction remains controversial. The objective here was to compare the effectiveness and safety of neuraxial anesthesia versus general anesthesia for urological surgery. DESIGN AND SETTING Systematic review, Universidade Federal de Alagoas. METHODS We searched the Cochrane Central Register of Controlled Trials in the Cochrane Library (Issue 10, 2012), Medline via PubMed (1966 to October 2012), Lilacs (1982 to October 2012), SciELO and EMBASE (1974 to October 2012). The reference lists of the studies included and of one systematic review in the same field were also analyzed. The studies included were randomized controlled trials (RCT) that analyzed neuraxial anesthesia and general anesthesia for urological surgery. RESULTS The titles and abstracts of 2720 articles were analyzed. Among these, 16 studies were identified and 11 fulfilled the inclusion criteria. One RCT was published twice. The study validity was: Jadad score &amp;#x3E; 3 in one RCT; seven RCTs with unclear risk of bias as the most common response; and five RCTs not fulfilling half of the Delphi list items. The frequency of mortality was not significant between study groups in three RCTs. Meta-analysis was not performed. CONCLUSION At the moment, the evidence available cannot prove that neuraxial anesthesia is more effective and safer than general anesthesia for urological surgery. There were insufficient data to pool the results relating to mortality, stroke, myocardial infarction, length of hospitalization, quality of life, degree of satisfaction, postoperative cognitive dysfunction and blood transfusion requirements.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barbosa</LastName><ForeName>Fabiano Timbo</ForeName><Initials>FT</Initials><AffiliationInfo><Affiliation>Surgery Department, Universidade Federal de Alagoas, Macei&#xf3;, Alagoas, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castro</LastName><ForeName>Aldemar Araujo</ForeName><Initials>AA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Sao Paulo Med J</MedlineTA><NlmUniqueID>100897261</NlmUniqueID><ISSNLinking>1516-3180</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000767" MajorTopicYN="N">Anesthesia, Epidural</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013520" MajorTopicYN="Y">Urologic Surgical Procedures</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="por"><AbstractText Label="CONTEXTO E OBJETIVO:">A escolha da melhor t&#xe9;cnica anest&#xe9;sica para cirurgias urol&#xf3;gicas para reduzir mortalidade permanece controversa. O objetivo foi comparar a efetividade e seguran&#xe7;a da anestesia neuroaxial versus anestesia geral para cirurgias urol&#xf3;gicas.</AbstractText><AbstractText Label="TIPO DE ESTUDO E LOCAL:">Revis&#xe3;o sistem&#xe1;tica, Universidade Federal de Alagoas.</AbstractText><AbstractText Label="M&#xc9;TODO:">Fizemos a busca em Cochrane Central Register of Controlled Trials na Cochrane Library (2012, volume 10), Medline via PubMed (1966 at&#xe9; outubro de 2012), Lilacs (1982 at&#xe9; outubro de 2012), SciELO e EMBASE (1974 at&#xe9; outubro de 2012). As listas de refer&#xea;ncias dos estudos inclu&#xed;dos e de uma revis&#xe3;o sistem&#xe1;tica em urologia tamb&#xe9;m foram analisadas. Os estudos inclu&#xed;dos foram ensaios cl&#xed;nicos randomizados (ECR) que analisaram as anestesias neuroaxial e geral para cirurgias urol&#xf3;gicas.</AbstractText><AbstractText Label="RESULTADOS:">Os t&#xed;tulos e resumos de 2.720 artigos foram analisados. Entre eles, 16 estudos foram identificados e 11 preencheram os crit&#xe9;rios de inclus&#xe3;o. Um ECR foi publicado duas vezes. A validade dos estudos foi: escore de Jadad &gt; 3 em um ECR; sete ECRs com indeterminado risco de vi&#xe9;s como a resposta mais comum; cinco ECR sem preenchimento da metade dos itens da lista de Delphi. A frequ&#xea;ncia de mortalidade n&#xe3;o foi significante entre os grupos de estudo em tr&#xea;s ECR. A metan&#xe1;lise n&#xe3;o foi realizada.</AbstractText><AbstractText Label="CONCLUS&#xc3;O:">At&#xe9; o momento, as evid&#xea;ncias dispon&#xed;veis n&#xe3;o puderam provar que a anestesia neuroaxial seja mais efetiva e segura do que a anestesia geral para cirurgias urol&#xf3;gicas. N&#xe3;o houve dados suficientes para reunir os resultados de mortalidade, infarto cerebral, infarto do mioc&#xe1;rdio, dura&#xe7;&#xe3;o de interna&#xe7;&#xe3;o hospitalar, qualidade de vida, grau de satisfa&#xe7;&#xe3;o, disfun&#xe7;&#xe3;o cognitiva p&#xf3;s-operat&#xf3;ria e necessidade de transfus&#xe3;o sangu&#xed;nea.</AbstractText></OtherAbstract><CoiStatement><b>Conflict of interest:</b> None</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2013</Year><Month>6</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23903267</ArticleId><ArticleId IdType="pmc">PMC10852109</ArticleId><ArticleId IdType="doi">10.1590/1516-3180.2013.1313535</ArticleId><ArticleId IdType="pii">S1516-31802013000300179</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Barbosa FT, Castro AA, Miranda CT. Anestesia neuroaxial comparada &#xe0; anestesia geral para procedimentos na metade inferior do corpo: revis&#xe3;o sistem&#xe1;tica de revis&#xf5;es sistem&#xe1;ticas [Neuraxial anesthesia compared to general anesthesia for procedures on the lower half of the body: systematic review of systematic reviews] Rev Bras Anestesiol. 2012;62(2):239&#x2013;243.</Citation><ArticleIdList><ArticleId IdType="pubmed">22440378</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodgers A, Walker N, Schug S, et al. Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ. 2000;321(7275):1493&#x2013;1493.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC27550</ArticleId><ArticleId IdType="pubmed">11118174</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiong HY, Liew LC, Samuel M, Consigliere D, Esuvaranathan K. A meta-analysis of local anesthesia for transrectal ultrasound-guided biopsy of the prostate. Prostate Cancer Prostatic Dis. 2007;10(2):127&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pubmed">17211441</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Green S.  Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration; 2011. http://www.cochrane-handbook.org Accessed in 2013 (Feb 13)</Citation></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">8721797</ArticleId></ArticleIdList></Reference><Reference><Citation>Verhagen AP, de Vet HC, de Bie RA, et al. The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol. 1998;51(12):1235&#x2013;1241.</Citation><ArticleIdList><ArticleId IdType="pubmed">10086815</ArticleId></ArticleIdList></Reference><Reference><Citation>Shnaider I, Chung F. Outcomes in day surgery. Curr Opin Anaesthesiol. 2006;19(6):622&#x2013;629.</Citation><ArticleIdList><ArticleId IdType="pubmed">17093366</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothwell PM. External validity of randomised controlled trials: &#x201c;to whom do the results of this trial apply?&#x201d;. Lancet. 2005;365(9453):82&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">15639683</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane IMS  . ReviewManager (RevMan) Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2011. http://ims.cochrane.org/revman/ Accessed in 2013 (Feb 13)</Citation></Reference><Reference><Citation>Karacalar S, Bilen CY, Sarihasan B, Sarikaya S. Spinal-epidural anesthesia versus general anesthesia in the management of percutaneous nephrolithotripsy. J Endourol. 2009;23(10):1591&#x2013;1597.</Citation><ArticleIdList><ArticleId IdType="pubmed">19698035</ArticleId></ArticleIdList></Reference><Reference><Citation>Tikuisis R, Miliauskas P, Samalavicius NE, Zurauskas A, Sruogis A. Epidural and general anesthesia versus general anesthesia in radical prostatectomy. Medicina (Kaunas) 2009;45(10):772&#x2013;777.</Citation><ArticleIdList><ArticleId IdType="pubmed">19996663</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connor PJ, Hanson J, Finucane BT. Induced hypotension with epidural/general anesthesia reduces transfusion in radical prostate surgery. Can J Anaesth. 2006;53(9):873&#x2013;880.</Citation><ArticleIdList><ArticleId IdType="pubmed">16960264</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozyuvaci E, Altan A, Karadeniz T, et al. General anesthesia versus epidural and general anesthesia in radical cystectomy. Urol Int. 2005;74(1):62&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">15711112</ArticleId></ArticleIdList></Reference><Reference><Citation>Salonia A, Crescenti A, Suardi N, et al. General versus spinal anesthesia in patients undergoing radical retropubic prostatectomy: results of a prospective, randomized study. Urology. 2004;64(1):95&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">15245943</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown DR, Hoter RE, Patterson DE, et al. Intrathecal anesthesia and recovery from radical prostatectomy: a prospective, randomized, controlled trial. Anesthesiology. 2004;100(4):926&#x2013;934.</Citation><ArticleIdList><ArticleId IdType="pubmed">15087629</ArticleId></ArticleIdList></Reference><Reference><Citation>Dauri M, Costa F, Servetti S, et al. Combined general and epidural anesthesia with ropivacaine for renal transplantation. Minerva Anestesiol. 2003;69(12):873&#x2013;884.</Citation><ArticleIdList><ArticleId IdType="pubmed">14743119</ArticleId></ArticleIdList></Reference><Reference><Citation>Shir Y, Raja SN, Frank SM, Brendler CB. Intraoperative blood loss during radical retropubic prostatectomy: epidural versus general anesthesia. Urology. 1995;45(6):993&#x2013;999.</Citation><ArticleIdList><ArticleId IdType="pubmed">7771032</ArticleId></ArticleIdList></Reference><Reference><Citation>Shir Y, Raja SN, Frank SM. The effect of epidural versus general anesthesia on postoperative pain and analgesic requirements in patients undergoing radical prostatectomy. Anesthesiology. 1994;80(1):49&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">8291729</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendolin H, Alhava E. Effect of epidural versus general anaesthesia on peroperative blood loss during retropubic prostatectomy. Int Urol Nephrol. 1982;14(4):399&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pubmed">7182376</ArticleId></ArticleIdList></Reference><Reference><Citation>McGowan SW, Smith GF. Anaesthesia for transurethral prostatectomy. A comparison of spinal intradural analgesia with two methods of general anaesthesia. Anaesthesia. 1980;35(9):847&#x2013;853.</Citation><ArticleIdList><ArticleId IdType="pubmed">7446925</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry DA, Wilson A. Meta-analysis. Part 1: An assessment of its aims, validity and reliability. Med J Aust. 1992;156(1):31&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">1734191</ArticleId></ArticleIdList></Reference><Reference><Citation>Gauss A, Jahn SK, Eberhart LH, et al. Kardioprotektion durch thorakale Periduralan&#xe4;sthesie?: Metaanalyse [Cardioprotection by thoracic epidural anesthesia?: meta-analysis] Anaesthesist. 2011;60(10):950&#x2013;962.</Citation><ArticleIdList><ArticleId IdType="pubmed">21993475</ArticleId></ArticleIdList></Reference><Reference><Citation>Myles PS, Hunt JO, Fletcher H, et al. Relation between quality of recovery in hospital and quality of life at 3 months after cardiac surgery. Anesthesiology. 2001;95(4):862&#x2013;867.</Citation><ArticleIdList><ArticleId IdType="pubmed">11605925</ArticleId></ArticleIdList></Reference><Reference><Citation>Silbert B, Evered L, Scott DA. Cognitive decline in the elderly: is anaesthesia implicated? Best Pract Res Clin Anaesthesiol. 2011;25(3):379&#x2013;393.</Citation><ArticleIdList><ArticleId IdType="pubmed">21925403</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilotta F, Doronzio A, Stazi E, et al. Early postoperative cognitive dysfunction and postoperative delirium after anaesthesia with various hypnotics: study protocol for a randomised controlled trial-the PINOCCHIO trial. Trials. 2011;12:170&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3155116</ArticleId><ArticleId IdType="pubmed">21733178</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36746889</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1970-9366</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Internal and emergency medicine</Title><ISOAbbreviation>Intern Emerg Med</ISOAbbreviation></Journal><ArticleTitle>Direct oral anticoagulants in patients with a left-sided bioprosthetic heart valve: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>535</StartPage><EndPage>547</EndPage><MedlinePgn>535-547</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11739-023-03208-9</ELocationID><Abstract><AbstractText>To compare the efficacy/effectiveness and safety of DOACs versus VKAs in patients with a previously and newly surgically implanted BHV with or without AF. A systematic search on MEDLINE and EMBASE was performed till November 2022. Treatment effects were estimated with relative risk (RR) and 95% confidence intervals (CIs). Statistical heterogeneity was assessed with the I<sup>2</sup> statistic. Four randomized controlled trials (RCTs), 2 subgroup analysis from ARISTOTLE and ENGAGE-AF-TIMI 48 and 4 observational studies were included for a total of 5808 patients, 1893 on DOACs and 3915 on VKAs. AF prevalence was 98.28%. In the overall analysis, DOACs vs VKAs were associated with a RR for stroke/transient ischemic attack (TIA)/systemic embolism (SE) of 0.63 (95% CI 0.51-0.79; I<sup>2</sup>&#x2009;=&#x2009;0%) and a RR of major bleeding of 0.50 (95% CI 0.39-0.63; I<sup>2</sup>&#x2009;=&#x2009;0%) in a median follow-up of 19&#xa0;months (IQR 4.5-33.4). In the 3 RCTs (DAWA, RIVER, ENAVLE), DOACs vs VKAs were associated with a RR of stroke/TIA/SE and major bleeding of 0.38 (95% CI 0.13-1.58, I<sup>2</sup>&#x2009;=&#x2009;0%) and of 0.68 (95% CI 0.32-1.44; I<sup>2</sup>&#x2009;=&#x2009;5%) respectively. In patients randomized during the first three months from valve surgery, DOACs vs VKAs were associated with a RR of stroke/TIA/SE and major bleeding of 0.54 (95% CI 0.14-2.08; I<sup>2</sup>&#x2009;=&#x2009;0%) and of 0.76 (95% CI 0.05-10.72; I<sup>2</sup>&#x2009;=&#x2009;66%). In previously implanted BHV patients with AF, DOACs showed a risk-benefit profile at least comparable to VKAs. DOACs showed a similar, even if underpowered, risk-benefit profile during the first three months after BHV implantation prevalently in patients with AF.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Societ&#xe0; Italiana di Medicina Interna (SIMI).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Galliazzo</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Internal Medicine, Ospedale San Valentino-AULSS 2 Marca Trevigiana, Via Palmiro Togliatti, 1, 31044, Montebelluna, Treviso, Italy. galliazzosil@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pelitti</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Internal Medicine Residency Program, School of Medicine, University of Insubria, Varese and Como, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campiotti</LastName><ForeName>Leonardo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medicine and Surgery, ASST Settelaghi, University of Insubria, Varese, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poli</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Thrombosis Center, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Squizzato</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Research Center On Thromboembolic Disorders and Antithrombotic Therapies, ASST Lariana, University of Insubria, Como, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Intern Emerg Med</MedlineTA><NlmUniqueID>101263418</NlmUniqueID><ISSNLinking>1828-0447</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>12001-79-5</RegistryNumber><NameOfSubstance UI="D014812">Vitamin K</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Intern Emerg Med. 2023 Jun;18(4):1247. doi: 10.1007/s11739-023-03257-0.</RefSource><PMID Version="1">37038026</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Intern Emerg Med. 2023 Aug;18(5):1269-1272. doi: 10.1007/s11739-023-03288-7.</RefSource><PMID Version="1">37243834</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="Y">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="Y">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004617" MajorTopicYN="Y">Embolism</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006351" MajorTopicYN="N">Heart Valves</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014812" MajorTopicYN="N">Vitamin K</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Direct oral anticoaguants</Keyword><Keyword MajorTopicYN="N">Surgical bioprostheses</Keyword><Keyword MajorTopicYN="N">Vitamin K antagonists</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>6</Day><Hour>23</Hour><Minute>17</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36746889</ArticleId><ArticleId IdType="doi">10.1007/s11739-023-03208-9</ArticleId><ArticleId IdType="pii">10.1007/s11739-023-03208-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M (2006) Burden of valvular heart diseases: a population-based study. Lancet 368:1005&#x2013;1011. https://doi.org/10.1016/S0140-6736(06)69208-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(06)69208-8</ArticleId><ArticleId IdType="pubmed">16980116</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun JC, Davidson MJ, Lamy A, Eikelboom JW (2009) Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends. Lancet 374:565&#x2013;576. https://doi.org/10.1016/S0140-6736(09)60780-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(09)60780-7</ArticleId><ArticleId IdType="pubmed">19683642</ArticleId></ArticleIdList></Reference><Reference><Citation>Heras M, Chesebro JH, Fuster V, Penny WJ, Grill DE, Bailey KR, Danielson GK, Orszulak TA, Pluth JR, Puga FJ, Schaff HV, Larsonkeller JJ (1995) High risk of thromboemboli early after bioprosthetic cardiac valve replacement. J Am Coll Cardiol 25:1111&#x2013;1119. https://doi.org/10.1016/0735-1097(94)00563-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0735-1097(94)00563-6</ArticleId><ArticleId IdType="pubmed">7897124</ArticleId></ArticleIdList></Reference><Reference><Citation>Kannel WB, Wolf PA, Benjamin EJ, Levy D (1998) Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol. https://doi.org/10.1016/s0002-9149(98)00583-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0002-9149(98)00583-9</ArticleId><ArticleId IdType="pubmed">9809895</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM (2011) ROCKET AF investigators, rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365:883&#x2013;891. https://doi.org/10.1056/NEJMoa1009638</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1009638</ArticleId><ArticleId IdType="pubmed">21830957</ArticleId></ArticleIdList></Reference><Reference><Citation>Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L (2009) RE-LY steering committee and investigators, dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139&#x2013;1151. https://doi.org/10.1056/NEJMoa0905561</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0905561</ArticleId><ArticleId IdType="pubmed">19717844</ArticleId></ArticleIdList></Reference><Reference><Citation>Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L (2011) ARISTOTLE committees and investigators, apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365:981&#x2013;992. https://doi.org/10.1056/NEJMoa1107039</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1107039</ArticleId><ArticleId IdType="pubmed">21870978</ArticleId></ArticleIdList></Reference><Reference><Citation>Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Spinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM (2013) ENGAGE AF-TIMI 48 Investigators, Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 369:2093&#x2013;2104. https://doi.org/10.1056/NEJMoa1310907</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1310907</ArticleId><ArticleId IdType="pubmed">24251359</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG (2009) PRISMA Group, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535. https://doi.org/10.1136/bmj.b2535</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2535</ArticleId><ArticleId IdType="pubmed">19622551</ArticleId><ArticleId IdType="pmc">2714657</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim CY, Seo J, Kim YJ, Lee SH, De Caterina R, Lee S, Hong GE (2021) Efficacy and safety of edoxaban in patients early after surgical bioprosthetic valve implantation or valve repair: a randomized clinical trial. J Thorac Cardiovasc Surg. https://doi.org/10.1016/j.jtcvs.2021.01.127</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2021.01.127</ArticleId><ArticleId IdType="pubmed">35058062</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. https://doi.org/10.1111/j.1538-7836.2005.01204.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2005.01204.x</ArticleId><ArticleId IdType="pubmed">15842354</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JAC, Savovi&#x107; J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldrige SM, Emberson JR, Hernan MA, Hopewell S, Hrobjartsson A, Junqueira DR, Juni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ doi: https://doi.org/10.1136/bmj.l4898 .</Citation></Reference><Reference><Citation>Deeks J, Higgins J, et al (2019) Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (eds) Cochrane handbook for systematic reviews of interventions version 6.0 (updated July 2019). Cochrane</Citation></Reference><Reference><Citation>Higgins JPT, Li T et al (2019) Choosing effect measures and computing estimates of effect. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (eds) Cochrane handbook for systematic reviews of interventions version 6.0 (updated July 2019). Cochrane</Citation></Reference><Reference><Citation>Dur&#xe3;es AR, de Souza RP, de Almeida NB, Albuquerque FP, de Bulh&#xf5;es FV, de Souza Fernandes AM, Aras R (2016) Dabigatran versus warfarin after bioprosthesis valve replacement for the management of atrial fibrillation postoperatively: DAWA pilot study. Drugs R D 16:149&#x2013;154. https://doi.org/10.1007/s40268-016-0124-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40268-016-0124-1</ArticleId><ArticleId IdType="pubmed">26892845</ArticleId><ArticleId IdType="pmc">4875919</ArticleId></ArticleIdList></Reference><Reference><Citation>Renda G, De Caterina R, Carnicelli A, Nordio F, Mercuri M, Ruff C, Giugliano R (2016) Outcomes in 2824 patients with valvular heart disease treated with edoxaban or warfarin in the engage AF-TIMI 48 trial. J Am Coll Cardiol 67(13S):2194</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(16)32195-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Strange JE, Sindet-Pedersen C, Staerk L, Grove EL, Gerds TA, Torp-Pedersen C, Gislason GH, Butt JH, Fosboel EL, Olesen JB (2019) Dabigatran versus vitamin K antagonists in patients with atrial fibrillation and valvular heart disease. Eur Heart J 40(1):2996</Citation></Reference><Reference><Citation>Di Biase L (2016) Use of direct oral anticoagulants in patients with atrial fibrillation and valvular heart lesions. J Am Heart Assoc 5:e002776. https://doi.org/10.1161/JAHA.115.002776</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.115.002776</ArticleId><ArticleId IdType="pubmed">26892528</ArticleId><ArticleId IdType="pmc">4802477</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadlapati A, Groh C, Malaisrie SC, Gajjar M, Krise J, Meyers S, Passman R (2016) Efficacy and safety of novel oral anticoagulants in patients with bioprosthetic valves. Clin Res Cardiol 105:268&#x2013;272. https://doi.org/10.1007/s00392-015-0919-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-015-0919-z</ArticleId><ArticleId IdType="pubmed">26384981</ArticleId></ArticleIdList></Reference><Reference><Citation>Noseworthy PA, Yao X, Shah ND, Gersh BJ (2016) Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and valvular heart disease. Int J Cardiol 209:181&#x2013;183. https://doi.org/10.1016/j.ijcard.2016.02.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2016.02.005</ArticleId><ArticleId IdType="pubmed">26896618</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampton ML, Tellor KB, Armbruster AL, Theodos G, Schwarze MW (2020) Evaluation of the safety and effectiveness of direct-acting oral anticoagulants in patients with atrial fibrillation and coexisting valvular heart disease. Am J Cardiovasc Drugs 20:611&#x2013;617. https://doi.org/10.1007/s40256-020-00398-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40256-020-00398-x</ArticleId><ArticleId IdType="pubmed">32043243</ArticleId></ArticleIdList></Reference><Reference><Citation>Gue YX, Lip GYH (2021) In patients with AF and a bioprosthetic mitral valve, rivaroxaban was noninferior to warfarin for time to clinical events. Ann Intern Med 174:JC43. https://doi.org/10.7326/ACPJ202104200-043</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/ACPJ202104200-043</ArticleId><ArticleId IdType="pubmed">33819059</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondo Y, Kobayashi Y (2022) Use of novel antithrombotic therapies for patients with atrial fibrillation and bioprosthetic valves. Circ J 86:425&#x2013;426. https://doi.org/10.1253/circj.CJ-21-1029</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-21-1029</ArticleId><ArticleId IdType="pubmed">35095088</ArticleId></ArticleIdList></Reference><Reference><Citation>Mentias A, Saad M, Michael M, Nakhla S, Menon V, Harb S, Chaudhury P, Johnston D, Saliba W, Wazni O, Svensson L, Desai MY, Kapadia S (2022) Direct oral anticoagulants versus warfarin in patients with atrial fibrillation and valve replacement or repair. J Am Heart Assoc 11:e026666. https://doi.org/10.1161/JAHA.122.026666</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.122.026666</ArticleId><ArticleId IdType="pubmed">36000413</ArticleId><ArticleId IdType="pmc">9496414</ArticleId></ArticleIdList></Reference><Reference><Citation>Christersson C, Held C, Modica A, Westerbergh J, Batra G (2022) Oral anticoagulant treatment after bioprosthetic valvular intervention or valvuloplasty in patients with atrial fibrillation-A SWEDEHEART study. PLoS ONE 17:e0262580. https://doi.org/10.1371/journal.pone.0262580</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0262580</ArticleId><ArticleId IdType="pubmed">35025950</ArticleId><ArticleId IdType="pmc">8757947</ArticleId></ArticleIdList></Reference><Reference><Citation>Guimar&#xe3;es HP, Lopes RD, de Barros E, Silva PGM, Liporace IL, Sampaio RO, Tarasoutchi F, Hoffmann-Filho CR, de Lemos R, Soares Patriota R, Leiria TLL, Lamprea D, Precoma DB, Atik FA, Silveira FS, Farias FR, Barreto DO, Almeida AP, Zilli AC, de Souza Neto JD, Cavalcante MA, Fugueira FAMS, Kojima FCS, Damiani L, Santos RHN, Valeis N, Campos VB, Saraiva JFK, Fonseca FH, Pinto IM, Magalh&#xe3;es CC, Ferreira JFM, Alexander JH, Pavanello R, Cavalcanti AB, Berwanger O (2020) Rivaroxaban in patients with atrial fibrillation and a bioprosthetic mitral valve. N Engl J Med 383:2117&#x2013;2126. https://doi.org/10.1056/NEJMoa2029603</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2029603</ArticleId><ArticleId IdType="pubmed">33196155</ArticleId></ArticleIdList></Reference><Reference><Citation>Carnicelli AP, De Caterina R, Halperin JL, Renda G, Ruff CT, Trevisan M, Nordio F, Mercuri MF, Antman E, Giugliano RP (2017) Edoxaban for the prevention of thromboembolism in patients with atrial fibrillation and bioprosthetic valves. Circulation 135:1273&#x2013;1275. https://doi.org/10.1161/CIRCULATIONAHA.116.026714</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.116.026714</ArticleId><ArticleId IdType="pubmed">28209729</ArticleId></ArticleIdList></Reference><Reference><Citation>Guimar&#xe3;es PO, Pokorney SD, Lopes RD, Wojdyla DM, Gersh BJ, Giczewska A, Carnicelli A, Lewis BS, Hanna M, Wallentin L, Vinereanu D, Alexander JH, Granger CB (2019) Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: insights from the ARISTOTLE trial. Clin Cardiol 42:568&#x2013;571. https://doi.org/10.1002/clc.23178</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clc.23178</ArticleId><ArticleId IdType="pubmed">30907005</ArticleId><ArticleId IdType="pmc">6522998</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan L, Doctor JN, Adams JL, Romley JA, Nguyen LA, An J, Lee MS (2021) Comparison of direct oral anticoagulants versus warfarin in patients with atrial fibrillation and bioprosthetic heart valves. Am J Cardiol. 146: 22&#x2013;8.https:// doi: https://doi.org/10.1016/j.amjcard.2021.01.016 .</Citation></Reference><Reference><Citation>Pasciolla S, Zizza LF, Le T, Wright K (2020) Comparison of the Efficacy and Safety of Direct Oral Anticoagulants and Warfarin After Bioprosthetic Valve Replacements, Clin DrugInvestig. 40: 839&#x2013;45. https:// doi: https://doi.org/10.1007/s40261-020-00939-x .</Citation></Reference><Reference><Citation>Russo V, Carbone A, Attena E, Rago A, Mazzone C, Proietti R, Parisi V, Scotti A, Nigro G, Golino P, D&#x2019;Onofrio A (2019) Clinical benefit of direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and bioprosthetic heart valves. Clin Ther 41:2549&#x2013;2557. https://doi.org/10.1016/j.clinthera.2019.10.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2019.10.008</ArticleId><ArticleId IdType="pubmed">31735436</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannacio VA, Mannacio L, Antignano A, Mauro C, Mastroroberto P, Musumeci F, Zebele C, Iannelli G (2022) New oral anticoagulants versus warfarin in atrial fibrillation after early postoperative period in patients with bioprosthetic aortic valve. Ann Thorac Surg 113:75&#x2013;82. https://doi.org/10.1016/j.athoracsur.2021.03.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2021.03.016</ArticleId><ArticleId IdType="pubmed">33744222</ArticleId></ArticleIdList></Reference><Reference><Citation>Piepiorka-Broniecka M, Michalski TA, Figatowski T, Wojtowicz A, Jurowiecki J, Stanska A, Rogowski J, Jaguszewski MJ (2022) NOAC versus warfarin in the treatment of atrial fibrillation during the first three months after bioprosthetic aortic valve replacement. Cardiol J 29:355&#x2013;357. https://doi.org/10.5603/CJ.a2021.0158</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/CJ.a2021.0158</ArticleId><ArticleId IdType="pubmed">34897639</ArticleId><ArticleId IdType="pmc">9007476</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, Camm AJ, Weitz JI, Lewis BS, Parkhomenko A, Yamashita T, Antman EM (2014) Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 383:955&#x2013;962. https://doi.org/10.1016/S0140-6736(13)62343-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)62343-0</ArticleId><ArticleId IdType="pubmed">24315724</ArticleId></ArticleIdList></Reference><Reference><Citation>Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstr&#xf6;m-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau JP, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL (2021) Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European association for cardio-thoracic surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European society of cardiology (ESC) developed with the special contribution of the European heart rhythm association (EHRA) of the ESC. Eur Heart J 42:373&#x2013;498. https://doi.org/10.1093/eurheartj/ehaa612</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa612</ArticleId><ArticleId IdType="pubmed">32860505</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, Capodanno D, Conradi L, De Bonis M, De Paulis R, Delgado V, Freemantle N, Gilard M, Haugaa KH, Jeppsson A, J&#xfc;ni P, Pierard L, Prendergast BD, S&#xe1;daba JR, Tribouilloy C, Wojakowski W (2022) 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J 43(7):561&#x2013;632. https://doi.org/10.1093/eurheartj/ehab395</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab395</ArticleId><ArticleId IdType="pubmed">34453165</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardoso R, Ternes CMP, Justino GB, Fernandes A, Rocha AV, Knijnik L, d&#x2019;Avila A, Lopes RD (2021) Non-vitamin K antagonists versus warfarin in patients with atrial fibrillation and bioprosthetic valves: a systematic review and meta-analysis. Am J Med 21:00589&#x2013;00591. https://doi.org/10.1016/j.amjmed.2021.08.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2021.08.026</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalra A, Raza S, Jafry BH, King HE, Lahorra JA, Svensson LG, Kapadia SR (2021) Off-label use of direct oral anticoagulants in patients receiving surgical mechanical and bioprosthetic heart valves. JAMA New Open 3:e211259. https://doi.org/10.1001/jamanetworkopen.2021.1259</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.1259</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Mieghem NM, Unverdorben M, Hengstenberg C, M&#xf6;llmann H, Mehran R, L&#xf3;pez-Otero D, Nombela-Franco L, Moreno R, Nordbeck P, Thiele H, Lang I, Zamorano JL, Shawl F, Yamamoto M, Watanabe Y, Hayashida K, Hambrecht R, Meincke F, Vranckx P, Jin J, Boersma E, Rod&#xe9;s-Cabau J, Ohlmann P, Capranzano P, Kim HS, Pilgrim T, Anderson R, Baber U, Duggal A, Laeis P, Lanz H, Chen C, Valgimigli M, Veltkamp R, Saito S, Dangas GD (2021) Edoxaban versus vitamin K antagonist for atrial fibrillation after TAVR. N Engl J Med 385:2150&#x2013;2160. https://doi.org/10.1056/NEJMoa2111016</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2111016</ArticleId><ArticleId IdType="pubmed">34449183</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37678462</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>30</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2341-1929</ISSN><JournalIssue CitedMedium="Internet"><Volume>70</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Revista espanola de anestesiologia y reanimacion</Title><ISOAbbreviation>Rev Esp Anestesiol Reanim (Engl Ed)</ISOAbbreviation></Journal><ArticleTitle>Anesthetic management of endovascular neurosurgical procedures in acute ischemic stroke patients: A systematic review of meta-analyses.</ArticleTitle><Pagination><StartPage>580</StartPage><EndPage>592</EndPage><MedlinePgn>580-592</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.redare.2023.02.007</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2341-1929(23)00142-7</ELocationID><Abstract><AbstractText>Restoration of cerebral circulation in the ischemic area is the most critical treatment task for reducing irreversible neuronal injury in ischemic stroke patients. The recanalizaci&#xf3;n of appropriately selected patients became indispensable for improving clinical outcomes and resulted in the widespread revascularization techniques. There is no clear answer as to which anesthetic modality to use in ischemic stroke patients undergoing neuro-endovascular procedures. The purpose of this systematic review is to conduct a qualitative analysis of systematic reviews and meta-analyses (RSs &amp; MAs) comparing general anesthesia and non-general anesthesia methods for cerebral endovascular interventions in acute ischemic stroke patients. We developed a protocol with the inclusion and exclusion criteria for matched publications and conducted a literature search in PubMed and Google Scholar. The literature search yielded 52 potential publications. Ten relevant RSs &amp; MAs were included and analysed in this review. The decision about which anesthesia method to use for endovascular procedures in managing acute ischemic stroke patients should be made based on the patient's personal characteristics, pathophysiological phenotypes, clinical characteristics, and institutional experience.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Sociedad Espa&#xf1;ola de Anestesiolog&#xed;a, Reanimaci&#xf3;n y Terap&#xe9;utica del Dolor. Publicado por Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Viderman</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Surgery (Section of Anesthesiology, Intensive Care, and Pain Medicine), Nazarbayev University School of Medicine (NUSOM), Astana, Kazakhstan. Electronic address: dmitriy.viderman@nu.edu.kz.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bilotta</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Departamento de Anestesia y Cuidado Intensivo, Universidad de Roma La Sapienza, Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badenes</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Departamento de Anestesiolog&#xed;a y Cuidado Intensivo, Hospital Cl&#xed;nico Universitario de Valencia, Universidad de Valencia, Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdildin</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Engineering and Digital Sciences, Nazarbayev University, Astana, Kazakhstan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Rev Esp Anestesiol Reanim (Engl Ed)</MedlineTA><NlmUniqueID>101778594</NlmUniqueID><ISSNLinking>2341-1929</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000777">Anesthetics</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000777" MajorTopicYN="Y">Anesthetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002545" MajorTopicYN="Y">Brain Ischemia</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000083242" MajorTopicYN="Y">Ischemic Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000078202" MajorTopicYN="N">Systematic Reviews as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015201" MajorTopicYN="N">Meta-Analysis as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Accidente cerebrovascular isqu&#xe9;mico</Keyword><Keyword MajorTopicYN="N">Anestesia general</Keyword><Keyword MajorTopicYN="N">Anesthetic management</Keyword><Keyword MajorTopicYN="N">Endovascular therapy</Keyword><Keyword MajorTopicYN="N">General anesthesia</Keyword><Keyword MajorTopicYN="N">Intra-Arterial therapy</Keyword><Keyword MajorTopicYN="N">Ischemic stroke</Keyword><Keyword MajorTopicYN="N">Manejo anest&#xe9;sico</Keyword><Keyword MajorTopicYN="N">Sedaci&#xf3;n</Keyword><Keyword MajorTopicYN="N">Sedation</Keyword><Keyword MajorTopicYN="N">Terapia endovascular</Keyword><Keyword MajorTopicYN="N">Terapia intraarterial</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>4</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>8</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>7</Day><Hour>19</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37678462</ArticleId><ArticleId IdType="doi">10.1016/j.redare.2023.02.007</ArticleId><ArticleId IdType="pii">S2341-1929(23)00142-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32727840</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>30</Day></DateCompleted><DateRevised><Year>2020</Year><Month>10</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1526-632X</ISSN><JournalIssue CitedMedium="Internet"><Volume>95</Volume><Issue>12</Issue><PubDate><Year>2020</Year><Month>Sep</Month><Day>22</Day></PubDate></JournalIssue><Title>Neurology</Title><ISOAbbreviation>Neurology</ISOAbbreviation></Journal><ArticleTitle>Prospective observational cohort study of early recurrent TIA: Features, frequency, and outcome.</ArticleTitle><Pagination><StartPage>e1733</StartPage><EndPage>e1744</EndPage><MedlinePgn>e1733-e1744</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1212/WNL.0000000000010317</ELocationID><Abstract><AbstractText Label="OBJECTIVES">To evaluate the frequency, clinical and etiologic features, and short- and long-term outcomes of early recurrent TIA.</AbstractText><AbstractText Label="METHODS">This prospective observational cohort study enrolled all consecutive patients with TIA referred to our emergency department and diagnosed by a vascular neurologist. Expedited assessment and best secondary prevention were performed within 24 hours. Primary endpoints were stroke and a composite outcome including stroke, acute coronary syndrome, and vascular death at 3, 12, and, for a subset of patients, 60 months; secondary outcomes were TIA relapse, cerebral hemorrhage, new-onset atrial fibrillation, and death resulting from other causes. Concordance between index TIA and subsequent stroke etiologies was also evaluated.</AbstractText><AbstractText Label="RESULTS">A total of 1,035 patients (822 with a single TIA, 213 with recurrent TIA = 21%) were enrolled from August 2010 to December 2017. Capsular warning syndrome and large artery atherosclerosis showed the strongest relationship with early recurrent TIA. The risk of stroke was significantly higher in the early recurrent TIA subgroup at each follow-up, and most stroke episodes occurred within 48 hours of index TIA. TIAs with lesion, dysarthria, and leukoaraiosis were the 3- and 12-month independent predictors of stroke incidence after early recurrent TIA subgroup. Index TIA and subsequent stroke etiologies showed substantial concordance. An ABCD<sub>3</sub> score &gt;6 predicted a higher risk of stroke recurrence over the entire follow-up.</AbstractText><AbstractText Label="CONCLUSIONS">Our study evaluated long-term outcome after early recurrent TIA. Our observations support the importance of promptly detecting and treating patients with early recurrent TIAs to reduce the high early and long-term risk of poor clinical outcomes.</AbstractText><CopyrightInformation>&#xa9; 2020 American Academy of Neurology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Foschi</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Neurology Unit (M.F., L.P., F.R., M.G.), Neuroradiology Unit (L.S.), Angiology and Blood Coagulation Unit (E.F., M.F.), Internal Medicine Unit (D.D.E., E.S.), and Vascular Surgery Unit (G.F.), S. Orsola-Malpighi University Hospital; and IRCCS Istituto delle Scienze Neurologiche di Bologna (F.R., P.C., M.G.), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pavolucci</LastName><ForeName>Lucia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>From the Neurology Unit (M.F., L.P., F.R., M.G.), Neuroradiology Unit (L.S.), Angiology and Blood Coagulation Unit (E.F., M.F.), Internal Medicine Unit (D.D.E., E.S.), and Vascular Surgery Unit (G.F.), S. Orsola-Malpighi University Hospital; and IRCCS Istituto delle Scienze Neurologiche di Bologna (F.R., P.C., M.G.), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rondelli</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>From the Neurology Unit (M.F., L.P., F.R., M.G.), Neuroradiology Unit (L.S.), Angiology and Blood Coagulation Unit (E.F., M.F.), Internal Medicine Unit (D.D.E., E.S.), and Vascular Surgery Unit (G.F.), S. Orsola-Malpighi University Hospital; and IRCCS Istituto delle Scienze Neurologiche di Bologna (F.R., P.C., M.G.), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spinardi</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>From the Neurology Unit (M.F., L.P., F.R., M.G.), Neuroradiology Unit (L.S.), Angiology and Blood Coagulation Unit (E.F., M.F.), Internal Medicine Unit (D.D.E., E.S.), and Vascular Surgery Unit (G.F.), S. Orsola-Malpighi University Hospital; and IRCCS Istituto delle Scienze Neurologiche di Bologna (F.R., P.C., M.G.), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Favaretto</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-1811-7798</Identifier><AffiliationInfo><Affiliation>From the Neurology Unit (M.F., L.P., F.R., M.G.), Neuroradiology Unit (L.S.), Angiology and Blood Coagulation Unit (E.F., M.F.), Internal Medicine Unit (D.D.E., E.S.), and Vascular Surgery Unit (G.F.), S. Orsola-Malpighi University Hospital; and IRCCS Istituto delle Scienze Neurologiche di Bologna (F.R., P.C., M.G.), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filippini</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Neurology Unit (M.F., L.P., F.R., M.G.), Neuroradiology Unit (L.S.), Angiology and Blood Coagulation Unit (E.F., M.F.), Internal Medicine Unit (D.D.E., E.S.), and Vascular Surgery Unit (G.F.), S. Orsola-Malpighi University Hospital; and IRCCS Istituto delle Scienze Neurologiche di Bologna (F.R., P.C., M.G.), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Degli Esposti</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>From the Neurology Unit (M.F., L.P., F.R., M.G.), Neuroradiology Unit (L.S.), Angiology and Blood Coagulation Unit (E.F., M.F.), Internal Medicine Unit (D.D.E., E.S.), and Vascular Surgery Unit (G.F.), S. Orsola-Malpighi University Hospital; and IRCCS Istituto delle Scienze Neurologiche di Bologna (F.R., P.C., M.G.), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strocchi</LastName><ForeName>Enrico</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>From the Neurology Unit (M.F., L.P., F.R., M.G.), Neuroradiology Unit (L.S.), Angiology and Blood Coagulation Unit (E.F., M.F.), Internal Medicine Unit (D.D.E., E.S.), and Vascular Surgery Unit (G.F.), S. Orsola-Malpighi University Hospital; and IRCCS Istituto delle Scienze Neurologiche di Bologna (F.R., P.C., M.G.), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faggioli</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>From the Neurology Unit (M.F., L.P., F.R., M.G.), Neuroradiology Unit (L.S.), Angiology and Blood Coagulation Unit (E.F., M.F.), Internal Medicine Unit (D.D.E., E.S.), and Vascular Surgery Unit (G.F.), S. Orsola-Malpighi University Hospital; and IRCCS Istituto delle Scienze Neurologiche di Bologna (F.R., P.C., M.G.), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cortelli</LastName><ForeName>Pietro</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-3633-8818</Identifier><AffiliationInfo><Affiliation>From the Neurology Unit (M.F., L.P., F.R., M.G.), Neuroradiology Unit (L.S.), Angiology and Blood Coagulation Unit (E.F., M.F.), Internal Medicine Unit (D.D.E., E.S.), and Vascular Surgery Unit (G.F.), S. Orsola-Malpighi University Hospital; and IRCCS Istituto delle Scienze Neurologiche di Bologna (F.R., P.C., M.G.), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guarino</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Neurology Unit (M.F., L.P., F.R., M.G.), Neuroradiology Unit (L.S.), Angiology and Blood Coagulation Unit (E.F., M.F.), Internal Medicine Unit (D.D.E., E.S.), and Vascular Surgery Unit (G.F.), S. Orsola-Malpighi University Hospital; and IRCCS Istituto delle Scienze Neurologiche di Bologna (F.R., P.C., M.G.), Italy. maria.guarino@aosp.bo.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Bologna TIA Study-Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurology</MedlineTA><NlmUniqueID>0401060</NlmUniqueID><ISSNLinking>0028-3878</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="N">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Rinaldi</LastName><ForeName>Rita</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>D'Angelo</LastName><ForeName>Roberto</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nicodemo</LastName><ForeName>Marianna</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stracciari</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mondini</LastName><ForeName>Susanna</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Amato</LastName><ForeName>Alfio</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Donti</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Muscari</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maria Puddu</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Veronesi</LastName><ForeName>Maddalena</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>D'Addato</LastName><ForeName>Sergio</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Faccioli</LastName><ForeName>Luca</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cavazza</LastName><ForeName>Mario</ForeName><Initials>M</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32727840</ArticleId><ArticleId IdType="doi">10.1212/WNL.0000000000010317</ArticleId><ArticleId IdType="pii">WNL.0000000000010317</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23897485</PMID><DateCompleted><Year>2013</Year><Month>12</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-493X</ISSN><JournalIssue CitedMedium="Internet"><Volume>2013</Volume><Issue>7</Issue><PubDate><Year>2013</Year><Month>Jul</Month><Day>29</Day></PubDate></JournalIssue><Title>The Cochrane database of systematic reviews</Title><ISOAbbreviation>Cochrane Database Syst Rev</ISOAbbreviation></Journal><ArticleTitle>Neuraxial anaesthesia for lower-limb revascularization.</ArticleTitle><Pagination><StartPage>CD007083</StartPage><MedlinePgn>CD007083</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">CD007083</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/14651858.CD007083.pub3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Lower-limb revascularization is a surgical procedure that is performed to restore an adequate blood supply to the limbs. Lower-limb revascularization surgery is used to reduce pain and sometimes to improve lower-limb function. Neuraxial anaesthesia is an anaesthetic technique that uses local anaesthetics next to the spinal cord to block nerve function. Neuraxial anaesthesia may lead to improved survival. This systematic review was originally published in 2010 and was first updated in 2011 and again in 2013.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To determine the rates of death and major complications associated with spinal and epidural anaesthesia as compared with other types of anaesthesia for lower-limb revascularization in patients aged 18 years or older who are affected by obstruction of lower-limb vessels.</AbstractText><AbstractText Label="SEARCH METHODS" NlmCategory="METHODS">The original review was published in 2010 and was based on a search until June 2008. In 2011 we reran the search until February 2011 and updated the review. For this second updated version of the review, we searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, LILACS, CINAHL and Web of Science from 2011 to April 2013.</AbstractText><AbstractText Label="SELECTION CRITERIA" NlmCategory="METHODS">We included randomized controlled trials comparing neuraxial anaesthesia (spinal or epidural anaesthesia) versus other types of anaesthesia in adults (18 years or older) with arterial vascular obstruction undergoing lower-limb revascularization surgery.</AbstractText><AbstractText Label="DATA COLLECTION AND ANALYSIS" NlmCategory="METHODS">Two review authors independently performed data extraction and assessed trial quality. We pooled the data on mortality, myocardial infarction, lower-limb amputation and pneumonia. We summarized dichotomous data as odds ratio (OR) with 95% confidence interval (CI) using a random-effects model.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">In this updated version of the review, we found no new studies that met our inclusion criteria. We included in this review four studies that compared neuraxial anaesthesia with general anaesthesia. The total number of participants was 696, of whom 417 were allocated to neuraxial anaesthesia and 279 to general anaesthesia. Participants allocated to neuraxial anaesthesia had a mean age of 67 years, and 59% were men. Participants allocated to general anaesthesia had a mean age of 67 years, and 66% were men. Four studies had an unclear risk of bias. No difference was observed between participants allocated to neuraxial or general anaesthesia in mortality rate (OR 0.89, 95% CI 0.38 to 2.07; 696 participants; four trials), myocardial infarction (OR 1.23, 95% CI 0.56 to 2.70; 696 participants; four trials), and lower-limb amputation (OR 0.84, 95% CI 0.38 to 1.84; 465 participants; three trials). Pneumonia was less common after neuraxial anaesthesia than after general anaesthesia (OR 0.37, 95% CI 0.15 to 0.89; 201 participants; two trials). Evidence was insufficient for cerebral stroke, duration of hospital stay, postoperative cognitive dysfunction, complications in the anaesthetic recovery room and transfusion requirements. No data described nerve dysfunction, postoperative wound infection, patient satisfaction, postoperative pain score, claudication distance and pain at rest.</AbstractText><AbstractText Label="AUTHORS' CONCLUSIONS" NlmCategory="CONCLUSIONS">Available evidence from included trials that compared neuraxial anaesthesia with general anaesthesia was insufficient to rule out clinically important differences for most clinical outcomes. Neuraxial anaesthesia may reduce pneumonia. No conclusions can be drawn with regard to mortality, myocardial infarction and rate of lower-limb amputation, or less common outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barbosa</LastName><ForeName>Fabiano T</ForeName><Initials>FT</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Armando Lages Emergency Hospital, Macei&#xf3;, Brazil. fabianotimbo@yahoo.com.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Juc&#xe1;</LastName><ForeName>M&#xe1;rio J</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><LastName>Castro</LastName><ForeName>Aldemar A</ForeName><Initials>AA</Initials></Author><Author ValidYN="Y"><LastName>Cavalcante</LastName><ForeName>Jairo C</ForeName><Initials>JC</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>07</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cochrane Database Syst Rev</MedlineTA><NlmUniqueID>100909747</NlmUniqueID><ISSNLinking>1361-6137</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007083. doi: 10.1002/14651858.CD007083.pub2.</RefSource><PMID Version="1">20091615</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000671" MajorTopicYN="N">Amputation, Surgical</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000767" MajorTopicYN="N">Anesthesia, Epidural</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000775" MajorTopicYN="N">Anesthesia, Spinal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035002" MajorTopicYN="N">Lower Extremity</DescriptorName><QualifierName UI="Q000098" MajorTopicYN="Y">blood supply</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="N">Pneumonia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014656" MajorTopicYN="N">Vascular Surgical Procedures</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Fabiano T Barbosa: none known. M&#xe1;rio J Juc&#xe1;: none known. Aldemar A Castro: none known. Jairo C Cavalcante: none known.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>7</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23897485</ArticleId><ArticleId IdType="pmc">PMC10984249</ArticleId><ArticleId IdType="doi">10.1002/14651858.CD007083.pub3</ArticleId></ArticleIdList><ReferenceList><Title>References to studies included in this review</Title><ReferenceList><Title>Bode 1996 {published data only}</Title><Reference><Citation>Bode Jr RH, Lewis KP, Zarich SW, Pierce ET, Roberts M, Kowalchuk GJ, et al. Cardiac outcome after peripheral vascular surgery: comparison of general and regional anaesthesia. Anesthesiology 1996;84(1):3&#x2010;13. [PUBMED: 8572352]</Citation><ArticleIdList><ArticleId IdType="pubmed">8572352</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce ET, Pomposelli Jr FB, Stanley GD, Lewis KP, Cass JL, LoGerfo FW, et al. Anesthesia type does not influence early graft patency or limb salvage rates of lower extremity arterial bypass. Journal of Vascular Surgery 1997;25(2):226&#x2010;32. [PUBMED: 9052557]</Citation><ArticleIdList><ArticleId IdType="pubmed">9052557</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Christopherson 1993 {published data only}</Title><Reference><Citation>Christopherson R, Beattie C, Frank SM, Norris EJ, Meinert CL, Gottlieb SO, et al. Perioperative morbidity in patients randomized to epidural or general anaesthesia for lower extremity vascular surgery. Anesthesiology 1993;79(3):422&#x2010;34. [PUBMED: 8363066]</Citation><ArticleIdList><ArticleId IdType="pubmed">8363066</ArticleId></ArticleIdList></Reference><Reference><Citation>Christopherson R, Glavan NJ, Norris EJ, Beattie C, Rock P, Frank SM, et al. Control of blood pressure and heart rate in patients randomized to epidural or general anaesthesia for lower extremity vascular surgery. Journal of Clinical Anesthesia 1996;8(7):578&#x2010;84. [PUBMED: 8910181]</Citation><ArticleIdList><ArticleId IdType="pubmed">8910181</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cook 1986 {published data only}</Title><Reference><Citation>Cook PT, Davies MJ, Cronin KD, Moran P. A prospective randomised trial comparing spinal anaesthesia using hyperbaric cinchocaine with general anaesthesia for lower limb vascular surgery. Anaesthesia and Intensive Care 1986;14(4):373&#x2010;80. [PUBMED: 3551674]</Citation><ArticleIdList><ArticleId IdType="pubmed">3551674</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Dodds 2007 {published data only}</Title><Reference><Citation>Dodds TM, Fillinger MP, Walsh DB, Surgenor SD, Mandel D, Yeager MP. Clinical outcomes after lower extremity revascularization: a comparison of epidural and general anaesthesia. The Journal of Applied Research 2007;7(3):238&#x2010;49. [NLM UID: 101132979]</Citation></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to studies excluded from this review</Title><ReferenceList><Title>Ballotta 2003 {published data only}</Title><Reference><Citation>Ballotta E, Renon L, Tofano M, Giau G. Prospective randomized study on bilateral above&#x2010;knee femoropopliteal revascularization: polytetrafluoroethylene graft versus reversed saphenous vein. Journal of Vascular Surgery 2003;38(5):1051&#x2010;5. [PUBMED: 14603216]</Citation><ArticleIdList><ArticleId IdType="pubmed">14603216</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ballotta 2004 {published data only}</Title><Reference><Citation>Ballota E, Renon L, Rossi A, Barbon B, Terranova O, Giau G. Prospective randomized study on reversed saphenous vein infrapopliteal bypass to treat limb&#x2010;threatening ischemia: common femoral artery versus superficial femoral or popliteal and tibial arteries as inflow. Journal of Vascular Surgery 2004;40(4):732&#x2010;40. [PUBMED: 15472602]</Citation><ArticleIdList><ArticleId IdType="pubmed">15472602</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Barkmeier 1997 {published data only}</Title><Reference><Citation>Barkmeier LD, Hood DB, Sumner DS, Mansour MA, Hodgson KJ, Mattos MA, et al. Local anaesthesia for infrainguinal arterial reconstruction. The American Journal of Surgery 1997;174(2):202&#x2010;4. [PUBMED: 9293845]</Citation><ArticleIdList><ArticleId IdType="pubmed">9293845</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Breslow 1993 {published data only}</Title><Reference><Citation>Breslow MJ, Parker SD, Frank SM, Norris EJ, Yates H, Raff H, et al. Determinants of catecholamine and cortisol responses to lower extremity revascularization. Anesthesiology 1993;79(6):1202&#x2010;9. [PUBMED: 8267195]</Citation><ArticleIdList><ArticleId IdType="pubmed">8267195</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Casati 1999 {published data only}</Title><Reference><Citation>Casati A, Fanelli G, Aldegheri G, Colnaghi E, Casaletti E, Cedrati V, et al. Frequency of hypotension during conventional or asymmetric hyperbaric spinal block. Regional Anesthesia and Pain Medicine 1999;24(3):214&#x2010;9. [PUBMED: 10338170]</Citation><ArticleIdList><ArticleId IdType="pubmed">10338170</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Gallinger 1997 {published data only}</Title><Reference><Citation>Gallinger Elu, Seleznev MN, Babalyan GV. Use of combined lidocaine and bupivacaine spinal&#x2010;epidural anaesthesia in peripheral vascular surgery of the lower limbs. Anesteziologiia I Reanimatologiia 1997;5(2):60&#x2010;2. [PUBMED: 9432896]</Citation><ArticleIdList><ArticleId IdType="pubmed">9432896</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Gonz&#xe1;lez&#x2010;Fajardo 1995 {published data only}</Title><Reference><Citation>Gonz&#xe1;lez&#x2010;Fajardo JA, P&#xe9;rez&#x2010;Burkhardt JL, Mateo AM. Intraoperative fibrinolytic therapy for salvage of limbs with acute arterial ischaemia: an adjunct to thromboembolectomy. Annals of Vascular Surgery 1995;9(2):179&#x2010;86. [PUBMED: 7786704]</Citation><ArticleIdList><ArticleId IdType="pubmed">7786704</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Hertzer 1981 {published data only}</Title><Reference><Citation>Hertzer NR. Fatal myocardial infarction following lower extremity revascularization: two hundred seventy&#x2010;three patients followed six to eleven postoperative years. Annals of Surgery 1981;193(4):492&#x2010;8. [PUBMED: 7212811]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1345103</ArticleId><ArticleId IdType="pubmed">7212811</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lurquin 1993 {published data only}</Title><Reference><Citation>Lurquin P, Mendes da Costa PR. Surgical pathology of aorta and arteries of the lower limbs in the elderly. Acta Chirurgica Belgica 1993;93(3):131&#x2010;4. [PUBMED: 8372587]</Citation><ArticleIdList><ArticleId IdType="pubmed">8372587</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Peduto 2003 {published data only}</Title><Reference><Citation>Peduto VA, Baroncini S, Montanini S, Proietti R, Rosignoli L, Tufano R, et al. A prospective, randomized, double&#x2010;blind comparison of epidural levobupivacaine 0.5% with epidural ropivacaine 0.75% for lower limb procedures. European Journal of Anesthesiology 2003;20(12):979&#x2010;83. [PUBMED: 14690101]</Citation><ArticleIdList><ArticleId IdType="pubmed">14690101</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Reuben 1994 {published data only}</Title><Reference><Citation>Reuben SS, Dunn SM, Duprat KM, O&#xb4;Sullivan P. An intrathecal fentanyl dose&#x2010;response study in lower extremity revascularization procedures. Anesthesiology 1994;81(6):1371&#x2010;5. [PUBMED: 7992905]</Citation><ArticleIdList><ArticleId IdType="pubmed">7992905</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rivers 1991 {published data only}</Title><Reference><Citation>Rivers SP, Scher LA, Sheehan E, Veith FJ. Epidural versus general anesthesia for infrainguinal arterial reconstruction. Journal of Vascular Surgery 1991;14(6):764&#x2010;8. [PUBMED: 1960806]</Citation><ArticleIdList><ArticleId IdType="pubmed">1960806</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Romano 1980 {published data only}</Title><Reference><Citation>Romano E, Gullo A, Alagni G, Mocavero G. Anesthesia problems in reconstructive vascular surgery problems in reconstructive vascular surgery of the lower extremities [Problemi di anestesia nella chiruria vascolare ricostruttiva degli arti inferiori]. Minerva Cardioangiologica 1980;28(7&#x2010;8):525&#x2010;38. [PUBMED: 7453972]</Citation><ArticleIdList><ArticleId IdType="pubmed">7453972</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sabat&#xe9; 1994 {published data only}</Title><Reference><Citation>Sabat&#xe9; A, Asbert R, Gracia T, Camprubi I, Sopena R, Udina E. Regional anaesthesia and elderly patients: continuous subarachnoid anaesthesia versus single dose in peripheral vascular surgery. Regional Anesthesia 1994;19(2):79&#x2010;84.</Citation></Reference></ReferenceList><ReferenceList><Title>Singh 2006 {published data only}</Title><Reference><Citation>Singh N, Sidawy AN, Dezee K, Neville RF, Weiswasser J, Arora S, et al. The effects of the type of anaesthesia on outcomes of lower extremity infrainguinal bypass. Journal of Vascular Surgery 2006;44(5):964&#x2010;8. [PUBMED: 17000075]</Citation><ArticleIdList><ArticleId IdType="pubmed">17000075</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Vascular Society 1995 {published data only}</Title><Reference><Citation>No authors listed. Critical limb ischaemia: management and outcome. Report of a national survey. The Vascular Surgical Society of Great Britain and Ireland. European Journal Vascular Endovascular Surgery 1995;10(1):108&#x2010;3. [PUBMED: 7633958]</Citation><ArticleIdList><ArticleId IdType="pubmed">7633958</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>Additional references</Title><ReferenceList><Title>Afolabi 2007</Title><Reference><Citation>Afolabi BB, Lesi FEA, Merah NA. Regional versus general anaesthesia for caesarean section. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858.CD004350.pub2]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD004350.pub2</ArticleId><ArticleId IdType="pubmed">17054201</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Altman 1991</Title><Reference><Citation>Altman DG. Randomisation. BMJ 1991;302(22):1481&#x2010;2. [PUBMED: 1855013]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1670173</ArticleId><ArticleId IdType="pubmed">1855013</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bode 1994</Title><Reference><Citation>Bode Jr RH, Lewis KP. Con: regional anaesthesia is not better than general anaesthesia for lower extremity revascularization. Journal of Cardiothoracic and Vascular Anesthesia 1994;8(1):118&#x2010;21. [PUBMED: 8167271]</Citation><ArticleIdList><ArticleId IdType="pubmed">8167271</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bonnet 2005</Title><Reference><Citation>Bonnet F, Marret E. Influence of anaesthetic and analgesic techniques on outcome after surgery. British Journal of Anaesthesia 2005;95:52&#x2010;8. [PUBMED: 15579487]</Citation><ArticleIdList><ArticleId IdType="pubmed">15579487</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Borgeat 2003</Title><Reference><Citation>Borgeat A, Ekatodramis G. Orthopaedic surgery in the elderly. Best Practice &amp; Research. Clinical Anaesthesiology 2003;17(2):235&#x2010;44. [PUBMED: 12817917]</Citation><ArticleIdList><ArticleId IdType="pubmed">12817917</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Castro 1999</Title><Reference><Citation>Castro AA, Clark OA, Atallah AN. Optimal search strategy for clinical trials in the Latin American and Caribbean Health Science Literature database (LILACS database: update). Sao Paulo Medical Journal 1999;117(3):138&#x2010;9. [PUBMED: 10511734]</Citation><ArticleIdList><ArticleId IdType="pubmed">10511734</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Christopherson 1996</Title><Reference><Citation>Christopherson R, Glavan NJ, Norris EJ, Beattie C, Rock P, Frank SM, et al. Control of blood pressure and heart rate in patients randomized to epidural or general anaesthesia for lower extremity vascular surgery. Journal of Clinical Anesthesia 1996;8(7):578&#x2010;84. [PUBMED: 8910181]</Citation><ArticleIdList><ArticleId IdType="pubmed">8910181</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Dickersin 1994</Title><Reference><Citation>Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ 1994;309(6964):1286&#x2010;91. [PUBMED: 7718048]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2541778</ArticleId><ArticleId IdType="pubmed">7718048</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Fukuse 2005</Title><Reference><Citation>Fukuse T, Satoda N, Hijiya K, Fujinaga T. Importance of a comprehensive geriatric assessment in prediction of complications following thoracic surgery in elderly patients. Chest 2005;127(3):886&#x2010;91. [PUBMED: 15764772]</Citation><ArticleIdList><ArticleId IdType="pubmed">15764772</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Green 2005</Title><Reference><Citation>Green S, Higgins J, editors. Glossary. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. The Cochrane Collaboration, August 1, 2009. http://www.cochrane.org/resources/handbook/.</Citation></Reference></ReferenceList><ReferenceList><Title>Higgins 2002</Title><Reference><Citation>Higgins JP, Thompson SG. Quantifying heterogeneity in a meta&#x2010;analysis. Statistics in Medicine 2002;15(21):1539&#x2010;58. [PUBMED: 12111919]</Citation><ArticleIdList><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Higgins 2011</Title><Reference><Citation>Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane&#x2010;handbook.org.</Citation></Reference></ReferenceList><ReferenceList><Title>Howard&#x2010;Alpe 2006</Title><Reference><Citation>Howard&#x2010;Alpe GM, Sear JW, Foex P. Methods of detecting atherosclerosis in non&#x2010;cardiac surgical patients: the role of biochemical markers. British Journal of Anaesthesia 2006;97(6):758&#x2010;69. [PUBMED: 17074779]</Citation><ArticleIdList><ArticleId IdType="pubmed">17074779</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lefebvre 1996</Title><Reference><Citation>Lefebvre C, McDonald S. Development of a sensitive search strategy for reports of randomized controlled trials in EMBASE. Fourth International Cochrane Colloquium, October 20&#x2010;24, 1996, Adelaide, Australia. 1996.</Citation></Reference></ReferenceList><ReferenceList><Title>Liu 2007</Title><Reference><Citation>Liu SS, Wu CL. Effect of postoperative analgesia on major postoperative complications: a systematic update of the evidence. Anesthesia Analgesia 2007;104(3):689&#x2010;02. [PUBMED: 17312231]</Citation><ArticleIdList><ArticleId IdType="pubmed">17312231</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Manojlovi&#x107; 2013</Title><Reference><Citation>Manojlovi&#x107; V, Popovi&#x107; V, Nikoli&#x107; D, Milosevi&#x107; D, Pasternak J, Ka&#x107;anski M. Analysis of associated diseases in patients with acute critical lower limb ischemia. Medicinski Pregled 2013;66(1&#x2010;2):41&#x2010;5. [PUBMED: 23534299]</Citation><ArticleIdList><ArticleId IdType="pubmed">23534299</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Parker 2011</Title><Reference><Citation>Parker MJ, Handoll HHG, Griffiths R. Anaesthesia for hip fracture surgery in adults. Cochrane Database of Systematic Reviews 2004, Issue 4. [DOI: 10.1002/14651858.CD000521.pub2]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD000521.pub2</ArticleId><ArticleId IdType="pubmed">15494999</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Pierce 1997</Title><Reference><Citation>Pierce ET, Pomposelli Jr FB, Stanley GD, Lewis KP, Cass JL, LoGerfo FW, et al. Anesthesia type does not influence early graft patency or limb salvage rates of lower extremity arterial bypass. Journal of Vascular Surgery 1997;25(2):226&#x2010;32. [PUBMED: 9052557]</Citation><ArticleIdList><ArticleId IdType="pubmed">9052557</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rasmussen 2000</Title><Reference><Citation>Rasmussen LS, Moller JT. Central nervous system dysfunction after anaesthesia in the geriatric patient. Anesthesiology Clinics of North America 2000;18(1):59&#x2010;70. [PUBMED: 10935000]</Citation><ArticleIdList><ArticleId IdType="pubmed">10935000</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>RevMan 5.1 [Computer program]</Title><Reference><Citation>Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration. RevMan 5.1 (Review Manager) (RevMan) [Computer program]. Version 5.1.. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.</Citation></Reference></ReferenceList><ReferenceList><Title>Rodgers 2000</Title><Reference><Citation>Rodgers A, Walker N, Schug S, McKee A, Kehlet H, Zundert A, et al. Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. British Medical Journal 2000;321:1493&#x2010;7. [PUBMED: 11118174]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC27550</ArticleId><ArticleId IdType="pubmed">11118174</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Schulz 2002</Title><Reference><Citation>Schulz KF, Chalmers I, Altman DG. The landscape and lexicon of blinding in randomized trials. Annals of Internal Medicine 2002;136(5):254&#x2010;9. [PUBMED: 11827510]</Citation><ArticleIdList><ArticleId IdType="pubmed">11827510</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sim 2005</Title><Reference><Citation>Sim J, Wright CC. The kappa statistic in reliability studies: use, interpretation, and sample size requirements. Physical Therapy 2005;85(3):257&#x2010;68. [PUBMED: 15733050]</Citation><ArticleIdList><ArticleId IdType="pubmed">15733050</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Smaka 2013</Title><Reference><Citation>Smaka TJ, Miller TE, Hutchens MP, Schenning K, Fleisher LA, Gan TJ, et al. Anesthesia for vascular surgery. In: Barash PG, Cullen BF, Stoelting RK, Cahalan MK, Stock MC, Ortega R editor(s). Clinical Anesthesia. 7th Edition. Philadelphia: Wolters Kluwer/Lippincott Williams &amp; Wilkins, 2013:1112&#x2010;43.</Citation></Reference></ReferenceList><ReferenceList><Title>Tonner 2003</Title><Reference><Citation>Tonner PH, Kampen J, Scholz J. Pathophysiological changes in the elderly. Best Practice &amp; Research. Clinical Anaesthesiology 2003;17(2):163&#x2010;77. [PUBMED: 12817912]</Citation><ArticleIdList><ArticleId IdType="pubmed">12817912</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Tuman 1994</Title><Reference><Citation>Tuman KJ, Ivankovich AD. Pro: regional anaesthesia is better than general anaesthesia for lower extremity revascularization. Journal of Cardiothoracic and Vascular Anesthesia 1994;8(1):114&#x2010;7. [PUBMED: 8167270]</Citation><ArticleIdList><ArticleId IdType="pubmed">8167270</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Venkataraman 2006</Title><Reference><Citation>Venkataraman R. Vascular surgery critical care: perioperative cardiac optimization to improve survival. Critical Care Medicine 2006;34 Suppl(9):200&#x2010;7. [PUBMED: 16917424]</Citation><ArticleIdList><ArticleId IdType="pubmed">16917424</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zaugg 2000</Title><Reference><Citation>Zaugg M, Lucchinetti E. Respiratory function in the elderly. Anesthesiology Clinics of North America 2000;18(1):47&#x2010;57. [PUBMED: 10934999]</Citation><ArticleIdList><ArticleId IdType="pubmed">10934999</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to other published versions of this review</Title><ReferenceList><Title>Barbosa 2010</Title><Reference><Citation>Barbosa FT, Juc&#xe1; MJ, Castro AA, Cavalcante JC. Neuraxial anaesthesia for lower&#x2010;limb revascularization. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD007083.pub2]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD007083.pub2</ArticleId><ArticleId IdType="pubmed">20091615</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35700906</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>14</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1615-5947</ISSN><JournalIssue CitedMedium="Internet"><Volume>86</Volume><PubDate><Year>2022</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Annals of vascular surgery</Title><ISOAbbreviation>Ann Vasc Surg</ISOAbbreviation></Journal><ArticleTitle>Staged Versus Synchronous Carotid Endarterectomy and Coronary Artery Bypass Grafting: A Meta-Analysis and Systematic Review.</ArticleTitle><Pagination><StartPage>428</StartPage><EndPage>439</EndPage><MedlinePgn>428-439</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.avsg.2022.05.027</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0890-5096(22)00290-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">There are several treatment options for patients with concomitant carotid and coronary artery disease, and it is difficult to identify an optimal treatment strategy that has consensus. Here, we performed a meta-analysis to compare the early and long-term outcomes of staged and synchronous carotid endarterectomy and coronary artery bypass grafting approaches.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a meta-analysis that compared staged and synchronous carotid endarterectomy and coronary artery bypass grafting approaches between July 1976 and September 2021. PubMed, EMBASE, and the Cochrane Library were systematically searched for related articles.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Nineteen studies were identified with a total of 39,269 and 30,066 patients in the synchronous and staged groups, respectively. Early mortality was lower in the staged group than in the synchronous group (odds ratio OR 1.256, 95% confidence interval CI 1.006-1.569, P=&#xa0;P&#xa0;&lt;&#xa0;0.05, I<sup>2</sup>&#xa0;=&#xa0;54.5%), and stroke rates were significantly higher in the synchronous group (OR 1.356, 95% CI 1.232-1.493, P&#xa0;&lt;&#xa0;0.05, I<sup>2</sup>&#xa0;=&#xa0;33.3%). The rate of myocardial ischemia was significantly higher in the staged group than in the synchronous group (OR 0.757, 95% CI 0.635-0.903, P&#xa0;&lt;&#xa0;0.05, I<sup>2</sup>&#xa0;=&#xa0;51.5%), and this meta-analysis also showed a significantly higher risk of transient ischemic attacks (TIAs) in the synchronous group (OR 1.335, 95% CI 1.055-1.688, P&#xa0;&lt;&#xa0;0.05, I<sup>2</sup>&#xa0;=&#xa0;0.00%). The secondary outcomes, including the rate of reoperation, were significantly lower for the staged procedure than for the synchronous procedure (OR 1.177, 95% CI 1.052-1.318, P&#xa0;&lt;&#xa0;0.05, I<sup>2</sup>&#xa0;=&#xa0;4.2%), and the rate of wound infection was significantly higher in the synchronous group than in the staged group (OR 0.457, 95% CI 0.403-0.519, P&#xa0;&lt;&#xa0;0.05, I<sup>2</sup>&#xa0;=&#xa0;0.0%). There was no significant difference in the rate of cardiac arrhythmia between the two groups (OR 0.544, 95% CI 0.265-1.117, P&#xa0;&gt;&#xa0;0.05, I<sup>2</sup>&#xa0;=&#xa0;12.7%). There was also no statistical significance in the long-term results regarding the incidence of stroke, myocardial ischemia, and mortality between the synchronous and staged groups (P&#xa0;&gt;&#xa0;0.05).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Patients treated with the synchronous approach had a significantly higher risk of early mortality, stroke, TIA, wound infection, and reoperation and a lower risk of myocardial ischemia than those treated with the staged approach. There was no significant difference in the long-term results between the 2 groups.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Chao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yi-Fan</ForeName><Initials>YF</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xin-Yu</ForeName><Initials>XY</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China. Electronic address: yangxinyu@tmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Ann Vasc Surg</MedlineTA><NlmUniqueID>8703941</NlmUniqueID><ISSNLinking>0890-5096</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016894" MajorTopicYN="Y">Endarterectomy, Carotid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016893" MajorTopicYN="Y">Carotid Stenosis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001026" MajorTopicYN="N">Coronary Artery Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003324" MajorTopicYN="Y">Coronary Artery Disease</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014946" MajorTopicYN="Y">Wound Infection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>14</Day><Hour>19</Hour><Minute>25</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35700906</ArticleId><ArticleId IdType="doi">10.1016/j.avsg.2022.05.027</ArticleId><ArticleId IdType="pii">S0890-5096(22)00290-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32493183</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>27</Day></DateCompleted><DateRevised><Year>2020</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1708-539X</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Vascular</Title><ISOAbbreviation>Vascular</ISOAbbreviation></Journal><ArticleTitle>Completion imaging techniques and their clinical role after carotid endarterectomy: Systematic review of the literature.</ArticleTitle><Pagination><StartPage>794</StartPage><EndPage>807</EndPage><MedlinePgn>794-807</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1708538120929793</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Completion imaging has been suggested for the intraoperative quality control assessment of the carotid endarterectomy technical success, in order to immediately resolve pathologic findings and accordingly improve patients' outcome. The aim of this study was to present existing evidence of different completion imaging techniques after carotid endarterectomy and their role on clinical outcome.</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">A systematic review was performed searching in MEDLINE, CENTRAL, and Cochrane databases including studies reporting on completion imaging techniques after carotid endarterectomy.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 12,378 patients in 35 studies (20 retrospective and 15 prospective) underwent a completion imaging technique after carotid endarterectomy: in 19 studies, 5340 patients underwent arteriography; in 5 studies, 2095 angioscopy; in 21 studies, 5722 DUS; and in 2 studies, 150 patients underwent transcranial Doppler. Ten studies assessed&#x2009;&gt;&#x2009;1 imaging technique. The mean age was 67&#x2009;&#xb1;&#x2009;7&#x2009;years old (69% males) with common co-morbidities to be hypertension (74%), smoking (64%), and hyperlipidemia (54%). Almost half of the patients (4949; 44%) were treated for symptomatic disease. In 1104 (9.7%) patients, a major defect was identified intra-operatively, while in 329 patients (2.9%), a minor defect. Common pathological findings were the presence of mural thrombus, carotid dissection, residual stenosis, and intimal flaps. An immediate re-intervention was undertaken in 75% (790/1053) of the patients to treat a major intra-operative imaging finding. In patients with re-intervention, only 2.3% (14/609) had an intra-operative stroke and 0.8% (5/609), a transient ischemic attack, while only 1.4% (8/575) had a stroke and 0.2% a transient ischemic attack (1/575) during 30-day post-operative period. No intra-operative death was reported. In the same period, the restenosis rate of internal and common carotid artery was 0.5% (3/575) and 0.2% (1/575), respectively.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Completion imaging techniques can detect defects in almost 10% of patients that may lead to immediate intra-operative surgical revision with low intra-operative stroke/transient ischemic attack rate and low early carotid restenosis. During the 30-day follow-up period, in those patients, the incidence of stroke/transient ischemic attack may be low but present. This review cannot provide any evidence on which completion imaging technique is better, and the clinical impact conferred by each technique in the absence of a randomized control studies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Spanos</LastName><ForeName>Konstantinos</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-2891-777X</Identifier><AffiliationInfo><Affiliation>Department of Vascular Surgery, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nana</LastName><ForeName>Petroula</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kouvelos</LastName><ForeName>George</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-5443-2066</Identifier><AffiliationInfo><Affiliation>Department of Vascular Surgery, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Batzalexis</LastName><ForeName>Konstantinos</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsagkas</LastName><ForeName>Miltiadis M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giannoukas</LastName><ForeName>Athanasios D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Vascular</MedlineTA><NlmUniqueID>101196722</NlmUniqueID><ISSNLinking>1708-5381</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015901" MajorTopicYN="Y">Angiography, Digital Subtraction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017546" MajorTopicYN="Y">Angioscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016893" MajorTopicYN="N">Carotid Stenosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002561" MajorTopicYN="N">Cerebrovascular Disorders</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016894" MajorTopicYN="N">Endarterectomy, Carotid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018616" MajorTopicYN="Y">Ultrasonography, Doppler, Duplex</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017585" MajorTopicYN="Y">Ultrasonography, Doppler, Transcranial</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Completion imaging</Keyword><Keyword MajorTopicYN="N">DUS</Keyword><Keyword MajorTopicYN="N">angioscopy</Keyword><Keyword MajorTopicYN="N">carotid endarterectomy</Keyword><Keyword MajorTopicYN="N">eversion endarterectomy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32493183</ArticleId><ArticleId IdType="doi">10.1177/1708538120929793</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28474994</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>11</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1933-0693</ISSN><JournalIssue CitedMedium="Internet"><Volume>128</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of neurosurgery</Title><ISOAbbreviation>J Neurosurg</ISOAbbreviation></Journal><ArticleTitle>Meta-analysis of the surgical outcomes of symptomatic moyamoya disease in adults.</ArticleTitle><Pagination><StartPage>793</StartPage><EndPage>799</EndPage><MedlinePgn>793-799</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3171/2016.11.JNS161688</ELocationID><ELocationID EIdType="pii" ValidYN="Y">2016.11.JNS161688</ELocationID><Abstract><AbstractText>OBJECTIVE The purpose of this study was to evaluate treatment outcomes of future stroke prevention, perioperative complications, and angiographic revascularization in adults with symptomatic moyamoya disease (MMD) according to treatment modalities and surgical techniques. METHODS A systemic literature review was performed based on searches of the PubMed, Embase, and Cochrane Central databases. A fixed-effects model was used in cases of heterogeneity less than 50%. Publication bias was determined by Begg's funnel plot, Egger's test of the intercept, and the Begg and Mazumdar rank correlation test. RESULTS Eleven articles were included in the meta-analysis. Bypass surgery significantly decreased the future stroke events compared with conservative treatments in adult MMD (odds ratio [OR] 0.301, p &lt; 0.001). Direct bypass showed better future stroke prevention than indirect bypass (OR 0.494, p = 0.028). There was no meaningful difference in perioperative complications between direct and indirect bypass (OR 0.665, p = 0.176). Direct bypass was associated with better angiographic outcomes than indirect bypass (OR 6.832, p &lt; 0.001). CONCLUSIONS Bypass surgery can be effective in preventing future stoke events in adults with MMD. Direct bypass seems to provide better risk reduction with respect to stroke than indirect bypass in these patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jeon</LastName><ForeName>Jin Pyeong</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>1Department of Neurosurgery, Hallym University College of Medicine, Chuncheon; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jeong Eun</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>2Department of Neurosurgery, Seoul National University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Won-Sang</ForeName><Initials>WS</Initials><AffiliationInfo><Affiliation>2Department of Neurosurgery, Seoul National University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bang</LastName><ForeName>Jae Seung</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>2Department of Neurosurgery, Seoul National University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Son</LastName><ForeName>Young-Je</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>2Department of Neurosurgery, Seoul National University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Chang Wan</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>2Department of Neurosurgery, Seoul National University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>05</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosurg</MedlineTA><NlmUniqueID>0253357</NlmUniqueID><ISSNLinking>0022-3085</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Neurosurg. 2018 Jul;129(1):270-273. doi: 10.3171/2017.10.JNS172628.</RefSource><PMID Version="1">29726767</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D002533" MajorTopicYN="N">Cerebral Angiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002548" MajorTopicYN="N">Cerebral Revascularization</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009072" MajorTopicYN="N">Moyamoya Disease</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CI = confidence interval</Keyword><Keyword MajorTopicYN="N">ICA = internal carotid artery</Keyword><Keyword MajorTopicYN="N">MCA = middle cerebral artery</Keyword><Keyword MajorTopicYN="N">MMD = moyamoya disease</Keyword><Keyword MajorTopicYN="N">NOS = Newcastle-Ottawa Scale</Keyword><Keyword MajorTopicYN="N">OR = odds ratio</Keyword><Keyword MajorTopicYN="N">TIA = transient ischemic attack</Keyword><Keyword MajorTopicYN="N">moyamoya disease</Keyword><Keyword MajorTopicYN="N">postoperative</Keyword><Keyword MajorTopicYN="N">stroke</Keyword><Keyword MajorTopicYN="N">vascular disorders</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28474994</ArticleId><ArticleId IdType="doi">10.3171/2016.11.JNS161688</ArticleId><ArticleId IdType="pii">2016.11.JNS161688</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36797071</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1526-632X</ISSN><JournalIssue CitedMedium="Internet"><Volume>100</Volume><Issue>16</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>18</Day></PubDate></JournalIssue><Title>Neurology</Title><ISOAbbreviation>Neurology</ISOAbbreviation></Journal><ArticleTitle>General Anesthesia Compared With Non-GA in Endovascular Thrombectomy for Ischemic Stroke: A Systematic Review and Meta-analysis of Randomized Controlled Trials.</ArticleTitle><Pagination><StartPage>e1655</StartPage><EndPage>e1663</EndPage><MedlinePgn>e1655-e1663</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1212/WNL.0000000000207066</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES">Endovascular thrombectomy (EVT) for large vessel occlusion ischemic stroke is either performed under general anesthesia (GA) or with non-GA techniques such as conscious sedation or local anesthesia alone. Previous small meta-analyses have demonstrated superior recanalization rates and improved functional recovery with GA when compared with non-GA techniques. The publication of further randomized controlled trials (RCTs) could provide updated guidance when choosing between GA and non-GA techniques.</AbstractText><AbstractText Label="METHODS">A systematic search for trials in which stroke EVT patients were randomized to GA or non-GA was performed in Medline, Embase, and the Cochrane Central Register of Controlled Trials. A systematic review and meta-analysis using a random-effects model was performed.</AbstractText><AbstractText Label="RESULTS">Seven RCTs were included in the systematic review and meta-analysis. These trials included a total of 980 participants (GA, N = 487; non-GA, N = 493). GA improves recanalization by 9.0% (GA 84.6% vs non-GA 75.6%; odds ratio [OR] 1.75, 95% CI 1.26-2.42, <i>p</i> = 0.0009), and the proportion of patients with functional recovery improves by 8.4% (GA 44.6% vs non-GA 36.2%; OR 1.43, 95% CI 1.04-1.98, <i>p</i> = 0.03). There was no difference in hemorrhagic complications or 3-month mortality.</AbstractText><AbstractText Label="DISCUSSION">In patients with ischemic stroke treated with EVT, GA is associated with higher recanalization rates and improved functional recovery at 3 months compared with non-GA techniques. Conversion to GA and subsequent intention-to-treat analysis will underestimate the true therapeutic benefit. GA is established as effective in improving recanalization rates in EVT (7 Class 1 studies) with a high Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) certainty rating. GA is established as effective in improving functional recovery at 3 months in EVT (5 Class 1 studies) with a moderate GRADE certainty rating. Stroke services need to develop pathways to incorporate GA as the first choice for most EVT procedures in acute ischemic stroke with a level A recommendation for recanalization and level B recommendation for functional recovery.</AbstractText><CopyrightInformation>&#xa9; 2023 American Academy of Neurology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Campbell</LastName><ForeName>Douglas</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>From the Auckland City Hospital (D.C., E.B.); University of Otago (R.B.C.), Dunedin; and University of Auckland (J.H., P.A.B.), New Zealand. dcampbell@adhb.govt.nz.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butler</LastName><ForeName>Elise</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>From the Auckland City Hospital (D.C., E.B.); University of Otago (R.B.C.), Dunedin; and University of Auckland (J.H., P.A.B.), New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campbell</LastName><ForeName>Ruby Blythe</ForeName><Initials>RB</Initials><AffiliationInfo><Affiliation>From the Auckland City Hospital (D.C., E.B.); University of Otago (R.B.C.), Dunedin; and University of Auckland (J.H., P.A.B.), New Zealand. dcampbell@adhb.govt.nz.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Jess</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>From the Auckland City Hospital (D.C., E.B.); University of Otago (R.B.C.), Dunedin; and University of Auckland (J.H., P.A.B.), New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barber</LastName><ForeName>P Alan</ForeName><Initials>PA</Initials><Identifier Source="ORCID">0000-0003-2469-9023</Identifier><AffiliationInfo><Affiliation>From the Auckland City Hospital (D.C., E.B.); University of Otago (R.B.C.), Dunedin; and University of Auckland (J.H., P.A.B.), New Zealand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurology</MedlineTA><NlmUniqueID>0401060</NlmUniqueID><ISSNLinking>0028-3878</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002545" MajorTopicYN="Y">Brain Ischemia</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017131" MajorTopicYN="N">Thrombectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000083242" MajorTopicYN="Y">Ischemic Stroke</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="Y">Endovascular Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors report no relevant disclosures. Go to Neurology.org/N for full disclosures.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>16</Day><Hour>21</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36797071</ArticleId><ArticleId IdType="pmc">PMC10115505</ArticleId><ArticleId IdType="doi">10.1212/WNL.0000000000207066</ArticleId><ArticleId IdType="pii">WNL.0000000000207066</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van den Berg LA, Koelman DLH, Berkhemer OA, et al. . Type of anesthesia and differences in clinical outcome after intra-arterial treatment for ischemic stroke. Stroke. 2015;46(5):1257-1262. doi:10.1161/STROKEAHA.115.008699.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.115.008699</ArticleId><ArticleId IdType="pubmed">25851766</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkhemer OA, van den Berg LA, Fransen PS, et al. . The effect of anesthetic management during intra-arterial therapy for acute stroke in MR CLEAN. Neurology. 2016;87(7):656-664. doi:10.1212/wnl.0000000000002976.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0000000000002976</ArticleId><ArticleId IdType="pubmed">27421546</ArticleId></ArticleIdList></Reference><Reference><Citation>Bekelis K, Missios S, MacKenzie TA, Tjoumakaris S, Jabbour P. Anesthesia technique and outcomes of mechanical thrombectomy in patients with acute ischemic stroke. Stroke. 2017;48(2):361-366. doi:10.1161/strokeaha.116.015343.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/strokeaha.116.015343</ArticleId><ArticleId IdType="pmc">PMC5263179</ArticleId><ArticleId IdType="pubmed">28070000</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell BCV, van Zwam WH, Goyal M, et al. . Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data. Lancet Neurol. 2018;17(1):47-53. doi:10.1016/S1474-4422(17)30407-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30407-6</ArticleId><ArticleId IdType="pubmed">29263006</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Jia L, Fang F, Ma L, Cai B, Faramand A. General anesthesia versus conscious sedation for intracranial mechanical thrombectomy: a systematic review and meta-analysis of randomized clinical trials. JAMA. 2019;8(12):e011754. doi:10.1161/jaha.118.011754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/jaha.118.011754</ArticleId><ArticleId IdType="pmc">PMC6645641</ArticleId><ArticleId IdType="pubmed">31181981</ArticleId></ArticleIdList></Reference><Reference><Citation>Schonenberger S, Henden PL, Simonsen CZ, et al. . Association of general anesthesia vs procedural sedation with functional outcome among patients with acute ischemic stroke undergoing thrombectomy: a systematic review and meta-analysis. JAMA. 2019;322(13):1283-1293. doi:10.1001/jama.2019.11455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.11455</ArticleId><ArticleId IdType="pmc">PMC6777267</ArticleId><ArticleId IdType="pubmed">31573636</ArticleId></ArticleIdList></Reference><Reference><Citation>Gravel G, Boulouis G, Benhassen W, et al. . Anaesthetic management during intracranial mechanical thrombectomy: systematic review and meta-analysis of current data. J Neurol Neurosurg Psychiatry. 2019;90(1):68-74. doi:10.1136/jnnp-2018-318549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-318549</ArticleId><ArticleId IdType="pubmed">30257967</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell D, Diprose WK, Deng C, Barber PA. General anesthesia versus conscious sedation in endovascular thrombectomy for stroke: a meta-analysis of 4 randomized controlled trials. J Neurosurg Anaesthesiol. 2021;33(1):21-27. doi:10.1097/ana.0000000000000646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ana.0000000000000646</ArticleId><ArticleId IdType="pubmed">31567645</ArticleId></ArticleIdList></Reference><Reference><Citation>Powers WJ, Rabinstein AA, Ackerson T, et al. . Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2018;49(3):e46-e99. doi:10.1161/STR.0000000000000158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STR.0000000000000158</ArticleId><ArticleId IdType="pubmed">29367334</ArticleId></ArticleIdList></Reference><Reference><Citation>Venema AM, Uyttenboogaart M, Absalom AR. Land of confusion: anaesthetic management during thrombectomy for acute ischaemic stroke. Br J Anaesth. 2019;122(3):300-304. doi:10.1016/j.bja.2018.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2018.12.004</ArticleId><ArticleId IdType="pubmed">30770046</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinsmore JE, Tan A. Anaesthesia for mechanical thrombectomy: a narrative review. Anaesthesia. 2022;77(suppl 1):59-68. doi:10.1111/anae.15586.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.15586</ArticleId><ArticleId IdType="pubmed">35001387</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng C, Campbell D, Diprose W, et al. . A pilot randomised controlled trial of the management of systolic blood pressure during endovascular thrombectomy for acute ischaemic stroke. Anaesthesia. 2020;75(6):739-746. doi:10.1111/anae.14940.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.14940</ArticleId><ArticleId IdType="pubmed">31833064</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurice A, Eugene F, Ronziere T, et al. . General anesthesia versus sedation, both with hemodynamic control, during intraarterial treatment for stroke: the GASS randomized trial. Anesthesiology. 2022;136(4):567-576. doi:10.1097/aln.0000000000004142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/aln.0000000000004142</ArticleId><ArticleId IdType="pubmed">35226737</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336-341. doi:10.1016/j.ijsu.2010.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2010.02.007</ArticleId><ArticleId IdType="pubmed">20171303</ArticleId></ArticleIdList></Reference><Reference><Citation>Accessed May 2, 2022. crd.york.ac.uk/prospero/display_record.php?ID=CRD42022315945.</Citation></Reference><Reference><Citation>Zaidat OO, Yoo AJ, Khatri P, et al. . Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke. 2013;44(9):2650-2663. doi:10.1161/strokeaha.113.001972.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/strokeaha.113.001972</ArticleId><ArticleId IdType="pmc">PMC4160883</ArticleId><ArticleId IdType="pubmed">23920012</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Sterne JAC, Savovi&#x107; J, et al. . A revised tool for assessing risk of bias in randomized trials. Cochrane Database Syst Rev. 2016;10:29-31.</Citation></Reference><Reference><Citation>Debray TPA, Moons KGM, Riley RD. Detecting small-study effects and funnel plot asymmetry in meta-analysis of survival data: a comparison of new and existing tests. Res Synth Methods. 2018;9(1):41-50. doi:10.1002/jrsm.1266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.1266</ArticleId><ArticleId IdType="pmc">PMC5873397</ArticleId><ArticleId IdType="pubmed">28975717</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, et al. . Grade: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-926. doi:10.1136/bmj.39489.470347.ad.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.ad</ArticleId><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Schonenberger S, Uhlmann L, Hacke W, et al. . Effect of conscious sedation vs general anesthesia on early neurological improvement among patients with ischemic stroke undergoing endovascular thrombectomy. JAMA. 2016;316(19):1986-1996. doi:10.1001/jama.2016.16623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.16623</ArticleId><ArticleId IdType="pubmed">27785516</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;whagen Hend&#xe9;n P, Rentzos A, Karlsson JE, et al. . General anesthesia versus conscious sedation for endovascular treatment of acute ischemic stroke. Stroke. 2017;48(6):1601-1607. doi:10.1161/strokeaha.117.016554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/strokeaha.117.016554</ArticleId><ArticleId IdType="pubmed">28522637</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonsen CZ, Yoo AJ, Sorensen LH, et al. . Effect of general anesthesia and conscious sedation during endovascular therapy on infarct growth and clinical outcomes in acute ischemic stroke. JAMA Neurol. 2018;75(4):470. doi:10.1001/jamaneurol.2017.4474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.4474</ArticleId><ArticleId IdType="pmc">PMC5885172</ArticleId><ArticleId IdType="pubmed">29340574</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, Liang F, Wu Y, et al. . Choice of ANesthesia for EndoVAScular Treatment of Acute Ischemic Stroke (CANVAS): results of the CANVAS pilot randomized controlled trial. J Neurosurg Anesthesiol. 2020;32(1):41-47. doi:10.1097/ana.0000000000000567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ana.0000000000000567</ArticleId><ArticleId IdType="pubmed">30531556</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren C, Xu G, Liu Y, Liu G, Wang J, Gao J. Effect of conscious sedation vs. general anesthesia on outcomes in patients undergoing mechanical thrombectomy for acute ischemic stroke: a prospective randomized clinical trial. Front Neurol. 2020;11:170. doi:10.3389/fneur.2020.00170.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00170</ArticleId><ArticleId IdType="pmc">PMC7105779</ArticleId><ArticleId IdType="pubmed">32265821</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu G, Shi Z, Li B, Shao W, Xu B. General anesthesia versus monitored anesthesia care during endovascular therapy for vertebrobasilar stroke. Am J Transl Res. 2021;13(3):1558-1567.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014376</ArticleId><ArticleId IdType="pubmed">33841679</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal M, Menon BK, van Zwam WH, et al. . Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387(10029):1723-1731. doi:10.1016/s0140-6736(16)00163-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(16)00163-x</ArticleId><ArticleId IdType="pubmed">26898852</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti A, Iacopino DG, Fodale V, Micalizzi S, Penna O, Santamaria L. Cerebral haemodynamic changes during propofol-remifentanil or sevoflurane anaesthesia: transcranial Doppler study under bispectral index monitoring. Br J Anaesth. 2006;97(3):333-339. doi:10.1093/bja/ael169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/ael169</ArticleId><ArticleId IdType="pubmed">16829673</ArticleId></ArticleIdList></Reference><Reference><Citation>Strebel S, Lam AM, Matta B, Mayberg TS, Aaslid R, Newell DW. Dynamic and static cerebral autoregulation during isoflurane, desflurane, and propofol anesthesia. Anesthesiology. 1995;83(1):66-76. doi:10.1097/00000542-199507000-00008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199507000-00008</ArticleId><ArticleId IdType="pubmed">7605020</ArticleId></ArticleIdList></Reference><Reference><Citation>Oshima T, Karasawa F, Okazaki Y, Wada H, Satoh T. Effects of sevoflurane on cerebral blood flow and cerebral metabolic rate of oxygen in human beings: a comparison with isoflurane. Eur J Anaesthesiol. 2005;20(7):543-547. doi:10.1017/s0265021503000863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s0265021503000863</ArticleId><ArticleId IdType="pubmed">12884987</ArticleId></ArticleIdList></Reference><Reference><Citation>Archer DP, Walker AM, McCann SK, Moser JJ, Appireddy RM. Anesthetic neuroprotection in experimental stroke in rodents: a systematic review and meta-analysis. Anesthesiology. 2017;126(4):653-665. doi:10.1097/aln.0000000000001534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/aln.0000000000001534</ArticleId><ArticleId IdType="pmc">PMC5354268</ArticleId><ArticleId IdType="pubmed">28182585</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishida K, Berger M, Nadler J, Warner D. Anesthetic neuroprotection: antecedents and an appraisal of preclinical and clinical data quality. Curr Pharm Des. 2014;20(36):5751-5765. doi:10.2174/1381612820666140204111701.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612820666140204111701</ArticleId><ArticleId IdType="pubmed">24502575</ArticleId></ArticleIdList></Reference><Reference><Citation>Zwerus R, Absalom A. Update on anesthetic neuroprotection. Curr Opin Anaesthesiol. 2015;28(4):424-430. doi:10.1097/aco.0000000000000212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/aco.0000000000000212</ArticleId><ArticleId IdType="pubmed">26087268</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell D, Deng C, McBryde F, et al. . Protocol for the MAnagement of Systolic blood pressure during Thrombectomy by Endovascular Route for acute ischemic STROKE randomized clinical trial: the MASTERSTROKE trial. Int J Stroke. 2021;17(7):810-814. doi:10.1177/17474930211059029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17474930211059029</ArticleId><ArticleId IdType="pubmed">34806930</ArticleId></ArticleIdList></Reference><Reference><Citation>Identifier ACTRN12621000074897. The feasibility and efficacy of a randomised controlled trial of propofol versus sevoflurane general anaesthesia on neurological recovery following endovascular clot retrieval in ischaemic stroke: PROSPER. Australia and New Zealand Clinical Trial Registry. Accessed May 1, 2022. anzctr.org.au.</Citation></Reference><Reference><Citation>Identifier NCT05051397. CO2 Modulation in Endovascular Thrombectomy for Acute Ischemic Stroke (COMET-AIS). ClinicalTrials.gov. NIH U.S. National Library of Medicine. Accessed May 1, 2022. clinicaltrials.gov/ct2/show/NCT03263117.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">28302610</PMID><DateCompleted><Year>2017</Year><Month>12</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1936-959X</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>5</Issue><PubDate><Year>2017</Year><Month>May</Month></PubDate></JournalIssue><Title>AJNR. American journal of neuroradiology</Title><ISOAbbreviation>AJNR Am J Neuroradiol</ISOAbbreviation></Journal><ArticleTitle>Selective-versus-Standard Poststent Dilation for Carotid Artery Disease: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>999</StartPage><EndPage>1005</EndPage><MedlinePgn>999-1005</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3174/ajnr.A5103</ELocationID><Abstract><AbstractText Label="BACKROUND" NlmCategory="BACKGROUND">The safety and efficacy of standard poststent angioplasty in patients undergoing carotid artery stent placement have not been well-established.</AbstractText><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">We conducted a systematic review of the literature to evaluate the safety and efficacy of carotid artery stent placement and analyzed outcomes of standard-versus-selective poststent angioplasty.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">A systematic search of MEDLINE, EMBASE, Scopus, and the Web of Science was performed for studies published between January 2000 and January 2015.</AbstractText><AbstractText Label="STUDY SELECTION" NlmCategory="METHODS">We included studies with &gt;30 patients describing standard or selective poststent angioplasty during carotid artery stent placement.</AbstractText><AbstractText Label="DATA ANALYSIS" NlmCategory="METHODS">A random-effects meta-analysis was used to pool the following outcomes: periprocedural stroke/TIA, procedure-related neurologic/cardiovascular morbidity/mortality, bradycardia/hypotension, long-term stroke at last follow-up, long-term primary patency, and technical success.</AbstractText><AbstractText Label="DATA SYNTHESIS" NlmCategory="RESULTS">We included 87 studies with 19,684 patients with 20,378 carotid artery stenoses. There was no difference in clinical (<i>P</i> = .49) or angiographic outcomes (<i>P</i> = .93) in carotid artery stent placement treatment with selective or standard poststent balloon angioplasty. Both selective and standard poststent angioplasty groups had a very high technical success of &gt;98% and a low procedure-related mortality of 0.9%. There were no significant differences between both groups in the incidence of restenosis (<i>P</i> = .93) or procedure-related complications (<i>P</i> = .37).</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">No comparison to a patient group without poststent dilation could be performed.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our meta-analysis demonstrated no significant difference in angiographic and clinical outcomes among series that performed standard poststent angioplasty and those that performed poststent angioplasty in only select patients.</AbstractText><CopyrightInformation>&#xa9; 2017 by American Journal of Neuroradiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Petr</LastName><ForeName>O</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-2258-1032</Identifier><AffiliationInfo><Affiliation>From the Departments of Neurologic Surgery (O.P., G.L.) petr.ondra@mayo.edu ondra.petr@yahoo.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurosurgery (O.P.), Medical University Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brinjikji</LastName><ForeName>W</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0001-5271-5524</Identifier><AffiliationInfo><Affiliation>Radiology (W.B., G.L.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murad</LastName><ForeName>M H</ForeName><Initials>MH</Initials><Identifier Source="ORCID">0000-0001-5502-5975</Identifier><AffiliationInfo><Affiliation>Division of Preventive Medicine (M.H.M.), Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glodny</LastName><ForeName>B</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-1504-1377</Identifier><AffiliationInfo><Affiliation>Departments of Radiology (B.G.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lanzino</LastName><ForeName>G</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-1479-465X</Identifier><AffiliationInfo><Affiliation>From the Departments of Neurologic Surgery (O.P., G.L.).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radiology (W.B., G.L.).</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>03</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AJNR Am J Neuroradiol</MedlineTA><NlmUniqueID>8003708</NlmUniqueID><ISSNLinking>0195-6108</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>AJNR Am J Neuroradiol. 2017 Nov;38(11):E98. doi: 10.3174/ajnr.A5435.</RefSource><PMID Version="1">29051206</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>AJNR Am J Neuroradiol. 2017 Nov;38(11):E97. doi: 10.3174/ajnr.A5346.</RefSource><PMID Version="1">29051210</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000800" MajorTopicYN="N">Angioplasty, Balloon</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016893" MajorTopicYN="N">Carotid Stenosis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018579" MajorTopicYN="N">Patient Selection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015607" MajorTopicYN="Y">Stents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28302610</ArticleId><ArticleId IdType="pmc">PMC7960390</ArticleId><ArticleId IdType="doi">10.3174/ajnr.A5103</ArticleId><ArticleId IdType="pii">ajnr.A5103</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ricotta JJ 2nd, Piazza M. Carotid endarterectomy or carotid artery stenting? Matching the patient to the intervention. Perspect Vasc Surg Endovasc Ther 2010;22:124&#x2013;36 10.1177/1531003510381136</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1531003510381136</ArticleId><ArticleId IdType="pubmed">20858617</ArticleId></ArticleIdList></Reference><Reference><Citation>Ederle J, Bonati LH, Dobson J, et al. ; CAVATAS Investigators. Endovascular treatment with angioplasty or stenting versus endarterectomy in patients with carotid artery stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): long-term follow-up of a randomised trial. Lancet Neurol 2009;8:898&#x2013;907 10.1016/S1474-4422(09)70228-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(09)70228-5</ArticleId><ArticleId IdType="pmc">PMC2755037</ArticleId><ArticleId IdType="pubmed">19717345</ArticleId></ArticleIdList></Reference><Reference><Citation>Ederle J, Dobson J, Featherstone RL, et al. ; International Carotid Stenting Study investigators. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial. Lancet 2010;375:985&#x2013;97 10.1016/S0140-6736(10)60239-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)60239-5</ArticleId><ArticleId IdType="pmc">PMC2849002</ArticleId><ArticleId IdType="pubmed">20189239</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadav JS, Wholey MH, Kuntz RE, et al. ; Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy Investigators. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004;351:1493&#x2013;501 10.1056/NEJMoa040127</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa040127</ArticleId><ArticleId IdType="pubmed">15470212</ArticleId></ArticleIdList></Reference><Reference><Citation>Brott TG, Hobson RW 2nd, Howard G, et al. ; CREST Investigators. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 2010;363:11&#x2013;23 10.1056/NEJMoa0912321</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0912321</ArticleId><ArticleId IdType="pmc">PMC2932446</ArticleId><ArticleId IdType="pubmed">20505173</ArticleId></ArticleIdList></Reference><Reference><Citation>North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445&#x2013;53 10.1056/NEJM199108153250701</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199108153250701</ArticleId><ArticleId IdType="pubmed">1852179</ArticleId></ArticleIdList></Reference><Reference><Citation>Kachel R. Results of balloon angioplasty in the carotid arteries. J Endovasc Surg 1996;3:22&#x2013;30</Citation><ArticleIdList><ArticleId IdType="pubmed">8798123</ArticleId></ArticleIdList></Reference><Reference><Citation>Gil-Peralta A, Mayol A, Marcos JR, et al. . Percutaneous transluminal angioplasty of the symptomatic atherosclerotic carotid arteries: results, complications, and follow-up. Stroke 1996;27:2271&#x2013;73 10.1161/01.STR.27.12.2271</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.STR.27.12.2271</ArticleId><ArticleId IdType="pubmed">8969792</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerber CW, Cromwell LD, Loehden OL. Catheter dilatation of proximal carotid stenosis during distal bifurcation endarterectomy. AJNR Am J Neuroradiol 1980;1:348&#x2013;49</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8332516</ArticleId><ArticleId IdType="pubmed">6779610</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson GG, Eliasziw M, Barr HW, et al. . The North American Symptomatic Carotid Endarterectomy Trial: surgical results in 1415 patients. Stroke 1999;30:1751&#x2013;58 10.1161/01.STR.30.9.1751</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.STR.30.9.1751</ArticleId><ArticleId IdType="pubmed">10471419</ArticleId></ArticleIdList></Reference><Reference><Citation>Phatouros CC, Higashida RT, Malek AM, et al. . Carotid artery stent placement for atherosclerotic disease: rationale, technique, and current status. Radiology 2000;217:26&#x2013;41 10.1148/radiology.217.1.r00oc2526</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiology.217.1.r00oc2526</ArticleId><ArticleId IdType="pubmed">11012420</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathur A, Dorros G, Iyer SS, et al. . Palmaz stent compression in patients following carotid artery stenting. Cathet Cardiovasc Diag 1997;41:137&#x2013;40</Citation><ArticleIdList><ArticleId IdType="pubmed">9184284</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin JB, Pache JC, Treggiari-Venzi M, et al. . Role of the distal balloon protection technique in the prevention of cerebral embolic events during carotid stent placement. Stroke 2001;32:479&#x2013;84</Citation><ArticleIdList><ArticleId IdType="pubmed">11157186</ArticleId></ArticleIdList></Reference><Reference><Citation>Manninen HI, R&#xe4;s&#xe4;nen HT, Vanninen RL, et al. . Stent placement versus percutaneous transluminal angioplasty of human carotid arteries in cadavers in situ: distal embolization and findings at intravascular US, MR imaging and histopathologic analysis. Radiology 1999;212:483&#x2013;92 10.1148/radiology.212.2.r99au48483</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiology.212.2.r99au48483</ArticleId><ArticleId IdType="pubmed">10429707</ArticleId></ArticleIdList></Reference><Reference><Citation>Vos JA, van den Berg JC, Ernst SM, et al. . Carotid angioplasty and stent placement: comparison of transcranial Doppler US data and clinical outcome with and without filtering cerebral protection devices in 509 patients. Radiology 2005;234:493&#x2013;99 10.1148/radiol.2342040119</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2342040119</ArticleId><ArticleId IdType="pubmed">15616120</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta R, Abou-Chebl A, Bajzer CT, et al. . Rate, predictors, and consequences of hemodynamic depression after carotid artery stenting. J Am Coll Cardiol 2006;47:1538&#x2013;43 10.1016/j.jacc.2005.08.079</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2005.08.079</ArticleId><ArticleId IdType="pubmed">16630988</ArticleId></ArticleIdList></Reference><Reference><Citation>Howell M, Krajcer Z, Dougherty K, et al. . Correlation of periprocedural systolic blood pressure changes with neurological events in high-risk carotid stent patients. J Endovasc Ther 2002;9:810&#x2013;16 10.1177/152660280200900614</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/152660280200900614</ArticleId><ArticleId IdType="pubmed">12546582</ArticleId></ArticleIdList></Reference><Reference><Citation>Park BD, Divinagracia T, Madej O, et al. . Predictors of clinically significant postprocedural hypotension after carotid endarterectomy and carotid angioplasty with stenting. J Vasc Surg 2009;50:526&#x2013;33 10.1016/j.jvs.2009.05.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2009.05.005</ArticleId><ArticleId IdType="pubmed">19700091</ArticleId></ArticleIdList></Reference><Reference><Citation>Qazi U, Obeid TE, Enwerem N, et al. . The effect of ballooning following carotid stent deployment on hemodynamic stability. J Vasc Surg 2014;59:756&#x2013;60 10.1016/j.jvs.2013.09.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2013.09.027</ArticleId><ArticleId IdType="pubmed">24342066</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghandehari K, Edraki K, Karimi M, et al. . Complications of angioplasty and stenting of cervicocerebral arteries in Iran. Asian Cardiovasc Thorac Ann 2010;18:49&#x2013;53 10.1177/0218492309355598</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0218492309355598</ArticleId><ArticleId IdType="pubmed">20124297</ArticleId></ArticleIdList></Reference><Reference><Citation>Ielasi A, Latib A, Godino C, et al. . Clinical outcomes following protected carotid artery stenting in symptomatic and asymptomatic patients. J Endovasc Ther 2010;17:298&#x2013;307 10.1583/09-2997.1</Citation><ArticleIdList><ArticleId IdType="doi">10.1583/09-2997.1</ArticleId><ArticleId IdType="pubmed">20557166</ArticleId></ArticleIdList></Reference><Reference><Citation>Micari A, Stabile E, Cremonesi A, et al. . Carotid artery stenting in octogenarians using a proximal endovascular occlusion cerebral protection device: a multicenter registry. Catheter Cardiovasc Interv 2010;76:9&#x2013;15 10.1002/ccd.22503</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.22503</ArticleId><ArticleId IdType="pubmed">20578188</ArticleId></ArticleIdList></Reference><Reference><Citation>Montorsi P, Galli S, Ravagnani P, et al. . Randomized trial of predilation versus direct stenting for treatment of carotid artery stenosis. Int J Cardiol 2010;138:233&#x2013;38 10.1016/j.ijcard.2008.08.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2008.08.012</ArticleId><ArticleId IdType="pubmed">18793813</ArticleId></ArticleIdList></Reference><Reference><Citation>Stabile E, Salemme L, Sorropago G, et al. . Proximal endovascular occlusion for carotid artery stenting: results from a prospective registry of 1,300 patients. J Am Coll Cardiol 2010;55:1661&#x2013;67 10.1016/j.jacc.2009.11.079</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2009.11.079</ArticleId><ArticleId IdType="pubmed">20394868</ArticleId></ArticleIdList></Reference><Reference><Citation>Almekhlafi MA, Couillard PL, Pandya A, et al. . Outcomes after carotid angioplasty and stenting in symptomatic octogenarians. Can J Neurol Sci 2011;38:446&#x2013;51 10.1017/S0317167100011859</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0317167100011859</ArticleId><ArticleId IdType="pubmed">21515504</ArticleId></ArticleIdList></Reference><Reference><Citation>Satya K, Dougherty K, Lee VV, et al. . Determinants and outcomes of asystole during carotid artery stenting. J Endovasc Ther 2011;18:513&#x2013;17 10.1583/11-3516R.1</Citation><ArticleIdList><ArticleId IdType="doi">10.1583/11-3516R.1</ArticleId><ArticleId IdType="pubmed">21861740</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimiagar I, Gur AY, Auriel E, et al. . Long-term follow-up of patients after carotid stenting with or without distal protective device in a single tertiary medical center. Vasc Endovasc Surg 2012;46:536&#x2013;41 10.1177/1538574412457471</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1538574412457471</ArticleId><ArticleId IdType="pubmed">22903330</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzaccaro D, Occhiuto MT, Stegher S, et al. . Long-term results of carotid artery stenting in patients 80 years and older. Perspect Vasc Surg Endovasc Ther 2012;24:49&#x2013;54 10.1177/1531003512459913</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1531003512459913</ArticleId><ArticleId IdType="pubmed">22965950</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammadian R, Sohrabi B, Mansourizadeh R, et al. . Unprotected carotid artery stenting: complications in 6 months follow-up. Neuroradiology 2012;54:225&#x2013;30 10.1007/s00234-011-0867-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00234-011-0867-x</ArticleId><ArticleId IdType="pubmed">21479568</ArticleId></ArticleIdList></Reference><Reference><Citation>Dumont TM, Wach MM, Mokin M, et al. . Perioperative complications after carotid artery stenting: a contemporary experience from the University at Buffalo neuroendovascular surgery team. Neurosurgery 2013;73:689&#x2013;93; discussion 693&#x2013;94 10.1227/NEU.0000000000000077</Citation><ArticleIdList><ArticleId IdType="doi">10.1227/NEU.0000000000000077</ArticleId><ArticleId IdType="pubmed">23842555</ArticleId></ArticleIdList></Reference><Reference><Citation>Lago A, Parkhutik V, Tembl JI, et al. . Diabetes does not affect outcome of symptomatic carotid stenosis treated with endovascular techniques. Eur Neurol 2013;69:263&#x2013;69 10.1159/000346000</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000346000</ArticleId><ArticleId IdType="pubmed">23429066</ArticleId></ArticleIdList></Reference><Reference><Citation>Ullery BW, Orlova K, Shang EK, et al. . Results of carotid angioplasty and stenting are equivalent for critical versus high-grade lesions in patients deemed high risk for carotid endarterectomy. J Surg Res 2013;185:21&#x2013;26 10.1016/j.jss.2013.07.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2013.07.027</ArticleId><ArticleId IdType="pubmed">23953786</ArticleId></ArticleIdList></Reference><Reference><Citation>Biggs NG, Rangarajan S, McClure DN. Has carotid artery stenting found its place? A 10-year regional centre perspective. ANZ J Surg 2016;86:179&#x2013;83 10.1111/ans.12517</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ans.12517</ArticleId><ArticleId IdType="pubmed">24456223</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez-Fern&#xe1;ndez F, Parrilla G, Garcia-Villalba B, et al. . Comparison between proximal versus distal protection devices in 287 cases of carotid revascularization using angioplasty and stenting: periprocedure complications, morbidity, and mortality. Cardiovasc Intervent Radiol 2014;37:639&#x2013;45 10.1007/s00270-013-0714-z:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00270-013-0714-z</ArticleId><ArticleId IdType="pubmed">23912495</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan CE, Lee CJ, Chin JA, et al. . High-risk anatomic variables and plaque characteristics in carotid artery stenting. Vasc Endovascular Surg 2014;48:452&#x2013;59 10.1177/1538574414551577</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1538574414551577</ArticleId><ArticleId IdType="pubmed">25252921</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen JE, Gomori JM, Itshayek E, et al. . Ischemic complications after tailored carotid artery stenting in different subpopulations with high-grade stenosis: feared but rare. J Clin Neurosci 2015;22:189&#x2013;94 10.1016/j.jocn.2014.09.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2014.09.005</ArticleId><ArticleId IdType="pubmed">25444995</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogata A, Sonobe M, Kato N, et al. . Carotid artery stenting without post-stenting balloon dilatation. J Neurointerv Surg 2014;6:517&#x2013;20 10.1136/neurintsurg-2013-010873</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/neurintsurg-2013-010873</ArticleId><ArticleId IdType="pmc">PMC4145433</ArticleId><ArticleId IdType="pubmed">24014467</ArticleId></ArticleIdList></Reference><Reference><Citation>Oteros Fernandez R, Jimenez-Gomez E, Bravo-Rodriguez F, et al. . Unprotected carotid artery stenting in symptomatic patients with high-grade stenosis: results and long-term follow-up in a single-center experience. AJNR Am J Neuroradiol 2012;33:1285&#x2013;91 10.3174/ajnr.A2951</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A2951</ArticleId><ArticleId IdType="pmc">PMC7965519</ArticleId><ArticleId IdType="pubmed">22422184</ArticleId></ArticleIdList></Reference><Reference><Citation>Tallarita T, Rabinstein AA, Cloft H, et al. . Are distal protection devices &#x2018;protective&#x2019; during carotid angioplasty and stenting? Stroke 2011;42:1962&#x2013;66 10.1161/STROKEAHA.110.607820</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.110.607820</ArticleId><ArticleId IdType="pubmed">21566230</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansour OY, Weber J, Niesen W, et al. . Carotid angioplasty and stenting without protection devices: safety and efficacy concerns&#x2013;single center experience. Clin Neuroradiol 2011;21:65&#x2013;73 10.1007/s00062-011-0057-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00062-011-0057-6</ArticleId><ArticleId IdType="pubmed">21562830</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez A, Gil-Peralta A, Mayol A, et al. . Internal carotid artery stenting in patients with near occlusion: 30-day and long-term outcome. AJNR Am J Neuroradiol 2011;32:252&#x2013;58 10.3174/ajnr.A2285</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A2285</ArticleId><ArticleId IdType="pmc">PMC7965724</ArticleId><ArticleId IdType="pubmed">21051515</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177&#x2013;88 10.1016/0197-2456(86)90046-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-2456(86)90046-2</ArticleId><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ 2003;326:219 10.1136/bmj.326.7382.219</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.326.7382.219</ArticleId><ArticleId IdType="pmc">PMC1125071</ArticleId><ArticleId IdType="pubmed">12543843</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, et al. . Measuring inconsistency in meta-analyses. BMJ 2003;327:557&#x2013;60 10.1136/bmj.327.7414.557</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539&#x2013;58 10.1002/sim.1186</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1186</ArticleId><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubartelli P, Brusa G, Arrigo A, et al. . Transcranial Doppler monitoring during stenting of the carotid bifurcation: evaluation of two different distal protection devices in preventing embolization. J Endovasc Ther 2006;13:436&#x2013;42 10.1583/05-1804MR.1</Citation><ArticleIdList><ArticleId IdType="doi">10.1583/05-1804MR.1</ArticleId><ArticleId IdType="pubmed">16928156</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackerstaff RG, Suttorp MJ, van den Berg JC, et al. ; Antonius Carotid Endarterectomy, Angioplasty, and Stenting Study Group. Prediction of early cerebral outcome by transcranial Doppler monitoring in carotid bifurcation angioplasty and stenting. J Vasc Surg 2005;41:618&#x2013;24 10.1016/j.jvs.2005.01.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2005.01.034</ArticleId><ArticleId IdType="pubmed">15874925</ArticleId></ArticleIdList></Reference><Reference><Citation>Park B, Shapiro D, Dahn M, et al. . Carotid artery angioplasty with stenting and postprocedure hypotension. Am J Surg 2005;190:691&#x2013;95 10.1016/j.amjsurg.2005.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2005.07.004</ArticleId><ArticleId IdType="pubmed">16226941</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrish W, Grahovac S, Douen A, et al. . Intracranial hemorrhage after stenting and angioplasty of extracranial carotid stenosis. AJNR Am J Neuroradiol 2000;21:1911&#x2013;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7974294</ArticleId><ArticleId IdType="pubmed">11110546</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadi R, Schillinger M, Lang W, et al. . Carotid artery stenting in older patients: is age a risk factor for poor outcome? J Endovasc Ther 2002;9:559&#x2013;65 10.1177/152660280200900501</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/152660280200900501</ArticleId><ArticleId IdType="pubmed">12431135</ArticleId></ArticleIdList></Reference><Reference><Citation>Criado FJ, Lingelbach JM, Ledesma DF, et al. . Carotid artery stenting in a vascular surgery practice. J Vasc Surg 2002;35:430&#x2013;34 10.1067/mva.2002.121209</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mva.2002.121209</ArticleId><ArticleId IdType="pubmed">11877688</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson RW 2nd, Lal BK, Chakhtoura EY, et al. . Carotid artery closure for endarterectomy does not influence results of angioplasty-stenting for restenosis. J Vasc Surg 2002;35:435&#x2013;38 10.1067/mva.2002.122022</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mva.2002.122022</ArticleId><ArticleId IdType="pubmed">11877689</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao HL, Lin LY, Lu CJ, et al. . Long-term results of elective stenting for severe carotid artery stenosis in Taiwan. Cardiology 2002;97:89&#x2013;93 10.1159/000057678</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000057678</ArticleId><ArticleId IdType="pubmed">11978955</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonius Carotid Endaterectomy, Angioplasty, and Stenting Study Group. Transcranial Doppler monitoring in angioplasty and stenting of the carotid bifurcation. J Endovasc Ther 2003;10:702&#x2013;10 10.1177/152660280301000404</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/152660280301000404</ArticleId><ArticleId IdType="pubmed">14533974</ArticleId></ArticleIdList></Reference><Reference><Citation>Cernetti C, Reimers B, Picciolo A, et al. . Carotid artery stenting with cerebral protection in 100 consecutive patients: immediate and two-year follow-up results. Ital Heart J 2003;4:695&#x2013;700</Citation><ArticleIdList><ArticleId IdType="pubmed">14664282</ArticleId></ArticleIdList></Reference><Reference><Citation>Cremonesi A, Manetti R, Setacci F, et al. . Protected carotid stenting: clinical advantages and complications of embolic protection devices in 442 consecutive patients. Stroke 2003;34:1936&#x2013;41 10.1161/01.STR.0000081000.23561.61</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.STR.0000081000.23561.61</ArticleId><ArticleId IdType="pubmed">12843347</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuura M, Terada T, Matsumoto H, et al. . Clinical results of stenting for cervical internal carotid stenoses. Interv Neuroradiol 2003;9:133&#x2013;36</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3553468</ArticleId><ArticleId IdType="pubmed">20591242</ArticleId></ArticleIdList></Reference><Reference><Citation>Wholey MH, Wholey MH, Tan WA, et al. . A comparison of balloon-mounted and self-expanding stents in the carotid arteries: immediate and long-term results of more than 500 patients. J Endovasc Ther 2003;10:171&#x2013;81 10.1177/152660280301000203</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/152660280301000203</ArticleId><ArticleId IdType="pubmed">12877596</ArticleId></ArticleIdList></Reference><Reference><Citation>Eskandari MK, Longo GM, Vijungco JD, et al. . Does carotid stenting measure up to endarterectomy? A vascular surgeon's experience. Arch Surg 2004;139:734&#x2013;38 10.1001/archsurg.139.7.734</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.139.7.734</ArticleId><ArticleId IdType="pubmed">15249405</ArticleId></ArticleIdList></Reference><Reference><Citation>Faries PL, Dayal R, Clair DG, et al. . Continuity in the treatment of carotid artery disease: results of a carotid stenting program initiated by vascular surgeons. Ann Vasc Surg 2004;18:669&#x2013;76 10.1007/s10016-004-0101-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10016-004-0101-y</ArticleId><ArticleId IdType="pubmed">15599624</ArticleId></ArticleIdList></Reference><Reference><Citation>Kastrup A, Schulz JB, Raygrotzki S, et al. . Comparison of angioplasty and stenting with cerebral protection versus endarterectomy for treatment of internal carotid artery stenosis in elderly patients. J Vasc Surg 2004;40:945&#x2013;51 10.1016/j.jvs.2004.08.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2004.08.022</ArticleId><ArticleId IdType="pubmed">15557909</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadato A, Satow T, Ishii A, et al. . Use of a large angioplasty balloon for predilation is a risk factor for embolic complications in protected carotid stenting. Neurol Med Chir (Tokyo) 2004;44:337&#x2013;42; discussion 343 10.2176/nmc.44.337</Citation><ArticleIdList><ArticleId IdType="doi">10.2176/nmc.44.337</ArticleId><ArticleId IdType="pubmed">15347209</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaldi G, Aiazzi L, Baruzzi F, et al. . Angioplasty and stenting of the cervical carotid bifurcation under filter protection: a prospective study in a series of 53 patients. J Neuroradiol 2005;32:109&#x2013;17 10.1016/S0150-9861(05)83125-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0150-9861(05)83125-6</ArticleId><ArticleId IdType="pubmed">15984402</ArticleId></ArticleIdList></Reference><Reference><Citation>Cayne NS, Faries PL, Trocciola SM, et al. . Carotid angioplasty and stent-induced bradycardia and hypotension: impact of prophylactic atropine administration and prior carotid endarterectomy. J Vasc Surg 2005;41:956&#x2013;61 10.1016/j.jvs.2005.02.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2005.02.038</ArticleId><ArticleId IdType="pubmed">15944593</ArticleId></ArticleIdList></Reference><Reference><Citation>Coppi G, Moratto R, Silingardi R, et al. . PRIAMUS: proximal flow blockage cerebral protection during carotid stenting&#x2014;results from a multicenter Italian registry. J Cardiovasc Surg (Torino) 2005;46:219&#x2013;27</Citation><ArticleIdList><ArticleId IdType="pubmed">15956919</ArticleId></ArticleIdList></Reference><Reference><Citation>Eskandari MK, Longo GM, Matsumura JS, et al. . Carotid stenting done exclusively by vascular surgeons: first 175 cases. Ann Surg 2005;242:431&#x2013;36; discussion 436&#x2013;38</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1357751</ArticleId><ArticleId IdType="pubmed">16135929</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadkhodayan Y, Derdeyn CP, Cross DT 3rd, et al. . Procedure complications of carotid angioplasty and stent placement without cerebral protection devices. Neurosurg Focus 2005;18:e1</Citation><ArticleIdList><ArticleId IdType="pubmed">15669795</ArticleId></ArticleIdList></Reference><Reference><Citation>Li SM, Li D, Ling F, et al. . Carotid artery stenting: experience of a single institute in China. Interv Neuroradiol 2005;11:205&#x2013;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3404774</ArticleId><ArticleId IdType="pubmed">20584476</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin PH, Bush RL, Peden EK, et al. . Carotid artery stenting with neuroprotection: assessing the learning curve and treatment outcome. Am J Surg 2005;190:850&#x2013;57 10.1016/j.amjsurg.2005.08.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2005.08.008</ArticleId><ArticleId IdType="pubmed">16307933</ArticleId></ArticleIdList></Reference><Reference><Citation>Longo GM, Kibbe MR, Eskandari MK. Carotid artery stenting in octogenarians: is it too risky? Ann Vasc Surg 2005;19:812&#x2013;16 10.1007/s10016-005-7977-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10016-005-7977-z</ArticleId><ArticleId IdType="pubmed">16200469</ArticleId></ArticleIdList></Reference><Reference><Citation>Reimers B, Sievert H, Schuler GC, et al. . Proximal endovascular flow blockage for cerebral protection during carotid artery stenting: results from a prospective multicenter registry. J Endovasc Ther 2005;12:156&#x2013;65 10.1583/04-1400MR.1</Citation><ArticleIdList><ArticleId IdType="doi">10.1583/04-1400MR.1</ArticleId><ArticleId IdType="pubmed">15823062</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaer RA, Derubertis BG, Trocciola SM, et al. . Safety and efficacy of carotid angioplasty and stenting in high-risk patients. Am Surg 2006;72:694&#x2013;98; discussion 698&#x2013;99</Citation><ArticleIdList><ArticleId IdType="pubmed">16913312</ArticleId></ArticleIdList></Reference><Reference><Citation>Faries PL, Trocciola SM, De Rubertis B, et al. . Hemodynamic instability after carotid artery angioplasty and stening is associated with increased age and female gender. Vas Dis Management 2006;3:200&#x2013;05</Citation></Reference><Reference><Citation>Gr&#xf6;schel K, Ernemann U, Schulz JB, et al. . Statin therapy at carotid angioplasty and stent placement: effect on procedure-related stroke, myocardial infarction, and death. Radiology 2006;240:145&#x2013;51 10.1148/radiol.2401050603</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2401050603</ArticleId><ArticleId IdType="pubmed">16793975</ArticleId></ArticleIdList></Reference><Reference><Citation>Halabi M, Gruberg L, Pitchersky S, et al. . Carotid artery stenting in surgical high-risk patients. Catheter Cardiovasc Interv 2006;67:513&#x2013;18 10.1002/ccd.20640</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.20640</ArticleId><ArticleId IdType="pubmed">16534816</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon BJ, Han MH, Kang HS, et al. . Protection filter-related events in extracranial carotid artery stenting: a single-center experience. J Endovasc Ther 2006;13:711&#x2013;22 10.1583/06-1900.1</Citation><ArticleIdList><ArticleId IdType="doi">10.1583/06-1900.1</ArticleId><ArticleId IdType="pubmed">17154708</ArticleId></ArticleIdList></Reference><Reference><Citation>Nano G, Dalainas I, Bianchi P, et al. . Ballooning-induced bradycardia during carotid stenting in primary stenosis and restenosis. Neuroradiology 2006;48:533&#x2013;36 10.1007/s00234-006-0096-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00234-006-0096-x</ArticleId><ArticleId IdType="pubmed">16670918</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotroneo AR, Iezzi R. Cutting balloon angioplasty (CBA) versus conventional balloon angioplasty (PTA) in the pre-dilatation of carotid artery stenosis: our preliminary experience. Cardiovasc Intervent Radiol 2007;30:1210&#x2013;17 10.1007/s00270-007-9171-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00270-007-9171-x</ArticleId><ArticleId IdType="pubmed">17909883</ArticleId></ArticleIdList></Reference><Reference><Citation>Criado E, Fontcuberta J, Orgaz A, et al. . Transcervical carotid stenting with carotid artery flow reversal: 3-year follow-up of 103 stents. J Vasc Surg 2007;46:864&#x2013;69 10.1016/j.jvs.2007.07.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2007.07.028</ArticleId><ArticleId IdType="pubmed">17980271</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawarada O, Yokoi Y, Takemoto K, et al. . Double-wire technique in balloon-protected carotid artery stenting. J Interv Cardio 2007;20:55&#x2013;62 10.1111/j.1540-8183.2007.00218.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8183.2007.00218.x</ArticleId><ArticleId IdType="pubmed">17300405</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin PH, Zhou W, Kougias P, et al. . Factors associated with hypotension and bradycardia after carotid angioplasty and stenting. J Vasc Surg 2007;46:846&#x2013;53; discussion 853&#x2013;54 10.1016/j.jvs.2007.07.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2007.07.020</ArticleId><ArticleId IdType="pubmed">17980268</ArticleId></ArticleIdList></Reference><Reference><Citation>Maynar M, Baldi S, Rostagno R, et al. . Carotid stenting without use of balloon angioplasty and distal protection devices: preliminary experience in 100 cases. AJNR Am J Neuroradiol 2007;28:1378&#x2013;83 10.3174/ajnr.A0543</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A0543</ArticleId><ArticleId IdType="pmc">PMC7977659</ArticleId><ArticleId IdType="pubmed">17698546</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Heyden J, Suttorp MJ, Bal ET, et al. . Staged carotid angioplasty and stenting followed by cardiac surgery in patients with severe asymptomatic carotid artery stenosis: early and long-term results. Circulation 2007;116:2036&#x2013;42 10.1161/CIRCULATIONAHA.106.658625</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.658625</ArticleId><ArticleId IdType="pubmed">17938290</ArticleId></ArticleIdList></Reference><Reference><Citation>Younis GA, Gupta K, Mortazavi A, et al. . Predictors of carotid stent restenosis. Catheter Cardiovasc Interv 2007;69:673&#x2013;82 10.1002/ccd.20809</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.20809</ArticleId><ArticleId IdType="pubmed">17351931</ArticleId></ArticleIdList></Reference><Reference><Citation>AbuRahma AF, Bates MC, Eads K, et al. . Safety and efficacy of carotid angioplasty/stenting in 100 consecutive high surgical risk patients: immediate and long-term follow-up. Vasc Endovasc Surg 2008;42:433&#x2013;39 10.1177/1538574408318477</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1538574408318477</ArticleId><ArticleId IdType="pubmed">18583300</ArticleId></ArticleIdList></Reference><Reference><Citation>Bussi&#xe8;re M, Pelz DM, Kalapos P, et al. . Results using a self-expanding stent alone in the treatment of severe symptomatic carotid bifurcation stenosis. J Neurosurg 2008;109:454&#x2013;60 10.3171/JNS/2008/109/9/0454</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/JNS/2008/109/9/0454</ArticleId><ArticleId IdType="pubmed">18759576</ArticleId></ArticleIdList></Reference><Reference><Citation>Bussi&#xe8;re M, Lownie SP, Lee D, et al. . Hemodynamic instability during carotid artery stenting: the relative contribution of stent deployment versus balloon dilation. J Neurosurg 2009;110:905&#x2013;12 10.3171/2008.9.JNS08509</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2008.9.JNS08509</ArticleId><ArticleId IdType="pubmed">19231933</ArticleId></ArticleIdList></Reference><Reference><Citation>Buszman P, Debi&#x144;ski M, Gruszka A, et al. . Early and late outcomes of percutaneous transluminal angioplasty of cephalad arteries. Kardiol Pol 2008;66:233&#x2013;42, discussion 243</Citation><ArticleIdList><ArticleId IdType="pubmed">18393110</ArticleId></ArticleIdList></Reference><Reference><Citation>Castriota F, de Campos Martins EC, Setacci C, et al. . Cutting balloon angioplasty in percutaneous carotid interventions. J Endovasc Ther 2008;15:655&#x2013;62 10.1583/08-2408.1</Citation><ArticleIdList><ArticleId IdType="doi">10.1583/08-2408.1</ArticleId><ArticleId IdType="pubmed">19090627</ArticleId></ArticleIdList></Reference><Reference><Citation>Cieri E, De Rango P, Maccaroni MR, et al. . Is haemodynamic depression during carotid stenting a predictor of peri-procedural complications? Eur J Vasc Endovasc Surg 2008;35:399&#x2013;404 10.1016/j.ejvs.2007.10.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejvs.2007.10.020</ArticleId><ArticleId IdType="pubmed">18178113</ArticleId></ArticleIdList></Reference><Reference><Citation>Diehm N, Katzen BT, Dick F, et al. . Influence of stent type on hemodynamic depression after carotid artery stent placement. J Vasc Interv Radiol 2008;19:23&#x2013;30 10.1016/j.jvir.2007.09.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvir.2007.09.020</ArticleId><ArticleId IdType="pubmed">18192464</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry M, Henry I, Polydorou A, et al. . Carotid angioplasty and stenting in octogenarians: is it safe? Catheter Cardiovasc Interv 2008;72:309&#x2013;17 10.1002/ccd.21574</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.21574</ArticleId><ArticleId IdType="pubmed">18729151</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieniazek P, Musialek P, Kablak-Ziembicka A, et al. . Carotid artery stenting with patient- and lesion-tailored selection of the neuroprotection system and stent type: early and 5-year results from a prospective academic registry of 535 consecutive procedures (TARGET-CAS). J Endovasc Ther 2008;15:249&#x2013;62 10.1583/07-2264.1</Citation><ArticleIdList><ArticleId IdType="doi">10.1583/07-2264.1</ArticleId><ArticleId IdType="pubmed">18540694</ArticleId></ArticleIdList></Reference><Reference><Citation>Roffi M, Greutmann M, Schwarz U, et al. . Flow impairment during protected carotid artery stenting: impact of filter device design. J Endovasc Ther 2008;15:103&#x2013;09 10.1583/07-2252.1</Citation><ArticleIdList><ArticleId IdType="doi">10.1583/07-2252.1</ArticleId><ArticleId IdType="pubmed">18254671</ArticleId></ArticleIdList></Reference><Reference><Citation>Velez CA, White CJ, Reilly JP, et al. . Carotid artery stent placement is safe in the very elderly (&gt; or =80 years). Catheter Cardiovasc Interv 2008;72:303&#x2013;08 10.1002/ccd.21635</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.21635</ArticleId><ArticleId IdType="pubmed">18726941</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown KE, Usman A, Kibbe MR, et al. . Carotid stenting using tapered and nontapered stents: associated neurological complications and restenosis rates. Ann Vasc Surg 2009;23:439&#x2013;45 10.1016/j.avsg.2008.11.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.avsg.2008.11.007</ArticleId><ArticleId IdType="pubmed">19128933</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein LJ, Khan HU, Sambol EB, et al. . Carotid artery stenting is safe and associated with comparable outcomes in men and women. J Vasc Surg 2009;49:315&#x2013;23; discussion 323&#x2013;24 10.1016/j.jvs.2008.08.110</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2008.08.110</ArticleId><ArticleId IdType="pubmed">19216949</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonetti G, Gandini R, Versaci F, et al. . Carotid artery stenting: findings based on 8 years' experience [in English, Italian]. Radiol Med 2009;114:95&#x2013;110 10.1007/s11547-008-0326-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11547-008-0326-x</ArticleId><ArticleId IdType="pubmed">18820992</ArticleId></ArticleIdList></Reference><Reference><Citation>Theron J, Venturi C, Reul J, et al. . Immediate and 30-day clinical outcome of patients treated with the TwinOne cerebral protection system: multicenter experience in 217 cases. Cardiovasc Intervent Radiol 2009;32:1139&#x2013;45 10.1007/s00270-009-9686-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00270-009-9686-4</ArticleId><ArticleId IdType="pubmed">19730937</ArticleId></ArticleIdList></Reference><Reference><Citation>Veselka J, Cern&#xe1; D, Zimolov&#xe1; P, et al. . Feasibility, safety, and early outcomes of direct carotid artery stent implantation with use of the FilterWire EZ Embolic Protection System. Catheter Cardiovasc Interv 2009;73:733&#x2013;38 10.1002/ccd.21936</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.21936</ArticleId><ArticleId IdType="pubmed">19198010</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung C, Cayne NS, Adelman MA, et al. . Improved hemodynamic outcomes with glycopyrrolate over atropine in carotid angioplasty and stenting. Perspect Vasc Surg Endovasc Ther 2010;22:164&#x2013;70 10.1177/1531003510388277</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1531003510388277</ArticleId><ArticleId IdType="pubmed">21098497</ArticleId></ArticleIdList></Reference><Reference><Citation>Shabaneh B, Dougherty K, Hernandez E, et al. . Catheter aspiration thrombectomy during carotid stenting is safe and potentially efficacious: a pilot retrospective study. J Cardiovasc Surg (Torino) 2010;51:865&#x2013;72</Citation><ArticleIdList><ArticleId IdType="pubmed">21124284</ArticleId></ArticleIdList></Reference><Reference><Citation>Knur R. Carotid artery stenting with distal filter protection: single-center experience in high-surgical-risk patients. Heart Vessels 2011;26:125&#x2013;30 10.1007/s00380-010-0002-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00380-010-0002-7</ArticleId><ArticleId IdType="pubmed">21052692</ArticleId></ArticleIdList></Reference><Reference><Citation>Mak CS, Chambers BR, Clark DJ, et al. . Multidisciplinary approach to carotid stenting. Intern Med J 2011;41:789&#x2013;94 10.1111/j.1445-5994.2010.02285.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1445-5994.2010.02285.x</ArticleId><ArticleId IdType="pubmed">20561100</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendiz OA, Sampaolesi AH, Londero HF, et al. . Initial experience with transradial access for carotid artery stenting. Vasc Endovasc Surg 2011;45:499&#x2013;503 10.1177/1538574411405547</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1538574411405547</ArticleId><ArticleId IdType="pubmed">21844492</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizwan Khalid M, Khalid F, Farooqui FA, et al. . Can experienced physicians with high peripheral interventional volume but low carotid artery stenting (CAS) volume achieve low complication rates during CAS? EuroIntervention 2011;6:744&#x2013;47 10.4244/EIJV6I6A126</Citation><ArticleIdList><ArticleId IdType="doi">10.4244/EIJV6I6A126</ArticleId><ArticleId IdType="pubmed">21205599</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu YM, Wong HF, Chen YL, et al. . Carotid stenting of asymptomatic and symptomatic carotid artery stenoses with and without the use of a distal embolic protection device. Acta Cardiol 2011;66:453&#x2013;58 10.2143/AC.66.4.2126593</Citation><ArticleIdList><ArticleId IdType="doi">10.2143/AC.66.4.2126593</ArticleId><ArticleId IdType="pubmed">21894801</ArticleId></ArticleIdList></Reference><Reference><Citation>Harada K, Morioka J, Higa T, et al. . Significance of combining distal filter protection and a guiding catheter with temporary balloon occlusion for carotid artery stenting: clinical results and evaluation of debris capture. Ann Vasc Surg 2012;26:929&#x2013;36 10.1016/j.avsg.2012.04.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.avsg.2012.04.022</ArticleId><ArticleId IdType="pubmed">22944567</ArticleId></ArticleIdList></Reference><Reference><Citation>Moratto R, Veronesi J, Silingardi R, et al. . Urgent carotid artery stenting with technical modifications for patients with transient ischemic attacks and minor stroke. J Endovasc Ther 2012;19:627&#x2013;35 10.1583/JEVT-12-3852MR.1</Citation><ArticleIdList><ArticleId IdType="doi">10.1583/JEVT-12-3852MR.1</ArticleId><ArticleId IdType="pubmed">23046328</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessler I, Gory B, Macian F, et al. . Carotid artery stenting in patients with symptomatic carotid stenosis: a single-center series. J Neuroradiol 2013;40:38&#x2013;44 10.1016/j.neurad.2012.03.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurad.2012.03.003</ArticleId><ArticleId IdType="pubmed">22633044</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyawaki S, Maeda K. Surgical treatment for cervical carotid artery stenosis in the elderly: importance of perioperative management of ischemic cardiac complications. Neurol Med Chir (Tokyo) 2014;54:120&#x2013;25 10.2176/nmc.oa2012-0436</Citation><ArticleIdList><ArticleId IdType="doi">10.2176/nmc.oa2012-0436</ArticleId><ArticleId IdType="pmc">PMC4508703</ArticleId><ArticleId IdType="pubmed">24257501</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinozaki N, Ogata N, Ikari Y. Plaque protrusion detected by intravascular ultrasound during carotid artery stenting. J Stroke Cerebrovasc Dis 2014;23:2622&#x2013;25 10.1016/j.jstrokecerebrovasdis.2014.06.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2014.06.007</ArticleId><ArticleId IdType="pubmed">25304722</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23850912</PMID><DateCompleted><Year>2013</Year><Month>11</Month><Day>13</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1558-3597</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><Issue>12</Issue><PubDate><Year>2013</Year><Month>Sep</Month><Day>17</Day></PubDate></JournalIssue><Title>Journal of the American College of Cardiology</Title><ISOAbbreviation>J Am Coll Cardiol</ISOAbbreviation></Journal><ArticleTitle>Meta-analysis and systematic review of the predictive value of carotid plaque hemorrhage on cerebrovascular events by magnetic resonance imaging.</ArticleTitle><Pagination><StartPage>1081</StartPage><EndPage>1091</EndPage><MedlinePgn>1081-1091</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacc.2013.06.015</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0735-1097(13)02529-1</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This study sought to conduct a systematic review and meta-analysis to determine precise estimates of the predictive value of carotid intraplaque hemorrhage (IPH) as determined by magnetic resonance imaging (MRI) for cerebrovascular events.</AbstractText><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">There is emerging evidence that MR-based carotid atherosclerotic plaque assessment identifies high-risk features associated with cerebrovascular events. However, available data are based on smaller samples with heterogeneous source populations despite a promising value for noninvasive risk stratification.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched PubMed, EMBASE, and the Cochrane Library through September 2012 for studies that followed &gt;35&#xa0;individuals after baseline MRI. Independent observers abstracted information on populations, MR&#xa0;techniques, outcomes, and study quality. Risk estimates of the presence of IPH for cerebrovascular events were&#xa0;derived in&#xa0;random effects regression analysis, and causes of heterogeneity were determined in meta-regression analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 8 eligible studies including 689 participants who underwent carotid MRI. The prevalence of IPH at baseline was high (49.0%). Over a median follow-up of 19.6 months, a total of 108 cerebrovascular events occurred (15.7% event rate). The presence of IPH was associated with an &#x223c;6-fold higher risk for events (hazard ratio [HR]: 5.69; 95% confidence interval [CI]: 2.98 to 10.87). The annualized event rate in subjects with detectable IPH was 17.71% compared with 2.43% in patients without IPH. Meta-regression analysis showed symptomatic subjects had higher risks as compared with asymptomatic subjects (HR: 11.71, 95% CI: 5.17 to 26.48 vs. HR: 3.50, 95% CI: 2.59 to 4.73, p&#xa0;= 0.0065), Also, differences were observed for sex and sample size (all p&#xa0;&lt; 0.01), with moderate visual publication bias due to missing smaller sample-size studies (p&#xa0;= 0.18).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Presence of IPH on MRI strongly predicts cerebrovascular events. Homogenization of future studies is warranted to allow for sufficient assessment of level of evidence for intervention trials.</AbstractText><CopyrightInformation>Copyright &#xa9; 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Saam</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Clinical Radiology, Ludwig-Maximilians-University Hospital Munich, Munich, Germany. Electronic address: tobias.saam@med.lmu.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hetterich</LastName><ForeName>Holger</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Clinical Radiology, Ludwig-Maximilians-University Hospital Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoffmann</LastName><ForeName>Verena</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Epidemiology, Ludwig-Maximilians-University Hospital Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Chun</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Radiology, University of Washington, Seattle, Washington.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dichgans</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Stroke and Dementia Research, Ludwig-Maximilians-University Hospital Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poppert</LastName><ForeName>Holger</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Technische Universit&#xe4;t M&#xfc;nchen, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koeppel</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Vascular and Endovascular Surgery, Ludwig-Maximilians-University Hospital Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoffmann</LastName><ForeName>Ulrich</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Division of Vascular Medicine, Medical Clinic and Policlinic IV, Ludwig-Maximilians-University Hospital Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reiser</LastName><ForeName>Maximilian F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Institute of Clinical Radiology, Ludwig-Maximilians-University Hospital Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bamberg</LastName><ForeName>Fabian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute of Clinical Radiology, Ludwig-Maximilians-University Hospital Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>07</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Coll Cardiol</MedlineTA><NlmUniqueID>8301365</NlmUniqueID><ISSNLinking>0735-1097</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Am Coll Cardiol. 2014 May 27;63(20):2172-2173. doi: 10.1016/j.jacc.2013.11.062.</RefSource><PMID Version="1">24613325</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Am Coll Cardiol. 2014 May 27;63(20):2173-2174. doi: 10.1016/j.jacc.2014.02.527.</RefSource><PMID Version="1">24613330</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D002340" MajorTopicYN="N">Carotid Artery Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002561" MajorTopicYN="N">Cerebrovascular Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058226" MajorTopicYN="N">Plaque, Atherosclerotic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CI</Keyword><Keyword MajorTopicYN="N">HR</Keyword><Keyword MajorTopicYN="N">IPH</Keyword><Keyword MajorTopicYN="N">MRI</Keyword><Keyword MajorTopicYN="N">TIA</Keyword><Keyword MajorTopicYN="N">confidence interval</Keyword><Keyword MajorTopicYN="N">hazard ratio</Keyword><Keyword MajorTopicYN="N">intraplaque hemorrhage</Keyword><Keyword MajorTopicYN="N">magnetic resonance imaging</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">noninvasive&#xa0;imaging</Keyword><Keyword MajorTopicYN="N">plaque hemorrhage</Keyword><Keyword MajorTopicYN="N">prognostic value</Keyword><Keyword MajorTopicYN="N">transient ischemic attack</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2013</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>6</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23850912</ArticleId><ArticleId IdType="doi">10.1016/j.jacc.2013.06.015</ArticleId><ArticleId IdType="pii">S0735-1097(13)02529-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">24109565</PMID><DateCompleted><Year>2014</Year><Month>02</Month><Day>20</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2225-319X</ISSN><JournalIssue CitedMedium="Print"><Volume>2</Volume><Issue>5</Issue><PubDate><Year>2013</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Annals of cardiothoracic surgery</Title><ISOAbbreviation>Ann Cardiothorac Surg</ISOAbbreviation></Journal><ArticleTitle>A systematic review and meta-analysis on the safety and efficacy of the frozen elephant trunk technique in aortic arch surgery.</ArticleTitle><Pagination><StartPage>581</StartPage><EndPage>591</EndPage><MedlinePgn>581-91</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3978/j.issn.2225-319X.2013.09.07</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The treatment of complex pathologies of the aortic arch and proximal descending aorta represents a significant challenge for cardiac surgeons. Various surgical techniques and prostheses have been implemented over the past several decades, all with varying degrees of success. The introduction of the frozen elephant trunk (FET) technique facilitates one-stage repair of such pathologies. The present systematic review and meta-analysis aims to assess the safety and efficacy of the FET approach in the current literature.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Electronic searches were performed using six databases from their inception to July 2013. Relevant studies utilizing the FET technique were identified. Data were extracted and analyzed according to predefined clinical endpoints.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Seventeen studies were identified for inclusion for qualitative and quantitative analyses, all of which were observational reports. Pooled mortality was 8.3%, while stroke and spinal cord injuries were 4.9% and 5.1% respectively. Cardiopulmonary bypass time, myocardial ischemia time, and circulatory arrest time strongly correlated with perioperative mortality in a linear relationship, while moderate correlations between cerebral perfusion time and mortality, and circulatory arrest time and spinal cord injury, were also identified. Five-year survival, reported in five studies, ranged between 63-88%.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Overall, results of the present systematic review and meta-analysis suggest that the FET procedure can be performed with acceptable mortality and morbidity risks.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>David H</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>The Systematic Review Unit, Collaborative Research (CORE) Group, Sydney, Australia;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wan</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Di Eusanio</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Black</LastName><ForeName>Deborah</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Tristan D</ForeName><Initials>TD</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Ann Cardiothorac Surg</MedlineTA><NlmUniqueID>101605877</NlmUniqueID><ISSNLinking>2225-319X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Frozen elephant trunk</Keyword><Keyword MajorTopicYN="N">aortic dissection</Keyword><Keyword MajorTopicYN="N">hybrid procedure</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword><Keyword MajorTopicYN="N">thoracic aneurysm</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2013</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24109565</ArticleId><ArticleId IdType="pmc">PMC3791206</ArticleId><ArticleId IdType="doi">10.3978/j.issn.2225-319X.2013.09.07</ArticleId><ArticleId IdType="pii">acs-02-05-581</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Borst HG, Walterbusch G, Schaps D. Extensive aortic replacement using &#x201c;elephant trunk&#x201d; prosthesis. Thorac Cardiovasc Surg 1983;31:37-40</Citation><ArticleIdList><ArticleId IdType="pubmed">6189250</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinemann MK, Buehner B, Jurmann MJ, et al. Use of the &#x201c;elephant trunk Technique&#x201d; in aortic surgery. Ann Thorac Surg 1995;60:2-6; discussion 7</Citation><ArticleIdList><ArticleId IdType="pubmed">7598596</ArticleId></ArticleIdList></Reference><Reference><Citation>Estrera AL, Miller CC 3rd, Porat EE, et al. Staged repair of extensive aortic aneurysms. Ann Thorac Surg 2002;74:S1803-5; discussion S1825-32.</Citation><ArticleIdList><ArticleId IdType="pubmed">12440669</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato M, Ohnishi K, Kaneko M, et al. New graft-implanting method for thoracic aortic aneurysm or dissection with a stented graft. Circulation 1996;94:II188-93</Citation><ArticleIdList><ArticleId IdType="pubmed">8901744</ArticleId></ArticleIdList></Reference><Reference><Citation>Baraki H, Hagl C, Khaladj N, et al. The frozen elephant trunk technique for treatment of thoracic aortic aneurysms. Ann Thorac Surg 2007;83:S819-23; discussion S824-31.</Citation><ArticleIdList><ArticleId IdType="pubmed">17257934</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman A, Damberg AL, Sch&#xe4;lte G, et al. Thoracic stent graft sizing for frozen elephant trunk repair in acute type A dissection. J Thorac Cardiovasc Surg 2013;145:964-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22507842</ArticleId></ArticleIdList></Reference><Reference><Citation>Reviews NCf, Dissemination. Undertaking systematic reviews of research on effectiveness: CRD&#x2019;s guidance for those carrying out or commissioning reviews. CRD Report 4. 2001.</Citation></Reference><Reference><Citation>Usui A, Fujimoto K, Ishiguchi T, et al. Cerebrospinal dysfunction after endovascular stent-grafting via a median sternotomy: the frozen elephant trunk procedure. Ann Thorac Surg 2002;74:S1821-4; discussion S1825-32.</Citation><ArticleIdList><ArticleId IdType="pubmed">12440674</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores J, Kunihara T, Shiiya N, et al. Extensive deployment of the stented elephant trunk is associated with an increased risk of spinal cord injury. J Thorac Cardiovasc Surg 2006;131:336-42</Citation><ArticleIdList><ArticleId IdType="pubmed">16434262</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimamura K, Kuratani T, Matsumiya G, et al. Long-term results of the open stent-grafting technique for extended aortic arch disease. J Thorac Cardiovasc Surg 2008;135:1261-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18544367</ArticleId></ArticleIdList></Reference><Reference><Citation>Pochettino A, Brinkman WT, Moeller P, et al. Antegrade thoracic stent grafting during repair of acute DeBakey I dissection prevents development of thoracoabdominal aortic aneurysms. Ann Thorac Surg 2009;88:482-9; discussion 489-90</Citation><ArticleIdList><ArticleId IdType="pubmed">19632398</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchida N, Katayama A, Tamura K, et al. Long-term results of the frozen elephant trunk technique for extended aortic arch disease. Eur J Cardiothorac Surg 2010;37:1338-45</Citation><ArticleIdList><ArticleId IdType="pubmed">20303777</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Huang F, Xu M, et al. The stented elephant trunk procedure combined total arch replacement for Debakey I aortic dissection: operative result and follow-up. Interact Cardiovasc Thorac Surg 2010;11:594-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20716557</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L, Qi R, Zhu J, et al. Total arch replacement combined with stented elephant trunk implantation: a new &#x201c;standard&#x201d; therapy for type a dissection involving repair of the aortic arch? Circulation 2011;123:971-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21339481</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakob H, Tsagakis K, Pacini D, et al. The International E-vita Open Registry: data sets of 274 patients. J Cardiovasc Surg (Torino) 2011;52:717-23</Citation><ArticleIdList><ArticleId IdType="pubmed">21894139</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi E, Gu T, Yu L, et al. Repair of Stanford type A aortic dissection with ascending aorta and hemiarch replacement combined with stent-graft elephant trunk technique by using innominate cannulation. J Thorac Cardiovasc Surg 2011;142:1458-63</Citation><ArticleIdList><ArticleId IdType="pubmed">21458010</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen K, Tang H, Jing R, et al. Application of triple-branched stent graft for Stanford type A aortic dissection: potential risks. Eur J Cardiothorac Surg 2012;41:e12-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22223699</ArticleId></ArticleIdList></Reference><Reference><Citation>Leontyev S, Borger MA, Etz CD, et al. Experience with the conventional and frozen elephant trunk techniques: a single-centre study. Eur J Cardiothorac Surg. 2013 [Epub ahead of print]</Citation><ArticleIdList><ArticleId IdType="pubmed">23677901</ArticleId></ArticleIdList></Reference><Reference><Citation>Ius F, Fleissner F, Pichlmaier M, et al. Total aortic arch replacement with the frozen elephant trunk technique: 10-year follow-up single-centre experience. Eur J Cardiothorac Surg. 2013 [Epub ahead of print]</Citation><ArticleIdList><ArticleId IdType="pubmed">23660556</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma WG, Zheng J, Dong SB, et al. Sun&#x2019;s procedure of total arch replacement using a tetrafurcated graft with stented elephant trunk implantation: analysis of early outcome in 398 patients with acute type A aortic dissection. Ann Cardiothorac Surg 2013;2:621-8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3791189</ArticleId><ArticleId IdType="pubmed">24109570</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Eusanio M, Pantaleo A, Murana G, et al. Frozen elephant trunk&#x2014;the Bologna&#x2019;s experience. Ann Cardiothorac Surg 2013;2:597-605</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3791204</ArticleId><ArticleId IdType="pubmed">24109567</ArticleId></ArticleIdList></Reference><Reference><Citation>Roselli EE, Rafael A, Soltesz EG, et al. Simplified frozen elephant trunk repair for acute DeBakey type I dissection. J Thorac Cardiovasc Surg 2013;145:S197-201</Citation><ArticleIdList><ArticleId IdType="pubmed">23260435</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Z, Meng W, Zhu D, et al. Treatment strategies for left subclavian artery during total arch replacement combined with stented elephant trunk implantation. J Thorac Cardiovasc Surg. 2013 [Epub ahead of print]</Citation><ArticleIdList><ArticleId IdType="pubmed">23523037</ArticleId></ArticleIdList></Reference><Reference><Citation>Usui A, Ueda Y, Akita T, et al. Mid-term results of an endovascular stent-graft by means of median sternotomy for distal aortic arch aneurysm. Artif Organs 2002;26:1044-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12460383</ArticleId></ArticleIdList></Reference><Reference><Citation>Safi HJ, Miller CC, 3rd, Estrera AL, et al. Staged repair of extensive aortic aneurysms: morbidity and mortality in the elephant trunk technique. Circulation 2001;104:2938-42</Citation><ArticleIdList><ArticleId IdType="pubmed">11739309</ArticleId></ArticleIdList></Reference><Reference><Citation>LeMaire SA, Carter SA, Coselli JS. The elephant trunk technique for staged repair of complex aneurysms of the entire thoracic aorta. Ann Thorac Surg 2006;81:1561-9; discussion 1569</Citation><ArticleIdList><ArticleId IdType="pubmed">16631635</ArticleId></ArticleIdList></Reference><Reference><Citation>Safi HJ, Miller CC 3rd, Estrera AL, et al. Optimization of aortic arch replacement: two-stage approach. Ann Thorac Surg 2007;83:S815-8; discussion S824-31.</Citation><ArticleIdList><ArticleId IdType="pubmed">17257933</ArticleId></ArticleIdList></Reference><Reference><Citation>Ius F, Hagl C, Haverich A, et al. Elephant trunk procedure 27 years after Borst: what remains and what is new? Eur J Cardiothorac Surg 2011;40:1-11</Citation><ArticleIdList><ArticleId IdType="pubmed">21388822</ArticleId></ArticleIdList></Reference><Reference><Citation>Svensson LG, Kim KH, Blackstone EH, et al. Elephant trunk procedure: newer indications and uses. Ann Thorac Surg 2004;78:109-16; discussion 109-16</Citation><ArticleIdList><ArticleId IdType="pubmed">15223413</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuno T, Toyama M, Tabuchi N, et al. Stented elephant trunk procedure combined with ascending aorta and arch replacement for acute type A aortic dissection. Eur J Cardiothorac Surg 2002;22:504-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12297163</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Eusanio M, Armaro A, Di Marco L, et al. Short- and midterm results after hybrid treatment of chronic aortic dissection with the frozen elephant trunk technique. Eur J Cardiothorac Surg 2011;40:875-80</Citation><ArticleIdList><ArticleId IdType="pubmed">21382727</ArticleId></ArticleIdList></Reference><Reference><Citation>Okita Y, Minatoya K, Tagusari O, et al. Prospective comparative study of brain protection in total aortic arch replacement: deep hypothermic circulatory arrest with retrograde cerebral perfusion or selective antegrade cerebral perfusion. Ann Thorac Surg 2001;72:72-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11465234</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazui T, Yamashita K, Washiyama N, et al. Aortic arch replacement using selective cerebral perfusion. Ann Thorac Surg 2007;83:S796-8; discussion S824-31.</Citation><ArticleIdList><ArticleId IdType="pubmed">17257929</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao P, De Rango P, Czerny M, et al. Systematic review of clinical outcomes in hybrid procedures for aortic arch dissections and other arch diseases. J Thorac Cardiovasc Surg 2012;144:1286-300, 1300.e1-2.</Citation><ArticleIdList><ArticleId IdType="pubmed">22789301</ArticleId></ArticleIdList></Reference><Reference><Citation>Karck M, Kamiya H.Progress of the treatment for extended aortic aneurysms; is the frozen elephant trunk technique the next standard in the treatment of complex aortic disease including the arch? Eur J Cardiothorac Surg 2008;33:1007-13</Citation><ArticleIdList><ArticleId IdType="pubmed">18406159</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacini D, Tsagakis K, Jakob H, et al. The frozen elephant trunk for the treatment of chronic dissection of the thoracic aorta: a multicenter experience. Ann Thorac Surg 2011;92:1663-70; discussion 1670.</Citation><ArticleIdList><ArticleId IdType="pubmed">22051263</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishihara H, Uchida N, Yamasaki C, et al. Extensive primary repair of the thoracic aorta in Stanford type A acute aortic dissection by means of a synthetic vascular graft with a self-expandable stent. J Thorac Cardiovasc Surg 2002;123:1035-40</Citation><ArticleIdList><ArticleId IdType="pubmed">12063448</ArticleId></ArticleIdList></Reference><Reference><Citation>Chavan A, Karck M, Hagl C, et al. Hybrid endograft for one-step treatment of multisegment disease of the thoracic aorta. J Vasc Interv Radiol 2005;16:823-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15947046</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoli S, Roder F, Etz CD, et al. Predicting the risk of paraplegia after thoracic and thoracoabdominal aneurysm repair. Ann Thorac Surg 2010;90:1237-44; discussion 1245</Citation><ArticleIdList><ArticleId IdType="pubmed">20868820</ArticleId></ArticleIdList></Reference><Reference><Citation>Etz CD, Luehr M, Kari FA, et al. Selective cerebral perfusion at 28 degrees C--is the spinal cord safe? Eur J Cardiothorac Surg 2009;36:946-55</Citation><ArticleIdList><ArticleId IdType="pubmed">19640727</ArticleId></ArticleIdList></Reference><Reference><Citation>Minatoya K, Ogino H, Matsuda H, et al. Evolving selective cerebral perfusion for aortic arch replacement: high flow rate with moderate hypothermic circulatory arrest. Ann Thorac Surg 2008;86:1827-31</Citation><ArticleIdList><ArticleId IdType="pubmed">19021987</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamiya H, Hagl C, Kropivnitskaya I, et al. The safety of moderate hypothermic lower body circulatory arrest with selective cerebral perfusion: a propensity score analysis. J Thorac Cardiovasc Surg 2007;133:501-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17258589</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39531998</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4529</ISSN><JournalIssue CitedMedium="Internet"><Volume>99</Volume><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of clinical anesthesia</Title><ISOAbbreviation>J Clin Anesth</ISOAbbreviation></Journal><ArticleTitle>Continuation versus discontinuation of renin-angiotensin aldosterone system inhibitors before non-cardiac surgery: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>111679</StartPage><MedlinePgn>111679</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinane.2024.111679</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0952-8180(24)00308-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">A large number of patients undergoing noncardiac surgeries are on long-term use of angiotensin-converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARBs). The current guidelines regarding the continuation or discontinuation of renin-angiotensin-aldosterone system inhibitors (RAAS) inhibitors before noncardiac surgery are conflicting. This meta-analysis aims to evaluate whether continuing or withholding RAAS inhibitors before noncardiac surgery influences perioperative mortality and complications.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A thorough literature search was performed across PubMed/MEDLINE, Embase, and the Cochrane Library from their inception up to August 30, 2024 to identify eligible randomized controlled trials (RCTs) and cohort studies. Clinical outcomes were evaluated using a random-effects model to pool odds ratios (ORs) with 95&#xa0;% confidence intervals (CIs).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The analysis included 16 studies with a total of 59,105 patients on RAAS inhibitors before noncardiac surgery. Withholding RAAS inhibitors was associated with a significantly lower incidence of intraoperative hypotension (OR&#xa0;=&#xa0;0.49; 95&#xa0;% CI&#xa0;=&#xa0;0.29 to 0.83) and acute kidney injury (AKI) (OR&#xa0;=&#xa0;0.88; 95&#xa0;% CI&#xa0;=&#xa0;0.82 to 0.95) than continuing the therapy. However, there was no statistically significant difference in reducing mortality (OR&#xa0;=&#xa0;1.10; 95&#xa0;% CI&#xa0;=&#xa0;0.86 to 1.40), major adverse cardiovascular events (MACE) (OR&#xa0;=&#xa0;1.27; 95&#xa0;% CI&#xa0;=&#xa0;0.75 to 2.16), myocardial infarction (OR&#xa0;=&#xa0;0.83; 95&#xa0;% CI&#xa0;=&#xa0;0.27 to 2.59) or stroke events (OR&#xa0;=&#xa0;0.70; 95&#xa0;% CI&#xa0;=&#xa0;0.36 to 1.36) between the two groups.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Withholding RAAS inhibitors before noncardiac surgery reduces intraoperative hypotension and AKI with nonsignificant effects on mortality and MACE.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Mushood</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Rawalpindi Medical University, Rawalpindi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fatima</LastName><ForeName>Eeshal</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medicine, Services Institute of Medical Sciences, Lahore, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shafiq</LastName><ForeName>Aimen</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahsan</LastName><ForeName>Areeba</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, Foundation University Medical College, Islamabad, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zulfiqar</LastName><ForeName>Eeshal</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masood</LastName><ForeName>Fouad</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, King Abdulaziz Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Raheel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Royal Brompton Hospital, London, UK; Department of Cardiology, National Heart and Lung Institute, Imperial College London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yasmin</LastName><ForeName>Farah</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asghar</LastName><ForeName>Muhammad Sohaib</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA; Department of Internal Medicine, AdventHealth, Sebring, FL, USA. Electronic address: msohaibasghar123@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Anesth</MedlineTA><NlmUniqueID>8812166</NlmUniqueID><ISSNLinking>0952-8180</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000806">Angiotensin-Converting Enzyme Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057911">Angiotensin Receptor Antagonists</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>J Clin Anesth. 2025 Jan;100:111705. doi: 10.1016/j.jclinane.2024.111705.</RefSource><PMID Version="1">39603926</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012084" MajorTopicYN="Y">Renin-Angiotensin System</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000806" MajorTopicYN="Y">Angiotensin-Converting Enzyme Inhibitors</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057911" MajorTopicYN="Y">Angiotensin Receptor Antagonists</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D028761" MajorTopicYN="N">Withholding Treatment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011300" MajorTopicYN="N">Preoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Angiotensin receptor blockers</Keyword><Keyword MajorTopicYN="N">Angiotensin-converting enzyme inhibitors</Keyword><Keyword MajorTopicYN="N">Hypertension</Keyword><Keyword MajorTopicYN="N">Non-cardiac surgery</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>25</Day><Hour>1</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>13</Day><Hour>14</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>12</Day><Hour>18</Hour><Minute>9</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39531998</ArticleId><ArticleId IdType="doi">10.1016/j.jclinane.2024.111679</ArticleId><ArticleId IdType="pii">S0952-8180(24)00308-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25622933</PMID><DateCompleted><Year>2015</Year><Month>12</Month><Day>29</Day></DateCompleted><DateRevised><Year>2015</Year><Month>03</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1496-8975</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><Issue>4</Issue><PubDate><Year>2015</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Canadian journal of anaesthesia = Journal canadien d'anesthesie</Title><ISOAbbreviation>Can J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Combined general and neuraxial anesthesia versus general anesthesia: a population-based cohort study.</ArticleTitle><Pagination><StartPage>356</StartPage><EndPage>368</EndPage><MedlinePgn>356-68</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12630-015-0315-1</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To determine whether combining spinal or epidural anesthesia with general anesthesia (combined anesthesia) reduces major medical complications of elective surgery compared with general anesthesia alone.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a propensity-matched population-based historical cohort study using large healthcare databases from Ontario, Canada. We identified patients undergoing 21 different elective procedures that were amenable to either combined anesthesia or general anesthesia alone in 108 hospitals from 2004 to 2011. We assessed the following four outcomes together as a composite and individually in the 30&#xa0;days following surgery: acute kidney injury, stroke, myocardial infarction, and all-cause mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Prior to matching, we identified 21,701 patients receiving general anesthesia and 8,042 patients receiving combined anesthesia. After matching, our cohort included 12,379 patients. Twenty-eight baseline characteristics were well-matched between the combined (n&#xa0;=&#xa0;4,773) and general anesthesia groups (n&#xa0;=&#xa0;7,606). Mean patient age was 66&#xa0;yr. Relative to general anesthesia alone, combined anesthesia was not associated with a reduced risk for the composite outcome [104/4,773 (2.2%) vs 162/7,606 (2.1%); odds ratio (OR) 0.97; 95% confidence interval (CI) 0.75 to 1.24] or for any of the four component outcomes when examined separately: acute kidney injury (OR 0.93; 95% CI 0.58 to 1.51), stroke (OR 0.79; 95% CI 0.36 to 1.73), myocardial infarction (OR 1.04; 95% CI 0.69 to 1.57), and all-cause mortality (OR 0.91; 95% CI 0.59 to 1.42).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The addition of spinal or epidural anesthesia to general anesthesia was not associated with a reduced risk of major medical complications among 21 different elective procedures when compared with general anesthesia alone.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nash</LastName><ForeName>Danielle M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Institute for Clinical Evaluative Sciences Western, London Health Sciences Centre, 800 Commissioners Rd. E, Room ELL-113A, London, ON, N6A 4G5, Canada, danielle.nash@ices.on.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mustafa</LastName><ForeName>Reem A</ForeName><Initials>RA</Initials></Author><Author ValidYN="Y"><LastName>McArthur</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Wijeysundera</LastName><ForeName>Duminda N</ForeName><Initials>DN</Initials></Author><Author ValidYN="Y"><LastName>Paterson</LastName><ForeName>J Michael</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Sharan</LastName><ForeName>Sumit</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Vinden</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Wald</LastName><ForeName>Ron</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Welk</LastName><ForeName>Blayne</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Sessler</LastName><ForeName>Daniel I</ForeName><Initials>DI</Initials></Author><Author ValidYN="Y"><LastName>Devereaux</LastName><ForeName>P J</ForeName><Initials>PJ</Initials></Author><Author ValidYN="Y"><LastName>Walsh</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Garg</LastName><ForeName>Amit X</ForeName><Initials>AX</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>01</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Can J Anaesth</MedlineTA><NlmUniqueID>8701709</NlmUniqueID><ISSNLinking>0832-610X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000767" MajorTopicYN="N">Anesthesia, Epidural</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000775" MajorTopicYN="N">Anesthesia, Spinal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009864" MajorTopicYN="N" Type="Geographic">Ontario</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>12</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25622933</ArticleId><ArticleId IdType="doi">10.1007/s12630-015-0315-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38887243</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2296-2565</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in public health</Title><ISOAbbreviation>Front Public Health</ISOAbbreviation></Journal><ArticleTitle>Comparison of regional vs. general anesthesia on the risk of dementia: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1362461</StartPage><MedlinePgn>1362461</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1362461</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fpubh.2024.1362461</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Dementia is a gradual and ongoing cognitive decline due to damage to nerve cells in the brain. This meta-analysis aimed to assess the potential relationship between regional anesthesia (RA) and the risk of dementia.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Electronic databases including Embase, Medline, Google Scholar, and Cochrane Library were searched for studies investigating the association between RA and dementia risk from inception to March 2022. The primary outcome was the risk of dementia in patients who underwent RA (RA group) and those who received general anesthesia (GA group). Secondary outcomes included identifying other potential risk factors for dementia and comparing dementia risk between individuals receiving RA and those not receiving surgery/anesthesia (placebo group).</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Eight cohort studies published between 2014 and 2023 were included in this analysis. A meta-analysis of the available data demonstrated no differences in baseline characteristics and morbidities (i.e., age, male proportion, hypertension, diabetes, depression, and severe comorbidities) between the RA and GA groups (all <i>p</i>&#x2009;&gt;&#x2009;0.05). Initial analysis revealed that the risk of dementia was higher in the GA group than in the RA group (HR&#x2009;=&#x2009;1.81, 95% CI&#x2009;=&#x2009;1.29-2.55, <i>p</i>&#x2009;=&#x2009;0.007, <i>I</i> <sup>2</sup> =&#x2009;99%, five studies). However, when a study featuring a relatively younger population was excluded from the sensitivity analysis, the results showed a similar risk of dementia (HR, 1.17; <i>p</i>&#x2009;=&#x2009;0.13) between the GA and RA groups. The pooled results revealed no difference in dementia risk between the RA and placebo groups (HR&#x2009;=&#x2009;1.2, 95% CI&#x2009;=&#x2009;0.69-2.07, <i>p</i>&#x2009;=&#x2009;0.52, <i>I</i> <sup>2</sup> =&#x2009;68%, three studies). Sensitivity analysis revealed that the evidence was not stable, suggesting that limited datasets precluded strong conclusions on this outcome. Anxiety, stroke history, hypertension, diabetes, hyperlipidemia, and diabetes are potential predictors of dementia.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Our results emphasize that, while RA could be protective against dementia risk compared to GA, the association between the type of anesthesia and dementia risk might vary among different age groups. Owing to the significant prevalence of dementia among older people and their surgical needs, further investigations are warranted to clarify the association between dementia risk and regional anesthesia.<b>Systematic review registration</b>: https://www.crd.york.ac.uk/prospero/, CRD42023411324.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Chen, Sun, Chen, Chen, Lan, Hung and Ko.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Chen</LastName><ForeName>I-Wen</ForeName><Initials>IW</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Chi Mei Medical Center, Liouying, Tainan City, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Sun</LastName><ForeName>Cheuk-Kwan</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, E-Da Dachang Hospital, I-Shou University, Kaohsiung City, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine for International Students, College of Medicine, I-Shou University, Kaohsiung City, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jen-Yin</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>School of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung City, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Chi Mei Medical Center, Tainan City, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Hsiao-Tien</ForeName><Initials>HT</Initials><AffiliationInfo><Affiliation>Department of Chinese Medicine, Chi Mei Medical Center, Tainan City, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lan</LastName><ForeName>Kuo-Mao</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Chi Mei Medical Center, Liouying, Tainan City, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hung</LastName><ForeName>Kuo-Chuan</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Chi Mei Medical Center, Tainan City, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ko</LastName><ForeName>Ching-Chung</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>School of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung City, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Imaging, Chi Mei Medical Center, Tainan City, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health and Nutrition, Chia Nan University of Pharmacy and Science, Tainan City, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Public Health</MedlineTA><NlmUniqueID>101616579</NlmUniqueID><ISSNLinking>2296-2565</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000765" MajorTopicYN="Y">Anesthesia, Conduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cognitive function</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">general anesthesia</Keyword><Keyword MajorTopicYN="N">regional anesthesia</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>18</Day><Hour>23</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>18</Day><Hour>3</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38887243</ArticleId><ArticleId IdType="pmc">PMC11182446</ArticleId><ArticleId IdType="doi">10.3389/fpubh.2024.1362461</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Whalley LJ, Dick FD, McNeill G. A life-course approach to the aetiology of late-onset dementias. Lancet Neurol. (2006) 5:87&#x2013;96. doi: 10.1016/S1474-4422(05)70286-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(05)70286-6</ArticleId><ArticleId IdType="pubmed">16361026</ArticleId></ArticleIdList></Reference><Reference><Citation>Arvanitakis Z, Shah RC, Bennett DA. Diagnosis and management of dementia. JAMA. (2019) 322:1589&#x2013;99. doi: 10.1001/jama.2019.4782, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.4782</ArticleId><ArticleId IdType="pmc">PMC7462122</ArticleId><ArticleId IdType="pubmed">31638686</ArticleId></ArticleIdList></Reference><Reference><Citation>LoGiudice D, Watson R. Dementia in older people: an update. Intern Med J. (2014) 44:1066&#x2013;73. doi: 10.1111/imj.12572</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imj.12572</ArticleId><ArticleId IdType="pubmed">25367725</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribbe MW, Ljunggren G, Steel K, Topinkov&#xe1; E, Hawes C, Ikegami N, et al. . Nursing homes in 10 nations: a comparison between countries and settings. Age Ageing. (1997) 26:3&#x2013;12. doi: 10.1093/ageing/26.suppl_2.3</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/26.suppl_2.3</ArticleId><ArticleId IdType="pubmed">9464548</ArticleId></ArticleIdList></Reference><Reference><Citation>Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. . Dementia prevention, intervention, and care: 2020 report of the lancet commission. Lancet. (2020) 396:413&#x2013;46. doi: 10.1016/S0140-6736(20)30367-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30367-6</ArticleId><ArticleId IdType="pmc">PMC7392084</ArticleId><ArticleId IdType="pubmed">32738937</ArticleId></ArticleIdList></Reference><Reference><Citation>Wimo A, J&#xf6;nsson L, Gustavsson A, McDaid D, Ersek K, Georges J, et al. . The economic impact of dementia in Europe in 2008&#x2014;cost estimates from the Eurocode project. Int J Geriatr Psychiatry. (2011) 26:825&#x2013;32. doi: 10.1002/gps.2610</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.2610</ArticleId><ArticleId IdType="pubmed">21744385</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson LE, Evans CJ, Cripps RL, Leniz J, Yorganci E, Sleeman KE. Factors associated with emergency department visits by people with dementia near the end of life: a systematic review. J Am Med Dir Assoc. (2021) 22:2046&#x2013;2055.e35. doi: 10.1016/j.jamda.2021.06.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2021.06.012</ArticleId><ArticleId IdType="pubmed">34273269</ArticleId></ArticleIdList></Reference><Reference><Citation>Benner M, Steiner V, Pierce LL. Family caregivers&#x2019; reports of hospitalizations and emergency department visits in community-dwelling individuals with dementia. Dementia. (2018) 17:585&#x2013;95. doi: 10.1177/1471301216653537, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301216653537</ArticleId><ArticleId IdType="pubmed">29968510</ArticleId></ArticleIdList></Reference><Reference><Citation>Etzioni DA, Liu JH, Maggard MA, Ko CY. The aging population and its impact on the surgery workforce. Ann Surg. (2003) 238:170&#x2013;7. doi: 10.1097/01.SLA.0000081085.98792.3d, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.SLA.0000081085.98792.3d</ArticleId><ArticleId IdType="pmc">PMC1422682</ArticleId><ArticleId IdType="pubmed">12894008</ArticleId></ArticleIdList></Reference><Reference><Citation>Harms S, Larson R, Sahmoun A, Beal J. Obesity increases the likelihood of total joint replacement surgery among younger adults. Int Orthop. (2007) 31:23&#x2013;6. doi: 10.1007/s00264-006-0130-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00264-006-0130-y</ArticleId><ArticleId IdType="pmc">PMC2267551</ArticleId><ArticleId IdType="pubmed">16688455</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells V, Hearn T, McCaul K, Anderton S, Wigg A, Graves S. Changing incidence of primary total hip arthroplasty and total knee arthroplasty for primary osteoarthritis. J Arthroplast. (2002) 17:267&#x2013;73. doi: 10.1054/arth.2002.30414</Citation><ArticleIdList><ArticleId IdType="doi">10.1054/arth.2002.30414</ArticleId><ArticleId IdType="pubmed">11938500</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilz V, Hanstein T, Skripitz R. Projections of primary hip arthroplasty in Germany until 2040. Acta Orthop. (2018) 89:308&#x2013;13. doi: 10.1080/17453674.2018.1446463, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17453674.2018.1446463</ArticleId><ArticleId IdType="pmc">PMC6055773</ArticleId><ArticleId IdType="pubmed">29504824</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JJ, Choi GJ, Kang H, Baek CW, Jung YH, Shin HY, et al. . Relationship between surgery under general anesthesia and the development of dementia: a systematic review and meta-analysis. Biomed Res Int. (2020) 2020:1&#x2013;22. doi: 10.1155/2020/3234013</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/3234013</ArticleId><ArticleId IdType="pmc">PMC7165327</ArticleId><ArticleId IdType="pubmed">32337238</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen PL, Yang CW, Tseng YK, Sun WZ, Wang JL, Wang SJ, et al. . Risk of dementia after anaesthesia and surgery. Br J Psychiatry. (2014) 204:188&#x2013;93. doi: 10.1192/bjp.bp.112.119610, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.bp.112.119610</ArticleId><ArticleId IdType="pmc">PMC3939441</ArticleId><ArticleId IdType="pubmed">23887997</ArticleId></ArticleIdList></Reference><Reference><Citation>Strand AK, Nyqvist F, Ekdahl A, Wingren G, Eintrei C. Is there a relationship between anaesthesia and dementia? Acta Anaesthesiol Scand. (2019) 63:440&#x2013;7. doi: 10.1111/aas.13302, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.13302</ArticleId><ArticleId IdType="pubmed">30511411</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. . GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. (2008) 336:924&#x2013;6. doi: 10.1136/bmj.39489.470347.AD, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.AD</ArticleId><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiello Bowles EJ, Larson EB, Pong RP, Walker RL, Anderson ML, Yu O, et al. . Anesthesia exposure and risk of dementia and Alzheimer's disease: a prospective study. J Am Geriatr Soc. (2016) 64:602&#x2013;7. doi: 10.1111/jgs.14024, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.14024</ArticleId><ArticleId IdType="pmc">PMC4803643</ArticleId><ArticleId IdType="pubmed">26865152</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YC, Oyang YJ, Lin TY, Sun WZ. Risk assessment of dementia after hysterectomy: analysis of 14-year data from the National Health Insurance Research Database in Taiwan. J Chin Med Assoc. (2020) 83:394&#x2013;9. doi: 10.1097/JCMA.0000000000000286, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JCMA.0000000000000286</ArticleId><ArticleId IdType="pubmed">32149891</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon Y-S, Lee J-J, Lee S-H, Kim C, Yu H, Sohn J-H, et al. . Risk of dementia in patients who underwent surgery under neuraxial anesthesia: a nationwide cohort study. J Personal Med. (2021) 11:1386. doi: 10.3390/jpm11121386, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm11121386</ArticleId><ArticleId IdType="pmc">PMC8708516</ArticleId><ArticleId IdType="pubmed">34945858</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun M, Chen WM, Wu SY, Zhang J. Dementia risk amongst older adults with hip fracture receiving general anaesthesia or regional anaesthesia: a propensity-score-matched population-based cohort study. Br J Anaesth. (2023) 130:305&#x2013;13. doi: 10.1016/j.bja.2022.11.014, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2022.11.014</ArticleId><ArticleId IdType="pubmed">36593163</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun M, Chen WM, Wu SY, Zhang J. Dementia risk after major elective surgery based on the route of anaesthesia: a propensity score-matched population-based cohort study. EClinicalMedicine. (2023) 55:101727. doi: 10.1016/j.eclinm.2022.101727, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101727</ArticleId><ArticleId IdType="pmc">PMC9641180</ArticleId><ArticleId IdType="pubmed">36386032</ArticleId></ArticleIdList></Reference><Reference><Citation>Velkers C, Berger M, Gill SS, Eckenhoff R, Stuart H, Whitehead M, et al. . Association between exposure to general versus regional anesthesia and risk of dementia in older adults. J Am Geriatr Soc. (2021) 69:58&#x2013;67. doi: 10.1111/jgs.16834, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.16834</ArticleId><ArticleId IdType="pmc">PMC7942805</ArticleId><ArticleId IdType="pubmed">33025584</ArticleId></ArticleIdList></Reference><Reference><Citation>Evered LA, Chan MT, Han R, Chu MH, Cheng BP, Scott DA, et al. . Anaesthetic depth and delirium after major surgery: a randomised clinical trial. Br J Anaesth. (2021) 127:704&#x2013;12. doi: 10.1016/j.bja.2021.07.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2021.07.021</ArticleId><ArticleId IdType="pmc">PMC8579421</ArticleId><ArticleId IdType="pubmed">34465469</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen LS, Johnson T, Kuipers HM, Kristensen D, Siersma VD, Vila P, et al. . Does anaesthesia cause postoperative cognitive dysfunction? A randomised study of regional versus general anaesthesia in 438 elderly patients. Acta Anaesthesiol Scand. (2003) 47:260&#x2013;6. doi: 10.1034/j.1399-6576.2003.00057.x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1399-6576.2003.00057.x</ArticleId><ArticleId IdType="pubmed">12648190</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, Li J, Yuan L, Wu J, Jiang C, Daniels J, et al. . Effect of regional vs general anesthesia on incidence of postoperative delirium in older patients undergoing hip fracture surgery: the RAGA randomized trial. JAMA. (2022) 327:50&#x2013;8. doi: 10.1001/jama.2021.22647, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.22647</ArticleId><ArticleId IdType="pmc">PMC8689436</ArticleId><ArticleId IdType="pubmed">34928310</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhushan S, Huang X, Duan Y, Xiao Z. The impact of regional versus general anesthesia on postoperative neurocognitive outcomes in elderly patients undergoing hip fracture surgery: a systematic review and meta-analysis. Int J Surg. (2022) 105:106854. doi: 10.1016/j.ijsu.2022.106854, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2022.106854</ArticleId><ArticleId IdType="pubmed">36031067</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch EP, Lazor MA, Gellis JE, Orav J, Goldman L, Marcantonio ER. The impact of postoperative pain on the development of postoperative delirium. Anesth Analg. (1998) 86:781&#x2013;5. PMID:</Citation><ArticleIdList><ArticleId IdType="pubmed">9539601</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaurio LE, Sands LP, Wang Y, Mullen EA, Leung JM. Postoperative delirium: the importance of pain and pain management. Anesth Analg. (2006) 102:1267&#x2013;73. doi: 10.1213/01.ane.0000199156.59226.af</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ane.0000199156.59226.af</ArticleId><ArticleId IdType="pubmed">16551935</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong Y, Zhang G, Zhang B, Moir RD, Xia W, Marcantonio ER, et al. . The common inhalational anesthetic sevoflurane induces apoptosis and increases beta-amyloid protein levels. Arch Neurol. (2009) 66:620&#x2013;31. doi: 10.1001/archneurol.2009.48, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2009.48</ArticleId><ArticleId IdType="pmc">PMC2748878</ArticleId><ArticleId IdType="pubmed">19433662</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Z, Dong Y, Maeda U, Alfille P, Culley DJ, Crosby G, et al. . The common inhalation anesthetic isoflurane induces apoptosis and increases amyloid beta protein levels. Anesthesiology. (2006) 104:988&#x2013;94. doi: 10.1097/00000542-200605000-00015, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200605000-00015</ArticleId><ArticleId IdType="pubmed">16645451</ArticleId></ArticleIdList></Reference><Reference><Citation>Eckenhoff RG, Johansson JS, Wei H, Carnini A, Kang B, Wei W, et al. . Inhaled anesthetic enhancement of amyloid-beta oligomerization and cytotoxicity. Anesthesiology. (2004) 101:703&#x2013;9. doi: 10.1097/00000542-200409000-00019, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200409000-00019</ArticleId><ArticleId IdType="pubmed">15329595</ArticleId></ArticleIdList></Reference><Reference><Citation>Perucho J, Rubio I, Casarejos MJ, Gomez A, Rodriguez-Navarro JA, Solano RM, et al. . Anesthesia with isoflurane increases amyloid pathology in mice models of Alzheimer's disease. J Alzheimer's Dis. (2010) 19:1245&#x2013;57. doi: 10.3233/JAD-2010-1318</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2010-1318</ArticleId><ArticleId IdType="pubmed">20308791</ArticleId></ArticleIdList></Reference><Reference><Citation>Seitz DP, Shah PS, Herrmann N, Beyene J, Siddiqui N. Exposure to general anesthesia and risk of Alzheimer's disease: a systematic review and meta-analysis. BMC Geriatr. (2011) 11:83. doi: 10.1186/1471-2318-11-83</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2318-11-83</ArticleId><ArticleId IdType="pmc">PMC3258207</ArticleId><ArticleId IdType="pubmed">22168260</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. (2011) 10:819&#x2013;28. doi: 10.1016/S1474-4422(11)70072-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(11)70072-2</ArticleId><ArticleId IdType="pmc">PMC3647614</ArticleId><ArticleId IdType="pubmed">21775213</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabayan B, Sorond F. Reducing risk of dementia in older age. JAMA. (2017) 317:2028. doi: 10.1001/jama.2017.2247</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.2247</ArticleId><ArticleId IdType="pubmed">28510681</ArticleId></ArticleIdList></Reference><Reference><Citation>Hebert LE, Weuve J, Scherr PA, Evans DA. Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology. (2013) 80:1778&#x2013;83. doi: 10.1212/WNL.0b013e31828726f5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31828726f5</ArticleId><ArticleId IdType="pmc">PMC3719424</ArticleId><ArticleId IdType="pubmed">23390181</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimer's Association . 2023 Alzheimer's disease facts and figures. Alzheimers Dement. (2023) 19:1598&#x2013;1695. doi: 10.1002/alz.13016</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.13016</ArticleId><ArticleId IdType="pubmed">36918389</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q, Wang T, Kang D, Chen L. Protective effect of apolipoprotein E epsilon 3 on sporadic Alzheimer's disease in the Chinese population: a meta-analysis. Sci Rep. (2022) 12:13620. doi: 10.1038/s41598-022-18033-x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-18033-x</ArticleId><ArticleId IdType="pmc">PMC9365782</ArticleId><ArticleId IdType="pubmed">35948759</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J-H, Lin K-P, Chen Y-C. Risk factors for dementia. J Formos Med Assoc. (2009) 108:754&#x2013;64. doi: 10.1016/S0929-6646(09)60402-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0929-6646(09)60402-2</ArticleId><ArticleId IdType="pubmed">19864195</ArticleId></ArticleIdList></Reference><Reference><Citation>Abolhasani E, Hachinski V, Ghazaleh N, Azarpazhooh MR, Mokhber N, Martin J. Air pollution and incidence of dementia: a systematic review and meta-analysis. Neurology. (2023) 100:e242&#x2013;54. doi: 10.1212/WNL.0000000000201419</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000201419</ArticleId><ArticleId IdType="pubmed">36288998</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal R, Tripathi CB. Association of apolipoprotein E genetic variation in Alzheimer's disease in Indian population: a meta-analysis. Am J Alzheimers Dis Other Dement. (2014) 29:575&#x2013;82. doi: 10.1177/1533317514531443, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1533317514531443</ArticleId><ArticleId IdType="pmc">PMC10852589</ArticleId><ArticleId IdType="pubmed">25551132</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen K, Launer LJ, Dewey ME, Letenneur L, Ott A, Copeland JR, et al. . Gender differences in the incidence of AD and vascular dementia: the EURODEM studies. EURODEM incidence research group. Neurology. (1999) 53:1992&#x2013;7. doi: 10.1212/WNL.53.9.1992</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.53.9.1992</ArticleId><ArticleId IdType="pubmed">10599770</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruitenberg A, Ott A, van Swieten JC, Hofman A, Breteler MM. Incidence of dementia: does gender make a difference? Neurobiol Aging. (2001) 22:575&#x2013;80. doi: 10.1016/S0197-4580(01)00231-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0197-4580(01)00231-7</ArticleId><ArticleId IdType="pubmed">11445258</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Pousa S, Vilalta-Franch J, Llin&#xe0;s-Regla J, Garre-Olmo J, Rom&#xe1;n GC. Incidence of dementia in a rural community in Spain: the Girona cohort study. Neuroepidemiology. (2004) 23:170&#x2013;7. doi: 10.1159/000078502</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000078502</ArticleId><ArticleId IdType="pubmed">15272219</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N, et al. . Incidence and etiology of dementia in a large elderly Italian population. Neurology. (2005) 64:1525&#x2013;30. doi: 10.1212/01.WNL.0000160107.02316.BF, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000160107.02316.BF</ArticleId><ArticleId IdType="pubmed">15883312</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27406422</PMID><DateCompleted><Year>2017</Year><Month>02</Month><Day>22</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0317-1671</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>5</Issue><PubDate><Year>2016</Year><Month>Sep</Month></PubDate></JournalIssue><Title>The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques</Title><ISOAbbreviation>Can J Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>Outcomes of General Anesthesia and Conscious Sedation in Endovascular Treatment for Stroke.</ArticleTitle><Pagination><StartPage>655</StartPage><EndPage>658</EndPage><MedlinePgn>655-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1017/cjn.2016.256</ELocationID><Abstract><AbstractText>Background Recent studies have strongly indicated the benefits of endovascular therapy for acute ischemic stroke, but what remains a continued debate is the role for general anaesthesia versus conscious sedation (CS) for such procedures. Retrospective studies have found poorer neurological outcomes in patients who underwent general anesthesia (GA); however, some have revealed worse baseline stroke severity in these patients. Methods This study is a retrospective cohort study aimed at comparing mortality and morbidity of GA versus CS in patients treated with endovascular intervention in acute ischemic stroke. Chi-square and t-test analyses were used. Results Patients in the GA (n=42) group were more likely to be deceased than those in the CS (n=67) group at hospital discharge, 3 months, and 6 months poststroke onset. Morbidity, as defined by modified Rankin Score, was significantly greater in the GA group at hospital discharge, and a similar trend was seen in morbidity at 3 months postdischarge. Conclusion General anesthesia for endovascular intervention in acute ischemic stroke was associated with increased mortality and poorer neurological incomes compared with conscious sedation. In our study, age, gender, history of hypertension, history of diabetes, and baseline National Institute of Health Stroke Scale were not significantly different between the groups. Although the need for a randomized, prospective study on this topic is clear, our study represents further corroboration of the safety and efficacy of conscious sedation in these procedures.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Just</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>1Clinical Neurological Sciences,Schulich School of Medicine Dentistry,Western University,London,Ontario,Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizek</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>2Clinical Neurological Sciences,Western University,London,Ontario,Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tryphonopoulos</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>3Department of Anesthesiology,Western University,London,Ontario,Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pelz</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>4Department of Medical Imaging,Western University,London,Ontario,Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arango</LastName><ForeName>Miguel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>3Department of Anesthesiology,Western University,London,Ontario,Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>07</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Can J Neurol Sci</MedlineTA><NlmUniqueID>0415227</NlmUniqueID><ISSNLinking>0317-1671</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002545" MajorTopicYN="N">Brain Ischemia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016292" MajorTopicYN="N">Conscious Sedation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="N">Endovascular Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018709" MajorTopicYN="N">Statistics, Nonparametric</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="Y">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anaesthesia</Keyword><Keyword MajorTopicYN="N">cerebrovascular disease</Keyword><Keyword MajorTopicYN="N">cerebrovascular surgery</Keyword><Keyword MajorTopicYN="N">endovascular</Keyword><Keyword MajorTopicYN="N">interventional neuroradiology</Keyword><Keyword MajorTopicYN="N">neurosurgery - vascular</Keyword><Keyword MajorTopicYN="N">neurovascular</Keyword><Keyword MajorTopicYN="N">stroke</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27406422</ArticleId><ArticleId IdType="doi">10.1017/cjn.2016.256</ArticleId><ArticleId IdType="pii">S0317167116002560</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23686977</PMID><DateCompleted><Year>2013</Year><Month>09</Month><Day>05</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1524-4628</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>7</Issue><PubDate><Year>2013</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Stroke</Title><ISOAbbreviation>Stroke</ISOAbbreviation></Journal><ArticleTitle>Endovascular treatment of intracranial aneurysms in elderly patients: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1897</StartPage><EndPage>1902</EndPage><MedlinePgn>1897-902</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1161/STROKEAHA.113.001524</ELocationID><Abstract><AbstractText Label="BACKGROUND AND PURPOSE" NlmCategory="OBJECTIVE">Use of endovascular coiling for treatment of ruptured and unruptured intracranial aneurysms (IAs) in the elderly is increasing. We performed a meta-analysis of the literature examining clinical and angiographic outcomes for treatment of IAs in the elderly.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a comprehensive review of the literature from 1995 to 2012, reporting series of patients &#x2265;65 years of age with ruptured or unruptured IAs treated with endovascular approach. Event rates were pooled across studies using random effects meta-analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 21 studies reporting on 1511 patients were included. Long-term aneurysm occlusion rates were 79% (95% confidence interval [CI], 70%-85%). Perioperative stroke occurred in 4% (95% CI, 3%-6%), with similar rates between patients with ruptured (5%; 95% CI, 3%-7%) and unruptured aneurysms (4%; 95% CI, 1%-14%; P=0.68). Intraprocedural rupture occurred in 1% (95% CI, 0%-3%) and 4% (95% CI, 2-6%; P=0.04) of patients with unruptured and ruptured aneurysms, respectively. Perioperative mortality rate for patients with ruptured aneurysms was 23% (95% CI, 17%-30%) and 1% (95% CI, 0%-6%) for patients with unruptured aneurysms (P&lt;0.01). Rates of good clinical outcome at 1 year were 93% (95% CI, 88%-96%) and 66% (95% CI, 59%-72%) in patients with unruptured and ruptured aneurysms, respectively.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study suggests that endovascular treatment of IAs in the elderly is associated with high long-term occlusion rates. Given the morbidity and mortality associated with endovascular treatment of IAs in the elderly, careful patient selection, especially in the case of patients with unruptured aneurysm, is recommended.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sturiale</LastName><ForeName>Carmelo L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Department of Neurologic Surgery, Mayo Clinic College of Medicine, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brinjikji</LastName><ForeName>Waleed</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Murad</LastName><ForeName>Mohammad H</ForeName><Initials>MH</Initials></Author><Author ValidYN="Y"><LastName>Lanzino</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>05</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Stroke</MedlineTA><NlmUniqueID>0235266</NlmUniqueID><ISSNLinking>0039-2499</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017542" MajorTopicYN="N">Aneurysm, Ruptured</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="N">Endovascular Procedures</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002532" MajorTopicYN="N">Intracranial Aneurysm</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="Y">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">coiling</Keyword><Keyword MajorTopicYN="N">elderly</Keyword><Keyword MajorTopicYN="N">endovascular treatment</Keyword><Keyword MajorTopicYN="N">intracranial aneurysms</Keyword><Keyword MajorTopicYN="N">subarachnoid hemorrhage</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23686977</ArticleId><ArticleId IdType="doi">10.1161/STROKEAHA.113.001524</ArticleId><ArticleId IdType="pii">STROKEAHA.113.001524</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31530593</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>30</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>9</Issue><PubDate><Year>2019</Year><Month>Sep</Month><Day>17</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Tranexamic acid in cardiac surgery: a systematic review and meta-analysis (protocol).</ArticleTitle><Pagination><StartPage>e028585</StartPage><MedlinePgn>e028585</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e028585</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2018-028585</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Bleeding during cardiac surgery is associated with increased morbidity and mortality. Tranexamic acid is an antifibrinolytic with proven efficacy in major surgeries. Current clinical practice guidelines recommend intraoperative use in cardiac procedures. However, several complications have been reported with tranexamic acid including seizures. This review intends to summarise the evidence examining the efficacy and safety of tranexamic acid in patients undergoing cardiac surgery.</AbstractText><AbstractText Label="METHODS/DESIGN">We will search MEDLINE, Embase, PubMED, ACPJC, CINAHL and the Cochrane trial registry for eligible randomised controlled trials, the search dates for all databases will be from inception until 1 January 2019, investigating the perioperative use of topical and/or intravenous tranexamic acid as a stand-alone antifibrinolytic agent compared with placebo in patients undergoing open cardiac surgery. We categorised outcomes as patient critical or patient important. Selected patient-critical outcomes are: mortality (intensive care unit, hospital and 30-day endpoints), reoperation within 24&#x2009;hours, postoperative bleeding requiring transfusion of packed red blood cells, myocardial infarction, stroke, pulmonary embolism, bowel infarction, upper or lower limb deep vein thrombosis and seizures. Those outcomes, we perceived as clinical experts to be most patient valued and patients were not involved in outcomes selection process. We will not apply publication date, language, journal or methodological quality restrictions. Two reviewers will independently screen and identify eligible studies using predefined eligibility criteria and then review full reports of all potentially relevant citations. A third reviewer will resolve disagreements if consensus cannot be achieved. We will present the results as relative risk with 95% CIs for dichotomous outcomes and as mean difference or standardised mean difference for continuous outcomes with 95% CIs. We will assess the quality of evidence using the Grading of Recommendations, Assessment, Development and Evaluation approach.</AbstractText><AbstractText Label="ETHICS AND DISSEMINATION">Formal ethical approval is not required as primary data will not be collected. The results will be disseminated through a peer-reviewed publication TRIAL REGISTRATION NUMBER: CRD42018105904.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alaifan</LastName><ForeName>Thamer</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-9547-9186</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Critical Care, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alenazy</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, Critical Care, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiang Wang</LastName><ForeName>Dominic</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Schulich School of Medicine and Dentistry, University of Western, London, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernando</LastName><ForeName>Shannon M</ForeName><Initials>SM</Initials><Identifier Source="ORCID">0000-0003-4549-4289</Identifier><AffiliationInfo><Affiliation>Division of Critical Care, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spence</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-1267-9455</Identifier><AffiliationInfo><Affiliation>Departments of Anesthesia and Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Population Health Research Institute, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belley-Cote</LastName><ForeName>Emilie</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Population Health Research Institute, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Critical Care, Cardiology, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence &amp; Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fox-Robichaud</LastName><ForeName>Alison</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9912-3606</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Critical Care, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ainswoth</LastName><ForeName>Craig</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine, Critical Care, Cardiology, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karachi</LastName><ForeName>Tim</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Medicine, Critical Care, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kyeremanteng</LastName><ForeName>Kwadwo</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Critical Care, University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zarychanski</LastName><ForeName>Ryan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Sections of Critical Care Medicine and of Hematology/Medical Oncology, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whitlock</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Population Health Research Institute, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence &amp; Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Division of Cardiac Surgery, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rochwerg</LastName><ForeName>Bram</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-8293-7061</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Critical Care, McMaster University, Hamilton, Ontario, Canada rochwerg@mcmaster.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000933">Antifibrinolytic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>6T84R30KC1</RegistryNumber><NameOfSubstance UI="D014148">Tranexamic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000933" MajorTopicYN="N">Antifibrinolytic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015201" MajorTopicYN="N">Meta-Analysis as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000078202" MajorTopicYN="N">Systematic Reviews as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014148" MajorTopicYN="N">Tranexamic Acid</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">bleeding</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">seizure</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword><Keyword MajorTopicYN="N">tranexamic acid</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>9</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31530593</ArticleId><ArticleId IdType="pmc">PMC6756438</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2018-028585</ArticleId><ArticleId IdType="pii">bmjopen-2018-028585</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sullivan MT, Cotten R, Read EJ, et al. . Blood collection and transfusion in the United States in 2001. Transfusion 2007;47:385&#x2013;94. 10.1111/j.1537-2995.2007.01128.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1537-2995.2007.01128.x</ArticleId><ArticleId IdType="pubmed">17319817</ArticleId></ArticleIdList></Reference><Reference><Citation>Colson PH, Gaudard P, Fellahi J-L, et al. . Active bleeding after cardiac surgery: a prospective observational multicenter study. PLoS One 2016;11:e0162396 10.1371/journal.pone.0162396</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0162396</ArticleId><ArticleId IdType="pmc">PMC5010224</ArticleId><ArticleId IdType="pubmed">27588817</ArticleId></ArticleIdList></Reference><Reference><Citation>Kristensen KL, Rauer LJ, Mortensen PE, et al. . Reoperation for bleeding in cardiac surgery. Interact Cardiovasc Thorac Surg 2012;14:709&#x2013;13. 10.1093/icvts/ivs050</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivs050</ArticleId><ArticleId IdType="pmc">PMC3352720</ArticleId><ArticleId IdType="pubmed">22368106</ArticleId></ArticleIdList></Reference><Reference><Citation>Vivacqua A, Koch CG, Yousuf AM, et al. . Morbidity of bleeding after cardiac surgery: is it blood transfusion, reoperation for bleeding, or both? Ann Thorac Surg 2011;91:1780&#x2013;90. 10.1016/j.athoracsur.2011.03.105</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2011.03.105</ArticleId><ArticleId IdType="pubmed">21619974</ArticleId></ArticleIdList></Reference><Reference><Citation>Paparella D, Galeone A, Venneri MT, et al. . Activation of the coagulation system during coronary artery bypass grafting: comparison between on-pump and off-pump techniques. J Thorac Cardiovasc Surg 2006;131:290&#x2013;7. 10.1016/j.jtcvs.2005.10.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2005.10.018</ArticleId><ArticleId IdType="pubmed">16434256</ArticleId></ArticleIdList></Reference><Reference><Citation>Ickx BE, Faraoni D. Management of the clotting system: a European perspective. Curr Opin Anaesthesiol 2012;25:80&#x2013;5. 10.1097/ACO.0b013e32834ef3d1</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0b013e32834ef3d1</ArticleId><ArticleId IdType="pubmed">22157197</ArticleId></ArticleIdList></Reference><Reference><Citation>Hess PJ. Systemic inflammatory response to coronary artery bypass graft surgery. Am J Health Syst Pharm 2005;62(18 Suppl 4):S6&#x2013;9. 10.2146/ajhp050302</Citation><ArticleIdList><ArticleId IdType="doi">10.2146/ajhp050302</ArticleId><ArticleId IdType="pubmed">16227195</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagano D, Milojevic M, Meesters MI, et al. . 2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery. Eur J Cardiothorac Surg 2018;53:79&#x2013;111. 10.1093/ejcts/ezx325</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezx325</ArticleId><ArticleId IdType="pubmed">29029100</ArticleId></ArticleIdList></Reference><Reference><Citation>Ker K, Edwards P, Perel P, et al. . Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ 2012;344:e3054 10.1136/bmj.e3054</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.e3054</ArticleId><ArticleId IdType="pmc">PMC3356857</ArticleId><ArticleId IdType="pubmed">22611164</ArticleId></ArticleIdList></Reference><Reference><Citation>CRASH-2 trial collaborators Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010;376:23&#x2013;32. 10.1016/S0140-6736(10)60835-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)60835-5</ArticleId><ArticleId IdType="pubmed">20554319</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraris VA, Brown JR, Despotis GJ, et al. . 2011 Update to the Society of thoracic surgeons and the Society of cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 2011;91:944&#x2013;82. 10.1016/j.athoracsur.2010.11.078</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2010.11.078</ArticleId><ArticleId IdType="pubmed">21353044</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs 1999;57:1005&#x2013;32. 10.2165/00003495-199957060-00017</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00003495-199957060-00017</ArticleId><ArticleId IdType="pubmed">10400410</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukes AS, Moore KA, Muse KN, et al. . Tranexamic acid treatment for heavy menstrual bleeding. Obstet Gynecol 2010;116:865&#x2013;75. 10.1097/AOG.0b013e3181f20177</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AOG.0b013e3181f20177</ArticleId><ArticleId IdType="pubmed">20859150</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukeik M, Alshryda S, Haddad FS, et al. . Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg Br 2011;93-B:39&#x2013;46. 10.1302/0301-620X.93B1.24984</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.93B1.24984</ArticleId><ArticleId IdType="pubmed">21196541</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison JJ, Dubose JJ, Rasmussen TE, et al. . Military application of tranexamic acid in trauma emergency resuscitation (MATTERS) study. Arch Surg 2012;147:113&#x2013;9. 10.1001/archsurg.2011.287</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.2011.287</ArticleId><ArticleId IdType="pubmed">22006852</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JR, Birkmeyer NJO, O'Connor GT. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery. Circulation 2007;115:2801&#x2013;13. 10.1161/CIRCULATIONAHA.106.671222</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.671222</ArticleId><ArticleId IdType="pubmed">17533182</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma V, Katznelson R, Jerath A, et al. . The association between tranexamic acid and convulsive seizures after cardiac surgery: a multivariate analysis in 11 529 patients. Anaesthesia 2014;69:124&#x2013;30. 10.1111/anae.12516</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.12516</ArticleId><ArticleId IdType="pubmed">24588023</ArticleId></ArticleIdList></Reference><Reference><Citation>Koster A, B&#xf6;rgermann J, Zittermann A, et al. . Moderate dosage of tranexamic acid during cardiac surgery with cardiopulmonary bypass and convulsive seizures: incidence and clinical outcome. Br J Anaesth 2013;110:34&#x2013;40. 10.1093/bja/aes310</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aes310</ArticleId><ArticleId IdType="pubmed">22986419</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z-F, Zhang F-J, Huo Y-F, et al. . Intraoperative tranexamic acid is associated with postoperative stroke in patients undergoing cardiac surgery. PLoS One 2017;12:e0177011 10.1371/journal.pone.0177011</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0177011</ArticleId><ArticleId IdType="pmc">PMC5446127</ArticleId><ArticleId IdType="pubmed">28552944</ArticleId></ArticleIdList></Reference><Reference><Citation>Myles PS, Smith JA, Forbes A, et al. . Tranexamic acid in patients undergoing coronary-artery surgery. N Engl J Med 2017;376:136&#x2013;48. 10.1056/NEJMoa1606424</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1606424</ArticleId><ArticleId IdType="pubmed">27774838</ArticleId></ArticleIdList></Reference><Reference><Citation>Borger MA, Ivanov J, Weisel RD, et al. . Stroke during coronary bypass surgery: principal role of cerebral macroemboli. Eur J Cardiothorac Surg 2001;19:627&#x2013;32. 10.1016/S1010-7940(01)00649-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1010-7940(01)00649-2</ArticleId><ArticleId IdType="pubmed">11343943</ArticleId></ArticleIdList></Reference><Reference><Citation>Sander M, Spies CD, Martiny V, et al. . Mortality associated with administration of high-dose tranexamic acid and aprotinin in primary open-heart procedures: a retrospective analysis. Critical Care 2010;14 10.1186/cc9216</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc9216</ArticleId><ArticleId IdType="pmc">PMC2945131</ArticleId><ArticleId IdType="pubmed">20682059</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigaut S, Tremey B, Ouattara A, et al. . Comparison of two doses of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass. Anesthesiology 2014;120:590&#x2013;600. 10.1097/ALN.0b013e3182a443e8</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3182a443e8</ArticleId><ArticleId IdType="pubmed">23903022</ArticleId></ArticleIdList></Reference><Reference><Citation>Waldow T, Szlapka M, Haferkorn M, et al. . Prospective clinical trial on dosage optimizing of tranexamic acid in non-emergency cardiac surgery procedures. Clin Hemorheol Microcirc 2013;55:457&#x2013;68. 10.3233/CH-131782</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/CH-131782</ArticleId><ArticleId IdType="pubmed">24113504</ArticleId></ArticleIdList></Reference><Reference><Citation>McCormack PL. Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis. Drugs 2012;72:585&#x2013;617. 10.2165/11209070-000000000-00000</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/11209070-000000000-00000</ArticleId><ArticleId IdType="pubmed">22397329</ArticleId></ArticleIdList></Reference><Reference><Citation>Cilia La Corte AL, Philippou H, Ari&#xeb;ns RAS, et al. . Role of fibrin structure in thrombosis and vascular disease. Adv Protein Chem Struct Biol 2011;83:75&#x2013;127. 10.1016/B978-0-12-381262-9.00003-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-381262-9.00003-3</ArticleId><ArticleId IdType="pubmed">21570666</ArticleId></ArticleIdList></Reference><Reference><Citation>Sniecinski RM, Chandler WL. Activation of the hemostatic system during cardiopulmonary bypass. Anesth Analg 2011;113:1319&#x2013;33. 10.1213/ANE.0b013e3182354b7e</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e3182354b7e</ArticleId><ArticleId IdType="pubmed">22003219</ArticleId></ArticleIdList></Reference><Reference><Citation>McIlroy DR, Myles PS, Phillips LE, et al. . Antifibrinolytics in cardiac surgical patients receiving aspirin: a systematic review and meta-analysis. Br J Anaesth 2009;102:168&#x2013;78. 10.1093/bja/aen377</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aen377</ArticleId><ArticleId IdType="pubmed">19151047</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai Z, Chu H, Wang S, et al. . The effect of tranexamic acid to reduce blood loss and transfusion on off-pump coronary artery bypass surgery: a systematic review and cumulative meta-analysis. J Clin Anesth 2018;44:23&#x2013;31. 10.1016/j.jclinane.2017.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2017.10.004</ArticleId><ArticleId IdType="pubmed">29107853</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Altman DG, G&#xf8;tzsche PC, et al. . The Cochrane collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928 10.1136/bmj.d5928</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>
Higgins JPT, Green S, eds
Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011.  Available: www.cochrane-handbook.org
</Citation></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, et al. . GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924&#x2013;6. 10.1136/bmj.39489.470347.AD</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.AD</ArticleId><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsaros D, Petricevic M, Snow NJ, et al. . Tranexamic acid reduces postbypass blood use. Ann Thorac Surg 1996;61:1131&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">8607670</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">19608798</PMID><DateCompleted><Year>2009</Year><Month>07</Month><Day>30</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>109</Volume><Issue>2</Issue><PubDate><Year>2009</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>The efficacy of an intraoperative cell saver during cardiac surgery: a meta-analysis of randomized trials.</ArticleTitle><Pagination><StartPage>320</StartPage><EndPage>330</EndPage><MedlinePgn>320-30</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ane.0b013e3181aa084c</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Cell salvage may be used during cardiac surgery to avoid allogeneic blood transfusion. It has also been claimed to improve patient outcomes by removing debris from shed blood, which may increase the risk of stroke or neurocognitive dysfunction. In this study, we sought to determine the overall safety and efficacy of cell salvage in cardiac surgery by performing a systematic review and meta-analysis of published randomized controlled trials.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A comprehensive search was undertaken to identify all randomized trials of cell saver use during cardiac surgery. MEDLINE, Cochrane Library, EMBASE, and abstract databases were searched up to November 2008. All randomized trials comparing cell saver use and no cell saver use in cardiac surgery and reporting at least one predefined clinical outcome were included. The random effects model was used to calculate the odds ratios (OR, 95% confidence intervals [CI]) and the weighted mean differences (WMD, 95% CI) for dichotomous and continuous variables, respectively.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Thirty-one randomized trials involving 2282 patients were included in the meta-analysis. During cardiac surgery, the use of an intraoperative cell saver reduced the rate of exposure to any allogeneic blood product (OR 0.63, 95% CI: 0.43-0.94, P = 0.02) and red blood cells (OR 0.60, 95% CI: 0.39-0.92, P = 0.02) and decreased the mean volume of total allogeneic blood products transfused per patient (WMD -256 mL, 95% CI: -416 to -95 mL, P = 0.002). There was no difference in hospital mortality (OR 0.65, 95% CI: 0.25-1.68, P = 0.37), postoperative stroke or transient ischemia attack (OR 0.59, 95% CI: 0.20-1.76, P = 0.34), atrial fibrillation (OR 0.92, 95% CI: 0.69-1.23, P = 0.56), renal dysfunction (OR 0.86, 95% CI: 0.41-1.80, P = 0.70), infection (OR 1.25, 95% CI: 0.75-2.10, P = 0.39), patients requiring fresh frozen plasma (OR 1.16, 95% CI: 0.82-1.66, P = 0.40), and patients requiring platelet transfusions (OR 0.90, 95% CI: 0.63-1.28, P = 0.55) between cell saver and noncell saver groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Current evidence suggests that the use of a cell saver reduces exposure to allogeneic blood products or red blood cell transfusion for patients undergoing cardiac surgery. Subanalyses suggest that a cell saver may be beneficial only when it is used for shed blood and/or residual blood or during the entire operative period. Processing cardiotomy suction blood with a cell saver only during cardiopulmonary bypass has no significant effect on blood conservation and increases fresh frozen plasma transfusion.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Guyan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Medicine, London Health Sciences Centre, University of Western Ontario, London, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bainbridge</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Janet</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Davy</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001793" MajorTopicYN="N">Blood Preservation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D023381" MajorTopicYN="N">Endpoint Determination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017707" MajorTopicYN="N">Erythrocyte Transfusion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010949" MajorTopicYN="N">Plasma</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017713" MajorTopicYN="N">Platelet Transfusion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017594" MajorTopicYN="N">Publication Bias</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>52</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>7</Month><Day>18</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>7</Month><Day>18</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>7</Month><Day>31</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19608798</ArticleId><ArticleId IdType="doi">10.1213/ane.0b013e3181aa084c</ArticleId><ArticleId IdType="pii">109/2/320</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27636576</PMID><DateCompleted><Year>2017</Year><Month>06</Month><Day>29</Day></DateCompleted><DateRevised><Year>2018</Year><Month>01</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>123</Volume><Issue>4</Issue><PubDate><Year>2016</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>The Association Between Mild Intraoperative Hypotension and Stroke in General Surgery Patients.</ArticleTitle><Pagination><StartPage>933</StartPage><EndPage>939</EndPage><MedlinePgn>933-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000001526</ELocationID><Abstract><AbstractText Label="BACKGROUND">Intraoperative hypotension may contribute to perioperative strokes. We therefore tested the hypothesis that intraoperative hypotension is associated with perioperative stroke.</AbstractText><AbstractText Label="METHODS">After institutional review board approval for this case-control study, we identified patients who had nonneurological, noncardiac, and noncarotid surgery under general anesthesia at the Cleveland Clinic between 2005 and 2011 and experienced a postoperative stroke. Control patients not experiencing postoperative stroke were matched in a 4-to-1 ratio using propensity scores and restriction to the same procedure type as stroke patients. The association between intraoperative hypotension, measured as time-integrated area under a mean arterial pressure (MAP) of 70 mm Hg, and postoperative stroke was assessed using zero-inflated negative binomial regression.</AbstractText><AbstractText Label="RESULTS">Among 106&#x2009;337 patients meeting inclusion criteria, we identified 120 who had confirmed postoperative stroke events based on manual chart review. Four-to-one propensity matching yielded a final matched sample of 104 stroke cases and 398 controls. There was no association between stroke and intraoperative hypotension. Stroke patients were not more likely than controls to have been hypotensive (odds ratio, 0.49 [0.18-1.38]), and among patients with intraoperative hypotension, stroke patients did not experience a greater degree of hypotension than controls (ratio of geometric means, 1.07 [0.76-1.53]).</AbstractText><AbstractText Label="CONCLUSIONS">In our propensity score-matched case-control study, we did not find an association between intraoperative hypotension, defined as MAP &lt; 70 mm Hg, and postoperative stroke.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hsieh</LastName><ForeName>Jason K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>From the *Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio; Departments of &#x2020;Quantitative Health Sciences, &#x2021;Outcomes Research, and &#xa7;General Anesthesiology, Anesthesiology Institute, Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalton</LastName><ForeName>Jarrod E</ForeName><Initials>JE</Initials></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Dongsheng</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Farag</LastName><ForeName>Ehab S</ForeName><Initials>ES</Initials></Author><Author ValidYN="Y"><LastName>Sessler</LastName><ForeName>Daniel I</ForeName><Initials>DI</Initials></Author><Author ValidYN="Y"><LastName>Kurz</LastName><ForeName>Andrea M</ForeName><Initials>AM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Anesth Analg. 2016 Oct;123(4):814-5. doi: 10.1213/ANE.0000000000001572.</RefSource><PMID Version="1">27636570</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27636576</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000001526</ArticleId><ArticleId IdType="pii">00000539-201610000-00020</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37057905</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>26</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-9159</ISSN><JournalIssue CitedMedium="Internet"><Volume>109</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>01</Day></PubDate></JournalIssue><Title>International journal of surgery (London, England)</Title><ISOAbbreviation>Int J Surg</ISOAbbreviation></Journal><ArticleTitle>Effect of regional versus general anesthesia on thirty-day outcomes following carotid endarterectomy: a cohort study.</ArticleTitle><Pagination><StartPage>1291</StartPage><EndPage>1298</EndPage><MedlinePgn>1291-1298</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/JS9.0000000000000356</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The effect of regional versus general anesthesia on carotid endarterectomy outcomes is debated. This study assesses the effect of anesthetic technique on major morbidity and mortality and additional secondary endpoints following carotid endarterectomy.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">This was a retrospective propensity-matched-cohort analysis investigating elective carotid endarterectomy patients in the 2015-2019 American College of Surgeons National Surgical Quality Improvement Program ( n =37&#xa0;204). The primary endpoint was 30-day mortality and major morbidity, defined as stroke, myocardial infarction, or death. Secondary endpoints included minor morbidity, bleeding events, healthcare resource utilization, and length of hospital stay. Univariate, multivariable, and survival analyses were applied.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The 1&#xa0;:&#xa0;1 propensity-matched-cohort included 8304 patients (4152 in each group). Regional anesthesia was associated with similar incidences of major morbidity and mortality [odds ratio (OR), 0.81 (95% CI, 0.61-1.09); P = 0.162] and unplanned resource utilization [OR, 0.93 (95% CI, 0.78-1.11); P = 0.443], but lower incidences of minor morbidity [OR, 0.60 (95% CI, 0.44-0.81); P &lt; 0.001] and bleeding events [OR, 0.49 (95% CI, 0.30-0.78); P = 0.002], and a shorter length of hospital stay [1.4 vs. 1.6 days; mean difference, -0.16 days (95% CI, -0.25 to -0.07); P &lt; 0.001]. On multivariable analysis, regional anesthesia remained independently predictive of minor morbidity [adjusted odds ratio (AOR), 0.58 (95% CI, 0.42-0.79); P = 0.001] and bleeding events [AOR, 0.49 (95% CI, 0.30-0.77); P = 0.003]. Significance was maintained on survival analysis for these two endpoints. A mortality benefit was observed on univariate [OR, 0.50 (95% CI, 0.25-1.00); P = 0.045], multivariable [AOR, 0.49 (95% CI, 0.24-0.96); P = 0.043], and survival analysis ( P = 0.045).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Carotid endarterectomy patients receiving regional anesthesia experience favorable outcomes compared to propensity-matched general anesthesia controls.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kline</LastName><ForeName>Leigh A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Virginia Health.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kothandaraman</LastName><ForeName>Venkatraman</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Virginia, Charlottesville, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knio</LastName><ForeName>Ziyad O</ForeName><Initials>ZO</Initials><Identifier Source="ORCID">0000-0001-5696-873</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Virginia Health.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zuo</LastName><ForeName>Zhiyi</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-3542-5047</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Virginia Health.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT05706688</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Surg</MedlineTA><NlmUniqueID>101228232</NlmUniqueID><ISSNLinking>1743-9159</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016894" MajorTopicYN="Y">Endarterectomy, Carotid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000765" MajorTopicYN="Y">Anesthesia, Conduction</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>9</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37057905</ArticleId><ArticleId IdType="pmc">PMC10389611</ArticleId><ArticleId IdType="doi">10.1097/JS9.0000000000000356</ArticleId><ArticleId IdType="pii">01279778-202305000-00025</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rerkasem A, Orrapin S, Howard DP, et al. . Local versus general anaesthesia for carotid endarterectomy. Cochrane Database Syst Rev 2021;10:CD000126.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8511439</ArticleId><ArticleId IdType="pubmed">34642940</ArticleId></ArticleIdList></Reference><Reference><Citation>Hans SS, Jareunpoon O. Prospective evaluation of electroencephalography, carotid artery stump pressure, and neurologic changes during 314 consecutive carotid endarterectomies performed in awake patients. J Vasc Surg 2007;45:511&#x2013;515.</Citation><ArticleIdList><ArticleId IdType="pubmed">17275248</ArticleId></ArticleIdList></Reference><Reference><Citation>GALA Trial Collaborative Group, Lewis SC, Warlow CP, Bodenham AR, et al. . General anaesthesia versus local anaesthesia for carotid surgery (GALA): a multicentre, randomised controlled trial. Lancet 2008;372:2132&#x2013;2142.</Citation><ArticleIdList><ArticleId IdType="pubmed">19041130</ArticleId></ArticleIdList></Reference><Reference><Citation>Unic-Stojanovic D, Babic S, Neskovic V. General versus regional anesthesia for carotid endarterectomy. J Cardiothorac Vasc Anesth 2013;27:1379&#x2013;1383.</Citation><ArticleIdList><ArticleId IdType="pubmed">23287445</ArticleId></ArticleIdList></Reference><Reference><Citation>Zdrehu&#x15f; C. Anaesthesia for carotid endarterectomy &#x2013; general or loco-regional? Rom J Anaesth Intensive Care 2015;22:17&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5505327</ArticleId><ArticleId IdType="pubmed">28913451</ArticleId></ArticleIdList></Reference><Reference><Citation>Licker M. Regional or general anaesthesia for carotid endarterectomy: does it matter? Eur J Anaesthesiol 2016;33:241&#x2013;243.</Citation><ArticleIdList><ArticleId IdType="pubmed">26928169</ArticleId></ArticleIdList></Reference><Reference><Citation>McCleary AJ, Maritati G, Gough MJ. Carotid endarterectomy; local or general anaesthesia? Eur J Vasc Endovasc Surg 2001;22:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">11461095</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodenham AR, Howell SJ. General anaesthesia vs local anaesthesia: an ongoing story. Br J Anaesth 2009;103:785&#x2013;789.</Citation><ArticleIdList><ArticleId IdType="pubmed">19918020</ArticleId></ArticleIdList></Reference><Reference><Citation>Paraskevas KI, Mikhailidis DP, Oikonomou K, et al. . Local versus general anesthesia for carotid endarterectomy: issues beyond stroke, myocardial infarction, and death rates. Angiology 2012;63:405&#x2013;408.</Citation><ArticleIdList><ArticleId IdType="pubmed">22210736</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;rer O, Yapici F, Yapici N, et al. . Comparison between local and general anesthesia for carotid endarterectomy: early and late results. Vasc Endovascular Surg 2012;46:131&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pubmed">22232328</ArticleId></ArticleIdList></Reference><Reference><Citation>Mofidi R, Nimmo AF, Moores C, et al. . Regional versus general anaesthesia for carotid endarterectomy: impact of change in practice. Surgeon 2006;4:158&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pubmed">16764201</ArticleId></ArticleIdList></Reference><Reference><Citation>Watts K, Lin PH, Bush RL, et al. . The impact of anesthetic modality on the outcome of carotid endarterectomy. Am J Surg 2004;188:741&#x2013;747.</Citation><ArticleIdList><ArticleId IdType="pubmed">15619493</ArticleId></ArticleIdList></Reference><Reference><Citation>Sternbach Y, Illig KA, Zhang R, et al. . Hemodynamic benefits of regional anesthesia for carotid endarterectomy. J Vasc Surg 2002;35:333&#x2013;339.</Citation><ArticleIdList><ArticleId IdType="pubmed">11854732</ArticleId></ArticleIdList></Reference><Reference><Citation>Markovic D, Vlajkovic G, Sindjelic R, et al. . Cervical plexus block versus general anesthesia in carotid surgery: single center experience. Arch Med Sci 2012;8:1035&#x2013;1040.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3542493</ArticleId><ArticleId IdType="pubmed">23319978</ArticleId></ArticleIdList></Reference><Reference><Citation>Schechter MA, Shortell CK, Scarborough JE. Regional versus general anesthesia for carotid endarterectomy: the American College of Surgeons National Surgical Quality Improvement Program perspective. Surgery 2012;152:309&#x2013;314.</Citation><ArticleIdList><ArticleId IdType="pubmed">22749369</ArticleId></ArticleIdList></Reference><Reference><Citation>Sideso E, Walton J, Handa A. General or local anesthesia for carotid endarterectomy&#x2013;the &#x201c;real-world&#x201d; experience. Angiology 2011;62:609&#x2013;613.</Citation><ArticleIdList><ArticleId IdType="pubmed">21555313</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrero E, Ferri M, Viazzo A, Ferrero M, et al. . Carotid endarterectomy: comparison between general and local anesthesia. Revision of our experience with 428 consecutive cases. Ann Vasc Surg 2010;24:1034&#x2013;1037.</Citation><ArticleIdList><ArticleId IdType="pubmed">20800430</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobo M, Mour&#xe3;o J, Afonso G. Carotid endarterectomy: review of 10 years of practice of general and locoregional anesthesia in a tertiary care hospital in Portugal. Braz J Anesthesiol 2015;65:249&#x2013;254.</Citation><ArticleIdList><ArticleId IdType="pubmed">26123143</ArticleId></ArticleIdList></Reference><Reference><Citation>Leichtle SW, Mouawad NJ, Welch K, et al. . Outcomes of carotid endarterectomy under general and regional anesthesia from the American College of Surgeons&#x2019; National Surgical Quality Improvement Program. J Vasc Surg 2012;56:81&#x2013;88.e3.</Citation><ArticleIdList><ArticleId IdType="pubmed">22480761</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Martinez-Wilson H, Neuman MD, et al. . Outcome of carotid endarterectomy after regional anesthesia versus general anesthesia - A retrospective study using two independent databases. Transl Perioper Pain Med 2014;1:14&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4444227</ArticleId><ArticleId IdType="pubmed">26023678</ArticleId></ArticleIdList></Reference><Reference><Citation>Dakour Aridi H, Paracha N, Nejim B, et al. . Anesthetic type and hospital outcomes after carotid endarterectomy from the Vascular Quality Initiative database. J Vasc Surg 2018;67:1419&#x2013;1428.</Citation><ArticleIdList><ArticleId IdType="pubmed">29242070</ArticleId></ArticleIdList></Reference><Reference><Citation>Lutz H-J, Michael R, Gahl B, et al. . Local versus general anaesthesia for carotid endarterectomy&#x2013;improving the gold standard&#x202f;? Eur J Vasc Endovasc Surg 2008;36:145&#x2013;149.</Citation><ArticleIdList><ArticleId IdType="pubmed">18485760</ArticleId></ArticleIdList></Reference><Reference><Citation>Papavasiliou AK, Magnadottir HB, Gonda T, et al. . Clinical outcomes after carotid endarterectomy: comparison of the use of regional and general anesthetics. J Neurosurg 2000;92:291&#x2013;296.</Citation><ArticleIdList><ArticleId IdType="pubmed">10659017</ArticleId></ArticleIdList></Reference><Reference><Citation>Lumas S, Hsiang W, Akhtar S, et al. . Regional anesthesia is underutilized for carotid endarterectomy despite improved perioperative outcomes compared with general anesthesia. Ann Vasc Surg 2021;73:336&#x2013;343.</Citation><ArticleIdList><ArticleId IdType="pubmed">33373769</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain AS, Mullard A, Oppat WF, et al. . Increased resource utilization and overall morbidity are associated with general versus regional anesthesia for carotid endarterectomy in data collected by the Michigan Surgical Quality Collaborative. J Vasc Surg 2017;66:802&#x2013;809.</Citation><ArticleIdList><ArticleId IdType="pubmed">28433337</ArticleId></ArticleIdList></Reference><Reference><Citation>Agha R, Abdall-Razak A, Crossley E, et al. . for the STROCSS Group. The STROCSS 2019 guideline: strengthening the reporting of cohort studies in surgery. Int J Surg 2019;72:156&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pubmed">31704426</ArticleId></ArticleIdList></Reference><Reference><Citation>
R Core Team
(2022). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-project.org/
.</Citation></Reference><Reference><Citation>Ho D, Imai K, King G, et al. . MatchIt: nonparametric preprocessing for parametric causal inference. J Stat Soft 2011;42:1&#x2013;28.</Citation></Reference><Reference><Citation>Malik OS, Brovman EY, Urman RD. The use of regional or local anesthesia for carotid endarterectomies may reduce blood loss and pulmonary complications. J Cardiothorac Vasc Anesth 2019;33:935&#x2013;942.</Citation><ArticleIdList><ArticleId IdType="pubmed">30243870</ArticleId></ArticleIdList></Reference><Reference><Citation>King G, Nielsen R. Why propensity scores should not be used for matching. Polit Anal 2019;27:435&#x2013;454.</Citation></Reference><Reference><Citation>
Lin L, Chu H. (2020). fragility: Assessing and Visualizing Fragility of Clinical Results with Binary Outcomes. R package version 1.1. URL https://CRAN.R-project.org/package=fragility

</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9159630</ArticleId><ArticleId IdType="pubmed">35648746</ArticleId></ArticleIdList></Reference><Reference><Citation>Feinstein AR. The unit fragility index: an additional appraisal of &#x201c;statistical significance&#x201d; for a contrast of two proportions. J Clin Epidemiol 1990;43:201&#x2013;209.</Citation><ArticleIdList><ArticleId IdType="pubmed">2303850</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh M, Srinathan SK, McAuley DF, et al. . The statistical significance of randomized controlled trial results is frequently fragile: a case for a Fragility Index. J Clin Epidemiol 2014;67:622&#x2013;628.</Citation><ArticleIdList><ArticleId IdType="pubmed">24508144</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhury MZI, Turin TC. Variable selection strategies and its importance in clinical prediction modelling. Fam Med Community Health 2020;8:e000262.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7032893</ArticleId><ArticleId IdType="pubmed">32148735</ArticleId></ArticleIdList></Reference><Reference><Citation>Portet S. A primer on model selection using the Akaike Information Criterion. Infect Dis Model 2020;5:111&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6962709</ArticleId><ArticleId IdType="pubmed">31956740</ArticleId></ArticleIdList></Reference><Reference><Citation>
Harrell FE, Jr. (2020). rms: Regression Modeling Strategies. R package version 6.0-0. URL https://CRAN.R-project.org/package=rms

</Citation></Reference><Reference><Citation>
Therneau T (2020). A Package for Survival Analysis in R. R package version 3.2-7. URL https://CRAN.R-project.org/package=survival

</Citation></Reference><Reference><Citation>Therneau TM, Grambsch PM. Modeling Survival Data: Extending the Cox Model. Springer; 2000.</Citation></Reference><Reference><Citation>Orlick&#xfd; M, Hrb&#xe1;&#x10d; T, Same&#x161; M, et al. . Anesthesia type determines risk of cerebral infarction after carotid endarterectomy. J Vasc Surg, 70 2019:138&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pubmed">30792052</ArticleId></ArticleIdList></Reference><Reference><Citation>Love A, Hollyoak MA. Carotid endarterectomy and local anaesthesia: reducing the disasters. Cardiovasc Surg 2000;8:429&#x2013;435.</Citation><ArticleIdList><ArticleId IdType="pubmed">10996095</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40071979</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1473-6500</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>3</Issue><PubDate><Year>2025</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>Current opinion in anaesthesiology</Title><ISOAbbreviation>Curr Opin Anaesthesiol</ISOAbbreviation></Journal><ArticleTitle>Anesthetic management of neurosurgical emergencies.</ArticleTitle><Pagination><StartPage>303</StartPage><EndPage>309</EndPage><MedlinePgn>303-309</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ACO.0000000000001471</ELocationID><Abstract><AbstractText Label="PURPOSE OF REVIEW" NlmCategory="OBJECTIVE">Neuroanesthesia presents unique challenges that require up-to-date knowledge in identification and management and multidisciplinary collaboration for optimal patient outcomes. This review paper aims to enhance the reader's understanding and preparedness for intraoperative emergencies based on current literature updates and consensus recommendations.</AbstractText><AbstractText Label="RECENT FINDINGS" NlmCategory="RESULTS">Recent findings in traumatic brain injury (TBI) emphasize the importance of controlling intracranial pressure (ICP) and maintaining cerebral perfusion. However, they also challenge the efficacy of sole ICP targeting interventions, suggesting potential benefits from multimodal monitoring approaches. In the context of acute stroke, recent randomized trials have demonstrated that general anesthesia (GA) compared with sedation techniques results in higher recanalization rates, with no significant difference in complications or long-term outcomes. Furthermore, multiple trials and a meta-analysis have shown that intensive blood pressure management following recanalization with endovascular therapy (EVT) offers no benefit and may impose harm when compared with conservative blood pressure targets.</AbstractText><AbstractText Label="SUMMARY" NlmCategory="CONCLUSIONS">Optimal management of neuroanesthetic emergencies requires up-to-date knowledge, training, and interdisciplinary coordination to ensure the best possible outcomes. Significant research effort has been devoted to advancing neuroanesthesia practice, so that in the last 2 years, several fundamental management questions have benefitted from randomized controlled trials (RCTs) from multiple groups, as well as meta-analyses of these RCTs. These address ICP and complementary physiologic monitoring for intracranial compartment syndrome after TBI, GA versus sedation for EVT, and postrecanalization blood pressure management. In this review, we have highlighted this important work as well as the next steps in further refining answers to these questions.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bou Sleiman</LastName><ForeName>Vanessa</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Multispecialty Anesthesia, Cleveland Clinic, Cleveland, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benson</LastName><ForeName>Bryan</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Gumbert</LastName><ForeName>Sam</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>02</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Curr Opin Anaesthesiol</MedlineTA><NlmUniqueID>8813436</NlmUniqueID><ISSNLinking>0952-7907</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019635" MajorTopicYN="Y">Neurosurgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000070642" MajorTopicYN="Y">Brain Injuries, Traumatic</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004630" MajorTopicYN="N">Emergencies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007427" MajorTopicYN="N">Intracranial Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="Y">Anesthesia</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute stroke</Keyword><Keyword MajorTopicYN="N">intracranial pressure</Keyword><Keyword MajorTopicYN="N">neuroanesthesia emergencies</Keyword><Keyword MajorTopicYN="N">traumatic brain injury</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>19</Day><Hour>12</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>3</Month><Day>12</Day><Hour>12</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>3</Month><Day>12</Day><Hour>9</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40071979</ArticleId><ArticleId IdType="doi">10.1097/ACO.0000000000001471</ArticleId><ArticleId IdType="pii">00001503-990000000-00267</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Xiong C, Hanafy S, Chan V, et al. Comorbidity in adults with traumatic brain injury and all-cause mortality: a systematic review. BMJ Open. 2019; 9:e029072.</Citation></Reference><Reference><Citation>Dash HH, Chavali S. Management of traumatic brain injury patients. Korean J Anesthesiol. 2018; 71:12&#x2013;21.</Citation></Reference><Reference><Citation>Wiles MD. Management of traumatic brain injury: a narrative review of current evidence. Anaesthesia. 2022; 77:102&#x2013;112.</Citation></Reference><Reference><Citation>Battaglini D, Anania P, Rocco PRM, et al. Escalate and de-escalate therapies for intracranial pressure control in traumatic brain injury. Front Neurol. 2020; 11:564751.</Citation></Reference><Reference><Citation>Godoy DA, Brasil S, Iaccarino C, et al. The intracranial compartmental syndrome: a proposed model for acute brain injury monitoring and management. Crit Care. 2023; 27:137.</Citation></Reference><Reference><Citation>Casta&#xf1;o-Leon AM, Gomez PA, Jimenez-Roldan L, et al. Intracranial pressure monitoring in patients with severe traumatic brain injury: extension of the recommendations and the effect on outcome by propensity score matching. Neurosurgery. 2022; 91:437&#x2013;449.</Citation></Reference><Reference><Citation>Carney N, Totten AM, O&#x2019;Reilly C, et al. Brain Trauma Foundation. Guidelines for the management of severe traumatic brain injury. 4th ed. 2016.</Citation></Reference><Reference><Citation>Carney N, Totten AM, O&#x2019;Reilly C, et al. Guidelines for the management of severe traumatic brain injury, fourth edition. Neurosurgery. 2017; 80:6&#x2013;15.</Citation></Reference><Reference><Citation>Chesnut R, Aguilera S, Buki A, et al. A management algorithm for adult patients with both brain oxygen and intracranial pressure monitoring: the Seattle International Severe Traumatic Brain Injury Consensus Conference (SIBICC). Intensive Care Med. 2020; 46:919&#x2013;929.</Citation></Reference><Reference><Citation>Roldan M, Abay TY, Kyriacou PA. Non-invasive techniques for multimodal monitoring in traumatic brain injury: systematic review and meta-analysis. J Neurotrauma. 2020; 37:2445&#x2013;2453.</Citation></Reference><Reference><Citation>Payen JF, Launey Y, Chabanne R, et al.; OXY-TC Trial Collaborators. Intracranial pressure monitoring with and without brain tissue oxygen pressure monitoring for severe traumatic brain injury in France (OXY-TC): an open-label, randomised controlled superiority trial. Lancet Neurol. 2023; 22:1005&#x2013;1014.</Citation></Reference><Reference><Citation>Santana LS, Diniz JBC, Solla DJF, et al. Brain tissue oxygen combined with intracranial pressure monitoring versus isolated intracranial pressure monitoring in patients with traumatic brain injury: an updated systematic review and meta-analysis. Neurol Sci. 2024; 45:3051&#x2013;3059.</Citation></Reference><Reference><Citation>Bernard F, Barsan W, Diaz-Arrastia R, et al. Brain oxygen optimization in severe traumatic brain injury (BOOST-3): a multicentre, randomised, blinded-endpoint, comparative effectiveness study of brain tissue oxygen and intracranial pressure monitoring versus intracranial pressure alone. BMJ Open. 2022; 12:e060188.</Citation></Reference><Reference><Citation>Dietvorst S, Depreitere B, Meyfroidt G. Beyond intracranial pressure: monitoring cerebral perfusion and autoregulation in severe traumatic brain injury. Curr Opin Crit Care. 2023; 29:85&#x2013;88.</Citation></Reference><Reference><Citation>Stein KY, Amenta F, Gomez A, et al. Associations between intracranial pressure thresholds and multimodal monitoring in acute traumatic neural injury: a scoping review. Acta Neurochir (Wien). 2023; 165:1987&#x2013;2000.</Citation></Reference><Reference><Citation>Chen M, Wu H, Li Z, et al. Intracranial-pressure-monitoring-assisted management associated with favorable outcomes in moderate traumatic brain injury patients with a GCS of 9-11. J Clin Med. 2022; 11:6661.</Citation></Reference><Reference><Citation>Nattino G, Gamberini L, Brissy O, et al.; CREACTIVE Consortium. Comparative effectiveness of intracranial pressure monitoring on 6-month outcomes of critically Ill patients with traumatic brain injury. JAMA Netw Open. 2023; 6:e2334214.</Citation></Reference><Reference><Citation>Campbell D, Butler E, Campbell RB, et al. General anesthesia compared with non-GA in endovascular thrombectomy for ischemic stroke: a systematic review and meta-analysis of randomized controlled trials. Neurology. 2023; 100:e1655&#x2013;e1e63.</Citation></Reference><Reference><Citation>Maurice A, Eug&#xe8;ne F, Ronzi&#xe8;re T, et al.; GASS (General Anesthesia versus Sedation for Acute Stroke Treatment) Study Group and the French Society of Anesthesiologists (SFAR) Research Network. General anesthesia versus sedation, both with hemodynamic control, during intraarterial treatment for stroke: the GASS randomized trial. Anesthesiology. 2022; 136:567&#x2013;576.</Citation></Reference><Reference><Citation>Chabanne R, Geeraerts T, Begard M, et al.; ANARLF NetworkAMETIS Study Group. Outcomes after endovascular therapy with procedural sedation vs general anesthesia in patients with acute ischemic stroke: the AMETIS randomized clinical trial. JAMA Neurol. 2023; 80:474&#x2013;483.</Citation></Reference><Reference><Citation>Liang F, Wu Y, Wang X, et al.; CANVAS II Group. General anesthesia vs conscious sedation for endovascular treatment in patients with posterior circulation acute ischemic stroke: an exploratory randomized clinical trial. JAMA Neurol. 2023; 80:64&#x2013;72.</Citation></Reference><Reference><Citation>Farag E, Liang C, Mascha EJ, et al. Oxygen saturation and postoperative mortality in patients with acute ischemic stroke treated by endovascular thrombectomy. Anesth Analg. 2022; 134:369&#x2013;379.</Citation></Reference><Reference><Citation>Yang P, Song L, Zhang Y, et al.; ENCHANTED2/MT Investigators. Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial. Lancet. 2022; 400:1585&#x2013;1596.</Citation></Reference><Reference><Citation>Nam HS, Kim YD, Heo J, et al.; OPTIMAL-BP Trial Investigators. Intensive vs conventional blood pressure lowering after endovascular thrombectomy in acute ischemic stroke: the OPTIMAL-BP randomized clinical trial. JAMA. 2023; 330:832&#x2013;842.</Citation></Reference><Reference><Citation>Mazighi M, Richard S, Lapergue B, et al.; BP-TARGET Investigators. Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): a multicentre, open-label, randomised controlled trial. Lancet Neurol. 2021; 20:265&#x2013;274.</Citation></Reference><Reference><Citation>Mistry EA, Hart KW, Davis LT, et al. Blood pressure management after endovascular therapy for acute ischemic stroke: the BEST-II randomized clinical trial. JAMA. 2023; 330:821&#x2013;831.</Citation></Reference><Reference><Citation>Ghozy S, Mortezaei A, Elfil M, et al. Intensive vs conventional blood pressure control after thrombectomy in acute ischemic stroke: a systematic review and meta-analysis. JAMA Netw Open. 2024; 7:e240179.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33552435</PMID><DateRevised><Year>2021</Year><Month>05</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2000-9666</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jan</Month><Day>26</Day></PubDate></JournalIssue><Title>Journal of community hospital internal medicine perspectives</Title><ISOAbbreviation>J Community Hosp Intern Med Perspect</ISOAbbreviation></Journal><ArticleTitle>Outcomes of surgical versus transcatheter aortic valve replacement in nonagenarians- a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>128</StartPage><EndPage>134</EndPage><MedlinePgn>128-134</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/20009666.2020.1843235</ELocationID><Abstract><AbstractText><b>Introduction</b>: Since the approval of transcatheter aortic valve replacement (TAVR), nonagenarian group patients are being increasingly considered for TAVR. Therefore, we compared the clinical outcomes of surgical aortic valve replacement (SAVR) vs TAVR in nonagenarians with severe aortic stenosis. <b>Methods</b>: A literature search was performed using MEDLINE, Embase, Web of Science, Cochrane, and Clinicaltrials.gov for studies reporting the comparative outcomes of TAVR versus SAVR in nonagenarians. The primary endpoint was short-term mortality. Secondary endpoints were post-operative incidences of stroke or transient ischemic attack (TIA), vascular complications, acute kidney injury (AKI), transfusion requirement, and length of hospital stay. <b>Results</b>: Four retrospective studies qualified for inclusion with a total of 8,389 patients (TAVR&#xa0;=&#xa0;3,112, SAVR&#xa0;=&#xa0;5,277). Short-term mortality was similar between the two groups [RR&#xa0;=&#xa0;0.91 (95% CI: 0.76-1.10), p =&#xa0;0.318]. The average length of hospital stay was shorter by 3&#xa0;days in the TAVR group (p&#xa0;=&#xa0;0.037). TAVR was associated with a significantly lower risk of AKI [RR&#xa0;=&#xa0;0.72 (95% CI: 0.62-0.83), p &lt;&#xa0;0.001] and a lower risk of transfusion [RR&#xa0;=&#xa0;0.71 (95% CI: 0.62-0.81), p &lt;&#xa0;0.001]. There was no difference in risk of stroke/TIA[RR&#xa0;=&#xa0;1.01 (95% CI: 0.70-1.45), p =&#xa0;0.957]. The risk of vascular complications was significantly higher in the TAVR group [RR&#xa0;=&#xa0;3.39 (95% CI: 2.65-4.333), p &lt;&#xa0;0.001]. <b>Conclusion</b>: In this high-risk population, TAVR compared to SAVR has similar short-term mortality benefit but has lower risks of perioperative complications and a higher number of patients being discharged to home.</AbstractText><CopyrightInformation>&#xa9; 2020 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group on behalf of Greater Baltimore Medical Center.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Latif</LastName><ForeName>Azka</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Creighton University School of Medicine, Omaha, Nebraska, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahsan</LastName><ForeName>Muhammad Junaid</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Creighton University School of Medicine, Omaha, Nebraska, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lateef</LastName><ForeName>Noman</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Creighton University School of Medicine, Omaha, Nebraska, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kapoor</LastName><ForeName>Vikas</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Creighton University School of Medicine, Omaha, Nebraska, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mirza</LastName><ForeName>Mohsin Mansoor</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Creighton University School of Medicine, Omaha, Nebraska, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anwer</LastName><ForeName>Faiz</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Core</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, CHI Health Heart and Vascular Institute, Omaha, Nebraska.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanmantha Reddy</LastName><ForeName>Arun</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, CHI Health Heart and Vascular Institute, Omaha, Nebraska.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Community Hosp Intern Med Perspect</MedlineTA><NlmUniqueID>101601396</NlmUniqueID><ISSNLinking>2000-9666</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Nonagenarians</Keyword><Keyword MajorTopicYN="N">SAVR</Keyword><Keyword MajorTopicYN="N">TAVR</Keyword><Keyword MajorTopicYN="N">elderly</Keyword><Keyword MajorTopicYN="N">in-hospital outcomes</Keyword><Keyword MajorTopicYN="N">short-term outcomes</Keyword><Keyword MajorTopicYN="N">surgical aortic valve replacement</Keyword><Keyword MajorTopicYN="N">trans-catheter aortic valve replacement</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>8</Day><Hour>5</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>1</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33552435</ArticleId><ArticleId IdType="pmc">PMC7850375</ArticleId><ArticleId IdType="doi">10.1080/20009666.2020.1843235</ArticleId><ArticleId IdType="pii">1843235</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>He W, Muenchrath M.. US Census Bureau, American Community Survey Reports, ACS-17, 90 in the USA: 2006&#x2013;2008: US Government Printing Office, Washington, DC, 2011. 2011.</Citation></Reference><Reference><Citation>Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368(9540):1005&#x2013;1011.</Citation><ArticleIdList><ArticleId IdType="pubmed">16980116</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Geldorp M, Heuvelman HJ, Kappetein AP, et al. Quality of life among patients with severe aortic stenosis. Neth Heart J. 2013;21(1):21&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3528854</ArticleId><ArticleId IdType="pubmed">23229811</ArticleId></ArticleIdList></Reference><Reference><Citation>Bach DS, Cimino N, Deeb GM. Unoperated patients with severe aortic stenosis. J Am Coll Cardiol. 2007;50(20):2018&#x2013;2019.</Citation><ArticleIdList><ArticleId IdType="pubmed">17996571</ArticleId></ArticleIdList></Reference><Reference><Citation>Assmann A, Minol J-P, Mehdiani A, et al. Cardiac surgery in nonagenarians: not only feasible, but also reasonable? Interact Cardiovasc Thorac Surg. 2013;17(2):340&#x2013;343.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3715162</ArticleId><ArticleId IdType="pubmed">23628651</ArticleId></ArticleIdList></Reference><Reference><Citation>Mack MC, Szerlip M, Herbert MA, et al. Outcomes of treatment of nonagenarians with severe aortic stenosis. Ann Thorac Surg. 2015;100(1):74&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">26013708</ArticleId></ArticleIdList></Reference><Reference><Citation>Murashita T, Greason KL, Suri RM, et al. Aortic valve replacement for severe aortic valve stenosis in the nonagenarian patient. Ann Thorac Surg. 2014;98(5):1593&#x2013;1597.</Citation><ArticleIdList><ArticleId IdType="pubmed">25200726</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkhouli M, Zack C, Sarraf M, et al. Outcomes for surgical and transcatheter aortic valve replacement in nonagenarians. J Am Coll Cardiol. 2016;1):350.</Citation></Reference><Reference><Citation>Elgendy IY, Mahmoud AN, Elbadawi A, et al. In&#x2010;hospital outcomes of transcatheter versus surgical aortic valve replacement for nonagenarians. Catheterization and Cardiovascular Interventions. 2019 Apr 1;93(5):989&#x2013;995.</Citation><ArticleIdList><ArticleId IdType="pubmed">30569661</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindroos M, Kupari M, Heikkila J, et al. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. 1993;21:1220&#x2013;1225.</Citation><ArticleIdList><ArticleId IdType="pubmed">8459080</ArticleId></ArticleIdList></Reference><Reference><Citation>Horstkotte D, Loogen F. The natural history of aortic valve stenosis. Eur Heart J. 1988;9(suppl_E):57&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">3042404</ArticleId></ArticleIdList></Reference><Reference><Citation>Varadarajan P, Kapoor N, Bansal RC, et al. Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis. Ann Thorac Surg. 2006;82(6):2111&#x2013;2115.</Citation><ArticleIdList><ArticleId IdType="pubmed">17126120</ArticleId></ArticleIdList></Reference><Reference><Citation>Leon&#xa0;MB, Smith CR, Mack M, et&#xa0;al.Transcatheter&#xa0;aortic-valve implantation for aortic stenosis in patients who cannot undergo&#xa0;surgery.&#xa0;N&#xa0;Engl J&#xa0;Med.&#xa0;2010;363(17):1597&#x2013;1607.</Citation><ArticleIdList><ArticleId IdType="pubmed">20961243</ArticleId></ArticleIdList></Reference><Reference><Citation>Zack CJ, Al-Qahtani F, Kawsara A, et al. Comparative outcomes of surgical and transcatheter aortic valve replacement for aortic stenosis in nonagenarians. Am J Cardiol. 2017;119(6):893&#x2013;899.</Citation><ArticleIdList><ArticleId IdType="pubmed">28061996</ArticleId></ArticleIdList></Reference><Reference><Citation>Gummert JF, Barten MJ, Hans C, et al. Mediastinitis and cardiac surgery&#x2013;an updated risk factor analysis in 10,373 consecutive adult patients. Thorac Cardiovasc Surg. 2002;50(2):87&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">11981708</ArticleId></ArticleIdList></Reference><Reference><Citation>Grube&#xa0;E, Laborde JC, Gerckens U, et&#xa0;al.Percutaneous implantation of the CoreValve&#xa0;self-expanding valve prosthesis in&#xa0;high-risk patients with aortic valve&#xa0;disease.&#xa0;Circulation.&#xa0;2006;114(15):1616&#x2013;1624.</Citation><ArticleIdList><ArticleId IdType="pubmed">17015786</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb JG, Chandavimol M, Thompson CR, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation. 2006;113(6):842&#x2013;850.</Citation><ArticleIdList><ArticleId IdType="pubmed">16461813</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. European heart journal. 2007 Jan 1;28(2):230&#x2013;268.</Citation><ArticleIdList><ArticleId IdType="pubmed">17259184</ArticleId></ArticleIdList></Reference><Reference><Citation>Eltchaninoff H, Prat A, Gilard M, et al. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J. 2011;32(2):191&#x2013;197.</Citation><ArticleIdList><ArticleId IdType="pubmed">20843959</ArticleId></ArticleIdList></Reference><Reference><Citation>Thourani VH, Kodali S, Makkar RR, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016;387(10034):2218&#x2013;2225.</Citation><ArticleIdList><ArticleId IdType="pubmed">27053442</ArticleId></ArticleIdList></Reference><Reference><Citation>Latib A, Maisano F, Bertoldi L, et al. Transcatheter vs surgical aortic valve replacement in intermediate-surgical-risk patients with aortic stenosis: a propensity score-matched case-control study. Am Heart J. 2012;164(6):910&#x2013;917.</Citation><ArticleIdList><ArticleId IdType="pubmed">23194492</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen HH, Klaaborg K, Nissen H, et al. A prospective, randomised trial of transapical transcatheter aortic valve implantation vs. surgical aortic valve replacement in operable elderly patients with aortic stenosis: the STACCATO trial. EuroIntervention. 2012;8(3):383&#x2013;389.</Citation><ArticleIdList><ArticleId IdType="pubmed">22581299</ArticleId></ArticleIdList></Reference><Reference><Citation>Jilaihawi H, Chakravarty T, Weiss RE, et al. Meta-analysis of complications in aortic valve replacement: comparison of Medtronic-Corevalve, Edwards-Sapien and surgical aortic valve replacement in 8,536 patients. Catheter Cardiovasc Interv. 2012;80(1):128&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pubmed">22415849</ArticleId></ArticleIdList></Reference><Reference><Citation>Thourani VH, Jensen HA, Babaliaros V, et al. Outcomes in nonagenarians undergoing transcatheter aortic valve replacement in the PARTNER-I Trial. Annals of Thoracic Surgery. 2015;100(3):785&#x2010;92; discussion 793.</Citation><ArticleIdList><ArticleId IdType="pubmed">26242213</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25756746</PMID><DateCompleted><Year>2016</Year><Month>03</Month><Day>14</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8191</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>5</Issue><PubDate><Year>2015</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of cardiac surgery</Title><ISOAbbreviation>J Card Surg</ISOAbbreviation></Journal><ArticleTitle>Transaortic TAVI Is a Valid Alternative to Transapical Approach.</ArticleTitle><Pagination><StartPage>381</StartPage><EndPage>390</EndPage><MedlinePgn>381-90</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jocs.12527</ELocationID><Abstract><AbstractText Label="BACKGROUND AND AIM" NlmCategory="OBJECTIVE">Transcatheter aortic valve implantation (TAVI) can be performed via a number of different anatomical approaches based on patient characteristics and operator choice. The aim of this study was to compare procedural outcomes between transaortic (TAo) and transapical (TA) approaches in an effort to establish whether any differences exist.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review and meta-analysis of the current literature reporting outcomes for patients undergoing TAo and TA TAVI was performed to compare outcomes using each vascular approach to valve deployment.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 10 studies and 1736 patients were included. A total of 193 patients underwent TAo and 1543 TA TAVI. No significant difference in 30-day mortality was identified (TAo 9.4, TA 10.4 p = 0.7). There were no significant differences identified between TAo and TA TAVI in procedural success rate (96.3% vs. 93.7% p = 0.3), stroke and transient ischemic attack (TIA) incidence (1.8% vs. 2.3% p = 0.7), major bleed (5.8% vs. 5.5% p = 0.97) or pacemaker insertion rates (6.1% vs. 7.4% p = 0.56). In addition, the incidence of clinically significant paravalvular regurgitation (PVR) was the same between groups (6.7% vs. 11% p = 0.43).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Comparison of TAo and TA approaches revealed equivalent outcomes in 30-day mortality, procedural success, major bleeding, stroke/TIA incidence, pacemaker insertion rates and paravalvular leak. Heart teams should be familiar with the use of both TA and TAo access and tailor their selection on a case-to-case basis.</AbstractText><CopyrightInformation>&#xa9; 2015 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>O' Sullivan</LastName><ForeName>Katie E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>The Heart Team, Mater Private Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hurley</LastName><ForeName>Eoghan T</ForeName><Initials>ET</Initials></Author><Author ValidYN="Y"><LastName>Segurado</LastName><ForeName>Ricardo</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Sugrue</LastName><ForeName>Declan</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Hurley</LastName><ForeName>John P</ForeName><Initials>JP</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>03</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Card Surg</MedlineTA><NlmUniqueID>8908809</NlmUniqueID><ISSNLinking>0886-0440</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001024" MajorTopicYN="N">Aortic Valve Stenosis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065467" MajorTopicYN="N">Transcatheter Aortic Valve Replacement</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25756746</ArticleId><ArticleId IdType="doi">10.1111/jocs.12527</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27495048</PMID><DateCompleted><Year>2017</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>95</Volume><Issue>31</Issue><PubDate><Year>2016</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>A meta-analysis for efficacy and safety evaluation of transcatheter left atrial appendage occlusion in patients with nonvalvular atrial fibrillation.</ArticleTitle><Pagination><StartPage>e4382</StartPage><MedlinePgn>e4382</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e4382</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000004382</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This meta-analysis was conducted to evaluate the efficacy and safety of transcatheter left atrial appendage (LAA) occlusion in patients with nonvalvular atrial fibrillation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The randomized controlled trials (RCT) or observational studies with any transcatheter LAA occlusion devices were searched in PubMed, Embase, and Cochrane library from inception to November 2015. The incidence rates from individual studies were combined to evaluate the procedural efficacy and safety, including all-cause death, cardiac/neurological death, stroke, transient ischemic attack (TIA), thrombosis, hemorrhagic complications, and pericardial effusion/tamponade.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Thirty-eight studies involving 3585 patients and 6 different occlusion devices were eligible for our inclusion criteria. The procedural failure rate for LAA closure was 0.02 (95% CI: 0.02-0.03). The all-cause mortality was 0.03 (95% CI: 0.02-0.03) and cardiac/neurological mortality was 0 (95% CI: 0.00-0.01). The stroke/TIA rate was estimated only 0.01 (95% CI: 0.01-0.01). The incidence of thrombus on devices was 0.01 (95% CI: 0.01-0.02). The major hemorrhagic complication rate was estimated 0.01 (95% CI: 0.00-0.01). Pericardial effusion/tamponade was estimated 0.02 (95% CI: 0.02-0.03). No heterogeneity was observed for above pooled estimates (I&#x200a;=&#x200a;0). In devices subgroups analysis, the all-cause mortality and cardiac/neurological mortality of PLAATO group were the highest (P&#x200a;=&#x200a;0.01 and P&#x200a;&lt;&#x200a;0.01 respectively), whereas the incidence of thrombus on devices in the ACP group was the highest (P&#x200a;&lt;&#x200a;0.01). In follow-up period subgroups analysis, there were significant differences in all-cause death, stroke/TIA, major hemorrhage, and pericardial effusion/tamponade events between the shorter and longer follow-up period subgroups (P&#x200a;&lt;&#x200a;0.05). However, the differences among the subgroups were numerically small.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">the pooled data demonstrated that transcatheter LAA occlusion was effective and safe in the patients with nonvalvular atrial fibrillation who were not suitable for lifelong antithrombotic therapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Zhonghai</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Drum Tower Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xinlin</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Han</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Jun</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Qing</ForeName><Initials>Q</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lian</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Biao</ForeName><Initials>B</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D020517" MajorTopicYN="N">Atrial Appendage</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="N">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061214" MajorTopicYN="Y">Patient Safety</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055989" MajorTopicYN="N">Septal Occluder Device</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no funding and conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>8</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27495048</ArticleId><ArticleId IdType="pmc">PMC4979802</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000004382</ArticleId><ArticleId IdType="pii">00005792-201608020-00034</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jais P, Hocini M, Macle L, et al. Distinctive electrophysiological properties of pulmonary veins in patients with atrial fibrillation. Circulation 2002; 106:2479&#x2013;2485.</Citation><ArticleIdList><ArticleId IdType="pubmed">12417546</ArticleId></ArticleIdList></Reference><Reference><Citation>Atienza F, Almendral J, Moreno J, et al. Activation of inward rectifier potassium channels accelerates atrial fibrillation in humans: evidence for a reentrant mechanism. Circulation 2006; 114:2434&#x2013;2442.</Citation><ArticleIdList><ArticleId IdType="pubmed">17101853</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardu C, Santamaria M, Paolisso G. Marfella R. microRNA expression changes after atrial fibrillation catheter ablation. Pharmacogenomics 2015; 16:1863&#x2013;1877.</Citation><ArticleIdList><ArticleId IdType="pubmed">26554530</ArticleId></ArticleIdList></Reference><Reference><Citation>January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 2014; 130:2071&#x2013;2104.</Citation><ArticleIdList><ArticleId IdType="pubmed">24682348</ArticleId></ArticleIdList></Reference><Reference><Citation>Santulli G, Pagano G, Sardu C, et al. Calcium release channel RyR2 regulates insulin release and glucose homeostasis. J Clin Invest 2015; 125:4316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4639985</ArticleId><ArticleId IdType="pubmed">26524594</ArticleId></ArticleIdList></Reference><Reference><Citation>Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 2010; 12:1360&#x2013;1420.</Citation><ArticleIdList><ArticleId IdType="pubmed">20876603</ArticleId></ArticleIdList></Reference><Reference><Citation>Marfella R, Sasso FC, Siniscalchi M, et al. Brief episodes of silent atrial fibrillation predict clinical vascular brain disease in type 2 diabetic patients. J Am Coll Cardiol 2013; 62:525&#x2013;530.</Citation><ArticleIdList><ArticleId IdType="pubmed">23684685</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzo MR, Sasso FC, Marfella R, et al. Autonomic dysfunction is associated with brief episodes of atrial fibrillation in type 2 diabetes. J Diabetes Complications 2015; 29:88&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">25266244</ArticleId></ArticleIdList></Reference><Reference><Citation>Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146:857&#x2013;867.</Citation><ArticleIdList><ArticleId IdType="pubmed">17577005</ArticleId></ArticleIdList></Reference><Reference><Citation>Mant J, Hobbs FD, Fletcher K, et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007; 370:493&#x2013;503.</Citation><ArticleIdList><ArticleId IdType="pubmed">17693178</ArticleId></ArticleIdList></Reference><Reference><Citation>Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361:1139&#x2013;1151.</Citation><ArticleIdList><ArticleId IdType="pubmed">19717844</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011; 365:883&#x2013;891.</Citation><ArticleIdList><ArticleId IdType="pubmed">21830957</ArticleId></ArticleIdList></Reference><Reference><Citation>Hylek EM, Evans-Molina C, Shea C, et al. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation 2007; 115:2689&#x2013;2696.</Citation><ArticleIdList><ArticleId IdType="pubmed">17515465</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes DR, Kar S, Price MJ, et al. Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol 2014; 64:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">24998121</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes DR, Reddy VY, Turi ZG, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 2009; 374:534&#x2013;542.</Citation><ArticleIdList><ArticleId IdType="pubmed">19683639</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003; 327:557&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Davey SG, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315:629&#x2013;634.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmid M, Gloekler S, Saguner AM, et al. Transcatheter left atrial appendage closure in patients with atrial fibrillation. Kardiovaskulare Medizin 2013; 16:123&#x2013;130.</Citation></Reference><Reference><Citation>Helsen F, Nuyens D, De Meester P, et al. Left atrial appendage occlusion: single center experience with PLAATO LAA Occlusion System and AMPLATZER Cardiac Plug. J Cardiol 2013; 62:44&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">23668912</ArticleId></ArticleIdList></Reference><Reference><Citation>Gloekler S, Shakir S, Doblies J, et al. Early results of first versus second generation Amplatzer occluders for left atrial appendage closure in patients with atrial fibrillation. Clin Res Cardiol 2015; 104:656&#x2013;665.</Citation><ArticleIdList><ArticleId IdType="pubmed">25736061</ArticleId></ArticleIdList></Reference><Reference><Citation>Chun KR, Bordignon S, Urban V, et al. Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience. Heart Rhythm 2013; 10:1792&#x2013;1799.</Citation><ArticleIdList><ArticleId IdType="pubmed">23973952</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuo Y, Sandri M, Mangner N, et al. Interventional closure of the left atrial appendage for stroke prevention. Circ J 2014; 78:619&#x2013;624.</Citation><ArticleIdList><ArticleId IdType="pubmed">24419803</ArticleId></ArticleIdList></Reference><Reference><Citation>De Backer O, Loupis AM, Ihlemann N, et al. Percutaneous left atrial appendage closure for stroke prevention. Dan Med J 2014; 61:A4879.</Citation><ArticleIdList><ArticleId IdType="pubmed">25162439</ArticleId></ArticleIdList></Reference><Reference><Citation>Nietlispach F, Gloekler S, Krause R, et al. Amplatzer left atrial appendage occlusion: single center 10-year experience. Catheter Cardiovasc Interv 2013; 82:283&#x2013;289.</Citation><ArticleIdList><ArticleId IdType="pubmed">23412815</ArticleId></ArticleIdList></Reference><Reference><Citation>Sievert H, Lesh MD, Trepels T, et al. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience. Circulation 2002; 105:1887&#x2013;1889.</Citation><ArticleIdList><ArticleId IdType="pubmed">11997272</ArticleId></ArticleIdList></Reference><Reference><Citation>Meier B, Palacios I, Windecker S, et al. Transcatheter left atrial appendage occlusion with amplatzer devices to obviate anticoagulation in patients with atrial fibrillation. Catheter Cardio Inte 2003; 60:417&#x2013;422.</Citation><ArticleIdList><ArticleId IdType="pubmed">14571497</ArticleId></ArticleIdList></Reference><Reference><Citation>Omran H, Hardung D, Schmidt H, et al. Mechanical occlusion of the left atrial appendage. J Cardiovasc Electrophysiol 2003; 14 (9 suppl):S56&#x2013;S59.</Citation><ArticleIdList><ArticleId IdType="pubmed">12950520</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostermayer SH, Reisman M, Kramer PH, et al. Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. J Am Coll Cardiol 2005; 46:9&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">15992628</ArticleId></ArticleIdList></Reference><Reference><Citation>Sick PB, Schuler G, Hauptmann KE, et al. Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. J Am Coll Cardiol 2007; 49:1490&#x2013;1495.</Citation><ArticleIdList><ArticleId IdType="pubmed">17397680</ArticleId></ArticleIdList></Reference><Reference><Citation>Block PC, Burstein S, Casale PN, et al. Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study. JACC Cardiovasc Interv 2009; 2:594&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pubmed">19628179</ArticleId></ArticleIdList></Reference><Reference><Citation>Ussia GP, Mule M, Cammalleri V, et al. Percutaneous closure of left atrial appendage to prevent embolic events in high-risk patients with chronic atrial fibrillation. Catheter Cardiovasc Interv 2009; 74:217&#x2013;222.</Citation><ArticleIdList><ArticleId IdType="pubmed">19472361</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayard YL, Omran H, Neuzil P, et al. PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study. Eurointervention 2010; 6:220&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pubmed">20562072</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JW, Bethencourt A, Sievert H, et al. Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience. Catheter Cardiovasc Interv 2011; 77:700&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pubmed">20824765</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim YL, Joung B, On YK, et al. Early experience using a left atrial appendage occlusion device in patients with atrial fibrillation. Yonsei Med J 2012; 53:83&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3250321</ArticleId><ArticleId IdType="pubmed">22187236</ArticleId></ArticleIdList></Reference><Reference><Citation>Montenegro MJ, Quintella EF, Damonte A, et al. Percutaneous occlusion of left atrial appendage with the Amplatzer Cardiac PlugTM in atrial fibrillation. ARQ Bras Cardiol 2012; 98:143&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pubmed">22286325</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam YY, Yip GW, Yu CM, et al. Left atrial appendage closure with AMPLATZER cardiac plug for stroke prevention in atrial fibrillation: initial Asia-Pacific experience. Catheter Cardiovasc Interv 2012; 79:794&#x2013;800.</Citation><ArticleIdList><ArticleId IdType="pubmed">21542102</ArticleId></ArticleIdList></Reference><Reference><Citation>SR G, JL H, V F, et al. Percutaneous left atrial appendage closure for stroke prevention in patients with atrial fibrillation: an assessment of net clinical benefit. Eur Heart J 2012.</Citation><ArticleIdList><ArticleId IdType="pubmed">23008509</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerios EE, Schmid M, Gloekler S, et al. Left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation. ARQ Bras Cardiol 2012; 98:528&#x2013;536.</Citation><ArticleIdList><ArticleId IdType="pubmed">22584492</ArticleId></ArticleIdList></Reference><Reference><Citation>Streb W, Szymala M, Kukulski T, et al. Percutaneous closure of the left atrial appendage using the Amplatzer Cardiac Plug in patients with atrial fibrillation: evaluation of safety and feasibility. Kardiol Pol 2013; 71:8&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">23348528</ArticleId></ArticleIdList></Reference><Reference><Citation>Danna P, Proietti R, Sagone A, et al. Does left atrial appendage closure with a cardiac plug system reduce the stroke risk in nonvalvular atrial fibrillation patients? A single-center case series. Pacing Clin Electrophysiol 2013; 36:347&#x2013;353.</Citation><ArticleIdList><ArticleId IdType="pubmed">23252940</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy VY, Mobius-Winkler S, Miller MA, et al. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). J Am Coll Cardiol 2013; 61:2551&#x2013;2556.</Citation><ArticleIdList><ArticleId IdType="pubmed">23583249</ArticleId></ArticleIdList></Reference><Reference><Citation>Urena M, Rodes-Cabau J, Freixa X, et al. Percutaneous left atrial appendage closure with the AMPLATZER cardiac plug device in patients with nonvalvular atrial fibrillation and contraindications to anticoagulation therapy. J Am Coll Cardiol 2013; 62:96&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">23665098</ArticleId></ArticleIdList></Reference><Reference><Citation>Kefer J, Vermeersch P, Budts W, et al. Transcatheter left atrial appendage closure for stroke prevention in atrial fibrillation with Amplatzer cardiac plug: the Belgian Registry. Acta Cardiol 2013; 68:551&#x2013;558.</Citation><ArticleIdList><ArticleId IdType="pubmed">24579432</ArticleId></ArticleIdList></Reference><Reference><Citation>Abelson M. Left atrial appendage closure in patients with atrial fibrillation in whom warfarin is contra-indicated: initial South African experience. Cardiovasc J AFR 2013; 24:107&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3721860</ArticleId><ArticleId IdType="pubmed">24217039</ArticleId></ArticleIdList></Reference><Reference><Citation>Meincke F, Schmidt-Salzmann M, Kreidel F, et al. New technical and anticoagulation aspects for left atrial appendage closure using the WATCHMAN&#xae; device in patients not taking warfarin. Eurointervention 2013; 9:463&#x2013;468.</Citation><ArticleIdList><ArticleId IdType="pubmed">23965351</ArticleId></ArticleIdList></Reference><Reference><Citation>Meerkin D, Butnaru A, Dratva D, et al. Early safety of the Amplatzer Cardiac Plug for left atrial appendage occlusion. Int J Cardiol 2013; 168:3920&#x2013;3925.</Citation><ArticleIdList><ArticleId IdType="pubmed">23890886</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Minguez JR, Eldoayen-Gragera J, Gonzalez-Fernandez R, et al. Immediate and one-year results in 35 consecutive patients after closure of left atrial appendage with the Amplatzer cardiac plug. Rev Esp Cardiol (Engl Ed) 2013; 66:90&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">24775381</ArticleId></ArticleIdList></Reference><Reference><Citation>Horstmann S, Zugck C, Krumsdorf U, et al. Left atrial appendage occlusion in atrial fibrillation after intracranial hemorrhage. Neurology 2014; 82:135&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3897438</ArticleId><ArticleId IdType="pubmed">24319042</ArticleId></ArticleIdList></Reference><Reference><Citation>Freixa X, Abualsaud A, Chan J, et al. Left atrial appendage occlusion: initial experience with the Amplatzer Amulet. Int J Cardiol 2014; 174:492&#x2013;496.</Citation><ArticleIdList><ArticleId IdType="pubmed">24820753</ArticleId></ArticleIdList></Reference><Reference><Citation>Koermendy D, Nietlispach F, Shakir S, et al. Amplatzer left atrial appendage occlusion through a patent foramen ovale. Catheter Cardiovasc Interv 2014; 84:1190&#x2013;1196.</Citation><ArticleIdList><ArticleId IdType="pubmed">24399612</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiebe J, Bertog S, Franke J, et al. Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation. Catheter Cardiovasc Interv 2014; 83:796&#x2013;802.</Citation><ArticleIdList><ArticleId IdType="pubmed">24327462</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam SC, Bertog S, Gafoor S, et al. Left atrial appendage closure using the Amulet device: an initial experience with the second generation amplatzer cardiac plug. Catheter Cardiovasc Interv 2015; 85:297&#x2013;303.</Citation><ArticleIdList><ArticleId IdType="pubmed">25158644</ArticleId></ArticleIdList></Reference><Reference><Citation>Minguez JR, Asensio JM, Gragera JE, et al. Two-year clinical outcome from the Iberian registry patients after left atrial appendage closure. Heart 2015; 101:877&#x2013;883.</Citation><ArticleIdList><ArticleId IdType="pubmed">25573984</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieuwlaat R, Capucci A, Camm AJ, et al. Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Heart J 2005; 26:2422&#x2013;2434.</Citation><ArticleIdList><ArticleId IdType="pubmed">16204266</ArticleId></ArticleIdList></Reference><Reference><Citation>Camm AJ, Lip GY, De Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation&#x2014;developed with the special contribution of the European Heart Rhythm Association. Europace 2012; 14:1385&#x2013;1413.</Citation><ArticleIdList><ArticleId IdType="pubmed">22923145</ArticleId></ArticleIdList></Reference><Reference><Citation>Lip GY, Frison L, Halperin JL, et al. Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort. Stroke 2010; 41:2731&#x2013;2738.</Citation><ArticleIdList><ArticleId IdType="pubmed">20966417</ArticleId></ArticleIdList></Reference><Reference><Citation>Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361:1139&#x2013;1151.</Citation><ArticleIdList><ArticleId IdType="pubmed">19717844</ArticleId></ArticleIdList></Reference><Reference><Citation>Hylek EM, Held C, Alexander JH, et al. Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes. J Am Coll Cardiol 2014; 63:2141&#x2013;2147.</Citation><ArticleIdList><ArticleId IdType="pubmed">24657685</ArticleId></ArticleIdList></Reference><Reference><Citation>Landmesser U, Holmes DJ. Left atrial appendage closure: a percutaneous transcatheter approach for stroke prevention in atrial fibrillation. Eur Heart J 2012; 33:698&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pubmed">22041550</ArticleId></ArticleIdList></Reference><Reference><Citation>Viles-Gonzalez JF, Kar S, Douglas P, et al. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy. J Am Coll Cardiol 2012; 59:923&#x2013;929.</Citation><ArticleIdList><ArticleId IdType="pubmed">22381428</ArticleId></ArticleIdList></Reference><Reference><Citation>Boersma LV, Schmidt B, Betts TR, et al. Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry. Eur Heart J 2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4996118</ArticleId><ArticleId IdType="pubmed">26822918</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32966681</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>28</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8167</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>12</Issue><PubDate><Year>2020</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of cardiovascular electrophysiology</Title><ISOAbbreviation>J Cardiovasc Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Sex-based differences in procedural complications associated with atrial fibrillation catheter ablation: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>3176</StartPage><EndPage>3186</EndPage><MedlinePgn>3176-3186</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jce.14758</ELocationID><Abstract><AbstractText Label="BACKGROUND">Women undergoing atrial fibrillation catheter ablation (AFCA) have higher rates of vascular complications and major bleeding. However, most studies have been underpowered to detect differences in rarer complications such as stroke/transient ischemic attack (TIA) and procedural mortality.</AbstractText><AbstractText Label="METHODS">We performed a systematic review of databases (PubMed, World of Science,&#xa0;and Embase) to identify studies published since 2010 reporting AFCA complications by sex. Six complications of interest were&#xa0;(1) vascular/groin complications; (2) pericardial effusion/tamponade; (3) stroke/TIA; (4) permanent phrenic nerve injury; (5) major bleeding; and&#xa0;(6) procedural mortality. For meta-analysis, random effects models were used when heterogeneity between studies was &#x2265;50% (vascular complications and&#xa0;major bleeding) and fixed effects models for other endpoints.</AbstractText><AbstractText Label="RESULTS">Of 5716 citations, 19 studies met inclusion criteria, comprising 244,353 patients undergoing AFCA, of whom 33% were women. Women were older (65.3&#x2009;&#xb1;&#x2009;11.2 vs. 60.4&#x2009;&#xb1;&#x2009;13.2 years), more likely hypertensive (60.6% vs. 55.5%) and diabetic (18.3% vs. 16.5%), and had higher CHA<sub>2</sub> DS<sub>2</sub> -VASc scores (3.0&#x2009;&#xb1;&#x2009;1.8 vs. 1.4&#x2009;&#xb1;&#x2009;1.4) (p&#x2009;&lt;&#x2009;.0001 for all comparisons). The rates of all six complications were significantly higher in women. However, despite statistically significant differences, the overall incidences of major complications were very low in both sexes: stroke/TIA (women 0.51% vs. men 0.39%) and procedural mortality (women 0.25% vs. men 0.19%).</AbstractText><AbstractText Label="CONCLUSION">Women experience significantly higher rates of AFCA complications. However, the incidence of major procedural complications is very low in both sexes. The higher rate of complications in women may be partially attributable to older age and a higher prevalence of comorbidities at the time of ablation. More detailed studies are needed to better define the mechanisms of increased risk in women and to identify strategies for closing the sex gap.</AbstractText><CopyrightInformation>&#xa9; 2020 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Campbell</LastName><ForeName>Martin L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larson</LastName><ForeName>John</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-0708-9330</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, School of Medicine, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farid</LastName><ForeName>Talha</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiology Division, Section of Cardiac Electrophysiology, Emory University School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Westerman</LastName><ForeName>Stacy</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiology Division, Section of Cardiac Electrophysiology, Emory University School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lloyd</LastName><ForeName>Michael S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiology Division, Section of Cardiac Electrophysiology, Emory University School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Anand D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiology Division, Section of Cardiac Electrophysiology, Emory University School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leon</LastName><ForeName>Angel R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiology Division, Section of Cardiac Electrophysiology, Emory University School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Chami</LastName><ForeName>Mikhael F</ForeName><Initials>MF</Initials><Identifier Source="ORCID">0000-0003-4978-7177</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiology Division, Section of Cardiac Electrophysiology, Emory University School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merchant</LastName><ForeName>Faisal M</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiology Division, Section of Cardiac Electrophysiology, Emory University School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiovasc Electrophysiol</MedlineTA><NlmUniqueID>9010756</NlmUniqueID><ISSNLinking>1045-3873</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="Y">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="Y">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ablation</Keyword><Keyword MajorTopicYN="N">atrial fibrillation</Keyword><Keyword MajorTopicYN="N">complications</Keyword><Keyword MajorTopicYN="N">female</Keyword><Keyword MajorTopicYN="N">gender</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>23</Day><Hour>17</Hour><Minute>37</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32966681</ArticleId><ArticleId IdType="doi">10.1111/jce.14758</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Asad ZUA, Yousif A, Khan MS, Al-Khatib SM, Stavrakis S. Catheter ablation versus medical therapy for atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials. Circ Arrhythm Electrophysiol. 2019;12:e007414.</Citation></Reference><Reference><Citation>Beck H, Curtis AB. Sex differences in outcomes of ablation of atrial fibrillation. J Atr Fibrillation. 2014;6:1024.</Citation></Reference><Reference><Citation>Westerman S, Wenger N. Gender differences in atrial fibrillation: a review of epidemiology, management, and outcomes. Curr Cardiol Rev. 2019;15:136-144.</Citation></Reference><Reference><Citation>Spragg DD, Dalal D, Cheema A, et al. Complications of catheter ablation for atrial fibrillation: incidence and predictors. J Cardiovasc Electrophysiol. 2008;19:627-631.</Citation></Reference><Reference><Citation>Cheung JW, Cheng EP, Wu X, et al. Sex-based differences in outcomes, 30-day readmissions, and costs following catheter ablation of atrial fibrillation: the United States Nationwide Readmissions Database 2010-14. Eur Heart J. 2019;40:3035-3043A.</Citation></Reference><Reference><Citation>Mohanty S, Trivedi C, Gianni C, Natale A. Gender specific considerations in atrial fibrillation treatment: a review. Expert Opin Pharmacother. 2018;19:365-374.</Citation></Reference><Reference><Citation>Cheng X, Hu Q, Gao L, Liu J, Qin S, Zhang D. Sex-related differences in catheter ablation of atrial fibrillation: a systematic review and meta-analysis. Europace. 2019;21:1509-1518.</Citation></Reference><Reference><Citation>Hoyt H, Bhonsale A, Chilukuri K, et al. Complications arising from catheter ablation of atrial fibrillation: temporal trends and predictors. Heart Rhythm. 2011;8:1869-1874.</Citation></Reference><Reference><Citation>Di Biase L, Burkhardt JD, Mohanty P, et al. Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio. Circulation. 2010;121:2550-2556.</Citation></Reference><Reference><Citation>Friedman DJ, Pokorney SD, Ghanem A, et al. Predictors of cardiac perforation with catheter ablation of atrial fibrillation. JACC Clin Electrophysiol. 2020;6:636-645.</Citation></Reference><Reference><Citation>Enriquez A, Saenz LC, Rosso R, et al. Use of intracardiac echocardiography in interventional cardiology: working with the anatomy rather than fighting it. Circulation. 2018;137:2278-2294.</Citation></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.</Citation></Reference><Reference><Citation>Elayi CS, Darrat Y, Suffredini JM, et al. Sex differences in complications of catheter ablation for atrial fibrillation: results on 85,977 patients. J Interv Card Electrophysiol. 2018;53:333-339.</Citation></Reference><Reference><Citation>Kaiser DW, Fan J, Schmitt S, et al. Gender differences in clinical outcomes after catheter ablation of atrial fibrillation. JACC Clin Electrophysiol. 2016;2:703-710.</Citation></Reference><Reference><Citation>Kornej J, Kosiuk J, Hindricks G, et al. Sex-related predictors for thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry. Clinical Research in Cardiology. 2015;104:603-610.</Citation></Reference><Reference><Citation>Michowitz Y, Rahkovich M, Oral H, et al. Effects of sex on the incidence of cardiac tamponade after catheter ablation of atrial fibrillation results from a worldwide survey in 34 943 atrial fibrillation ablation procedures. Circulation: Arrhythmia and Electrophysiology. 2014;7:274-280.</Citation></Reference><Reference><Citation>Patel D, Mohanty P, Di Biase L, et al. Outcomes and complications of catheter ablation for atrial fibrillation in females. Heart Rhythm. 2010;7:167-172.</Citation></Reference><Reference><Citation>Piccini JP, Sinner MF, Greiner MA, et al. Outcomes of medicare beneficiaries undergoing catheter ablation for atrial fibrillation. Circulation. 2012;126:2200-2207.</Citation></Reference><Reference><Citation>Stabile G, Bertaglia E, Pappone A, et al. Low incidence of permanent complications during catheter ablation for atrial fibrillation using open-irrigated catheters: A multicentre registry. Europace. 2014;16:1154-1159.</Citation></Reference><Reference><Citation>Takigawa M, Kuwahara T, Takahashi A, et al. Differences in catheter ablation of paroxysmal atrial fibrillation between males and females. Int J Cardiol. 2013;168:1984-1991.</Citation></Reference><Reference><Citation>Zhang XD, Tan HW, Gu J, et al. Efficacy and safety of catheter ablation for long-standing persistent atrial fibrillation in women. Pacing&#xa0;Clin&#xa0;Electrophysiol. 2013;36:1236-1244.</Citation></Reference><Reference><Citation>Zylla MM, Brachmann J, Lewalter T, et al. Sex-related outcome of atrial fibrillation ablation: insights from the German Ablation Registry. Heart Rhythm. 2016;13:1837-1844.</Citation></Reference><Reference><Citation>Garg J, Patel B, Chaudhary R, et al. Predictors of 30-day readmissions after catheter ablation for atrial fibrillation in the USA. J Interv Card Electrophysiol. 2019;55:243-250.</Citation></Reference><Reference><Citation>Grecu M, Blomstr&#xf6;m-Lundqvist C, Kautzner J, et al. In-hospital and 12-month follow-up outcome from the ESC-EORP EHRA Atrial Fibrillation Ablation Long-Term registry: sex differences. Europace. 2020;22:66-73.</Citation></Reference><Reference><Citation>Kloosterman M, Chua W, Fabritz L, et al. Sex differences in catheter ablation of atrial fibrillation: results from AXAFA-AFNET 5. EP Europace. 2020;22:1-10.</Citation></Reference><Reference><Citation>Kuck KH, Brugada J, F&#xfc;rnkranz A, et al. Impact of female sex on clinical outcomes in the FIRE AND ICE trial of catheter ablation for atrial fibrillation. Circulation Arrhythmia and electrophysiology. 2018;11:e006204.</Citation></Reference><Reference><Citation>Odozynski G, Dal Forno ARJ, Lewandowski A, Nascimento HG, D'Avila A. Paroxysmal atrial fibrillation in females: understanding gender differences. Arq Bras Cardiol. 2018;110:449-454.</Citation></Reference><Reference><Citation>Ricciardi D, Arena G, Verlato R, et al. Sex effect on efficacy of pulmonary vein cryoablation in patients with atrial fibrillation: data from the multicenter real-world 1STOP project. J Interv Card Electrophysiol. 2019;56:9-18.</Citation></Reference><Reference><Citation>Roh SY, Shim J, Lee KN, et al. Gender-related difference in clinical outcome of the patient with atrial fibrillation after radiofrequency catheter ablation. Korean Circ J. 2018;48:605-618.</Citation></Reference><Reference><Citation>Ueberham L, K&#xf6;nig S, Hohenstein S, et al. Sex differences of resource utilisation and outcomes in patients with atrial arrhythmias and heart failure. Heart. 2020;106:527-533.</Citation></Reference><Reference><Citation>Kaiser DW, Fan J, Schmitt S, et al. Gender differences in clinical outcomes after catheter ablation of atrial fibrillation. JACC&#xa0;Clin&#xa0;Electrophysiol. 2016;2:703-710.</Citation></Reference><Reference><Citation>Cheung JW, Cheng EP, Wu X, et al. Sex-based differences in outcomes, 30-day readmissions, and costs following catheter ablation of atrial fibrillation: the United States Nationwide Readmissions Database 2010-14. Eur Heart J. 2019;40:3035-3043.</Citation></Reference><Reference><Citation>Sharma PS, Padala SK, Gunda S, Koneru JN, Ellenbogen KA. Vascular Complications during catheter ablation of cardiac arrhythmias: a comparison between vascular ultrasound guided access and conventional vascular access. J Cardiovasc Electrophysiol. 2016;27:1160-1166.</Citation></Reference><Reference><Citation>Wynn GJ, Haq I, Hung J, et al. Improving safety in catheter ablation for atrial fibrillation: a prospective study of the use of ultrasound to guide vascular access. J Cardiovasc Electrophysiol. 2014;25:680-685.</Citation></Reference><Reference><Citation>Hsu LF, JA&#xcf;S P, Hocini M, et al. Incidence and prevention of cardiac tamponade complicating ablation for atrial fibrillation. Pacing Clin Electrophysiol. 2005;28(suppl 1):S106-S109.</Citation></Reference><Reference><Citation>Merchant FM, Delurgio DB. Catheter ablation of atrial fibrillation and risk of asymptomatic cerebral embolism. Pacing Clin Electrophysiol. 2014;37:389-97.</Citation></Reference><Reference><Citation>Winkle RA, Mead RH, Engel G, Patrawala RA. Safety of lower activated clotting times during atrial fibrillation ablation using open irrigated tip catheters and a single transseptal puncture. Am J Cardiol. 2011;107:704-708.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36352566</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>11</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1998-4022</ISSN><JournalIssue CitedMedium="Internet"><Volume>70</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Season>Sep-Oct</Season></PubDate></JournalIssue><Title>Neurology India</Title><ISOAbbreviation>Neurol India</ISOAbbreviation></Journal><ArticleTitle>Modified Eversion Carotid Endarterectomy: A Novel Surgical Technique for Carotid Artery Stenosis Treatment.</ArticleTitle><Pagination><StartPage>1787</StartPage><EndPage>1792</EndPage><MedlinePgn>1787-1792</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/0028-3886.359282</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Carotid endarterectomy (CEA) has been the standard therapy for carotid artery stenosis (CAS). Modified eversion carotid endarterectomy (mECEA) was recently introduced to treat CAS. However, the short-term safety and long-term efficacy of mECEA are still controversial among studies. This systematic review aims to summarize the current literatures about safety and efficacy of mECEA in treating CAS.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A systematic review of mECEA was conducted in the main bibliographic databases in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement. Clinical studies on the safety and efficacy of mECEA in treating CAS with clinical results of transient ischemic attack (TIA), stroke, death, and restenosis were included.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The initial search and screening found 15 references from the main databases, and 7 studies were finally included after full-text article assessment, which consisted of 3 single-arm studies and 4 comparative studies. The risks of postoperative complications including TIA, stroke, myocardial infarction (MI), and death ranged from 1.1% to 2%, 0% to 2.5%, 0% to 4.4%, and 0% to 2.32%, respectively. The mECEA was significantly related to lower risk of carotid artery occlusion, incision numbness, and shorter lengths of stay in hospital and average scar when separately compared with conventional CEA (cCEA), CEA with patch closure (pCEA), and eversion CEA (eCEA).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">The mECEA is a promising surgical option for CAS with acceptable clinical outcomes. In order to prove its safety and efficacy, future practices need to be conducted by more medical workers in more large-scale trials.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Xuanwu Hospital, Capital Medical University; China International Neuroscience Institute (China-INI), Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Xuesong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Xuanwu Hospital, Capital Medical University; China International Neuroscience Institute (China-INI), Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Yao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Xuanwu Hospital, Capital Medical University; China International Neuroscience Institute (China-INI), Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yinhang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Xuanwu Hospital, Capital Medical University; China International Neuroscience Institute (China-INI), Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Renjie</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Xuanwu Hospital, Capital Medical University; China International Neuroscience Institute (China-INI), Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yutong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Xuanwu Hospital, Capital Medical University; China International Neuroscience Institute (China-INI), Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Ran</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Xuanwu Hospital, Capital Medical University; China International Neuroscience Institute (China-INI), Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Xuanwu Hospital, Capital Medical University; China International Neuroscience Institute (China-INI), Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiao</LastName><ForeName>Liqun</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Xuanwu Hospital, Capital Medical University; China International Neuroscience Institute (China-INI); Department of Interventional Neuroradiology, Xuanwu Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Neurol India</MedlineTA><NlmUniqueID>0042005</NlmUniqueID><ISSNLinking>0028-3886</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016894" MajorTopicYN="Y">Endarterectomy, Carotid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016893" MajorTopicYN="Y">Carotid Stenosis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="Y">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002340" MajorTopicYN="Y">Carotid Artery Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015607" MajorTopicYN="N">Stents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Carotid artery stenosis</Keyword><Keyword MajorTopicYN="N">modified eversion carotid endarterectomy</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword></KeywordList><CoiStatement>None</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>10</Day><Hour>1</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36352566</ArticleId><ArticleId IdType="doi">10.4103/0028-3886.359282</ArticleId><ArticleId IdType="pii">ni_2022_70_5_1787_359282</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25635593</PMID><DateCompleted><Year>2015</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1175</ISSN><JournalIssue CitedMedium="Internet"><Volume>122</Volume><Issue>4</Issue><PubDate><Year>2015</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Anesthesiology</Title><ISOAbbreviation>Anesthesiology</ISOAbbreviation></Journal><ArticleTitle>Randomized double-blinded comparison of norepinephrine and phenylephrine for maintenance of blood pressure during spinal anesthesia for cesarean delivery.</ArticleTitle><Pagination><StartPage>736</StartPage><EndPage>745</EndPage><MedlinePgn>736-45</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ALN.0000000000000601</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">During spinal anesthesia for cesarean delivery, phenylephrine can cause reflexive decreases in maternal heart rate and cardiac output. Norepinephrine has weak &#x3b2;-adrenergic receptor agonist activity in addition to potent &#x3b1;-adrenergic receptor activity and therefore may be suitable for maintaining blood pressure with less negative effects on heart rate and cardiac output compared with phenylephrine.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In a randomized, double-blinded study, 104 healthy patients having cesarean delivery under spinal anesthesia were randomized to have systolic blood pressure maintained with a computer-controlled infusion of norepinephrine 5 &#x3bc;g/ml or phenylephrine 100 &#x3bc;g/ml. The primary outcome compared was cardiac output. Blood pressure heart rate and neonatal outcome were also compared.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Normalized cardiac output 5 min after induction was greater in the norepinephrine group versus the phenylephrine group (median 102.7% [interquartile range, 94.3 to 116.7%] versus 93.8% [85.0 to 103.1%], P = 0.004, median difference 9.8%, 95% CI of difference between medians 2.8 to 16.1%). From induction until uterine incision, for norepinephrine versus phenylephrine, systolic blood pressure and stroke volume were similar, heart rate and cardiac output were greater, systemic vascular resistance was lower, and the incidence of bradycardia was smaller. Neonatal outcome was similar between groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">When given by computer-controlled infusion during spinal anesthesia for cesarean delivery, norepinephrine was effective for maintaining blood pressure and was associated with greater heart rate and cardiac output compared with phenylephrine. Further work would be of interest to confirm the safety and efficacy of norepinephrine as a vasopressor in obstetric patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ngan Kee</LastName><ForeName>Warwick D</ForeName><Initials>WD</Initials><AffiliationInfo><Affiliation>From the Department of Anaesthesia and Intensive Care, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong, China (W.D.N.K., F.F.N., P.E.T., K.S.K.); and Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Kowloon, Hong Kong, China (S.W.Y.L.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Shara W Y</ForeName><Initials>SW</Initials></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Floria F</ForeName><Initials>FF</Initials></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Perpetua E</ForeName><Initials>PE</Initials></Author><Author ValidYN="Y"><LastName>Khaw</LastName><ForeName>Kim S</ForeName><Initials>KS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesthesiology</MedlineTA><NlmUniqueID>1300217</NlmUniqueID><ISSNLinking>0003-3022</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>1WS297W6MV</RegistryNumber><NameOfSubstance UI="D010656">Phenylephrine</NameOfSubstance></Chemical><Chemical><RegistryNumber>X4W3ENH1CV</RegistryNumber><NameOfSubstance UI="D009638">Norepinephrine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Anesthesiology. 2015 Apr;122(4):728-30. doi: 10.1097/ALN.0000000000000602.</RefSource><PMID Version="1">25654435</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000775" MajorTopicYN="Y">Anesthesia, Spinal</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001794" MajorTopicYN="N">Blood Pressure</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001795" MajorTopicYN="N">Blood Pressure Determination</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002585" MajorTopicYN="Y">Cesarean Section</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016343" MajorTopicYN="N">Monitoring, Intraoperative</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009638" MajorTopicYN="N">Norepinephrine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010656" MajorTopicYN="N">Phenylephrine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25635593</ArticleId><ArticleId IdType="doi">10.1097/ALN.0000000000000601</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">35753807</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>08</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>129</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Inclusion, characteristics, and outcomes of male and female participants in large international perioperative studies.</ArticleTitle><Pagination><StartPage>336</StartPage><EndPage>345</EndPage><MedlinePgn>336-345</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2022.05.019</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(22)00258-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">We compared baseline characteristics and outcomes and evaluated the subgroup effects of randomised interventions by sex in males and females in large international perioperative trials.</AbstractText><AbstractText Label="METHODS">Nine randomised trials and two cohort studies recruiting adult patients, conducted between 1995 and 2020, were included. Baseline characteristics and outcomes common to six or more studies were evaluated. Regression models included terms for sex, study, and an interaction between the two. Comparing outcomes without adjustment for baseline characteristics represents the 'total effect' of sex on the outcome.</AbstractText><AbstractText Label="RESULTS">Of 54 626 participants, 58% were male and 42% were female. Females were less likely to have ASA physical status &#x2265;3 (56% vs 64%), to smoke (15% vs 23%), have coronary artery disease (21% vs 32%), or undergo vascular surgery (10% vs 23%). The pooled incidence of death was 1.6% in females and 1.8% in males (risk ratio [RR] 0.92; 95% confidence interval [CI]: 0.81-1.05; P=0.20), of myocardial infarction was 4.2% vs 4.5% (RR 0.92; 95% CI: 0.81-1.03; P=0.10), of stroke was 0.5% vs 0.6% (RR 1.03; 95% CI: 0.79-1.35; P=0.81), and of surgical site infection was 8.6% vs 8.3% (RR 1.03; 95% CI: 0.79-1.35; P=0.70). Treatment effects of three interventions demonstrated statistically significant effect modification by sex.</AbstractText><AbstractText Label="CONCLUSIONS">Females were in the minority in all included studies. They were healthier than males, but outcomes were comparable. Further research is needed to understand the reasons for this discrepancy.</AbstractText><AbstractText Label="CLINICAL TRIAL REGISTRATION">International Registry of Meta-Research (UID: IRMR_000011; 5 January 2021).</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Leslie</LastName><ForeName>Kate</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Critical Care, University of Melbourne, Melbourne, VIC, Australia; Department of Anaesthesiology and Perioperative Medicine, Central Clinical School, Monash University, Melbourne, VIC, Australia; Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Parkville, VIC, Australia. Electronic address: kate.leslie@mh.org.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Myles</LastName><ForeName>Paul S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Perioperative Medicine, Central Clinical School, Monash University, Melbourne, VIC, Australia; Department of Anaesthesiology and Perioperative Medicine, Alfred Health, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devereaux</LastName><ForeName>P J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Division of Perioperative Care, McMaster University, Hamilton, ON, Canada; Anesthesiology, Perioperative Medicine, and Surgical Research Group, Population Health Research Institute, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peyton</LastName><ForeName>Philip J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Department of Critical Care, University of Melbourne, Melbourne, VIC, Australia; Department of Anaesthesia, Austin Health, Heidelberg, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Story</LastName><ForeName>David A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Department of Critical Care, University of Melbourne, Melbourne, VIC, Australia; Department of Anaesthesia, Austin Health, Heidelberg, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wijeysundera</LastName><ForeName>Duminda N</ForeName><Initials>DN</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, ON, Canada; Department of Anesthesia, St Michael's Hospital, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuthbertson</LastName><ForeName>Brian H</ForeName><Initials>BH</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, ON, Canada; Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Short</LastName><ForeName>Timothy G</ForeName><Initials>TG</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Auckland University, Auckland, New Zealand; Department of Anaesthesia, Auckland City Hospital, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corcoran</LastName><ForeName>Tom&#xe1;s B</ForeName><Initials>TB</Initials><AffiliationInfo><Affiliation>School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia; School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia; Department of Anaesthesia and Pain Medicine, Royal Perth Hospital, Perth, WA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kasza</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003324" MajorTopicYN="Y">Coronary Artery Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006304" MajorTopicYN="N">Health Status</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="Y">Myocardial Infarction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">inclusion and diversity</Keyword><Keyword MajorTopicYN="N">perioperative trials</Keyword><Keyword MajorTopicYN="N">prospective cohort study</Keyword><Keyword MajorTopicYN="N">randomised controlled trial</Keyword><Keyword MajorTopicYN="N">sex and gender</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>26</Day><Hour>22</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35753807</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2022.05.019</ArticleId><ArticleId IdType="pii">S0007-0912(22)00258-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37120319</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>General Anesthesia Versus Local Anesthesia in Patients Undergoing Transcatheter Aortic Valve Replacement: An Updated Meta-Analysis and Systematic Review.</ArticleTitle><Pagination><StartPage>1358</StartPage><EndPage>1367</EndPage><MedlinePgn>1358-1367</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2023.03.007</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(23)00173-8</ELocationID><Abstract><AbstractText Label="OBJECTIVES">For patients with aortic stenosis, transcatheter aortic valve replacement (TAVR) offers a less invasive treatment modality than conventional surgical valve replacement. Although the surgery is performed traditionally under general anesthesia (GA), recent studies have described success with TAVR using local anesthesia (LA) and/or conscious sedation. The study authors performed a pairwise meta-analysis to compare the clinical outcomes of TAVR based on operative anesthesia management.</AbstractText><AbstractText Label="DESIGN">A random effects pairwise meta-analysis via the Mantel-Haenszel method.</AbstractText><AbstractText Label="SETTING">Not applicable, as this is a meta-analysis.</AbstractText><AbstractText Label="PARTICIPANTS">No individual patient data were used.</AbstractText><AbstractText Label="INTERVENTIONS">Not applicable, as this is a meta-analysis.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS">The authors comprehensively searched the PubMed, Embase, and Cochrane databases to identify studies comparing TAVR performed using LA or GA. Outcomes were pooled as risk ratios (RR) or standard mean differences (SMD) and their 95% CIs. The authors' pooled analysis included 14,388 patients from 40 studies (7,754 LA; 6,634 GA). Compared to GA TAVR, LA TAVR was associated with significantly lower rates of 30-day mortality (RR 0.69; p &lt; 0.01) and stroke (RR 0.78; p&#xa0;=&#xa0;0.02). Additionally, LA TAVR patients had lower rates of 30-day major and/or life-threatening bleeding (RR 0.64; p&#xa0;=&#xa0;0.01), 30-day major vascular complications (RR 0.76; p&#xa0;=&#xa0;0.02), and long-term mortality (RR 0.75; p&#xa0;=&#xa0;0.009). No significant difference was seen between the 2 groups for a 30-day paravalvular leak (RR 0.88, p&#xa0;=&#xa0;0.12).</AbstractText><AbstractText Label="CONCLUSIONS">Transcatheter aortic valve replacement performed using LA is associated with lower rates of adverse clinical outcomes, including 30-day mortality and stroke. No difference was seen between the 2 groups for a 30-day paravalvular leak. These results support the use of minimally invasive forms of TAVR without GA.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Adham</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>City University of New York School of Medicine, New York, NY. Electronic address: aahmed018@citymail.cuny.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathew</LastName><ForeName>Dave M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>City University of New York School of Medicine, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathew</LastName><ForeName>Serena M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>City University of New York School of Medicine, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Awad</LastName><ForeName>Ahmed K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Ain Shams University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varghese</LastName><ForeName>Kathryn S</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>City University of New York School of Medicine, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khaja</LastName><ForeName>Sofia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>City University of New York School of Medicine, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vega</LastName><ForeName>Eamon</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>City University of New York School of Medicine, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pandey</LastName><ForeName>Roshan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>City University of New York School of Medicine, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Jeremiah J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>City University of New York School of Medicine, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathew</LastName><ForeName>Christopher S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>City University of New York School of Medicine, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>City University of New York School of Medicine, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>George</LastName><ForeName>Jerrin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Toledo College of Medicine and Life Sciences, Toledo, OH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Awad</LastName><ForeName>Ayman K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Ain Shams University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fusco</LastName><ForeName>Peter J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>City University of New York School of Medicine, New York, NY.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065467" MajorTopicYN="Y">Transcatheter Aortic Valve Replacement</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000772" MajorTopicYN="N">Anesthesia, Local</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001024" MajorTopicYN="Y">Aortic Valve Stenosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001021" MajorTopicYN="N">Aortic Valve</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">TAVR</Keyword><Keyword MajorTopicYN="N">anesthesia</Keyword><Keyword MajorTopicYN="N">localized sedation</Keyword></KeywordList><CoiStatement>Conflict of Interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>30</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>29</Day><Hour>21</Hour><Minute>58</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37120319</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2023.03.007</ArticleId><ArticleId IdType="pii">S1053-0770(23)00173-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37325224</PMID><DateRevised><Year>2023</Year><Month>06</Month><Day>19</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-2295</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in neurology</Title><ISOAbbreviation>Front Neurol</ISOAbbreviation></Journal><ArticleTitle>Global trends in perioperative stroke research from 2003 to 2022: a web of science-based bibliometric and visual analysis.</ArticleTitle><Pagination><StartPage>1185326</StartPage><MedlinePgn>1185326</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1185326</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fneur.2023.1185326</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Perioperative stroke is a potentially devastating complication in surgical patients, which has attracted global attention. This retrospective bibliometric and visual analysis evaluates the status and global trends in perioperative stroke research.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Papers published between 2003 and 2022 were retrieved from the Web of Science core collection. Extracted data were summarized and analyzed using Microsoft Excel and further bibliometric and co-occurrence analyses were conducted using VOSviewer and CiteSpace software.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Publications on perioperative stroke have increased over the years. The USA topped the list of countries with the highest number of publications and citations, while Canada had the highest mean citation frequency. The Journal of Vascular Surgery and Annals of Thoracic Surgery had the highest number of publications and citation frequency for perioperative stroke. Regarding authors, Malas, Mahmoud B. contributed the most publications to the field, and Harvard University had the highest number of publications (409 papers). Based on an overlay visualization map, timeline view, and the strongest strength burst of keywords, "antiplatelet therapy," "antithrombotic therapy," "carotid revascularization," "bleeding complications," "postoperative cognitive dysfunction," "intraoperative hypotension," "thrombectomy," "cerebral revascularization," "valve surgery," "tranexamic acid," and "frozen elephant trunk" were trending topics in perioperative stroke research.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Publications regarding perioperative stroke have experienced rapid growth in the past 20 years and are likely to continuously increase. Research on perioperative antiplatelet and antithrombotic, cardiovascular surgery, postoperative cognitive dysfunction, thrombectomy, tranexamic acid, and frozen elephant trunk has attracted increasing attention, and these topics are emerging hotspots of present research and possible candidates for future research.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Ji, Shi, Fan, Jiang, Yang, Tao and Ye.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Ji</LastName><ForeName>Shunpan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Air Force Medical Center, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate School of China Medical University, Shenyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Shi</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Air Force Medical Center, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate School of China Medical University, Shenyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Xiaojing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Air Force Medical Center, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Tian</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Air Force Medical Center, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xiaoming</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Air Force Medical Center, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tao</LastName><ForeName>Tianzhu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Air Force Medical Center, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate School of China Medical University, Shenyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Air Force Medical Center, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate School of China Medical University, Shenyang, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Neurol</MedlineTA><NlmUniqueID>101546899</NlmUniqueID><ISSNLinking>1664-2295</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anesthesia</Keyword><Keyword MajorTopicYN="N">bibliometric</Keyword><Keyword MajorTopicYN="N">perioperative period</Keyword><Keyword MajorTopicYN="N">stroke</Keyword><Keyword MajorTopicYN="N">surgery</Keyword><Keyword MajorTopicYN="N">visualized study</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>16</Day><Hour>4</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37325224</ArticleId><ArticleId IdType="pmc">PMC10264628</ArticleId><ArticleId IdType="doi">10.3389/fneur.2023.1185326</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJ, Culebras A, et al. . An updated definition of stroke for the 21st century: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. (2013) 44:2064&#x2013;89. 10.1161/STR.0b013e318296aeca</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STR.0b013e318296aeca</ArticleId><ArticleId IdType="pmc">PMC11078537</ArticleId><ArticleId IdType="pubmed">23652265</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlisides PE, Moore LE, Whalin MK, Robicsek SA, Gelb AW, Lele AV, et al. . Perioperative care of patients at high risk for stroke during or after non-cardiac, non-neurological surgery: 2020 guidelines from the society for neuroscience in anesthesiology and critical care. J Neurosurg Anesthesiol. (2020) 32:210&#x2013;26. 10.1097/ANA.0000000000000686</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ANA.0000000000000686</ArticleId><ArticleId IdType="pubmed">32433102</ArticleId></ArticleIdList></Reference><Reference><Citation>Mashour GA SA, Kheterpal S. Perioperative stroke and associated mortality after noncardiac, nonneurologic surgery. Anesthesiology. (2011) 114:1289&#x2013;96. 10.1097/ALN.0b013e318216e7f4</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e318216e7f4</ArticleId><ArticleId IdType="pubmed">21478735</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuro VI. Perioperative covert stroke in patients undergoing non-cardiac surgery (neurovision): a prospective cohort study. Lancet. (2019) 394:1022&#x2013;9. 10.1016/S0140-6736(19)31795-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)31795-7</ArticleId><ArticleId IdType="pubmed">31422895</ArticleId></ArticleIdList></Reference><Reference><Citation>Smilowitz NR, Gupta N, Ramakrishna H, Guo Y, Berger JS, Bangalore S. Perioperative major adverse cardiovascular and cerebrovascular events associated with noncardiac surgery. JAMA Cardiol. (2017) 2:181&#x2013;7. 10.1001/jamacardio.2016.4792</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2016.4792</ArticleId><ArticleId IdType="pmc">PMC5563847</ArticleId><ArticleId IdType="pubmed">28030663</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan HH, Xu J, Teoh HL, Chan BP, Seet RC, Venketasubramanian N, et al. . Decline in changing montreal cognitive assessment (moca) scores is associated with post-stroke cognitive decline determined by a formal neuropsychological evaluation. PLoS ONE. (2017) 12:e0173291. 10.1371/journal.pone.0173291</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0173291</ArticleId><ArticleId IdType="pmc">PMC5367691</ArticleId><ArticleId IdType="pubmed">28346532</ArticleId></ArticleIdList></Reference><Reference><Citation>Saltman AP, Silver FL, Fang J, Stamplecoski M, Kapral MK. Care and Outcomes of Patients with in-Hospital Stroke. JAMA Neurol. (2015) 72:749&#x2013;55. 10.1001/jamaneurol.2015.0284</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2015.0284</ArticleId><ArticleId IdType="pubmed">25938195</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K, Xing D, Dong S, Lin J. The global state of research in nonsurgical treatment of knee osteoarthritis: a bibliometric and visualized study. BMC Musculoskelet Disord. (2019) 20:407. 10.1186/s12891-019-2804-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12891-019-2804-9</ArticleId><ArticleId IdType="pmc">PMC6727547</ArticleId><ArticleId IdType="pubmed">31484517</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S. Co-Authorship networks: a review of the literature. Aslib J. Inf. Manage. (2015) 67:55&#x2013;73. 10.1108/AJIM-09-2014-0116</Citation><ArticleIdList><ArticleId IdType="doi">10.1108/AJIM-09-2014-0116</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleminski R, Kazienko P, Kajdanowicz T. Analysis of direct citation, co-citation and bibliographic coupling in scientific topic identification. J. Inf. Sc. (2020) 48:349&#x2013;73. 10.1177/0165551520962775</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0165551520962775</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastian S, Ippolito JA, Lopez SA, Eloy JA, Beebe KS. The use of the H-index in academic orthopaedic surgery. J Bone Joint Surg Am. (2017) 99:e14. 10.2106/JBJS.15.01354</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.15.01354</ArticleId><ArticleId IdType="pubmed">28196042</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutzko DC, Andraska EA, Obi AT, Henke PK, Osborne NH. Risk factors associated with perioperative myocardial infarction in major open vascular surgery. Ann Vasc Surg. (2018) 47:24&#x2013;30. 10.1016/j.avsg.2017.08.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.avsg.2017.08.030</ArticleId><ArticleId IdType="pmc">PMC5805566</ArticleId><ArticleId IdType="pubmed">28893702</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharifpour M, Moore LE, Shanks AM, Didier TJ, Kheterpal S, Mashour GA. Incidence, predictors, and outcomes of perioperative stroke in noncarotid major vascular surgery. Anesthesia Analgesia. (2013) 116:424&#x2013;34. 10.1213/ANE.0b013e31826a1a32</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e31826a1a32</ArticleId><ArticleId IdType="pubmed">23115255</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedrich S, Ng PY, Platzbecker K, Burns SM, Banner-Goodspeed V, Weimar C, et al. . Patent foramen ovale and long-term risk of ischaemic stroke after surgery. Eur Heart J. (2019) 40:914&#x2013;24. 10.1093/eurheartj/ehy402</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy402</ArticleId><ArticleId IdType="pmc">PMC6416532</ArticleId><ArticleId IdType="pubmed">30020431</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasivej T, Sathirapanya P, Kongkamol C. Incidence and risk factors of perioperative stroke in noncardiac, and nonaortic and its major branches surgery. J Stroke Cerebrovasc Dis. (2016) 25:1172&#x2013;6. 10.1016/j.jstrokecerebrovasdis.2016.01.051</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2016.01.051</ArticleId><ArticleId IdType="pubmed">26922129</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilcox T, Smilowitz NR, Xia Y, Berger JS. Cardiovascular risk scores to predict perioperative stroke in noncardiac surgery. Stroke. (2019) 50:2002&#x2013;6. 10.1161/STROKEAHA.119.024995</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.119.024995</ArticleId><ArticleId IdType="pmc">PMC10027603</ArticleId><ArticleId IdType="pubmed">31234757</ArticleId></ArticleIdList></Reference><Reference><Citation>Group PS, Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, et al. . Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (poise trial): a randomised controlled trial. Lancet. (2008) 371:1839&#x2013;47. 10.1016/S0140-6736(08)60601-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(08)60601-7</ArticleId><ArticleId IdType="pubmed">18479744</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajibandeh S, Hajibandeh S, Antoniou SA, Torella F, Antoniou GA. Effect of beta-blockers on perioperative outcomes in vascular and endovascular surgery: a systematic review and meta-analysis. Br J Anaesth. (2017) 118:11&#x2013;21. 10.1093/bja/aew380</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aew380</ArticleId><ArticleId IdType="pubmed">28039238</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xf8;rgensen ME, Hlatky MA, K&#xf8;ber L, Sanders RD, Torp-Pedersen C, Gislason GH, et al. . &#x3b2;-Blocker&#x2013;associated risks in patients with uncomplicated hypertension undergoing noncardiac surgery. JAMA Inte. Med. (2015) 175:5346. 10.1001/jamainternmed.2015.5346</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2015.5346</ArticleId><ArticleId IdType="pubmed">26436291</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Delgado JC, Park J, Kim J, Kwon JH, Park SJ, Min JJ, et al. . Association between perioperative &#x3b2;-blocker use and clinical outcome of non-cardiac surgery in coronary revascularized patients without severe ventricular dysfunction or heart failure. Plos ONE. (2018) 13:311. 10.1371/journal.pone.0201311</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0201311</ArticleId><ArticleId IdType="pmc">PMC6070245</ArticleId><ArticleId IdType="pubmed">30067841</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen RJ, Chu H, Tsai LW. Impact of beta-blocker initiation timing on mortality risk in patients with diabetes mellitus undergoing noncardiac surgery: a nationwide population-based cohort study. J Am Heart Assoc. (2017) 6:4392. 10.1161/JAHA.116.004392</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.116.004392</ArticleId><ArticleId IdType="pmc">PMC5523631</ArticleId><ArticleId IdType="pubmed">28073770</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma B, Sun J, Diao S, Zheng B, Li H. Effects of perioperative statins on patient outcomes after noncardiac surgery: a meta-analysis. Ann Med. (2018) 50:402&#x2013;9. 10.1080/07853890.2018.1471217</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2018.1471217</ArticleId><ArticleId IdType="pubmed">29741972</ArticleId></ArticleIdList></Reference><Reference><Citation>London MJ, Schwartz GG, Hur K, Henderson WG. Association of perioperative statin use with mortality and morbidity after major noncardiac surgery. JAMA Intern Med. (2017) 177:231&#x2013;42. 10.1001/jamainternmed.2016.8005</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2016.8005</ArticleId><ArticleId IdType="pubmed">27992624</ArticleId></ArticleIdList></Reference><Reference><Citation>Douketis JD, Spyropoulos AC, Kaatz S, Becker RC, Caprini JA, Dunn AS, et al. . Perioperative bridging anticoagulation in patients with atrial fibrillation. New England J. Med. (2015) 373:823&#x2013;33. 10.1056/NEJMoa1501035</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1501035</ArticleId><ArticleId IdType="pmc">PMC4931686</ArticleId><ArticleId IdType="pubmed">26095867</ArticleId></ArticleIdList></Reference><Reference><Citation>Devereaux PJ, Mrkobrada M, Sessler DI, Leslie K, Alonso-Coello P, Kurz A, et al. . Aspirin in patients undergoing noncardiac surgery. New England J. Med. (2014) 370:1494&#x2013;503. 10.1056/NEJMoa1401105</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1401105</ArticleId><ArticleId IdType="pubmed">24679062</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlisides PE, Moore LE. Stroke in surgical patients. Anesthesiology. (2021) 134:480&#x2013;92. 10.1097/ALN.0000000000003664</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003664</ArticleId><ArticleId IdType="pubmed">33411913</ArticleId></ArticleIdList></Reference><Reference><Citation>Christiansen MN. Risks of cardiovascular adverse events and death in patients with previous stroke undergoing emergency noncardiac, nonintracranial surgery: the importance of operative timing. Anesthesiology. (2017) 127:9&#x2013;19. 10.1097/ALN.0000000000001685</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001685</ArticleId><ArticleId IdType="pubmed">28514242</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu CC. Propensity score-matched comparison of postoperative adverse outcomes between geriatric patients given a general or a neuraxial anesthetic for hip surgery: a population-based study. Anesthesiology. (2015) 123:136&#x2013;47. 10.1097/ALN.0000000000000695</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000695</ArticleId><ArticleId IdType="pubmed">25955981</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh JK, Dalton JE, Yang D, Farag ES, Sessler DI, Kurz AM. The association between mild intraoperative hypotension and stroke in general surgery patients. Anesth Analg. (2016) 123:933&#x2013;9. 10.1213/ANE.0000000000001526</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000001526</ArticleId><ArticleId IdType="pubmed">27636576</ArticleId></ArticleIdList></Reference><Reference><Citation>Benesch C, Glance LG, Derdeyn CP, Fleisher LA, Holloway RG, Messe SR, et al. . Perioperative neurological evaluation and management to lower the risk of acute stroke in patients undergoing noncardiac, nonneurological surgery: a scientific statement from the american heart association/american stroke association. Circulation. (2021) 143:e923&#x2013;e46. 10.1161/CIR.0000000000000968</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000968</ArticleId><ArticleId IdType="pubmed">33827230</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi B, Ono M, Brown C, Brady K, Easley RB, Yenokyan G, et al. . Predicting the limits of cerebral autoregulation during cardiopulmonary bypass. Anesth Analg. (2012) 114:503&#x2013;10. 10.1213/ANE.0b013e31823d292a</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e31823d292a</ArticleId><ArticleId IdType="pmc">PMC3288415</ArticleId><ArticleId IdType="pubmed">22104067</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiba MH MB, Ansari S, Belle A, Cummings BC, Rajajee V, Patil PG, et al. . Novel noninvasive method of cerebrovascular blood volume assessment using brain bioimpedance. J Neurotrauma. (2017) 34:3089&#x2013;96. 10.1089/neu.2017.5090</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2017.5090</ArticleId><ArticleId IdType="pubmed">28657491</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo-Vecino JM, Ripolles-Melchor J, Mythen MG, Casans-Frances R, Balik A, Artacho JP, et al. . Effect of goal-directed haemodynamic therapy on postoperative complications in low-moderate risk surgical patients: a multicentre randomised controlled trial (fedora trial). Br J Anaesth. (2018) 120:734&#x2013;44. 10.1016/j.bja.2017.12.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2017.12.018</ArticleId><ArticleId IdType="pubmed">29576114</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher JA VL, Mikulis DJ. Magnetic resonance imaging-based cerebrovascular reactivity and hemodynamic reserve. Stroke. (2018) 49:2011&#x2013;8. 10.1161/STROKEAHA.118.021012</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.118.021012</ArticleId><ArticleId IdType="pubmed">29986929</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z YY, Leung CC, Chan MT, Gelb AW. Study group for perioperative stroke in china (posic). clinical diagnostic tools for screening of perioperative stroke in general surgery: a systematic review. Br J Anaesth. (2016) 116:328&#x2013;38. 10.1093/bja/aev452</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aev452</ArticleId><ArticleId IdType="pubmed">26821695</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlisides PE, Kunkler B, Thompson A, Zierau M, Lobo R, Strasser MO, et al. . Cerebrovascular disease and perioperative neurologic vulnerability: a prospective cohort study. Front Neurol. (2019) 10:560. 10.3389/fneur.2019.00560</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00560</ArticleId><ArticleId IdType="pmc">PMC6558425</ArticleId><ArticleId IdType="pubmed">31231299</ArticleId></ArticleIdList></Reference><Reference><Citation>Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. . Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke. (2019) 50:e344&#x2013;418. 10.1161/STR.0000000000000211</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STR.0000000000000211</ArticleId><ArticleId IdType="pubmed">31662037</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal M, Menon BK, van Zwam WH, Dippel DW, Mitchell PJ, Demchuk AM, et al. . Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. (2016) 387:1723&#x2013;31. 10.1016/S0140-6736(16)00163-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)00163-X</ArticleId><ArticleId IdType="pubmed">26898852</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33862187</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>27</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6809</ISSN><JournalIssue CitedMedium="Internet"><Volume>74</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of vascular surgery</Title><ISOAbbreviation>J Vasc Surg</ISOAbbreviation></Journal><ArticleTitle>Literature review of primary versus patching versus eversion as carotid endarterectomy closure.</ArticleTitle><Pagination><StartPage>666</StartPage><EndPage>675</EndPage><MedlinePgn>666-675</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jvs.2021.02.051</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0741-5214(21)00491-2</ELocationID><Abstract><AbstractText Label="BACKGROUND">Which type of closure after carotid endarterectomy (CEA), whether primary, patching, or eversion, will provide the optimal results has remained controversial. In the present study, we compared the results of randomized controlled trials (RCTs) and systematic meta-analyses of the various types of closure.</AbstractText><AbstractText Label="METHODS">We conducted a PubMed literature review search to find studies that had compared CEA with primary closure, CEA with patching, and/or eversion CEA (ECEA) during the previous three decades with an emphasis on RCTs, previously reported systematic meta-analyses, large multicenter observational studies (Vascular Quality Initiative data), and recent single-center large studies.</AbstractText><AbstractText Label="RESULTS">The results from RCTs comparing primary patching vs primary closure were as follows. Most of the randomized trials showed CEA with patching was superior to CEA with primary closure in lowering the perioperative stroke rates, stroke and death rates, carotid thrombosis rates, and late restenosis rates. These studies also showed no significant differences between the preferential use of several patch materials, including synthetic patches (polyethylene terephthalate [Dacron; DuPont, Wilmington, Del], Acuseal [Gore Medical, Flagstaff, Ariz], polytetrafluoroethylene, or pericardial patches) and vein patches (saphenous or jugular). The results from observational studies comparing patching vs primary closure were as follows. The Vascular Study Group of New England data showed that the use of patching increased from 71% to 91% (P&#xa0;&lt; .001). Also, the 1-year restenosis and occlusion (P&#xa0;&lt; .01) and 1-year stroke and transient ischemic attack (P&#xa0;&lt; .03) rates were significantly lower statistically with patch closure. The results from the RCTs comparing ECEA vs conventional CEA (CCEA) were as follows. Several RCTs that had compared ECEA with CCEA showed equivalency of CCEA vs ECEA (level 1 evidence) with patching in the perioperative carotid thrombosis and stroke rates. At 4&#xa0;years after treatment, the incidence of carotid stenosis was lower for ECEA than for primary closure (3.6% vs 9.2%; P&#xa0;= .01) but was comparable between patching and eversion (1.5% for patching vs 2.8% for eversion).</AbstractText><AbstractText Label="CONCLUSIONS">Routine carotid patching or ECEA was superior to primary closure (level 1 evidence). We found no significant differences between the preferential use of several patch materials. The rates of significant post-CEA stenosis for CEA with patching was similar to that with ECEA, and both were superior to primary closure.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>AbuRahma</LastName><ForeName>Ali F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Department of Surgery, West Virginia University-Charleston Division, Charleston, WV. Electronic address: ali.aburahma@camc.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Darling</LastName><ForeName>R Clement</ForeName><Initials>RC</Initials><Suffix>3rd</Suffix><AffiliationInfo><Affiliation>Division of Vascular Surgery, Albany Medical College, Albany, NY.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vasc Surg</MedlineTA><NlmUniqueID>8407742</NlmUniqueID><ISSNLinking>0741-5214</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Vasc Surg. 2021 Oct;74(4):1431-1432. doi: 10.1016/j.jvs.2021.05.061.</RefSource><PMID Version="1">34598761</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Vasc Surg. 2021 Oct;74(4):1432-1433. doi: 10.1016/j.jvs.2021.06.029.</RefSource><PMID Version="1">34598762</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D002340" MajorTopicYN="N">Carotid Artery Diseases</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016894" MajorTopicYN="Y">Endarterectomy, Carotid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006488" MajorTopicYN="Y">Hemostasis, Surgical</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Carotid endarterectomy closure</Keyword><Keyword MajorTopicYN="N">Eversion CEA</Keyword><Keyword MajorTopicYN="N">Patching</Keyword><Keyword MajorTopicYN="N">Primary closure</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>16</Day><Hour>20</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33862187</ArticleId><ArticleId IdType="doi">10.1016/j.jvs.2021.02.051</ArticleId><ArticleId IdType="pii">S0741-5214(21)00491-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24607561</PMID><DateCompleted><Year>2016</Year><Month>05</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2044-6055</ISSN><JournalIssue CitedMedium="Print"><Volume>4</Volume><Issue>3</Issue><PubDate><Year>2014</Year><Month>Mar</Month><Day>07</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Systematic review of percutaneous closure versus medical therapy in patients with cryptogenic stroke and patent foramen ovale.</ArticleTitle><Pagination><StartPage>e004282</StartPage><MedlinePgn>e004282</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e004282</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2013-004282</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To provide a comprehensive comparison of patent foramen ovale (PFO) closure versus medical therapy in patients with cryptogenic stroke or transient ischaemic attack (TIA) and demonstrated PFO.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Systematic review with complete case meta-analysis and sensitivity analyses. Data sources included MEDLINE and EMBASE from 1980 up to May 2013. All randomised controlled trials (RCTs) comparing treatment with percutaneous catheter-based closure of PFO to anticoagulant or antiplatelet therapy in patients with cryptogenic stroke or TIA and echocardiographically confirmed PFO or atrial septal defect (ASD) were eligible.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">1967 participants with prior stroke or TIA and echocardiographically confirmed PFO or ASD.</AbstractText><AbstractText Label="PRIMARY OUTCOME MEASURES" NlmCategory="METHODS">The primary outcome of interest was recurrence of ischaemic stroke. We utilised data from complete cases only for the primary endpoint and combined data from trials to estimate the pooled risk ratio (RR) and associated 95% CIs calculated using random effects models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 284 potentially eligible articles of which three RCTs including 2303 patients proved eligible and 1967 patients had complete data. Of the 1026 patients randomised to PFO closure and followed to study conclusion 22 experienced non-fatal ischaemic strokes, as did 34 of 941 patients randomised to medical therapy (risk ratio (RR) 0.61, 95% CI 0.34 to 1.07; heterogeneity: p=0.34, I(2)=8%, confidence in estimates low due to risk of bias and imprecision). Analyses for ischaemic stroke restricted to 'per-protocol' patients or patients with concomitant atrial septal aneurysm did not substantially change the observed RRs. Complication rates associated with either PFO closure or medical therapy were low.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Pooled data from three RCTs provides insufficient support that PFO closure is preferable to medical therapy for secondary prevention of cryptogenic stroke in patients with PFO.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Spencer</LastName><ForeName>Frederick A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Department of Medicine, Mcmaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopes</LastName><ForeName>Luciane C</ForeName><Initials>LC</Initials></Author><Author ValidYN="Y"><LastName>Kennedy</LastName><ForeName>Sean A</ForeName><Initials>SA</Initials></Author><Author ValidYN="Y"><LastName>Guyatt</LastName><ForeName>Gordon</ForeName><Initials>G</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>03</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010975">Platelet Aggregation Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054092" MajorTopicYN="N">Foramen Ovale, Patent</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="N">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010975" MajorTopicYN="N">Platelet Aggregation Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055502" MajorTopicYN="N">Secondary Prevention</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>3</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24607561</ArticleId><ArticleId IdType="pmc">PMC3948581</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2013-004282</ArticleId><ArticleId IdType="pii">bmjopen-2013-004282</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Webster MW, Chancellor AM, Smith HJ, et al. Patent foramen ovale in young stroke patients. Lancet 1988;2:11&#x2013;12</Citation><ArticleIdList><ArticleId IdType="pubmed">2898621</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechat P, Mas JL, Lascault G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988;318:1148&#x2013;52</Citation><ArticleIdList><ArticleId IdType="pubmed">3362165</ArticleId></ArticleIdList></Reference><Reference><Citation>Khairy P, O'Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann Intern Med 2003;139:753&#x2013;60</Citation><ArticleIdList><ArticleId IdType="pubmed">14597460</ArticleId></ArticleIdList></Reference><Reference><Citation>Furlan AJ, Reisman M, Massaro J, et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med 2012;366:991&#x2013;9</Citation><ArticleIdList><ArticleId IdType="pubmed">22417252</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll JD, Saver JL, Thaler DE, et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med 2013;368:1092&#x2013;100</Citation><ArticleIdList><ArticleId IdType="pubmed">23514286</ArticleId></ArticleIdList></Reference><Reference><Citation>Meier B, Kalesan B, Mattle HP, et al. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med 2013;368:1083&#x2013;91</Citation><ArticleIdList><ArticleId IdType="pubmed">23514285</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924&#x2013;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist G, et al. GRADE guidelines: 4. Rating the quality of evidence&#x2014;study limitations (risk of bias). J Clin Epidemiol 2011;64:407&#x2013;15</Citation><ArticleIdList><ArticleId IdType="pubmed">21247734</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines 6. Rating the quality of evidence&#x2014;imprecision. J Clin Epidemiol 2011;64:1283&#x2013;93</Citation><ArticleIdList><ArticleId IdType="pubmed">21839614</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines: 7. Rating the quality of evidence&#x2014;inconsistency. J Clin Epidemiol 2011;64:1294&#x2013;302</Citation><ArticleIdList><ArticleId IdType="pubmed">21803546</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines: 8. Rating the quality of evidence&#x2014;indirectness. J Clin Epidemiol 2011;64:1303&#x2013;10</Citation><ArticleIdList><ArticleId IdType="pubmed">21802903</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Montori V, et al. GRADE guidelines: 5. Rating the quality of evidence&#x2014;publication bias. J Clin Epidemiol 2011;64:1277&#x2013;82</Citation><ArticleIdList><ArticleId IdType="pubmed">21802904</ArticleId></ArticleIdList></Reference><Reference><Citation>Akl EA, Briel M, You JJ, et al. Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic review. BMJ 2012;344:e2809.</Citation><ArticleIdList><ArticleId IdType="pubmed">22611167</ArticleId></ArticleIdList></Reference><Reference><Citation>Murad MH, Montori VM, Walter SD, et al. Estimating risk difference from relative association measures in meta-analysis can infrequently pose interpretational challenges. J Clin Epidemiol 2009;62:865&#x2013;7</Citation><ArticleIdList><ArticleId IdType="pubmed">19230610</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng EH, Emenyonu N, Bwana MB, et al. Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa. JAMA 2008;300:506&#x2013;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3711416</ArticleId><ArticleId IdType="pubmed">18677022</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X, Briel M, Walter SD, et al. Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses. BMJ 2010;340:c117.</Citation><ArticleIdList><ArticleId IdType="pubmed">20354011</ArticleId></ArticleIdList></Reference><Reference><Citation>Pineda AM, Nascimento FO, Yang SC, et al. A meta-analysis of transcatheter closure of patent foramen ovale versus medical therapy for prevention of recurrent thromboembolic events in patients with cryptogenic cerebrovascular events. Catheter Cardiovasc Interv 2013;82:968.&#x2013;</Citation><ArticleIdList><ArticleId IdType="pubmed">23832613</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitsios GD, Thaler DE, Kent DM. Potentially large yet uncertain benefits: a meta-analysis of patent foramen ovale closure trials. Stroke 2013;44:2640&#x2013;3</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3821529</ArticleId><ArticleId IdType="pubmed">23868270</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan AR, Bin Abdulhak AA, Sheikh MA, et al. Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis. JACC Cardiovas Interv 2013;6:1316&#x2013;23</Citation><ArticleIdList><ArticleId IdType="pubmed">24139929</ArticleId></ArticleIdList></Reference><Reference><Citation>Aryal MR, Pradhan R, Pandit AA, et al. A &#x2018;teapot&#x2019; atrial septal aneurysm with spontaneous thrombus in an asymptomatic patient. Circulation 2013;128:e409&#x2013;10</Citation><ArticleIdList><ArticleId IdType="pubmed">24249622</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider B, Hanrath P, Vogel P, et al. Improved morphologic characterization of atrial septal aneurysm by transesophageal echocardiography: relation to cerebrovascular events. J AmColl Cardiol 1990;16:1000&#x2013;9</Citation><ArticleIdList><ArticleId IdType="pubmed">2212349</ArticleId></ArticleIdList></Reference><Reference><Citation>Cujec B, Mainra R, Johnson DH. Prevention of recurrent cerebral ischemic events in patients with patent foramen ovale and cryptogenic strokes or transient ischemic attacks. Can J Cardiol 1999;15:57&#x2013;64</Citation><ArticleIdList><ArticleId IdType="pubmed">10024860</ArticleId></ArticleIdList></Reference><Reference><Citation>Orgera MA, O'Malley PG, Taylor AJ. Secondary prevention of cerebral ischemia in patent foramen ovale: systematic review and meta-analysis. South Med J 2001;94:699&#x2013;703</Citation><ArticleIdList><ArticleId IdType="pubmed">11531177</ArticleId></ArticleIdList></Reference><Reference><Citation>Homma S, Sacco RL, Di Tullio MR, et al. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 2002;105:2625&#x2013;31</Citation><ArticleIdList><ArticleId IdType="pubmed">12045168</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35787764</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>06</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1522-6662</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>31</Day></PubDate></JournalIssue><Title>The heart surgery forum</Title><ISOAbbreviation>Heart Surg Forum</ISOAbbreviation></Journal><ArticleTitle>Comparative Efficacy of Local and General Anesthesia for Transcatheter Aortic Valve Implantation: A Meta-Analysis and Systematic Review.</ArticleTitle><Pagination><StartPage>E364</StartPage><EndPage>E373</EndPage><MedlinePgn>E364-E373</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1532/hsf.4631</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">This meta-analysis aimed to compare the potential effects of local anesthesia (LA) and general anesthesia (GA) for transcatheter aortic valve implantation (TAVI).</AbstractText><AbstractText Label="MEASUREMENTS" NlmCategory="METHODS">All relevant studies were searched from Pubmed, EMbase, Web of Science, and the Cochrane Library (January 1, 2016, to June 1, 2021). The main outcomes of this literature meta-analysis were 30-day mortality, procedural time, new pacemaker implantation, total stay in the hospital, use of the vasoactive drug, and intra-and postoperative complications and emergencies, including conversion to open, myocardial infarction, pulmonary complication, vascular complication, renal injury/failure, stroke, transesophageal echocardiography, life-threatening/major bleeding, cardiac tamponade, and emergency PCI. Pooled risk ratio (RR) and mean difference (MD) together with a 95% confidence interval (CI) were calculated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 17 studies, including 20938 patients, in the final analysis, fulfilled the inclusion criteria. Intra-and postoperative complications (myocardial infarction, vascular complication, renal injury/failure, stroke, and cardiac tamponade) undergoing TAVI in severe AS patients under GA do not offer a significant difference compared with LA. No differences were observed between LA and GA for new pacemaker implantation, total stay in the hospital, transesophageal echocardiography, and emergency PCI. LA has lower mortality compared with GA (RR 0.69, P = 0.600), pulmonary complications (RR 0.54, P = 0.278), life-threatening/major bleeding (RR 0.85, P = 0.855), and lower times of conversion to open (RR 0.22, P = 0.746). LA has many advantages, including a shorter procedure duration (MD=-0.38, P = 0.000) and reduction of the use of the vasoactive drug (RR 0.57, P = 0.000).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">For TAVI, both LA with or without sedation and GA are feasible and safe. LA appears a feasible alternative to GA for AS patients undergoing TAVI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Lulu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Third Affiliated Hospital of Soochow University, Changzhou 213000, China. 871758700@qq.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Baihan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>NO.971 Hospital of The People's Liberation Army Navy, China. 871758700@qq.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chao</LastName><ForeName>Ce</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, The Third Affiliated Hospital of Soochow University, Changzhou 213000, China. 871758700@qq.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, The Third Affiliated Hospital of Soochow University, Changzhou 213000, China. 871758700@qq.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiaoying</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, The Third Affiliated Hospital of Soochow University, Changzhou 213000, China. 871758700@qq.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Jiang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Third Affiliated Hospital of Soochow University, Changzhou 213000, China. 871758700@qq.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Heart Surg Forum</MedlineTA><NlmUniqueID>100891112</NlmUniqueID><ISSNLinking>1098-3511</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000772" MajorTopicYN="Y">Anesthesia, Local</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001024" MajorTopicYN="N">Aortic Valve Stenosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002305" MajorTopicYN="N">Cardiac Tamponade</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062645" MajorTopicYN="N">Percutaneous Coronary Intervention</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065467" MajorTopicYN="Y">Transcatheter Aortic Valve Replacement</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>5</Day><Hour>17</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35787764</ArticleId><ArticleId IdType="doi">10.1532/hsf.4631</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31487905</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>05</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2072-6643</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>9</Issue><PubDate><Year>2019</Year><Month>Sep</Month><Day>04</Day></PubDate></JournalIssue><Title>Nutrients</Title><ISOAbbreviation>Nutrients</ISOAbbreviation></Journal><ArticleTitle>Effects of Vitamin C on Organ Function in Cardiac Surgery Patients: A Systematic Review and Meta-Analysis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2103</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/nu11092103</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Cardiac surgery is associated with oxidative stress and systemic inflammation, which both contribute to postoperative organ dysfunction. Vitamin C is a pleiotropic, antioxidant, and potentially organ-protective micronutrient. Past clinical trials and meta-analyses have focused predominantly on occurrence of postoperative atrial fibrillation. Therefore, we investigated the influence of perioperative vitamin C administration on clinically relevant parameters closer related to the patient's recovery, especially organ function, and overall outcomes after cardiac surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Randomized controlled trials (RCTs) comparing perioperative vitamin C administration versus placebo or standard of care in adult patients undergoing cardiac surgery were identified through systematic searches in Pubmed, EMBASE, and CENTRAL on 23 November 2018. Published and unpublished data were included. Assessed outcomes include organ function after cardiac surgery, adverse events, in-hospital mortality, intensive care unit, and hospital length-of-stay. Data was pooled only when appropriate.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 19 RCTs with 2008 patients were included in this meta-analysis. Vitamin C significantly decreased the incidence of atrial fibrillation (<i>p</i> = 0.008), ventilation time (<i>p</i> &lt; 0.00001), ICU length-of-stay (<i>p</i> = 0.004), and hospital length-of-stay (<i>p</i> &lt; 0.0001). However, on average, vitamin C had no significant effects on in-hospital mortality (<i>p</i> = 0.76), or on the incidence of stroke (<i>p</i> = 0.82). High statistical heterogeneity was observed in most analyses.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Vitamin C impacts clinically and economically important outcomes, such as ICU and hospital length-of-stay, duration of mechanical ventilation and lowers the incidence of atrial fibrillation. Due to missing reports on organ dysfunction, this meta-analysis cannot answer the question, if vitamin C can improve single- or multiorgan function after cardiac surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hill</LastName><ForeName>Aileen</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7013-3357</Identifier><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Medical Faculty RWTH Aachen, D-52074 Aachen, Germany. ahill@ukaachen.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Medical Faculty RWTH Aachen, D-52074 Aachen, Germany. ahill@ukaachen.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>3CARE-Cardiovascular Critical Care and Anesthesia Evaluation and Research, D-52074 Aachen, Germany. ahill@ukaachen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clasen</LastName><ForeName>Kai C</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Medical Faculty RWTH Aachen, D-52074 Aachen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Medical Faculty RWTH Aachen, D-52074 Aachen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>3CARE-Cardiovascular Critical Care and Anesthesia Evaluation and Research, D-52074 Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wendt</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Medical Faculty RWTH Aachen, D-52074 Aachen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>3CARE-Cardiovascular Critical Care and Anesthesia Evaluation and Research, D-52074 Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Majoros</LastName><ForeName>&#xc1;d&#xe1;m G</ForeName><Initials>&#xc1;G</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Medical Faculty RWTH Aachen, D-52074 Aachen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Student of the Medical Faculty RWTH Aachen University, D-52074 Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stoppe</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Medical Faculty RWTH Aachen, D-52074 Aachen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>3CARE-Cardiovascular Critical Care and Anesthesia Evaluation and Research, D-52074 Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adhikari</LastName><ForeName>Neill K J</ForeName><Initials>NKJ</Initials><Identifier Source="ORCID">0000-0003-4038-5382</Identifier><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON M4N 3M5, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heyland</LastName><ForeName>Daren K</ForeName><Initials>DK</Initials><AffiliationInfo><Affiliation>Clinical Evaluation Research Unit, Kingston General Hospital, Kingston, CA K7L 2V7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benstoem</LastName><ForeName>Carina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Medical Faculty RWTH Aachen, D-52074 Aachen, Germany. cbenstoem@ukaachen.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>3CARE-Cardiovascular Critical Care and Anesthesia Evaluation and Research, D-52074 Aachen, Germany. cbenstoem@ukaachen.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Nutrients</MedlineTA><NlmUniqueID>101521595</NlmUniqueID><ISSNLinking>2072-6643</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014815">Vitamins</NameOfSubstance></Chemical><Chemical><RegistryNumber>PQ6CK8PD0R</RegistryNumber><NameOfSubstance UI="D001205">Ascorbic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Nutrients. 2020 Dec 21;12(12):E3910. doi: 10.3390/nu12123910.</RefSource><PMID Version="1">33371532</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001205" MajorTopicYN="N">Ascorbic Acid</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="N">Heart Diseases</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014815" MajorTopicYN="N">Vitamins</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">antioxidant</Keyword><Keyword MajorTopicYN="N">ascorbic acid</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">organ dysfunction</Keyword><Keyword MajorTopicYN="N">oxidative stress</Keyword><Keyword MajorTopicYN="N">reperfusion injury</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword><Keyword MajorTopicYN="N">vitamin</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest that may be perceived as inappropriately influencing the representation or interpretation of reported research results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31487905</ArticleId><ArticleId IdType="pmc">PMC6769534</ArticleId><ArticleId IdType="doi">10.3390/nu11092103</ArticleId><ArticleId IdType="pii">nu11092103</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Levy J.H., Tanaka K.A. Inflammatory Response to Cardiopulmonary Bypass. Ann. Thorac. Surg. 2003;75:S715&#x2013;S720. doi: 10.1016/S0003-4975(02)04701-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0003-4975(02)04701-X</ArticleId><ArticleId IdType="pubmed">12607717</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard H. Identification of inflammatory mediators and their modulation by strategies for the management of the systemic inflammatory response during cardiac surgery. J. Cardiothorac. Vasc. Anesth. 2013;27:983&#x2013;1033.</Citation><ArticleIdList><ArticleId IdType="pubmed">23276596</ArticleId></ArticleIdList></Reference><Reference><Citation>Landis R.C., Brown J.R., Fitzgerald D., Likosky D.S., Shore-Lesserson L., Baker R.A., Hammon J.W. Attenuating the systemic inflammatory response to adult cardiopulmonary bypass: A critical review of the evidence base. J. Extra Corp. Technol. 2014;46:197&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4566828</ArticleId><ArticleId IdType="pubmed">26357785</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill A., Wendt S., Benstoem C., Neubauer C., Meybohm P., Langlois P., Adhikari N.K., Heyland D.K., Stoppe C. Vitamin c to improve organ dysfunction in cardiac surgery patients-review and pragmatic approach. Nutrients. 2018;10:974. doi: 10.3390/nu10080974.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu10080974</ArticleId><ArticleId IdType="pmc">PMC6115862</ArticleId><ArticleId IdType="pubmed">30060468</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoppe C., McDonald B., Benstoem C., Elke G., Meybohm P., Whitlock R., Fremes S., Fowler R., Lamarche Y., Jiang X., et al. Evaluation of persistent organ dysfunction plus death as a novel composite outcome in cardiac surgical patients. J. Cardiothorac. Vasc. Anesth. 2016;30:30&#x2013;38. doi: 10.1053/j.jvca.2015.07.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2015.07.035</ArticleId><ArticleId IdType="pubmed">26847748</ArticleId></ArticleIdList></Reference><Reference><Citation>Frei B., Stocker R., England L., Ames B.N. Ascorbate: The most effective antioxidant in human blood plasma. Adv. Exp. Med. Biol. 1990;264:155&#x2013;163.</Citation><ArticleIdList><ArticleId IdType="pubmed">2244489</ArticleId></ArticleIdList></Reference><Reference><Citation>Oudemans-van Straaten H.M., Spoelstra-de Man A.M., de Waard M.C. Vitamin c revisited. Crit. Care. 2014;18:460. doi: 10.1186/s13054-014-0460-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-014-0460-x</ArticleId><ArticleId IdType="pmc">PMC4423646</ArticleId><ArticleId IdType="pubmed">25185110</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger M.M., Oudemans-van Straaten H.M. Vitamin c supplementation in the critically ill patient. Curr. Opin. Clin. Nutr. Metab. Care. 2015;18:193&#x2013;201. doi: 10.1097/MCO.0000000000000148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCO.0000000000000148</ArticleId><ArticleId IdType="pubmed">25635594</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr A.C., Maggini S. Vitamin c and immune function. Nutrients. 2017;9:1211. doi: 10.3390/nu9111211.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu9111211</ArticleId><ArticleId IdType="pmc">PMC5707683</ArticleId><ArticleId IdType="pubmed">29099763</ArticleId></ArticleIdList></Reference><Reference><Citation>Spoelstra-de Man A.M.E., Elbers P.W.G., Oudemans-van Straaten H.M. Making sense of early high-dose intravenous vitamin c in ischemia/reperfusion injury. Crit. Care. 2018;22:70. doi: 10.1186/s13054-018-1996-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-018-1996-y</ArticleId><ArticleId IdType="pmc">PMC5861638</ArticleId><ArticleId IdType="pubmed">29558975</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker W.L., Coleman C.I. Meta-analysis of ascorbic acid for prevention of postoperative atrial fibrillation after cardiac surgery. Am. J. Health Syst. Pharm. 2016;73:2056&#x2013;2066. doi: 10.2146/ajhp160066.</Citation><ArticleIdList><ArticleId IdType="doi">10.2146/ajhp160066</ArticleId><ArticleId IdType="pubmed">27806938</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymeropoulos E., Bagos P., Papadimitriou M., Rizos I., Patsouris E., &#x3a4;oumpoulis I. Vitamin c for the prevention of postoperative atrial fibrillation after cardiac surgery: A meta-analysis. Adv. Pharm. Bull. 2016;6:243. doi: 10.15171/apb.2016.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.15171/apb.2016.033</ArticleId><ArticleId IdType="pmc">PMC4961983</ArticleId><ArticleId IdType="pubmed">27478787</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemilae H., Suonsyrjae T. Vitamin c for preventing atrial fibrillation in high risk patients: A systematic review and meta-analysis. BMC Cardiovasc. Disord. 2017;17:49. doi: 10.1186/s12872-017-0478-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12872-017-0478-5</ArticleId><ArticleId IdType="pmc">PMC5286679</ArticleId><ArticleId IdType="pubmed">28143406</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu X., Yuan L., Wang H., Li C., Cai J., Hu Y., Ma C. Efficacy and safety of vitamin c for atrial fibrillation after cardiac surgery: A meta-analysis with trial sequential analysis of randomized controlled trials. Int. J. Surg. 2017;37:58&#x2013;64. doi: 10.1016/j.ijsu.2016.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2016.12.009</ArticleId><ArticleId IdType="pubmed">27956113</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi R., Li Z.H., Chen D., Wu Q.C., Zhou X.L., Tie H.T. Sole and combined vitamin c supplementation can prevent postoperative atrial fibrillation after cardiac surgery: A systematic review and meta-analysis of randomized controlled trials. Clin. Cardiol. 2018;41:871&#x2013;878. doi: 10.1002/clc.22951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clc.22951</ArticleId><ArticleId IdType="pmc">PMC6489881</ArticleId><ArticleId IdType="pubmed">29603289</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J.P.T., Green S., editors. Cochrane Handbook for Systematic Reviews of Interventions.  [(accessed on 23 November 2018)];2011  The Cochrane Collaboration. Available online:  http://handbook.cochrane.org.</Citation></Reference><Reference><Citation>Deeks J.J., Higgins J.P.T., Altman D.G. Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration and John Wiley &amp; Sons Ltd.; Chichester, England: 2008. [(accessed on 23 November 2018)]. Analysing data and undertaking meta-analyses; pp. 243&#x2013;296. (Cochrane Book Series). Available online:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/9780470712184.ch9</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557&#x2013;560. doi: 10.1136/bmj.327.7414.557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadeghpour A., Alizadehasl A., Kyavar M., Sadeghi T., Moludi J., Gholizadeh F., Totonchi Z., Ghadrdoost B. Impact of vitamin c supplementation on post-cardiac surgery icu and hospital length-of-stay. Anesth. Pain Med. 2015;5:e25337. doi: 10.5812/aapm.25337.</Citation><ArticleIdList><ArticleId IdType="doi">10.5812/aapm.25337</ArticleId><ArticleId IdType="pmc">PMC4350190</ArticleId><ArticleId IdType="pubmed">25789244</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammed K.A.M.D., Hany M.E.M.D., Moataz E.R.M.D., Hani M.M.M.S.C. Role of ascorbic acid in reduction of the incidence of the atrial fibrillation in patients under b-blocker and undergoing coronary artery bypass graft operation in early post-operative period. J. Egypt. Soc. Cardio Thorac. Surg. 2017;25:198&#x2013;203.</Citation></Reference><Reference><Citation>Bakr H., Elsayegh T., Fatah M.A.E. Role of ascorbic acid and statin in reduction of the incidence of the atrial fibrillation in patients under b-blocker and undergoing coronary artery bypass graft operation in early post-operative period. J. Saudi Heart Assoc. 2015;27:299&#x2013;300. doi: 10.1016/j.jsha.2015.05.183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsha.2015.05.183</ArticleId></ArticleIdList></Reference><Reference><Citation>Healy R.M., Day D., van Gorder C. Ascorbic acid utilization for atrial-fibrillation prophylaxis post coronary-artery-bypass graft and valve replacement surgeries: An interim analysis of a prospective, randomized study. Pharmacotherapy. 2010;30:445e&#x2013;446e.</Citation></Reference><Reference><Citation>Van Wagoner D.R., Palumbo R., Li J., Carnes C.A., Gillinov A., McCarthy P.M., Chung M.K. Supplemental Vitamin C Did Not Reduce the Incidence of Atrial Arrhythmia following Cardiac Bypass Surgery.  [(accessed on 4 December 2016)];Heart Rhythm Soc. 2003  Available online:  http://www.mv.helsinki.fi/home/hemila/CAF/vanWagoner2003.pdf.</Citation></Reference><Reference><Citation>Antonic M., Lipovec R., Gregorcic F., Juric P., Kosir G. Perioperative ascorbic acid supplementation does not reduce the incidence of postoperative atrial fibrillation in on-pump coronary artery bypass graft patients. J. Cardiol. 2016;69:98&#x2013;102. doi: 10.1016/j.jjcc.2016.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jjcc.2016.01.010</ArticleId><ArticleId IdType="pubmed">26917198</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonic M. Effect of ascorbic acid on postoperative acute kidney injury in coronary artery bypass graft patients: A pilot study. Heart Surg. Forum. 2017;20:E214&#x2013;E218. doi: 10.1532/hsf.1811.</Citation><ArticleIdList><ArticleId IdType="doi">10.1532/hsf.1811</ArticleId><ArticleId IdType="pubmed">29087285</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjordahl P.M., Helmer S.D., Gosnell D.J., Wemmer G.E., O&#x2019;Hara W.W., Milfeld D.J. Perioperative supplementation with ascorbic acid does not prevent atrial fibrillation in coronary artery bypass graft patients. Am. J. Surg. 2012;204:862&#x2013;867. doi: 10.1016/j.amjsurg.2012.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2012.03.012</ArticleId><ArticleId IdType="pubmed">23022248</ArticleId></ArticleIdList></Reference><Reference><Citation>Colby J.A., Chen W.T., Baker W.L., Coleman C.I., Reinhart K., Kluger J., White C.M. Effect of ascorbic acid on inflammatory markers after cardiothoracic surgery. Am. J. Health Syst. Pharm. 2011;68:1632&#x2013;1639. doi: 10.2146/ajhp100703.</Citation><ArticleIdList><ArticleId IdType="doi">10.2146/ajhp100703</ArticleId><ArticleId IdType="pubmed">21856809</ArticleId></ArticleIdList></Reference><Reference><Citation>Dehghani M.R., Majidi N., Rahmani A., Asgari B., Rezaei Y. Effect of oral vitamin c on atrial fibrillation development after isolated coronary artery bypass grafting surgery: A prospective randomized clinical trial. Cardiol. J. 2014;21:492&#x2013;499. doi: 10.5603/CJ.a2013.0154.</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/CJ.a2013.0154</ArticleId><ArticleId IdType="pubmed">24293167</ArticleId></ArticleIdList></Reference><Reference><Citation>Demirag K., Askar F.Z., Uyar M., Cevik A., Ozmen D., Mutaf I., Bayindir O. The protective effects of high dose ascorbic acid and diltiazem on myocardial ischaemia-reperfusion injury. Middle East J. Anaesthesiol. 2001;16:67&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">11281049</ArticleId></ArticleIdList></Reference><Reference><Citation>Donovan P.C., Kramer R.S. Prophylaxis to Reduce Postoperative Atrial Fibrillation in Cardiac Surgery, nct00953212.  [(accessed on 23 November 2018)];ClinicalTrials.Gov. 2012  Available online:  https://clinicaltrials.gov/ct2/show/NCT00953212.</Citation></Reference><Reference><Citation>Eslami M., Badkoubeh R.S., Mousavi M., Radmehr H., Salehi M., Tavakoli N., Avadi M.R. Oral ascorbic acid in combination with beta-blockers is more effective than beta-blockers alone in the prevention of atrial fibrillation after coronary artery bypass grafting. Tex. Heart Inst. J. 2007;34:268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1995047</ArticleId><ArticleId IdType="pubmed">17948074</ArticleId></ArticleIdList></Reference><Reference><Citation>Jouybar R., Kabgani H., Kamalipour H., Shahbazi S., Allahyary E., Rasouli M., Akhlagh S.H., Shafa M., Ghazinoor M., Moeinvaziri M.T., et al. The perioperative effect of ascorbic acid on inflammatory response in coronary artery bypass graft surgery; a randomized controlled trial coronary artery bypass graft surgery. Int. Cardiovasc. Res. J. 2012;6:13&#x2013;17.</Citation></Reference><Reference><Citation>Knodell R.G., Tate M.A., Akl B.F., Wilson J.W. Vitamin c prophylaxis for posttransfusion hepatitis: Lack of effect in a controlled trial. Am. J. Clin. Nutr. 1981;34:20&#x2013;23. doi: 10.1093/ajcn/34.1.20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/34.1.20</ArticleId><ArticleId IdType="pubmed">7446455</ArticleId></ArticleIdList></Reference><Reference><Citation>Papoulidis P., Ananiadou O., Chalvatzoulis E., Ampatzidou F., Koutsogiannidis C., Karaiskos T., Madesis A., Drossos G. The role of ascorbic acid in the prevention of atrial fibrillation after elective on-pump myocardial revascularization surgery: A single-center experience&#x2013;a pilot study. Interact. Cardiovasc. Thorac. Surg. 2011;12:121&#x2013;124. doi: 10.1510/icvts.2010.240473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1510/icvts.2010.240473</ArticleId><ArticleId IdType="pubmed">21098510</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymeropoulos E. Vitamin C for Prophylaxis of Post-Operative Atrial Fibrillation in on-Pump Cardiac Surgery Procedures, nct01107730.  [(accessed on 23 November 2018)];ClincalTrials Gov. 2015  Available online:  https://clinicaltrials.gov/ct2/show/NCT00953212.</Citation></Reference><Reference><Citation>Safaei N., Babaei H., Azarfarin R., Jodati A.R., Yaghoubi A., Sheikhalizadeh M.A. Comparative effect of grape seed extract (vitis vinifera) and ascorbic acid in oxidative stress induced by on-pump coronary artery bypass surgery. Ann. Cardiac. Anaesth. 2017;20:45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5290695</ArticleId><ArticleId IdType="pubmed">28074795</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarzaeem M., Shayan N. Vitamin c in prevention of atrial fibrillation after coronary artery bypass graft: Double blind randomized clinical trial. Tehran Univ. Med. J. 2014;71:2014.</Citation></Reference><Reference><Citation>Geng J., Qian J., Si W., Cheng H., Ji F., Shen Z. The clinical benefits of perioperative antioxidant vitamin therapy in patients undergoing cardiac surgery: A meta-analysis. Interact. Cardiovasc. Thoracic. Surg. 2017;25:966&#x2013;974. doi: 10.1093/icvts/ivx178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivx178</ArticleId><ArticleId IdType="pubmed">28645181</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemilae H. Vitamin c and infections. Nutrients. 2017;9:339. doi: 10.3390/nu9040339.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu9040339</ArticleId><ArticleId IdType="pmc">PMC5409678</ArticleId><ArticleId IdType="pubmed">28353648</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali-Hassan-Sayegh S., Mirhosseini S.J., Rezaeisadrabadi M., Dehghan H.R., Sedaghat-Hamedani F., Kayvanpour E., Popov A.F., Liakopoulos O.J. Antioxidant supplementations for prevention of atrial fibrillation after cardiac surgery: An updated comprehensive systematic review and meta-analysis of 23 randomized controlled trials. Interact. Cardiovasc. Thoracic. Surg. 2014;18:646&#x2013;654. doi: 10.1093/icvts/ivu020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivu020</ArticleId><ArticleId IdType="pubmed">24556447</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoppe C., Ney J., Lomivorotov V.V., Efremov S.M., Benstoem C., Hill A., Nesterova E., Laaf E., Goetzenich A., McDonald B., et al. Prediction of prolonged icu stay in cardiac surgery patients as a useful method to identify nutrition risk in cardiac surgery patients: A post hoc analysis of a prospective observational study. JPEN. J. Parenter. Enteral Nutr. 2019;43:768&#x2013;779. doi: 10.1002/jpen.1486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jpen.1486</ArticleId><ArticleId IdType="pmc">PMC7379574</ArticleId><ArticleId IdType="pubmed">30506711</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali- Hasan- Al- Saegh S., Mirhosseini S.J., Tahernejad M., Mahdavi P., Shahidzadeh A., Karimi-Bondarabadi A.A., Dehghan A.M., Rahimizadeh E., Haddad F., Ghodratipour Z., et al. Impact of antioxidant supplementations on cardio-renal protection in cardiac surgery: An updated and comprehensive meta-analysis and systematic review. Cardiovasc. Ther. 2016;34:360&#x2013;370. doi: 10.1111/1755-5922.12207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1755-5922.12207</ArticleId><ArticleId IdType="pubmed">27344977</ArticleId></ArticleIdList></Reference><Reference><Citation>Baines M., Shenkin A. Use of antioxidants in surgery: A measure to reduce postoperative complications. Curr. Opin. Clin. Nutr. Metab. Care. 2002;5:665&#x2013;670. doi: 10.1097/00075197-200211000-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00075197-200211000-00009</ArticleId><ArticleId IdType="pubmed">12394642</ArticleId></ArticleIdList></Reference><Reference><Citation>Carnes C.A., Chung M.K., Nakayama T., Nakayama H., Baliga R.S., Piao S., Kanderian A., Pavia S., Hamlin R.L., McCarthy P.M., et al. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ. Res. 2001;89:e32&#x2013;e38. doi: 10.1161/hh1801.097644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/hh1801.097644</ArticleId><ArticleId IdType="pubmed">11557745</ArticleId></ArticleIdList></Reference><Reference><Citation>Das D., Sen C., Goswami A. Effect of vitamin c on adrenal suppression by etomidate induction in patients undergoing cardiac surgery: A randomized controlled trial. Ann. Car. Anaesth. 2016;19:410. doi: 10.4103/0971-9784.185522.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0971-9784.185522</ArticleId><ArticleId IdType="pmc">PMC4971968</ArticleId><ArticleId IdType="pubmed">27397444</ArticleId></ArticleIdList></Reference><Reference><Citation>Dingchao H., Zhiduan Q., Liye H., Xiaodong F. The protective effects of high-dose ascorbic acid on myocardium against reperfusion injury during and after cardiopulmonary bypass. Thorac. Cardiovasc. Surg. 1994;42:276&#x2013;278. doi: 10.1055/s-2007-1016504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2007-1016504</ArticleId><ArticleId IdType="pubmed">7863489</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebade A., Taha W.S., Saleh R.H., Fawzy F. Ascorbic acid versus magnesium for the prevention of atrial fibrillation after coronary artery bypass grafting surgery. Egypt. J. Cardiothorac. Anesth. 2014;8:59. doi: 10.4103/1687-9090.143259.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1687-9090.143259</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S., Benjo A.M., Pamidimukala C.K., Javed F., Garcia W., Macedo F.Y., Garcia D.C., Santana O., Nascimeto F.O., Pierce M., et al. Vitamin c decreases atrial fibrillation in cardiac surgery patients but vitamin e may decrease response: A randomized-controlled trial meta-analysis. Circ. Cardiovasc. Qual. Outcomes. 2013;6 doi: 10.1161/circoutcomes.6.suppl_1.A288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circoutcomes.6.suppl_1.A288</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C.C. Changes of creatine phosphokinase and malondialdehyde in the serum and clinical use of large doses of vitamin c following open heart surgery. Zhonghua Wai Ke Za zhi [Chin. J. Surg.] 1990;28:16&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">2364809</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T., Li G. Antioxidant interventions as novel preventive strategies for postoperative atrial fibrillation. Int. J. Cardiol. 2010;145:140&#x2013;142. doi: 10.1016/j.ijcard.2009.06.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2009.06.054</ArticleId><ArticleId IdType="pubmed">19616323</ArticleId></ArticleIdList></Reference><Reference><Citation>Moludi J., Keshavarz S., Pakzad R., Sedghi N., Sadeghi T., Alimoradi F. Effect of vitamin c supplementation in the prevention of atrial fibrillation. Tehran Univ. Med. J. 2016;73:791&#x2013;797.</Citation></Reference><Reference><Citation>Oktar G.L., Sinci V., Kalaycioglu S., Soncul H., G&#xf6;kg&#xf6;z L., Halit V., Ers&#xf6;z A. Biochemical and hemodynamic effects of ascorbic acid and alpha-tocopherol in coronary artery surgery. Scand. J. Clin. Lab. Invest. 2001;61:621&#x2013;629.</Citation><ArticleIdList><ArticleId IdType="pubmed">11768322</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasoli S., Kourliouros A., Harling L., Athanasiou T. Does prophylactic therapy with antioxidant vitamins have an effect on atrial fibrillation following cardiac surgery? Interact. Cardiovasc. Thorac. Surg. 2011;13:82&#x2013;85. doi: 10.1510/icvts.2011.268326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1510/icvts.2011.268326</ArticleId><ArticleId IdType="pubmed">21525032</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigo R., Cereceda M., Castillo R., Asenjo R., Zamorano J., Araya J., Castillo-Koch R., Espinoza J., Larra&#xed;n E. Prevention of atrial fibrillation following cardiac surgery: Basis for a novel therapeutic strategy based on non-hypoxic myocardial preconditioning. Pharmacol. Ther. 2008;118:104&#x2013;127. doi: 10.1016/j.pharmthera.2008.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2008.01.005</ArticleId><ArticleId IdType="pubmed">18346791</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigo R., Cereceda M., Castillo R., Asenjo R., Zamorano J., Araya J., Castillo-Koch R., Espinoza J., Larra&#xed;n E. Use of vitamins c and e as a prophylactic therapy to prevent postoperative atrial fibrillation. Int. J. Cardiol. 2009;138:221&#x2013;228. doi: 10.1016/j.ijcard.2009.04.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2009.04.043</ArticleId><ArticleId IdType="pubmed">19446899</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebrova T.I., Shipulin V.M., Afanas&#x2019;ev S.A., Vorob&#x2019;eva E.V., Ki&#x12d;ko O.G. The experience of the application of ascorbinic acid as antioxidant after coronary artery surgery with use of cardiopulmonary bypass. Kardiologiia. 2012;52:73&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">22839718</ArticleId></ArticleIdList></Reference><Reference><Citation>Sisto T., Paajanen H., Mets&#xe4;-Ketel&#xe4; T., Harmoinen A., Nordback I., Tarkka M. Pretreatment with antioxidants and allopurinol diminishes cardiac onset events in coronary artery bypass grafting. Ann. Thorac. Surg. 1995;59:1519&#x2013;1523. doi: 10.1016/0003-4975(95)00197-S.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0003-4975(95)00197-S</ArticleId><ArticleId IdType="pubmed">7771834</ArticleId></ArticleIdList></Reference><Reference><Citation>Samadikhah J., Golzari S.E.J., Sabermarouf B., karimzadeh I., Tizro P., Khanli H.M., Ghabili K. Efficacy of combination therapy of statin and vitamin c in comparison with statin in the prevention of post-cabg atrial fibrillation. Adv. Pharm. Bull. 2014;4:9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3885376</ArticleId><ArticleId IdType="pubmed">24409416</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30122331</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>04</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2165</ISSN><JournalIssue CitedMedium="Internet"><Volume>56</Volume><Issue>5</Issue><PubDate><Year>2018</Year><Month>Nov</Month></PubDate></JournalIssue><Title>European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery</Title><ISOAbbreviation>Eur J Vasc Endovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Effect of Left Subclavian Artery Revascularisation in Thoracic Endovascular Aortic Repair: A Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>644</StartPage><EndPage>651</EndPage><MedlinePgn>644-651</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejvs.2018.07.018</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1078-5884(18)30445-3</ELocationID><Abstract><AbstractText Label="OBJECTIVE/BACKGROUND" NlmCategory="OBJECTIVE">Thoracic endovascular aortic repair (TEVAR) is an emerging therapy for thoracic aortic pathologies. However, the role of left subclavian artery (LSA) revascularisation in patients with LSA coverage in TEVAR has not been established. A systematic review and meta-analysis was done to investigate the effect of LSA revascularisation in TEVAR when the LSA was covered.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PubMed, Embase, and the Cochrane Library were searched to find relevant randomised controlled trials (RCTs) and cohort studies. The Cochrane Risk of Bias Tool and Newcastle-Ottawa Scale was used to evaluate the methodological quality of RCTs and cohort studies respectively. Relative risks (RRs) with 95% confidence intervals (CIs) were calculated to express differences for dichotomous outcomes. Random effects models were used to combine outcomes for studies with I<sup>2</sup> &gt; 50%; otherwise, fixed effects models were used. Subgroup analyses and sensitivity analyses were performed to further validate the results.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Sixteen cohort studies with a total of 2591 patients were included in this systematic review and meta-analysis. The average score of the included studies was 7.56. Of the included patients, the peri-operative stroke rate was 6.8% (n&#xa0;=&#xa0;176/2591). The peri-operative stroke rates of the with and without LSA revascularisation groups were 5.4% and 7.8%, respectively. Compared with no LSA revascularisation, patients with LSA revascularisation had a significantly lower peri-operative stroke rate (RR 0.61; 95% CI 0.45-0.82; I<sup>2</sup>&#xa0;=&#xa0;20%) and peri-operative spinal cord ischaemia (SCI) rate (RR 0.59; 95% CI 0.39-0.90; I<sup>2</sup>&#xa0;=&#xa0;0). No significant difference was found between the with and without LSA revascularisation groups with respect to peri-operative mortality (RR 0.86; 95% CI 0.60-1.21; I<sup>2</sup>&#xa0;=&#xa0;35%) and peri-operative paraplegia (RR 0.81; 95% CI 0.45-1.44; I<sup>2</sup>&#xa0;=&#xa0;17%).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The results of this review reveal that LSA revascularisation was associated with significantly lower peri-operative stroke and SCI rates. LSA revascularisation should be recommended for patients with LSA coverage in TEVAR. High quality RCTs are needed to further validate the conclusion.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Qun</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xiao M</ForeName><Initials>XM</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Han</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Qiu N</ForeName><Initials>QN</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Xiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China. Electronic address: qinxiaoyahoo@sina.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>08</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Vasc Endovasc Surg</MedlineTA><NlmUniqueID>9512728</NlmUniqueID><ISSNLinking>1078-5884</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001013" MajorTopicYN="N">Aorta, Thoracic</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017545" MajorTopicYN="N">Aortic Aneurysm, Thoracic</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019917" MajorTopicYN="N">Blood Vessel Prosthesis Implantation</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="Y">Endovascular Procedures</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013348" MajorTopicYN="N">Subclavian Artery</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="Y">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aorta</Keyword><Keyword MajorTopicYN="N">Endovascular procedures</Keyword><Keyword MajorTopicYN="N">Revascularisation</Keyword><Keyword MajorTopicYN="N">Stroke</Keyword><Keyword MajorTopicYN="N">Subclavian artery</Keyword><Keyword MajorTopicYN="N">Thoracic</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30122331</ArticleId><ArticleId IdType="doi">10.1016/j.ejvs.2018.07.018</ArticleId><ArticleId IdType="pii">S1078-5884(18)30445-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33564908</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1438-8359</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of anesthesia</Title><ISOAbbreviation>J Anesth</ISOAbbreviation></Journal><ArticleTitle>Intraoperative hypotension and perioperative acute ischemic stroke in patients having major elective non-cardiovascular non-neurological surgery.</ArticleTitle><Pagination><StartPage>246</StartPage><EndPage>253</EndPage><MedlinePgn>246-253</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00540-021-02901-3</ELocationID><Abstract><AbstractText Label="PURPOSE">The association between intraoperative hypotension and perioperative acute ischemic stroke is not well described. We hypothesized that intraoperative hypotension would be associated with perioperative acute ischemic stroke.</AbstractText><AbstractText Label="METHODS">Four-year retrospective cohort study of elective non-cardiovascular, non-neurological surgical patients. Characteristics of patients who had perioperative acute ischemic stroke were compared against those of patients who did not have acute ischemic stroke. Multivariable logistic regression was used to determine whether hypotension was independently associated with increased odds of perioperative acute ischemic stroke.</AbstractText><AbstractText Label="RESULTS">Thirty-four of 9816 patients (0.3%) who met study inclusion criteria had perioperative acute ischemic stroke. Stroke patients were older and had more comorbidities including hypertension, coronary artery disease, diabetes mellitus, active tobacco use, chronic obstructive pulmonary disease, cerebral vascular disease, atrial fibrillation, and peripheral vascular disease (all P&#x2009;&lt;&#x2009;0.05). MAP&#x2009;&lt;&#x2009;65&#xa0;mmHg was not associated with increased odds of acute ischemic stroke when modeled as a continuous or categorical variable. MAP&#x2009;&lt;&#x2009;60&#xa0;mmHg for more than 20&#xa0;min was independently associated with increased odds of acute ischemic stroke, OR&#x2009;=&#x2009;2.67 [95% CI&#x2009;=&#x2009;1.21 to 5.88, P&#x2009;=&#x2009;0.02].</AbstractText><AbstractText Label="CONCLUSION">Our analysis suggests that when MAP is less than 60&#xa0;mmHg for more than 20&#xa0;min, there is increased odds of acute ischemic stroke. Further studies are needed to determine what MAP should be targeted during surgery to optimize cerebral perfusion and limit ischemic stroke risk.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mazzeffi</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2955-4915</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Maryland School of Medicine, 22 South Greene Street, S11C00, Baltimore, MD, 21201, USA. mmazzeffi@som.umaryland.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chow</LastName><ForeName>Jonathan H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Maryland School of Medicine, 22 South Greene Street, S11C00, Baltimore, MD, 21201, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anders</LastName><ForeName>Megan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Maryland School of Medicine, 22 South Greene Street, S11C00, Baltimore, MD, 21201, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gibbons</LastName><ForeName>Miranda</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Maryland School of Medicine, 22 South Greene Street, S11C00, Baltimore, MD, 21201, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okojie</LastName><ForeName>Uwagbale</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>University of Maryland School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Amber</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Maryland School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ibrahim</LastName><ForeName>Ikeoluwapo</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>University of Maryland School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>Nicholas A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Department of Neurology, Program in Trauma, University of Maryland School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martz</LastName><ForeName>Douglas</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Maryland School of Medicine, 22 South Greene Street, S11C00, Baltimore, MD, 21201, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rock</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Maryland School of Medicine, 22 South Greene Street, S11C00, Baltimore, MD, 21201, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>J Anesth</MedlineTA><NlmUniqueID>8905667</NlmUniqueID><ISSNLinking>0913-8668</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002545" MajorTopicYN="Y">Brain Ischemia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="Y">Hypotension</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000083242" MajorTopicYN="Y">Ischemic Stroke</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anesthesia</Keyword><Keyword MajorTopicYN="N">Hypotension</Keyword><Keyword MajorTopicYN="N">Stroke</Keyword><Keyword MajorTopicYN="N">Surgery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>10</Day><Hour>5</Hour><Minute>57</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33564908</ArticleId><ArticleId IdType="doi">10.1007/s00540-021-02901-3</ArticleId><ArticleId IdType="pii">10.1007/s00540-021-02901-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mashour GA, Shanks AM, Kheterpal S. Perioperative stroke and associated mortality after noncardiac, nonneurologic surgery. Anesthesiology. 2011;114:1289&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e318216e7f4</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman BT, Schumacher HC, Wang S, Shaefi S, Berman MF. Perioperative acute ischemic stroke in noncardiac and nonvascular surgery: incidence, risk factors, and outcomes. Anesthesiology. 2009;110:231&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e318194b5ff</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hader R, Al-Robaidi K, Jovin T, Jadhav A, Wechsler LR, Thirumala PD. The incidence of perioperative stroke: estimate using state and national databases and systematic review. J Stroke. 2019;21:290&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="doi">10.5853/jos.2019.00304</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuro VI. Perioperative covert stroke in patients undergoing non-cardiac surgery (NeuroVISION): a prospective cohort study. Lancet. 2019;394:1022&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)31795-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahuja S, Mascha EJ, Yang D, Maheshwari K, Cohen B, Khanna AK, Ruetzler K, Turan A, Sessler DI. Associations of intraoperative radial arterial systolic, diastolic, mean, and pulse pressures with myocardial and acute kidney injury after noncardiac surgery: a retrospective cohort analysis. Anesthesiology. 2020;132:291&#x2013;306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003048</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmasi V, Maheshwari K, Yang D, Mascha EJ, Singh A, Sessler DI, Kurz A. Relationship between intraoperative hypotension, defined by either reduction from baseline or absolute thresholds, and acute kidney and myocardial injury after noncardiac surgery: a retrospective cohort analysis. Anesthesiology. 2017;126:47&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001432</ArticleId></ArticleIdList></Reference><Reference><Citation>Haller G, Bampoe S, Cook T, Fleisher LA, Grocott MPW, Neuman M, Story D, Myles PS, St EPCG. Systematic review and consensus definitions for the standardised endpoints in perioperative medicine initiative: clinical indicators. Br J Anaesth. 2019;123:228&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2019.04.041</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJ, Culebras A, Elkind MS, George MG, Hamdan AD, Higashida RT, Hoh BL, Janis LS, Kase CS, Kleindorfer DO, Lee JM, Moseley ME, Peterson ED, Turan TN, Valderrama AL, Vinters HV, American Heart Association Stroke Council CoCS, Anesthesia, Council on Cardiovascular R, Intervention, Council on C, Stroke N, Council on E, Prevention, Council on Peripheral Vascular D, Council on Nutrition PA, Metabolism. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:2064&#x2013;89.</Citation></Reference><Reference><Citation>Bursac Z, Gauss CH, Williams DK, Hosmer DW. Purposeful selection of variables in logistic regression. Source Code Biol Med. 2008;3:17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1751-0473-3-17</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, Initiative S. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology. 2007;18:800&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0b013e3181577654</ArticleId></ArticleIdList></Reference><Reference><Citation>Wesselink EM, Kappen TH, Torn HM, Slooter AJC, van Klei WA. Intraoperative hypotension and the risk of postoperative adverse outcomes: a systematic review. Br J Anaesth. 2018;121:706&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2018.04.036</ArticleId></ArticleIdList></Reference><Reference><Citation>Bijker JB, Persoon S, Peelen LM, Moons KG, Kalkman CJ, Kappelle LJ, van Klei WA. Intraoperative hypotension and perioperative ischemic stroke after general surgery: a nested case-control study. Anesthesiology. 2012;116:658&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3182472320</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabate S, Mases A, Guilera N, Canet J, Castillo J, Orrego C, Sabate A, Fita G, Parramon F, Paniagua P, Rodriguez A, Sabate M, Group A. Incidence and predictors of major perioperative adverse cardiac and cerebrovascular events in non-cardiac surgery. Br J Anaesth. 2011;107:879&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aer268</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregory A, Stapelfeldt WH, Khanna AK, Smischney NJ, Boero IJ, Chen Q, Stevens M, Shaw AD. Intraoperative hypotension is associated with adverse clinical outcomes after noncardiac surgery. Anesth Analg. 2020. https://doi.org/10.1213/ANE.0000000000005250 (Online ahead of print. PMID: 33177322).</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005250</ArticleId><ArticleId IdType="pubmed">33177322</ArticleId></ArticleIdList></Reference><Reference><Citation>Drummond JC. Blood pressure and the brain: how low can you go? Anesth Analg. 2019;128:759&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000004034</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi B, Ono M, Brown C, Brady K, Easley RB, Yenokyan G, Gottesman RF, Hogue CW. Predicting the limits of cerebral autoregulation during cardiopulmonary bypass. Anesth Analg. 2012;114:503&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e31823d292a</ArticleId></ArticleIdList></Reference><Reference><Citation>Brady KM, Hudson A, Hood R, DeCaria B, Lewis C, Hogue CW. Personalizing the definition of hypotension to protect the brain. Anesthesiology. 2020;132:170&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003005</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis MR, Naik BI, Freundlich RE, Shanks AM, Heung M, Kim M, Burns ML, Colquhoun DA, Rangrass G, Janda A, Engoren MC, Saager L, Tremper KK, Kheterpal S, Aziz MF, Coffman T, Durieux ME, Levy WJ, Schonberger RB, Soto R, Wilczak J, Berman MF, Berris J, Biggs DA, Coles P, Craft RM, Cummings KC, Ellis TA 2nd, Fleishut PM, Helsten DL, Jameson LC, van Klei WA, Kooij F, LaGorio J, Lins S, Miller SA, Molina S, Nair B, Paganelli WC, Peterson W, Tom S, Wanderer JP, Wedeven C, Multicenter Perioperative Outcomes Group I. Preoperative risk and the association between hypotension and postoperative acute kidney injury. Anesthesiology. 2020;132:461&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003063</ArticleId></ArticleIdList></Reference><Reference><Citation>Haubrich C, Wendt A, Diehl RR, Klotzsch C. Dynamic autoregulation testing in the posterior cerebral artery. Stroke. 2004;35:848&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.STR.0000120729.99039.B6</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, Pessin MS, Lamy C, Mas JL, Caplan LR. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334:494&#x2013;500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199602223340803</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierik R, Uyttenboogaart M, Erasmus ME, Scheeren TWL, van den Bergh WM. Distribution of perioperative stroke in cardiac surgery. Eur J Neurol. 2019;26:184&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13793</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26821695</PMID><DateCompleted><Year>2016</Year><Month>06</Month><Day>23</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>116</Volume><Issue>3</Issue><PubDate><Year>2016</Year><Month>Mar</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Clinical diagnostic tools for screening of perioperative stroke in general surgery: a systematic review.</ArticleTitle><Pagination><StartPage>328</StartPage><EndPage>338</EndPage><MedlinePgn>328-38</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/bja/aev452</ELocationID><Abstract><AbstractText>Perioperative stroke is a devastating complication that carries high mortality and functional disability. Unfortunately, residual anaesthesia and analgesia may obscure important warning signs and may lead to a delay in the assessment and treatment of major stroke after surgery. The purpose of this review is to examine the utility of existing stroke scales, for the recognition of perioperative stroke in the general surgical population. A total of 21 stroke scales have been described in the literature. Diagnostic performance was reported in 17 scales. The majority of the stroke scales were designed to evaluate current neurological deficits after an established stroke event. Recent abbreviated stroke test, such as the Face, Arm, Speech Test (FAST), were developed to facilitate stroke identification in the emergency department. Only two stroke scales have been applied in the perioperative setting after cardiac, carotid and neurological surgeries. The modified National Institutes of Health Stroke Scale appears to be useful in detecting new subtle neurological deficits in critical care, or high dependency units after surgery. However, in the general postsurgical wards, given the concern about the workload required, abbreviated stroke tests may be more appropriate for routine regular stroke surveillance. It is hoped that these tests will provide rapid assessment of global neurological function to facilitate timely diagnosis and treatment of perioperative stroke.</AbstractText><CopyrightInformation>&#xa9; The Author 2016. Published by Oxford University Press on behalf of the British Journal of Anaesthesia. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Z</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China Department of Anaesthesiology, Peking University Third Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yue</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leung</LastName><ForeName>C C H</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, The Chinese University of Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>M T V</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, The Chinese University of Hong Kong, Hong Kong SAR, China mtvchan@cuhk.edu.hk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gelb</LastName><ForeName>A W</ForeName><Initials>AW</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Perioperative Care, University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Study Group for Perioperative Stroke In China (POSIC)</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>01</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059035" MajorTopicYN="N">Perioperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="Y">Surgical Procedures, Operative</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">diagnosis: screening</Keyword><Keyword MajorTopicYN="N">diagnostic tests</Keyword><Keyword MajorTopicYN="N">perioperative period</Keyword><Keyword MajorTopicYN="N">stroke</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Wu</LastName><ForeName>A S</ForeName><Initials>AS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yue</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sun</LastName><ForeName>Z</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guo</LastName><ForeName>X Y</ForeName><Initials>XY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ding</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wang</LastName><ForeName>D X</ForeName><Initials>DX</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tian</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mei</LastName><ForeName>W</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yao</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Xu</LastName><ForeName>X M</ForeName><Initials>XM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yao</LastName><ForeName>L N</ForeName><Initials>LN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chai</LastName><ForeName>W</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chan</LastName><ForeName>M T V</ForeName><Initials>MT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leung</LastName><ForeName>C C H</ForeName><Initials>CC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gelb</LastName><ForeName>A W</ForeName><Initials>AW</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26821695</ArticleId><ArticleId IdType="doi">10.1093/bja/aev452</ArticleId><ArticleId IdType="pii">S0007-0912(17)30441-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25639643</PMID><DateCompleted><Year>2015</Year><Month>06</Month><Day>25</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1941-3084</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>2</Issue><PubDate><Year>2015</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Circulation. Arrhythmia and electrophysiology</Title><ISOAbbreviation>Circ Arrhythm Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Electrocardiographic monitoring for detecting atrial fibrillation after ischemic stroke or transient ischemic attack: systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>263</StartPage><EndPage>269</EndPage><MedlinePgn>263-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1161/CIRCEP.114.002521</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Atrial fibrillation (AF) is a major cause of stroke. Although standard investigations after an event include electrocardiographic monitoring, the optimal duration to detect AF is unclear. We performed a systematic review and meta-analysis to determine whether the duration of electrocardiographic monitoring after an ischemic event is related to the detection of AF.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">Prospective studies that reported the proportion of new AF diagnosed using electrocardiographic monitoring for &gt; 12 hours in patients with recent stroke or transient ischemic attack were analyzed. Studies were excluded if the stroke was hemorrhagic or AF was previously diagnosed. A total of 31 articles met inclusion criteria. Longer duration of monitoring was associated with an increased detection of AF when examining monitoring time as a continuous variable (P &lt; 0.001 for metaregression analysis). When dichotomizing studies based on monitoring duration, studies with monitoring lasting &#x2264; 72 hours detected AF in 5.1%, whereas monitoring lasting &#x2265; 7 days detected AF in 15%. The proportion of new diagnosis increased to 29.15% with extended monitoring for 3 months. Significant heterogeneity within studies was detected for both groups (&#x2264; 72 hours, I(2) = 91.3%; &#x2265; 7 days, I(2) =7 5.8). When assessing the odds of AF detection in the 3 randomized controlled trial, there was a 7.26 increased odds of AF with long-term monitoring (95% confidence intervals [3.99-12.83]; P value &lt; 0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Longer duration of electrocardiographic monitoring after cryptogenic stroke is associated with a greater detection of AF. Future investigation is needed to determine the optimal duration of long-term monitoring.</AbstractText><CopyrightInformation>&#xa9; 2015 American Heart Association, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dussault</LastName><ForeName>Charles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>From the Division of Cardiac Electrophysiology, Department of Medicine, Sherbrooke University, Quebec, Canada (C.D., J.-F.R.); Division of Cardiac Surgery, Department of Surgery, University of Ottawa Heart Institute, Ontario, Canada (H.T.); Department of Cardiac Surgery, Boston Children's Hospital, MA (M.N.); Division of Cardiac Surgery, Anzhen Hospital, Department of Surgery, Capital Medical University, Beijing, China (Z.J.W.); and Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston (E.S.). charles.dussault@usherbrooke.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toeg</LastName><ForeName>Hadi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>From the Division of Cardiac Electrophysiology, Department of Medicine, Sherbrooke University, Quebec, Canada (C.D., J.-F.R.); Division of Cardiac Surgery, Department of Surgery, University of Ottawa Heart Institute, Ontario, Canada (H.T.); Department of Cardiac Surgery, Boston Children's Hospital, MA (M.N.); Division of Cardiac Surgery, Anzhen Hospital, Department of Surgery, Capital Medical University, Beijing, China (Z.J.W.); and Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston (E.S.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nathan</LastName><ForeName>Meena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Division of Cardiac Electrophysiology, Department of Medicine, Sherbrooke University, Quebec, Canada (C.D., J.-F.R.); Division of Cardiac Surgery, Department of Surgery, University of Ottawa Heart Institute, Ontario, Canada (H.T.); Department of Cardiac Surgery, Boston Children's Hospital, MA (M.N.); Division of Cardiac Surgery, Anzhen Hospital, Department of Surgery, Capital Medical University, Beijing, China (Z.J.W.); and Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston (E.S.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhi Jian</ForeName><Initials>ZJ</Initials><AffiliationInfo><Affiliation>From the Division of Cardiac Electrophysiology, Department of Medicine, Sherbrooke University, Quebec, Canada (C.D., J.-F.R.); Division of Cardiac Surgery, Department of Surgery, University of Ottawa Heart Institute, Ontario, Canada (H.T.); Department of Cardiac Surgery, Boston Children's Hospital, MA (M.N.); Division of Cardiac Surgery, Anzhen Hospital, Department of Surgery, Capital Medical University, Beijing, China (Z.J.W.); and Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston (E.S.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roux</LastName><ForeName>Jean-Francois</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>From the Division of Cardiac Electrophysiology, Department of Medicine, Sherbrooke University, Quebec, Canada (C.D., J.-F.R.); Division of Cardiac Surgery, Department of Surgery, University of Ottawa Heart Institute, Ontario, Canada (H.T.); Department of Cardiac Surgery, Boston Children's Hospital, MA (M.N.); Division of Cardiac Surgery, Anzhen Hospital, Department of Surgery, Capital Medical University, Beijing, China (Z.J.W.); and Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston (E.S.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Secemsky</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>From the Division of Cardiac Electrophysiology, Department of Medicine, Sherbrooke University, Quebec, Canada (C.D., J.-F.R.); Division of Cardiac Surgery, Department of Surgery, University of Ottawa Heart Institute, Ontario, Canada (H.T.); Department of Cardiac Surgery, Boston Children's Hospital, MA (M.N.); Division of Cardiac Surgery, Anzhen Hospital, Department of Surgery, Capital Medical University, Beijing, China (Z.J.W.); and Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston (E.S.).</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Circ Arrhythm Electrophysiol</MedlineTA><NlmUniqueID>101474365</NlmUniqueID><ISSNLinking>1941-3084</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Circ Arrhythm Electrophysiol. 2015 Apr;8(2):249-51. doi: 10.1161/CIRCEP.115.002835.</RefSource><PMID Version="1">25900985</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="N">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002545" MajorTopicYN="N">Brain Ischemia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="Y">Electrocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="Y">Heart Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="N">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">atrial fibrillation</Keyword><Keyword MajorTopicYN="N">electrocardiography</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">stroke</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>11</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>1</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25639643</ArticleId><ArticleId IdType="doi">10.1161/CIRCEP.114.002521</ArticleId><ArticleId IdType="pii">CIRCEP.114.002521</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34627675</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2165</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>Nov</Month></PubDate></JournalIssue><Title>European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery</Title><ISOAbbreviation>Eur J Vasc Endovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Overview and Diagnostic Accuracy of Near Infrared Spectroscopy in Carotid Endarterectomy: A Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>695</StartPage><EndPage>704</EndPage><MedlinePgn>695-704</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejvs.2021.08.022</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1078-5884(21)00679-1</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Carotid endarterectomy is recommended for the prevention of ischaemic stroke due to carotid stenosis. However, the risk of stroke after carotid endarterectomy has been estimated at 2% - 5%. Monitoring intra-operative cerebral oxygenation with near infrared spectroscopy (NIRS) has been assessed as a strategy to reduce intra- and post-operative complications. The aim was to summarise the diagnostic accuracy of NIRS to detect intra-operative ischaemic events, the values associated with ischaemic events, and the relative contribution of external carotid contamination to the NIRS signal in adults undergoing carotid endarterectomy.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">EMBASE, MEDLINE, Cochrane Centre Register of Controlled Trials, and reference lists through May 2019 were searched.</AbstractText><AbstractText Label="REVIEW METHODS" NlmCategory="METHODS">Non-randomised and randomised studies assessing NIRS as an intra-operative monitoring tool in carotid endarterectomy were included. Studies using NIRS as the reference were excluded. Risk of bias was assessed using the Newcastle Ottawa Scale, RoB-2, and QUADAS-2.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Seventy-six studies were included (n&#xa0;= 8 480), under local (n&#xa0;= 1 864) or general (n&#xa0;= 6 582) anaesthesia. Seven studies were eligible for meta-analysis (n&#xa0;= 524). As a tool for identifying intra-operative ischaemia, specificity increased with more stringent NIRS thresholds, while there was unpredictable variation in sensitivity across studies. A &#x394;20% threshold under local anaesthesia resulted in pooled estimates for sensitivity and specificity of 70.5% (95% confidence interval, CI, 54.1 - 82.9) and 92.4% (95% CI 85.5 - 96.1) compared with awake neurological monitoring. These studies had low or unclear risk of bias. NIRS signal consistently dropped across clamping and recovered to pre-clamp values upon de-clamp in most studies, and larger decreases were observed in patients with ischaemic events. The contribution of extracranial signal to change in signal across clamp varied from 3% to 50%.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">NIRS has low sensitivity and high specificity to identify intra-operative ischaemia compared with awake monitoring. Extracranial signal contribution was highly variable. Ultimately, data from high quality studies are desperately needed to determine the utility of NIRS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Jasmine M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Centre for Neuroscience Studies, Queen's University, Kingston, ON, Canada; School of Medicine, Queen's University, Kingston, ON, Canada. Electronic address: https://twitter.com/jasmine_m_khan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McInnis</LastName><ForeName>Carter L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>School of Medicine, Queen's University, Kingston, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ross-White</LastName><ForeName>Amanda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Library Services, Queen's University, Kingston, ON, Canada. Electronic address: https://twitter.com/AmandaRossWhite.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Day</LastName><ForeName>Andrew G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Kingston General Health Research Institute, Kingston, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Norman</LastName><ForeName>Patrick A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Kingston General Health Research Institute, Kingston, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boyd</LastName><ForeName>J Gordon</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Centre for Neuroscience Studies, Queen's University, Kingston, ON, Canada; Deptartment of Critical Care Medicine, Queen's University, Kingston, ON, Canada; Department of Medicine, Queen's University, Kingston, ON, Canada. Electronic address: gordon.boyd@kingstonhsc.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Vasc Endovasc Surg</MedlineTA><NlmUniqueID>9512728</NlmUniqueID><ISSNLinking>1078-5884</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016893" MajorTopicYN="N">Carotid Stenosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016894" MajorTopicYN="Y">Endarterectomy, Carotid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016343" MajorTopicYN="Y">Monitoring, Intraoperative</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019265" MajorTopicYN="Y">Spectroscopy, Near-Infrared</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Carotid endarterectomy</Keyword><Keyword MajorTopicYN="N">Cerebral ischaemia</Keyword><Keyword MajorTopicYN="N">Cerebral monitoring</Keyword><Keyword MajorTopicYN="N">Cerebral oximetry</Keyword><Keyword MajorTopicYN="N">Near infrared spectroscopy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>10</Day><Hour>20</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34627675</ArticleId><ArticleId IdType="doi">10.1016/j.ejvs.2021.08.022</ArticleId><ArticleId IdType="pii">S1078-5884(21)00679-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39366655</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-5568</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Anaesthesia, critical care &amp; pain medicine</Title><ISOAbbreviation>Anaesth Crit Care Pain Med</ISOAbbreviation></Journal><ArticleTitle>Effect of perioperative erythropoietin on postoperative morbidity and mortality after cardiac surgery: a meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>101428</StartPage><MedlinePgn>101428</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.accpm.2024.101428</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2352-5568(24)00086-9</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Cardiac surgery is known to have high rates of perioperative red blood cell (RBC) transfusions which are associated with increased postoperative mortality and morbidity. Perioperative erythropoietin (EPO) has been suggested to lower perioperative RBC transfusions, and the effect on postoperative morbidity or mortality is unknown.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The registered study protocol is available on PROSPERO (CRD42022314538). We searched the Pubmed, EMbase, and Cochrane CENTRAL databases for randomized controlled trials (RCT) of EPO in cardiac surgery. Outcomes were short-term mortality, acute kidney injury (AKI), re-operation, cerebrovascular accident (CVA), perioperative myocardial infarction (MI), infectious complications, and RBC transfusions. RCT studies of perioperative EPO that reported at least one prespecified outcome of interest were included.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 21 RCT's (n&#x2009;=&#x2009;2,763 patients) were included. Mortality analysis included 17 studies (EPO 1,272 patients, control 1,235) and showed no significant difference (risk difference (RD) 0.0004, 95%CI: -0.016, 0.009). EPO did not reduce the incidence of AKI (RD -0.006, 95% CI: -0.038, 0.026) and reoperation (RD 0.001, 95% CI: -0.013, 0.015). The incidence of CVA (RD -0.004, 95% CI: -0.015, 0.007) and perioperative MI (RD -0.008, 95% CI: -0.021, 0.005) was similar between the groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Although EPO had been proven to reduce perioperative RBC transfusions, we did not find that it reduces the incidence of postoperative short-term mortality, AKI, and reoperation. The study results support that perioperative EPO is also safe, with no rise in thrombotic events, including CVA and perioperative MI.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Soci&#xe9;t&#xe9; fran&#xe7;aise d'anesth&#xe9;sie et de r&#xe9;animation (Sfar). Published by Elsevier Masson SAS. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abraham</LastName><ForeName>Dana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Carmel Medical Center, Haifa, Israel; The Ruth &amp; Baruch Rappaport Faculty of Medicine, Technion, Haifa, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leviner</LastName><ForeName>Dror B</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Carmel Medical Center, Haifa, Israel; The Ruth &amp; Baruch Rappaport Faculty of Medicine, Technion, Haifa, Israel. Electronic address: drorleviner@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ronai</LastName><ForeName>Tom</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>The Ruth &amp; Baruch Rappaport Faculty of Medicine, Technion, Haifa, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwartz</LastName><ForeName>Naama</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Research Authority, Carmel Medical Center, Haifa, Israel; School of Public Health-University of Haifa, Haifa, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levi</LastName><ForeName>Amos</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Rabin Medical Center, Petach Tikva, Israel; School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharoni</LastName><ForeName>Erez</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Carmel Medical Center, Haifa, Israel; The Ruth &amp; Baruch Rappaport Faculty of Medicine, Technion, Haifa, Israel.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Anaesth Crit Care Pain Med</MedlineTA><NlmUniqueID>101652401</NlmUniqueID><ISSNLinking>2352-5568</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>11096-26-7</RegistryNumber><NameOfSubstance UI="D004921">Erythropoietin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017707" MajorTopicYN="Y">Erythrocyte Transfusion</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004921" MajorTopicYN="Y">Erythropoietin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012086" MajorTopicYN="N">Reoperation</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiac surgery</Keyword><Keyword MajorTopicYN="N">Erythropoietin</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Perioperative care</Keyword><Keyword MajorTopicYN="N">Postoperative outcomes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>24</Day><Hour>0</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>6</Day><Hour>7</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>19</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39366655</ArticleId><ArticleId IdType="doi">10.1016/j.accpm.2024.101428</ArticleId><ArticleId IdType="pii">S2352-5568(24)00086-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29759854</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>27</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-0938</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>7 Pt B</Issue><PubDate><Year>2018</Year><Season>Oct-Nov</Season></PubDate></JournalIssue><Title>Cardiovascular revascularization medicine : including molecular interventions</Title><ISOAbbreviation>Cardiovasc Revasc Med</ISOAbbreviation></Journal><ArticleTitle>A meta-analysis of reduced leaflet motion for surgical and transcatheter aortic valves: Relationship to cerebrovascular events and valve degeneration.</ArticleTitle><Pagination><StartPage>868</StartPage><EndPage>873</EndPage><MedlinePgn>868-873</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.carrev.2018.03.003</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1553-8389(18)30092-7</ELocationID><Abstract><AbstractText Label="BACKGROUND">Reduced leaflet motion (RLM) of transcatheter aortic valves (TAV) is observed in up to 4% of cases with similar frequency in surgical valves, with an overall incidence that differs based on prosthesis type and size. This phenomenon likely represents subclinical leaflet thrombosis. Herein we sought to analyze the existing reported literature to assess whether or not RLM is associated with subsequent valve degeneration or cerebrovascular events.</AbstractText><AbstractText Label="METHODS AND RESULTS">We searched PubMed, and EMBASE (2008-2017) to identify relevant studies. Studies with &lt;1-year follow-up, studies not evaluating RLM, and/or clinical outcomes were excluded. Our co-primary endpoints were the incidence of cerebrovascular events (stroke and/or transient ischemic attack-TIA) or structural valvular degeneration defined as moderate or greater regurgitation and/or a mean gradient &#x2265;20&#x202f;mm&#x202f;Hg. The literature search yielded 30 potential studies. Of these, six observational studies with a total population of 1704 patients met our selection criteria. RLM was associated with an increased risk of stroke or TIA (adjusted OR 2.60, 95% CI 1.56 to 4.34, p&#x202f;=&#x202f;0.004). At one year, RLM was associated with an increased risk of structural valve degeneration (adjusted OR 2.51, 95% CI 1.47 to 4.30, p&#x202f;=&#x202f;0.006). The association between RLM and clinical endpoints remained even after limiting analysis to transcatheter aortic valve replacement (TAVR) patients only.</AbstractText><AbstractText Label="CONCLUSIONS">In patients with bio prosthetic aortic valve, presence of RLM is associated with increased risk of stroke or TIA as well as structural valvular degeneration. These findings support ongoing surveillance efforts and evaluation of pharmacotherapies to address RLM in effort to minimize subsequent clinical events.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Makki</LastName><ForeName>Nader</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Ohio State University Wexner Medical Center, Columbus, OH 43210, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shreenivas</LastName><ForeName>Satya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department Cardiology, The Christ Hospital, Cincinnati, OH 45219, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kereiakes</LastName><ForeName>Dean</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department Cardiology, The Christ Hospital, Cincinnati, OH 45219, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lilly</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Ohio State University Wexner Medical Center, Columbus, OH 43210, United States. Electronic address: Scott.Lilly@osumc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>04</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cardiovasc Revasc Med</MedlineTA><NlmUniqueID>101238551</NlmUniqueID><ISSNLinking>1878-0938</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001021" MajorTopicYN="N">Aortic Valve</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001705" MajorTopicYN="Y">Bioprosthesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001807" MajorTopicYN="Y">Blood Vessel Prosthesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019918" MajorTopicYN="N">Heart Valve Prosthesis Implantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="Y">Hemodynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="N">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011474" MajorTopicYN="N">Prosthesis Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011475" MajorTopicYN="Y">Prosthesis Failure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065467" MajorTopicYN="N">Transcatheter Aortic Valve Replacement</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>1</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29759854</ArticleId><ArticleId IdType="doi">10.1016/j.carrev.2018.03.003</ArticleId><ArticleId IdType="pii">S1553-8389(18)30092-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34308613</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1827-191X</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Dec</Month></PubDate></JournalIssue><Title>The Journal of cardiovascular surgery</Title><ISOAbbreviation>J Cardiovasc Surg (Torino)</ISOAbbreviation></Journal><ArticleTitle>Early outcomes of routine delayed shunting in carotid endarterectomy for symptomatic patients.</ArticleTitle><Pagination><StartPage>573</StartPage><EndPage>581</EndPage><MedlinePgn>573-581</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.23736/S0021-9509.21.11845-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The role of shunting during carotid endarterectomy (CEA) in symptomatic patients is unclear. The aim was to evaluate early outcomes of CEA with routine "delayed" shunt insertion, for patients with symptomatic carotid stenosis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a single-center retrospective study of symptomatic patients undergoing CEA (2009-2020). All CEAs were performed under general anesthesia using a standardized technique, based on delayed routine shunt insertion after plaque removal. Primary endpoints were 30-days mortality and stroke. A logistic regression was performed to identify clinical and procedural factors associated with postoperative stroke.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Two-hundred-sixty-three CEAs were performed for TIA (N.=178, 47%) or acute ischemic stroke (N.=85, 32%). Mean delay of surgery was 6&#xb1;19 days, and early CEA (&lt;48 hours) was performed in 98 cases (37%). Conventional CEA was performed in 171 patients (67%), eversion CEA in 83 (33%). Early (30-days) mortality was 0.3%. Stroke/death rate was 2.3%. Female sex (OR=5.14, 95% CI: 1.32-24.93; P=0.023), use of anticoagulants (OR=10.57, 95% CI: 2.67-51.86; P=0.001), preoperative stroke (OR=5.34, 95% CI: 1.62-69.21; P=0.006), and the presence of preoperative CT/MRI cerebral ischemic lesions (OR=5.96, 95% CI: 1.52-28.59; P=0.013) were associated with early neurological complications. Statin medication (OR=0.18, 95% CI: 0.04-0.71; P=0.019) and CEA timing &lt;2 days (OR=0.14, 95% CI: 0.03-0.55; P=0.005) were protective from postoperative stroke. CEA outcomes were independent from time period (P=0.201) and operator's volume (P=0.768). A literature systematic review identified other four studies describing the CEA outcomes with routine shunting in symptomatic patients, with a large variability in the selection of patients, surgical technique, and description of the results.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Routine delayed shunting after plaque removal seems to be a safe and effective technique, that contributed to maintain a low complication rate in neurologically symptomatic patients. Statin use and expedited timing were associated with improved outcomes using this technique.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Squizzato</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>School of Medicine, Division of Vascular and Endovascular Surgery, Department of Cardiac, Thoracic Vascular Sciences and Public Health, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xodo</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Medicine, Division of Vascular and Endovascular Surgery, Department of Cardiac, Thoracic Vascular Sciences and Public Health, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taglialavoro</LastName><ForeName>Jacopo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Medicine, Division of Vascular and Endovascular Surgery, Department of Cardiac, Thoracic Vascular Sciences and Public Health, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zavatta</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Medicine, Division of Vascular and Endovascular Surgery, Department of Cardiac, Thoracic Vascular Sciences and Public Health, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grego</LastName><ForeName>Franco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>School of Medicine, Division of Vascular and Endovascular Surgery, Department of Cardiac, Thoracic Vascular Sciences and Public Health, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antonello</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Medicine, Division of Vascular and Endovascular Surgery, Department of Cardiac, Thoracic Vascular Sciences and Public Health, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piazza</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Medicine, Division of Vascular and Endovascular Surgery, Department of Cardiac, Thoracic Vascular Sciences and Public Health, University of Padua, Padua, Italy - michele.piazza@unipd.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>J Cardiovasc Surg (Torino)</MedlineTA><NlmUniqueID>0066127</NlmUniqueID><ISSNLinking>0021-9509</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016893" MajorTopicYN="N">Carotid Stenosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002560" MajorTopicYN="Y">Cerebrovascular Circulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016894" MajorTopicYN="Y">Endarterectomy, Carotid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="N">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061665" MajorTopicYN="Y">Time-to-Treatment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>26</Day><Hour>7</Hour><Minute>9</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34308613</ArticleId><ArticleId IdType="doi">10.23736/S0021-9509.21.11845-2</ArticleId><ArticleId IdType="pii">S0021-9509.21.11845-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40391684</PMID><DateRevised><Year>2025</Year><Month>06</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1747-4949</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>May</Month><Day>20</Day></PubDate></JournalIssue><Title>International journal of stroke : official journal of the International Stroke Society</Title><ISOAbbreviation>Int J Stroke</ISOAbbreviation></Journal><ArticleTitle>Incidence, characteristics, and consequences of fractures after acute ischemic stroke and TIA-A prospective cohort study.</ArticleTitle><Pagination><StartPage>17474930251345300</StartPage><MedlinePgn>17474930251345300</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/17474930251345300</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Recent advances in acute stroke therapy improved short-term outcome, but some of this benefit may be lost due to post-stroke complications, including fractures.</AbstractText><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">We assessed the incidence of fractures before and after stroke and transient ischemic attack (TIA), the risk factors for fractures, and the consequences for mortality, functional outcome, and quality of life.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Consecutive patients with acute ischemic stroke or TIA from the prospective STROKE-CARD Registry and the randomized controlled STROKE-CARD trial and its long-term follow-up were analyzed. We prospectively assessed all fractures using self-report and documentation, records of hospitals and general practitioners, and electronic health records with all radiographs.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 2513 patients were included (median age&#x2009;=&#x2009;72&#x2009;years (interquartile range, IQR&#x2009;=&#x2009;61-79), 39.2% female). In the first year after the event, 145 individuals (5.8%, 95% confidence interval (CI)&#x2009;=&#x2009;4.9%-6.7%) experienced 152 fractures corresponding to an incidence rate of 61.87 (95% CI&#x2009;=&#x2009;52.04-71.71) per 1000 person-years. Rates were similar after stroke and TIA (60.84 and 72.28 per 1000 person-years). The incidence of fractures was more than five times higher compared to the general population (age- and sex-adjusted hazard ratio (HR) for first fracture 5.36, 95% CI&#x2009;=&#x2009;2.49-11.52). The risk of fractures 1&#x2009;year before stroke/TIA was also increased (HR&#x2009;=&#x2009;2.99, 95% CI&#x2009;=&#x2009;1.39-6.42). Stroke/TIA further increased the risk of fractures as documented by a comparison between fractures 1&#x2009;year before and 1&#x2009;year after the event (age- and sex-adjusted risk ratio&#x2009;=&#x2009;1.69, 95% CI&#x2009;=&#x2009;1.10-2.58). The main risk factors for fractures were falls and osteoporosis. Fracture after stroke/TIA was associated with death (adjusted odds ratio (aOR)&#x2009;=&#x2009;2.16, 95% CI&#x2009;=&#x2009;1.20-3.89), inability to walk (aOR&#x2009;=&#x2009;2.06, 95% CI&#x2009;=&#x2009;1.08-3.93), and poor quality of life.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Patients with ischemic stroke and TIA are at high risk for future fractures. Fracture after stroke/TIA is strongly associated with death, poor functional outcome, and reduced health-related quality of life. Therefore, there is a need to incorporate fracture prevention into post-stroke care to improve patient outcomes.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">STROKE-CARD Registry (NCT04582825, https://clinicaltrials.gov/study/NCT04582825); STROKE-CARD trial (NCT02156778, https://clinicaltrials.gov/study/NCT02156778); STROKE-CARD long-term follow-up (NCT04205006, https://clinicaltrials.gov/study/NCT04205006).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Karisik</LastName><ForeName>Anel</ForeName><Initials>A</Initials><Identifier Source="ORCID">0009-0000-3075-5437</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VASCage-Centre on Clinical Stroke Research, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dejakum</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VASCage-Centre on Clinical Stroke Research, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moelgg</LastName><ForeName>Kurt</ForeName><Initials>K</Initials><Identifier Source="ORCID">0009-0004-3508-3923</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VASCage-Centre on Clinical Stroke Research, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Granna</LastName><ForeName>Julian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>VASCage-Centre on Clinical Stroke Research, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Felicetti</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0009-0009-0805-1519</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pechlaner</LastName><ForeName>Raimund</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-9006-5606</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayer-Suess</LastName><ForeName>Lukas</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-2856-0101</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toell</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buergi</LastName><ForeName>Lucie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VASCage-Centre on Clinical Stroke Research, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scherer</LastName><ForeName>Lukas</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VASCage-Centre on Clinical Stroke Research, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Willeit</LastName><ForeName>Karin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heidinger</LastName><ForeName>Martin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2816-1351</Identifier><AffiliationInfo><Affiliation>Austrian Federal Ministry of Social Affairs, Health, Care and Consumer Protection, Vienna, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lang</LastName><ForeName>Clemens</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery and Traumatology, Clinic Donaustadt, Vienna, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ludwig Boltzmann Institute Traumatology, Research Center in Cooperation with AUVA, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrari</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hospital St. John's of God, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krebs</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hospital St. John's of God, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kleyhons</LastName><ForeName>Rainer</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Austrian Federal Ministry of Social Affairs, Health, Care and Consumer Protection, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Resch</LastName><ForeName>Heinrich</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Metabolic Bone Diseases Unit, School of Medicine, Sigmund Freud University Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Willeit</LastName><ForeName>Johann</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seekircher</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Clinical Epidemiology, Public Health, Health Economics, Medical Statistics and Informatics, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tschiderer</LastName><ForeName>Lena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Clinical Epidemiology, Public Health, Health Economics, Medical Statistics and Informatics, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Willeit</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute of Clinical Epidemiology, Public Health, Health Economics, Medical Statistics and Informatics, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sykora</LastName><ForeName>Marek</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hospital St. John's of God, Vienna, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Faculty, Sigmund Freud Private University Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schett</LastName><ForeName>Georg</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg and Universit&#xe4;tsklinikum Erlangen, Erlangen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deutsches Zentrum Immuntherapie, Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg and Universit&#xe4;tsklinikum Erlangen, Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lang</LastName><ForeName>Wilfried</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>VASCage-Centre on Clinical Stroke Research, Innsbruck, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Faculty, Sigmund Freud Private University Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knoflach</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VASCage-Centre on Clinical Stroke Research, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiechl</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9836-2514</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VASCage-Centre on Clinical Stroke Research, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boehme</LastName><ForeName>Christian</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-1369-418X</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04582825</AccessionNumber><AccessionNumber>NCT02156778</AccessionNumber><AccessionNumber>NCT04205006</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Stroke</MedlineTA><NlmUniqueID>101274068</NlmUniqueID><ISSNLinking>1747-4930</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ischemic stroke</Keyword><Keyword MajorTopicYN="N">falls</Keyword><Keyword MajorTopicYN="N">fracture</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">prevention</Keyword><Keyword MajorTopicYN="N">transient ischemic attack</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>20</Day><Hour>17</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>20</Day><Hour>17</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>20</Day><Hour>7</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40391684</ArticleId><ArticleId IdType="doi">10.1177/17474930251345300</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39091002</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>02</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1643-3750</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><PubDate><Year>2024</Year><Month>Aug</Month><Day>02</Day></PubDate></JournalIssue><Title>Medical science monitor : international medical journal of experimental and clinical research</Title><ISOAbbreviation>Med Sci Monit</ISOAbbreviation></Journal><ArticleTitle>Transradial and Transfemoral Approaches for Vertebral Artery Stenting: A Single-Center, Prospective, Non-Inferiority Comparison.</ArticleTitle><Pagination><StartPage>e944183</StartPage><MedlinePgn>e944183</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.12659/MSM.944183</ELocationID><Abstract><AbstractText>BACKGROUND Vertebral artery origin stenosis (VAOS) has recently gained increased attention, with endovascular treatments like stent implantation showing high success and low complication rates, although less is known about VAOS compared to carotid artery stenosis. This study evaluated the safety and effectiveness of transradial (TRA) and transfemoral (TFA) approaches for VAOS stent placement. MATERIAL AND METHODS We recruited a total of 102 patients undergoing vertebral artery stenting in our hospital between January 2020 and November 2022. Patients were randomly assigned to undergo either radial or femoral approach for stent implantation in the vertebral artery, and the radial approach group secondary divided into 2 groups by patients' consent: ipsilateral or contralateral radial approach. The success rates of VAOS stent implantation, operation time, and postoperative hospitalization time were compared between the 3 groups. In addition, we compared the outcomes of stroke within 30 days, transient ischemic attack (TIA) within 30 days, and other indicators. RESULTS Of the 102 patients, the final success rate of stent implantation was not significantly different between the 3 groups. The time from sheath insertion to stent insertion in the ipsilateral TRA group (median time: 19 min [interquartile range (IQR): 12-24.5 min]) was significantly shorter than in the transfemoral approach (TFA) group (median time: 29 min [IQR: 21-35.5 min]) (P&lt;0.01; 95% confidence interval (95% CI): 10 min [6-14 min]). There were no statistically significant differences between the 3 groups in terms of cerebrovascular events within 1 month, and patient satisfaction and preference favored the radial approach. CONCLUSIONS The postoperative hospitalization time and operation time associated with the ipsilateral TRA were shorter, and patient acceptance and satisfaction were higher.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lv</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Emergency, Hangzhou Third People's Hospital, Hangzhou, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Changyang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cerebrovascular Disease, Hangzhou Third People's Hospital, Hangzhou, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Cong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Chunli</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cerebrovascular Disease, Hangzhou Third People's Hospital, Hangzhou, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cerebrovascular Diseases, Hangzhou Third People's Hospital, Hangzhou, Zhejiang, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Med Sci Monit</MedlineTA><NlmUniqueID>9609063</NlmUniqueID><ISSNLinking>1234-1010</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015607" MajorTopicYN="Y">Stents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017534" MajorTopicYN="Y">Radial Artery</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005263" MajorTopicYN="Y">Femoral Artery</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014711" MajorTopicYN="Y">Vertebral Artery</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="Y">Endovascular Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014715" MajorTopicYN="N">Vertebrobasilar Insufficiency</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of interest:</b> None declared</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>2</Day><Hour>1</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39091002</ArticleId><ArticleId IdType="pmc">PMC11302278</ArticleId><ArticleId IdType="doi">10.12659/MSM.944183</ArticleId><ArticleId IdType="pii">944183</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>aplan LR, Wityk RJ, Glass TA, et al. New England Medical Center Posterior Circulation registry. Ann Neurol. 2004;56(3):389&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">15349866</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatano T, Tsukahara T, Miyakoshi A, et al. Stent placement for atherosclerotic stenosis of the vertebral artery ostium: Angiographic and clinical outcomes in 117 consecutive patients. Neurosurgery. 2011;68(1):108&#x2013;16. discussion 116.</Citation><ArticleIdList><ArticleId IdType="pubmed">21099720</ArticleId></ArticleIdList></Reference><Reference><Citation>Gr&#xf6;schel K, Riecker A, Schulz JB, Ernemann U, Kastrup A. Systematic review of early recurrent stenosis after carotid angioplasty and stenting. Stroke. 2005;36(2):367&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">15625299</ArticleId></ArticleIdList></Reference><Reference><Citation>Stayman AN, Nogueira RG, Gupta R. A systematic review of stenting and angioplasty of symptomatic extracranial vertebral artery stenosis. Stroke. 2011;42(8):2212&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">21700936</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiemeneij F, Laarman GJ, Odekerken D, et al. A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: The access study. J Am Coll Cardiol. 1997;29(6):1269&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">9137223</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabara R, Gadesam R, Pendyala L, et al. Ambulatory discharge after transradial coronary intervention: Preliminary US single-center experience (Same-day TransRadial Intervention and Discharge Evaluation, the STRIDE Study) Am heart J. 2008;156(6):1141&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">19033010</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone JG, Zussman BM, Tonetti DA, et al. Transradial versus transfemoral approaches for diagnostic cerebral angiography: A prospective, single-center, non-inferiority comparative effectiveness study. J Neurointerv Surg. 2020;12(10):993&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">31974282</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao F, Lo WJ, Sun X, et al. Selective use of transradial access for endovascular treatment of severe intracranial vertebrobasilar artery stenosis. Clin Neurol Neurosurg. 2015;134:116&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">25988601</ArticleId></ArticleIdList></Reference><Reference><Citation>Folmar J, Sachar R, Mann T. Transradial approach for carotid artery stenting: A feasibility study. Catheter Cardiovasc Interv. 2007;69(3):355&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">17230545</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruzsa Z, Nemes B, Pint&#xe9;r L, et al. A randomised comparison of transradial and transfemoral approach for carotid artery stenting: RADCAR (RADial access for CARotid artery stenting) study. EuroIntervention. 2014;10(3):381&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">25042266</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee G, Stone SP, Werring DJ. Posterior circulation ischemic stroke. BMJ. 2018;361:k1185.</Citation><ArticleIdList><ArticleId IdType="pubmed">29674391</ArticleId></ArticleIdList></Reference><Reference><Citation>Wehman JC, Hanel RA, Guidot CA, et al. Atherosclerotic occlusive extracranial vertebral artery disease: Indications for intervention, endovascular techniques, short-term and long-term results. J Interv Cardiol. 2004;17(4):219&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">15318894</ArticleId></ArticleIdList></Reference><Reference><Citation>Biswas M, Hossain MS, Ahmed Rupok T, et al. The association of CYP2C19 LoF alleles with adverse clinical outcomes in stroke patients taking clopidogrel: An updated meta-analysis. Clin Transl Sci. 2024;17(4):e13792.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10997845</ArticleId><ArticleId IdType="pubmed">38581109</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YJ, Li JW, Zhang MJ, et al. The association between CYP2C19 genotype and of in-stent restenosis among patients with vertebral artery stent treatment. CNS Neurosci Ther. 2014;20(2):125&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6493190</ArticleId><ArticleId IdType="pubmed">24330577</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia DM, Chen ZB, Zhang MJ, et al. CYP2C19 polymorphisms and antiplatelet effects of clopidogrel in acute ischemic stroke in China. Stroke. 2013;44(6):1717&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">23640828</ArticleId></ArticleIdList></Reference><Reference><Citation>Mochizuki Y, Ishikawa T, Aihara Y, et al. Platelet aggregability as a predictor of restenosis following carotid endarterectomy. J Stroke Cerebrovasc Dis. 2019;28(3):665&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">30503678</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansour OY, Ibrahim A, Talaat M. Restenosis predictors after carotid angioplasty and stenting and its influence on procedure durability, single-center experience. J Stroke Cerebrovasc Dis. 2017;26(10):2215&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">28688714</ArticleId></ArticleIdList></Reference><Reference><Citation>Storey GS, Marks MP, Dake M, et al. Vertebral artery stenting following percutaneous transluminal angioplasty. Technical note. J Neurosurg. 1996;84(5):883&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">8622166</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pubmed">30615155</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022;79(2):e21&#x2013;e129.</Citation><ArticleIdList><ArticleId IdType="pubmed">34895950</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruzsa Z, Sasko K. Transradial/transbrachial carotid artery stenting with proximal or distal protection: A promising technique for the reduction of vascular complications and stroke. J Endovasc Ther. 2016;23(4):561&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">27413063</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel P, Haussen DC, Nogueira RG, Khandelwal P. The neuro radialist. Interv Cardiol Clin. 2020;9(1):75&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">31733743</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan NR, Peterson J, Dornbos D, III, et al. Predicting the degree of difficulty of the trans-radial approach in cerebral angiography. J Neurointerv Surg. 2021;13(6):552&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">32792364</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwok CS, Rashid M, Fraser D, et al. Intra-arterial vasodilators to prevent radial artery spasm: A systematic review and pooled analysis of clinical studies. Cardiovasc Revasc Med. 2015;16(8):484&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">26365608</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38762709</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>09</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-742X</ISSN><JournalIssue CitedMedium="Internet"><Volume>57</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of thrombosis and thrombolysis</Title><ISOAbbreviation>J Thromb Thrombolysis</ISOAbbreviation></Journal><ArticleTitle>Patent foramen ovale closure in ischemic stroke patients with and without thrombophilia: a systematic review and meta-analyses.</ArticleTitle><Pagination><StartPage>947</StartPage><EndPage>958</EndPage><MedlinePgn>947-958</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11239-024-02990-3</ELocationID><Abstract><AbstractText>Ischemic stroke patients with thrombophilia and patient foramen ovale (PFO) may have an increased risk of recurrent stroke and transient ischemic attack (TIA), and may benefit from PFO closure. However, screening for thrombophilia is not routinely performed and the impact of thrombophilia on prognosis after PFO closure is uncertain. We aim to compare the risk of recurrent stroke and TIA after PFO closure in patients with thrombophilia versus those without. We performed a systematic review and meta-analyses of the literature, with a comprehensive literature search performed on 12 January 2023. Studies comparing the outcomes of patients with and without thrombophilia after PFO closure were included. The primary outcome evaluated was a recurrence of acute cerebrovascular event (ACE), a composite of recurrent ischemic stroke and recurrent TIA. The secondary outcomes included recurrent ischemic stroke only or TIA only. A total of 8 cohort studies were included, with a total of 3514 patients. There was an increased risk of stroke/TIA in patients with thrombophilia compared to those without thrombophilia after PFO (OR: 1.42, 95% CI: 1.01-1.99, I<sup>2</sup>&#x2009;=&#x2009;50%). The association between risk of TIA only (OR: 1.36, 95% CI: 0.77-2.41, I<sup>2</sup>&#x2009;=&#x2009;0%) and stroke only (OR: 1.09, 95% CI: 0.54-2.21, I<sup>2</sup>&#x2009;=&#x2009;0%) with thrombophilia did not reach statistical significance. There is an increased risk of recurrent cerebral ischemia event in patients with thrombophilia compared to those without thrombophilia after PFO closure. Future large prospective studies are necessary to characterise the risk and benefits of PFO closure, as well as the appropriate medical treatment to reduce the risk of recurrent stroke and TIA in this high-risk population.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Xue Yang</ForeName><Initials>XY</Initials><AffiliationInfo><Affiliation>Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Nicholas Lx</ForeName><Initials>NL</Initials><AffiliationInfo><Affiliation>Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Wynne Yu</ForeName><Initials>WY</Initials><AffiliationInfo><Affiliation>Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neo</LastName><ForeName>Jia Hui</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Alethea He</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sia</LastName><ForeName>Ching-Hui</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, National University Heart Centre, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Vijay K</ForeName><Initials>VK</Initials><AffiliationInfo><Affiliation>Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, National University Hospital, National University Health System, 1E Kent Ridge Road, Singapore, 119228, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeo</LastName><ForeName>Leonard Ll</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, National University Hospital, National University Health System, 1E Kent Ridge Road, Singapore, 119228, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Yinghao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, National University Heart Centre, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chee Yen</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Division of Hematology, Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Jamie Sin Ying</ForeName><Initials>JSY</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, National University Hospital, National University Health System, 1E Kent Ridge Road, Singapore, 119228, Singapore. sinyingh@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Tan</LastName><ForeName>Benjamin Yq</ForeName><Initials>BY</Initials><AffiliationInfo><Affiliation>Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, National University Hospital, National University Health System, 1E Kent Ridge Road, Singapore, 119228, Singapore.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Thromb Thrombolysis</MedlineTA><NlmUniqueID>9502018</NlmUniqueID><ISSNLinking>0929-5305</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000083242" MajorTopicYN="Y">Ischemic Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019851" MajorTopicYN="Y">Thrombophilia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054092" MajorTopicYN="Y">Foramen Ovale, Patent</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="Y">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Closure</Keyword><Keyword MajorTopicYN="N">Ischemic stroke</Keyword><Keyword MajorTopicYN="N">Patent foramen ovale</Keyword><Keyword MajorTopicYN="N">Recurrence</Keyword><Keyword MajorTopicYN="N">Thrombophilia</Keyword><Keyword MajorTopicYN="N">Transient ischemic attack</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>9</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>19</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>18</Day><Hour>23</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38762709</ArticleId><ArticleId IdType="doi">10.1007/s11239-024-02990-3</ArticleId><ArticleId IdType="pii">10.1007/s11239-024-02990-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abrahamyan L, Schmidt S, Dharma AC, Everett C, Lee K, Canthiya DS, Kolker L, S., Horlick E (2023) Short- and long-term outcomes in patients with Thrombophilia Undergoing Transcatheter Closure of Patent Foramen Ovale. JACC: Cardiovasc Interventions 16(11):1360&#x2013;1366. https://doi.org/10.1016/j.jcin.2023.04.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2023.04.027</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf6;hm G, Al-Khaffaf H (2003) Thrombophilia and arterial disease. An up-to-date review of the literature for the vascular surgeon. Int Angiol 22(2):116&#x2013;124</Citation><ArticleIdList><ArticleId IdType="pubmed">12865876</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiasakul T, De Jesus E, Tong J, Chen Y, Crowther M, Garcia D, Chai-Adisaksopha C, Mess&#xe9; SR, Cuker A (2019) Inherited Thrombophilia and the risk of arterial ischemic stroke: a systematic review and Meta&#x2010;analysis. J Am Heart Association 8(19). https://doi.org/10.1161/JAHA.119.012877</Citation></Reference><Reference><Citation>Elzanaty AM, Patel N, Sabbagh E, Eltahawy EA (2021) Patent foramen ovale closure in the management of cryptogenic stroke: a review of current literature and guideline statements. Curr Med Res Opin 37(3):377&#x2013;384. https://doi.org/10.1080/03007995.2021.1876648</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03007995.2021.1876648</ArticleId><ArticleId IdType="pubmed">33460329</ArticleId></ArticleIdList></Reference><Reference><Citation>Farjat-Pasos JI, Nuche J, Mesnier J, Panagides V, Cloutier S, Houde C, Rod&#xe9;s-Cabau J (2022) Transcatheter patent Foramen Ovale Closure in Stroke patients with Thrombophilia: current status and future perspectives. J Stroke 24(3):335&#x2013;344. https://doi.org/10.5853/jos.2022.01697</Citation><ArticleIdList><ArticleId IdType="doi">10.5853/jos.2022.01697</ArticleId><ArticleId IdType="pubmed">36221936</ArticleId><ArticleId IdType="pmc">9561223</ArticleId></ArticleIdList></Reference><Reference><Citation>Girolami A, Simioni P, Scarano L, Girolami B (1997) Venous and arterial thrombophilia. Haematologica 82(1):96&#x2013;100</Citation><ArticleIdList><ArticleId IdType="pubmed">9107094</ArticleId></ArticleIdList></Reference><Reference><Citation>Hviid CVB, Simonsen CZ, Hvas A-M (2019) Recurrence risk in patients with cryptogenic stroke, patent Foramen Ovale, and Thrombophilia: a systematic review and Meta-analysis. Thromb Haemost 119(11):1839&#x2013;1848. https://doi.org/10.1055/s-0039-1693739</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0039-1693739</ArticleId><ArticleId IdType="pubmed">31378004</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent DM, Dahabreh IJ, Ruthazer R, Furlan AJ, Reisman M, Carroll JD, Saver JL, Smalling RW, J&#xfc;ni P, Mattle HP, Meier B, Thaler DE (2016) Device Closure of Patent Foramen Ovale after Stroke. J Am Coll Cardiol 67(8):907&#x2013;917. https://doi.org/10.1016/j.jacc.2015.12.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2015.12.023</ArticleId><ArticleId IdType="pubmed">26916479</ArticleId><ArticleId IdType="pmc">4769377</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, Kamel H, Kernan WN, Kittner SJ, Leira EC, Lennon O, Meschia JF, Nguyen TN, Pollak PM, Santangeli P, Sharrief AZ, Smith SC, Turan TN, Williams LS (2021) 2021 Guideline for the Prevention of Stroke in patients with stroke and transient ischemic attack: a Guideline from the American Heart Association/American Stroke Association. Stroke 52(7). https://doi.org/10.1161/STR.0000000000000375</Citation></Reference><Reference><Citation>Lechat P, Mas JL, Lascault G, Loron PH, Theard M, Klimczac M, Drobinski G, Thomas D, Grosgogeat Y (1988) Prevalence of patent Foramen Ovale in patients with stroke. N Engl J Med 318(18):1148&#x2013;1152. https://doi.org/10.1056/NEJM198805053181802</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM198805053181802</ArticleId><ArticleId IdType="pubmed">3362165</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu K, Song B, Palacios IF, Inglessis-Azuaje I, Deng W, McMullin D, Wang X, Lo EH, Xu Y, Buonanno FS, Ning M (2020) Patent Foramen Ovale Attributable Cryptogenic Embolism with Thrombophilia has higher risk for recurrence and responds to Closure. JACC: Cardiovasc Interventions 13(23):2745&#x2013;2752. https://doi.org/10.1016/j.jcin.2020.09.059</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2020.09.059</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;n F, S&#xe1;nchez PL, Doherty E, Colon-Hernandez PJ, Delgado G, Inglessis I, Scott N, Hung J, King MEE, Buonanno F, Demirjian Z, de Moor M, Palacios IF (2002) Percutaneous Transcatheter Closure of Patent Foramen Ovale in patients with paradoxical embolism. Circulation 106(9):1121&#x2013;1126. https://doi.org/10.1161/01.CIR.0000027819.19722.EE</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000027819.19722.EE</ArticleId><ArticleId IdType="pubmed">12196339</ArticleId></ArticleIdList></Reference><Reference><Citation>Martorell L, Mart&#xed;nez-Gonz&#xe1;lez J, Rodr&#xed;guez C, Gentile M, Calvayrac O, Badimon L (2008) Thrombin and protease-activated receptors (PARs) in atherothrombosis. Thromb Haemost 99(02):305&#x2013;315. https://doi.org/10.1160/TH07-08-0481</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH07-08-0481</ArticleId><ArticleId IdType="pubmed">18278179</ArticleId></ArticleIdList></Reference><Reference><Citation>Mas J-L, Derex L, Gu&#xe9;rin P, Guillon B, Habib G, Juliard J-M, Marijon E, Massardier E, Meneveau N, Vuillier F (2019) Transcatheter closure of patent foramen ovale to prevent stroke recurrence in patients with otherwise unexplained ischaemic stroke: Expert consensus of the French Neurovascular Society and the French Society of Cardiology. Arch Cardiovasc Dis 112(8&#x2013;9):532&#x2013;542. https://doi.org/10.1016/j.acvd.2019.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acvd.2019.06.002</ArticleId><ArticleId IdType="pubmed">31378692</ArticleId></ArticleIdList></Reference><Reference><Citation>Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, Jauch EC, Kidwell CS, Leslie-Mazwi TM, Ovbiagele B, Scott PA, Sheth KN, Southerland AM, Summers DV, Tirschwell DL (2019) Guidelines for the early management of patients with Acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of Acute ischemic stroke: a Guideline for Healthcare professionals from the American Heart Association/American Stroke Association. Stroke 50(12). https://doi.org/10.1161/STR.0000000000000211</Citation></Reference><Reference><Citation>Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJ, Buddy), Culebras A, Elkind MSV, George MG, Hamdan AD, Higashida RT, Hoh BL, Janis LS, Kase CS, Kleindorfer DO, Lee J-M, Moseley ME, Peterson ED, Turan TN, Valderrama AL, Vinters HV (2013) An updated definition of stroke for the 21st Century. Stroke 44(7):2064&#x2013;2089. https://doi.org/10.1161/STR.0b013e318296aeca</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STR.0b013e318296aeca</ArticleId><ArticleId IdType="pubmed">23652265</ArticleId><ArticleId IdType="pmc">11078537</ArticleId></ArticleIdList></Reference><Reference><Citation>Saver JL, Mattle HP, Thaler D (2018) Patent Foramen Ovale Closure Versus Medical Therapy for Cryptogenic ischemic stroke. Stroke 49(6):1541&#x2013;1548. https://doi.org/10.1161/STROKEAHA.117.018153</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.117.018153</ArticleId><ArticleId IdType="pubmed">29760277</ArticleId></ArticleIdList></Reference><Reference><Citation>Turc G, Calvet D, Gu&#xe9;rin P, Sroussi M, Chatellier G, Mas J (2018) Closure, Anticoagulation, or Antiplatelet Therapy for Cryptogenic Stroke with Patent Foramen Ovale: systematic review of randomized trials, sequential Meta-analysis, and New insights from the CLOSE Study. J Am Heart Association 7(12). https://doi.org/10.1161/JAHA.117.008356</Citation></Reference><Reference><Citation>Webster MWI, Smith HJ, Sharpe DN, Chancellor AM, Swift DL, Bass NM, Glasgow GL (1988) PATENT FORAMEN OVALE IN YOUNG STROKE PATIENTS. Lancet 332(8601):11&#x2013;12. https://doi.org/10.1016/S0140-6736(88)92944-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(88)92944-3</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25395655</PMID><DateCompleted><Year>2015</Year><Month>11</Month><Day>23</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1936-959X</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>3</Issue><PubDate><Year>2015</Year><Month>Mar</Month></PubDate></JournalIssue><Title>AJNR. American journal of neuroradiology</Title><ISOAbbreviation>AJNR Am J Neuroradiol</ISOAbbreviation></Journal><ArticleTitle>Conscious sedation versus general anesthesia during endovascular acute ischemic stroke treatment: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>525</StartPage><EndPage>529</EndPage><MedlinePgn>525-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3174/ajnr.A4159</ELocationID><Abstract><AbstractText Label="BACKGROUND AND PURPOSE" NlmCategory="OBJECTIVE">A number of studies have suggested that anesthesia type (conscious sedation versus general anesthesia) during intra-arterial treatment for acute ischemic stroke has implications for patient outcomes. We performed a systematic review and meta-analysis of studies comparing the clinical and angiographic outcomes of the 2 anesthesia types.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">In March 2014, we conducted a computerized search of MEDLINE and EMBASE for reports on anesthesia and endovascular treatment of acute ischemic stroke. Using random-effects meta-analysis, we evaluated the following outcomes: recanalization rate, good functional outcome (mRS &#x2264; 2), asymptomatic and symptomatic intracranial hemorrhage, death, vascular complications, respiratory complications, procedure time, time to groin, and time from symptom onset to recanalization.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Nine studies enrolling 1956 patients (814 with general anesthesia and 1142 with conscious sedation) were included. Compared with patients treated by using conscious sedation during stroke intervention, patients undergoing general anesthesia had higher odds of death (OR = 2.59; 95% CI, 1.87-3.58) and respiratory complications (OR = 2.09; 95% CI, 1.36-3.23) and lower odds of good functional outcome (OR = 0.43; 95% CI, 0.35-0.53) and successful angiographic outcome (OR = 0.54; 95% CI, 0.37-0.80). No difference in procedure time (P = .28) was seen between the groups. Preintervention NIHSS scores were available from 6 studies; in those, patients receiving general anesthesia had a higher average NIHSS score.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Patients with acute ischemic stroke undergoing intra-arterial therapy may have worse outcomes with general anesthesia compared with conscious sedation. However, the difference in stroke severity at the onset may confound the comparison in the available studies; thus, a randomized trial is necessary to confirm this association.</AbstractText><CopyrightInformation>&#xa9; 2015 by American Journal of Neuroradiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brinjikji</LastName><ForeName>W</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>From the Departments of Radiology (W.B., H.J.C., G.L., D.F.K.) brinjikji.waleed@mayo.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murad</LastName><ForeName>M H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Center for the Science of Healthcare Delivery and the Division of Preventive Medicine (M.H.M.), Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rabinstein</LastName><ForeName>A A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Neurology (A.A.R.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cloft</LastName><ForeName>H J</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>From the Departments of Radiology (W.B., H.J.C., G.L., D.F.K.) Neurosurgery (H.J.C., G.L., D.F.K.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lanzino</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>From the Departments of Radiology (W.B., H.J.C., G.L., D.F.K.) Neurosurgery (H.J.C., G.L., D.F.K.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kallmes</LastName><ForeName>D F</ForeName><Initials>DF</Initials><AffiliationInfo><Affiliation>From the Departments of Radiology (W.B., H.J.C., G.L., D.F.K.) Neurosurgery (H.J.C., G.L., D.F.K.).</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>11</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AJNR Am J Neuroradiol</MedlineTA><NlmUniqueID>8003708</NlmUniqueID><ISSNLinking>0195-6108</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002545" MajorTopicYN="N">Brain Ischemia</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002533" MajorTopicYN="N">Cerebral Angiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016292" MajorTopicYN="Y">Conscious Sedation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="Y">Endovascular Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020127" MajorTopicYN="N">Recovery of Function</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017131" MajorTopicYN="Y">Thrombectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015912" MajorTopicYN="N">Thrombolytic Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>3</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25395655</ArticleId><ArticleId IdType="pmc">PMC8013063</ArticleId><ArticleId IdType="doi">10.3174/ajnr.A4159</ArticleId><ArticleId IdType="pii">ajnr.A4159</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brinjikji W, Rabinstein AA, Kallmes DF, et al. . Patient outcomes with endovascular embolectomy therapy for acute ischemic stroke: a study of the National Inpatient Sample: 2006 to 2008. Stroke 2011;42:1648&#x2013;52</Citation><ArticleIdList><ArticleId IdType="pubmed">21493901</ArticleId></ArticleIdList></Reference><Reference><Citation>Saver JL. Time is brain&#x2013;quantified. Stroke 2006;37:263&#x2013;66</Citation><ArticleIdList><ArticleId IdType="pubmed">16339467</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonagh DL, Olson DM, Kalia JS, et al. . Anesthesia and sedation practices among neurointerventionalists during acute ischemic stroke endovascular therapy. Front Neurol 2010;1:118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3008915</ArticleId><ArticleId IdType="pubmed">21188256</ArticleId></ArticleIdList></Reference><Reference><Citation>Molina CA, Selim MH. General or local anesthesia during endovascular procedures: sailing quiet in the darkness or fast under a daylight storm. Stroke 2010;41:2720&#x2013;21</Citation><ArticleIdList><ArticleId IdType="pubmed">20930154</ArticleId></ArticleIdList></Reference><Reference><Citation>Brekenfeld C, Mattle HP, Schroth G. General is better than local anesthesia during endovascular procedures. Stroke 2010;41:2716&#x2013;17</Citation><ArticleIdList><ArticleId IdType="pubmed">20930156</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta R. Local is better than general anesthesia during endovascular acute stroke interventions. Stroke 2010;41:2718&#x2013;19</Citation><ArticleIdList><ArticleId IdType="pubmed">20930153</ArticleId></ArticleIdList></Reference><Reference><Citation>Deeks JJ, Dinnes J, D'Amico R, et al. . Evaluating non-randomised intervention studies. Health Technol Assess 2003;7:iii&#x2013;x, 1&#x2013;173</Citation><ArticleIdList><ArticleId IdType="pubmed">14499048</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177&#x2013;88</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, et al. . Measuring inconsistency in meta-analyses. BMJ 2003;327:557&#x2013;60</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Messick JM Jr, Newberg LA, Nugent M, et al. . Principles of neuroanesthesia for the nonneurosurgical patient with CNS pathophysiology. Anesth Analg 1985;64:143&#x2013;74</Citation><ArticleIdList><ArticleId IdType="pubmed">3882022</ArticleId></ArticleIdList></Reference><Reference><Citation>Steen PA. Inhalational versus intravenous anesthesia: cerebral effects. Acta Anaesthesiol Scand Suppl 1982;75:32&#x2013;35</Citation><ArticleIdList><ArticleId IdType="pubmed">6958159</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis MJ, Menon BK, Baghirzada LB, et al. . Anesthetic management and outcome in patients during endovascular therapy for acute stroke. Anesthesiology 2012;116:396&#x2013;405</Citation><ArticleIdList><ArticleId IdType="pubmed">22222475</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen KD, Landsfeldt U, Cold GE, et al. . Intracranial pressure and cerebral hemodynamic in patients with cerebral tumors: a randomized prospective study of patients subjected to craniotomy in propofol-fentanyl, isoflurane-fentanyl, or sevoflurane-fentanyl anesthesia. Anesthesiology 2003;98:329&#x2013;36</Citation><ArticleIdList><ArticleId IdType="pubmed">12552189</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberg M, Weaver J. General anesthesia. Anesth Prog 1991;38:172&#x2013;86</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2190299</ArticleId><ArticleId IdType="pubmed">1819969</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossitti S, Pfister M. 3D road-mapping in the endovascular treatment of cerebral aneurysms and arteriovenous malformations. Interv Neuroradiol 2009;15:283&#x2013;90</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3299374</ArticleId><ArticleId IdType="pubmed">20465911</ArticleId></ArticleIdList></Reference><Reference><Citation>Abou-Chebl A, Lin R, Hussain MS, et al. . Conscious sedation versus general anesthesia during endovascular therapy for acute anterior circulation stroke: preliminary results from a retrospective, multicenter study. Stroke 2010;41:1175&#x2013;79</Citation><ArticleIdList><ArticleId IdType="pubmed">20395617</ArticleId></ArticleIdList></Reference><Reference><Citation>Jumaa MA, Zhang F, Ruiz-Ares G, et al. . Comparison of safety and clinical and radiographic outcomes in endovascular acute stroke therapy for proximal middle cerebral artery occlusion with intubation and general anesthesia versus the nonintubated state. Stroke 2010;41:1180&#x2013;84</Citation><ArticleIdList><ArticleId IdType="pubmed">20431082</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabre P, Avenel A, Combes X, et al. . Morbidity related to emergency endotracheal intubation: a substudy of the KETAmine SEDation trial. Resuscitation 2011;82:517&#x2013;22</Citation><ArticleIdList><ArticleId IdType="pubmed">21345571</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Murphy-Lavoie H, Bugas C, et al. . Complications of emergency intubation with and without paralysis. Am J Emerg Med 1999;17:141&#x2013;43</Citation><ArticleIdList><ArticleId IdType="pubmed">10102312</ArticleId></ArticleIdList></Reference><Reference><Citation>Chamczuk AJ, Ogilvy CS, Snyder KV, et al. . Elective stenting for intracranial stenosis under conscious sedation. Neurosurgery 2010;67:1189&#x2013;93; discussion 1194</Citation><ArticleIdList><ArticleId IdType="pubmed">20871450</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan AE, Chaudhry SA, Zacharatos H, et al. . Increased rate of aspiration pneumonia and poor discharge outcome among acute ischemic stroke patients following intubation for endovascular treatment. Neurocrit Care 2012;16:246&#x2013;50</Citation><ArticleIdList><ArticleId IdType="pubmed">21993605</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi AI, Suri MF, Khan J, et al. . Endovascular treatment of intracranial aneurysms by using Guglielmi detachable coils in awake patients: safety and feasibility. J Neurosurg 2001;94:880&#x2013;85</Citation><ArticleIdList><ArticleId IdType="pubmed">11409514</ArticleId></ArticleIdList></Reference><Reference><Citation>Abou-Chebl A, Krieger DW, Bajzer CT, et al. . Intracranial angioplasty and stenting in the awake patient. J Neuroimaging 2006;16:216&#x2013;23</Citation><ArticleIdList><ArticleId IdType="pubmed">16808823</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogawa Y, Iwasaki K, Aoki K, et al. . The different effects of midazolam and propofol sedation on dynamic cerebral autoregulation. Anesth Analg 2010;111:1279&#x2013;84</Citation><ArticleIdList><ArticleId IdType="pubmed">20881283</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F, Deshaies EM, Singla A, et al. . Impact of anesthesia on mortality during endovascular clot removal for acute ischemic stroke. J Neurosurg Anesthesiol 2014;26:286&#x2013;90</Citation><ArticleIdList><ArticleId IdType="pubmed">24296538</ArticleId></ArticleIdList></Reference><Reference><Citation>Langner S, Khaw AV, Fretwurst T, et al. . Endovascular treatment of acute ischemic stroke under conscious sedation compared to general anesthesia: safety, feasibility and clinical and radiological outcome [in German]. Rofo 2013;185:320&#x2013;27</Citation><ArticleIdList><ArticleId IdType="pubmed">23420311</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichols C, Carrozzella J, Yeatts S, et al. . Is periprocedural sedation during acute stroke therapy associated with poorer functional outcomes? J Neurointerv Surg 2010;2:67&#x2013;70</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2860799</ArticleId><ArticleId IdType="pubmed">20431708</ArticleId></ArticleIdList></Reference><Reference><Citation>Abou-Chebl A, Zaidat OO, Castonguay AC, et al. . North American SOLITAIRE Stent-Retriever Acute Stroke Registry: choice of anesthesia and outcomes. Stroke 2014;45:1396&#x2013;401</Citation><ArticleIdList><ArticleId IdType="pubmed">24668201</ArticleId></ArticleIdList></Reference><Reference><Citation>Soize S, Kadziolka K, Estrade L, et al. . Mechanical thrombectomy in acute stroke: prospective pilot trial of the Solitaire FR device while under conscious sedation. AJNR Am J Neuroradiol 2013;34:360&#x2013;65</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7965094</ArticleId><ArticleId IdType="pubmed">22821923</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugg RM, Jackson AS, Holloway W, et al. . Is mechanical embolectomy performed in nonanesthetized patients effective? AJNR Am J Neuroradiol 2010;31:1533&#x2013;35</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7966107</ArticleId><ArticleId IdType="pubmed">20395385</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36057733</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>15</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1572-8595</ISSN><JournalIssue CitedMedium="Internet"><Volume>65</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing</Title><ISOAbbreviation>J Interv Card Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Outcomes of catheter ablation versus antiarrhythmic therapy in patients with atrial fibrillation: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>773</StartPage><EndPage>802</EndPage><MedlinePgn>773-802</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10840-022-01365-z</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Recent data have shown an advantage of rhythm control over rate control for the treatment of atrial fibrillation (AF). Nevertheless, the data regarding efficacy of catheter ablation (CA) compared with antiarrhythmic drugs (AADs) in patients with AF is lacking. Therefore, we sought to evaluate recurrence of arrhythmia, all-cause mortality, cardiovascular deaths, stroke/TIA, and all-cause readmissions of CA compared with AAD in patients with AF.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Systematically searched through PubMed, Google Scholar, EMBASE, and Cochrane for randomized control trials that compared CA and AAD in atrial fibrillation patients. Review Manager 5.4 and OpenMetaAnalyst were used to analyze the data. Data was pooled for the outcomes using random-effect models (DerSimonian and Laird) and reported as pooled odds ratio (OR).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 4822 patients were included. The CA group had 2417 patients while the AAD group included 2405 patients. Pooled data demonstrated that the CA arm had a statistically significant decrease in risk for recurrence of arrhythmia as compared to AAD (OR 0.25; [95% CI, 0.18-0.36]; p&#x2009;&lt;&#x2009;0.001). All-cause readmission was statistically significantly lower in CA as compared to AAD (OR 0.33; [95%CI, 0.17-0.63]; p&#x2009;&lt;&#x2009;0.001). For other secondary outcomes, there was no statistically significant difference between CA and AAD with regard to all-cause mortality (OR 0.75; [95% CI, 0.55-1.03]), cardiovascular death (OR 0.76; [95% CI, 0.22-2.54]), bleeding (OR 1.09, [95% CI 0.74, 1.61]), or stroke/TIA outcome (OR 0.90, [95% CI, 0.59-1.37]).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In this study of pooled data from 16 RCTs, CA utilization for atrial fibrillation had improved freedom from arrhythmia as well as reduced all-cause readmission compared with AAD.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Deshpande</LastName><ForeName>Radhika</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-3879-7943</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Memorial Medical Center, Southern Illinois University School of Medicine, N 1st St, Springfield, IL, 62781, USA. radhik.deshpande@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AlKhadra</LastName><ForeName>Yasser</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Southern Illinois University School of Medicine, Springfield, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singanallur</LastName><ForeName>Prashanth</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Memorial Medical Center, Southern Illinois University School of Medicine, N 1st St, Springfield, IL, 62781, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Botchway</LastName><ForeName>Albert</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Memorial Medical Center, Southern Illinois University School of Medicine, N 1st St, Springfield, IL, 62781, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Labedi</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Southern Illinois University School of Medicine, Springfield, IL, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Interv Card Electrophysiol</MedlineTA><NlmUniqueID>9708966</NlmUniqueID><ISSNLinking>1383-875X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000889" MajorTopicYN="N">Anti-Arrhythmia Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="Y">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antiarrhythmic medication</Keyword><Keyword MajorTopicYN="N">Atrial fibrillation</Keyword><Keyword MajorTopicYN="N">Catheter ablation</Keyword><Keyword MajorTopicYN="N">Rhythm control</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>3</Day><Hour>23</Hour><Minute>29</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36057733</ArticleId><ArticleId IdType="doi">10.1007/s10840-022-01365-z</ArticleId><ArticleId IdType="pii">10.1007/s10840-022-01365-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>L&#xe9;vy, Samuel et al. Management of atrial fibrillation: two decades of progress - a scientific statement from the European Cardiac Arrhythmia Society. J Interv Cardiac Electrophysiol : Int J Arrhythmias Pacing. 13 2022; https://doi.org/10.1007/s10840-022-01195-z</Citation></Reference><Reference><Citation>Kirchhof P, Camm AJ, Goette A, Brandes A, Eckardt L, Elvan A, Fetsch T, van Gelder IC, Haase D, Haegeli LM, Hamann F, Heidb&#xfc;chel H, Hindricks G, Kautzner J, Kuck KH, Mont L, Ng GA, Rekosz J, Schoen N, Schotten U, Suling A, Taggeselle J, Themistoclakis S, Vettorazzi E, Vardas P, Wegscheider K, Willems S, Crijns HJGM, Breithardt G, EAST-AFNET 4 Trial Investigators. Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med. 2020;383(14):1305&#x2013;16. https://doi.org/10.1056/NEJMoa2019422 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2019422</ArticleId></ArticleIdList></Reference><Reference><Citation>Asad ZUA, Yousif A, Khan MS, Al-Khatib SM, Stavrakis S. Catheter ablation versus medical therapy for atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials. Circ Arrhythm Electrophysiol. 2019;12(9):e007414. https://doi.org/10.1161/CIRCEP.119.007414 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.119.007414</ArticleId></ArticleIdList></Reference><Reference><Citation>Calkins, Hugh et al. HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace : European pacing, arrhythmias, and cardiac electrophysiology : J Working Groups Cardiac Pacing Arrhythmias Cardiac Cell Electrophysiol Eur Soc Cardiol. 2017;20 1 (2018): e1-e160. https://doi.org/10.1093/europace/eux274</Citation></Reference><Reference><Citation>Packer DL, et al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA. 2019;321(13):1261&#x2013;74. https://doi.org/10.1001/jama.2019.0693 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.0693</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, Prisma G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1000097</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunter RJ, et al. A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial). Circ Arrhythm Electrophysiol. 2014;7(1):31&#x2013;8. https://doi.org/10.1161/CIRCEP.113.000806 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.113.000806</ArticleId></ArticleIdList></Reference><Reference><Citation>Prabhu S, et al. Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: the CAMERA-MRI study. J Am Coll Cardiol. 2017;70(16):1949&#x2013;61. https://doi.org/10.1016/j.jacc.2017.08.041 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2017.08.041</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDonald MR, et al. Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial. Heart (British Cardiac Society). 2011;97(9):740&#x2013;7. https://doi.org/10.1136/hrt.2010.207340 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/hrt.2010.207340</ArticleId></ArticleIdList></Reference><Reference><Citation>McGuinness, LA, Higgins, JPT. Risk-of-Bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Syn Meth. 2020; 1- 7. https://doi.org/10.1002/jrsm.1411</Citation></Reference><Reference><Citation>Di Biase L, et al. Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial. Circulation. 2016;133(17):1637&#x2013;44. https://doi.org/10.1161/CIRCULATIONAHA.115.019406 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.115.019406</ArticleId></ArticleIdList></Reference><Reference><Citation>Ja&#xef;s P, et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation. 2008;118(24):2498&#x2013;505. https://doi.org/10.1161/CIRCULATIONAHA.108.772582 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.108.772582</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen JC, et al. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. New Engl J Med. 2012;367(17):1587&#x2013;95. https://doi.org/10.1056/NEJMoa1113566 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1113566</ArticleId></ArticleIdList></Reference><Reference><Citation>Oral H, et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. New Engl J Med. 2006;354(9):934&#x2013;41. https://doi.org/10.1056/NEJMoa050955 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa050955</ArticleId></ArticleIdList></Reference><Reference><Citation>Stabile G, et al. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study). Eur Heart J. 2006;27(2):216&#x2013;21. https://doi.org/10.1093/eurheartj/ehi583 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehi583</ArticleId></ArticleIdList></Reference><Reference><Citation>Pappone C, et al. Radiofrequency catheter ablation and antiarrhythmic drug therapy: a prospective, randomized, 4-year follow-up trial: the APAF study. Circ Arrhythm Electrophysiol. 2011;4(6):808&#x2013;14. https://doi.org/10.1161/CIRCEP.111.966408 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.111.966408</ArticleId></ArticleIdList></Reference><Reference><Citation>Forleo GB, et al. Catheter ablation of atrial fibrillation in patients with diabetes mellitus type 2: results from a randomized study comparing pulmonary vein isolation versus antiarrhythmic drug therapy. J Cardiovasc Electrophysiol. 2009;20(1):22&#x2013;8. https://doi.org/10.1111/j.1540-8167.2008.01275.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8167.2008.01275.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Krittayaphong R, et al. A randomized clinical trial of the efficacy of radiofrequency catheter ablation and amiodarone in the treatment of symptomatic atrial fibrillation. J Med Assoc Thail= Chotmaihet Thangphaet. 2003;86(Suppl 1):S8-16.</Citation></Reference><Reference><Citation>Morillo CA, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial. JAMA. 2014;311(7):692&#x2013;700. https://doi.org/10.1001/jama.2014.467 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.467</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade JG, et al. Cryoablation or drug therapy for initial treatment of atrial fibrillation. New Engl J Med. 2021;384(4):305&#x2013;15. https://doi.org/10.1056/NEJMoa2029980 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2029980</ArticleId></ArticleIdList></Reference><Reference><Citation>Mont L, et al. Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study). Eur Heart J. 2014;35(8):501&#x2013;7. https://doi.org/10.1093/eurheartj/eht457 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/eht457</ArticleId></ArticleIdList></Reference><Reference><Citation>Wazni OM, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA. 2005;293(21):2634&#x2013;40. https://doi.org/10.1001/jama.293.21.2634 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.293.21.2634</ArticleId></ArticleIdList></Reference><Reference><Citation>Wazni OM, et al. Cryoballoon ablation as initial therapy for atrial fibrillation. New Engl J Med. 2021;384(4):316&#x2013;24. https://doi.org/10.1056/NEJMoa2029554 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2029554</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilber DJ, et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA. 2010;303(4):333&#x2013;40. https://doi.org/10.1001/jama.2009.2029 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2009.2029</ArticleId></ArticleIdList></Reference><Reference><Citation>Blandino A, et al. Long-term efficacy and safety of two different rhythm control strategies in elderly patients with symptomatic persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2013;24(7):731&#x2013;8. https://doi.org/10.1111/jce.12126 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jce.12126</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, et al. The trend of change in catheter ablation versus antiarrhythmic drugs for the management of atrial fibrillation over time: a meta-analysis and meta-regression. J Geriatr Cardiol: JGC. 2018;15(6):441&#x2013;50. https://doi.org/10.11909/j.issn.1671-5411.2018.06.011 .</Citation><ArticleIdList><ArticleId IdType="doi">10.11909/j.issn.1671-5411.2018.06.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinberg JS, et al. Thirty-second gold standard definition of atrial fibrillation and its relationship with subsequent arrhythmia patterns: analysis of a large prospective device database. Circ Arrhythm Electrophysiol. 2018;11(7):e006274. https://doi.org/10.1161/CIRCEP.118.006274 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.118.006274</ArticleId></ArticleIdList></Reference><Reference><Citation>Calkins, Hugh, et al. HRS/EHRA/ECAS Expert Consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation Developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the .... Europace 2007;9.6: 335&#x2013;379.</Citation></Reference><Reference><Citation>Linz D, et al. Associations of obstructive sleep apnea with atrial fibrillation and continuous positive airway pressure treatment: a review. JAMA Cardiol. 2018;3(6):532&#x2013;40. https://doi.org/10.1001/jamacardio.2018.0095 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2018.0095</ArticleId></ArticleIdList></Reference><Reference><Citation>Turagam MK, et al. Assessment of catheter ablation or antiarrhythmic drugs for first-line therapy of atrial fibrillation: a meta-analysis of randomized clinical trials. JAMA Cardiol. 2021;6(6):697&#x2013;705. https://doi.org/10.1001/jamacardio.2021.0852 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2021.0852</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi L-Z, et al. Effect of catheter ablation versus antiarrhythmic drugs on atrial fibrillation: a meta-analysis of randomized controlled trials. Exp Ther Med. 2015;10(2):816&#x2013;22. https://doi.org/10.3892/etm.2015.2545 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2015.2545</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan AR, et al. Catheter ablation and antiarrhythmic drug therapy as first- or second-line therapy in the management of atrial fibrillation: systematic review and meta-analysis. Circ Arrhythm Electrophysiol. 2014;7(5):853&#x2013;60. https://doi.org/10.1161/CIRCEP.114.001853 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.114.001853</ArticleId></ArticleIdList></Reference><Reference><Citation>Hakalahti A, Biancari F, Nielsen JC, PekkaRaatikainen MJ. Radiofrequency ablation vs. antiarrhythmic drug therapy as first line treatment of symptomatic atrial fibrillation: systematic review and meta-analysis. EP Europace. 2015;17(3):370&#x2013;8. https://doi.org/10.1093/europace/euu376 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/euu376</ArticleId></ArticleIdList></Reference><Reference><Citation>Calkins H, et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses. Circ Arrhythm Electrophysiol. 2009;2(4):349&#x2013;61. https://doi.org/10.1161/CIRCEP.108.824789 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.108.824789</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravi V, et al. Mortality benefit of catheter ablation versus medical therapy in atrial fibrillation: an RCT only meta-analysis. J Cardiovasc Electrophysiol. 2022;33(2):178&#x2013;93. https://doi.org/10.1111/jce.15330 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jce.15330</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan SU, et al. The clinical benefits and mortality reduction associated with catheter ablation in subjects with atrial fibrillation: a systematic review and meta-analysis. JACC Clin Electrophysiol. 2018;4(5):626&#x2013;35. https://doi.org/10.1016/j.jacep.2018.03.003 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacep.2018.03.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol. 2003;91(6A):2D-8D. https://doi.org/10.1016/s0002-9149(02)03373-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0002-9149(02)03373-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang TJ, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. 2003;107(23):2920&#x2013;5. https://doi.org/10.1161/01.CIR.0000072767.89944.6E .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000072767.89944.6E</ArticleId></ArticleIdList></Reference><Reference><Citation>Patti G, et al. Thromboembolic risk, bleeding outcomes and effect of different antithrombotic strategies in very elderly patients with atrial fibrillation: a sub-analysis from the PREFER in AF (PREvention oF Thromboembolic Events-European Registry in Atrial Fibrillation). J Am Heart Assoc. 2017;6(7):e005657. https://doi.org/10.1161/JAHA.117.005657 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.117.005657</ArticleId></ArticleIdList></Reference><Reference><Citation>Noseworthy PA, et al. Trends and predictors of readmission after catheter ablation for atrial fibrillation, 2009&#x2013;2013. Am Heart J. 2015;170(3):483&#x2013;9. https://doi.org/10.1016/j.ahj.2015.05.018 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2015.05.018</ArticleId></ArticleIdList></Reference><Reference><Citation>Baysal E, et al. Decreasing time between first diagnosis of paroxysmal atrial fibrillation and cryoballoon ablation positively affects long-term consequences. J Interv Card Electrophysiol: Int J Arrhythm Pacing. 2022. https://doi.org/10.1007/s10840-022-01167-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10840-022-01167-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S, et al. Comparing the efficacy of catheter ablation strategies for persistent atrial fibrillation: a Bayesian analysis of randomized controlled trials. J Interv Card Electrophysiol: Int J Arrhythm Pacing. 2022. https://doi.org/10.1007/s10840-022-01246-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10840-022-01246-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X, et al. Comparative efficacy and safety of catheter ablation interventions for atrial fibrillation: comprehensive network meta-analysis of randomized controlled trials. J Interv Card Electrophysiol: Int J Arrhythm Pacing. 2021;62(1):199&#x2013;211. https://doi.org/10.1007/s10840-020-00878-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10840-020-00878-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui L, et al. Comparison of higher-power and conventional power ablation of atrial fibrillation using contact force-sensing catheters: a systematic review and meta-analysis. J Interv Card Electrophysiol: Int J Arrhythm Pacing. 2021;62(1):1&#x2013;7. https://doi.org/10.1007/s10840-021-00975-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10840-021-00975-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Anic A, et al. Pulsed field ablation: a promise that came true. Curr Opin Cardiol. 2021;36(1):5&#x2013;9. https://doi.org/10.1097/HCO.0000000000000810 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HCO.0000000000000810</ArticleId></ArticleIdList></Reference><Reference><Citation>Maan A, Koruth J. Pulsed field ablation: a new paradigm for catheter ablation of arrhythmias. Curr Cardiol Rep. 2022;24(2):103&#x2013;8. https://doi.org/10.1007/s11886-021-01630-z .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11886-021-01630-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijffels MCEF, Crijns HJGM. Rate versus rhythm control in atrial fibrillation. Cardiol Clin. 2004;22(1):63&#x2013;9. https://doi.org/10.1016/s0733-8651(03)00112-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0733-8651(03)00112-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Z, et al. Atrial fibrillation begets atrial fibrillation: autonomic mechanism for atrial electrical remodeling induced by short-term rapid atrial pacing. Circ Arrhythm Electrophysiol. 2008;1(3):184&#x2013;92. https://doi.org/10.1161/CIRCEP.108.784272 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.108.784272</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40542821</PMID><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1545-1550</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Jun</Month><Day>21</Day></PubDate></JournalIssue><Title>Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists</Title><ISOAbbreviation>J Endovasc Ther</ISOAbbreviation></Journal><ArticleTitle>A Systematic Review and Meta-Analysis of Outcome After Repeat Revascularization for Primary Carotid Artery Restenosis.</ArticleTitle><Pagination><StartPage>15266028251325054</StartPage><MedlinePgn>15266028251325054</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/15266028251325054</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Carotid artery restenosis can occur after both carotid artery stenting (CAS) and carotid endarterectomy (CEA). This systematic review and meta-analysis aim to determine which revascularization technique, CAS, or CEA, is superior for treating primary carotid restenosis, irrespective of the initial revascularization method used.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Systematic review and meta-analysis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials (CENTRALs) databases were searched for eligible studies on December 19th, 2023. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement was followed. Primary endpoint was the occurrence of transient ischemic attack (TIA) or any stroke. Secondary endpoints were technical success, death within 30&#x2009;days, myocardial infarction (MI), local complications, cerebral hyperperfusion syndrome (CHS), cranial nerve injury (CNI), dys-/arrythmia, secondary restenosis, repeat revascularization, and long-term survival. Results were adjusted for symptomatic status and primary treatment strategy.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Nineteen studies comprising 10,171 procedures in 10,041 patients were included. Baseline characteristics were comparable between groups. Main findings were (1) No difference in primary outcome; however, if adjusted for symptomatic status the rate of TIA/any stroke is higher (OR: 2.05, 95% CI: 1.29-3.27, p&#x2009;&lt;&#x2009;0.01) after CEA compared to CAS; (2) Significant higher rate of MI (OR: 1.85, 95% CI: 1.19-2.86, p&#x2009;&lt;&#x2009;0.01) after CEA; (3) Besides CNI, which appears to be commonly temporary and occurred only after CEA (7.56%, 95% CI: 4.21%-13.22%), no significant differences in other secondary endpoints were observed between groups. Long-term risk of secondary restenosis was similar between CEA compared to CAS (OR: 0.98, 95% CI: 0.39-2.49, p&#x2009;=&#x2009;0.95); (4) Correction for the index procedure did not affect conclusions.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Based on limited-quality studies, mostly retrospective and nonrandomized in design, both CAS and CEA represent feasible treatment approaches for patients with primary restenosis, with comparable primary outcome between the two groups. However, based on the obtained results, CAS appears to be preferable. Patients should be critically evaluated in a multidisciplinary team and further research is desirable.Clinical ImpactThis review expands on previous studies by incorporating a larger patient cohort and more recent literature while offering new insights into restenosis. Unlike earlier research, this study uniquely evaluates first repeat revascularization outcomes (CAS and CEA) independently of the initial procedure, suggesting that patient and plaque characteristics might be more influential than the primary technique. Sensitivity analysis confirmed this, as stratification by index procedure did not alter conclusions. Although lower TIA/stroke and mortality rates were observed in CAS-treated patients, these findings were not statistically significant in the overall group. These results may help guide clinical decision-making for optimal restenosis management.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>K&#xf6;k</LastName><ForeName>Mert</ForeName><Initials>M</Initials><Identifier Source="ORCID">0009-0000-5621-2772</Identifier><AffiliationInfo><Affiliation>Departments of Surgery (Division of Vascular Surgery), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>R&#xf6;der</LastName><ForeName>Franziska</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Departments of Surgery (Division of Vascular Surgery), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bokkers</LastName><ForeName>Reinoud P H</ForeName><Initials>RPH</Initials><Identifier Source="ORCID">0000-0001-6130-7311</Identifier><AffiliationInfo><Affiliation>Radiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uyttenboogaart</LastName><ForeName>Maarten</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neurology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gareb</LastName><ForeName>Barzi</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-3534-9176</Identifier><AffiliationInfo><Affiliation>Oral and Maxillofacial Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeebregts</LastName><ForeName>Clark J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Departments of Surgery (Division of Vascular Surgery), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Endovasc Ther</MedlineTA><NlmUniqueID>100896915</NlmUniqueID><ISSNLinking>1526-6028</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CAS</Keyword><Keyword MajorTopicYN="N">CEA</Keyword><Keyword MajorTopicYN="N">angioplasty [MeSH]</Keyword><Keyword MajorTopicYN="N">carotid [MeSH]</Keyword><Keyword MajorTopicYN="N">carotid stenosis [MeSH]</Keyword><Keyword MajorTopicYN="N">endarterectomy</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">reintervention</Keyword><Keyword MajorTopicYN="N">restenosis</Keyword><Keyword MajorTopicYN="N">stents [MeSH]</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>21</Day><Hour>18</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>21</Day><Hour>18</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>21</Day><Hour>10</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40542821</ArticleId><ArticleId IdType="doi">10.1177/15266028251325054</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34160457</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>100</Volume><Issue>25</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>25</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Meta-analysis of patent foramen ovale closure versus medical therapy for prevention of recurrent ischemic neurological events: Impact of medication type.</ArticleTitle><Pagination><StartPage>e26473</StartPage><MedlinePgn>e26473</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e26473</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000026473</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The optimal treatment strategy for patent foramen ovale (PFO) patients with cryptic stroke remains controversial. We performed this meta-analysis to evaluate the effect of PFO closure versus different types of medical therapy.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched PubMed, Embase, and Cochrane databases. The primary efficacy endpoints were the composite outcome of recurrent stroke and/or transient ischemic attack (TIA). Secondary efficacy endpoints included separate stroke and TIA. Safety endpoints included new-onset atrial fibrillation (AF)/atrial flutter and bleeding.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Compared with antiplatelet therapy, PFO closure significantly reduced the risk of composite outcome (odds ratio [OR] 0.37, 95% confidence interval [CI] 0.27-0.51), stroke (OR 0.22, 95% CI 0.13-0.36], and TIA (OR 0.57, 95% CI 0.34-0.98); Compared with the mixed medical therapy group (consist of antiplatelet therapy, anticoagulant therapy, or both), PFO closure still showed some benefits, but the effect was not as significant as that of antiplatelet therapy (composite outcome: OR 0.53, 95% CI 0.41-0.69; stroke: OR 0.48, 95% CI 0.34-0.68; TIA: OR 0.69, 95% CI 0.50-0.96); Compared with anticoagulant therapy, PFO closure showed no benefit (composite outcome: OR 0.77, 95% CI 0.46-1.28; stroke: OR 0.59, 95% CI 0.28-1.25; TIA: OR 1.01, 95% CI 0.50-2.04). In terms of safe endpoints, compared with antiplatelet therapy and anticoagulant therapy, PFO closure increased the risk of AF/atrial flutter (OR 9.56, 95% CI 2.85-32.06; OR 18.96, 95% CI 1.11-323.8, respectively) and reduced the risk of bleeding (OR 0.50, 95% CI 0.24-1.05; OR 0.13, 95% CI 0.04-0.46, respectively); compared with mixed medical therapy, PFO closure increased the risk of AF/atrial flutter (OR 4.40,95% CI 2.24-8.67), but there was no difference in bleeding (OR 0.97, 95% CI 0.56-1.68).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">With the addition of anticoagulants, the benefit of PFO closure decreased gradually. Patient groups that adopt individualized medical therapy strategies may benefit more.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Xuemei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Ultrasound, The Third People's Hospital of Yichang City.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Liang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Ultrasound, The First College of Clinical Medical Sciences, China Three Gorges University, Yichang, Hubei Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Chang</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3899-690</Identifier><AffiliationInfo><Affiliation>Department of Ultrasound, The First College of Clinical Medical Sciences, China Three Gorges University, Yichang, Hubei Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zhi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Ultrasound, The Third People's Hospital of Yichang City.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Heng</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Ultrasound, The First College of Clinical Medical Sciences, China Three Gorges University, Yichang, Hubei Province, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010975">Platelet Aggregation Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="N">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001282" MajorTopicYN="N">Atrial Flutter</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054092" MajorTopicYN="N">Foramen Ovale, Patent</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="N">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000083242" MajorTopicYN="N">Ischemic Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010975" MajorTopicYN="N">Platelet Aggregation Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055502" MajorTopicYN="N">Secondary Prevention</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors report no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>23</Day><Hour>12</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>6</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34160457</ArticleId><ArticleId IdType="pmc">PMC8238362</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000026473</ArticleId><ArticleId IdType="pii">00005792-202106250-00080</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 2000;55:1172&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">11071496</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaghi S, Bernstein RA, Passman R, et al. . Cryptogenic stroke: research and practice. Circ Res 2017;20:527&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">28154102</ArticleId></ArticleIdList></Reference><Reference><Citation>Nayor M, Maron BA. Contemporary Approach to paradoxical embolism. Circulation 2014;129:1892&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4053687</ArticleId><ArticleId IdType="pubmed">24799505</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Li D, Bai F, et al. . Patent foramen ovale closure or medical therapy for secondary prevention of cryptogenic stroke: an update meta-analysis of randomized controlled trials. Medicine (Baltimore) 2018;97:e11965.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6112940</ArticleId><ArticleId IdType="pubmed">30142823</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasceri V, Pelliccia F, Bressi E, et al. . Net clinical benefit of patent foramen ovale closure in patients with cryptogenic stroke: Meta-analysis and meta-regression of randomized trials. Int J Cardiol 2018;266:75&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">29887476</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, et al. . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009;151:264&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">19622511</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011.</Citation></Reference><Reference><Citation>Wells GA, Shea B, O&#x2019;Connell D, et al. . The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Metaanalyses. Ottawa, Ontario, Canada: Ottawa Hospital Research Institute; 2013.</Citation></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trial 1986;7:177&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, et al. . Measuring inconsistency in meta-analyses. BMJ 2003;327:557&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med 2004;23:1351&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">15116347</ArticleId></ArticleIdList></Reference><Reference><Citation>Furlan AJ, Reisman M, Massaro J, et al. . Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med 2012;366:991&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">22417252</ArticleId></ArticleIdList></Reference><Reference><Citation>Mas JL, Derumeaux G, Guillon B, et al. . Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N Engl J Med 2017;377:1011&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">28902593</ArticleId></ArticleIdList></Reference><Reference><Citation>Saver JL, Carroll JD, Thaler DE, et al. . Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med 2017;377:1022&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">28902590</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf8;ndergaard L, Kasner SE, Rhodes JF, et al. . Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med 2017;377:1033&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">28902580</ArticleId></ArticleIdList></Reference><Reference><Citation>Meier B, Kalesan B, Mattle HP, et al. . Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med 2013;368:1083&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">23514285</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee PH, Song JK, Kim JS, et al. . Cryptogenic stroke and high-risk patent foramen ovale: The DEFENSE-PFO trial. J Am Coll Cardiol 2018;71:2335&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">29544871</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahl A, J&#xfc;ni P, Mono ML, et al. . Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism. Circulation 2012;125:803&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">22238228</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim M, Kim S, Moon J, et al. . Effect of patent foramen ovale closure for prevention on recurrent stroke or transient ischemic attack in selected patients with cryptogenic stroke. J Interv Cardiol 2018;31:368&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">28833599</ArticleId></ArticleIdList></Reference><Reference><Citation>Alushi B, Biasco L, Orzan F, et al. . Patent foramen ovale treatment strategy: an Italian large prospective study. J Cardiovasc Med 2014;15:761&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">24978876</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon J, Kang WC, Kim S, et al. . Comparison of outcomes after device closure and medication alone in patients with patent foramen Ovale and cryptogenic stroke in Korean population. Yonsei Med J 2016;57:621&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4800350</ArticleId><ArticleId IdType="pubmed">26996560</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrer JU, Wessels T, Franke A, et al. . Stroke recurrence and its prevention in patients with patent foramen ovale. Can J Neurol Sci 2006;33:39&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">16583720</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzucco S, Bovi P, Carletti M, et al. . A model of multi-disciplinary approach to the diagnosis and treatment of young patients with cryptogenic stroke and patent foramen ovale. Cardiol Young 2012;22:327&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">22348793</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JY, Song JK, Song JM, et al. . Association between anatomic features of atrial septal abnormalities obtained by omni-plane transesophageal echocardiography and stroke recurrence in cryptogenic stroke patients with patent foramen ovale. Am J Cardiol 2010;106:129&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">20609660</ArticleId></ArticleIdList></Reference><Reference><Citation>Windecker S, Wahl A, Nedeltchev K, et al. . Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardio 2004;44:750&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">15312853</ArticleId></ArticleIdList></Reference><Reference><Citation>Pezzini A, Grassi M, Lodigiani C, et al. . Propensity score-based analysis of percutaneous closure versus medical therapy in patients with cryptogenic stroke and patent foramen ovale: the IPSYS registry (Italian project on stroke in young adults). Circ Cardiovasc Interv 2016;9:e003470.</Citation><ArticleIdList><ArticleId IdType="pubmed">27582111</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerrato P, Priano L, Imperiale D, et al. . Recurrent cerebrovascular ischaemic events in patients with interatrial septal abnormalities: a follow-up study. Neurol Sci 2006;26:411&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16601933</ArticleId></ArticleIdList></Reference><Reference><Citation>Casaubon L, McLaughlin P, Webb G, et al. . Recurrent stroke/TIA in cryptogenic stroke patients with patent foramen ovale. Can J Neurol Sci 2007;34:74&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">17352351</ArticleId></ArticleIdList></Reference><Reference><Citation>Paciaroni M, Agnelli G, Bertolini A, et al. . Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (foramen Ovale Registro Italiano) study. Cerebrovasc Dis 2011;31:109&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">21088390</ArticleId></ArticleIdList></Reference><Reference><Citation>Thanopoulos BV, Dardas PD, Karanasios E, et al. . Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke. Catheter Cardiovasc Interv 2006;68:741&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">17039525</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg A, Thawabi M, Rout A, et al. . Recurrent stroke reduction with patent foramen ovale closure versus medical therapy based on PFO characteristics: a meta-analysis of randomized controlled trials. Cardiology 2019;144:40&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">31574522</ArticleId></ArticleIdList></Reference><Reference><Citation>Patti G, Pelliccia F, Gaudio C, et al. . Meta-analysis of net long-term benefit of different therapeutic strategies in patients with cryptogenic stroke and patent foramen ovale. Am J Cardiol 2015;115:837&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">25620037</ArticleId></ArticleIdList></Reference><Reference><Citation>Messe SR, Gronseth G, Kent DM, et al. . Practice advisory: recurrent stroke with patent foramen ovale (update of practice parameter): report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology. Neurology 2016;87:815&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4999319</ArticleId><ArticleId IdType="pubmed">27466464</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39627856</PMID><DateCompleted><Year>2024</Year><Month>12</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1537-4505</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>Otology &amp; neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology</Title><ISOAbbreviation>Otol Neurotol</ISOAbbreviation></Journal><ArticleTitle>Cardiovascular Diseases and Sensorineural Hearing Loss-A Systematic Review of the Literature.</ArticleTitle><Pagination><StartPage>23</StartPage><EndPage>30</EndPage><MedlinePgn>23-30</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/MAO.0000000000004380</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To assess the relationship of cardiovascular disease (CVD) and sensorineural hearing loss (SNHL).</AbstractText><AbstractText Label="DATABASES REVIEWED" NlmCategory="UNASSIGNED">Ovid MEDLINE, Web of Science, Scopus, and Cochrane.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review was performed. Studies were identified using Ovid MEDLINE, Web of Science, Scopus, and Cochrane from 1946 to 2023. Per Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, abstracts were screened for primary review. Full texts were reviewed for secondary review.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There were 3,440 unique abstracts screened. After primary review of abstracts and secondary full text review, 68 articles were included. The relationship between SNHL and the following CVDs, risk factors, and interventions were ascertained: coronary artery bypass graft (CABG) surgery, coronary artery disease (CAD), carotid stenosis (CS), myocardial infarction (MI), percutaneous coronary intervention (PCI), other arteriosclerosis, cerebral small vascular disease, cerebrovascular accident (CVA), transient ischemic attack (TIA), peripheral vascular disease (PVD), hyperlipidemia (HLD), hypertension (HTN), and diabetes mellitus (DM). CABG and CAD were consistently associated with SNHL. DM was associated with SNHL, but HTN and HLD were not consistently associated.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">There is a complex relationship between CVDs and SNHL. CABG and CAD were consistently associated with SNHL. DM was associated with SNHL, but other CVD risk factors (HTN and HLD) did not appear to consistently correlate with SNHL, raising consideration that SNHL is a later finding in those with CVD.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024, Otology &amp; Neurotology, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Berezovsky</LastName><ForeName>Anna N</ForeName><Initials>AN</Initials><Identifier Source="ORCID">0000-0002-2084-8397</Identifier><AffiliationInfo><Affiliation>Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin, Milwaukee, WI.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Espahbodi</LastName><ForeName>Mana</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, University of Utah School of Medicine, Salt Lake City, UT.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>LaPrade</LastName><ForeName>Samantha L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin, Milwaukee, WI.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Friedland</LastName><ForeName>David R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin, Milwaukee, WI.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harris</LastName><ForeName>Michael S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin, Milwaukee, WI.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Otol Neurotol</MedlineTA><NlmUniqueID>100961504</NlmUniqueID><ISSNLinking>1531-7129</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006319" MajorTopicYN="Y">Hearing Loss, Sensorineural</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="Y">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors disclose no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>12</Day><Hour>18</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>4</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>3</Day><Hour>23</Hour><Minute>59</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39627856</ArticleId><ArticleId IdType="doi">10.1097/MAO.0000000000004380</ArticleId><ArticleId IdType="pii">00129492-202501000-00005</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cardiovascular diseases (CVDs). Updated June 11, 2021. Accessed March 1, 2023. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases- (cvds)</Citation></Reference><Reference><Citation>Jung W, Kim J, Cho IY, Jeon KH, Song YM. Association between serum lipid levels and sensorineural hearing loss in Korean adult population. Korean J Fam Med 2022;43:334&#x2013;43.</Citation></Reference><Reference><Citation>About Multiple Cause of Death, 1999&#x2013;2020. Accessed February 21, 2022. https://wonder.cdc.gov/mcd-icd10.html</Citation></Reference><Reference><Citation>Shargorodsky J, Curhan SG, Eavey R, Curhan GC. A prospective study of cardiovascular risk factors and incident hearing loss in men. Laryngoscope 2010;120:1887&#x2013;91.</Citation></Reference><Reference><Citation>Huddle MG, Goman AM, Kernizan FC, et al. The economic impact of adult hearing loss: a systematic review. JAMA Otolaryngol Head Neck Surg 2017;143:1040&#x2013;8.</Citation></Reference><Reference><Citation>Friedland DR, Cederberg C, Tarima S. Audiometric pattern as a predictor of cardiovascular status: development of a model for assessment of risk. Laryngoscope 2009;119:473&#x2013;86.</Citation></Reference><Reference><Citation>Agrawal Y, Platz EA, Niparko JK. Risk factors for hearing loss in US adults: data from the National Health and Nutrition Examination Survey, 1999 to 2002. Otol Neurotol 2009;30:139&#x2013;45.</Citation></Reference><Reference><Citation>Schuknecht HF, Gacek MR. Cochlear pathology in presbycusis. Ann Otol Rhinol Laryngol 1993;102(1 Pt 2):1&#x2013;16.</Citation></Reference><Reference><Citation>Schardt C, Adams MB, Owens T, Keitz S, Fontelo P. Utilization of the PICO framework to improve searching PubMed for clinical questions. BMC Med Inform Decis Mak 2007;7:16.</Citation></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009;6:e1000100.</Citation></Reference><Reference><Citation>Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan&#x2014;a web and mobile app for systematic reviews. Syst Rev 2016;5:210.</Citation></Reference><Reference><Citation>EndNote. Version EndNote 20. Clarivate; 2013.</Citation></Reference><Reference><Citation>Moola S, Munn Z, Sears K, et al. Conducting systematic reviews of association (etiology): the Joanna Briggs Institute's approach. Int J Evid Based Healthc 2015;13:163&#x2013;9.</Citation></Reference><Reference><Citation>Tyagi S, Friedland DR, Rein L, et al. Abnormal hearing patterns are not associated with endothelium-dependent vasodilation and carotid intima-media thickness: the Framingham heart study. Vasc Med 2021;26:595&#x2013;601.</Citation></Reference><Reference><Citation>Munjal SK, Malik P, Sharma A, Panda NK, Thingnum SK. Effects of cardiopulmonary bypass surgery on auditory function: a preliminary study. ISRN Otolaryngol 2013;2013:453920.</Citation></Reference><Reference><Citation>Iriz A, Cagli K, Gocer C, et al. Effects of open heart surgery on hearing thresholds measured by high frequency audiometry. J Laryngol Otol 2008;122:795&#x2013;8.</Citation></Reference><Reference><Citation>Gates GA, Cobb JL, D'Agostino RB, Wolf PA. The relation of hearing in the elderly to the presence of cardiovascular disease and cardiovascular risk factors. Arch Otolaryngol Head Neck Surg 1993;119:156&#x2013;61.</Citation></Reference><Reference><Citation>Sommer J, Brennan-Jones CG, Eikelboom RH, et al. A population-based study of the association between dysglycaemia and hearing loss in middle age. Diabet Med 2017;34:683&#x2013;90.</Citation></Reference><Reference><Citation>Yoshioka M, Uchida Y, Sugiura S, et al. The impact of arterial sclerosis on hearing with and without occupational noise exposure: a population-based aging study in males. Auris Nasus Larynx 2010;37:558&#x2013;64.</Citation></Reference><Reference><Citation>Lee JS, Choi HG, Jang JH, et al. Analysis of predisposing factors for hearing loss in adults. J Korean Med Sci 2015;30:1175&#x2013;82.</Citation></Reference><Reference><Citation>Michaud DS, Marro L, McNamee JP. High frequency hearing impairment and cardiovascular disease in Canada: results from the Canadian Health Measures Survey. J Acoust Soc Am 2021;150:1001.</Citation></Reference><Reference><Citation>Kim SJ, Reed N, Betz JF, et al. Association between microvascular retinal signs and age-related hearing loss in the atherosclerosis risk in communities neurocognitive study (ARIC-NCS). JAMA Otolaryngol Head Neck Surg 2020;146:152&#x2013;9.</Citation></Reference><Reference><Citation>Cruickshanks KJ, Nondahl DM, Dalton DS, et al. Smoking, central adiposity, and poor glycemic control increase risk of hearing impairment. J Am Geriatr Soc 2015;63:918&#x2013;24.</Citation></Reference><Reference><Citation>Eckert MA, Kuchinsky SE, Vaden KI, et al. White matter hyperintensities predict low frequency hearing in older adults. J Assoc Res Otolaryngol 2013;14:425&#x2013;33.</Citation></Reference><Reference><Citation>Sharma S, Prajapati V, Sharma A, Tan BYQ, Sharma VK. Hearing impairment in stroke patients- findings from a pilot study conducted in India. Indian J Otolaryngol Head Neck Surg 2022;74(Suppl 1):651&#x2013;7.</Citation></Reference><Reference><Citation>Koohi N, Vickers DA, Lakshmanan R, et al. Hearing characteristics of stroke patients: prevalence and characteristics of hearing impairment and auditory processing disorders in stroke patients. J Am Acad Audiol 2017;28:491&#x2013;505.</Citation></Reference><Reference><Citation>Michaud JL, H&#xe9;on E, Guilbert F, et al. Natural history of Alstrom syndrome in early childhood: onset with dilated cardiomyopathy. J Pediatr 1996;128:225&#x2013;9.</Citation></Reference><Reference><Citation>Zheng J, Cheng Y, Zhan Y, et al. Cardiocerebrovascular risk in sensorineural hearing loss: results from the National Health and nutrition examination survey 2015 to 2018. Front Neurol 2023;14:1115252.</Citation></Reference><Reference><Citation>Bae SH, Kwak SH, Choi JY, Jung J. Synergistic effect of smoking on age-related hearing loss in patients with diabetes. Sci Rep 2020;10:18893.</Citation></Reference><Reference><Citation>Choi JS, Wu F, Park S, et al. Factors associated with unilateral hearing loss and impact on communication in US adults. Otolaryngol Head Neck Surg 2021;165:868&#x2013;75.</Citation></Reference><Reference><Citation>Rigters SC, Metselaar M, Wieringa MH, et al. Contributing determinants to hearing loss in elderly men and women: results from the population-based Rotterdam study. Audiol Neurootol 2016;21:10&#x2013;5.</Citation></Reference><Reference><Citation>Chongvisal S, Supavanich W, Thongyai K, et al. Hearing and balance survey in Thai elders. Article Siriraj Med J 2019;71:131&#x2013;42.</Citation></Reference><Reference><Citation>Dement J, Welch LS, Ringen K, Cranford K, Quinn P. Hearing loss among older construction workers: updated analyses. Am J Ind Med 2018;61:326&#x2013;35.</Citation></Reference><Reference><Citation>Kim H, Ha J, Park HY. Pure tone audiometry threshold changes for 10 years in the same individuals of general population: a retrospective cohort study. Ann Otol Rhinol Laryngol 2019;128:433&#x2013;40.</Citation></Reference><Reference><Citation>Kim H, Lee J-J, Moon Y, Park HY. Longitudinal pure-tone threshold changes in the same subjects: analysis of factors affecting hearing. Laryngoscope 2019;129:470&#x2013;6.</Citation></Reference><Reference><Citation>Gopinath B, Flood VM, Teber E, McMahon CM, Mitchell P. Dietary intake of cholesterol is positively associated and use of cholesterol-lowering medication is negatively associated with prevalent age-related hearing loss. J Nutr 2011;141:1355&#x2013;61.</Citation></Reference><Reference><Citation>Odeh OI, Kuti MA, Fasunla AJ, Nwaorgu OG. Sensorineural hearing loss and dyslipidemia: is there any relationship? West Afr J Med 2015;34:27&#x2013;31.</Citation></Reference><Reference><Citation>Preyer S, Baisch A, Bless D, Gummer AW. Distortion product otoacoustic emissions in human hypercholesterolemia. Hear Res 2001;152(1&#x2013;2):139&#x2013;51.</Citation></Reference><Reference><Citation>Mick PT, Kabir R, Pichora-Fuller MK, et al. Associations between cardiovascular risk factors and audiometric hearing: findings from the Canadian longitudinal study on aging. Ear Hear 2023;44:1332&#x2013;43.</Citation></Reference><Reference><Citation>Baiduc RR, Spankovich C, Vu TH, et al. Jackson heart study: aggregate cardiovascular disease risk and auditory profiles. Laryngoscope Investig Otolaryngol 2023;8:495&#x2013;504.</Citation></Reference><Reference><Citation>Del Vecchio V, Tricarico L, Pisani A, et al. Vascular factors in patients with midlife sensorineural hearing loss and the progression to mild cognitive impairment. Medicina (Kaunas) 2023;59:481.</Citation></Reference><Reference><Citation>Jones NS, Davis A. A prospective case-control study of 50 consecutive patients presenting with hyperlipidaemia. Clin Otolaryngol Allied Sci 2001;26:189&#x2013;96.</Citation></Reference><Reference><Citation>Suzuki K, Kaneko M, Murai K. Influence of serum lipids on auditory function. Laryngoscope 2000;110(10 Pt 1):1736&#x2013;8.</Citation></Reference><Reference><Citation>Przewozny T, Gojska-Grymajlo A, Kwarciany M, et al. Hypertension is associated with dysfunction of both peripheral and central auditory system. J Hypertens 2016;34:736&#x2013;44.</Citation></Reference><Reference><Citation>Ravi Babu P, Durga Prasad B, Sowmya L, Krishna Sasanka KSBS. Clinical outcomes of systemic hypertension on inner ear functions. Article Indian J Public Health 2016;7:268&#x2013;71.</Citation></Reference><Reference><Citation>Rolim LP, Samelli AG, Moreira RR, et al. Effects of diabetes mellitus and systemic arterial hypertension on elderly patients' hearing. Braz J Otorhinolaryngol 2018;84:754&#x2013;63.</Citation></Reference><Reference><Citation>Cruickshanks KJ, Dhar S, Dinces E, et al. Hearing impairment prevalence and associated risk factors in the Hispanic Community Health Study/Study of Latinos. JAMA Otolaryngol Head Neck Surg 2015;141:641&#x2013;8.</Citation></Reference><Reference><Citation>Helzner EP, Cauley JA, Pratt SR, et al. Race and sex differences in age-related hearing loss: the health, aging and body composition study. J Am Geriatr Soc 2005;53:2119&#x2013;27.</Citation></Reference><Reference><Citation>Nawaz MU, Vinayak S, Rivera E, et al. Association between hypertension and hearing loss. Cureus 2021;13:e18025.</Citation></Reference><Reference><Citation>Baiduc RR, Ramsey M, Sanders A, Vance EA. Association between nonoptimal blood pressure and cochlear function. Ear Hear 2021;42:393&#x2013;404.</Citation></Reference><Reference><Citation>Meneses-Barriviera CL, Bazoni JA, Doi MY, Marchiori LLM. Probable association of hearing loss, hypertension and diabetes mellitus in the elderly. Int Arch Otorhinolaryngol 2018;22:337&#x2013;41.</Citation></Reference><Reference><Citation>Morita Y, Sasaki T, Takahashi K, et al. Age-related hearing loss is strongly associated with cognitive decline regardless of the APOE4 polymorphism. Otol Neurotol 2019;40:1263&#x2013;7.</Citation></Reference><Reference><Citation>Soares MA, Sanches SG, Matas CG, Samelli AG. The audiological profile of adults with and without hypertension. Clinics (Sao Paulo) 2016;71:187&#x2013;92.</Citation></Reference><Reference><Citation>Samelli AG, Santos IS, Padilha FYOMM, et al. Hearing loss, tinnitus, and hypertension: analysis of the baseline data from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Clinics (Sao Paulo) 2021;76:e2370.</Citation></Reference><Reference><Citation>Oh KH, Cho H, Lee SK, Shin C, Choi J. Characteristics of hearing loss among older adults in the Korean genome and epidemiology study: a community-based longitudinal cohort study with an 8-year follow-up. Clin Exp Otorhinolaryngol 2023;16:132&#x2013;40.</Citation></Reference><Reference><Citation>Ting J, Jiang K, Du S, et al. Longitudinal blood pressure patterns from mid- to late life and late-life hearing loss in the atherosclerosis risk in communities study. J Gerontol A Biol Sci Med Sci 2022;77:640&#x2013;6.</Citation></Reference><Reference><Citation>Kasemsuwan L, Sriwanyong S, Krittiyawong S, Sunetrworakul J, Jiamsuchon K. Hearing in young diabetic patients. J Med Assoc Thai 2001;84:1389&#x2013;94.</Citation></Reference><Reference><Citation>Lasagni A, Giordano P, Lacilla M, et al. Cochlear, auditory brainstem responses in type 1 diabetes: relationship with metabolic variables and diabetic complications. Diabet Med 2016;33:1260&#x2013;7.</Citation></Reference><Reference><Citation>Ma FC, Gomez-Marin O, Lee DJ, Balkany T. Diabetes and hearing impairment in Mexican American adults: a population-based study. J Laryngol Otol 1998;112:835&#x2013;9.</Citation></Reference><Reference><Citation>Samelli AG, Santos IS, Moreira RR, et al. Diabetes mellitus and sensorineural hearing loss: is there an association? Baseline of the Brazilian longitudinal study of adult health (ELSA-Brasil). Clinics (Sao Paulo) 2017;72:5&#x2013;10.</Citation></Reference><Reference><Citation>Ozkurt FE, Akdag M, Tuna MM, et al. Hearing impairment in middle-aged patients with diabetes. Biotechnol Biotechnol Equip 2016;30:737&#x2013;41.</Citation></Reference><Reference><Citation>Vaughan N, James K, McDermott D, Griest S, Fausti S. A 5-year prospective study of diabetes and hearing loss in a veteran population. Otol Neurotol 2006;27:37&#x2013;43.</Citation></Reference><Reference><Citation>Cayonu M, Capraz M, Acar A, Altundag A, Salihoglu M. Hearing loss related with type 2 diabetes in an elderly population. J Int Adv Otol 2014;10:72&#x2013;5.</Citation></Reference><Reference><Citation>Loader B, Stokic D, Riedl M, et al. Combined analysis of audiologic performance and the plasma biomarker stromal cell-derived factor 1a in type 2 diabetic patients. Otol Neurotol 2008;29:739&#x2013;44.</Citation></Reference><Reference><Citation>Ren HH, Wang ZG, Mao ZY, et al. Hearing loss in type 2 diabetes in association with diabetic neuropathy. Arch Med Res 2017;48:631&#x2013;7.</Citation></Reference><Reference><Citation>Ren J, Zhao P, Chen L, et al. Hearing loss in middle-aged subjects with type 2 diabetes mellitus. Arch Med Res 2009;40:18&#x2013;23.</Citation></Reference><Reference><Citation>Uchida Y, Sugiura S, Ando F, Nakashima T, Shimokata H. Diabetes reduces auditory sensitivity in middle-aged listeners more than in elderly listeners: a population- based study of age-related hearing loss. Med Sci Monit 2010;16:PH63&#x2013;8.</Citation></Reference><Reference><Citation>Ulu S, Bucak A, Ulu MS, et al. Neutrophil-lymphocyte ratio as a new predictive and prognostic factor at the hearing loss of diabetic patients. Eur Arch Otorhinolaryngol 2014;271:2681&#x2013;6.</Citation></Reference><Reference><Citation>Horv&#xe1;th M, Herold Z, K&#xfc;stel M, et al. Changes in the cochlear and retrocochlear parts of the auditory system in 19&#x2013;39 and 40&#x2013;60 years old patients with type 1 diabetes mellitus. PLoS One 2023;18:e0285740.</Citation></Reference><Reference><Citation>Bainbridge KE, Hoffman HJ, Cowie CC. Diabetes and hearing impairment in the United States: audiometric evidence from the National Health and Nutrition Examination Survey, 1999 to 2004. Ann Intern Med 2008;149:1&#x2013;10.</Citation></Reference><Reference><Citation>Frisina ST, Mapes F, Kim S, Frisina DR, Frisina RD. Characterization of hearing loss in aged type II diabetics. Hear Res 2006;211(1&#x2013;2):103&#x2013;13.</Citation></Reference><Reference><Citation>Li J, Zhang Y, Fu X, et al. Alteration of auditory function in type 2 diabetic and pre-diabetic patients. Acta Otolaryngol 2018;138:542&#x2013;7.</Citation></Reference><Reference><Citation>Ozel HE, Ozkiris M, Gencer ZK, Saydam L. Audiovestibular functions in noninsulin-dependent diabetes mellitus. Acta Otolaryngol 2014;134:51&#x2013;7.</Citation></Reference><Reference><Citation>Mitchell P, Gopinath B, McMahon CM, et al. Relationship of type 2 diabetes to the prevalence, incidence and progression of age-related hearing loss. Diabet Med 2009;26:483&#x2013;8.</Citation></Reference><Reference><Citation>Venkatasubbaiah C, Ananth R, Ahmed SM. An analysis and comparison of brainstem auditory evoked potentials among South Indian middle-aged and elderly subjects and patients with type II diabetes mellitus. J Evol Med Dent Sci 2016;5:4332&#x2013;6.</Citation></Reference><Reference><Citation>Konrad-Martin D, Reavis KM, Austin D, et al. Hearing impairment in relation to severity of diabetes in a veteran cohort. Ear Hear 2015;36:381&#x2013;94.</Citation></Reference><Reference><Citation>Mozaffari M, Tajik A, Ariaei N, Ali-Ehyaii F, Behnam H. Diabetes mellitus and sensorineural hearing loss among non-elderly people. East Mediterr Health J 2010;16:947&#x2013;52.</Citation></Reference><Reference><Citation>Wackym PA, Linthicum FH Jr. Diabetes mellitus and hearing loss: clinical and histopathologic relationships. Am J Otol 1986;7:176&#x2013;82.</Citation></Reference><Reference><Citation>Malakar AK, Choudhury D, Halder B, et al. A review on coronary artery disease, its risk factors, and therapeutics. J Cell Physiol 2019;234:16812&#x2013;23.</Citation></Reference><Reference><Citation>Lu L, Liu M, Sun R, Zheng Y, Zhang P. Myocardial infarction: symptoms and treatments. Cell Biochem Biophys 2015;72:865&#x2013;7.</Citation></Reference><Reference><Citation>Helzner EP, Patel AS, Pratt S, et al. Hearing sensitivity in older adults: associations with cardiovascular risk factors in the health, aging and body composition study. J Am Geriatr Soc 2011;59:972&#x2013;9.</Citation></Reference><Reference><Citation>Kim C, Sohn JH, Jang MU, et al. Ischemia as a potential etiologic factor in idiopathic unilateral sudden sensorineural hearing loss: analysis of posterior circulation arteries. Hear Res 2016;331:144&#x2013;51.</Citation></Reference><Reference><Citation>Arenberg IK, Allen GW, Deboer A. Sudden deafness immediately following cardiopulmonary bypass. J Laryngol Otol 1972;86:73&#x2013;7.</Citation></Reference><Reference><Citation>Sadeghi MM, Radman M, Bidaki R, Sonbolestan M. Sensorineural hearing loss in patients with coronary artery bypass surgery. Adv Biomed Res 2013;2:5.</Citation></Reference><Reference><Citation>Tan CJ, Koh JWT, Tan BKJ, et al. Association between hearing loss and cardiovascular disease: a meta-analysis. Otolaryngol Head Neck Surg 2024;170:694&#x2013;707.</Citation></Reference><Reference><Citation>Grotta JC. Clinical practice. N Engl J Med 2013;369:1143&#x2013;50.</Citation></Reference><Reference><Citation>Emery DJ, Ferguson RD, Williams JS. Pulsatile tinnitus cured by angioplasty and stenting of petrous carotid artery stenosis. Arch Otolaryngol Head Neck Surg 1998;124:460&#x2013;1.</Citation></Reference><Reference><Citation>Bains NK, Early E, French BR, et al. Effect of angioplasty and stent placement on sensorineural hearing loss and pulsatile tinnitus in a patient with severe internal carotid artery stenosis. J Stroke Cerebrovasc Dis 2022;31:106718.</Citation></Reference><Reference><Citation>Torpy JM, Glass TJ, Glass RM. Retinopathy. JAMA 2007;298:944&#x2013;4.</Citation></Reference><Reference><Citation>Nomiya R, Nomiya S, Kariya S, et al. Generalized arteriosclerosis and changes of the cochlea in young adults. Otol Neurotol 2008;29:1193&#x2013;7.</Citation></Reference><Reference><Citation>Chojdak-&#x141;ukasiewicz J, Dziadkowiak E, Zimny A, Paradowski B. Cerebral small vessel disease: a review. Adv Clin Exp Med 2021;30:349&#x2013;56.</Citation></Reference><Reference><Citation>Powers WJ. Acute ischemic stroke. N Engl J Med 2020;383:252&#x2013;60.</Citation></Reference><Reference><Citation>Amarenco P. Transient ischemic attack. N Engl J Med 2020;382:1933&#x2013;41.</Citation></Reference><Reference><Citation>Koga K, Hakuba N, Watanabe F, et al. Transient cochlear ischemia causes delayed cell death in the organ of Corti: an experimental study in gerbils. J Comp Neurol 2003;456:105&#x2013;11.</Citation></Reference><Reference><Citation>Khosravipour M, Rajati F. Sensorineural hearing loss and risk of stroke: a systematic review and meta-analysis. Sci Rep 2021;11:11021.</Citation></Reference><Reference><Citation>Sontheimer DL. Peripheral vascular disease: diagnosis and treatment. Am Fam Physician 2006;73:1971&#x2013;6.</Citation></Reference><Reference><Citation>Alloubani A, Nimer R, Samara R. Relationship between hyperlipidemia, cardiovascular disease and stroke: a systematic review. Curr Cardiol Rev 2021;17:e051121189015.</Citation></Reference><Reference><Citation>Simpson AN, Matthews LJ, Dubno JR. Lipid and C-reactive protein levels as risk factors for hearing loss in older adults. Otolaryngol Head Neck Surg 2013;148:664&#x2013;70.</Citation></Reference><Reference><Citation>Lee YY, Choo O-S, Kim YJ, et al. Atorvastatin prevents hearing impairment in the presence of hyperlipidemia. Biochim Biophys Acta Mol Cell Res 1867;2020:118850.</Citation></Reference><Reference><Citation>Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2018;71:e13&#x2013;e115.</Citation></Reference><Reference><Citation>Elliott WJ. Systemic hypertension. Curr Probl Cardiol 2007;32:201&#x2013;59.</Citation></Reference><Reference><Citation>Przewozny T, Gojska-Grymajlo A, Kwarciany M, Gasecki D, Narkiewicz K. Hypertension and cochlear hearing loss. Blood Press 2015;24:199&#x2013;205.</Citation></Reference><Reference><Citation>Pippitt K, Li M, Gurgle HE. Diabetes mellitus: screening and diagnosis. Am Fam Physician 2016;93:103&#x2013;9.</Citation></Reference><Reference><Citation>Leon BM, Maddox TM. Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes 2015;6:1246&#x2013;58.</Citation></Reference><Reference><Citation>Austin DF, Konrad-Martin D, Griest S, et al. Diabetes-related changes in hearing. Laryngoscope 2009;119:1788&#x2013;96.</Citation></Reference><Reference><Citation>Fukushima H, Cureoglu S, Schachern PA, et al. Effects of type 2 diabetes mellitus on cochlear structure in humans. Arch Otolaryngol Head Neck Surg 2006;132:934&#x2013;8.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38417474</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1535-6280</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>May</Month></PubDate></JournalIssue><Title>Current problems in cardiology</Title><ISOAbbreviation>Curr Probl Cardiol</ISOAbbreviation></Journal><ArticleTitle>Transcarotid versus trans-axillary/subclavian transcatheter aortic valve replacement (TAVR): A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>102488</StartPage><MedlinePgn>102488</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cpcardiol.2024.102488</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0146-2806(24)00127-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Transcatheter Aortic Valve Replacement (TAVR) is the treatment of choice in patients with severe aortic stenosis. Transcarotid (TCa) or Trans-axillary/subclavian (TAx/Sc) are safer and less invasive non-femoral approaches, where transfemoral access is difficult or impossible to obtain.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This meta-analysis was performed based on PRISMA guidelines after registering in PROSPERO (CRD42023482842). This meta-analysis was performed to compare the safety of the transcarotid and trans-axillary/subclavian approach for TAVR including studies from inception to October 2023.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Seven studies with a total of 6227 patients were included in the analysis (TCa: 2566; TAx/Sc: 3661). Transcarotid TAVR approach had a favorable trend for composite of stroke and all-cause mortality (OR 0.79, CI 0.60-1.04), all-cause mortality, stroke, major vascular complication, and new requirement of permanent pacemaker though those were statistically insignificant. On sub-analysis of the results of the studies based on the territory (USA vs French), composite outcome of all cause mortality, stroke and major bleeding (OR 0.54, CI 0.54-0.81), composite of stroke and all cause mortality (OR 0.64, CI 0.50-0.81), and stroke/TIA (OR 0.53, CI 0.39-0.73) showed lower odds of occurrence among patient managed with TCa approach in the American cohort.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Overall, transcarotid approach had favorable though statistically insignificant odds for composite (stroke and all-cause mortality) and individual outcomes (stroke, all-cause mortality, etc.). There are significant variations in observed outcomes based on study's geographic location. Large prospective randomized clinical trials comparing the two approaches with representative samples are necessary to guide the clinicians in choosing among these approaches.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dawadi</LastName><ForeName>Sagun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Nepalese Army Institute of Health Sciences, Kathmandu, 44600, Nepal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oli</LastName><ForeName>Prakash Raj</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Province Hospital, Birendranagar, Surkhet, Karnali Province 21700, Nepal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shrestha</LastName><ForeName>Dhan Bahadur</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Mount Sinai Hospital, Chicago, IL 60608, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shtembari</LastName><ForeName>Jurgen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Mount Sinai Hospital, Chicago, IL 60608, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pant</LastName><ForeName>Kailash</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Cardiovascular Medicine, University of Illinois College of Medicine, OSF Healthcare, Peoria, IL 61614, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shrestha</LastName><ForeName>Bishesh</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine, Bassett Medical Center, 1 Atwell Rd, Cooperstown, NY 13326, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mattumpuram</LastName><ForeName>Jishanth</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine, University of Louisville School of Medicine, 550 S Jackson St, Louisville, KY 40202, USA. Electronic address: jishanth.mattumpuram@louisville.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katz</LastName><ForeName>Daniel H</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine, Bassett Medical Center, 1 Atwell Rd, Cooperstown, NY 13326, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Curr Probl Cardiol</MedlineTA><NlmUniqueID>7701802</NlmUniqueID><ISSNLinking>0146-2806</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065467" MajorTopicYN="Y">Transcatheter Aortic Valve Replacement</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001024" MajorTopicYN="Y">Aortic Valve Stenosis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001366" MajorTopicYN="Y">Axillary Artery</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013348" MajorTopicYN="Y">Subclavian Artery</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002339" MajorTopicYN="N">Carotid Arteries</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001021" MajorTopicYN="N">Aortic Valve</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Trans-axillary/subclavian TAVR</Keyword><Keyword MajorTopicYN="N">Transcarotid TAVR</Keyword><Keyword MajorTopicYN="N">Transcatheter aortic valve replacement</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors report no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>29</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>28</Day><Hour>19</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38417474</ArticleId><ArticleId IdType="doi">10.1016/j.cpcardiol.2024.102488</ArticleId><ArticleId IdType="pii">S0146-2806(24)00127-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35469509</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2385-2011</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences</Title><ISOAbbreviation>Interv Neuroradiol</ISOAbbreviation></Journal><ArticleTitle>Carotid artery stenting without embolic protection: A randomized multicenter trial (the CASWEP trial).</ArticleTitle><Pagination><StartPage>419</StartPage><EndPage>425</EndPage><MedlinePgn>419-425</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/15910199221094388</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Carotid artery stenting (CAS) with a carotid protection device (CPD) has become the standard practice in patients with severe carotid stenosis and high surgical risk. However, the clinical efficacy and safety of CPDs are still controversial issues. We aimed to compare the clinical outcomes of the CAS without CPD with CAS combined with CPD.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a multicenter randomized prospective study registered with http://clinicaltrials.gov (NCT02781181). After the exclusion, 279 patients were enrolled (139 patients in the CAS with CPD group and 140 patients in the CAS without CPD group). The primary outcome was a combination of peri-procedural in-hospital transient ischemic attack (TIA), ipsilateral stroke, or death. The secondary outcome was new ischemic brain lesions on post-procedural diffusion-weighted magnetic resonance imaging (DW-MRI).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Two patients died in CAS without CPD group, one patient died in CAS with CPD group. TIA was only seen in patients who underwent CAS under protection (n&#x2009;=&#x2009;5). The combined primary outcome of TIA, ipsilateral stroke, and death rate was not different between groups (5.7% vs. 2.8%; p&#x2009;=&#x2009;0.254). New defects were noted on the post-procedural DW-MRI in 28% of patients in the CPD group and 27% of patients in the no CPD group (p&#x2009;=&#x2009;0.881).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study suggests that CAS without CPD is not associated with higher rates of peri-procedural TIA, stroke, and death or new ischemic brain lesions on post-procedural DW-MRI compared to CAS with CPD in selected symptomatic and asymptomatic patients with significant carotid artery stenosis provided that there is no visible thrombus.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gorgulu</LastName><ForeName>Sevket</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Acibadem University Medical Faculty, Istanbul, Turkey.</Affiliation><Identifier Source="RINGGOLD">385158</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahin</LastName><ForeName>Muslum</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Istinye University Medical Faculty, Istanbul, Turkey.</Affiliation><Identifier Source="RINGGOLD">469683</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Norgaz</LastName><ForeName>Niyazi Tugrul</ForeName><Initials>NT</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Acibadem University Medical Faculty, Istanbul, Turkey.</Affiliation><Identifier Source="RINGGOLD">385158</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pala</LastName><ForeName>Sel&#xe7;uk</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University of Health Sciences, Kartal Kosuyolu High Speciality Educational and Research Hospital, Istanbul, Turkey.</Affiliation><Identifier Source="RINGGOLD">111350</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sar&#x131;</LastName><ForeName>Munevver</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2061-415X</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, University of Health Sciences, Kartal Kosuyolu High Speciality Educational and Research Hospital, Istanbul, Turkey.</Affiliation><Identifier Source="RINGGOLD">111350</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yalcin</LastName><ForeName>Ahmet Arif</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University of Health Sciences, Mehmet Akif Ersoy Chest and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sipahi</LastName><ForeName>Ilke</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Memorial Sisli Hospital, Istanbul, Turkey.</Affiliation><Identifier Source="RINGGOLD">64117</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02781181</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Interv Neuroradiol</MedlineTA><NlmUniqueID>9602695</NlmUniqueID><ISSNLinking>1591-0199</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016893" MajorTopicYN="Y">Carotid Stenosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="Y">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D038524" MajorTopicYN="N">Diffusion Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015607" MajorTopicYN="N">Stents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002339" MajorTopicYN="N">Carotid Arteries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016894" MajorTopicYN="Y">Endarterectomy, Carotid</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">carotid artery stenting</Keyword><Keyword MajorTopicYN="N">embolic complication</Keyword><Keyword MajorTopicYN="N">protection device</Keyword></KeywordList><CoiStatement>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>26</Day><Hour>5</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35469509</ArticleId><ArticleId IdType="pmc">PMC10399495</ArticleId><ArticleId IdType="doi">10.1177/15910199221094388</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Moore WS, Barnett HJ, Bebe HG, et al. Guidelines for carotid endarterectomy. A multidisciplinary consensus statement from the ad hoc committee, American heart association. Stroke 1995; 26: 188&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pubmed">7839390</ArticleId></ArticleIdList></Reference><Reference><Citation>Roubin GS, Iyer S, Halkin A, et al. Realizing the potential of carotid artery stenting: proposed paradigms for patient selection and procedural technique. Circulation 2006; 113: 2021&#x2013;2030.</Citation><ArticleIdList><ArticleId IdType="pubmed">16636190</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodney PP, Schermerhorn ML, Powell RJ. Current status of carotid artery stenting. J Vasc Surg 2006; 43: 406&#x2013;411.</Citation><ArticleIdList><ArticleId IdType="pubmed">16476626</ArticleId></ArticleIdList></Reference><Reference><Citation>Brott TG, Howard G, Roubin GS, et al. Long-Term results of stenting versus endarterectomy for carotid-artery stenosis. N Engl J Med 2016; 374: 1021&#x2013;1031.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4874663</ArticleId><ArticleId IdType="pubmed">26890472</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardaioli P, Giordan M, Panfili M, et al. Complication with an embolic protection device during carotid angioplasty. Catheter Cardiovasc Interv 2004; 62: 234&#x2013;236.</Citation><ArticleIdList><ArticleId IdType="pubmed">15170718</ArticleId></ArticleIdList></Reference><Reference><Citation>Higashida RT, Meyers PM, Phatouros CC, et al. ; technology assessment committees of the American society of interventional and therapeutic neuroradiology and the society of interventional radiology. Reporting standards for carotid artery angioplasty and stent placement. J Vasc Interv Radiol 2004; 15: 421&#x2013;422.</Citation><ArticleIdList><ArticleId IdType="pubmed">15126667</ArticleId></ArticleIdList></Reference><Reference><Citation>Coggia M, Go&#xeb;au-Brissonni&#xe8;re O, Duval JL, et al. Embolic risk of the different stages of carotid bifurcation balloon angioplasty: an experimental study. J Vasc Surg 2000; 31: 550&#x2013;557.</Citation><ArticleIdList><ArticleId IdType="pubmed">10709069</ArticleId></ArticleIdList></Reference><Reference><Citation>Cloft HJ. Distal protection: may be less than you think. AJNR Am J Neuroradiol 2008; 29: 407&#x2013;478.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8118873</ArticleId><ArticleId IdType="pubmed">18079189</ArticleId></ArticleIdList></Reference><Reference><Citation>Kastrup A, Gr&#xf6;schel K, Krapf H, et al. Early outcome of carotid angioplasty and stenting with and without cerebral protection devices: a systematic review of the literature. Stroke 2003; 34: 813&#x2013;819.</Citation><ArticleIdList><ArticleId IdType="pubmed">12624315</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho YD, Kim SE, Lim JW, et al. Protected versus unprotected carotid artery stenting: meta-analysis of the current literature. J Korean Neurosurg Soc 2018; 61: 458&#x2013;466.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6046577</ArticleId><ArticleId IdType="pubmed">29631386</ArticleId></ArticleIdList></Reference><Reference><Citation>Aboyans V, Ricco JB, Bartelink MEL, et al..; ESC Scientific Document Group. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European society for vascular surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries endorsed by: the European stroke organization (ESO) the task force for the diagnosis and treatment of peripheral arterial diseases of the European society of cardiology (ESC) and of the European society for vascular surgery (ESVS). Eur Heart J. 2018; 39:763&#x2013;816.</Citation><ArticleIdList><ArticleId IdType="pubmed">28886620</ArticleId></ArticleIdList></Reference><Reference><Citation>Huibers A, Calvet D, Kennedy F, et al. Mechanism of procedural stroke following carotid endarterectomy or carotid artery stenting within the international carotid stenting study (ICSS) randomised trial. Eur J Vasc Endovasc Surg 2015; 50: 281&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4580136</ArticleId><ArticleId IdType="pubmed">26160210</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnan GA, Davis SM, Chambers BR, et al. Surgery for prevention of stroke. Lancet 1998; 351: 1372&#x2013;1373.</Citation><ArticleIdList><ArticleId IdType="pubmed">9593402</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacco RL, Kasner SE, Broderick JP, et al. An updated definition of stroke for the 21 century: a statement for healthcare professionals from the American heart association/American stroke association. Stroke 2013; 44: 2064&#x2013;2089.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11078537</ArticleId><ArticleId IdType="pubmed">23652265</ArticleId></ArticleIdList></Reference><Reference><Citation>Easton JD, Saver JL, Albers GW, et al. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American heart association/American stroke association stroke council; council on cardiovascular surgery and anesthesia; council on cardiovascular radiology and intervention; council on cardiovascular nursing; and the interdisciplinary council on peripheral vascular disease. The American academy of neurology affirms the value of this statement as an educational tool for neurologists. Stroke 2009; 40: 2276&#x2013;2293.</Citation><ArticleIdList><ArticleId IdType="pubmed">19423857</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldi S, Zander T, Rabellino M, et al. Carotid artery stenting without angioplasty and cerebral protection: a single-center experience with up to 7 years&#x2019; follow-up. AJNR Am J Neuroradiol 2011; 32: 759&#x2013;763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7965876</ArticleId><ArticleId IdType="pubmed">21349967</ArticleId></ArticleIdList></Reference><Reference><Citation>Oteros R, Jimenez-Gomez E, Bravo-Rodriguez F, et al. Unprotected carotid artery stenting in symptomatic patients with high-grade stenosis: results and long-term follow-up in a single-center experience. AJNR Am J Neuroradiol 2012; 33: 1285&#x2013;1291.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7965519</ArticleId><ArticleId IdType="pubmed">22422184</ArticleId></ArticleIdList></Reference><Reference><Citation>CAVATAS Investigators. Endovascular versus surgical treatment in patients with carotid stenosis in the carotid and vertebral artery transluminal angioplasty study (CAVATAS): a randomized trial. Lancet 2001; 357: 1729&#x2013;1737.</Citation><ArticleIdList><ArticleId IdType="pubmed">11403808</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadav JS, Wholey MH, Kuntz RE, et al. Stenting and angioplasty with protection in patients at high risk for endarterectomy investigators. Stenting and angioplasty with protection in patients at high risk for endarterectomy investigators. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004; 351: 1493&#x2013;1501.</Citation><ArticleIdList><ArticleId IdType="pubmed">15470212</ArticleId></ArticleIdList></Reference><Reference><Citation>SPACE Collaborative Group, Ringleb PA, Allenberg J, Br&#xfc;ckmann H, et al.. 30 Day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet. 2006; 368:1239&#x2013;1247.</Citation><ArticleIdList><ArticleId IdType="pubmed">17027729</ArticleId></ArticleIdList></Reference><Reference><Citation>Mas JL, Trinquart L, Leys D, et al.; EVA-3S investigators. Endarterectomy versus angioplasty in patients with symptomatic severe carotid stenosis (EVA-3S) trial: results up to 4 years from a randomised, multicentre trial. Lancet Neurol 2008;7:885&#x2013;892.</Citation><ArticleIdList><ArticleId IdType="pubmed">18774745</ArticleId></ArticleIdList></Reference><Reference><Citation>International Carotid Stenting Study investigators, Ederle J, Dobson J, Featherstone RL, et al.. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (international carotid stenting study): an interim analysis of a randomised controlled trial. Lancet. 2010; 375:985&#x2013;997.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2849002</ArticleId><ArticleId IdType="pubmed">20189239</ArticleId></ArticleIdList></Reference><Reference><Citation>Brott TG, Hobson RW, 2nd, Howard G, et al.. CREST Investigators. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010; 363:11&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2932446</ArticleId><ArticleId IdType="pubmed">20505173</ArticleId></ArticleIdList></Reference><Reference><Citation>Doig D, Turner EL, Dobson J, et al.; ICSS Investigators. Predictors of stroke, myocardial infarction or death within 30 days of carotid artery stenting: results from the international carotid stenting study. Eur J Vasc Endovasc Surg. 2016; 51:327&#x2013;334.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4786052</ArticleId><ArticleId IdType="pubmed">26602322</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen O, Fiehler J, Hartmann M, et al. Protection or nonprotection in carotid stent angioplasty: the influence of interventional techniques on outcome data from the SPACE trial. Stroke 2009; 40: 841&#x2013;846.</Citation><ArticleIdList><ArticleId IdType="pubmed">19150863</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawkins BM, Kennedy KF, Giri J, et al. Pre-procedural risk quantification for carotid stenting using the CAS score: a report from the NCDR CARE registry. J Am Coll Cardiol 2012; 60: 1617&#x2013;1622.</Citation><ArticleIdList><ArticleId IdType="pubmed">22999733</ArticleId></ArticleIdList></Reference><Reference><Citation>Macdonald S, Evans DH, Griffiths PD, et al. Filter-protected versus unprotected carotid artery stenting: a randomised trial. Cerebrovasc Dis 2010; 29: 282&#x2013;289.</Citation><ArticleIdList><ArticleId IdType="pubmed">20090320</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbato JE, Dillavou E, Horowitz MB, et al. A randomized trial of carotid artery stenting with and without cerebral protection. J Vasc Surg 2008; 47: 760&#x2013;765.</Citation><ArticleIdList><ArticleId IdType="pubmed">18295439</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaeger HJ, Mathias KD, Hauth E, et al. Cerebral ischemia detected with diffusion-weighted MR imaging after stent implantation in the carotid artery. AJNR Am J Neuroradiol 2002; 23: 200&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7975271</ArticleId><ArticleId IdType="pubmed">11847042</ArticleId></ArticleIdList></Reference><Reference><Citation>Poppert H, Wolf O, Resch M, et al. Differences in number, size and location of intracranial microembolic lesions after surgical versus endovascular treatment without protection device of carotid artery stenosis. J Neurol 2004; 251: 1198&#x2013;1203.</Citation><ArticleIdList><ArticleId IdType="pubmed">15503097</ArticleId></ArticleIdList></Reference><Reference><Citation>Pi&#xf1;ero P, Gonz&#xe1;lez A, Mayol A, et al. Silent ischemia after neuroprotected percutaneous carotid stenting: a diffusion-weighted MRI study. AJNR Am J Neuroradiol 2006; 27: 1338&#x2013;1345.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8133917</ArticleId><ArticleId IdType="pubmed">16775293</ArticleId></ArticleIdList></Reference><Reference><Citation>Maleux G, Demaerel P, Verbeken E, et al. Cerebral ischemia after filter-protected carotid artery stenting is common and cannot be predicted by the presence of substantial amount of debris captured by the filter device. AJNR Am J Neuroradiol 2006; 27: 1830&#x2013;1833.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7977920</ArticleId><ArticleId IdType="pubmed">17032852</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonati LH, Jongen LM, Haller S, et al.. ICSS-MRI study group. New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the international carotid stenting study (ICSS). Lancet Neurol. 2010; 9:353&#x2013;362.</Citation><ArticleIdList><ArticleId IdType="pubmed">20189458</ArticleId></ArticleIdList></Reference><Reference><Citation>Naggara O, Touz&#xe9; E, Beyssen B, et al.l.; EVA-3S Investigators. Anatomical and technical factors associated with stroke or death during carotid angioplasty and stenting: results from the endarterectomy versus angioplasty in patients with symptomatic severe carotid stenosis (EVA-3S) trial and systematic review. Stroke. 2011; 42:380&#x2013;388.</Citation><ArticleIdList><ArticleId IdType="pubmed">21183750</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Mubarak N, Roubin GS, Vitek JJ, et al. Effect of the distal-balloon protection system on microembolization during carotid stenting. Circulation 2001; 104: 1999&#x2013;2002.</Citation><ArticleIdList><ArticleId IdType="pubmed">11673335</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Mubarak N, Vitek JJ, Iyer S, et al. Embolization via collateral circulation during carotid stenting with the distal balloon protection system. J Endovasc Ther 2001; 8: 354&#x2013;357.</Citation><ArticleIdList><ArticleId IdType="pubmed">11552727</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31181981</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>13</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2047-9980</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>12</Issue><PubDate><Year>2019</Year><Month>Jun</Month><Day>18</Day></PubDate></JournalIssue><Title>Journal of the American Heart Association</Title><ISOAbbreviation>J Am Heart Assoc</ISOAbbreviation></Journal><ArticleTitle>General Anesthesia Versus Conscious Sedation for Intracranial Mechanical Thrombectomy: A Systematic Review and Meta-analysis of Randomized Clinical Trials.</ArticleTitle><Pagination><StartPage>e011754</StartPage><MedlinePgn>e011754</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e011754</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1161/JAHA.118.011754</ELocationID><Abstract><AbstractText>Background Endovascular therapy is the standard of care for severe acute ischemic stroke caused by large-vessel occlusion in the anterior circulation, but there is uncertainty regarding the optimal anesthetic approach during this therapy. Meta-analyses of observational studies suggest that general anesthesia increases morbidity and mortality compared with conscious sedation. We performed a systematic review and meta-analysis of randomized clinical trials to examine the effect of anesthetic strategy during endovascular treatment for acute ischemic stroke. Methods and Results Systematic review and meta-analysis according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines has been registered with the PROSPERO (International Prospective Register of Ongoing Systematic Reviews) ( CRD 42018103684). Medline, EMBASE, and CENTRAL databases were searched through August 1, 2018. Meta-analyses were conducted using a random-effects model to pool odds ratio with corresponding 95% CI . The primary outcome was 90-day functional independence (modified Rankin Scale 0-2). In the results, 3 trials with a total of 368 patients were selected. Among patients with ischemic stroke undergoing endovascular therapy, general anesthesia was significantly associated with higher odds of functional independence (odds ratio 1.87, 95% CI 1.15-3.03, I<sup>2</sup>=17%) and successful recanalization (odds ratio 1.94, 95% CI 1.13-3.3) compared with conscious sedation. However, general anesthesia was associated with a higher risk of 20% mean arterial pressure decrease (odds ratio 10.76, 95% CI 5.25-22.07). There were no significant differences in death, symptomatic intracranial hemorrhage, anesthesiologic complication, intensive care unit length of stay, pneumonia, and interventional complication. Conclusions Moderate-quality evidence suggests that general anesthesia results in significantly higher rates of functional independence than conscious sedation in patients with ischemic stroke undergoing endovascular therapy. Large randomized clinical trials are required to confirm the benefit.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>1 Affiliated Hospital of Chengdu University Chengdu Sichuan China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Lu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>2 Shanxi Provincial People's Hospital Taiyuan Shanxi China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>3 West China Hospital Sichuan University Chengdu Sichuan China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Lu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>3 West China Hospital Sichuan University Chengdu Sichuan China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Bowen</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>3 West China Hospital Sichuan University Chengdu Sichuan China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faramand</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>4 University of Pittsburgh Medical Center Pittsburgh PA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>06</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Heart Assoc</MedlineTA><NlmUniqueID>101580524</NlmUniqueID><ISSNLinking>2047-9980</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002545" MajorTopicYN="N">Brain Ischemia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016292" MajorTopicYN="Y">Conscious Sedation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017131" MajorTopicYN="N">Thrombectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anesthesia</Keyword><Keyword MajorTopicYN="N">endovascular treatment</Keyword><Keyword MajorTopicYN="N">meta&#x2010;analysis</Keyword><Keyword MajorTopicYN="N">stroke</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>6</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31181981</ArticleId><ArticleId IdType="pmc">PMC6645641</ArticleId><ArticleId IdType="doi">10.1161/JAHA.118.011754</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Badhiwala JH, Nassiri F, Alhazzani W, Selim MH, Farrokhyar F, Spears J, Kulkarni AV, Singh S, Alqahtani A, Rochwerg B, Alshahrani M, Murty NK, Alhazzani A, Yarascavitch B, Reddy K, Zaidat OO, Almenawer SA. Endovascular thrombectomy for acute ischemic stroke: a meta&#x2010;analysis. JAMA. 2015;314:1832&#x2013;1843.</Citation><ArticleIdList><ArticleId IdType="pubmed">26529161</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues FB, Neves JB, Caldeira D, Ferro JM, Ferreira JJ, Costa J. Endovascular treatment versus medical care alone for ischaemic stroke: systematic review and meta&#x2010;analysis. BMJ. 2016;353:i1754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4834754</ArticleId><ArticleId IdType="pubmed">27091337</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal M, Menon BK, van Zwam WH, Dippel DW, Mitchell PJ, Demchuk AM, Davalos A, Majoie CB, van der Lugt A, de Miquel MA, Donnan GA, Roos YB, Bonafe A, Jahan R, Diener HC, van den Berg LA, Levy EI, Berkhemer OA, Pereira VM, Rempel J, Millan M, Davis SM, Roy D, Thornton J, Roman LS, Ribo M, Beumer D, Stouch B, Brown S, Campbell BC, van Oostenbrugge RJ, Saver JL, Hill MD, Jovin TG; Collaborators H . Endovascular thrombectomy after large&#x2010;vessel ischaemic stroke: a meta&#x2010;analysis of individual patient data from five randomised trials. Lancet. 2016;387:1723&#x2013;1731.</Citation><ArticleIdList><ArticleId IdType="pubmed">26898852</ArticleId></ArticleIdList></Reference><Reference><Citation>Touma L, Filion KB, Sterling LH, Atallah R, Windle SB, Eisenberg MJ. Stent retrievers for the treatment of acute ischemic stroke: a systematic review and meta&#x2010;analysis of randomized clinical trials. JAMA Neurol. 2016;73:275&#x2013;281.</Citation><ArticleIdList><ArticleId IdType="pubmed">26810499</ArticleId></ArticleIdList></Reference><Reference><Citation>Emiru T, Chaudhry SA, Qureshi AI. A survey of preprocedural intubation practices for endovascular treatment of acute ischemic stroke. J Vasc Interv Neurol. 2014;7:30&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4188254</ArticleId><ArticleId IdType="pubmed">25298857</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinjikji W, Murad MH, Rabinstein AA, Cloft HJ, Lanzino G, Kallmes DF. Conscious sedation versus general anesthesia during endovascular acute ischemic stroke treatment: a systematic review and meta&#x2010;analysis. AJNR Am J Neuroradiol. 2015;36:525&#x2013;529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013063</ArticleId><ArticleId IdType="pubmed">25395655</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouyang F, Chen Y, Zhao Y, Dang G, Liang J, Zeng J. Selection of patients and anesthetic types for endovascular treatment in acute ischemic stroke: a meta&#x2010;analysis of randomized controlled trials. PLoS One. 2016;11:e0151210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4783038</ArticleId><ArticleId IdType="pubmed">26953574</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinjikji W, Pasternak J, Murad MH, Cloft HJ, Welch TL, Kallmes DF, Rabinstein AA. Anesthesia&#x2010;related outcomes for endovascular stroke revascularization: a systematic review and meta&#x2010;analysis. Stroke. 2017;48:2784&#x2013;2791.</Citation><ArticleIdList><ArticleId IdType="pubmed">28904228</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell BCV, van Zwam WH, Goyal M, Menon BK, Dippel DWJ, Demchuk AM, Bracard S, White P, Davalos A, Majoie C, van der Lugt A, Ford GA, de la Ossa NP, Kelly M, Bourcier R, Donnan GA, Roos Y, Bang OY, Nogueira RG, Devlin TG, van den Berg LA, Clarencon F, Burns P, Carpenter J, Berkhemer OA, Yavagal DR, Pereira VM, Ducrocq X, Dixit A, Quesada H, Epstein J, Davis SM, Jansen O, Rubiera M, Urra X, Micard E, Lingsma HF, Naggara O, Brown S, Guillemin F, Muir KW, van Oostenbrugge RJ, Saver JL, Jovin TG, Hill MD, Mitchell PJ. Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta&#x2010;analysis of individual patient data. Lancet Neurol. 2018;17:47&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">29263006</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilyas A, Chen CJ, Ding D, Foreman PM, Buell TJ, Ironside N, Taylor DG, Kalani MY, Park MS, Southerland AM, Worrall BB. Endovascular mechanical thrombectomy for acute ischemic stroke under general anesthesia versus conscious sedation: a systematic review and meta&#x2010;analysis. World Neurosurg. 2018;112:e355&#x2013;e367.</Citation><ArticleIdList><ArticleId IdType="pubmed">29355808</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing R, Dai HJ, Lin F, Ge WY, Pan LH. Conscious sedation versus general anesthesia for patients with acute ischemic stroke undergoing endovascular therapy: a systematic review and meta&#x2010;analysis. Biomed Res Int. 2018;2018:2318489.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5896359</ArticleId><ArticleId IdType="pubmed">29789778</ArticleId></ArticleIdList></Reference><Reference><Citation>Gravel G, Boulouis G, Benhassen W, Rodriguez&#x2010;Regent C, Trystram D, Edjlali&#x2010;Goujon M, Meder JF, Oppenheim C, Bracard S, Brinjikji W, Naggara ON. Anaesthetic management during intracranial mechanical thrombectomy: systematic review and meta&#x2010;analysis of current data. J Neurol Neurosurg Psychiatry. 2019;90:68&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">30257967</ArticleId></ArticleIdList></Reference><Reference><Citation>Abou&#x2010;Chebl A, Lin R, Hussain MS, Jovin TG, Levy EI, Liebeskind DS, Yoo AJ, Hsu DP, Rymer MM, Tayal AH, Zaidat OO, Natarajan SK, Nogueira RG, Nanda A, Tian M, Hao Q, Kalia JS, Nguyen TN, Chen M, Gupta R. Conscious sedation versus general anesthesia during endovascular therapy for acute anterior circulation stroke: preliminary results from a retrospective, multicenter study. Stroke. 2010;41:1175&#x2013;1179.</Citation><ArticleIdList><ArticleId IdType="pubmed">20395617</ArticleId></ArticleIdList></Reference><Reference><Citation>Abou&#x2010;Chebl A, Yeatts SD, Yan B, Cockroft K, Goyal M, Jovin T, Khatri P, Meyers P, Spilker J, Sugg R, Wartenberg KE, Tomsick T, Broderick J, Hill MD. Impact of general anesthesia on safety and outcomes in the endovascular arm of interventional management of stroke (IMS) III trial. Stroke. 2015;46:2142&#x2013;2148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4519363</ArticleId><ArticleId IdType="pubmed">26138125</ArticleId></ArticleIdList></Reference><Reference><Citation>Mundiyanapurath S, Schonenberger S, Rosales ML, Carrilho Romeiro AM, Mohlenbruch M, Bendszus M, Hacke W, Bosel J. Circulatory and respiratory parameters during acute endovascular stroke therapy in conscious sedation or general anesthesia. J Stroke Cerebrovasc Dis. 2015;24:1244&#x2013;1249.</Citation><ArticleIdList><ArticleId IdType="pubmed">25906939</ArticleId></ArticleIdList></Reference><Reference><Citation>Just C, Rizek P, Tryphonopoulos P, Pelz D, Arango M. Outcomes of general anesthesia and conscious sedation in endovascular treatment for stroke. Can J Neurol Sci. 2016;43:655&#x2013;658.</Citation><ArticleIdList><ArticleId IdType="pubmed">27406422</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichols C, Carrozzella J, Yeatts S, Tomsick T, Broderick J, Khatri P. Is periprocedural sedation during acute stroke therapy associated with poorer functional outcomes? J Neurointerv Surg. 2010;2:67&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2860799</ArticleId><ArticleId IdType="pubmed">20431708</ArticleId></ArticleIdList></Reference><Reference><Citation>Bracard S, Ducrocq X, Mas JL, Soudant M, Oppenheim C, Moulin T, Guillemin F; Investigators T . Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurol. 2016;15:1138&#x2013;1147.</Citation><ArticleIdList><ArticleId IdType="pubmed">27567239</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkhemer OA, van den Berg LA, Fransen PS, Beumer D, Yoo AJ, Lingsma HF, Schonewille WJ, van den Berg R, Wermer MJ, Boiten J, Lycklama ANGJ, Nederkoorn PJ, Hollmann MW, van Zwam WH, van der Lugt A, van Oostenbrugge RJ, Majoie CB, Dippel DW, Roos YB; Investigators MC . The effect of anesthetic management during intra&#x2010;arterial therapy for acute stroke in MR CLEAN. Neurology. 2016;87:656&#x2013;664.</Citation><ArticleIdList><ArticleId IdType="pubmed">27421546</ArticleId></ArticleIdList></Reference><Reference><Citation>Schonenberger S, Uhlmann L, Hacke W, Schieber S, Mundiyanapurath S, Purrucker JC, Nagel S, Klose C, Pfaff J, Bendszus M, Ringleb PA, Kieser M, Mohlenbruch MA, Bosel J. Effect of conscious sedation vs general anesthesia on early neurological improvement among patients with ischemic stroke undergoing endovascular thrombectomy: a randomized clinical trial. JAMA. 2016;316:1986&#x2013;1996.</Citation><ArticleIdList><ArticleId IdType="pubmed">27785516</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowhagen Henden P, Rentzos A, Karlsson JE, Rosengren L, Leiram B, Sundeman H, Dunker D, Schnabel K, Wikholm G, Hellstrom M, Ricksten SE. General anesthesia versus conscious sedation for endovascular treatment of acute ischemic stroke: the AnStroke trial (anesthesia during stroke). Stroke. 2017;48:1601&#x2013;1607.</Citation><ArticleIdList><ArticleId IdType="pubmed">28522637</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonsen CZ, Yoo AJ, Sorensen LH, Juul N, Johnsen SP, Andersen G, Rasmussen M. Effect of general anesthesia and conscious sedation during endovascular therapy on infarct growth and clinical outcomes in acute ischemic stroke: a randomized clinical trial. JAMA Neurol. 2018;75:470&#x2013;477.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5885172</ArticleId><ArticleId IdType="pubmed">29340574</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta&#x2010;analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151:W65&#x2013;W94.</Citation><ArticleIdList><ArticleId IdType="pubmed">19622512</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinichi A. Cochrane handbook for systematic reviews of interventions. Online Kensaku. 2014;35:154&#x2013;155.</Citation></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck&#x2010;Ytter Y, Alonso&#x2010;Coello P, Schunemann HJ; Group GW . GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924&#x2013;926.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Alshurafa M, Briel M, Akl EA, Haines T, Moayyedi P, Gentles SJ, Rios L, Tran C, Bhatnagar N, Lamontagne F, Walter SD, Guyatt GH. Inconsistent definitions for intention&#x2010;to&#x2010;treat in relation to missing outcome data: systematic review of the methods literature. PLoS One. 2012;7:e49163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3499557</ArticleId><ArticleId IdType="pubmed">23166608</ArticleId></ArticleIdList></Reference><Reference><Citation>Jumaa MA, Zhang F, Ruiz&#x2010;Ares G, Gelzinis T, Malik AM, Aleu A, Oakley JI, Jankowitz B, Lin R, Reddy V, Zaidi SF, Hammer MD, Wechsler LR, Horowitz M, Jovin TG. Comparison of safety and clinical and radiographic outcomes in endovascular acute stroke therapy for proximal middle cerebral artery occlusion with intubation and general anesthesia versus the nonintubated state. Stroke. 2010;41:1180&#x2013;1184.</Citation><ArticleIdList><ArticleId IdType="pubmed">20431082</ArticleId></ArticleIdList></Reference><Reference><Citation>Langner S, Khaw AV, Fretwurst T, Angermaier A, Hosten N, Kirsch M. Endovascular treatment of acute ischemic stroke under conscious sedation compared to general anesthesia&#x2014;safety, feasibility and clinical and radiological outcome[in German]. RoFo. 2013;185:320&#x2013;327.</Citation><ArticleIdList><ArticleId IdType="pubmed">23420311</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonsen CZ, Sorensen LH, Juul N, Johnsen SP, Yoo AJ, Andersen G, Rasmussen M. Anesthetic strategy during endovascular therapy: general anesthesia or conscious sedation? (GOLIATH&#x2014;general or local anesthesia in intra arterial therapy) a single&#x2010;center randomized trial. Int J Stroke. 2016;11:1045&#x2013;1052.</Citation><ArticleIdList><ArticleId IdType="pubmed">27405859</ArticleId></ArticleIdList></Reference><Reference><Citation>Athiraman U, Sultan&#x2010;Qurraie A, Nair B, Tirschwell DL, Ghodke B, Havenon AD, Hallam DK, Kim LJ, Becker KJ, Sharma D. Endovascular treatment of acute ischemic stroke under general anesthesia: predictors of good outcome. J Neurosurg Anesthesiol. 2018;30:223&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pubmed">28763432</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis MJ, Menon BK, Baghirzada LB, Campos&#x2010;Herrera CR, Goyal M, Hill MD, Archer DP; Calgary Stroke P . Anesthetic management and outcome in patients during endovascular therapy for acute stroke. Anesthesiology. 2012;116:396&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pubmed">22222475</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Green S. The Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. Oxford: The Cochrane Collaboration; 2011.</Citation></Reference><Reference><Citation>Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta&#x2010;analysis detected by a simple, graphical test. BMJ. 1997;315:629&#x2013;634.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheth SA, Jahan R, Gralla J, Pereira VM, Nogueira RG, Levy EI, Zaidat OO, Saver JL; Trialists S&#x2010;S . Time to endovascular reperfusion and degree of disability in acute stroke. Ann Neurol. 2015;78:584&#x2013;593.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4955570</ArticleId><ArticleId IdType="pubmed">26153450</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36156053</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1537-1921</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of neurosurgical anesthesiology</Title><ISOAbbreviation>J Neurosurg Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>General Anesthesia Versus Nongeneral Anesthesia for Patients With Acute Posterior Circulation Stroke Undergoing Endovascular Therapy: A Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>274</StartPage><EndPage>283</EndPage><MedlinePgn>274-283</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ANA.0000000000000873</ELocationID><Abstract><AbstractText>There is continued controversy regarding the optimal anesthetic technique for endovascular therapy in patients with acute posterior circulation ischemic stroke. To compare the clinical outcomes general anesthesia (GA) and non-GA, we performed a systematic review and meta-analysis of randomized controlled trials and observational studies focused on the anesthetic management for endovascular therapy in patients with acute posterior circulation stroke, without language restriction. In addition, we compared clinical outcomes among the studies with different non-GA types (conscious sedation or local anesthesia). Outcome variables were functional independence, excellent outcomes, favorable outcomes, mortality, successful recanalization, hemodynamic instability, intracerebral hemorrhage, and respiratory or vascular complications. Eight studies including 1777 patients were identified. Although GA was associated with a lower odds of functional independence at 90 days (odds ratio [OR]: 0.55; 95% confidence interval [CI] 0.38 to 0.81; P =0.009), substantial heterogeneity was noted ( I2 =65%). Subgroup analysis showed that GA was associated with higher odds of mortality than conscious sedation (OR: 1.83; 95% CI, 1.30 to 2.57; I2 =0%), but there was no difference between GA and local anesthesia ( I2 =0%). Interestingly, subgroup analysis did not identify a relationship between functional independence and GA compared with local anesthesia (OR: 0.90; 95% CI, 0.64 to 1.25; P =0.919; I2 =0%). This meta-analysis demonstrates that GA is associated with worse outcomes in patients with acute posterior circulation stroke undergoing endovascular therapy based on current studies.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xinyan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Youxuan</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Fa</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Jian</LastName><ForeName>Minyu</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Yun</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yunzhen</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Ruquan</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-4335-8670</Identifier></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosurg Anesthesiol</MedlineTA><NlmUniqueID>8910749</NlmUniqueID><ISSNLinking>0898-4921</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000777">Anesthetics</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002545" MajorTopicYN="Y">Brain Ischemia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017131" MajorTopicYN="N">Thrombectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016292" MajorTopicYN="N">Conscious Sedation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000083242" MajorTopicYN="Y">Ischemic Stroke</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000777" MajorTopicYN="Y">Anesthetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="Y">Endovascular Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>26</Day><Hour>16</Hour><Minute>11</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36156053</ArticleId><ArticleId IdType="doi">10.1097/ANA.0000000000000873</ArticleId><ArticleId IdType="pii">00008506-202307000-00005</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>GBD 2016 Neurology Collaborators. Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:439&#x2013;458. doi: 10.1016/s1474-4422(19)30034-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1474-4422(19)30034-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Sparaco M, Ciolli L, Zini A. Posterior circulation ischaemic stroke-a review part I: anatomy, aetiology and clinical presentations. Neurol Sci. 2019;40:1995&#x2013;2006. doi: 10.1007/s10072-019-03977-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-019-03977-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommer P, Posekany A, Serles W, et al. Is functional outcome different in posterior and anterior circulation stroke? Stroke. 2018;49:2728&#x2013;2732. doi: 10.1161/strokeaha.118.021785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/strokeaha.118.021785</ArticleId></ArticleIdList></Reference><Reference><Citation>Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019;50:e344&#x2013;e418. doi:10.1161/str.0000000000000211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/str.0000000000000211</ArticleId></ArticleIdList></Reference><Reference><Citation>Turc G, Bhogal P, Fischer U, et al. European Stroke Organisation (ESO) - European Society for Minimally Invasive Neurological Therapy (ESMINT) Guidelines on Mechanical Thrombectomy in Acute Ischaemic StrokeEndorsed by Stroke Alliance for Europe (SAFE). Eur Stroke J. 2019;4:6&#x2013;12. doi:10.1177/2396987319832140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2396987319832140</ArticleId></ArticleIdList></Reference><Reference><Citation>Chinese Society of Neurology CSS, Neurovascular Inervention Group oF Chinese Society of Neurology. Chinese guideline for the endovascular treatment of acute ischemic stroke 2018. Chin J Neurol. 2018;51:683&#x2013;691. doi:10.3760/cma.j.issn.1006-7876.2018.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.issn.1006-7876.2018.09.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Dai Q, Ye R, et al. Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurol. 2020;19:115&#x2013;122. doi:10.1016/s1474-4422(19)30395-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1474-4422(19)30395-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Langezaal LCM, van der Hoeven E, Mont&#x2019;Alverne FJA, et al. Endovascular therapy for stroke due to basilar-artery occlusion. N Engl J Med. 2021;384:1910&#x2013;1920. doi:10.1056/NEJMoa2030297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2030297</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinjikji W, Murad MH, Rabinstein AA, et al. Conscious sedation versus general anesthesia during endovascular acute ischemic stroke treatment: a systematic review and meta-analysis. AJNR Am J Neuroradiol. 2015;36:525&#x2013;529. doi:10.3174/ajnr.A4159.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A4159</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xf6;nenberger S, Hend&#xe9;n PL, Simonsen CZ, et al. Association of general anesthesia vs procedural sedation with functional outcome among patients with acute ischemic stroke undergoing thrombectomy: a systematic review and meta-analysis. JAMA. 2019;322:1283&#x2013;1293. doi:10.1001/jama.2019.11455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.11455</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurice A, Eug&#xe8;ne F, Ronzi&#xe8;re T, et al. General anesthesia versus sedation, both with hemodynamic control, during intraarterial treatment for stroke: the GASS randomized trial. Anesthesiology. 2022;136:567&#x2013;576. doi:10.1097/aln.0000000000004142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/aln.0000000000004142</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;350:g7647. doi:10.1136/bmj.g7647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.g7647</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Altman DG, G&#xf8;tzsche PC, et al. The Cochrane Collaboration&#x2019;s tool for assessing risk of bias in randomised trials. Bmj. 2011;343:d5928. doi:10.1136/bmj.d5928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells GA, Shea B, O&#x2019;Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.html . Accessed October 19, 2009.</Citation></Reference><Reference><Citation>Jadhav AP, Bouslama M, Aghaebrahim A, et al. Monitored anesthesia care vs intubation for vertebrobasilar stroke endovascular therapy. JAMA Neurol. 2017;74:704&#x2013;709. doi:10.1001/jamaneurol.2017.0192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.0192</ArticleId></ArticleIdList></Reference><Reference><Citation>Du H, Tong X, Sun X, et al. Effect of anesthesia strategy during endovascular therapy on 90-day outcomes in acute basilar artery occlusion: a retrospective observational study. BMC Neurol. 2020;20:398. doi:10.1186/s12883-020-01979-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-020-01979-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu G, Shi Z, Li B, et al. General anesthesia versus monitored anesthesia care during endovascular therapy for vertebrobasilar stroke. Am J Transl Res. 2021;13:1558&#x2013;1567.</Citation></Reference><Reference><Citation>Li F, Wan J, Song J, et al. Impact of anesthetic strategy on outcomes for patients with acute basilar artery occlusion undergoing mechanical thrombectomy. J Neurointerv Surg. 2021:1&#x2013;5. doi:10.1136/neurintsurg-2021-018000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/neurintsurg-2021-018000</ArticleId></ArticleIdList></Reference><Reference><Citation>Mokin M, Sonig A, Sananthan S, et al. Analysis of outcomes from the endovascular treatment of posterior circulation strokes in the modern era of stent retriever thrombectomy. Stroke. 2016;47:782&#x2013;788.</Citation></Reference><Reference><Citation>Terce&#xf1;o M, Silva Y, Bashir S, et al. Impact of general anesthesia on posterior circulation large vessel occlusions after endovascular thrombectomy. Int J Stroke. 2021;16:792&#x2013;797. doi:10.1177/1747493020976247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1747493020976247</ArticleId></ArticleIdList></Reference><Reference><Citation>Weyland CS, Chen M, Potreck A, et al. Sedation mode during endovascular stroke treatment in the posterior circulation&#x2014;is conscious sedation for eligible patients feasible? Front Neurol. 2021;12:711558. doi:10.3389/fneur.2021.711558.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.711558</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu L, Jadhav AP, Chen J, et al. Local anesthesia vs general anesthesia during endovascular therapy for acute posterior circulation stroke. J Neurol Sci. 2020;416:117045. doi:10.1016/j.jns.2020.117045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.117045</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal N, Malhotra K, Ishfaq MF, et al. Current evidence for anesthesia management during endovascular stroke therapy: updated systematic review and meta-analysis. J Neurointerv Surg. 2019;11:107&#x2013;113. doi:10.1136/neurintsurg-2018-013916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/neurintsurg-2018-013916</ArticleId></ArticleIdList></Reference><Reference><Citation>Markus HS, van der Worp HB, Rothwell PM. Posterior circulation ischaemic stroke and transient ischaemic attack: diagnosis, investigation, and secondary prevention. Lancet Neurol. 2013;12:989&#x2013;998. doi:10.1016/s1474-4422(13)70211-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1474-4422(13)70211-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell D, Diprose WK, Deng C, et al. General anesthesia versus conscious sedation in endovascular thrombectomy for stroke: a meta-analysis of 4 randomized controlled trials. J Neurosurg Anesthesiol. 2021;33:21&#x2013;27. doi:10.1097/ana.0000000000000646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ana.0000000000000646</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan TF, Zhang JR, Liu L. Effect of ceneral anesthesia vs. conscious sedation on the outcomes of acute ischemic stroke patients after endovascular therapy: a meta-analysis of randomized clinical trials. Front Neurol. 2019;10:1131. doi:10.3389/fneur.2019.01131.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.01131</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis MJ, Menon BK, Baghirzada LB, et al. Anesthetic management and outcome in patients during endovascular therapy for acute stroke. Anesthesiology. 2012;116:396&#x2013;405. doi:10.1097/ALN.0b013e318242a5d2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e318242a5d2</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen M, Espelund US, Juul N, et al. The influence of blood pressure management on neurological outcome in endovascular therapy for acute ischaemic stroke. Br J Anaesth. 2018;120:1287&#x2013;1294. doi: 10.1016/j.bja.2018.01.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2018.01.039</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xf6;nenberger S, Uhlmann L, Hacke W, et al. Effect of conscious sedation vs general anesthesia on early neurological improvement among patients with ischemic stroke undergoing endovascular thrombectomy: a randomized clinical trial. JAMA. 2016;316:1986&#x2013;1996. doi:10.1001/jama.2016.16623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.16623</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonsen CZ, Yoo AJ, S&#xf8;rensen LH, et al. Effect of general anesthesia and conscious sedation during endovascular therapy on infarct growth and clinical outcomes in acute ischemic stroke: a randomized clinical trial. JAMA Neurol. 2018;75:470&#x2013;477. doi:10.1001/jamaneurol.2017.4474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.4474</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, Liang F, Wu Y, et al. Choice of aNesthesia for endoVAScular treatment of acute ischemic stroke (CANVAS): results of the CANVAS pilot randomized controlled trial. J Neurosurg Anesthesiol. 2020;32:41&#x2013;47. doi:10.1097/ana.0000000000000567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ana.0000000000000567</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;whagen Hend&#xe9;n P, Rentzos A, Karlsson JE, et al. General anesthesia versus conscious sedation for endovascular treatment of acute ischemic stroke: the AnStroke trial (Anesthesia During Stroke). Stroke. 2017;48:1601&#x2013;1607. doi:10.1161/strokeaha.117.016554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/strokeaha.117.016554</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi CE, Brambrink AM, Aziz MF, et al. Association of intraprocedural blood pressure and end tidal carbon dioxide with outcome after acute stroke intervention. Neurocrit Care. 2014;20:202&#x2013;208. doi:10.1007/s12028-013-9921-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12028-013-9921-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusy DA, Hofer A, Rasmussen M, et al. Assessment of anesthesia practice patterns for endovascular therapy for acute ischemic stroke: a Society for Neuroscience in Anesthesiology and Critical Care (SNACC) member survey. J Neurosurg Anesthesiol. 2021;33:343&#x2013;346. doi:10.1097/ana.0000000000000661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ana.0000000000000661</ArticleId></ArticleIdList></Reference><Reference><Citation>Komatsu R, You J, Mascha EJ, et al. Anesthetic induction with etomidate, rather than propofol, is associated with increased 30-day mortality and cardiovascular morbidity after noncardiac surgery. Anesth Analg. 2013;117:1329&#x2013;1337. doi:10.1213/ANE.0b013e318299a516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e318299a516</ArticleId></ArticleIdList></Reference><Reference><Citation>Oshima T, Karasawa F, Satoh T. Effects of propofol on cerebral blood flow and the metabolic rate of oxygen in humans. Acta Anaesthesiol Scand. 2002;46:831&#x2013;835. doi:10.1034/j.1399-6576.2002.460713.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1399-6576.2002.460713.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivasankar C, Stiefel M, Miano TA, et al. Anesthetic variation and potential impact of anesthetics used during endovascular management of acute ischemic stroke. J Neurointerv Surg. 2016;8:1101&#x2013;1106. doi:10.1136/neurintsurg-2015-011998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/neurintsurg-2015-011998</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33775311</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2653</ISSN><JournalIssue CitedMedium="Internet"><Volume>86</Volume><PubDate><Year>2021</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia</Title><ISOAbbreviation>J Clin Neurosci</ISOAbbreviation></Journal><ArticleTitle>General anesthesia versus conscious sedation for endovascular therapy in acute ischemic stroke: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>10</StartPage><EndPage>17</EndPage><MedlinePgn>10-17</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jocn.2021.01.012</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0967-5868(21)00019-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Endovascular thrombectomy (EVT) is the first-line treatment for patients with acute ischemic stroke (AIS). However, the optimal anesthetic modality during EVT is unclear. Therefore, this systematic review and meta-analysis is aimed to summarize the current literatures from RCTs to provide new clinical evidence of choosing anesthetic modality for AIS patients when receiving EVT.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Literature search was conducted in following databases, EMBASE, MEDLINE, Web of Science, and the Cochrane Library, for relevant randomized controlled trials (RCTs) comparing general anesthesia (GA) and conscious sedation (CS) for AIS patients during EVT. We used the Cochrane Collaboration criteria for assessment of risk bias of included studies. The heterogeneity of outcomes was assessed by I<sup>2</sup>statistic.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">5 RCTs with 498 patients were included. GA was conducted in 251 patients and CS in 247 patients. EVT under GA in AIS patients had higher rates of successful recanalization (RR: 1.13, 95% CI: 1.04-1.23; P&#xa0;=&#xa0;0.004; I<sup>2</sup>&#xa0;=&#xa0;40.6%) and functional independence at 3&#xa0;months (RR: 1.28, 95% CI: 1.05-1.55; P&#xa0;=&#xa0;0.013; I<sup>2</sup>&#xa0;=&#xa0;18.2%) than CS. However, GA was associated with higher risk of mean arterial pressure (MAP) drop (RR: 1.71, 95% CI: 1.19-2.47; P&#xa0;&lt;&#xa0;0.01; I<sup>2</sup>&#xa0;=&#xa0;80%) and pneumonia (RR: 2.32, 95% CI: 1.23-4.37; P&#xa0;=&#xa0;0.009; I<sup>2</sup>&#xa0;=&#xa0;33.5%). There was no difference between GA and CS groups in mortality at 3&#xa0;months, interventional complications, intracerebral hemorrhage and cerebral infarction after 30&#xa0;days.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">GA was superior over CS in successful recanalization and functional independence at 3&#xa0;months when performing EVT in AIS patients. However, GA was associated with higher risk of MAP drop and pneumonia. Therefore, results of ongoing RCTs will provide new clinical evidence of anesthetic modality selection during EVT in the future.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Xuesong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China; China International Neuroscience Institute (China-INI), Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China; China International Neuroscience Institute (China-INI), Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China; China International Neuroscience Institute (China-INI), Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Yao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China; China International Neuroscience Institute (China-INI), Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>China Medical University, Shenyang, Liaoning Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lyu</LastName><ForeName>Xiajie</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Weifang Medical University, Weifang, Shandong Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Kun</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Evidence-Based Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Medical Library, Xuanwu Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Haiqing</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Qingfeng</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China; China International Neuroscience Institute (China-INI), Beijing, China. Electronic address: leavesyan@sina.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiao</LastName><ForeName>Liqun</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China; China International Neuroscience Institute (China-INI), Beijing, China; Department of Interventional Neuroradiology, Xuanwu Hospital, Capital Medical University, Beijing, China. Electronic address: liqunjiao@sina.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Scotland</Country><MedlineTA>J Clin Neurosci</MedlineTA><NlmUniqueID>9433352</NlmUniqueID><ISSNLinking>0967-5868</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016292" MajorTopicYN="N">Conscious Sedation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="N">Endovascular Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000083242" MajorTopicYN="N">Ischemic Stroke</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute ischemic stroke</Keyword><Keyword MajorTopicYN="N">Conscious sedation</Keyword><Keyword MajorTopicYN="N">Endovascular thrombectomy</Keyword><Keyword MajorTopicYN="N">General anesthesia</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>29</Day><Hour>5</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33775311</ArticleId><ArticleId IdType="doi">10.1016/j.jocn.2021.01.012</ArticleId><ArticleId IdType="pii">S0967-5868(21)00019-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30066392</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>10</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-6576</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>2</Issue><PubDate><Year>2019</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Acta anaesthesiologica Scandinavica</Title><ISOAbbreviation>Acta Anaesthesiol Scand</ISOAbbreviation></Journal><ArticleTitle>Association between perioperative hyperoxia and cerebrovascular complications after laparotomy-A post-hoc follow-up study.</ArticleTitle><Pagination><StartPage>164</StartPage><EndPage>170</EndPage><MedlinePgn>164-170</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/aas.13235</ELocationID><Abstract><AbstractText Label="BACKGROUND">Perioperative hyperoxia has been linked to increased long-term mortality. Vasoconstrictive and cellular side effects to hyperoxia have been suggested to increase the risk of coronary and cerebral ischemia. The aim of this post-hoc analysis of a large randomized trial was to compare the effects of 80% vs 30% perioperative oxygen on the long-term risk of stroke or transient cerebral ischemia (TCI) in patients undergoing abdominal surgery.</AbstractText><AbstractText Label="METHODS">A total of 1386 patients were randomized to 80% or 30% perioperative oxygen during acute or elective open abdominal surgery. Median follow-up was 3.9&#xa0;years. Primary outcome was a composite of the long-term occurrence of stroke or TCI. Secondary outcomes included long-term mortality without stroke or TCI, and incidences of neurological admission, psychiatric admission, and dementia. Outcomes were analyzed in Cox regression models.</AbstractText><AbstractText Label="RESULTS">Stroke or TCI occurred in 20 (3.0%) patients given 80% oxygen vs 22 (3.2%) patients given 30% oxygen with an adjusted hazard ratio (HR) of 0.96 [95% CI 0.52-1.76]. Composite secondary outcome of death, stroke, or TCI had a HR of 1.21 [95% CI 1.00-1.47] for 80% compared to 30% oxygen. HRs for secondary outcomes were HR 1.14 [95% CI 0.79-1.64] for neurological admission, 1.34 [95% CI 0.95-1.88] for psychiatric admission and 0.54 [95% CI 0.16-1.80] for dementia.</AbstractText><AbstractText Label="CONCLUSION">Stroke or TCI did not seem related to perioperative inspiratory oxygen fraction. Due to few events, this study cannot exclude that perioperative hyperoxia increases risk of mortality, stroke, or TCI after abdominal surgery.</AbstractText><CopyrightInformation>&#xa9; 2018 The Acta Anaesthesiologica Scandinavica Foundation. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kongebro</LastName><ForeName>Emilie Katrine</ForeName><Initials>EK</Initials><Identifier Source="ORCID">0000-0003-0579-3276</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jorgensen</LastName><ForeName>Lars N</ForeName><Initials>LN</Initials><Identifier Source="ORCID">0000-0001-7465-5374</Identifier><AffiliationInfo><Affiliation>Digestive Disease Center, Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siersma</LastName><ForeName>Volkert D</ForeName><Initials>VD</Initials><Identifier Source="ORCID">0000-0003-1941-2681</Identifier><AffiliationInfo><Affiliation>The Research Unit for General Practice and Section&#xa0;of General Practice, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyhoff</LastName><ForeName>Christian Sahlholt</ForeName><Initials>CS</Initials><Identifier Source="ORCID">0000-0002-4885-4609</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>07</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Anaesthesiol Scand</MedlineTA><NlmUniqueID>0370270</NlmUniqueID><ISSNLinking>0001-5172</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000005" MajorTopicYN="N">Abdomen</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002561" MajorTopicYN="N">Cerebrovascular Disorders</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="N">Dementia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003718" MajorTopicYN="N" Type="Geographic">Denmark</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018496" MajorTopicYN="N">Hyperoxia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="N">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007813" MajorTopicYN="N">Laparotomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001523" MajorTopicYN="N">Mental Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009422" MajorTopicYN="N">Nervous System Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059035" MajorTopicYN="N">Perioperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cerebrovascular events</Keyword><Keyword MajorTopicYN="N">hyperoxia</Keyword><Keyword MajorTopicYN="N">laparotomy</Keyword><Keyword MajorTopicYN="N">oxygen inhalation therapy</Keyword><Keyword MajorTopicYN="N">perioperative</Keyword><Keyword MajorTopicYN="N">surgical procedures</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30066392</ArticleId><ArticleId IdType="doi">10.1111/aas.13235</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37459844</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1421-9751</ISSN><JournalIssue CitedMedium="Internet"><Volume>148</Volume><Issue>6</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Cardiology</Title><ISOAbbreviation>Cardiology</ISOAbbreviation></Journal><ArticleTitle>The Effect of Peri-Device Leaks on Ischaemic Stroke/Transient Ischaemic Attack/Systemic Embolism after Left Atrial Appendage Closure: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>581</StartPage><EndPage>592</EndPage><MedlinePgn>581-592</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1159/000532019</ELocationID><Abstract><AbstractText Label="BACKGROUND">Left atrial appendage closure (LAAC) is a safe and effective method for preventing embolic events in patients with non-valvular atrial fibrillation. However, peri-device leaks (PDLs) are sometimes unavoidable. Controversy exists regarding whether PDLs lead to embolic events.</AbstractText><AbstractText Label="OBJECTIVES">This study aimed to explore the association between PDLs and embolic events, including ischaemic stroke, transient ischaemic attacks (TIAs), and systemic embolism (SE).</AbstractText><AbstractText Label="METHODS">We conducted a systematic search of the PubMed, Web of Science, MEDLINE, and Cochrane Library databases for studies published up to September 25, 2022, to compare the rate of ischaemic stroke/TIA/SE between the PDL group and the non-PDL group after LAAC.</AbstractText><AbstractText Label="RESULTS">Thirteen studies comprising 54,405 patients were included in the meta-analysis. The PDL group detected by transoesophageal echocardiography (TEE) had a significantly higher rate of ischaemic stroke/TIA/SE than the non-PDL group (OR: 1.20, 95% CI: 1.08-1.33, p = 0.0009). However, no difference in ischaemic stroke/TIA/SE was found between the PDL and non-PDL subgroups of the cardiac computed tomography angiography (CCTA) group (OR: 1.12, 95% CI: 0.51-2.50, p = 0.77). CCTA and TEE showed different rates of PDL detection, with the CCTA group having a higher rate of PDL detection (p &amp;lt; 0.0001), especially for trivial leaks.</AbstractText><AbstractText Label="CONCLUSIONS">PDL detected by TEE increases the risk of embolic events after LAAC. However, no association was found between PDL and ischaemic stroke/TIA/SE in the CCTA group, which showed a higher rate of PDL detection than TEE, particularly for trivial leaks. In the future, CCTA may be used to explore the relationship between PDL size and ischaemic stroke/TIA/SE.</AbstractText><CopyrightInformation>&#xa9; 2023 S. Karger AG, Basel.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>He</LastName><ForeName>Yin-Ge</ForeName><Initials>YG</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Zhengzhou No. 7 People's Hospital, Zhengzhou, China, 1206695426@qq.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Shao-Hua</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Zhengzhou No. 7 People's Hospital, Zhengzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Liang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Zhengzhou No. 7 People's Hospital, Zhengzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Zhengzhou No. 7 People's Hospital, Zhengzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Xu-Tan</ForeName><Initials>XT</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Zhengzhou No. 7 People's Hospital, Zhengzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Pan-Pan</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Zhengzhou No. 7 People's Hospital, Zhengzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Yu-Jie</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Zhengzhou No. 7 People's Hospital, Zhengzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cardiology</MedlineTA><NlmUniqueID>1266406</NlmUniqueID><ISSNLinking>0008-6312</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="Y">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000097546" MajorTopicYN="N">Left Atrial Appendage Closure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002545" MajorTopicYN="Y">Brain Ischemia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="Y">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000083242" MajorTopicYN="Y">Ischemic Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004617" MajorTopicYN="Y">Embolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020517" MajorTopicYN="Y">Atrial Appendage</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017548" MajorTopicYN="N">Echocardiography, Transesophageal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006328" MajorTopicYN="N">Cardiac Catheterization</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Atrial fibrillation</Keyword><Keyword MajorTopicYN="N">Left atrial appendage closure</Keyword><Keyword MajorTopicYN="N">Peri-device leak</Keyword><Keyword MajorTopicYN="N">Stroke</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>17</Day><Hour>19</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>17</Day><Hour>18</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37459844</ArticleId><ArticleId IdType="doi">10.1159/000532019</ArticleId><ArticleId IdType="pii">000532019</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36446142</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>30</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-5506</ISSN><JournalIssue CitedMedium="Internet"><Volume>101</Volume><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Sleep medicine</Title><ISOAbbreviation>Sleep Med</ISOAbbreviation></Journal><ArticleTitle>Frequency and evolution of sleep-wake disturbances after ischemic stroke: A 2-year prospective study of 437 patients.</ArticleTitle><Pagination><StartPage>244</StartPage><EndPage>251</EndPage><MedlinePgn>244-251</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.sleep.2022.10.007</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1389-9457(22)01162-5</ELocationID><Abstract><AbstractText Label="OBJECTIVE">In the absence of systematic and longitudinal data, this study prospectively assessed both frequency and evolution of sleep-wake disturbances (SWD) after stroke.</AbstractText><AbstractText Label="METHODS">In 437 consecutively recruited patients with ischemic stroke or transient ischemic attack (TIA), stroke characteristics and outcome were assessed within the 1<sup>st</sup> week and 3.2&#xa0;&#xb1;&#xa0;0.3 years (M&#xb1;SD) after the acute event. SWD were assessed by interview and questionnaires at 1 and 3 months as well as 1 and 2 years after the acute event. Sleep disordered breathing (SDB) was assessed by respirography in the acute phase and repeated in one fifth of the participants 3 months and 1 year later.</AbstractText><AbstractText Label="RESULTS">Patients (63.8% male, 87% ischemic stroke and mean age 65.1&#xa0;&#xb1;&#xa0;13.0 years) presented with mean NIHSS-score of 3.5&#xa0;&#xb1;&#xa0;4.5&#xa0;at admission. In the acute phase, respiratory event index was &gt;15/h in 34% and &gt;30/h in 15% of patients. Over the entire observation period, the frequencies of excessive daytime sleepiness (EDS), fatigue and insomnia varied between 10-14%, 22-28% and 20-28%, respectively. Mean insomnia and EDS scores decreased from acute to chronic stroke, whereas restless legs syndrome (RLS) percentages (6-9%) and mean fatigue scores remained similar. Mean self-reported sleep duration was enhanced at acute stroke (month 1: 07:54&#xa0;&#xb1;&#xa0;01:27h) and decreased at chronic stage (year 2: 07:43&#xa0;&#xb1;&#xa0;01:20h).</AbstractText><AbstractText Label="CONCLUSIONS">This study documents a high frequency of SDB, insomnia, fatigue and a prolonged sleep duration after stroke/TIA, which can persist for years. Considering the negative effects of SWD on physical, brain and mental health these data suggest the need for a systematic assessment and management of post-stroke SWD.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Authors. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Duss</LastName><ForeName>Simone B</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Switzerland; Interdisciplinary Sleep-Wake-Epilepsy-Center, Inselspital, Bern University Hospital, University of Bern, Switzerland. Electronic address: simone.duss@insel.ch.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bauer-Gambelli</LastName><ForeName>Stefan A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Switzerland; Interdisciplinary Sleep-Wake-Epilepsy-Center, Inselspital, Bern University Hospital, University of Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernasconi</LastName><ForeName>Corrado</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dekkers</LastName><ForeName>Martijn P J</ForeName><Initials>MPJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Switzerland; Interdisciplinary Sleep-Wake-Epilepsy-Center, Inselspital, Bern University Hospital, University of Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gorban-Peric</LastName><ForeName>Corina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Switzerland; Interdisciplinary Sleep-Wake-Epilepsy-Center, Inselspital, Bern University Hospital, University of Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuen</LastName><ForeName>Doris</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seiler</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Switzerland; Interdisciplinary Sleep-Wake-Epilepsy-Center, Inselspital, Bern University Hospital, University of Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oberholzer</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alexiev</LastName><ForeName>Filip</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Switzerland; Interdisciplinary Sleep-Wake-Epilepsy-Center, Inselspital, Bern University Hospital, University of Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lippert</LastName><ForeName>Julian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brill</LastName><ForeName>Anne-Kathrin</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Interdisciplinary Sleep-Wake-Epilepsy-Center, Inselspital, Bern University Hospital, University of Bern, Switzerland; Department of Pulmonary Medicine and Allergology, Inselspital, Bern University Hospital, University of Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ott</LastName><ForeName>Sebastian R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine and Allergology, Inselspital, Bern University Hospital, University of Bern, Switzerland; Department of Pulmonary Medicine and Thoracic Surgery, St. Claraspital, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zubler</LastName><ForeName>Fr&#xe9;d&#xe9;ric</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horvath</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>Markus H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Switzerland; Interdisciplinary Sleep-Wake-Epilepsy-Center, Inselspital, Bern University Hospital, University of Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manconi</LastName><ForeName>Mauro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Sleep Medicine Unit, Neurocenter of Southern Switzerland, EOC, Ospedale Civico, Lugano, Switzerland; Faculty of Biomedical Sciences, Universit&#xe0; della Svizzera Italiana, Lugano, Switzerland; Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bassetti</LastName><ForeName>Claudio L A</ForeName><Initials>CLA</Initials><AffiliationInfo><Affiliation>Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Switzerland; Interdisciplinary Sleep-Wake-Epilepsy-Center, Inselspital, Bern University Hospital, University of Bern, Switzerland; Department of Neurology, Sechenov First Moscow State Medical University, Moscow, Russia. Electronic address: claudio.bassetti@insel.ch.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Sleep Med</MedlineTA><NlmUniqueID>100898759</NlmUniqueID><ISSNLinking>1389-9457</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006970" MajorTopicYN="Y">Disorders of Excessive Somnolence</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="Y">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000083242" MajorTopicYN="Y">Ischemic Stroke</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012890" MajorTopicYN="N">Sleep</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012891" MajorTopicYN="N">Sleep Apnea Syndromes</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007319" MajorTopicYN="N">Sleep Initiation and Maintenance Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012893" MajorTopicYN="Y">Sleep Wake Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Excessive daytime sleepiness</Keyword><Keyword MajorTopicYN="N">Fatigue</Keyword><Keyword MajorTopicYN="N">Insomnia</Keyword><Keyword MajorTopicYN="N">Outcome</Keyword><Keyword MajorTopicYN="N">Restless legs syndrome</Keyword><Keyword MajorTopicYN="N">Sleep</Keyword><Keyword MajorTopicYN="N">Sleep disordered breathing</Keyword><Keyword MajorTopicYN="N">Sleep duration</Keyword><Keyword MajorTopicYN="N">Stroke</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare no conflict of interest, neither financially nor non-financially.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>29</Day><Hour>18</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36446142</ArticleId><ArticleId IdType="doi">10.1016/j.sleep.2022.10.007</ArticleId><ArticleId IdType="pii">S1389-9457(22)01162-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33861494</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>10</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8167</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>7</Issue><PubDate><Year>2021</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of cardiovascular electrophysiology</Title><ISOAbbreviation>J Cardiovasc Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Uninterrupted versus interrupted direct oral anticoagulation for catheter ablation of atrial fibrillation: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1995</StartPage><EndPage>2004</EndPage><MedlinePgn>1995-2004</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jce.15043</ELocationID><Abstract><AbstractText Label="INTRODUCTION">To evaluate the safety of uninterrupted versus interrupted direct oral anticoagulation (DOAC) for patients undergoing catheter ablation (CA) of atrial fibrillation (AF).</AbstractText><AbstractText Label="METHODS">We conducted a systematic search of MEDLINE and EMBASE for randomized controlled trials (RCT) and observational studies comparing uninterrupted versus interrupted DOAC for patients undergoing CA of AF. Primary outcome was major bleeding. Secondary outcomes included minor bleeding, stroke or transient ischemic attack (TIA) or thromboembolism (TE), silent cerebral ischemic events, and cardiac tamponade. Meta-analysis was stratified by study design. Risk ratios (RR) with 95% confidence intervals&#xa0;were calculated using random effects model and Mantel-Haenszel method was used to pool RR.</AbstractText><AbstractText Label="RESULTS">A total of 13 studies (7 randomized, 6 observational) comprising 3595 patients were included. The RCT restricted analysis did not show any difference in terms of major bleeding (risk ratio [RR]&#x2009;=&#x2009;0.79; [0.35-1.79]), minor bleeding (RR&#x2009;=&#x2009;0.99 [0.68-1.43]), stroke or TIA or TE (RR&#x2009;=&#x2009;0.80 [0.19-3.32]), silent cerebral ischemic events (RR&#x2009;=&#x2009;0.64 [0.32-1.28]), and cardiac tamponade (RR&#x2009;=&#x2009;0.61 [0.20-1.92]). Observational study restricted analysis showed a protective effect of uninterrupted DOAC on silent cerebral ischemic events (RR&#x2009;=&#x2009;0.45 [0.31-0.67]) and no difference in other outcomes.</AbstractText><AbstractText Label="CONCLUSIONS">There is no difference in bleeding and thromboembolic outcomes with uninterrupted versus interrupted DOAC for CA of AF and observational data suggests that uninterrupted DOACs are protective against silent cerebral ischemic lesions.</AbstractText><CopyrightInformation>&#xa9; 2021 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Asad</LastName><ForeName>Zain Ul Abideen</ForeName><Initials>ZUA</Initials><Identifier Source="ORCID">0000-0003-3110-7049</Identifier><AffiliationInfo><Affiliation>Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akhtar</LastName><ForeName>Khawaja H</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jafry</LastName><ForeName>Ali H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Muhammad Haris</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Nishtar Medical College, Multan, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Muhammad Shahzeb</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0003-1250-6351</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, John H. Stroger Jr. Hospital of Cook Country, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munir</LastName><ForeName>Muhammad Bilal</ForeName><Initials>MB</Initials><Identifier Source="ORCID">0000-0002-9804-898X</Identifier><AffiliationInfo><Affiliation>Section of Electrophysiology, Division of Cardiology, University of California San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lakkireddy</LastName><ForeName>Dhanunjaya R</ForeName><Initials>DR</Initials><Identifier Source="ORCID">0000-0002-1492-2693</Identifier><AffiliationInfo><Affiliation>Electrophysiology Section, Kansas City Heart Rhythm Institute, Overland Park, Kansas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gopinathannair</LastName><ForeName>Rakesh</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-4611-3687</Identifier><AffiliationInfo><Affiliation>Electrophysiology Section, Kansas City Heart Rhythm Institute, Overland Park, Kansas, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiovasc Electrophysiol</MedlineTA><NlmUniqueID>9010756</NlmUniqueID><ISSNLinking>1045-3873</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="Y">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">atrial fibrillation</Keyword><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">direct-acting oral anticoagulants</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>16</Day><Hour>12</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33861494</ArticleId><ArticleId IdType="doi">10.1111/jce.15043</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Asad ZUA , Yousif A , Khan MS , Al-Khatib SM , Stavrakis S . Catheter ablation versus medical therapy for atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials. Circ Arrhythm Electrophysiol. 2019;12(9):e007414. https://doi.org/10.1161/CIRCEP.119.007414</Citation></Reference><Reference><Citation>Calkins H , Hindricks G , Cappato R , et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace. 2018;20(1):e1-e160. https://doi.org/10.1093/europace/eux274</Citation></Reference><Reference><Citation>Di Biase L , Burkhardt JD , Santangeli P , et al. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial. Circulation. 2014;129(25):2638-2644. https://doi.org/10.1161/CIRCULATIONAHA.113.006426</Citation></Reference><Reference><Citation>January CT , Wann LS , Calkins H , et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2019;74(1):104-132. https://doi.org/10.1016/j.jacc.2019.01.011</Citation></Reference><Reference><Citation>Romero J , Cerrud-Rodriguez RC , Alviz I , et al. Significant benefit of uninterrupted DOACs versus VKA during catheter ablation of atrial fibrillation. JACC Clin Electrophysiol. 2019;5(12):1396-1405. https://doi.org/10.1016/j.jacep.2019.08.010</Citation></Reference><Reference><Citation>Cappato R , Marchlinski FE , Hohnloser SH , et al. Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation. Eur Heart J. 2015;36(28):1805-1811. https://doi.org/10.1093/eurheartj/ehv177</Citation></Reference><Reference><Citation>Hohnloser SH , Camm AJ. Safety and efficacy of dabigatran etexilate during catheter ablation of atrial fibrillation: a meta-analysis of the literature. Europace. 2013;15(10):1407-1411. https://doi.org/10.1093/europace/eut241</Citation></Reference><Reference><Citation>Stroup DF , Berlin JA , Morton SC , et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008-2012.</Citation></Reference><Reference><Citation>Rao G , Lopez-Jimenez F , Boyd J , et al. Methodological standards for meta-analyses and qualitative systematic reviews of cardiac prevention and treatment studies: a scientific statement From the American Heart Association. Circulation. 2017;136(10):e172-e194. https://doi.org/10.1161/CIR.0000000000000523</Citation></Reference><Reference><Citation>Moher D , Liberati A , Tetzlaff J , Altman DG . PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264-269. https://doi.org/10.7326/0003-4819-151-4-200908180-00135</Citation></Reference><Reference><Citation>Covidence systematic review software. Veritas Health Innovation, Melbourne. www.covidence.org</Citation></Reference><Reference><Citation>Higgins JP , Altman DG , G&#xf8;tzsche PC , et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. https://doi.org/10.1136/bmj.d5928</Citation></Reference><Reference><Citation>Wells G , Shea B , Peterson J , Welch V , Losos M , Tugwell P . The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.&#xa0;Accessed December 29, 2020.</Citation></Reference><Reference><Citation>Asad ZUA , Khan SU , Amritphale A , et al. Early vs late discharge in low-risk ST-elevation myocardial infarction patients treated with percutaneous coronary intervention: a systematic review and meta-analysis. Cardiovasc Revasc Med. 2020;21(11):1360-1368. https://doi.org/10.1016/j.carrev.2020.04.030</Citation></Reference><Reference><Citation>DerSimonian R , Kacker R. Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials. 2007;28(2):105-114. https://doi.org/10.1016/j.cct.2006.04.004</Citation></Reference><Reference><Citation>Ando M , Inden Y , Yoshida Y , et al. Differences in prothrombotic response between the uninterrupted and interrupted apixaban therapies in patients undergoing cryoballoon ablation for paroxysmal atrial fibrillation: a randomized controlled study. Heart Vessels. 2019;34(9):1533-1541. https://doi.org/10.1007/s00380-019-01370-9</Citation></Reference><Reference><Citation>Aoyama D , Miyazaki S , Hasegawa K , et al. Feasibility of uninterrupted direct oral anticoagulants with temporary switching to dabigatran (&#x201c;dabigatran bridge&#x201d;) for catheter ablation of atrial fibrillation. Int Heart J. 2019;60(6):1315-1320. https://doi.org/10.1536/ihj.19-143</Citation></Reference><Reference><Citation>Camm AJ , Turpie AGG , Hess S , et al. Outcomes after catheter ablation and cardioversion in patients with non-valvular atrial fibrillation: results from the prospective, observational XANTUS study. Europace. 2018;20(6):e87-e95. https://doi.org/10.1093/europace/eux127</Citation></Reference><Reference><Citation>Di CY , Wan Z , Lin WH. [Efficacy and safety of Rivaroxaban anticoagulant therapy in the treatment of atrial fibrillation cryoablation]. Zhonghua Yi Xue Za Zhi. 2017;97(33):2591-2594. https://doi.org/10.3760/cma.j.issn.0376-2491.2017.33.008</Citation></Reference><Reference><Citation>M&#xfc;ller P , Halbfass P , Sz&#xf6;ll&#xf6;si A , et al. Impact of periprocedural anticoagulation strategy on the incidence of new-onset silent cerebral events after radiofrequency catheter ablation of atrial fibrillation. J Interv Card Electrophysiol. 2016;46(3):203-211. https://doi.org/10.1007/s10840-016-0117-6</Citation></Reference><Reference><Citation>Nagao T , Suzuki H , Matsunaga S , et al. Impact of periprocedural anticoagulation therapy on the incidence of silent stroke after atrial fibrillation ablation in patients receiving direct oral anticoagulants: uninterrupted vs. interrupted by one dose strategy. Europace. 2019;21(4):590-597. https://doi.org/10.1093/europace/euy224</Citation></Reference><Reference><Citation>Nakamura K , Naito S , Sasaki T , et al. Uninterrupted vs. interrupted periprocedural direct oral anticoagulants for catheter ablation of atrial fibrillation: a prospective randomized single-centre study on post-ablation thrombo-embolic and haemorrhagic events. Europace. 2019;21(2):259-267. https://doi.org/10.1093/europace/euy148</Citation></Reference><Reference><Citation>Nakamura K , Sasaki T , Take Y , et al. Postablation cerebral embolisms in balloon-based atrial fibrillation ablation with periprocedural direct oral anticoagulants: A comparison between cryoballoon and HotBalloon ablation. J Cardiovasc Electrophysiol. 2019;30(1):39-46. https://doi.org/10.1111/jce.13762</Citation></Reference><Reference><Citation>Nakamura R , Okishige K , Shigeta T , et al. Clinical comparative study regarding interrupted and uninterrupted dabigatran therapy during perioperative periods of cryoballoon ablation for paroxysmal atrial fibrillation. J Cardiol. 2019;74(2):150-155. https://doi.org/10.1016/j.jjcc.2019.02.003</Citation></Reference><Reference><Citation>Reynolds MR , Allison JS , Natale A , et al. A Prospective randomized trial of apixaban dosing during atrial fibrillation ablation: the AEIOU trial. JACC Clin Electrophysiol. 2018;4(5):580-588. https://doi.org/10.1016/j.jacep.2017.11.005</Citation></Reference><Reference><Citation>Yamaji H , Murakami T , Hina K , et al. Activated clotting time on the day of atrial fibrillation ablation for minimally interrupted and uninterrupted direct oral anticoagulation therapy: sequential changes, differences among direct oral anticoagulants, and ablation safety outcomes. J Cardiovasc Electrophysiol. 2019;30(12):2823-2833. https://doi.org/10.1111/jce.14260</Citation></Reference><Reference><Citation>Yoshimura A , Iriki Y , Ichiki H , et al. Evaluation of safety and efficacy of periprocedural use of rivaroxaban and apixaban in catheter ablation for atrial fibrillation. J Cardiol. 2017;69(1):228-235. https://doi.org/10.1016/j.jjcc.2016.03.014</Citation></Reference><Reference><Citation>Yu HT , Shim J , Park J , et al. When is it appropriate to stop non-vitamin K antagonist oral anticoagulants before catheter ablation of atrial fibrillation? A multicentre prospective randomized study. Eur Heart J. 2019;40(19):1531-1537. https://doi.org/10.1093/eurheartj/ehy870</Citation></Reference><Reference><Citation>Calkins H , Willems S , Gerstenfeld EP , et al. Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation. N Engl J Med. 2017;376(17):1627-1636. https://doi.org/10.1056/NEJMoa1701005</Citation></Reference><Reference><Citation>Hohnloser SH , Camm J , Cappato R , et al. Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial. Eur Heart J. 2019;40(36):3013-3021. https://doi.org/10.1093/eurheartj/ehz190</Citation></Reference><Reference><Citation>Gupta A , Perera T , Ganesan A , et al. Complications of catheter ablation of atrial fibrillation: a systematic review. Circ Arrhythm Electrophysiol. 2013;6(6):1082-1088. https://doi.org/10.1161/CIRCEP.113.000768</Citation></Reference><Reference><Citation>Julia S , James U. Direct oral anticoagulants: A quick guide. Eur Cardiol. 2017;12(1):40-45. https://doi.org/10.15420/ecr.2017:11:2</Citation></Reference><Reference><Citation>Rahman H , Khan SU , DePersis M , Hammad T , Nasir F , Kaluski E. Meta-analysis of safety and efficacy of oral anticoagulants in patients requiring catheter ablation for atrial fibrillation. Cardiovasc Revasc Med. 2019;20(2):147-152. https://doi.org/10.1016/j.carrev.2018.05.007</Citation></Reference><Reference><Citation>Kirchhof P , Haeusler KG , Blank B , et al. Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation. Eur Heart J. 2018;39(32):2942-2955. https://doi.org/10.1093/eurheartj/ehy176</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34430642</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2305-5839</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>14</Issue><PubDate><Year>2021</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Annals of translational medicine</Title><ISOAbbreviation>Ann Transl Med</ISOAbbreviation></Journal><ArticleTitle>Intraoperative completion studies in carotid endarterectomy: systematic review and meta-analysis of techniques and outcomes.</ArticleTitle><Pagination><StartPage>1201</StartPage><MedlinePgn>1201</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1201</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.21037/atm-20-2931</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Declining perioperative stroke and death rates over the past 3 decades have been paralleled by an increasing use of intraoperative completion studies (ICS) following carotid endarterectomy (CEA). Techniques applied include angiography, intraoperative duplex ultrasound (IDUS), flowmetry, and angioscopy. This systematic review and meta-analysis is aiming on providing an overview of techniques and corresponding outcomes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A PubMed based systematic literature review comprising the years 1980 through 2020 was performed using predefined keywords to identify articles on different ICS techniques. Pooled analyses and meta-analyses estimating risk ratios (RR) and 95% confidence intervals (CI) were performed to compare outcomes of different ICS modes to nonapplication of any ICS. I<sup>2</sup> values were assessed to quantify study heterogeneities.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Identification of 34 studies including patients undergoing CEA with angiography (n=53,218), IDUS (n=20,030), flowmetry (n=16,812), and angioscopy (n=2,291). Corresponding rates of perioperative stroke were 1.5%, 1.8%, 3.6%, and 1.5%, perioperative stroke or death occurred in 1.7%, 1.9%, 2.2%, and 2.0%. Intraoperative surgical revision rates were 6.2%, 5.9%, and 7.9% after CEA with angiography, IDUS, and angioscopy, respectively. Compared to nonapplication of any ICS, the pooled analysis revealed angiography to be significantly associated with lower rates of stroke (RR 0.47; 95% CI, 0.36-0.62; P&lt;0.0001) and stroke or death (RR 0.76; 95% CI, 0.70-0.83; P&lt;0.0001). IDUS was significantly associated with lower rates of stroke (RR 0.56; 95% CI, 0.43-0.73; P&lt;0.0001) and stroke or death (RR 0.83; 95% CI, 0.74-0.93; P=0.0018), whereas angioscopy showed a significant association with a lower stroke rate (RR 0.48; 95% CI, 0.033-0.68; P=0.0001), but no effect on the combined stroke or death rate. Angioscopy was associated with a higher intraoperative revision rate compared to angiography (RR 1.29; 95% CI, 1.07-1.54; P=0.006). The meta-analyses confirmed lower perioperative stroke or death rates for angiography (RR 0.83; 95% CI, 0.76-0.91) and IDUS (RR 0.86; 95% CI, 0.76-0.98) compared to non-application of any ICS, whereas flowmetry showed no significant association.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study represents the first systematic literature review and meta-analysis on usage of ICSs in CEA. Data strongly indicate a significant beneficial effect of angiography, IDUS, and angioscopy on perioperative CEA outcomes. Any carotid surgeon should consider implementation of ICSs in his routine armamentarium.</AbstractText><CopyrightInformation>2021 Annals of Translational Medicine. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Knappich</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department for Vascular and Endovascular Surgery, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lang</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department for Vascular and Endovascular Surgery, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsantilas</LastName><ForeName>Pavlos</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department for Vascular and Endovascular Surgery, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmid</LastName><ForeName>Sofie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department for Vascular and Endovascular Surgery, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kallmayer</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department for Vascular and Endovascular Surgery, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haller</LastName><ForeName>Bernhard</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute of Medical Informatics, Statistics and Epidemiology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eckstein</LastName><ForeName>Hans-Henning</ForeName><Initials>HH</Initials><AffiliationInfo><Affiliation>Department for Vascular and Endovascular Surgery, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Ann Transl Med</MedlineTA><NlmUniqueID>101617978</NlmUniqueID><ISSNLinking>2305-5839</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Angiography</Keyword><Keyword MajorTopicYN="N">angioscopy</Keyword><Keyword MajorTopicYN="N">carotid endarterectomy (CEA)</Keyword><Keyword MajorTopicYN="N">flowmetry</Keyword><Keyword MajorTopicYN="N">quality control</Keyword><Keyword MajorTopicYN="N">ultrasound</Keyword></KeywordList><CoiStatement>Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/atm-20-2931). The series &#x201c;Carotid Artery Stenosis and Stroke &#x2013; Prevention and Treatment Part II&#x201d; was commissioned by the editorial office without any funding or sponsorship. CK reports personal fees from Medistim ASA Norway, outside the submitted work. HHE reports grants from Medistim Company, during the conduct of the study. The other authors have no other conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34430642</ArticleId><ArticleId IdType="pmc">PMC8350645</ArticleId><ArticleId IdType="doi">10.21037/atm-20-2931</ArticleId><ArticleId IdType="pii">atm-09-14-1201</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Naylor AR, Ricco JB, de Borst GJ, et al. Management of Atherosclerotic Carotid and Vertebral Artery Disease: 2017 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 2018;55:3-81. 10.1016/j.ejvs.2017.06.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejvs.2017.06.021</ArticleId><ArticleId IdType="pubmed">28851594</ArticleId></ArticleIdList></Reference><Reference><Citation>Lokuge K, de Waard DD, Halliday A, et al. Meta-analysis of the procedural risks of carotid endarterectomy and carotid artery stenting over time. Br J Surg 2018;105:26-36. 10.1002/bjs.10717</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.10717</ArticleId><ArticleId IdType="pmc">PMC5767749</ArticleId><ArticleId IdType="pubmed">29205297</ArticleId></ArticleIdList></Reference><Reference><Citation>Munster AB, Franchini AJ, Qureshi MI, et al. Temporal trends in safety of carotid endarterectomy in asymptomatic patients: systematic review. Neurology 2015;85:365-72. 10.1212/WNL.0000000000001781</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001781</ArticleId><ArticleId IdType="pmc">PMC4520814</ArticleId><ArticleId IdType="pubmed">26115734</ArticleId></ArticleIdList></Reference><Reference><Citation>Kallmayer MA, Tsantilas P, Knappich C, et al. Trends und Ergebnisse der Karotischirurgie in Deutschland 2003&#x2013;2013. Gefasschirurgie 2015;20:289-98. 10.1007/s00772-015-0040-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00772-015-0040-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014;45:2160-236. 10.1161/STR.0000000000000024</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STR.0000000000000024</ArticleId><ArticleId IdType="pubmed">24788967</ArticleId></ArticleIdList></Reference><Reference><Citation>European Stroke Organisation Executive Committee, ESO Writing Committee . Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008;25:457-507. 10.1159/000131083</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000131083</ArticleId><ArticleId IdType="pubmed">18477843</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricotta JJ, Aburahma A, Ascher E, et al. Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease: executive summary. J Vasc Surg 2011;54:832-6. 10.1016/j.jvs.2011.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2011.07.004</ArticleId><ArticleId IdType="pubmed">21889705</ArticleId></ArticleIdList></Reference><Reference><Citation>Tendera M, Aboyans V, Bartelink ML, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 2011;32:2851-906. 10.1093/eurheartj/ehr211</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehr211</ArticleId><ArticleId IdType="pubmed">21873417</ArticleId></ArticleIdList></Reference><Reference><Citation>Eckstein HH, Kuhnl A, Dorfler A, et al. The diagnosis, treatment and follow-up of extracranial carotid stenosis. Dtsch Arztebl Int 2013;110:468-76. 10.3238/arztebl.2013.0468</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.2013.0468</ArticleId><ArticleId IdType="pmc">PMC3722642</ArticleId><ArticleId IdType="pubmed">23964303</ArticleId></ArticleIdList></Reference><Reference><Citation>Eckstein HH, Kuhnl A, Berkefeld J, et al. S3-Leitlinie zur Diagnostik, Therapie und Nachsorge der extracraniellen Carotisstenose 2020. Available online: https://www.awmf.org/uploads/tx_szleitlinien/004-028l_extracranielle-Carotisstenose-Diagnostik-Therapie-Nachsorge_2020-02_03.pdf</Citation></Reference><Reference><Citation>Knappich C, Kuehnl A, Tsantilas P, et al. Intraoperative Completion Studies, Local Anesthesia, and Antiplatelet Medication Are Associated With Lower Risk in Carotid Endarterectomy. Stroke 2017;48:955-62. 10.1161/STROKEAHA.116.014869</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.116.014869</ArticleId><ArticleId IdType="pubmed">28283609</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramaniam RM, Suarez-Cuervo C, Wilson RF, et al. Effectiveness of Prevention Strategies for Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis. Ann Intern Med 2016;164:406-16. 10.7326/M15-1456</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M15-1456</ArticleId><ArticleId IdType="pubmed">26830221</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisbord SD, Gallagher M, Jneid H, et al. Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine. N Engl J Med 2018;378:603-14. 10.1056/NEJMoa1710933</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1710933</ArticleId><ArticleId IdType="pubmed">29130810</ArticleId></ArticleIdList></Reference><Reference><Citation>Derdeyn CP, Moran CJ, Cross DT, et al. Intraoperative digital subtraction angiography: a review of 112 consecutive examinations. Am J Neuroradiol 1995;16:307-18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8338324</ArticleId><ArticleId IdType="pubmed">7726077</ArticleId></ArticleIdList></Reference><Reference><Citation>Ascher E, Markevich N, Kallakuri S, et al. Intraoperative carotid artery duplex scanning in a modern series of 650 consecutive primary endarterectomy procedures. J Vasc Surg 2004;39:416-20. 10.1016/j.jvs.2003.09.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2003.09.019</ArticleId><ArticleId IdType="pubmed">14743146</ArticleId></ArticleIdList></Reference><Reference><Citation>Parsa P, Hodgkiss-Harlow K, Bandyk DF. Interpretation of intraoperative arterial duplex ultrasound testing. Semin Vasc Surg 2013;26:105-10. 10.1053/j.semvascsurg.2013.11.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.semvascsurg.2013.11.003</ArticleId><ArticleId IdType="pubmed">24636607</ArticleId></ArticleIdList></Reference><Reference><Citation>Mays BW, Towne JB, Seabrook GR, et al. Intraoperative carotid evaluation. Arch Surg 2000;135:525-8. 10.1001/archsurg.135.5.525</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.135.5.525</ArticleId><ArticleId IdType="pubmed">10807275</ArticleId></ArticleIdList></Reference><Reference><Citation>Schanzer A, Hoel A, Owens CD, et al. Restenosis after carotid endarterectomy performed with routine intraoperative duplex ultrasonography and arterial patch closure: a contemporary series. Vasc Endovascular Surg 2007;41:200-5. 10.1177/1538574407301141</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1538574407301141</ArticleId><ArticleId IdType="pubmed">17595385</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullenix PS, Tollefson DF, Olsen SB, et al. Intraoperative duplex ultrasonography as an adjunct to technical excellence in 100 consecutive carotid endarterectomies. Am J Surg 2003;185:445-9. 10.1016/S0002-9610(03)00039-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9610(03)00039-4</ArticleId><ArticleId IdType="pubmed">12727565</ArticleId></ArticleIdList></Reference><Reference><Citation>Aleksic M, Heckenkamp J, Gawenda M, et al. Pulsatility index determination by flowmeter measurement: a new indicator for vascular resistance? Eur Surg Res 2004;36:345-9. 10.1159/000081642</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000081642</ArticleId><ArticleId IdType="pubmed">15591742</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharpe R, Sayers RD, McCarthy MJ, et al. The war against error: a 15 year experience of completion angioscopy following carotid endarterectomy. Eur J Vasc Endovasc Surg 2012;43:139-45. 10.1016/j.ejvs.2011.09.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejvs.2011.09.011</ArticleId><ArticleId IdType="pubmed">21978466</ArticleId></ArticleIdList></Reference><Reference><Citation>Naylor AR, Sayers RD, McCarthy MJ, et al. Closing the loop: a 21-year audit of strategies for preventing stroke and death following carotid endarterectomy. Eur J Vasc Endovasc Surg 2013;46:161-70. 10.1016/j.ejvs.2013.05.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejvs.2013.05.005</ArticleId><ArticleId IdType="pubmed">23770263</ArticleId></ArticleIdList></Reference><Reference><Citation>Osman HY, Gibbons CP. Completion angioscopy following carotid endarterectomy by the eversion technique or the standard longitudinal arteriotomy with patch closure. Ann R Coll Surg Engl 2001;83:149-53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2503587</ArticleId><ArticleId IdType="pubmed">11432129</ArticleId></ArticleIdList></Reference><Reference><Citation>Karnik R, Ammerer HP, Winkler WB, et al. Initial experience with intravascular ultrasound imaging during carotid endarterectomy. Stroke 1994;25:35-9. 10.1161/01.STR.25.1.35</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.STR.25.1.35</ArticleId><ArticleId IdType="pubmed">8266379</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee CH, Jung YS, Yang HJ, et al. An innovative method for detecting surgical errors using indocyanine green angiography during carotid endarterectomy: a preliminary investigation. Acta Neurochir (Wien) 2012;154:67-73. 10.1007/s00701-011-1212-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00701-011-1212-1</ArticleId><ArticleId IdType="pubmed">22068716</ArticleId></ArticleIdList></Reference><Reference><Citation>Courbier R, Jausseran JM, Reggi M, et al. Routine intraoperative carotid angiography: its impact on operative morbidity and carotid restenosis. J Vasc Surg 1986;3:343-50. 10.1016/0741-5214(86)90020-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0741-5214(86)90020-0</ArticleId><ArticleId IdType="pubmed">3944936</ArticleId></ArticleIdList></Reference><Reference><Citation>Bredenberg CE, Iannettoni M, Rosenbloom M, et al. Operative angiography by intraarterial digital subtraction angiography: a new technique for quality control of carotid endarterectomy. J Vasc Surg 1989;9:530-4. 10.1016/0741-5214(89)90468-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0741-5214(89)90468-0</ArticleId><ArticleId IdType="pubmed">2651726</ArticleId></ArticleIdList></Reference><Reference><Citation>Donaldson MC, Ivarsson BL, Mannick JA, et al. Impact of completion angiography on operative conduct and results of carotid endarterectomy. Ann Surg 1993;217:682-7. 10.1097/00000658-199306000-00010</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-199306000-00010</ArticleId><ArticleId IdType="pmc">PMC1242877</ArticleId><ArticleId IdType="pubmed">8507114</ArticleId></ArticleIdList></Reference><Reference><Citation>Westerband A, Mills JL, Berman SS, et al. The influence of routine completion arteriography on outcome following carotid endarterectomy. Ann Vasc Surg 1997;11:14-9. 10.1007/s100169900004</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s100169900004</ArticleId><ArticleId IdType="pubmed">9061134</ArticleId></ArticleIdList></Reference><Reference><Citation>Zannetti S, Cao P, De Rango P, et al. Intraoperative assessment of technical perfection in carotid endarterectomy: a prospective analysis of 1305 completion procedures. Collaborators of the EVEREST study group. Eversion versus standard carotid endartectomy. Eur J Vasc Endovasc Surg 1999;18:52-8. 10.1053/ejvs.1999.0856</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/ejvs.1999.0856</ArticleId><ArticleId IdType="pubmed">10388640</ArticleId></ArticleIdList></Reference><Reference><Citation>Woelfle KD, Bruijnen H, Neu J, et al. The role of intraoperative digital subtraction angiography for quality control of standard carotid endarterectomy using patch angioplasty. Cardiovasc Surg 2002;10:116-22. 10.1016/S0967-2109(01)00131-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0967-2109(01)00131-4</ArticleId><ArticleId IdType="pubmed">11888739</ArticleId></ArticleIdList></Reference><Reference><Citation>Pratesi C, Dorigo W, Troisi N, et al. Routine completion angiography during carotid endarterectomy is not mandatory. Eur J Vasc Endovasc Surg 2006;32:369-73. 10.1016/j.ejvs.2006.04.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejvs.2006.04.022</ArticleId><ArticleId IdType="pubmed">16777443</ArticleId></ArticleIdList></Reference><Reference><Citation>Rockman CB, Halm EA. Intraoperative imaging: does it really improve perioperative outcomes of carotid endarterectomy? Semin Vasc Surg 2007;20:236-43. 10.1053/j.semvascsurg.2007.10.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.semvascsurg.2007.10.003</ArticleId><ArticleId IdType="pubmed">18082840</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricco JB, Regnault de la Mothe G, Fujita S, et al. Impact of routine completion angiography on the results of primary carotid endarterectomy: a prospective study in a teaching hospital. Eur J Vasc Endovasc Surg 2011;41:579-88. 10.1016/j.ejvs.2011.01.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejvs.2011.01.015</ArticleId><ArticleId IdType="pubmed">21334227</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancelevee J, Maurel B, Gaudin M, et al. Is it mandatory to carry out completion arteriography after carotid endarterectomy with patch angioplasty? Ann Vasc Surg 2013;27:719-26. 10.1016/j.avsg.2011.08.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.avsg.2011.08.031</ArticleId><ArticleId IdType="pubmed">23880454</ArticleId></ArticleIdList></Reference><Reference><Citation>Wieker CM, Harcos K, Ronellenfitsch U, et al. Impact of routine completion angiography on outcome after carotid endarterectomy. J Vasc Surg 2019;69:824-31. 10.1016/j.jvs.2018.06.210</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2018.06.210</ArticleId><ArticleId IdType="pubmed">30292609</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz RA, Peterson GJ, Noland KA, et al. Intraoperative duplex scanning after carotid artery reconstruction: a valuable tool. J Vasc Surg 1988;7:620-4. 10.1016/0741-5214(88)90003-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0741-5214(88)90003-1</ArticleId><ArticleId IdType="pubmed">2966867</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawchuk AP, Flanigan DP, Machi J, et al. The fate of unrepaired minor technical defects detected by intraoperative ultrasonography during carotid endarterectomy. J Vasc Surg 1989;9:671-5. 10.1016/S0741-5214(89)70038-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0741-5214(89)70038-0</ArticleId><ArticleId IdType="pubmed">2657116</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandyk DF, Mills JL, Gahtan V, et al. Intraoperative duplex scanning of arterial reconstructions: fate of repaired and unrepaired defects. J Vasc Surg 1994;20:426-32. 10.1016/0741-5214(94)90142-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0741-5214(94)90142-2</ArticleId><ArticleId IdType="pubmed">8084036</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker WH, Koustas G, Burke K, et al. Intraoperative duplex scanning and late carotid artery stenosis. J Vasc Surg 1994;19:829-32. 10.1016/S0741-5214(94)70007-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0741-5214(94)70007-9</ArticleId><ArticleId IdType="pubmed">8170036</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu A, Gregory D, Morrison L, et al. The role of intra-operative duplex imaging in arterial reconstructions. Am J Surg 1996;171:500-1. 10.1016/S0002-9610(96)00013-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9610(96)00013-X</ArticleId><ArticleId IdType="pubmed">8651394</ArticleId></ArticleIdList></Reference><Reference><Citation>Papanicolaou G, Toms C, Yellin AE, et al. Relationship between intraoperative color-flow duplex findings and early restenosis after carotid endarterectomy: a preliminary report. J Vasc Surg 1996;24:588-95. 10.1016/S0741-5214(96)70074-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0741-5214(96)70074-5</ArticleId><ArticleId IdType="pubmed">8911407</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipski DA, Bergamini TM, Garrison RN, et al. Intraoperative duplex scanning reduces the incidence of residual stenosis after carotid endarterectomy. J Surg Res 1996;60:317-20. 10.1006/jsre.1996.0050</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jsre.1996.0050</ArticleId><ArticleId IdType="pubmed">8598661</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker RA, Fox AD, Magee TR, et al. Intraoperative duplex scanning as a means of quality control during carotid endarterectomy. Eur J Vasc Endovasc Surg 1996;11:364-7. 10.1016/S1078-5884(96)80087-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1078-5884(96)80087-6</ArticleId><ArticleId IdType="pubmed">8601251</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorffner R, Metz VM, Trattnig S, et al. Intraoperative and early postoperative colour Doppler sonography after carotid artery reconstruction: follow-up of technical defects. Neuroradiology 1997;39:117-21. 10.1007/s002340050377</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s002340050377</ArticleId><ArticleId IdType="pubmed">9045972</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinmetz OK, MacKenzie K, Nault P, et al. Intraoperative duplex scanning for carotid endarterectomy. Eur J Vasc Endovasc Surg 1998;16:153-8. 10.1016/S1078-5884(98)80158-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1078-5884(98)80158-5</ArticleId><ArticleId IdType="pubmed">9728436</ArticleId></ArticleIdList></Reference><Reference><Citation>Padayachee TS, Brooks MD, Modaresi KB, et al. Intraoperative high resolution duplex imaging during carotid endarterectomy: which abnormalities require surgical correction? Eur J Vasc Endovasc Surg 1998;15:387-93. 10.1016/S1078-5884(98)80198-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1078-5884(98)80198-6</ArticleId><ArticleId IdType="pubmed">9633492</ArticleId></ArticleIdList></Reference><Reference><Citation>Seelig MH, Oldenburg WA, Chowla A, et al. Use of intraoperative duplex ultrasonography and routine patch angioplasty in patients undergoing carotid endarterectomy. Mayo Clin Proc 1999;74:870-6. 10.4065/74.9.870</Citation><ArticleIdList><ArticleId IdType="doi">10.4065/74.9.870</ArticleId><ArticleId IdType="pubmed">10488787</ArticleId></ArticleIdList></Reference><Reference><Citation>Panneton JM, Berger MW, Lewis BD, et al. Intraoperative duplex ultrasound during carotid endarterectomy. Vasc Surg 2001;35:1-9. 10.1177/153857440103500102</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/153857440103500102</ArticleId><ArticleId IdType="pubmed">11668362</ArticleId></ArticleIdList></Reference><Reference><Citation>Ascher E, Markevich N, Hingorani AP, et al. Internal carotid artery flow volume measurement and other intraoperative duplex scanning parameters as predictors of stroke after carotid endarterectomy. J Vasc Surg 2002;35:439-44. 10.1067/mva.2002.120044</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mva.2002.120044</ArticleId><ArticleId IdType="pubmed">11877690</ArticleId></ArticleIdList></Reference><Reference><Citation>Padayachee TS, Arnold JA, Thomas N, et al. Correlation of intra-operative duplex findings during carotid endarterectomy with neurological events and recurrent stenosis at one year. Eur J Vasc Endovasc Surg 2002;24:435-9. 10.1053/ejvs.2002.1743</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/ejvs.2002.1743</ArticleId><ArticleId IdType="pubmed">12435344</ArticleId></ArticleIdList></Reference><Reference><Citation>Ott C, Heller G, Odermatt M, et al. Intraoperative duplex ultrasonography in carotid endarterectomy: the impact on indication for immediate revision and intermediate-term outcome. Vasa 2008;37:151-6. 10.1024/0301-1526.37.2.151</Citation><ArticleIdList><ArticleId IdType="doi">10.1024/0301-1526.37.2.151</ArticleId><ArticleId IdType="pubmed">18622965</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan JY, Durward QJ, Pary JK, et al. Use of intraoperative duplex ultrasonography for identification and patch repair of kinking stenosis after carotid endarterectomy: a single-surgeon retrospective experience. World Neurosurg 2014;81:334-43. 10.1016/j.wneu.2012.11.055</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2012.11.055</ArticleId><ArticleId IdType="pubmed">23178918</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaunt ME, Naylor AR, Ratliff DA, et al. Role of completion angioscopy in detecting technical error after carotid endarterectomy. Br J Surg 1994;81:42-4. 10.1002/bjs.1800810113</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.1800810113</ArticleId><ArticleId IdType="pubmed">8313115</ArticleId></ArticleIdList></Reference><Reference><Citation>Lennard N, Smith JL, Gaunt ME, et al. A policy of quality control assessment helps to reduce the risk of intraoperative stroke during carotid endarterectomy. Eur J Vasc Endovasc Surg 1999;17:234-40. 10.1053/ejvs.1998.0723</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/ejvs.1998.0723</ArticleId><ArticleId IdType="pubmed">10092897</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.</Citation><ArticleIdList><ArticleId IdType="pubmed">13655060</ArticleId></ArticleIdList></Reference><Reference><Citation>Robins J, Greenland S, Breslow NE. A general estimator for the variance of the Mantel-Haenszel odds ratio. Am J Epidemiol 1986;124:719-23. 10.1093/oxfordjournals.aje.a114447</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a114447</ArticleId><ArticleId IdType="pubmed">3766505</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thomas J, Chandler J, et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Available online: www.training.cochrane.org/handbook</Citation></Reference><Reference><Citation>Huedo-Medina TB, Sanchez-Meca J, Marin-Martinez F, et al. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods 2006;11:193-206. 10.1037/1082-989X.11.2.193</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/1082-989X.11.2.193</ArticleId><ArticleId IdType="pubmed">16784338</ArticleId></ArticleIdList></Reference><Reference><Citation>Balduzzi S, Rucker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health 2019;22:153-60. 10.1136/ebmental-2019-300117</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ebmental-2019-300117</ArticleId><ArticleId IdType="pmc">PMC10231495</ArticleId><ArticleId IdType="pubmed">31563865</ArticleId></ArticleIdList></Reference><Reference><Citation>Lingenfelter KA, Fuller BC, Sullivan TM. Intraoperative assessment of carotid endarterectomy: a comparison of techniques. Ann Vasc Surg 1995;9:235-40. 10.1007/BF02135281</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02135281</ArticleId><ArticleId IdType="pubmed">7632550</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler GA, Calligaro KD, Kolakowski S, et al. Comparison of intraoperative completion flowmeter versus duplex ultrasonography and contrast arteriography for carotid endarterectomy. Vasc Endovascular Surg 2006;40:482-6. 10.1177/1538574406290846</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1538574406290846</ArticleId><ArticleId IdType="pubmed">17202095</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallaert JB, Goodney PP, Vignati JJ, et al. Completion imaging after carotid endarterectomy in the Vascular Study Group of New England. J Vasc Surg 2011;54:376-85, 85.e1-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3237118</ArticleId><ArticleId IdType="pubmed">21458209</ArticleId></ArticleIdList></Reference><Reference><Citation>Knappich C, Schmid S, Tsantilas P, et al. Prospective Comparison of Duplex Ultrasound and Angiography for Intra-operative Completion Studies after Carotid Endarterectomy. Eur J Vasc Endovasc Surg 2020;59:881-9. 10.1016/j.ejvs.2020.02.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejvs.2020.02.017</ArticleId><ArticleId IdType="pubmed">32197998</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothwell PM, Eliasziw M, Gutnikov SA, et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003;361:107-16. 10.1016/S0140-6736(03)12228-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(03)12228-3</ArticleId><ArticleId IdType="pubmed">12531577</ArticleId></ArticleIdList></Reference><Reference><Citation>Naylor AR. Time to rethink management strategies in asymptomatic carotid artery disease. Nat Rev Cardiol 2011;9:116-24. 10.1038/nrcardio.2011.151</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrcardio.2011.151</ArticleId><ArticleId IdType="pubmed">21989048</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">21239976</PMID><DateCompleted><Year>2011</Year><Month>03</Month><Day>03</Day></DateCompleted><DateRevised><Year>2014</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1175</ISSN><JournalIssue CitedMedium="Internet"><Volume>114</Volume><Issue>2</Issue><PubDate><Year>2011</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Anesthesiology</Title><ISOAbbreviation>Anesthesiology</ISOAbbreviation></Journal><ArticleTitle>Thoracic epidural anesthesia for cardiac surgery: a randomized trial.</ArticleTitle><Pagination><StartPage>262</StartPage><EndPage>270</EndPage><MedlinePgn>262-70</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ALN.0b013e318201d2de</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The addition of thoracic epidural anesthesia (TEA) to general anesthesia (GA) during cardiac surgery may have a beneficial effect on clinical outcomes. TEA in cardiac surgery, however, is controversial because the insertion of an epidural catheter in patients requiring full heparinization for cardiopulmonary bypass may lead to an epidural hematoma. The clinical effects of fast-track GA plus TEA were compared with those of with fast-track GA alone.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A randomized controlled trial was conducted in 654 elective cardiac surgical patients who were randomly assigned to combined GA and TEA versus GA alone. Follow-up was at 30 days and 1 yr after surgery. The primary endpoint was 30-day survival free from myocardial infarction, pulmonary complications, renal failure, and stroke.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Thirty-day survival free from myocardial infarction, pulmonary complications, renal failure, and stroke was 85.2% in the TEA group and 89.7% in the GA group (P = 0.23). At 1 yr follow-up, survival free from myocardial infarction, pulmonary complications, renal failure, and stroke was 84.6% in the TEA group and 87.2% in the GA group (P = 0.42). Postoperative pain scores were low in both groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study was unable to demonstrate a clinically relevant benefit of TEA on the frequency of major complications after elective cardiac surgery, compared with fast-track cardiac anesthesia without epidural anesthesia. Given the potentially devastating complications of an epidural hematoma after insertion of an epidural catheter, it is questionable whether this procedure should be applied routinely in cardiac surgical patients who require full heparinization.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Svircevic</LastName><ForeName>Vesna</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Anesthesiology Resident, Department of Anesthesiology, University Medical Centre Utrecht, Utrecht, The Netherlands. v.svircevic@umcutrecht.nl</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nierich</LastName><ForeName>Arno P</ForeName><Initials>AP</Initials></Author><Author ValidYN="Y"><LastName>Moons</LastName><ForeName>Karel G M</ForeName><Initials>KG</Initials></Author><Author ValidYN="Y"><LastName>Diephuis</LastName><ForeName>Jan C</ForeName><Initials>JC</Initials></Author><Author ValidYN="Y"><LastName>Ennema</LastName><ForeName>Jacob J</ForeName><Initials>JJ</Initials></Author><Author ValidYN="Y"><LastName>Brandon Bravo Bruinsma</LastName><ForeName>George J</ForeName><Initials>GJ</Initials></Author><Author ValidYN="Y"><LastName>Kalkman</LastName><ForeName>Cor J</ForeName><Initials>CJ</Initials></Author><Author ValidYN="Y"><LastName>van Dijk</LastName><ForeName>Diederik</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesthesiology</MedlineTA><NlmUniqueID>1300217</NlmUniqueID><ISSNLinking>0003-3022</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000767" MajorTopicYN="Y">Anesthesia, Epidural</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051437" MajorTopicYN="N">Renal Insufficiency</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013904" MajorTopicYN="N">Thoracic Vertebrae</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21239976</ArticleId><ArticleId IdType="doi">10.1097/ALN.0b013e318201d2de</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32081531</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>23</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2165</ISSN><JournalIssue CitedMedium="Internet"><Volume>59</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Apr</Month></PubDate></JournalIssue><Title>European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery</Title><ISOAbbreviation>Eur J Vasc Endovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Editor's Choice - Prognostic Role of Pre-Operative Symptom Status in Carotid Endarterectomy: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>516</StartPage><EndPage>524</EndPage><MedlinePgn>516-524</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejvs.2020.01.022</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1078-5884(20)30068-X</ELocationID><Abstract><AbstractText Label="OBJECTIVE">This study investigates the prognostic significance of pre-operative symptom status and type of symptom in outcomes after carotid endarterectomy (CEA).</AbstractText><AbstractText Label="METHODS">This review was conducted and reported in accordance with the Preferred Reporting Items for Systematic reviews and Meta-analysis (PRISMA) to identify studies reporting peri-operative outcomes of CEA in symptomatic and asymptomatic patients. The last search was conducted in August 2019 and a methodological assessment was performed using the Newcastle Ottawa Scale. A meta-analysis of outcome data using the odds ratio (OR) as the summary statistic was conducted, and the precision of the effect was reported as 95% confidence interval (CI). Fixed effect or random effects models were used to calculate the pooled estimates.</AbstractText><AbstractText Label="RESULTS">Eighteen studies reporting a total of 91&#xa0;895 patients were included in the meta-analysis. Asymptomatic patients had a lower peri-operative risk of stroke (OR 0.5, 95% CI 0.45-0.54; p&#xa0;&lt;&#xa0;.001) and death (OR 0.66, 95% CI 0.57-0.77; p&#xa0;&lt;&#xa0;.001) than symptomatic patients, but the risk of myocardial infarction was not significantly different (OR 0.98, 95% CI 0.84-1.15; p&#xa0;=&#xa0;.82). Those suffering a pre-procedural stroke had an increased peri-operative risk of stroke and death vs. patients suffering a pre-procedural transient ischaemic attack or amaurosis fugax.</AbstractText><AbstractText Label="CONCLUSION">Patients undergoing CEA after a stroke have worse peri-operative outcomes in terms of stroke and death. Further research needs to be performed to ascertain the value of this finding in risk stratification systems and to investigate potential aetiological associations between pre-operative symptom status and peri-operative risk following a CEA.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ball</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Vascular and Endovascular Surgery, The Royal Oldham Hospital, Pennine Acute Hospitals NHS Trust, Manchester, UK; Division of Cardiovascular Sciences, School of Medical Sciences, University of Manchester, Manchester, UK. Electronic address: steball@doctors.org.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ball</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Vascular and Endovascular Surgery, The Royal Oldham Hospital, Pennine Acute Hospitals NHS Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antoniou</LastName><ForeName>George A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Department of Vascular and Endovascular Surgery, The Royal Oldham Hospital, Pennine Acute Hospitals NHS Trust, Manchester, UK; Division of Cardiovascular Sciences, School of Medical Sciences, University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Vasc Endovasc Surg</MedlineTA><NlmUniqueID>9512728</NlmUniqueID><ISSNLinking>1078-5884</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Eur J Vasc Endovasc Surg. 2020 Apr;59(4):525. doi: 10.1016/j.ejvs.2019.12.036.</RefSource><PMID Version="1">31928907</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D020757" MajorTopicYN="N">Amaurosis Fugax</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016893" MajorTopicYN="N">Carotid Stenosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016894" MajorTopicYN="N">Endarterectomy, Carotid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="N">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057234" MajorTopicYN="N">Preoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063189" MajorTopicYN="Y">Symptom Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amaurosis fugax</Keyword><Keyword MajorTopicYN="N">Asymptomatic</Keyword><Keyword MajorTopicYN="N">Carotid endarterectomy</Keyword><Keyword MajorTopicYN="N">Peri-operative</Keyword><Keyword MajorTopicYN="N">Stroke</Keyword><Keyword MajorTopicYN="N">Transient ischaemic attack</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32081531</ArticleId><ArticleId IdType="doi">10.1016/j.ejvs.2020.01.022</ArticleId><ArticleId IdType="pii">S1078-5884(20)30068-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27306799</PMID><DateCompleted><Year>2018</Year><Month>05</Month><Day>09</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-2614</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>4</Issue><PubDate><Year>2017</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of clinical monitoring and computing</Title><ISOAbbreviation>J Clin Monit Comput</ISOAbbreviation></Journal><ArticleTitle>A systematic review of pulse pressure variation and stroke volume variation to predict fluid responsiveness during cardiac and thoracic surgery.</ArticleTitle><Pagination><StartPage>677</StartPage><EndPage>684</EndPage><MedlinePgn>677-684</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10877-016-9898-5</ELocationID><Abstract><AbstractText>This systematic review aims to summarize the published data on the reliability of pulse pressure variation (PPV) and stroke volume variation (SVV) to predict fluid responsiveness in an open-chest setting during cardio-thoracic surgery. The analysis included studies reporting receiver operating characteristics or correlation coefficients between PPV/SVV and change in any hemodynamic variables after a fluid challenge test in open-chest conditions. The literature search included seven studies. Increase in cardiac index and stroke volume index after a fluid challenge were the most adopted end-point variables. PPV and SVV showed similar area under the receiver operating characteristic curve values but high heterogeneity among studies. Cardiac and thoracic studies did not differ between PPV/SVV pooled area under the receiver operating characteristic curve. Studies exploring correlation between dynamic indices and end-point variable increase after fluid challenge showed conflicting results. The great heterogeneity between studies was due to small sample size and differences among protocol designs (different monitor devices, mechanical ventilation settings, fluid challenge methodologies, surgical incisions, and end-point variables). PPV and SVV seem to be inaccurate in predicting fluid responsiveness in an open-chest setting during cardio-thoracic surgery. Given the high heterogeneity of published data, more studies are needed to define the role of PPV/SVV in this context.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Piccioni</LastName><ForeName>Federico</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-9589-1891</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia, Intensive Care and Palliative Care, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy. federico.piccioni@istitutotumori.mi.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernasconi</LastName><ForeName>Filippo</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>School of Anesthesia and Intensive Care, University of Milan, Via Festa del Perdono 7, 20122, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tramontano</LastName><ForeName>Giulia T A</ForeName><Initials>GTA</Initials><AffiliationInfo><Affiliation>School of Anesthesia and Intensive Care, University of Milan, Via Festa del Perdono 7, 20122, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Langer</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Intensive Care and Palliative Care, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, University of Milan, Via Festa del Perdono 7, 20122, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>06</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Clin Monit Comput</MedlineTA><NlmUniqueID>9806357</NlmUniqueID><ISSNLinking>1387-1307</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001794" MajorTopicYN="Y">Blood Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="N">Fluid Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016343" MajorTopicYN="Y">Monitoring, Intraoperative</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063177" MajorTopicYN="N">Pulse Wave Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="Y">Stroke Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019616" MajorTopicYN="Y">Thoracic Surgical Procedures</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anesthesia, general</Keyword><Keyword MajorTopicYN="N">Cardiac surgical procedure</Keyword><Keyword MajorTopicYN="N">Fluid therapy</Keyword><Keyword MajorTopicYN="N">Meta-analysis as topic</Keyword><Keyword MajorTopicYN="N">Pulse wave analysis</Keyword><Keyword MajorTopicYN="N">Thoracic surgery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27306799</ArticleId><ArticleId IdType="doi">10.1007/s10877-016-9898-5</ArticleId><ArticleId IdType="pii">10.1007/s10877-016-9898-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Intensive Care Med. 2003 Mar;29(3):476-80</Citation><ArticleIdList><ArticleId IdType="pubmed">12579420</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaesthesia. 2010 Jul;65(7):704-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20477782</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2009 Oct;62(10):1006-12</Citation><ArticleIdList><ArticleId IdType="pubmed">19631508</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Fr Anesth Reanim. 2011 Feb;30(2):117-21</Citation><ArticleIdList><ArticleId IdType="pubmed">21324633</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiothorac Vasc Anesth. 2010 Oct;24(5):772-5</Citation><ArticleIdList><ArticleId IdType="pubmed">20638869</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Anaesthesiol. 2011 Jan;28(1):39-44</Citation><ArticleIdList><ArticleId IdType="pubmed">21088596</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2005 Apr;31(4):517-23</Citation><ArticleIdList><ArticleId IdType="pubmed">15754196</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Anaesth. 2004 Jun;92(6):808-13</Citation><ArticleIdList><ArticleId IdType="pubmed">15096443</ArticleId></ArticleIdList></Reference><Reference><Citation>J Anesth. 2011 Oct;25(5):777-80</Citation><ArticleIdList><ArticleId IdType="pubmed">21744128</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Res Pract. 2012;2012:687018</Citation><ArticleIdList><ArticleId IdType="pubmed">22778929</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Anaesth. 2005 Mar;94(3):318-23</Citation><ArticleIdList><ArticleId IdType="pubmed">15591333</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Monit Comput. 2011 Feb;25(1):45-56</Citation><ArticleIdList><ArticleId IdType="pubmed">20390324</ArticleId></ArticleIdList></Reference><Reference><Citation>Biosci Trends. 2014 Feb;8(1):59-63</Citation><ArticleIdList><ArticleId IdType="pubmed">24647114</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesth Analg. 2011 Jun;112(6):1392-402</Citation><ArticleIdList><ArticleId IdType="pubmed">20966436</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinics (Sao Paulo). 2013 Jul;68(7):1065-70</Citation><ArticleIdList><ArticleId IdType="pubmed">23917675</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Card Anaesth. 2008 Jan-Jun;11(1):27-34</Citation><ArticleIdList><ArticleId IdType="pubmed">18182756</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Crit Care. 2013 Aug;19(4):346-52</Citation><ArticleIdList><ArticleId IdType="pubmed">23817029</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cardiothorac Surg. 2006 Jul;30(1):90-5</Citation><ArticleIdList><ArticleId IdType="pubmed">16723238</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2009 Feb;37(2):510-5</Citation><ArticleIdList><ArticleId IdType="pubmed">19114886</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Anaesth. 2013 Apr;110(4):510-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23447502</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2009 Sep;37(9):2642-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19602972</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Med Res Methodol. 2005 Apr 20;5:13</Citation><ArticleIdList><ArticleId IdType="pubmed">15840177</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Anaesthesiol Scand. 2007 Oct;51(9):1258-67</Citation><ArticleIdList><ArticleId IdType="pubmed">17714575</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32403063</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>10</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-8952</ISSN><JournalIssue CitedMedium="Internet"><Volume>131</Volume><Issue>7</Issue><PubDate><Year>2020</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology</Title><ISOAbbreviation>Clin Neurophysiol</ISOAbbreviation></Journal><ArticleTitle>Diagnostic accuracy of various EEG changes during carotid endarterectomy to detect 30-day perioperative stroke: A systematic review.</ArticleTitle><Pagination><StartPage>1508</StartPage><EndPage>1516</EndPage><MedlinePgn>1508-1516</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clinph.2020.03.037</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1388-2457(20)30144-9</ELocationID><Abstract><AbstractText Label="OBJECTIVES">We assessed whether significant intraoperative electroencephalography (EEG) changes have predictive value for perioperative stroke within 30&#xa0;days after carotid endarterectomy (CEA) procedures for carotid stenosis (CS) patients. We also assessed the diagnostic accuracy of various EEG changes in predicting perioperative stroke.</AbstractText><AbstractText Label="METHODS">We searched databases for reports with outcomes of CS patients who underwent CEA with intraoperative EEG monitoring. We calculated the sensitivity, specificity, and diagnostic odds ratio (DOR) of EEG changes for predicting perioperative stroke. Sensitivity and specificity were presented with forest plots and a summary receiver operating characteristic (ROC) curve.</AbstractText><AbstractText Label="RESULTS">The meta-analysis included 10,672 patients. Intraoperative EEG changes predicted 30-day stroke with a sensitivity of 46% (95% CI, 38-54%) and specificity of 86% (95% CI, 83-88%). The estimated DOR was 5.79 (95% CI, 3.86-8.69). The estimated DOR for reversible and irreversible EEG changes were 8.25 (95% CI, 3.34-20.34) and 70.84 (95% CI, 36.01-139.37), respectively.</AbstractText><AbstractText Label="CONCLUSION">Intraoperative EEG changes have high specificity but modest sensitivity for predicting perioperative stroke following CEA. Patients with irreversible EEG changes are at high risk for perioperative stroke.</AbstractText><AbstractText Label="SIGNIFICANCE">Intraoperative EEG changes can help surgeons predict the risk of perioperative stroke for CS patients following CEA.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reddy</LastName><ForeName>Rajiv P</ForeName><Initials>RP</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sudadi</LastName><ForeName>Shreya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balzer</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA; Department of Neuroscience, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crammond</LastName><ForeName>Donald J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anetakis</LastName><ForeName>Katherine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thirumala</LastName><ForeName>Parthasarathy D</ForeName><Initials>PD</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA; Department of Neurology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. Electronic address: thirumalapd@upmc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Clin Neurophysiol</MedlineTA><NlmUniqueID>100883319</NlmUniqueID><ISSNLinking>1388-2457</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004569" MajorTopicYN="N">Electroencephalography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016894" MajorTopicYN="N">Endarterectomy, Carotid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064795" MajorTopicYN="N">Intraoperative Neurophysiological Monitoring</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Carotid endarterectomy/CEA</Keyword><Keyword MajorTopicYN="N">Carotid stenosis/CS</Keyword><Keyword MajorTopicYN="N">Electroencephalography/EEG</Keyword><Keyword MajorTopicYN="N">Perioperative</Keyword><Keyword MajorTopicYN="N">Stroke/transient ischemic attack/TIA</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest None of the authors have potential conflicts of interest to be disclosed.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>12</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32403063</ArticleId><ArticleId IdType="doi">10.1016/j.clinph.2020.03.037</ArticleId><ArticleId IdType="pii">S1388-2457(20)30144-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37753546</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1757-7861</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Orthopaedic surgery</Title><ISOAbbreviation>Orthop Surg</ISOAbbreviation></Journal><ArticleTitle>Comparing the Effect of Spinal and General Anesthesia for Hip Fracture Surgery in Older Patients: A Meta-analysis of Randomized Clinical Trials.</ArticleTitle><Pagination><StartPage>3254</StartPage><EndPage>3262</EndPage><MedlinePgn>3254-3262</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/os.13895</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Hip fractures are the most common fractures among older adults, with most patients undergoing surgery. The debate regarding the type of anesthetic technique for hip fracture surgery is still ongoing. This meta-analysis aimed to compare the intraoperative and postoperative outcomes of spinal and general anesthesia in older patients undergoing hip fracture surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Eligible studies that compared the effects of spinal and general anesthesia were systematically searched from PubMed, Embase, and the Cochrane Library until May 27, 2022. The intraoperative and postoperative outcomes of the two anesthesia techniques were compared. Quality assessment, heterogeneity analysis, and publication bias of the studies were also assessed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Nine articles of methodological quality were included in the meta-analysis. The pooled results revealed that there were significant differences in hypotension (risk ratio [RR] (95% confidence interval [CI])&#x2009;=&#x2009;0.81 (0.68, 0.97), p&#x2009;=&#x2009;0.02) and ephedrine dose (weighted mean difference [WMD] [95%CI] =&#x2009;-20.94 [-37.50, -4.37] mg, p&#x2009;=&#x2009;0.01) between the spinal and general anesthesia groups. However, no significant differences were observed in the use of ephedrine (RR [95% CI]&#x2009;=&#x2009;0.77 [0.19, 3.05]), blood loss (WMD [95%CI]&#x2009;=&#x2009;-34.38 [-89.56, 20.80) mL], myocardial infarction (RR [95% CI]&#x2009;=&#x2009;0.78 [0.31, 1.94] mL), heart failure (RR [95% CI]&#x2009;=&#x2009;0.87 [0.17, 4.36] mL), stroke (RR [95%CI)&#x2009;=&#x2009;0.65 [0.22, 1.95] mL), postoperative nausea and vomiting (RR [95% CI]&#x2009;=&#x2009;0.88 [0.17, 4.35] mL), delirium (RR [95% CI]&#x2009;=&#x2009;1.08 [0.89, 1.31] mL), and mortality (RR [95% CI]&#x2009;=&#x2009;1.10 [0.72, 1.68] mL) (all p&#x2009;&lt;&#x2009;0.05). No publication bias was observed in any of the included studies.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Compared to general anesthesia, spinal anesthesia was associated with a lower risk of intraoperative hypotension and lower doses of ephedrine in older patients undergoing hip fracture surgery.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Orthopaedic Surgery published by Tianjin Hospital and John Wiley &amp; Sons Australia, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Hua</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Trauma, Honghui Hospital, Xi'an Jiaotong University, Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Honghui Hospital, Xi'an Jiaotong University, Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Cheng</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-7514-4939</Identifier><AffiliationInfo><Affiliation>Department of Orthopedic Trauma, Honghui Hospital, Xi'an Jiaotong University, Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Teng</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Trauma, Honghui Hospital, Xi'an Jiaotong University, Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ming</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4411-7791</Identifier><AffiliationInfo><Affiliation>Department of Orthopedic Trauma, Honghui Hospital, Xi'an Jiaotong University, Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zhong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Trauma, Honghui Hospital, Xi'an Jiaotong University, Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Yibo</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-4923-4820</Identifier><AffiliationInfo><Affiliation>Department of Orthopedic Trauma, Honghui Hospital, Xi'an Jiaotong University, Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Trauma, Honghui Hospital, Xi'an Jiaotong University, Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Nursing, Honghui Hospital, Xi'an Jiaotong University, Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Kun</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Trauma, Honghui Hospital, Xi'an Jiaotong University, Xi'an, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2022JQ-299</GrantID><Agency>Shaanxi Province Natural Science Fundamental Research Project</Agency><Country/></Grant><Grant><GrantID>2022JQ-759</GrantID><Agency>Shaanxi Province Natural Science Fundamental Research Project</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Orthop Surg</MedlineTA><NlmUniqueID>101501666</NlmUniqueID><ISSNLinking>1757-7853</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>GN83C131XS</RegistryNumber><NameOfSubstance UI="D004809">Ephedrine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004809" MajorTopicYN="N">Ephedrine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="Y">Hip Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="Y">Hypotension</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000775" MajorTopicYN="Y">Anesthesia, Spinal</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ephedrine</Keyword><Keyword MajorTopicYN="N">Hypotension</Keyword><Keyword MajorTopicYN="N">Intraoperative outcomes</Keyword><Keyword MajorTopicYN="N">Older population</Keyword><Keyword MajorTopicYN="N">Postoperative outcomes</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>5</Day><Hour>17</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>27</Day><Hour>3</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37753546</ArticleId><ArticleId IdType="pmc">PMC10693995</ArticleId><ArticleId IdType="doi">10.1111/os.13895</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huette P, Abou&#x2010;Arab O, Djebara A&#x2010;E, Terrasi B, Beyls C, Guinot PG, et al. Risk factors and mortality of patients undergoing hip fracture surgery: a one&#x2010;year follow&#x2010;up study. Sci Rep. 2020;10:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7296002</ArticleId><ArticleId IdType="pubmed">32541939</ArticleId></ArticleIdList></Reference><Reference><Citation>
World Health Organization
. Fact Sheet Burns. 2018. https://www.who.int/news-room/fact-sheets/detail/burns. Accessed 23 Apr 2019.</Citation></Reference><Reference><Citation>Kowark A, Adam C, Ahrens J, Bajbouj M, Bollheimer C, Borowski M, et al. Improve hip fracture outcome in the elderly patient (iHOPE): a study protocol for a pragmatic, multicentre randomised controlled trial to test the efficacy of spinal versus general anaesthesia. BMJ Open. 2018;8:e023609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6196806</ArticleId><ArticleId IdType="pubmed">30341135</ArticleId></ArticleIdList></Reference><Reference><Citation>Borgstr&#xf6;m F, Karlsson L, Orts&#xe4;ter G, et al. Fragility fractures in Europe: burden, management and opportunities. Arch Osteoporos. 2020;15:1&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7166207</ArticleId><ArticleId IdType="pubmed">32306163</ArticleId></ArticleIdList></Reference><Reference><Citation>Paccou J, Lenne X, Ficheur G, Theis D, Cortet B, Bruandet A. Analysis of hip fractures in France during the first COVID&#x2010;19 lockdown in spring 2020. JAMA Netw Open. 2021;4:e2134972.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8600388</ArticleId><ArticleId IdType="pubmed">34787657</ArticleId></ArticleIdList></Reference><Reference><Citation>Murthy S, Hepner D, Cooper Z, Bader A, Neuman M. Controversies in anaesthesia for noncardiac surgery in older adults. Br J Anaesth. 2015;115:ii15&#x2013;ii25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4809989</ArticleId><ArticleId IdType="pubmed">26658197</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman MD, Silber JH, Elkassabany NM, Ludwig JM, Fleisher LA. Comparative effectiveness of regional versus general anesthesia for hip fracture surgery in adults. J Am Soc Anesthesiol. 2012;117:72&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">22713634</ArticleId></ArticleIdList></Reference><Reference><Citation>Guay J, Parker MJ, Gajendragadkar PR, Kopp S. Anaesthesia for hip fracture surgery in adults. Cochrane Database Syst Rev. 2016;2017:CD000521.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6464323</ArticleId><ArticleId IdType="pubmed">26899415</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng X, Tan Y, Gao Y, Liu Z. Comparative efficacy of Neuraxial and general anesthesia for hip fracture surgery: a meta&#x2010;analysis of randomized clinical trials. BMC Anesthesiol. 2020;20:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7325684</ArticleId><ArticleId IdType="pubmed">32605591</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, Li J, Yuan L, et al. Effect of regional vs general anesthesia on incidence of postoperative delirium in older patients undergoing hip fracture surgery: the RAGA randomized trial. J Am Med Assoc. 2021;327:1708.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8689436</ArticleId><ArticleId IdType="pubmed">34928310</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman MD, Feng R, Carson JL, Gaskins LJ, Dillane D, Sessler DI, et al. Spinal anesthesia or general anesthesia for hip surgery in older adults. N Engl J Med. 2021;385:2025&#x2013;2035.</Citation><ArticleIdList><ArticleId IdType="pubmed">34623788</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarsilla M. Cochrane handbook for systematic reviews of interventions. J Multidiscip Eval. 2008;6:142&#x2013;148.</Citation></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta&#x2010;analyses. Br Med J. 2003;327:557&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta&#x2010;analysis detected by a simple, graphical test. BMJ. 1997;315:629&#x2013;634.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Biboulet P, Jourdan A, Van Haevre V, et al. Hemodynamic profile of target&#x2010;controlled spinal anesthesia compared with 2 target&#x2010;controlled general anesthesia techniques in elderly patients with cardiac comorbidities. Reg Anesth Pain Med. 2012;37:433&#x2013;440.</Citation><ArticleIdList><ArticleId IdType="pubmed">22609644</ArticleId></ArticleIdList></Reference><Reference><Citation>Casati A, Aldegheri G, Vinciguerra E, Marsan A, Fraschini G, Torri G. Randomized comparison between sevoflurane anaesthesia and unilateral spinal anaesthesia in elderly patients undergoing orthopaedic surgery. Eur J Anaesthesiol. 2003;20:640&#x2013;646.</Citation><ArticleIdList><ArticleId IdType="pubmed">12932066</ArticleId></ArticleIdList></Reference><Reference><Citation>Haghighi M, Sedighinejad A, Nabi BN, Mardani&#x2010;Kivi M, Tehran SG, Mirfazli SA, et al. Is spinal anesthesia with low dose lidocaine better than sevoflorane anesthesia in patients undergoing hip fracture surgery. Arch Bone Jt Surg. 2017;5:226&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5592363</ArticleId><ArticleId IdType="pubmed">28913379</ArticleId></ArticleIdList></Reference><Reference><Citation>Messina A, Frassanito L, Colombo D, Vergari A, Draisci G, Della Corte F, et al. Hemodynamic changes associated with spinal and general anesthesia for hip fracture surgery in severe ASA III elderly population: a pilot trial. Minerva Anestesiol. 2013;79:1021&#x2013;1029.</Citation><ArticleIdList><ArticleId IdType="pubmed">23635998</ArticleId></ArticleIdList></Reference><Reference><Citation>Meuret P, Bouvet L, Villet B, Hafez M, Allaouchiche B, Boselli E. Hypobaric unilateral spinal Anaesthesia versus general Anaesthesia in elderly patients undergoing hip fracture surgical repair: a prospective randomised open trial. Turk J Anaesthesiol Reanim. 2018;46:121&#x2013;130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5937458</ArticleId><ArticleId IdType="pubmed">29744247</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin S, Kim SH, Park KK, Kim SJ, Bae JC, Choi YS. Effects of anesthesia techniques on outcomes after hip fracture surgery in elderly patients: a prospective, randomized, controlled trial. J Clin Med. 2020;9:9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7355551</ArticleId><ArticleId IdType="pubmed">32466360</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzimas P, Samara E, Petrou A, Korompilias A, Chalkias A, Papadopoulos G. The influence of anesthetic techniques on postoperative cognitive function in elderly patients undergoing hip fracture surgery: general vs spinal anesthesia. Injury. 2018;49:2221&#x2013;2226.</Citation><ArticleIdList><ArticleId IdType="pubmed">30526923</ArticleId></ArticleIdList></Reference><Reference><Citation>Soleimanha M, Sedighinejad A, Haghighi M, Nabi BN, Mirbolook AR, Mardani&#x2010;Kivi M. Hemodynamic and arterial blood gas parameters during cemented hip hemiarthroplasty in elderly patients. Arch Bone Jt Surg. 2014;2:163&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4225020</ArticleId><ArticleId IdType="pubmed">25386576</ArticleId></ArticleIdList></Reference><Reference><Citation>Haghighi M, Sedighinejad A, Mirbolook A, Nabi BN, Farahmand M, Leili EK, et al. Effect of intravenous intraoperative esmolol on pain management following lower limb orthopedic surgery. Korean J Pain. 2015;28:198&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4500784</ArticleId><ArticleId IdType="pubmed">26175880</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivas E, Turan A. Geriatric patients undergoing non&#x2010;elective surgery for hip fracture: can management be optimized? J Clin Anesth. 2020;59:112&#x2013;113.</Citation><ArticleIdList><ArticleId IdType="pubmed">31330458</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong H, Wang Y, Wang Y, Wang B. Comparison of the effect and clinical value in general anesthesia and combined spinal&#x2010;epidural anesthesia in elderly patients undergoing hip arthroplasty. Exp Ther Med. 2019;17:4421&#x2013;4426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6489064</ArticleId><ArticleId IdType="pubmed">31086576</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn EJ, Kim HJ, Kim KW, Choi HR, Kang H, Bang SR. Comparison of general anaesthesia and regional anaesthesia in terms of mortality and complications in elderly patients with hip fracture: a nationwide population&#x2010;based study. BMJ Open. 2019;9:e029245.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6738684</ArticleId><ArticleId IdType="pubmed">31501111</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu C&#x2010;C, Weng S&#x2010;F, Chen K&#x2010;T, Chien CC, Shieh JP, Chen JY, et al. Propensity score&#x2013;matched comparison of postoperative adverse outcomes between geriatric patients given a general or a neuraxial anesthetic for hip surgery: a population&#x2010;based study. Anesthesiology. 2015;123:136&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pubmed">25955981</ArticleId></ArticleIdList></Reference><Reference><Citation>Str&#xf8;m C, Rasmussen LS, Steinmetz J. Practical management of anaesthesia in the elderly. Drugs Aging. 2016;33:765&#x2013;777.</Citation><ArticleIdList><ArticleId IdType="pubmed">27798767</ArticleId></ArticleIdList></Reference><Reference><Citation>Ing C, Sun LS, Friend AF, Kim M, Berman MF, Paganelli W, et al. Differences in intraoperative hemodynamics between spinal and general anesthesia in infants undergoing pyloromyotomy. Pediatr Anaesth. 2017;27:733&#x2013;741.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5461197</ArticleId><ArticleId IdType="pubmed">28419639</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu S, Zhang Z&#x2010;Y, Hua Y&#x2010;Q, Li J, Cai Z&#x2010;D. A comparison of regional and general anaesthesia for total replacement of the hip or knee: a meta&#x2010;analysis. J Bone Jt Surg, Br Vol. 2009;91:935&#x2013;942.</Citation><ArticleIdList><ArticleId IdType="pubmed">19567860</ArticleId></ArticleIdList></Reference><Reference><Citation>White SM, Moppett I, Griffiths R, et al. Secondary analysis of outcomes after 11,085 hip fracture operations from the prospective UK Anaesthesia Sprint audit of practice (ASAP&#x2010;2). Anaesthesia. 2016;71:506&#x2013;514.</Citation><ArticleIdList><ArticleId IdType="pubmed">26940645</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim BH, Lee S, Yoo B, Lee WY, Lim Y, Kim MC, et al. Risk factors associated with outcomes of hip fracture surgery in elderly patients. Korean J Anesthesiol. 2015;68:561&#x2013;567.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4667141</ArticleId><ArticleId IdType="pubmed">26634079</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakobsson J, Kalman S, Lindeberg&#x2010;Lindvet M, Bartha E. Is postspinal hypotension a sign of impaired cardiac performance in the elderly? An observational mechanistic study. Br J Anaesth. 2017;119:1178&#x2013;1185.</Citation><ArticleIdList><ArticleId IdType="pubmed">29040402</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferr&#xe9; F, Martin C, Bosch L, Kurrek M, Lairez O, Minville V. Control of spinal anesthesia&#x2010;induced hypotension in adults. Local Reg Anesthesia. 2020;13:39&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7276328</ArticleId><ArticleId IdType="pubmed">32581577</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonin M, Delsuc C, Meuret P, Caruso L, Deleat&#x2010;Besson R, Lamblin A, et al. Hypobaric unilateral spinal anesthesia versus general anesthesia for hip fracture surgery in the elderly: a randomized controlled trial. Anesth Analg. 2022;135:1262&#x2013;1270.</Citation><ArticleIdList><ArticleId IdType="pubmed">36135347</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Donnell C, Black N, McCourt K, et al. Development of a Core outcome set for studies evaluating the effects of anaesthesia on perioperative morbidity and mortality following hip fracture surgery. Br J Anaesth. 2019;122:120&#x2013;130.</Citation><ArticleIdList><ArticleId IdType="pubmed">30579390</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39258365</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1941-7632</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Circulation. Cardiovascular interventions</Title><ISOAbbreviation>Circ Cardiovasc Interv</ISOAbbreviation></Journal><ArticleTitle>Stroke Prevention With Prophylactic Left Atrial Appendage Occlusion in Cardiac Surgery Patients Without Atrial Fibrillation: A Meta-Analysis of Randomized and Propensity-Score Studies.</ArticleTitle><Pagination><StartPage>e014296</StartPage><MedlinePgn>e014296</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1161/CIRCINTERVENTIONS.124.014296</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The role of left atrial appendage occlusion (LAAO) in patients without previous atrial fibrillation (AF) is not established. This meta-analysis was conducted on patients with normal sinus rhythm who underwent cardiac surgery, with and without concomitant LAAO, to evaluate its effect on the incidence of cerebrovascular accidents (CVAs).</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A systematic review was conducted from inception until December 2023 for randomized and propensity-score studies comparing CVA in patients without AF undergoing cardiac surgery with or without LAAO.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Six studies met our inclusion criteria with a total of 4130 patients: 2146 in the LAAO group and 1984 in the no-LAAO group. The risk ratio of postoperative AF was 1.05 (95% CI, 0.86-1.28); <i>P</i>=0.628. The CVA rates at 5 years were 6.8&#xb1;1.0% in the no-LAAO group and 4.3&#xb1;0.8% in the LAAO group (log-rank <i>P</i>=0.021). The Cox regression analysis for CVA in patients undergoing LAAO reported a hazard ratio of 0.65 (95% CI, 0.45-0.94); <i>P</i>=0.022. Landmark analysis at 4 years highlighted a significant difference in overall survival between no-LAAO and LAAO groups, 86&#xb1;12.2% versus 89.6&#xb1;11.0%; <i>P</i>=0.041.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">In this meta-analysis of patients without previous AF undergoing cardiac surgery, LAAO was associated with a decreased risk of CVA, no difference in the incidence of postoperative atrial fibrillation, and a significant overall survival benefit at a 4-year landmark analysis. Although these findings support LAAO, the randomized LeAAPS trial (Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial), LAA-CLOSURE trial (A Randomized Prospective Multicenter Trial for Stroke Prevention by Prophylactic Surgical Closure of the Left Atrial Appendage in Patients Undergoing Bioprosthetic Aortic Valve Surgery), and LAACS-2 trial (Left Atrial Appendage Closure by Surgery-2) will help define the effectiveness of LAAO in patients undergoing cardiac surgery who have risk factors for AF and CVA.</AbstractText><AbstractText Label="REGISTRATION" NlmCategory="UNASSIGNED">URL: https://www.crd.york.ac.uk/prospero/; Unique identifier: CRD42024496366.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Baudo</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3754-6704</Identifier><AffiliationInfo><Affiliation>Department of Cardiac Surgery Research (M.B., S.S., Y.Y., M.S., B.R.), Lankenau Heart Institute, Main Line Health, Wynnewood, PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sicouri</LastName><ForeName>Serge</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-1822-768X</Identifier><AffiliationInfo><Affiliation>Department of Cardiac Surgery Research (M.B., S.S., Y.Y., M.S., B.R.), Lankenau Heart Institute, Main Line Health, Wynnewood, PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamashita</LastName><ForeName>Yoshiyuki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery Research (M.B., S.S., Y.Y., M.S., B.R.), Lankenau Heart Institute, Main Line Health, Wynnewood, PA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lankenau Institute for Medical Research, and Department of Cardiac Surgery (Y.Y., B.R.), Lankenau Heart Institute, Main Line Health, Wynnewood, PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Senzai</LastName><ForeName>Mikiko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery Research (M.B., S.S., Y.Y., M.S., B.R.), Lankenau Heart Institute, Main Line Health, Wynnewood, PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCarthy</LastName><ForeName>Patrick M</ForeName><Initials>PM</Initials><Identifier Source="ORCID">0000-0001-6729-2405</Identifier><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Bluhm Cardiovascular Institute, Northwestern Medicine, Chicago, IL (P.M.M.C.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerdisch</LastName><ForeName>Marc W</ForeName><Initials>MW</Initials><Identifier Source="ORCID">0000-0001-9489-038X</Identifier><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Franciscan Health Indianapolis, IN (M.W.G.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whitlock</LastName><ForeName>Richard P</ForeName><Initials>RP</Initials><Identifier Source="ORCID">0000-0002-6863-5884</Identifier><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada (R.P.W.).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Population Health Research Institute, Hamilton, ON, Canada (R.P.W.).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada (R.P.W.).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Critical Care, Department of Medicine (R.P.W.), McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Department of Surgery (R.P.W.), McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramlawi</LastName><ForeName>Basel</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-0471-0910</Identifier><AffiliationInfo><Affiliation>Department of Cardiac Surgery Research (M.B., S.S., Y.Y., M.S., B.R.), Lankenau Heart Institute, Main Line Health, Wynnewood, PA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lankenau Institute for Medical Research, and Department of Cardiac Surgery (Y.Y., B.R.), Lankenau Heart Institute, Main Line Health, Wynnewood, PA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Circ Cardiovasc Interv</MedlineTA><NlmUniqueID>101499602</NlmUniqueID><ISSNLinking>1941-7640</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Circ Cardiovasc Interv. 2024 Oct;17(10):e014633. doi: 10.1161/CIRCINTERVENTIONS.124.014633.</RefSource><PMID Version="1">39258361</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020517" MajorTopicYN="Y">Atrial Appendage</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="N">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">left atrial appendage occlusion</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">sinus rhythm</Keyword><Keyword MajorTopicYN="N">stroke</Keyword></KeywordList><CoiStatement>Dr Ramlawi reports a relationship as consultant/advisory board for Medtronic, Inc, Boston Scientific Corporation, AtriCure, Inc, and Corcym, Inc. Dr McCarthy reports a relationship with Edwards Lifesciences Corporation that includes consulting or advisory and speaking and lecture fees; with Medtronic, Inc that includes: speaking and lecture fees; with AtriCure Inc that includes: speaking and lecture fees; and with Egnite that includes: past consulting or advisory. Marc W. Gerdisch reports a relation as consultant for Artivion, Inc, AtriCure Inc, BioStable Science and Engineering, Edwards Lifesciences LLC, and Zimmer Biomet Holdings Inc. Dr Whitlock reports receiving grant support from Bayer and Roche, grant support and honoraria from Boehringer Ingelheim, and consulting fees from AtriCure and PhaseBio. The remaining authors report no conflicts.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>22</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>11</Day><Hour>7</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>11</Day><Hour>5</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39258365</ArticleId><ArticleId IdType="doi">10.1161/CIRCINTERVENTIONS.124.014296</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36039496</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>17</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2385-2011</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences</Title><ISOAbbreviation>Interv Neuroradiol</ISOAbbreviation></Journal><ArticleTitle>Outcomes of transcarotid artery revascularization: A systematic review.</ArticleTitle><Pagination><StartPage>396</StartPage><EndPage>403</EndPage><MedlinePgn>396-403</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/15910199221123283</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Ischemic stroke and disability caused by carotid artery stenosis have always been worldwide problems. At present, carotid endarterectomy (CEA) and transfemoral carotid artery stenting (TFCAS) have been commonly used to treat carotid artery stenosis. Recently, transcarotid artery revascularization (TCAR) seems to be another option.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched PubMed and Embase to find literatures comparing TCAR with TFCAS and CEA. The primary outcomes were stroke, myocardial infarction (MI), transient ischemic attack (TIA), death, cranial nerve injure (CNI), and operative time. Secondary outcomes were stroke, death, MI in the elderly; cost; radiation; and entry site complication.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Initial search of the literature included 165 articles, of which 12 studies were chosen in the end. These studies demonstrated high technical success rate of TCAR. Patients who received TCAR had lower risks of death, stroke/death and less radiation exposure compared to TFCAS. In meta analysis, the risk of stroke was significantly lower in TCAR group than TFCAS (OR 0.63; 95%CI 0.47-0.85). And there was no significant difference in TIA and MI. TCAR was associated with shorter operative time, lower risk of CNI and less blood loss compared to CEA. In older patients, the effect of TCAR was significantly better than that of TFCAS.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">TCAR is associated with a lower risk of perioperative stroke compared to TFCAS. TCAR is also associated with shorter operative time, lower risk of CNI and less blood loss compared to CEA. TCAR may be a promising treatment option besides TFCAS and CEA.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Haoliang</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-9019-1327</Identifier><AffiliationInfo><Affiliation>Department of Vascular and Endovascular Surgery, First Affiliated Hospital of Zhengzhou University, Henan, China.</Affiliation><Identifier Source="RINGGOLD">191599</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Key Vascular Physiology and Applied Research Laboratory of Zhengzhou City, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhiwei</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Vascular and Endovascular Surgery, First Affiliated Hospital of Zhengzhou University, Henan, China.</Affiliation><Identifier Source="RINGGOLD">191599</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Mingxing</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Vascular and Endovascular Surgery, First Affiliated Hospital of Zhengzhou University, Henan, China.</Affiliation><Identifier Source="RINGGOLD">191599</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Vascular and Endovascular Surgery, First Affiliated Hospital of Zhengzhou University, Henan, China.</Affiliation><Identifier Source="RINGGOLD">191599</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Shunbo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Vascular and Endovascular Surgery, First Affiliated Hospital of Zhengzhou University, Henan, China.</Affiliation><Identifier Source="RINGGOLD">191599</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Boao</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Vascular and Endovascular Surgery, First Affiliated Hospital of Zhengzhou University, Henan, China.</Affiliation><Identifier Source="RINGGOLD">191599</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Cong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Vascular and Endovascular Surgery, First Affiliated Hospital of Zhengzhou University, Henan, China.</Affiliation><Identifier Source="RINGGOLD">191599</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Liwei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Vascular and Endovascular Surgery, First Affiliated Hospital of Zhengzhou University, Henan, China.</Affiliation><Identifier Source="RINGGOLD">191599</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Hualong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Vascular and Endovascular Surgery, First Affiliated Hospital of Zhengzhou University, Henan, China.</Affiliation><Identifier Source="RINGGOLD">191599</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Key Vascular Physiology and Applied Research Laboratory of Zhengzhou City, Henan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Interv Neuroradiol</MedlineTA><NlmUniqueID>9602695</NlmUniqueID><ISSNLinking>1591-0199</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016893" MajorTopicYN="Y">Carotid Stenosis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016894" MajorTopicYN="Y">Endarterectomy, Carotid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015607" MajorTopicYN="N">Stents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002548" MajorTopicYN="N">Cerebral Revascularization</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="N">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Carotid artery stenosis</Keyword><Keyword MajorTopicYN="N">TCAR</Keyword><Keyword MajorTopicYN="N">carotid artery stenting</Keyword><Keyword MajorTopicYN="N">carotid endarterectomy</Keyword><Keyword MajorTopicYN="N">transcarotid artery revascularization</Keyword></KeywordList><CoiStatement>Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>17</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>30</Day><Hour>2</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36039496</ArticleId><ArticleId IdType="pmc">PMC11310721</ArticleId><ArticleId IdType="doi">10.1177/15910199221123283</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Petty GW, Brown RD, Jr., Whisnant JP, et al. Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke 1999; 30: 2513&#x2013;2516. 1999/12/03.</Citation><ArticleIdList><ArticleId IdType="pubmed">10582970</ArticleId></ArticleIdList></Reference><Reference><Citation>Litsky J, Stilp E, Njoh R, et al. Management of symptomatic carotid disease in 2014. Curr Cardiol Rep 2014; 16: 462. 2014/01/28.</Citation><ArticleIdList><ArticleId IdType="pubmed">24464307</ArticleId></ArticleIdList></Reference><Reference><Citation>Lackey AR, Erben Y, Franco JADR, et al. Transcarotid Artery Revascularization Results in Low Rates of Periprocedural Neurologic Events, Myocardial Infarction, and Death. Curr Cardiol Rep 2020; 22.</Citation><ArticleIdList><ArticleId IdType="pubmed">31940109</ArticleId></ArticleIdList></Reference><Reference><Citation>Naylor AR, Ricco JB, de Borst GJ, et al. Editor&#x2019;s choice &#x2013; management of atherosclerotic carotid and vertebral artery disease: 2017 clinical practice guidelines of the European society for vascular surgery (ESVS). Eur J Vasc Endovasc Surg 2018; 55: 3&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">28851594</ArticleId></ArticleIdList></Reference><Reference><Citation>Noiphithak R, Liengudom A. Recent update on carotid endarterectomy versus carotid artery stenting. Cerebrovasc Dis 2017; 43: 68&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">27898402</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray WA, Chaturvedi S, Verta P. Thirty-day outcomes for carotid artery stenting in 6320 patients from 2 prospective, multicenter, high-surgical-risk registries. Circulation Cardiovascular Interventions 2009; 2: 159&#x2013;166. 2009/12/25.</Citation><ArticleIdList><ArticleId IdType="pubmed">20031712</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurm HS, Nallamothu BK, Yadav J. Safety of carotid artery stenting for symptomatic carotid artery disease: a meta-analysis. Eur Heart J 2008; 29: 113&#x2013;119. 2007/09/21.</Citation><ArticleIdList><ArticleId IdType="pubmed">17881346</ArticleId></ArticleIdList></Reference><Reference><Citation>Naazie IN, Cui CL, Osaghae I, et al. A systematic review and meta-analysis of transcarotid artery revascularization with dynamic flow reversal versus transfemoral carotid artery stenting and carotid endarterectomy. Ann Vasc Surg 2020; 69: 426&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pubmed">32505684</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25: 603&#x2013;605. 2010/07/24.</Citation><ArticleIdList><ArticleId IdType="pubmed">20652370</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway AM, Nguyen Tran NT, Qato K, et al. Complexity of aortic arch anatomy affects the outcomes of transcarotid artery revascularization versus transfemoral carotid artery stenting. Ann Vasc Surg 2020; 67: 78&#x2013;89. 2020/04/28.</Citation><ArticleIdList><ArticleId IdType="pubmed">32339690</ArticleId></ArticleIdList></Reference><Reference><Citation>Schermerhorn ML, Liang P, Eldrup-Jorgensen J, et al. Association of transcarotid artery revascularization vs transfemoral carotid artery stenting with stroke or death among patients with carotid artery stenosis. Jama 2019; 322: 2313&#x2013;2322. 2019/12/18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6990823</ArticleId><ArticleId IdType="pubmed">31846015</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin JC, Kolvenbach RR, Pinter L. Protected carotid artery stenting and angioplasty via transfemoral versus transcervical approaches. Vasc Endovascular Surg 2005; 39: 499&#x2013;503. 2005/12/31.</Citation><ArticleIdList><ArticleId IdType="pubmed">16382271</ArticleId></ArticleIdList></Reference><Reference><Citation>Yee EJ, Wang SK, Timsina LR, et al. Propensity-Matched outcomes of transcarotid artery revascularization versus carotid endarterectomy. J Surg Res 2020; 252: 22&#x2013;29. 2020/03/31.</Citation><ArticleIdList><ArticleId IdType="pubmed">32222590</ArticleId></ArticleIdList></Reference><Reference><Citation>Schermerhorn ML, Liang P, Dakour-Aridi H, et al. In-hospital outcomes of transcarotid artery revascularization and carotid endarterectomy in the society for vascular surgery vascular quality initiative. J Vasc Surg 2020; 71: 87&#x2013;95. 2019/06/23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6918010</ArticleId><ArticleId IdType="pubmed">31227410</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashyap VS, Schneider PA, Foteh M, et al. Early outcomes in the ROADSTER 2 study of transcarotid artery revascularization in patients with significant carotid artery disease. Stroke 2020; 51: 2620&#x2013;2629. 2020/08/20.</Citation><ArticleIdList><ArticleId IdType="pubmed">32811386</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayarajan S, Szpila B, Jim J. Single-Center Cost Analysis Comparing High-Risk Carotid Endarterectomy and Transcarotid Artery Revascularization. J Vasc Surg 2019; 69.</Citation></Reference><Reference><Citation>Plessers M, Van Herzeele I, Hemelsoet D, et al. Transcervical carotid stenting with dynamic flow reversal demonstrates embolization rates comparable to carotid endarterectomy. Journal of Endovascular Therapy : An Official Journal of the International Society of Endovascular Specialists 2016; 23: 249&#x2013;254. 2016/01/23.</Citation><ArticleIdList><ArticleId IdType="pubmed">26794908</ArticleId></ArticleIdList></Reference><Reference><Citation>Malas MB, Dakour-Aridi H, Kashyap VS, et al. TransCarotid revascularization with dynamic flow reversal versus carotid endarterectomy in the vascular quality initiative surveillance project. Ann Surg 2020; 276: 398&#x2013;403. 2020/09/18.</Citation><ArticleIdList><ArticleId IdType="pubmed">32941280</ArticleId></ArticleIdList></Reference><Reference><Citation>Dakour-Aridi H, Kashyap VS, Wang GJ, et al. The impact of age on in-hospital outcomes after transcarotid artery revascularization, transfemoral carotid artery stenting, and carotid endarterectomy. J Vasc Surg 2020; 72: 931&#x2013;942.e932.</Citation><ArticleIdList><ArticleId IdType="pubmed">32035784</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui C, Ramakrishnan G, Murphy J, et al. Cost-Effectiveness of TransCarotid Artery Revascularization versus Carotid Endarterectomy. J Vasc Surg 2021; 74: 1910&#x2013;1918. 2021/06/29.</Citation><ArticleIdList><ArticleId IdType="pubmed">34182030</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang P, Soden P, Wyers MC, et al. The role of transfemoral carotid artery stenting with proximal balloon occlusion embolic protection in the contemporary endovascular management of carotid artery stenosis. J Vasc Surg 2020; 72: 1701&#x2013;1710.</Citation><ArticleIdList><ArticleId IdType="pubmed">32251772</ArticleId></ArticleIdList></Reference><Reference><Citation>Lal BK, Jordan W, Kashyap VS, et al. Clinical competence statement of the society for vascular surgery on training and credentialing for transcarotid artery revascularization. J Vasc Surg 2020; 72: 779&#x2013;789.</Citation><ArticleIdList><ArticleId IdType="pubmed">32569715</ArticleId></ArticleIdList></Reference><Reference><Citation>Lackey AR, Erben Y, Franco J, et al. Transcarotid artery revascularization results in low rates of periprocedural neurologic events, myocardial infarction, and Death. Curr Cardiol Rep 2020; 22: 3. 2020/01/16.</Citation><ArticleIdList><ArticleId IdType="pubmed">31940109</ArticleId></ArticleIdList></Reference><Reference><Citation>Leal I, Orgaz A, Flores &#xc1;, et al. A diffusion-weighted magnetic resonance imaging-based study of transcervical carotid stenting with flow reversal versus transfemoral filter protection. J Vasc Surg 2012; 56: 1585&#x2013;1590.</Citation><ArticleIdList><ArticleId IdType="pubmed">22960021</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinter L, Ribo M, Loh C, et al. Safety and feasibility of a novel transcervical access neuroprotection system for carotid artery stenting in the PROOF study. J Vasc Surg 2011; 54: 1317&#x2013;1323. 2011/06/11.</Citation><ArticleIdList><ArticleId IdType="pubmed">21658889</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniou GA, Georgiadis GS, Georgakarakos EI, et al. Meta-analysis and Meta-Regression Analysis of Outcomes of Carotid Endarterectomy and Stenting in the Elderly. JAMA Surg 2013; 148: 1140&#x2013;1152.</Citation><ArticleIdList><ArticleId IdType="pubmed">24154858</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard G, Roubin GS, Jansen O, et al. Association between age and risk of stroke or death from carotid endarterectomy and carotid stenting: a meta-analysis of pooled patient data from four randomised trials. The Lancet 2016; 387: 1305&#x2013;1311.</Citation><ArticleIdList><ArticleId IdType="pubmed">26880122</ArticleId></ArticleIdList></Reference><Reference><Citation>Ederle J, Dobson J, Featherstone RL, et al. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (international carotid stenting study): an interim analysis of a randomised controlled trial. Lancet (London, England) 2010; 375: 985&#x2013;997. 2010/03/02.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2849002</ArticleId><ArticleId IdType="pubmed">20189239</ArticleId></ArticleIdList></Reference><Reference><Citation>Eckstein HH, Ringleb P, Allenberg JR, et al. Results of the stent-protected angioplasty versus carotid endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial. The Lancet Neurology 2008; 7: 893&#x2013;902. 2008/09/09.</Citation><ArticleIdList><ArticleId IdType="pubmed">18774746</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashyap VS, King AH, Foteh MI, et al. A multi-institutional analysis of transcarotid artery revascularization compared to carotid endarterectomy. J Vasc Surg 2019; 70: 123&#x2013;129. 2019/01/10.</Citation><ArticleIdList><ArticleId IdType="pubmed">30622007</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumins NH, King AH, Jim J, et al. Duration of blood flow reversal during transcarotid artery revascularization does not affect outcome. J Vasc Surg 2020; 72: 584&#x2013;588.</Citation><ArticleIdList><ArticleId IdType="pubmed">31901361</ArticleId></ArticleIdList></Reference><Reference><Citation>King AH, Kumins NH, Foteh MI, et al. The learning curve of transcarotid artery revascularization. J Vasc Surg 2019; 70: 516&#x2013;521. 2019/02/06.</Citation><ArticleIdList><ArticleId IdType="pubmed">30718112</ArticleId></ArticleIdList></Reference><Reference><Citation>King AH, Motaganahalli RL, Siddiqui A, et al. Temporary reversal of blood flow during transcarotid artery revascularization does not change brain electrical activity in lead-in cases of the ROADSTER 1 multicenter trial. J Endovasc Ther 2018; 25: 773&#x2013;778.</Citation><ArticleIdList><ArticleId IdType="pubmed">30191765</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivere LA, Ronald J, Williams Z, et al. Cerebral monitoring during transcarotid artery revascularization with flow reversal via transcranial Doppler ultrasound examination. J Vasc Surg 2020; 73: 125&#x2013;131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577965</ArticleId><ArticleId IdType="pubmed">32334047</ArticleId></ArticleIdList></Reference><Reference><Citation>Dakour-Aridi H, Schermerhorn ML, Husain F, et al. Outcomes of transcarotid artery revascularization with dynamic flow reversal in patients with contralateral carotid artery occlusion. J Vasc Surg 2020; 73: 524&#x2013;532.</Citation><ArticleIdList><ArticleId IdType="pubmed">32569716</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SK, King AH, Kashyap VS, et al. Treatment of carotid restenosis using transcarotid revascularization. Vasc Endovascular Surg 2020; 54: 436&#x2013;440. 2020/05/13.</Citation><ArticleIdList><ArticleId IdType="pubmed">32394802</ArticleId></ArticleIdList></Reference><Reference><Citation>Pourier VE, de Borst GJ. Technical options for treatment of in-stent restenosis after carotid artery stenting. J Vasc Surg 2016; 64: 1486&#x2013;1496. 2016/10/26.</Citation><ArticleIdList><ArticleId IdType="pubmed">27776704</ArticleId></ArticleIdList></Reference><Reference><Citation>Lal BK, Beach KW, Roubin GS, et al. Restenosis after carotid artery stenting and endarterectomy: a secondary analysis of CREST, a randomised controlled trial. The Lancet Neurology 2012; 11: 755&#x2013;763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3912998</ArticleId><ArticleId IdType="pubmed">22857850</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerges M, Zia S. Endovascular repair of carotid artery pseudoaneurysm using transcarotid artery revascularization flow reversal technique. Ann Vasc Surg 2020; 66: 668.e611&#x2013;668.e614.</Citation><ArticleIdList><ArticleId IdType="pubmed">31926273</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizwan M, Smith C, Faro S, et al. Transcarotid artery stenting for carotid artery pseudoaneurysm using flow reversal technique. Journal of Vascular Surgery Cases and Innovative Techniques 2018; 4: 115&#x2013;118. 2018/06/27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6012998</ArticleId><ArticleId IdType="pubmed">29942896</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu WW, Liang P, O&#x2019;Donnell TFX, et al. Anatomic eligibility for transcarotid artery revascularization and transfemoral carotid artery stenting. J Vasc Surg 2019; 69: 1452&#x2013;1460.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6478535</ArticleId><ArticleId IdType="pubmed">30853384</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumins NH, King AH, Ambani RN, et al. Anatomic criteria in the selection of treatment modality for atherosclerotic carotid artery disease. J Vasc Surg 2020; 72: 1395&#x2013;1404.</Citation><ArticleIdList><ArticleId IdType="pubmed">32145991</ArticleId></ArticleIdList></Reference><Reference><Citation>Malas MB, Leal J, Kashyap V, et al. Technical aspects of transcarotid artery revascularization using the ENROUTE transcarotid neuroprotection and stent system. J Vasc Surg 2017; 65: 916&#x2013;920. 2017/02/27.</Citation><ArticleIdList><ArticleId IdType="pubmed">28236931</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">21478735</PMID><DateCompleted><Year>2011</Year><Month>08</Month><Day>09</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1175</ISSN><JournalIssue CitedMedium="Internet"><Volume>114</Volume><Issue>6</Issue><PubDate><Year>2011</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Anesthesiology</Title><ISOAbbreviation>Anesthesiology</ISOAbbreviation></Journal><ArticleTitle>Perioperative stroke and associated mortality after noncardiac, nonneurologic surgery.</ArticleTitle><Pagination><StartPage>1289</StartPage><EndPage>1296</EndPage><MedlinePgn>1289-96</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ALN.0b013e318216e7f4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Stroke is a leading cause of morbidity and mortality in the United States and occurs in the perioperative period. The authors studied the incidence, predictors, and outcomes of perioperative stroke using the American College of Surgeons National Surgical Quality Improvement Program.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Data on 523,059 noncardiac, nonneurologic patients in the American College of Surgeons National Surgical Quality Improvement Program database were analyzed for the current study. The incidence of perioperative stroke was identified. Logistic regression was applied to a derivation cohort of 350,031 patients to generate independent predictors of stroke and develop a risk model. The risk model was subsequently applied to a validation cohort of 173,028 patients. The role of perioperative stroke in 30-day mortality was also assessed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The incidence of perioperative stroke in both the derivation and validation cohorts was 0.1%. Multivariate analysis revealed the following independent predictors of stroke in the derivation cohort: age &#x2265; 62 yr, history of myocardial infarction within 6 months before surgery, acute renal failure, history of stroke, dialysis, hypertension, history of transient ischemic attack, chronic obstructive pulmonary disease, current tobacco use, and body mass index 35-40 kg/m&#xb2; (protective). These risk factors were confirmed in the validation cohort. Surgical procedure also influenced the incidence of stroke. Perioperative stroke was associated with an 8-fold increase in perioperative mortality within 30 days (95% CI, 4.6-12.6).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Noncardiac, nonneurologic surgery carries a risk of perioperative stroke, which is associated with higher mortality. The models developed in this study may be informative for clinicians and patients regarding risk and prevention of this complication.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mashour</LastName><ForeName>George A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Division of Neuroanesthesiology, Center for Perioperative Outcomes Research, University of Michigan Medical School, Ann Arbor, Michigan, USA. gmashour@umich.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shanks</LastName><ForeName>Amy M</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Kheterpal</LastName><ForeName>Sachin</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesthesiology</MedlineTA><NlmUniqueID>1300217</NlmUniqueID><ISSNLinking>0003-3022</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Anesthesiology. 2011 Jun;114(6):1263-4. doi: 10.1097/ALN.0b013e318216e86a.</RefSource><PMID Version="1">21422994</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059035" MajorTopicYN="Y">Perioperative Period</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21478735</ArticleId><ArticleId IdType="doi">10.1097/ALN.0b013e318216e7f4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34985520</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>25</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>04</Day></PubDate></JournalIssue><Title>JAMA network open</Title><ISOAbbreviation>JAMA Netw Open</ISOAbbreviation></Journal><ArticleTitle>Risk of Subsequent Stroke Among Patients Receiving Outpatient vs Inpatient Care for Transient Ischemic Attack: A Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>e2136644</StartPage><MedlinePgn>e2136644</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2136644</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2021.36644</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Transient ischemic attack (TIA) often indicates a high risk of subsequent cerebral ischemic events. Timely preventive measures improve the outcome.</AbstractText><AbstractText Label="OBJECTIVE">To estimate and compare the risk of subsequent ischemic stroke among patients with TIA or minor ischemic stroke (mIS) by care setting.</AbstractText><AbstractText Label="DATA SOURCES">MEDLINE, Web of Science, Scopus, Embase, International Clinical Trials Registry Platform, ClinicalTrials.gov, Trip Medical Database, CINAHL, and all Evidence-Based Medicine review series were searched from the inception of each database until October 1, 2020.</AbstractText><AbstractText Label="STUDY SELECTION">Studies evaluating the occurrence of ischemic stroke after TIA or mIS were included. Cohorts without data on evaluation time for reporting subsequent stroke, with retrospective diagnosis of the index event after stroke occurrence, and with a report of outcomes that were not limited to patients with TIA or mIS were excluded. Two authors independently screened the titles and abstracts and provided the list of candidate studies for full-text review; discrepancies and disagreements in all steps of the review were addressed by input from a third reviewer.</AbstractText><AbstractText Label="DATA EXTRACTION AND SYNTHESIS">The study was prepared and reported following the Preferred Reporting Items for Systematic Reviews and Meta-analyses, Meta-analysis of Observational Studies in Epidemiology, Methodological Expectations of Cochrane Intervention Reviews, and Enhancing the Quality and Transparency of Health Research guidelines. The Risk of Bias in Nonrandomized Studies-of Exposures (ROBINS-E) tool was used for critical appraisal of cohorts, and funnel plots, Begg-Mazumdar rank correlation, Kendall &#x3c4;2, and the Egger bias test were used for evaluating the publication bias. All meta-analyses were conducted under random-effects models.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">Risk of subsequent ischemic stroke among patients with TIA or mIS who received care at rapid-access TIA or neurology clinics, inpatient units, emergency departments (EDs), and unspecified or multiple settings within 4 evaluation intervals (ie, 2, 7, 30, and 90 days).</AbstractText><AbstractText Label="RESULTS">The analysis included 226&#x202f;683 patients from 71 articles recruited between 1981 and 2018; 5636 patients received care at TIA clinics (mean [SD] age, 65.7 [3.9] years; 2291 of 4513 [50.8%] men), 130&#x202f;139 as inpatients (mean [SD] age, 78.3 [4.0] years; 49&#x202f;458 of 128&#x202f;745 [38.4%] men), 3605 at EDs (mean [SD] age, 68.9 [3.9] years; 1596 of 3046 [52.4%] men), and 87&#x202f;303 patients received care in an unspecified setting (mean [SD] age, 70.8 [3.8] years, 43&#x202f;495 of 87&#x202f;303 [49.8%] men). Among the patients who were treated at a TIA clinic, the risk of subsequent stroke following a TIA or mIS was 0.3% (95% CI, 0.0%-1.2%) within 2 days, 1.0% (95% CI, 0.3%-2.0%) within 7 days, 1.3% (95% CI, 0.4%-2.6%) within 30 days, and 2.1% (95% CI, 1.4%-2.8%) within 90 days. Among the patients who were treated as inpatients, the risk of subsequent stroke was to 0.5% (95% CI, 0.1%-1.1%) within 2 days, 1.2% (95% CI, 0.4%-2.2%) within 7 days, 1.6% (95% CI, 0.6%-3.1%) within 30 days, and 2.8% (95% CI, 2.1%-3.5%) within 90 days. The risk of stroke among patients treated at TIA clinics was not significantly different from those hospitalized. Compared with the inpatient cohort, TIA clinic patients were younger and had had lower ABCD2 (age, blood pressure, clinical features, duration of TIA, diabetes) scores (inpatients with ABCD2 score &gt;3, 1101 of 1806 [61.0%]; TIA clinic patients with ABCD2 score &gt;3, 1933 of 3703 [52.2%]).</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">In this systematic review and meta-analysis, the risk of subsequent stroke among patients who were evaluated in a TIA clinic was not higher than those hospitalized. Patients who received treatment in EDs without further follow-up had a higher risk of subsequent stroke. These findings suggest that TIA clinics can be an effective component of the TIA care component pathway.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shahjouei</LastName><ForeName>Shima</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neurology Department, Neuroscience Institute, Geisinger Health System, Danville, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jiang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Molecular and Functional Genomics, Geisinger Health System, Danville, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koza</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abedi</LastName><ForeName>Vida</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Molecular and Functional Genomics, Geisinger Health System, Danville, Pennsylvania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biocomplexity Institute, Virginia Tech, Blacksburg, Virginia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sadr</LastName><ForeName>Alireza Vafaei</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>Department de Physique Theorique and Center for Astroparticle Physics, University Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Qiushi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Industrial and Manufacturing Engineering, Pennsylvania State University, University Park.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mowla</LastName><ForeName>Ashkan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Stroke and Endovascular Neurosurgery, Department of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Griffin</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Industrial and Manufacturing Engineering, Pennsylvania State University, University Park.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ranta</LastName><ForeName>Annemarei</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Wellington Hospital, Wellington, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Otago, Wellington, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zand</LastName><ForeName>Ramin</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Neurology Department, Neuroscience Institute, Geisinger Health System, Danville, Pennsylvania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Netw Open</MedlineTA><NlmUniqueID>101729235</NlmUniqueID><ISSNLinking>2574-3805</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000553" MajorTopicYN="N">Ambulatory Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="Y">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Ranta reported receiving grants from Health Research Council of New Zealand during the conduct of the study. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>5</Day><Hour>12</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34985520</ArticleId><ArticleId IdType="pmc">PMC8733831</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.36644</ArticleId><ArticleId IdType="pii">2787633</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lavall&#xe9;e PC, Meseguer E, Abboud H, et al. . A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol. 2007;6(11):953-960. doi:10.1016/S1474-4422(07)70248-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(07)70248-X</ArticleId><ArticleId IdType="pubmed">17928270</ArticleId></ArticleIdList></Reference><Reference><Citation>Prabhakaran S, Silver AJ, Warrior L, McClenathan B, Lee VH. Misdiagnosis of transient ischemic attacks in the emergency room. Cerebrovasc Dis. 2008;26(6):630-635. doi:10.1159/000166839</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000166839</ArticleId><ArticleId IdType="pubmed">18984948</ArticleId></ArticleIdList></Reference><Reference><Citation>Hackam DG, Spence JD. Combining multiple approaches for the secondary prevention of vascular events after stroke: a quantitative modeling study. Stroke. 2007;38(6):1881-1885. doi:10.1161/STROKEAHA.106.475525</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.106.475525</ArticleId><ArticleId IdType="pubmed">17431209</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahjouei S, Sadighi A, Chaudhary D, et al. . A 5-decade analysis of incidence trends of ischemic stroke after transient ischemic attack: a systematic review and meta-analysis. JAMA Neurol. 2020;17822:1-11. doi:10.1001/jamaneurol.2020.3627</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.3627</ArticleId><ArticleId IdType="pmc">PMC7551236</ArticleId><ArticleId IdType="pubmed">33044505</ArticleId></ArticleIdList></Reference><Reference><Citation>Edlow JA, Kim S, Pelletier AJ, Camargo CAJ Jr. National study on emergency department visits for transient ischemic attack, 1992-2001. Acad Emerg Med. 2006;13(6):666-672.</Citation><ArticleIdList><ArticleId IdType="pubmed">16609106</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez L, Kim-Tenser MA, Sanossian N, et al. . Trends in transient ischemic attack hospitalizations in the United States. J Am Heart Assoc. 2016;5(9):1-9. doi:10.1161/JAHA.116.004026</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.116.004026</ArticleId><ArticleId IdType="pmc">PMC5079046</ArticleId><ArticleId IdType="pubmed">27664805</ArticleId></ArticleIdList></Reference><Reference><Citation>Khare S. Risk factors of transient ischemic attack: an overview. J Midlife Health. 2016;7(1):2-7. doi:10.4103/0976-7800.179166</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0976-7800.179166</ArticleId><ArticleId IdType="pmc">PMC4832890</ArticleId><ArticleId IdType="pubmed">27134474</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranta A, Barber PA. Transient ischemic attack service provision: a review of available service models. Neurology. 2016;86(10):947-953. doi:10.1212/WNL.0000000000002339</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002339</ArticleId><ArticleId IdType="pubmed">26802089</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders LM, Srikanth VK, Jolley DJ, et al. . Monash transient ischemic attack triaging treatment: safety of a transient ischemic attack mechanism-based outpatient model of care. Stroke. 2012;43(11):2936-2941. doi:10.1161/STROKEAHA.112.664060</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.112.664060</ArticleId><ArticleId IdType="pubmed">22984016</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarhult SJ, Howell ML, Barnaure-Nachbar I, et al. . Implementation of a rapid, protocol-based TIA management pathway. West J Emerg Med. 2018;19(2):216-223. doi:10.5811/westjem.2017.9.35341</Citation><ArticleIdList><ArticleId IdType="doi">10.5811/westjem.2017.9.35341</ArticleId><ArticleId IdType="pmc">PMC5851491</ArticleId><ArticleId IdType="pubmed">29560046</ArticleId></ArticleIdList></Reference><Reference><Citation>Benavente L, Calleja S, Larrosa D, et al. . Long term evolution of patients treated in a TIA unit. Int Arch Med. 2013;6(1):19. doi:10.1186/1755-7682-6-19</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1755-7682-6-19</ArticleId><ArticleId IdType="pmc">PMC3716896</ArticleId><ArticleId IdType="pubmed">23635082</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster F, Saposnik G, Kapral MK, Fang J, O&#x2019;Callaghan C, Hachinski V. Organized outpatient care: stroke prevention clinic referrals are associated with reduced mortality after transient ischemic attack and ischemic stroke. Stroke. 2011;42(11):3176-3182. doi:10.1161/STROKEAHA.111.621524</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.111.621524</ArticleId><ArticleId IdType="pubmed">21921281</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothwell PM, Giles MF, Flossmann E, et al. . A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet. 2005;366(9479):29-36. doi:10.1016/S0140-6736(05)66702-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(05)66702-5</ArticleId><ArticleId IdType="pubmed">15993230</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadighi A, Abedi V, Stanciu A, et al. . Six-month outcome of transient ischemic attack and its mimics. Front Neurol. 2019;10:294. doi:10.3389/fneur.2019.00294</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00294</ArticleId><ArticleId IdType="pmc">PMC6445867</ArticleId><ArticleId IdType="pubmed">30972019</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranta A, Dovey S, Weatherall M, O&#x2019;Dea D, Gommans J, Tilyard M. Cluster randomized controlled trial of TIA electronic decision support in primary care. Neurology. 2015;84(15):1545-1551. doi:10.1212/WNL.0000000000001472</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001472</ArticleId><ArticleId IdType="pubmed">25795645</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Shamseer L, Clarke M, et al. ; PRISMA-P Group . Preferred Reporting Items for Systematic Review and Meta-analysis Protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1. doi:10.1186/2046-4053-4-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-4-1</ArticleId><ArticleId IdType="pmc">PMC4320440</ArticleId><ArticleId IdType="pubmed">25554246</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroup DF, Berlin JA, Morton SC, et al. . Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008-2012. doi:10.1001/jama.283.15.2008</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.283.15.2008</ArticleId><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandler J, Churchill R, Lasserson T, Tovey D, Higgins J. Methodological standards for the conduct of new Cochrane Intervention Reviews. Accessed December 1, 2021. http://www.editorial-unit.cochrane.org/mecir</Citation></Reference><Reference><Citation>Equator Network . Enhancing the quality and transparency of health research. Accessed December 1, 2021. https://www.equator-network.org</Citation></Reference><Reference><Citation>Panuganti KK, Tadi P, Lui F. Transient Ischemic Attack. StatPearls Publishing; 2019.</Citation><ArticleIdList><ArticleId IdType="pubmed">29083778</ArticleId></ArticleIdList></Reference><Reference><Citation>Easton JD, Saver JL, Albers GW, et al. ; American Heart Association; American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; Interdisciplinary Council on Peripheral Vascular Disease . Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardio. Stroke. 2009;40(6):2276-2293. doi:10.1161/STROKEAHA.108.192218</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.108.192218</ArticleId><ArticleId IdType="pubmed">19423857</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer U, Baumgartner A, Arnold M, et al. . What is a minor stroke? Stroke. 2010;41(4):661-666. doi:10.1161/STROKEAHA.109.572883</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.109.572883</ArticleId><ArticleId IdType="pubmed">20185781</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan RL, Thayer KA, Santesso N, et al. ; GRADE Working Group . A risk of bias instrument for non-randomized studies of exposures: a users&#x2019; guide to its application in the context of GRADE. Environ Int. 2019;122(122):168-184. doi:10.1016/j.envint.2018.11.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envint.2018.11.004</ArticleId><ArticleId IdType="pmc">PMC8221004</ArticleId><ArticleId IdType="pubmed">30473382</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan RL, Thayer KA, Santesso N, et al. . Evaluation of the risk of bias in non-randomized studies of interventions (ROBINS-I) and the &#x2018;target experiment&#x2019; concept in studies of exposures: Rationale and preliminary instrument development. Environ Int. 2018;120:382-387. doi:10.1016/j.envint.2018.08.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envint.2018.08.018</ArticleId><ArticleId IdType="pmc">PMC9581061</ArticleId><ArticleId IdType="pubmed">30125855</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreiliger G. Statistical Assessment and Adjustment of Publication Bias in the Cochrane Database of Systematic Reviews. Master&#x2019;s Thesis. University of Zurich; 2019.</Citation></Reference><Reference><Citation>Albers GW, Hart RG, Lutsep HL, Newell DW, Sacco RL. AHA scientific statement: supplement to the guidelines for the management of transient ischemic attacks: a statement from the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks, Stroke Council, American Heart Association. Stroke. 1999;30(11):2502-2511. doi:10.1161/01.STR.30.11.2502</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.STR.30.11.2502</ArticleId><ArticleId IdType="pubmed">10548693</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothwell PM, Giles MF, Chandratheva A, et al. ; Early use of Existing Preventive Strategies for Stroke (EXPRESS) study . Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet. 2007;370(9596):1432-1442. doi:10.1016/S0140-6736(07)61448-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)61448-2</ArticleId><ArticleId IdType="pubmed">17928046</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfgang V. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36(3):1-48. doi:10.18637/jss.v036.i03</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v036.i03</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang BP, Rostanski S, Willey J, et al. . Safety and feasibility of a rapid outpatient management strategy for transient ischemic attack and minor stroke: the Rapid Access Vascular Evaluation-Neurology (RAVEN) approach. Ann Emerg Med. 2019;74(4):562-571. doi:10.1016/j.annemergmed.2019.05.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2019.05.025</ArticleId><ArticleId IdType="pmc">PMC6756973</ArticleId><ArticleId IdType="pubmed">31326206</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta D, Bowen E, Foy C. Four-year follow-up of transient ischemic attacks, strokes, and mimics: a retrospective transient ischemic attack clinic cohort study. Stroke. 2015;46(5):1227-1232. doi:10.1161/STROKEAHA.114.008632</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.114.008632</ArticleId><ArticleId IdType="pubmed">25813193</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison JK, Sloan B, Dawson J, Lees KR, Morrison DS. The ABCD and ABCD2 as predictors of stroke in transient ischemic attack clinic outpatients: a retrospective cohort study over 14 years. QJM. 2010;103(9):679-685. doi:10.1093/qjmed/hcq108</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcq108</ArticleId><ArticleId IdType="pubmed">20601651</ArticleId></ArticleIdList></Reference><Reference><Citation>Majidi S, Leon Guerrero CR, Burger KM, Rothrock JF. Inpatient versus outpatient management of TIA or minor stroke: clinical outcome. J Vasc Interv Neurol. 2017;9(4):49-53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5501129</ArticleId><ArticleId IdType="pubmed">28702120</ArticleId></ArticleIdList></Reference><Reference><Citation>Arsava EM, Furie KL, Schwamm LH, Sorensen AG, Ay H. Prediction of early stroke risk in transient symptoms with infarction: relevance to the new tissue-based definition. Stroke. 2011;42(8):2186-2190. doi:10.1161/STROKEAHA.110.604280</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.110.604280</ArticleId><ArticleId IdType="pmc">PMC3144273</ArticleId><ArticleId IdType="pubmed">21680907</ArticleId></ArticleIdList></Reference><Reference><Citation>Ay H, Arsava EM, Johnston SC, et al. . Clinical- and imaging-based prediction of stroke risk after transient ischemic attack: the CIP model. Stroke. 2009;40(1):181-186. doi:10.1161/STROKEAHA.108.521476</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.108.521476</ArticleId><ArticleId IdType="pubmed">18948609</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifati DM, Lorenzi A, Ermani M, et al. . Carotid stenosis as predictor of stroke after transient ischemic attacks. J Neurol Sci. 2011;303(1-2):85-89. doi:10.1016/j.jns.2011.01.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2011.01.005</ArticleId><ArticleId IdType="pubmed">21276596</ArticleId></ArticleIdList></Reference><Reference><Citation>Geil K, Gonz&#xe1;lez-Concepci&#xf3;n JJ, Jim&#xe9;nez-Vel&#xe1;zquez IZ, Medina B, Velazco X. Management and outcome of transient ischemic attacks in Ponce, Puerto Rico. Bol Asoc Med P R. 2008;100(3):11-14.</Citation><ArticleIdList><ArticleId IdType="pubmed">19227709</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen H, Kerr D, Kelly A-M. Comparison of prognostic performance of scores to predict risk of stroke in ED patients with transient ischaemic attack. Eur J Emerg Med. 2010;17(6):346-348. doi:10.1097/MEJ.0b013e328337b1c6</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MEJ.0b013e328337b1c6</ArticleId><ArticleId IdType="pubmed">20164775</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad O, Penglase RG, Chen MS, Harvey I, Hughes AR, Lueck CJ. A retrospective analysis of inpatient compared to outpatient care for the management of patients with transient ischaemic attack. J Clin Neurosci. 2013;20(7):988-992. doi:10.1016/j.jocn.2012.09.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2012.09.016</ArticleId><ArticleId IdType="pubmed">23712054</ArticleId></ArticleIdList></Reference><Reference><Citation>Lichtman JH, Jones SB, Watanabe E, et al. . Elderly women have lower rates of stroke, cardiovascular events, and mortality after hospitalization for transient ischemic attack. Stroke. 2009;40(6):2116-2122. doi:10.1161/STROKEAHA.108.543009</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.108.543009</ArticleId><ArticleId IdType="pmc">PMC2757938</ArticleId><ArticleId IdType="pubmed">19228857</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu CM, Manns BJ, Hill MD, Ghali WA, Donaldson C, Buchan AM. Rapid evaluation after high-risk TIA is associated with lower stroke risk. Can J Neurol Sci. 2009;36(4):450-455. doi:10.1017/S0317167100007770</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0317167100007770</ArticleId><ArticleId IdType="pubmed">19650355</ArticleId></ArticleIdList></Reference><Reference><Citation>Vigen T, Thommessen B, R&#xf8;nning OM. Stroke risk is low after urgently treated transient ischemic attack. J Stroke Cerebrovasc Dis. 2018;27(2):291-295. doi:10.1016/j.jstrokecerebrovasdis.2017.08.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2017.08.037</ArticleId><ArticleId IdType="pubmed">29108805</ArticleId></ArticleIdList></Reference><Reference><Citation>Appelros P, H&#xe1;ls Berglund M, Str&#xf6;m JO. Long-term risk of stroke after transient ischemic attack. Cerebrovasc Dis. 2017;43(1-2):25-30. doi:10.1159/000451061</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000451061</ArticleId><ArticleId IdType="pubmed">27750222</ArticleId></ArticleIdList></Reference><Reference><Citation>Felgueiras R, Magalh&#xe3;es R, Silva MR, Silva MC, Correia M. Transient ischemic attack: incidence and early risk of stroke in northern Portugal from 1998&#x2013;2000 to 2009&#x2013;2011. Int J Stroke. 2019;0(0):1-11.</Citation><ArticleIdList><ArticleId IdType="pubmed">30734663</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujinami J, Uehara T, Kimura K, et al. . Incidence and predictors of ischemic stroke events during hospitalization in patients with transient ischemic attack. Cerebrovasc Dis. 2014;37(5):330-335. doi:10.1159/000360757</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000360757</ArticleId><ArticleId IdType="pubmed">24903456</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill MD, Yiannakoulias N, Jeerakathil T, Tu JV, Svenson LW, Schopflocher DP. The high risk of stroke immediately after transient ischemic attack: a population-based study. Neurology. 2004;62(11):2015-2020. doi:10.1212/01.WNL.0000129482.70315.2F</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000129482.70315.2F</ArticleId><ArticleId IdType="pubmed">15184607</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleindorfer D, Panagos P, Pancioli A, et al. . Incidence and short-term prognosis of transient ischemic attack in a population-based study. Stroke. 2005;36(4):720-723. doi:10.1161/01.STR.0000158917.59233.b7</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.STR.0000158917.59233.b7</ArticleId><ArticleId IdType="pubmed">15731465</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundararajan V, Thrift AG, Phan TG, Choi PM, Clissold B, Srikanth VK. Trends over time in the risk of stroke after an incident transient ischemic attack. Stroke. 2014;45(11):3214-3218. doi:10.1161/STROKEAHA.114.006575</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.114.006575</ArticleId><ArticleId IdType="pubmed">25256181</ArticleId></ArticleIdList></Reference><Reference><Citation>Nahab F, Leach G, Kingston C, et al. . Impact of an emergency department observation unit transient ischemic attack protocol on length of stay and cost. J Stroke Cerebrovasc Dis. 2012;21(8):673-678. doi:10.1016/j.jstrokecerebrovasdis.2011.02.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2011.02.017</ArticleId><ArticleId IdType="pubmed">21482142</ArticleId></ArticleIdList></Reference><Reference><Citation>Gon Y, Sakaguchi M, Okazaki S, Mochizuki H, Kitagawa K. Prevalence of positive diffusion-weighted imaging findings and ischemic stroke recurrence in transient ischemic attack. J Stroke Cerebrovasc Dis. 2015;24(5):1000-1007. doi:10.1016/j.jstrokecerebrovasdis.2014.12.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2014.12.023</ArticleId><ArticleId IdType="pubmed">25813066</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvarajah JR, Smith CJ, Hulme S, Georgiou RF, Vail A, Tyrrell PJ; NORTHSTAR Collaborators . Prognosis in patients with transient ischaemic attack (TIA) and minor stroke attending TIA services in the North West of England: the NORTHSTAR Study. J Neurol Neurosurg Psychiatry. 2008;79(1):38-43. doi:10.1136/jnnp.2007.129163</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2007.129163</ArticleId><ArticleId IdType="pubmed">18033799</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivot JM, Wolford C, Castle J, et al. . Two aces: transient ischemic attack work-up as outpatient assessment of clinical evaluation and safety. Stroke. 2011;42(7):1839-1843. doi:10.1161/STROKEAHA.110.608380</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.110.608380</ArticleId><ArticleId IdType="pubmed">21617143</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheong E, Toner P, Dowie G, Jannes J, Kleinig T. Evaluation of a CTA-triage based transient ischemic attack service: a retrospective single center cohort study. J Stroke Cerebrovasc Dis. 2018;27(12):3436-3442. doi:10.1016/j.jstrokecerebrovasdis.2018.08.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2018.08.006</ArticleId><ArticleId IdType="pubmed">30193811</ArticleId></ArticleIdList></Reference><Reference><Citation>Vora N, Tung CE, Mlynash M, et al. . TIA triage in emergency department using acute MRI (TIA-TEAM): a feasibility and safety study. Int J Stroke. 2015;10(3):343-347. doi:10.1111/ijs.12390</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijs.12390</ArticleId><ArticleId IdType="pubmed">25367837</ArticleId></ArticleIdList></Reference><Reference><Citation>Correia M, Fonseca AC, Canh&#xe3;o P. Short-term outcome of patients with possible transient ischemic attacks: a prospective study. BMC Neurol. 2015;15(1):78. doi:10.1186/s12883-015-0333-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-015-0333-1</ArticleId><ArticleId IdType="pmc">PMC4431458</ArticleId><ArticleId IdType="pubmed">25963672</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahlquist RT, Young JM, Reyner K, et al. . Initiation of the ABCD3-I algorithm for expediated evaluation of transient ischemic attack patients in an emergency department. Am J Emerg Med. 2020;38(4):741-745. doi:10.1016/j.ajem.2019.06.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2019.06.018</ArticleId><ArticleId IdType="pubmed">31230922</ArticleId></ArticleIdList></Reference><Reference><Citation>Montassier E, Lim TX, Goffinet N, et al. . Results of an outpatient transient ischemic attack evaluation: a 90-day follow-up study. J Emerg Med. 2013;44(5):970-975. doi:10.1016/j.jemermed.2012.09.145</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jemermed.2012.09.145</ArticleId><ArticleId IdType="pubmed">23478183</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavall&#xe9;e PC, Sissani L, Labreuche J, et al. . Clinical significance of isolated atypical transient symptoms in a cohort with transient ischemic attack. Stroke. 2017;48(6):1495-1500. doi:10.1161/STROKEAHA.117.016743</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.117.016743</ArticleId><ArticleId IdType="pubmed">28487336</ArticleId></ArticleIdList></Reference><Reference><Citation>Wasserman J, Perry J, Dowlatshahi D, et al. . Stratified, urgent care for transient ischemic attack results in low stroke rates. Stroke. 2010;41(11):2601-2605. doi:10.1161/STROKEAHA.110.586842</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.110.586842</ArticleId><ArticleId IdType="pubmed">20947856</ArticleId></ArticleIdList></Reference><Reference><Citation>von Weitzel-Mudersbach P, Johnsen SP, Andersen G. Low risk of vascular events following urgent treatment of transient ischaemic attack: the Aarhus TIA study. Eur J Neurol. 2011;18(11):1285-1290. doi:10.1111/j.1468-1331.2011.03452.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2011.03452.x</ArticleId><ArticleId IdType="pubmed">21645177</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsivgoulis G, Stamboulis E, Sharma VK, et al. . Multicenter external validation of the ABCD2 score in triaging TIA patients. Neurology. 2010;74(17):1351-1357. doi:10.1212/WNL.0b013e3181dad63e</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181dad63e</ArticleId><ArticleId IdType="pubmed">20421579</ArticleId></ArticleIdList></Reference><Reference><Citation>Cucchiara BL, Messe SR, Sansing L, et al. . D-dimer, magnetic resonance imaging diffusion-weighted imaging, and ABCD2 score for transient ischemic attack risk stratification. J Stroke Cerebrovasc Dis. 2009;18(5):367-373. doi:10.1016/j.jstrokecerebrovasdis.2009.01.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2009.01.006</ArticleId><ArticleId IdType="pubmed">19717021</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al. . Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet. 2007;369(9558):283-292. doi:10.1016/S0140-6736(07)60150-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)60150-0</ArticleId><ArticleId IdType="pubmed">17258668</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvet D, Touz&#xe9; E, Oppenheim C, Turc G, Meder JF, Mas JL. DWI lesions and TIA etiology improve the prediction of stroke after TIA. Stroke. 2009;40(1):187-192. doi:10.1161/STROKEAHA.108.515817</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.108.515817</ArticleId><ArticleId IdType="pubmed">18988917</ArticleId></ArticleIdList></Reference><Reference><Citation>Coutts SB, Hill MD, Campos CR, et al. ; VISION study group . Recurrent events in transient ischemic attack and minor stroke: what events are happening and to which patients? Stroke. 2008;39(9):2461-2466. doi:10.1161/STROKEAHA.107.513234</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.107.513234</ArticleId><ArticleId IdType="pubmed">18617658</ArticleId></ArticleIdList></Reference><Reference><Citation>Stead LG, Bellolio MF, Suravaram S, et al. . Evaluation of transient ischemic attack in an emergency department observation unit. Neurocrit Care. 2009;10(2):204-208. doi:10.1007/s12028-008-9146-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12028-008-9146-z</ArticleId><ArticleId IdType="pubmed">18850077</ArticleId></ArticleIdList></Reference><Reference><Citation>Stead LG, Suravaram S, Bellolio MF, et al. . An assessment of the incremental value of the ABCD2 score in the emergency department evaluation of transient ischemic attack. Ann Emerg Med. 2011;57(1):46-51. doi:10.1016/j.annemergmed.2010.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2010.07.001</ArticleId><ArticleId IdType="pmc">PMC3030982</ArticleId><ArticleId IdType="pubmed">20855130</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado P, Chac&#xf3;n P, Penalba A, et al. . Lipoprotein-associated phospholipase A(2) activity is associated with large-artery atherosclerotic etiology and recurrent stroke in TIA patients. Cerebrovasc Dis. 2012;33(2):150-158. doi:10.1159/000334193</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000334193</ArticleId><ArticleId IdType="pubmed">22178747</ArticleId></ArticleIdList></Reference><Reference><Citation>Jov&#xe9; M, Mauri-Capdevila G, Su&#xe1;rez I, et al. . Metabolomics predicts stroke recurrence after transient ischemic attack. Neurology. 2015;84(1):36-45. doi:10.1212/WNL.0000000000001093</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001093</ArticleId><ArticleId IdType="pmc">PMC4336096</ArticleId><ArticleId IdType="pubmed">25471397</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancelli I, Janes F, Gigli GL, et al. . Incidence of transient ischemic attack and early stroke risk: validation of the ABCD2 score in an Italian population-based study. Stroke. 2011;42(10):2751-2757. doi:10.1161/STROKEAHA.110.612705</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.110.612705</ArticleId><ArticleId IdType="pubmed">21836095</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladstone DJ, Kapral MK, Fang J, Laupacis A, Tu JV. Management and outcomes of transient ischemic attacks in Ontario. CMAJ. 2004;170(7):1099-1104. doi:10.1503/cmaj.1031349</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.1031349</ArticleId><ArticleId IdType="pmc">PMC374216</ArticleId><ArticleId IdType="pubmed">15051693</ArticleId></ArticleIdList></Reference><Reference><Citation>Ildstad F, Ellekj&#xe6;r H, Wethal T, et al. . Stroke risk after transient ischemic attack in a Norwegian prospective cohort. BMC Neurol. 2019;19(1):2-9. doi:10.1186/s12883-018-1225-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-018-1225-y</ArticleId><ArticleId IdType="pmc">PMC6317188</ArticleId><ArticleId IdType="pubmed">30606138</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiyohara T, Kamouchi M, Kumai Y, et al. ; Fukuoka Stroke Registry Investigators . ABCD3 and ABCD3-I scores are superior to ABCD2 score in the prediction of short- and long-term risks of stroke after transient ischemic attack. Stroke. 2014;45(2):418-425. doi:10.1161/STROKEAHA.113.003077</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.113.003077</ArticleId><ArticleId IdType="pubmed">24335223</ArticleId></ArticleIdList></Reference><Reference><Citation>Lisabeth LD, Ireland JK, Risser JMH, et al. . Stroke risk after transient ischemic attack in a population-based setting. Stroke. 2004;35(8):1842-1846. doi:10.1161/01.STR.0000134416.89389.9d</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.STR.0000134416.89389.9d</ArticleId><ArticleId IdType="pubmed">15192239</ArticleId></ArticleIdList></Reference><Reference><Citation>Ovbiagele B, Cruz-Flores S, Lynn MJ, Chimowitz MI; Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group . Early stroke risk after transient ischemic attack among individuals with symptomatic intracranial artery stenosis. Arch Neurol. 2008;65(6):733-737. doi:10.1001/archneur.65.6.733</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.65.6.733</ArticleId><ArticleId IdType="pubmed">18541793</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry JJ, Sharma M, Sivilotti MLA, et al. . A prospective cohort study of patients with transient ischemic attack to identify high-risk clinical characteristics. Stroke. 2014;45(1):92-100. doi:10.1161/STROKEAHA.113.003085</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.113.003085</ArticleId><ArticleId IdType="pubmed">24262323</ArticleId></ArticleIdList></Reference><Reference><Citation>Purroy F, Jim&#xe9;nez Caballero PE, Gorospe A, et al. . How predictors and patterns of stroke recurrence after a TIA differ during the first year of follow-up. J Neurol. 2014;261(8):1614-1621. doi:10.1007/s00415-014-7390-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-014-7390-z</ArticleId><ArticleId IdType="pubmed">24912470</ArticleId></ArticleIdList></Reference><Reference><Citation>Sciolla R, Melis F; SINPAC Group . Rapid identification of high-risk transient ischemic attacks: prospective validation of the ABCD score. Stroke. 2008;39(2):297-302. doi:10.1161/STROKEAHA.107.496612</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.107.496612</ArticleId><ArticleId IdType="pubmed">18174479</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheehan OC, Kyne L, Kelly LA, et al. . Population-based study of ABCD2 score, carotid stenosis, and atrial fibrillation for early stroke prediction after transient ischemic attack: the North Dublin TIA study. Stroke. 2010;41(5):844-850. doi:10.1161/STROKEAHA.109.571844</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.109.571844</ArticleId><ArticleId IdType="pubmed">20299667</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Khaled M, Matthis C, Eggers J. The prognostic impact of the stroke unit care versus conventional care in treatment of patients with transient ischemic attack: a prospective population-based German study. J Vasc Interv Neurol. 2013;5(2):22-26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3584817</ArticleId><ArticleId IdType="pubmed">23459173</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelter ST, Amort M, Jax F, et al. . Optimizing the risk estimation after a transient ischaemic attack - the ABCDE&#x2295; score. Eur J Neurol. 2012;19(1):55-61. doi:10.1111/j.1468-1331.2011.03428.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2011.03428.x</ArticleId><ArticleId IdType="pubmed">21554497</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghia D, Thomas P, Cordato D, et al. . Low positive predictive value of the ABCD2 score in emergency department transient ischaemic attack diagnoses: the South Western Sydney transient ischaemic attack study. Intern Med J. 2012;42(8):913-918. doi:10.1111/j.1445-5994.2011.02564.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1445-5994.2011.02564.x</ArticleId><ArticleId IdType="pubmed">21790923</ArticleId></ArticleIdList></Reference><Reference><Citation>Guarino M, Rondelli F, Favaretto E, et al. . Short-and long-term stroke risk after urgent management of transient ischaemic attack: the Bologna TIA clinical pathway. Eur Neurol. 2015;74(1-2):1-7. doi:10.1159/000430810</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000430810</ArticleId><ArticleId IdType="pubmed">26044401</ArticleId></ArticleIdList></Reference><Reference><Citation>Palomeras Soler E, Fossas Felip P, Cano Orgaz AT, Sanz Cartagena P, Casado Ruiz V, Muriana Batista D. Rapid assessment of transient ischaemic attack in a hospital with no on-call neurologist. Neurologia. 2015;30(6):325-330. doi:10.1016/j.nrl.2013.12.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nrl.2013.12.021</ArticleId><ArticleId IdType="pubmed">24953410</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross MA, Compton S, Medado P, Fitzgerald M, Kilanowski P, O&#x2019;Neil BJ. An emergency department diagnostic protocol for patients with transient ischemic attack: a randomized controlled trial. Ann Emerg Med. 2007;50(2):109-119. doi:10.1016/j.annemergmed.2007.03.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2007.03.008</ArticleId><ArticleId IdType="pubmed">17490788</ArticleId></ArticleIdList></Reference><Reference><Citation>Raser JM, Cucchiara BL. Modifications of the ABCD2 score do not improve the risk stratification of transient ischemic attack patients. J Stroke Cerebrovasc Dis. 2012;21(6):467-470. doi:10.1016/j.jstrokecerebrovasdis.2010.11.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2010.11.005</ArticleId><ArticleId IdType="pubmed">21388829</ArticleId></ArticleIdList></Reference><Reference><Citation>Bos MJ, van Rijn MJE, Witteman JCM, Hofman A, Koudstaal PJ, Breteler MM. Incidence and prognosis of transient neurological attacks. JAMA. 2007;298(24):2877-2885. doi:10.1001/jama.298.24.2877</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.298.24.2877</ArticleId><ArticleId IdType="pubmed">18159057</ArticleId></ArticleIdList></Reference><Reference><Citation>De Marchis GM, Weck A, Audebert H, et al. . Copeptin for the prediction of recurrent cerebrovascular events after transient ischemic attack: results from the CoRisk study. Stroke. 2014;45(10):2918-2923. doi:10.1161/STROKEAHA.114.005584</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.114.005584</ArticleId><ArticleId IdType="pubmed">25169950</ArticleId></ArticleIdList></Reference><Reference><Citation>Eliasziw M, Kennedy J, Hill MD, Buchan AM, Barnett HJM; North American Symptomatic Carotid Endarterectomy Trial Group . Early risk of stroke after a transient ischemic attack in patients with internal carotid artery disease. CMAJ. 2004;170(7):1105-1109. doi:10.1503/cmaj.1030460</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.1030460</ArticleId><ArticleId IdType="pmc">PMC374217</ArticleId><ArticleId IdType="pubmed">15051694</ArticleId></ArticleIdList></Reference><Reference><Citation>Song B, Fang H, Zhao L, et al. . Validation of the ABCD3-I score to predict stroke risk after transient ischemic attack. Stroke. 2013;44(5):1244-1248. doi:10.1161/STROKEAHA.113.000969</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.113.000969</ArticleId><ArticleId IdType="pubmed">23532014</ArticleId></ArticleIdList></Reference><Reference><Citation>Weimar C, Benemann J, Huber R, et al. ; German Stroke Study Collaboration . Long-term mortality and risk of stroke after transient ischemic attack: a hospital-based cohort study. J Neurol. 2009;256(4):639-644. doi:10.1007/s00415-009-0150-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-009-0150-9</ArticleId><ArticleId IdType="pubmed">19373427</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Khaled M, Eggers J. Early hospitalization of patients with TIA: a prospective, population-based study. J Stroke Cerebrovasc Dis. 2014;23(1):99-105.</Citation><ArticleIdList><ArticleId IdType="pubmed">23164482</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohara T, Uehara T, Sato S, et al. ; PROMISE-TIA Study Investigators . Small vessel occlusion is a high-risk etiology for early recurrent stroke after transient ischemic attack. Int J Stroke. 2019;14(9):871-877. doi:10.1177/1747493019840931</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1747493019840931</ArticleId><ArticleId IdType="pubmed">30917776</ArticleId></ArticleIdList></Reference><Reference><Citation>Ottaviani M, Vanni S, Moroni F, Peiman N, Boddi M, Grifoni S. Urgent carotid duplex and head computed tomography versus ABCD2 score for risk stratification of patients with transient ischemic attack. Eur J Emerg Med. 2016;23(1):19-23. doi:10.1097/MEJ.0000000000000165</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MEJ.0000000000000165</ArticleId><ArticleId IdType="pubmed">24849610</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricci S, Celani MG, La Rosa F, et al. . A community-based study of incidence, risk factors and outcome of transient ischaemic attacks in Umbria, Italy: the SEPIVAC study. J Neurol. 1991;238(2):87-90. doi:10.1007/BF00315687</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00315687</ArticleId><ArticleId IdType="pubmed">1856742</ArticleId></ArticleIdList></Reference><Reference><Citation>Raposo N, Albucher JF, Rousseau V, Acket B, Chollet F, Olivot JM. ED referral dramatically reduces delays of initial evaluation in a French TIA clinic. Front Neurol. 2018;9:914. doi:10.3389/fneur.2018.00914</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00914</ArticleId><ArticleId IdType="pmc">PMC6212543</ArticleId><ArticleId IdType="pubmed">30416483</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim J-S, Hong K-S, Kim G-M, et al. . Cerebral microbleeds and early recurrent stroke after transient ischemic attack: results from the Korean Transient Ischemic Attack Expression Registry. JAMA Neurol. 2015;72(3):301-308. doi:10.1001/jamaneurol.2014.3958</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.3958</ArticleId><ArticleId IdType="pubmed">25580844</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranta A, Weatherall M, Gommans J, Tilyard M, Odea D, Dovey S. Appropriateness of general practitioner imaging requests for transient ischaemic attack patients: secondary analysis of a cluster randomised controlled trial. J Prim Health Care. 2017;9(2):131-135. doi:10.1071/HC17005</Citation><ArticleIdList><ArticleId IdType="doi">10.1071/HC17005</ArticleId><ArticleId IdType="pubmed">29530224</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosier GW, Phillips SJ, Doucette SP, Magee KD, Gubitz GJ. Transient ischemic attack: management in the emergency department and impact of an outpatient neurovascular clinic. CJEM. 2016;18(5):331-339. doi:10.1017/cem.2016.3</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/cem.2016.3</ArticleId><ArticleId IdType="pubmed">26879765</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapral MK, Hall R, Fang J, et al. . Association between hospitalization and care after transient ischemic attack or minor stroke. Neurology. 2016;86(17):1582-1589. doi:10.1212/WNL.0000000000002614</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002614</ArticleId><ArticleId IdType="pmc">PMC4844241</ArticleId><ArticleId IdType="pubmed">27016521</ArticleId></ArticleIdList></Reference><Reference><Citation>Wardlaw JM, Brazzelli M, Chappell FM, et al. . ABCD2 score and secondary stroke prevention: meta-analysis and effect per 1,000 patients triaged. Neurology. 2015;85(4):373-380. doi:10.1212/WNL.0000000000001780</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001780</ArticleId><ArticleId IdType="pmc">PMC4520819</ArticleId><ArticleId IdType="pubmed">26136519</ArticleId></ArticleIdList></Reference><Reference><Citation>Merwick A, Albers GW, Amarenco P, et al. . Addition of brain and carotid imaging to the ABCD2 score to identify patients at early risk of stroke after transient ischaemic attack: a multicentre observational study. Lancet Neurol. 2010;9(11):1060-1069. doi:10.1016/S1474-4422(10)70240-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70240-4</ArticleId><ArticleId IdType="pubmed">20934388</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong MEH, Chan YH, Lin WP, Chung WL. Validating the ABCD(2) score for predicting stroke risk after transient ischemic attack in the ED. Am J Emerg Med. 2010;28(1):44-48. doi:10.1016/j.ajem.2008.09.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2008.09.027</ArticleId><ArticleId IdType="pubmed">20006200</ArticleId></ArticleIdList></Reference><Reference><Citation>Holzer K, Feurer R, Sadikovic S, et al. . Prognostic value of the ABCD2 score beyond short-term follow-up after transient ischemic attack (TIA)&#x2014;a cohort study. BMC Neurol. 2010;10:50. doi:10.1186/1471-2377-10-50</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-10-50</ArticleId><ArticleId IdType="pmc">PMC2906428</ArticleId><ArticleId IdType="pubmed">20565966</ArticleId></ArticleIdList></Reference><Reference><Citation>Asimos AW, Johnson AM, Rosamond WD, et al. . A multicenter evaluation of the ABCD2 score&#x2019;s accuracy for predicting early ischemic stroke in admitted patients with transient ischemic attack. Ann Emerg Med. 2010;55(2):201-210.e5. doi:10.1016/j.annemergmed.2009.05.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2009.05.002</ArticleId><ArticleId IdType="pubmed">19556026</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta I, Bloch S, Morales M, Bornstein NM, Savitz SI, Hallevi H. Predicting the need for hospital admission of TIA patients. J Neurol Sci. 2014;336(1-2):83-86. doi:10.1016/j.jns.2013.10.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2013.10.011</ArticleId><ArticleId IdType="pmc">PMC3947084</ArticleId><ArticleId IdType="pubmed">24209902</ArticleId></ArticleIdList></Reference><Reference><Citation>Koton S, Rothwell PM, Study OV. Performance of the ABCD and ABCD2 scores in TIA patients with carotid stenosis and atrial fibrillation. Cerebrovasc Dis. 2007;24(2-3):231-235. doi:10.1159/000104483</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000104483</ArticleId><ArticleId IdType="pubmed">17630483</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford AL, Williams JA, Spencer M, et al. . Reducing door-to-needle times using Toyota&#x2019;s lean manufacturing principles and value stream analysis. Stroke. 2012;43(12):3395-3398. doi:10.1161/STROKEAHA.112.670687</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.112.670687</ArticleId><ArticleId IdType="pmc">PMC3508290</ArticleId><ArticleId IdType="pubmed">23138440</ArticleId></ArticleIdList></Reference><Reference><Citation>Coben JH, Owens PL, Steiner CA, Crocco TJ. Hospital and demographic influences on the disposition of transient ischemic attack. Acad Emerg Med. 2008;15(2):171-176. doi:10.1111/j.1553-2712.2008.00041.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1553-2712.2008.00041.x</ArticleId><ArticleId IdType="pubmed">18275447</ArticleId></ArticleIdList></Reference><Reference><Citation>Australian Stroke Foundation . Clinical guidelines for stroke management&#x2014;chapter 2: early assessment and diagnosis. Accessed December 1, 2021. https://app.magicapp.org/#/guideline/3993/section/45730</Citation></Reference><Reference><Citation>Frank A, Bowen A, Young GR, James MA. The latest national clinical guideline for stroke. Clin Med (Lond). 2017;17(5):478. doi:10.7861/clinmedicine.17-5-478</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmedicine.17-5-478</ArticleId><ArticleId IdType="pmc">PMC6301935</ArticleId><ArticleId IdType="pubmed">28974606</ArticleId></ArticleIdList></Reference><Reference><Citation>Wein T, Lindsay MP, Cote R, et al. . Canadian stroke best practice recommendations: secondary prevention of stroke, sixth edition practice guidelines, update 2017. Int J Stroke. 2018;13(4):420-443. doi:10.1177/1747493017743062</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1747493017743062</ArticleId><ArticleId IdType="pubmed">29171361</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferro JM, Falc&#xe3;o I, Rodrigues G, et al. . Diagnosis of transient ischemic attack by the nonneurologist: a validation study. Stroke. 1996;27(12):2225-2229. doi:10.1161/01.STR.27.12.2225</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.STR.27.12.2225</ArticleId><ArticleId IdType="pubmed">8969785</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadighi A, Stanciu A, Banciu M, et al. . Rate and associated factors of transient ischemic attack misdiagnosis. eNeurologicalSci. 2019;15:100193. doi:10.1016/j.ensci.2019.100193</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ensci.2019.100193</ArticleId><ArticleId IdType="pmc">PMC6529772</ArticleId><ArticleId IdType="pubmed">31193470</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadarajan V, Perry RJ, Johnson J, Werring DJ. Transient ischaemic attacks: mimics and chameleons. Pract Neurol. 2014;14(1):23-31. doi:10.1136/practneurol-2013-000782</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/practneurol-2013-000782</ArticleId><ArticleId IdType="pmc">PMC3913122</ArticleId><ArticleId IdType="pubmed">24453269</ArticleId></ArticleIdList></Reference><Reference><Citation>Castle J, Mlynash M, Lee K, et al. . Agreement regarding diagnosis of transient ischemic attack fairly low among stroke-trained neurologists. Stroke. 2010;41(7):1367-1370. doi:10.1161/STROKEAHA.109.577650</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.109.577650</ArticleId><ArticleId IdType="pubmed">20508192</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomasello F, Mariani F, Fieschi C, et al. . Assessment of inter-observer differences in the Italian multicenter study on reversible cerebral ischemia. Stroke. 1982;13(1):32-35. doi:10.1161/01.STR.13.1.32</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.STR.13.1.32</ArticleId><ArticleId IdType="pubmed">7064176</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraaijeveld CL, van Gijn J, Schouten HJ, Staal A, Staal A. Interobserver agreement for the diagnosis of transient ischemic attacks. Stroke. 1984;15(4):723-725. doi:10.1161/01.STR.15.4.723</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.STR.15.4.723</ArticleId><ArticleId IdType="pubmed">6464066</ArticleId></ArticleIdList></Reference><Reference><Citation>Koudstaal PJ, Gerritsma JG, van Gijn J. Clinical disagreement on the diagnosis of transient ischemic attack: is the patient or the doctor to blame? Stroke. 1989;20(2):300-301. doi:10.1161/01.STR.20.2.300</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.STR.20.2.300</ArticleId><ArticleId IdType="pubmed">2919420</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta D. Diagnosis of TIA (DOT) score&#x2014;design and validation of a new clinical diagnostic tool for transient ischaemic attack. BMC Neurol. 2016;16(1):20. doi:10.1186/s12883-016-0535-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-016-0535-1</ArticleId><ArticleId IdType="pmc">PMC4746899</ArticleId><ArticleId IdType="pubmed">26857238</ArticleId></ArticleIdList></Reference><Reference><Citation>Abedi V, Goyal N, Tsivgoulis G, et al. . Novel screening tool for stroke using artificial neural network. Stroke. 2017;48(6):1678-1681. doi:10.1161/STROKEAHA.117.017033</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.117.017033</ArticleId><ArticleId IdType="pubmed">28438906</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanciu A, Banciu M, Sadighi A, et al. . A predictive analytics model for differentiating between transient ischemic attacks (TIA) and its mimics. BMC Med Inform Decis Mak. 2020;20(1):112. doi:10.1186/s12911-020-01154-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-020-01154-6</ArticleId><ArticleId IdType="pmc">PMC7302339</ArticleId><ArticleId IdType="pubmed">32552700</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul NLM, Koton S, Simoni M, Geraghty OC, Luengo-Fernandez R, Rothwell PM. Feasibility, safety and cost of outpatient management of acute minor ischaemic stroke: a population-based study. J Neurol Neurosurg Psychiatry. 2013;84(3):356-361. doi:10.1136/jnnp-2012-303585</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-303585</ArticleId><ArticleId IdType="pmc">PMC5321491</ArticleId><ArticleId IdType="pubmed">23172867</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavall&#xe9;e P, Amarenco P. TIA clinic: a major advance in management of transient ischemic attacks. Front Neurol Neurosci. 2014;33:30-40. doi:10.1159/000351890</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000351890</ArticleId><ArticleId IdType="pubmed">24157555</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29355808</PMID><DateCompleted><Year>2018</Year><Month>05</Month><Day>21</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-8769</ISSN><JournalIssue CitedMedium="Internet"><Volume>112</Volume><PubDate><Year>2018</Year><Month>Apr</Month></PubDate></JournalIssue><Title>World neurosurgery</Title><ISOAbbreviation>World Neurosurg</ISOAbbreviation></Journal><ArticleTitle>Endovascular Mechanical Thrombectomy for Acute Ischemic Stroke Under General Anesthesia Versus Conscious Sedation: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>e355</StartPage><EndPage>e367</EndPage><MedlinePgn>e355-e367</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2018.01.049</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1878-8750(18)30089-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Endovascular mechanical thrombectomy (EMT) is the standard of care for eligible patients presenting with anterior circulation acute ischemic stroke (AIS) due to emergent large vessel occlusion (ELVO). The aim of this systematic review and meta-analysis is to compare the outcomes between patients undergoing general anesthesia (GA) versus conscious sedation (CS) for these procedures.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A literature review was performed to identify studies reporting the EMT outcomes of AIS patients who underwent GA or CS for the procedure. Baseline, treatment, and outcomes data were analyzed. Good outcome was defined as a modified Rankin Scale score of 0-2 at 3 months, and successful reperfusion was defined as modified thrombolysis in cerebral infarction grade of 2b-3.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Nine studies, comprising a total of 1379 patients treated with GA (n&#xa0;= 761) or CS (n&#xa0;= 618) for EMT, were included. Based on pooled data, GA achieved good outcome in 35% and successful reperfusion in 81%, whereas CS achieved good outcome in 41% and successful reperfusion in 75%. Meta-analyses showed no significant differences in the rates of good outcome (P&#xa0;= 0.51) or successful reperfusion (P&#xa0;= 0.39) between the GA and CS groups. The rates of pneumonia were significantly higher in the GA group (21% vs. 11%; P&#xa0;= 0.01).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The use of either GA or CS during EMT for patients with anterior circulation acute ELVO does not yield significantly different rates of functional independence at 3 months.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ilyas</LastName><ForeName>Adeel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama, USA. Electronic address: adeelilyas@uabmc.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Ching-Jen</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Virginia, Charlottesville, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Dale</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Barrow Neurological Institute, Phoenix, Arizona, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foreman</LastName><ForeName>Paul M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buell</LastName><ForeName>Thomas J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Virginia, Charlottesville, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ironside</LastName><ForeName>Natasha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Auckland City Hospital, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Davis G</ForeName><Initials>DG</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Virginia, Charlottesville, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalani</LastName><ForeName>M Yashar</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Virginia, Charlottesville, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Min S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Virginia, Charlottesville, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Southerland</LastName><ForeName>Andrew M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Virginia, Charlottesville, Virginia, USA; Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Worrall</LastName><ForeName>Bradford B</ForeName><Initials>BB</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Virginia, Charlottesville, Virginia, USA; Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>World Neurosurg</MedlineTA><NlmUniqueID>101528275</NlmUniqueID><ISSNLinking>1878-8750</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>World Neurosurg. 2018 Jul;115:488. doi: 10.1016/j.wneu.2018.04.034.</RefSource><PMID Version="1">29958379</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002545" MajorTopicYN="N">Brain Ischemia</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016292" MajorTopicYN="Y">Conscious Sedation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="N">Endovascular Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017131" MajorTopicYN="N">Thrombectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anterior circulation</Keyword><Keyword MajorTopicYN="N">Conscious sedation</Keyword><Keyword MajorTopicYN="N">Endovascular</Keyword><Keyword MajorTopicYN="N">General anesthesia</Keyword><Keyword MajorTopicYN="N">Review</Keyword><Keyword MajorTopicYN="N">Stroke</Keyword><Keyword MajorTopicYN="N">Thrombectomy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>1</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29355808</ArticleId><ArticleId IdType="doi">10.1016/j.wneu.2018.01.049</ArticleId><ArticleId IdType="pii">S1878-8750(18)30089-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">28040765</PMID><DateCompleted><Year>2017</Year><Month>09</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1569-9285</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>3</Issue><PubDate><Year>2017</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Interactive cardiovascular and thoracic surgery</Title><ISOAbbreviation>Interact Cardiovasc Thorac Surg</ISOAbbreviation></Journal><ArticleTitle>Classification and outcomes of extended arch repair for acute Type A aortic dissection: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>450</StartPage><EndPage>459</EndPage><MedlinePgn>450-459</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/icvts/ivw355</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Distal extent of repair in patients undergoing surgery for acute Type A aortic dissection (ATAAD) is controversial. Emerging hybrid techniques involving open and endovascular surgery have been reported in small numbers by select individual centres. A systematic review and meta-analysis was performed to investigate the outcomes following extended arch repair for ATAAD. A classification system is proposed of the different techniques to facilitate discussion and further investigation.</AbstractText><AbstractText Label="METHODS">Using Ovid MEDLINE, 38 studies were identified reporting outcomes for 2140 patients. Studies were categorized into four groups on the basis of extent of surgical aortic resection and the method of descending thoracic aortic stent graft deployment; during circulatory arrest (frozen stented elephant trunk) or with normothermic perfusion and use of fluoroscopy (warm stent graft): (I) surgical total arch replacement, (II) total arch and frozen stented elephant trunk, (III) hemiarch and frozen stented elephant trunk and (IV) total arch and warm stent graft. Perioperative event rates were obtained for each of the four groups and the entire cohort using pooled summary estimates. Linearized rates of late mortality and reoperation were calculated.</AbstractText><AbstractText Label="RESULTS">Overall pooled hospital mortality for extended arch techniques was 8.6% (95% CI 7.2-10.0). Pooled data categorized by surgical technique resulted in hospital mortality of 11.9% for total arch, 8.6% total arch and frozen stented elephant trunk, 6.3% hemiarch and frozen stented elephant trunk and 5.5% total arch and 'warm stent graft'. Overall incidence of stroke for the entire cohort was 5.7% (95% CI 3.6-8.2). Rate of spinal cord ischaemia was 2.0% (95% CI 1.2-3.0). Pooled linearized rate of late mortality was 1.66%/pt-yr (95% CI 1.34-2.07) with linearized rate of re-operation of 1.62%/pt-yr (95% CI 1.24-2.05).</AbstractText><AbstractText Label="CONCLUSIONS">Perioperative results of extended arch procedures are encouraging. Further follow-up is required to see if long-term complications are reduced with these emerging techniques. The proposed classification system will facilitate future comparison of short- and long-term results of different techniques of extended arch repair for ATAAD.</AbstractText><CopyrightInformation>&#xa9; The Author 2016. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Holly N</ForeName><Initials>HN</Initials><AffiliationInfo><Affiliation>Toronto Western Hospital EW 1-433, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boodhwani</LastName><ForeName>Munir</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ouzounian</LastName><ForeName>Maral</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saczkowski</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Hospital of the Sacred Heart of Montreal and the University of Montreal, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gregory</LastName><ForeName>Alexander J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herget</LastName><ForeName>Eric J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Diagnostic Imaging, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Appoo</LastName><ForeName>Jehangir J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Interact Cardiovasc Thorac Surg</MedlineTA><NlmUniqueID>101158399</NlmUniqueID><ISSNLinking>1569-9285</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000784" MajorTopicYN="N">Aortic Dissection</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001013" MajorTopicYN="N">Aorta, Thoracic</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017545" MajorTopicYN="N">Aortic Aneurysm, Thoracic</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019917" MajorTopicYN="N">Blood Vessel Prosthesis Implantation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015607" MajorTopicYN="Y">Stents</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aorta</Keyword><Keyword MajorTopicYN="N">Aortic dissection</Keyword><Keyword MajorTopicYN="N">Aortic repair</Keyword><Keyword MajorTopicYN="N">Extended arch</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>9</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>1</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28040765</ArticleId><ArticleId IdType="doi">10.1093/icvts/ivw355</ArticleId><ArticleId IdType="pii">ivw355</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40157449</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1615-5947</ISSN><JournalIssue CitedMedium="Internet"><Volume>116</Volume><PubDate><Year>2025</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Annals of vascular surgery</Title><ISOAbbreviation>Ann Vasc Surg</ISOAbbreviation></Journal><ArticleTitle>Efficacy and Safety of Tranexamic Acid in Noncardiac Arterial Procedures: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>109</StartPage><EndPage>119</EndPage><MedlinePgn>109-119</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.avsg.2025.03.015</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0890-5096(25)00147-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Noncardiac arterial procedures (NCAPs) are associated with a high risk of bleeding. Tranexamic acid (TXA) is used among surgical disciplines to reduce blood loss; however, its effectiveness and safety in NCAP remain unclear. This review evaluates the efficacy and safety of TXA during NCAP.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Systematic review and meta-analysis was performed in accordance with Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines. Literature searches in PubMed, Embase, and Cochrane databases (October 2023 and October 2024) identified studies investigating TXA in open and endovascular NCAP. Meta-analyses were conducted using Cochrane's Review Manager.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Five studies (n = 4304) were identified. One randomized controlled trial of TXA in noncardiac surgery (n = 9535), including a vascular cohort (14.8%; n = 699 TXA, n = 700 placebo), showed lower composite bleeding outcomes in the overall cohort receiving TXA (9.5% vs 11.7%; P &lt; 0.001), but not in the vascular cohort (hazard ratio 0.85; 95% confidence interval [CI] 0.64-1.13). Another trial found no difference in blood loss or transfusion rates in 100 patients undergoing open abdominal aortic aneurysm surgery. Both trials reported no increased cardiovascular or thromboembolic complications (TECs) or 30-day mortality. A prospective study showed similar thrombosis-related technical failure rates in traumatic vascular injury patients (TXA 6.3% vs 3.8%, P = 0.14) and no significant differences in bleeding or hematoma (TXA 11.4% vs 4.3%, P = 0.13). In 297 carotid endarterectomy (CEA) patients, TXA significantly reduced postoperative hematoma (7.9% vs 1.3%; P = 0.01) without increasing TEC or stroke. TXA during an intraoperative hemostasis protocol during CEA (TXA n = 8) reported similar results. Meta-analysis showed no significant differences in TEC (risk ratio [RR] 1.10; 95% CI 0.71-1.70) or reoperation rates (RR 0.55; 95% CI 0.19-1.63).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">TXA does not increase the risk of TEC in NCAP. However, there is currently insufficient evidence that TXA reduces bleeding complications.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Steunenberg</LastName><ForeName>Thomas A H</ForeName><Initials>TAH</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Amsterdam University Medical Center, Location Vrije Universiteit, Amsterdam, The Netherlands; Department of Vascular Surgery, Amsterdam University Medical Center, Location University of Amsterdam, Amsterdam, The Netherlands; Department of Vascular Surgery, Dijklander Hospital, Hoorn, The Netherlands; Amsterdam Cardiovascular Sciences, Atherosclerosis &amp; Aortic Diseases, Amsterdam, The Netherlands. Electronic address: t.a.h.steunenberg@amsterdamumc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakker</LastName><ForeName>Nathalie C</ForeName><Initials>NC</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Amsterdam University Medical Center, Location Vrije Universiteit, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiersema</LastName><ForeName>Arno M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Amsterdam University Medical Center, Location Vrije Universiteit, Amsterdam, The Netherlands; Department of Vascular Surgery, Dijklander Hospital, Hoorn, The Netherlands; Amsterdam Cardiovascular Sciences, Atherosclerosis &amp; Aortic Diseases, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tournoij</LastName><ForeName>Erik</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Dijklander Hospital, Hoorn, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeung</LastName><ForeName>Kak Khee</ForeName><Initials>KK</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Amsterdam University Medical Center, Location Vrije Universiteit, Amsterdam, The Netherlands; Department of Vascular Surgery, Amsterdam University Medical Center, Location University of Amsterdam, Amsterdam, The Netherlands; Amsterdam Cardiovascular Sciences, Atherosclerosis &amp; Aortic Diseases, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jongkind</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Amsterdam University Medical Center, Location Vrije Universiteit, Amsterdam, The Netherlands; Department of Vascular Surgery, Dijklander Hospital, Hoorn, The Netherlands; Amsterdam Cardiovascular Sciences, Atherosclerosis &amp; Aortic Diseases, Amsterdam, The Netherlands. Electronic address: v.jongkind@amsterdamummc.nl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>03</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Ann Vasc Surg</MedlineTA><NlmUniqueID>8703941</NlmUniqueID><ISSNLinking>0890-5096</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>6T84R30KC1</RegistryNumber><NameOfSubstance UI="D014148">Tranexamic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000933">Antifibrinolytic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014148" MajorTopicYN="Y">Tranexamic Acid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000933" MajorTopicYN="Y">Antifibrinolytic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="Y">Blood Loss, Surgical</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019106" MajorTopicYN="Y">Postoperative Hemorrhage</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>2</Day><Hour>3</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>3</Month><Day>30</Day><Hour>23</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>3</Month><Day>29</Day><Hour>20</Hour><Minute>36</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40157449</ArticleId><ArticleId IdType="doi">10.1016/j.avsg.2025.03.015</ArticleId><ArticleId IdType="pii">S0890-5096(25)00147-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30051178</PMID><DateCompleted><Year>2019</Year><Month>05</Month><Day>07</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1861-0692</ISSN><JournalIssue CitedMedium="Internet"><Volume>108</Volume><Issue>2</Issue><PubDate><Year>2019</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Clinical research in cardiology : official journal of the German Cardiac Society</Title><ISOAbbreviation>Clin Res Cardiol</ISOAbbreviation></Journal><ArticleTitle>Interventional closure vs. medical therapy of patent foramen ovale for secondary prevention of stroke: updated meta-analysis.</ArticleTitle><Pagination><StartPage>157</StartPage><EndPage>166</EndPage><MedlinePgn>157-166</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00392-018-1334-z</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">We aimed to explore whether interventional closure of patent foramen ovale (PFO) results in reduction of composite outcome [stroke/transitory ischemic attack (TIA), death, and thrombolysis in myocardial infarction-TIMI bleeding], stroke and stroke/TIA compared to medical treatment in patients with cryptogenic stroke.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">Searching the PUBMED and Cochrane library database, we performed meta-analysis from all randomized controlled studies that compared effects of interventional PFO closure with medical treatment on stroke prevention. 3560 patients from six randomized trials were included. Interventional PFO closure reduced composite outcome (RR of 0.47, 0.26-0.85, p&#x2009;=&#x2009;0.01), stroke (RR of 0.38, 0.18-0.82, p&#x2009;=&#x2009;0.01) and stroke/TIA (RR of 0.56, 0.43-0.74, p&#x2009;&lt;&#x2009;0.0001). Analysis had 70.5% power to detect observed reduction of RR for the primary outcome, 70.6% for stroke and 98.7% for stroke/TIA. Bleeding rates were comparable (RR of 0.91, 0.60-1.38, p&#x2009;=&#x2009;0.66), while there was higher burden of new AF (RR of 5.54, 3-10.2, p&#x2009;&lt;&#x2009;0.0001) after interventional closure. Subgroup analysis revealed that patients with large shunts had substantial less recurrent strokes over patients with small shunts (p for interaction&#x2009;=&#x2009;0.02). Use of Amplatzer PFO device was associated with substantial less AF (RR of 2.36, p&#x2009;=&#x2009;0.06) compared with other devices (RR of 8.93, p&#x2009;&lt;&#x2009;0.0001) (p for interaction&#x2009;=&#x2009;0.04), with comparable benefit for stroke prevention (p for interaction&#x2009;=&#x2009;0.73).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Interventional closure of PFO resulted in significant reduction of stroke and stroke/TIA compared with antiplatelets/anticoagulants with comparable bleeding rates between the groups, whereas AF occurred more frequently in the intervention group. Patients with large shunts had more benefit from interventional closure.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vukadinovi&#x107;</LastName><ForeName>Davor</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-7094-5961</Identifier><AffiliationInfo><Affiliation>Universit&#xe4;t des Saarlandes, Klinik f&#xfc;r Innere Medizin III, Kardiologie, Angiologie und internistische Intensivmedizin, Kirrberger Strasse, 66421, Homburg, Germany. Davor.Vukadinovic@uks.eu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schirmer</LastName><ForeName>Stephan H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Universit&#xe4;t des Saarlandes, Klinik f&#xfc;r Innere Medizin III, Kardiologie, Angiologie und internistische Intensivmedizin, Kirrberger Strasse, 66421, Homburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vukadinovi&#x107;</LastName><ForeName>Aleksandra Nikolovska</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Universit&#xe4;t des Saarlandes, Klinik f&#xfc;r Innere Medizin III, Kardiologie, Angiologie und internistische Intensivmedizin, Kirrberger Strasse, 66421, Homburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ukena</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Universit&#xe4;t des Saarlandes, Klinik f&#xfc;r Innere Medizin III, Kardiologie, Angiologie und internistische Intensivmedizin, Kirrberger Strasse, 66421, Homburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scheller</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Universit&#xe4;t des Saarlandes, Klinik f&#xfc;r Innere Medizin III, Kardiologie, Angiologie und internistische Intensivmedizin, Kirrberger Strasse, 66421, Homburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahfoud</LastName><ForeName>Felix</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Universit&#xe4;t des Saarlandes, Klinik f&#xfc;r Innere Medizin III, Kardiologie, Angiologie und internistische Intensivmedizin, Kirrberger Strasse, 66421, Homburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xf6;hm</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Universit&#xe4;t des Saarlandes, Klinik f&#xfc;r Innere Medizin III, Kardiologie, Angiologie und internistische Intensivmedizin, Kirrberger Strasse, 66421, Homburg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>07</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Clin Res Cardiol</MedlineTA><NlmUniqueID>101264123</NlmUniqueID><ISSNLinking>1861-0684</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010975">Platelet Aggregation Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054092" MajorTopicYN="N">Foramen Ovale, Patent</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010975" MajorTopicYN="N">Platelet Aggregation Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055502" MajorTopicYN="N">Secondary Prevention</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055989" MajorTopicYN="Y">Septal Occluder Device</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cryptogenic stroke</Keyword><Keyword MajorTopicYN="N">Interventional PFO closure</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Patent foramen ovale</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30051178</ArticleId><ArticleId IdType="doi">10.1007/s00392-018-1334-z</ArticleId><ArticleId IdType="pii">10.1007/s00392-018-1334-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Neurology. 2000 Oct 24;55(8):1172-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11071496</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2001 Dec 13;345(24):1740-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11742048</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2002 Jun 4;105(22):2625-31</Citation><ArticleIdList><ArticleId IdType="pubmed">12045168</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2003 Jan 25;326(7382):219</Citation><ArticleIdList><ArticleId IdType="pubmed">12543843</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2007 Nov 29;357(22):2262-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18046029</ArticleId></ArticleIdList></Reference><Reference><Citation>Phys Ther. 2008 Feb;88(2):156-75</Citation><ArticleIdList><ArticleId IdType="pubmed">18073267</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroke. 2009 Jul;40(7):2349-55</Citation><ArticleIdList><ArticleId IdType="pubmed">19443800</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2009 Aug 18;151(4):264-9, W64</Citation><ArticleIdList><ArticleId IdType="pubmed">19622511</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Heart J. 2010 Dec;31(23):2915-57</Citation><ArticleIdList><ArticleId IdType="pubmed">20801927</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2012 Mar 15;366(11):991-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22417252</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2013 Mar 21;368(12):1083-91</Citation><ArticleIdList><ArticleId IdType="pubmed">23514285</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2013 Mar 21;368(12):1092-100</Citation><ArticleIdList><ArticleId IdType="pubmed">23514286</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013;8(3):e59202</Citation><ArticleIdList><ArticleId IdType="pubmed">23544056</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2013 Aug 13;81(7):619-25</Citation><ArticleIdList><ArticleId IdType="pubmed">23864310</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Neurol. 2014 Apr;13(4):429-38</Citation><ArticleIdList><ArticleId IdType="pubmed">24646875</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroke. 2014 Jul;45(7):2160-236</Citation><ArticleIdList><ArticleId IdType="pubmed">24788967</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2014 Jun 26;370(26):2467-77</Citation><ArticleIdList><ArticleId IdType="pubmed">24963566</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2014 Jun 26;370(26):2478-86</Citation><ArticleIdList><ArticleId IdType="pubmed">24963567</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2016 Aug 23;87(8):815-21</Citation><ArticleIdList><ArticleId IdType="pubmed">27466464</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2017 Sep 5;136(10):e172-e194</Citation><ArticleIdList><ArticleId IdType="pubmed">28784624</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2017 Sep 14;377(11):1033-1042</Citation><ArticleIdList><ArticleId IdType="pubmed">28902580</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2017 Sep 14;377(11):1022-1032</Citation><ArticleIdList><ArticleId IdType="pubmed">28902590</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2017 Sep 14;377(11):1011-1021</Citation><ArticleIdList><ArticleId IdType="pubmed">28902593</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Res Cardiol. 2018 Sep;107(9):745-755</Citation><ArticleIdList><ArticleId IdType="pubmed">29500568</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2018 May 22;71(20):2335-2342</Citation><ArticleIdList><ArticleId IdType="pubmed">29544871</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Res Cardiol. 2018 Sep;107(9):788-798</Citation><ArticleIdList><ArticleId IdType="pubmed">29644412</ArticleId></ArticleIdList></Reference><Reference><Citation>Control Clin Trials. 1996 Feb;17(1):1-12</Citation><ArticleIdList><ArticleId IdType="pubmed">8721797</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33590368</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>17</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1437-2320</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Neurosurgical review</Title><ISOAbbreviation>Neurosurg Rev</ISOAbbreviation></Journal><ArticleTitle>The impact of diabetes mellitus on carotid artery stenting: a meta-analysis.</ArticleTitle><Pagination><StartPage>3039</StartPage><EndPage>3046</EndPage><MedlinePgn>3039-3046</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10143-021-01499-0</ELocationID><Abstract><AbstractText>Diabetes is considered to be one of the important factors affecting the prognosis of patients undergoing carotid endarterectomy (CEA), but its effect on carotid stenting (CAS) has not been determined. We performed this analysis to evaluate the impact of diabetes mellitus (DM) on carotid stenting. Studies were searched in the MEDLINE, EMBASE, and Cochrane Library databases for all available studies comparing the outcomes of diabetic and nondiabetic patients who underwent CAS. A meta-analysis was performed using the Mantel-Haenszel model to calculate odds ratios (ORs) with RevMan 5.3 software. Five studies with high quality were ultimately included. A total of 3364 patients underwent CAS, including 1042 diabetic patients and 2322 nondiabetic patients. Meta-analysis showed that there was no statistically significant difference in the risk of perioperative stroke(OR,1.20;95%CI,0.74-1.97;P = 0.46;I<sup>2</sup> = 24%), transient ischemic attack(TIA)(OR,1.46;95%CI,0.80-2.66;P=0.22;I<sup>2</sup>=37%), myocardial infarction(MI)(OR,1.12;95%CI,0.47-2.67;P=0.80;I<sup>2</sup>=0%), mortality (OR,1.77;95%CI,0.91-3.42;P = 0.09;I<sup>2</sup>=0%), and composite of stroke or death (OR,1.26;95%CI,0.87-1.81;P = 0.22;I<sup>2</sup>=35%) between diabetic and nondiabetic patients receiving CAS. Sensitivity analysis showed that the meta-analysis results of all outcome events were stable. Compared with nondiabetic patients, diabetes did not increase the risk of the following: perioperative stroke, TIA, MI, mortality, and composite of stroke or death in patients receiving CAS. This study may be used to guide carotid artery stenosis patients with diabetes to choose the optimal treatment option. However, due to the limited number of studies and the different technical levels of institutions, the results should be interpreted caution.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Shan-Shan</ForeName><Initials>SS</Initials><Identifier Source="ORCID">0000-0003-2979-9234</Identifier><AffiliationInfo><Affiliation>Department of Neurology, The People's Hospital of Leshan, Baita Street 238#, Leshan, 614000, Sichuan province, China. 1697705783@qq.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Jia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, The People's Hospital of Leshan, Baita Street 238#, Leshan, 614000, Sichuan province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Ling-Wen</ForeName><Initials>LW</Initials><AffiliationInfo><Affiliation>Department of Neurology, The People's Hospital of Leshan, Baita Street 238#, Leshan, 614000, Sichuan province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Dao-Bao</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>Department of Neurology, The People's Hospital of Leshan, Baita Street 238#, Leshan, 614000, Sichuan province, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Neurosurg Rev</MedlineTA><NlmUniqueID>7908181</NlmUniqueID><ISSNLinking>0344-5607</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002339" MajorTopicYN="N">Carotid Arteries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016893" MajorTopicYN="Y">Carotid Stenosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="Y">Diabetes Mellitus</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016894" MajorTopicYN="Y">Endarterectomy, Carotid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015607" MajorTopicYN="N">Stents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CAS</Keyword><Keyword MajorTopicYN="N">Carotid artery stenting</Keyword><Keyword MajorTopicYN="N">Diabetes mellitus</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>1</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33590368</ArticleId><ArticleId IdType="doi">10.1007/s10143-021-01499-0</ArticleId><ArticleId IdType="pii">10.1007/s10143-021-01499-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adegbala O, Martin KD, Otuada D, Akinyemiju T (2017) Diabetes Mellitus with Chronic Complications in Relation to Carotid Endarterectomy and Carotid Artery Stenting Outcomes. J Stroke Cerebrovasc Dis 26(1):217&#x2013;224</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2016.09.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Casana R, Malloggi C, Odero A Jr, Tolva V, Bulbulia R, Halliday A, Silani V (2018) Is diabetes a marker of higher risk after carotid revascularization? Experience from a single centre. Diab Vasc Dis Res 15(4):314&#x2013;321</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1479164118769530</ArticleId></ArticleIdList></Reference><Reference><Citation>Debing E, Aerden D, Van den Brande P (2011) Diabetes mellitus is a predictor for early adverse outcome after carotid endarterectomy. Vasc Endovasc Surg 45(1):28&#x2013;32</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1538574410385714</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorigo W, Pulli R, Pratesi G, Fargion A, Marek J, Innocenti AA, Pratesi C (2011) Early and long-term results of carotid endarterectomy in diabetic patients. J Vasc Surg 53(1):44&#x2013;52</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2010.08.030</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurm HS, Lincoff A, Lee D (2004) Outcome of acute ST segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: Lessons from the GUSTO V trial. J Am Coll Cardiol 43:542&#x2013;548</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2003.09.038</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurm HS, Rajagopal V, Sachar R, Abou-Chebl A, Kapadia SR, Bajzer C, Yadav JS (2007) Impact of diabetes mellitus on outcome of patients undergoing carotid artery stenting: insights from a single center registry. Catheter Cardiovasc Interv 69(4):541&#x2013;545</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.21020</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain MA et al (2016) Impact of diabetes on carotid artery revascularization. J Vasc Surg 63(4):1099&#x2013;107.e4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2015.12.041</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong MJ, Kwon H, Jung CH, Kwon SU, Kim MJ, Han Y, Kwon TW, Cho YP (2019) Comparison of outcomes after carotid endarterectomy between type 2 diabetic and non-diabetic patients with significant carotid stenosis. Cardiovasc Diabetol 18(1):41</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-019-0848-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y et al (2017) Comparison of clinical outcomes after drug-eluting stent implantation in diabetic versus nondiabetic patients in China: A retrospective study. Medicine 96(17):e6647</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000006647</ArticleId></ArticleIdList></Reference><Reference><Citation>Lago A, Parkhutik V, Tembl JI, Bermejo A, Aparici F, Mainar E, V&#xe1;zquez-A&#xf1;&#xf3;n V (2013) Diabetes Does not Affect Outcome of Symptomatic Carotid Stenosis Treated with Endovascular Techniques. Eur Neurol 69(5):263&#x2013;269</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000346000</ArticleId></ArticleIdList></Reference><Reference><Citation>Mas JL, Chatellier G, Beyssen B (2007) Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. J Vasc Surg 45(1):218</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2006.11.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Michael Schluter EA (2007) Impact of Diabetes, Patient Age, and Gender on the 30-Day Incidence of Stroke and Death in Patients Undergoing Carotid Artery Stenting With Embolus Protection:A Post-Hoc Subanalysis of a Prospective Multicenter Registry. J Endovasc Ther 14:271&#x2013;278</Citation><ArticleIdList><ArticleId IdType="doi">10.1583/06-2036.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Parlani GM et al (2012) Diabetes is not a predictor of outcome for carotid revascularization with stenting as it may be for carotid endarterectomy. J Vasc Surg 55(1):79&#x2013;89</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2011.07.080</ArticleId></ArticleIdList></Reference><Reference><Citation>Pistolese GR, Appolloni A, Ronchey S, Martelli E (2001) Carotid endarterectomy in diabetic patients. J Vasc Surg 33(1):148&#x2013;154</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mva.2001.110510</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarwar N et al (2010) Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375(9733):2215&#x2013;2222</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)60484-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Saw J (2014) Carotid Artery Stenting for Stroke Prevention. Can J Cardiol 30(1):22&#x2013;34</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2013.09.030</ArticleId></ArticleIdList></Reference><Reference><Citation>SPACE Collaborative Group, Ringleb P, Allenberg J, Fraedrich G, Hartmann M, Eckstein HH (2006) 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet 368:1239&#x2013;1247</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(06)69122-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283(15):2008&#x2013;2012</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.283.15.2008</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss JS, Sumpio BE (2006) Review of Prevalence and Outcome of Vascular Disease in Patients with Diabetes Mellitus. Eur J Vasc Endovasc Surg 31(2):143&#x2013;150</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejvs.2005.08.015</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadav JS, Wholey M, Kuntz R (2004) Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk Patients. N Engl J Med 351:1493&#x2013;1501</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa040127</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuo X, Zhang C, Feng J, Ouyang S, Niu P, Dai Z (2019) In-hospital, short-term and long-term adverse clinical outcomes observed in patients with type 2 diabetes mellitus vs non-diabetes mellitus following percutaneous coronary intervention: A meta-analysis including 139,774 patients. Medicine (Baltimore) 98(8):e14669</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000014669</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37386846</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>06</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-9592</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Paediatric anaesthesia</Title><ISOAbbreviation>Paediatr Anaesth</ISOAbbreviation></Journal><ArticleTitle>The association between intraoperative fluid management and perioperative allogenic blood transfusion during adolescent idiopathic scoliosis surgery.</ArticleTitle><Pagination><StartPage>829</StartPage><EndPage>836</EndPage><MedlinePgn>829-836</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/pan.14722</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Bleeding and transfusion remain important concerns during surgical correction of scoliosis even when multiple conservative strategies, such as preoperative recombinant erythropoietin and/or antifibrinolytic agents, are used. The current work aimed to determine the impact of other potential risk factors, especially the volume of intraoperative fluid intake, on the perioperative risk of allogenic transfusion during surgical correction of adolescent idiopathic scoliosis.</AbstractText><AbstractText Label="METHODS">This prospective study included all cases of adolescent idiopathic scoliosis operated in a single center during 2&#x2009;years (2018-2020). Predictors analyzed were as follows: body mass index, preoperative hemoglobin concentration, thoracoplasty, preoperative halo-gravity, volume of intraoperative crystalloid administration, use of esophageal Doppler (for goal-directed fluid therapy), and duration of surgery. Statistical analyses were performed using a multivariable logistic regression model.</AbstractText><AbstractText Label="RESULTS">Two hundred patients were included in the analysis. Multivariable analysis found: an increased volume of intraoperative crystalloid administration as a significant predictor of allogenic blood transfusion. Receiving operator characteristics analysis found the model exhibiting an area under the curve of 0.85 (95% confidence interval: 0.75-0.95). Optimizing stroke volume using esophageal Doppler was associated with a decrease in intraoperative crystalloid intake.</AbstractText><AbstractText Label="CONCLUSION">These results indicate a statistical association between the increase in crystalloid intake and the risk of allogenic blood transfusion during surgical correction of adolescent idiopathic scoliosis. Controlled studies are needed to address the causative relation between intraoperative fluid intake and the risk of allogenic transfusion.</AbstractText><CopyrightInformation>&#xa9; 2023 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pardessus</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Paris-Cit&#xe9;, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Robert Debr&#xe9; Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loiselle</LastName><ForeName>Maud</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Paris-Cit&#xe9;, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Robert Debr&#xe9; Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silins</LastName><ForeName>Vilnis</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Paris-Cit&#xe9;, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Robert Debr&#xe9; Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horlin</LastName><ForeName>Anne-Laure</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Paris-Cit&#xe9;, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Robert Debr&#xe9; Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brouns</LastName><ForeName>Kelly</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Paris-Cit&#xe9;, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Robert Debr&#xe9; Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marsac</LastName><ForeName>Lucile</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Paris-Cit&#xe9;, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Robert Debr&#xe9; Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fait</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Paris-Cit&#xe9;, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Robert Debr&#xe9; Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ilharreborde</LastName><ForeName>Brice</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Paris-Cit&#xe9;, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>FHU I2D2. Robert Debr&#xe9; Hospital, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of orthopedic surgery, Robert Debr&#xe9; Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Julien-Marsollier</LastName><ForeName>Florence</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-1703-2338</Identifier><AffiliationInfo><Affiliation>Universit&#xe9; de Paris-Cit&#xe9;, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Robert Debr&#xe9; Hospital, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>FHU I2D2. Robert Debr&#xe9; Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dahmani</LastName><ForeName>Souhayl</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-1577-1030</Identifier><AffiliationInfo><Affiliation>Universit&#xe9; de Paris-Cit&#xe9;, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Robert Debr&#xe9; Hospital, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>FHU I2D2. Robert Debr&#xe9; Hospital, Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Paediatr Anaesth</MedlineTA><NlmUniqueID>9206575</NlmUniqueID><ISSNLinking>1155-5645</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000933">Antifibrinolytic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Paediatr Anaesth. 2024 Feb;34(2):187-188. doi: 10.1111/pan.14792.</RefSource><PMID Version="1">37916747</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012600" MajorTopicYN="Y">Scoliosis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000933" MajorTopicYN="Y">Antifibrinolytic Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013123" MajorTopicYN="Y">Spinal Fusion</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">pediatric</Keyword><Keyword MajorTopicYN="N">scoliosis</Keyword><Keyword MajorTopicYN="N">transfusion</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>30</Day><Hour>2</Hour><Minute>38</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37386846</ArticleId><ArticleId IdType="doi">10.1111/pan.14722</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Mange TR, Sucato DJ, Poppino KF, Jo CH, Ramo BR. The incidence and risk factors for perioperative allogeneic blood transfusion in primary idiopathic scoliosis surgery. Spine Deform. 2020;8(4):695-702.</Citation></Reference><Reference><Citation>Renshaw TS. Idiopathic scoliosis in children. Curr Opin Pediatr. 1993;5(4):407-412.</Citation></Reference><Reference><Citation>Dupuis C, Michelet D, Hilly J, et al. Predictive factors for homologous transfusion during paediatric scoliosis surgery. Anaesth Crit Care Pain Med. 2015;34(6):327-332.</Citation></Reference><Reference><Citation>McVey MJ, Lau W, Naraine N, Zaarour C, Zeller R. Perioperative blood conservation strategies for pediatric scoliosis surgery. Spine Deform. 2021;9(5):1289-1302.</Citation></Reference><Reference><Citation>Kwan MK, Loh KW, Chung WH, Chiu CK, Hasan MS, Chan CYW. Perioperative outcome and complications following single-staged posterior spinal fusion (PSF) using pedicle screw instrumentation in adolescent idiopathic scoliosis (AIS): a review of 1057 cases from a single Centre. BMC Musculoskelet Disord. 2021;22(1):413.</Citation></Reference><Reference><Citation>Dong Y, Tang N, Wang S, Zhang J, Zhao H. Risk factors for blood transfusion in adolescent patients with scoliosis undergoing scoliosis surgery: a study of 722 cases in a single center. BMC Musculoskelet Disord. 2021;22(1):13.</Citation></Reference><Reference><Citation>Rohozynskyi VA, Levytskyi AF, Dolianytskyi MM, Benzar IM. Treatment of severe spinal deformations in children with idiopathic scoliosis using halo-gravity traction. Wiad Lek. 2020;73(10):2144-2149.</Citation></Reference><Reference><Citation>Chan CY, Lim CY, Shahnaz Hasan M, Kwan MK. The use of pre-operative halo traction to minimize risk for correction of severe scoliosis in a patient with Fontan circulation: a case report and review of literature. Eur Spine J. 2016;25(Suppl 1):245-250.</Citation></Reference><Reference><Citation>Hu M, Lai A, Zhang Z, et al. Intraoperative halo-femoral traction during posterior spinal arthrodesis for adolescent idiopathic scoliosis curves between 70&#xb0; and 100&#xb0;: a randomized controlled trial. J Neurosurg Spine. 2022;36(1):78-85.</Citation></Reference><Reference><Citation>Jessen MK, Vallentin MF, Holmberg MJ, et al. Goal-directed haemodynamic therapy during general anaesthesia for noncardiac surgery: a systematic review and meta-analysis. Br J Anaesth. 2022;128(3):416-433.</Citation></Reference><Reference><Citation>Lorente JV, Reguant F, Arnau A, et al. Effect of goal-directed haemodynamic therapy guided by non-invasive monitoring on perioperative complications in elderly hip fracture patients within an enhanced recovery pathway. Perioper Med (Lond). 2022;11(1):46.</Citation></Reference><Reference><Citation>Rusy LM, Hainsworth KR, Nelson TJ, et al. Gabapentin use in pediatric spinal fusion patients: a randomized, double-blind, controlled trial. Anesth Analg. 2010;110(5):1393-1398.</Citation></Reference><Reference><Citation>Mayell A, Srinivasan I, Campbell F, Peliowski A. Analgesic effects of gabapentin after scoliosis surgery in children: a randomized controlled trial. Paediatr Anaesth. 2014;24(12):1239-1244.</Citation></Reference><Reference><Citation>Julien-Marsollier F, Assaker R, Michelet D, et al. Effects of opioid-reduced anesthesia during scoliosis surgery in children: a prospective observational study. Pain Manag. 2021;11(6):679-687.</Citation></Reference><Reference><Citation>Julien-Marsollier F, Michelet D, Assaker R, et al. Enhanced recovery after surgical correction of adolescent idiopathic scoliosis. Paediatr Anaesth. 2020;30(10):1068-1076.</Citation></Reference><Reference><Citation>Le Bot A, Michelet D, Hilly J, et al. Efficacy of intraoperative dexmedetomidine compared with placebo for surgery in adults: a meta-analysis of published studies. Minerva Anestesiol. 2015;81(10):1105-1117.</Citation></Reference><Reference><Citation>Malhotra NR, Shaffrey CI. Intraoperative electrophysiological monitoring in spine surgery. Spine (Phila Pa 1976). 2010;35(25):2167-2179.</Citation></Reference><Reference><Citation>Bourdaud N, Francois C, Jacqmarcq O, et al. Addition of droperidol to prophylactic ondansetron and dexamethasone in children at high risk for postoperative vomiting. A randomized, controlled, double-blind study. Br J Anaesth. 2017;118(6):918-923.</Citation></Reference><Reference><Citation>Hermans V, De Pooter F, De Groote F, De Hert S, van der Linden P. Effect of dexamethasone on nausea, vomiting, and pain in paediatric tonsillectomy. Br J Anaesth. 2012;109(3):427-431.</Citation></Reference><Reference><Citation>Silins V, Brasher C, Antus F, et al. Predicting postoperative morphine consumption in children. Anaesth Crit Care Pain Med. 2017;36(3):179-184.</Citation></Reference><Reference><Citation>Michelet D, Julien-Marsollier F, Hilly J, Diallo T, Vidal C, Dahmani S. Predictive factors of intraoperative cell salvage during pediatric scoliosis surgery. Cell saver during scoliosis surgery in children. Anaesth Crit Care Pain Med. 2018;37(2):141-146.</Citation></Reference><Reference><Citation>Holliday MA, Segar WE. The maintenance need for water in parenteral fluid therapy. Pediatrics. 1957;19(5):823-832.</Citation></Reference><Reference><Citation>Haute autorit&#xe9; de sant&#xe9; (HAS). Transfusion of allogenic red cells: products, indications and alternatives. Professionnal recommandations. 2015. Accessed February, 12, 2023 https://www.has-sante.fr/jcms/c_1349939/fr/transfusions-de-globules-rouges-homologues-produits-indications-alternatives</Citation></Reference><Reference><Citation>Brasher C, Gafsous B, Dugue S, et al. Postoperative pain management in children and infants: an update. Paediatr Drugs. 2014;16(2):129-140.</Citation></Reference><Reference><Citation>Bellon M, Michelet D, Carrara N, et al. Correction to: efficacy of the game ready((R)) cooling device on postoperative analgesia after scoliosis surgery in children. Eur Spine J. 2019;28(5):1254.</Citation></Reference><Reference><Citation>Ilharreborde B, Simon AL, Ferrero E, Mazda K. How to optimize axial correction without altering thoracic sagittal alignment in hybrid constructs with sublaminar bands: description of the "frame" technique. Spine Deform. 2019;7(2):245-253.</Citation></Reference><Reference><Citation>Ilharreborde B, Pesenti S, Ferrero E, et al. Correction of hypokyphosis in thoracic adolescent idiopathic scoliosis using sublaminar bands: a 3D multicenter study. Eur Spine J. 2018;27(2):350-357.</Citation></Reference><Reference><Citation>Sanford EL, Zurakowski D, Litvinova A, Zalieckas JM, Cravero JP. The association between high-volume intraoperative fluid administration and outcomes among pediatric patients undergoing large bowel resection. Paediatr Anaesth. 2019;29(4):315-321.</Citation></Reference><Reference><Citation>Pencina MJ, D'Agostino RB. Evaluating discrimination of risk prediction models: the C statistic. Jama. 2015;314(10):1063-1064.</Citation></Reference><Reference><Citation>Tolles J, Meurer WJ. Logistic regression: relating patient characteristics to outcomes. Jama. 2016;316(5):533-534.</Citation></Reference><Reference><Citation>Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49(12):1373-1379.</Citation></Reference><Reference><Citation>Meurer WJ, Tolles J. Logistic regression diagnostics: understanding how well a model predicts outcomes. Jama. 2017;317(10):1068-1069.</Citation></Reference><Reference><Citation>Coste J, Pouchot J. A grey zone for quantitative diagnostic and screening tests. Int J Epidemiol. 2003;32(2):304-313.</Citation></Reference><Reference><Citation>Eisler LD, Lenke LG, Sun LS, Li G, Kim M. Do antifibrinolytic agents reduce the risk of blood transfusion in children undergoing spinal fusion?: a propensity score-matched comparison using a National Database. Spine (Phila Pa 1976). 2020;45(15):1055-1061.</Citation></Reference><Reference><Citation>Goobie SM, Faraoni D. Tranexamic acid and perioperative bleeding in children: what do we still need to know? Curr Opin Anaesthesiol. 2019;32(3):343-352.</Citation></Reference><Reference><Citation>Tzortzopoulou A, Cepeda MS, Schumann R, Carr DB. Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children. Cochrane Database Syst Rev. 2008;16(3):Cd006883.</Citation></Reference><Reference><Citation>Goobie SM, Zurakowski D, Glotzbecker MP, et al. Tranexamic acid is efficacious at decreasing the rate of blood loss in adolescent scoliosis surgery: a randomized placebo-controlled trial. J Bone Joint Surg Am. 2018;100(23):2024-2032.</Citation></Reference><Reference><Citation>Dick AG, Pinder RJ, Lyle SA, Ember T, Mallinson C, Lucas J. Reducing allogenic blood transfusion in pediatric scoliosis surgery:: reporting 15&#x2009;years of a multidisciplinary, evidence-based quality improvement project. Global Spine J. 2019;9(8):843-849.</Citation></Reference><Reference><Citation>Brazel PW, McPhee IB. Inappropriate secretion of antidiuretic hormone in postoperative scoliosis patients: the role of fluid management. Spine (Phila Pa 1976). 1996;21(6):724-727.</Citation></Reference><Reference><Citation>Lee NJ, Fields MW, Boddapati V, et al. The risks, reasons, and costs for 30- and 90-day readmissions after fusion surgery for adolescent idiopathic scoliosis. J Neurosurg Spine. 2020;34:1-9.</Citation></Reference><Reference><Citation>Lieh-Lai MW, Stanitski DF, Sarnaik AP, et al. Syndrome of inappropriate antidiuretic hormone secretion in children following spinal fusion. Crit Care Med. 1999;27(3):622-627.</Citation></Reference><Reference><Citation>Bellon M, Le Bot A, Michelet D, et al. Efficacy of intraoperative dexmedetomidine compared with placebo for postoperative pain management: a meta-analysis of published studies. Pain Ther. 2016;5(1):63-80.</Citation></Reference><Reference><Citation>Lu Z. Dexmedetomidine is associated with intraoperative hypotension and may bring poor postoperative outcomes. Int J Geriatr Psychiatry. 2021;36(9):1464.</Citation></Reference><Reference><Citation>Yang SS, Gelinas C, Yim E, et al. Association of intraoperative dexmedetomidine use with postoperative hypotension in unilateral hip and knee arthroplasties: a historical cohort study. Can J Anaesth= Journal Canadien d'anesthesie. 2022;69(12):1459-1470.</Citation></Reference><Reference><Citation>Alomari S, Lubelski D, Lo SL, et al. Surgeon specialty effect on early outcomes of elective posterior spinal fusion for adolescent idiopathic scoliosis: a propensity-matched analysis of 965 patients. Eur Spine J. 2022;31(9):2355-2361.</Citation></Reference><Reference><Citation>Sarwahi V, Tran E, Vora R, et al. The volume-cost relationship: how does surgical volume affect cost and value in AIS surgery. Clin Spine Surg. 2022;35(9):E706-e713.</Citation></Reference><Reference><Citation>Cheung ZB, Selverian S, Cho BH, Ball CJ, Kang-Wook CS. Idiopathic scoliosis in children and adolescents: emerging techniques in surgical treatment. World Neurosurg. 2019;130:e737-e742.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29803011</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>19</Day></DateCompleted><DateRevised><Year>2019</Year><Month>03</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4529</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><PubDate><Year>2018</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of clinical anesthesia</Title><ISOAbbreviation>J Clin Anesth</ISOAbbreviation></Journal><ArticleTitle>The effect of oral hydration on the risk or aspiration and hemodynamic stability before the induction of anesthesia: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>7</StartPage><EndPage>11</EndPage><MedlinePgn>7-11</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinane.2018.05.015</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0952-8180(18)30209-5</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Preoperative oral rehydration solutions (ORS) are frequently used in clinical practice in Japan, although their effect remains to be explained. The purpose of this study was to investigate the clinical outcomes associated with ORS usage.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Systematic review and meta-analysis.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Surgical departments at each hospital.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">A total of 546 patients with American Society of Anesthesiologists physical status classification I or II (non-pregnant adults only) reported in six articles.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Patients in the included studies had originally been randomly allocated to the ORS or control group.</AbstractText><AbstractText Label="MEASUREMENTS" NlmCategory="METHODS">Incidence of aspiration and vomiting during induction of anesthesia, gastric fluid volume (absolute volume), gastric pH, stroke volume variation (SVV) during induction of anesthesia. Risk difference (RD) or mean difference (MD) with 95% confidence interval (CI) were calculated using a random effects model.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">There was no aspiration or vomiting in either group [3 studies, 428 patients, RD 0 (95% CI -0.01 to 0.01), I<sup>2</sup>&#x202f;=&#x202f;0%]. ORS administration caused no significant difference in gastric volume [4 studies, 486 participants, MD -1.12&#x202f;ml (95% CI -5.61 to 3.36), I<sup>2</sup>&#x202f;=&#x202f;62%] or gastric pH [4 studies, 486 participants, MD -0.03. (95% CI -0.37 to 0.31), I<sup>2</sup>&#x202f;=&#x202f;0%] compared with the control group. In contrast, ORS resulted in a significant reduction in SVV during the anesthesia induction period [3 studies, 118 participants, MD -3.02 (95% CI -5.44 to -0.59), I<sup>2</sup>&#x202f;=&#x202f;65%].</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our systematic review indicates that oral rehydration therapy does not increase the risk of aspiration or vomiting. In contrast, it may help stabilize circulatory dynamics during anesthesia induction.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oshima</LastName><ForeName>Shinji</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Hamamatsu Medical Center, Hamamatsu, Shizuoka, Japan. Electronic address: m1401514015@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aoki</LastName><ForeName>Yoshitaka</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Shizuoka General Hospital, Shizuoka, Shizuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kawasaki</LastName><ForeName>Yohei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Clinical Research Center, Chiba University Hospital, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yokoyama</LastName><ForeName>Junichiro</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Shizuoka General Hospital, Shizuoka, Shizuoka, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>05</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Anesth</MedlineTA><NlmUniqueID>8812166</NlmUniqueID><ISSNLinking>0952-8180</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="N">Anesthesia</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="N">Fluid Therapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007432" MajorTopicYN="N">Intraoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011300" MajorTopicYN="N">Preoperative Care</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053120" MajorTopicYN="N">Respiratory Aspiration</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014839" MajorTopicYN="N">Vomiting</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aspiration</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Oral rehydration therapy</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword><Keyword MajorTopicYN="N">Vomiting</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29803011</ArticleId><ArticleId IdType="doi">10.1016/j.jclinane.2018.05.015</ArticleId><ArticleId IdType="pii">S0952-8180(18)30209-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28816542</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>05</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1362-301X</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>13-14</Issue><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>Brain injury</Title><ISOAbbreviation>Brain Inj</ISOAbbreviation></Journal><ArticleTitle>The fate of asymptomatic severe carotid stenosis in the era of best medical therapy.</ArticleTitle><Pagination><StartPage>1711</StartPage><EndPage>1717</EndPage><MedlinePgn>1711-1717</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/02699052.2017.1346285</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Medical therapy for asymptomatic carotid artery stenosis (ACAS) may obviate the carotid revascularization, according to recent literature reports, but many studies also considered moderate carotid artery stenosis (50-69% NASCET). This study reviews the most recent series of ACAS focusing on ipsilateral transient ischemic attack (TIA) stroke and annual risk of stroke in patients with ACAS &#x2265;70%, thereby also evaluating the adherence to best medical therapy (BMT).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review consisting of all the series of patients with ACAS being treated medically was performed, which was published after 2005. The annual pooled risk of ipsilateral TIA-stroke and stroke in patients with ACAS &#x2265;70% was calculated. A subgroup of studies with BMT defined as &#x2265;90% of the patients in antiplatelet and statin therapy was performed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eleven studies, with the enrolling period from 1996 to 2009, were reviewed. Overall, 2185 patients were considered, with a follow-up from 2 to 13 years, for a total of 6834 patients/year. The pooled risk was 3.4%/year for ipsilateral TIA-stroke and 1.6%/year for stroke. Five studies, published from 2014, had BMT adherence, for a total of 1665 patients/year. The pooled risk was 3.5%/year for ipsilateral TIA-stroke and for stroke.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The most recent series of ACAS &#x2265;70% and BMT had an overall stroke rate which is relatively low; however, the risk of developing symptoms is still relevant (3.4%/year).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pini</LastName><ForeName>Rodolfo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>a Vascular Surgery Unit, Policlinico S. Orsola-Malpighi , University of Bologna , Bologna , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faggioli</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>a Vascular Surgery Unit, Policlinico S. Orsola-Malpighi , University of Bologna , Bologna , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vacirca</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>a Vascular Surgery Unit, Policlinico S. Orsola-Malpighi , University of Bologna , Bologna , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cacioppa</LastName><ForeName>Laura Maria</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>a Vascular Surgery Unit, Policlinico S. Orsola-Malpighi , University of Bologna , Bologna , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallitto</LastName><ForeName>Enrico</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>a Vascular Surgery Unit, Policlinico S. Orsola-Malpighi , University of Bologna , Bologna , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gargiulo</LastName><ForeName>Mauro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>a Vascular Surgery Unit, Policlinico S. Orsola-Malpighi , University of Bologna , Bologna , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stella</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>a Vascular Surgery Unit, Policlinico S. Orsola-Malpighi , University of Bologna , Bologna , Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>08</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Brain Inj</MedlineTA><NlmUniqueID>8710358</NlmUniqueID><ISSNLinking>0269-9052</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002317">Cardiovascular Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058070" MajorTopicYN="N">Asymptomatic Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002317" MajorTopicYN="N">Cardiovascular Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016893" MajorTopicYN="N">Carotid Stenosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016894" MajorTopicYN="N">Endarterectomy, Carotid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="N">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055118" MajorTopicYN="N">Medication Adherence</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Asymptomatic carotid artery stenosis</Keyword><Keyword MajorTopicYN="N">best medical therapy</Keyword><Keyword MajorTopicYN="N">follow-up</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28816542</ArticleId><ArticleId IdType="doi">10.1080/02699052.2017.1346285</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33236863</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>30</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1827-1855</ISSN><JournalIssue CitedMedium="Internet"><Volume>64</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of neurosurgical sciences</Title><ISOAbbreviation>J Neurosurg Sci</ISOAbbreviation></Journal><ArticleTitle>Carotid plaque vulnerability on magnetic resonance imaging and risk of future ischemic events: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>480</StartPage><EndPage>486</EndPage><MedlinePgn>480-486</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.23736/S0390-5616.20.04959-0</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Magnetic resonance imaging (MRI) can characterize carotid plaque features, including intraplaque hemorrhage (IPH), lipid-rich necrotic core (LRNC), and thin/ruptured fibrous cap (TRFC), that have increased tendency to cause future cerebrovascular ischemic events. We performed a systematic review and meta-analysis of studies evaluating association of MRI-identified high-risk plaque features, including IPH, LRNC, and TRFC, with risks of subsequent ischemic events of stroke, transient ischemic attack (TIA), or amaurosis fugax (AF) over follow-up duration of &#x2265;3 months.</AbstractText><AbstractText Label="EVIDENCE ACQUISITION" NlmCategory="METHODS">Multiple databases were searched for relevant publications between January 2000 and March 2020. Studies reporting outcomes of future ischemic events of stroke, TIA, or AF for individual MRI-identified high-risk carotid plaque features over follow-up duration of &#x2265;3 months were included. Random effects meta-analysis was performed to estimate odds ratios (OR) and 95% confidence intervals (CI) comparing outcomes between MRI-positive and MRI-negative groups.</AbstractText><AbstractText Label="EVIDENCE SYNTHESIS" NlmCategory="RESULTS">Fifteen studies including 2350 patients were included. The annual rate of future ischemic events was 11.9% for MRI-positive IPH, 5.4% for LRNC, and 5.7% for TRFC. IPH, LRNC, and TRFC were associated with increased risk of future ischemic events (OR 6.37; 95% CI, 3.96 to 10.24), (OR 4.34; 95% CI, 1.65 to 11.42), and (OR 10.60, 95% CI 3.56 to 31.58), respectively.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The current study findings strengthen the assertion that MRI-positive "high-risk" or "vulnerable" plaque features, including IPH, LRNC, and/or TRFC can predict risks of future ischemic events of stroke, TIA, or AF.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rizvi</LastName><ForeName>Asim</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Radiology, Mayo Clinic, Rochester, MN, USA - drasimrizvi@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, The University of Texas Medical Branch at Galveston, Galveston, TX, USA - drasimrizvi@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>- drasimrizvi@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seyedsaadat</LastName><ForeName>Seyed M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Radiology, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alzuabi</LastName><ForeName>Muayad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Evidence-based Practice Center, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murad</LastName><ForeName>Mohammed H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Evidence-based Practice Center, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huston</LastName><ForeName>John</ForeName><Initials>J</Initials><Suffix>3rd</Suffix><AffiliationInfo><Affiliation>Department of Radiology, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lehman</LastName><ForeName>Vance T</ForeName><Initials>VT</Initials><AffiliationInfo><Affiliation>Department of Radiology, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lanzino</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saba</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Radiology, University of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brinjikji</LastName><ForeName>Waleed</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Radiology, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Joint Department of Medical Imaging, Toronto Western Hospital, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>J Neurosurg Sci</MedlineTA><NlmUniqueID>0432557</NlmUniqueID><ISSNLinking>0390-5616</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002339" MajorTopicYN="N">Carotid Arteries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016893" MajorTopicYN="Y">Carotid Stenosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058226" MajorTopicYN="Y">Plaque, Atherosclerotic</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>25</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33236863</ArticleId><ArticleId IdType="doi">10.23736/S0390-5616.20.04959-0</ArticleId><ArticleId IdType="pii">S0390-5616.20.04959-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35014001</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1496-8975</ISSN><JournalIssue CitedMedium="Internet"><Volume>69</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Canadian journal of anaesthesia = Journal canadien d'anesthesie</Title><ISOAbbreviation>Can J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Morbidity and mortality in patients managed with high compared with low blood pressure targets during on-pump cardiac surgery: a systematic review and meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>374</StartPage><EndPage>386</EndPage><MedlinePgn>374-386</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12630-021-02171-3</ELocationID><Abstract><AbstractText Label="PURPOSE">Many believe that blood pressure management during cardiac surgery is associated with postoperative outcomes. We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) to determine the impact of high compared with low intraoperative blood pressure targets on postoperative morbidity and mortality in adults undergoing cardiac surgery on cardiopulmonary bypass (CPB). Our primary objective was to inform the design of a future large RCT.</AbstractText><AbstractText Label="SOURCE">We searched MEDLINE, EMBASE, Web of Science, CINAHL, and CENTRAL for RCTs comparing high with low intraoperative blood pressure targets in adult patients undergoing any cardiac surgical procedure on CPB. We screened reference lists, grey literature, and conference proceedings.</AbstractText><AbstractText Label="PRINCIPAL FINDINGS">We included eight RCTs (N =1,116 participants); all examined the effect of blood pressure management only during the CPB. Trial definitions of high compared with low blood pressure varied and, in some, there was a discrepancy between the target and achieved mean arterial pressure. We observed no difference in delirium, cognitive decline, stroke, acute kidney injury, or mortality between high and low blood pressure targets (very-low to low quality evidence). Higher blood pressure targets may have increased the risk of requiring a blood transfusion (three trials; n = 456 participants; relative risk, 1.4; 95% confidence interval, 1.1 to 1.9; P = 0.01; moderate quality evidence) but this finding was based on a small number of trials.</AbstractText><AbstractText Label="CONCLUSION">Individual trial definitions of high and low blood pressure targets varied, limiting inferences. The effect of high (compared with low) blood pressure targets on other morbidity and mortality after cardiac surgery remains unclear because of limitations with the body of existing evidence. Research to determine the optimal management of blood pressure during cardiac surgery is required.</AbstractText><AbstractText Label="STUDY REGISTRATION">PROSPERO (CRD42020177376); registered: 5 July 2020.</AbstractText><CopyrightInformation>&#xa9; 2022. Canadian Anesthesiologists' Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McEwen</LastName><ForeName>Charlotte C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Surgery (Cardiac Surgery), McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amir</LastName><ForeName>Takhliq</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiu</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>Jack</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Health Sciences Library, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kennedy</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Health Research Methods, Evaluation, and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grocott</LastName><ForeName>Hilary P</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Medicine, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kashani</LastName><ForeName>Hessam</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Medicine, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazer</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brudney</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Critical Care) and Anesthesia and Perioperative Medicine, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kavosh</LastName><ForeName>Morvarid</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Medicine, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacobsohn</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Critical Care) and Anesthesia and Perioperative Medicine, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vedel</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Anesthesiology, Copenhagen University Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Eugene</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whitlock</LastName><ForeName>Richard P</ForeName><Initials>RP</Initials><AffiliationInfo><Affiliation>Departments of Surgery (Cardiac Surgery) and Health Research Methods, Evaluation, and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Perioperative Research Division, Population Health Research Institute, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belley-Cot&#xe9;</LastName><ForeName>Emilie P</ForeName><Initials>EP</Initials><AffiliationInfo><Affiliation>Perioperative Research Division, Population Health Research Institute, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Medicine (Cardiology and Critical Care) and Health Research Methods, Evaluation, and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spence</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-1267-9455</Identifier><AffiliationInfo><Affiliation>Perioperative Research Division, Population Health Research Institute, Hamilton, ON, Canada. jessicaspence13@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Anesthesia and Critical Care and Health Research Methods, Evaluation, and Impact, McMaster University, Hamilton, ON, Canada. jessicaspence13@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><VernacularTitle>Morbidit&#xe9; et mortalit&#xe9; des patients pris en charge avec des cibles &#xe9;lev&#xe9;es ou basses de pression art&#xe9;rielle pendant la chirurgie cardiaque sous circulation extracorporelle&#xa0;: une revue syst&#xe9;matique et une m&#xe9;ta-analyse d&#x2019;&#xe9;tudes randomis&#xe9;es contr&#xf4;l&#xe9;es.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Can J Anaesth</MedlineTA><NlmUniqueID>8701709</NlmUniqueID><ISSNLinking>0832-610X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Can J Anaesth. 2022 Jun;69(6):799-800. doi: 10.1007/s12630-022-02205-4.</RefSource><PMID Version="1">35165836</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="N">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="Y">Hypotension</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009017" MajorTopicYN="N">Morbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="fre"><AbstractText Label="UNLABELLED">R&#xe9;SUM&#xe9;: OBJECTIF: Pour beaucoup, la prise en charge de la pression art&#xe9;rielle pendant la chirurgie cardiaque serait associ&#xe9;e aux issues postop&#xe9;ratoires. Nous avons r&#xe9;alis&#xe9; une revue syst&#xe9;matique et une m&#xe9;ta-analyse d&#x2019;&#xe9;tudes randomis&#xe9;es contr&#xf4;l&#xe9;es (ERC) afin de d&#xe9;terminer l&#x2019;impact de cibles perop&#xe9;ratoires de pression art&#xe9;rielle &#xe9;lev&#xe9;es par rapport &#xe0; des cibles basses sur la morbidit&#xe9; et la mortalit&#xe9; postop&#xe9;ratoires d&#x2019;adultes b&#xe9;n&#xe9;ficiant d&#x2019;une chirurgie cardiaque sous circulation extracorporelle (CEC). Notre objectif principal &#xe9;tait d&#x2019;orienter la conception d&#x2019;une future ERC d&#x2019;envergure.</AbstractText><AbstractText Label="SOURCES" NlmCategory="METHODS">Nous avons analys&#xe9; les bases de donn&#xe9;es MEDLINE, EMBASE, Web of Science, CINAHL et CENTRAL afin d&#x2019;en tirer les ERC comparant des cibles de pression art&#xe9;rielle perop&#xe9;ratoire &#xe9;lev&#xe9;es &#xe0; des cibles basses chez des patients adultes b&#xe9;n&#xe9;ficiant d&#x2019;une intervention chirurgicale cardiaque sous CEC. Nous avons pass&#xe9; au crible les listes de r&#xe9;f&#xe9;rences, la litt&#xe9;rature grise et les travaux de congr&#xe8;s.</AbstractText><AbstractText Label="CONSTATATIONS PRINCIPALES" NlmCategory="UNASSIGNED">Nous avons inclus huit ERC (N = 1116 participants); toutes les &#xe9;tudes ont examin&#xe9; l&#x2019;effet de la prise en charge de la pression art&#xe9;rielle uniquement pendant la CEC. Les d&#xe9;finitions d&#x2019;une pression art&#xe9;rielle &#xe9;lev&#xe9;e ou basse variaient d&#x2019;une &#xe9;tude &#xe0; l&#x2019;autre et, dans certains cas, un &#xe9;cart a &#xe9;t&#xe9; not&#xe9; entre la pression art&#xe9;rielle cible et la pression art&#xe9;rielle moyenne atteinte. Nous n&#x2019;avons observ&#xe9; aucune diff&#xe9;rence dans les taux de delirium, de d&#xe9;clin cognitif, d&#x2019;accident vasculaire c&#xe9;r&#xe9;bral, d&#x2019;insuffisance r&#xe9;nale aigu&#xeb; ou de mortalit&#xe9; entre les cibles de pression art&#xe9;rielle &#xe9;lev&#xe9;e et basse (donn&#xe9;es probantes de qualit&#xe9; tr&#xe8;s faible &#xe0; faible). Des cibles de pression art&#xe9;rielle plus &#xe9;lev&#xe9;es pourraient avoir augment&#xe9; le risque de transfusion sanguine (trois &#xe9;tudes; n = 456 participants; risque relatif, 1,4; intervalle de confiance &#xe0; 95 %, 1,1 &#xe0; 1,9; P = 0,01; donn&#xe9;es probantes de qualit&#xe9; mod&#xe9;r&#xe9;e), mais ce r&#xe9;sultat se fondait sur un petit nombre d&#x2019;&#xe9;tudes.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Les d&#xe9;finitions individuelles des cibles d&#x2019;hypertension et d&#x2019;hypotension art&#xe9;rielle variaient, ce qui a limit&#xe9; les inf&#xe9;rences. L&#x2019;effet de cibles de pression art&#xe9;rielle &#xe9;lev&#xe9;e (par rapport &#xe0; une pression art&#xe9;rielle basse) sur d&#x2019;autres mesures de la morbidit&#xe9; et de la mortalit&#xe9; apr&#xe8;s une chirurgie cardiaque demeure incertain en raison des limites de l&#x2019;ensemble des donn&#xe9;es probantes existantes. Des recherches visant &#xe0; d&#xe9;terminer la prise en charge optimale de la pression art&#xe9;rielle pendant la chirurgie cardiaque sont n&#xe9;cessaires. ENREGISTREMENT DE L&#x2019;&#xe9;TUDE: PROSPERO (CRD42020177376); enregistr&#xe9;e le 5 juillet 2020.</AbstractText><CopyrightInformation>&#xa9; 2022. Canadian Anesthesiologists' Society.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Blood pressure targets</Keyword><Keyword MajorTopicYN="N">Cardiac surgery</Keyword><Keyword MajorTopicYN="N">Cardiopulmonary bypass</Keyword><Keyword MajorTopicYN="N">Morbidity and mortality</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>59</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35014001</ArticleId><ArticleId IdType="doi">10.1007/s12630-021-02171-3</ArticleId><ArticleId IdType="pii">10.1007/s12630-021-02171-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Murphy GS, Hessel EA 2<sup>nd</sup>, Groom RC. Optimal perfusion during cardiopulmonary bypass: an evidence-based approach. Anesth Analg 2009; 108: 1394-417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0b013e3181875e2e</ArticleId><ArticleId IdType="pubmed">19372313</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono M, Brady K, Easley RB, et al. Duration and magnitude of blood pressure below cerebral autoregulation threshold during cardiopulmonary bypass is associated with major morbidity and operative mortality. J Thorac Cardiovasc Surg 2014; 147: 483-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2013.07.069</ArticleId><ArticleId IdType="pubmed">24075467</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudiger A, Begdeda H, Babic D, et al. Intra-operative events during cardiac surgery are risk factors for the development of delirium in the ICU. Crit Care 2016; DOI: https://doi.org/10.1186/s13054-016-1445-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1445-8</ArticleId><ArticleId IdType="pubmed">27716402</ArticleId><ArticleId IdType="pmc">5084342</ArticleId></ArticleIdList></Reference><Reference><Citation>Siepe M, Pfeiffer T, Gieringer A, et al. Increased systemic perfusion pressure during cardiopulmonary bypass is associated with less early postoperative cognitive dysfunction and delirium. Eur J Cardiothorac Surg 2011; 40: 200-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2010.11.024</ArticleId><ArticleId IdType="pubmed">21168339</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold JP, Charlson ME, Williams-Russo P, et al. Improvement of outcomes after coronary artery bypass. A randomized trial comparing intraoperative high versus low mean arterial pressure. J Thorac Cardiovasc Surg 1995; 110: 1302-11.</Citation></Reference><Reference><Citation>Vedel AG, Holmgaard F, Rasmussen LS, et al. High-target versus low-target blood pressure management during cardiopulmonary bypass to prevent cerebral injury in cardiac surgery patients: a randomized controlled trial. Circulation 2018; 137: 1770-80.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.117.030308</ArticleId><ArticleId IdType="pubmed">29339351</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronson S, Stafford-Smith M, Phillips-Bute B, et al. Intraoperative systolic blood pressure variability predicts 30-day mortality in aortocoronary bypass surgery patients. Anesthesiology 2010; 113: 305-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3181e07ee9</ArticleId><ArticleId IdType="pubmed">20571360</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson ME, Peterson JC, Krieger KH, et al. Improvement of outcomes after coronary artery bypass II: a randomized trial comparing intraoperative high versus customized mean arterial pressure. J Card Surg 2007; 22: 465-72.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8191.2007.00471.x</ArticleId><ArticleId IdType="pubmed">18039205</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Akiyoshi K, Nakano M, et al. Determining thresholds for three indices of autoregulation to identify the lower limit of autoregulation during cardiac surgery. Crit Care Med 2021; 49: 650-60.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004737</ArticleId><ArticleId IdType="pubmed">33278074</ArticleId><ArticleId IdType="pmc">7979429</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thomas J, Chandler J, et al. Cochrane Handbook for Systematic Reviews of Interventions&#xa0;version 6.2&#xa0;(updated February&#xa0;2021). Cochrane, 2021. Available from URL: www.training.cochrane.org/handbook (accessed November 2021).</Citation></Reference><Reference><Citation>Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015; DOI: https://doi.org/10.1186/2046-4053-4-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-4-1</ArticleId><ArticleId IdType="pubmed">26693720</ArticleId><ArticleId IdType="pmc">4688988</ArticleId></ArticleIdList></Reference><Reference><Citation>Veritas Health Innovation. Covidence Systematic Review Software. Melbourne, Australia. Available from ULR: www.covidence.org (accessed November 2021).</Citation></Reference><Reference><Citation>Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; DOI: https://doi.org/10.1136/bmj.d5928 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pubmed">22096256</ArticleId><ArticleId IdType="pmc">3196245</ArticleId></ArticleIdList></Reference><Reference><Citation>The Cochrane Collaboration. Review Manager (RevMan). Computer Program, Version 5.4. 2020.</Citation></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 2014; DOI: https://doi.org/10.1186/1471-2288-14-135 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-135</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId><ArticleId IdType="pmc">4383202</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-2456(86)90046-2</ArticleId><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>IntHout J, Ioannidis JP, Borm GF. The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method. BMC Med Res Methodol 2014; DOI: https://doi.org/10.1186/1471-2288-14-25 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-25</ArticleId><ArticleId IdType="pubmed">24548571</ArticleId><ArticleId IdType="pmc">4015721</ArticleId></ArticleIdList></Reference><Reference><Citation>Deeks JJ, Higgins JP, Altman DG; Cochrane Statistical Methods Group. Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, et al. (Eds). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from URL: training.cochrane.org/handbook (accessed November 2021).</Citation></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.AD</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId><ArticleId IdType="pmc">2335261</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirvinskas E, Benetis R, Raliene L, Andrejaitiene J. The influence of mean arterial blood pressure during cardiopulmonary bypass on postoperative renal dysfunction in elderly patients. Perfusion 2012; 27: 193-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0267659112436751</ArticleId><ArticleId IdType="pubmed">22337760</ArticleId></ArticleIdList></Reference><Reference><Citation>Urzua J, Troncoso S, Bugedo G, et al. Renal function and cardiopulmonary bypass: effect of perfusion pressure. J Cardiothorac Vasc Anesth 1992; 6: 299-303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/1053-0770(92)90144-V</ArticleId><ArticleId IdType="pubmed">1610995</ArticleId></ArticleIdList></Reference><Reference><Citation>Azau A, Markowicz P, Corbeau JJ, et al. Increasing mean arterial pressure during cardiac surgery does not reduce the rate of postoperative acute kidney injury. Perfusion 2014; 29: 496-504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0267659114527331</ArticleId><ArticleId IdType="pubmed">24619062</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagheri K, Motamedi O, Aghavoudi O, Akbari M. The effects of mean arterial pressure during cardiopulmonary bypass on clinical and paraclinical parameters during and after coronary artery bypass graft surgery. J Isfahan Med Sch 2012; 29: 1-10.</Citation></Reference><Reference><Citation>Kandler K, Nilsson JC, Oturai P, et al. Higher arterial pressure during cardiopulmonary bypass may not reduce the risk of acute kidney injury. J Cardiothorac Surg 2019; DOI: https://doi.org/10.1186/s13019-019-0929-4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13019-019-0929-4</ArticleId><ArticleId IdType="pubmed">31196131</ArticleId><ArticleId IdType="pmc">6567467</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen MH, Draegert C, Vedel AG, et al. Long-term survival and cognitive function according to blood pressure management during cardiac surgery. A follow-up. Acta Anaesthesiol Scand 2020; 64: 936-44.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.13595</ArticleId><ArticleId IdType="pubmed">32270483</ArticleId></ArticleIdList></Reference><Reference><Citation>Reich DL, Bodian CA, Krol M, Kuroda M, Osinski T, Thys DM. Intraoperative hemodynamic predictors of mortality, stroke, and myocardial infarction after coronary artery bypass surgery. Anesth Analg 1999; 89: 814-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/00000539-199910000-00002</ArticleId><ArticleId IdType="pubmed">10512249</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown CH 4<sup>th</sup>, Neufeld KJ, Tian J, et al. Effect of targeting mean arterial pressure during cardiopulmonary bypass by monitoring cerebral autoregulation on postsurgical delirium among older patients: a nested randomized clinical trial. JAMA Surg 2019; 154: 819-26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2019.1163</ArticleId><ArticleId IdType="pubmed">31116358</ArticleId><ArticleId IdType="pmc">6537779</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogue CW, Brown CH 4<sup>th</sup>, Hori D, et al. Personalized blood pressure management during cardiac surgery with cerebral autoregulation monitoring: a randomized trial. Semin Thorac Cardiovasc Surg 2021; 33: 429-38.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.semtcvs.2020.09.032</ArticleId><ArticleId IdType="pubmed">33186735</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijnberge M, Schenk J, Bulle E, et al. Association of intraoperative hypotension with postoperative morbidity and mortality: systematic review and meta-analysis. BJS Open 2021; DOI: https://doi.org/10.1093/bjsopen/zraa018 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bjsopen/zraa018</ArticleId><ArticleId IdType="pubmed">33609377</ArticleId><ArticleId IdType="pmc">7893468</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamontagne F, Day AG, Meade MO, et al. Pooled analysis of higher versus lower blood pressure targets for vasopressor therapy septic and vasodilatory shock. Intensive Care Med 2018; 44: 12-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-017-5016-5</ArticleId><ArticleId IdType="pubmed">29260272</ArticleId></ArticleIdList></Reference><Reference><Citation>Sessler DI, Bloomstone JA, Aronson S, et al. Perioperative Quality Initiative consensus statement on intraoperative blood pressure, risk and outcomes for elective surgery. Br J Anaesth 2019; 122: 563-74.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2019.01.013</ArticleId><ArticleId IdType="pubmed">30916004</ArticleId></ArticleIdList></Reference><Reference><Citation>Authors/Task Force Members; Kunst G, Milojevic M, et al. 2019 EACTS/EACTA/EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery. Br J Anaesth 2019; 123: 713-57.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29049073</PMID><DateCompleted><Year>2017</Year><Month>12</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>125</Volume><Issue>6</Issue><PubDate><Year>2017</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>Postoperative Outcomes in Obstructive Sleep Apnea Patients Undergoing Cardiac Surgery: A Systematic Review and Meta-analysis of Comparative Studies.</ArticleTitle><Pagination><StartPage>2030</StartPage><EndPage>2037</EndPage><MedlinePgn>2030-2037</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000002558</ELocationID><Abstract><AbstractText Label="BACKGROUND">Obstructive sleep apnea (OSA) is a common comorbidity in patients undergoing cardiac surgery and may predispose patients to postoperative complications. The purpose of this meta-analysis is to determine the evidence of postoperative complications associated with OSA patients undergoing cardiac surgery.</AbstractText><AbstractText Label="METHODS">A literature search of Cochrane Database of Systematic Reviews, Medline, Medline In-process, Web of Science, Scopus, EMBASE, Cochrane Central Register of Controlled Trials, and CINAHL until October 2016 was performed. The search was constrained to studies in adult cardiac surgical patients with diagnosed or suspected OSA. All included studies must report at least 1 postoperative complication. The primary outcome is major adverse cardiac or cerebrovascular events (MACCEs) up to 30 days after surgery, which includes death from all-cause mortality, myocardial infarction, myocardial injury, nonfatal cardiac arrest, revascularization process, pulmonary embolism, deep venous thrombosis, newly documented postoperative atrial fibrillation (POAF), stroke, and congestive heart failure. Secondary outcome is newly documented POAF. The other exploratory outcomes include the following: (1) postoperative tracheal intubation and mechanical ventilation; (2) infection and/or sepsis; (3) unplanned intensive care unit (ICU) admission; and (4) duration of stay in hospital and ICU. Meta-analysis and meta- regression were conducted using Cochrane Review Manager 5.3 (Cochrane, London, UK) and OpenBUGS v3.0, respectively.</AbstractText><AbstractText Label="RESULTS">Eleven comparative studies were included (n = 1801 patients; OSA versus non-OSA: 688 vs 1113, respectively). MACCEs were 33.3% higher odds in OSA versus non-OSA patients (OSA versus non-OSA: 31% vs 10.6%; odds ratio [OR], 2.4; 95% confidence interval [CI], 1.38-4.2; P = .002). The odds of newly documented POAF (OSA versus non-OSA: 31% vs 21%; OR, 1.94; 95% CI, 1.13-3.33; P = .02) was higher in OSA compared to non-OSA. Even though the postoperative tracheal intubation and mechanical ventilation (OSA versus non-OSA: 13% vs 5.4%; OR, 2.67; 95% CI, 1.03-6.89; P = .04) were significantly higher in OSA patients, the length of ICU stay and hospital stay were not significantly prolonged in patients with OSA compared to non-OSA. The majority of OSA patients were not treated with continuous positive airway pressure therapy. Meta-regression and sensitivity analysis of the subgroups did not impact the OR of postoperative complications for OSA versus non-OSA groups.</AbstractText><AbstractText Label="CONCLUSIONS">Our meta-analysis demonstrates that after cardiac surgery, MACCEs and newly documented POAF were 33.3% and 18.1% higher odds in OSA versus non-OSA patients, respectively.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nagappa</LastName><ForeName>Mahesh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Perioperative Medicine, London Health Sciences Centre and St Joseph Health Care, Western University, London, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patra</LastName><ForeName>Jayadeep</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Jean</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Mandeep</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaw</LastName><ForeName>Roop</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Departments of Hospital Medicine.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Outcomes Research (Anesthesiology), Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Davy</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centre for Medical Evidence, Decision Integrity and Clinical Impact (MEDICI), Western University, London, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia &amp; Perioperative Medicine, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Frances</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Anesth Analg. 2018 Jul;127(1):315-317. doi: 10.1213/ANE.0000000000003383.</RefSource><PMID Version="1">29677056</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Anesth Analg. 2018 Jul;127(1):314-315. doi: 10.1213/ANE.0000000000003382.</RefSource><PMID Version="1">29677064</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020181" MajorTopicYN="N">Sleep Apnea, Obstructive</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>12</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29049073</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000002558</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29500568</PMID><DateCompleted><Year>2018</Year><Month>11</Month><Day>09</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1861-0692</ISSN><JournalIssue CitedMedium="Internet"><Volume>107</Volume><Issue>9</Issue><PubDate><Year>2018</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Clinical research in cardiology : official journal of the German Cardiac Society</Title><ISOAbbreviation>Clin Res Cardiol</ISOAbbreviation></Journal><ArticleTitle>Patent foramen ovale closure or medical therapy for cryptogenic ischemic stroke: an updated meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>745</StartPage><EndPage>755</EndPage><MedlinePgn>745-755</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00392-018-1224-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Previous randomized controlled trials (RCT) failed to demonstrate benefits of patent foramen ovale (PFO) closure (PFO-C) over medical therapy (MT) for secondary prevention of cryptogenic ischemic stroke. Three recently published RCTs, however, turned out positive for PFO-C and warrant an updated meta-analysis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Data from all available RCTs on PFO-C vs. MT for secondary prevention of cryptogenic ischemic stroke up until October 2017 were abstracted and analyzed in a comprehensive meta-analysis. Clinical efficacy outcomes were recurrent stroke, recurrent TIA, and their combination; safety outcomes were mortality, major bleeding, venous thromboembolism (VTE), and new-onset atrial fibrillation/flutter (NOAF).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Five trials including a total of 3440 patients were included in the meta-analysis. PFO-C significantly reduced recurrent stroke [odds ratio (OR) 0.41, 95% confidence interval (CI) 0.19-0.90; p&#x2009;=&#x2009;0.03] and the combination of recurrent stroke&#x2009;+&#x2009;TIA (OR 0.53, CI 0.36-0.80; p&#x2009;=&#x2009;0.002) compared to MT; recurrent TIA alone showed no differences (OR 0.77; CI 0.51-1.14; p&#x2009;=&#x2009;0.19). NOAF was significantly more frequent after PFO-C (OR 5.75, CI 3.09-10.70; p&#x2009;&lt;&#x2009;0.00001). Mortality (OR 0.80, CI 0.39-1.67), major bleeding (OR 0.96, CI 0.48-1.92), and VTE (OR 2.45, CI 0.75-7.99) remained neutral. Trials with superior patient selection for PFO-C showed advantageous results compared to MT.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">PFO-C after cryptogenic ischemic stroke is safe and effective to reduce the risk of recurrent stroke and recurrent stroke&#x2009;+&#x2009;TIA, albeit with an increased risk for NOAF.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schulze</LastName><ForeName>Volker</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Cardiology, Pulmonology and Vascular Medicine, Heinrich-Heine-University, Moorenstr. 5, 40225, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yingfeng</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Cardiology, Pulmonology and Vascular Medicine, Heinrich-Heine-University, Moorenstr. 5, 40225, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karathanos</LastName><ForeName>Athanasios</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Cardiology, Pulmonology and Vascular Medicine, Heinrich-Heine-University, Moorenstr. 5, 40225, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brockmeyer</LastName><ForeName>Maximilian</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Cardiology, Pulmonology and Vascular Medicine, Heinrich-Heine-University, Moorenstr. 5, 40225, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeus</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Cardiology, Pulmonology and Vascular Medicine, Heinrich-Heine-University, Moorenstr. 5, 40225, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polzin</LastName><ForeName>Amin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Cardiology, Pulmonology and Vascular Medicine, Heinrich-Heine-University, Moorenstr. 5, 40225, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perings</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Cardiology, Pulmonology and Vascular Medicine, Heinrich-Heine-University, Moorenstr. 5, 40225, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelm</LastName><ForeName>Malte</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Cardiology, Pulmonology and Vascular Medicine, Heinrich-Heine-University, Moorenstr. 5, 40225, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Research Institute D&#xfc;sseldorf (CARID), D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolff</LastName><ForeName>Georg</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-1734-6177</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Cardiology, Pulmonology and Vascular Medicine, Heinrich-Heine-University, Moorenstr. 5, 40225, D&#xfc;sseldorf, Germany. georg.wolff@med.uni-duesseldorf.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Clin Res Cardiol</MedlineTA><NlmUniqueID>101264123</NlmUniqueID><ISSNLinking>1861-0684</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005343">Fibrinolytic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002545" MajorTopicYN="N">Brain Ischemia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005343" MajorTopicYN="N">Fibrinolytic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054092" MajorTopicYN="N">Foramen Ovale, Patent</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055502" MajorTopicYN="N">Secondary Prevention</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055989" MajorTopicYN="Y">Septal Occluder Device</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015912" MajorTopicYN="N">Thrombolytic Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Closure</Keyword><Keyword MajorTopicYN="N">Cryptogenic stroke</Keyword><Keyword MajorTopicYN="N">Occluder</Keyword><Keyword MajorTopicYN="N">PFO</Keyword><Keyword MajorTopicYN="N">Patent foramen ovale</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>1</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29500568</ArticleId><ArticleId IdType="doi">10.1007/s00392-018-1224-4</ArticleId><ArticleId IdType="pii">10.1007/s00392-018-1224-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>N Engl J Med. 2017 Sep 14;377(11):1022-1032</Citation><ArticleIdList><ArticleId IdType="pubmed">28902590</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2016 Sep 15;375(11):e26</Citation><ArticleIdList><ArticleId IdType="pubmed">27626542</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Neurol. 2014 Apr;13(4):429-38</Citation><ArticleIdList><ArticleId IdType="pubmed">24646875</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroke. 2008 Dec;39(12):3131-6</Citation><ArticleIdList><ArticleId IdType="pubmed">18818401</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2001 Dec 13;345(24):1740-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11742048</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Cardiol. 2011 Nov 17;153(1):4-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21420189</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2014 Jun 26;370(26):2467-77</Citation><ArticleIdList><ArticleId IdType="pubmed">24963566</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Med. 2002 Aug 30;21(16):2295-312</Citation><ArticleIdList><ArticleId IdType="pubmed">12210615</ArticleId></ArticleIdList></Reference><Reference><Citation>Control Clin Trials. 1986 Sep;7(3):177-88</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2013 Mar 21;368(12):1092-100</Citation><ArticleIdList><ArticleId IdType="pubmed">23514286</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Stroke. 2010 Feb;5(1):4-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20088986</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2009 Jul 21;339:b2700</Citation><ArticleIdList><ArticleId IdType="pubmed">19622552</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2018 Mar 6;168(5):335-342</Citation><ArticleIdList><ArticleId IdType="pubmed">29310136</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Cardiol. 2008 May 1;101(9):1353-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18435971</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2017 Sep 14;377(11):1011-1021</Citation><ArticleIdList><ArticleId IdType="pubmed">28902593</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2012 Mar 15;366(11):991-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22417252</ArticleId></ArticleIdList></Reference><Reference><Citation>Neth Heart J. 2008 Oct;16(10):332-6</Citation><ArticleIdList><ArticleId IdType="pubmed">18958256</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2003 Sep 6;327(7414):557-60</Citation><ArticleIdList><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroke. 2012 Dec;43(12):3387-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23033345</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2017 Sep 14;377(11):1033-1042</Citation><ArticleIdList><ArticleId IdType="pubmed">28902580</ArticleId></ArticleIdList></Reference><Reference><Citation>JACC Cardiovasc Interv. 2017 Nov 13;10(21):2228-2230</Citation><ArticleIdList><ArticleId IdType="pubmed">29122137</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2016 Mar 1;67(8):907-17</Citation><ArticleIdList><ArticleId IdType="pubmed">26916479</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Heart J. 2015 Jan 7;36(2):120-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25112661</ArticleId></ArticleIdList></Reference><Reference><Citation>Contemp Clin Trials. 2015 Nov;45(Pt A):139-45</Citation><ArticleIdList><ArticleId IdType="pubmed">26343745</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1988 May 5;318(18):1148-52</Citation><ArticleIdList><ArticleId IdType="pubmed">3362165</ArticleId></ArticleIdList></Reference><Reference><Citation>Control Clin Trials. 1986 Dec;7(4):267-75</Citation><ArticleIdList><ArticleId IdType="pubmed">3802849</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Lung Circ. 2014 Apr;23(4):303-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24495944</ArticleId></ArticleIdList></Reference><Reference><Citation>Contemp Clin Trials. 2007 Feb;28(2):105-14</Citation><ArticleIdList><ArticleId IdType="pubmed">16807131</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2016 Aug 23;87(8):815-21</Citation><ArticleIdList><ArticleId IdType="pubmed">27466464</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2017 Mar 7;135(10):e146-e603</Citation><ArticleIdList><ArticleId IdType="pubmed">28122885</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayo Clin Proc. 1984 Jan;59(1):17-20</Citation><ArticleIdList><ArticleId IdType="pubmed">6694427</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2000 Oct 24;55(8):1172-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11071496</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2013 Mar 21;368(12):1083-91</Citation><ArticleIdList><ArticleId IdType="pubmed">23514285</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroke. 2014 Jul;45(7):2160-236</Citation><ArticleIdList><ArticleId IdType="pubmed">24788967</ArticleId></ArticleIdList></Reference><Reference><Citation>Catheter Cardiovasc Interv. 2009 Nov 15;74(6):889-95</Citation><ArticleIdList><ArticleId IdType="pubmed">19626689</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardiology. 2008;111(1):47-50</Citation><ArticleIdList><ArticleId IdType="pubmed">18239392</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroke. 2012 Nov;43(11):3147-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22989503</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Bull. 1968 Apr;69(4):269-277</Citation><ArticleIdList><ArticleId IdType="pubmed">5659656</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2018 Mar 6;168(5):343-350</Citation><ArticleIdList><ArticleId IdType="pubmed">29310133</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2015 Sep 08;(9):CD009938</Citation><ArticleIdList><ArticleId IdType="pubmed">26346232</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2004 Jan 21;43(2):302-9</Citation><ArticleIdList><ArticleId IdType="pubmed">14736453</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroke. 2009 Jul;40(7):2349-55</Citation><ArticleIdList><ArticleId IdType="pubmed">19443800</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35331593</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>30</Day></DateCompleted><DateRevised><Year>2022</Year><Month>08</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0828</ISSN><JournalIssue CitedMedium="Internet"><Volume>100</Volume><PubDate><Year>2022</Year><Month>Jun</Month></PubDate></JournalIssue><Title>European journal of internal medicine</Title><ISOAbbreviation>Eur J Intern Med</ISOAbbreviation></Journal><ArticleTitle>P2Y12 inhibitors plus aspirin for acute treatment and secondary prevention in minor stroke and high-risk transient ischemic attack: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>46</StartPage><EndPage>55</EndPage><MedlinePgn>46-55</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejim.2022.03.017</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0953-6205(22)00106-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">Aspirin is a cornerstone of preventive treatment for stroke recurrence, but during the last few years the role of dual antiplatelet therapy (DAPT) is much more emerging.</AbstractText><AbstractText Label="OBJECTIVE">This systematic review aimed to compare early use of P2Y12 inhibitors (clopidogrel/ticagrelor) plus aspirin to aspirin alone for acute treatment and secondary prevention in acute non-cardioembolic minor ischemic stroke or TIA.</AbstractText><AbstractText Label="METHODS">A systematic search on MEDLINE and EMBASE was performed. Treatment effects were estimated with RRs and 95% CI. We used RevMan 5.4 for data analyses. We assessed methodological quality of selected studies according to Rob2 tools and quality of evidence with GRADE approach.</AbstractText><AbstractText Label="RESULTS">Four RCTs were included, enrolling 21,459 patients. Compared to aspirin alone, DAPT was superior in reducing stroke recurrence (RR 0.74, 95% CI 0.67-0.82, P &lt;0.00001, absolute risk difference by 2%, NNT 50) and disabling stroke defined as mRS&gt;2 (RR 0.84, 95% CI 0.75-0.95, P&#xa0;=&#xa0;0.004), with no impact on all causes of mortality (RR 1.30, 95% CI 0.90-1.89, P&#xa0;=&#xa0;0.16). An increased risk of major bleeding was emerged (RR 2.54, 95% CI 1.65-3.92, P &lt;0.0001, absolute risk difference by 0,4%, NNH 250), in particular with ticagrelor, but there was no correlation between therapy duration and bleeding risk, as appeared from one-month (RR 3.06, 95% CI 1.64 to 5.69) and three-month (RR 2.09, 95% CI 1.18 to 3.69) follow-up analysis.</AbstractText><AbstractText Label="CONCLUSIONS">Early administration of P2Y12 inhibitors plus aspirin in patients with acute non-cardioembolic minor ischemic stroke or TIA reduced the incidence of ischemic stroke recurrence, impacting more significantly than the increased bleeding risk and influencing patients' quality of life by reducing disabling stroke.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pomero</LastName><ForeName>Fulvio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Michele and Pietro Ferrero Hospital, Via Tanaro 7, 12060 Verduno, CN, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galli</LastName><ForeName>Eleonora</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Michele and Pietro Ferrero Hospital, Via Tanaro 7, 12060 Verduno, CN, Italy; Department of Internal Medicine, University of Turin, Corso Dogliotti 14, 10126 Torino, Italy. Electronic address: eleonora.galli@unito.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellesini</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine and Surgery, Research Center on Thromboembolic Disorders and Antithrombotic Therapies, University of Insubria, Viale Luigi Borri 57, 21100 Varese, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maroni</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Hypertension Dyslipidemia and Cardiovascular Risk Clinic, ASST Valle Olona, Sant'Antonio Abate Hospital, Via Eusebio Pastori, 21013 Gallarate, VA, Italy; Ospedale di Circolo, Via Arnaldo da Brescia 1, 21052 Busto Arsizio, VA, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Squizzato</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine and Surgery, Research Center on Thromboembolic Disorders and Antithrombotic Therapies, University of Insubria, Viale Luigi Borri 57, 21100 Varese, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Eur J Intern Med</MedlineTA><NlmUniqueID>9003220</NlmUniqueID><ISSNLinking>0953-6205</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010975">Platelet Aggregation Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>GLH0314RVC</RegistryNumber><NameOfSubstance UI="D000077486">Ticagrelor</NameOfSubstance></Chemical><Chemical><RegistryNumber>R16CO5Y76E</RegistryNumber><NameOfSubstance UI="D001241">Aspirin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001241" MajorTopicYN="N">Aspirin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="Y">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000083242" MajorTopicYN="Y">Ischemic Stroke</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010975" MajorTopicYN="N">Platelet Aggregation Inhibitors</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055502" MajorTopicYN="N">Secondary Prevention</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077486" MajorTopicYN="N">Ticagrelor</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aspirin</Keyword><Keyword MajorTopicYN="N">Clopidogrel</Keyword><Keyword MajorTopicYN="N">Ischemic stroke</Keyword><Keyword MajorTopicYN="N">Ticagrelor</Keyword><Keyword MajorTopicYN="N">Transient ischemic attack</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>25</Day><Hour>5</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35331593</ArticleId><ArticleId IdType="doi">10.1016/j.ejim.2022.03.017</ArticleId><ArticleId IdType="pii">S0953-6205(22)00106-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33758063</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>18</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1759-8486</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of neurointerventional surgery</Title><ISOAbbreviation>J Neurointerv Surg</ISOAbbreviation></Journal><ArticleTitle>Local anesthesia as a distinct comparator versus conscious sedation and general anesthesia in endovascular stroke treatment: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>221</StartPage><EndPage>226</EndPage><MedlinePgn>221-226</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/neurintsurg-2021-017360</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The optimal anesthetic modality for endovascular treatment (EVT) in acute ischemic stroke (AIS) is undetermined. Comparisons of general anesthesia (GA) with composite non-GA cohorts of conscious sedation (CS) and local anesthesia (LA) without sedation have provided conflicting results. There has been emerging interest in assessing whether LA alone may be associated with improved outcomes. We conducted a systematic review and meta-analysis to evaluate clinical and procedural outcomes comparing LA with CS and GA.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We reviewed the literature for studies reporting outcome variables in LA versus CS and LA versus GA comparisons. The primary outcome was 90 day good functional outcome (modified Rankin Scale (mRS) score of &#x2264;2). Secondary outcomes included mortality, symptomatic intracerebral hemorrhage, excellent functional outcome (mRS score &#x2264;1), successful reperfusion (Thrombolysis in Cerebral Infarction (TICI) &gt;2b), procedural time metrics, and procedural complications. Random effects meta-analysis was performed on unadjusted and adjusted data.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eight non-randomized studies of 7797 patients (2797 LA, 2218 CS, and 2782 GA) were identified. In the LA versus GA comparison, no statistically significant differences were found in unadjusted analyses for 90 day good functional outcome or mortality (OR=1.22, 95%&#x2009;CI 0.84 to 1.76, p=0.3&#x2009;and OR=0.83, 95%&#x2009;CI 0.64 to 1.07, p=0.15, respectively) or in the LA versus CS comparison (OR=1.14, 95%&#x2009;CI 0.76 to 1.71, p=0.53&#x2009;and OR=0.88, 95%&#x2009;CI 0.62 to 1.24, p=0.47, respectively). There was a tendency towards achieving excellent functional outcome (mRS &#x2264;1) in the LA group versus the GA group (OR=1.44, 95%&#x2009;CI 1.00 to 2.08, p=0.05, I<sup>2</sup>=70%). Analysis of adjusted data demonstrated a tendency towards higher odds of death at 90 days in the GA versus the LA group (OR=1.24, 95%&#x2009;CI 1.00 to 1.54, p=0.05, I<sup>2</sup>=0%).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">LA without sedation was not significantly superior to CS or GA in improving outcomes when performing EVT for AIS. However, the quality of the included studies impaired interpretation, and inclusion of an LA arm in future well designed multicenter, randomized controlled trials is warranted.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Butt</LastName><ForeName>Waleed</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Interventional Neuroradiology, Nottingham University Hospitals NHS Trust, Nottingham, UK mohammad.butt2@nuh.nhs.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Dhillon</LastName><ForeName>Permesh Singh</ForeName><Initials>PS</Initials><Identifier Source="ORCID">0000-0003-4353-4515</Identifier><AffiliationInfo><Affiliation>Interventional Neuroradiology, Nottingham University Hospitals NHS Trust, Nottingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Nottingham Biomedical Research Centre, Nottingham, Nottinghamshire, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Podlasek</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>NIHR Nottingham Biomedical Research Centre, Nottingham, Nottinghamshire, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malik</LastName><ForeName>Luqman</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Interventional Neuroradiology, Nottingham University Hospitals NHS Trust, Nottingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nair</LastName><ForeName>Sujit</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Interventional Neuroradiology, Nottingham University Hospitals NHS Trust, Nottingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hewson</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Anaesthesia and Critical Care Research Group, Division of Clinical Neuroscience, School of Medicine, University of Nottingham, Nottingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>England</LastName><ForeName>Timothy J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Vascular Medicine, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vascular Medicine, Division of Medical Sciences and GEM, School of Medicine, University of Nottingham, Nottingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lenthall</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Interventional Neuroradiology, Nottingham University Hospitals NHS Trust, Nottingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McConachie</LastName><ForeName>Norman</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Interventional Neuroradiology, Nottingham University Hospitals NHS Trust, Nottingham, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Neurointerv Surg</MedlineTA><NlmUniqueID>101517079</NlmUniqueID><ISSNLinking>1759-8478</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000772" MajorTopicYN="N">Anesthesia, Local</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002545" MajorTopicYN="Y">Brain Ischemia</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016292" MajorTopicYN="N">Conscious Sedation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="Y">Endovascular Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000083242" MajorTopicYN="Y">Ischemic Stroke</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015337" MajorTopicYN="N">Multicenter Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017131" MajorTopicYN="N">Thrombectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">angiography</Keyword><Keyword MajorTopicYN="N">brain</Keyword><Keyword MajorTopicYN="N">stroke</Keyword><Keyword MajorTopicYN="N">thrombectomy</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>3</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>6</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33758063</ArticleId><ArticleId IdType="doi">10.1136/neurintsurg-2021-017360</ArticleId><ArticleId IdType="pii">neurintsurg-2021-017360</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35468598</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1421-9751</ISSN><JournalIssue CitedMedium="Internet"><Volume>147</Volume><Issue>3</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Cardiology</Title><ISOAbbreviation>Cardiology</ISOAbbreviation></Journal><ArticleTitle>Comparison between Amplatzer and Watchman Left Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>290</StartPage><EndPage>297</EndPage><MedlinePgn>290-297</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1159/000524626</ELocationID><Abstract><AbstractText Label="INTRODUCTION">The Amplatzer and Watchman left atrial appendage closure (LAAC) devices are the two most frequently used devices for LAAC devices worldwide. This meta-analysis aimed to compare the safety and efficacy of the two devices.</AbstractText><AbstractText Label="METHODS">We searched the PubMed, EMBASE, and the Cochrane Library for studies up to February 6, 2022 that compared the safety and efficacy of the Amplatzer and Watchman devices.</AbstractText><AbstractText Label="RESULTS">Fifteen studies including 2,150 patients in randomized controlled trials and 2,526 patients in observational studies were included in the meta-analysis. Amplatzer device was associated with higher rates of major procedure-related complications (odds ratio [OR]: 1.99, 95% confidence interval [CI]: 1.45-2.74, p &lt; 0.0001) and device embolization (OR: 1.99, 95% CI: 1.09-3.64, p = 0.03). However, Amplatzer device had lower rates of total peridevice leak (PDL) (OR: 0.48, 95% CI: 0.27-0.83, p = 0.009), significant PDL (OR: 0.27, 95% CI: 0.12-0.57, p = 0.0007) and device-related thrombus (DRT) (OR: 0.67, 95% CI: 0.48-0.95, p = 0.02). No statistical differences were observed between the two devices in other safety and efficacy endpoints, such as pericardial effusion, cardiac tamponade, air embolism, vascular complications, ischemic stroke/transient ischemic attack (TIA), hemorrhagic stroke, all-cause death, cardiovascular death, and bleeding.</AbstractText><AbstractText Label="CONCLUSIONS">Amplatzer LAAC device was associated with higher rates of major procedure-related complications, especially in device embolization. Watchman LAAC device was associated with higher rates of PDL and DRT. There were no significant differences between two devices in ischemic stroke/TIA, hemorrhagic stroke, all-cause death, cardiovascular death, and bleeding.</AbstractText><CopyrightInformation>&#xa9; 2022 S. Karger AG, Basel.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Qiao</LastName><ForeName>Jianzhong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Tongling People's Hospital, Tongling, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Tongling People's Hospital, Tongling, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Tongling People's Hospital, Tongling, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Lingxin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Tongling People's Hospital, Tongling, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Tieniu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Tongling People's Hospital, Tongling, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Tongling People's Hospital, Tongling, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiong</LastName><ForeName>Enlai</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Tongling People's Hospital, Tongling, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cardiology</MedlineTA><NlmUniqueID>1266406</NlmUniqueID><ISSNLinking>0008-6312</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D020517" MajorTopicYN="Y">Atrial Appendage</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="Y">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000083302" MajorTopicYN="Y">Hemorrhagic Stroke</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="Y">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000083242" MajorTopicYN="Y">Ischemic Stroke</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="Y">Thrombosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amplatzer amulet</Keyword><Keyword MajorTopicYN="N">Amplatzer cardiac plug</Keyword><Keyword MajorTopicYN="N">Atrial fibrillation</Keyword><Keyword MajorTopicYN="N">Left atrial appendage closure</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Watchman</Keyword><Keyword MajorTopicYN="N">Watchman FLX</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>25</Day><Hour>20</Hour><Minute>21</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35468598</ArticleId><ArticleId IdType="doi">10.1159/000524626</ArticleId><ArticleId IdType="pii">000524626</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35241374</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2165</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Apr</Month></PubDate></JournalIssue><Title>European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery</Title><ISOAbbreviation>Eur J Vasc Endovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Editor's Choice - Peri-Operative Outcomes of Carotid Endarterectomy are Not Improved on Dual Antiplatelet Therapy vs. Aspirin Monotherapy: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>546</StartPage><EndPage>555</EndPage><MedlinePgn>546-555</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejvs.2021.12.037</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1078-5884(21)01030-3</ELocationID><Abstract><AbstractText Label="OBJECTIVE">A systematic review and meta-analysis of the peri-operative outcomes of carotid endarterectomy (CEA) on dual antiplatelet therapy (DAPT) vs. aspirin monotherapy was carried out, to determine optimal peri-operative management with these antiplatelet agents.</AbstractText><AbstractText Label="DATA SOURCES">The Web of Science, Pubmed, and Embase databases were searched from inception to July 2021. The corresponding authors of excluded articles were contacted to obtain additional data for possible inclusion.</AbstractText><AbstractText Label="REVIEW METHODS">The main outcomes included ischaemic complications (stroke, transient ischaemic attack [TIA], and transcranial Doppler [TCD] measured micro-emboli), haemorrhagic complications (haemorrhagic stroke, neck haematoma, and re-operation for bleeding), and composite outcomes. Pooled estimates using odds ratios (ORs) were combined using a random or fixed effects model based on the results of the chi square test and calculation of I<sup>2</sup>.</AbstractText><AbstractText Label="RESULTS">In total, 47 411 patients were included in 11 studies, with 14 345 (30.2%) receiving DAPT and 33 066 (69.7%) receiving aspirin only. There was no significant difference in the rates of peri-operative stroke (OR 0.87, 95% confidence interval [CI] 0.72 - 1.05) and TIA (OR 0.78, 95% CI 0.52 - 1.17) despite a significant reduction in TCD measured micro-emboli (OR 0.19, 95% CI 0.10 - 0.35) in the DAPT compared with the aspirin monotherapy group. Subgroup analysis did not reveal any significant difference in ischaemic stroke risk between patients with asymptomatic and symptomatic carotid artery stenosis. DAPT was associated with an increased risk of neck haematoma (OR 2.79, 95% CI 1.87 - 4.18) and re-operation for bleeding (OR 1.98, 95% CI 1.77 - 2.23) vs. aspirin. Haemorrhagic stroke was an under reported outcome in the literature.</AbstractText><AbstractText Label="CONCLUSION">This meta-analysis found that CEA while on DAPT increased the risk of haemorrhagic complications, with similar rates of ischaemic complications, vs. aspirin monotherapy. This suggests that the risks of performing CEA on DAPT outweigh the benefits, even in patients with symptomatic carotid stenosis. The overall quality of studies was low, and improved reporting of CEA outcomes in the literature is necessary.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ku</LastName><ForeName>Jerry C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Division of Neurosurgery, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taslimi</LastName><ForeName>Shervin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Neurosurgery, Department of Surgery, Kingston General Hospital, Toronto, ON, Canada. Electronic address: Shervin.Taslimi@kingstonhsc.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zuccato</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Neurosurgery, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasarikovski</LastName><ForeName>Christopher R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Division of Neurosurgery, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nasr</LastName><ForeName>Nathalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Toulouse University Hospital, Toulouse, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chechik</LastName><ForeName>Ofir</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Sackler Faculty of Medicine, Tel-Aviv Medical Centre, Tel Aviv University, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chisci</LastName><ForeName>Emiliano</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Surgery, Vascular and Endovascular Surgery Unit, "San Giovanni di Dio" Hospital, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bissacco</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>School of Vascular Surgery, Universit&#xe0; degli Studi di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larrue</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Toulouse University Hospital, Toulouse, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rabinovich</LastName><ForeName>Yefim</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Sackler Faculty of Medicine, Tel-Aviv Medical Centre, Tel Aviv University, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michelagnoli</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, Vascular and Endovascular Surgery Unit, "San Giovanni di Dio" Hospital, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Settembrini</LastName><ForeName>Piergiorgio G</ForeName><Initials>PG</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, Ospedale San Carlo Borromeo, ASST Santi Paolo e Carlo, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Priola</LastName><ForeName>Stefano M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Division of Neurosurgery, Health Sciences North, Sudbury, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cusimano</LastName><ForeName>Michael D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Division of Neurosurgery, University of Toronto, Toronto, ON, Canada; Division of Neurosurgery, St. Michael's Hospital, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Victor X D</ForeName><Initials>VXD</Initials><AffiliationInfo><Affiliation>Division of Neurosurgery, University of Toronto, Toronto, ON, Canada; Division of Neurosurgery, Sunnybrook Hospital, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Macdonald</LastName><ForeName>R Loch</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of California San Francisco, Fresno Campus, Fresno, CA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Vasc Endovasc Surg</MedlineTA><NlmUniqueID>9512728</NlmUniqueID><ISSNLinking>1078-5884</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010975">Platelet Aggregation Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>R16CO5Y76E</RegistryNumber><NameOfSubstance UI="D001241">Aspirin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Eur J Vasc Endovasc Surg. 2022 Apr;63(4):556. doi: 10.1016/j.ejvs.2022.01.004.</RefSource><PMID Version="1">35248438</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001241" MajorTopicYN="N">Aspirin</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002545" MajorTopicYN="Y">Brain Ischemia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016893" MajorTopicYN="Y">Carotid Stenosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016894" MajorTopicYN="Y">Endarterectomy, Carotid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006406" MajorTopicYN="N">Hematoma</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000083302" MajorTopicYN="Y">Hemorrhagic Stroke</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="Y">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010975" MajorTopicYN="N">Platelet Aggregation Inhibitors</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antiplatelet therapy</Keyword><Keyword MajorTopicYN="N">Carotid artery stenosis</Keyword><Keyword MajorTopicYN="N">Carotid endarterectomy</Keyword><Keyword MajorTopicYN="N">Ischaemic stroke</Keyword><Keyword MajorTopicYN="N">Peri-operative complications</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>4</Day><Hour>5</Hour><Minute>36</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35241374</ArticleId><ArticleId IdType="doi">10.1016/j.ejvs.2021.12.037</ArticleId><ArticleId IdType="pii">S1078-5884(21)01030-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39087284</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2651-5032</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>5</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Turkish neurosurgery</Title><ISOAbbreviation>Turk Neurosurg</ISOAbbreviation></Journal><ArticleTitle>Is There a Risk of Stroke During Anterior Cervical Discectomy? A Randomized Controlled Trial.</ArticleTitle><Pagination><StartPage>794</StartPage><EndPage>801</EndPage><MedlinePgn>794-801</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5137/1019-5149.JTN.44169-23.3</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To examine the effects of different retractor techniques for anterior cervical discectomy on cerebral oxygen saturation.</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">In this study, a prospective comparative design was employed to examine the effects of different retractor techniques on a cohort of 48 adult patients with ASA I-II classification who underwent anterior cervical discectomy under general anesthesia. The study was conducted under assessor-blinded conditions, and the patients were divided equally into two groups: the self-retaining retractor group and the hand-held retractor group. In addition to standard anaesthesia monitoring, the utilization of cerebral oximetry monitoring was implemented for all patients. A total of 7 measurements were obtained at various stages, including preoperative, during anaesthesia induction, surgical positioning, surgical retraction, release of retractors, after correction of extension position, and prior to extubation. The main objective of this study was to evaluate the impact of neck position and surgical retraction on brain perfusion, as measured by regional cerebral oximetry.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Sociodemographic data, duration of operation, hemodynamic parameters, bilateral regional cerebral oxygen saturation (rScO<sub>2</sub>), and Mini Mental State Examination (MMSE) scores did not differ significantly between the two groups. In both groups, the bilateral rScO<sub>2</sub> decreased significantly with positioning and the left rScO<sub>2</sub> decreased significantly following the installation of retractors. Only the left rScO<sub>2</sub> increased significantly upon the release of both retractors. Following the correction of the neck position, bilateral rScO<sub>2</sub> increased significantly in both groups (p &lt; 0.001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The rScO<sub>2</sub> of the left carotid artery was shown to significantly decrease due to the indirect impact of the retractors. After extending the head and neck, bilateral rScO<sub>2</sub> values decreased significantly in both groups. However, despite this decline, there was no significant decrease in brain perfusion that would result in ischemia. The absence of a statistically significant distinction between the groups implies that it is unlikely to have an impact on brain perfusion.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gumus</LastName><ForeName>Nevin Esra</ForeName><Initials>NE</Initials><AffiliationInfo><Affiliation>Samsun Training and Research Hospital, Anesthesia Clinic, Samsun, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoldas</LastName><ForeName>Tuba Kuvvet</ForeName><Initials>TK</Initials></Author><Author ValidYN="Y"><LastName>Koksal</LastName><ForeName>Vaner</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Karkucak</LastName><ForeName>Ahmet</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Bayraktar</LastName><ForeName>Birol</ForeName><Initials>B</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Turkey</Country><MedlineTA>Turk Neurosurg</MedlineTA><NlmUniqueID>9423821</NlmUniqueID><ISSNLinking>1019-5149</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017586" MajorTopicYN="Y">Diskectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002574" MajorTopicYN="Y">Cervical Vertebrae</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010092" MajorTopicYN="Y">Oximetry</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000089382" MajorTopicYN="N">Oxygen Saturation</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>17</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>1</Day><Hour>4</Hour><Minute>44</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39087284</ArticleId><ArticleId IdType="doi">10.5137/1019-5149.JTN.44169-23.3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31001938</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>06</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1598-6357</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>15</Issue><PubDate><Year>2019</Year><Month>Apr</Month><Day>22</Day></PubDate></JournalIssue><Title>Journal of Korean medical science</Title><ISOAbbreviation>J Korean Med Sci</ISOAbbreviation></Journal><ArticleTitle>Evaluation of Propofol in Comparison with Other General Anesthetics for Surgery in Children Younger than 3 Years: a Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>e124</StartPage><MedlinePgn>e124</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e124</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3346/jkms.2019.34.e124</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Despite well-known advantages, propofol remains off-label in many countries for general anesthesia in children under 3 years of age due to insufficient evidence regarding its use in this population. This study aimed to evaluate the efficacy and safety of propofol compared with other general anesthetics in children under 3 years of age undergoing surgery through a systematic review and meta-analysis of existing randomized clinical trials.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A comprehensive literature search was conducted of MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials to find all randomized clinical trials comparing propofol with another general anesthetic that included children under 3 years of age. The relative risk or arcsine-transformed risk difference for dichotomous outcomes and the weighted or standardized mean difference for continuous outcomes were estimated using a random-effects model.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 249 young children from 6 publications were included. The children who received propofol had statistically significantly lower systolic and diastolic blood pressures, but hypotension was not observed in the propofol groups. The heart rate, stroke volume index, and cardiac index were not significantly different between the propofol and control groups. The propofol groups showed slightly shorter recovery times and a lower incidence of emergence agitation than the control groups, while no difference was observed for the incidence of hypotension, desaturation, and apnea.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This systematic review and meta-analysis indicates that propofol use for general anesthesia in young healthy children undergoing surgery does not increase complications and that propofol could be at least comparable to other anesthetic agents.</AbstractText><CopyrightInformation>&#xa9; 2019 The Korean Academy of Medical Sciences.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Hyunsook</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-0955-4176</Identifier><AffiliationInfo><Affiliation>Division of Medical Statistics, Medical Research Collaborating Center, Seoul National University Hospital, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hahn</LastName><ForeName>Seokyung</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-4684-4917</Identifier><AffiliationInfo><Affiliation>Division of Medical Statistics, Medical Research Collaborating Center, Seoul National University Hospital, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Interdisciplinary Program in Medical Informatics, Seoul National University Graduate School, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Seoul National University College of Medicine, Seoul, Korea. hahns@snu.ac.kr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Yunhee</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-5305-1803</Identifier><AffiliationInfo><Affiliation>Division of Medical Statistics, Medical Research Collaborating Center, Seoul National University Hospital, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jang</LastName><ForeName>Myoung Jin</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0001-8123-5001</Identifier><AffiliationInfo><Affiliation>Division of Medical Statistics, Medical Research Collaborating Center, Seoul National University Hospital, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Sunhee</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-2668-3685</Identifier><AffiliationInfo><Affiliation>Interdisciplinary Program in Medical Informatics, Seoul National University Graduate School, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Ji Hyun</ForeName><Initials>JH</Initials><Identifier Source="ORCID">0000-0002-8384-8191</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hee Soo</ForeName><Initials>HS</Initials><Identifier Source="ORCID">0000-0002-2661-7944</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HC15C1523</GrantID><Acronym>MHW</Acronym><Agency>Ministry of Health and Welfare</Agency><Country>Korea</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>04</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>J Korean Med Sci</MedlineTA><NlmUniqueID>8703518</NlmUniqueID><ISSNLinking>1011-8934</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018686">Anesthetics, Intravenous</NameOfSubstance></Chemical><Chemical><RegistryNumber>JI8Z5M7NA3</RegistryNumber><NameOfSubstance UI="D013874">Thiopental</NameOfSubstance></Chemical><Chemical><RegistryNumber>YI7VU623SF</RegistryNumber><NameOfSubstance UI="D015742">Propofol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Korean Med Sci. 2019 Jul 22;34(28):e191. doi: 10.3346/jkms.2019.34.e191.</RefSource><PMID Version="1">31327177</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Korean Med Sci. 2019 Jul 22;34(28):e192. doi: 10.3346/jkms.2019.34.e192.</RefSource><PMID Version="1">31327178</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018686" MajorTopicYN="N">Anesthetics, Intravenous</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071257" MajorTopicYN="N">Emergence Delirium</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015742" MajorTopicYN="N">Propofol</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013874" MajorTopicYN="N">Thiopental</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Child</Keyword><Keyword MajorTopicYN="N">General Anesthesia</Keyword><Keyword MajorTopicYN="N">Infant</Keyword><Keyword MajorTopicYN="N">Propofol</Keyword><Keyword MajorTopicYN="N">Systematic Review</Keyword></KeywordList><CoiStatement>The authors have no potential conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>4</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>4</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>4</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31001938</ArticleId><ArticleId IdType="pmc">PMC6473090</ArticleId><ArticleId IdType="doi">10.3346/jkms.2019.34.e124</ArticleId><ArticleId IdType="pii">34.e124</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chidambaran V, Costandi A, D'Mello A. Propofol: a review of its role in pediatric anesthesia and sedation. CNS Drugs. 2015;29(7):543&#x2013;563.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4554966</ArticleId><ArticleId IdType="pubmed">26290263</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. WHO Model List of Essential Medicines for Children. 6th ed. Geneva: World Health Organization; 2017.</Citation></Reference><Reference><Citation>British Medical Association; Royal Pharmaceutical Society; Royal College of Paediatrics and Child Health; Neonatal and Paediatric Pharmacists Group. BNF for Children 2011&#x2013;2012 [Internet]  [Accessed 21 Jun, 2017].   www.bnfc.org.</Citation></Reference><Reference><Citation>Karen T, Schlager GW, Bendix I, Sifringer M, Herrmann R, Pantazis C, et al. Effect of propofol in the immature rat brain on short- and long-term neurodevelopmental outcome. PLoS One. 2013;8(5):e64480.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3667818</ArticleId><ArticleId IdType="pubmed">23737984</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvo I, Landoni G, Mucchetti M, Cabrini L, Pani L. Use and reimbursement of off-label drugs in pediatric anesthesia: the Italian experience. Paediatr Anaesth. 2014;24(6):625&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pubmed">24796404</ArticleId></ArticleIdList></Reference><Reference><Citation>Korea Institute of Drug Safety &amp; Risk Management. Drug Saf Inf. 2013;(52):94&#x2013;105.</Citation></Reference><Reference><Citation>Shimazawa R, Ikeda M. Approval status and evidence for WHO essential medicines for children in the United States, United Kingdom, and Japan: a cross-sectional study. J Pharm Policy Pract. 2017;10(1):4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5217454</ArticleId><ArticleId IdType="pubmed">28070339</ArticleId></ArticleIdList></Reference><Reference><Citation>Coppini R, Simons SH, Mugelli A, Allegaert K. Clinical research in neonates and infants: challenges and perspectives. Pharmacol Res. 2016;108:80&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">27142783</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith MC, Williamson J, Yaster M, Boyd GJ, Heitmiller ES. Off-label use of medications in children undergoing sedation and anesthesia. Anesth Analg. 2012;115(5):1148&#x2013;1154.</Citation><ArticleIdList><ArticleId IdType="pubmed">22451593</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah PS, Shah VS. Propofol for procedural sedation/anaesthesia in neonates. Cochrane Database Syst Rev. 2011;(3):CD007248.</Citation><ArticleIdList><ArticleId IdType="pubmed">21412900</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrum SF, Hannallah RS, Verghese PM, Welborn LG, Norden JM, Ruttiman U. Comparison of propofol and thiopental for rapid anesthesia induction in infants. Anesth Analg. 1994;78(3):482&#x2013;485.</Citation><ArticleIdList><ArticleId IdType="pubmed">8109764</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng X, Zuo Y, Zhao Q, Gu E, Huang Y. Comparison of the effects of dexmedetomidine and propofol on hemodynamics and oxygen balance in children with complex congenital heart disease undergoing cardiac surgery. Congenit Heart Dis. 2015;10(3):E123&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">25346460</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Chichester: John Wiley &amp; Sons; 2011.</Citation></Reference><Reference><Citation>R&#xfc;cker G, Schwarzer G, Carpenter J, Olkin I. Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta-analysis with zero cells. Stat Med. 2009;28(5):721&#x2013;738.</Citation><ArticleIdList><ArticleId IdType="pubmed">19072749</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539&#x2013;1558.</Citation><ArticleIdList><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36(3):1&#x2013;48.</Citation></Reference><Reference><Citation>Aun CS, Sung RY, O'Meara ME, Short TG, Oh TE. Cardiovascular effects of i.v. induction in children: comparison between propofol and thiopentone. Br J Anaesth. 1993;70(6):647&#x2013;653.</Citation><ArticleIdList><ArticleId IdType="pubmed">8329259</ArticleId></ArticleIdList></Reference><Reference><Citation>Wodey E, Chonow L, Beneux X, Azzis O, Bansard JY, Ecoffey C. Haemodynamic effects of propofol vs thiopental in infants: an echocardiographic study. Br J Anaesth. 1999;82(4):516&#x2013;520.</Citation><ArticleIdList><ArticleId IdType="pubmed">10472214</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen IT, Finkel JC, Hannallah RS, Goodale DB. Clinical and biochemical effects of propofol EDTA vs sevoflurane in healthy infants and young children. Paediatr Anaesth. 2004;14(2):135&#x2013;142.</Citation><ArticleIdList><ArticleId IdType="pubmed">14962329</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinmetz J, Holm-Knudsen R, S&#xf8;rensen MK, Eriksen K, Rasmussen LS. Hemodynamic differences between propofol-remifentanil and sevoflurane anesthesia for repair of cleft lip and palate in infants. Paediatr Anaesth. 2007;17(1):32&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">17184429</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajan S, Gotluru P, Andews S, Paul J. Evaluation of endotracheal intubating conditions without the use of muscle relaxants following induction with propofol and sevoflurane in pediatric cleft lip and palate surgeries. J Anaesthesiol Clin Pharmacol. 2014;30(3):360&#x2013;365.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4152676</ArticleId><ArticleId IdType="pubmed">25190944</ArticleId></ArticleIdList></Reference><Reference><Citation>Annila P, Viitanen H, Reinikainen P, Baer G, Lindgren L. Induction characteristics of thiopentone/suxamethonium, propofol/alfentanil or halothane alone in children aged 1&#x2013;3 years. Eur J Anaesthesiol. 1999;16(6):359&#x2013;366.</Citation><ArticleIdList><ArticleId IdType="pubmed">10434162</ArticleId></ArticleIdList></Reference><Reference><Citation>Viitanen H, Tarkkila P, Mennander S, Viitanen M, Annila P. Sevoflurane-maintained anesthesia induced with propofol or sevoflurane in small children: induction and recovery characteristics. Can J Anaesth. 1999;46(1):21&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">10078398</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang P, Jang YE, Kim EH, Lee JH, Kim JT, Kim HS. Safety and efficacy of propofol anesthesia for pediatric target-controlled infusion in children below 3 years of age: a retrospective observational study. Expert Opin Drug Saf. 2018;17(10):983&#x2013;989.</Citation><ArticleIdList><ArticleId IdType="pubmed">30221553</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim MS, Lee JH, Han SW, Im YJ, Kang HJ, Lee JR. A randomized comparison of the i-gel with the self-pressurized air-Q intubating laryngeal airway in children. Paediatr Anaesth. 2015;25(4):405&#x2013;412.</Citation><ArticleIdList><ArticleId IdType="pubmed">25559870</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghanta S, Abdel-Latif ME, Lui K, Ravindranathan H, Awad J, Oei J. Propofol compared with the morphine, atropine, and suxamethonium regimen as induction agents for neonatal endotracheal intubation: a randomized, controlled trial. Pediatrics. 2007;119(6):e1248&#x2013;e1255.</Citation><ArticleIdList><ArticleId IdType="pubmed">17485450</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh TK, Kwon K. Issues in propofol sedation for pediatric patients using target control Infusion (TCI): safety in children 1&#x2013;3 years old versus children older than 3 years of age. Pediatr Ther. 2016;6(2):291.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37404522</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2229-5097</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Surgical neurology international</Title><ISOAbbreviation>Surg Neurol Int</ISOAbbreviation></Journal><ArticleTitle>Prevalence and risk factors of unruptured intracranial aneurysms in ischemic stroke patients - A global meta-analysis.</ArticleTitle><Pagination><StartPage>222</StartPage><MedlinePgn>222</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">222</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.25259/SNI_190_2023</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Unruptured intracranial aneurysms (UIAs) have an estimated global prevalence of 2.8% in the adult population; however, UIA was identified among more than 10% of ischemic stroke patients. Many epidemiological studies and reviews have pointed to the presence of UIA among patients with ischemic stroke; yet, the extent of this association is not fully known. We performed a systematic review and meta-analysis to determine the prevalence of UIA in patients admitted to hospitals with ischemic stroke and transient ischemic attack (TIA) at both global and continental levels and evaluate factors associated with UIA in this population.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We identified, in five databases, all studies describing UIA in ischemic stroke and TIA patients between January 1, 2000, and December 20, 2021. Included studies were of observational and experimental design.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Our search yielded 3581 articles of which 23 were included, with a total of 25,420 patients. The pooled prevalence of UIA was 5% (95% confidence interval [CI] = 4-6%) with stratified results showing 6% (95% CI = 4-9%), 6% (95% CI = 5-7%), and 4% (95% CI = 2-5%) in North America, Asia, and Europe, respectively. Significant risk factors were large vessel occlusion (odds ratios [OR] = 1.22, 95% CI = 1.01-1.47) and hypertension (OR = 1.45, 95% CI = 1.24-1.69), while protective factors were male sex (OR = 0.60, 95% CI = 0.53-0.68) and diabetes (OR = 0.82, 95% CI = 0.72-0.95).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The prevalence of UIA is notably higher in ischemic stroke patients than the general population. Physicians should be aware of common risk factors in stroke and aneurysm formation for appropriate prevention.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2023 Surgical Neurology International.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ortiz</LastName><ForeName>Andres Felipe Herrera</ForeName><Initials>AFH</Initials><AffiliationInfo><Affiliation>Department of Radiology, Fundaci&#xf3;n Santa Fe de Bogot&#xe1;, Bogota, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suriano</LastName><ForeName>Enrico Stefano</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Department of Medicine, Santa Casa de S&#xe3;o Paulo Medical School, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eltawil</LastName><ForeName>Yasmin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Medicine, San Francisco School of Medicine, San Francisco, California, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sekhon</LastName><ForeName>Manraj</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of California, Riverside School of Medicine, Riverside, California, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gebran</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garland</LastName><ForeName>Mateo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Rutgers New Jersey Medical School, Newark, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuenca</LastName><ForeName>Nury Tatiana Rinc&#xf3;n</ForeName><Initials>NTR</Initials><AffiliationInfo><Affiliation>Department of Medicine, Fundacion Universitaria de Ciencias de la Salud, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cadavid</LastName><ForeName>Tatiana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, Fundaci&#xf3;n Universitaria Sanitas, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almarie</LastName><ForeName>Bassel</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Surgery, Cantonal Hospital of St. Gallen, St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Surg Neurol Int</MedlineTA><NlmUniqueID>101535836</NlmUniqueID><ISSNLinking>2152-7806</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adults</Keyword><Keyword MajorTopicYN="N">Computed tomography angiography</Keyword><Keyword MajorTopicYN="N">Ischemic stroke</Keyword><Keyword MajorTopicYN="N">Magnetic resonance angiography</Keyword><Keyword MajorTopicYN="N">Prevalence</Keyword><Keyword MajorTopicYN="N">Unruptured intracranial aneurysm</Keyword></KeywordList><CoiStatement>There are no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>5</Day><Hour>13</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>5</Day><Hour>13</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>5</Day><Hour>10</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37404522</ArticleId><ArticleId IdType="pmc">PMC10316137</ArticleId><ArticleId IdType="doi">10.25259/SNI_190_2023</ArticleId><ArticleId IdType="pii">10.25259/SNI_190_2023</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aoki T, Nishimura M. Targeting chronic inflammation in cerebral aneurysms: Focusing on NF-KB as a putative target of medical therapy. Expert Opin Ther Targets. 2010;14:265&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">20128708</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballotta E, Giau GD, Manara R, Baracchini C. Extracranial severe carotid stenosis and incidental intracranial aneurysms. Ann Vasc Surg. 2006;20:5&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16378155</ArticleId></ArticleIdList></Reference><Reference><Citation>Can A, Castro VM, Yu S, Dligach D, Finan S, Gainer VS, et al. Antihyperglycemic agents are inversely associated with intracranial aneurysm rupture. Stroke. 2018;49:34&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29203688</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalouhi N, Hoh BL, Hasan D. Review of cerebral aneurysm formation, growth, and rupture. Stroke. 2013;44:3613&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">24130141</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalouhi N, Ali MS, Jabbour PM, Tjoumakaris SI, Gonzalez LF, Rosenwasser RH, et al. Biology of intracranial aneurysms: Role of inflammation. J Cereb Blood Flow Metab. 2012;32:1659&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3434628</ArticleId><ArticleId IdType="pubmed">22781330</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalouhi N, Ali MS, Starke RM, Jabbour PM, Tjoumakaris SI, Gonzalez LF, et al. Cigarette smoke and inflammation: Role in cerebral aneurysm formation and rupture. Mediators Inflamm. 2012;2012:271582.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3532877</ArticleId><ArticleId IdType="pubmed">23316103</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalouhi N, Points L, Pierce GL, Ballas Z, Jabbour P, Hasan D. Localized increase of chemokines in the lumen of human cerebral aneurysms. Stroke. 2013;44:2594&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3829607</ArticleId><ArticleId IdType="pubmed">23887838</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen ML, Gupta A, Chatterjee A, Khazanova D, Dou E, Patel H, et al. Association between unruptured intracranial aneurysms and downstream stroke. Stroke. 2018;49:2029&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6205209</ArticleId><ArticleId IdType="pubmed">30354970</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu WT, Hong CT, Chi NF, Hu CJ, Hu HH, Chan L. The risk of intravenous thrombolysis-induced intracranial hemorrhage in Taiwanese patients with unruptured intracranial aneurysm. PLoS One. 2017;12:e0180021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5491104</ArticleId><ArticleId IdType="pubmed">28662192</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding C, Toll V, Ouyang B, Chen M. Younger age of menopause in women with cerebral aneurysms. J Neurointerv Surg. 2012;5:327&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">22700728</ArticleId></ArticleIdList></Reference><Reference><Citation>Doyle SJ, George BP, Holloway RG, Kelly AG. Incidental findings in radiographic imaging for in-patients with acute ischemic stroke. J Stroke Cerebrovasc Dis. 2018;27:3131&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">30077600</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards NJ, Kamel H, Josephson SA. The safety of intravenous thrombolysis for ischemic stroke in patients with pre-existing cerebral aneurysms. Stroke. 2012;43:412&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">22156701</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal N, Tsivgoulis G, Zand R, Sharma VK, Barlinn K, Male S, et al. Systemic thrombolysis in acute ischemic stroke patients with unruptured intracranial aneurysms. Neurology. 2015;85:1452&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4631074</ArticleId><ArticleId IdType="pubmed">26408492</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo J, Dhaliwall JK, Chan KK, Ghanim H, Al Koudsi N, Lam L, et al. In vivo effect of insulin to decrease matrix metalloproteinase-2 and-9 activity after arterial injury. J Vasc Res. 2013;50:279&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">23988659</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe9;man LM, Jongen LM, Van der Worp HB, Rinkel GJ, Hendrikse J. Incidental intracranial aneurysms in patients with internal carotid artery stenosis. Stroke. 2009;40:1341&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">19228836</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera Ortiz AF, Camacho EC, Rojas JC, Camacho TC, Guevara SZ, Cuenca NT, et al. A practical guide to perform a systematic literature review and meta-analysis. Princ Pract Clin Res J. 2021;7:47&#x2013;57.</Citation></Reference><Reference><Citation>Herrera Ortiz AF, Cuenca NT, Beaujon LJ. Brain changes in magnetic resonance imaging caused by child abuse: A systematic literature review. Rev Cuarzo. 2021;27:27&#x2013;33.</Citation></Reference><Reference><Citation>Hokari M, Isobe M, Imai T, Chiba Y, Iwamoto N, Isu T. The impact of atherosclerotic factors on cerebral aneurysm is location dependent: Aneurysms in stroke patients and healthy controls. J Stroke Cerebrovasc Dis. 2014;23:2301&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">25156785</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurford R, Taveira I, Kuker W, Rothwell PM. Prevalence, predictors and prognosis of incidental intracranial aneurysms in patients with suspected TIA and minor stroke: A population-based study and systematic review. J Neurol Neurosurg Psychiatry. 2020;92:542&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8053340</ArticleId><ArticleId IdType="pubmed">33148817</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikawa F, Morita A, Tominari S, Nakayama T, Shiokawa Y, Date I, et al. Rupture risk of small unruptured cerebral aneurysms. J Neurosurg. 2020;132:69&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">30684948</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikawa Y, Hirayama T, Nakamura Y, Ikeda K. Incidental cerebral aneurysms in acute stroke patients: Comparison of asymptomatic healthy controls. J Neurol Sci. 2010;298:42&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">20864121</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamous MA, Nagahiro S, Kitazato KT, Tamura T, Kuwayama K, Satoh K. Role of estrogen deficiency in the formation and progression of cerebral aneurysms. Part II: experimental study of the effects of hormone replacement therapy in rats. J Neurosurg. 2005;103:1052&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">16381192</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiranukool J, Thiarawat P, Galassi W. Prevalence of intracranial aneurysms among acute ischemic stroke patients. Surg Neurol Int. 2020;11:341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7656034</ArticleId><ArticleId IdType="pubmed">33194275</ArticleId></ArticleIdList></Reference><Reference><Citation>Juvela S, Poussa K, Porras M. Factors affecting formation and growth of intracranial aneurysms. Stroke. 2001;32:485&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">11157187</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanesa-Thasan R, Cox M, Patel M, Curtis B, Hurst RW, Kung D, et al. Actionable vascular and other incidental findings on CTA in patients undergoing acute stroke intervention. Neuroradiol J. 2018;31:572&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6243459</ArticleId><ArticleId IdType="pubmed">30238833</ArticleId></ArticleIdList></Reference><Reference><Citation>Kappelle L, Eliasziw M, Fox A, Barnett HM. Small, unruptured intracranial aneurysms and management of symptomatic carotid artery stenosis. Neurology. 2000;55:307&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10908914</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JH, Suh SH, Chung J, Oh YJ, Ahn SJ, Lee KY. Prevalence and characteristics of unruptured cerebral aneurysms in ischemic stroke patients. J Stroke. 2016;18:321&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5066432</ArticleId><ArticleId IdType="pubmed">27488981</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JT, Park MS, Yoon W, Cho KH. Detection and significance of incidental unruptured cerebral aneurysms in patients undergoing intravenous thrombolysis for acute ischemic stroke. J Neuroimaging. 2012;22:197&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pubmed">21143548</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SC, Singh M, Huang J, Prestigiacomo CJ, Winfree CJ, Solomon RA, et al. Matrix metalloproteinase-9 in cerebral aneurysms. Neurosurgery. 1997;41:642&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">9310982</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai LT, Morgan MK, Patel NJ. Smoking increases the risk of de novo intracranial aneurysms. World Neurosurg. 2014;82:e195&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pubmed">24518886</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindbohm JV, Kaprio J, Jousilahti P, Salomaa V, Korja M. Risk factors of sudden death from subarachnoid hemorrhage. Stroke. 2017;48:2399&#x2013;404.</Citation><ArticleIdList><ArticleId IdType="pubmed">28739833</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackey J, Khoury JC, Alwell K, Moomaw CJ, Kissela BM, Flaherty ML, et al. Stable incidence but declining case-fatality rates of subarachnoid hemorrhage in a population. Neurology. 2016;87:2192&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5123555</ArticleId><ArticleId IdType="pubmed">27770074</ArticleId></ArticleIdList></Reference><Reference><Citation>Melsen W, Bootsma M, Rovers M, Bonten M. The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses. Clin Microbiol Infect. 2014;20:123&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">24320992</ArticleId></ArticleIdList></Reference><Reference><Citation>Metaxa E, Tremmel M, Natarajan SK, Xiang J, Paluch RA, Mandelbaum M, et al. Characterization of critical hemodynamics contributing to aneurysmal remodeling at the basilar terminus in a rabbit model. Stroke. 2010;41:1774&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2913882</ArticleId><ArticleId IdType="pubmed">20595660</ArticleId></ArticleIdList></Reference><Reference><Citation>Mittal MK, Seet RC, Zhang Y, Brown RD, Rabinstein AA. Safety of intravenous thrombolysis in acute ischemic stroke patients with saccular intracranial aneurysms. J Stroke Cerebrovasc Dis. 2013;22:639&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">22341666</ArticleId></ArticleIdList></Reference><Reference><Citation>Mhurchu CN, Anderson C, Jamrozik K, Hankey G, Dunbabin D. Hormonal factors and risk of aneurysmal subarachnoid hemorrhage. Stroke. 2001;32:606&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">11239175</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ. 2009;339:b2535.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2714657</ArticleId><ArticleId IdType="pubmed">19622551</ArticleId></ArticleIdList></Reference><Reference><Citation>Mowla A, Singh K, Mehla S, Ahmed MK, Shirani P, Kamal H, et al. Is acute reperfusion therapy safe in acute ischemic stroke patients who harbor unruptured intracranial aneurysm? Int J Stroke. 2015;10:113&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">26377963</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy G, Docherty AJ. The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol. 1992;7:120&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">1497900</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh YS, Shon YM, Kim BS, Cho AH. Long-term follow-up of incidental intracranial aneurysms in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis. 2013;22:329&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">22018506</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh YS, Lee SJ, Shon YM, Yang DW, Kim BS, Cho AH. Incidental unruptured intracranial aneurysms in patients with acute ischemic stroke. Cerebrovasc Dis. 2008;26:650&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">18984951</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel K, Zafar M, Ziganshin B, Elefteriades J. Diabetes mellitus: Is it protective against aneurysm? A narrative review. Cardiology. 2018;141:107&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">30453299</ArticleId></ArticleIdList></Reference><Reference><Citation>Reggiani F, Labanca V, Mancuso P, Rabascio C, Talarico G, Orecchioni S, et al. Adipose progenitor cell secretion of GMCSF and MMP9 promotes a stromal and immunological microenvironment that supports breast cancer progression. Cancer Res. 2017;77:5169&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">28754674</ArticleId></ArticleIdList></Reference><Reference><Citation>Rong Z, Li L, Fei F, Luo L, Qu Y. Combined treatment of glibenclamide and CoCl2 decreases MMP9 expression and inhibits growth in highly metastatic breast cancer. J Exp Clin Cancer Res. 2013;32:32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3680297</ArticleId><ArticleId IdType="pubmed">23714264</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheth KN, Shah N, Morovati T, Hermann LD, Cronin CA. Intravenous rt-PA is not associated with increased risk of hemorrhage in patients with intracranial aneurysms. Neurocrit Care. 2012;17:199&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pubmed">22752394</ArticleId></ArticleIdList></Reference><Reference><Citation>Shono Y, Sugimori H, Matsuo R, Fukushima Y, Wakisaka Y, Kuroda J, et al. Safety of antithrombotic therapy for patients with acute ischemic stroke harboring unruptured intracranial aneurysm. Int J Stroke. 2018;13:734&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">29543141</ArticleId></ArticleIdList></Reference><Reference><Citation>Starke RM, Chalouhi N, Ali MS, Jabbour PM, Tjoumakaris SI, Gonzalez LF, et al. The role of oxidative stress in cerebral aneurysm formation and rupture. Curr Neurovasc Res. 2013;10:247&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3845363</ArticleId><ArticleId IdType="pubmed">23713738</ArticleId></ArticleIdList></Reference><Reference><Citation>Texakalidis P, Sweid A, Mouchtouris N, Peterson EC, Sioka C, Rangel-Castilla L, et al. Aneurysm formation, growth, and rupture: The biology and physics of cerebral aneurysms. World Neurosurg. 2019;130:277&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">31323409</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson BG, Brown RD, Amin-Hanjani S, Broderick JP, Cockroft KM, Connolly ES, et al. Guidelines for the management of patients with unruptured intracranial aneurysms. Stroke. 2015;46:2368&#x2013;400.</Citation><ArticleIdList><ArticleId IdType="pubmed">26089327</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlak MH, Algra A, Brandenburg R, Rinkel GJ. Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: A systematic review and meta-analysis. Lancet Neurol. 2011;10:626&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">21641282</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlak MH, Rinkel GJ, Greebe P, Algra A. Independent risk factors for intracranial aneurysms and their joint effect. Stroke. 2013;44:984&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">23422088</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiebers DO. Unruptured intracranial aneurysms: Natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet. 2003;362:103&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">12867109</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Duan Z, Liu Y, Zhou C, Jiao Z, Zhao Y, et al. Incidental unruptured intracranial aneurysms do not impact outcome in patients with acute cerebral infarction. Front Neurol. 2021;12:613027.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8107683</ArticleId><ArticleId IdType="pubmed">33981282</ArticleId></ArticleIdList></Reference><Reference><Citation>Zibold F, Kleine JF, Zimmer C, Poppert H, Boeckh-Behrens T. Aneurysms in the target vessels of stroke patients subjected to mechanical thrombectomy: Prevalence and impact on treatment. J NeuroInterv Surg. 2015;8:1016&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">26566879</ArticleId></ArticleIdList></Reference><Reference><Citation>Zlowodzki M, Poolman RW, Kerkhoffs GM, Tornetta P, 3rd, Bhandari M, On behalf of the International Evidence-Based Orthopedic Surgery Working Group How to interpret a meta-analysis and judge its value as a guide for clinical practice. Acta Orthop. 2007;78:598&#x2013;609.</Citation><ArticleIdList><ArticleId IdType="pubmed">17966018</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39617217</PMID><DateCompleted><Year>2025</Year><Month>01</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8511</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association</Title><ISOAbbreviation>J Stroke Cerebrovasc Dis</ISOAbbreviation></Journal><ArticleTitle>Timing of anticoagulation for patients with atrial fibrillation after acute ischemic stroke: Systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>108159</StartPage><MedlinePgn>108159</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jstrokecerebrovasdis.2024.108159</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1052-3057(24)00602-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Patients with acute ischemic stroke (AIS) in the setting of atrial fibrillation (Afib) will need to start/resume anticoagulation (AC) as it is the mainstay for secondary stroke prevention. Several studies have compared the safety and outcomes of starting/resuming AC in early or late start windows (ESW or LSW) but there is no consensus in clinical practice on the optimal timing of anticoagulation. This meta-analysis aims to compare the safety and outcome measures after resuming AC in the ESW versus LSW in patients with Afib after AIS.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Following the PRISMA guidelines, a comprehensive systematic review was conducted using PubMed, Embase, Web of Science, and Scopus. Studies meeting inclusion criteria underwent rigorous risk of bias assessment using the ROBINS-I tool. We compared the safety and outcome measures after resuming AC in the ESW versus LSW in patients with Afib after AIS. Using the R software version 4.3.1, meta-analyses were conducted employing random-effect models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">This meta-analysis included data derived from 7 studies (2 randomized controlled trials and 5 prospective observational studies). Rates of recurrent ischemic stroke/transient ischemic attack (TIA) in patients who started AC in the ESW were comparable to those who started AC in the LSW (OR 0.72, 95 % CI 0.49-1.04; p = 0.083). Similarly, the rates of symptomatic intracranial hemorrhage (sICH) and mortality were comparable between the patients who started AC in the ESW versus LSW (OR 1.66, 95 % CI 0.43-6.47; p = 0.464) and (OR 0.88, 95 % CI 0.65-1.19; p = 0.402), respectively. Finally, using available data from 5 studies, rates of major bleeding were comparable as well between the patients who started AC in ESW versus LSW (OR 0.99, 95 % CI 0.50-1.96; p = 0.970).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Among patients with Afib and AIS who are starting AC in the ESW versus LSW, there were no differences in the outcome measures, specifically stroke/TIA, sICH, mortality, or major bleeding.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Al-Janabi</LastName><ForeName>Omar M</ForeName><Initials>OM</Initials><AffiliationInfo><Affiliation>Department of Neurology, Baptist Health Lexington, Lexington, KY 40503, USA. Electronic address: Omar.Al-Janabi@bhsi.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Odeh</LastName><ForeName>Anas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, An Najah National University, Nablus, Palestine. Electronic address: anas.odeh.ps@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gajjar</LastName><ForeName>Aryan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of California, Los Angeles, CA, USA. Electronic address: agajjar1@g.ucla.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Misra</LastName><ForeName>Avi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Mayo Clinic, Rochester, MN, USA. Electronic address: Misra.Avanish@mayo.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahmood</LastName><ForeName>Yamama M</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>Pharmacy Service, University of Kentucky Healthcare, Lexington, KY, USA. Electronic address: ymma222@uky.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taha</LastName><ForeName>Amira M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Fayoum University, Fayoum, Egypt. Electronic address: am7529@fayoum.edu.eg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Rishabh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Mayo Clinic, Rochester, MN, USA; Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, USA. Electronic address: Gupta324@umn.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghozy</LastName><ForeName>Sherief</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Mayo Clinic, Rochester, MN, USA; Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, USA. Electronic address: ghozy.sherief@mayo.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rabinstein</LastName><ForeName>Alejandro A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Neurology, Mayo Clinic, Rochester, MN, USA. Electronic address: rabinstein.alejandro@mayo.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kallmes</LastName><ForeName>David F</ForeName><Initials>DF</Initials><AffiliationInfo><Affiliation>Department of Radiology, Mayo Clinic, Rochester, MN, USA. Electronic address: david.kallmes@mayo.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Stroke Cerebrovasc Dis</MedlineTA><NlmUniqueID>9111633</NlmUniqueID><ISSNLinking>1052-3057</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="Y">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="Y">Anticoagulants</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000083242" MajorTopicYN="Y">Ischemic Stroke</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061665" MajorTopicYN="Y">Time-to-Treatment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="Y">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="Y">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055502" MajorTopicYN="N">Secondary Prevention</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020300" MajorTopicYN="N">Intracranial Hemorrhages</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute ischemic stroke</Keyword><Keyword MajorTopicYN="N">Anticoagulation</Keyword><Keyword MajorTopicYN="N">Atrial fibrillation</Keyword><Keyword MajorTopicYN="N">Early start window</Keyword><Keyword MajorTopicYN="N">Late start window</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword></KeywordList><CoiStatement>Declaration of competing interest David F. Kallmes declares the following financial interests/personal relationships which may be considered as potential competing interests: he holds equity in Nested Knowledge, Superior Medical Editors, and Conway Medical, Marblehead Medical and Piraeus Medical. He receives grant support from MicroVention, Medtronic, Balt, and Insera Therapeutics; has served on the Data Safety Monitoring Board for Vesalio; and received royalties from Medtronic. All other authors declare that they have no known competing financial interests or personal relationships that could have influenced the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>1</Month><Day>9</Day><Hour>0</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>2</Day><Hour>5</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>1</Day><Hour>19</Hour><Minute>28</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39617217</ArticleId><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2024.108159</ArticleId><ArticleId IdType="pii">S1052-3057(24)00602-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38794845</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2060</ISSN><JournalIssue CitedMedium="Internet"><Volume>56</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Annals of medicine</Title><ISOAbbreviation>Ann Med</ISOAbbreviation></Journal><ArticleTitle>Hemodynamic changes in the prone position according to fluid loading after anaesthesia induction in patients undergoing lumbar spine surgery: a randomized, assessor-blind, prospective study.</ArticleTitle><Pagination><StartPage>2356645</StartPage><MedlinePgn>2356645</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2356645</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1080/07853890.2024.2356645</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">A change from the supine to prone position causes hemodynamic alterations. We aimed to evaluate the effect of fluid preloading in the supine position, the subsequent hemodynamic changes in the prone position and postoperative outcomes.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="UNASSIGNED">This prospective, assessor-blind, randomized controlled trial was conducted between March and June 2023. Adults scheduled for elective orthopaedic lumbar surgery under general anaesthesia were enrolled. In total, 80 participants were randomly assigned to fluid maintenance (M) or loading (L) groups. Both groups were administered intravenous fluid at a rate of 2&#x2009;ml/kg/h until surgical incision; Group L was loaded with an additional 5&#x2009;ml/kg intravenous fluid for 10&#x2009;min after anaesthesia induction. The primary outcome was incidence of hypotension before surgical incision. Secondary outcomes included differences in the mean blood pressure (mBP), heart rate, pleth variability index (PVi), stroke volume variation (SVV), pulse pressure variation (PPV), stroke volume index and cardiac index before surgical incision between the two groups. Additionally, postoperative complications until postoperative day 2 and postoperative hospital length of stay were investigated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Hypotension was prevalent in Group M before surgical incision and could be predicted by a baseline PVi &gt;16. The mBP was significantly higher in Group L immediately after fluid loading. The PVi, SVV and PPV were lower in Group L after fluid loading, with continued differences at 2-3 time points for SVV and PPV. Other outcomes did not differ between the two groups.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Fluid loading after inducing general anaesthesia could reduce the occurrence of hypotension until surgical incision in patients scheduled for surgery in the prone position. Additionally, hypotension could be predicted in patients with a baseline PVi &gt;16. Therefore, intravenous fluid loading is strongly recommended in patients with high baseline PVi to prevent hypotension after anaesthesia induction and in the prone position.</AbstractText><AbstractText Label="TRIAL NUMBER" NlmCategory="UNASSIGNED">KCT0008294 (date of registration: 16 March 2023).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sangho</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-5943-7715</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Kyung Hee University College of Medicine, Kyung Hee University Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Doh Yoon</ForeName><Initials>DY</Initials><Identifier Source="ORCID">0009-0002-2884-3977</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Kyung Hee University College of Medicine, Kyung Hee University Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Jihoon</ForeName><Initials>J</Initials><Identifier Source="ORCID">0009-0005-7093-6538</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Kyung Hee University College of Medicine, Kyung Hee University Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Kyungmi</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-2833-1912</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Korea University Anam Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Ann Hee</ForeName><Initials>AH</Initials><Identifier Source="ORCID">0000-0002-8775-5582</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Kyung Hee University College of Medicine, Kyung Hee University Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Hee Yong</ForeName><Initials>HY</Initials><Identifier Source="ORCID">0000-0001-7506-1375</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Kyung Hee University College of Medicine, Kyung Hee University Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Sung Wook</ForeName><Initials>SW</Initials><Identifier Source="ORCID">0000-0001-8594-9271</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Kyung Hee University College of Medicine, Kyung Hee University Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Mi Kyeong</ForeName><Initials>MK</Initials><Identifier Source="ORCID">0000-0001-6118-4630</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Kyung Hee University College of Medicine, Kyung Hee University Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jung Eun</ForeName><Initials>JE</Initials><Identifier Source="ORCID">0000-0001-5125-3129</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Jeong-Hyun</ForeName><Initials>JH</Initials><Identifier Source="ORCID">0000-0003-1995-1220</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Kyung Hee University College of Medicine, Kyung Hee University Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ann Med</MedlineTA><NlmUniqueID>8906388</NlmUniqueID><ISSNLinking>0785-3890</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016684" MajorTopicYN="N">Prone Position</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="Y">Hemodynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="Y">Fluid Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008159" MajorTopicYN="Y">Lumbar Vertebrae</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="Y">Hypotension</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016037" MajorTopicYN="N">Single-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056888" MajorTopicYN="N">Patient Positioning</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019637" MajorTopicYN="N">Orthopedic Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="plain-language-summary" Language="eng"><AbstractText>Fluid preloading could reduce the occurrence of hypotension in the prone position. Hypotension could be predicted in patients with a baseline PVi &gt;16. Intravenous fluid preloading is strongly recommended in patients with high baseline PVi to prevent hypotension after anaesthesia induction and in the prone position.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anaesthesia induction</Keyword><Keyword MajorTopicYN="N">fluid loading</Keyword><Keyword MajorTopicYN="N">hemodynamic changes</Keyword><Keyword MajorTopicYN="N">lumbar spine surgery</Keyword><Keyword MajorTopicYN="N">postoperative complications</Keyword><Keyword MajorTopicYN="N">prone position</Keyword></KeywordList><CoiStatement>The authors report no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>25</Day><Hour>10</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>25</Day><Hour>10</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>25</Day><Hour>3</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38794845</ArticleId><ArticleId IdType="pmc">PMC11133492</ArticleId><ArticleId IdType="doi">10.1080/07853890.2024.2356645</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schnake KJ, Rappert D, Storzer B, et al. . Lumbar fusion &#x2013; indications and techniques. Orthopade. 2019;48(1):50&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">30552449</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH, Lee JH, Yoon KS, et al. . Effect of intraoperative position used in posterior lumbar interbody fusion on the maintenance of lumbar lordosis. J Neurosurg Spine. 2008;8(3):263&#x2013;270. doi: 10.3171/SPI/2008/8/3/263.</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/SPI/2008/8/3/263</ArticleId><ArticleId IdType="pubmed">18312078</ArticleId></ArticleIdList></Reference><Reference><Citation>Edgcombe H, Carter K, Yarrow S.. Anaesthesia in the prone position. Br J Anaesth. 2008;100(2):165&#x2013;183. doi: 10.1093/bja/aem380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aem380</ArticleId><ArticleId IdType="pubmed">18211991</ArticleId></ArticleIdList></Reference><Reference><Citation>Dharmavaram S, Jellish WS, Nockels RP, et al. . Effect of prone positioning systems on hemodynamic and cardiac function during lumbar spine surgery: an echocardiographic study. Spine (Phila Pa 1976). 2006;31(12):1388&#x2013;1393; discussion 1394. doi: 10.1097/01.brs.0000218485.96713.44.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.brs.0000218485.96713.44</ArticleId><ArticleId IdType="pubmed">16721305</ArticleId></ArticleIdList></Reference><Reference><Citation>Jozwiak M, Monnet X, Teboul JL.. Optimizing the circulation in the prone patient. Curr Opin Crit Care. 2016;22(3):239&#x2013;245. doi: 10.1097/MCC.0000000000000308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCC.0000000000000308</ArticleId><ArticleId IdType="pubmed">27101363</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao D, Low S, Di Fenza R, et al. . Prone positioning of intubated patients with an elevated body-mass index. N Engl J Med. 2022;386(14):e34. doi: 10.1056/NEJMvcm2108494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMvcm2108494</ArticleId><ArticleId IdType="pubmed">35388669</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni L, Fan Y, Bian J, et al. . Effect of body mass on oxygenation and intra-abdominal pressure when using a Jackson surgical table in the prone position during lumbar surgery. Spine (Phila Pa 1976). 2018;43(14):965&#x2013;970. doi: 10.1097/BRS.0000000000002505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0000000000002505</ArticleId><ArticleId IdType="pubmed">29200177</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali A, Dorman Y, Abdullah T, et al. . Ability of mini-fluid challenge to predict fluid responsiveness in obese patients undergoing surgery in the prone position. Minerva Anestesiol. 2019;85(9):981&#x2013;988. doi: 10.23736/S0375-9393.19.13276-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S0375-9393.19.13276-2</ArticleId><ArticleId IdType="pubmed">30994311</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai C, Adda I, Teboul JL, et al. . Effects of prone positioning on venous return in patients with acute respiratory distress syndrome. Crit Care Med. 2021;49(5):781&#x2013;789. doi: 10.1097/CCM.0000000000004849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004849</ArticleId><ArticleId IdType="pubmed">33590997</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin SJ, Park YS, Kim SH, et al. . Effect of prone positional apparatus on the occurrence of acute kidney injury after spine surgery. World Neurosurg. 2019;128:e597&#x2013;e602. doi: 10.1016/j.wneu.2019.04.216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2019.04.216</ArticleId><ArticleId IdType="pubmed">31054343</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim E, Kim HC, Lim YJ, et al. . Comparison of intra-abdominal pressure among 3 prone positional apparatuses after changing from the supine to the prone position and applying positive end-expiratory pressure in healthy euvolemic patients: a prospective observational study. J Neurosurg Anesthesiol. 2017;29(1):14&#x2013;20. doi: 10.1097/ANA.0000000000000257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ANA.0000000000000257</ArticleId><ArticleId IdType="pubmed">26580125</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee CT, Lee TS, Chiu CT, et al. . Mini-fluid challenge test predicts stroke volume and arterial pressure fluid responsiveness during spine surgery in prone position: a STARD-compliant diagnostic accuracy study. Medicine. 2020;99(6):e19031. doi: 10.1097/MD.0000000000019031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000019031</ArticleId><ArticleId IdType="pmc">PMC7015642</ArticleId><ArticleId IdType="pubmed">32028416</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul A, Sriganesh K, Chakrabarti D, et al. . Effect of preanesthetic fluid loading on postinduction hypotension and advanced cardiac parameters in patients with chronic compressive cervical myelopathy: a randomized controlled trial. J Neurosci Rural Pract. 2022;13(3):462&#x2013;470. doi: 10.1055/s-0042-1749459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0042-1749459</ArticleId><ArticleId IdType="pmc">PMC9357500</ArticleId><ArticleId IdType="pubmed">35946018</ArticleId></ArticleIdList></Reference><Reference><Citation>Biais M, Bernard O, Ha JC, et al. . Abilities of pulse pressure variations and stroke volume variations to predict fluid responsiveness in prone position during scoliosis surgery. Br J Anaesth. 2010;104(4):407&#x2013;413. doi: 10.1093/bja/aeq031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aeq031</ArticleId><ArticleId IdType="pubmed">20190260</ArticleId></ArticleIdList></Reference><Reference><Citation>Messina A, Montagnini C, Cammarota G, et al. . Assessment of fluid responsiveness in prone neurosurgical patients undergoing protective ventilation: role of dynamic indices, tidal volume challenge, and end-expiratory occlusion test. Anesth Analg. 2020;130(3):752&#x2013;761. doi: 10.1213/ANE.0000000000004494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000004494</ArticleId><ArticleId IdType="pubmed">31651455</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger K, Francony G, Bouzat P, et al. . Prone position affects stroke volume variation performance in predicting fluid responsiveness in neurosurgical patients. Minerva Anestesiol. 2015;81(6):628&#x2013;635.</Citation><ArticleIdList><ArticleId IdType="pubmed">25263024</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer MO, Lemoine S, Tavernier B, et al. . Individualized fluid management using the pleth variability index: a randomized clinical trial. Anesthesiology. 2020;133(1):31&#x2013;40. doi: 10.1097/ALN.0000000000003260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003260</ArticleId><ArticleId IdType="pubmed">32205547</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannesson M, Desebbe O, Rosamel P, et al. . Pleth variability index to monitor the respiratory variations in the pulse oximeter plethysmographic waveform amplitude and predict fluid responsiveness in the operating theatre. Br J Anaesth. 2008;101(2):200&#x2013;206. doi: 10.1093/bja/aen133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aen133</ArticleId><ArticleId IdType="pubmed">18522935</ArticleId></ArticleIdList></Reference><Reference><Citation>Forget P, Lois F, de Kock M.. Goal-directed fluid management based on the pulse oximeter-derived pleth variability index reduces lactate levels and improves fluid management. Anesth Analg. 2010;111(4):910&#x2013;914. doi: 10.1213/ANE.0b013e3181eb624f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e3181eb624f</ArticleId><ArticleId IdType="pubmed">20705785</ArticleId></ArticleIdList></Reference><Reference><Citation>Jammer I, Wickboldt N, Sander M, et al. . Standards for definitions and use of outcome measures for clinical effectiveness research in perioperative medicine: European Perioperative Clinical Outcome (EPCO) definitions: a statement from the ESA-ESICM joint taskforce on perioperative outcome measures. Eur J Anaesthesiol. 2015;32(2):88&#x2013;105. doi: 10.1097/EJA.0000000000000118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000000118</ArticleId><ArticleId IdType="pubmed">25058504</ArticleId></ArticleIdList></Reference><Reference><Citation>Niven DJ, L&#xe9;ger C, Stelfox HT, et al. . Fever in the critically ill: a review of epidemiology, immunology, and management. J Intensive Care Med. 2012;27(5):290&#x2013;297. doi: 10.1177/0885066611402463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0885066611402463</ArticleId><ArticleId IdType="pubmed">21441283</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179&#x2013;c184. doi: 10.1159/000339789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000339789</ArticleId><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Monnet X, Gu&#xe9;rin L, Jozwiak M, et al. . Pleth variability index is a weak predictor of fluid responsiveness in patients receiving norepinephrine. Br J Anaesth. 2013;110(2):207&#x2013;213. doi: 10.1093/bja/aes373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aes373</ArticleId><ArticleId IdType="pubmed">23103777</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SH, Chun YM, Oh YJ, et al. . Prediction of fluid responsiveness in the beach chair position using dynamic preload indices. J Clin Monit Comput. 2016;30(6):995&#x2013;1002. doi: 10.1007/s10877-015-9821-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-015-9821-5</ArticleId><ArticleId IdType="pubmed">26719298</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YF, Song LL, Ma W, et al. . Dynamic variables to predict fluid responsiveness in young children. Pediatr Int. 2023;65(1):e15477. doi: 10.1111/ped.15477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ped.15477</ArticleId><ArticleId IdType="pubmed">36652421</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee HC, Tsai YF, Tsai HI, et al. . Pulse oximeter-derived pleth variability index is a reliable indicator of cardiac preload in patients undergoing liver transplantation. Transplant Proc. 2016;48(4):1055&#x2013;1058. doi: 10.1016/j.transproceed.2015.12.106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.transproceed.2015.12.106</ArticleId><ArticleId IdType="pubmed">27320555</ArticleId></ArticleIdList></Reference><Reference><Citation>Thirunelli RK, Nanjundaswamy NH.. A prospective observational study of plethysmograph variability index and perfusion index in predicting hypotension with propofol induction in noncardiac surgeries. Anesth Essays Res. 2021;15(2):167&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8916132</ArticleId><ArticleId IdType="pubmed">35281362</ArticleId></ArticleIdList></Reference><Reference><Citation>Y&#xfc;ksek A. Utility of the pleth variability index in predicting anesthesia-induced hypotension in geriatric patients. Turk J Med Sci. 2021;51(1):134&#x2013;139. doi: 10.3906/sag-1912-132.</Citation><ArticleIdList><ArticleId IdType="doi">10.3906/sag-1912-132</ArticleId><ArticleId IdType="pmc">PMC7991892</ArticleId><ArticleId IdType="pubmed">32892541</ArticleId></ArticleIdList></Reference><Reference><Citation>Rijs K, Mercier FJ, Lucas DN, et al. . Fluid loading therapy to prevent spinal hypotension in women undergoing elective caesarean section: network meta-analysis, trial sequential analysis and meta-regression. Eur J Anaesthesiol. 2020;37(12):1126&#x2013;1142. doi: 10.1097/EJA.0000000000001371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000001371</ArticleId><ArticleId IdType="pmc">PMC7752245</ArticleId><ArticleId IdType="pubmed">33109924</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37940953</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Nov</Month><Day>08</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Reliability of pulse pressure and stroke volume variation in assessing fluid responsiveness in the operating room: a metanalysis and a metaregression.</ArticleTitle><Pagination><StartPage>431</StartPage><MedlinePgn>431</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">431</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-023-04706-0</ELocationID><Abstract><AbstractText Label="BACKGROUND">Pulse pressure and stroke volume variation (PPV and SVV) have been widely used in surgical patients as predictors of fluid challenge (FC) response. Several factors may affect the reliability of these indices in predicting fluid responsiveness, such as the position of the patient, the use of laparoscopy and the opening of the abdomen or the chest, combined FC characteristics, the tidal volume (Vt) and the type of anesthesia.</AbstractText><AbstractText Label="METHODS">Systematic review and metanalysis of PPV and SVV use in surgical adult patients. The QUADAS-2 scale was used to assess the risk of bias of included studies. We adopted a metanalysis pooling of aggregate data from 5 subgroups of studies with random effects models using the common-effect inverse variance model. The area under the curve (AUC) of pooled receiving operating characteristics (ROC) curves was reported. A metaregression was performed using FC type, volume, and rate as independent variables.</AbstractText><AbstractText Label="RESULTS">We selected 59 studies enrolling 2,947 patients, with a median of fluid responders of 55% (46-63). The pooled AUC for the PPV was 0.77 (0.73-0.80), with a mean threshold of 10.8 (10.6-11.0). The pooled AUC for the SVV was 0.76 (0.72-0.80), with a mean threshold of 12.1 (11.6-12.7); 19 studies (32.2%) reported the grey zone of PPV or SVV, with a median of 56% (40-62) and 57% (46-83) of patients included, respectively. In the different subgroups, the AUC and the best thresholds ranged from 0.69 and 0.81 and from 6.9 to 11.5% for the PPV, and from 0.73 to 0.79 and 9.9 to 10.8% for the SVV. A high Vt and the choice of colloids positively impacted on PPV performance, especially among patients with closed chest and abdomen, or in prone position.</AbstractText><AbstractText Label="CONCLUSION">The overall performance of PPV and SVV in operating room in predicting fluid responsiveness is moderate, ranging close to an AUC of 0.80 only some subgroups of surgical patients. The grey zone of these dynamic indices is wide and should be carefully considered during the assessment of fluid responsiveness. A high Vt and the choice of colloids for the FC are factors potentially influencing PPV reliability.</AbstractText><AbstractText Label="TRIAL REGISTRATION">PROSPERO (CRD42022379120), December 2022. https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=379120.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Messina</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care Medicine, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089, Rozzano - Milan, Italy. antonio.messina@humanitas.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072, Pieve Emanuele, Milan, Italy. antonio.messina@humanitas.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caporale</LastName><ForeName>Mariagiovanna</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calabr&#xf2;</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care Medicine, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089, Rozzano - Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lionetti</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care Medicine, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089, Rozzano - Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bono</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care Medicine, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089, Rozzano - Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matronola</LastName><ForeName>Guia Margherita</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brunati</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frassanito</LastName><ForeName>Luciano</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morenghi</LastName><ForeName>Emanuela</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care Medicine, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089, Rozzano - Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antonelli</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chew</LastName><ForeName>Michelle S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Biomedical and Clinical Sciences, Link&#xf6;ping University, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cecconi</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care Medicine, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089, Rozzano - Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003102">Colloids</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care. 2023 Dec 7;27(1):482. doi: 10.1186/s13054-023-04765-3.</RefSource><PMID Version="1">38062505</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care. 2024 Jan 12;28(1):22. doi: 10.1186/s13054-023-04796-w.</RefSource><PMID Version="1">38216947</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001794" MajorTopicYN="N">Blood Pressure</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="Y">Hemodynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009873" MajorTopicYN="Y">Operating Rooms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003102" MajorTopicYN="N">Colloids</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="N">Fluid Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Fluid responsiveness</Keyword><Keyword MajorTopicYN="N">Fluid therapy</Keyword><Keyword MajorTopicYN="N">Hemodynamic monitoring</Keyword><Keyword MajorTopicYN="N">Pulse pressure variation</Keyword><Keyword MajorTopicYN="N">Stroke volume variation</Keyword></KeywordList><CoiStatement>Prof. Michelle Chew is a Critical Care journal editor and received travel reimbursements and speaker fees from Edwards Lifesciences and from AOP Health. Dr. Messina received travel expenses and registration for meetings, congresses, and courses and lecture fees from Vygon, Phlips, Edwards; Prof. Cecconi is a consultant for Edwards Lifesciences.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>9</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>8</Day><Hour>23</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37940953</ArticleId><ArticleId IdType="pmc">PMC10631038</ArticleId><ArticleId IdType="doi">10.1186/s13054-023-04706-0</ArticleId><ArticleId IdType="pii">10.1186/s13054-023-04706-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Thiele RH, Raghunathan K, Brudney CS, Lobo DN, Martin D, Senagore A, Cannesson M, Gan TJ, Mythen MM, Shaw AD, Miller TE. Perioperative quality initiative IW: American society for enhanced recovery (aser) and perioperative quality initiative (poqi) joint consensus statement on perioperative fluid management within an enhanced recovery pathway for colorectal surgery. Perioper Med. 2016;5:24. doi: 10.1186/s13741-016-0049-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13741-016-0049-9</ArticleId><ArticleId IdType="pmc">PMC5027098</ArticleId><ArticleId IdType="pubmed">27660701</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldheiser A, Aziz O, Baldini G, Cox BP, Fearon KC, Feldman LS, Gan TJ, Kennedy RH, Ljungqvist O, Lobo DN, Miller T, Radtke FF, Ruiz Garces T, Schricker T, Scott MJ, Thacker JK, Ytrebo LM, Carli F. Enhanced recovery after surgery (eras) for gastrointestinal surgery, part 2: consensus statement for anaesthesia practice. Acta Anaesthesiol Scand. 2016;60:289&#x2013;334. doi: 10.1111/aas.12651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.12651</ArticleId><ArticleId IdType="pmc">PMC5061107</ArticleId><ArticleId IdType="pubmed">26514824</ArticleId></ArticleIdList></Reference><Reference><Citation>Makaryus R, Miller TE, Gan TJ. Current concepts of fluid management in enhanced recovery pathways. Br J Anaesth. 2018;120:376&#x2013;383. doi: 10.1016/j.bja.2017.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2017.10.011</ArticleId><ArticleId IdType="pubmed">29406186</ArticleId></ArticleIdList></Reference><Reference><Citation>Navarro LH, Bloomstone JA, Auler JO, Jr, Cannesson M, Rocca GD, Gan TJ, Kinsky M, Magder S, Miller TE, Mythen M, Perel A, Reuter DA, Pinsky MR, Kramer GC. Perioperative fluid therapy: a statement from the international fluid optimization group. Perioper Med. 2015;4:3. doi: 10.1186/s13741-015-0014-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13741-015-0014-z</ArticleId><ArticleId IdType="pmc">PMC4403901</ArticleId><ArticleId IdType="pubmed">25897397</ArticleId></ArticleIdList></Reference><Reference><Citation>Biais M, Ehrmann S, Mari A, Conte B, Mahjoub Y, Desebbe O, Pottecher J, Lakhal K, Benzekri-Lefevre D, Molinari N, Boulain T, Lefrant JY, Muller L, AzuRea G. Clinical relevance of pulse pressure variations for predicting fluid responsiveness in mechanically ventilated intensive care unit patients: the grey zone approach. Crit Care. 2014;18:587. doi: 10.1186/s13054-014-0587-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-014-0587-9</ArticleId><ArticleId IdType="pmc">PMC4240833</ArticleId><ArticleId IdType="pubmed">25658489</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahjoub Y, Lejeune V, Muller L, Perbet S, Zieleskiewicz L, Bart F, Veber B, Paugam-Burtz C, Jaber S, Ayham A, Zogheib E, Lasocki S, Vieillard-Baron A, Quintard H, Joannes-Boyau O, Plantefeve G, Montravers P, Duperret S, Lakhdari M, Ammenouche N, Lorne E, Slama M, Dupont H. Evaluation of pulse pressure variation validity criteria in critically ill patients: a prospective observational multicentre point-prevalence study. Br J Anaesth. 2014;112:681&#x2013;685. doi: 10.1093/bja/aet442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aet442</ArticleId><ArticleId IdType="pubmed">24374504</ArticleId></ArticleIdList></Reference><Reference><Citation>De Backer D, Heenen S, Piagnerelli M, Koch M, Vincent JL. Pulse pressure variations to predict fluid responsiveness: influence of tidal volume. Intensive Care Med. 2005;31:517&#x2013;523. doi: 10.1007/s00134-005-2586-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-005-2586-4</ArticleId><ArticleId IdType="pubmed">15754196</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannesson M, Le Manach Y, Hofer CK, Goarin JP, Lehot JJ, Vallet B, Tavernier B. Assessing the diagnostic accuracy of pulse pressure variations for the prediction of fluid responsiveness: a "gray zone" approach. Anesthesiology. 2011;115:231&#x2013;241. doi: 10.1097/ALN.0b013e318225b80a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e318225b80a</ArticleId><ArticleId IdType="pubmed">21705869</ArticleId></ArticleIdList></Reference><Reference><Citation>Futier E, Constantin JM, Paugam-Burtz C, Pascal J, Eurin M, Neuschwander A, Marret E, Beaussier M, Gutton C, Lefrant JY, Allaouchiche B. A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Eng J Med. 2013;369(5):428&#x2013;37. doi: 10.1056/NEJMoa1301082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1301082</ArticleId><ArticleId IdType="pubmed">23902482</ArticleId></ArticleIdList></Reference><Reference><Citation>Eikermann M, Kurth T. Apply protective mechanical ventilation in the operating room in an individualized approach to perioperative respiratory care. Anesthesiology. 2015;123:12&#x2013;14. doi: 10.1097/ALN.0000000000000707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000707</ArticleId><ArticleId IdType="pubmed">25978325</ArticleId></ArticleIdList></Reference><Reference><Citation>Messina A, Pelaia C, Bruni A, Garofalo E, Bonicolini E, Longhini F, Dellara E, Saderi L, Romagnoli S, Sotgiu G, Cecconi M, Navalesi P. Fluid challenge during anesthesia: a systematic review and meta-analysis. Anesth Analg. 2018;127:1353&#x2013;1364. doi: 10.1213/ANE.0000000000003834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000003834</ArticleId><ArticleId IdType="pubmed">30300177</ArticleId></ArticleIdList></Reference><Reference><Citation>Messina A, Sotgiu G, Saderi L, Cammarota G, Capuano L, Colombo D, Bennett V, Payen D, Navalesi P, Cecconi M. Does the definition of fluid responsiveness affect passive leg raising reliability? A methodological ancillary analysis from a multicentric study. Minerva Anestesiol. 2021;88(4):272&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">34709017</ArticleId></ArticleIdList></Reference><Reference><Citation>Messina A, Palandri C, De Rosa S, Danzi V, Bonaldi E, Montagnini C, Baino S, Villa F, Sala F, Zito P, Negri K, Della Corte F, Cammarota G, Saderi L, Sotgiu G, Monge Garcia MI, Cecconi M. Pharmacodynamic analysis of a fluid challenge with 4 ml kg(&#x2212;&#xa0;1) over 10 or 20 min: a multicenter cross-over randomized clinical trial. J Clin Monit Comput. 2022;36:1193&#x2013;1203. doi: 10.1007/s10877-021-00756-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-021-00756-3</ArticleId><ArticleId IdType="pmc">PMC8423602</ArticleId><ArticleId IdType="pubmed">34494204</ArticleId></ArticleIdList></Reference><Reference><Citation>Barthelemy R, Kindermans M, Delval P, Collet M, Gaugain S, Cecconi M, Mebazaa A, Chousterman BG. Accuracy of cumulative volumes of fluid challenge to assess fluid responsiveness in critically ill patients with acute circulatory failure: a pharmacodynamic approach. Br J Anaesth. 2022;128:236&#x2013;243. doi: 10.1016/j.bja.2021.10.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2021.10.049</ArticleId><ArticleId IdType="pubmed">34895718</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, Group P Preferred reporting items for systematic reviews and meta-analyses: the prisma statement. BMJ. 2009;339:b2535. doi: 10.1136/bmj.b2535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2535</ArticleId><ArticleId IdType="pmc">PMC2714657</ArticleId><ArticleId IdType="pubmed">19622551</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM. Group Q&#x2013;Quadas-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529&#x2013;536. doi: 10.7326/0003-4819-155-8-201110180-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-155-8-201110180-00009</ArticleId><ArticleId IdType="pubmed">22007046</ArticleId></ArticleIdList></Reference><Reference><Citation>Messina A, Dell'Anna A, Baggiani M, Torrini F, Maresca GM, Bennett V, Saderi L, Sotgiu G, Antonelli M, Cecconi M. Functional hemodynamic tests: a systematic review and a metanalysis on the reliability of the end-expiratory occlusion test and of the mini-fluid challenge in predicting fluid responsiveness. Crit Care. 2019;23:264. doi: 10.1186/s13054-019-2545-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-019-2545-z</ArticleId><ArticleId IdType="pmc">PMC6664788</ArticleId><ArticleId IdType="pubmed">31358025</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539&#x2013;1558. doi: 10.1002/sim.1186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1186</ArticleId><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>de Courson H, Chauvet J, Le Gall L, Georges D, Boyer P, Verchere E, Nouette-Gaulain K, Biais M. Utility of changes in end-tidal carbon dioxide after volume expansion to assess fluid responsiveness in the operating room: a prospective observational study. Br J Anaesth. 2020;125:672&#x2013;679. doi: 10.1016/j.bja.2020.07.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2020.07.018</ArticleId><ArticleId IdType="pubmed">32863016</ArticleId></ArticleIdList></Reference><Reference><Citation>Bubenek-Turconi SI, Hendy A, Baila S, Dragan A, Chioncel O, Valeanu L, Morosanu B, Iliescu VA. The value of a superior vena cava collapsibility index measured with a miniaturized transoesophageal monoplane continuous echocardiography probe to predict fluid responsiveness compared to stroke volume variations in open major vascular surgery: a prospective cohort study. J Clin Monit Comput. 2020;34:491&#x2013;499. doi: 10.1007/s10877-019-00346-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-019-00346-4</ArticleId><ArticleId IdType="pmc">PMC7223808</ArticleId><ArticleId IdType="pubmed">31278544</ArticleId></ArticleIdList></Reference><Reference><Citation>Joosten A, Boudart C, Vincent JL, Vanden Eynden F, Barvais L, Van Obbergh L, Rinehart J, Desebbe O. Ability of a new smartphone pulse pressure variation and cardiac output application to predict fluid responsiveness in patients undergoing cardiac surgery. Anesth Analg. 2019;128:1145&#x2013;1151. doi: 10.1213/ANE.0000000000003652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000003652</ArticleId><ArticleId IdType="pubmed">31094781</ArticleId></ArticleIdList></Reference><Reference><Citation>Biais M, de Courson H, Lanchon R, Pereira B, Bardonneau G, Griton M, Sesay M, Nouette-Gaulain K. Mini-fluid challenge of 100 ml of crystalloid predicts fluid responsiveness in the operating room. Anesthesiology. 2017;127:450&#x2013;456. doi: 10.1097/ALN.0000000000001753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001753</ArticleId><ArticleId IdType="pubmed">28640019</ArticleId></ArticleIdList></Reference><Reference><Citation>Biais M, Lanchon R, Sesay M, Le Gall L, Pereira B, Futier E, Nouette-Gaulain K. Changes in stroke volume induced by lung recruitment maneuver predict fluid responsiveness in mechanically ventilated patients in the operating room. Anesthesiology. 2017;126:260&#x2013;267. doi: 10.1097/ALN.0000000000001459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001459</ArticleId><ArticleId IdType="pubmed">27922547</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen J, Dai S, Tao X, Chen X, Xu L. Corrected flow time and respirophasic variation in blood flow peak velocity of radial artery predict fluid responsiveness in gynecological surgical patients with mechanical ventilation. BMC Anesthesiol. 2022;22:299. doi: 10.1186/s12871-022-01837-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-022-01837-9</ArticleId><ArticleId IdType="pmc">PMC9484168</ArticleId><ArticleId IdType="pubmed">36123625</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordstrom J, Hallsjo-Sander C, Shore R, Bjorne H. Stroke volume optimization in elective bowel surgery: a comparison between pulse power wave analysis (lidcorapid) and oesophageal doppler (cardioq) Br J Anaesth. 2013;110:374&#x2013;380. doi: 10.1093/bja/aes399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aes399</ArticleId><ArticleId IdType="pubmed">23171725</ArticleId></ArticleIdList></Reference><Reference><Citation>Messina A, Montagnini C, Cammarota G, De Rosa S, Giuliani F, Muratore L, Della Corte F, Navalesi P, Cecconi M. Tidal volume challenge to predict fluid responsiveness in the operating room: an observational study. Eur J Anaesthesiol. 2019;36:583&#x2013;591. doi: 10.1097/EJA.0000000000000998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000000998</ArticleId><ArticleId IdType="pubmed">31021879</ArticleId></ArticleIdList></Reference><Reference><Citation>Biais M, Larghi M, Henriot J, de Courson H, Sesay M, Nouette-Gaulain K. End-expiratory occlusion test predicts fluid responsiveness in patients with protective ventilation in the operating room. Anesth Analg. 2017;125:1889&#x2013;1895. doi: 10.1213/ANE.0000000000002322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000002322</ArticleId><ArticleId IdType="pubmed">28742783</ArticleId></ArticleIdList></Reference><Reference><Citation>De Broca B, Garnier J, Fischer MO, Archange T, Marc J, Abou-Arab O, Dupont H, Lorne E, Guinot PG. Stroke volume changes induced by a recruitment maneuver predict fluid responsiveness in patients with protective ventilation in the operating theater. Medicine. 2016;95:e4259. doi: 10.1097/MD.0000000000004259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000004259</ArticleId><ArticleId IdType="pmc">PMC4956831</ArticleId><ArticleId IdType="pubmed">27428237</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura A, Suehiro K, Juri T, Tanaka K, Mori T. Changes in corrected carotid flow time induced by recruitment maneuver predict fluid responsiveness in patients undergoing general anesthesia. J Clin Monit Comput. 2022;36:1069&#x2013;1077. doi: 10.1007/s10877-021-00736-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-021-00736-7</ArticleId><ArticleId IdType="pubmed">34191254</ArticleId></ArticleIdList></Reference><Reference><Citation>Messina A, Lionetti G, Foti L, Bellotti E, Marcomini N, Cammarota G, Bennett V, Saderi L, Sotgiu G, Della Corte F, Protti A, Monge Garcia MI, Romagnoli S, Cecconi M. Mini fluid challenge and end-expiratory occlusion test to assess fluid responsiveness in the operating room (maneuver study): a multicentre cohort study. Eur J Anaesthesiol. 2021;38:422&#x2013;431. doi: 10.1097/EJA.0000000000001406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000001406</ArticleId><ArticleId IdType="pubmed">33399372</ArticleId></ArticleIdList></Reference><Reference><Citation>Weil G, Motamed C, Eghiaian A, Monnet X, Suria S. Comparison of proaqt/pulsioflex. Anaesth Crit Care Pain Med. 2019;38:153&#x2013;159. doi: 10.1016/j.accpm.2018.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.accpm.2018.03.011</ArticleId><ArticleId IdType="pubmed">29679768</ArticleId></ArticleIdList></Reference><Reference><Citation>Weil G, Motamed C, Monnet X, Eghiaian A, Le Maho AL. End-expiratory occlusion test to predict fluid responsiveness is not suitable for laparotomic surgery. Anesth Analg. 2020;130:151&#x2013;158. doi: 10.1213/ANE.0000000000004205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000004205</ArticleId><ArticleId IdType="pubmed">31846441</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura A, Suehiro K, Juri T, Fujimoto Y, Yoshida H, Tanaka K, Mori T, Nishikawa K. Hemodynamic changes via the lung recruitment maneuver can predict fluid responsiveness in stroke volume and arterial pressure during one-lung ventilation. Anesth Analg. 2021;133:44&#x2013;52. doi: 10.1213/ANE.0000000000005375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005375</ArticleId><ArticleId IdType="pubmed">33687175</ArticleId></ArticleIdList></Reference><Reference><Citation>Jun JH, Chung RK, Baik HJ, Chung MH, Hyeon JS, Lee YG, Park SH. The tidal volume challenge improves the reliability of dynamic preload indices during robot-assisted laparoscopic surgery in the trendelenburg position with lung-protective ventilation. BMC Anesthesiol. 2019;19:142. doi: 10.1186/s12871-019-0807-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-019-0807-6</ArticleId><ArticleId IdType="pmc">PMC6686427</ArticleId><ArticleId IdType="pubmed">31390982</ArticleId></ArticleIdList></Reference><Reference><Citation>Zlicar M, Novak-Jankovic V, Blagus R, Cecconi M. Predictive values of pulse pressure variation and stroke volume variation for fluid responsiveness in patients with pneumoperitoneum. J Clin Monit Comput. 2018;32:825&#x2013;832. doi: 10.1007/s10877-017-0081-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-017-0081-4</ArticleId><ArticleId IdType="pubmed">29149433</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim DH, Shin S, Kim JY, Kim SH, Jo M, Choi YS. Pulse pressure variation and pleth variability index as predictors of fluid responsiveness in patients undergoing spinal surgery in the prone position. Ther Clin Risk Manag. 2018;14:1175&#x2013;1183. doi: 10.2147/TCRM.S170395.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/TCRM.S170395</ArticleId><ArticleId IdType="pmc">PMC6038863</ArticleId><ArticleId IdType="pubmed">30013353</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee CT, Lee TS, Chiu CT, Teng HC, Cheng HL, Wu CY. Mini-fluid challenge test predicts stroke volume and arterial pressure fluid responsiveness during spine surgery in prone position: a stard-compliant diagnostic accuracy study. Medicine. 2020;99:e19031. doi: 10.1097/MD.0000000000019031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000019031</ArticleId><ArticleId IdType="pmc">PMC7015642</ArticleId><ArticleId IdType="pubmed">32028416</ArticleId></ArticleIdList></Reference><Reference><Citation>Guinot PG, de Broca B, Bernard E, Abou Arab O, Lorne E, Dupont H. Respiratory stroke volume variation assessed by oesophageal doppler monitoring predicts fluid responsiveness during laparoscopy. Br J Anaesth. 2014;112:660&#x2013;664. doi: 10.1093/bja/aet430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aet430</ArticleId><ArticleId IdType="pubmed">24366723</ArticleId></ArticleIdList></Reference><Reference><Citation>Marik PE, Cavallazzi R, Vasu T, Hirani A. Dynamic changes in arterial waveform derived variables and fluid responsiveness in mechanically ventilated patients: a systematic review of the literature. Crit Care Med. 2009;37:2642&#x2013;2647. doi: 10.1097/CCM.0b013e3181a590da.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181a590da</ArticleId><ArticleId IdType="pubmed">19602972</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Lu B, Sheng X, Jin N. Accuracy of stroke volume variation in predicting fluid responsiveness: a systematic review and meta-analysis. J Anesth. 2011;25:904&#x2013;916. doi: 10.1007/s00540-011-1217-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-011-1217-1</ArticleId><ArticleId IdType="pubmed">21892779</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann M, Feibicke T, Keyl C, Prasser C, Moritz S, Graf BM, Wiesenack C. Accuracy of stroke volume variation compared with pleth variability index to predict fluid responsiveness in mechanically ventilated patients undergoing major surgery. Eur J Anaesthesiol. 2010;27:555&#x2013;561. doi: 10.1097/EJA.0b013e328335fbd1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0b013e328335fbd1</ArticleId><ArticleId IdType="pubmed">20035228</ArticleId></ArticleIdList></Reference><Reference><Citation>Aya HD, Ster IC, Fletcher N, Grounds RM, Rhodes A, Cecconi M. Pharmacodynamic analysis of a fluid challenge. Crit Care Med. 2016;44:880&#x2013;891. doi: 10.1097/CCM.0000000000001517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000001517</ArticleId><ArticleId IdType="pubmed">26683506</ArticleId></ArticleIdList></Reference><Reference><Citation>Messina A, Calabro L, Pugliese L, Lulja A, Sopuch A, Rosalba D, Morenghi E, Hernandez G, Monnet X, Cecconi M. Fluid challenge in critically ill patients receiving haemodynamic monitoring: a systematic review and comparison of two decades. Crit Care. 2022;26:186. doi: 10.1186/s13054-022-04056-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-022-04056-3</ArticleId><ArticleId IdType="pmc">PMC9210670</ArticleId><ArticleId IdType="pubmed">35729632</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofer CK, M&#xfc;ller SM, Furrer L, Klaghofer R, Genoni M, Zollinger A. Stroke volume and pulse pressure variation for prediction of fluid responsiveness in patients undergoing off-pump coronary artery bypass grafting. Chest. 2005;128:848&#x2013;854. doi: 10.1378/chest.128.2.848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.128.2.848</ArticleId><ArticleId IdType="pubmed">16100177</ArticleId></ArticleIdList></Reference><Reference><Citation>Preisman S, Kogan S, Berkenstadt H, Perel A. Predicting fluid responsiveness in patients undergoing cardiac surgery: functional haemodynamic parameters including the respiratory systolic variation test and static preload indicators. Br J Anaesth. 2005;95:746&#x2013;755. doi: 10.1093/bja/aei262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aei262</ArticleId><ArticleId IdType="pubmed">16286349</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannesson M, Attof Y, Rosamel P, Desebbe O, Joseph P, Metton O, Bastien O, Lehot JJ. Respiratory variations in pulse oximetry plethysmographic waveform amplitude to predict fluid responsiveness in the operating room. Anesthesiology. 2007;106:1105&#x2013;1111. doi: 10.1097/01.anes.0000267593.72744.20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.anes.0000267593.72744.20</ArticleId><ArticleId IdType="pubmed">17525584</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH, Kim JT, Yoon SZ, Lim YJ, Jeon Y, Bahk JH, Kim CS. Evaluation of corrected flow time in oesophageal doppler as a predictor of fluid responsiveness. Br J Anaesth. 2007;99:343&#x2013;348. doi: 10.1093/bja/aem179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aem179</ArticleId><ArticleId IdType="pubmed">17621598</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannesson M, Slieker J, Desebbe O, Bauer C, Chiari P, Henaine R, Lehot JJ. The ability of a novel algorithm for automatic estimation of the respiratory variations in arterial pulse pressure to monitor fluid responsiveness in the operating room. Anesthesia Analgesia. 2008;106:1195&#x2013;1200. doi: 10.1213/01.ane.0000297291.01615.5c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ane.0000297291.01615.5c</ArticleId><ArticleId IdType="pubmed">18349192</ArticleId></ArticleIdList></Reference><Reference><Citation>Messina A, Romano SM, Bonicolini E, Colombo D, Cammarota G, Chiostri M, Della Corte F, Navalesi P, Payen D, Romagnoli S. Cardiac cycle efficiency and dicrotic pressure variations: new parameters for fluid therapy: an observational study. Eur J Anaesthesiol. 2017;34:755&#x2013;763. doi: 10.1097/EJA.0000000000000661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000000661</ArticleId><ArticleId IdType="pubmed">28722695</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannesson M, Desebbe O, Rosamel P, Delannoy B, Robin J, Bastien O, Lehot JJ. Pleth variability index to monitor the respiratory variations in the pulse oximeter plethysmographic waveform amplitude and predict fluid responsiveness in the operating theatre. Br J Anaesth. 2008;101:200&#x2013;206. doi: 10.1093/bja/aen133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aen133</ArticleId><ArticleId IdType="pubmed">18522935</ArticleId></ArticleIdList></Reference><Reference><Citation>Min JJ, Kim TK, Lee JH, Park J, Cho HS, Kim WS, Lee YT. Evaluation of augmented pulse pressure variation using the valsalva manoeuvre as a predictor of fluid responsiveness under open-chest conditions: a prospective observational study. Eur J Anaesthesiol. 2017;34:254&#x2013;261. doi: 10.1097/EJA.0000000000000613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000000613</ArticleId><ArticleId IdType="pubmed">28207430</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannesson M, Musard H, Desebbe O, Boucau C, Simon R, H&#xe9;naine R, Lehot JJ. The ability of stroke volume variations obtained with vigileo/flotrac system to monitor fluid responsiveness in mechanically ventilated patients. Anesth Analg. 2009;108:513&#x2013;517. doi: 10.1213/ane.0b013e318192a36b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0b013e318192a36b</ArticleId><ArticleId IdType="pubmed">19151280</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong DM, Ahn HJ, Park HW, Yang M, Kim JA, Park J. Stroke volume variation and pulse pressure variation are not useful for predicting fluid responsiveness in thoracic surgery. Anesth Analg. 2017;125:1158&#x2013;1165. doi: 10.1213/ANE.0000000000002056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000002056</ArticleId><ArticleId IdType="pubmed">28504996</ArticleId></ArticleIdList></Reference><Reference><Citation>Derichard A, Robin E, Tavernier B, Costecalde M, Fleyfel M, Onimus J, Lebuffe G, Chambon JP, Vallet B. Automated pulse pressure and stroke volume variations from radial artery: evaluation during major abdominal surgery. Br J Anaesth. 2009;103:678&#x2013;684. doi: 10.1093/bja/aep267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aep267</ArticleId><ArticleId IdType="pubmed">19797246</ArticleId></ArticleIdList></Reference><Reference><Citation>Min JJ, Lee JH, Hong KY, Choi SJ. Utility of stroke volume variation measured using non-invasive bioreactance as a predictor of fluid responsiveness in the prone position. J Clin Monit Comput. 2017;31:397&#x2013;405. doi: 10.1007/s10877-016-9859-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-016-9859-z</ArticleId><ArticleId IdType="pubmed">26964992</ArticleId></ArticleIdList></Reference><Reference><Citation>de Waal EE, Rex S, Kruitwagen CL, Kalkman CJ, Buhre WF. Dynamic preload indicators fail to predict fluid responsiveness in open-chest conditions. Crit Care Med. 2009;37:510&#x2013;515. doi: 10.1097/CCM.0b013e3181958bf7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181958bf7</ArticleId><ArticleId IdType="pubmed">19114886</ArticleId></ArticleIdList></Reference><Reference><Citation>Biais M, Bernard O, Ha JC, Degryse C, Sztark F. Abilities of pulse pressure variations and stroke volume variations to predict fluid responsiveness in prone position during scoliosis surgery. Br J Anaesth. 2010;104:407&#x2013;413. doi: 10.1093/bja/aeq031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aeq031</ArticleId><ArticleId IdType="pubmed">20190260</ArticleId></ArticleIdList></Reference><Reference><Citation>Suehiro K, Okutani R. Stroke volume variation as a predictor of fluid responsiveness in patients undergoing one-lung ventilation. J Cardiothorac Vasc Anesth. 2010;24:772&#x2013;775. doi: 10.1053/j.jvca.2010.03.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2010.03.014</ArticleId><ArticleId IdType="pubmed">20638869</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH, Jeon Y, Bahk JH, Gil NS, Hong DM, Kim JH, Kim HJ. Pulse pressure variation as a predictor of fluid responsiveness during one-lung ventilation for lung surgery using thoracotomy: randomised controlled study. Eur J Anaesthesiol. 2011;28:39&#x2013;44. doi: 10.1097/EJA.0b013e32834089cf.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0b013e32834089cf</ArticleId><ArticleId IdType="pubmed">21088596</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf8;iseth L, Hoff IE, Skare O, Kirkeb&#xf8;en KA, Landsverk SA. Photoplethysmographic and pulse pressure variations during abdominal surgery. Acta Anaesthesiol Scand. 2011;55:1221&#x2013;1230. doi: 10.1111/j.1399-6576.2011.02527.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-6576.2011.02527.x</ArticleId><ArticleId IdType="pubmed">22092127</ArticleId></ArticleIdList></Reference><Reference><Citation>Biais M, Stecken L, Ottolenghi L, Roullet S, Quinart A, Masson F, Sztark F. The ability of pulse pressure variations obtained with cnap&#x2122; device to predict fluid responsiveness in the operating room. Anesth Analg. 2011;113:523&#x2013;528. doi: 10.1213/ANE.0b013e3182240054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e3182240054</ArticleId><ArticleId IdType="pubmed">21642606</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali A, Abdullah T, Sabanci PA, Dogan L, Orhan-Sungur M, Akinci IO. Comparison of ability of pulse pressure variation to predict fluid responsiveness in prone and supine position: an observational study. J Clin Monit Comput. 2019;33:573&#x2013;580. doi: 10.1007/s10877-018-0195-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-018-0195-3</ArticleId><ArticleId IdType="pubmed">30117033</ArticleId></ArticleIdList></Reference><Reference><Citation>Suehiro K, Okutani R. Influence of tidal volume for stroke volume variation to predict fluid responsiveness in patients undergoing one-lung ventilation. J Anesth. 2011;25:777&#x2013;780. doi: 10.1007/s00540-011-1200-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-011-1200-x</ArticleId><ArticleId IdType="pubmed">21744128</ArticleId></ArticleIdList></Reference><Reference><Citation>Vistisen ST, Berg JM, Boekel MF, Modestini M, Bergman R, Jainandunsing JS, Mariani MA, Scheeren TWL. Using extra systoles and the micro-fluid challenge to predict fluid responsiveness during cardiac surgery. J Clin Monit Comput. 2019;33:777&#x2013;786. doi: 10.1007/s10877-018-0218-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-018-0218-0</ArticleId><ArticleId IdType="pubmed">30414054</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf8;iseth L, Hoff IE, Myre K, Landsverk SA, Kirkeb&#xf8;en KA. Dynamic variables of fluid responsiveness during pneumoperitoneum and laparoscopic surgery. Acta Anaesthesiol Scand. 2012;56:777&#x2013;786. doi: 10.1111/j.1399-6576.2011.02641.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-6576.2011.02641.x</ArticleId><ArticleId IdType="pubmed">22288953</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali A, Aygun E, Abdullah T, Bolsoy-Deveci S, Orhan-Sungur M, Canbaz M, Ozkan Akinci I. A challenge with 5 cmh2o of positive end-expiratory pressure predicts fluid responsiveness in neurosurgery patients with protective ventilation: an observational study. Minerva Anestesiol. 2019;85:1184&#x2013;1192. doi: 10.23736/S0375-9393.19.13721-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S0375-9393.19.13721-2</ArticleId><ArticleId IdType="pubmed">31213047</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim KM, Gwak MS, Choi SJ, Kim MH, Park MH, Heo BY. Pulse pressure variation and stroke volume variation to predict fluid responsiveness in patients undergoing carotid endarterectomy. Korean J Anesthesiol. 2013;65:237&#x2013;243. doi: 10.4097/kjae.2013.65.3.237.</Citation><ArticleIdList><ArticleId IdType="doi">10.4097/kjae.2013.65.3.237</ArticleId><ArticleId IdType="pmc">PMC3790035</ArticleId><ArticleId IdType="pubmed">24101958</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali A, Dorman Y, Abdullah T, Yasa C, Orhan-Sungur M, Akinci IO, Ergin-Ozcan P. Ability of mini-fluid challenge to predict fluid responsiveness in obese patients undergoing surgery in the prone position. Minerva Anestesiol. 2019;85:981&#x2013;988. doi: 10.23736/S0375-9393.19.13276-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S0375-9393.19.13276-2</ArticleId><ArticleId IdType="pubmed">30994311</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo H, Kong YG, Jin SJ, Chin JH, Kim HY, Lee YK, Hwang JH, Kim YK. Dynamic arterial elastance in predicting arterial pressure increase after fluid challenge during robot-assisted laparoscopic prostatectomy: a prospective observational study. Medicine. 2015;94:e1794. doi: 10.1097/MD.0000000000001794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000001794</ArticleId><ArticleId IdType="pmc">PMC4616778</ArticleId><ArticleId IdType="pubmed">26469925</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger K, Francony G, Bouzat P, Halle C, Genty C, Oddoux M, Gay E, Albaladejo P, Payen JF. Prone position affects stroke volume variation performance in predicting fluid responsiveness in neurosurgical patients. Minerva Anestesiol. 2015;81:628&#x2013;635.</Citation><ArticleIdList><ArticleId IdType="pubmed">25263024</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe R, Suehiro K, Mukai A, Tanaka K, Yamada T, Mori T, Nishikawa K. Changes in stroke volume induced by lung recruitment maneuver can predict fluid responsiveness during intraoperative lung-protective ventilation in prone position. BMC Anesthesiol. 2021;21:303. doi: 10.1186/s12871-021-01527-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-021-01527-y</ArticleId><ArticleId IdType="pmc">PMC8638171</ArticleId><ArticleId IdType="pubmed">34856928</ArticleId></ArticleIdList></Reference><Reference><Citation>Tusman G, Groisman I, Maidana GA, Scandurra A, Arca JM, Bohm SH, Suarez-Sipmann F. The sensitivity and specificity of pulmonary carbon dioxide elimination for noninvasive assessment of fluid responsiveness. Anesth Analg. 2016;122:1404&#x2013;1411. doi: 10.1213/ANE.0000000000001047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000001047</ArticleId><ArticleId IdType="pubmed">26505574</ArticleId></ArticleIdList></Reference><Reference><Citation>Montenij LJ, Sonneveld JP, Nierich AP, Buhre WF, de Waal EE. Diagnostic accuracy of stroke volume variation measured with uncalibrated arterial waveform analysis for the prediction of fluid responsiveness in patients with impaired left ventricular function: a prospective, observational study. J Clin Monit Comput. 2016;30:481&#x2013;486. doi: 10.1007/s10877-015-9743-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-015-9743-2</ArticleId><ArticleId IdType="pmc">PMC4960272</ArticleId><ArticleId IdType="pubmed">26227160</ArticleId></ArticleIdList></Reference><Reference><Citation>Flick M, Sand U, Bergholz A, Kouz K, Reiter B, Flotzinger D, Saugel B, Kubitz JC. Right ventricular and pulmonary artery pulse pressure variation and systolic pressure variation for the prediction of fluid responsiveness: an interventional study in coronary artery bypass surgery patients. J Clin Monit Comput. 2022;36:1817&#x2013;1825. doi: 10.1007/s10877-022-00830-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-022-00830-4</ArticleId><ArticleId IdType="pubmed">35233702</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29335335</PMID><DateCompleted><Year>2018</Year><Month>03</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1524-4628</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Stroke</Title><ISOAbbreviation>Stroke</ISOAbbreviation></Journal><ArticleTitle>Closure of Patent Foramen Ovale Versus Medical Therapy in Patients With Cryptogenic Stroke or Transient Ischemic Attack: Updated Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>412</StartPage><EndPage>418</EndPage><MedlinePgn>412-418</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1161/STROKEAHA.117.020030</ELocationID><Abstract><AbstractText Label="BACKGROUND AND PURPOSE">Previous systematic reviews and meta-analyses compared the efficacy and safety of patent foramen ovale (PFO) closure versus medical treatment in patients with cryptogenic stroke or transient ischemic attack (TIA). Recently, new evidence from randomized trials became available.</AbstractText><AbstractText Label="METHODS">We searched PubMed until September 24, 2017, for trials comparing PFO closure with medical treatment in patients with cryptogenic stroke/TIA using the items: stroke or cerebrovascular accident or TIA and patent foramen ovale or paradoxical embolism and trial or study.</AbstractText><AbstractText Label="RESULTS">Among 851 identified articles, 5 were eligible. In 3627 patients with 3.7-year mean follow-up, there was significant difference in ischemic stroke recurrence (0.53 versus 1.1 per 100 patient-years, respectively; odds ratio [OR], 0.43; 95% confidence intervals (CI), 0.21-0.90; relative risk reduction, 50.5%; absolute risk reduction, 2.11%; and number needed to treat to prevent 1 event, 46.5 for 3.7 years). There was no significant difference in TIAs (0.78 versus 0.98 per 100 patient-years, respectively; OR, 0.80; 95% CI, 0.53-1.19) and all-cause mortality (0.18 versus 0.23 per 100 patient-years, respectively; OR, 0.73; 95% CI, 0.34-1.56). New-onset atrial fibrillation occurred more frequently in the PFO closure arm (1.3 versus 0.25 per 100 patient-years, respectively; OR, 5.15; 95% CI, 2.18-12.15) and resolved in 72% of cases within 45 days, whereas rates of myocardial infarction (0.12 versus 0.09 per 100 patient-years, respectively; OR, 1.22; 95% CI, 0.25-5.91) and any serious adverse events (7.3 versus 7.3 per 100 patient-years, respectively; OR, 1.07; 95% CI, 0.92-1.25) were similar.</AbstractText><AbstractText Label="CONCLUSIONS">In patients with cryptogenic stroke/TIA and PFO who have their PFO closed, ischemic stroke recurrence is less frequent compared with patients receiving medical treatment. Atrial fibrillation is more frequent but mostly transient. There is no difference in TIA, all-cause mortality, or myocardial infarction.</AbstractText><CopyrightInformation>&#xa9; 2018 American Heart Association, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ntaios</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>From the Department of Medicine, University of Thessaly, Larissa, Greece (G.N., D.S., K.M.); Stroke Service, Department of Neurosciences, Leeds Teaching Hospitals NHS Trust and Medical School, University of Leeds, United Kingdom (V.P.); Hellenic Cardiovascular Research Society, Athens, Greece (K.V.); Department of Neurology, Klinikum Frankfurt H&#xf6;chst, Frankfurt, Germany (T.S.); Department of Neurology, Heidelberg University, Germany (T.S.); and Stroke Center, Lausanne University Hospital, Switzerland (P.M.). gntaios@med.uth.gr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papavasileiou</LastName><ForeName>Vasileios</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>From the Department of Medicine, University of Thessaly, Larissa, Greece (G.N., D.S., K.M.); Stroke Service, Department of Neurosciences, Leeds Teaching Hospitals NHS Trust and Medical School, University of Leeds, United Kingdom (V.P.); Hellenic Cardiovascular Research Society, Athens, Greece (K.V.); Department of Neurology, Klinikum Frankfurt H&#xf6;chst, Frankfurt, Germany (T.S.); Department of Neurology, Heidelberg University, Germany (T.S.); and Stroke Center, Lausanne University Hospital, Switzerland (P.M.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sagris</LastName><ForeName>Dimitrios</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>From the Department of Medicine, University of Thessaly, Larissa, Greece (G.N., D.S., K.M.); Stroke Service, Department of Neurosciences, Leeds Teaching Hospitals NHS Trust and Medical School, University of Leeds, United Kingdom (V.P.); Hellenic Cardiovascular Research Society, Athens, Greece (K.V.); Department of Neurology, Klinikum Frankfurt H&#xf6;chst, Frankfurt, Germany (T.S.); Department of Neurology, Heidelberg University, Germany (T.S.); and Stroke Center, Lausanne University Hospital, Switzerland (P.M.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Makaritsis</LastName><ForeName>Konstantinos</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>From the Department of Medicine, University of Thessaly, Larissa, Greece (G.N., D.S., K.M.); Stroke Service, Department of Neurosciences, Leeds Teaching Hospitals NHS Trust and Medical School, University of Leeds, United Kingdom (V.P.); Hellenic Cardiovascular Research Society, Athens, Greece (K.V.); Department of Neurology, Klinikum Frankfurt H&#xf6;chst, Frankfurt, Germany (T.S.); Department of Neurology, Heidelberg University, Germany (T.S.); and Stroke Center, Lausanne University Hospital, Switzerland (P.M.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vemmos</LastName><ForeName>Konstantinos</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>From the Department of Medicine, University of Thessaly, Larissa, Greece (G.N., D.S., K.M.); Stroke Service, Department of Neurosciences, Leeds Teaching Hospitals NHS Trust and Medical School, University of Leeds, United Kingdom (V.P.); Hellenic Cardiovascular Research Society, Athens, Greece (K.V.); Department of Neurology, Klinikum Frankfurt H&#xf6;chst, Frankfurt, Germany (T.S.); Department of Neurology, Heidelberg University, Germany (T.S.); and Stroke Center, Lausanne University Hospital, Switzerland (P.M.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steiner</LastName><ForeName>Thorsten</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>From the Department of Medicine, University of Thessaly, Larissa, Greece (G.N., D.S., K.M.); Stroke Service, Department of Neurosciences, Leeds Teaching Hospitals NHS Trust and Medical School, University of Leeds, United Kingdom (V.P.); Hellenic Cardiovascular Research Society, Athens, Greece (K.V.); Department of Neurology, Klinikum Frankfurt H&#xf6;chst, Frankfurt, Germany (T.S.); Department of Neurology, Heidelberg University, Germany (T.S.); and Stroke Center, Lausanne University Hospital, Switzerland (P.M.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michel</LastName><ForeName>Patrik</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>From the Department of Medicine, University of Thessaly, Larissa, Greece (G.N., D.S., K.M.); Stroke Service, Department of Neurosciences, Leeds Teaching Hospitals NHS Trust and Medical School, University of Leeds, United Kingdom (V.P.); Hellenic Cardiovascular Research Society, Athens, Greece (K.V.); Department of Neurology, Klinikum Frankfurt H&#xf6;chst, Frankfurt, Germany (T.S.); Department of Neurology, Heidelberg University, Germany (T.S.); and Stroke Center, Lausanne University Hospital, Switzerland (P.M.).</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Stroke</MedlineTA><NlmUniqueID>0235266</NlmUniqueID><ISSNLinking>0039-2499</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005343">Fibrinolytic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Stroke. 2018 May;49(5):e209. doi: 10.1161/STROKEAHA.118.020831.</RefSource><PMID Version="1">29622621</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Stroke. 2018 May;49(5):e210. doi: 10.1161/STROKEAHA.118.021080.</RefSource><PMID Version="1">29622622</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Stroke. 2018 May;49(5):e212. doi: 10.1161/STROKEAHA.118.021403.</RefSource><PMID Version="1">29643255</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Stroke. 2018 May;49(5):e211. doi: 10.1161/STROKEAHA.118.021173.</RefSource><PMID Version="1">29643260</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Stroke. 2018 May;49(5):e213. doi: 10.1161/STROKEAHA.118.021281.</RefSource><PMID Version="1">29643262</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002545" MajorTopicYN="N">Brain Ischemia</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005343" MajorTopicYN="N">Fibrinolytic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054092" MajorTopicYN="N">Foramen Ovale, Patent</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="N">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">embolism, paradoxical</Keyword><Keyword MajorTopicYN="N">foramen ovale, patent</Keyword><Keyword MajorTopicYN="N">ischemic attack, transient</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29335335</ArticleId><ArticleId IdType="doi">10.1161/STROKEAHA.117.020030</ArticleId><ArticleId IdType="pii">STROKEAHA.117.020030</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29741972</PMID><DateCompleted><Year>2019</Year><Month>10</Month><Day>29</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2060</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>5</Issue><PubDate><Year>2018</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Annals of medicine</Title><ISOAbbreviation>Ann Med</ISOAbbreviation></Journal><ArticleTitle>Effects of perioperative statins on patient outcomes after noncardiac surgery: a meta-analysis.</ArticleTitle><Pagination><StartPage>402</StartPage><EndPage>409</EndPage><MedlinePgn>402-409</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/07853890.2018.1471217</ELocationID><Abstract><AbstractText Label="BACKGROUND">Cardiovascular complications are strongly correlated with a higher risk of mortality during follow-up after noncardiac surgery. However, controversy remains regarding whether perioperative administration of hydroxymethylglutaryl-CoA reductase inhibitors (statins) has a beneficial effect on patient outcomes.</AbstractText><AbstractText Label="OBJECTIVE">We performed a meta-analysis to validate the hypothesis that perioperative statins improve patient outcomes after noncardiac surgery.</AbstractText><AbstractText Label="METHODS">Electronic databases (PubMed, Web of Science, EMBASE, and the Cochrane Library) were searched for randomized controlled trials (RCTs) published up to 10 November 2017. RCTs were eligible for inclusion if they compared perioperative statin treatment with control treatment in patients scheduled for noncardiac surgery and reported data pertaining to clinical outcomes.</AbstractText><AbstractText Label="RESULTS">Twelve RCTs involving 4707 patients (2371 in the perioperative statin group and 2336 in the control group) were ultimately included in this meta-analysis. The incidences of postoperative myocardial infarction, composite of death/myocardial infarction/stroke and new cases of atrial fibrillation were all lower in patients treated with statins than in control group patients, as shown by the fixed-effects model (odds ratio (OR)&#x2009;=&#x2009;0.460, 95% confidence interval (CI)&#x2009;=&#x2009;0.324-0.653, p&#x2009;=&#x2009;0 for myocardial infarction; OR&#x2009;=&#x2009;0.617, 95% CI&#x2009;=&#x2009;0.476-0.801, p&#x2009;=&#x2009;0 for composite of death/myocardial infarction/stroke; OR&#x2009;=&#x2009;0.406, 95% CI&#x2009;=&#x2009;0.247-0.666, p&#x2009;=&#x2009;0 for new atrial fibrillation). No significant differences in the incidences of stroke or transient ischemic attack, all-cause mortality and cardiovascular mortality were observed between the statin and control arms.</AbstractText><AbstractText Label="CONCLUSIONS">This meta-analysis supports the hypothesis that perioperative statins effectively reduce the incidences of postoperative myocardial infarction, composite of death/myocardial infarction/stroke and new cases of atrial fibrillation in patients undergoing noncardiac surgery. Key Messages Cardiovascular complications are strongly correlated with a higher risk of mortality during follow-up after noncardiac surgery. We performed a meta-analysis to confirm the hypothesis that perioperative statins improve patient outcomes after noncardiac surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Baoxin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>a Department of Cardiology , The Affiliated Hospital of Binzhou Medical University , Binzhou , Shandong , China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Jingwu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>a Department of Cardiology , The Affiliated Hospital of Binzhou Medical University , Binzhou , Shandong , China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diao</LastName><ForeName>Shuling</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>a Department of Cardiology , The Affiliated Hospital of Binzhou Medical University , Binzhou , Shandong , China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>a Department of Cardiology , The Affiliated Hospital of Binzhou Medical University , Binzhou , Shandong , China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Hua</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>b Department of Oncology , The Affiliated Hospital of Binzhou Medical University , Binzhou , Shandong , China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>05</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ann Med</MedlineTA><NlmUniqueID>8906388</NlmUniqueID><ISSNLinking>0785-3890</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019161">Hydroxymethylglutaryl-CoA Reductase Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019161" MajorTopicYN="N">Hydroxymethylglutaryl-CoA Reductase Inhibitors</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Statins</Keyword><Keyword MajorTopicYN="N">hydroxymethylglutaryl-CoA reductase inhibitor</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">noncardiac surgery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29741972</ArticleId><ArticleId IdType="doi">10.1080/07853890.2018.1471217</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40018495</PMID><DateRevised><Year>2025</Year><Month>04</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Impact of Dual Antiplatelet Therapy Versus Monotherapy in Acute Stroke Management: A Systematic Review.</ArticleTitle><Pagination><StartPage>e78138</StartPage><MedlinePgn>e78138</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e78138</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.78138</ELocationID><Abstract><AbstractText>This systematic review evaluates the comparative efficacy and safety of dual antiplatelet therapy (DAPT) versus monotherapy in the management of acute ischemic stroke and transient ischemic attack (TIA). Six studies, published between 2019 and 2024, were included, focusing on patient outcomes such as stroke recurrence, functional recovery, and safety measures. The findings consistently demonstrated that DAPT, particularly combinations like aspirin with clopidogrel or cilostazol, significantly reduced stroke recurrence and improved functional outcomes as compared to monotherapy, without a notable increase in major bleeding risk. Timing and duration of therapy were identified as critical factors, with early initiation and prolonged DAPT showing promising results in high-risk populations, including those with intracranial arterial stenosis or large artery atherosclerosis. Genetic polymorphisms, such as CYP2B6 variants, further influenced treatment efficacy, highlighting the potential for personalized therapeutic approaches. While the evidence underscores the clinical value of DAPT, it also identifies gaps&#xa0;such as the need for real-world studies and investigations into long-term safety. This review contributes to advancing stroke management by providing a nuanced, evidence-based perspective on the role of DAPT in reducing vascular events and disability.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025, Adil Areeb et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Adil Areeb</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neurology, Avicenna Tajik State Medical University, Dushanbe, TJK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohanty</LastName><ForeName>Rakesh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Anesthesiology, King's College Hospital, London, GBR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hisoriya</LastName><ForeName>Hiren B</ForeName><Initials>HB</Initials><AffiliationInfo><Affiliation>Internal Medicine, Poona Hospital and Research Centre, Pune, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mithani</LastName><ForeName>Javeria</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Internal Medicine, Karachi Medical and Dental College, Karachi, PAK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogungbemi</LastName><ForeName>Oluwatobiloba T</ForeName><Initials>OT</Initials><AffiliationInfo><Affiliation>Internal Medicine, Caucasus's International University, Tbilisi, GEO.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pathak</LastName><ForeName>Kesha</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Internal Medicine, Gujarat Adani Institute of Medical Sciences, Bhuj, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farooq</LastName><ForeName>Umar</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Medicine and Surgery, Avicenna Medical College, Lahore, PAK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Dhaheri</LastName><ForeName>Rauda</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cardiology, Dubai Medical College for Girls, Dubai, ARE.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aziz</LastName><ForeName>Ahmad Zubair</ForeName><Initials>AZ</Initials><AffiliationInfo><Affiliation>Internal Medicine, Hunan Normal University, Khanpur, PAK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kausar</LastName><ForeName>Nishath</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Internal Medicine, Sitara Medical Center, Hyderabad, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raza</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Internal Medicine, Nishtar Medical University, Multan, PAK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D016441">Retracted Publication</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>01</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="RetractionIn"><RefSource>Cureus. 2025 Apr 1;17(4):r176. doi: 10.7759/cureus.r176.</RefSource><PMID Version="1">40177233</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">aspirin</Keyword><Keyword MajorTopicYN="N">cilostazol</Keyword><Keyword MajorTopicYN="N">clopidogrel</Keyword><Keyword MajorTopicYN="N">dual antiplatelet therapy</Keyword><Keyword MajorTopicYN="N">genetic polymorphisms</Keyword><Keyword MajorTopicYN="N">ischemic stroke</Keyword><Keyword MajorTopicYN="N">personalized medicine</Keyword><Keyword MajorTopicYN="N">stroke management</Keyword><Keyword MajorTopicYN="N">stroke recurrence</Keyword><Keyword MajorTopicYN="N">transient ischemic attack</Keyword></KeywordList><CoiStatement>Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>1</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>2</Month><Day>28</Day><Hour>5</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>1</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40018495</ArticleId><ArticleId IdType="pmc">PMC11867216</ArticleId><ArticleId IdType="doi">10.7759/cureus.78138</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stroke in the 21st century: a snapshot of the burden, epidemiology, and quality of life. Donkor ES. Stroke Res Treat. 2018;2018:3238165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6288566</ArticleId><ArticleId IdType="pubmed">30598741</ArticleId></ArticleIdList></Reference><Reference><Citation>Antithrombotic therapy to prevent recurrent strokes in ischemic cerebrovascular disease: JACC Scientific Expert Panel. Del Brutto VJ, Chaturvedi S, Diener HC, Romano JG, Sacco RL. J Am Coll Cardiol. 2019;74:786&#x2013;803.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7291776</ArticleId><ArticleId IdType="pubmed">31395130</ArticleId></ArticleIdList></Reference><Reference><Citation>Efficacy and safety of using dual versus monotherapy antiplatelet agents in secondary stroke prevention: systematic review and meta-analysis of randomized controlled clinical trials. Trifan G, Gorelick PB, Testai FD. Circulation. 2021;143:2441&#x2013;2453.</Citation><ArticleIdList><ArticleId IdType="pubmed">33926204</ArticleId></ArticleIdList></Reference><Reference><Citation>Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studies. Harris J, Pouwels KB, Johnson T, et al. Health Technol Assess. 2023;27:1&#x2013;257.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10363958</ArticleId><ArticleId IdType="pubmed">37435838</ArticleId></ArticleIdList></Reference><Reference><Citation>Association between genetic polymorphisms and sites of cervicocerebral artery atherosclerosis. Chutinet A, Suwanwela NC, Snabboon T, Chaisinanunkul N, Furie KL, Phanthumchinda K. J Stroke Cerebrovasc Dis. 2012;21:379&#x2013;385.</Citation><ArticleIdList><ArticleId IdType="pubmed">21296594</ArticleId></ArticleIdList></Reference><Reference><Citation>Using the full PICO model as a search tool for systematic reviews resulted in lower recall for some PICO elements. Frandsen TF, Bruun Nielsen MF, Lindhardt CL, Eriksen MB. J Clin Epidemiol. 2020;127:69&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">32679315</ArticleId></ArticleIdList></Reference><Reference><Citation>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Page MJ, McKenzie JE, Bossuyt PM, et al. BMJ. 2021;372:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8008539</ArticleId><ArticleId IdType="pubmed">33781348</ArticleId></ArticleIdList></Reference><Reference><Citation>Eligibility criteria in systematic reviews: a methodological review. McCrae N, Blackstock M, Purssell E. Int J Nurs Stud. 2015;52:1269&#x2013;1276.</Citation><ArticleIdList><ArticleId IdType="pubmed">25726430</ArticleId></ArticleIdList></Reference><Reference><Citation>Association between CYP2B6 polymorphisms and efficacy of clopidogrel in minor stroke or transient ischemic attack. Qiu X, Zhang Y, Gu H, et al. Stroke. 2023;54:1770&#x2013;1776.</Citation><ArticleIdList><ArticleId IdType="pubmed">37264909</ArticleId></ArticleIdList></Reference><Reference><Citation>Time to treatment and disability attributed to index stroke in the POINT trial. Balali P, Easton JD, Johnston SC, Cucchiara B. J Stroke Cerebrovasc Dis. 2024;33:107988.</Citation><ArticleIdList><ArticleId IdType="pubmed">39222701</ArticleId></ArticleIdList></Reference><Reference><Citation>Dual antiplatelet therapy using cilostazol in patients with stroke and intracranial arterial stenosis. Uchiyama S, Toyoda K, Omae K, et al. J Am Heart Assoc. 2021;10:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8751870</ArticleId><ArticleId IdType="pubmed">34622679</ArticleId></ArticleIdList></Reference><Reference><Citation>Dual antiplatelet use for extended period targeted to acute ischemic stroke with presumed atherosclerotic origin (DURATION) trial: rationale and design. Kim JT, Kang J, Kim BJ, et al.  https://pubmed.ncbi.nlm.nih.gov/36974902/ Int J Stroke. 2023;18:1015&#x2013;1020.</Citation><ArticleIdList><ArticleId IdType="pubmed">36974902</ArticleId></ArticleIdList></Reference><Reference><Citation>Association of timing for starting dual antiplatelet treatment with cilostazol and recurrent stroke: a CSPS.com trial post hoc analysis. Toyoda K, Omae K, Hoshino H, et al. Neurology. 2022;98:0&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8967394</ArticleId><ArticleId IdType="pubmed">35074890</ArticleId></ArticleIdList></Reference><Reference><Citation>Ipsilateral nonstenotic carotid disease in minor ischemic stroke: an exploratory analysis of the POINT randomized clinical trial. Bulwa Z, Saleh Velez FG, Brorson JR, Pinto CB. J Stroke Cerebrovasc Dis. 2020;29:105115.</Citation><ArticleIdList><ArticleId IdType="pubmed">33066893</ArticleId></ArticleIdList></Reference><Reference><Citation>Dual or mono antiplatelet therapy for patients with acute ischemic stroke or transient ischemic attack: systematic review and meta-analysis of randomized controlled trials. Geeganage CM, Diener HC, Algra A, et al. Stroke. 2012;43:1058&#x2013;1066.</Citation><ArticleIdList><ArticleId IdType="pubmed">22282894</ArticleId></ArticleIdList></Reference><Reference><Citation>Dual antiplatelet therapy for the acute management and long-term secondary prevention of ischemic stroke and transient ischemic attack, an updated review. Chan BP, Wong LY, Tan BY, Yeo LL, Venketasubramanian N. J Cardiovasc Dev Dis. 2024;11:48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10889184</ArticleId><ArticleId IdType="pubmed">38392262</ArticleId></ArticleIdList></Reference><Reference><Citation>Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Berger PB, Bhatt DL, Fuster V, et al. Circulation. 2010;121:2575&#x2013;2583.</Citation><ArticleIdList><ArticleId IdType="pubmed">20516378</ArticleId></ArticleIdList></Reference><Reference><Citation>Dual antiplatelet therapy in the management of acute minor ischemic stroke and high-risk transient ischemic attack: an expert consensus statement from Taiwan Stroke Society and Taiwan Society of Emergency Medicine. Chen PL, Chen YJ, Chung CP, et al.  https://pubmed.ncbi.nlm.nih.gov/36313610/ J Acute Med. 2022;12:85&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9561483</ArticleId><ArticleId IdType="pubmed">36313610</ArticleId></ArticleIdList></Reference><Reference><Citation>Recent advances in the management of transient ischemic attacks. Ortiz-Garcia J, Gomez CR, Schneck MJ, Biller J. Fac Rev. 2022;11:19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9340656</ArticleId><ArticleId IdType="pubmed">35949262</ArticleId></ArticleIdList></Reference><Reference><Citation>Transient ischemic attacks preceding ischemic stroke and the possible preconditioning of the human brain: a systematic review and meta-analysis. Ghozy S, Kacimi SE, Elfil M, et al. Front Neurol. 2021;12:755167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8652229</ArticleId><ArticleId IdType="pubmed">34899573</ArticleId></ArticleIdList></Reference><Reference><Citation>Personalized dual antiplatelet therapy in acute coronary syndromes: striking a balance between bleeding and thrombosis. Shpigelman J, Proshkina A, Daly MJ, Cox D. Curr Cardiol Rep. 2023;25:693&#x2013;710.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10307718</ArticleId><ArticleId IdType="pubmed">37261665</ArticleId></ArticleIdList></Reference><Reference><Citation>Dual antiplatelet treatment up to 72 hours after ischemic stroke. Gao Y, Chen W, Pan Y, et al. N Engl J Med. 2023;389:2413&#x2013;2424.</Citation><ArticleIdList><ArticleId IdType="pubmed">38157499</ArticleId></ArticleIdList></Reference><Reference><Citation>Duration of dual antiplatelet therapy: a systematic review for the 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Bittl JA, Baber U, Bradley SM, Wijeysundera DN. J Am Coll Cardiol. 2016;68:1116&#x2013;1139.</Citation><ArticleIdList><ArticleId IdType="pubmed">27036919</ArticleId></ArticleIdList></Reference><Reference><Citation>Genetic polymorphisms in pharmaceuticals and chemotherapy. Gummadi AC, Guddati AK. World J Oncol. 2021;12:149&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8577603</ArticleId><ArticleId IdType="pubmed">34804277</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24353155</PMID><DateCompleted><Year>2014</Year><Month>04</Month><Day>02</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-493X</ISSN><JournalIssue CitedMedium="Internet"><Issue>12</Issue><PubDate><Year>2013</Year><Month>Dec</Month><Day>19</Day></PubDate></JournalIssue><Title>The Cochrane database of systematic reviews</Title><ISOAbbreviation>Cochrane Database Syst Rev</ISOAbbreviation></Journal><ArticleTitle>Local versus general anaesthesia for carotid endarterectomy.</ArticleTitle><Pagination><StartPage>CD000126</StartPage><MedlinePgn>CD000126</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/14651858.CD000126.pub4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Carotid endarterectomy may significantly reduce the risk of stroke in people with recently symptomatic, severe carotid artery stenosis. However, there are significant perioperative risks that may be reduced by performing the operation under local rather than general anaesthetic. This is an update of a Cochrane Review first published in 1996, and previously updated in 2004 and 2008.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To determine whether carotid endarterectomy under local anaesthetic: (1) reduces the risk of perioperative stroke and death compared with general anaesthetic; (2) reduces the complication rate (other than stroke) following carotid endarterectomy; and (3) is acceptable to patients and surgeons.</AbstractText><AbstractText Label="SEARCH METHODS" NlmCategory="METHODS">We searched the Cochrane Stroke Group Trials Register (September 2013), MEDLINE (1966 to September 2013), EMBASE (1980 to September 2013) and Index to Scientific and Technical Proceedings (ISTP) (1980 to September 2013). We also handsearched relevant journals, and searched the reference lists of articles identified.</AbstractText><AbstractText Label="SELECTION CRITERIA" NlmCategory="METHODS">Randomised trials comparing the use of local anaesthetic to general anaesthetic for carotid endarterectomy were considered for inclusion.</AbstractText><AbstractText Label="DATA COLLECTION AND ANALYSIS" NlmCategory="METHODS">Three review authors independently assessed trial quality and extracted data. We calculated a pooled Peto odds ratio (OR) and corresponding 95% confidence interval (CI) for the following outcomes that occurred within 30 days of surgery: stroke, death, stroke or death, myocardial infarction, local haemorrhage, cranial nerve injuries, and shunted arteries.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">We included 14 randomised trials involving 4596 operations, of which 3526 were from the single largest trial (GALA). In general, reporting of methodology in the included studies was poor. All studies were unable to blind patients and surgical teams to randomised treatment allocation and for most studies the blinding of outcome assessors was unclear. There was no statistically significant difference in the incidence of stroke within 30 days of surgery between the local anaesthesia group and the general anaesthesia group. The incidence of strokes in the local anaesthesia group was 3.2% compared to 3.5% in the general anaesthesia group (Peto OR 0.92, 95% CI 0.67 to 1.28). There was no statistically significant difference in the proportion of patients who had a stroke or died within 30 days of surgery. In the local anaesthesia group 3.6% of patients had a stroke or died compared to 4.2% of patients in the general anaesthesia group (Peto OR 0.85, 95% CI 0.63 to 1.16). There was a non-significant trend towards lower operative mortality with local anaesthetic. In the local anaesthesia group 0.9% of patients died within 30 days of surgery compared to 1.5% of patients in the general anaesthesia group (Peto OR 0.62, 95% CI 0.36 to 1.07). However, neither the GALA trial or the pooled analysis were adequately powered to reliably detect an effect on mortality.</AbstractText><AbstractText Label="AUTHORS' CONCLUSIONS" NlmCategory="CONCLUSIONS">The proportion of patients who had a stroke or died within 30 days of surgery did not differ significantly between the two types of anaesthetic techniques used during carotid endarterectomy. This systematic review provides evidence to suggest that patients and surgeons can choose either anaesthetic technique, depending on the clinical situation and their own preferences.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vaniyapong</LastName><ForeName>Tanat</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand, 50200.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chongruksut</LastName><ForeName>Wilaiwan</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Rerkasem</LastName><ForeName>Kittipan</ForeName><Initials>K</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CZB/4/784</GrantID><Acronym>CSO_</Acronym><Agency>Chief Scientist Office</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>12</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cochrane Database Syst Rev</MedlineTA><NlmUniqueID>100909747</NlmUniqueID><ISSNLinking>1361-6137</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>Cochrane Database Syst Rev. 2008 Oct 08;(4):CD000126. doi: 10.1002/14651858.CD000126.pub3.</RefSource><PMID Version="1">18843606</PMID></CommentsCorrections><CommentsCorrections RefType="UpdateIn"><RefSource>Cochrane Database Syst Rev. 2021 Oct 13;10:CD000126. doi: 10.1002/14651858.CD000126.pub5.</RefSource><PMID Version="1">34642940</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000772" MajorTopicYN="Y">Anesthesia, Local</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016894" MajorTopicYN="N">Endarterectomy, Carotid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24353155</ArticleId><ArticleId IdType="doi">10.1002/14651858.CD000126.pub4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38800328</PMID><DateRevised><Year>2024</Year><Month>05</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Comparison of Effectiveness and Safety of Dual Antiplatelet Therapy (DAPT) With Clopidogrel and Aspirin Versus Aspirin Monotherapy in Patients With Mild-to-Moderate Stroke and Transient Ischemic Attack: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>e58909</StartPage><MedlinePgn>e58909</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e58909</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.58909</ELocationID><Abstract><AbstractText>The aim of this meta-analysis was to assess the effectiveness and safety of the combination of clopidogrel and aspirin in patients&#xa0;with mild ischemic stroke or transient ischemic attack (TIA).&#xa0;The methodologies employed in this meta-analysis strictly followed the commonly used reporting formats for systematic reviews and meta-analyses. The methodologies employed in this meta-analysis strictly followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA).&#xa0;Until March 25, 2024, we conducted thorough searches on PubMed, EMBASE (Excerpta Medica Database), and the Cochrane Library to locate studies investigating the efficacy and safety of dual antiplatelet therapy (DAPT) in patients with mild or moderate stroke or TIA. Outcomes assessed in this meta-analysis included&#xa0;stroke (including ischemic&#xa0;stroke and hemorrhagic stroke), myocardial infarction, all bleeding events, and moderate to severe bleeding events. A total of 12 studies were included in this meta-analysis.&#xa0;The total number of enrolled patients across these studies was 35,369, with 16,957 receiving DAPT and 18,412 receiving aspirin monotherapy. The&#xa0;risk of developing stroke was significantly lower in patients receiving the combination of clopidogrel and aspirin compared to the aspirin monotherapy group (relative risk (RR): 0.77, 95% confidence interval (CI): 0.72 to 0.83, p-value&lt;0.0001). No significant differences were there in terms of all bleeding events&#xa0;(RR: 1.37, 95% CI: 0.92 to 2.04, p-value: 0.12) and moderate to severe bleeding events&#xa0;(RR: 1.18, 95% CI: 0.86 to 1.63, p-value: 0.30). These findings highlight the importance of carefully weighing the potential benefits against the risks, especially in clinical decision-making for patients with TIA or ischemic stroke. Further research is warranted to elucidate optimal strategies for balancing stroke prevention with bleeding risk mitigation in this patient population.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024, Sinha et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sinha</LastName><ForeName>Tanya</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Medical Education, Tribhuvan University, Kirtipur, NPL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riaz</LastName><ForeName>Areeba</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medicine, Quiad-e-Azam Medical College, Bahawalpur, PAK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rawat</LastName><ForeName>Anurag</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Interventional Cardiology, Himalayan Institute of Medical Sciences, Dehradun, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phoo</LastName><ForeName>Chaw N</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>Internal Medicine, University of Medicine, Mandalay, Mandalay, MMR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nageye</LastName><ForeName>Maymona E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Internal Medicine - Pediatrics, Avalon University School of Medicine, Willemstad, CUW.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaudhari</LastName><ForeName>Sandipkumar S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Cardiothoracic Surgery, University of Alabama at Birmingham, Birmingham, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Family Medicine, University of North Dakota School of Medicine and Health Sciences, Fargo, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Calvin R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Research and Development, Shing Huei Group, Taipei, TWN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amin</LastName><ForeName>Adil</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiology, Pakistan Navy Ship Shifa, Karachi, PAK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">aspirin</Keyword><Keyword MajorTopicYN="N">clopidogrel</Keyword><Keyword MajorTopicYN="N">dual anti-platelet therapy</Keyword><Keyword MajorTopicYN="N">stroke</Keyword><Keyword MajorTopicYN="N">transient ischemic attack</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>27</Day><Hour>4</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38800328</ArticleId><ArticleId IdType="pmc">PMC11118889</ArticleId><ArticleId IdType="doi">10.7759/cureus.58909</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Transient ischemic attack and minor stroke are the most common manifestations of acute cerebrovascular disease: a prospective, population-based study--the Aarhus TIA study. von Weitzel-Mudersbach P, Andersen G, Hundborg HH, Johnsen SP. Neuroepidemiology. 2013;40:50&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">23075482</ArticleId></ArticleIdList></Reference><Reference><Citation>Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services. Coull AJ, Lovett JK, Rothwell PM. BMJ. 2004;328:326.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC338101</ArticleId><ArticleId IdType="pubmed">14744823</ArticleId></ArticleIdList></Reference><Reference><Citation>Short-term prognosis after emergency department diagnosis of TIA. Johnston SC, Gress DR, Browner WS, Sidney S. JAMA. 2000;284:2901&#x2013;2906.</Citation><ArticleIdList><ArticleId IdType="pubmed">11147987</ArticleId></ArticleIdList></Reference><Reference><Citation>Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. Wang Y, Wang Y, Zhao X, et al. N Engl J Med. 2013;369:11&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">23803136</ArticleId></ArticleIdList></Reference><Reference><Citation>Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. Johnston SC, Easton JD, Farrant M, et al. N Engl J Med. 2018;379:215&#x2013;225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6193486</ArticleId><ArticleId IdType="pubmed">29766750</ArticleId></ArticleIdList></Reference><Reference><Citation>2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Kleindorfer DO, Towfighi A, Chaturvedi S, et al. Stroke. 2021;52:0&#x2013;467.</Citation><ArticleIdList><ArticleId IdType="pubmed">34024117</ArticleId></ArticleIdList></Reference><Reference><Citation>Dual or mono antiplatelet therapy for patients with acute ischemic stroke or transient ischemic attack: systematic review and meta-analysis of randomized controlled trials. Geeganage CM, Diener HC, Algra A, et al. Stroke. 2012;43:1058&#x2013;1066.</Citation><ArticleIdList><ArticleId IdType="pubmed">22282894</ArticleId></ArticleIdList></Reference><Reference><Citation>The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit. Herbert JM, Dol F, Bernat A, Falotico R, Lal&#xe9; A, Savi P. https://pubmed.ncbi.nlm.nih.gov/9759636/ Thromb Haemost. 1998;80:512&#x2013;518.</Citation><ArticleIdList><ArticleId IdType="pubmed">9759636</ArticleId></ArticleIdList></Reference><Reference><Citation>Clopidogrel with aspirin in acute minor stroke or transient ischemic attack (CHANCE) trial: one-year outcomes. Wang Y, Pan Y, Zhao X, et al. Circulation. 2015;132:40&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">25957224</ArticleId></ArticleIdList></Reference><Reference><Citation>Aspirin plus clopidogrel versus aspirin mono-therapy for ischemic stroke: a meta-analysis. Ye MB, Chen YL, Wang Q, An J, Ye F, Jing P. Scand Cardiovasc J. 2019;53:169&#x2013;175.</Citation><ArticleIdList><ArticleId IdType="pubmed">31112048</ArticleId></ArticleIdList></Reference><Reference><Citation>Clopidogrel plus aspirin vs aspirin alone in patients with acute mild to moderate stroke: the ATAMIS randomized clinical trial. Chen HS, Cui Y, Wang XH, et al. JAMA Neurol. 2024</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10928538</ArticleId><ArticleId IdType="pubmed">38466274</ArticleId></ArticleIdList></Reference><Reference><Citation>Dual versus mono antiplatelet therapy in mild-to-moderate stroke during hospitalization. Fan H, Wang Y, Liu T, et al. Ann Clin Transl Neurol. 2022;9:506&#x2013;514.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8994979</ArticleId><ArticleId IdType="pubmed">35278046</ArticleId></ArticleIdList></Reference><Reference><Citation>Preliminary evidence of a high risk of bleeding on aspirin plus clopidogrel in aspirin-na&#xef;ve patients in the acute phase after TIA or minor ischaemic stroke. Geraghty OC, Kennedy J, Chandratheva A, Marquardt L, Buchan AM, Rothwell PM. Cerebrovasc Dis. 2010;29:460&#x2013;467.</Citation><ArticleIdList><ArticleId IdType="pubmed">20299785</ArticleId></ArticleIdList></Reference><Reference><Citation>Effect of clopidogrel plus ASA vs. ASA early after TIA and ischaemic stroke: a substudy of the CHARISMA trial. Hankey GJ, Johnston SC, Easton JD, et al. Int J Stroke. 2011;6:3&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">21205234</ArticleId></ArticleIdList></Reference><Reference><Citation>Clopidogrel plus aspirin versus aspirin alone for preventing early neurological deterioration in patients with acute ischemic stroke. He F, Xia C, Zhang JH, et al. J Clin Neurosci. 2015;22:83&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">25212871</ArticleId></ArticleIdList></Reference><Reference><Citation>Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuk AM, Buchan AM. Lancet Neurol. 2007;6:961&#x2013;969.</Citation><ArticleIdList><ArticleId IdType="pubmed">17931979</ArticleId></ArticleIdList></Reference><Reference><Citation>Comparative effectiveness of dual antiplatelet therapy with aspirin and clopidogrel versus aspirin monotherapy in mild-to-moderate acute ischemic stroke according to the risk of recurrent stroke: an analysis of 15 000 patients from a nationwide, multicenter registry. Lee HL, Kim JT, Lee JS, et al. Circ Cardiovasc Qual Outcomes. 2020;13:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">33201737</ArticleId></ArticleIdList></Reference><Reference><Citation>Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Markus HS, Droste DW, Kaps M, Larrue V, Lees KR, Siebler M, Ringelstein EB. Circulation. 2005;111:2233&#x2013;2240.</Citation><ArticleIdList><ArticleId IdType="pubmed">15851601</ArticleId></ArticleIdList></Reference><Reference><Citation>Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. Wong KS, Chen C, Fu J, et al. Lancet Neurol. 2010;9:489&#x2013;497.</Citation><ArticleIdList><ArticleId IdType="pubmed">20335070</ArticleId></ArticleIdList></Reference><Reference><Citation>A comparative study of dual versus monoantiplatelet therapy in patients with acute large-artery atherosclerosis stroke. Yi X, Lin J, Wang C, Zhang B, Chi W. J Stroke Cerebrovasc Dis. 2014;23:1975&#x2013;1981.</Citation><ArticleIdList><ArticleId IdType="pubmed">24739593</ArticleId></ArticleIdList></Reference><Reference><Citation>Portal vein embolization for hepatocellular carcinoma. Shindoh J, D Tzeng CW, Vauthey JN. Liver Cancer. 2012;1:159&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3760463</ArticleId><ArticleId IdType="pubmed">24159580</ArticleId></ArticleIdList></Reference><Reference><Citation>Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. N Engl J Med. 2001;345:494&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pubmed">11519503</ArticleId></ArticleIdList></Reference><Reference><Citation>Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. Steinhubl SR, Berger PB, Mann JT 3rd, Fry ET, DeLago A, Wilmer C, Topol EJ. JAMA. 2002;288:2411&#x2013;2420.</Citation><ArticleIdList><ArticleId IdType="pubmed">12435254</ArticleId></ArticleIdList></Reference><Reference><Citation>Platelet function testing and risk of bleeding complications. Ferreiro JL, Sibbing D, Angiolillo DJ. Thromb Haemost. 2010;103:1128&#x2013;1135.</Citation><ArticleIdList><ArticleId IdType="pubmed">20352168</ArticleId></ArticleIdList></Reference><Reference><Citation>Recurrent stroke and cardiac risks after first ischemic stroke: the Northern Manhattan Study. Dhamoon MS, Sciacca RR, Rundek T, Sacco RL, Elkind MS. Neurology. 2006;66:641&#x2013;646.</Citation><ArticleIdList><ArticleId IdType="pubmed">16534100</ArticleId></ArticleIdList></Reference><Reference><Citation>Dual antiplatelet therapy may increase the risk of non-intracranial haemorrhage in patients with minor strokes: a subgroup analysis of the CHANCE trial. Wang D, Gui L, Dong Y, et al. Stroke Vasc Neurol. 2016;1:29&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5435197</ArticleId><ArticleId IdType="pubmed">28959461</ArticleId></ArticleIdList></Reference><Reference><Citation>Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans. Cadroy Y, Bossavy JP, Thalamas C, Sagnard L, Sakariassen K, Boneu B. Circulation. 2000;101:2823&#x2013;2828.</Citation><ArticleIdList><ArticleId IdType="pubmed">10859288</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36426842</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1940-1574</ISSN><JournalIssue CitedMedium="Internet"><Volume>74</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Angiology</Title><ISOAbbreviation>Angiology</ISOAbbreviation></Journal><ArticleTitle>Racial Disparity Among Patients Undergoing Surgical Aortic Valve Replacement and Transcatheter Aortic Valve Replacement in the United States.</ArticleTitle><Pagination><StartPage>812</StartPage><EndPage>821</EndPage><MedlinePgn>812-821</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/00033197221137025</ELocationID><Abstract><AbstractText>Transcatheter aortic valve replacement (TAVR) has emerged as a minimally invasive alternative to surgical aortic valve replacement (SAVR). However, racial disparities in the utilization of TAVR persist. This meta-analysis attempts to determine whether the prevalence of adverse outcomes (procedure-related complications) represent barriers to the use of TAVR among African Americans (AA). The TAVR cohort consisted of 89.6% Caucasian (C) and 4.7% AA, while the SAVR cohort included 86.9% C and 6.4% AA. The utilization rate (UR) of TAVR was 1.48 and .35 among C and AA, respectively, while the UR of SAVR was 1.44 and .48 among C and AA, respectively. Following TAVR, for AA the odds ratio (OR) was greater for stroke (OR = 1.22, <i>P</i> = .02) and transient ischemic attack (TIA) (OR = 1.57, <i>P</i> &lt; .001) and lower for undergoing the insertion of a permanent pacemaker (OR = .81, <i>P</i> &lt; .001). While there was a significant difference between C and AA in TAVR and SAVR utilization, outcomes between groups following TAVR are comparable; therefore, adverse outcomes do not appear to be a barrier to the use of TAVR among eligible AA.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kulkarni</LastName><ForeName>Abha</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2365-6582</Identifier><AffiliationInfo><Affiliation>Rutgers Robert Wood Johnson Medical School, Piscataway, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arafat</LastName><ForeName>Mohammod</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Linle</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Shiochee</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kassotis</LastName><ForeName>John</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2588-9331</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Angiology</MedlineTA><NlmUniqueID>0203706</NlmUniqueID><ISSNLinking>0003-3197</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001021" MajorTopicYN="N">Aortic Valve</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065467" MajorTopicYN="Y">Transcatheter Aortic Valve Replacement</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001024" MajorTopicYN="Y">Aortic Valve Stenosis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019918" MajorTopicYN="Y">Heart Valve Prosthesis Implantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">aortic stenosis</Keyword><Keyword MajorTopicYN="N">racial disparities</Keyword><Keyword MajorTopicYN="N">surgical aortic valve replacement</Keyword><Keyword MajorTopicYN="N">transcatheter aortic valve replacement</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>25</Day><Hour>7</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36426842</ArticleId><ArticleId IdType="doi">10.1177/00033197221137025</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29789778</PMID><DateCompleted><Year>2018</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2314-6141</ISSN><JournalIssue CitedMedium="Internet"><Volume>2018</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>BioMed research international</Title><ISOAbbreviation>Biomed Res Int</ISOAbbreviation></Journal><ArticleTitle>Conscious Sedation versus General Anesthesia for Patients with Acute Ischemic Stroke Undergoing Endovascular Therapy: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>2318489</StartPage><MedlinePgn>2318489</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2318489</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2018/2318489</ELocationID><Abstract><AbstractText>The aim of this study is to compare the effect of conscious sedation (CS) with general anesthesia (GA) on clinical outcomes in patients with acute ischemic stroke (AIS) undergoing endovascular therapy (EVT). MEDLINE, EMBASE, and Cochrane Central Registers of Controlled Trials (from inception to July 2017) were searched for reports on CS and GA of AIS undergoing EVT. Two reviewers assessed the eligibility of the identified studies and extracted data. Data were analyzed using the fixed-effects model, and the sources of heterogeneity were explored by sensitive analysis. Trial sequential analysis was conducted to monitor boundaries for the limitation of global type I error, and GRADE system was demonstrated to evaluate the quality of evidence. A total of thirteen studies were finally identified. Pooled analysis of the incidence of mRS score &#x2266; 2 after hospital discharge and one or three months in the CS group was higher than that in the GA group. The all-causing mortality of AIS patients in the CS group was lower than that in the GA group. There were no differences in the proportion of IA rtPA and thrombolysis between the two groups. Compared with AIS patients receiving GA, the all-causing mortality in the AIS patients receiving CS was decreased, while incidence of mRS score &#x2266; 2 at hospital discharge and one or three months was increased.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jing</LastName><ForeName>Ren</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Tumor Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Laboratory of Perioperative Medicine Research Center, Tumor Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Hui-Jun</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Tumor Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Laboratory of Perioperative Medicine Research Center, Tumor Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Fei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Tumor Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Laboratory of Perioperative Medicine Research Center, Tumor Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ge</LastName><ForeName>Wan-Yun</ForeName><Initials>WY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Tumor Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Laboratory of Perioperative Medicine Research Center, Tumor Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Ling-Hui</ForeName><Initials>LH</Initials><Identifier Source="ORCID">0000-0002-3379-6549</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Tumor Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Laboratory of Perioperative Medicine Research Center, Tumor Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biomed Res Int</MedlineTA><NlmUniqueID>101600173</NlmUniqueID></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002545" MajorTopicYN="N">Brain Ischemia</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016292" MajorTopicYN="N">Conscious Sedation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="Y">Endovascular Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>3</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29789778</ArticleId><ArticleId IdType="pmc">PMC5896359</ArticleId><ArticleId IdType="doi">10.1155/2018/2318489</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Meyers P. M., Schumacher H. C., Alexander M. J., et al. Performance and training standards for Endovascular acute ischemic Stroke treatment. Neurology. 2012;79(13):S234&#x2013;S238. doi: 10.1212/WNL.0b013e318269595b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318269595b</ArticleId><ArticleId IdType="pubmed">23008404</ArticleId></ArticleIdList></Reference><Reference><Citation>Stam J. Current concepts: thrombosis of the cerebral veins and sinuses. The New England Journal of Medicine. 2005;352(17):1791&#x2013;1798. doi: 10.1056/NEJMra042354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra042354</ArticleId><ArticleId IdType="pubmed">15858188</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiteley W. N., Emberson J., Lees K. R., et al. Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis. The Lancet Neurology. 2016;15(9):925&#x2013;933. doi: 10.1016/S1474-4422(16)30076-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(16)30076-X</ArticleId><ArticleId IdType="pubmed">27289487</ArticleId></ArticleIdList></Reference><Reference><Citation>Saver J. L., Jahan R., Levy E. I., et al. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. The Lancet. 2012;380(9849):1241&#x2013;1249. doi: 10.1016/S0140-6736(12)61384-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(12)61384-1</ArticleId><ArticleId IdType="pubmed">22932715</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon B. K., Sajobi T. T., Zhang Y., et al. Analysis of Workflow and Time to Treatment on Thrombectomy Outcome in the Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke (ESCAPE) Randomized, Controlled Trial. Circulation. 2016;133:2279&#x2013;2286.</Citation><ArticleIdList><ArticleId IdType="pubmed">27076599</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Den Berg L. A., Dijkgraaf M. G. W., Berkhemer O. A., et al. Two-year outcome after endovascular treatment for acute ischemic stroke. The New England Journal of Medicine. 2017;376(14):1341&#x2013;1349. doi: 10.1056/NEJMoa1612136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1612136</ArticleId><ArticleId IdType="pubmed">28379802</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell B. C. V., Donnan G. A., Lees K. R., et al. Endovascular stent thrombectomy: the new standard of care for large vessel ischaemic stroke. The Lancet Neurology. 2015;14(8):846&#x2013;854. doi: 10.1016/S1474-4422(15)00140-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(15)00140-4</ArticleId><ArticleId IdType="pubmed">26119323</ArticleId></ArticleIdList></Reference><Reference><Citation>Abou-Chebl A., Lin R., Shazam Hussain M., et al. Conscious sedation versus general anesthesia during endovascular therapy for acute anterior circulation stroke: Preliminary results from a retrospective, multicenter study. Stroke. 2010;41(6):1175&#x2013;1179. doi: 10.1161/STROKEAHA.109.574129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.109.574129</ArticleId><ArticleId IdType="pubmed">20395617</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Berg L. A., Koelman D. L., Berkhemer O. A., et al. Type of anesthesia and differences in clinical outcome after intra-arterial treatment for ischemic stroke. Stroke. 2015;46:1257&#x2013;1262.</Citation><ArticleIdList><ArticleId IdType="pubmed">25851766</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xf6;nenberger S., Uhlmann L., Hacke W., et al. Effect of conscious sedation vs general anesthesia on early neurological improvement among patients with ischemic stroke undergoing endovascular thrombectomy: a randomized clinical trial. Journal of the American Medical Association. 2016;316(19):1986&#x2013;1996. doi: 10.1001/jama.2016.16623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.16623</ArticleId><ArticleId IdType="pubmed">27785516</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinjikji W., Murad M. H., Rabinstein A. A., Cloft H. J., Lanzino G., Kallmes D. F. Conscious sedation versus general anesthesia during endovascular acute ischemic stroke treatment: a systematic review and meta-analysis. American Journal of Neuroradiology. 2015;36(3):525&#x2013;529. doi: 10.3174/ajnr.A4159.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A4159</ArticleId><ArticleId IdType="pmc">PMC8013063</ArticleId><ArticleId IdType="pubmed">25395655</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis M. J., Menon B. K., Baghirzada L. B., et al. Anesthetic management and outcome in patients during endovascular therapy for acute stroke. Anesthesiology. 2012;116(2):396&#x2013;405. doi: 10.1097/ALN.0b013e318242a5d2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e318242a5d2</ArticleId><ArticleId IdType="pubmed">22222475</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan A. E., Akbar U., Chaudhry S. A., et al. Rate and prognosis of patients under conscious sedation requiring emergent intubation during neuroendovascular procedures. American Journal of Neuroradiology. 2013;34(7):1375&#x2013;1379. doi: 10.3174/ajnr.A3385.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A3385</ArticleId><ArticleId IdType="pmc">PMC8051502</ArticleId><ArticleId IdType="pubmed">23370474</ArticleId></ArticleIdList></Reference><Reference><Citation>John S., Thebo U., Gomes J., et al. Intra-arterial therapy for acute ischemic stroke under general anesthesia versus monitored anesthesia care. Cerebrovascular Disease. 2014;38(4):262&#x2013;267. doi: 10.1159/000368216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000368216</ArticleId><ArticleId IdType="pubmed">25401730</ArticleId></ArticleIdList></Reference><Reference><Citation>Jumaa M. A., Zhang F., Ruiz-Ares G., et al. Comparison of safety and clinical and radiographic outcomes in endovascular acute stroke therapy for proximal middle cerebral artery occlusion with intubation and general anesthesia versus the nonintubated state. Stroke. 2010;41(6):1180&#x2013;1184. doi: 10.1161/STROKEAHA.109.574194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.109.574194</ArticleId><ArticleId IdType="pubmed">20431082</ArticleId></ArticleIdList></Reference><Reference><Citation>Just C., Rizek P., Tryphonopoulos P., Pelz D., Arango M. Outcomes of general anesthesia and conscious sedation in endovascular treatment for stroke. Canadian Journal of Neurological Sciences. 2016;43(5):655&#x2013;658. doi: 10.1017/cjn.2016.256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/cjn.2016.256</ArticleId><ArticleId IdType="pubmed">27406422</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F., Deshaies E. M., Singla A., et al. Impact of anesthesia on mortality during endovascular clot removal for acute ischemic stroke. Journal of Neurosurgical Anesthesiology. 2014;26(4):286&#x2013;290. doi: 10.1097/ANA.0000000000000031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ANA.0000000000000031</ArticleId><ArticleId IdType="pubmed">24296538</ArticleId></ArticleIdList></Reference><Reference><Citation>Hend&#xe9;n P. L., Rentzos A., Karlsson J.-E., et al. General anesthesia versus conscious sedation for endovascular treatment of acute ischemic stroke: the anstroke trial (anesthesia during stroke) Stroke. 2017;48(6):1601&#x2013;1607. doi: 10.1161/STROKEAHA.117.016554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.117.016554</ArticleId><ArticleId IdType="pubmed">28522637</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichols C., Carrozzella J., Yeatts S., Tomsick T., Broderick J., Khatri P. Is periprocedural sedation during acute stroke therapy associated with poorer functional outcomes? Journal of NeuroInterventional Surgery. 2010;2(1):67&#x2013;70. doi: 10.1136/jnis.2009.001768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnis.2009.001768</ArticleId><ArticleId IdType="pmc">PMC2860799</ArticleId><ArticleId IdType="pubmed">20431708</ArticleId></ArticleIdList></Reference><Reference><Citation>Slezak A., Kurmann R., Oppliger L., et al. Impact of anesthesia on the outcome of acute ischemic stroke after endovascular treatment with the Solitaire stent retriever. American Journal of Neuroradiology. 2017;38(7):1362&#x2013;1367. doi: 10.3174/ajnr.A5183.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A5183</ArticleId><ArticleId IdType="pmc">PMC7959912</ArticleId><ArticleId IdType="pubmed">28473340</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugg R. M., Jackson A. S., Holloway W., Martin C. O., Akhtar N., Rymer M. Is mechanical embolectomy performed in nonanesthetized patients effective? American Journal of Neuroradiology. 2010;31(8):1533&#x2013;1535. doi: 10.3174/ajnr.A2091.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A2091</ArticleId><ArticleId IdType="pmc">PMC7966107</ArticleId><ArticleId IdType="pubmed">20395385</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D., Liberati A., Tetzlaff J. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Journal of Clinical Epidemiology. 2009;62(10):1006&#x2013;1012. doi: 10.1016/j.jclinepi.2009.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2009.06.005</ArticleId><ArticleId IdType="pubmed">19631508</ArticleId></ArticleIdList></Reference><Reference><Citation>Prabhakar H., Singh G. P., Mahajan C., Kapoor I., Kalaivani M., Anand V. Intravenous versus inhalational techniques for rapid emergence from anaesthesia in patients undergoing brain tumour surgery. Cochrane Database of Systematic Reviews. 2016;2016(9) doi: 10.1002/14651858.CD010467.pub2.CD010467</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD010467.pub2</ArticleId><ArticleId IdType="pmc">PMC6457852</ArticleId><ArticleId IdType="pubmed">27611234</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt G. H., Oxman A. D., Vist G. E., et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. British Medical Journal. 2008;336(7650):924&#x2013;926. doi: 10.1136/bmj.39489.470347.AD.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.AD</ArticleId><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Study C. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990&#x2013;2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:743&#x2013;800.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4561509</ArticleId><ArticleId IdType="pubmed">26063472</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortality GBD and Causes of Death C. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980&#x2013;2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459&#x2013;1544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5388903</ArticleId><ArticleId IdType="pubmed">27733281</ArticleId></ArticleIdList></Reference><Reference><Citation>Lincoff A. M., Nicholls S. J., Riesmeyer J. S., et al. Evacetrapib and cardiovascular outcomes in high-risk vascular disease. The New England Journal of Medicine. 2017;376:1933&#x2013;1942.</Citation><ArticleIdList><ArticleId IdType="pubmed">28514624</ArticleId></ArticleIdList></Reference><Reference><Citation>Boysen G., Brander T., Christensen H., Gideon R., Truelsen T. Homocysteine and risk of recurrent stroke. Stroke. 2003;34(5):1258&#x2013;1261. doi: 10.1161/01.STR.0000069017.78624.37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.STR.0000069017.78624.37</ArticleId><ArticleId IdType="pubmed">12702838</ArticleId></ArticleIdList></Reference><Reference><Citation>Riccio P. M., Klein F. R., Cassara F. P., et al. Newly diagnosed atrial fibrillation linked to wake-up stroke and TIA: hypothetical implications. Neurology. 2013;80(20):1834&#x2013;1840. doi: 10.1212/WNL.0b013e318292a330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318292a330</ArticleId><ArticleId IdType="pubmed">23596075</ArticleId></ArticleIdList></Reference><Reference><Citation>Messick J. M., Newberg L. A., Nugent M., Faust R. J. Principles of neuroanesthesia for the nonneurosurgical patient with CNS pathophysiology. Anesthesia and Analgesia. 1985;64(2):143&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pubmed">3882022</ArticleId></ArticleIdList></Reference><Reference><Citation>Steen P. A. Inhalation versus intravenous anesthesia: cerebral effects. Acta Anaesthesiologica Scandinavica. 1982;75:32&#x2013;35. doi: 10.1111/j.1399-6576.1982.tb01878.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-6576.1982.tb01878.x</ArticleId><ArticleId IdType="pubmed">6958159</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen K. D., Landsfeldt U., Cold G. E., et al. Intracranial pressure and cerebral hemodynamic in patients with cerebral tumors: a randomized prospective study of patients subjected to craniotomy in propofol-fentanyl, isoflurane-fentanyl, or sevoflurane-fentanyl anesthesia. Anesthesiology. 2003;98(2):329&#x2013;336. doi: 10.1097/00000542-200302000-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200302000-00010</ArticleId><ArticleId IdType="pubmed">12552189</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberg M., Weaver J. General anesthesia. Anesthesia Progress. 1991;38:172&#x2013;186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2190299</ArticleId><ArticleId IdType="pubmed">1819969</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinjikji W., Pasternak J., Murad M. H., et al. Anesthesia-related outcomes for endovascular stroke revascularization: a systematic review and meta-analysis. Stroke. 2017;48(10):2784&#x2013;2791. doi: 10.1161/STROKEAHA.117.017786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.117.017786</ArticleId><ArticleId IdType="pubmed">28904228</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossitti S., Pfister M. 3D road-mapping in the endovascular treatment of cerebral aneurysms and arteriovenous malformations. Interventional Neuroradiology. 2009;15(3):283&#x2013;290. doi: 10.1177/159101990901500305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/159101990901500305</ArticleId><ArticleId IdType="pmc">PMC3299374</ArticleId><ArticleId IdType="pubmed">20465911</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39259060</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>11</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>103</Volume><Issue>22</Issue><PubDate><Year>2024</Year><Month>May</Month><Day>31</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Incidence and associated factors of delirium after primary total joint arthroplasty in elderly patients: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>e38395</StartPage><MedlinePgn>e38395</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e38395</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000038395</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">A total of 1.5% to 20.2% of total joint arthroplasty patients experience delirium. Until now, no formal systematic review or meta-analysis was performed to summarize the risk factors of delirium after primary total joint arthroplasty (TJA).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A comprehensive search encompassing Medline, Embase, and the Cochrane central database was conducted, incorporating studies available up to June 2023. We systematically reviewed research on the risk factors contributing to delirium following TJA in elderly patients, without language restrictions. The methodological quality of the included studies was evaluated using the Newcastle-Ottawa Scale. Data synthesis through pooling and a meta-analysis were performed to analyze the findings.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 23 studies altogether included 71,095 patients with primary TJA, 2142 cases of delirium occurred after surgery, suggesting the accumulated incidence of 3.0%. The results indicated that age, current smoker, heavy drinker, mini-mental state examination score, hypertension, diabetes mellitus, chronic kidney disease, history of stroke, coronary arterial disease, dementia, history of psychiatric illness, American Society of Anesthesiologists physical status III-IV, general anesthesia, anesthesia time, operative time, intraoperative blood loss, blood transfusion, &#x3b2;-blockers, ACEI drugs, use of psychotropic drugs, preoperative C-reactive protein level, and preoperative albumin level were significantly associated with postoperative delirium after primary TJA.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Related prophylaxis strategies should be implemented in the elderly involved with above-mentioned risk factors to prevent delirium after primary TJA.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yanju</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Nursing Department, Cangzhou People's Hospital, Cangzhou, Hebei, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Yanjie</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Ziyu</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diao</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Pharmacy Department, Cangzhou People's Hospital, Cangzhou, Hebei, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Runping</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Nursing Department, Cangzhou People's Hospital, Cangzhou, Hebei, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jinzhu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Nursing Department, Cangzhou People's Hospital, Cangzhou, Hebei, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Yuhong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Oncology Department, Cangzhou People's Hospital, Cangzhou, Hebei, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Huiyuan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Nursing Department, Cangzhou People's Hospital, Cangzhou, Hebei, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yanjiang</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-5332-2535</Identifier><AffiliationInfo><Affiliation>Trauma Emergency Center, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019643" MajorTopicYN="N">Arthroplasty, Replacement</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003693" MajorTopicYN="Y">Delirium</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>11</Day><Hour>12</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>11</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>11</Day><Hour>10</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39259060</ArticleId><ArticleId IdType="pmc">PMC11142822</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000038395</ArticleId><ArticleId IdType="pii">00005792-202405310-00008</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fisher BW, Flowerdew G. A simple model for predicting postoperative delirium in older patients undergoing elective orthopedic surgery. J Am Geriatr Soc. 1995;43:175&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">7836644</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton GM, Wheeler K, Di Michele J, Lalu MM, McIsaac DI. A systematic review and meta-analysis examining the impact of incident postoperative delirium on mortality. Anesthesiology. 2017;127:78&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">28459734</ArticleId></ArticleIdList></Reference><Reference><Citation>Katlic MR, Robinson TN. The costs of postoperative delirium. JAMA Surg. 2021;156:470&#x2013;1.</Citation><ArticleIdList><ArticleId IdType="pubmed">33625474</ArticleId></ArticleIdList></Reference><Reference><Citation>Martocchia A, Curto M, Comite F, et al. . The prevention and treatment of delirium in elderly patients following hip fracture surgery. Recent Patents CNS Drug Discov. 2015;10:55&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">25687439</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Zhao X, Gao L, Wang Y, Wang J. Incidence and associated factors of delirium after orthopedic surgery in elderly patients: a systematic review and meta-analysis. Aging Clin Exp Res. 2021;33:1493&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pubmed">32772312</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham EL, McGuinness B, McAuley DF, et al. . CSF beta-amyloid 1-42 concentration predicts delirium following elective arthroplasty surgery in an observational cohort study. Ann Surg. 2019;269:1200&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">31082921</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J, Sprung J, Weingarten TN. Delirium following total joint replacement surgery. Bosn J Basic Med Sci. 2019;19:81&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6387679</ArticleId><ArticleId IdType="pubmed">29984677</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstein SM, Poultsides L, Baaklini LR, et al. . Postoperative delirium in total knee and hip arthroplasty patients: a study of perioperative modifiable risk factors. Br J Anaesth. 2018;120:999&#x2013;1008.</Citation><ArticleIdList><ArticleId IdType="pubmed">29661417</ArticleId></ArticleIdList></Reference><Reference><Citation>OuYang CL, Hao XY, Yu Y, et al. . Intraoperative allogeneic transfusion is associated with postoperative delirium in older patients after total knee and hip arthroplasty. Front Surg. 2022;9:1048197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9849749</ArticleId><ArticleId IdType="pubmed">36684187</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng J, Wu G, Chen J, Chen H. Preoperative C-reactive protein/albumin ratio, a risk factor for postoperative delirium in elderly patients after total joint arthroplasty. J Arthroplasty. 2019;34:2601&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">31326244</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu RJ. Diagnostic and statistical manual of mental disorders: DSM-IV. Encycl Neurol Sci. 2003;25:4&#x2013;8.</Citation></Reference><Reference><Citation>Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990;113:941&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">2240918</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">20652370</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med. 1997;127:820&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">9382404</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Zheng C, Zhong J, et al. . Preoperative prognostic nutritional index is useful factor for predicting postoperative delirium after primary total joint arthroplasty. BMC Musculoskelet Disord. 2021;22:778.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8436555</ArticleId><ArticleId IdType="pubmed">34511076</ArticleId></ArticleIdList></Reference><Reference><Citation>Freter SH, Dunbar MJ, MacLeod H, Morrison M, MacKnight C, Rockwood K. Predicting post-operative delirium in elective orthopaedic patients: the Delirium Elderly At-Risk (DEAR) instrument. Age Ageing. 2005;34:169&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">15713861</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowery DP, Wesnes K, Ballard CG. Subtle attentional deficits in the absence of dementia are associated with an increased risk of post-operative delirium. Dement Geriatr Cogn Disord. 2007;23:390&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">17396030</ArticleId></ArticleIdList></Reference><Reference><Citation>Jankowski CJ, Trenerry MR, Cook DJ, et al. . Cognitive and functional predictors and sequelae of postoperative delirium in elderly patients undergoing elective joint arthroplasty. Anesth Analg. 2011;112:1186&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">21415433</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosmak FS, Gibim PT, Guimar&#xe3;es S, Ammirati AL. Incidence of delirium in postoperative patients treated with total knee and hip arthroplasty. Rev Assoc Med Bras (1992). 2017;63:248&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">28489131</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham EL, Mawhinney T, Beverland D, et al. . Observational cohort study examining apolipoprotein E status and preoperative neuropsychological performance as predictors of post-operative delirium in an older elective arthroplasty population. Age Ageing. 2017;46:779&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">28383643</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi J, Liu C, Chen L, Chen J. Postoperative serum albumin decrease independently predicts delirium in the elderly subjects after total joint arthroplasty. Curr Pharm Des. 2020;26:386&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">31880243</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Qin J. Modified frailty index independently predicts postoperative delirium and delayed neurocognitive recovery after elective total joint arthroplasty. J Arthroplasty. 2021;36:449&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">32863073</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D, Li Y, Li Q, et al. . Risk factors and a nomogram model establishment for postoperative delirium in elderly patients undergoing arthroplasty surgery: a single-center retrospective study. Biomed Res Int. 2021;2021:6607386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8660191</ArticleId><ArticleId IdType="pubmed">34901277</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L, Lei G. Albumin/fibrinogen ratio, an independent risk factor for postoperative delirium after total joint arthroplasty. Geriatr Gerontol Int. 2022;22:412&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">35365967</ArticleId></ArticleIdList></Reference><Reference><Citation>Priner M, Jourdain M, Bouche G, Merlet-Chicoine I, Chaumier J-A, Paccalin M. Usefulness of the short IQCODE for predicting postoperative delirium in elderly patients undergoing hip and knee replacement surgery. Gerontology. 2008;54:116&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">18285677</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen PB, J&#xf8;rgensen CC, Kehlet H; Lundbeck Foundation Centre for Fast-track Hip and Knee Replacement Collaborative Group. Delirium after fast-track hip and knee arthroplasty - a cohort study of 6331 elderly patients. Acta Anaesthesiol Scand. 2017;61:767&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">28681427</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W, Ke X, Wang X, et al. . Prevalence and risk factors for postoperative delirium in total joint arthroplasty patients: a prospective study. Gen Hosp Psychiatry. 2017;46:55&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">28622817</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin X, Tang J, Liu C, et al. . Cerebrospinal fluid cholinergic biomarkers are associated with postoperative delirium in elderly patients undergoing Total hip/knee replacement: a prospective cohort study. BMC Anesthesiol. 2020;20:246.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7520969</ArticleId><ArticleId IdType="pubmed">32988381</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer M, G&#xf6;tz J, Parik L, et al. . Postoperative delirium is a risk factor for complications and poor outcome after total hip and knee arthroplasty. Acta Orthop. 2021;92:695&#x2013;700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8635535</ArticleId><ArticleId IdType="pubmed">34607501</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin X, Li XX, Dong R, Wang B, Bi Y-L. Habitual tea consumption and postoperative delirium after total hip/knee arthroplasty in elderly patients: the PNDABLE study. Brain Behav. 2022;12:e2612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9226797</ArticleId><ArticleId IdType="pubmed">35555872</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y, Peng X, Lin X, et al. . Potential value of serum lipid in the identification of postoperative delirium undergoing knee/hip arthroplasty: the perioperative neurocognitive disorder and biomarker lifestyle study. Front Psychiatry. 2022;13:870317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9039337</ArticleId><ArticleId IdType="pubmed">35492710</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y, Yu N, Lin X, et al. . Preoperative cerebrospinal fluid biomarkers may be associated with postoperative delirium in patients undergoing knee/hip arthroplasty: the PNDABLE study. BMC Geriatr. 2023;23:282.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10173592</ArticleId><ArticleId IdType="pubmed">37165310</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothberg MB, Herzig SJ, Pekow PS, Avrunin J, Lagu T, Lindenauer PK. Association between sedating medications and delirium in older inpatients. J Am Geriatr Soc. 2013;61:923&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">23631415</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirijello A, D&#x2019;Angelo C, Ferrulli A, et al. . Identification and management of alcohol withdrawal syndrome. Drugs. 2015;75:353&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4978420</ArticleId><ArticleId IdType="pubmed">25666543</ArticleId></ArticleIdList></Reference><Reference><Citation>Plas M, Rotteveel E, Izaks GJ, et al. . Cognitive decline after major oncological surgery in the elderly. Eur J Cancer. 2017;86:394&#x2013;402.</Citation><ArticleIdList><ArticleId IdType="pubmed">29100194</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang CK, Chu CL, Chou MY, et al. . Developing a prediction model for post-operative delirium and long-term outcomes among older patients receiving elective orthopedic surgery: a prospective cohort study in Taiwan. Rejuvenation Res. 2015;18:347&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">25768947</ArticleId></ArticleIdList></Reference><Reference><Citation>Siepe M, Pfeiffer T, Gieringer A, et al. . Increased systemic perfusion pressure during cardiopulmonary bypass is associated with less early postoperative cognitive dysfunction and delirium. Eur J Cardiothorac Surg. 2011;40:200&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">21168339</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, Zhang YH, Fu HQ, Zhang Q-M, Wang T-L. Ulinastatin may significantly improve postoperative cognitive function of elderly patients undergoing spinal surgery by reducing the translocation of lipopolysaccharide and systemic inflammation. Front Pharmacol. 2018;9:1007.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6189321</ArticleId><ArticleId IdType="pubmed">30356711</ArticleId></ArticleIdList></Reference><Reference><Citation>Domingueti CP, Dusse LM, Carvalho M, et al. . Diabetes mellitus: the linkage between oxidative stress, inflammation, hypercoagulability and vascular complications. J Diabetes Complications. 2016;30:738&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">26781070</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudolph JL, Ramlawi B, Kuchel GA, et al. . Chemokines are associated with delirium after cardiac surgery. J Gerontol A Biol Sci Med Sci. 2008;63:184&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2735245</ArticleId><ArticleId IdType="pubmed">18314455</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang H, Kumar S, Ely EW, Gezalian MM, Lahiri S. Acute kidney injury-associated delirium: a review of clinical and pathophysiological mechanisms. Crit Care. 2022;26:258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9420275</ArticleId><ArticleId IdType="pubmed">36030220</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahir M, Malik SS, Ahmed U, Kozdryk J, Naqvi SH, Malik A. Risk factors for onset of delirium after neck of femur fracture surgery: a prospective observational study. SICOT J. 2018;4:27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6040837</ArticleId><ArticleId IdType="pubmed">29995625</ArticleId></ArticleIdList></Reference><Reference><Citation>Sieber FE, Neufeld KJ, Gottschalk A, et al. . Effect of depth of sedation in older patients undergoing hip fracture repair on postoperative delirium: the STRIDE randomized clinical trial. JAMA Surg. 2018;153:987&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6583071</ArticleId><ArticleId IdType="pubmed">30090923</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YL, Wong J, Ng SY. Delirium in patients following general anaesthesia. Ann Acad Med Singapore. 2022;51:71&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">35224602</ArticleId></ArticleIdList></Reference><Reference><Citation>Katznelson R, Djaiani G, Mitsakakis N, et al. . Delirium following vascular surgery: increased incidence with preoperative beta-blocker administration. Can J Anaesth. 2009;56:793&#x2013;801.</Citation><ArticleIdList><ArticleId IdType="pubmed">19711147</ArticleId></ArticleIdList></Reference><Reference><Citation>Kudchadkar SR. Benzodiazepines and delirium in the young and old: truth be told or still not sold? Crit Care Med. 2017;45:1562&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">28816839</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassie GM, Nguyen TA, Kalisch Ellett LM, Pratt NL, Roughead EE. Preoperative medication use and postoperative delirium: a systematic review. BMC Geriatr. 2017;17:298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5747155</ArticleId><ArticleId IdType="pubmed">29284416</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24605834</PMID><DateCompleted><Year>2014</Year><Month>12</Month><Day>04</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1933-0693</ISSN><JournalIssue CitedMedium="Internet"><Volume>121</Volume><Issue>2</Issue><PubDate><Year>2014</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of neurosurgery</Title><ISOAbbreviation>J Neurosurg</ISOAbbreviation></Journal><ArticleTitle>The frequency of postoperative stroke in moyamoya disease following combined revascularization: a single-university series and systematic review.</ArticleTitle><Pagination><StartPage>432</StartPage><EndPage>440</EndPage><MedlinePgn>432-40</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3171/2014.1.JNS13946</ELocationID><Abstract><AbstractText Label="OBJECT" NlmCategory="OBJECTIVE">Although combined direct and indirect anastomosis in patients with moyamoya disease immediately increases cerebral blood flow, the surgical procedure is more complex. Data pertinent to the postoperative complications associated with combined bypass are relatively scarce compared with those associated with indirect bypass. This study investigated the incidence and characteristics of postoperative stroke in combined bypass and compared them with those determined from a literature review to obtain data from a large population.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 358 revascularization procedures in 236 patients were retrospectively assessed by reviewing clinical charts and radiological data. PubMed was searched for published studies on surgical treatment to determine the incidence of postoperative complications in a larger population.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Seventeen instances of postoperative stroke were observed in 16 patients (4.7% per surgery, 95% CI 2.8%-7.5%). Postoperative stroke was more frequent (7.9% per surgery) in adults than in pediatric patients (1.7% per surgery, OR 4.07, 95% CI 1.12-14.7; p &lt; 0.05). Acute progression of stenoocclusive changes were identified in the major cerebral arteries (anterior cerebral artery, n = 3; middle cerebral artery, n = 1; posterior cerebral artery, n = 2). The postoperative stroke rate was comparable with that (5.4%) determined from a literature search that included studies reporting more than 2000 direct/combined procedures. No differences in the stroke rates between the direct/combined and indirect procedures were found. In the literature review, direct/combined bypass was more often associated with excellent revascularization (angiographic opacification greater than two-thirds) than indirect bypass (p &lt; 0.05).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This experience of 358 consecutive procedures is one of the largest series for which the postoperative stoke rate for direct/combined bypass performed with a unified strategy has been reported. A systematic review confirmed that the postoperative stroke rate for the direct/combined procedure was comparable to that for the indirect procedure.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kazumata</LastName><ForeName>Ken</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ito</LastName><ForeName>Masaki</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Tokairin</LastName><ForeName>Kikutaro</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Ito</LastName><ForeName>Yasuhiro</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Houkin</LastName><ForeName>Kiyohiro</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Nakayama</LastName><ForeName>Naoki</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Kuroda</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Ishikawa</LastName><ForeName>Tatsuya</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Kamiyama</LastName><ForeName>Hiroyasu</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>03</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosurg</MedlineTA><NlmUniqueID>0253357</NlmUniqueID><ISSNLinking>0022-3085</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002544" MajorTopicYN="N">Cerebral Infarction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002548" MajorTopicYN="N">Cerebral Revascularization</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020300" MajorTopicYN="N">Intracranial Hemorrhages</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009072" MajorTopicYN="N">Moyamoya Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019635" MajorTopicYN="N">Neurosurgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACA = anterior cerebral artery</Keyword><Keyword MajorTopicYN="N">ICH = intracerebral hemorrhage</Keyword><Keyword MajorTopicYN="N">MCA = middle cerebral artery</Keyword><Keyword MajorTopicYN="N">MMD = moyamoya disease</Keyword><Keyword MajorTopicYN="N">PCA = posterior cerebral artery</Keyword><Keyword MajorTopicYN="N">STA = superficial temporal artery</Keyword><Keyword MajorTopicYN="N">TIA = transient ischemic attack</Keyword><Keyword MajorTopicYN="N">cerebral infarction</Keyword><Keyword MajorTopicYN="N">complication</Keyword><Keyword MajorTopicYN="N">intracranial hemorrhage</Keyword><Keyword MajorTopicYN="N">moyamoya disease</Keyword><Keyword MajorTopicYN="N">revascularization</Keyword><Keyword MajorTopicYN="N">vascular disorders</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24605834</ArticleId><ArticleId IdType="doi">10.3171/2014.1.JNS13946</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40320349</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>8</Issue><PubDate><Year>2025</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Outcomes Following Perioperative Stroke in Cardiac Surgery Patients: A Retrospective Cohort Study.</ArticleTitle><Pagination><StartPage>2067</StartPage><EndPage>2078</EndPage><MedlinePgn>2067-2078</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2025.04.010</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(25)00314-3</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To identify independent predictors of 30-day mortality, adverse discharge, and length of hospital stay following a perioperative stroke among cardiac surgical patients, and to measure trends in outcomes over time.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">A retrospective cohort study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database from 2005 to 2020.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Cardiac surgery patients with perioperative stroke (n = 906).</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">None. Observational analysis.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">Patient demographics, comorbid conditions, timing of stroke, procedure characteristics, and type of anesthesia information were extracted. The least absolute shrinkage and selection operator technique were employed to identify variables associated with 30-day mortality (the primary outcome), adverse discharge (death or a nonhome facility), and length of hospital stay. Perioperative stroke occurred a median (interquartile range) of 4 days (2-8 days) after surgery, 15% (134/906) of patients died, and 52% (351/906) were discharged to a facility that was not home. Factors significantly associated with 30-day mortality included increasing age, postoperative complications, fewer days from operation to stroke, and increased operative time (C-statistic = 0.794). Significant temporal changes in mortality or adverse discharge outcomes were not identified over the 15-year study period.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Cardiac perioperative strokes are associated with high rates of nonhome discharge and mortality, and those occurring sooner after cardiac surgery were associated with higher mortality, in addition to other factors. Outcomes did not change significantly over the 15-year study period. Further research should focus on effective interventions to improve outcomes after stroke following cardiac surgery.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Farmer</LastName><ForeName>Jaycee R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Pharmacology &amp; Therapeutics, The University of British Columbia, Vancouver, BC, Canada; Department of Anesthesia, St. Paul's Hospital, Providence Health Care, Vancouver, BC, Canada. Electronic address: jayfarm@student.ubc.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sutherland</LastName><ForeName>Jason M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Centre for Health Services and Policy Research, Faculty of Medicine, School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada; Centre for Advancing Health Outcomes, St. Paul's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Field</LastName><ForeName>Thalia S</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Vancouver Stroke Program &amp; Division of Neurology, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McIsaac</LastName><ForeName>Daniel I</ForeName><Initials>DI</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of Ottawa, Ottawa, Ontario, Canada; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gelb</LastName><ForeName>Adrian W</ForeName><Initials>AW</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of California San Francisco, San Francisco, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Lily W</ForeName><Initials>LW</Initials><AffiliationInfo><Affiliation>Department of Neurovascular Neurology, Stanford University, Palo Alto, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Terri</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Pharmacology &amp; Therapeutics, The University of British Columbia, Vancouver, BC, Canada; Department of Anesthesia, St. Paul's Hospital, Providence Health Care, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwarz</LastName><ForeName>Stephan K W</ForeName><Initials>SKW</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Pharmacology &amp; Therapeutics, The University of British Columbia, Vancouver, BC, Canada; Department of Anesthesia, St. Paul's Hospital, Providence Health Care, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flexman</LastName><ForeName>Alana M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Pharmacology &amp; Therapeutics, The University of British Columbia, Vancouver, BC, Canada; Department of Anesthesia, St. Paul's Hospital, Providence Health Care, Vancouver, BC, Canada; Centre for Advancing Health Outcomes, St. Paul's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">adverse outcomes</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">perioperative stroke</Keyword><Keyword MajorTopicYN="N">risk prediction, perioperative complications</Keyword></KeywordList><CoiStatement>Declaration of competing interest J.R.F. J.M.S., L.Z. and T.S. have no conflicts of interest or disclosures to report. T.S.F. is a member of the Editorial Board of the Canadian Journal of Neurological Sciences and Stroke; has received consulting fees from HLS Therapeutics, Roche Canada, and AstraZeneca. as well as in-kind study medication from Bayer Canada; has served as an expert witness for the Canadian Medical Protective Association; and is a Board member of DESTINE Health. D.I.M. is a member of the Editorial Boards of Anesthesiology and the Canadian Journal of Anesthesia/Journal Canadien d&#x2019;anesth&#xe9;sie. A.W.G. is a member of the Editorial Board of the Canadian Journal of Anesthesia/Journal Canadien d&#x2019;anesth&#xe9;sie; a Board member of the World Federation of Societies of Anesthesiologists; and has received consulting fees from UpToDate and Haisco Pharmaceuticals. S.K.W.S. is the Editor-in-Chief of the Canadian Journal of Anesthesia/Journal Canadien d&#x2019;anesth&#xe9;sie; he has no financial relationships with commercial entities. A. M. F. is the Editor-in-Chief of the Journal of Neurosurgical Anesthesiology and has received consultant fees from UpToDate and research funding from Eisai, Inc.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>21</Day><Hour>0</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>5</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>4</Day><Hour>22</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40320349</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2025.04.010</ArticleId><ArticleId IdType="pii">S1053-0770(25)00314-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31879176</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>01</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0267</ISSN><JournalIssue CitedMedium="Internet"><Volume>51</Volume><Issue>2</Issue><PubDate><Year>2020</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Injury</Title><ISOAbbreviation>Injury</ISOAbbreviation></Journal><ArticleTitle>The prognostic implication of perioperative cardiac enzyme elevation in patients with fractured neck of femur: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>164</StartPage><EndPage>173</EndPage><MedlinePgn>164-173</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.injury.2019.12.012</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0020-1383(19)30782-X</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Neck of Femur (NOF) fractures are a common injury in comorbid elderly patients which are associated with increased rates of morbidity and mortality following fracture. Because of their injury, patients can experience reductions in quality of life and independent living leading to transfer to nursing home or dependent levels of care. Numerous factors are associated with either complications or reductions in survival following fractured NOF. From the VISION cohort there is evidence that troponin elevation in the post-operative period following a diverse range of non-cardiac surgical procedures may lead to an increased risk of mortality in the absence of classical ischaemic or cardiac symptoms. The aim of this systematic review and meta-analysis is to validate the utility of perioperative troponin elevation as a prognostic indicator for mortality and cardiac morbidity in those with fractured NOF.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The PRISMA guidelines for the conduct of meta-analyses were followed. An electronic search was conducted of the EMBASE, MEDLINE (Ovid) and Biosis databases. Studies were included for analysis if they stratified outcomes by perioperative troponin elevation in surgically managed fractured NOF and reported sufficient data on troponin elevation and mortality following surgery. Primary and secondary outcomes assessed were all-cause post-operative mortality and a composite measure of cardiac complications (myocardial infarction, cardiac failure and arrhythmia) respectively.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eleven studies met inclusion criteria giving a total of 1363 patients. Overall, 497 patients (36.5%) experienced an elevation in troponin levels following surgery. Perioperative troponin elevation was significantly associated with all-cause mortality (OR 2.6; 95% CI 1.5 - 4.6; p &lt;0.001) and cardiac complications (OR 7.4; 95% CI 3.5 - 15.8; p &lt;0.001). Patient factors significantly associated with troponin elevation included pre-existing coronary artery disease, cardiac failure, hypertension, previous stroke and previous myocardial infarction.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Perioperative troponin elevation is significantly associated with increased mortality and post-operative cardiac complications following fractured NOF and may be a useful prognostic indicator in these patients. Future research should further stratify patients by the magnitude of troponin elevation and further refine the risk factors.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lowe</LastName><ForeName>Matthew J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Auckland City Hospital, Auckland, New Zealand. Electronic address: matthewlowe77@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lightfoot</LastName><ForeName>Nicholas J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Medicine, Middlemore Hospital, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Injury</MedlineTA><NlmUniqueID>0226040</NlmUniqueID><ISSNLinking>0020-1383</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014336">Troponin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="N">Arrhythmias, Cardiac</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005265" MajorTopicYN="N">Femoral Neck Fractures</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="N">Heart Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="N">Heart Failure</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059035" MajorTopicYN="N">Perioperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014336" MajorTopicYN="N">Troponin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biomarker</Keyword><Keyword MajorTopicYN="N">Hip fracture</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Neck of femur</Keyword><Keyword MajorTopicYN="N">Prognosis</Keyword><Keyword MajorTopicYN="N">Troponin</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The senior author (NJL) has previously received honoraria, travel and accommodation expenses unrelated to the subject of this paper from Merck, Sharp and Dohme. No authors received any benefits for this study that would constitute a conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31879176</ArticleId><ArticleId IdType="doi">10.1016/j.injury.2019.12.012</ArticleId><ArticleId IdType="pii">S0020-1383(19)30782-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25423271</PMID><DateCompleted><Year>2015</Year><Month>03</Month><Day>31</Day></DateCompleted><DateRevised><Year>2015</Year><Month>02</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1933-0693</ISSN><JournalIssue CitedMedium="Internet"><Volume>122</Volume><Issue>2</Issue><PubDate><Year>2015</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of neurosurgery</Title><ISOAbbreviation>J Neurosurg</ISOAbbreviation></Journal><ArticleTitle>Unstable moyamoya disease: clinical features and impact on perioperative ischemic complications.</ArticleTitle><Pagination><StartPage>400</StartPage><EndPage>407</EndPage><MedlinePgn>400-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3171/2014.10.JNS14231</ELocationID><Abstract><AbstractText Label="OBJECT" NlmCategory="OBJECTIVE">Unstable moyamoya disease, reasonably defined as cases exhibiting either rapid disease progression or repeated ischemic stroke, represents a challenge in the treatment of moyamoya disease. Despite its overall efficacy, direct bypass for such unstable disease remains controversial in terms of safety. This study aims to reveal factors associated with unstable disease and to assess its impact on postoperative silent or symptomatic ischemic lesions.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective cohort study included both pediatric and adult patients with moyamoya disease who had undergone 140 consecutive direct bypass procedures at Kyoto University Hospital. "Unstable moyamoya disease" was defined as either the rapid progression of a steno-occlusive lesion or repeat ischemic stroke, either occurring within 6 months of surgery. The extent of progression was determined through a comparison of the findings between 2 different MR angiography sessions performed before surgery. The clinical variables of the stable and unstable disease groups were compared, and the association between unstable disease and postoperative diffusion-weighted imaging (DWI)-detected lesion was assessed through univariate and multivariate analyses with generalized estimating equations.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 134 direct bypass procedures performed after patients had undergone at least 2 sessions of MR angiography, 24 (17.9%) were classified as cases of unstable disease. Age younger than 3 years (p=0.029), underlying disease causing moyamoya syndrome (p=0.049), and radiographic evidence of infarction (p=0.030) were identified as factors associated with unstable disease. Postoperative DWI-defined lesions were detected after 13 of 140 procedures (9.3%), although only 4 lesions (2.9%) could be classified as a permanent complication. The incidence of postoperative DWI-detected lesions in the unstable group was notable at 33.3% (8 of 24). Univariate analysis revealed that unstable disease (p&lt;0.001), underlying disease (p=0.028), and recent stroke (p=0.012) were factors associated with DWI-detected lesions. Unstable disease remained statistically significant after adjustment for covariates in both the primary and sensitivity analyses (primary analysis: OR 6.62 [95% CI 1.79-24.5]; sensitivity analysis: OR 5.36 [95% CI 1.47-19.6]).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Unstable moyamoya disease, more prevalent in younger patients and those with underlying disease, is a possible risk factor for perioperative ischemic complications. Recognition of unstable moyamoya disease may contribute to an improved surgical result through focused perioperative management based on appropriate surgical risk stratification.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Funaki</LastName><ForeName>Takeshi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Departments of 1 Neurosurgery and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takahashi</LastName><ForeName>Jun C</ForeName><Initials>JC</Initials></Author><Author ValidYN="Y"><LastName>Takagi</LastName><ForeName>Yasushi</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Kikuchi</LastName><ForeName>Takayuki</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Yoshida</LastName><ForeName>Kazumichi</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Mitsuhara</LastName><ForeName>Takafumi</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Kataoka</LastName><ForeName>Hiroharu</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Okada</LastName><ForeName>Tomohisa</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Fushimi</LastName><ForeName>Yasutaka</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Miyamoto</LastName><ForeName>Susumu</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>11</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosurg</MedlineTA><NlmUniqueID>0253357</NlmUniqueID><ISSNLinking>0022-3085</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002548" MajorTopicYN="N">Cerebral Revascularization</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D038524" MajorTopicYN="N">Diffusion Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="Y">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018810" MajorTopicYN="N">Magnetic Resonance Angiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009072" MajorTopicYN="N">Moyamoya Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACA = anterior cerebral artery</Keyword><Keyword MajorTopicYN="N">DWI = diffusion-weighted imaging</Keyword><Keyword MajorTopicYN="N">GEE = generalized estimating equation</Keyword><Keyword MajorTopicYN="N">ICA = internal carotid artery</Keyword><Keyword MajorTopicYN="N">MCA = middle cerebral artery</Keyword><Keyword MajorTopicYN="N">MRA = MR angiography</Keyword><Keyword MajorTopicYN="N">PCA = posterior cerebral artery</Keyword><Keyword MajorTopicYN="N">STA = superficial temporal artery</Keyword><Keyword MajorTopicYN="N">TIA = transient ischemic attack</Keyword><Keyword MajorTopicYN="N">cerebral revascularization</Keyword><Keyword MajorTopicYN="N">intraoperative complication</Keyword><Keyword MajorTopicYN="N">mRS = modified Rankin Scale</Keyword><Keyword MajorTopicYN="N">moyamoya disease</Keyword><Keyword MajorTopicYN="N">rapid progression</Keyword><Keyword MajorTopicYN="N">vascular disorders</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25423271</ArticleId><ArticleId IdType="doi">10.3171/2014.10.JNS14231</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">19661467</PMID><DateCompleted><Year>2009</Year><Month>11</Month><Day>17</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1524-4628</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>10</Issue><PubDate><Year>2009</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Stroke</Title><ISOAbbreviation>Stroke</ISOAbbreviation></Journal><ArticleTitle>Systematic review of the operative risks of carotid endarterectomy for recently symptomatic stenosis in relation to the timing of surgery.</ArticleTitle><Pagination><StartPage>e564</StartPage><EndPage>e572</EndPage><MedlinePgn>e564-72</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1161/STROKEAHA.109.558528</ELocationID><Abstract><AbstractText Label="BACKGROUND AND PURPOSE" NlmCategory="OBJECTIVE">Reliable data on the risk of carotid endarterectomy (CEA) in relation to timing of surgery are necessary to plan CEA most effectively, to adjust risks for case-mix, and to understand the mechanisms of operative stroke.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a systematic review of all studies published from 1980 to 2008 inclusive that reported the risk of stroke and death due to CEA in relation to the time between presenting symptom and surgery. Pooled estimates of risk by the time since the last event were obtained by Mantel-Haenszel meta-analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 494 published operative series, only 47 stratified risk by timing of surgery. The pooled absolute risks of stroke and death after urgent CEA were high in patients with stroke-in-evolution (20.2%, 95% CI 12.0 to 28.4) and in patients with crescendo TIA (11.4%, 6.1 to 16.7), with no trends toward reduced risks in more recent studies. However, there was no significant difference between early and later CEA in neurologically stable patients with recent TIA or nondisabling stroke (&lt;1 week versus &gt; or = 1 week, OR=1.2, 0.9 to 1.7, P=0.17; &lt;2 weeks versus &gt; or = 2 weeks, OR=1.2, 0.9 to 1.6, P=0.13).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Emergency endarterectomy for stroke-in-evolution has a high operative risk, but the risk may be somewhat lower in patients with crescendo TIA. Surgery in the first week in neurologically stable patients with TIA or minor stroke is not associated with a substantially higher operative risk than delayed surgery. More data are required on the risk and benefit of more urgent surgery for TIA and minor stroke and for early versus delayed surgery in patients with major nondisabling stroke.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rerkasem</LastName><ForeName>Kittipan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Vascular Surgery Division, Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rothwell</LastName><ForeName>Peter M</ForeName><Initials>PM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2009</Year><Month>08</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Stroke</MedlineTA><NlmUniqueID>0235266</NlmUniqueID><ISSNLinking>0039-2499</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016893" MajorTopicYN="N">Carotid Stenosis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016894" MajorTopicYN="N">Endarterectomy, Carotid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="N">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009026" MajorTopicYN="N">Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>85</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>8</Month><Day>8</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>8</Month><Day>8</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19661467</ArticleId><ArticleId IdType="doi">10.1161/STROKEAHA.109.558528</ArticleId><ArticleId IdType="pii">STROKEAHA.109.558528</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26169456</PMID><DateCompleted><Year>2016</Year><Month>09</Month><Day>06</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1615-5947</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>8</Issue><PubDate><Year>2015</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Annals of vascular surgery</Title><ISOAbbreviation>Ann Vasc Surg</ISOAbbreviation></Journal><ArticleTitle>Management of Patients with Internal Carotid Artery Near-total Occlusion: An Updated Meta-analysis.</ArticleTitle><Pagination><StartPage>1664</StartPage><EndPage>1672</EndPage><MedlinePgn>1664-72</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.avsg.2015.05.015</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0890-5096(15)00566-X</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The decision for revascularization in patients with near-total internal carotid artery (ICA) occlusion still remains controversial. We undertook an extensive review of the literature and conducted a meta-analysis aiming to investigate the appropriate therapeutic approach for patients with near-total ICA occlusion.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A multiple electronic health database search was performed on all articles published up to December 2014. All available data were analyzed giving emphasis on the applied therapeutic approach (best medical therapy [BMT], carotid endarterectomy [CEA], and carotid artery stenting [CAS]), whereas the main endpoints of the meta-analysis were transient ischemic attack (TIA), stroke, stroke-related death, myocardial infarction (MI), major adverse event (MAE), overall mortality, and restenosis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Five articles on BMT and CEA, 8 articles on CEA, and 11 articles on CAS were deemed eligible. A statistically significant difference was recorded in pooled stroke incidence rates (IRs) per 100 patient-years (p-ys) of BMT (IR = 6.19) compared with CEA (IR = 2.24, P = 0.002) and CAS (IR = 1.64, P &lt; 0.001) studies. No statistically significant differences were recorded in pooled IRs per 100 p-ys between CEA and CAS, concerning TIA (P = 0.96), stroke (P = 0.44), stroke-related death (P = 0.30), and MAE (P = 0.99), whereas a borderline significance was recorded concerning overall mortality (P = 0.08) and restenosis (P = 0.08). No nominally significant effects were demonstrated with respect to almost all the studied potential modifiers in meta-regression analysis among the eligible studies.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">An intervention is probably indicated for patients with near-total ICA occlusion. The results of our study underline the need for including patients with near-total ICA occlusion in future randomized controlled trials. Meanwhile, the treatment of these patients should be individualized.</AbstractText><CopyrightInformation>Copyright &#xa9; 2015 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mylonas</LastName><ForeName>Spyridon N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, University of Athens, Attikon Hospital, Athens, Greece. Electronic address: spyrosmylonas@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antonopoulos</LastName><ForeName>Constantine N</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Athens University Medical School, Attikon University Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moulakakis</LastName><ForeName>Konstantinos G</ForeName><Initials>KG</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Athens University Medical School, Attikon University Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kakisis</LastName><ForeName>John D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Athens University Medical School, Attikon University Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liapis</LastName><ForeName>Christos D</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Athens University Medical School, Attikon University Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>07</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Ann Vasc Surg</MedlineTA><NlmUniqueID>8703941</NlmUniqueID><ISSNLinking>0890-5096</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002343" MajorTopicYN="Y">Carotid Artery, Internal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016893" MajorTopicYN="N">Carotid Stenosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016894" MajorTopicYN="N">Endarterectomy, Carotid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015607" MajorTopicYN="N">Stents</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26169456</ArticleId><ArticleId IdType="doi">10.1016/j.avsg.2015.05.015</ArticleId><ArticleId IdType="pii">S0890-5096(15)00566-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29502959</PMID><DateCompleted><Year>2019</Year><Month>07</Month><Day>22</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-0938</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>5 Pt A</Issue><PubDate><Year>2018</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Cardiovascular revascularization medicine : including molecular interventions</Title><ISOAbbreviation>Cardiovasc Revasc Med</ISOAbbreviation></Journal><ArticleTitle>Proximal embolic protection versus distal filter protection versus combined protection in carotid artery stenting: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>545</StartPage><EndPage>552</EndPage><MedlinePgn>545-552</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.carrev.2017.12.010</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1553-8389(17)30465-7</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Proximal embolic protection devices (P-EPD) and distal filters (DF) are used to prevent distal cerebral embolizations during carotid artery stenting (CAS). We compared their comparative effectiveness in regards to prevention of intraprocedural and periprocedural adverse events, including ischemic lesions (ipsilateral and contralateral), stroke, transient ischemic attacks (TIA) and death. We also compared the combination of the two neuroprotection strategies vs. a single strategy in regards to ischemic lesions and stroke.</AbstractText><AbstractText Label="MATERIALS &amp; METHODS">This study was performed according to the PRISMA and MOOSE guidelines and eligible studies were identified through search of PubMed, Scopus and Cochrane Central. A meta-analysis was conducted with the use of a random effects model. The I-square statistic was used to assess for heterogeneity.</AbstractText><AbstractText Label="RESULTS">Twenty-nine studies involving 16,307 patients were included. There was a significant reduction in ischemic lesions with the use of P-EPD among observational studies (RR: 0.66 [0.45-0.97]). There were no statistically significant differences for the other outcomes between the two treatment groups.</AbstractText><AbstractText Label="CONCLUSIONS">There is a number of studies reporting outcomes on the comparison between P-EPD and DF for CAS. P-EDP can reduce distal embolization phenomena resulting into ischemic lesions when compared to DF based on the results from real-world studies. P-EPD was not superior however, in regards to periprocedural stroke, TIA and death. Further studies are anticipated to provide a clear answer to this debate.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Texakalidis</LastName><ForeName>Pavlos</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Aristotle University of Thessaloniki, Thessaloniki, Greece; Society of Junior Doctors, Menalou 5 Street, 15123 Athens, Greece. Electronic address: pavlostex.med@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Letsos</LastName><ForeName>Alexandros</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Crete, Heraklion, Greece; Society of Junior Doctors, Menalou 5 Street, 15123 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kokkinidis</LastName><ForeName>Damianos G</ForeName><Initials>DG</Initials><AffiliationInfo><Affiliation>Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY, United States; Society of Junior Doctors, Menalou 5 Street, 15123 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schizas</LastName><ForeName>Dimitrios</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>1st Department of Surgery, National and Kapodistrian University of Athens, Laikon Hospital, 11527 Athens, Greece; Society of Junior Doctors, Menalou 5 Street, 15123 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karaolanis</LastName><ForeName>Georgios</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>1st Department of Surgery, National and Kapodistrian University of Athens, Laikon Hospital, 11527 Athens, Greece; Society of Junior Doctors, Menalou 5 Street, 15123 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giannopoulos</LastName><ForeName>Stefanos</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>1st Department of Surgery, National and Kapodistrian University of Athens, Laikon Hospital, 11527 Athens, Greece; Society of Junior Doctors, Menalou 5 Street, 15123 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giannopoulos</LastName><ForeName>Spyridon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>1st Department of Surgery, National and Kapodistrian University of Athens, Laikon Hospital, 11527 Athens, Greece; Society of Junior Doctors, Menalou 5 Street, 15123 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Economopoulos</LastName><ForeName>Konstantinos P</ForeName><Initials>KP</Initials><AffiliationInfo><Affiliation>Division of Surgery, Duke University School of Medicine; Society of Junior Doctors, Menalou 5 Street, 15123 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakoyannis</LastName><ForeName>Christos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>1st Department of Surgery, National and Kapodistrian University of Athens, Laikon Hospital, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>12</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cardiovasc Revasc Med</MedlineTA><NlmUniqueID>101238551</NlmUniqueID><ISSNLinking>1878-0938</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002340" MajorTopicYN="N">Carotid Artery Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057186" MajorTopicYN="N">Comparative Effectiveness Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057505" MajorTopicYN="Y">Embolic Protection Devices</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="N">Endovascular Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020766" MajorTopicYN="N">Intracranial Embolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065840" MajorTopicYN="N">Protective Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015607" MajorTopicYN="Y">Stents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Carotid artery stenting,</Keyword><Keyword MajorTopicYN="N">Embolic protection device,</Keyword><Keyword MajorTopicYN="N">Neuroprotection</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29502959</ArticleId><ArticleId IdType="doi">10.1016/j.carrev.2017.12.010</ArticleId><ArticleId IdType="pii">S1553-8389(17)30465-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33070548</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>22</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2153-8174</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Sep</Month><Day>30</Day></PubDate></JournalIssue><Title>Reviews in cardiovascular medicine</Title><ISOAbbreviation>Rev Cardiovasc Med</ISOAbbreviation></Journal><ArticleTitle>Efficacy and safety of left atrial appendage occlusion in atrial fibrillation patients with chronic kidney disease: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>443</StartPage><EndPage>451</EndPage><MedlinePgn>443-451</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.31083/j.rcm.2020.03.62</ELocationID><Abstract><AbstractText>Atrial fibrillation (AF) is the most common arrhythmia among the elderly, and more frequently occur in those with chronic kidney disease (CKD). Left atrial appendage occlusion (LAAO) is used as a mechanical alternative approach for prevention of AF-related thromboembolisms. This meta-analysis was conducted to provide suggestions for the clinical application of LAAO in AF patients with CKD. The incidence of perioperative adverse events and other clinical effects after operation was by a single rate meta-analysis. Results showed that incidence of adverse events in the perioperative period after LAAO was generally low, with only pericardial effusion / tamponade (1.90%) and mortality rate (1.10%). During the follow-up period, the incidence of stroke/transient ischemic attack (TIA) and bleeding were 2.17% and 4.53%, respectively. A low incidence rate of adverse events was found in the perioperative period following LAAO. These results indicate that LAAO more effectively prevents the occurrence of stroke/TIA and minimizes bleeding events than oral anticoagulants.</AbstractText><CopyrightInformation>&#xa9; 2020 Zhang et al. Published by IMR press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hai-Fu</ForeName><Initials>HF</Initials><AffiliationInfo><Affiliation>Division of Cardiology, The Affiliated Hospital of Hangzhou Normal University, Hangzhou 310015, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Hangzhou Normal University, Hangzhou 311121, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Qin-Xia</ForeName><Initials>QX</Initials><AffiliationInfo><Affiliation>School of Medicine, Hangzhou Normal University, Hangzhou 311121, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yuan-Yuan</ForeName><Initials>YY</Initials><AffiliationInfo><Affiliation>Division of Cardiology, The Affiliated Hospital of Hangzhou Normal University, Hangzhou 310015, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Dong</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Cardiology, The Affiliated Hospital of Hangzhou Normal University, Hangzhou 310015, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Zhao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Division of Cardiology, The Affiliated Hospital of Hangzhou Normal University, Hangzhou 310015, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiao</LastName><ForeName>Qi-Bin</ForeName><Initials>QB</Initials><AffiliationInfo><Affiliation>Division of Cardiology, The Affiliated Hospital of Hangzhou Normal University, Hangzhou 310015, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Hangzhou Normal University, Hangzhou 311121, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xing-Wei</ForeName><Initials>XW</Initials><AffiliationInfo><Affiliation>Division of Cardiology, The Affiliated Hospital of Hangzhou Normal University, Hangzhou 310015, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Hangzhou Normal University, Hangzhou 311121, P. R. China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Singapore</Country><MedlineTA>Rev Cardiovasc Med</MedlineTA><NlmUniqueID>100960007</NlmUniqueID><ISSNLinking>1530-6550</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020517" MajorTopicYN="N">Atrial Appendage</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="N">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="Y">Heart Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="N">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051436" MajorTopicYN="N">Renal Insufficiency, Chronic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Atrial fibrillation</Keyword><Keyword MajorTopicYN="N">chronic kidney disease</Keyword><Keyword MajorTopicYN="N">left atrial appendage occlusion</Keyword></KeywordList><CoiStatement>All authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>19</Day><Hour>0</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33070548</ArticleId><ArticleId IdType="doi">10.31083/j.rcm.2020.03.62</ArticleId><ArticleId IdType="pii">1601433459184-1886833784</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39252294</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>103</Volume><Issue>36</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>06</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Recent advances in Del Nido cardioplegia: A comprehensive analysis of randomized clinical trials in adult cardiac surgery.</ArticleTitle><Pagination><StartPage>e39453</StartPage><MedlinePgn>e39453</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e39453</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000039453</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Del Nido cardioplegia (DNC) has extensively been used for pediatric population undergoing cardiac surgery. However, its use in adult cardiac surgeries have been limited thus, its benefits are not yet fully known. This analysis was performed to evaluate the impact of DNC versus any other type of cardioplegia in adult patients who are undergoing cardiac surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We systematically searched PubMed, Cochrane Library, and Scopus from database inception till March 2023, and moderate to high-quality randomized controlled trials were included which compared DNC to other cardioplegia. The primary outcome was postoperative stroke and/or transient ischemic attack (TIA). Secondary outcomes included spontaneous rhythm return, postoperative myocardial infarction, all-cause mortality, postoperative atrial fibrillation, defibrillation after coronary reperfusion, postoperative intra-aortic balloon pump, postoperative kidney injury, postoperative low cardiac output syndrome, inotropic support, cardiopulmonary bypass time, cross-clamp time, blood transfusion, cardioplegia volume, hospital stay, intensive care unit stay, mechanical ventilation stay, postoperative left ventricular ejection fraction, and cardiac markers.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In this meta-analysis, 13 studies were included with a patient population of 2207. Stroke and/or TIA studies (risk ratio [RR]: 0.54, 95% CI [0.29, 1.00]) and all-cause mortality studies (RR: 1.30, 95% CI [0.66, 2.56]) were insignificant. From the secondary outcomes, spontaneous rhythm return (RR: 1.58, 95% CI [1.02, 2.45]), defibrillation after coronary reperfusion (RR: 0.49, 95% CI [0.30, 0.79]), inotropic support (RR: 0.70, 95% CI [0.57, 0.85]), composite risk of stroke and/or TIA and/or acute kidney injury and mortality (RR: 0.72, 95% CI [0.53, 0.99]), cross-clamp time (mean difference [MD]: -6.01, 95% CI [-11.14, -0.89]), blood transfusion (RR: 0.73, 95% CI [0.60, 0.90]), cardioplegia volume (MD: -537.17, 95% CI [-758.89, -315.45]), troponin T (MD: -1.71, 95% CI [-2.11, -1.32]), creatine phosphokinase-MB (MD: -2.96, 95% CI [-5.84, -0.07]) were significant. Whereas all other secondary outcomes were found to be insignificant.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">No significant difference was observed between patients undergoing Del Nido administration in comparison to other cardioplegia solutions for the primary outcome, stroke or/and TIA.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Shaheed Mohtarma Benazir Bhutto Medical College Lyari, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raja</LastName><ForeName>Adarsh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Shaheed Mohtarma Benazir Bhutto Medical College Lyari, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Virwani</LastName><ForeName>Vikash</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Aga Khan University and Hospital, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raja</LastName><ForeName>Sandesh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hussain</LastName><ForeName>Syed Yawar</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Shaheed Mohtarma Benazir Bhutto Medical College Lyari, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moeed</LastName><ForeName>Abdul</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Shanta</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Liaquat National Hospital and Medical College, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abbas</LastName><ForeName>Johar</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Liaquat National Hospital and Medical College, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fadelallah Eljack</LastName><ForeName>Mohammed Mahmmoud</ForeName><Initials>MM</Initials><Identifier Source="ORCID">0000-0002-2370-9368</Identifier><AffiliationInfo><Affiliation>University of Bakhtalruda Faculty of Medicine and Health Sciences, Al-Dewaym, Sudan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asghar</LastName><ForeName>Muhammad Sohaib</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002314">Cardioplegic Solutions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000712134">Del Nido cardioplegia solution</NameOfSubstance></Chemical><Chemical><RegistryNumber>660YQ98I10</RegistryNumber><NameOfSubstance UI="D011189">Potassium Chloride</NameOfSubstance></Chemical><Chemical><RegistryNumber>3OWL53L36A</RegistryNumber><NameOfSubstance UI="D008353">Mannitol</NameOfSubstance></Chemical><Chemical><RegistryNumber>98PI200987</RegistryNumber><NameOfSubstance UI="D008012">Lidocaine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012996">Solutions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004573">Electrolytes</NameOfSubstance></Chemical><Chemical><RegistryNumber>7487-88-9</RegistryNumber><NameOfSubstance UI="D008278">Magnesium Sulfate</NameOfSubstance></Chemical><Chemical><RegistryNumber>8MDF5V39QO</RegistryNumber><NameOfSubstance UI="D017693">Sodium Bicarbonate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="Y">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006324" MajorTopicYN="Y">Heart Arrest, Induced</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002314" MajorTopicYN="N">Cardioplegic Solutions</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011189" MajorTopicYN="N">Potassium Chloride</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008353" MajorTopicYN="N">Mannitol</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008012" MajorTopicYN="N">Lidocaine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012996" MajorTopicYN="N">Solutions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004573" MajorTopicYN="N">Electrolytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008278" MajorTopicYN="N">Magnesium Sulfate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017693" MajorTopicYN="N">Sodium Bicarbonate</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no funding and conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>10</Day><Hour>1</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39252294</ArticleId><ArticleId IdType="pmc">PMC11383727</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000039453</ArticleId><ArticleId IdType="pii">00005792-202409060-00081</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nicolas J, Soriano K, Salter B, Gross CR, Oloomi M, Dangas G. Myocardial infarction after cardiac surgery: when to intervene? J Thorac Cardiovasc Surg. 2023;165:1195&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pubmed">34556356</ArticleId></ArticleIdList></Reference><Reference><Citation>Levitsky S. Is hypothermic fibrillatory arrest a rational alternative to cardioplegic arrest?
Ann Thorac Surg. 1987;43:127&#x2013;8. https://pubmed.ncbi.nlm.nih.gov/3492973/.
</Citation><ArticleIdList><ArticleId IdType="pubmed">3492973</ArticleId></ArticleIdList></Reference><Reference><Citation>Chambers DJ, Fallouh HB. Cardioplegia and cardiac surgery: pharmacological arrest and cardioprotection during global ischemia and reperfusion. Pharmacol Ther. 2010;127:41&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">20398698</ArticleId></ArticleIdList></Reference><Reference><Citation>Habertheuer A, Kocher A, Laufer G, et al. . Cardioprotection: a review of current practice in global ischemia and future translational perspective. Biomed Res Int. 2014;2014:325725.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4172998</ArticleId><ArticleId IdType="pubmed">25276778</ArticleId></ArticleIdList></Reference><Reference><Citation>Modelado y Simulaci&#xf3;n de la Actividad El&#xe9;ctrica de C&#xe9;lulas Ventriculares. [cited 2023 Sep 1]. http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0120-62302008000400008. Accessed September 1, 2023.</Citation></Reference><Reference><Citation>Carvajal C, Goyal A, Tadi P. Cardioplegia. Treasure Island (FL) : StatPearls. 2023.  Jul 24 [cited 2023 Sep 1]; https://www.ncbi.nlm.nih.gov/books/NBK554463/.</Citation></Reference><Reference><Citation>Kotani Y, Tweddell J, Gruber P, et al. . Current cardioplegia practice in pediatric cardiac surgery: a North American multiinstitutional survey. Ann Thorac Surg. 2013;96:923&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">23915588</ArticleId></ArticleIdList></Reference><Reference><Citation>Matte GS, del Nido PJ. History and use of del Nido cardioplegia solution at Boston Children&#x2019;s Hospital.
2012; https://pubmed.ncbi.nlm.nih.gov/23198389/. Accessed September 1, 2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4557532</ArticleId><ArticleId IdType="pubmed">23198389</ArticleId></ArticleIdList></Reference><Reference><Citation>Braathen B, Jeppsson A, Scherst&#xe9;n H, et al. . One single dose of histidine&#x2013;tryptophan&#x2013;ketoglutarate solution gives equally good myocardial protection in elective mitral valve surgery as repetitive cold blood cardioplegia: a prospective randomized study. J Thorac Cardiovasc Surg. 2011;141:995&#x2013;1001.</Citation><ArticleIdList><ArticleId IdType="pubmed">20800244</ArticleId></ArticleIdList></Reference><Reference><Citation>Najjar M, George I, Akashi H, et al. . Feasibility and safety of continuous retrograde administration of Del Nido cardioplegia: a case series. J Cardiothorac Surg. 2015;10:176.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4662002</ArticleId><ArticleId IdType="pubmed">26612068</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra P, Jadhav RB, Mohapatra CKR, et al. . Comparison of del Nido cardioplegia and St. Thomas Hospital solution - two types of cardioplegia in adult cardiac surgery. Kardiochir Torakochirurgia Pol. 2016;13:295&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5233756</ArticleId><ArticleId IdType="pubmed">28096823</ArticleId></ArticleIdList></Reference><Reference><Citation>Ad N. del Nido cardioplegia: ready for prime time in adult cardiac surgery? J Thorac Cardiovasc Surg. 2015;149:637&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">25726885</ArticleId></ArticleIdList></Reference><Reference><Citation>Timek T, Willekes C, Hulme O, et al. . Propensity matched analysis of del Nido cardioplegia in adult coronary artery bypass grafting: initial experience with 100 consecutive patients. Ann Thorac Surg. 2016;101:2237&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">27016843</ArticleId></ArticleIdList></Reference><Reference><Citation>Smigla G, Jaquiss R, Walczak R, et al. . Assessing the safety of del Nido cardioplegia solution in adult congenital cases. Perfusion. 2014;29:554&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">25009226</ArticleId></ArticleIdList></Reference><Reference><Citation>Ota T, Yerebakan H, Neely RC, et al. . Short-term outcomes in adult cardiac surgery in the use of del Nido cardioplegia solution. Perfusion. 2016;31:27&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">26228274</ArticleId></ArticleIdList></Reference><Reference><Citation>Fresilli S, Labanca R, Monaco F, et al. . Del Nido Study Group. Del Nido cardioplegia in adult cardiac surgery: meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth. 2023;37:1152&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">37080841</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, et al. . The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2714672</ArticleId><ArticleId IdType="pubmed">19622552</ArticleId></ArticleIdList></Reference><Reference><Citation>RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:4898.</Citation><ArticleIdList><ArticleId IdType="pubmed">31462531</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range.
BMC Med Res Methodol. 2014;14:135. https://bmcmedresmethodol.biomedcentral.com/articles/10.1186/1471-2288-14-135#Bib1.
</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-135#Bib1</ArticleId><ArticleId IdType="pmc">PMC4383202</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA. (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022).
Cochrane, . 2022; https://training.cochrane.org/handbook. Accessed September 1, 2023.</Citation></Reference><Reference><Citation>Demir D, Balci A, Kahraman N, et al. . The comparison of del nido cardioplegia and crystalloid-based blood cardioplegia in adult isolated coronary bypass surgery: a randomized controlled trial. Niger J Clin Pract. 2022;25:1998&#x2013;2004.</Citation><ArticleIdList><ArticleId IdType="pubmed">36537457</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukdad L, Toppen W, Sanaiha Y, et al. . Incidence of cerebral microemboli in single-dose vs. multidose cardioplegia in adult cardiac surgery. J Extra Corpor Technol. 2018;50:143&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6146277</ArticleId><ArticleId IdType="pubmed">30250339</ArticleId></ArticleIdList></Reference><Reference><Citation>Matte GS, Del Nido PJ. History and use of del Nido Cardioplegia solution at Boston children&#x2019;s hospital. J Extra Corpor Technol. 2012;44:98&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4557532</ArticleId><ArticleId IdType="pubmed">23198389</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Lin H, Zhao Y, et al. . Del Nido Cardioplegia for myocardial protection in adult cardiac surgery: a systematic review and meta-analysis. ASAIO J. 2018;64:360&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">28863040</ArticleId></ArticleIdList></Reference><Reference><Citation>An KR, Rahman IA, Tam DY, et al. . A systematic review and meta-analysis of del Nido versus conventional cardioplegia in adult cardiac surgery. Innovations (Phila). 2019;14:385&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">31347414</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai K, Cheng X, Zhang P, et al. . Del Nido cardioplegia for myocardial protection in adult cardiac surgery: a systematic review and update meta-analysis. Perfusion. 2023;38:6&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">34263684</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37937943</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2044</ISSN><JournalIssue CitedMedium="Internet"><Volume>77</Volume><Issue>7</Issue><PubDate><Year>2022</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Anaesthesia</Title><ISOAbbreviation>Anaesthesia</ISOAbbreviation></Journal><ArticleTitle>A randomised controlled feasibility trial of a clinical protocol to manage hypotension during major non-cardiac surgery.</ArticleTitle><Pagination><StartPage>795</StartPage><EndPage>807</EndPage><MedlinePgn>795-807</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/anae.15715</ELocationID><Abstract><AbstractText>Intra-operative hypotension is a risk factor for postoperative morbidity and mortality. Minimally invasive monitors that derive other haemodynamic parameters, such as stroke volume, may better inform the management of hypotension. As a prelude to a multicentre randomised controlled trial, we conducted a single-centre feasibility trial of a protocol to treat hypotension as informed by minimally invasive haemodynamic monitoring during non-cardiac surgery. We recruited adults aged &#x2265;40&#x2009;years with cardiovascular risk factors who underwent non-cardiac surgery requiring invasive arterial pressure monitoring. Participants were randomly allocated to usual care, or a clinical protocol informed by an arterial waveform contour analysis monitor. Participants, outcome assessors, clinicians outside operating theatres and analysts were blinded to treatment allocation. Feasibility was evaluated based on: consent rate; recruitment rate; structured feedback from anaesthesia providers; and between-group differences in blood pressure, processes-of-care and outcomes. The consent rate among eligible patients was 33%, with 30 participants randomly allocated to the protocol and 30 to usual care. Anaesthesia providers rated the protocol to be feasible and acceptable. The protocol was associated with reduced fluid balance and hypotension exposure in the peri-operative setting. Postoperative complications included: acute myocardial injury in 18 (30%); acute kidney injury in 17 (28%); and surgical site infection in 7 (12%). The severity of complications was rated as moderate or severe in 25 (42%) participants. In summary, this single-centre study confirmed the feasibility of a multicentre trial to assess the efficacy and safety of a physiologically guided treatment protocol for intra-operative hypotension based on minimally invasive haemodynamic monitors.</AbstractText><CopyrightInformation>&#xa9; 2022 Association of Anaesthetists.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wijeysundera</LastName><ForeName>D N</ForeName><Initials>DN</Initials><Identifier Source="ORCID">0000-0002-5897-8605</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia, St. Michael's Hospital, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duncan</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Management, Toronto General Hospital, University Health Network, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno Garijo</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jerath</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meineri</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Heart Centre Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parotto</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Management, Toronto General Hospital, University Health Network, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>W&#x105;sowicz</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Management, Toronto General Hospital, University Health Network, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCluskey</LastName><ForeName>S A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Management, Toronto General Hospital, University Health Network, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>AMIGO&#x2010;1 Study Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Anaesthesia</MedlineTA><NlmUniqueID>0370524</NlmUniqueID><ISSNLinking>0003-2409</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062186" MajorTopicYN="N">Arterial Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001794" MajorTopicYN="N">Blood Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002985" MajorTopicYN="N">Clinical Protocols</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="Y">Hypotension</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="kor"><AbstractText>&#xc218;&#xc220; &#xc911; &#xc800;&#xd608;&#xc555;&#xc740; &#xc218;&#xc220; &#xd6c4; &#xc774;&#xd658;&#xc728;&#xacfc; &#xc0ac;&#xb9dd;&#xb960;&#xc758; &#xc704;&#xd5d8;&#xc778;&#xc790;&#xc774; &#xb2e4;. 1&#xd68c; &#xbc15;&#xcd9c;&#xb7c9;&#xacfc; &#xac19;&#xc740; &#xb2e4;&#xb978; &#xd608;&#xc5ed;&#xd559;&#xc801; &#xbcc0;&#xc218;&#xb4e4;&#xc744; &#xb3c4;&#xcd9c;&#xd560; &#xb54c;, &#xcd5c; &#xc18c;&#xd55c;&#xc758; &#xce68;&#xc2b5;&#xc131; &#xce21;&#xc815;&#xc740; &#xc800;&#xd608;&#xc555;&#xc758; &#xad00;&#xb9ac;&#xb97c; &#xb354; &#xc798; &#xc54c;&#xb9b4; &#xc218;&#xb3c4; &#xc788;&#xb2e4;. &#xb2e4;&#xc911; &#xc13c;&#xd130; &#xbb34;&#xc791;&#xc704; &#xb300;&#xc870; &#xc2dc;&#xd5d8;&#xc758; &#xc2dc;&#xcd08;&#xb85c;, &#xc800;&#xc790;&#xb4e4;&#xc740; &#xbe44;&#xc2ec;&#xc7a5; &#xc218;&#xc220; &#xc911; &#xcd5c;&#xc18c;&#xc758; &#xce68;&#xc2b5;&#xc801; &#xd608;&#xc5ed;&#xd559;&#xc801; &#xbaa8;&#xb2c8;&#xd130;&#xb9c1;&#xc5d0; &#xc758;&#xd574; &#xace0;&#xc9c0;&#xb41c; &#xb300;&#xb85c; &#xc800; &#xd608;&#xc555;&#xc744; &#xce58;&#xb8cc;&#xd558;&#xae30; &#xc704;&#xd55c; &#xd504;&#xb85c;&#xd1a0;&#xcf5c;&#xc758; &#xb2e8;&#xc77c; &#xc13c;&#xd130; &#xc2e4;&#xd604; &#xac00;&#xb2a5;&#xc131; &#xc2dc; &#xd5d8;&#xc744; &#xc218;&#xd589;&#xd558;&#xc600;&#xb2e4;. &#xc800;&#xc790;&#xb4e4;&#xc740; &#xce68;&#xc2b5;&#xc801; &#xb3d9;&#xb9e5;&#xc555; &#xce21;&#xc815;&#xc774; &#xd544;&#xc694;&#xd558;&#xace0;, &#xbe44;&#xc2ec;&#xc7a5; &#xc218;&#xc220;&#xc744; &#xbc1b;&#xc544; &#xc2ec;&#xd608;&#xad00; &#xc704;&#xd5d8; &#xc694;&#xc778;&#xc774; &#xc788;&#xb294; 40&#xc138; &#xc774;&#xc0c1; &#xc131;&#xc778; &#xc744; &#xbaa8;&#xc9d1;&#xd558;&#xc600;&#xb2e4;. &#xd53c;&#xc2e4;&#xd5d8;&#xc790;&#xb4e4;&#xc740; &#xb3d9;&#xb9e5; &#xd30c;&#xd615; &#xc724;&#xacfd; &#xbd84;&#xc11d; &#xce21;&#xc815;&#xc5d0; &#xc758; &#xd574; &#xc54c;&#xb824;&#xc9c4; &#xc784;&#xc0c1; &#xd504;&#xb85c;&#xd1a0;&#xcf5c; &#xb610;&#xb294; &#xc77c;&#xbc18; &#xce58;&#xb8cc;&#xc5d0; &#xbb34;&#xc791;&#xc704;&#xb85c; &#xbc30;&#xc815;&#xb418; &#xc5c8;&#xb2e4;. &#xce58;&#xb8cc; &#xd560;&#xb2f9;&#xacfc; &#xad00;&#xb828;, &#xd53c;&#xc2e4;&#xd5d8;&#xc790;, &#xacb0;&#xacfc; &#xd3c9;&#xac00;&#xc790;, &#xc218;&#xc220;&#xc2e4; &#xbc16;&#xc758; &#xc784;&#xc0c1; &#xc758;&#xc0ac; &#xbc0f; &#xbd84;&#xc11d;&#xac00;&#xc5d0;&#xac8c; &#xbe14;&#xb77c;&#xc778;&#xb4dc;&#xb85c; &#xc9c4;&#xd589;&#xb418;&#xc5c8;&#xb2e4;. &#xc2e4;&#xd604; &#xac00;&#xb2a5; &#xc131;&#xc740; &#xb3d9;&#xc758;&#xc728;, &#xcc44;&#xc6a9;&#xb960;, &#xb9c8;&#xcde8;&#xacfc; &#xc758;&#xc0ac;&#xc758; &#xad6c;&#xc870;&#xc801; &#xd53c;&#xb4dc;&#xbc31;&#xacfc; &#xd608;&#xc555;, &#xce58;&#xb8cc; &#xacfc;&#xc815; &#xbc0f; &#xacb0;&#xacfc;&#xc758; &#xadf8;&#xb8f9; &#xac04; &#xcc28;&#xc774;&#xc5d0; &#xae30;&#xcd08;&#xd558;&#xc5ec; &#xd3c9;&#xac00;&#xb418;&#xc5c8;&#xb2e4;. &#xb300;&#xc0c1; &#xd658;&#xc790;&#xc758; &#xb3d9;&#xc758;&#xc728;&#xc740; 33%&#xc600;&#xc73c;&#xba70;, 30&#xba85;&#xc758; &#xd53c;&#xc2e4;&#xd5d8;&#xc790;&#xb294; &#xd504;&#xb85c;&#xd1a0;&#xcf5c;&#xc5d0; &#xbb34;&#xc791;&#xc704;&#xb85c; &#xbc30;&#xc815;&#xb418;&#xc5c8;&#xace0;, 30&#xba85;&#xc740; &#xc77c;&#xbc18; &#xce58;&#xb8cc;&#xc5d0; &#xbc30;&#xc815;&#xb418;&#xc5c8;&#xb2e4;. &#xb9c8;&#xcde8; &#xacfc; &#xc758;&#xc0ac;&#xb4e4;&#xc740; &#xc774; &#xd504;&#xb85c;&#xd1a0;&#xcf5c;&#xc774; &#xc2e4;&#xd604; &#xac00;&#xb2a5;&#xd558;&#xba70; &#xc218;&#xc6a9; &#xac00;&#xb2a5;&#xd558;&#xb2e4;&#xace0; &#xd3c9;&#xac00;&#xd558;&#xc600;&#xb2e4;. &#xc774; &#xd504;&#xb85c;&#xd1a0;&#xcf5c;&#xc740; &#xc218;&#xc220; &#xc804; &#xd658;&#xacbd;&#xc5d0;&#xc11c; &#xccb4;&#xc561; &#xade0;&#xd615; &#xac10;&#xc18c; &#xbc0f; &#xc800;&#xd608;&#xc555; &#xb178;&#xcd9c;&#xacfc; &#xad00;&#xb828;&#xc774; &#xc788;&#xc5c8;&#xb2e4;. &#xc218;&#xc220; &#xd6c4; &#xd569;&#xbcd1;&#xc99d;&#xc740; &#xae09;&#xc131; &#xc2ec;&#xadfc; &#xc190;&#xc0c1; 18&#xba85;(30%), &#xae09;&#xc131; &#xc2e0;&#xc7a5; &#xc190;&#xc0c1; 17&#xba85;(28%), &#xc218;&#xc220; &#xbd80;&#xc704; &#xac10;&#xc5fc; 7&#xba85;(12%)&#xc744; &#xd3ec;&#xd568;&#xd55c;&#xb2e4;. &#xd569;&#xbcd1;&#xc99d;&#xc758; &#xc2ec;&#xac01;&#xc131;&#xc740; 25&#xba85;(42%)&#xc758; &#xd53c;&#xc2e4;&#xd5d8; &#xc790;&#xc5d0;&#xc11c; &#xc911;&#xb4f1;&#xb3c4; &#xb610;&#xb294; &#xc911;&#xc99d;&#xc778; &#xac83;&#xc73c;&#xb85c; &#xd3c9;&#xac00;&#xb418;&#xc5c8;&#xb2e4;. &#xc694;&#xc57d;&#xd558;&#xba74;, &#xc774; &#xb2e8;&#xc77c; &#xc13c;&#xd130; &#xc5f0;&#xad6c;&#xb294; &#xcd5c;&#xc18c;&#xd55c;&#xc758; &#xce68;&#xc2b5;&#xc801; &#xd608;&#xd589;&#xb3d9;&#xd0dc;&#xc801; &#xce21;&#xc815;&#xc744; &#xae30;&#xbc18; &#xc73c;&#xb85c; &#xc218;&#xc220; &#xc911; &#xc800;&#xd608;&#xc555;&#xc5d0; &#xb300;&#xd55c; &#xc0dd;&#xb9ac;&#xd559;&#xc801;&#xc73c;&#xb85c; &#xc720;&#xb3c4;&#xb41c; &#xce58;&#xb8cc; &#xd504;&#xb85c; &#xd1a0;&#xcf5c;&#xc758; &#xc720;&#xd6a8;&#xc131;&#xacfc; &#xc548;&#xc804;&#xc131;&#xc744; &#xd3c9;&#xac00;&#xd558;&#xae30; &#xc704;&#xd55c; &#xb2e4;&#xc911; &#xc13c;&#xd130; &#xc2dc;&#xd5d8;&#xc758; &#xc2e4;&#xd604; &#xac00;&#xb2a5;&#xc131;&#xc744; &#xd655;&#xc778;&#xd558;&#xc600;&#xb2e4;.</AbstractText><CopyrightInformation>&#xa9; 2022 Association of Anaesthetists.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">blood pressure</Keyword><Keyword MajorTopicYN="N">haemodynamic monitor</Keyword><Keyword MajorTopicYN="N">intra&#x2010;operative hypotension</Keyword><Keyword MajorTopicYN="N">postoperative complications</Keyword><Keyword MajorTopicYN="N">pulse contour analysis</Keyword><Keyword MajorTopicYN="N">surgery</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Pazmino-Canizares</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carroll</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Poonawalla</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beattie</LastName><ForeName>W S</ForeName><Initials>WS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clarke</LastName><ForeName>H A</ForeName><Initials>HA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jerath</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kulkarni</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meineri</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garijo</LastName><ForeName>J Moreno</ForeName><Initials>JM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parotto</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sellers</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vidal</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>W&#x105;sowicz</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wei</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>8</Day><Hour>8</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37937943</ArticleId><ArticleId IdType="doi">10.1111/anae.15715</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Gregory A, Stapelfeldt WH, Khanna AK, et&#x2009;al. Intraoperative hypotension is associated with adverse clinical outcomes after noncardiac surgery. Anesthesia and Analgesia 2021; 132: 1654&#x2013;65.</Citation></Reference><Reference><Citation>Wesselink EM, Kappen TH, Torn HM, Slooter AJC, van Klei WA. Intraoperative hypotension and the risk of postoperative adverse outcomes: a systematic review. British Journal of Anaesthesia 2018; 121: 706&#x2013;21.</Citation></Reference><Reference><Citation>Wijnberge M, Schenk J, Bulle E, et&#x2009;al. Association of intraoperative hypotension with postoperative morbidity and mortality: systematic review and meta&#x2010;analysis. British Journal of Surgery Open 2021; 5: zraa018.</Citation></Reference><Reference><Citation>Salmasi V, Maheshwari K, Yang D, et&#x2009;al. Relationship between intraoperative hypotension, defined by either reduction from baseline or absolute thresholds, and acute kidney and myocardial injury after noncardiac surgery: a retrospective cohort analysis. Anesthesiology 2017; 126: 47&#x2013;65.</Citation></Reference><Reference><Citation>Ahuja S, Mascha EJ, Yang D, et&#x2009;al. Associations of intraoperative radial arterial systolic, diastolic, mean, and pulse pressures with myocardial and acute kidney injury after noncardiac surgery: a retrospective cohort analysis. Anesthesiology 2020; 132: 291&#x2013;306.</Citation></Reference><Reference><Citation>Sessler DI, Bloomstone JA, Aronson S, et&#x2009;al. Perioperative quality initiative consensus statement on intraoperative blood pressure, risk and outcomes for elective surgery. British Journal of Anaesthesia 2019; 122: 563&#x2013;74.</Citation></Reference><Reference><Citation>Mathis MR, Naik BI, Freundlich RE, et&#x2009;al. Preoperative risk and the association between hypotension and postoperative acute kidney injury. Anesthesiology 2020; 132: 461&#x2013;75.</Citation></Reference><Reference><Citation>Egal M, de Geus HR, van Bommel J, Groeneveld AB. Targeting oliguria reversal in perioperative restrictive fluid management does not influence the occurrence of renal dysfunction: a systematic review and meta&#x2010;analysis. European Journal of Anaesthesiology 2016; 33: 425&#x2013;35.</Citation></Reference><Reference><Citation>Kouz K, Bergholz A, Timmermann LM, et&#x2009;al. The relation between mean arterial pressure and cardiac index in major abdominal surgery patients: a prospective observational cohort study. Anesthesia and Analgesia 2022; 134: 322&#x2013;9.</Citation></Reference><Reference><Citation>Marik PE, Baram M, Vahid B. Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest 2008; 134: 172&#x2013;8.</Citation></Reference><Reference><Citation>Lilot M, Ehrenfeld JM, Lee C, Harrington B, Cannesson M, Rinehart J. Variability in practice and factors predictive of total&#x2009;crystalloid administration during abdominal surgery: retrospective two&#x2010;centre analysis. British Journal of Anaesthesia 2015; 114: 767&#x2013;76.</Citation></Reference><Reference><Citation>Messina A, Pelaia C, Bruni A, et&#x2009;al. Fluid challenge during anesthesia: a systematic review and meta&#x2010;analysis. Anesthesia and Analgesia 2018; 127: 1353&#x2013;64.</Citation></Reference><Reference><Citation>Cannesson M, Le Manach Y, Hofer CK, et&#x2009;al. Assessing the diagnostic accuracy of pulse pressure variations for the prediction of fluid responsiveness: a &#x201c;gray zone&#x201d; approach. Anesthesiology 2011; 115: 231&#x2013;41.</Citation></Reference><Reference><Citation>MacDonald N, Ahmad T, Mohr O, et&#x2009;al. Dynamic preload markers to predict fluid responsiveness during and after major gastrointestinal surgery: an observational substudy of the OPTIMISE trial. British Journal of Anaesthesia 2015; 114: 598&#x2013;604.</Citation></Reference><Reference><Citation>Levey AS, Stevens LA, Schmid CH, et&#x2009;al. A new equation&#x2009;to estimate glomerular filtration rate. Annals of Internal Medicine 2009; 150: 604&#x2013;12.</Citation></Reference><Reference><Citation>Edwards MR, Forbes G, MacDonald N, et&#x2009;al. Optimisation of Perioperative Cardiovascular Management to Improve Surgical Outcome II (OPTIMISE II) trial: study protocol for a multicentre international trial of cardiac output&#x2010;guided fluid therapy with low&#x2010;dose inotrope infusion compared with usual care in patients undergoing major elective gastrointestinal surgery. British Medical Journal Open 2019; 9: e023455.</Citation></Reference><Reference><Citation>Navarro LH, Bloomstone JA, Auler JO, et&#x2009;al. Perioperative fluid therapy: a statement from the international fluid optimization group. PerioperativeMedicine 2015; 4: 3.</Citation></Reference><Reference><Citation>Semler MW, Self WH, Wanderer JP, et&#x2009;al. Balanced crystalloids versus saline in critically ill adults. New England Journal of Medicine 2018; 378: 829&#x2013;39.</Citation></Reference><Reference><Citation>Carson JL, Terrin ML, Noveck H, et&#x2009;al. Liberal or restrictive transfusion in high&#x2010;risk patients after hip surgery. New England Journal of Medicine 2011; 365: 2453&#x2013;62.</Citation></Reference><Reference><Citation>Hovaguimian F, Myles PS. Restrictive versus liberal transfusion strategy in the perioperative and acute care settings: a context&#x2010;specific systematic review and meta&#x2010;analysis of randomized controlled trials. Anesthesiology 2016; 125: 46&#x2013;61.</Citation></Reference><Reference><Citation>Sun LY, Wijeysundera DN, Tait GA, Beattie WS. Association of intraoperative hypotension with acute kidney injury after elective noncardiac surgery. Anesthesiology 2015; 123: 515&#x2013;23.</Citation></Reference><Reference><Citation>International Surgical Outcome Study Group. Prospective observational cohort study on grading the severity of postoperative complications in global surgery research. British Journal of Surgery 2019; 106: e73&#x2013;80.</Citation></Reference><Reference><Citation>Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD. Fourth universal definition of myocardial infarction. Circulation 2018; 138: e618&#x2013;51.</Citation></Reference><Reference><Citation>Eldridge SM, Lancaster GA, Campbell MJ, et&#x2009;al. Defining feasibility and pilot studies in preparation for randomised controlled trials: development of a conceptual framework. PLoS One 2016; 11: e0150205.</Citation></Reference><Reference><Citation>Lee EC, Whitehead AL, Jacques RM, Julious SA. The statistical interpretation of pilot trials: should significance thresholds be&#xa0;reconsidered? BMC Medical Research Methodology 2014; 14: 41.</Citation></Reference><Reference><Citation>Lee TH, Marcantonio ER, Mangione CM, et&#x2009;al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100: 1043&#x2013;9.</Citation></Reference><Reference><Citation>Duceppe E, Parlow J, MacDonald P, et&#x2009;al. Canadian Cardiovascular Society guidelines on perioperative cardiac risk assessment and management for patients who undergo noncardiac surgery. Canadian Journal of Cardiology 2017; 33: 17&#x2013;32.</Citation></Reference><Reference><Citation>Chu R, Walter SD, Guyatt G, et&#x2009;al. Assessment and implication of prognostic imbalance in randomized controlled trials with a binary outcome &#x2013; a simulation study. PLoS One 2012; 7: e36677.</Citation></Reference><Reference><Citation>Futier E, Lefrant JY, Guinot PG, et&#x2009;al. Effect of individualized vs standard blood pressure management strategies on postoperative organ dysfunction among high&#x2010;risk patients undergoing major surgery: a randomized clinical trial. Journal of the American Medical Assocation 2017; 318: 1346&#x2013;57.</Citation></Reference><Reference><Citation>Wanner PM, Wulff DU, Djurdjevic M, Korte W, Schnider TW, Filipovic M. Targeting higher intraoperative blood pressures does not reduce adverse cardiovascular events following noncardiac surgery. Journal of the American College of Cardiology 2021; 78: 1753&#x2013;64.</Citation></Reference><Reference><Citation>Panjasawatwong K, Sessler DI, Stapelfeldt WH, et&#x2009;al. A randomized trial of a supplemental alarm for critically low systolic blood pressure. Anesthesia and Analgesia 2015; 121: 1500&#x2013;7.</Citation></Reference><Reference><Citation>Maheshwari K, Shimada T, Yang D, et&#x2009;al. Hypotension prediction index for prevention of hypotension during moderate&#x2010; to high&#x2010;risk noncardiac surgery. Anesthesiology 2020; 133: 1214&#x2013;22.</Citation></Reference><Reference><Citation>Wijnberge M, Geerts BF, Hol L, et&#x2009;al. Effect of a machine learning&#x2010;derived early warning system for intraoperative hypotension vs standard care on depth and duration of intraoperative hypotension during elective noncardiac surgery: the HYPE randomized clinical trial. Journal of the American Medical Association 2020; 323: 1052&#x2013;60.</Citation></Reference><Reference><Citation>Naylor AJ, Sessler DI, Maheshwari K, et&#x2009;al. Arterial catheters for early detection and treatment of hypotension during major noncardiac surgery: a randomized trial. Anesthesia and Analgesia 2020; 131: 1540&#x2013;50.</Citation></Reference><Reference><Citation>Maheshwari K, Khanna S, Bajracharya GR, et&#x2009;al. A randomized trial of continuous noninvasive blood pressure monitoring during noncardiac surgery. Anesthesia and Analgesia 2018; 127: 424&#x2013;31.</Citation></Reference><Reference><Citation>Donovan JL, de Salis I, Toerien M, Paramasivan S, Hamdy FC, Blazeby JM. The intellectual challenges and emotional consequences of equipoise contributed to the fragility of recruitment in six randomized controlled trials. Journal of Clinical Epidemiology 2014; 67: 912&#x2013;20.</Citation></Reference><Reference><Citation>Donovan JL, Rooshenas L, Jepson M, et&#x2009;al. Optimising recruitment and informed consent in randomised controlled trials: the development and implementation of the quintet recruitment intervention (QRI). Trials 2016; 17: 283.</Citation></Reference><Reference><Citation>Donovan JL, Paramasivan S, de Salis I, Toerien M. Clear obstacles and hidden challenges: understanding recruiter perspectives in six pragmatic randomised controlled trials. Trials 2014; 15: 5.</Citation></Reference><Reference><Citation>Arnold DM, Burns KE, Adhikari NK, et&#x2009;al. The design and interpretation of pilot trials in clinical research in critical care. Critical Care Medicine 2009; 37: S69&#x2013;74.</Citation></Reference><Reference><Citation>Abdellatif S, Hladkowicz E, Lalu MM, Boet S, Gagne S, McIsaac DI. Patient prioritization of routine and patient&#x2010;reported postoperative outcome measures: a prospective, nested cross&#x2010;sectional study. Canadian Journal of Anesthesia 2022. Epub 31 Jan. https://doi.org/10.1007/s12630&#x2010;022&#x2010;02191&#x2010;7</Citation></Reference><Reference><Citation>Reiterer C, Kabon B, Halvorson S, et&#x2009;al. Hemodynamic responses to crystalloid and colloid fluid boluses during noncardiac surgery. Anesthesiology 2022; 136: 127&#x2013;37.</Citation></Reference><Reference><Citation>Myles PS, Bellomo R, Corcoran T, et&#x2009;al. Restrictive versus liberal fluid therapy for major abdominal surgery. New England Journal of Medicine 2018; 378: 2263&#x2013;74.</Citation></Reference><Reference><Citation>Aykanat VM, Myles PS, Weinberg L, Burrell A, Bellomo R. Low&#x2010;concentration norepinephrine infusion for major surgery: a safety and feasibility pilot randomized controlled trial. Anesthesia and Analgesia 2022; 134: 410&#x2013;8.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38128732</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-5568</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Anaesthesia, critical care &amp; pain medicine</Title><ISOAbbreviation>Anaesth Crit Care Pain Med</ISOAbbreviation></Journal><ArticleTitle>Mortality in patients with septic cardiomyopathy identified by longitudinal strain by speckle tracking echocardiography: An updated systematic review and meta-analysis with trial sequential analysis.</ArticleTitle><Pagination><StartPage>101339</StartPage><MedlinePgn>101339</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.accpm.2023.101339</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2352-5568(23)00147-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Septic cardiomyopathy is associated with poor outcomes but its definition remains unclear. In a previous meta-analysis, left ventricular (LV) longitudinal strain (LS) showed significant prognostic value in septic patients, but findings were not robust due to a limited number of studies, differences in effect size and no adjustment for confounders.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted an updated systematic review (PubMed and Scopus up to 14.02.2023) and meta-analysis to investigate the association between LS and survival in septic patients. We included studies reporting global (from three apical views) or regional LS (one or two apical windows). A secondary analysis evaluated the association between LV ejection fraction (EF) and survival using data from the selected studies.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We included fourteen studies (1678 patients, survival 69.6%) and demonstrated an association between better performance (more negative LS) and survival with a mean difference (MD) of -1.45%[-2.10, -0.80] (p&#x2009;&lt;&#x2009;0.0001;I<sup>2</sup>&#x2009;=&#x2009;42%). No subgroup differences were found stratifying studies according to number of views used to calculate LS (p&#x2009;=&#x2009;0.31;I<sup>2</sup>&#x2009;=&#x2009;16%), severity of sepsis (p&#x2009;=&#x2009;0.42;I<sup>2</sup>&#x2009;=&#x2009;0%), and sepsis criteria (p&#x2009;=&#x2009;0.59;I<sup>2</sup>&#x2009;=&#x2009;0%). Trial sequential analysis and sensitivity analyses confirmed the primary findings. Grade of evidence was low. In the included studies, thirteen reported LVEF and we found an association between higher LVEF and survival (MD&#x2009;=&#x2009;2.44% [0.44,4.45]; p&#x2009;=&#x2009;0.02;I<sup>2</sup>&#x2009;=&#x2009;42%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We confirmed that more negative LS values are associated with higher survival in septic patients. The clinical relevance of this difference and whether the use of LS may improve understanding of septic cardiomyopathy and prognostication deserve further investigation. The association found between LVEF and survival is of unlikely clinical meaning.</AbstractText><AbstractText Label="REGISTRATION" NlmCategory="BACKGROUND">PROSPERO number CRD42023432354.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pruszczyk</LastName><ForeName>Andrzej</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>2nd Department of Anesthesiology and Intensive Care, Medical University of Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zawadka</LastName><ForeName>Mateusz</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>2nd Department of Anesthesiology and Intensive Care, Medical University of Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andruszkiewicz</LastName><ForeName>Pawel</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>2nd Department of Anesthesiology and Intensive Care, Medical University of Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>LaVia</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, "Policlinico-San Marco" University Hospital, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herpain</LastName><ForeName>Antoine</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, St.-Pierre University Hospital, Universit&#xe9; Libre de Bruxelles, 1050 Brussels, Belgium; Experimental Laboratory of Intensive Care, Universit&#xe9; Libre de Bruxelles, 1050 Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sato</LastName><ForeName>Ryota</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, OH, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dugar</LastName><ForeName>Siddharth</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, OH, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chew</LastName><ForeName>Michelle S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Biomedical and Clinical Sciences, Link&#xf6;ping University, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanfilippo</LastName><ForeName>Filippo</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, "Policlinico-San Marco" University Hospital, Catania, Italy; Department of General Surgery and Medico-Surgical Specialties, School of Anaesthesia and Intensive Care, University of Catania, Catania, Italy. Electronic address: filipposanfi@yahoo.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Anaesth Crit Care Pain Med</MedlineTA><NlmUniqueID>101652401</NlmUniqueID><ISSNLinking>2352-5568</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="Y">Cardiomyopathies</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="Y">Echocardiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Critical care</Keyword><Keyword MajorTopicYN="N">Intensive care</Keyword><Keyword MajorTopicYN="N">Left ventricle</Keyword><Keyword MajorTopicYN="N">Septic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">Speckle tracking</Keyword><Keyword MajorTopicYN="N">Systolic function</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>22</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>21</Day><Hour>19</Hour><Minute>26</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38128732</ArticleId><ArticleId IdType="doi">10.1016/j.accpm.2023.101339</ArticleId><ArticleId IdType="pii">S2352-5568(23)00147-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27332677</PMID><DateCompleted><Year>2017</Year><Month>09</Month><Day>25</Day></DateCompleted><DateRevised><Year>2017</Year><Month>09</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1827-191X</ISSN><JournalIssue CitedMedium="Internet"><Volume>58</Volume><Issue>6</Issue><PubDate><Year>2017</Year><Month>Dec</Month></PubDate></JournalIssue><Title>The Journal of cardiovascular surgery</Title><ISOAbbreviation>J Cardiovasc Surg (Torino)</ISOAbbreviation></Journal><ArticleTitle>A prospective randomized trial comparing endarterectomy to stenting in severe asymptomatic carotid stenosis.</ArticleTitle><Pagination><StartPage>814</StartPage><EndPage>817</EndPage><MedlinePgn>814-817</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.23736/S0021-9509.16.09513-6</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">For an asymptomatic patient with severe carotid stenosis the most important question is how to prevent an ischemic stroke. Carotid artery stenosis is the estimated cause of stroke in 8-20% of the cases. Today more than 50% of procedures for carotid stenosis are done on asymptomatic patients, but few of the randomized controlled trials comparing carotid endarterectomy and stenting examined specifically these patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">All patients with severe (&gt;70%) asymptomatic carotid artery stenosis seen in the Carmel medical center vascular clinic were prospectively screened and randomized 1:1 for carotid endarterectomy (CEA) or carotid stenting (CAS). Patients eligible for both procedures were enrolled. The primary objectives of the study were: 1) periprocedural complications - stroke (CVA), transient ischemic attack (TIA), myocardial infarction (MI), and death; 2) long-term results: mortality, prevention of ipsilateral stroke or TIA, and freedom from restenosis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">One-hundred and thirty-six patients were treated with mean follow-up of 26 months. There was no difference in short and long term results between the two groups. Thirty day morbidity included: 1 CVA in each group with no MI. Long-term results included 4 deaths in each group; none from CVA. One TIA was noted after CAS, and 3 cases of restenosis were found in CEA and one in CAS.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">CAS is a maturing procedure and has improved significantly over the past several years. Future developments of stents and protection devices will achieve better perioperative results. This along with our excellent long term results will promote the use of stenting for suitable patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mannheim</LastName><ForeName>Dallit</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Carmel Medical Center, Haifa, Israel - dallit@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karmeli</LastName><ForeName>Ron</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Carmel Medical Center, Haifa, Israel.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>06</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>J Cardiovasc Surg (Torino)</MedlineTA><NlmUniqueID>0066127</NlmUniqueID><ISSNLinking>0021-9509</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058070" MajorTopicYN="N">Asymptomatic Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016893" MajorTopicYN="N">Carotid Stenosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016894" MajorTopicYN="Y">Endarterectomy, Carotid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="N">Endovascular Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="N">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007557" MajorTopicYN="N">Israel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015607" MajorTopicYN="Y">Stents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>6</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>6</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27332677</ArticleId><ArticleId IdType="doi">10.23736/S0021-9509.16.09513-6</ArticleId><ArticleId IdType="pii">R37Y9999N00A16062201</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34284934</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2165</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Oct</Month></PubDate></JournalIssue><Title>European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery</Title><ISOAbbreviation>Eur J Vasc Endovasc Surg</ISOAbbreviation></Journal><ArticleTitle>The Diagnostic Accuracy of Intra-Operative Near Infrared Spectroscopy in Carotid Artery Endarterectomy Under Regional Anaesthesia: Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>522</StartPage><EndPage>531</EndPage><MedlinePgn>522-531</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejvs.2021.05.042</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1078-5884(21)00460-3</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Intra-operative near infrared spectroscopy (NIRS) is a non-invasive tool used to monitor regional cerebral oxygen saturation during carotid endarterectomy (CEA), for which accuracy remains unclear. Therefore, this systematic review and meta-analysis aimed to determine the diagnostic accuracy of NIRS in patients undergoing CEA under regional anaesthesia (RA).</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">MEDLINE, Scopus, and Web of Science were searched for studies that compared NIRS with the "awake test" in patients undergoing CEA under RA.</AbstractText><AbstractText Label="REVIEW METHODS" NlmCategory="METHODS">Bivariable random effects meta-analysis was performed to determine the diagnostic accuracy of NIRS to detect cerebral ischaemia. Meta-regression was performed to explore causes of heterogeneity. Meta-analysis of proportions was also performed to determine the accuracy of NIRS in predicting 30 day stroke. Study quality was evaluated using the QUADAS-2 criteria.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eleven primary studies were included, assessing 1 237 participants. The meta-analysis obtained a partial area under the summary receiver operating characteristic curve for diagnosing brain ischaemia of 0.646, with a summary sensitivity of 72.0% (95% confidence interval [CI] 58.1 - 82.7; I<sup>2</sup>&#xa0;= 48.6%) and a specificity of 84.1% (95% CI 78.5-88.4; I<sup>2</sup>&#xa0;= 48.6%). In meta-regression analysis, the frequency of hypertension (p&#xa0;= .011) and patients with symptomatic carotid stenosis (p&#xa0;= .031) were significant effect modifiers. Higher frequency of arterial hypertension (z score&#xa0;= -2.15; p&#xa0;= .032) and diabetes (z score&#xa0;= -2.12; p&#xa0;= .034) were associated with lower summary sensitivity, while a higher frequency of symptomatic carotid stenosis (z score&#xa0;= 2.11; p&#xa0;= .035) was associated with higher summary sensitivity. Point estimate sensitivity and specificity for predicting 30 day stroke occurrence were 41% (95% CI 19.5 - 66.6; I<sup>2</sup>&#xa0;= 0%) and 81.4% (95% CI 74.4 - 86.9, I<sup>2</sup>&#xa0;= 65.6%), respectively.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The results of this study suggest that NIRS as a cerebral monitoring technique does not have sufficiently high sensitivity or specificity to be used alone in the neurological monitoring of patients undergoing CEA under RA.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Duarte-Gamas</LastName><ForeName>Lu&#xed;s</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Angiology and Vascular Surgery, Centro Hospitalar Universit&#xe1;rio de S&#xe3;o Jo&#xe3;o, Porto, Portugal; Department of Surgery and Physiology, Faculdade de Medicina da Universidade do Porto, Porto, Portugal. Electronic address: afonso_gamas@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pereira-Neves</LastName><ForeName>Ant&#xf3;nio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Angiology and Vascular Surgery, Centro Hospitalar Universit&#xe1;rio de S&#xe3;o Jo&#xe3;o, Porto, Portugal; Department of Surgery and Physiology, Faculdade de Medicina da Universidade do Porto, Porto, Portugal; Department of Biomedicine - Unity of Anatomy, Faculdade de Medicina da Universidade do Porto, Porto, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sousa</LastName><ForeName>Joel</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Angiology and Vascular Surgery, Centro Hospitalar Universit&#xe1;rio de S&#xe3;o Jo&#xe3;o, Porto, Portugal; Department of Surgery and Physiology, Faculdade de Medicina da Universidade do Porto, Porto, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sousa-Pinto</LastName><ForeName>Bernardo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Centre for Health Technology and Services Research (CINTESIS), Porto, Portugal; MEDCIDS - Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rocha-Neves</LastName><ForeName>Jo&#xe3;o</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Angiology and Vascular Surgery, Centro Hospitalar Universit&#xe1;rio de S&#xe3;o Jo&#xe3;o, Porto, Portugal; Department of Surgery and Physiology, Faculdade de Medicina da Universidade do Porto, Porto, Portugal; Department of Biomedicine - Unity of Anatomy, Faculdade de Medicina da Universidade do Porto, Porto, Portugal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Vasc Endovasc Surg</MedlineTA><NlmUniqueID>9512728</NlmUniqueID><ISSNLinking>1078-5884</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000765" MajorTopicYN="Y">Anesthesia, Conduction</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002545" MajorTopicYN="N">Brain Ischemia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016893" MajorTopicYN="N">Carotid Stenosis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002560" MajorTopicYN="Y">Cerebrovascular Circulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016894" MajorTopicYN="Y">Endarterectomy, Carotid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016343" MajorTopicYN="Y">Monitoring, Intraoperative</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019265" MajorTopicYN="Y">Spectroscopy, Near-Infrared</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Carotid artery disease</Keyword><Keyword MajorTopicYN="N">Carotid endarterectomy</Keyword><Keyword MajorTopicYN="N">Cerebral oxymetry</Keyword><Keyword MajorTopicYN="N">Near-infrared spectroscpy</Keyword><Keyword MajorTopicYN="N">Neurological monitoring</Keyword><Keyword MajorTopicYN="N">Regional anesthesia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>21</Day><Hour>5</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34284934</ArticleId><ArticleId IdType="doi">10.1016/j.ejvs.2021.05.042</ArticleId><ArticleId IdType="pii">S1078-5884(21)00460-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29923453</PMID><DateCompleted><Year>2019</Year><Month>11</Month><Day>13</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1545-1550</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>4</Issue><PubDate><Year>2018</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists</Title><ISOAbbreviation>J Endovasc Ther</ISOAbbreviation></Journal><ArticleTitle>Effect of Open- vs Closed-Cell Stent Design on Periprocedural Outcomes and Restenosis After Carotid Artery Stenting: A Systematic Review and Comprehensive Meta-analysis.</ArticleTitle><Pagination><StartPage>523</StartPage><EndPage>533</EndPage><MedlinePgn>523-533</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1526602818783505</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To compare periprocedural complications and in-stent restenosis rates associated with open- vs closed-cell stent designs used in carotid artery stenting (CAS).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic search was conducted to identify all randomized and observational studies published in English up to October 31, 2017, that compared open- vs closed-cell stent designs in CAS. Identified studies were included if they reported the following outcomes: stroke, transient ischemic attack (TIA), myocardial infarction (MI), hemodynamic depression, new ischemic lesions detected on imaging, and death within 30 days, as well as the incidence of in-stent restenosis. A random-effects model meta-analysis was employed. Model results are reported as the odds ratio (OR) and 95% confidence interval (CI). The I<sup>2</sup> statistic was used to assess heterogeneity.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Thirty-three studies (2 randomized trials) comprising 20, 291 patients (mean age 71.3&#xb1;3.0 years; 74.6% men) were included. Patients in the open-cell stent group had a statistically significant lower risk of restenosis &#x2a7e;40% (OR 0.42, 95% CI 0.19 to 0.92; I<sup>2</sup>=0%) and &#x2a7e;70% (OR 0.23, 95% CI 0.10 to 0.52; I<sup>2</sup>=0%) at a mean follow-up of 24 months. No statistically significant differences were identified for periprocedural stroke, TIA, new ischemic lesions, MI, hemodynamic depression, or death within 30 days after CAS. Sensitivity analysis of the 2 randomized controlled trials only did not point to any significant differences either.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Use of open-cell stent design in CAS is associated with a decreased risk for restenosis when compared to the closed-cell stent, without significant differences in periprocedural outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Texakalidis</LastName><ForeName>Pavlos</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-8715-6651</Identifier><AffiliationInfo><Affiliation>1 Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>2 Aristotle University of Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giannopoulos</LastName><ForeName>Stefanos</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>3 251 Hellenic Air Force General Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kokkinidis</LastName><ForeName>Damianos G</ForeName><Initials>DG</Initials><Identifier Source="ORCID">0000-0002-1381-4754</Identifier><AffiliationInfo><Affiliation>4 Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lanzino</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>1 Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>06</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Endovasc Ther</MedlineTA><NlmUniqueID>100896915</NlmUniqueID><ISSNLinking>1526-6028</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016893" MajorTopicYN="N">Carotid Stenosis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="N">Endovascular Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011474" MajorTopicYN="N">Prosthesis Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015607" MajorTopicYN="Y">Stents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">carotid artery stenting</Keyword><Keyword MajorTopicYN="N">closed-cell design</Keyword><Keyword MajorTopicYN="N">complications</Keyword><Keyword MajorTopicYN="N">in-stent restenosis</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">open-cell design</Keyword><Keyword MajorTopicYN="N">stenosis</Keyword><Keyword MajorTopicYN="N">stent</Keyword><Keyword MajorTopicYN="N">stroke</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29923453</ArticleId><ArticleId IdType="doi">10.1177/1526602818783505</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">30028329</PMID><DateRevised><Year>2020</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1673-5374</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>7</Issue><PubDate><Year>2018</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Neural regeneration research</Title><ISOAbbreviation>Neural Regen Res</ISOAbbreviation></Journal><ArticleTitle>Is transesophageal echocardiography needed for evaluating tissue-based transient ischemic attack?</ArticleTitle><Pagination><StartPage>1212</StartPage><EndPage>1215</EndPage><MedlinePgn>1212-1215</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/1673-5374.235058</ELocationID><Abstract><AbstractText>Transient ischemic attack (TIA) is a warning signal for stroke. A comprehensive evaluation of TIA may reduce the risk for subsequent stroke. Data on the findings of cardiac evaluation with transesophageal echocardiography (TEE) in patients with TIA are sparse. Our aims were to determine the frequency of TEE performance and to investigate the findings of TEE in patients with TIA based on the new definition of TIA (i.e., transient neurological symptoms without evidence of infarction). During a 4-year period (2011-2014), 1071 patients (mean age, 70 &#xb1; 13 years; female, 49.7%) with TIA were included in a prospective study and evaluated. Of 1071 consecutive patients suffering from TIA, 288 patients (27%) underwent TEE. The median time between admission and TEE was 6 days. Patients with TIA who were evaluated by TEE were younger (67 vs. 71 years, P &lt; 0.001) than those who were not evaluated by TEE. They had a higher rate of sensibility disturbance as a TIA symptom (39% vs. 31%, P = 0.012) but a lower rate of previous stroke (15% vs. 25%, P = 0.001) and atrial fibrillation (2% vs. 21%, P &lt; 0.001) than those who did not. Foramen ovale was detected in 71 patients (25.7%), atrial septal aneurysm in 13 patients (4.6%), and severe atherosclerotic plaques (grade 4 and 5) in the aortic arch in 25 patients (8.7%). One patient (0.3%) had a fibroma detected by TEE. In 17 of the 288 patients (6%) who underwent TEE, the indication for anticoagulation therapy was based on the TEE results, and 1 patient with fibroma underwent heart surgery. During hospitalization, 7 patients experienced a subsequent stroke, and 27 patients had a recurrent TIA. At 3 months following discharge, the rates of readmission, stroke, recurrent TIA, and death were 19%, 2.7%, 4.2%, and 1.6%, respectively. The rates of mortality (0.9% vs. 1.8%, P = 0.7), stroke risk (1.9% vs. 3.0%, P = 0.8), and recurrent TIA (5.0% vs. 3.9%, P = 0.8) were similar in patients who underwent TEE and in those who did not. Performing TEE in patients with tissue-based TIA is helpful in detecting cardiac sources for embolism and may indicate for anticoagulation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Al-Khaled</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of L&#xfc;beck, L&#xfc;beck, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scheef</LastName><ForeName>Bj&#xf6;rn</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of L&#xfc;beck, L&#xfc;beck; Department of Ophthalmology, University of Rostock, Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Br&#xfc;ning</LastName><ForeName>Toralf</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of L&#xfc;beck, L&#xfc;beck, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Neural Regen Res</MedlineTA><NlmUniqueID>101316351</NlmUniqueID><ISSNLinking>1673-5374</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anticoagulation</Keyword><Keyword MajorTopicYN="N">management</Keyword><Keyword MajorTopicYN="N">therapy change</Keyword><Keyword MajorTopicYN="N">transesophageal echocardiography</Keyword><Keyword MajorTopicYN="N">transient ischemic stroke</Keyword></KeywordList><CoiStatement>The authors reported that they have no any conflicts of interest</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30028329</ArticleId><ArticleId IdType="pmc">PMC6065226</ArticleId><ArticleId IdType="doi">10.4103/1673-5374.235058</ArticleId><ArticleId IdType="pii">NeuralRegenRes_2018_13_7_1212_235058</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO MONICA Project Principal Investigators. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol. 1988;41:105&#x2013;114.</Citation><ArticleIdList><ArticleId IdType="pubmed">3335877</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Khaled M, Eggers J. MRI findings and stroke risk in TIA patients with different symptom durations. Neurology. 2013;80:1920&#x2013;1926.</Citation><ArticleIdList><ArticleId IdType="pubmed">23616156</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Khaled M, Eggers J. Early hospitalization of patients with TIA: a prospective, population-based study. J Stroke Cerebrovasc Dis. 2014;23:99&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pubmed">23164482</ArticleId></ArticleIdList></Reference><Reference><Citation>Albers GW, Caplan LR, Easton JD, Fayad PB, Mohr JP, Saver JL, Sherman DG, Group TIAW. Transient ischemic attack--proposal for a new definition. N Engl J Med. 2002;347:1713&#x2013;1716.</Citation><ArticleIdList><ArticleId IdType="pubmed">12444191</ArticleId></ArticleIdList></Reference><Reference><Citation>Amarenco P, Lavallee PC, Labreuche J, Albers GW, Bornstein NM, Canhao P, Caplan LR, Donnan GA, Ferro JM, Hennerici MG, Molina C, Rothwell PM, Sissani L, Skoloudik D, Steg PG, Touboul PJ, Uchiyama S, Vicaut E, Wong LK, Investigators TIo. One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke. N Engl J Med. 2016;374:1533&#x2013;1542.</Citation><ArticleIdList><ArticleId IdType="pubmed">27096581</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogousslavsky J, Hachinski VC, Boughner DR, Fox AJ, Vinuela F, Barnett HJ. Clinical predictors of cardiac and arterial lesions in carotid transient ischemic attacks. Arch Neurol. 1986;43:229&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pubmed">3947271</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll JD, Saver JL, Thaler DE, Smalling RW, Berry S, MacDonald LA, Marks DS, Tirschwell DL, Investigators R. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med. 2013;368:1092&#x2013;1100.</Citation><ArticleIdList><ArticleId IdType="pubmed">23514286</ArticleId></ArticleIdList></Reference><Reference><Citation>Censori B, Colombo F, Valsecchi MG, Clivati L, Zonca A, Camerlingo M, Casto L, De Tommasi MS, Mamoli A. Early transoesophageal echocardiography in cryptogenic and lacunar stroke and transient ischaemic attack. J Neurol Neurosurg Psychiatry. 1998;64:624&#x2013;627.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2170100</ArticleId><ArticleId IdType="pubmed">9598678</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawn B, Hasnie AM, Calzada N, Longaker RA, Stoddard MF. Transesophageal echocardiography impacts management and evaluation of patients with stroke, transient ischemic attack, or peripheral embolism. Echocardiography. 2006;23:202&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pubmed">16524390</ArticleId></ArticleIdList></Reference><Reference><Citation>de Bruijn SF, Agema WR, Lammers GJ, van der Wall EE, Wolterbeek R, Holman ER, Bollen EL, Bax JJ. Transesophageal echocardiography is superior to transthoracic echocardiography in management of patients of any age with transient ischemic attack or stroke. Stroke. 2006;37:2531&#x2013;2534.</Citation><ArticleIdList><ArticleId IdType="pubmed">16946152</ArticleId></ArticleIdList></Reference><Reference><Citation>Easton JD, Saver JL, Albers GW, Alberts MJ, Chaturvedi S, Feldmann E, Hatsukami TS, Higashida RT, Johnston SC, Kidwell CS, Lutsep HL, Miller E, Sacco RL American Heart Association; American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; Interdisciplinary Council on Peripheral Vascular Disease. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke. 2009;40:2276&#x2013;2293.</Citation><ArticleIdList><ArticleId IdType="pubmed">19423857</ArticleId></ArticleIdList></Reference><Reference><Citation>European Stroke Organisation Executive C, Committee ESOW. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008;25:457&#x2013;507.</Citation><ArticleIdList><ArticleId IdType="pubmed">18477843</ArticleId></ArticleIdList></Reference><Reference><Citation>Giles MF, Rothwell PM. Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol. 2007;6:1063&#x2013;1072.</Citation><ArticleIdList><ArticleId IdType="pubmed">17993293</ArticleId></ArticleIdList></Reference><Reference><Citation>Giles MF, Albers GW, Amarenco P, Arsava EM, Asimos AW, Ay H, Calvet D, Coutts SB, Cucchiara BL, Demchuk AM, Johnston SC, Kelly PJ, Kim AS, Labreuche J, Lavallee PC, Mas JL, Merwick A, Olivot JM, Purroy F, Rosamond WD, et al. Early stroke risk and ABCD2 score performance in tissue- vs time-defined TIA: a multicenter study. Neurology. 2011;77:1222&#x2013;1228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3179650</ArticleId><ArticleId IdType="pubmed">21865578</ArticleId></ArticleIdList></Reference><Reference><Citation>Hausmann D, Mugge A, Becht I, Daniel WG. Diagnosis of patent foramen ovale by transesophageal echocardiography and association with cerebral and peripheral embolic events. Am J Cardiol. 1992;70:668&#x2013;672.</Citation><ArticleIdList><ArticleId IdType="pubmed">1510018</ArticleId></ArticleIdList></Reference><Reference><Citation>Jauch EC, Saver JL, Adams HP, Jr, Bruno A, Connors JJ, Demaerschalk BM, Khatri P, McMullan PW, Jr, Qureshi AI, Rosenfield K, Scott PA, Summers DR, Wang DZ, Wintermark M, Yonas H American Heart Association Stroke C, Council on Cardiovascular N, Council on Peripheral Vascular D, Council on Clinical C. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870&#x2013;947.</Citation><ArticleIdList><ArticleId IdType="pubmed">23370205</ArticleId></ArticleIdList></Reference><Reference><Citation>Laufs U, Hoppe UC, Rosenkranz S, Kirchhof P, Bohm M, Diener HC, Endres M, Grond M, Hacke W, Meinertz T, Ringelstein EB, Rother J, Dichgans M. Cardiological evaluation after cerebral ischaemia: Consensus statement of the Working Group Heart and Brain of the German Cardiac Society-Cardiovascular Research (DGK) and the German Stroke Society (DSG) Clin Res Cardiol. 2010;99:609&#x2013;625.</Citation><ArticleIdList><ArticleId IdType="pubmed">20680306</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavallee PC, Meseguer E, Abboud H, Cabrejo L, Olivot JM, Simon O, Mazighi M, Nifle C, Niclot P, Lapergue B, Klein IF, Brochet E, Steg PG, Leseche G, Labreuche J, Touboul PJ, Amarenco P. A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol. 2007;6:953&#x2013;960.</Citation><ArticleIdList><ArticleId IdType="pubmed">17928270</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall J. The natural history of transient ischaemic cerebro-vascular attacks. Q J Med. 1964;33:309&#x2013;324.</Citation><ArticleIdList><ArticleId IdType="pubmed">14176665</ArticleId></ArticleIdList></Reference><Reference><Citation>Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, Coste J, Patent Foramen O Atrial Septal Aneurysm Study G. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med. 2001;345:1740&#x2013;1746.</Citation><ArticleIdList><ArticleId IdType="pubmed">11742048</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris JG, Duffis EJ, Fisher M. Cardiac workup of ischemic stroke: can we improve our diagnostic yield? Stroke. 2009;40:2893&#x2013;2898.</Citation><ArticleIdList><ArticleId IdType="pubmed">19478214</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallesen LP, Ragaller M, Kepplinger J, Barlinn K, Zerna C, Siepmann T, Wiedemann B, Braun S, Weise M, Bodechtel U, Puetz V. Diagnostic impact of transesophageal echocardiography in patients with acute cerebral ischemia. Echocardiography. 2016;33:555&#x2013;561.</Citation><ArticleIdList><ArticleId IdType="pubmed">27103483</ArticleId></ArticleIdList></Reference><Reference><Citation>Redgrave JN, Coutts SB, Schulz UG, Briley D, Rothwell PM. Systematic review of associations between the presence of acute ischemic lesions on diffusion-weighted imaging and clinical predictors of early stroke risk after transient ischemic attack. Stroke. 2007;38:1482&#x2013;1488.</Citation><ArticleIdList><ArticleId IdType="pubmed">17379821</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringleb P, Schellinger PD, Hacke W, Europaischen S. European Stroke Organisation 2008 guidelines for managing acute cerebral infarction or transient ischemic attack. Part 1. Nervenarzt. 2008;79:936&#x2013;957.</Citation><ArticleIdList><ArticleId IdType="pubmed">18654756</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothwell PM, Warlow CP. Timing of TIAs preceding stroke: time window for prevention is very short. Neurology. 2005;64:817&#x2013;820.</Citation><ArticleIdList><ArticleId IdType="pubmed">15753415</ArticleId></ArticleIdList></Reference><Reference><Citation>Strandberg M, Marttila RJ, Helenius H, Hartiala J. Transoesophageal echocardiography in selecting patients for anticoagulation after ischaemic stroke or transient ischaemic attack. J Neurol Neurosurg Psychiatry. 2002;73:29&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1757302</ArticleId><ArticleId IdType="pubmed">12082041</ArticleId></ArticleIdList></Reference><Reference><Citation>Wehrum T, Guenther F, Fuchs A, Schuchardt F, Hennemuth A, Harloff A. Measurement of cardiac valve and aortic blood flow velocities in stroke patients: a comparison of 4D flow MRI and echocardiography. Int J Cardiovasc Imaging. 2018 doi: 10.1007/s10554-018-1298-0.</Citation><ArticleIdList><ArticleId IdType="pubmed">29327165</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25500940</PMID><DateCompleted><Year>2015</Year><Month>04</Month><Day>29</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>114</Volume><Issue>3</Issue><PubDate><Year>2015</Year><Month>Mar</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>LiDCO-based fluid management in patients undergoing hip fracture surgery under spinal anaesthesia: a randomized trial and systematic review.</ArticleTitle><Pagination><StartPage>444</StartPage><EndPage>459</EndPage><MedlinePgn>444-59</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/bja/aeu386</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Hip fracture is a condition with high mortality and morbidity in elderly frail patients. Intraoperative fluid optimization may be associated with benefit in this population. We investigated whether intraoperative fluid management using pulse-contour analysis cardiac monitoring, compared with standard care in patients undergoing spinal anaesthesia, would provide benefits in terms of reduced time until medically fit for discharge and postoperative complications.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients undergoing surgical repair of fractured neck of femur, aged &gt;60 yr, receiving spinal anaesthesia were enrolled in this single-centre, blinded, randomized, parallel group trial. Patients were allocated to either anaesthetist-directed fluid therapy or a pulse-contour-guided fluid optimization strategy using colloid (Gelofusine) boluses to optimize stroke volume. The primary outcome was time until medically fit for discharge. Secondary outcomes included postoperative complications, mobility, and mortality. We updated a systematic review to include relevant trials to 2014.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We recruited 130 patients. Time until medically fit for discharge was similar in both groups, mean [95% confidence interval (CI)] 12.2 (11.1-13.5) vs 13.1 (11.9-14.5) days (P=0.31), as was total length of stay 14.2 (12.9-15.8) vs 15.3 (13.8-17.2) days (P=0.32). There were no significant differences in complications, function, or mortality. An updated meta-analysis (four studies, 355 patients) found non-significant reduction in early mortality [relative risk 0.66 (0.24-1.79)] and in-hospital complications [relative risk 0.80 (0.61-1.05)].</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Goal-directed fluid therapy during hip fracture repair under spinal anaesthesia does not result in a significant reduction in length of stay or postoperative complications. There is insufficient evidence to either support or discount its routine use.</AbstractText><AbstractText Label="CLINICAL TRIAL REGISTRATION" NlmCategory="BACKGROUND">ISRCTN88284896.</AbstractText><CopyrightInformation>&#xa9; The Author 2014. Published by Oxford University Press on behalf of the British Journal of Anaesthesia. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moppett</LastName><ForeName>I K</ForeName><Initials>IK</Initials><AffiliationInfo><Affiliation>Anaesthesia and Critical Care, Division of Clinical Neuroscience , Queen's Medical Centre, Nottingham University Hospitals NHS Trust, University of Nottingham, Nottingham NG7 2UH, UK iain.moppett@nottingham.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rowlands</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Anaesthesia and Critical Care, Division of Clinical Neuroscience , Queen's Medical Centre, Nottingham University Hospitals NHS Trust, University of Nottingham, Nottingham NG7 2UH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mannings</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Anaesthesia and Critical Care, Division of Clinical Neuroscience , Queen's Medical Centre, Nottingham University Hospitals NHS Trust, University of Nottingham, Nottingham NG7 2UH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moran</LastName><ForeName>C G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>Department of Trauma and Orthopaedics, Queen's Medical Centre, Nottingham University Hospitals NHS Trust, University of Nottingham, Nottingham NG7 2UH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiles</LastName><ForeName>M D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Department of Anaesthetics, Sheffield Teaching Hospitals NHS Foundation Trust, Glossop Road, Sheffield S10 2JF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>NOTTS Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ISRCTN</DataBankName><AccessionNumberList><AccessionNumber>ISRCTN88284896</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>PB-PG-0407-13073</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>12</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010952">Plasma Substitutes</NameOfSubstance></Chemical><Chemical><RegistryNumber>9015-56-9</RegistryNumber><NameOfSubstance UI="D011097">Polygeline</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000775" MajorTopicYN="Y">Anesthesia, Spinal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002302" MajorTopicYN="Y">Cardiac Output</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005265" MajorTopicYN="Y">Femoral Neck Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="Y">Fluid Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008991" MajorTopicYN="Y">Monitoring, Physiologic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010952" MajorTopicYN="Y">Plasma Substitutes</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011097" MajorTopicYN="Y">Polygeline</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">aged</Keyword><Keyword MajorTopicYN="N">aged, 60 and over</Keyword><Keyword MajorTopicYN="N">anaesthesia, spinal</Keyword><Keyword MajorTopicYN="N">cardiac output</Keyword><Keyword MajorTopicYN="N">femoral fractures, surgery</Keyword><Keyword MajorTopicYN="N">fluid therapy, methods</Keyword><Keyword MajorTopicYN="N">haemodynamics, methods</Keyword><Keyword MajorTopicYN="N">hip fractures</Keyword><Keyword MajorTopicYN="N">infusions, i.v.</Keyword><Keyword MajorTopicYN="N">randomized controlled trial</Keyword><Keyword MajorTopicYN="N">stroke volume, physiology</Keyword><Keyword MajorTopicYN="N">treatment outcome</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Van deWalt</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Corrie</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Waits</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Whiteley</LastName><ForeName>W</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bardsley</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bray</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Evley</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25500940</ArticleId><ArticleId IdType="doi">10.1093/bja/aeu386</ArticleId><ArticleId IdType="pii">S0007-0912(17)31811-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31721242</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8159</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Pacing and clinical electrophysiology : PACE</Title><ISOAbbreviation>Pacing Clin Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Efficacy and safety of catheter ablation combined with left atrial appendage occlusion for nonvalvular atrial fibrillation: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>123</StartPage><EndPage>132</EndPage><MedlinePgn>123-132</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/pace.13845</ELocationID><Abstract><AbstractText>Atrial fibrillation (AF) is currently the most prevalent arrhythmia in clinical practice, with stroke being one of its major complications. Combining catheter ablation and percutaneous left atrial appendage occlusion (LAAO) into a "one-stop" intervention could reduce stroke incidence in selected high-risk patients and, at the same time, relieve AF symptoms in a single procedure. This meta-analysis analyzed the efficacy and safety of catheter ablation combined with LAAO for nonvalvular AF. PubMed, EMBASE, and the Cochrane Library were searched from inception to April 2019 to identify relevant citations. Efficacy indexes were procedural success, AF recurrence, stroke/transient ischemic attacks (TIA), and device-related thrombus (DRT). Safety indexes were all-cause death, major hemorrhagic complications, and pericardial effusion/cardiac tamponade. The incidence rate of events (ratio of events to patients) and 95% confidence interval (CI) were calculated as summary results. A forest plot was constructed to present pooled rates. Eighteen studies (two randomized controlled trials and 16 observational studies) were included. The results showed that one-stop intervention has significant efficacy and safety, with procedural success of .98 (95% CI, .97-1.00), AF recurrence of .24 (95% CI, .15-.35), stroke/TIA of .01 (95% CI, .00-.01), DRT of .00 (95% CI, .00-.01), all-cause mortality of .00 (95% CI, .00-.00), cardiac/neurological mortality of .00 (95% CI, .00-.00), major hemorrhagic complications of .01 (95% CI, .00-.02), and pericardial effusion/cardiac tamponade of .01 (95% CI, .00-.01). A single procedure with catheter ablation and LAAO in AF is a feasible strategy with significant efficacy and safety.</AbstractText><CopyrightInformation>&#xa9; 2019 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Fanghui</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-6580-3726</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Dongze</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Emergency Medicine, Laboratory of Emergency Medicine, West China Hospital, Sichuan University, Chengdu, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Disaster Medical Center, Sichuan University, Chengdu, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Yisong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Emergency Medicine, Laboratory of Emergency Medicine, West China Hospital, Sichuan University, Chengdu, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Disaster Medical Center, Sichuan University, Chengdu, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Hua</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pu</LastName><ForeName>Xiaobo</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Hongde</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Rui</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-8164-9183</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pacing Clin Electrophysiol</MedlineTA><NlmUniqueID>7803944</NlmUniqueID><ISSNLinking>0147-8389</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D020517" MajorTopicYN="N">Atrial Appendage</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="N">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">atrial fibrillation</Keyword><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">left atrial appendage occlusion</Keyword><Keyword MajorTopicYN="N">stroke prevention</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31721242</ArticleId><ArticleId IdType="doi">10.1111/pace.13845</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Calkins H, Kuck KH, Cappato R, et&#xa0;al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Heart Rhythm. 2012;9:632-696.</Citation></Reference><Reference><Citation>Blomstr&#xf6;m-Lundqvist C, Gizurarson S, Schwieler J, et&#xa0;al. Effect of catheter ablation vs antiarrhythmic medication on quality of life in patients with atrial fibrillation: tThe CAPTAF randomized clinical trial. JAMA. 2019;321:1059-1068.</Citation></Reference><Reference><Citation>Packer DL, Mark DB, Robb RA, et&#xa0;al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: The CABANA randomized clinical trial. JAMA. 2019;321:1261-1274.</Citation></Reference><Reference><Citation>McLellan AJ, Ling LH, Azzopardi S, et&#xa0;al. A minimal or maximal ablation strategy to achieve pulmonary vein isolation for paroxysmal atrial fibrillation: A prospective multi-centre randomized controlled trial (the minimax study). Eur Heart J. 2015;36:1812-1821.</Citation></Reference><Reference><Citation>Mohanty S, Mohanty P, Di Biase L, et&#xa0;al. Results from a single-blind, randomized study comparing the impact of different ablation approaches on long-term procedure outcome in coexistent atrial fibrillation and flutter (APPROVAL). Circulation. 2013;127:53-60.</Citation></Reference><Reference><Citation>De Backer O, Arnous S, Ihlemann N, et&#xa0;al. Percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation: An update. Open Heart. 2014;1:e00002.</Citation></Reference><Reference><Citation>Deshpande CG, Kogut S, Willey C. Real-world health care costs based on medication adherence and risk of stroke and bleeding in patients treated with novel anticoagulant therapy. J Manag Care Spec Pharm. 2018;24:430-439.</Citation></Reference><Reference><Citation>Camm AJ, Lip GY, De Caterina R, et&#xa0;al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Europace. 2012;14:1385-1413.</Citation></Reference><Reference><Citation>Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation. 2007;115:2689-2696.</Citation></Reference><Reference><Citation>Wallentin L, Yusuf S, Ezekowitz MD, et&#xa0;al. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: An analysis of the RE-LY trial. Lancet. 2010;376:975-983.</Citation></Reference><Reference><Citation>Granger CB, Alexander JH, McMurray JJ, et&#xa0;al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365:981-992.</Citation></Reference><Reference><Citation>Patti G, Pengo V, Marcucci R, et&#xa0;al. The left atrial appendage: From embryology to prevention of thromboembolism. Eur Heart J. 2017;38:877-887.</Citation></Reference><Reference><Citation>Reddy VY, D S, Sievert H. PROTECT AF Investigators. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman left atrial appendage system for embolic protection in patients with atrial fibrillation) trial. Circulation. 2013;127:20-29.</Citation></Reference><Reference><Citation>Reddy VY, Sievert H, Halperin J, et&#xa0;al. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: A randomized clinical trial. JAMA. 2014;312:1988-1998.</Citation></Reference><Reference><Citation>January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American college of cardiology/American heart association task force on clinical practice guidelines and the Heart Rhythm Society in collaboration with the society of thoracic surgeons. Circulation. 2019;140:e125-e151.</Citation></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560.</Citation></Reference><Reference><Citation>Whiting PF, Rutjes AW, Westwood ME, Mallett S, et&#xa0;al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529-536.</Citation></Reference><Reference><Citation>Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;316:629-634.</Citation></Reference><Reference><Citation>Alipour A, Swaans MJ, van Dijk VF, et&#xa0;al. Ablation for atrial fibrillation combined with left atrial appendage closure. JACC Clin Electrophysiol. 2015;1:486-495.</Citation></Reference><Reference><Citation>Calvo N, Salterain N, Arguedas H, et&#xa0;al. Combined catheter ablation and left atrial appendage closure as a hybrid procedure for the treatment of atrial fibrillation. Europace. 2015;17:1533-1540.</Citation></Reference><Reference><Citation>Du X, Chu H, Ye P, et&#xa0;al. Combination of left atrial appendage closure and catheter ablation in a single procedure for patients with atrial fibrillation: Multicenter experience. J Formos Med Assoc. 2019;118:891-897.</Citation></Reference><Reference><Citation>Fassini G, Conti S, Moltrasio M, et&#xa0;al. Concomitant cryoballoon ablation and percutaneous closure of left atrial appendage in patients with atrial fibrillation. Europace. 2016;18:1705-1710.</Citation></Reference><Reference><Citation>Feng XF, Zhang PP, Sun J, Wang QS, Li YG. Feasibility and safety of left atrial appendage closure using the LAmbre device in patients with nonvalvular atrial fibrillation with or without prior catheter ablation. Int Heart J. 2019;60:63-70.</Citation></Reference><Reference><Citation>Heeger CH, Rillig A, Lin T, et&#xa0;al. Feasibility and clinical efficacy of left atrial ablation for the treatment of atrial tachyarrhythmias in patients with left atrial appendage closure devices. Heart Rhythm. 2015;12:1524-1531.</Citation></Reference><Reference><Citation>Hu H, Cui K, Jiang J, Fu H, Zeng R. Safety and efficacy analysis of one-stop intervention for treating nonvalvular atrial fibrillation. Pacing Clin Electrophysiol. 2018;41:28-34.</Citation></Reference><Reference><Citation>Li X, Li J, Chu H, et&#xa0;al. Combination of catheter ablation for non-valvular atrial fibrillation and left atrial appendage occlusion in a single procedure. Exp Ther Med. 2018;16:2094-2100.</Citation></Reference><Reference><Citation>Liu FZ, Lin WD, Liao HT, et&#xa0;al. Mid-term outcomes of concomitant left atrial appendage closure and catheter ablation for non-valvular atrial fibrillation: A multicenter registry. Heart Vessels. 2019;34:860-867.</Citation></Reference><Reference><Citation>Panikker S, Jarman JW, Virmani R, et&#xa0;al. Left atrial appendage electrical isolation and concomitant device occlusion to treat persistent atrial fibrillation: A first-in-human safety, feasibility, and efficacy study. Circ Arrhythm Electrophysiol. 2016;9:e003710.</Citation></Reference><Reference><Citation>Phillips KP, Pokushalov E, Romanov A, et&#xa0;al. Combining Watchman left atrial appendage closure and catheter ablation for atrial fibrillation: Multicentre registry results of feasibility and safety during implant and 30 days follow-up. Europace. 2018;20:949-955.</Citation></Reference><Reference><Citation>Phillips KP, Walker DT, Humphries JA. Combined catheter ablation for atrial fibrillation and Watchman(R) left atrial appendage occlusion procedures: five-year experience. J Arrhythm. 2016;32:119-126.</Citation></Reference><Reference><Citation>Romanov A, Pokushalov E, Artemenko S, et&#xa0;al. Does left atrial appendage closure improve the success of pulmonary vein isolation? Results of a randomized clinical trial. J Interv Card Electrophysiol. 2015;44:9-16.</Citation></Reference><Reference><Citation>Swaans MJ, Post MC, Rensing BJ, Boersma LV. Ablation for atrial fibrillation in combination with left atrial appendage closure: First results of a feasibility study. J Am Heart Assoc. 2012;1:e002212.</Citation></Reference><Reference><Citation>Turagam MK, Lavu M, Afzal MR, et&#xa0;al. Catheter ablation for atrial fibrillation in patients with watchman left atrial appendage occlusion device: Results from a multicenter registry. J Cardiovasc Electrophysiol. 2017;28:139-146.</Citation></Reference><Reference><Citation>Walker DT, Humphries JA, Phillips KP. Combined catheter ablation for atrial fibrillation and Watchman((R)) left atrial appendage occlusion procedures: A single centre experience. J Atr Fibrillation. 2012;5:687.</Citation></Reference><Reference><Citation>Walker DT, Phillips KP. Left atrial catheter ablation subsequent to Watchman(R) left atrial appendage device implantation: A single centre experience. Europace. 2015;17:1402-1406.</Citation></Reference><Reference><Citation>Wintgens L, Romanov A, Phillips K, et&#xa0;al. Combined atrial fibrillation ablation and left atrial appendage closure: Long-term follow-up from a large multicentre registry. Europace. 2018;20:1783-1789.</Citation></Reference><Reference><Citation>Lloyd-Jones D, Adams R, Carnethon M, et&#xa0;al. Heart disease and stroke statistics-2009 update: A report from the AHA Statistics Committee and Stroke Statistics Sub- committee. Circulation. 2009;119:e21-181.</Citation></Reference><Reference><Citation>Hart RG, Pearce LA, Aguilar MI. Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857-867.</Citation></Reference><Reference><Citation>Kita K, Carlson S, Huntsinger M, Tun H, Sohn J, Doshi RN. Safety and feasibility of combined atrial fibrillation ablation and left atrial appendage occlusion after left atrial appendage electrical isolation. J Interv Card Electrophysiol. 2019;8:45-48.</Citation></Reference><Reference><Citation>Bolao IG, Calvo N, Macias A, et&#xa0;al. Ablation of atrial fibrillation in combination with left atrial appendage occlusion in a single procedure. Rationale and technique. J Atr Fibrillation. 2016;8:61-66.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">19850894</PMID><DateCompleted><Year>2010</Year><Month>01</Month><Day>12</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1524-4628</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>12</Issue><PubDate><Year>2009</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Stroke</Title><ISOAbbreviation>Stroke</ISOAbbreviation></Journal><ArticleTitle>Doppler embolic signals in cerebrovascular disease and prediction of stroke risk: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>3711</StartPage><EndPage>3717</EndPage><MedlinePgn>3711-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1161/STROKEAHA.109.563056</ELocationID><Abstract><AbstractText Label="BACKGROUND AND PURPOSE" NlmCategory="OBJECTIVE">Asymptomatic embolic signals (ES) detected using transcranial Doppler have been reported in patients with potential cerebral embolic sources. They may be useful in risk stratification and in assessing therapies. First, it is essential to show whether they predict stroke risk.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review and meta-analysis was performed to determine the prognostic value of ES in different potential cerebral embolic sources. Studies were identified that used transcranial Doppler to detect ES and included prospective stroke/TIA follow-up. Numbers of ES-positive and ES-negative patients were extracted with stroke/TIA and stroke alone outcomes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">ES are most frequent in large artery disease, less frequent in cardioembolic stroke, and infrequent in lacunar stroke. Data relating ES to future stroke risk were available for acute stroke, large artery disease, and the perioperative period of carotid endarterectomy. For symptomatic carotid stenosis, ES predicted stroke alone (OR, 9.57; 95%CI, 1.54 to 59.38; P=0.02) and stroke/TIA (OR, 6.36; 95% CI, 2.90-13.96; P&lt;0.00001). For asymptomatic carotid stenosis, ES predicted stroke alone (OR, 7.46; 95% CI, 2.24-24.89; P=0.001) and stroke/TIA (OR, 12.00; 95% CI, 2.43-59.34; P=0.002) but with heterogeneity (P=0.004). In acute stroke ES predicted stroke alone (OR, 2.44; 95% CI, 1.17-5.08; P=0.02) and stroke/TIA (OR, 3.71; 95% CI, 1.64-8.38; P=0.002). A high frequency of ES immediately after carotid endarterectomy predicted stroke alone (OR, 24.54; 95% CI, 7.88-76.43; P&lt;0.00001) and stroke/TIA (OR, 32.04; 95% CI, 11.36-90.39; P&lt;0.00001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">ES predict stroke risk in acute stroke, symptomatic carotid stenosis, and postoperatively after carotid endarterectomy; in asymptomatic carotid stenosis, data are less robust. In these conditions ES may be useful in risk stratification and in assessing therapeutic efficacy. For other embolic sources, further prospective data are required.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>King</LastName><ForeName>Alice</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinical Neuroscience, St. George's University of London, Cranmer Terrace, London, SW17 0RE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Markus</LastName><ForeName>Hugh S</ForeName><Initials>HS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2009</Year><Month>10</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Stroke</MedlineTA><NlmUniqueID>0235266</NlmUniqueID><ISSNLinking>0039-2499</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002536" MajorTopicYN="N">Cerebral Arteries</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020766" MajorTopicYN="N">Intracranial Embolism</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017585" MajorTopicYN="N">Ultrasonography, Doppler, Transcranial</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>43</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19850894</ArticleId><ArticleId IdType="doi">10.1161/STROKEAHA.109.563056</ArticleId><ArticleId IdType="pii">STROKEAHA.109.563056</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22277949</PMID><DateCompleted><Year>2012</Year><Month>04</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1175</ISSN><JournalIssue CitedMedium="Internet"><Volume>116</Volume><Issue>3</Issue><PubDate><Year>2012</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Anesthesiology</Title><ISOAbbreviation>Anesthesiology</ISOAbbreviation></Journal><ArticleTitle>Intraoperative hypotension and perioperative ischemic stroke after general surgery: a nested case-control study.</ArticleTitle><Pagination><StartPage>658</StartPage><EndPage>664</EndPage><MedlinePgn>658-64</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ALN.0b013e3182472320</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Postoperative stroke is a rare but major complication after surgery. The most often proposed mechanism is an embolus originating from the heart or great vessels. The role of intraoperative hypotension in the occurrence and evolution of postoperative stroke is largely unknown.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A case-control study was conducted among 48,241 patients who underwent noncardiac and nonneurosurgical procedures in the period from January 2002 to June 2009. A total of 42 stroke cases (0.09%) were matched on age and type of surgery to 252 control patients. Conditional logistic regression analysis was used to estimate the effect of the duration of intraoperative hypotension (defined according to a range of blood pressure thresholds) on the occurrence of an ischemic stroke within 10 days after surgery, adjusted for potential confounding factors.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">After correction for potential confounders and multiple testing, the duration that the mean blood pressure was decreased more than 30% from baseline remained statistically significantly associated with the occurrence of a postoperative stroke.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Intraoperative hypotension might play a role in the development of postoperative ischemic stroke. Especially for mean blood pressure values decreasing more than 30% from baseline blood pressure, an association with postoperative ischemic stroke risks was observed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bijker</LastName><ForeName>Jilles B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands. j.b.bijker@umcutrecht.nl</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Persoon</LastName><ForeName>Suzanne</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Peelen</LastName><ForeName>Linda M</ForeName><Initials>LM</Initials></Author><Author ValidYN="Y"><LastName>Moons</LastName><ForeName>Karel G M</ForeName><Initials>KG</Initials></Author><Author ValidYN="Y"><LastName>Kalkman</LastName><ForeName>Cor J</ForeName><Initials>CJ</Initials></Author><Author ValidYN="Y"><LastName>Kappelle</LastName><ForeName>L Jaap</ForeName><Initials>LJ</Initials></Author><Author ValidYN="Y"><LastName>van Klei</LastName><ForeName>Wilton A</ForeName><Initials>WA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesthesiology</MedlineTA><NlmUniqueID>1300217</NlmUniqueID><ISSNLinking>0003-3022</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22277949</ArticleId><ArticleId IdType="doi">10.1097/ALN.0b013e3182472320</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33674158</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2165</ISSN><JournalIssue CitedMedium="Internet"><Volume>61</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>May</Month></PubDate></JournalIssue><Title>European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery</Title><ISOAbbreviation>Eur J Vasc Endovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Editor's Choice - Early and Late Outcomes after Transcarotid Revascularisation for Internal Carotid Artery Stenosis: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>725</StartPage><EndPage>738</EndPage><MedlinePgn>725-738</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejvs.2021.01.039</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1078-5884(21)00090-3</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Transcarotid/transcervical revascularisation (TCAR) is an alternative to carotid endarterectomy (CEA) and transfemoral carotid stenting (tfCAS). This review aimed to evaluate pooled data on patients undergoing TCAR.</AbstractText><AbstractText Label="DATA SOURCES">Medline, Embase, Scopus, and Cochrane Library databases were used.</AbstractText><AbstractText Label="REVIEW METHODS">This systematic review was conducted under Systematic Reviews and Meta-Analysis guidelines. Eligible studies (published online up to September 2020) reported 30 day mortality and stroke/transient ischaemic attack (TIA) rates in patients undergoing TCAR. Data were pooled in a random effects model and weight of effect for each study was also reported. Quality of studies was evaluated according to Newcastle - Ottawa scale.</AbstractText><AbstractText Label="RESULTS">Eighteen studies (three low, seven medium, and eight high quality) included 4 852 patients (4 867 TCAR procedures). The pooled 30 day mortality rate was 0.7% (n&#xa0;= 32) (95% confidence interval [CI] 0.5 - 1.0), 30 day stroke rate 1.4% (n&#xa0;= 62) (95% CI 1.0 - 1.7), and 30 day stroke/TIA rate 2.0% (n&#xa0;= 92) (95% CI 1.4 - 2.7). Pooled technical success was 97.6% (95% CI 95.9 - 98.8). The cranial nerve injury rate was 1.2% (95% CI 0.7 - 1.9) (n&#xa0;= 14; data from 10 studies) while the early myocardial infarction (MI) rate was 0.4% (95% CI 0.2 - 0.6) (n&#xa0;= 16; data from 17 studies). The haematoma/bleeding rate was 3.4% (95% CI 1.7 - 5.8) (n&#xa0;= 135; data from 10 studies), with one third of these cases needing drainage or intervention. Within a follow up of 3 - 40 months the restenosis rate was 4% (95% CI 0.1 - 13.1) (data from nine studies; n&#xa0;= 64/530 patients) and death/stroke rate 4.5% (95% CI 1.8 - 8.4) (data from five studies; n&#xa0;= 184/3 742 patients). Symptomatic patients had a higher risk of early stroke/TIA than asymptomatic patients (2.5% vs. 1.2%; odds ratio 1.99; 95% CI 1.01 - 3.92); p&#xa0;= .046; data from eight studies).</AbstractText><AbstractText Label="CONCLUSION">TCAR is associated with promising early and late outcomes, with symptomatic patients having a higher risk of early cerebrovascular events. More prospective comparative studies are needed in order to verify TCAR as an established alternative treatment technique.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Galyfos</LastName><ForeName>George C</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>Vascular Surgery Unit, First Department of Propedeutic Surgery, National and Kapodistrian University of Athens, Hippocration Hospital, Athens, Greece. Electronic address: georgegalyfos@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsoutsas</LastName><ForeName>Ioannis</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Vascular Surgery Department, Sismanogleio General Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konstantopoulos</LastName><ForeName>Theofanis</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Vascular Surgery Department, Sismanogleio General Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galanopoulos</LastName><ForeName>Georgios</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Vascular Surgery Department, Sismanogleio General Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sigala</LastName><ForeName>Frangiska</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Vascular Surgery Unit, First Department of Propedeutic Surgery, National and Kapodistrian University of Athens, Hippocration Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filis</LastName><ForeName>Konstantinos</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Vascular Surgery Unit, First Department of Propedeutic Surgery, National and Kapodistrian University of Athens, Hippocration Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papavassiliou</LastName><ForeName>Vassilios</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Vascular Surgery Department, Sismanogleio General Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Vasc Endovasc Surg</MedlineTA><NlmUniqueID>9512728</NlmUniqueID><ISSNLinking>1078-5884</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016893" MajorTopicYN="N">Carotid Stenosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020209" MajorTopicYN="N">Cranial Nerve Injuries</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016894" MajorTopicYN="N">Endarterectomy, Carotid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="N">Endovascular Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Angioplasty (Mesh)</Keyword><Keyword MajorTopicYN="N">Carotid artery stenosis (Mesh)</Keyword><Keyword MajorTopicYN="N">Repair (non-Mesh)</Keyword><Keyword MajorTopicYN="N">Stenting (Mesh)</Keyword><Keyword MajorTopicYN="N">Transcarotid (non-Mesh)</Keyword><Keyword MajorTopicYN="N">Transcervical (non-Mesh)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>6</Day><Hour>5</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33674158</ArticleId><ArticleId IdType="doi">10.1016/j.ejvs.2021.01.039</ArticleId><ArticleId IdType="pii">S1078-5884(21)00090-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31573636</PMID><DateCompleted><Year>2019</Year><Month>10</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1538-3598</ISSN><JournalIssue CitedMedium="Internet"><Volume>322</Volume><Issue>13</Issue><PubDate><Year>2019</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA</Title><ISOAbbreviation>JAMA</ISOAbbreviation></Journal><ArticleTitle>Association of General Anesthesia vs Procedural Sedation With Functional Outcome Among Patients With Acute Ischemic Stroke Undergoing Thrombectomy: A Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>1283</StartPage><EndPage>1293</EndPage><MedlinePgn>1283-1293</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jama.2019.11455</ELocationID><Abstract><AbstractText Label="IMPORTANCE" NlmCategory="OBJECTIVE">General anesthesia during thrombectomy for acute ischemic stroke has been associated with poor neurological outcome in nonrandomized studies. Three single-center randomized trials reported no significantly different or improved outcomes for patients who received general anesthesia compared with procedural sedation.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To detect differences in functional outcome at 3 months between patients who received general anesthesia vs procedural sedation during thrombectomy for anterior circulation acute ischemic stroke.</AbstractText><AbstractText Label="DATA SOURCE" NlmCategory="METHODS">MEDLINE search for English-language articles published from January 1, 1980, to July 31, 2019.</AbstractText><AbstractText Label="STUDY SELECTION" NlmCategory="METHODS">Randomized clinical trials of adults with a National Institutes of Health Stroke Scale score of at least 10 and anterior circulation acute ischemic stroke assigned to receive general anesthesia or procedural sedation during thrombectomy.</AbstractText><AbstractText Label="DATA EXTRACTION AND SYNTHESIS" NlmCategory="METHODS">Individual patient data were obtained from 3 single-center, randomized, parallel-group, open-label treatment trials with blinded end point evaluation that met inclusion criteria and were analyzed using fixed-effects meta-analysis.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES" NlmCategory="METHODS">Degree of disability, measured via the modified Rankin Scale (mRS) score (range 0-6; lower scores indicate less disability), analyzed with the common odds ratio (cOR) to detect the ordinal shift in the distribution of disability over the range of mRS scores.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 368 patients (mean [SD] age, 71.5 [12.9] years; 163 [44.3%] women; median [interquartile range] National Institutes of Health Stroke Scale score, 17 [14-21]) were included in the analysis, including 183 (49.7%) who received general anesthesia and 185 (50.3%) who received procedural sedation. The mean 3-month mRS score was 2.8 (95% CI, 2.5-3.1) in the general anesthesia group vs 3.2 (95% CI, 3.0-3.5) in the procedural sedation group (difference, 0.43 [95% CI, 0.03-0.83]; cOR, 1.58 [95% CI, 1.09-2.29]; P&#x2009;=&#x2009;.02). Among prespecified adverse events, only hypotension (decline in systolic blood pressure of more than 20% from baseline) (80.8% vs 53.1%; OR, 4.26 [95% CI, 2.55-7.09]; P&#x2009;&lt;&#x2009;.001) and blood pressure variability (systolic blood pressure &gt;180 mm Hg or &lt;120 mm Hg) (79.7 vs 62.3%; OR, 2.42 [95% CI, 1.49-3.93]; P&#x2009;&lt;&#x2009;.001) were significantly more common in the general anesthesia group.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE" NlmCategory="CONCLUSIONS">Among patients with acute ischemic stroke involving the anterior circulation undergoing thrombectomy, the use of protocol-based general anesthesia, compared with procedural sedation, was significantly associated with less disability at 3 months. These findings should be interpreted tentatively, given that the individual trials examined were single-center trials and disability was the primary outcome in only 1 trial.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sch&#xf6;nenberger</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hend&#xe9;n</LastName><ForeName>Pia L&#xf6;whagen</ForeName><Initials>PL</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simonsen</LastName><ForeName>Claus Z</ForeName><Initials>CZ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uhlmann</LastName><ForeName>Lorenz</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klose</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pfaff</LastName><ForeName>Johannes A R</ForeName><Initials>JAR</Initials><AffiliationInfo><Affiliation>Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoo</LastName><ForeName>Albert J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Radiology, Neuroendovascular Service, Texas Stroke Institute, Fort Worth.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xf8;rensen</LastName><ForeName>Leif H</ForeName><Initials>LH</Initials><AffiliationInfo><Affiliation>Department of Neuroradiology, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ringleb</LastName><ForeName>Peter A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wick</LastName><ForeName>Wolfgang</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Cancer Consortium (DKTK), German Cancer Research Center, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kieser</LastName><ForeName>Meinhard</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xf6;hlenbruch</LastName><ForeName>Markus A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasmussen</LastName><ForeName>Mads</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Section of Neuroanesthesia, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rentzos</LastName><ForeName>Alexandros</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Radiology, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xf6;sel</LastName><ForeName>Julian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Klinikum Kassel, Kassel, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA</MedlineTA><NlmUniqueID>7501160</NlmUniqueID><ISSNLinking>0098-7484</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>JAMA. 2019 Dec 24;322(24):2445. doi: 10.1001/jama.2019.20482.</RefSource><PMID Version="1">31860027</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002545" MajorTopicYN="N">Brain Ischemia</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016292" MajorTopicYN="N">Conscious Sedation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004185" MajorTopicYN="N">Disability Evaluation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006233" MajorTopicYN="N">Persons with Disabilities</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017131" MajorTopicYN="Y">Thrombectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Simonsen reported receiving grants from Novo Nordisk Foundation during the conduct of the study and personal fees from Bayer and Pfizer outside the submitted work. Dr Pfaff reported receiving personal fees from Stryker and MircoVention outside the submitted work. Dr Yoo reported receiving grants from Neuravi, Penumbra, Cerenovus, Medtronic, Stryker, and Genentech and owns equity in Insera Therapeutics outside the submitted work. Dr Ringleb reported receiving personal fees from Boehringer Ingelheim, Bayer, Pfizer, Daiichi Sankyo, Covidien, and Bristol-Myers Squibb outside the submitted work. Dr Wick reported receiving research support from Appendix, Boehringer Ingelheim, Pfizer, Roche, and Vaximm. Dr M&#xf6;hlenbruch reported receiving personal fees from Codman, MicroVention, Phenox, and Stryker outside the submitted work. Dr Rentzos reported receiving personal fees from Abbott Medical Sweden and I4L Innovation for Life outside the submitted work. Dr Rasmussen reported receiving a grant from the Health Research Foundation of Central Denmark Region. Dr B&#xf6;sel reported receiving personal fees from Boehringer Ingelheim, Medtronic, and Zoll and support from an award from the Patient-Centered Outcomes Research Institute outside the submitted work. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>4</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31573636</ArticleId><ArticleId IdType="pmc">PMC6777267</ArticleId><ArticleId IdType="doi">10.1001/jama.2019.11455</ArticleId><ArticleId IdType="pii">2752061</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Goyal M, Menon BK, van Zwam WH, et al. ; HERMES collaborators . Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387(10029):1723-1731. doi:10.1016/S0140-6736(16)00163-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)00163-X</ArticleId><ArticleId IdType="pubmed">26898852</ArticleId></ArticleIdList></Reference><Reference><Citation>Jumaa MA, Zhang F, Ruiz-Ares G, et al. . Comparison of safety and clinical and radiographic outcomes in endovascular acute stroke therapy for proximal middle cerebral artery occlusion with intubation and general anesthesia versus the nonintubated state. Stroke. 2010;41(6):1180-1184. doi:10.1161/STROKEAHA.109.574194</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.109.574194</ArticleId><ArticleId IdType="pubmed">20431082</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis MJ, Menon BK, Baghirzada LB, et al. ; Calgary Stroke Program . Anesthetic management and outcome in patients during endovascular therapy for acute stroke. Anesthesiology. 2012;116(2):396-405. doi:10.1097/ALN.0b013e318242a5d2</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e318242a5d2</ArticleId><ArticleId IdType="pubmed">22222475</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Berg LA, Koelman DL, Berkhemer OA, et al. ; MR CLEAN pretrial study group; Participating centers . Type of anesthesia and differences in clinical outcome after intra-arterial treatment for ischemic stroke. Stroke. 2015;46(5):1257-1262. doi:10.1161/STROKEAHA.115.008699</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.115.008699</ArticleId><ArticleId IdType="pubmed">25851766</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkhemer OA, van den Berg LA, Fransen PS, et al. ; MR CLEAN investigators . The effect of anesthetic management during intra-arterial therapy for acute stroke in MR CLEAN. Neurology. 2016;87(7):656-664. doi:10.1212/WNL.0000000000002976</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002976</ArticleId><ArticleId IdType="pubmed">27421546</ArticleId></ArticleIdList></Reference><Reference><Citation>Abou-Chebl A, Yeatts SD, Yan B, et al. . Impact of general anesthesia on safety and outcomes in the endovascular arm of Interventional Management of Stroke (IMS) III trial. Stroke. 2015;46(8):2142-2148. doi:10.1161/STROKEAHA.115.008761</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.115.008761</ArticleId><ArticleId IdType="pmc">PMC4519363</ArticleId><ArticleId IdType="pubmed">26138125</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinjikji W, Murad MH, Rabinstein AA, Cloft HJ, Lanzino G, Kallmes DF. Conscious sedation versus general anesthesia during endovascular acute ischemic stroke treatment: a systematic review and meta-analysis. AJNR Am J Neuroradiol. 2015;36(3):525-529. doi:10.3174/ajnr.A4159</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A4159</ArticleId><ArticleId IdType="pmc">PMC8013063</ArticleId><ArticleId IdType="pubmed">25395655</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell BCV, van Zwam WH, Goyal M, et al. ; HERMES collaborators . Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data. Lancet Neurol. 2018;17(1):47-53. doi:10.1016/S1474-4422(17)30407-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30407-6</ArticleId><ArticleId IdType="pubmed">29263006</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivasankar C, Stiefel M, Miano TA, et al. . Anesthetic variation and potential impact of anesthetics used during endovascular management of acute ischemic stroke. J Neurointerv Surg. 2016;8(11):1101-1106. doi:10.1136/neurintsurg-2015-011998</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/neurintsurg-2015-011998</ArticleId><ArticleId IdType="pmc">PMC5557370</ArticleId><ArticleId IdType="pubmed">26614493</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xf6;nenberger S, Uhlmann L, Hacke W, et al. . Effect of conscious sedation vs general anesthesia on early neurological improvement among patients with ischemic stroke undergoing endovascular thrombectomy: a randomized clinical trial. JAMA. 2016;316(19):1986-1996. doi:10.1001/jama.2016.16623</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.16623</ArticleId><ArticleId IdType="pubmed">27785516</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;whagen Hend&#xe9;n P, Rentzos A, Karlsson JE, et al. . General anesthesia versus conscious sedation for endovascular treatment of acute ischemic stroke: the AnStroke trial (anesthesia during stroke). Stroke. 2017;48(6):1601-1607. doi:10.1161/STROKEAHA.117.016554</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.117.016554</ArticleId><ArticleId IdType="pubmed">28522637</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonsen CZ, Yoo AJ, S&#xf8;rensen LH, et al. . Effect of general anesthesia and conscious sedation during endovascular therapy on infarct growth and clinical outcomes in acute ischemic stroke: a randomized clinical trial. JAMA Neurol. 2018;75(4):470-477. doi:10.1001/jamaneurol.2017.4474</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.4474</ArticleId><ArticleId IdType="pmc">PMC5885172</ArticleId><ArticleId IdType="pubmed">29340574</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazighi M, Serfaty JM, Labreuche J, et al. ; RECANALISE investigators . Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study. Lancet Neurol. 2009;8(9):802-809. doi:10.1016/S1474-4422(09)70182-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(09)70182-6</ArticleId><ArticleId IdType="pubmed">19647488</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas AK, Gordon LT, Cernasov PM, Bulevich JB. The effect of testing can increase or decrease misinformation susceptibility depending on the retention interval. Cogn Res Princ Implic. 2017;2(1):45. doi:10.1186/s41235-017-0081-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41235-017-0081-4</ArticleId><ArticleId IdType="pmc">PMC5698386</ArticleId><ArticleId IdType="pubmed">29214206</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke DL, Ensor J, Riley RD. Meta-analysis using individual participant data: one-stage and two-stage approaches, and why they may differ. Stat Med. 2017;36(5):855-875. doi:10.1002/sim.7141</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.7141</ArticleId><ArticleId IdType="pmc">PMC5297998</ArticleId><ArticleId IdType="pubmed">27747915</ArticleId></ArticleIdList></Reference><Reference><Citation>Eker OF, Saver JL, Goyal M, et al. ; SWIFT PRIME investigators . Impact of anesthetic management on safety and outcomes following mechanical thrombectomy for ischemic stroke in SWIFT PRIME cohort. Front Neurol. 2018;9:702. doi:10.3389/fneur.2018.00702</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00702</ArticleId><ArticleId IdType="pmc">PMC6123376</ArticleId><ArticleId IdType="pubmed">30210431</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichols C, Carrozzella J, Yeatts S, Tomsick T, Broderick J, Khatri P. Is periprocedural sedation during acute stroke therapy associated with poorer functional outcomes? J Neurointerv Surg. 2010;2(1):67-70. doi:10.1136/jnis.2009.001768</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnis.2009.001768</ArticleId><ArticleId IdType="pmc">PMC2860799</ArticleId><ArticleId IdType="pubmed">20431708</ArticleId></ArticleIdList></Reference><Reference><Citation>Slezak A, Kurmann R, Oppliger L, et al. . Impact of anesthesia on the outcome of acute ischemic stroke after endovascular treatment with the solitaire stent retriever. AJNR Am J Neuroradiol. 2017;38(7):1362-1367. doi:10.3174/ajnr.A5183</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A5183</ArticleId><ArticleId IdType="pmc">PMC7959912</ArticleId><ArticleId IdType="pubmed">28473340</ArticleId></ArticleIdList></Reference><Reference><Citation>Bracard S, Ducrocq X, Mas JL, et al. ; THRACE investigators . Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurol. 2016;15(11):1138-1147. doi:10.1016/S1474-4422(16)30177-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(16)30177-6</ArticleId><ArticleId IdType="pubmed">27567239</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff JAR, Sch&#xf6;nenberger S, Nagel S, et al. . Effect of general anesthesia versus conscious sedation for stroke thrombectomy on angiographic workflow in a randomized trial: a post hoc analysis of the SIESTA trial. Radiology. 2018;286(3):1016-1021. doi:10.1148/radiol.2017171002</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2017171002</ArticleId><ArticleId IdType="pubmed">29083986</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;whagen Hend&#xe9;n P, Rentzos A, Karlsson JE, et al. . Hypotension during endovascular treatment of ischemic stroke is a risk factor for poor neurological outcome. Stroke. 2015;46(9):2678-2680. doi:10.1161/STROKEAHA.115.009808</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.115.009808</ArticleId><ArticleId IdType="pubmed">26173727</ArticleId></ArticleIdList></Reference><Reference><Citation>Whalin MK, Halenda KM, Haussen DC, et al. . Even small decreases in blood pressure during conscious sedation affect clinical outcome after stroke thrombectomy: an analysis of hemodynamic thresholds. AJNR Am J Neuroradiol. 2017;38(2):294-298. doi:10.3174/ajnr.A4992</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A4992</ArticleId><ArticleId IdType="pmc">PMC7963817</ArticleId><ArticleId IdType="pubmed">27811133</ArticleId></ArticleIdList></Reference><Reference><Citation>Treurniet KM, Berkhemer OA, Immink RV, et al. ; MR CLEAN investigators . A decrease in blood pressure is associated with unfavorable outcome in patients undergoing thrombectomy under general anesthesia. J Neurointerv Surg. 2018;10(2):107-111. doi:10.1136/neurintsurg-2017-012988</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/neurintsurg-2017-012988</ArticleId><ArticleId IdType="pubmed">28404769</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xf6;nenberger S, Uhlmann L, Ungerer M, et al. . Association of blood pressure with short- and long-term functional outcome after stroke thrombectomy: post hoc analysis of the SIESTA trial. Stroke. 2018;49(6):1451-1456. doi:10.1161/STROKEAHA.117.019709</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.117.019709</ArticleId><ArticleId IdType="pubmed">29720440</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen M, Espelund US, Juul N, et al. . The influence of blood pressure management on neurological outcome in endovascular therapy for acute ischaemic stroke. Br J Anaesth. 2018;120(6):1287-1294. doi:10.1016/j.bja.2018.01.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2018.01.039</ArticleId><ArticleId IdType="pubmed">29793595</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">19660899</PMID><DateCompleted><Year>2009</Year><Month>10</Month><Day>15</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6809</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>4</Issue><PubDate><Year>2009</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of vascular surgery</Title><ISOAbbreviation>J Vasc Surg</ISOAbbreviation></Journal><ArticleTitle>Processes of care for carotid endarterectomy: surgical and anesthesia considerations.</ArticleTitle><Pagination><StartPage>921</StartPage><EndPage>933</EndPage><MedlinePgn>921-33</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jvs.2009.04.071</ELocationID><Abstract><AbstractText>There are still some vascular surgeons who do not use carotid patching routinely in all patients undergoing CEA, however, based on the data presented in this review, there is Level 1 evidence to support the routine use of carotid patching. Meanwhile, there is no Level 1 evidence to support selective patching for CEA, however a Grade D recommendation may be used to recommend that primary closure can be safely practiced in a large ICA (&gt;6mm). A meta-analysis/systemic review of well-conducted prospective randomized trials (Level 1 evidence) concluded that there was no difference in stroke/death rates between conventional CEA with patch closure and eversion CEA. The incidence of significant restenosis with eversion CEA is also similar to CEA with patch closure, however eversion CEA had a lower restenosis rate than patients undergoing CEA with primary closure. Prior to the GALA trial, there was insufficient evidence from randomized clinical trials comparing CEA under local anesthesia versus general anesthesia to support the superiority of either technique in reducing major perioperative events, i.e. stroke, MI, or death. However, the GALA trial concluded that the perioperative stroke/MI and death rates were equivalent in both techniques.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>AbuRahma</LastName><ForeName>Ali F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Robert C. Byrd Health Sciences Center of West Virginia University, Charleston Area Medical Center, Charleston, WV 25304, USA. ali.aburahma@camc.org</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2009</Year><Month>08</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vasc Surg</MedlineTA><NlmUniqueID>8407742</NlmUniqueID><ISSNLinking>0741-5214</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000772" MajorTopicYN="N">Anesthesia, Local</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016893" MajorTopicYN="N">Carotid Stenosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016894" MajorTopicYN="N">Endarterectomy, Carotid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011182" MajorTopicYN="N">Postoperative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011300" MajorTopicYN="N">Preoperative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013536" MajorTopicYN="Y">Suture Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018616" MajorTopicYN="N">Ultrasonography, Doppler, Duplex</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>92</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2009</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2009</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2009</Year><Month>4</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>8</Month><Day>8</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>8</Month><Day>8</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19660899</ArticleId><ArticleId IdType="doi">10.1016/j.jvs.2009.04.071</ArticleId><ArticleId IdType="pii">S0741-5214(09)01015-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31914059</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>29</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>99</Volume><Issue>2</Issue><PubDate><Year>2020</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Long-term efficacy after closure of patent foramen ovale for ischemic neurological events in young adults: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>e18675</StartPage><MedlinePgn>e18675</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e18675</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000018675</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The efficacy of patent foramen ovale (PFO) closure remains controversial, and it is unclear which patient groups are best benefited. We performed this meta-analysis to clarify the efficacy of PFO closure of younger patients for prevention of recurrent ischemic neurological events.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We systematically searched for studies of PFO closure for younger patients under the age of 55, and pooled available data on PFO closure of younger vs older patients and on PFO closure of younger patients vs medical therapy. The primary endpoints were the composite outcome of recurrent ischemic neurological events [stroke and/or transient ischemic attack (TIA)]. The secondary endpoints included recurrent stroke, TIA, atrial fibrillation (AF) and bleeding events. We calculated the odds ratios (OR) and 95% confidence interval (CI) using fixed-effect and random-effect models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Three randomized controlled trials (RCT) and 13 observational studies were eligible. Compared with older patients undergoing PFO closure, younger patients undergoing closure had a lower risk of composite outcome (OR: 0.40, 95% CI: 0.28 to .56; P &lt; .001) and AF (OR: 0.25, 95% CI: 0.10-0.61; P&#x200a;=&#x200a;.003). Compared with medical therapy, PFO closure of younger patients reduced the risk of composite outcome (OR: 0.50, 95% CI: 0.33-0.75; P&lt;.001); there was no statistical difference in total complications of AF and bleeding events (OR: 2.15, 95% CI: 0.15-30.37; P&#x200a;=&#x200a;.57). Separate analysis of stroke and TIA showed that PFO closure in younger patients was more effective in preventing stroke (OR: 0.45, 95% CI: 0.28-0.72; P&#x200a;&lt;&#x200a;.001) and TIA (OR: 0.35, 95% CI: 0.21-0.58); P&#x200a;&lt;&#x200a;.001) compared with older patients. Compared with medical therapy, PFO closure of younger patients reduced the risk of stroke (OR: 0.26, 95% CI: 0.13-0.51; P&#x200a;&lt;&#x200a;.001); but there was no difference in the risk of TIA (OR: 1.07, 95% CI: 0.16-7.01; P&#x200a;=&#x200a;.94).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Compared with PFO closure of older patients and medical therapy, PFO closure of younger patients can benefit more for the prevention of recurrent ischemic neurological events. Our results indicate that PFO closure is the best treatment strategy for younger patients under the age of 55.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Liang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Ultrasound, The First College of Clinical Medical Sciences, China Three Gorges University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Xuemei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Ultrasound, The Third People's Hospital of Yichang City, Yichang, Hubei Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Chang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Ultrasound, The First College of Clinical Medical Sciences, China Three Gorges University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Ultrasound, The First College of Clinical Medical Sciences, China Three Gorges University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Fangyuan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Ultrasound, The First College of Clinical Medical Sciences, China Three Gorges University.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="N">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054092" MajorTopicYN="N">Foramen Ovale, Patent</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="N">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no funding and conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>1</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31914059</ArticleId><ArticleId IdType="pmc">PMC6959863</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000018675</ArticleId><ArticleId IdType="pii">00005792-202001100-00050</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pasceri V, Pelliccia F, Bressi E, et al. Net clinical benefit of patent foramen ovale closure in patients with cryptogenic stroke: Meta-analysis and meta-regression of randomized trials. Int J Cardiol 2018;266:75&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">29887476</ArticleId></ArticleIdList></Reference><Reference><Citation>Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 2000;55:1172&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">11071496</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent DM, Ruthazer R, Weimar C, et al. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology 2013;81:619&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3775694</ArticleId><ArticleId IdType="pubmed">23864310</ArticleId></ArticleIdList></Reference><Reference><Citation>Negr&#xe3;o EM, Brandi IV, Nunes SV, et al. Patent foramen ovale and ischemic stroke in young people: statistical association or causal relation? Arq Bras Cardiol 2007;88:514&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">17589624</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009;151:264&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">19622511</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011.</Citation></Reference><Reference><Citation>Wells GA, Shea B, O&#x2019;Connell D, et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses. Ottawa, Ontario, Canada: Ottawa Hospital Research Institute; 2013.</Citation></Reference><Reference><Citation>Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med 2004;23:1351&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">15116347</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trial 1986;7:177&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003;327:557&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Homma S, Di Tullio MR, Sacco RL, et al. Surgical closure of patent foramen ovale in cryptogenic stroke patients. Stroke 1997;28:2376&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">9412617</ArticleId></ArticleIdList></Reference><Reference><Citation>Cifarelli A, Musto C, Parma A, et al. Long-term outcome of transcatheter patent foramen ovale closure in patients with paradoxical embolism. Int J Cardiol 2010;141:304&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">19178959</ArticleId></ArticleIdList></Reference><Reference><Citation>Harms V, Reisman M, Fuller CJ, et al. Outcomes after transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Am J Cardiol 2007;99:1312&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">17478164</ArticleId></ArticleIdList></Reference><Reference><Citation>Scacciatella P, Meynet I, Presbitero P, et al. Recurrent cerebral ischemia after patent foramen ovale percutaneous closure in older patients: A two-center registry study. Catheter Cardiovasc Interv 2016;87:508&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">26106024</ArticleId></ArticleIdList></Reference><Reference><Citation>Spies C, Khandelwal A, Timmemanns I, et al. Recurrent events following patent foramen ovale closure in patients above 55 years of age with presumed paradoxical embolism. Catheter Cardiovasc Interv 2008;72:966&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">18942060</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiblawi FM, Sommer RJ, Levchuck SG. Transcatheter closure of patent foramen ovale in older adults. Catheter Cardiovasc Interv 2006;68:136&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">16755591</ArticleId></ArticleIdList></Reference><Reference><Citation>Luermans JG, Budts W, Ten Berg JM, et al. Comparison of outcome after patent foramen ovale closure in older versus younger patients. EuroIntervention 2011;7:209&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">21646063</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariucci E, Donti A, Salomone L, et al. Recurrent stroke after transcatheter PFO closure in cryptogenic stroke or tia:long-term follow-up. Cardiol Res Pract 2017;2017:9849425.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5753007</ArticleId><ArticleId IdType="pubmed">29430320</ArticleId></ArticleIdList></Reference><Reference><Citation>Dearani JA, Ugurlu BS, Danielson GK, et al. Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation 1999;100:II171&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">10567299</ArticleId></ArticleIdList></Reference><Reference><Citation>Danese A, Stegagno C, Tomelleri G, et al. Clinical outcomes of secondary prevention strategies for young patients with cryptogenic stroke and patent foramen ovale. Acta Cardiol 2017;72:410&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">28705105</ArticleId></ArticleIdList></Reference><Reference><Citation>Horner S, Niederkorn K, Gattringer T, et al. Management of right-to-left shunt in cryptogenic cerebrovascular disease: results from the observational Austrian paradoxical cerebral embolism trial (TACET) registry. J Neurol 2013;260:260&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">22865239</ArticleId></ArticleIdList></Reference><Reference><Citation>Pezzini A, Grassi M, Lodigiani C, et al. Propensity score-based analysis of percutaneous closure versus medical therapy in patients with cryptogenic stroke and patent foramen ovale: the IPSYS registry (Italian project on stroke in young adults). Circ Cardiovasc Interv 2016;9:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">27582111</ArticleId></ArticleIdList></Reference><Reference><Citation>Paciaroni M, Agnelli G, Bertolini A, et al. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study. Cerebrovasc Dis 2011;31:109&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">21088390</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf8;ndergaard L, Kasner SE, Rhodes JF, et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med 2017;377:1033&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">28902580</ArticleId></ArticleIdList></Reference><Reference><Citation>Mas JL, Derumeaux G, Guillon B, et al. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N Engl J Med 2017;377:1011&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">28902593</ArticleId></ArticleIdList></Reference><Reference><Citation>Saver JL, Carroll JD, Thaler DE, et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med 2017;377:1022&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">28902590</ArticleId></ArticleIdList></Reference><Reference><Citation>Furlan AJ, Reisman M, Massaro J, et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med 2012;366:991&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">22417252</ArticleId></ArticleIdList></Reference><Reference><Citation>Meier B, Kalesan B, Mattle HP, et al. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med 2013;368:1083&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">23514285</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee PH, Song JK, Kim JS, et al. Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO trial. J Am Coll Cardiol 2018;71:2335&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">29544871</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahal K, Yousuf A, Watti H, et al. Who benefits from percutaneous closure of patent foramen ovale medical therapy for stroke prevention? In-depth and updated meta-analysis of randomized trials. World J Cardiol 2019;11:126&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6503458</ArticleId><ArticleId IdType="pubmed">31110604</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuijpers T, Spencer FA, Siemieniuk RAC, et al. Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline. BMJ 2018;362:k2515.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6058599</ArticleId><ArticleId IdType="pubmed">30045912</ArticleId></ArticleIdList></Reference><Reference><Citation>Vidale S, Russo F, Campana C, et al. Patent foramen ovale closure versus medical therapy in cryptogenic strokes and transient ischemic attacks: a meta-analysis of randomized trials. Angiology 2019;70:325&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">30270651</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinthaler M, Ozga AK, Sinning D, et al. Revival of transcatheter PFO closure: a meta-analysis of randomized controlled trials - impact of shunt size and age. Am Heart J 2018;201:95&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">29910060</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31449948</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>13</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1615-5947</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><PubDate><Year>2020</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Annals of vascular surgery</Title><ISOAbbreviation>Ann Vasc Surg</ISOAbbreviation></Journal><ArticleTitle>Synchronous Carotid Endarterectomy and Coronary Artery Bypass Graft versus Staged Carotid Artery Stenting and Coronary Artery Bypass Graft for Patients with Concomitant Severe Coronary and Carotid Stenosis: A Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>463</StartPage><EndPage>473.e4</EndPage><MedlinePgn>463-473.e4</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.avsg.2019.06.018</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0890-5096(19)30593-X</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Owing to the systemic nature of atherosclerosis, medium and large arteries at different sites are commonly simultaneously affected. As a result, severe coronary artery disease (CAD) requiring coronary artery bypass graft (CABG) frequently coexists with significant carotid stenosis that warrants revascularization. The aim of this study was to compare synchronous carotid endarterectomy (CEA) and CABG vs. staged carotid artery stenting (CAS) and CABG for patients with concomitant CAD and carotid artery stenosis in terms of perioperative (30-day) outcomes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This study was performed according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines. Eligible studies were identified through a search of PubMed, Scopus, and Cochrane until July 2018. A meta-analysis was conducted with the use of a random-effects model. The I-square statistic was used to assess heterogeneity.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Five studies comprising 16,712 patients were included in this meta-analysis. Perioperative stroke (odds ratio [OR]: 0.84; 95% confidence interval [CI]: 0.43-1.64; I<sup>2</sup> = 39.1%), transient ischemic attack (TIA; OR: 0.32; 95% CI: 0.04-2.67; I<sup>2</sup> = 27.6%), and myocardial infarction (MI) rates (OR: 0.56; 95% CI: 0.08-3.85; I<sup>2</sup> = 68.9%) were similar between the two groups. However, patients who underwent simultaneous CEA and CABG were at a statistically significant higher risk for perioperative mortality (OR: 1.80; 95% CI: 1.05-3.06; I<sup>2</sup> = 0.0%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The current meta-analysis did not detect statistically significant differences in the rates of perioperative stroke, TIA, and MI between the groups. However, patients in the simultaneous CEA and CABG group had a significantly higher risk of 30-day mortality. Future randomized trials or prospective cohorts are needed to validate our results.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Giannopoulos</LastName><ForeName>Stefanos</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, 251 HAF and VA Hospital, Athens, Greece. Electronic address: stefanosgiannopoulosmed@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Texakalidis</LastName><ForeName>Pavlos</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Emory University School of Medicine, Atlanta, GA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Charisis</LastName><ForeName>Nektarios</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Surgical Oncology, Department of Surgery, Stony Brook University Hospital, Stony Brook, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jonnalagadda</LastName><ForeName>Anil K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Division of Cardiology, MedStar Washington Hospital Center, Washington, DC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaitidis</LastName><ForeName>Nikolaos</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, 401 General Army Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giannopoulos</LastName><ForeName>Spyridon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaskoutis</LastName><ForeName>Christos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, 401 General Army Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Machinis</LastName><ForeName>Theofilos</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Virginia Commonwealth University, Richmond, VA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koullias</LastName><ForeName>George J</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>Division of Vascular and Endovascular Surgery, Department of Surgery, Stony Brook University Hospital, Stony Brook, NY.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Ann Vasc Surg</MedlineTA><NlmUniqueID>8703941</NlmUniqueID><ISSNLinking>0890-5096</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Ann Vasc Surg. 2020 May;65:e306-e307. doi: 10.1016/j.avsg.2019.08.080.</RefSource><PMID Version="1">31622752</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016893" MajorTopicYN="N">Carotid Stenosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001026" MajorTopicYN="Y">Coronary Artery Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D023921" MajorTopicYN="N">Coronary Stenosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016894" MajorTopicYN="Y">Endarterectomy, Carotid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="N">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>5</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31449948</ArticleId><ArticleId IdType="doi">10.1016/j.avsg.2019.06.018</ArticleId><ArticleId IdType="pii">S0890-5096(19)30593-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38354181</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>2</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Safety and efficacy of percutaneous Watchman 2.5 device versus Amplatzer Amulet for left atrial appendage closure in patients with non-valvular atrial fibrillation: A systematic review and study-level meta-analysis.</ArticleTitle><Pagination><StartPage>e0295804</StartPage><MedlinePgn>e0295804</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0295804</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0295804</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">In patients with non-valvular atrial fibrillation (NVAF), mechanical occlusion of the left atrial appendage (LAA) using a permanently implanted device may be an effective alternative to oral anti-coagulants (OAC). To facilitate left atrial appendage closure (LAAC), multiple percutaneous devices have been proposed. Watchman Generation 2.5 and Amplatzer Amulet are the two most popular used devices for preventing stroke in patients with NVAF. We sought to compare safety and efficacy outcomes between Watchman 2.5 and Amplatzer Amulet in patients undergoing LAAC procedure.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We carried out a comprehensive and systematic search of the databases PubMed and Scopus, for all studies that compared the safety and efficacy of Watchman 2.5 and Amplatzer Amulet devices, from inception, till June 2023. We performed the statistical analysis using Review Manager (V.5.4.1 Cochrane Collaboration, London, United Kingdom). The safety outcomes of interest included device success, device-related thrombus, device embolization perioperatively and at follow-up, perioperative pericardial perfusion events, and perioperative cardiac tamponade events. Efficacy outcomes were all-cause mortality perioperatively and at follow-up, cardiovascular (CV) mortality at follow-up, stroke, major and minor bleeding events at follow-up, transient ischemic attack (TIA) in follow-up period, thromboembolic events in follow-up period, and peri-device leakage in perioperative period. All data was analysed using a random-effects model, and presented as risk ratios (RRs) with 95% confidence intervals (95%CIs).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Regarding safety outcomes, device success was non-significantly reduced in Watchman group when compared with Amulet (RR 0.99, p = 0.57; I2 = 34%). In contrast, device-related thrombus was non-significantly increased in Watchman 2.5 group in comparison to Amulet (RR 1.44, p = 0.11; I2 = 0%). There was no significant difference between the devices in terms of device embolization in the perioperative (RR 0.36, p = 0.38; I2 = 22%) and follow-up (RR 2.24, p = 0.13; I2 = 0%) periods. Likewise, there was no significant difference in the risks of pericardial effusion (RR 0.98, p = 0.98; I2 = 0%), and cardiac tamponade (RR 0.65, p = 0.76; I2 = 62%) perioperatively. Regarding efficacy outcomes, no significant difference was observed in all-cause mortality between devices perioperatively (RR 0.51, p = 0.32; I2 = 0%) and at follow-up (RR 1.08, p = 0.56; I2 = 0%). CV-mortality was non-significantly reduced in Watchman group when compared with Amulet (RR 0.57, p = 0.20; I2 = 0%). The Amulet device was not superior to the Watchman device in terms of stroke at follow-up (RR 1.13, p = 0.63; I2 = 0%). Sub-group analysis showed comparable ischaemic and haemorrhagic stroke events between two devices. Furthermore, at follow-up, there was no significant difference in major (RR 1.06, p = 0.63; I2 = 0%) and minor bleeding events (RR 1.81, p = 0.17; I2 = 0%) between the two devices. No difference was observed for trans-ischemic attack (RR 1.89, p = 0.24; I2 = 0%) and thromboembolic events (RR 0.96, p = 0.96; I2 = 0%) at follow-up. No significant difference was observed between devices for peri-device leakage in perioperative period (RR 2.16, p = 0.05; I2 = 0%).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The data suggested that LAAC is safe and efficacious procedure irrespective of device used, with generally low complication rates. Watchman generation 2.5 remains non-superior to Amplatzer Amulet in terms of safety and efficacy outcomes.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2024 Yasmin et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yasmin</LastName><ForeName>Farah</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Yale University School of Medicine, New Haven, CT, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>Eman</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-2977-0741</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moeed</LastName><ForeName>Abdul</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4429-1391</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaidi</LastName><ForeName>Farwa</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Umar</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>IU Health Ball Memorial Hospital, Muncie, IN, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Virwani</LastName><ForeName>Vikash</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Medical College, Aga Khan University, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020517" MajorTopicYN="N">Atrial Appendage</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="Y">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000097546" MajorTopicYN="Y">Left Atrial Appendage Closure</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055989" MajorTopicYN="Y">Septal Occluder Device</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>14</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>14</Day><Hour>13</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38354181</ArticleId><ArticleId IdType="pmc">PMC10866506</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0295804</ArticleId><ArticleId IdType="pii">PONE-D-23-29074</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ball J, Carrington MJ, McMurray JJV, Stewart S. Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. Int J Cardiol [Internet]. 2013. 
Sep
1 [cited 2023 Aug 18];167(5):1807&#x2013;24. Available from: https://pubmed.ncbi.nlm.nih.gov/23380698/
doi: 10.1016/j.ijcard.2012.12.093

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2012.12.093</ArticleId><ArticleId IdType="pubmed">23380698</ArticleId></ArticleIdList></Reference><Reference><Citation>Shameem R, Ansell J. Disadvantages of VKA and requirements for novel anticoagulants. Best Pract Res Clin Haematol [Internet]. 2013. 
Jun [cited 2023 Aug 19];26(2):103&#x2013;14. Available from: https://pubmed.ncbi.nlm.nih.gov/23953899/
</Citation><ArticleIdList><ArticleId IdType="pubmed">23953899</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmancik P, Herman D, Neuzil P, Hala P, Taborsky M, Kala P, et al.. 4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation. J Am Coll Cardiol [Internet]. 2022. 
Jan
4 [cited 2023 Aug 19];79(1):1&#x2013;14. Available from: https://pubmed.ncbi.nlm.nih.gov/34748929/
doi: 10.1016/j.jacc.2021.10.023

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2021.10.023</ArticleId><ArticleId IdType="pubmed">34748929</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al.. 2016. 
ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J [Internet]. 2016 Jan
1 [cited 2023 Aug 19];37(38). Available from: https://pubmed.ncbi.nlm.nih.gov/27567408/</Citation><ArticleIdList><ArticleId IdType="pubmed">28038729</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes DR, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, et al.. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol [Internet]. 2014. 
Jul
8 [cited 2023 Jul 25];64(1):1&#x2013;12. Available from: https://pubmed.ncbi.nlm.nih.gov/24998121/
doi: 10.1016/j.jacc.2014.04.029

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2014.04.029</ArticleId><ArticleId IdType="pubmed">24998121</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, et al.. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009. Aug 15;374(9689):534&#x2013;42. doi: 10.1016/S0140-6736(09)61343-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(09)61343-X</ArticleId><ArticleId IdType="pubmed">19683639</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JW, Bethencourt A, Sievert H, Santoro G, Meier B, Walsh K, et al.. Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience. Catheter Cardiovasc Interv [Internet]. 2011. 
Apr
1 [cited 2023 Aug 19];77(5):700&#x2013;6. Available from: https://pubmed.ncbi.nlm.nih.gov/20824765/
doi: 10.1002/ccd.22764

</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.22764</ArticleId><ArticleId IdType="pubmed">20824765</ArticleId></ArticleIdList></Reference><Reference><Citation>Lakkireddy D, Thaler D, Ellis CR, Swarup V, Sondergaard L, Carroll J, et al.. Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial. Circulation [Internet]. 2021. 
Nov
9 [cited 2023 Jul 19];144(19):1543&#x2013;52. Available from: https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.121.057063

</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.121.057063</ArticleId><ArticleId IdType="pmc">PMC8570346</ArticleId><ArticleId IdType="pubmed">34459659</ArticleId></ArticleIdList></Reference><Reference><Citation>Landmesser U, Tondo C, Camm J, Diener H-C, Paul V, Schmidt B, et al.. Left atrial appendage occlusion with the AMPLATZER Amulet device: one-year follow-up from the prospective global Amulet observational registry. EuroIntervention. 2018;14(5):e590&#x2013;7. doi: 10.4244/EIJ-D-18-00344</Citation><ArticleIdList><ArticleId IdType="doi">10.4244/EIJ-D-18-00344</ArticleId><ArticleId IdType="pubmed">29806820</ArticleId></ArticleIdList></Reference><Reference><Citation>Boersma LVA, Schmidt B, Betts TR, Sievert H, Tamburino C, Teiger E, et al.. EWOLUTION: Design of a registry to evaluate real-world clinical outcomes in patients with AF and high stroke risk-treated with the WATCHMAN left atrial appendage closure technology. Catheter Cardiovasc Interv [Internet]. 2016. 
Sep
1 [cited 2023 Oct 31];88(3):460&#x2013;5. Available from: https://pubmed.ncbi.nlm.nih.gov/26719158/
doi: 10.1002/ccd.26358

</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.26358</ArticleId><ArticleId IdType="pubmed">26719158</ArticleId></ArticleIdList></Reference><Reference><Citation>Kretzler L, Mues C, Wunderlich C, Langbein A, Spitzer SG, Gerk U, et al.. Short term outcome after left atrial appendage occlusion with the AMPLATZER Amulet and WATCHMAN device: results from the ORIGINAL registry (saxOnian RegIstry analyzinG and followINg left atrial Appendage cLosure). BMC Cardiovasc Disord [Internet]. 2022. 
Dec
1 [cited 2023 Jul 27];22(1):1&#x2013;10. Available from: https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-022-02708-4
</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12872-022-02708-4</ArticleId><ArticleId IdType="pmc">PMC9205092</ArticleId><ArticleId IdType="pubmed">35710343</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, Antes G, Atkins D, et al.. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med [Internet]. 2009. 
Jul
1 [cited 2023 Aug 19];6(7). Available from: https://pubmed.ncbi.nlm.nih.gov/19621072/</Citation></Reference><Reference><Citation>Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, et al.. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane database Syst Rev [Internet]. 2019. 
Oct
3 [cited 2023 Aug 19];10(10):ED000142. Available from: https://pubmed.ncbi.nlm.nih.gov/31643080/
doi: 10.1002/14651858.ED000142

</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.ED000142</ArticleId><ArticleId IdType="pmc">PMC10284251</ArticleId><ArticleId IdType="pubmed">31643080</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JAC, Savovi&#x107; J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al.. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;l4898&#x2013;l4898. doi: 10.1136/bmj.l4898</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l4898</ArticleId><ArticleId IdType="pubmed">31462531</ArticleId></ArticleIdList></Reference><Reference><Citation>Luchini C, Veronese N, Nottegar A, Shin J Il, Gentile G, Granziol U, et al.. Assessing the quality of studies in meta-research: Review/guidelines on the most important quality assessment tools. Pharm Stat [Internet]. 2021. 
Jan
1 [cited 2023 Aug 19];20(1):185&#x2013;95. Available from: https://pubmed.ncbi.nlm.nih.gov/32935459/
doi: 10.1002/pst.2068

</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pst.2068</ArticleId><ArticleId IdType="pubmed">32935459</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ [Internet]. 2003. 
Sep
6 [cited 2023 Aug 19];327(7414):557&#x2013;60. Available from: https://pubmed.ncbi.nlm.nih.gov/12958120/
doi: 10.1136/bmj.327.7414.557

</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Chun KRJ, Bordignon S, Weise FK, Nagase T, Perrotta L, et al.. Left atrial appendage occlusion using LAmbre Amulet and Watchman in atrial fibrillation. J Cardiol [Internet]. 2019. 
Apr
1 [cited 2023 Aug 19];73(4):299&#x2013;306. Available from: https://pubmed.ncbi.nlm.nih.gov/30583991/
doi: 10.1016/j.jjcc.2018.10.010

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jjcc.2018.10.010</ArticleId><ArticleId IdType="pubmed">30583991</ArticleId></ArticleIdList></Reference><Reference><Citation>Fastner C, Hoffmann L, Aboukoura M, Behnes M, Lang S, Borggrefe M, et al.. Real-world experience comparing two common left atrial appendage closure devices. BMC Cardiovasc Disord [Internet]. 2018. 
Aug
20 [cited 2023 Aug 19];18(1). Available from: https://pubmed.ncbi.nlm.nih.gov/30126370/
doi: 10.1186/s12872-018-0899-9

</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12872-018-0899-9</ArticleId><ArticleId IdType="pmc">PMC6102880</ArticleId><ArticleId IdType="pubmed">30126370</ArticleId></ArticleIdList></Reference><Reference><Citation>Kefer J, Vermeersch P, Budts W, Depotter T, Aminian A, Benit E, et al.. Transcatheter left atrial appendage closure for stroke prevention in atrial fibrillation with Amplatzer cardiac plug: the Belgian Registry. Acta Cardiol [Internet]. 2013. 
Dec [cited 2023 Aug 19];68(6):551&#x2013;8. Available from: https://pubmed.ncbi.nlm.nih.gov/24579432/
doi: 10.1080/ac.68.6.8000001

</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/ac.68.6.8000001</ArticleId><ArticleId IdType="pubmed">24579432</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansour MJ, Harnay E, Al Ayouby A, Mansourati V, Jobic Y, Gilard M, et al.. One year outcome and analysis of peri-device leak of left atrial appendage occlusion devices. J Interv Card Electrophysiol [Internet]. 2022. 
Jun
1 [cited 2023 Aug 19];64(1):27&#x2013;34. Available from: https://pubmed.ncbi.nlm.nih.gov/34002319/
doi: 10.1007/s10840-021-01002-1

</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10840-021-01002-1</ArticleId><ArticleId IdType="pubmed">34002319</ArticleId></ArticleIdList></Reference><Reference><Citation>Radinovic A, Falasconi G, Marzi A, D&#x2019;Angelo G, Limite L, Paglino G, et al.. Long-term outcome of left atrial appendage occlusion with multiple devices. Int J Cardiol. 2021. Dec 1;344:66&#x2013;72. doi: 10.1016/j.ijcard.2021.09.051</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2021.09.051</ArticleId><ArticleId IdType="pubmed">34599944</ArticleId></ArticleIdList></Reference><Reference><Citation>Saad M, Risha O, Sano M, Fink T, Heeger C-H, Vogler J, et al.. Comparison between Amulet and Watchman left atrial appendage closure devices: A real-world, single center experience. IJC Hear Vasc. 2021;37:100893. doi: 10.1016/j.ijcha.2021.100893</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcha.2021.100893</ArticleId><ArticleId IdType="pmc">PMC8529070</ArticleId><ArticleId IdType="pubmed">34712772</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu MZ, Song H, Song GM, Bai X. Safety and efficacy of the Amplatzer Amulet and Watchman 2.5 for left atrial appendage occlusion: A systematic review and meta-analysis. Pacing Clin Electrophysiol [Internet]. 2022. 
Oct
1 [cited 2023 Jul 27];45(10):1237&#x2013;47. Available from: https://pubmed.ncbi.nlm.nih.gov/35933600/
doi: 10.1111/pace.14576

</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pace.14576</ArticleId><ArticleId IdType="pubmed">35933600</ArticleId></ArticleIdList></Reference><Reference><Citation>Lakkireddy D. Left Atrial Appendage Occlusion Device Embolization (The LAAODE Study): Understanding the Timing and Clinical Consequences from a Worldwide Experience. J Atr Fibrillation. 2021;13(5). doi: 10.4022/jafib.2516</Citation><ArticleIdList><ArticleId IdType="doi">10.4022/jafib.2516</ArticleId><ArticleId IdType="pmc">PMC8691350</ArticleId><ArticleId IdType="pubmed">34950344</ArticleId></ArticleIdList></Reference><Reference><Citation>Hildick-Smith D, Landmesser U, Camm AJ, Diener H-C, Paul V, Schmidt B, et al.. Left atrial appendage occlusion with the AmplatzerTM AmuletTM device: full results of the prospective global observational study. Eur Heart J. 2020;41(30):2894&#x2013;901.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7421773</ArticleId><ArticleId IdType="pubmed">32243499</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy VY, Holmes D, Doshi SK, Neuzil P, Kar S. Safety of Percutaneous Left Atrial Appendage Closure. Circulation. 2011;123(4):417&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">21242484</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf6;bius-Winkler S. Percutaneous left atrial appendage closure: Technical aspects and prevention of periprocedural complications with the watchman device. World J Cardiol. 2015;7(2):65. doi: 10.4330/wjc.v7.i2.65</Citation><ArticleIdList><ArticleId IdType="doi">10.4330/wjc.v7.i2.65</ArticleId><ArticleId IdType="pmc">PMC4325303</ArticleId><ArticleId IdType="pubmed">25717354</ArticleId></ArticleIdList></Reference><Reference><Citation>Aminian A, De Backer O, Nielsen-Kudsk JE, Mazzone P, Berti S, Fischer S, et al.. Incidence and clinical impact of major bleeding following left atrial appendage occlusion: insights from the Amplatzer Amulet Observational Post-Market Study. EuroIntervention. 2021;17(9):774&#x2013;82. doi: 10.4244/EIJ-D-20-01309</Citation><ArticleIdList><ArticleId IdType="doi">10.4244/EIJ-D-20-01309</ArticleId><ArticleId IdType="pmc">PMC9724974</ArticleId><ArticleId IdType="pubmed">33495144</ArticleId></ArticleIdList></Reference><Reference><Citation>Boersma L V, Ince H, Kische S, Pokushalov E, Schmitz T, Schmidt B, et al.. Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology. Circ Arrhythmia Electrophysiol. 2019;12(4).</Citation><ArticleIdList><ArticleId IdType="pubmed">30939908</ArticleId></ArticleIdList></Reference><Reference><Citation>Boersma L V, Ince H, Kische S, Pokushalov E, Schmitz T, Schmidt B, et al.. Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial. Hear Rhythm. 2017;14(9):1302&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">28577840</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy VY, M&#xf6;bius-Winkler S, Miller MA, Neuzil P, Schuler G, Wiebe J, et al.. Left Atrial Appendage Closure With the Watchman Device in Patients With a Contraindication for Oral Anticoagulation. J Am Coll Cardiol. 2013;61(25):2551&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">23583249</ArticleId></ArticleIdList></Reference><Reference><Citation>Berti S, Santoro G, Brscic E, Montorfano M, Vignali L, Danna P, et al.. Left atrial appendage closure using AMPLATZERTM devices: A large, multicenter, Italian registry. Int J Cardiol. 2017;248:103&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">28797952</ArticleId></ArticleIdList></Reference><Reference><Citation>Lempereur M, Aminian A, Freixa X, Gafoor S, Kefer J, Tzikas A, et al.. Device-associated thrombus formation after left atrial appendage occlusion: A systematic review of events reported with the Watchman, the Amplatzer Cardiac Plug and the Amulet. Catheter Cardiovasc Interv. 2017;90(5):E111&#x2013;21. doi: 10.1002/ccd.26903</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.26903</ArticleId><ArticleId IdType="pubmed">28145040</ArticleId></ArticleIdList></Reference><Reference><Citation>Simard T, Jung RG, Lehenbauer K, Piayda K, Praco&#x144; R, Jackson GG, et al.. Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion. J Am Coll Cardiol. 2021;78(4):297&#x2013;313.</Citation><ArticleIdList><ArticleId IdType="pubmed">34294267</ArticleId></ArticleIdList></Reference><Reference><Citation>Freixa X, Chan JLK, Tzikas A, Garceau P, Basmadjian A, Ibrahim R. The AmplatzerTM Cardiac Plug 2 for left atrial appendage occlusion: novel features and first-in-man experience. EuroIntervention. 2013;8(9):1094&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">23339815</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang S-J, Wong SC, Mosadegh B. Leaks after Left Atrial Appendage Closure: Ignored or Neglected? Cardiology. 2021;146(3):384&#x2013;91. doi: 10.1159/000513901</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000513901</ArticleId><ArticleId IdType="pubmed">33735867</ArticleId></ArticleIdList></Reference><Reference><Citation>Saw J, Fahmy P, DeJong P, Lempereur M, Spencer R, Tsang M, et al.. Cardiac CT angiography for device surveillance after endovascular left atrial appendage closure. Eur Hear J&#x2013;Cardiovasc Imaging. 2015;16(11):1198&#x2013;206. doi: 10.1093/ehjci/jev067</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jev067</ArticleId><ArticleId IdType="pmc">PMC4609159</ArticleId><ArticleId IdType="pubmed">25851318</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfrum M, Attinger-Toller A, Shakir S, Gloekler S, Seifert B, Moschovitis A, et al.. Percutaneous left atrial appendage occlusion: Effect of device positioning on outcome. Catheter Cardiovasc Interv. 2016;88(4):656&#x2013;64. doi: 10.1002/ccd.26646</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.26646</ArticleId><ArticleId IdType="pubmed">27465268</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">21396854</PMID><DateCompleted><Year>2011</Year><Month>06</Month><Day>28</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2165</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>5</Issue><PubDate><Year>2011</Year><Month>May</Month></PubDate></JournalIssue><Title>European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery</Title><ISOAbbreviation>Eur J Vasc Endovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Stroke after cardiac surgery and its association with asymptomatic carotid disease: an updated systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>607</StartPage><EndPage>624</EndPage><MedlinePgn>607-24</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejvs.2011.02.016</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">(i) Prevalence of stroke in neurologically symptomatic/asymptomatic patients with unilateral/bilateral carotid disease (including occlusion) undergoing cardiac surgery without prophylactic carotid endarterectomy (CEA) or carotid stenting (CAS). (ii) Prevalence of stroke in asymptomatic patients with unilateral/bilateral carotid disease (excluding occlusion) who underwent isolated cardiac surgery. (iii) Prevalence of stroke in the hemisphere ipsilateral to a non-operated asymptomatic stenosis in patients with severe bilateral carotid disease undergoing a synchronous unilateral CEA&#xa0;+&#xa0;cardiac procedure.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Systematic Review and meta-analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Cardiac surgery patients with a symptomatic/asymptomatic 50-99% stenosis or occlusion incurred a 7.4% stroke risk (95%CI 4.8-9.9), increasing to 9.1% (95%CI 4.8-16) in those with 80-99% stenoses or occlusion. After excluding patients with a history of stroke/TIA and those with isolated/bilateral occlusions, the stroke risk fell to 3.8% (95%CI 2.0-4.8) in patients with asymptomatic 50-99% stenoses and 2.0% in those with 70-99% stenoses (95%CI 1.0-5.7). The prevalence of ipsilateral stroke in patients with a unilateral, asymptomatic 50-99% stenosis was 2.0% (1.0-3.8), while the risk of any stroke was only 2.9% (2%-5.7%). These risks did not increase with stenosis severity (70-99%, 80-99%). Patients with bilateral, asymptomatic 50-99% stenoses or a 50-99% stenosis&#xa0;+&#xa0;contralateral occlusion incurred a 6.5% stroke risk following cardiac surgery, while the risk of death/stroke was 9.1% (3.8%-20.6%). Patients with bilateral 80-99% stenoses undergoing a unilateral synchronous cardiac/carotid revascularisation incurred a 5.7% risk of stroke in the hemisphere ipsilateral to the non-operated, contralateral stenosis.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">There is no compelling evidence supporting a role for prophylactic CEA/CAS in cardiac surgery patients with unilateral asymptomatic carotid disease. Prophylactic CEA/CAS might still be considered in patients with severe, bilateral asymptomatic carotid disease, but such a strategy would only benefit 1-2% of all cardiac surgery patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Naylor</LastName><ForeName>A R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>The Department of Vascular Surgery at Leicester Royal Infirmary, Leicester LE2 7LX, UK. ross.naylor@uhl-tr.nhs.uk</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bown</LastName><ForeName>M J</ForeName><Initials>MJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>03</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Vasc Endovasc Surg</MedlineTA><NlmUniqueID>9512728</NlmUniqueID><ISSNLinking>1078-5884</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002340" MajorTopicYN="N">Carotid Artery Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="N">Heart Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>1</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21396854</ArticleId><ArticleId IdType="doi">10.1016/j.ejvs.2011.02.016</ArticleId><ArticleId IdType="pii">S1078-5884(11)00085-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27397116</PMID><DateCompleted><Year>2018</Year><Month>01</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2165</ISSN><JournalIssue CitedMedium="Internet"><Volume>52</Volume><Issue>5</Issue><PubDate><Year>2016</Year><Month>Nov</Month></PubDate></JournalIssue><Title>European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery</Title><ISOAbbreviation>Eur J Vasc Endovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Transcranial Doppler Ultrasound Detection of Microemboli as a Predictor of Cerebral Events in Patients with Symptomatic and Asymptomatic Carotid Disease: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>565</StartPage><EndPage>580</EndPage><MedlinePgn>565-580</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejvs.2016.05.019</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1078-5884(16)30123-X</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Identification of patients who will benefit from carotid endarterectomy is not entirely effective, primarily utilising degree of carotid stenosis. This study aimed at determining if microembolic signals (MES) detected by transcranial Doppler ultrasound (TCD) can provide clinically useful information regarding stroke risk in patients with carotid atherosclerosis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A meta-analysis of prospective studies was performed. Three analyses were proposed investigating MES detection as a predictor of: stroke or TIA, stroke alone, and stroke or TIA but with an increased positivity threshold. Subgroup analysis was used to compare pre-operative (symptomatic or asymptomatic) patients and peri- or post-operative patients.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-eight studies reported data regarding both MES status and neurological outcome. Of these, 22 papers reported data on stroke and TIA as an outcome, 19 on stroke alone, and eight on stroke and TIA with increased positivity threshold. At the median pre-test probability of 3.0%, the post-test probabilities of a stroke after a positive and negative TCD were 7.1% (95% CI 5-10.1) and 1.2% (95% CI 0.6-2.5), respectively. In addition, the sensitivities and specificities of each outcome showed that increasing the threshold for positivity to 10 MES per hour would make TCD a more clinically useful tool in peri- and post-operative patients.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">TCD provides clinically useful information about stroke risk for patients with carotid disease and is technically feasible in most patients. However, the generally weak level of evidence constituting this review means definitive recommendations cannot be made.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Best</LastName><ForeName>L M J</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Division of Surgery and Interventional Science UCL, London, UK. Electronic address: lawrence.best.11@ucl.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Webb</LastName><ForeName>A C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>University College London Medical School, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gurusamy</LastName><ForeName>K S</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>Division of Surgery and Interventional Science UCL, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>S F</ForeName><Initials>SF</Initials><AffiliationInfo><Affiliation>Division of Surgery and Interventional Science UCL, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richards</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Surgery and Interventional Science UCL, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>07</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Vasc Endovasc Surg</MedlineTA><NlmUniqueID>9512728</NlmUniqueID><ISSNLinking>1078-5884</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Eur J Vasc Endovasc Surg. 2016 Nov;52(5):703-704. doi: 10.1016/j.ejvs.2016.07.093.</RefSource><PMID Version="1">27590525</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058070" MajorTopicYN="N">Asymptomatic Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016893" MajorTopicYN="N">Carotid Stenosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016894" MajorTopicYN="N">Endarterectomy, Carotid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020766" MajorTopicYN="N">Intracranial Embolism</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="N">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018579" MajorTopicYN="N">Patient Selection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017585" MajorTopicYN="Y">Ultrasonography, Doppler, Transcranial</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Carotid disease</Keyword><Keyword MajorTopicYN="N">Microembolic signals</Keyword><Keyword MajorTopicYN="N">Stroke</Keyword><Keyword MajorTopicYN="N">Transcranial Doppler ultrasound</Keyword><Keyword MajorTopicYN="N">Transient ischaemic attack</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27397116</ArticleId><ArticleId IdType="doi">10.1016/j.ejvs.2016.05.019</ArticleId><ArticleId IdType="pii">S1078-5884(16)30123-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">19223138</PMID><DateCompleted><Year>2014</Year><Month>08</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6809</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>6</Issue><PubDate><Year>2009</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of vascular surgery</Title><ISOAbbreviation>J Vasc Surg</ISOAbbreviation></Journal><ArticleTitle>Neurological complications after left subclavian artery coverage during thoracic endovascular aortic repair: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1594</StartPage><EndPage>1601</EndPage><MedlinePgn>1594-601</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jvs.2008.12.075</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Recent studies suggest an increased risk of neurologic complications after coverage of the left subclavian artery (LSA) during thoracic endovascular aortic repair (TEVAR). The preventative role of preoperative revascularization of the LSA using carotid-subclavian bypass or transposition remains controversial. We assessed this increased risk and the role of revascularization by undertaking a systematic review and meta-analysis of the literature.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In the absence of any randomized controlled trials, the Pubmed and Embase databases were searched to identify all series reporting TEVAR without LSA coverage compared with LSA coverage with and without revascularization. The incidence of neurologic complications, namely cerebrovascular accident (CVA) and spinal cord ischemia (SCI), were recorded for each group. Pooled odds ratios (POR) were then calculated for postoperative CVA and SCI.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Compared with patients without LSA coverage, the risk of CVA was increased both in patients with LSA coverage alone (4.7% vs 2.7%; POR, 2.28; 95% confidence interval [CI], 1.28-4.09; P = .005) and in those with LSA coverage after revascularization (4.1% vs 2.6%; POR, 3.18; 95% CI, 1.17-8.65; P = .02). The risk of SCI was also increased in patients requiring LSA coverage (2.8% vs 2.3%; POR, 2.39; 95% CI, 1.30-4.39; P = .005) but not for LSA coverage after revascularization (0.8% vs 2.7%; POR, 1.69; 95% CI, 0.56-5.15; P = .35).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The risk of neurologic complications is increased after coverage of the LSA during TEVAR. Preemptive revascularization offers no protection against CVA, perhaps indicating a heterogeneous etiology. Revascularization may reduce the risk of SCI, although limited data tempers this conclusion. Improved or perhaps compulsory reporting to registries of a minimum data set may help further assess the exact etiology of these complications and identify a higher-risk subset of patients in whom revascularization might prove protective.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cooper</LastName><ForeName>David G</ForeName><Initials>DG</Initials><AffiliationInfo><Affiliation>Cambridge Vascular Unit, Cambridge University Hospitals NHS Trust, Addenbrooke's Hospital, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walsh</LastName><ForeName>Stewart R</ForeName><Initials>SR</Initials></Author><Author ValidYN="Y"><LastName>Sadat</LastName><ForeName>Umar</ForeName><Initials>U</Initials></Author><Author ValidYN="Y"><LastName>Noorani</LastName><ForeName>Ayesha</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Hayes</LastName><ForeName>Paul D</ForeName><Initials>PD</Initials></Author><Author ValidYN="Y"><LastName>Boyle</LastName><ForeName>Jonathan R</ForeName><Initials>JR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2009</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vasc Surg</MedlineTA><NlmUniqueID>8407742</NlmUniqueID><ISSNLinking>0741-5214</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001013" MajorTopicYN="N">Aorta, Thoracic</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001018" MajorTopicYN="N">Aortic Diseases</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001807" MajorTopicYN="N">Blood Vessel Prosthesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019917" MajorTopicYN="N">Blood Vessel Prosthesis Implantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011474" MajorTopicYN="N">Prosthesis Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020760" MajorTopicYN="N">Spinal Cord Ischemia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013348" MajorTopicYN="N">Subclavian Artery</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>49</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2008</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2008</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2008</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>2</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>2</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>8</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19223138</ArticleId><ArticleId IdType="doi">10.1016/j.jvs.2008.12.075</ArticleId><ArticleId IdType="pii">S0741-5214(08)02380-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39243003</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2253</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>06</Day></PubDate></JournalIssue><Title>BMC anesthesiology</Title><ISOAbbreviation>BMC Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Index of Consciousness monitoring may effectively predict and prevent circulatory stress induced by endotracheal intubation under general anesthesia: a prospective randomized controlled trial.</ArticleTitle><Pagination><StartPage>316</StartPage><MedlinePgn>316</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">316</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12871-024-02701-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">The primary objective of anesthesiologists during the induction of anaesthesia is to mitigate the operative stress response resulting from endotracheal intubation. In this prospective, randomized controlled trial, our aim was to assess the feasibility and efficacy of employing Index of Consciousness (IoC, IoC1 and IoC2) monitoring in predicting and mitigating circulatory stress induced by endotracheal intubation for laparoscopic cholecystectomy patients under general anesthesia (GA).</AbstractText><AbstractText Label="METHODS">We enrolled one hundred and twenty patients scheduled for laparoscopic cholecystectomy under GA and randomly allocated them to two groups: IoC monitoring guidance (Group T, n&#x2009;=&#x2009;60) and bispectral index (BIS) monitoring guidance (Group C, n&#x2009;=&#x2009;60). The primary endpoints included the heart rate (HR) and mean arterial pressure (MAP) of the patients, as well as the rate of change (ROC) at specific time points during the endotracheal intubation period. Secondary outcomes encompassed the systemic vascular resistance index (SVRI), cardiac output index (CI), stroke volume index (SVI), ROC at specific time points, the incidence of adverse events (AEs), and the induction dosage of remifentanil and propofol during the endotracheal intubation period in both groups.</AbstractText><AbstractText Label="RESULTS">The mean (SD) HR at 1&#xa0;min after intubation under IoC monitoring guidance was significantly lower than that under BIS monitoring guidance (76 (16) beats/min vs. 82 (16) beats/min, P&#x2009;=&#x2009;0.049, respectively). Similarly, the mean (SD) MAP at 1&#xa0;min after intubation under IoC monitoring guidance was lower than that under BIS monitoring guidance (90 (20) mmHg vs. 98 (19) mmHg, P&#x2009;=&#x2009;0.031, respectively). At each time point from 1 to 5&#xa0;min after intubation, the number of cases with HR ROC of less than 10% in Group T was significantly higher than in Group C (P&#x2009;&lt;&#x2009;0.05). Furthermore, between 1 and 3&#xa0;min and at 5&#xa0;min post-intubation, the number of cases with HR ROC between 20 to 30% or 40% in Group T was significantly lower than that in Group C (P&#x2009;&lt;&#x2009;0.05). At 1&#xa0;min post-intubation, the number of cases with MAP ROC of less than 10% in Group T was significantly higher than that in Group C (P&#x2009;&lt;&#x2009;0.05), and the number of cases with MAP ROC between 10 to 20% in Group T was significantly lower than that in Group C (P&#x2009;&lt;&#x2009;0.01). Patients in Group T exhibited superior hemodynamic stability during the peri-endotracheal intubation period compared to those in Group C. There were no significant differences in the frequencies of AEs between the two groups (P&#x2009;&gt;&#x2009;0.05).</AbstractText><AbstractText Label="CONCLUSION">This promising monitoring technique has the potential to predict the circulatory stress response, thereby reducing the incidence of adverse reactions during the peri-endotracheal intubation period. This technology holds promise for optimizing anesthesia management.</AbstractText><AbstractText Label="TRAIL REGISTRATION">Chinese Clinical Trail Registry Identifier: ChiCTR2300070237 (20/04/2022).</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Cao</LastName><ForeName>Shan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xuanwu Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Kan</LastName><ForeName>Minhui</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xuanwu Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Yitong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xuanwu Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Chunxiu</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Evidence-Based Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Tianlong</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xuanwu Hospital, Capital Medical University, Beijing, China. w_tl5595@hotmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ChiCTR</DataBankName><AccessionNumberList><AccessionNumber>ChiCTR2300070237</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Anesthesiol</MedlineTA><NlmUniqueID>100968535</NlmUniqueID><ISSNLinking>1471-2253</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>YI7VU623SF</RegistryNumber><NameOfSubstance UI="D015742">Propofol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="Y">Intubation, Intratracheal</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016343" MajorTopicYN="Y">Monitoring, Intraoperative</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056805" MajorTopicYN="Y">Consciousness Monitors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="Y">Heart Rate</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017081" MajorTopicYN="N">Cholecystectomy, Laparoscopic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003243" MajorTopicYN="N">Consciousness</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013312" MajorTopicYN="N">Stress, Physiological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062186" MajorTopicYN="N">Arterial Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015742" MajorTopicYN="N">Propofol</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bispectral index</Keyword><Keyword MajorTopicYN="N">Endotracheal intubation</Keyword><Keyword MajorTopicYN="N">Index of Consciousness</Keyword><Keyword MajorTopicYN="N">Stress response</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>7</Day><Hour>14</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>7</Day><Hour>14</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>6</Day><Hour>23</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39243003</ArticleId><ArticleId IdType="pmc">PMC11378600</ArticleId><ArticleId IdType="doi">10.1186/s12871-024-02701-8</ArticleId><ArticleId IdType="pii">10.1186/s12871-024-02701-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tohya A, Kohjitani A, Ohno S, Yamashita K, Manabe Y, Sugimura M. Effects of glucose-insulin infusion during major oral and maxillofacial surgery on postoperative complications and outcomes. JA clinical reports. 2018;4(1):9. 10.1186/s40981-018-0148-3. 10.1186/s40981-018-0148-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40981-018-0148-3</ArticleId><ArticleId IdType="pmc">PMC5804688</ArticleId><ArticleId IdType="pubmed">29457119</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Peng G, Chen L, Guo M, Zhou J, Liu Y, Chen Z, Wang L. Effect of transcutaneous electrical acupoint stimulation on remifentanil dosage during craniotomy aneurysm clipping: a prospective, randomized controlled study. BMC complementary medicine and therapies. 2023;23(1):453. 10.1186/s12906-023-04297-x. 10.1186/s12906-023-04297-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12906-023-04297-x</ArticleId><ArticleId IdType="pmc">PMC10717748</ArticleId><ArticleId IdType="pubmed">38093254</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta M, Rohilla R, Gupta P, Tamilchelvan H, Joshi U, Kanwat J. Nebulized dexmedetomidine for attenuating hemodynamic response to laryngoscopy and endotracheal intubation in adult patients undergoing surgeries under general anaesthesia: a systematic review and meta-analysis of randomized controlled trials. BMC Anesthesiol. 2023;23(1):406. 10.1186/s12871-023-02366-9. 10.1186/s12871-023-02366-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-023-02366-9</ArticleId><ArticleId IdType="pmc">PMC10712167</ArticleId><ArticleId IdType="pubmed">38082217</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng S, Yang S, Xiao W, Wang X, Yang K, Wang T. Effects of perioperative goal-directed fluid therapy combined with the application of alpha-1 adrenergic agonists on postoperative outcomes: a systematic review and meta-analysis. BMC Anesthesiol. 2018;18(1):113. 10.1186/s12871-018-0564-y. 10.1186/s12871-018-0564-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-018-0564-y</ArticleId><ArticleId IdType="pmc">PMC6098606</ArticleId><ArticleId IdType="pubmed">30119644</ArticleId></ArticleIdList></Reference><Reference><Citation>Borsook D, George E, Kussman B, Becerra L. Anesthesia and perioperative stress: consequences on neural networks and postoperative behaviors. Prog Neurobiol. 2010;92(4):601&#x2013;12. 10.1016/j.pneurobio.2010.08.006. 10.1016/j.pneurobio.2010.08.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2010.08.006</ArticleId><ArticleId IdType="pubmed">20727935</ArticleId></ArticleIdList></Reference><Reference><Citation>Wildes TS, Mickle AM, Ben Abdallah A, Maybrier HR, Oberhaus J, Budelier TP, Kronzer A, McKinnon SL, Park D, Torres BA, Graetz TJ, Emmert DA, Palanca BJ, Goswami S, Jordan K, Lin N, Fritz BA, Stevens TW, Jacobsohn E, Schmitt EM, et al. Effect of Electroencephalography-Guided Anesthetic Administration on Postoperative Delirium Among Older Adults Undergoing Major Surgery: The ENGAGES Randomized Clinical Trial. JAMA. 2019;321(5):473&#x2013;83. 10.1001/jama.2018.22005. 10.1001/jama.2018.22005</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2018.22005</ArticleId><ArticleId IdType="pmc">PMC6439616</ArticleId><ArticleId IdType="pubmed">30721296</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen EW, Valencia JF, L&#xf3;pez A, Anglada T, Agust&#xed; M, Ramos Y, Serra R, Jospin M, Pineda P, Gambus P. Monitoring hypnotic effect and nociception with two EEG-derived indices, qCON and qNOX, during general anaesthesia. Acta Anaesthesiol Scand. 2014;58(8):933&#x2013;41. 10.1111/aas.12359. 10.1111/aas.12359</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.12359</ArticleId><ArticleId IdType="pubmed">24995461</ArticleId></ArticleIdList></Reference><Reference><Citation>Shalbaf A, Saffar M, Sleigh JW, Shalbaf R. Monitoring the Depth of Anesthesia Using a New Adaptive Neurofuzzy System. IEEE J Biomed Health Inform. 2018;22(3):671&#x2013;7. 10.1109/JBHI.2017.2709841. 10.1109/JBHI.2017.2709841</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/JBHI.2017.2709841</ArticleId><ArticleId IdType="pubmed">28574372</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen EW, Jospin M, Gambus PL, Vallverdu M, Caminal P. Validation of the Index of Consciousness (IoC) during sedation/analgesia for ultrasonographic endoscopy. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference. 2008;2008:5552&#x2013;5. 10.1109/IEMBS.2008.4650472.10.1109/IEMBS.2008.4650472</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/IEMBS.2008.4650472</ArticleId><ArticleId IdType="pubmed">19163975</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M, Wu H, Yang D, Li F, Li Z, Wang S, He R. Effects of small-dose remifentanil combined with index of consciousness monitoring on gastroscopic polypectomy: a prospective, randomized, single-blinded trial. Trials. 2018;19(1):392. 10.1186/s13063-018-2783-4. 10.1186/s13063-018-2783-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-018-2783-4</ArticleId><ArticleId IdType="pmc">PMC6052636</ArticleId><ArticleId IdType="pubmed">30021625</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Kang Z, Xie W, Lin H, Liu Y. Effects of Depth of Anesthesia Monitored by IoC on Patients Undergoing Laparoscopic Radical Resection of Colorectal Cancer. Molecular therapy Methods &amp; clinical development. 2020;18:304&#x2013;11. 10.1016/j.omtm.2020.05.032. 10.1016/j.omtm.2020.05.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtm.2020.05.032</ArticleId><ArticleId IdType="pmc">PMC7330423</ArticleId><ArticleId IdType="pubmed">32637458</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu G, Zhang L, Wang X, Yu A, Zhang Z, Yu J. Effects of indexes of consciousness (IoC1 and IoC2) monitoring on remifentanil dosage in modified radical mastectomy: a randomized trial. Trials. 2016;17:167. 10.1186/s13063-016-1298-0. 10.1186/s13063-016-1298-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-016-1298-0</ArticleId><ArticleId IdType="pmc">PMC4810508</ArticleId><ArticleId IdType="pubmed">27026012</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi F, Fan L, Wang C, Liu Y, Yang S, Fan Z, Miao F, Kan M, Feng K, Wang T. Index of consciousness monitoring during general anesthesia may effectively enhance rehabilitation in elderly patients undergoing laparoscopic urological surgery: a randomized controlled clinical trial. BMC Anesthesiol. 2023;23(1):331. 10.1186/s12871-023-02300-z. 10.1186/s12871-023-02300-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-023-02300-z</ArticleId><ArticleId IdType="pmc">PMC10548750</ArticleId><ArticleId IdType="pubmed">37794331</ArticleId></ArticleIdList></Reference><Reference><Citation>Moharari RS, Shahinpour S, Etezadi F, Najafi A, Khajavi MR, Pourfakhr P. Comparison of Goal-Directed Fluid Therapy using LiDCOrapid System with Regular Fluid Therapy in Patients Undergoing Spine Surgery as a Randomised Clinical Trial. Romanian journal of anaesthesia and intensive care. 2022;28(1):1&#x2013;9. 10.2478/rjaic-2021-0001. 10.2478/rjaic-2021-0001</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/rjaic-2021-0001</ArticleId><ArticleId IdType="pmc">PMC9949010</ArticleId><ArticleId IdType="pubmed">36846537</ArticleId></ArticleIdList></Reference><Reference><Citation>Sangkum L, Liu GL, Yu L, Yan H, Kaye AD, Liu H. Minimally invasive or noninvasive cardiac output measurement: an update. J Anesth. 2016;30(3):461&#x2013;80. 10.1007/s00540-016-2154-9. 10.1007/s00540-016-2154-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-016-2154-9</ArticleId><ArticleId IdType="pubmed">26961819</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall AP, Thompson JP, Leslie NA, Fox AJ, Kumar N, Rowbotham DJ. Comparison of different doses of remifentanil on the cardiovascular response to laryngoscopy and tracheal intubation. Br J Anaesth. 2000;84(1):100&#x2013;2. 10.1093/oxfordjournals.bja.a013362. 10.1093/oxfordjournals.bja.a013362</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.bja.a013362</ArticleId><ArticleId IdType="pubmed">10740557</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson JP, Hall AP, Russell J, Cagney B, Rowbotham DJ. Effect of remifentanil on the haemodynamic response to orotracheal intubation. Br J Anaesth. 1998;80(4):467&#x2013;9. 10.1093/bja/80.4.467. 10.1093/bja/80.4.467</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/80.4.467</ArticleId><ArticleId IdType="pubmed">9640152</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahy BG, Chau DF. The Technology of Processed Electroencephalogram Monitoring Devices for Assessment of Depth of Anesthesia. Anesth Analg. 2018;126(1):111&#x2013;7. 10.1213/ANE.0000000000002331. 10.1213/ANE.0000000000002331</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000002331</ArticleId><ArticleId IdType="pubmed">28786839</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SK, Jeong MA, Sung JM, Yeon HJ, Chang JH, Lim H. Effect of remifentanil infusion on the hemodynamic response during induction of anesthesia in hypertensive and normotensive patients: a prospective observational study. J Int Med Res. 2019;47(12):6254&#x2013;67. 10.1177/0300060519883568. 10.1177/0300060519883568</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0300060519883568</ArticleId><ArticleId IdType="pmc">PMC7045677</ArticleId><ArticleId IdType="pubmed">31680598</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouvet L, Stoian A, Rimmel&#xe9; T, Allaouchiche B, Chassard D, Boselli E. Optimal remifentanil dosage for providing excellent intubating conditions when co-administered with a single standard dose of propofol. Anaesthesia. 2009;64(7):719&#x2013;26. 10.1111/j.1365-2044.2009.05916.x. 10.1111/j.1365-2044.2009.05916.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.2009.05916.x</ArticleId><ArticleId IdType="pubmed">19624626</ArticleId></ArticleIdList></Reference><Reference><Citation>Avidan MS, Zhang L, Burnside BA, Finkel KJ, Searleman AC, Selvidge JA, Saager L, Turner MS, Rao S, Bottros M, Hantler C, Jacobsohn E, Evers AS. Anesthesia awareness and the bispectral index. N Engl J Med. 2008;358(11):1097&#x2013;108. 10.1056/NEJMoa0707361. 10.1056/NEJMoa0707361</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0707361</ArticleId><ArticleId IdType="pubmed">18337600</ArticleId></ArticleIdList></Reference><Reference><Citation>Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC Jr, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA Sr, Williamson JD, Wright JT Jr. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):e13&#x2013;115. 10.1161/HYP.0000000000000065. 10.1161/HYP.0000000000000065</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYP.0000000000000065</ArticleId><ArticleId IdType="pubmed">29133356</ArticleId></ArticleIdList></Reference><Reference><Citation>Bijker JB, van Klei WA, Kappen TH, van Wolfswinkel L, Moons KG, Kalkman CJ. Incidence of intraoperative hypotension as a function of the chosen definition: literature definitions applied to a retrospective cohort using automated data collection. Anesthesiology. 2007;107(2):213&#x2013;20. 10.1097/01.anes.0000270724.40897.8e. 10.1097/01.anes.0000270724.40897.8e</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.anes.0000270724.40897.8e</ArticleId><ArticleId IdType="pubmed">17667564</ArticleId></ArticleIdList></Reference><Reference><Citation>Palermo NE, Gianchandani RY, McDonnell ME, Alexanian SM. Stress Hyperglycemia During Surgery and Anesthesia: Pathogenesis and Clinical Implications. Curr DiabRep. 2016;16(3):33. 10.1007/s11892-016-0721-y.10.1007/s11892-016-0721-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11892-016-0721-y</ArticleId><ArticleId IdType="pubmed">26957107</ArticleId></ArticleIdList></Reference><Reference><Citation>Granell M, Petrini G, Kot P, Murcia M, Morales J, Guijarro R, de Andr&#xe9;s JA. Intubation with vivasight double-lumen tube versus conventional double-lumen tube in adult patients undergoing lung resection: A retrospective analysis. Ann Card Anaesth. 2022;25(3):279&#x2013;85. 10.4103/aca.aca_43_21. 10.4103/aca.aca_43_21</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/aca.aca_43_21</ArticleId><ArticleId IdType="pmc">PMC9387622</ArticleId><ArticleId IdType="pubmed">35799554</ArticleId></ArticleIdList></Reference><Reference><Citation>Chilkoti GT, Karthik G, Rautela R. Evaluation of postoperative analgesic efficacy and perioperative hemodynamic changes with low dose intravenous dexmedetomidine infusion in patients undergoing laparoscopic cholecystectomy - A randomised, double-blinded, placebo-controlled trial. J Anaesthesiol Clin Pharmacol. 2020;36(1):72&#x2013;7. 10.4103/joacp.JOACP_184_17. 10.4103/joacp.JOACP_184_17</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/joacp.JOACP_184_17</ArticleId><ArticleId IdType="pmc">PMC7047684</ArticleId><ArticleId IdType="pubmed">32174662</ArticleId></ArticleIdList></Reference><Reference><Citation>Laferri&#xe8;re-Langlois P, Morisson L, Jeffries S, Duclos C, Espitalier F, Richeb&#xe9; P. Depth of Anesthesia and Nociception Monitoring: Current State and Vision For 2050. Anesth Analg. 2024;138(2):295&#x2013;307. 10.1213/ANE.0000000000006860. 10.1213/ANE.0000000000006860</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000006860</ArticleId><ArticleId IdType="pubmed">38215709</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Santvliet H, Vereecke HEM. Progress in the validation of nociception monitoring in guiding intraoperative analgesic therapy. Curr Opin Anaesthesiol. 2024;37(4):352&#x2013;61. 10.1097/ACO.0000000000001390. 10.1097/ACO.0000000000001390</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0000000000001390</ArticleId><ArticleId IdType="pubmed">38841919</ArticleId></ArticleIdList></Reference><Reference><Citation>Herzog, M., Rudzki, M., Pl&#xf6;&#xdf;l, S., Plontke, S., &amp; Kellner, P. (2021). Depth of sedation during drug induced sedation endoscopy monitored by BiSpectral Index&#xae; and Cerebral State Index&#xae;. Sleep &amp; breathing = Schlaf &amp; Atmung, 25(2), 1029&#x2013;1035. 10.1007/s11325-020-02180-4.</Citation><ArticleIdList><ArticleId IdType="pubmed">32857320</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta A, Sethi N, Sood J, Panday BC, Gupta M, Choudhary P, Puri GD. The Effect of Dexmedetomidine on Propofol Requirements During Anesthesia Administered by Bispectral Index-Guided Closed-Loop Anesthesia Delivery System: A Randomized Controlled Study. Anesth Analg. 2019;129(1):84&#x2013;91. 10.1213/ANE.0000000000003470. 10.1213/ANE.0000000000003470</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000003470</ArticleId><ArticleId IdType="pubmed">29787410</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannister CF, Brosius KK, Sigl JC, Meyer BJ, Sebel PS. The effect of bispectral index monitoring on anesthetic use and recovery in children anesthetized with sevoflurane in nitrous oxide. Anesth Analg. 2001;92(4):877&#x2013;81. 10.1097/00000539-200104000-00015. 10.1097/00000539-200104000-00015</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000539-200104000-00015</ArticleId><ArticleId IdType="pubmed">11273918</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SW, Lee H, Ahn H. Bispectral Index Versus Standard Monitoring in Sedation for Endoscopic Procedures: A Systematic Review and Meta-Analysis. Dig Dis Sci. 2016;61(3):814&#x2013;24. 10.1007/s10620-015-3945-9. 10.1007/s10620-015-3945-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10620-015-3945-9</ArticleId><ArticleId IdType="pubmed">26531839</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamb&#xfa;s PL, Jensen EW, Jospin M, Borrat X, Mart&#xed;nez Pall&#xed; G, Fern&#xe1;ndez-Candil J, Valencia JF, Barba X, Caminal P, Troc&#xf3;niz IF. Modeling the effect of propofol and remifentanil combinations for sedation-analgesia in endoscopic procedures using an Adaptive Neuro Fuzzy Inference System (ANFIS). Anesth Analg. 2011;112(2):331&#x2013;9. 10.1213/ANE.0b013e3182025a70. 10.1213/ANE.0b013e3182025a70</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e3182025a70</ArticleId><ArticleId IdType="pubmed">21131550</ArticleId></ArticleIdList></Reference><Reference><Citation>Budal BS. The effect of sufentanil on the index of analgesic status (IoC2) change and hemodynamic responses after double&#x2011;lumen endobronchial intubation. Chongqing: ChongQing Medical University 2017:1&#x2013;47. 10.7666/d.D01261114.</Citation></Reference><Reference><Citation>Choi BH, Lee YC. Effective Bolus Dose of Sufentanil to Attenuate Cardiovascular Responses in Laryngoscopic Double-Lumen Endobronchial Intubation. Anesthesiology and pain medicine. 2016;6(2): e33640. 10.5812/aapm.33640. 10.5812/aapm.33640</Citation><ArticleIdList><ArticleId IdType="doi">10.5812/aapm.33640</ArticleId><ArticleId IdType="pmc">PMC4886625</ArticleId><ArticleId IdType="pubmed">27252903</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang XW, Cao JB, Lv BS, Mi WD, Wang ZQ, Zhang C, Wang HL, Xu Z. Effect of perioperative dexmedetomidine on the endocrine modulators of stress response: a meta-analysis. Clin Exp Pharmacol Physiol. 2015;42(8):828&#x2013;36. 10.1111/1440-1681.12431. 10.1111/1440-1681.12431</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1440-1681.12431</ArticleId><ArticleId IdType="pubmed">26016707</ArticleId></ArticleIdList></Reference><Reference><Citation>Grillot, N., Lebuffe, G., Huet, O., Lasocki, S., Pichon, X., Oudot, M., Bruneau, N., David, J. S., Bouzat, P., Jobert, A., Tching-Sin, M., Feuillet, F., Cinotti, R., Asehnoune, K., Roquilly, A., &amp; Atlanrea Study GroupSoci&#xe9;t&#xe9; Fran&#xe7;aise d&#x2019;Anesth&#xe9;sie R&#xe9;animation (SFAR) Research Network. Effect of Remifentanil vs Neuromuscular Blockers During Rapid Sequence Intubation on Successful Intubation Without Major Complications Among Patients at Risk of Aspiration: A Randomized Clinical Trial. JAMA. 2023;329(1):28&#x2013;38. 10.1001/jama.2022.23550. 10.1001/jama.2022.23550</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.23550</ArticleId><ArticleId IdType="pmc">PMC9856823</ArticleId><ArticleId IdType="pubmed">36594947</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Zhu Z, Sun Y, Wang T, Lu Y, Che W, Liu W, Xu Y. The Rehabilitation Efficacy of the Novel Metronomic Breathing Technique for Gerontic Patients After Percutaneous Coronary Intervention for Acute Myocardial Infarction-A Pilot Study. Clin Interv Aging. 2024;19:1029&#x2013;39. 10.2147/CIA.S458675. 10.2147/CIA.S458675</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CIA.S458675</ArticleId><ArticleId IdType="pmc">PMC11166167</ArticleId><ArticleId IdType="pubmed">38863479</ArticleId></ArticleIdList></Reference><Reference><Citation>Nash CM. Vasoplegic Syndrome in Patients Undergoing Cardiac Surgery: A Literature Review. AACN Adv Crit Care. 2021;32(2):137&#x2013;45. 10.4037/aacnacc2021299. 10.4037/aacnacc2021299</Citation><ArticleIdList><ArticleId IdType="doi">10.4037/aacnacc2021299</ArticleId><ArticleId IdType="pubmed">34161970</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharif, D., Sharif-Rasslan, A., Odeh, M., Shahla, C., Khalil, A., &amp; Rosenschien, U. (2014). Effects of Left Ventricular Wall Motion Abnormality on Global and Regional Diastolic Function of the Left and Right Ventricles at Rest and After Stress. Cardiology research, 5(6), 176&#x2013;182. 10.14740/cr366w.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5358266</ArticleId><ArticleId IdType="pubmed">28352450</ArticleId></ArticleIdList></Reference><Reference><Citation>Christakis GT, Fremes SE, Koch JP, Harwood S, Juhasz S, Sharpe E, Deemar KA, Hamilton C, Chen E, Rao V. Determinants of low systemic vascular resistance during cardiopulmonary bypass. Ann Thorac Surg. 1994;58(4):1040&#x2013;9. 10.1016/0003-4975(94)90451-0. 10.1016/0003-4975(94)90451-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0003-4975(94)90451-0</ArticleId><ArticleId IdType="pubmed">7944747</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahajan S, Gu J, Lu Y, Khera R, Spatz ES, Zhang M, Sun N, Zheng X, Zhao H, Lu H, Ma ZJ, Krumholz HM. Hemodynamic Phenotypes of Hypertension Based on Cardiac Output and Systemic Vascular Resistance. Am J Med. 2020;133(4):e127&#x2013;39. 10.1016/j.amjmed.2019.08.042. 10.1016/j.amjmed.2019.08.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2019.08.042</ArticleId><ArticleId IdType="pubmed">31525336</ArticleId></ArticleIdList></Reference><Reference><Citation>Magder S. The meaning of blood pressure. Critical care (London, England). 2018;22(1):257. 10.1186/s13054-018-2171-1. 10.1186/s13054-018-2171-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-018-2171-1</ArticleId><ArticleId IdType="pmc">PMC6180453</ArticleId><ArticleId IdType="pubmed">30305136</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheeren TWL, Ramsay MAE. New Developments in Hemodynamic Monitoring. J Cardiothorac Vasc Anesth. 2019;33(Suppl 1):S67&#x2013;72. 10.1053/j.jvca.2019.03.043. 10.1053/j.jvca.2019.03.043</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2019.03.043</ArticleId><ArticleId IdType="pubmed">31279355</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiszt, R., Czippelova, B., Cernanova Krohova, J., Mazgutova, N., Turianikova, Z., Lazarova, Z., &amp; Javorka, M. (2022). Stroke volume variation as an index of fluid responsiveness can be impaired by mental stress. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 73(2), 10.26402/jpp.2022.2.11. 10.26402/jpp.2022.2.11.</Citation><ArticleIdList><ArticleId IdType="pubmed">36193967</ArticleId></ArticleIdList></Reference><Reference><Citation>Prabhu SP, Nileshwar A, Krishna HM, Prabhu M. Changes in stroke volume variation and cardiac index during open major bowel surgery. Niger J Clin Pract. 2021;24(11):1682&#x2013;8. 10.4103/njcp.njcp_30_20. 10.4103/njcp.njcp_30_20</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/njcp.njcp_30_20</ArticleId><ArticleId IdType="pubmed">34782509</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi M, Xiao W, Yang S, Wang S, Zhou L, Wan A, Feng S, Yao D, Wang C, Wang T. Pre-incisional Preventive Precise Multimodal Analgesia May Enhance the Rehabilitation Process of Acute Postoperative Pain Following Total Laparoscopic Hysterectomy: A Randomized Controlled Trial. Pain Physician. 2023;26(3):E123&#x2013;31. PMID: 37192230.</Citation><ArticleIdList><ArticleId IdType="pubmed">37192230</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleischmann A, Pilge S, Kiel T, Kratzer S, Schneider G, Kreuzer M. Substance-Specific Differences in Human Electroencephalographic Burst Suppression Patterns. Front Hum Neurosci. 2018;12:368. 10.3389/fnhum.2018.00368. 10.3389/fnhum.2018.00368</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnhum.2018.00368</ArticleId><ArticleId IdType="pmc">PMC6160564</ArticleId><ArticleId IdType="pubmed">30297992</ArticleId></ArticleIdList></Reference><Reference><Citation>Frohlich J, Johnson MA, McArthur DL, Lutkenhoff ES, Dell&#x2019;Italia J, Real C, Shrestha V, Spivak NM, Ruiz Tejeda JE, Vespa PM, Monti MM. Sedation-Induced Burst Suppression Predicts Positive Outcome Following Traumatic Brain Injury. Front Neurol. 2021;12: 750667. 10.3389/fneur.2021.750667. 10.3389/fneur.2021.750667</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.750667</ArticleId><ArticleId IdType="pmc">PMC8727767</ArticleId><ArticleId IdType="pubmed">35002918</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39395644</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>29</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1535-6280</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Current problems in cardiology</Title><ISOAbbreviation>Curr Probl Cardiol</ISOAbbreviation></Journal><ArticleTitle>Left atrial appendage occlusion devices vs direct oral anticoagulants for atrial fibrillation: An updated systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>102880</StartPage><MedlinePgn>102880</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cpcardiol.2024.102880</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0146-2806(24)00515-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Direct Oral Anticoagulants (DOACs) are the first line anticoagulation for patients with non-valvular atrial fibrillation (NVAF). Percutaneous Left Atrial Appendage Occlusion (LAAO) has emerged as a new therapy and its safety and effectiveness compared with DOACs are still controversial.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review of randomized controlled trials and observational studies was conducted, focusing on patients with NVAF. Outcomes analyzed included: (1) all-cause mortality; (2) cardiovascular (CV) mortality; (3) thromboembolic events; (4) stroke or transient ischemic attack (TIA); (5) bleeding events; and a (6) composite of death, hemorrhagic, and thromboembolic events. We performed a subgroup analysis of major bleeding according to different definitions: (1) Bleeding Academic Research Consortium (BARC); (2) International Society on Thrombosis and Haemostasis (ISTH); and (3) other definitions.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Ten studies involving 18,507 patients were included, with 42.35 % undergoing LAAO. In pooled analysis, LAAO was associated with lower rates of all-cause mortality (HR 0.63; 95 % CI 0.50-0.80), cardiovascular mortality (HR 0.56; 95 % CI 0.45-0.70), and of the composite outcome (HR 0.73; 95 % CI 0.58-0.92). A trend towards lower stroke/TIA events was observed but not statistically significant. Overall bleeding events did not significantly differ between groups; using the ISTH definition, LAAO showed significantly lower incidence of bleeding events (HR 0.63; 95 % CI 0.43-0.91). No difference was found in thromboembolic events.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">LAAO was associated with a significantly lower all-cause mortality and cardiovascular mortality, as well as the composite of death, hemorrhagic or thromboembolic events, as compared with DOACs.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fernandes</LastName><ForeName>Julia M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Faculdade Israelita de Ci&#xea;ncias da Sa&#xfa;de Albert Einstein, Rua Comendador Elias Jafet, 755- S&#xe3;o Paulo, S&#xe3;o Paulo, 05653-000, Brazil. Electronic address: julia.marquesfernandes5@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinheiro</LastName><ForeName>Rafael P S</ForeName><Initials>RPS</Initials><AffiliationInfo><Affiliation>Universidade Federal do Rio de Janeiro, Rua Professor Rodolpho Paulo Rocco, 255- Rio de Janeiro, Rio de Janeiro, 21941-617, Brazil. Electronic address: rafael.petri.pinheiro@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serpa</LastName><ForeName>Frans</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, Texas, 75390, USA. Electronic address: frans.serpa@utsouthwestern.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Andrade</LastName><ForeName>Naieli M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Escola Bahiana de Medicina e Sa&#xfa;de P&#xfa;blica- Bahia, Av. Dom Jo&#xe3;o VI, 275, Salvador, Bahia, 40290-000, Brazil. Electronic address: naieli.m.andrade@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pereira</LastName><ForeName>Vinicius</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Facultad Ciencias Biom&#xe9;dicas, Universidad Austral, Av. Juan Domingo Per&#xf3;n, 1500- Pilar, Buenos Aires, B1629, Argentina. Electronic address: vini.josep13@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sbardelotto</LastName><ForeName>&#xc2;ngelo E E</ForeName><Initials>&#xc2;EE</Initials><AffiliationInfo><Affiliation>Universidade Federal do Rio de Janeiro, Rua Professor Rodolpho Paulo Rocco, 255- Rio de Janeiro, Rio de Janeiro, 21941-617, Brazil. Electronic address: sbardelottoangelo@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomes</LastName><ForeName>Wilton F</ForeName><Initials>WF</Initials><AffiliationInfo><Affiliation>INC Hospital, Department of Interventional Cardiology, Universidade Federal do Paran&#xe1;, Faculdades Pequeno Pr&#xed;ncipe, Hospital Santa Casa de Miseric&#xf3;rdia de Curitiba, Rua Jeremias Maciel Perretto, 300, Curitiba, Paran&#xe1;, 81210-310, Brazil. Electronic address: wiltonfg@cardiol.br.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Curr Probl Cardiol</MedlineTA><NlmUniqueID>7701802</NlmUniqueID><ISSNLinking>0146-2806</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="Y">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020517" MajorTopicYN="Y">Atrial Appendage</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="Y">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013923" MajorTopicYN="N">Thromboembolism</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055989" MajorTopicYN="N">Septal Occluder Device</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>30</Day><Hour>11</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>13</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>12</Day><Hour>19</Hour><Minute>19</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39395644</ArticleId><ArticleId IdType="doi">10.1016/j.cpcardiol.2024.102880</ArticleId><ArticleId IdType="pii">S0146-2806(24)00515-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">17109365</PMID><DateCompleted><Year>2007</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2012</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0301-1526</ISSN><JournalIssue CitedMedium="Print"><Volume>35</Volume><Issue>4</Issue><PubDate><Year>2006</Year><Month>Nov</Month></PubDate></JournalIssue><Title>VASA. Zeitschrift fur Gefasskrankheiten</Title><ISOAbbreviation>Vasa</ISOAbbreviation></Journal><ArticleTitle>General versus locoregional anesthesia in carotid surgery: a prospective randomised trial.</ArticleTitle><Pagination><StartPage>232</StartPage><EndPage>238</EndPage><MedlinePgn>232-8</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">To evaluate the influence of anesthetic technique on perioperative neurological and cardiopulmonary complication rates in patients undergoing carotid endarterectomy.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">186 patients with symptomatic internal carotid artery (ICA) stenosis &gt; 70% or asymptomatic ICA stenosis &gt; 80% were prospectively randomized for either locoregional (LA) or general anesthesia (GA).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Neurological complication rates were similar in both groups (GA 2% vs. LA 2%). Cardiopulmonary complication rates were not significantly different (GA 4% vs LA 1%). There were no stroke-related deaths, but one patient from the GA group died from severe postoperative pneumonia. Thus, a significant difference in combined stroke/cardiopulmonary related death between the two groups (GA 1% vs LA 0%) could not be found. However, perioperative cardiopulmonary monitoring showed that significantly more patients operated under general anesthesia had hypertensive events, with systolic blood pressure values greater than 180 mmHg on postoperative day one. There were no differences in the number of postoperatively hypotensive episodes (systolic blood pressure values &lt; 100 mmHg) between the two groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Significant differences in the perioperative neurological and cardiopulmonary complication rates between general and locoregional anesthesia in patients undergoing carotid endarterectomy could not be observed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kasprzak</LastName><ForeName>P M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Department of Surgery/Vascular Surgery, Regensburg University Medical Center, Regensburg, Germany. piotr.kasprzak@klinik.uni-regensburg.de</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altmeppen</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Angerer</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Mann</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Mackh</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>T&#xf6;pel</LastName><ForeName>I</ForeName><Initials>I</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vasa</MedlineTA><NlmUniqueID>0317051</NlmUniqueID><ISSNLinking>0301-1526</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000765" MajorTopicYN="Y">Anesthesia, Conduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002343" MajorTopicYN="N">Carotid Artery, Internal</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016893" MajorTopicYN="N">Carotid Stenosis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016894" MajorTopicYN="Y">Endarterectomy, Carotid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002546" MajorTopicYN="N">Ischemic Attack, Transient</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009460" MajorTopicYN="N">Neurologic Examination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="N">Respiratory Insufficiency</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013610" MajorTopicYN="N">Tachycardia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>11</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>3</Month><Day>1</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>11</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17109365</ArticleId><ArticleId IdType="doi">10.1024/0301-1526.35.4.232</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>